Citrus Sinensis ID: 014704
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 420 | 2.2.26 [Sep-21-2011] | |||||||
| Q42479 | 529 | Calcium-dependent protein | yes | no | 0.871 | 0.691 | 0.811 | 0.0 | |
| Q9FMP5 | 528 | Calcium-dependent protein | no | no | 0.897 | 0.714 | 0.720 | 1e-168 | |
| Q3E9C0 | 523 | Calcium-dependent protein | no | no | 0.9 | 0.722 | 0.718 | 1e-167 | |
| P53683 | 533 | Calcium-dependent protein | no | no | 0.978 | 0.771 | 0.637 | 1e-160 | |
| Q38868 | 541 | Calcium-dependent protein | no | no | 0.992 | 0.770 | 0.606 | 1e-159 | |
| Q9C6P3 | 521 | Calcium-dependent protein | no | no | 0.911 | 0.735 | 0.686 | 1e-159 | |
| P49101 | 513 | Calcium-dependent protein | N/A | no | 0.919 | 0.752 | 0.658 | 1e-157 | |
| P28582 | 532 | Calcium-dependent protein | N/A | no | 0.866 | 0.684 | 0.689 | 1e-156 | |
| Q9ZSA2 | 531 | Calcium-dependent protein | no | no | 0.895 | 0.708 | 0.670 | 1e-152 | |
| Q8RWL2 | 534 | Calcium-dependent protein | no | no | 0.888 | 0.698 | 0.660 | 1e-151 |
| >sp|Q42479|CDPK3_ARATH Calcium-dependent protein kinase 3 OS=Arabidopsis thaliana GN=CPK3 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 641 bits (1653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 297/366 (81%), Positives = 337/366 (92%)
Query: 55 GRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDV 114
GR+LG+PME+VR TY FGRELGRGQFGVTYLVTHK+TKQQ ACKSI +R+L+++DD+EDV
Sbjct: 64 GRILGRPMEEVRRTYEFGRELGRGQFGVTYLVTHKETKQQVACKSIPTRRLVHKDDIEDV 123
Query: 115 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLC 174
RREVQIMHHL+GHRNIV+LKGAYEDRHSVNLIM+LC GGELFDRII+KG YSERAAA+LC
Sbjct: 124 RREVQIMHHLSGHRNIVDLKGAYEDRHSVNLIMELCEGGELFDRIISKGLYSERAAADLC 183
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 234
RQMV VVH CHSMGVMHRDLKPENFLF S E+SPLKATDFGLSVFFKPGD FKDLVGSA
Sbjct: 184 RQMVMVVHSCHSMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDKFKDLVGSA 243
Query: 235 YYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294
YYVAPEVL+RNYG EADIWSAGVILYILLSGVPPFWGE E IFDAIL+G +DFS+DPWP
Sbjct: 244 YYVAPEVLKRNYGPEADIWSAGVILYILLSGVPPFWGENETGIFDAILQGQLDFSADPWP 303
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNK 354
+S AKD+V+KML DPK+RL+AAEVLNHPW+R DG+ASDKPLD AVL+RMKQFRAMNK
Sbjct: 304 ALSDGAKDLVRKMLKYDPKDRLTAAEVLNHPWIREDGEASDKPLDNAVLSRMKQFRAMNK 363
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQL 414
LKK+ALKVIAENLSEEEI+GLKEMFKS+DTDN+G +T EEL+ GLPKLG+++SE+E+RQL
Sbjct: 364 LKKMALKVIAENLSEEEIIGLKEMFKSLDTDNNGIVTLEELRTGLPKLGSKISEAEIRQL 423
Query: 415 MEAVSL 420
MEA +
Sbjct: 424 MEAADM 429
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Functions in abscisic acid (ABA) regulation of guard cell S-type anion-and Ca(2+)-permeable channels and stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 592 bits (1526), Expect = e-168, Method: Compositional matrix adjust.
Identities = 276/383 (72%), Positives = 326/383 (85%), Gaps = 6/383 (1%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
PP PP + +G VLG+PMEDV+ +Y G+ELGRGQFGVT+L T K T QF
Sbjct: 46 PPSPP------PATKQGPIGPVLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQF 99
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL 155
ACK+I+ RKL+N++D+EDVRREVQIMHHLTG NIVELKGAYED+HSV+L+M+LCAGGEL
Sbjct: 100 ACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGEL 159
Query: 156 FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
FDRIIAKGHYSERAAA+L R +V +VH CHSMGV+HRDLKPENFL + E+SPLKATDF
Sbjct: 160 FDRIIAKGHYSERAAASLLRTIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDF 219
Query: 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ 275
GLSVF+KPG+VFKD+VGSAYY+APEVL+R YG EADIWS GV+LYILL GVPPFW E+E
Sbjct: 220 GLSVFYKPGEVFKDIVGSAYYIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESEN 279
Query: 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASD 335
IF+AILRGH+DFSSDPWP+IS AKD+VKKML++DPK+RL+AA+VLNHPW++ DG+A D
Sbjct: 280 GIFNAILRGHVDFSSDPWPSISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPD 339
Query: 336 KPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEEL 395
PLD AV++R+KQF+AMN KKVAL+VIA LSEEEIMGLKEMFK MDTD+SGTIT EEL
Sbjct: 340 VPLDNAVMSRLKQFKAMNNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEEL 399
Query: 396 KAGLPKLGTRLSESEVRQLMEAV 418
+ GL K GTRLSE EV+QLMEA
Sbjct: 400 RQGLAKQGTRLSEYEVQQLMEAA 422
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E9C0|CDPKY_ARATH Calcium-dependent protein kinase 34 OS=Arabidopsis thaliana GN=CPK34 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 588 bits (1517), Expect = e-167, Method: Compositional matrix adjust.
Identities = 275/383 (71%), Positives = 325/383 (84%), Gaps = 5/383 (1%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
PP P P++ +G VLG+PMEDV+++Y G+ELGRGQFGVT+L T K T QF
Sbjct: 40 PPASPPPATK-----QGPIGPVLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQF 94
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL 155
ACK+I+ RKL+N++D+EDVRREVQIMHHLTG NIVELKGAYED+HSV+L+M+LCAGGEL
Sbjct: 95 ACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGEL 154
Query: 156 FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
FDRIIAKGHYSERAAA+L R +V ++H CHSMGV+HRDLKPENFL S E+SPLKATDF
Sbjct: 155 FDRIIAKGHYSERAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDF 214
Query: 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ 275
GLSVF+KPG+VFKD+VGSAYY+APEVLRR YG EADIWS GV+LYILL GVPPFW E+E
Sbjct: 215 GLSVFYKPGEVFKDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESEN 274
Query: 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASD 335
IF+AIL G +DFSSDPWP IS AKD+V+KML++DPK+RL+AA+VLNHPW++ DG+A D
Sbjct: 275 GIFNAILSGQVDFSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPD 334
Query: 336 KPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEEL 395
PLD AV++R+KQF+AMN KKVAL+VIA LSEEEIMGLKEMFK MDTDNSGTIT EEL
Sbjct: 335 VPLDNAVMSRLKQFKAMNNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEEL 394
Query: 396 KAGLPKLGTRLSESEVRQLMEAV 418
+ GL K GTRLSE EV+QLMEA
Sbjct: 395 RQGLAKQGTRLSEYEVQQLMEAA 417
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53683|CDPK2_ORYSJ Calcium-dependent protein kinase isoform 2 OS=Oryza sativa subsp. japonica GN=CPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 566 bits (1459), Expect = e-160, Method: Compositional matrix adjust.
Identities = 273/428 (63%), Positives = 335/428 (78%), Gaps = 17/428 (3%)
Query: 2 GNCNGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGR----- 56
G NG S H T T +HP + PP R + SA +
Sbjct: 16 GGANGYGYS----HQTKPAQTTPSYNHP---QPPPPAEVRYTPSAMNPPVVPPVVAPPKP 68
Query: 57 ----VLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE 112
+LGKP +DVR+ Y G+ELGRGQFGVTYL T + +Q+ACKSIS RKL+++ D E
Sbjct: 69 TPDTILGKPYDDVRSVYSLGKELGRGQFGVTYLCTEIASGKQYACKSISKRKLVSKADKE 128
Query: 113 DVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN 172
D+RRE+QIM HL+G +NIVE +GAYED+ +V+++M+LCAGGELFDRIIAKGHYSERAAA
Sbjct: 129 DIRREIQIMQHLSGQQNIVEFRGAYEDKSNVHVVMELCAGGELFDRIIAKGHYSERAAAT 188
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232
+CR +V VV+ CH MGVMHRDLKPENFL ++ E++ LKATDFGLSVF + G +++D+VG
Sbjct: 189 ICRAVVNVVNICHFMGVMHRDLKPENFLLATKEENAMLKATDFGLSVFIEEGKMYRDIVG 248
Query: 233 SAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292
SAYYVAPEVLRRNYG E D+WSAGVILYILLSGVPPFW ETE+ IFDAIL+G IDF S P
Sbjct: 249 SAYYVAPEVLRRNYGKEIDVWSAGVILYILLSGVPPFWAETEKGIFDAILQGEIDFESQP 308
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAM 352
WP+IS SAKD+V+KML DPK+R+++A+VL HPW+R DG+ASDKP+D AVL+RMKQFRAM
Sbjct: 309 WPSISESAKDLVRKMLTQDPKKRITSAQVLQHPWLR-DGEASDKPIDSAVLSRMKQFRAM 367
Query: 353 NKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVR 412
NKLKK+ALKVIA NL+EEEI GLK+MF +MDTDNSGTIT+EELKAGL KLG++LSE+EV+
Sbjct: 368 NKLKKMALKVIASNLNEEEIKGLKQMFTNMDTDNSGTITYEELKAGLAKLGSKLSEAEVK 427
Query: 413 QLMEAVSL 420
QLMEA +
Sbjct: 428 QLMEAADV 435
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q38868|CDPK9_ARATH Calcium-dependent protein kinase 9 OS=Arabidopsis thaliana GN=CPK9 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1447), Expect = e-159, Method: Compositional matrix adjust.
Identities = 270/445 (60%), Positives = 329/445 (73%), Gaps = 28/445 (6%)
Query: 1 MGNC------------NGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSA-- 46
MGNC NG + ++ T DP P + P P P +S
Sbjct: 1 MGNCFAKNHGLMKPQQNGNTTRSVEVGVTNQDP---PSYTPQARTTQQPEKPGSVNSQPP 57
Query: 47 -----------TSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
+ T++ +L EDV+ Y G+ELGRGQFGVTYL T T +++
Sbjct: 58 PWRAAAAAPGLSPKTTTKSNSILENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKY 117
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL 155
ACKSIS +KL+ + D +D+RRE+QIM HL+G NIVE KGAYED +VNL+M+LCAGGEL
Sbjct: 118 ACKSISKKKLVTKADKDDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGEL 177
Query: 156 FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
FDRIIAKGHY+ERAAA++CRQ+V VV CH MGV+HRDLKPENFL SS E + +KATDF
Sbjct: 178 FDRIIAKGHYTERAAASVCRQIVNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDF 237
Query: 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ 275
GLSVF + G V++D+VGSAYYVAPEVLRR YG E DIWSAG+ILYILLSGVPPFW ETE+
Sbjct: 238 GLSVFIEEGKVYRDIVGSAYYVAPEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEK 297
Query: 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASD 335
IFDAIL GHIDF S PWP+ISSSAKD+V++ML ADPK R+SAA+VL HPW+R G+ASD
Sbjct: 298 GIFDAILEGHIDFESQPWPSISSSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASD 357
Query: 336 KPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEEL 395
KP+D AVL+RMKQFRAMNKLKK+ALKVIAEN+ EEI GLK MF ++DTDNSGTIT+EEL
Sbjct: 358 KPIDSAVLSRMKQFRAMNKLKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEEL 417
Query: 396 KAGLPKLGTRLSESEVRQLMEAVSL 420
K GL KLG++L+E+EV+QLM+A +
Sbjct: 418 KEGLAKLGSKLTEAEVKQLMDAADV 442
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C6P3|CDPKX_ARATH Calcium-dependent protein kinase 33 OS=Arabidopsis thaliana GN=CPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1445), Expect = e-159, Method: Compositional matrix adjust.
Identities = 263/383 (68%), Positives = 312/383 (81%)
Query: 38 GPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFAC 97
G +P A S +L KP EDV+ Y +ELGRGQFGVTYL T K T ++FAC
Sbjct: 42 GTNQPPPWRNPAKHSGAAAILEKPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTGKRFAC 101
Query: 98 KSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD 157
KSIS +KL+ + D ED+RRE+QIM HL+G NIVE KGAYED +VNL+M+LCAGGELFD
Sbjct: 102 KSISKKKLVTKGDKEDMRREIQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFD 161
Query: 158 RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217
RI+AKGHYSERAAA++CRQ+V VV+ CH MGVMHRDLKPENFL SS E + +KATDFGL
Sbjct: 162 RILAKGHYSERAAASVCRQIVNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGL 221
Query: 218 SVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
SVF + G V+KD+VGSAYYVAPEVL+R YG E DIWSAG+ILYILLSGVPPFW ETE+ I
Sbjct: 222 SVFIEEGRVYKDIVGSAYYVAPEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGI 281
Query: 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKP 337
FDAIL G IDF S PWP+IS+SAKD+V++ML DPK R+SAAEVL HPW+R G+ASDKP
Sbjct: 282 FDAILEGEIDFESQPWPSISNSAKDLVRRMLTQDPKRRISAAEVLKHPWLREGGEASDKP 341
Query: 338 LDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKA 397
+D AVL+RMKQFRAMNKLKK+ALKVIAEN+ EEI GLK MF ++DTDNSGTIT+EELK
Sbjct: 342 IDSAVLSRMKQFRAMNKLKKLALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKE 401
Query: 398 GLPKLGTRLSESEVRQLMEAVSL 420
GL KLG+RL+E+EV+QLM+A +
Sbjct: 402 GLAKLGSRLTEAEVKQLMDAADV 424
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49101|CDPK2_MAIZE Calcium-dependent protein kinase 2 OS=Zea mays GN=CPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 556 bits (1432), Expect = e-157, Method: Compositional matrix adjust.
Identities = 262/398 (65%), Positives = 320/398 (80%), Gaps = 12/398 (3%)
Query: 35 DPPGPPRPSSSATSATSSS------------VGRVLGKPMEDVRNTYIFGRELGRGQFGV 82
+PP SAT+SS +LGK EDVR+ Y FG+ELGRGQFGV
Sbjct: 19 NPPQQAAEVRYTPSATNSSAVPPVAVPPKPTADTILGKQYEDVRSVYSFGKELGRGQFGV 78
Query: 83 TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142
TYL T + +Q+ACKSIS RKL+++ D ED+RRE+QIM HL+G NIVE +GAYED+ +
Sbjct: 79 TYLCTEIASGRQYACKSISKRKLVSKADREDIRREIQIMQHLSGQPNIVEFRGAYEDKSN 138
Query: 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFS 202
V+++M+LCAGGELFDRIIAKGHY+ERAAA +CR +V VV+ CH MGVMHRDLKPENFL +
Sbjct: 139 VHVVMELCAGGELFDRIIAKGHYTERAAATICRAVVNVVNICHFMGVMHRDLKPENFLLA 198
Query: 203 SSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYIL 262
+ E++ LKATDFGLSVF + G +++D+VGSAYYVAPEVLRR+YG E D+WSAGVILYIL
Sbjct: 199 TMEENAMLKATDFGLSVFIEEGKMYRDIVGSAYYVAPEVLRRSYGKEIDVWSAGVILYIL 258
Query: 263 LSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
LSGVPPFW E E+ IFDAIL IDF S PWP+IS SAKD+V+KML DPK+RL++A+VL
Sbjct: 259 LSGVPPFWAEIEKGIFDAILHEEIDFESQPWPSISESAKDLVRKMLTRDPKKRLTSAQVL 318
Query: 323 NHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSM 382
H W+R G+ASDKP+D AVL+RMKQFRAMNKLKK+ALKVIA NL+EEEI GLK+MF +M
Sbjct: 319 QHQWLREGGEASDKPIDSAVLSRMKQFRAMNKLKKMALKVIASNLNEEEIKGLKQMFMNM 378
Query: 383 DTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420
DTDNSGTIT+EELKAGL KLG++LSE+EV+QLMEA +
Sbjct: 379 DTDNSGTITYEELKAGLAKLGSKLSEAEVKQLMEAADV 416
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28582|CDPK_DAUCA Calcium-dependent protein kinase OS=Daucus carota PE=2 SV=2 | Back alignment and function description |
|---|
Score = 552 bits (1422), Expect = e-156, Method: Compositional matrix adjust.
Identities = 251/364 (68%), Positives = 308/364 (84%)
Query: 57 VLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRR 116
+LGKP ED+R Y G+ELGRGQFG Y T + Q +ACKSI RKL++++D ED++R
Sbjct: 69 ILGKPFEDIRGKYTLGKELGRGQFGCVYQCTENSSGQLYACKSILKRKLVSKNDKEDIKR 128
Query: 117 EVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQ 176
E+QI+ HL+G NIVE KG +EDR SV+L+M+LCAGGELFDRIIA+GHYSERAAA +CRQ
Sbjct: 129 EIQILQHLSGQPNIVEFKGVFEDRQSVHLVMELCAGGELFDRIIAQGHYSERAAATICRQ 188
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY 236
+V VVH CH MGVMHRDLKPENFL SS +D+ LKATDFGLSVF + G V++++VGSAYY
Sbjct: 189 IVNVVHVCHFMGVMHRDLKPENFLLSSKDKDAMLKATDFGLSVFIEEGKVYRNIVGSAYY 248
Query: 237 VAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296
VAPEVLRR+YG E DIWSAGVILYILLSGVPPFW E E+ IFDAIL G IDF S+PWP++
Sbjct: 249 VAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDAILEGVIDFESEPWPSV 308
Query: 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLK 356
S+SAKD+V+KML DP+ R+++A+VL+HPWMR G+ASDKP+D AVL+RMKQFRAMNKLK
Sbjct: 309 SNSAKDLVRKMLTQDPRRRITSAQVLDHPWMREGGEASDKPIDSAVLSRMKQFRAMNKLK 368
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416
++ALKVIAE+LSEEEI GLK MF +MDTD SGTIT+EELK+GL +LG++LSE EV+QLM+
Sbjct: 369 QLALKVIAESLSEEEIKGLKSMFANMDTDKSGTITYEELKSGLARLGSKLSEVEVQQLMD 428
Query: 417 AVSL 420
A +
Sbjct: 429 AADV 432
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZSA2|CDPKL_ARATH Calcium-dependent protein kinase 21 OS=Arabidopsis thaliana GN=CPK21 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 539 bits (1389), Expect = e-152, Method: Compositional matrix adjust.
Identities = 254/379 (67%), Positives = 309/379 (81%), Gaps = 3/379 (0%)
Query: 42 PSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSIS 101
PSS+ S +LGKP ED+R Y G+ELGRGQFG+TY+ T +ACKSI
Sbjct: 55 PSSNPVSVRDPDT--ILGKPFEDIRKFYSLGKELGRGQFGITYMCKEIGTGNTYACKSIL 112
Query: 102 SRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA 161
RKLI++ D EDV+RE+QIM +L+G NIVE+KGAYEDR S++L+M+LCAGGELFDRIIA
Sbjct: 113 KRKLISKQDKEDVKREIQIMQYLSGQPNIVEIKGAYEDRQSIHLVMELCAGGELFDRIIA 172
Query: 162 KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221
+GHYSERAAA + R +V VV CH MGV+HRDLKPENFL SS E++ LKATDFGLSVF
Sbjct: 173 QGHYSERAAAGIIRSIVNVVQICHFMGVVHRDLKPENFLLSSKEENAMLKATDFGLSVFI 232
Query: 222 KPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI 281
+ G V++D+VGSAYYVAPEVLRR+YG E DIWSAGVILYILLSGVPPFW E E+ IFD +
Sbjct: 233 EEGKVYRDIVGSAYYVAPEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDEV 292
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIA 341
++G IDF S+PWP+IS SAKD+V+KML DPK R++AA+VL HPW++ G+A DKP+D A
Sbjct: 293 IKGEIDFVSEPWPSISESAKDLVRKMLTKDPKRRITAAQVLEHPWIK-GGEAPDKPIDSA 351
Query: 342 VLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPK 401
VL+RMKQFRAMNKLKK+ALKVIAE+LSEEEI GLK MF ++DTD SGTIT+EELK GL +
Sbjct: 352 VLSRMKQFRAMNKLKKLALKVIAESLSEEEIKGLKTMFANIDTDKSGTITYEELKTGLTR 411
Query: 402 LGTRLSESEVRQLMEAVSL 420
LG+RLSE+EV+QLMEA +
Sbjct: 412 LGSRLSETEVKQLMEAADV 430
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWL2|CDPKT_ARATH Calcium-dependent protein kinase 29 OS=Arabidopsis thaliana GN=CPK29 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 534 bits (1375), Expect = e-151, Method: Compositional matrix adjust.
Identities = 247/374 (66%), Positives = 307/374 (82%), Gaps = 1/374 (0%)
Query: 47 TSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI 106
++++ S +G +L +PM D+ Y +ELGRGQFG+TY T K +++ACKSIS RKLI
Sbjct: 63 STSSGSQIGPILNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRKLI 122
Query: 107 NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYS 166
R D+EDVRREV I+ HLTG NIVE +GAYED+ +++L+M+LC+GGELFDRII KG YS
Sbjct: 123 RRKDIEDVRREVMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGSYS 182
Query: 167 ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
E+ AAN+ RQ+V VVH CH MGV+HRDLKPENFL S+ EDSP+KATDFGLSVF + G V
Sbjct: 183 EKEAANIFRQIVNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEGKV 242
Query: 227 FKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI 286
++D+VGSAYYVAPEVL RNYG E D+WSAGV+LYILLSGVPPFWGETE++IF+AIL G +
Sbjct: 243 YRDIVGSAYYVAPEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEGKL 302
Query: 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRM 346
D + PWP IS SAKD+++KML DPK+R++AAE L HPWM D SDKP++ AVL RM
Sbjct: 303 DLETSPWPTISESAKDLIRKMLIRDPKKRITAAEALEHPWM-TDTKISDKPINSAVLVRM 361
Query: 347 KQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRL 406
KQFRAMNKLKK+ALKVIAENLSEEEI GLK+ FK+MDTD SGTITF+EL+ GL +LG++L
Sbjct: 362 KQFRAMNKLKKLALKVIAENLSEEEIKGLKQTFKNMDTDESGTITFDELRNGLHRLGSKL 421
Query: 407 SESEVRQLMEAVSL 420
+ESE++QLMEA +
Sbjct: 422 TESEIKQLMEAADV 435
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 420 | ||||||
| 224053829 | 515 | calcium dependent protein kinase 3 [Popu | 0.985 | 0.803 | 0.824 | 0.0 | |
| 224075036 | 520 | calcium dependent protein kinase 22 [Pop | 0.985 | 0.796 | 0.838 | 0.0 | |
| 225426094 | 528 | PREDICTED: calcium-dependent protein kin | 0.995 | 0.791 | 0.816 | 0.0 | |
| 255537639 | 528 | calcium-dependent protein kinase, putati | 0.9 | 0.715 | 0.880 | 0.0 | |
| 356513317 | 518 | PREDICTED: calcium-dependent protein kin | 0.973 | 0.789 | 0.805 | 0.0 | |
| 356497285 | 505 | PREDICTED: calcium-dependent protein kin | 0.964 | 0.801 | 0.814 | 0.0 | |
| 356513319 | 532 | PREDICTED: calcium-dependent protein kin | 0.971 | 0.766 | 0.789 | 0.0 | |
| 147814808 | 482 | hypothetical protein VITISV_032639 [Viti | 0.869 | 0.757 | 0.893 | 0.0 | |
| 356539541 | 505 | PREDICTED: calcium-dependent protein kin | 0.964 | 0.801 | 0.811 | 0.0 | |
| 114804153 | 514 | CDPK1 [Ipomoea nil] gi|397746248|gb|AFO6 | 0.966 | 0.789 | 0.773 | 0.0 |
| >gi|224053829|ref|XP_002298000.1| calcium dependent protein kinase 3 [Populus trichocarpa] gi|222845258|gb|EEE82805.1| calcium dependent protein kinase 3 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1844), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/421 (82%), Positives = 376/421 (89%), Gaps = 7/421 (1%)
Query: 1 MGNCNGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPP-GPPRPSSSATSATSSSVGRVLG 59
MGNCN L SS + + P + G+K+ PP P P S +S++VGRVLG
Sbjct: 1 MGNCNSLASSSSTTTNHRNPPPSN-----GGIKVLPPNASPPPRSQFLHHSSAAVGRVLG 55
Query: 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ 119
+PMEDVRNTY FGRE+GRGQFGVTYLVTHK+TKQ FACKSI+ RKLINRDD+EDV REVQ
Sbjct: 56 RPMEDVRNTYTFGREVGRGQFGVTYLVTHKETKQHFACKSIAKRKLINRDDIEDVLREVQ 115
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
IMHHLTGHRN+VELKGAYEDRHSVNLIM+LC GGELFDRII KGHYSERAAANLCRQ+VT
Sbjct: 116 IMHHLTGHRNVVELKGAYEDRHSVNLIMELCEGGELFDRIITKGHYSERAAANLCRQIVT 175
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
VVH CH+MGV+HRDLKPENFLF S+ EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP
Sbjct: 176 VVHNCHTMGVIHRDLKPENFLFLSTHEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 235
Query: 240 EVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
EVLRRNYGAE DIWSAGVILYILLSGVPPFWGETEQ+IFD+ILRGHIDFSSDPWP+ISSS
Sbjct: 236 EVLRRNYGAEVDIWSAGVILYILLSGVPPFWGETEQAIFDSILRGHIDFSSDPWPSISSS 295
Query: 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVA 359
AKD+VK+ML ADPKER+SA EVLNHPWMR DG ASDKPLDIAVLTRMKQFRAMNKLKK+A
Sbjct: 296 AKDLVKQMLRADPKERISAVEVLNHPWMREDG-ASDKPLDIAVLTRMKQFRAMNKLKKIA 354
Query: 360 LKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419
LKVIAENLSEEEIMGLKEMFKSMDTDN+GTITFEELKAGLPKLGT+LSESEVRQLMEA
Sbjct: 355 LKVIAENLSEEEIMGLKEMFKSMDTDNNGTITFEELKAGLPKLGTKLSESEVRQLMEAAD 414
Query: 420 L 420
+
Sbjct: 415 V 415
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075036|ref|XP_002304529.1| calcium dependent protein kinase 22 [Populus trichocarpa] gi|222841961|gb|EEE79508.1| calcium dependent protein kinase 22 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/426 (83%), Positives = 384/426 (90%), Gaps = 12/426 (2%)
Query: 1 MGNCNGLPSSQTQLHSTTADPDTGPGHHPNG-LKIDPPG---PPRPSSSATSATS--SSV 54
MGNCN LPSS + +TT D P PNG +K+ PP PPR S+ S ++V
Sbjct: 1 MGNCNSLPSSSST--TTTTDHHNTP---PNGVIKVLPPTATPPPRSQHHHHSSASGSTAV 55
Query: 55 GRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDV 114
GRVLG+P EDVRNTYIFGRELGRGQFGVTYLVTHK+TKQ FACKSI+SRKLINRDD+EDV
Sbjct: 56 GRVLGRPREDVRNTYIFGRELGRGQFGVTYLVTHKETKQHFACKSIASRKLINRDDIEDV 115
Query: 115 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLC 174
RREVQIMHHLTGHRNIVELKGAYED+HSVNLIM+LC GGELFDRIIAKGHYSERAAANLC
Sbjct: 116 RREVQIMHHLTGHRNIVELKGAYEDQHSVNLIMELCEGGELFDRIIAKGHYSERAAANLC 175
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 234
RQ+VTVVH CH+MGV+HRDLKPENFLF S+ EDSPLKATDFGLSVFFKPGDVFKDLVGSA
Sbjct: 176 RQIVTVVHNCHTMGVIHRDLKPENFLFLSTHEDSPLKATDFGLSVFFKPGDVFKDLVGSA 235
Query: 235 YYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294
YYVAPEVLRRNYGAE DIWSAGVILYILLSGVPPFWG+TEQ IFD+ILRGHIDFSSDPWP
Sbjct: 236 YYVAPEVLRRNYGAEVDIWSAGVILYILLSGVPPFWGDTEQVIFDSILRGHIDFSSDPWP 295
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNK 354
+ISSSAKD+VK+M+ ADPKER+SA EVLNHPWMR DG ASDKPLDIAVLTRMKQFRAMNK
Sbjct: 296 SISSSAKDLVKQMVRADPKERISAVEVLNHPWMREDG-ASDKPLDIAVLTRMKQFRAMNK 354
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQL 414
LKKVALKVIAENLSEEEIMGLKEMFKSMDTDN+GTITFEELKAGLPKLGT+LSESEVRQL
Sbjct: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNNGTITFEELKAGLPKLGTKLSESEVRQL 414
Query: 415 MEAVSL 420
MEA +
Sbjct: 415 MEAADV 420
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225426094|ref|XP_002272270.1| PREDICTED: calcium-dependent protein kinase 3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 711 bits (1834), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/430 (81%), Positives = 380/430 (88%), Gaps = 12/430 (2%)
Query: 1 MGNCNGLPSSQTQLHSTTADPDTGP-----GHHPNGLKIDPPGPPRPSSSATSATS---- 51
MGNCNGLPS TQ A D G H NGL + PP P P T+A
Sbjct: 1 MGNCNGLPSGDTQFQ-INAGRDGGVRPSSHAHSSNGLNVRPPSPSPPPPPRTAAPVVHRP 59
Query: 52 -SSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD 110
+ GRVLG+PMEDVR TYIFGRELGRGQFGVTYLVTHK+TK+QFACKSI++RKL+NRDD
Sbjct: 60 LAGNGRVLGRPMEDVRQTYIFGRELGRGQFGVTYLVTHKETKEQFACKSIATRKLVNRDD 119
Query: 111 VEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA 170
+EDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL+M+LCAGGELFDRIIAKGHYSERAA
Sbjct: 120 IEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLVMELCAGGELFDRIIAKGHYSERAA 179
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230
A LCRQ+VTVVH CH+MGVMHRDLKPENFLF S+AEDSPLKATDFGLSVFFKPGDVFKDL
Sbjct: 180 AALCRQIVTVVHNCHTMGVMHRDLKPENFLFLSTAEDSPLKATDFGLSVFFKPGDVFKDL 239
Query: 231 VGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS 290
VGSAYYVAPEVLRR+YGAEADIWSAGVIL+ILLSGVPPFWGE EQSIFD ILRGHIDFSS
Sbjct: 240 VGSAYYVAPEVLRRSYGAEADIWSAGVILFILLSGVPPFWGENEQSIFDTILRGHIDFSS 299
Query: 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFR 350
DPWP+IS+SAKD+VKKML ADPKERL+A +VLNHPWM+ DG ASDKP+DIAVLTR+KQFR
Sbjct: 300 DPWPSISNSAKDLVKKMLRADPKERLTAIDVLNHPWMKEDG-ASDKPIDIAVLTRVKQFR 358
Query: 351 AMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESE 410
AMNKLKKVALKVIAENLSEEEI+GLKEMFKSMDTDNSGTIT+EELK GLPKLGT+LSESE
Sbjct: 359 AMNKLKKVALKVIAENLSEEEIIGLKEMFKSMDTDNSGTITYEELKNGLPKLGTKLSESE 418
Query: 411 VRQLMEAVSL 420
VRQLMEA +
Sbjct: 419 VRQLMEAADV 428
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255537639|ref|XP_002509886.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223549785|gb|EEF51273.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1822), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/378 (88%), Positives = 360/378 (95%)
Query: 43 SSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISS 102
S++ SA ++VGRVLG+PMEDVR+ Y FGRELGRGQFGVTYLVTHK+TKQQFACKSI++
Sbjct: 51 SNNRPSAAPAAVGRVLGRPMEDVRSIYAFGRELGRGQFGVTYLVTHKETKQQFACKSIAT 110
Query: 103 RKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK 162
RKLINRDD+EDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL+M+LCAGGELFDRIIAK
Sbjct: 111 RKLINRDDIEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLVMELCAGGELFDRIIAK 170
Query: 163 GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
GHYSERAAANLCRQ+VTVVH CHSMGV+HRDLKPENFLF S+ E+SPLKATDFGLSVFFK
Sbjct: 171 GHYSERAAANLCRQIVTVVHDCHSMGVIHRDLKPENFLFLSTDENSPLKATDFGLSVFFK 230
Query: 223 PGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL 282
PGD FKDLVGSAYYVAPEVLRRNYG DIWSAGVILYILLSGVPPFWGETEQ+IFD +L
Sbjct: 231 PGDTFKDLVGSAYYVAPEVLRRNYGPAIDIWSAGVILYILLSGVPPFWGETEQAIFDTVL 290
Query: 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAV 342
RGHIDFSSDPWP+ISSSAKD+VKKML AD K+R+SAAEVLNHPWMRVDGDASDKPLDIAV
Sbjct: 291 RGHIDFSSDPWPSISSSAKDLVKKMLTADAKDRISAAEVLNHPWMRVDGDASDKPLDIAV 350
Query: 343 LTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL 402
LTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDN+GTIT+EELKAGLPKL
Sbjct: 351 LTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNNGTITYEELKAGLPKL 410
Query: 403 GTRLSESEVRQLMEAVSL 420
GT+LSESEV+QLMEA +
Sbjct: 411 GTKLSESEVKQLMEAADV 428
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513317|ref|XP_003525360.1| PREDICTED: calcium-dependent protein kinase 3-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1809), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/427 (80%), Positives = 375/427 (87%), Gaps = 18/427 (4%)
Query: 1 MGNCN---GLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGP----PRPSSSATSATSSS 53
MGNC+ G P++ + H H NG+ + PP P TS++SSS
Sbjct: 1 MGNCSSGAGAPTTYSDDHP-----------HHNGITVLPPNSNPSPQLPKPPPTSSSSSS 49
Query: 54 VGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED 113
+GRVLG+PMEDVR+ YIFGRELGRGQFGVTYLVTHK TK+QFACKSI++RKL+NRDD++D
Sbjct: 50 LGRVLGRPMEDVRSIYIFGRELGRGQFGVTYLVTHKATKEQFACKSIATRKLVNRDDIDD 109
Query: 114 VRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL 173
+RREVQIMHHLTGHRNIVELKGAYEDRHSVNL+M+LCAGGELFDRII KGHYSERAAAN
Sbjct: 110 IRREVQIMHHLTGHRNIVELKGAYEDRHSVNLVMELCAGGELFDRIITKGHYSERAAANS 169
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
CRQ+VTVVH CHSMGVMHRDLKPENFL + +DSPLKATDFGLSVFFKPGDVF+DLVGS
Sbjct: 170 CRQIVTVVHNCHSMGVMHRDLKPENFLLLNKNDDSPLKATDFGLSVFFKPGDVFRDLVGS 229
Query: 234 AYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293
AYYVAPEVLRR+YG EADIWSAGVILYILLSGVPPFW E EQ IFDAILRGHIDF+SDPW
Sbjct: 230 AYYVAPEVLRRSYGPEADIWSAGVILYILLSGVPPFWAENEQGIFDAILRGHIDFASDPW 289
Query: 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMN 353
P+ISSSAKD+VKKML ADPKERLSA EVLNHPWMRVDGDA DKPLDIAVLTRMKQFRAMN
Sbjct: 290 PSISSSAKDLVKKMLRADPKERLSAVEVLNHPWMRVDGDAPDKPLDIAVLTRMKQFRAMN 349
Query: 354 KLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQ 413
KLKKVALKVIAENLSEEEI+GLKEMFKSMDTDNSGTITFEELKAGLPKLGT+LSESEVRQ
Sbjct: 350 KLKKVALKVIAENLSEEEIIGLKEMFKSMDTDNSGTITFEELKAGLPKLGTKLSESEVRQ 409
Query: 414 LMEAVSL 420
LMEA +
Sbjct: 410 LMEAADV 416
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356497285|ref|XP_003517491.1| PREDICTED: calcium-dependent protein kinase 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1808), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/420 (81%), Positives = 372/420 (88%), Gaps = 15/420 (3%)
Query: 1 MGNCNGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGK 60
MGNCN SSQTQ HS D P + NG+ + PP + SVGRVLG+
Sbjct: 1 MGNCNSEASSQTQPHS---DHHPQPRSNSNGITVLPPN-----------SKPSVGRVLGR 46
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
PMEDVR+TY FGRELGRGQFGVTYLVTHK TKQQFACKSI++ KL++RDD+EDVRREVQI
Sbjct: 47 PMEDVRSTYTFGRELGRGQFGVTYLVTHKHTKQQFACKSIATPKLVHRDDLEDVRREVQI 106
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
MHHLTGHRNIVELKGAYEDRHSVNLIM+LC GGELFDRIIAKGHYSERAAA+LCRQ+VTV
Sbjct: 107 MHHLTGHRNIVELKGAYEDRHSVNLIMELCGGGELFDRIIAKGHYSERAAADLCRQIVTV 166
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 240
VH CH+MGVMHRDLKPENFLF S E+SPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE
Sbjct: 167 VHDCHTMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 226
Query: 241 VLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
VLRR+YG EADIWSAGVIL+ILLSGVPPFW + EQ IFDAILRGHIDF+SDPWP+ISSSA
Sbjct: 227 VLRRSYGPEADIWSAGVILFILLSGVPPFWSKKEQGIFDAILRGHIDFTSDPWPSISSSA 286
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVAL 360
KD+VKKML ADPK+RLSA EVL+HPWMR DG ASDKPLD+AVL+RMKQFRAMNKLKKVAL
Sbjct: 287 KDLVKKMLRADPKQRLSAVEVLDHPWMREDG-ASDKPLDVAVLSRMKQFRAMNKLKKVAL 345
Query: 361 KVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420
KVIAENLSEEEI+GLKEMFKSMDTDNSGTITFEELKAGLPKLGT++SESEVRQLMEA +
Sbjct: 346 KVIAENLSEEEIIGLKEMFKSMDTDNSGTITFEELKAGLPKLGTKVSESEVRQLMEAADV 405
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513319|ref|XP_003525361.1| PREDICTED: calcium-dependent protein kinase 3-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 694 bits (1792), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/438 (78%), Positives = 376/438 (85%), Gaps = 30/438 (6%)
Query: 1 MGNCN---GLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGP----PRPSSSATSATSSS 53
MGNC+ G P++ + H H NG+ + PP P TS++SSS
Sbjct: 1 MGNCSSGAGAPTTYSDDHP-----------HHNGITVLPPNSNPSPQLPKPPPTSSSSSS 49
Query: 54 VGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED 113
+GRVLG+PMEDVR+ YIFGRELGRGQFGVTYLVTHK TK+QFACKSI++RKL+NRDD++D
Sbjct: 50 LGRVLGRPMEDVRSIYIFGRELGRGQFGVTYLVTHKATKEQFACKSIATRKLVNRDDIDD 109
Query: 114 VRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL 173
+RREVQIMHHLTGHRNIVELKGAYEDRHSVNL+M+LCAGGELFDRII KGHYSERAAAN
Sbjct: 110 IRREVQIMHHLTGHRNIVELKGAYEDRHSVNLVMELCAGGELFDRIITKGHYSERAAANS 169
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
CRQ+VTVVH CHSMGVMHRDLKPENFL + +DSPLKATDFGLSVFFKPGDVF+DLVGS
Sbjct: 170 CRQIVTVVHNCHSMGVMHRDLKPENFLLLNKNDDSPLKATDFGLSVFFKPGDVFRDLVGS 229
Query: 234 AYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWG------------ETEQSIFDAI 281
AYYVAPEVLRR+YG EADIWSAGVILYILLSGVPPFW E EQ IFDAI
Sbjct: 230 AYYVAPEVLRRSYGPEADIWSAGVILYILLSGVPPFWAGIFTLFVNLLCEENEQGIFDAI 289
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIA 341
LRGHIDF+SDPWP+ISSSAKD+VKKML ADPKERLSA EVLNHPWMRVDGDA DKPLDIA
Sbjct: 290 LRGHIDFASDPWPSISSSAKDLVKKMLRADPKERLSAVEVLNHPWMRVDGDAPDKPLDIA 349
Query: 342 VLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPK 401
VLTRMKQFRAMNKLKKVALKVIAENLSEEEI+GLKEMFKSMDTDNSGTITFEELKAGLPK
Sbjct: 350 VLTRMKQFRAMNKLKKVALKVIAENLSEEEIIGLKEMFKSMDTDNSGTITFEELKAGLPK 409
Query: 402 LGTRLSESEVRQLMEAVS 419
LGT+LSESEVRQLMEAVS
Sbjct: 410 LGTKLSESEVRQLMEAVS 427
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147814808|emb|CAN61364.1| hypothetical protein VITISV_032639 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 694 bits (1790), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/366 (89%), Positives = 353/366 (96%), Gaps = 1/366 (0%)
Query: 55 GRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDV 114
GRVLG+PMEDVR TYIFGRELGRGQFGVTYLVTHK+TK+QFACKSI++RKL+NRDD+EDV
Sbjct: 18 GRVLGRPMEDVRQTYIFGRELGRGQFGVTYLVTHKETKEQFACKSIATRKLVNRDDIEDV 77
Query: 115 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLC 174
RREVQIMHHLTGHRNIVELKGAYEDRHSVNL+M+LCAGGELFDRIIAKGHYSERAAA LC
Sbjct: 78 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLVMELCAGGELFDRIIAKGHYSERAAAALC 137
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 234
RQ+VTVVH CH+MGVMHRDLKPENFLF S+AEDSPLKATDFGLSVFFKPGDVFKDLVGSA
Sbjct: 138 RQIVTVVHNCHTMGVMHRDLKPENFLFLSTAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 197
Query: 235 YYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294
YYVAPEVLRR+YGAEADIWSAGVIL+ILLSGVPPFWGE EQSIFD ILRGHIDFSSDPWP
Sbjct: 198 YYVAPEVLRRSYGAEADIWSAGVILFILLSGVPPFWGENEQSIFDTILRGHIDFSSDPWP 257
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNK 354
+IS+SAKD+VKKML ADPKERL+A +VLNHPWM+ DG ASDKP+DIAVLTR+KQFRAMNK
Sbjct: 258 SISNSAKDLVKKMLRADPKERLTAIDVLNHPWMKEDG-ASDKPIDIAVLTRVKQFRAMNK 316
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQL 414
LKKVALKVIAENLSEEEI+GLKEMFKSMDTDNSGTIT+EELK GLPKLGT+LSESEVRQL
Sbjct: 317 LKKVALKVIAENLSEEEIIGLKEMFKSMDTDNSGTITYEELKNGLPKLGTKLSESEVRQL 376
Query: 415 MEAVSL 420
MEA +
Sbjct: 377 MEAADV 382
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356539541|ref|XP_003538256.1| PREDICTED: calcium-dependent protein kinase 3-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 692 bits (1787), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/420 (81%), Positives = 368/420 (87%), Gaps = 15/420 (3%)
Query: 1 MGNCNGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGK 60
MGNCN PSSQTQ HS NG+ + PP + SVGRVLG+
Sbjct: 1 MGNCNSEPSSQTQPHSDHH---HHHPQPSNGITVLPPN-----------SKPSVGRVLGR 46
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
PMED R+TY FGRELGRGQFGVTY VTHK TKQQFACKSI++RKL++RDD+EDVRREVQI
Sbjct: 47 PMEDARSTYTFGRELGRGQFGVTYQVTHKHTKQQFACKSIATRKLVHRDDLEDVRREVQI 106
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
MHHLTGHRNIVELKGAYEDRHSVNLIM+LC GGELFDRIIAKGHYSERAAA+LCRQ+VTV
Sbjct: 107 MHHLTGHRNIVELKGAYEDRHSVNLIMELCGGGELFDRIIAKGHYSERAAADLCRQIVTV 166
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 240
VH CH+MGVMHRDLKPENFLF S E+SPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE
Sbjct: 167 VHDCHTMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 226
Query: 241 VLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
VLRR+YG ADIWSAGVIL+ILLSGVPPFW E EQ IFDAILRGHIDF+SDPWP+ISSSA
Sbjct: 227 VLRRSYGPGADIWSAGVILFILLSGVPPFWSEKEQGIFDAILRGHIDFASDPWPSISSSA 286
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVAL 360
KD+VKKML ADPK+RLSA EVLNHPWMR DG ASDKPLD+AVL+RMKQFRAMNKLKKVAL
Sbjct: 287 KDLVKKMLRADPKQRLSAVEVLNHPWMREDG-ASDKPLDVAVLSRMKQFRAMNKLKKVAL 345
Query: 361 KVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420
KVIAENLSEEEI+GLKEMFKSMDTDNSGTITFEELKAGLPKLGT++SESEVRQLMEA +
Sbjct: 346 KVIAENLSEEEIIGLKEMFKSMDTDNSGTITFEELKAGLPKLGTKVSESEVRQLMEAADV 405
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|114804153|gb|ABC47163.2| CDPK1 [Ipomoea nil] gi|397746248|gb|AFO63177.1| calcium dependent protein kinase 1 [Ipomoea nil] | Back alignment and taxonomy information |
|---|
Score = 681 bits (1758), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/428 (77%), Positives = 372/428 (86%), Gaps = 22/428 (5%)
Query: 1 MGNCNGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATS--------S 52
MG+CN +PSS +T+A G + DPP PP+ + + S
Sbjct: 1 MGSCNSIPSSP--FAATSA-----------GGESDPP-PPKNDITVLPPSQPPPPRPFLS 46
Query: 53 SVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE 112
VGRVLG+PMEDV +TYIFG ELGRGQFGVTYLVTH+ T+++ ACKSI++RKL+++DDV+
Sbjct: 47 GVGRVLGRPMEDVHSTYIFGGELGRGQFGVTYLVTHRKTRERLACKSIATRKLLSKDDVD 106
Query: 113 DVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN 172
DVRREVQIMHHLTGHRNIVELKG YEDR+ V+L+M+LCAGGELFDRIIAKGHYSERAAA
Sbjct: 107 DVRREVQIMHHLTGHRNIVELKGTYEDRNHVHLVMELCAGGELFDRIIAKGHYSERAAAG 166
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232
LCRQMVTV+HYCHSMGVMHRDLKPENFLF SS E+SPLKATDFGLSVFFKPGD FKDLVG
Sbjct: 167 LCRQMVTVLHYCHSMGVMHRDLKPENFLFLSSDENSPLKATDFGLSVFFKPGDTFKDLVG 226
Query: 233 SAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292
SAYYVAPEVLRRNYG EADIWSAGVILYILLSGVPPFWGE EQSIFDA+LRGH+DFSSDP
Sbjct: 227 SAYYVAPEVLRRNYGPEADIWSAGVILYILLSGVPPFWGENEQSIFDAVLRGHLDFSSDP 286
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAM 352
WP+ISSSAKD+VKKML +DPKERLSA +VLNHPWMR DGDASDKP+DIA L+RMKQFRAM
Sbjct: 287 WPSISSSAKDLVKKMLRSDPKERLSATDVLNHPWMREDGDASDKPIDIAALSRMKQFRAM 346
Query: 353 NKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVR 412
NKLKKVALKVIAENLSEEEI+GLKEMFKS+DTD+SGTIT+EELKAGL K+GT+LSESEVR
Sbjct: 347 NKLKKVALKVIAENLSEEEIIGLKEMFKSIDTDDSGTITYEELKAGLTKMGTKLSESEVR 406
Query: 413 QLMEAVSL 420
QLMEA +
Sbjct: 407 QLMEAADV 414
|
Source: Ipomoea nil Species: Ipomoea nil Genus: Ipomoea Family: Convolvulaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 420 | ||||||
| TAIR|locus:2128409 | 529 | CDPK6 "calcium-dependent prote | 0.864 | 0.686 | 0.812 | 1.7e-162 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.857 | 0.681 | 0.75 | 1.3e-148 | |
| TAIR|locus:2150225 | 523 | CPK34 "AT5G19360" [Arabidopsis | 0.857 | 0.688 | 0.747 | 1.2e-147 | |
| TAIR|locus:2015846 | 521 | CPK33 "calcium-dependent prote | 0.864 | 0.696 | 0.713 | 7e-141 | |
| TAIR|locus:2092399 | 541 | CPK9 "calmodulin-domain protei | 0.864 | 0.670 | 0.702 | 1.3e-139 | |
| TAIR|locus:2138897 | 531 | CPK21 "calcium-dependent prote | 0.861 | 0.681 | 0.688 | 5.2e-136 | |
| TAIR|locus:2204340 | 561 | CPK29 "calcium-dependent prote | 0.861 | 0.645 | 0.674 | 8.4e-136 | |
| TAIR|locus:2175503 | 610 | CPK1 "calcium dependent protei | 0.864 | 0.595 | 0.669 | 1.5e-131 | |
| TAIR|locus:2075885 | 646 | CPK2 "calmodulin-domain protei | 0.864 | 0.561 | 0.661 | 3.1e-131 | |
| TAIR|locus:2036783 | 551 | CPK19 "calcium-dependent prote | 0.854 | 0.651 | 0.669 | 5e-131 |
| TAIR|locus:2128409 CDPK6 "calcium-dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1582 (562.0 bits), Expect = 1.7e-162, P = 1.7e-162
Identities = 295/363 (81%), Positives = 334/363 (92%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
LG+PME+VR TY FGRELGRGQFGVTYLVTHK+TKQQ ACKSI +R+L+++DD+EDVRRE
Sbjct: 67 LGRPMEEVRRTYEFGRELGRGQFGVTYLVTHKETKQQVACKSIPTRRLVHKDDIEDVRRE 126
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
VQIMHHL+GHRNIV+LKGAYEDRHSVNLIM+LC GGELFDRII+KG YSERAAA+LCRQM
Sbjct: 127 VQIMHHLSGHRNIVDLKGAYEDRHSVNLIMELCEGGELFDRIISKGLYSERAAADLCRQM 186
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VVH CHSMGVMHRDLKPENFLF S E+SPLKATDFGLSVFFKPGD FKDLVGSAYYV
Sbjct: 187 VMVVHSCHSMGVMHRDLKPENFLFLSKDENSPLKATDFGLSVFFKPGDKFKDLVGSAYYV 246
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVL+RNYG EADIWSAGVILYILLSGVPPFWGE E IFDAIL+G +DFS+DPWP +S
Sbjct: 247 APEVLKRNYGPEADIWSAGVILYILLSGVPPFWGENETGIFDAILQGQLDFSADPWPALS 306
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
AKD+V+KML DPK+RL+AAEVLNHPW+R DG+ASDKPLD AVL+RMKQFRAMNKLKK
Sbjct: 307 DGAKDLVRKMLKYDPKDRLTAAEVLNHPWIREDGEASDKPLDNAVLSRMKQFRAMNKLKK 366
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
+ALKVIAENLSEEEI+GLKEMFKS+DTDN+G +T EEL+ GLPKLG+++SE+E+RQLMEA
Sbjct: 367 MALKVIAENLSEEEIIGLKEMFKSLDTDNNGIVTLEELRTGLPKLGSKISEAEIRQLMEA 426
Query: 418 VSL 420
+
Sbjct: 427 ADM 429
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1451 (515.8 bits), Expect = 1.3e-148, P = 1.3e-148
Identities = 270/360 (75%), Positives = 318/360 (88%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
LG+PMEDV+ +Y G+ELGRGQFGVT+L T K T QFACK+I+ RKL+N++D+EDVRRE
Sbjct: 62 LGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRRE 121
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
VQIMHHLTG NIVELKGAYED+HSV+L+M+LCAGGELFDRIIAKGHYSERAAA+L R +
Sbjct: 122 VQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRTI 181
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V +VH CHSMGV+HRDLKPENFL + E+SPLKATDFGLSVF+KPG+VFKD+VGSAYY+
Sbjct: 182 VQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYI 241
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVL+R YG EADIWS GV+LYILL GVPPFW E+E IF+AILRGH+DFSSDPWP+IS
Sbjct: 242 APEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSIS 301
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
AKD+VKKML++DPK+RL+AA+VLNHPW++ DG+A D PLD AV++R+KQF+AMN KK
Sbjct: 302 PQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFKK 361
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
VAL+VIA LSEEEIMGLKEMFK MDTD+SGTIT EEL+ GL K GTRLSE EV+QLMEA
Sbjct: 362 VALRVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGTRLSEYEVQQLMEA 421
|
|
| TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1442 (512.7 bits), Expect = 1.2e-147, P = 1.2e-147
Identities = 269/360 (74%), Positives = 316/360 (87%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
LG+PMEDV+++Y G+ELGRGQFGVT+L T K T QFACK+I+ RKL+N++D+EDVRRE
Sbjct: 57 LGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVRRE 116
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
VQIMHHLTG NIVELKGAYED+HSV+L+M+LCAGGELFDRIIAKGHYSERAAA+L R +
Sbjct: 117 VQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRTI 176
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V ++H CHSMGV+HRDLKPENFL S E+SPLKATDFGLSVF+KPG+VFKD+VGSAYY+
Sbjct: 177 VQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYI 236
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVLRR YG EADIWS GV+LYILL GVPPFW E+E IF+AIL G +DFSSDPWP IS
Sbjct: 237 APEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVIS 296
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
AKD+V+KML++DPK+RL+AA+VLNHPW++ DG+A D PLD AV++R+KQF+AMN KK
Sbjct: 297 PQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFKK 356
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
VAL+VIA LSEEEIMGLKEMFK MDTDNSGTIT EEL+ GL K GTRLSE EV+QLMEA
Sbjct: 357 VALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAKQGTRLSEYEVQQLMEA 416
|
|
| TAIR|locus:2015846 CPK33 "calcium-dependent protein kinase 33" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1378 (490.1 bits), Expect = 7.0e-141, P = 7.0e-141
Identities = 259/363 (71%), Positives = 306/363 (84%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L KP EDV+ Y +ELGRGQFGVTYL T K T ++FACKSIS +KL+ + D ED+RRE
Sbjct: 62 LEKPYEDVKLFYTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRRE 121
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+QIM HL+G NIVE KGAYED +VNL+M+LCAGGELFDRI+AKGHYSERAAA++CRQ+
Sbjct: 122 IQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYSERAAASVCRQI 181
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VV+ CH MGVMHRDLKPENFL SS E + +KATDFGLSVF + G V+KD+VGSAYYV
Sbjct: 182 VNVVNICHFMGVMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYYV 241
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVL+R YG E DIWSAG+ILYILLSGVPPFW ETE+ IFDAIL G IDF S PWP+IS
Sbjct: 242 APEVLKRRYGKEIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSIS 301
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
+SAKD+V++ML DPK R+SAAEVL HPW+R G+ASDKP+D AVL+RMKQFRAMNKLKK
Sbjct: 302 NSAKDLVRRMLTQDPKRRISAAEVLKHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLKK 361
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
+ALKVIAEN+ EEI GLK MF ++DTDNSGTIT+EELK GL KLG+RL+E+EV+QLM+A
Sbjct: 362 LALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEGLAKLGSRLTEAEVKQLMDA 421
Query: 418 VSL 420
+
Sbjct: 422 ADV 424
|
|
| TAIR|locus:2092399 CPK9 "calmodulin-domain protein kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1366 (485.9 bits), Expect = 1.3e-139, P = 1.3e-139
Identities = 255/363 (70%), Positives = 305/363 (84%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L EDV+ Y G+ELGRGQFGVTYL T T +++ACKSIS +KL+ + D +D+RRE
Sbjct: 80 LENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACKSISKKKLVTKADKDDMRRE 139
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+QIM HL+G NIVE KGAYED +VNL+M+LCAGGELFDRIIAKGHY+ERAAA++CRQ+
Sbjct: 140 IQIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRIIAKGHYTERAAASVCRQI 199
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VV CH MGV+HRDLKPENFL SS E + +KATDFGLSVF + G V++D+VGSAYYV
Sbjct: 200 VNVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGKVYRDIVGSAYYV 259
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVLRR YG E DIWSAG+ILYILLSGVPPFW ETE+ IFDAIL GHIDF S PWP+IS
Sbjct: 260 APEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGHIDFESQPWPSIS 319
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
SSAKD+V++ML ADPK R+SAA+VL HPW+R G+ASDKP+D AVL+RMKQFRAMNKLKK
Sbjct: 320 SSAKDLVRRMLTADPKRRISAADVLQHPWLREGGEASDKPIDSAVLSRMKQFRAMNKLKK 379
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
+ALKVIAEN+ EEI GLK MF ++DTDNSGTIT+EELK GL KLG++L+E+EV+QLM+A
Sbjct: 380 LALKVIAENIDTEEIQGLKAMFANIDTDNSGTITYEELKEGLAKLGSKLTEAEVKQLMDA 439
Query: 418 VSL 420
+
Sbjct: 440 ADV 442
|
|
| TAIR|locus:2138897 CPK21 "calcium-dependent protein kinase 21" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1332 (473.9 bits), Expect = 5.2e-136, P = 5.2e-136
Identities = 250/363 (68%), Positives = 303/363 (83%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
LGKP ED+R Y G+ELGRGQFG+TY+ T +ACKSI RKLI++ D EDV+RE
Sbjct: 69 LGKPFEDIRKFYSLGKELGRGQFGITYMCKEIGTGNTYACKSILKRKLISKQDKEDVKRE 128
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+QIM +L+G NIVE+KGAYEDR S++L+M+LCAGGELFDRIIA+GHYSERAAA + R +
Sbjct: 129 IQIMQYLSGQPNIVEIKGAYEDRQSIHLVMELCAGGELFDRIIAQGHYSERAAAGIIRSI 188
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VV CH MGV+HRDLKPENFL SS E++ LKATDFGLSVF + G V++D+VGSAYYV
Sbjct: 189 VNVVQICHFMGVVHRDLKPENFLLSSKEENAMLKATDFGLSVFIEEGKVYRDIVGSAYYV 248
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVLRR+YG E DIWSAGVILYILLSGVPPFW E E+ IFD +++G IDF S+PWP+IS
Sbjct: 249 APEVLRRSYGKEIDIWSAGVILYILLSGVPPFWAENEKGIFDEVIKGEIDFVSEPWPSIS 308
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
SAKD+V+KML DPK R++AA+VL HPW++ G+A DKP+D AVL+RMKQFRAMNKLKK
Sbjct: 309 ESAKDLVRKMLTKDPKRRITAAQVLEHPWIK-GGEAPDKPIDSAVLSRMKQFRAMNKLKK 367
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
+ALKVIAE+LSEEEI GLK MF ++DTD SGTIT+EELK GL +LG+RLSE+EV+QLMEA
Sbjct: 368 LALKVIAESLSEEEIKGLKTMFANIDTDKSGTITYEELKTGLTRLGSRLSETEVKQLMEA 427
Query: 418 VSL 420
+
Sbjct: 428 ADV 430
|
|
| TAIR|locus:2204340 CPK29 "calcium-dependent protein kinase 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1311 (466.6 bits), Expect = 8.4e-136, Sum P(2) = 8.4e-136
Identities = 245/363 (67%), Positives = 299/363 (82%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L +PM D+ Y +ELGRGQFG+TY T K +++ACKSIS RKLI R D+EDVRRE
Sbjct: 101 LNRPMIDLSALYDLHKELGRGQFGITYKCTDKSNGREYACKSISKRKLIRRKDIEDVRRE 160
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
V I+ HLTG NIVE +GAYED+ +++L+M+LC+GGELFDRII KG YSE+ AAN+ RQ+
Sbjct: 161 VMILQHLTGQPNIVEFRGAYEDKDNLHLVMELCSGGELFDRIIKKGSYSEKEAANIFRQI 220
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VVH CH MGV+HRDLKPENFL S+ EDSP+KATDFGLSVF + G V++D+VGSAYYV
Sbjct: 221 VNVVHVCHFMGVVHRDLKPENFLLVSNEEDSPIKATDFGLSVFIEEGKVYRDIVGSAYYV 280
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVL RNYG E D+WSAGV+LYILLSGVPPFWGETE++IF+AIL G +D + PWP IS
Sbjct: 281 APEVLHRNYGKEIDVWSAGVMLYILLSGVPPFWGETEKTIFEAILEGKLDLETSPWPTIS 340
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
SAKD+++KML DPK+R++AAE L HPWM D SDKP++ AVL RMKQFRAMNKLKK
Sbjct: 341 ESAKDLIRKMLIRDPKKRITAAEALEHPWM-TDTKISDKPINSAVLVRMKQFRAMNKLKK 399
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
+ALKVIAENLSEEEI GLK+ FK+MDTD SGTITF+EL+ GL +LG++L+ESE++QLMEA
Sbjct: 400 LALKVIAENLSEEEIKGLKQTFKNMDTDESGTITFDELRNGLHRLGSKLTESEIKQLMEA 459
Query: 418 VSL 420
+
Sbjct: 460 ADV 462
|
|
| TAIR|locus:2175503 CPK1 "calcium dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1290 (459.2 bits), Expect = 1.5e-131, P = 1.5e-131
Identities = 243/363 (66%), Positives = 292/363 (80%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L + E+ + Y GR+LG+GQFG T+L K T ++FACKSI+ RKL+ +DVEDVRRE
Sbjct: 139 LQRKTENFKEFYSLGRKLGQGQFGTTFLCVEKTTGKEFACKSIAKRKLLTDEDVEDVRRE 198
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+QIMHHL GH N++ +KGAYED +V+L+M+ CAGGELFDRII +GHY+ER AA L R +
Sbjct: 199 IQIMHHLAGHPNVISIKGAYEDVVAVHLVMECCAGGELFDRIIQRGHYTERKAAELTRTI 258
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V VV CHS+GVMHRDLKPENFLF S EDS LK DFGLS+FFKP DVF D+VGS YYV
Sbjct: 259 VGVVEACHSLGVMHRDLKPENFLFVSKHEDSLLKTIDFGLSMFFKPDDVFTDVVGSPYYV 318
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVLR+ YG EAD+WSAGVI+YILLSGVPPFW ETEQ IF+ +L G +DFSSDPWP+IS
Sbjct: 319 APEVLRKRYGPEADVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSIS 378
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
SAKD+V+KML DPK+RL+A +VL HPW++VDG A DKPLD AVL+RMKQF AMNK KK
Sbjct: 379 ESAKDLVRKMLVRDPKKRLTAHQVLCHPWVQVDGVAPDKPLDSAVLSRMKQFSAMNKFKK 438
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
+AL+VIAE+LSEEEI GLKEMF +D D SG ITFEELKAGL ++G L ESE+ LM+A
Sbjct: 439 MALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQA 498
Query: 418 VSL 420
+
Sbjct: 499 ADV 501
|
|
| TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1287 (458.1 bits), Expect = 3.1e-131, P = 3.1e-131
Identities = 240/363 (66%), Positives = 293/363 (80%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L + E+ + Y GR+LG+GQFG T+L K T ++ACKSIS RKL+ +DVEDVRRE
Sbjct: 175 LQRKTENFKEFYSLGRKLGQGQFGTTFLCLEKGTGNEYACKSISKRKLLTDEDVEDVRRE 234
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+QIMHHL GH N++ +KGAYED +V+L+M+LC+GGELFDRII +GHY+ER AA L R +
Sbjct: 235 IQIMHHLAGHPNVISIKGAYEDVVAVHLVMELCSGGELFDRIIQRGHYTERKAAELARTI 294
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
V V+ CHS+GVMHRDLKPENFLF S EDS LK DFGLS+FFKP +VF D+VGS YYV
Sbjct: 295 VGVLEACHSLGVMHRDLKPENFLFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGSPYYV 354
Query: 238 APEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
APEVLR+ YG E+D+WSAGVI+YILLSGVPPFW ETEQ IF+ +L G +DFSSDPWP+IS
Sbjct: 355 APEVLRKRYGPESDVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSIS 414
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
SAKD+V+KML DPK RL+A +VL HPW+++DG A DKPLD AVL+RMKQF AMNK KK
Sbjct: 415 ESAKDLVRKMLVRDPKRRLTAHQVLCHPWVQIDGVAPDKPLDSAVLSRMKQFSAMNKFKK 474
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
+AL+VIAE+LSEEEI GLK+MFK +D DNSG ITFEELKAGL ++G L ESE+ LM+A
Sbjct: 475 MALRVIAESLSEEEIAGLKQMFKMIDADNSGQITFEELKAGLKRVGANLKESEILDLMQA 534
Query: 418 VSL 420
+
Sbjct: 535 ADV 537
|
|
| TAIR|locus:2036783 CPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1285 (457.4 bits), Expect = 5.0e-131, P = 5.0e-131
Identities = 241/360 (66%), Positives = 293/360 (81%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
LG+P ED++ Y GRELGRGQFG+TY+ T + + FACKSI RKLI D EDVRRE
Sbjct: 87 LGRPFEDIKEKYSLGRELGRGQFGITYICTEISSGKNFACKSILKRKLIRTKDREDVRRE 146
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+QIMH+L+G NIVE+KGAYEDR SV+L+M+LC GGELFD+I +GHYSE+AAA + R +
Sbjct: 147 IQIMHYLSGQPNIVEIKGAYEDRQSVHLVMELCEGGELFDKITKRGHYSEKAAAEIIRSV 206
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAE-DSPLKATDFGLSVFFKPGDVFKDLVGSAYY 236
V VV CH MGV+HRDLKPENFL SS E S LKATDFG+SVF + G V++D+VGSAYY
Sbjct: 207 VKVVQICHFMGVIHRDLKPENFLLSSKDEASSMLKATDFGVSVFIEEGKVYEDIVGSAYY 266
Query: 237 VAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296
VAPEVL+RNYG DIWSAGVILYILL G PPFW ET++ IF+ ILRG IDF S+PWP+I
Sbjct: 267 VAPEVLKRNYGKAIDIWSAGVILYILLCGNPPFWAETDKGIFEEILRGEIDFESEPWPSI 326
Query: 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLK 356
S SAKD+V+ ML DPK+R +AA+VL HPW+R G+ASDKP+D AVL+RMKQ RAMNKLK
Sbjct: 327 SESAKDLVRNMLKYDPKKRFTAAQVLEHPWIREGGEASDKPIDSAVLSRMKQLRAMNKLK 386
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416
K+A K IA+NL EEE+ GLK MF +MDTD SGTIT++ELK+GL KLG+RL+E+EV+QL+E
Sbjct: 387 KLAFKFIAQNLKEEELKGLKTMFANMDTDKSGTITYDELKSGLEKLGSRLTETEVKQLLE 446
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q42479 | CDPK3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8114 | 0.8714 | 0.6918 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CPK3 | calcium dependent protein kinase 3 (516 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | eugene3.01330027 | hypothetical protein (876 aa) | • | 0.800 | |||||||
 | eugene3.00121046 | hypothetical protein (907 aa) | • | 0.800 | |||||||
 | eugene3.00010578 | hypothetical protein (927 aa) | • | 0.800 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 420 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-105 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-96 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-72 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-66 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-65 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-64 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-62 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-58 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-56 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-55 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-53 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-52 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-50 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-47 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-46 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-46 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-45 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-44 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-44 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-43 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-43 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-42 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-41 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-41 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-40 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-38 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-38 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-38 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-37 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-37 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-37 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-36 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-36 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-36 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-36 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-35 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-35 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-35 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-34 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-34 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-34 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-33 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-33 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-33 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-32 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-32 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-32 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-32 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-32 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-32 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-31 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-31 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-31 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-31 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-31 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-31 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-31 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-30 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-30 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-30 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-30 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-30 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-30 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-30 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-29 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-29 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-29 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-29 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-29 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-29 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-29 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-29 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-28 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-28 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-28 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-28 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-28 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-28 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-27 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-27 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-27 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-27 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-27 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-27 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-27 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-27 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-27 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-26 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-26 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-26 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-26 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-26 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-26 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-26 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-26 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-26 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-26 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-26 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-26 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-25 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-25 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-25 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-25 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-25 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-25 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-24 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-24 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-24 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-24 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-24 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-23 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-23 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-23 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-22 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-22 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-22 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-20 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-20 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-19 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-18 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-17 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-17 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-11 | |
| cd00051 | 63 | cd00051, EFh, EF-hand, calcium binding motif; A di | 5e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-08 | |
| cd00051 | 63 | cd00051, EFh, EF-hand, calcium binding motif; A di | 1e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-07 | |
| smart00054 | 29 | smart00054, EFh, EF-hand, calcium binding motif | 1e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| pfam00036 | 29 | pfam00036, efhand, EF hand | 3e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-06 | |
| pfam13405 | 30 | pfam13405, EF_hand_4, EF-hand domain | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| COG5126 | 160 | COG5126, FRQ1, Ca2+-binding protein (EF-Hand super | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-04 | |
| pfam13202 | 25 | pfam13202, EF_hand_3, EF hand | 2e-04 | |
| pfam13833 | 53 | pfam13833, EF_hand_6, EF-hand domain pair | 2e-04 | |
| PTZ00183 | 158 | PTZ00183, PTZ00183, centrin; Provisional | 2e-04 | |
| pfam13499 | 60 | pfam13499, EF_hand_5, EF-hand domain pair | 3e-04 | |
| PTZ00184 | 149 | PTZ00184, PTZ00184, calmodulin; Provisional | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| COG5126 | 160 | COG5126, FRQ1, Ca2+-binding protein (EF-Hand super | 9e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.001 | |
| COG5126 | 160 | COG5126, FRQ1, Ca2+-binding protein (EF-Hand super | 0.002 | |
| PTZ00183 | 158 | PTZ00183, PTZ00183, centrin; Provisional | 0.002 | |
| PTZ00184 | 149 | PTZ00184, PTZ00184, calmodulin; Provisional | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.004 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 312 bits (801), Expect = e-105
Identities = 109/261 (41%), Positives = 150/261 (57%), Gaps = 9/261 (3%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y +LG G FG YL K T + A K I +K+ + D E + RE++I+ L H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKL-KHP 57
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
NIV L +ED + L+M+ C GG+LFD + +G SE A RQ+++ + Y HS G
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YG 247
++HRDLKPEN L ED +K DFGL+ PG+ VG+ Y+APEVL YG
Sbjct: 118 IVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKDIVKK 306
DIWS GVILY LL+G PPF G+ + +F I + F W +IS AKD+++K
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEW-DISPEAKDLIRK 233
Query: 307 MLHADPKERLSAAEVLNHPWM 327
+L DP++RL+A E L HP+
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 287 bits (737), Expect = 7e-96
Identities = 106/265 (40%), Positives = 146/265 (55%), Gaps = 11/265 (4%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y R+LG G FG Y HK T + A K + R + RRE++I+ L H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRL-SHP 58
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
NIV L A+ED+ + L+M+ C GG+LFD + G SE A + Q++ + Y HS G
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEVLR--RN 245
++HRDLKPEN L E+ +K DFGL+ K VG+ +Y+APEVL
Sbjct: 119 IIHRDLKPENILLD---ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGE---TEQSIFDAILRGHIDFSSDPWPNISSSAKD 302
YG + D+WS GVILY LL+G PPF GE + + IL ++F W + S AKD
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 303 IVKKMLHADPKERLSAAEVLNHPWM 327
++KK L+ DP +R +A E+L HPW
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 2e-72
Identities = 93/258 (36%), Positives = 140/258 (54%), Gaps = 13/258 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG LV KDT + +A K + +K+I R +VE E I+ + H IV+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++ + L+++ GGELF + +G +SE A ++V + Y HS+G+++RDL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 195 KPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
KPEN L D +K TDFGL+ G G+ Y+APEVL YG D
Sbjct: 120 KPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
WS GV+LY +L+G PPF+ E + I++ IL+ + F +S A+D++ +L DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDP 232
Query: 313 KERL---SAAEVLNHPWM 327
+RL A E+ HP+
Sbjct: 233 TKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 9e-66
Identities = 83/261 (31%), Positives = 138/261 (52%), Gaps = 18/261 (6%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+++G+G FG YLV K + + K I + + + ED EV+I+ L H NI++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIK 63
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRI----IAKGHYSERAAANLCRQMVTVVHYCHSMG 188
++E++ + ++M+ GG+L +I + E + Q+ + Y HS
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 189 VMHRDLKPEN-FLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN- 245
++HRD+KP+N FL S + +K DFG+S V D+ K +VG+ YY++PE+ +
Sbjct: 124 ILHRDIKPQNIFLTS----NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI-SSSAKDIV 304
Y ++DIWS G +LY L + PF GE + IL+G P P+ SS +++V
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----PPIPSQYSSELRNLV 235
Query: 305 KKMLHADPKERLSAAEVLNHP 325
+L DP+ER S A++L P
Sbjct: 236 SSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 2e-65
Identities = 88/286 (30%), Positives = 140/286 (48%), Gaps = 33/286 (11%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ + FG+ +G G F L K+T +++A K + R+LI V+ V+ E +++ L G
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
H I++L ++D ++ +++ GEL I G E+ +++ + Y HS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-------------------- 226
G++HRDLKPEN L +D +K TDFG + P
Sbjct: 121 KGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 227 -FKDLVGSAYYVAPEVLRRNY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG 284
F VG+A YV+PE+L G +D+W+ G I+Y +L+G PPF G E F IL+
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237
Query: 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERL----SAAEVLNHPW 326
F PN AKD+++K+L DP++RL E+ HP+
Sbjct: 238 EYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 4e-64
Identities = 89/255 (34%), Positives = 126/255 (49%), Gaps = 44/255 (17%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG G FG YL K T ++ A K I + +E++ RE++I+ L H NIV+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLN-HPNIVKLY 57
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
G +ED + + L+M+ C GG L D + G SE + Q++ + Y HS G++HRD
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAPEVLRRN--YGAEA 250
LKPEN L S ++ +K DFGLS + K +VG+ Y+APEVL Y ++
Sbjct: 118 LKPENILLDS--DNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 251 DIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310
DIWS GVILY L KD+++KML
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200
Query: 311 DPKERLSAAEVLNHP 325
DP++R SA E+L H
Sbjct: 201 DPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 4e-62
Identities = 91/265 (34%), Positives = 138/265 (52%), Gaps = 19/265 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+ +G +G +L K T +A K I +I ++ V+ V E I+ +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLY 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + ++ L+M+ GG+L + G E A ++V + Y HS G++HRDL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVF-------FKPGDVFKD--LVGSAYYVAPEV-LRR 244
KP+N L S+ LK TDFGLS D +D +VG+ Y+APEV L +
Sbjct: 120 KPDNILIDSNGH---LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
+ D WS G ILY L G+PPF GET + IF IL G I++ D +S A D++
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234
Query: 305 KKMLHADPKERL---SAAEVLNHPW 326
K+L DP++RL S E+ NHP+
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPF 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 9e-58
Identities = 91/266 (34%), Positives = 136/266 (51%), Gaps = 20/266 (7%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
G LGRG FG YL KDT + A KS+ + +++E + RE++I+ L H NIV
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSG-DSEEELEALEREIRILSSLQ-HPNIV 62
Query: 132 ELKGAYEDR--HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
G+ D +++N+ ++ +GG L + G E RQ++ + Y HS G+
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGI 122
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK---PGDVFKDLVGSAYYVAPEVLRRN- 245
+HRD+K N L S +K DFG + G+ + G+ Y++APEV+R
Sbjct: 123 VHRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI----SSSAK 301
YG ADIWS G + + +G PP W E A+ I S +P P I S AK
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP-WSELGNP-MAALY--KIGSSGEP-PEIPEHLSEEAK 234
Query: 302 DIVKKMLHADPKERLSAAEVLNHPWM 327
D ++K L DPK+R +A E+L HP++
Sbjct: 235 DFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 6e-56
Identities = 86/262 (32%), Positives = 135/262 (51%), Gaps = 18/262 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG G FG LV K + FA K + R ++ E + E +I+ H IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILE-ECNHPFIVKLY 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++D+ + ++M+ C GGEL+ + +G + E A +V Y H+ G+++RDL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV-LRRNYGAEADIW 253
KPEN L S+ +K DFG + K G G+ YVAPE+ L + Y D W
Sbjct: 120 KPENLLLDSNGY---VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 254 SAGVILYILLSGVPPFWGETE--QSIFDAILRG--HIDFSSDPWPNISSSAKDIVKKMLH 309
S G++LY LL+G PPF + E I++ IL+G ++F + I +AKD++K++L
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN----YIDKAAKDLIKQLLR 232
Query: 310 ADPKERL-----SAAEVLNHPW 326
+P+ERL ++ H W
Sbjct: 233 RNPEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 7e-55
Identities = 93/274 (33%), Positives = 146/274 (53%), Gaps = 17/274 (6%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ + F + LG G FG LV HK + + +A K +S K++ VE V E +I+ +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR- 59
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
H +V L G+++D ++ L+M+ GGELF + G + E A Q+V + Y HS
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV-LRRN 245
+ +++RDLKPEN L S D +K TDFG + K L G+ Y+APE+ L +
Sbjct: 120 LDIVYRDLKPENLLLDS---DGYIKITDFGFAKRVKGRT--YTLCGTPEYLAPEIILSKG 174
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305
YG D W+ G+++Y +L+G PPF+ + I++ IL G + F S S AKD+++
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIR 230
Query: 306 KMLHADPKERL-----SAAEVLNHPWMR-VDGDA 333
+L D +RL ++ NHPW +D A
Sbjct: 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA 264
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 3e-53
Identities = 81/258 (31%), Positives = 131/258 (50%), Gaps = 14/258 (5%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
++G+G FG Y HK T ++ A K I + E + E+QI+ H NIV+
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVK 61
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMH 191
G+Y + + ++M+ C+GG L D + + +E A +C++++ + Y HS G++H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEA 250
RD+K N L +S E +K DFGLS +VG+ Y++APEV+ Y +A
Sbjct: 122 RDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 251 DIWSAGVILYILLSGVPPFWGETEQSIFDAILR-GHIDFSSDPWP-NISSSAKDIVKKML 308
DIWS G+ L G PP+ +E A+ + P S KD +KK L
Sbjct: 179 DIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL 235
Query: 309 HADPKERLSAAEVLNHPW 326
+P++R +A ++L HP+
Sbjct: 236 QKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 5e-52
Identities = 81/262 (30%), Positives = 130/262 (49%), Gaps = 8/262 (3%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ R +G+G FG +V +DTK+ FA K ++ +K + + V +V E +I+ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HP 60
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+V L +++D ++ L++DL GG+L + K +SE ++V + Y HS G
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL-RRNYG 247
++HRD+KP+N L E + TDF ++ P + G+ Y+APEVL R+ Y
Sbjct: 121 IIHRDIKPDNILLD---EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
D WS GV Y L G P+ G + D I S+ A D + K+
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRAKQETADVLYPATWSTEAIDAINKL 236
Query: 308 LHADPKERLSAA--EVLNHPWM 327
L DP++RL ++ NHP+
Sbjct: 237 LERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 173 bits (437), Expect = 6e-50
Identities = 96/295 (32%), Positives = 139/295 (47%), Gaps = 30/295 (10%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y R+LG G FG YL + + A K ++ + +VE RE+QI+ L
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRI---IAKGHYSERAAANLCRQMVTVVHYCH 185
NIV+L ++D S+ L+M+ GG L D + KG SE A + Q+++ + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-------FKDLVGSAYYVA 238
S G++HRD+KPEN L + +K DFGL+ VG+ Y+A
Sbjct: 119 SKGIIHRDIKPENILLDR--DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 239 PEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-------- 286
PEVL + +DIWS G+ LY LL+G+PPF GE S L+ I
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK-IILELPTPSL 235
Query: 287 --DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLD 339
S IS +A D++KK+L DPK RLS++ L+H + D
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290
|
Length = 384 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-47
Identities = 80/260 (30%), Positives = 128/260 (49%), Gaps = 10/260 (3%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ + +G FG YL + T FA K + +I ++ V +V+ E IM + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L +++ + + L+M+ GG+ I G E A ++V V H G++HR
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEA-D 251
D+KPEN L + LK TDFGLS + G K VG+ Y+APE + + D
Sbjct: 122 DIKPENLLIDQTGH---LKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311
WS G +++ L G PPF ET ++FD IL I++ + S A D++ ++L D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 312 PKERLSA---AEVLNHPWMR 328
P +RL A E+ +HP+ +
Sbjct: 236 PAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 37/286 (12%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG +LV KDT Q +A K + +I R+ + VR E I+ IV+L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-PWIVKLY 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++D + L+M+ GG+L + +I K + E A ++V + H +G +HRD+
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLS--------------------------VFFKPGDV-- 226
KP+N L + +K DFGL V +
Sbjct: 128 KPDNILIDADGH---IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184
Query: 227 --FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR 283
VG+ Y+APEVLR YG E D WS GVILY +L G PPF+ +T Q ++ I+
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIIN 244
Query: 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAE-VLNHPWMR 328
P P +S A D++ ++L DP++RL + E + +HP+ +
Sbjct: 245 WKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 4e-46
Identities = 80/266 (30%), Positives = 126/266 (47%), Gaps = 18/266 (6%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH 127
Y G +GRG FGV Y + +T A K IS K I + ++ + +E+ ++ +L H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLK-H 58
Query: 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM 187
NIV+ G+ E S+ +I++ G L I G + E A Q++ + Y H
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEVLR-RN 245
GV+HRD+K N L + +D +K DFG++ +VG+ Y++APEV+
Sbjct: 119 GVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP----NISSSAK 301
+DIWS G + LL+G PP++ + I D P IS K
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI-------VQDDHPPLPEGISPELK 228
Query: 302 DIVKKMLHADPKERLSAAEVLNHPWM 327
D + + DP R +A ++L HPW+
Sbjct: 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-45
Identities = 81/264 (30%), Positives = 128/264 (48%), Gaps = 20/264 (7%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
LG+G GV Y V HK T + +A K I + D E+ R RE++ +
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKI------HVDGDEEFRKQLLRELKTLRS-CESPY 60
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-G 188
+V+ GA+ ++++++ GG L D + G E A + RQ++ + Y H+
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFKDLVGSAYYVAPEVLR-RNY 246
++HRD+KP N L +S E +K DFG+S + D VG+ Y++PE ++ +Y
Sbjct: 121 IIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY 177
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP--NISSSAKDIV 304
ADIWS G+ L G PF Q F +++ D P S +D +
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLP-PGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236
Query: 305 KKMLHADPKERLSAAEVLNHPWMR 328
L DPK+R SAAE+L HP+++
Sbjct: 237 SACLQKDPKKRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 8e-45
Identities = 80/266 (30%), Positives = 136/266 (51%), Gaps = 17/266 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G G FG +LV + ++ +A K ++ ++I + V E +++ ++ H I+ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLF 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
D+ + ++M+ GGELF + G +S ++V + Y HS +++RDL
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL-RRNYGAEADIW 253
KPEN L + +K TDFG + K D L G+ Y+APEV+ + + D W
Sbjct: 128 KPENILLDK---EGHIKLTDFGFAK--KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWW 182
Query: 254 SAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPK 313
+ G+++Y +L G PPF+ + I++ IL G ++F ++ AKD++KK+L D
Sbjct: 183 ALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKLLVVDRT 238
Query: 314 ERL-----SAAEVLNHPWMR-VDGDA 333
RL A +V NH W + VD D
Sbjct: 239 RRLGNMKNGADDVKNHRWFKSVDWDD 264
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 83/293 (28%), Positives = 131/293 (44%), Gaps = 47/293 (16%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD---VEDVRREVQIMHHLT 125
Y +LG G +GV Y K T + A K I +L N ++ +R E+ ++ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI---RLDNEEEGIPSTALR-EISLLKELK 56
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAK--GHYSERAAANLCRQMVTVV 181
H NIV+L + L+ + C D + + K G S ++ Q++ +
Sbjct: 57 -HPNIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAPE 240
YCHS ++HRDLKP+N L + LK DFGL+ F P + V + +Y APE
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGV---LKLADFGLARAFGIPLRTYTHEVVTLWYRAPE 168
Query: 241 VL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAI----------LRG 284
+L ++Y DIWS G I +++G P F G++E IF + +
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228
Query: 285 HIDFSSDP--W---------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
D+ + P + D++ KML +P +R+SA E L HP+
Sbjct: 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 8e-44
Identities = 80/271 (29%), Positives = 124/271 (45%), Gaps = 33/271 (12%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
+G+G FG V K + K I + ++ + V EV I+ L H NIV
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-EVNILRELK-HPNIVR- 63
Query: 134 KGAYEDR------HSVNLIMDLCAGGELFDRIIAK-----GHYSERAAANLCRQMVTVVH 182
Y DR ++ ++M+ C GG+L ++I K + E + Q++ ++
Sbjct: 64 ---YYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 183 YCH-----SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-KDLVGSAYY 236
CH V+HRDLKP N +F + + +K DFGL+ F K VG+ YY
Sbjct: 120 ECHNRSDPGNTVLHRDLKPAN-IFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYY 176
Query: 237 VAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295
++PE L Y ++DIWS G ++Y L + PPF + + I G P
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF----RRIPY 232
Query: 296 ISSSA-KDIVKKMLHADPKERLSAAEVLNHP 325
SS +++K ML+ DP +R S E+L P
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 83/291 (28%), Positives = 129/291 (44%), Gaps = 39/291 (13%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-VRREVQIMHHLTG 126
Y +G G G+ + ++T + A K ++ R+L + + RE++ +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQAC-Q 57
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCH 185
H +V+L + L+M+ L + + + E + R ++ V Y H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--VFKDLVGSAYYVAPEVL- 242
+ G+MHRDLKP N L S+ D LK DFGL+ F + ++ V + +Y APE+L
Sbjct: 117 ANGIMHRDLKPANLLISA---DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 243 -RRNYGAEADIWSAGVILYILLSGVPPFWGET--EQ--SIFDAI---------------L 282
R Y D+W+ G I LL+G P F GE EQ +F +
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233
Query: 283 RGHIDFSSD---PW----PNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
I F P P+ S A D++K +L DP +RLSAAE L HP+
Sbjct: 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 7e-43
Identities = 89/264 (33%), Positives = 128/264 (48%), Gaps = 19/264 (7%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
++G+G +G +L KDT + A K + L ++V V E I+ T +V+L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
A++D + L M+ GG+ + G SE A +M V H +G +HRD
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADI 252
LKPENFL +S +K TDFGLS +VGS Y+APEVLR + Y D
Sbjct: 127 LKPENFLIDASGH---IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDY 181
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAIL-------RGHIDFSSDPWPNISSSAKDIVK 305
WS G +LY L G PPF G T ++ + R D DP N+S A D++
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYD---DPRFNLSDEAWDLIT 238
Query: 306 KMLHADPKERLSAAE-VLNHPWMR 328
K++ DP R + E + NHP+ +
Sbjct: 239 KLI-NDPSRRFGSLEDIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 2e-42
Identities = 89/277 (32%), Positives = 140/277 (50%), Gaps = 37/277 (13%)
Query: 78 GQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN--IVELKG 135
G +G YLV HK+T+Q+FA K I+ + LI R+ ++ V E I LT N +V +
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI---LTFAENPFVVSMFC 68
Query: 136 AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLK 195
++E + + ++M+ GG+ + G A + V + Y H+ G++HRDLK
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128
Query: 196 PENFLFSSSAEDSPLKATDFGLS--------VFFKPGDVFKD--------LVGSAYYVAP 239
P+N L +S +K TDFGLS G + KD + G+ Y+AP
Sbjct: 129 PDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185
Query: 240 EV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN--- 295
EV LR+ YG D W+ G+ILY L G PF+G+T + +F ++ I+ WP
Sbjct: 186 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-----WPEGDE 240
Query: 296 -ISSSAKDIVKKMLHADPKERL---SAAEVLNHPWMR 328
+ + A+D++ ++L +P ERL A EV H +
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 42/287 (14%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHLTGHRNI 130
++G G +GV Y K T + A K I R + RE++++ L H NI
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELN-HPNI 60
Query: 131 VELKGAYEDRHSVNLIMDLCAGG--ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
++L + + + L+ + +L + E + Q++ + +CHS G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVL--RRN 245
++HRDLKPEN L + + LK DFGL+ F P + V + +Y APE+L +
Sbjct: 119 ILHRDLKPENLLIN---TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 246 YGAEADIWSAGVILYILLSGVPPFWG--ETEQ--SIFDAI-------LRGHIDFSSD--- 291
Y DIWS G I LLS P F G E +Q IF + + +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235
Query: 292 --------PW----PNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
P PN S A D++ +MLH DP +R++A + L HP+
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 5e-41
Identities = 84/295 (28%), Positives = 136/295 (46%), Gaps = 49/295 (16%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-----VRREVQIMHH 123
Y G++LG G + V Y K+T + A K I KL R + +D RE++++
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTALREIKLLQE 58
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAG---GELFDRII--AKGHYSERAAANLCRQMV 178
L H NI+ L + + ++NL+ + + D+ I + +
Sbjct: 59 LK-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIK-----SYMLMTL 112
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYV 237
+ Y HS ++HRDLKP N L +S D LK DFGL+ F P V + +Y
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIAS---DGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169
Query: 238 APEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAI---------- 281
APE+L R+YG D+WS G I LL VP G+++ IF+A+
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 282 ---LRGHIDFSSDP-------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
L +++F P +P S A D+++++L +P +R++A + L HP+
Sbjct: 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 5e-40
Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 16/263 (6%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
G LG G FG + HK T + +A K + R+++ V+ V +E I+ L+ H IV
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIV 81
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+ +++D + V +++ GGELF + G + A ++V Y HS +++
Sbjct: 82 NMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIY 141
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEA 250
RDLKPEN L + +K TDFG + K D L G+ Y+APEV++ + +G
Sbjct: 142 RDLKPENLLLDN---KGHVKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVIQSKGHGKAV 196
Query: 251 DIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310
D W+ GV+LY ++G PPF+ +T I++ IL G + F + W A+D+VK +L
Sbjct: 197 DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGLLQT 252
Query: 311 DPKERLSA-----AEVLNHPWMR 328
D +RL A+V NHP+
Sbjct: 253 DHTKRLGTLKGGVADVKNHPYFH 275
|
Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 89/293 (30%), Positives = 140/293 (47%), Gaps = 43/293 (14%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ LG+G G +LV K T + FA K + +++I R+ V+ V E +I+ H +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL-ATLDHPFLPT 65
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
L +++ + L+MD C GGELF + SE A +++ + Y H +G++
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSV----------------------------FFK 222
+RDLKPEN L E + +DF LS F
Sbjct: 126 YRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 223 PGDVFK--DLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFD 279
F+ VG+ Y+APEV+ + +G+ D W+ G++LY +L G PF G F
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL----SAAEVLNHPWMR 328
IL+ + F P +SSSA+D+++K+L DP +RL AAE+ HP+ R
Sbjct: 243 NILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-38
Identities = 84/269 (31%), Positives = 138/269 (51%), Gaps = 17/269 (6%)
Query: 73 RELGRGQFGVTYLV---THKDTKQQFACKSISSRKLINR-DDVEDVRREVQIMHHLTGHR 128
R LG G +G +LV D + +A K + ++ + E R E Q++ +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+V L A++ ++LI+D GGELF + + H++E ++V + + H +G
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK--DLVGSAYYVAPEVLRR-- 244
+++RD+K EN L S + + TDFGLS F + + G+ Y+APEV+R
Sbjct: 126 IIYRDIKLENILLDS---EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182
Query: 245 -NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN-ISSSAKD 302
+ D WS GV+ + LL+G PF + EQ+ I R I S P+P +S+ A+D
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR-RILKSKPPFPKTMSAEARD 241
Query: 303 IVKKMLHADPKERL---SAAEVLNHPWMR 328
++K+L DPK+RL A E+ NHP+ +
Sbjct: 242 FIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 6e-38
Identities = 82/270 (30%), Positives = 132/270 (48%), Gaps = 16/270 (5%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
D R Y ++G G G Y T + T ++ A K + + + + E + E+ IM
Sbjct: 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMK 70
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY-SERAAANLCRQMVTVV 181
H NIV+ +Y + ++M+ GG L D I +E A +CR+++ +
Sbjct: 71 DCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDLVGSAYYVAPE 240
Y HS V+HRD+K +N L S +K DFG + K +VG+ Y++APE
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186
Query: 241 VLRRN-YGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFS-SDPWPNIS 297
V++R YG + DIWS G++ + G PP+ E +++F +G + W S
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW---S 243
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
KD + K L DP++R SA E+L HP++
Sbjct: 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 82/302 (27%), Positives = 126/302 (41%), Gaps = 68/302 (22%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--------REVQIMHHL 124
++G G +G Y +K T + A K I +E+ + RE++++ L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI---------RMENEKEGFPITAIREIKLLQKL 55
Query: 125 TGHRNIVELKGAYEDRHSVNLIM-------DLCAGGELFDRIIAKGHYSERAAANLCRQM 177
H NIV LK + ++ M DL G L D + ++E +Q+
Sbjct: 56 R-HPNIVRLKEIVTSKGKGSIYMVFEYMDHDL-TG--LLDS--PEVKFTESQIKCYMKQL 109
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP--GDVFKDLVGSAY 235
+ + Y HS G++HRD+K N L ++ LK DFGL+ + + + V + +
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLW 166
Query: 236 YVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR--GHIDFSSD 291
Y PE+L YG E D+WS G IL L G P F G TE + I G +
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN- 225
Query: 292 PWPN---------------------------ISSSAKDIVKKMLHADPKERLSAAEVLNH 324
WP I SA D++ K+L DPK+R+SA + L H
Sbjct: 226 -WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284
Query: 325 PW 326
+
Sbjct: 285 EY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 81/261 (31%), Positives = 126/261 (48%), Gaps = 16/261 (6%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACK--SISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
G LG G FG Y + D FA K S++ ++ V+ + +E+ ++ L H N
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPN 63
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
IV+ G + ++ + ++L GG L + G + E RQ++ + Y H
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYG 247
+HRD+K N L ++ +K DFG++ K GS Y++APEV+ + YG
Sbjct: 124 VHRDIKGANILVDTNGV---VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD--PWPN-ISSSAKDIV 304
ADIWS G + + +G PP W + E A+ I S + P P+ +S AKD +
Sbjct: 181 LAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVF--KIGRSKELPPIPDHLSDEAKDFI 235
Query: 305 KKMLHADPKERLSAAEVLNHP 325
K L DP R +AAE+L HP
Sbjct: 236 LKCLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 92/297 (30%), Positives = 133/297 (44%), Gaps = 47/297 (15%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMH 122
N Y +G G +GV +K T + A K K +D EDV+ REV+++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLR 55
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR-QMVTVV 181
L H NIV LK A+ + + L+ + L + + A A Q++ +
Sbjct: 56 QLR-HENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAI 113
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF--KPGDVFKDLVGSAYYVAP 239
YCHS ++HRD+KPEN L S E LK DFG + +P D V + +Y AP
Sbjct: 114 AYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE--------QSIFDAILRGHIDFS 289
E+L NYG D+W+ G I+ LL G P F G+++ + + FS
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230
Query: 290 SDP-------------------WPNISSS-AKDIVKKMLHADPKERLSAAEVLNHPW 326
S+P +P SS A D +K L DPKERL+ E+L HP+
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 85/293 (29%), Positives = 137/293 (46%), Gaps = 44/293 (15%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y ++LG G FG YL +K+T + A K + +K + ++ ++R EV+ + L H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLR-EVKSLRKLNEHP 58
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHS 186
NIV+LK + + + + + G L+ + +SE ++ Q++ + + H
Sbjct: 59 NIVKLKEVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-- 244
G HRDLKPEN L S +K DFGL+ + + D V + +Y APE+L R
Sbjct: 118 HGFFHRDLKPENLLVSGP---EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST 174
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWG--ETEQ--SIFDAILRGHIDFSSDPW------- 293
+Y + DIW+ G I+ L + P F G E +Q I ++L G + W
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKIC-SVL-GT--PTKQDWPEGYKLA 230
Query: 294 -------------------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
PN S A D++K ML DPK+R +A++ L HP+
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 88/283 (31%), Positives = 141/283 (49%), Gaps = 25/283 (8%)
Query: 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
G P + N ++ ++G G G+ + T K T +Q A K + RK R E + EV
Sbjct: 15 GDPRSYLDN-FV---KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR---ELLFNEV 67
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV 178
IM H NIVE+ +Y + ++M+ GG L D I+ +E A +C ++
Sbjct: 68 VIMRDYQ-HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVL 125
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD------LVG 232
+ + H+ GV+HRD+K ++ L +S D +K +DFG V K+ LVG
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFC-----AQVSKEVPRRKSLVG 177
Query: 233 SAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291
+ Y++APEV+ R YG E DIWS G+++ ++ G PP++ E I +
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKN 237
Query: 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDAS 334
+S + + +ML DP +R +AAE+LNHP++ G S
Sbjct: 238 L-HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 83/261 (31%), Positives = 132/261 (50%), Gaps = 15/261 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG LV K T + +A K + +I +D+V E +++ + T H + LK
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTALK 61
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + +M+ GGELF + + +SE A ++V+ + Y HS V++RDL
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
K EN + +D +K TDFGL G K G+ Y+APEVL N YG D
Sbjct: 122 KLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W GV++Y ++ G PF+ + + +F+ IL I F +S AK ++ +L DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 234
Query: 313 KERL-----SAAEVLNHPWMR 328
K+RL A E++ H +
Sbjct: 235 KQRLGGGPEDAKEIMEHRFFA 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 78/268 (29%), Positives = 130/268 (48%), Gaps = 22/268 (8%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
G ++G G FG Y + DT + A K I + + ++++ E++++ L H N+V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLK-HPNLV 62
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+ G R V + M+ C+GG L + + E Q++ + Y HS G++H
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-----GDVFKDLVGSAYYVAPEVLRRN- 245
RD+KP N + +K DFG +V K G+ + L G+ Y+APEV+
Sbjct: 123 RDIKPANIFLDHN---GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 246 ---YGAEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDPWP---NISS 298
+G ADIWS G ++ + +G P+ + E I + GH P P +S
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH----KPPIPDSLQLSP 235
Query: 299 SAKDIVKKMLHADPKERLSAAEVLNHPW 326
KD + + L +DPK+R +A+E+L HP+
Sbjct: 236 EGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 88/267 (32%), Positives = 132/267 (49%), Gaps = 18/267 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV HK +KQ +A K +S ++I R D E IM H IV+L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW-IVQLH 109
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++D + ++M+ GG+L + +++ E+ A ++V + HSMG +HRD+
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDV 168
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDL-VGSAYYVAPEVLRRN-----YG 247
KP+N L S LK DFG + G V D VG+ Y++PEVL+ YG
Sbjct: 169 KPDNMLLDKSGH---LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL--RGHIDFSSDPWPNISSSAKDIVK 305
E D WS GV LY +L G PF+ ++ + I+ + + F D IS AKD++
Sbjct: 226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD--IEISKQAKDLIC 283
Query: 306 KMLHADPKE--RLSAAEVLNHPWMRVD 330
L R E+ +HP+ + D
Sbjct: 284 AFLTDREVRLGRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 9e-36
Identities = 80/265 (30%), Positives = 134/265 (50%), Gaps = 25/265 (9%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN----RDDVEDVRREVQIMHHL--TGHR 128
+GRG +G Y H T + A K +IN DDV D++REV ++ L +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALK------IINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSM 187
NI + G+Y + +IM+ GG + R + K G +E+ + + R+++ + Y H +
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLR--R 244
GV+HRD+K N L +++ +K DFG++ + VG+ Y++APEV+ +
Sbjct: 121 GVIHRDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI-LRGHIDFSSDPWPNISSSAKDI 303
Y +ADIWS G+ +Y + +G PP+ ++ F A+ L S ++
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF 234
Query: 304 VKKMLHADPKERLSAAEVLNHPWMR 328
V L +PKERLSA E+L W++
Sbjct: 235 VAACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 88/269 (32%), Positives = 142/269 (52%), Gaps = 23/269 (8%)
Query: 73 RELGRGQFGVTYLV---THKDTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHR 128
+ LG+G +G + V T DT + FA K + ++ N+ D + E I+ + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
IV+L A++ + LI++ +GGELF + +G + E A ++ + + H G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGL---SVFFKPGDVFKDLVGSAYYVAPEVLRRN 245
+++RDLKPEN L + +K TDFGL S+ G V G+ Y+APE+L R+
Sbjct: 121 IIYRDLKPENILLDAQGH---VKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRS 175
Query: 246 -YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
+G D WS G ++Y +L+G PPF E + D IL+G ++ P ++ A+D++
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231
Query: 305 KKMLHADPKERL-----SAAEVLNHPWMR 328
KK+L +P RL AAEV +HP+ R
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 7e-35
Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 21/272 (7%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ LG+G FG L K T + +A K + ++ DDVE E +++ H + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L ++ + + +M+ GG+L I G + E A ++V + + H G+++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFK----PGDVFKDLVGSAYYVAPEVLR-RNYG 247
DLK +N L S + +K DFG+ K G G+ Y+APE+L + YG
Sbjct: 121 DLKLDNVLLDS---EGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
D W+ GV+LY +L+G PF G+ E +F +IL + + +S AK I+K
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSF 230
Query: 308 LHADPKERLSA-----AEVLNHPWMR-VDGDA 333
L +P++RL ++ HP+ R +D D
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDWDK 262
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 8e-35
Identities = 88/313 (28%), Positives = 137/313 (43%), Gaps = 64/313 (20%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-RDDVEDVR---REVQIMHHLTGHR 128
+ +G G +GV K T ++ A K K+ N DD+ D + RE++++ HL H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIK-----KISNVFDDLIDAKRILREIKLLRHL-RHE 59
Query: 129 NIVELK-----GAYEDRHSVNLIMDLCAGGELFD----RII-AKGHYSERAAANLCRQMV 178
NI+ L + ED + V ++ EL + ++I + ++ Q++
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVT------ELMETDLHKVIKSPQPLTDDHIQYFLYQIL 113
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK----DLVGSA 234
+ Y HS V+HRDLKP N L +S + LK DFGL+ P + K + V +
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNS---NCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 235 YYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAI------- 281
+Y APE+L Y DIWS G I LL+ P F G I + +
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230
Query: 282 -----------------LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
+ S +P S A D+++KML DPK+R++A E L H
Sbjct: 231 LKFITSEKARNYLKSLPKKPKKPL-SKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289
Query: 325 PWMRVDGDASDKP 337
P++ D D+P
Sbjct: 290 PYLAQLHDPEDEP 302
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 89/279 (31%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
ELG G FG Y HK+T A K I ++ + +++ED E+ I+ H NIV L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECK-HPNIVGL 67
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHR 192
AY + + ++++ C GG L ++ +E +CRQM+ +++ HS V+HR
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVL------RRN 245
DLK N L + + +K DFG+S K +D +G+ Y++APEV+
Sbjct: 128 DLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI------SSS 299
Y +ADIWS G+ L L PP E + +L+ S+P P + SSS
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP---HHELNPMRVLLK---ILKSEP-PTLDQPSKWSSS 237
Query: 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338
D +K L DP +R +AAE+L HP++ D K +
Sbjct: 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN--KAI 274
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 84/269 (31%), Positives = 132/269 (49%), Gaps = 31/269 (11%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
ELG G GV V H+ T + A K+I R IN + + RE+ I+H IV
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCN-SPYIVG 63
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRII--AKGHYSERAAANLCRQMVTVVHYCHS-MGV 189
GA+ + +++ M+ GG L D+I+ +G ER + ++ + Y H +
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG----DVFKDLVGSAYYVAPEVLRRN 245
+HRD+KP N L +S + +K DFG+S G + K VG++ Y+APE ++ N
Sbjct: 123 IHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERIQGN 174
Query: 246 -YGAEADIWSAGVILYILLSG-VP-PFWGETEQSIFDAILRGHID-----FSSDPWPNIS 297
Y ++DIWS G+ L L +G P P + IF+ +L+ ++ S + S
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE-LLQYIVNEPPPRLPSGKF---S 230
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPW 326
+D V L DP+ER S E+L HP+
Sbjct: 231 PDFQDFVNLCLIKDPRERPSYKELLEHPF 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 84/287 (29%), Positives = 134/287 (46%), Gaps = 42/287 (14%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI---- 130
+G+G FG Y V KDT++ +A K +S ++++ + +V H G RNI
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVA----------HTIGERNILVRT 50
Query: 131 --------VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
V LK +++ + L+ D +GGELF + +G +SE A ++V +
Sbjct: 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALE 110
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP----GDVFKDLVGSAYYVA 238
+ H +++RDLKPEN L + + DFGLS K G+ Y+A
Sbjct: 111 HLHKYDIVYRDLKPENILLDA---TGHIALCDFGLS---KANLTDNKTTNTFCGTTEYLA 164
Query: 239 PEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296
PEVL + Y D WS GV+++ + G PF+ E Q ++ I G + F P +
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVL 221
Query: 297 SSSAKDIVKKMLHADPKERLSA----AEVLNHPWMR-VDGDASDKPL 338
S + VK +L+ +P+ RL A E+ HP+ +D D K
Sbjct: 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQ 268
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 82/280 (29%), Positives = 131/280 (46%), Gaps = 17/280 (6%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+G+G FG Y K T Q A K I + D++ED+++E+Q + I +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRS-PYITK 63
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
G++ + +IM+ C GG D ++ G E A + R+++ + Y H G +HR
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEGKIHR 122
Query: 193 DLKPENFLFSSSAEDSPLKATDFG----LSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YG 247
D+K N L S + +K DFG L+ + F VG+ +++APEV++++ Y
Sbjct: 123 DIKAANILLSEEGD---VKLADFGVSGQLTSTMSKRNTF---VGTPFWMAPEVIKQSGYD 176
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
+ADIWS G+ L G PP + I + + S S KD V
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPFKDFVSLC 234
Query: 308 LHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMK 347
L+ DPKER SA E+L H +++ S L I + + K
Sbjct: 235 LNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIERIKKWK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 83/257 (32%), Positives = 131/257 (50%), Gaps = 15/257 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG LV K T + +A K + +I +D+V E +++ + T H + LK
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++ + +M+ GGELF + + ++E A ++V+ + Y HS V++RD+
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
K EN + +D +K TDFGL G K G+ Y+APEVL N YG D
Sbjct: 122 KLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W GV++Y ++ G PF+ + + +F+ IL I F +S AK ++ +L DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDP 234
Query: 313 KERL-----SAAEVLNH 324
K+RL A EV+ H
Sbjct: 235 KQRLGGGPSDAKEVMEH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 6e-34
Identities = 76/272 (27%), Positives = 122/272 (44%), Gaps = 20/272 (7%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ Y +G G V Y ++ A K I K + V+++R+EVQ M
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMS-QCN 57
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFD---RIIAKGHYSERAAANLCRQMVTVVHY 183
H N+V+ ++ + L+M +GG L D +G E A + ++++ + Y
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF-FKPGD----VFKDLVGSAYYVA 238
HS G +HRD+K N L ED +K DFG+S GD V K VG+ ++A
Sbjct: 118 LHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 239 PEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH---IDFSSDPW 293
PEV+ Y +ADIWS G+ L +G P+ + L+ ++ +D
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNHP 325
S S + ++ L DP +R +A E+L H
Sbjct: 235 K-YSKSFRKMISLCLQKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 81/290 (27%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDV-EDVRREVQIMHHLT--GHRNI 130
E+G G +G Y +T + A K + R ++ + + RE+ ++ L H NI
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 131 VEL----KGAYEDRH-SVNLIM-----DLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
V L G DR + L+ DL + G +L RQ++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQDLAT---YLSKCPKPG-LPPETIKDLMRQLLRG 119
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 240
V + HS ++HRDLKP+N L +S + +K DFGL+ + +V + +Y APE
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTLWYRAPE 176
Query: 241 VL-RRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFD--------------AI 281
VL + +Y D+WS G I L P F G +E IFD ++
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236
Query: 282 LRGHIDFSS-----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
R + P I D++KKML +P +R+SA E L HP+
Sbjct: 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 74/260 (28%), Positives = 126/260 (48%), Gaps = 13/260 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG L HK + +A K + + ++ + + + + E ++ H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + ++D GGELF + + + E A ++ + + Y HS+ +++RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
KPEN L S + TDFGL + G+ Y+APEVLR+ Y D
Sbjct: 123 KPENILLDS---QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W G +LY +L G+PPF+ ++D IL + PNIS SA+ +++ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDR 235
Query: 313 KERLSAA----EVLNHPWMR 328
+RL A E+ NH +
Sbjct: 236 TKRLGAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 6e-33
Identities = 83/308 (26%), Positives = 133/308 (43%), Gaps = 61/308 (19%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ +G G FG LV DT +A K++ ++ R+ V+ E I+ + +V+
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L +++D+ ++ +MD GG++ +I G + E A ++ + H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125
Query: 193 DLKPENFLFSSSAEDSPLKATDFGL---------SVFFKPGDVFK--------------- 228
D+KP+N L D +K TDFGL S +++ GD +
Sbjct: 126 DIKPDNILID---RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 229 --------------------DLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVP 267
LVG+ Y+APEVL R Y D WS GVILY +L G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 268 PFW----GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAE 320
PF ET+ + + HI +S A D++ + L ++RL A E
Sbjct: 243 PFLADTPAETQLKVINWETTLHI----PSQAKLSREASDLILR-LCCGAEDRLGKNGADE 297
Query: 321 VLNHPWMR 328
+ HP+ +
Sbjct: 298 IKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 9e-33
Identities = 80/265 (30%), Positives = 125/265 (47%), Gaps = 26/265 (9%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
+G G +G Y T + A K I KL DD E +++E+ ++ H NIV
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECR-HPNIVAY 65
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
G+Y R + ++M+ C GG L D + +G SE A +CR+ + + Y H G +HR
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVL----RRNYG 247
D+K N L + + +K DFG+S K +G+ Y++APEV + Y
Sbjct: 126 DIKGANILLTEDGD---VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYD 182
Query: 248 AEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDPWPNISSSAK----- 301
+ DIW+ G+ L PP + +++F I S+ P P + K
Sbjct: 183 GKCDIWALGITAIELAELQPPMFDLHPMRALF------LISKSNFPPPKLKDKEKWSPVF 236
Query: 302 -DIVKKMLHADPKERLSAAEVLNHP 325
D +KK L DPK+R +A ++L HP
Sbjct: 237 HDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 81/268 (30%), Positives = 140/268 (52%), Gaps = 18/268 (6%)
Query: 75 LGRGQFGVTYLV---THKDTKQQFACKSISSRKLINRDD-VEDVRREVQIMHHLTGHRNI 130
LG G +G +LV T DT + +A K + L+ + VE R E ++ H+ +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
V L A++ ++LI+D +GGE+F + + ++SE +++ + + H +G++
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIV 127
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFF--KPGDVFKDLVGSAYYVAPEVLR--RNY 246
+RD+K EN L S + + TDFGLS F + + G+ Y+APE++R +
Sbjct: 128 YRDIKLENILLDS---EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH 184
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN-ISSSAKDIVK 305
G D WS G++++ LL+G PF E E++ + R I P+P+ I A+D++
Sbjct: 185 GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR-RILKCDPPFPSFIGPEAQDLLH 243
Query: 306 KMLHADPKERLSAA-----EVLNHPWMR 328
K+L DPK+RL A E+ HP+ +
Sbjct: 244 KLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 78/299 (26%), Positives = 134/299 (44%), Gaps = 52/299 (17%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV KDT +A K + +++ ++ V VR E I+ + +V+L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVKLY 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++D + + LIM+ GG++ ++ K ++E + + + H +G +HRD+
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFK--------------PGDVFKDL---------- 230
KP+N L + +K +DFGL K F D
Sbjct: 128 KPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 231 ---------------VGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETE 274
VG+ Y+APEV + Y E D WS GVI+Y +L G PPF +
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
Query: 275 QSIFDAIL--RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAEVLNHPWMR 328
Q + I+ + + F + +S AKD++K++ + + RL E+ +HP+ +
Sbjct: 245 QETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 80/262 (30%), Positives = 128/262 (48%), Gaps = 25/262 (9%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG G +G Y HK+T Q A K + +D++++ +E+ I+ IV+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQ-CDSPYIVKYY 64
Query: 135 GAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
G+Y + ++M+ C G + D +I K +E A + Q + + Y HS +HR
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKKIHR 123
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD---LVGSAYYVAPEVLRR-NYGA 248
D+K N L + E+ K DFG+S + D ++G+ +++APEV++ Y
Sbjct: 124 DIKAGNILLN---EEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178
Query: 249 EADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDP--WPNISSSAKDIVK 305
+ADIWS G+ + G PP+ ++IF I SDP W S D VK
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPNKPPPTLSDPEKW---SPEFNDFVK 234
Query: 306 KMLHADPKERLSAAEVLNHPWM 327
K L DP+ER SA ++L HP++
Sbjct: 235 KCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 23/262 (8%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
++G G G+ + K + +Q A K + RK R E + EV IM H+N+VE+
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ-HQNVVEM 83
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
+Y + ++M+ GG L D I+++ +E A +C ++ + Y HS GV+HRD
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEAD 251
+K ++ L + D +K +DFG K K LVG+ Y++APEV+ R YG E D
Sbjct: 143 IKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK------DIVK 305
IWS G+++ ++ G PP++ ++ A+ R P P + ++ K D ++
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQ---AMKR----LRDSPPPKLKNAHKISPVLRDFLE 252
Query: 306 KMLHADPKERLSAAEVLNHPWM 327
+ML +P+ER +A E+L+HP++
Sbjct: 253 RMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 86/279 (30%), Positives = 143/279 (51%), Gaps = 17/279 (6%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
++G G G+ + T K T +Q A K + RK R E + EV IM H N+V++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYH-HENVVDM 84
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
+Y + ++M+ GG L D I+ +E A +C ++ + Y H+ GV+HRD
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEAD 251
+K ++ L +S D +K +DFG K K LVG+ Y++APEV+ R YG E D
Sbjct: 144 IKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311
IWS G+++ ++ G PP++ E I R ++ +SS + + ML +
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-RDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
Query: 312 PKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFR 350
P +R +A E+L HP++++ G S ++ M+Q+R
Sbjct: 260 PSQRATAQELLQHPFLKLAGPPS------CIVPLMRQYR 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 83/269 (30%), Positives = 141/269 (52%), Gaps = 19/269 (7%)
Query: 75 LGRGQFGVTYLV---THKDTKQQFACKSISSRKLINR-DDVEDVRREVQIMHHLTGHRNI 130
LG G +G +LV + D+ + +A K + ++ + E R E Q++ H+ +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
V L A++ ++LI+D GGELF + + + E+ ++V + + H +G++
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGII 127
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK--DLVGSAYYVAPEVLRRNYGA 248
+RD+K EN L S + + TDFGLS F +V + G+ Y+AP+++R G
Sbjct: 128 YRDIKLENILLDS---NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184
Query: 249 E---ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKDIV 304
D WS GV++Y LL+G PF + E++ I R I S P+P +S+ AKDI+
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR-RILKSEPPYPQEMSALAKDII 243
Query: 305 KKMLHADPKERL-----SAAEVLNHPWMR 328
+++L DPK+RL A E+ HP+ +
Sbjct: 244 QRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 7e-32
Identities = 82/267 (30%), Positives = 131/267 (49%), Gaps = 25/267 (9%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH--HLTGHRNIVE 132
LGRG FG L +K T + +A K++ +I RD+VE + E +I + H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L ++ V +M+ AGG+L I +SE A +V + Y H +++R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----LVGSAYYVAPEVL-RRNYG 247
DLK +N L + + +K DFGL K G F D G+ ++APEVL +Y
Sbjct: 126 DLKLDNLLLDT---EGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKDIVKK 306
D W GV++Y +L G PF G+ E+ +FD+I+ + +P +S A I+++
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-----RYPRFLSREAISIMRR 234
Query: 307 MLHADPKERLSAAE-----VLNHPWMR 328
+L +P+ RL + E V P+ R
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-31
Identities = 81/263 (30%), Positives = 126/263 (47%), Gaps = 17/263 (6%)
Query: 71 FGRELGRGQFGVTYLVTHKDTK-QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
F R LG G FG L T+K+ A K K+I + V+ V E +I++++ H
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPF 92
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
V L G+++D + L+++ GGE F + + Q+V + Y S+ +
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNI 152
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGA 248
++RDLKPEN L +D +K TDFG + L G+ Y+APE+L +G
Sbjct: 153 VYRDLKPENLLLD---KDGFIKMTDFGFAKVVDTRTY--TLCGTPEYIAPEILLNVGHGK 207
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML 308
AD W+ G+ +Y +L G PPF+ I+ IL G I F + ++ K ++KK+L
Sbjct: 208 AADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLMKKLL 263
Query: 309 HADPKERL-----SAAEVLNHPW 326
D +R A V HPW
Sbjct: 264 SHDLTKRYGNLKKGAQNVKEHPW 286
|
Length = 340 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 53/290 (18%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-DDVEDVR--REVQIMHHLTGHRNIV 131
+G G F + T + +A K + +E V RE+Q + L+ H NI+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK-----CMKKHFKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 132 ELKGAYEDRH--SVNLIMDLCAGGELFDRIIAKGHY-SERAAANLCRQMVTVVHYCHSMG 188
L DR + L+ +L L++ I + E+ + Q++ + + H G
Sbjct: 62 RLIEVLFDRKTGRLALVFEL-MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFG--LSVFFKPGDVFKDLVGSAYYVAPEVLRRN- 245
+ HRD+KPEN L +D LK DFG ++ KP + + + + +Y APE L +
Sbjct: 121 IFHRDIKPENILI----KDDILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDG 174
Query: 246 -YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH---------IDFSSDPW-- 293
YG + DIW+ G + + +LS P F G E D I + H +
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFRKSRH 231
Query: 294 -----------------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
PN S+ D++KK+L DP ER++A + L HP+
Sbjct: 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 79/269 (29%), Positives = 132/269 (49%), Gaps = 29/269 (10%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD------VEDVRREVQIMHHLT 125
G+ LG+G FG YL DT ++ A K + + D V + E+Q++ +L
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVP----FDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH 185
H IV+ G D ++++ M+ GG + D++ A G +E RQ++ V Y H
Sbjct: 63 -HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFG----LSVFFKPGDVFKDLVGSAYYVAPEV 241
S ++HRD+K N L S+ +K DFG L G K + G+ Y+++PEV
Sbjct: 122 SNMIVHRDIKGANILRDSAGN---VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFDAILRGHIDFSSDPW--PNI 296
+ YG +AD+WS G + +L+ PP W E E +IF + ++P ++
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPQLPSHV 232
Query: 297 SSSAKDIVKKMLHADPKERLSAAEVLNHP 325
S A++ +++ + K+R SA E+L H
Sbjct: 233 SPDARNFLRRTFVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 76/257 (29%), Positives = 125/257 (48%), Gaps = 13/257 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG V +DT++ +A K+I +++R +V E ++ + IV LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLK 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + L++ GGELF + +G + A +++ + H V++RDL
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADI 252
KPEN L + DFGL + K D G+ Y+APE+L Y D
Sbjct: 120 KPENILLDYQGH---IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W+ GV+LY +L+G+PPF+ E ++ IL+ + F AKD++ +L DP
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLLSRDP 232
Query: 313 KERL---SAAEVLNHPW 326
RL A E+ NHP+
Sbjct: 233 TRRLGYNGAQEIKNHPF 249
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 82/258 (31%), Positives = 132/258 (51%), Gaps = 16/258 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG LV K T + +A K + ++ +D+V E +++ + + H + LK
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRD 193
+++ + +M+ GGELF + + +SE A ++V+ + Y HS V++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 194 LKPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEAD 251
LK EN + +D +K TDFGL K G K G+ Y+APEVL N YG D
Sbjct: 122 LKLENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178
Query: 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311
W GV++Y ++ G PF+ + + +F+ IL I F +S AK ++ +L D
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLKKD 234
Query: 312 PKERL-----SAAEVLNH 324
PK+RL A E++ H
Sbjct: 235 PKQRLGGGPDDAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 5e-31
Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 12/264 (4%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R LG+G FG + T + +ACK + +++ R E QI+ + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-QFVVN 64
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVM 190
L AYE + ++ L++ + GG+L I G+ + E A +++ + H +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAE 249
+RDLKPEN L + ++ +D GL+V G+ + VG+ Y+APEVL + Y
Sbjct: 125 YRDLKPENILLD---DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
D W G ++Y ++ G PF G E+ + + R ++ S AK I K +L
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241
Query: 310 ADPKERL-----SAAEVLNHPWMR 328
DPK+RL A EV HP+ R
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 69/264 (26%), Positives = 143/264 (54%), Gaps = 14/264 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y+ +++G G FG LV K+ +Q+ K I+ K+ ++ E+ R+EV ++ ++ H
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMK-HP 59
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KG-HYSERAAANLCRQMVTVVHYCHS 186
NIV+ + ++E+ ++ ++MD C GG+L+ +I A +G + E + Q+ + + H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLR-R 244
++HRD+K +N + +D +K DFG++ V ++ + +G+ YY++PE+ R
Sbjct: 120 RKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR 176
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKDI 303
Y ++DIW+ G +LY + + F +++ I+RG S P + S +++
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG----SYPPVSSHYSYDLRNL 232
Query: 304 VKKMLHADPKERLSAAEVLNHPWM 327
V ++ +P++R S +L ++
Sbjct: 233 VSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-31
Identities = 80/263 (30%), Positives = 133/263 (50%), Gaps = 21/263 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG LV K + + +A K + +I +D+V E +++ + T H + LK
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + + +M+ GGELF + + +SE ++V+ + Y HS +++RDL
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPG----DVFKDLVGSAYYVAPEVLRRN-YGAE 249
K EN + +D +K TDFGL K G K G+ Y+APEVL N YG
Sbjct: 122 KLENLMLD---KDGHIKITDFGLC---KEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
D W GV++Y ++ G PF+ + + +F+ IL I F +S+ AK ++ +L
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLI 231
Query: 310 ADPKERL-----SAAEVLNHPWM 327
DP +RL A E++ H +
Sbjct: 232 KDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 72/258 (27%), Positives = 127/258 (49%), Gaps = 18/258 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G +G Y V Q +A K + + ++ + ED E++I+ + H NI+ K
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYK 65
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGH-----YSERAAANLCRQMVTVVHYCHSMGV 189
A+ D + + ++M+ G+L + I+K E+ + Q++ + H +
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLS-KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKI 124
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGA 248
+HRDLK N L ++ +K D G+S K ++ K +G+ +Y+APEV + R Y
Sbjct: 125 LHRDLKSANILLVANDL---VKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKGRPYSY 180
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI-SSSAKDIVKKM 307
++DIWS G +LY + + PPF + Q + + RG P P I S ++ ++ M
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY----PPIPPIYSQDLQNFIRSM 236
Query: 308 LHADPKERLSAAEVLNHP 325
L PK R + ++L P
Sbjct: 237 LQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 80/259 (30%), Positives = 130/259 (50%), Gaps = 15/259 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y R +G G FG LV H ++ Q++A K I R + VED R+E ++ + H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI--RLPKSSSAVEDSRKEAVLLAKMK-HP 58
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGH-YSERAAANLCRQMVTVVHYCHS 186
NIV K ++E + ++M+ C GG+L +I + +G + E QM V + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRR- 244
V+HRD+K +N + ++ +K DFG + + PG VG+ YYV PE+
Sbjct: 119 KRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKDI 303
Y ++DIWS G ILY L + PF + +++ + +G S P P + S + +
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG----SYKPLPSHYSYELRSL 231
Query: 304 VKKMLHADPKERLSAAEVL 322
+K+M +P+ R SA +L
Sbjct: 232 IKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 72/256 (28%), Positives = 126/256 (49%), Gaps = 13/256 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG L HK ++ +A K + + ++ + + + + E ++ H +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + ++D GGELF + + + E A ++ + + Y HS+ +++RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
KPEN L S + TDFGL + G+ Y+APEVL + Y D
Sbjct: 123 KPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W G +LY +L G+PPF+ ++D IL + PNI++SA+ +++ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 235
Query: 313 KERLSAA----EVLNH 324
+RL A E+ NH
Sbjct: 236 TKRLGAKDDFMEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 75/261 (28%), Positives = 126/261 (48%), Gaps = 19/261 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG L K + +A K + + ++NR + + + E ++ H +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + ++D GGELF + + + E A ++ + + Y HS+ +++RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPG----DVFKDLVGSAYYVAPEVLRRN-YGAE 249
KPEN L S + TDFGL K G D G+ Y+APEV+R+ Y
Sbjct: 123 KPENILLDSQGH---VVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
D W G +LY +L G+PPF+ ++D IL + P S +A I++++L
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232
Query: 310 ADPKERLSAA----EVLNHPW 326
D + RL A E+ HP+
Sbjct: 233 KDRQRRLGAKEDFLEIQEHPF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 75/277 (27%), Positives = 132/277 (47%), Gaps = 25/277 (9%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-------RDDVEDVRREVQIM 121
++ G +G+G +G YL + T + A K + I +D V+ +R E++ +
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
L H NIV+ G +++ ++ GG + + G + E+ Q++ +
Sbjct: 63 KDLD-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL 121
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-----LVGSAYY 236
Y HS G++HRDLK +N L + D K +DFG+S K D++ + + GS ++
Sbjct: 122 AYLHSKGILHRDLKADNLLVDA---DGICKISDFGISK--KSDDIYDNDQNMSMQGSVFW 176
Query: 237 VAPEVL---RRNYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFD-AILRGHIDFSS 290
+APEV+ + Y A+ DIWS G ++ + +G P W + E ++F R
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPIPP 235
Query: 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
D N+S A D + +P R +A E+L HP++
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
DV++ +GRG FG +V K T +A K + L+ ++ V E I+
Sbjct: 4 DVKSL------VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS- 56
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVH 182
++ I +L+ A++D+ ++ L+M+ GG+L + + + E A ++V +H
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDL-VGSAYYVAPE 240
H MG +HRD+KPEN L + +K DFG + V L VG+ Y+APE
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGH---IKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 241 VL-------RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL--RGHIDFSSD 291
VL + YG E D WS GVI Y ++ G PF T ++ I+ + + F D
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233
Query: 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
P +SS D+++ +L KERL + HP+
Sbjct: 234 --PKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 80/259 (30%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K T + FA K++ ++ DDVE E +++ H + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + + +M+ GG+L I + G + E A +++ + + H G+++RDL
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLR-RNYGAEADI 252
K +N L +D +K DFG+ G+ G+ Y+APE+L+ + Y D
Sbjct: 123 KLDNVLLD---KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW-PN-ISSSAKDIVKKMLHA 310
WS GV+LY +L G PF GE E +FD+IL + P P IS AKD + K+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSIL------NDRPHFPRWISKEAKDCLSKLFER 233
Query: 311 DPKERL-SAAEVLNHPWMR 328
DP +RL ++ HP+ R
Sbjct: 234 DPTKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 72/263 (27%), Positives = 125/263 (47%), Gaps = 18/263 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K T + +A K + +I DDVE E +++ + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + +M+ GG+L I G + E A ++ + + HS G+++RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 195 KPENFLFSSSAEDSPLKATDFGL---SVFFKPGDVFKDLVGSAYYVAPE-VLRRNYGAEA 250
K +N + + +K DFG+ ++F G + G+ Y+APE + + YG
Sbjct: 128 KLDNVMLDAEGH---IKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 251 DIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310
D W+ GV+LY +L+G PPF GE E +F +I+ ++ + ++S A I K +L
Sbjct: 183 DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLLTK 238
Query: 311 DPKERLSAA-----EVLNHPWMR 328
P +RL ++ H + R
Sbjct: 239 HPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-30
Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 15/279 (5%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
++G G G+ + T K + + A K + RK R E + EV IM H N+VE+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQ-HENVVEM 82
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
+Y + ++M+ GG L D I+ +E A +C ++ + H+ GV+HRD
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEAD 251
+K ++ L + D +K +DFG K K LVG+ Y++APE++ R YG E D
Sbjct: 142 IKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311
IWS G+++ ++ G PP++ E I R ++ +S S K + ++L D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 312 PKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFR 350
P +R +AAE+L HP++ G P I L R + R
Sbjct: 258 PAQRATAAELLKHPFLAKAG----PPSCIVPLMRQNRMR 292
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 62/261 (23%), Positives = 120/261 (45%), Gaps = 12/261 (4%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ ++G+G FGV + V K K+ +A K I K+ NR + E+ E +++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SS 59
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHS 186
I+ ++ D+ +N++M+ G+L + E Q++ + + HS
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-KDLVGSAYYVAPEVLR-R 244
++HRD+K N +K D G++ F +VG+ YY++PE+ +
Sbjct: 120 KKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
Y ++D+W+ GV+LY +G PF + ++ I+RG S + S ++
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMY---SQQLAQLI 233
Query: 305 KKMLHADPKERLSAAEVLNHP 325
+ L D ++R ++L +P
Sbjct: 234 DQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 94/313 (30%), Positives = 142/313 (45%), Gaps = 55/313 (17%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSI----SSRKLINRDDVEDVRREVQ 119
++ N Y+ + +G G FG+ + T Q A K I S+ L R RE++
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR-----TYRELK 61
Query: 120 IMHHLTGHRNIVELKGAY----EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR 175
++ HL H NI+ L + ED + V ++ G R++ ++
Sbjct: 62 LLKHLR-HENIISLSDIFISPLEDIYFVTELL-----GTDLHRLLTSRPLEKQFIQYFLY 115
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY 235
Q++ + Y HS GV+HRDLKP N L + E+ LK DFGL+ P V + Y
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGLARIQDPQ--MTGYVSTRY 170
Query: 236 YVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL----------- 282
Y APE++ + Y E DIWSAG I +L G P F G+ + F I
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230
Query: 283 -----------------RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHP 325
R + FS + N SA D+++KML DP++R+SAAE L HP
Sbjct: 231 NTICSENTLRFVQSLPKREPVPFSEK-FKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
Query: 326 WMRVDGDASDKPL 338
++ D +D+P+
Sbjct: 290 YLAPYHDPTDEPV 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 73/269 (27%), Positives = 127/269 (47%), Gaps = 17/269 (6%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSIS---SRKLINRDDVEDVRREVQIMHHLTGHR 128
G++LG G F Y T A K ++ + + VE +R+E+++M L H
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HP 63
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+I+ + GA + NL ++ AGG + + G + E N Q++ + Y H
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFG----LSVFFKPGDVFK-DLVGSAYYVAPEVLR 243
++HRD+K N L S+ + L+ DFG L+ F+ L+G+ ++APEVLR
Sbjct: 124 IIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 244 -RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP---NISSS 299
YG D+WS G ++ + + PP W + S A++ I ++ ++S
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP-WNAEKHSNHLALIF-KIASATTAPSIPEHLSPG 239
Query: 300 AKDIVKKMLHADPKERLSAAEVLNHPWMR 328
+D+ + L P++R + E+L HP R
Sbjct: 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 67/274 (24%), Positives = 117/274 (42%), Gaps = 44/274 (16%)
Query: 71 FGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
G++LG G FG K + A K++ + +E+ RE +IM L
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKL-D 59
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY-SERAAANLCRQ----MVTVV 181
H N+V+L G + + ++M+ GG+L + S + Q M
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME--- 116
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---- 237
Y S +HRDL N L E+ +K +DFGLS +DL YY
Sbjct: 117 -YLESKNFIHRDLAARNCLVG---ENLVVKISDFGLS---------RDLYDDDYYRKRGG 163
Query: 238 -------APEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDF 288
APE L+ + +++D+WS GV+L+ + + G P+ G + + + + + G+
Sbjct: 164 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR-- 221
Query: 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
PN D++ + DP++R + +E++
Sbjct: 222 -LPQPPNCPPELYDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 81/298 (27%), Positives = 134/298 (44%), Gaps = 21/298 (7%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
RE+G G FG Y T + A K +S + + +D+ +EV+ + L H N +E
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIE 79
Query: 133 LKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
KG Y H+ L+M+ C G ++ + + K E A +C + + Y HS +
Sbjct: 80 YKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL----RRNY 246
HRD+K N L + E +K DFG + P + F VG+ Y++APEV+ Y
Sbjct: 138 HRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILAMDEGQY 191
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-DFSSDPWPNISSSAKDIVK 305
+ D+WS G+ L PP + S I + SS+ W S ++ V
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDYFRNFVD 248
Query: 306 KMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVI 363
L P++R S+ E+L H ++ + +D+ T+ R ++ L+ +K I
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFVLRE-RPPTVIIDLIQRTK-DAVRELDNLQYRKMKKI 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 15/264 (5%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R LG+G FG L K++ + +A K + ++ DDVE E +I+ H + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L ++ + +M+ GG+L I + E A ++ + + + H G+++R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 193 DLKPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEA 250
DLK +N L + K DFG+ G G+ Y+APE+L+ YG
Sbjct: 121 DLKLDNVLLD---HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 251 DIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310
D W+ GV+LY +L G PF E E +F+AIL + + + W +S A DI+K +
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LSQDAVDILKAFMTK 233
Query: 311 DPKERLSAAE------VLNHPWMR 328
+P RL + +L HP+ +
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 85/319 (26%), Positives = 142/319 (44%), Gaps = 63/319 (19%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQ--FACKSIS---SRKLINRDDVEDVRREVQIMHH 123
Y +ELG+G +G+ + +T ++ A K I+ S+K++ + + RE++++ H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLRH 57
Query: 124 LTGHRNIVEL-------KGAYEDRHSVNLIM--DLCAGGELFDRIIAKGH-YSERAAANL 173
GH+NI L G + + + +M DL II G ++ +
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQ-------IIRSGQPLTDAHFQSF 110
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-----FK 228
Q++ + Y HS V+HRDLKP N L ++ E LK DFGL+ F
Sbjct: 111 IYQILCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFMT 167
Query: 229 DLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR--- 283
+ V + +Y APE++ ++Y D+WS G IL LL P F G+ + IL+
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227
Query: 284 ----------------------GHIDFSSDPW--PNISSSAKDIVKKMLHADPKERLSAA 319
+I PN + A D+++K+L DP +R+S
Sbjct: 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVE 287
Query: 320 EVLNHPWMRVDGDASDKPL 338
E L HP++ + D D+P+
Sbjct: 288 EALEHPYLAIWHDPDDEPV 306
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-29
Identities = 80/283 (28%), Positives = 138/283 (48%), Gaps = 27/283 (9%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-DVEDVRREVQIMHHLTGHRNIV 131
R +GRG + LV K T++ +A K + ++L+N D D++ V+ E + + H +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
L ++ + +++ GG+L + + E A ++ ++Y H G+++
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAE 249
RDLK +N L S +K TD+G+ +PGD G+ Y+APE+LR +YG
Sbjct: 120 RDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 250 ADIWSAGVILYILLSGVPPF---------WGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
D W+ GV+++ +++G PF TE +F IL I ++S A
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKA 232
Query: 301 KDIVKKMLHADPKERLSA------AEVLNHPWMR-VDGDASDK 336
++K L+ DPKERL A++ HP+ R VD D ++
Sbjct: 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQ 275
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-29
Identities = 71/256 (27%), Positives = 121/256 (47%), Gaps = 13/256 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG L K +A K + + ++ + + + E ++ H +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++ + ++D GGELF + + + E A ++ + + Y HS+ +++RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
KPEN L S + TDFGL +P + G+ Y+APEVLR+ Y D
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W G +LY +L G+PPF+ ++D IL + + +A D++ +LH D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235
Query: 313 KERLSAA----EVLNH 324
+ RL A E+ NH
Sbjct: 236 RRRLGAKADFLEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 75/264 (28%), Positives = 128/264 (48%), Gaps = 18/264 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
YI R LG+G FG L + K ++ +L ++ D E+ I+ L H
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE-RRDALNEIVILSLLQ-HP 59
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRII--AKGHYSERAAANLCRQMVTVVHYCHS 186
NI+ + D +++ + M+ GG L+D+I+ + E Q+V+ V Y H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 187 MGVMHRDLKPEN-FLFSSSAEDSPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVL 242
G++HRD+K N FL + +K DFG+S G + + +VG+ YY++PE+
Sbjct: 120 AGILHRDIKTLNIFL----TKAGLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPELC 173
Query: 243 R-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
+ Y ++DIW+ G +LY LL+ F ++ I++G+ + SS
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELI 230
Query: 302 DIVKKMLHADPKERLSAAEVLNHP 325
+V +L DP++R +A EVL+ P
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 23/264 (8%)
Query: 75 LGRGQFGVTYLV---THKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
LG+G FG +LV T D Q +A K + L RD V + E I+ + H IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEV-NHPFIV 61
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+L A++ + LI+D GG+LF R+ + ++E ++ + + HS+G+++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK---DLVGSAYYVAPEVL-RRNYG 247
RDLKPEN L E+ +K TDFGLS + D K G+ Y+APEV+ RR +
Sbjct: 122 RDLKPENILLD---EEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
AD WS GV+++ +L+G PF G+ + IL+ + +S A+ +++ +
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRAL 232
Query: 308 LHADPKERLSAA-----EVLNHPW 326
+P RL A E+ HP+
Sbjct: 233 FKRNPANRLGAGPDGVEEIKRHPF 256
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 76/270 (28%), Positives = 117/270 (43%), Gaps = 23/270 (8%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQF-ACKSISSRKLINRDD-------VEDVRREVQ 119
Y LG G FG Y V K+ Q A K I+ D + D+ EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCR 175
I+ H NIV + + + ++MDL G L + + K ++E N+
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 176 QMVTVVHYCH-SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 234
QMV + Y H ++HRDL P N + ED + TDFGL+ +P +VG+
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQKQPESKLTSVVGTI 177
Query: 235 YYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293
Y PE+++ YG +AD+W+ G ILY + + PPF+ S+ I ++ +P
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI----VEAVYEPL 233
Query: 294 PN--ISSSAKDIVKKMLHADPKERLSAAEV 321
P S D++ L D + R +V
Sbjct: 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 70/280 (25%), Positives = 120/280 (42%), Gaps = 51/280 (18%)
Query: 70 IFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
G++LG G FG T + + A K++ + +E+ RE +IM L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKL- 58
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY--SERAAANLCRQ----MVT 179
H NIV+L G + + ++M+ GG+L D + S + Q M
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME- 117
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV-- 237
Y S +HRDL N L E+ +K +DFGLS +DL YY
Sbjct: 118 ---YLESKNFIHRDLAARNCLVG---ENLVVKISDFGLS---------RDLYDDDYYKVK 162
Query: 238 ---------APEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286
APE L+ + +++D+WS GV+L+ + + G P+ G + + + + +G+
Sbjct: 163 GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR 222
Query: 287 DFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLN 323
P + ++ K ML DP++R + +E++
Sbjct: 223 L------PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-28
Identities = 88/287 (30%), Positives = 138/287 (48%), Gaps = 46/287 (16%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
ELG G FG Y +K+T A K I ++ + +++ED E++I+ H IV+L
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILAT-CNHPYIVKL 74
Query: 134 KGAYEDRHSVNLIMDLCAGGEL------FDRIIAKGHYSERAAANLCRQMVTVVHYCHSM 187
GA+ + ++++ C GG + DR + +E +CRQM+ + Y HSM
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGL-----TEPQIQVICRQMLEALQYLHSM 129
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSV----FFKPGDVFKDLVGSAYYVAPEVLR 243
++HRDLK N L + D +K DFG+S + D F +G+ Y++APEV+
Sbjct: 130 KIIHRDLKAGNVLLT---LDGDIKLADFGVSAKNVKTLQRRDSF---IGTPYWMAPEVVM 183
Query: 244 ------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
Y +ADIWS G+ L + PP + I + S+P P +S
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK------SEP-PTLS 236
Query: 298 SSAK------DIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338
+K D +K L P+ R SAA++L HP+ V S++PL
Sbjct: 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF--VSSVTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 18/268 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTG 126
YI + LG+G FG YLV K + K + + +N ++ +E Q++ L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD- 60
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN-----LCRQMVTVV 181
H IV+ ++ +R + +I + C G +L ++ H + + N Q++ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI-QLLLGV 119
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFKDLVGSAYYVAPE 240
HY H ++HRDLK +N ++ LK DFG+S D+ G+ YY++PE
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNL----LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175
Query: 241 VLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
L+ + Y +++DIWS G ILY + F G+ S+ I+ G + +
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYS---RQ 232
Query: 300 AKDIVKKMLHADPKERLSAAEVLNHPWM 327
I++ ML+ DP R SAAE+L +P++
Sbjct: 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 75/283 (26%), Positives = 122/283 (43%), Gaps = 37/283 (13%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ +G G +G Y HK T Q A K + + D+ E+++ E I+ +
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSN 61
Query: 127 HRNIVELKGAYEDRHSVN------LIMDLCAGG---ELFDRIIAKGH-YSERAAANLCRQ 176
H NI GA+ ++ L+M+LC GG +L + KG E A + R+
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAY 235
+ + Y H V+HRD+K +N L + +AE +K DFG+S ++ +G+ Y
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAE---VKLVDFGVSAQLDSTLGRRNTFIGTPY 178
Query: 236 YVAPEV------LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289
++APEV +Y A +D+WS G+ L G PP I R
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN----- 233
Query: 290 SDPWPNISSSAK------DIVKKMLHADPKERLSAAEVLNHPW 326
P P + S D + + L + ++R E+L HP+
Sbjct: 234 --PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 69/266 (25%), Positives = 131/266 (49%), Gaps = 16/266 (6%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ +++G+GQF V Y + A K + ++++ +D +E+ ++ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD- 60
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-----KGHYSERAAANLCRQMVTVV 181
H N+++ ++ + + +N++++L G+L R+I K ER Q+ + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK-DLVGSAYYVAPE 240
+ HS +MHRD+KP N ++ +K D GL FF LVG+ YY++PE
Sbjct: 120 EHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 241 VLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQ--SIFDAILRGHIDFSSDPWPNIS 297
+ N Y ++DIWS G +LY + + PF+G+ S+ I + D+ P + S
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADHYS 234
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLN 323
+D+V + ++ DP++R + VL
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-28
Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 16/263 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K T + +A K + ++ DDV+ E +I+ H + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + + +M+ GG+L +I + E + ++ + + H GV++RDL
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADI 252
K +N L + + K DFG+ G G+ Y+APE+L+ YG D
Sbjct: 123 KLDNILLDA---EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W+ GV++Y +++G PPF + E +F++IL H D W +S A I+K + +P
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVW--LSKEAVSILKAFMTKNP 235
Query: 313 KERLSAA-------EVLNHPWMR 328
+RL + HP+ +
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFK 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 86/310 (27%), Positives = 141/310 (45%), Gaps = 47/310 (15%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV KDT +A K + ++ ++ V +R E I+ G +V++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW-VVKMF 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++D+ ++ LIM+ GG++ ++ K SE A + V + H +G +HRD+
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFK---------------PGDV-FKDL-------- 230
KP+N L + +K +DFGL K P D F+++
Sbjct: 128 KPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 231 ------------VGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
VG+ Y+APEV ++ Y D WS GVI+Y +L G PPF ET Q
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
Query: 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAEVLNHPWMR-VD-GD 332
+ ++ P IS AKD++ + D + R+ E+ +HP+ VD G
Sbjct: 245 YRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWGH 303
Query: 333 ASDKPLDIAV 342
++P I +
Sbjct: 304 IRERPAAIPI 313
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 82/273 (30%), Positives = 139/273 (50%), Gaps = 21/273 (7%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSI------SSRKLINRDDVEDVRREVQIMH 122
+I G +G G FG YL + + + A K + +S K R ++ + RE+ ++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
L H NIV+ G+ D +N+ ++ GG + + G + E N RQ++ ++
Sbjct: 62 ELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-------VFFKPGDVFKDLVGSAY 235
Y H+ G++HRD+K N L + +K +DFG+S + K L GS +
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGG---IKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 236 YVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294
++APEV+++ Y +ADIWS G ++ +L+G PF T+ AI + + S +
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGENASPEIPS 234
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
NISS A D ++K D +R +AAE+L HP++
Sbjct: 235 NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 87/315 (27%), Positives = 136/315 (43%), Gaps = 57/315 (18%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ LG G FG L DTK +A K++ + ++ R+ V V+ E I+ + +V
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L +++D+ ++ +MD GG++ +I G + E A ++ V H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 193 DLKPENFLFSSSAEDSPLKATDFGL---------SVFFKPGDVFK--------------- 228
D+KP+N L D +K TDFGL S +++ GD +
Sbjct: 126 DIKPDNILID---RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 229 ------------------------DLVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILL 263
LVG+ Y+APEV LR Y D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 264 SGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAE 320
G PPF +T ++ P +S A D++ K+ P++RL A E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRG-PEDRLGKNGADE 301
Query: 321 VLNHPWMRVDGDASD 335
+ HP+ + +SD
Sbjct: 302 IKAHPFFKTIDFSSD 316
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 86/268 (32%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV HK T++ +A K +S ++I R D E IM +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVVQLF 109
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++D + ++M+ GG+L + +++ E+ A ++V + HSMG +HRD+
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 168
Query: 195 KPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDL-VGSAYYVAPEVLRRN-----YG 247
KP+N L S LK DFG + K G V D VG+ Y++PEVL+ YG
Sbjct: 169 KPDNMLLDKSGH---LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL--RGHIDFSSDPWPNISSSAKDIVK 305
E D WS GV LY +L G PF+ ++ + I+ + + F D +IS AK+++
Sbjct: 226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISKEAKNLIC 283
Query: 306 KMLHADPKERL---SAAEVLNHPWMRVD 330
L D + RL E+ H + + D
Sbjct: 284 AFL-TDREVRLGRNGVEEIKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-28
Identities = 65/256 (25%), Positives = 122/256 (47%), Gaps = 10/256 (3%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R +GRG FG+ +L K ++ K I ++ +D+ + E Q++ L+ H NI+E
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIE 63
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVM 190
+ + ++ ++M+ GG L + I + + E + Q++ +H+ H+ ++
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAE 249
HRDLK +N L +K DFG+S +VG+ Y++PE+ + Y +
Sbjct: 124 HRDLKTQNILLDK--HKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
+DIW+ G +LY L S F ++ I+ G SD S + ++ ML+
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---RYSPDLRQLILSMLN 238
Query: 310 ADPKERLSAAEVLNHP 325
DP +R ++++ P
Sbjct: 239 LDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 80/289 (27%), Positives = 134/289 (46%), Gaps = 47/289 (16%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRNI 130
+G G +GV + +++T Q A K K + +D ++ RE++++ L H N+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLK-HPNL 62
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGV 189
V L + + ++L+ + C + + + E + Q + V++CH
Sbjct: 63 VNLIEVFRRKRKLHLVFEYC-DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAPEVL--RRNY 246
+HRD+KPEN L + + +K DFG + PGD + D V + +Y APE+L Y
Sbjct: 122 IHRDVKPENILITKQGQ---IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETE--------QSIFDAILRGHID-FSS------- 290
G D+W+ G + LL+G P + G+++ +++ D I R H FS+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-HQQIFSTNQFFKGL 237
Query: 291 ------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
+PNISS A +K L DP ERLS E+L HP+
Sbjct: 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 79/266 (29%), Positives = 125/266 (46%), Gaps = 20/266 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG K T + +ACK + ++L R + E +I+ R IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKVSSRFIVSLA 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHR 192
A+E + + L+M L GG+L I G + E A Q++ + + H +++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEAD 251
DLKPEN L + ++ +D GL+V K G K G+ Y+APEVL+ Y D
Sbjct: 120 DLKPENVLLD---DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 252 IWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
++ G LY +++G PF E + + L +++ S AKD+ + +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK----FSPEAKDLCEAL 232
Query: 308 LHADPKERL-----SAAEVLNHPWMR 328
L DP++RL SA EV HP +
Sbjct: 233 LQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 82/290 (28%), Positives = 140/290 (48%), Gaps = 12/290 (4%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
D + Y ++G+G G + T Q+ A K I+ +K + E + E+ +M
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKE 72
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
L + NIV ++ + ++M+ AGG L D ++ + E A +CR+ + + +
Sbjct: 73 LK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEF 130
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVL 242
H+ V+HRD+K +N L D +K TDFG P + +VG+ Y++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 243 -RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
R+ YG + DIWS G++ ++ G PP+ E I +P +S +
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPIFR 246
Query: 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDGDASD-KPLDIAVLTRMKQFR 350
D + + L D ++R SA E+L HP++++ S PL +A MK R
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLILAAKEAMKSNR 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 76/269 (28%), Positives = 135/269 (50%), Gaps = 13/269 (4%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
D + Y ++G+G G Y T Q+ A K ++ L + E + E+ +M
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMRE 72
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
H NIV +Y + ++M+ AGG L D ++ + E A +CR+ + + +
Sbjct: 73 NK-HPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVL 242
HS V+HRD+K +N L D +K TDFG P + +VG+ Y++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 243 -RRNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWPNISSSA 300
R+ YG + DIWS G++ ++ G PP+ E ++++ G + + +S+
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIF 245
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRV 329
+D + + L D ++R SA E+L HP++++
Sbjct: 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 79/268 (29%), Positives = 132/268 (49%), Gaps = 18/268 (6%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSIS--SRKLINRDDVEDVRREVQIMHHLTGHRN 129
G+ LG+G FG YL DT ++ A K + +V + E+Q++ +L H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HER 65
Query: 130 IVELKGAYEDR--HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM 187
IV+ G DR ++ + M+ GG + D++ A G +E RQ++ + Y HS
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFG----LSVFFKPGDVFKDLVGSAYYVAPEVLR 243
++HRD+K N L S+ +K DFG L G + + G+ Y+++PEV+
Sbjct: 126 MIVHRDIKGANILRDSAGN---VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 244 -RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN-ISSSAK 301
YG +AD+WS G + +L+ PP W E E AI + ++ P+ IS A+
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTNPQLPSHISEHAR 239
Query: 302 DIVKKMLHADPKERLSAAEVLNHPWMRV 329
D + + + + R SA E+L HP+ ++
Sbjct: 240 DFLGCIF-VEARHRPSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 80/267 (29%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSI--SSRKLINRDDVEDVRREVQIMHHLTGHR 128
G+ LG+G FG YL DT ++ A K + +V + E+Q++ +L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HE 64
Query: 129 NIVELKGAYED--RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
IV+ G D ++++ M+ GG + D++ + G +E RQ++ V Y HS
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK----PGDVFKDLVGSAYYVAPEVL 242
++HRD+K N L S +K DFG S + G K + G+ Y+++PEV+
Sbjct: 125 NMIVHRDIKGANILRDSVGN---VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 243 R-RNYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFDAILRGHIDFSSDPW--PNIS 297
YG +ADIWS G + +L+ PP W E E +IF + ++P P++S
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPVLPPHVS 235
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNH 324
+D +K++ + K R SA E+L H
Sbjct: 236 DHCRDFLKRIF-VEAKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 12/264 (4%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R LG+G FG + T + +ACK + +++ R E QI+ + R +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS-RFVVS 64
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVM 190
L AYE + ++ L++ L GG+L I G + E A ++ + H ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAE 249
+RDLKPEN L + ++ +D GL+V G K VG+ Y+APEV++ Y
Sbjct: 125 YRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
D W+ G +LY +++G PF ++ + + R + + S A+ + K +L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 310 ADPKERL-----SAAEVLNHPWMR 328
DPKERL A EV HP +
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLFK 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 81/289 (28%), Positives = 132/289 (45%), Gaps = 35/289 (12%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
LG G G K+T FA K+I++ N D + + RE++I IV+
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKS-CKSPYIVK 63
Query: 133 LKGAYEDRHS--VNLIMDLCAGGELFDRIIAK-----GHYSERAAANLCRQMVTVVHYCH 185
GA+ D S + + M+ C GG L D I K G E+ + ++ + Y H
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----VGSAYYVAPEV 241
S ++HRD+KP N L + + +K DFG+S G++ L G+++Y+APE
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS-----GELVNSLAGTFTGTSFYMAPER 174
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS------DPWP 294
++ + Y +D+WS G+ L + PF E E + L +I +P
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234
Query: 295 NI--SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIA 341
I S KD +K+ L DP R + ++L HPW++ K +++A
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK---AQMKKKVNMA 280
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 82/306 (26%), Positives = 132/306 (43%), Gaps = 57/306 (18%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ LG G FG L DT +A K++ + ++NR+ V V+ E I+ + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWVVK 65
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L +++D+ ++ +MD GG++ +I + E A ++ + H MG +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFK--------------------PGDVFKD--- 229
D+KP+N L D +K TDFGL F+ P D++ D
Sbjct: 126 DIKPDNILIDL---DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 230 -------------------------LVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILL 263
LVG+ Y+APEV LR+ Y D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 264 SGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAE 320
G PPF T ++ P +S A D++ K+ + +ERL A +
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCS-AEERLGRNGADD 301
Query: 321 VLNHPW 326
+ HP+
Sbjct: 302 IKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 3e-27
Identities = 84/309 (27%), Positives = 136/309 (44%), Gaps = 31/309 (10%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+D ++ E+G G FG Y T+ T + A K +S + +D+ +EV+ +
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
L H N +E KG Y H+ L+M+ C G + K E A + + +
Sbjct: 77 QLK-HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 135
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
Y HS ++HRD+K N L + E +K DFG + P + F VG+ Y++APEV+
Sbjct: 136 YLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVI 189
Query: 243 ----RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-DFSSDPWPNIS 297
Y + D+WS G+ L PP + S I + S+ W +
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---T 246
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAV--LTRMK-------- 347
S + V L P+ER ++AE+L H ++R D+P + + + R K
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELLRHDFVR-----RDRPARVLIDLIQRTKDAVRELDN 301
Query: 348 -QFRAMNKL 355
Q+R M K+
Sbjct: 302 LQYRKMKKI 310
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 81/312 (25%), Positives = 134/312 (42%), Gaps = 72/312 (23%)
Query: 66 RNTYIFGRELGR---GQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR------- 115
R+ + + L R G +GV Y K T + A K + K+ E +
Sbjct: 2 RSVDEYEK-LNRIEEGTYGVVYRARDKKTGEIVALKKL---KM------EKEKEGFPITS 51
Query: 116 -REVQIMHHLTGHRNIVELK----GAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHY 165
RE+ I+ L H NIV +K G+ + + ++M DL + L + + K +
Sbjct: 52 LREINILLKL-QHPNIVTVKEVVVGS--NLDKIYMVMEYVEHDLKS---LMETM--KQPF 103
Query: 166 SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPG 224
+ L Q+++ V + H ++HRDLK N L ++ LK DFGL+ + P
Sbjct: 104 LQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAREYGSPL 160
Query: 225 DVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL 282
+ LV + +Y APE+L + Y D+WS G I LL+ P F G++E + I
Sbjct: 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220
Query: 283 R-------------------GHIDFSSDP-------WPNISSSAK--DIVKKMLHADPKE 314
+ F+ P +P +S S D++ ++L DP +
Sbjct: 221 KLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAK 280
Query: 315 RLSAAEVLNHPW 326
R+SA + L HP+
Sbjct: 281 RISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 80/292 (27%), Positives = 135/292 (46%), Gaps = 55/292 (18%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRNI 130
+G G +G+ HK+T Q A K K + +D + V+ RE++++ L H N+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQLR-HENL 62
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCR----QMVTVVHYC 184
V L + + + L+ E D + Y + R Q++ + +C
Sbjct: 63 VNLIEVFRRKKRLYLVF------EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAPEVLR 243
HS ++HRD+KPEN L S S +K DFG + PG+V+ D V + +Y APE+L
Sbjct: 117 HSHNIIHRDIKPENILVSQSG---VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173
Query: 244 RN--YGAEADIWSAGVILYILLSGVPPFWGETE------------------QSIFD---- 279
+ YG DIW+ G ++ +L+G P F G+++ Q IF
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233
Query: 280 -AILR----GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
A +R I+ +P +S D+ K+ L DP +R S++++L+H +
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 83/268 (30%), Positives = 135/268 (50%), Gaps = 20/268 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV HK +++ +A K +S ++I R D E IM +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM-AFANSPWVVQLF 109
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++D + ++M+ GG+L + +++ E+ A ++V + HSMG++HRD+
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDV 168
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDL-VGSAYYVAPEVLRRN-----YG 247
KP+N L LK DFG + + G V D VG+ Y++PEVL+ YG
Sbjct: 169 KPDNMLLDKHGH---LKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL--RGHIDFSSDPWPNISSSAKDIVK 305
E D WS GV L+ +L G PF+ ++ + I+ + ++F D IS AK+++
Sbjct: 226 RECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED--VEISKHAKNLIC 283
Query: 306 KMLHADPKERL---SAAEVLNHPWMRVD 330
L D + RL E+ HP+ + D
Sbjct: 284 AFL-TDREVRLGRNGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 8e-27
Identities = 82/279 (29%), Positives = 139/279 (49%), Gaps = 31/279 (11%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
ELG G FG Y +K+T A K I ++ + +++ED E+ I+ H NIV+L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILAS-CDHPNIVKL 67
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMH 191
A+ +++ ++++ CAGG + D ++ + +E +C+Q + ++Y H ++H
Sbjct: 68 LDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSV----FFKPGDVFKDLVGSAYYVAPEVLR---- 243
RDLK N LF+ D +K DFG+S + D F +G+ Y++APEV+
Sbjct: 127 RDLKAGNILFTL---DGDIKLADFGVSAKNTRTIQRRDSF---IGTPYWMAPEVVMCETS 180
Query: 244 --RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP--WPNISSS 299
R Y +AD+WS G+ L + PP + I + + P W SS
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW---SSE 237
Query: 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338
KD +KK L + R + ++L HP++ V+ S+KP+
Sbjct: 238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVN---SNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 76/259 (29%), Positives = 128/259 (49%), Gaps = 14/259 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG +L K T Q FA K++ ++ DDVE E +++ H + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + ++ +M+ GG+L I + + A +++ + + HS G+++RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLR-RNYGAEADI 252
K +N L + D +K DFG+ GD G+ Y+APE+L + Y D
Sbjct: 123 KLDNILLDT---DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP-WPN-ISSSAKDIVKKMLHA 310
WS GV+LY +L G PF G E+ +F +I +P +P ++ AKDI+ K+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIR------MDNPCYPRWLTREAKDILVKLFVR 233
Query: 311 DPKERLSA-AEVLNHPWMR 328
+P+ RL ++ HP+ R
Sbjct: 234 EPERRLGVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 73/264 (27%), Positives = 123/264 (46%), Gaps = 12/264 (4%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R LG+G FG + T + +ACK + +++ R E QI+ + R +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVS 64
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRI--IAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
L AYE + ++ L++ L GG+L I + + E A ++ + H ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAE 249
+RDLKPEN L ++ +D GL+V G+ + VG+ Y+APEV++ Y
Sbjct: 125 YRDLKPENILLDDYGH---IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
D W G ++Y ++ G PF E+ + + R + + S +A+ I +++L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 310 ADPKERL-----SAAEVLNHPWMR 328
DP RL A EV HP+ R
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 82/287 (28%), Positives = 136/287 (47%), Gaps = 12/287 (4%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
D + Y ++G+G G Y T Q+ A K ++ L + E + E+ +M
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRE 72
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
+ NIV +Y + ++M+ AGG L D ++ + E A +CR+ + + +
Sbjct: 73 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVL 242
HS V+HRD+K +N L D +K TDFG P + +VG+ Y++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 243 -RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
R+ YG + DIWS G++ ++ G PP+ E I +P +S+ +
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ERLSAVFR 246
Query: 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDGDASD-KPLDIAVLTRMK 347
D + + L D R SA E+L HP++++ S PL IA +K
Sbjct: 247 DFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAAKEAIK 293
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 74/267 (27%), Positives = 119/267 (44%), Gaps = 41/267 (15%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV KDT +A K + ++ ++ V +R E I+ +V++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVKMF 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++D+ ++ LIM+ GG++ ++ K +E + V + H +G +HRD+
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFK---------------PGD-VFKDL-------- 230
KP+N L S +K +DFGL K P D F+++
Sbjct: 128 KPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 231 ------------VGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
VG+ Y+APEV + Y D WS GVI+Y +L G PPF ET Q
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
Query: 278 FDAILRGHIDFSSDPWPNISSSAKDIV 304
+ ++ P IS AKD++
Sbjct: 245 YKKVMNWKETLIFPPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 85/308 (27%), Positives = 140/308 (45%), Gaps = 49/308 (15%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y+ + +GRG +G+ + +T ++ A K I++ NR D + RE++++ HL H
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLD-HE 64
Query: 129 NIVELKG--------AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
N++ +K A+ D + V +MD +L I + S+ Q++
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDT----DLHQIIRSSQTLSDDHCQYFLYQLLRG 120
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAP 239
+ Y HS V+HRDLKP N L +++ + LK DFGL+ + GD + V + +Y AP
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177
Query: 240 EVLRR--NYGAEADIWSAGVILYILLSGVPPFWG------------------ETEQSIFD 279
E+L Y D+WS G I LL P F G E +
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237
Query: 280 A-----ILRG-----HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329
+R F + +P+ + A D+++KML DP +R++ E L HP++
Sbjct: 238 NEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296
Query: 330 DGDASDKP 337
D SD+P
Sbjct: 297 LHDPSDEP 304
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 78/270 (28%), Positives = 141/270 (52%), Gaps = 28/270 (10%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN-IVEL 133
+GRG FG +V K+T Q +A K ++ +++ R + R E ++ + G R I L
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN--GDRRWITNL 66
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----QMVTVVHYCHSMGV 189
A++D +++ L+MD GG+L +++K + +R ++ R +MV + H +G
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLGY 123
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDL-VGSAYYVAPEVLRR--- 244
+HRD+KP+N L + ++ DFG + G V ++ VG+ Y++PE+L+
Sbjct: 124 VHRDIKPDNVLLDKNGH---IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 245 ---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL--RGHIDFSSDPWPNISSS 299
YG E D WS GV +Y +L G PF+ E+ + I+ + H F D ++S
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDVSEE 239
Query: 300 AKDIVKKMLHADPKERL---SAAEVLNHPW 326
AKD++++++ P+ RL + +HP+
Sbjct: 240 AKDLIRRLI-CSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 80/279 (28%), Positives = 132/279 (47%), Gaps = 34/279 (12%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
ELG+G +G Y V H+ T A K I R ++ + E+ I+H IV+
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDILHKAVSPY-IVDF 64
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV-TVVHYCHSM----G 188
GA+ +V + M+ G L D++ A G +E ++ R++ VV +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----VGSAYYVAPEVLRR 244
++HRD+KP N L + + + +K DFG+S G++ L +G Y+APE ++
Sbjct: 124 IIHRDVKPTNVLVNGNGQ---VKLCDFGVS-----GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 245 -------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIF---DAILRGHIDFSSDPWP 294
Y ++D+WS G+ + + G P+ ET +IF AI+ G D + P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG--DPPTLP-S 232
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDA 333
S A+D V K L+ P R + A++L HPW+ +A
Sbjct: 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 74/282 (26%), Positives = 137/282 (48%), Gaps = 25/282 (8%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R +GRG + LV K T++ +A K I + + +D++ V+ E + + H +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L ++ + +++ +GG+L + + E A ++ +++ H G+++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 193 DLKPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEA 250
DLK +N L + + +K TD+G+ +PGD G+ Y+APE+LR +YG
Sbjct: 121 DLKLDNVLLDA---EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 251 DIWSAGVILYILLSGVPPF---------WGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
D W+ GV+++ +++G PF TE +F IL I ++S A
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAS 233
Query: 302 DIVKKMLHADPKERLSA------AEVLNHPWMR-VDGDASDK 336
++K L+ DPKERL ++ +HP+ R +D D ++
Sbjct: 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ 275
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 69/244 (28%), Positives = 118/244 (48%), Gaps = 9/244 (3%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K T + +A K + +I DDVE E +++ + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + +M+ GG+L +I G + E A ++ + + HS G+++RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADI 252
K +N + S +K DFG+ G K G+ Y+APE++ + YG D
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W+ GV+LY +L+G PF GE E +F +I+ ++ + ++S A I K ++ P
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHP 240
Query: 313 KERL 316
+RL
Sbjct: 241 GKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 85/292 (29%), Positives = 125/292 (42%), Gaps = 53/292 (18%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED------VRREVQIMHHLTGH 127
++G G +GV Y +K T Q A K I R + E+ RE+ ++ L H
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKI-------RLESEEEGVPSTAIREISLLKELQ-H 58
Query: 128 RNIVELKGAYEDRHSVNLI-----MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
NIV L+ + LI MDL + D + + + Q++ +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSMDL---KKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEV 241
+CHS V+HRDLKP+N L + +K DFGL+ F P V+ V + +Y APEV
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGV---IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 242 L--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP----- 294
L Y DIWS G I + + P F G++E I R + D WP
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232
Query: 295 --------------------NISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
N+ D+++KML DP +R+SA + LNHP+
Sbjct: 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 88/316 (27%), Positives = 139/316 (43%), Gaps = 46/316 (14%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L K + +V + Y +G G +G T ++ A K +S R + + RE
Sbjct: 6 LNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRE 64
Query: 118 VQIMHHLTGHRNIVELKGAY------EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA 171
++++ H+ H N++ L + ED V L+ L G +L + I+ S+
Sbjct: 65 LRLLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADL-NNIVKCQKLSDDHIQ 121
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
L Q++ + Y HS G++HRDLKP N + ED LK DFGL+ D V
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLAR--HTDDEMTGYV 176
Query: 232 GSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL------- 282
+ +Y APE++ +Y DIWS G I+ LL+G F G I+
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 283 ------------RGHI---------DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
R +I DF + + + A D+++KML DP +R++AAE
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDF-KEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 322 LNHPWMRVDGDASDKP 337
L HP++ D D+P
Sbjct: 296 LAHPYLAEYHDPEDEP 311
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 99/322 (30%), Positives = 149/322 (46%), Gaps = 53/322 (16%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
N Y +++G G+FG +LV HK T++ F K+IS R L R+ + V EV +M L
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK- 70
Query: 127 HRNIVELKGAYEDR------HSVNLIMDLCAGGELFDRIIAK-----GHYSERAAANLCR 175
H+NIV Y DR + ++M+ C G+L R I K G E A ++ R
Sbjct: 71 HKNIVR----YIDRFLNKANQKLYILMEFCDAGDL-SRNIQKCYKMFGKIEEHAIVDITR 125
Query: 176 QMVTVVHYCHSMG-------VMHRDLKPENFLFSS--------SAEDSPL------KATD 214
Q++ + YCH++ V+HRDLKP+N S+ +A+ + L K D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVL---RRNYGAEADIWSAGVILYILLSGVPPFWG 271
FGLS + VG+ YY +PE+L ++Y ++D+W+ G I+Y L SG PF
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 272 ETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH------- 324
S + L+ D P S ++K +L+ KER SA + L +
Sbjct: 246 ANNFSQLISELKRGPDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302
Query: 325 -PWMRVDGDASDKPLDIAVLTR 345
P G A AV+ R
Sbjct: 303 PPVGAAGGGAGVAAAPGAVVAR 324
|
Length = 1021 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 90/336 (26%), Positives = 134/336 (39%), Gaps = 65/336 (19%)
Query: 62 MEDVRNTYIF-GRELGRGQFGVTYLVTHKDTKQQFACK-----SISSRKLINRDDVEDV- 114
+ YI G LG G +G T + A K IS+ +R V
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 115 -----RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA 169
RE++IM+ + H NI+ L Y + +NL+MD+ A +L + K +E
Sbjct: 63 IHFTTLRELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQ 120
Query: 170 AANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD 229
+ Q++ ++ H MHRDL P N +S K DFGL+ +
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSDT 177
Query: 230 L---------------VGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGE 272
L V + +Y APE+L Y D+WS G I LL+G P F GE
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237
Query: 273 TE----QSIFDAILRG---------------HIDFS-------SDPWPNISSSAKDIVKK 306
E IF+ L G + +F+ +PN S A D+++
Sbjct: 238 NEIDQLGRIFE--LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQS 295
Query: 307 MLHADPKERLSAAEVLNHPWMRVDG---DASDKPLD 339
+L +P ER+SA E L H + + D D S P +
Sbjct: 296 LLKLNPLERISAKEALKHEYFKSDPLPCDPSQLPFN 331
|
Length = 335 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 86/304 (28%), Positives = 145/304 (47%), Gaps = 33/304 (10%)
Query: 37 PGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFA 96
P P SSS++S+++S K + ++ +G G G Y V H+ T + +A
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELER----VNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 97 CKSISSRKLINRDDVEDVR----REVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152
K I N +D VR RE++I+ + H N+V+ ++ + ++++ G
Sbjct: 104 LKVIYG----NHED--TVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDG 156
Query: 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212
G L IA E+ A++ RQ+++ + Y H ++HRD+KP N L +S+ +K
Sbjct: 157 GSLEGTHIAD----EQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKI 209
Query: 213 TDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRR--NYGA----EADIWSAGVILYILLSG 265
DFG+S + + D VG+ Y++PE + N+GA DIWS GV + G
Sbjct: 210 ADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
Query: 266 VPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA--KDIVKKMLHADPKERLSAAEVLN 323
PF G Q + A L I S P ++S + + L +P +R SA ++L
Sbjct: 270 RFPF-GVGRQGDW-ASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
Query: 324 HPWM 327
HP++
Sbjct: 328 HPFI 331
|
Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 74/268 (27%), Positives = 130/268 (48%), Gaps = 11/268 (4%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
D + Y ++G+G G Y T Q+ A + ++ L + E + E+ +M
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRE 73
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
+ NIV +Y + ++M+ AGG L D ++ + E A +CR+ + + +
Sbjct: 74 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK-DLVGSAYYVAPEVL 242
HS V+HRD+K +N L D +K TDFG P + +VG+ Y++APEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 243 -RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
R+ YG + DIWS G++ ++ G PP+ E I +P +S+ +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFR 247
Query: 302 DIVKKMLHADPKERLSAAEVLNHPWMRV 329
D + + L D ++R SA E+L H ++++
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 68/244 (27%), Positives = 117/244 (47%), Gaps = 9/244 (3%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K T + +A K + +I DDVE E +++ + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + +M+ GG+L I G + E A ++ + + H G+++RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 195 KPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADI 252
K +N + S +K DFG+ G + G+ Y+APE++ + YG D
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W+ GV+LY +L+G PPF GE E +F +I+ ++ + ++S A I K ++ P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKGLMTKHP 240
Query: 313 KERL 316
+RL
Sbjct: 241 SKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 78/288 (27%), Positives = 121/288 (42%), Gaps = 46/288 (15%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-----VRREVQIMHHLTGHR 128
+LG G + Y ++ T + A K I D E+ RE+ +M L H
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEI-------HLDAEEGTPSTAIREISLMKELK-HE 58
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGG--ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
NIV L + + L+ + + D +G + Q++ + +CH
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVL--R 243
V+HRDLKP+N L + E LK DFGL+ F P + F + V + +Y AP+VL
Sbjct: 119 NRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 244 RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK-- 301
R Y DIWS G I+ +++G P F G + I R + WP IS +
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235
Query: 302 -----------------------DIVKKMLHADPKERLSAAEVLNHPW 326
D++ ++L +P+ R+SA + L HPW
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 23/280 (8%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R +GRG + LV K Q +A K + + + +D++ V+ E + + + +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L ++ + L+++ GG+L + + E A ++ +++ H G+++R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 193 DLKPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEA 250
DLK +N L D +K TD+G+ PGD G+ Y+APE+LR YG
Sbjct: 121 DLKLDNVLLD---ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 251 DIWSAGVILYILLSGVPPF-------WGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303
D W+ GV+++ +++G PF TE +F IL I +S A +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233
Query: 304 VKKMLHADPKERLSA------AEVLNHPWMR-VDGDASDK 336
+K L+ DPKERL +++ +H + R +D D +K
Sbjct: 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEK 273
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 84/313 (26%), Positives = 141/313 (45%), Gaps = 62/313 (19%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG LV KDT + +A K++ ++ +D + V+ E ++ + +V L
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSPWVVSLY 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
+++D + LIM+ GG+L +I +SE + V + H +G +HRD+
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSV-FFKPGD--VFKDL--------------------- 230
KP+N L +K +DFGLS F K D ++ L
Sbjct: 128 KPDNILIDR---GGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184
Query: 231 ------------------------VGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSG 265
VG+ Y+APE+ L++ YG E D WS G I++ L G
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244
Query: 266 VPPFWGETEQSIFDAIL--RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAE 320
PPF E + I+ R + F D ++S A+D++++++ + + RL A E
Sbjct: 245 WPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLI-TNAENRLGRGGAHE 301
Query: 321 VLNHPWMR-VDGD 332
+ +HP+ R VD D
Sbjct: 302 IKSHPFFRGVDWD 314
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 72/264 (27%), Positives = 122/264 (46%), Gaps = 12/264 (4%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R LG+G FG + T + +ACK + +++ R E +I+ + R +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-RFVVS 64
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVM 190
L AYE + ++ L++ + GG+L I G+ + E+ A ++ + ++
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAE 249
+RDLKPEN L ++ +D GL+V G+ + VG+ Y+APEV+ Y
Sbjct: 125 YRDLKPENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
D W G ++Y ++ G PF E+ + + R + + S AK I + +L
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 310 ADPKERL-----SAAEVLNHPWMR 328
+PKERL AA V HP +
Sbjct: 242 KNPKERLGCRGNGAAGVKQHPIFK 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 80/278 (28%), Positives = 130/278 (46%), Gaps = 26/278 (9%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K + FA K++ ++ DDVE E +++ + + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + + +M+ GG+L I KG + A ++V + + HS G+++RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-----LVGSAYYVAPEVLR-RNYGA 248
K +N + D +K DFG+ +VF D G+ Y+APE+L+ Y
Sbjct: 123 KLDNVMLD---RDGHIKIADFGMC----KENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP-WPNISSSAKDIVKKM 307
D WS GV+LY +L G PF G+ E +F++I +D P W I+ +KDI++K+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RVDTPHYPRW--ITKESKDILEKL 230
Query: 308 LHADPKERLS-AAEVLNHP------WMRVDGDASDKPL 338
DP RL + HP W ++ D P
Sbjct: 231 FERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPF 268
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 67/250 (26%), Positives = 126/250 (50%), Gaps = 12/250 (4%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+++GRGQF Y T ++ A K + ++++ +D +E+ ++ L H N+++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIK 66
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRII----AKGHYSERAAANLCRQMVTVVHYCHSMG 188
++ + + +N++++L G+L I K ER Q+ + V + HS
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-FKDLVGSAYYVAPEVLRRN-Y 246
VMHRD+KP N +++ +K D GL FF LVG+ YY++PE + N Y
Sbjct: 127 VMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR-GHIDFSSDPWPNISSSAKDIVK 305
++DIWS G +LY + + PF+G+ + ++F + D+ P + S +++V
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGD-KMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVS 242
Query: 306 KMLHADPKER 315
++ DP +R
Sbjct: 243 MCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 22/266 (8%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSI----SSRKLINRDDVEDVRREVQIMHHLTGH 127
G+ LGRG FG YL DT ++ A K + S++ +V + E+Q++ +L H
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE--TSKEVNALECEIQLLKNLR-H 63
Query: 128 RNIVELKGAYED--RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH 185
IV+ G D +++ ++ GG + D++ A G +E RQ++ V Y H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS----VFFKPGDVFKDLVGSAYYVAPEV 241
S ++HRD+K N L S+ +K DFG S G K + G+ Y+++PEV
Sbjct: 124 SNMIVHRDIKGANILRDSAGN---VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSS 299
+ YG +AD+WS + +L+ PP W E E AI + + P +S +
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTKPMLPDGVSDA 237
Query: 300 AKDIVKKMLHADPKERLSAAEVLNHP 325
+D +K++ + K R +A +L HP
Sbjct: 238 CRDFLKQIFVEE-KRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 69/259 (26%), Positives = 127/259 (49%), Gaps = 11/259 (4%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+++G G FG YL K + K I K+ ++ E ++EV ++ + H NIV
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMK-HPNIVT 63
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRI-IAKG-HYSERAAANLCRQMVTVVHYCHSMGVM 190
++++ + ++M+ C GG+L RI +G +SE + Q+ + + H ++
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLR-RNYGA 248
HRD+K +N S + + K DFG++ ++ VG+ YY++PE+ + R Y
Sbjct: 124 HRDIKSQNIFLSKNGMVA--KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML 308
+ DIWS G +LY L + PF G + I +G+ S PN S + ++ ++
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS---PNFSRDLRSLISQLF 238
Query: 309 HADPKERLSAAEVLNHPWM 327
P++R S +L P++
Sbjct: 239 KVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 82/298 (27%), Positives = 134/298 (44%), Gaps = 53/298 (17%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHLTGHRNIV 131
++G G +G Y KDT + A K + +L N + + RE++I+ L HRNIV
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKILRQLN-HRNIV 69
Query: 132 ELKGAYEDRH-SVNLIMDLCAGGELFDR-------IIAKG--HYSERAAANLCRQMVTVV 181
LK D+ +++ D A +F+ ++ G H+SE + +Q++ +
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGL 129
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV--FKDLVGSAYYVAP 239
+YCH +HRD+K N L ++ + +K DFGL+ + + + + V + +Y P
Sbjct: 130 NYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP--WPN 295
E+L YG D+WS G IL L + P F E + + I R + S P WP+
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR--LCGSPCPAVWPD 244
Query: 296 --------------------------ISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
I + A D++ ML DP +R +A E LN PW+
Sbjct: 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-25
Identities = 68/192 (35%), Positives = 103/192 (53%), Gaps = 16/192 (8%)
Query: 143 VNLIMDLCAGGELFDRIIAKGH----YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198
+ L++D G+L I ++ + E A L Q++ VH+ HS ++HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 199 FLFSSSAEDSPLKATDFGLSVFFK---PGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWS 254
L S + +K DFG S + DV + G+ YYVAPE+ RR Y +AD++S
Sbjct: 174 ILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFS 230
Query: 255 AGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKDIVKKMLHADPK 313
GV+LY LL+ PF GE + + L G DP P +IS ++IV +L +DPK
Sbjct: 231 LGVLLYELLTLKRPFDGENMEEVMHKTLAGRY----DPLPPSISPEMQEIVTALLSSDPK 286
Query: 314 ERLSAAEVLNHP 325
R S++++LN P
Sbjct: 287 RRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 91/326 (27%), Positives = 133/326 (40%), Gaps = 72/326 (22%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISS--------RKLINRDDVEDV 114
DV Y +G G +G+ THK T + A K IS R L
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--------- 51
Query: 115 RREVQIMHHLTGHRNIVELK-----GAYEDRHSVNLI---M--DLCAGGELFDRIIAKGH 164
RE++I+ H NI+ + ++E + V ++ M DL ++I H
Sbjct: 52 -REIKILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMETDLY-------KLIKTQH 102
Query: 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
S Q++ + Y HS V+HRDLKP N L +++ + LK DFGL+ P
Sbjct: 103 LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPE 159
Query: 225 DVFK----DLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWG------- 271
+ V + +Y APE++ + Y DIWS G IL +LS P F G
Sbjct: 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL 219
Query: 272 ------------ETEQSIFDAILRGHID----FSSDPW----PNISSSAKDIVKKMLHAD 311
E I R +I PW PN A D++ KML +
Sbjct: 220 NLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFN 279
Query: 312 PKERLSAAEVLNHPWMRVDGDASDKP 337
P +R++ E L HP++ D SD+P
Sbjct: 280 PHKRITVEEALAHPYLEQYHDPSDEP 305
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 64/274 (23%), Positives = 122/274 (44%), Gaps = 37/274 (13%)
Query: 70 IFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
G++LG G FG T + T+ + A K++ ++ + ++ E+ E IM L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKL- 58
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYC 184
H NIV L G + ++ + GG+L D + G + + + Q+ + Y
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV------- 237
S +HRDL N L + E+ +K +DFGLS +D+ YY
Sbjct: 119 ESKNFVHRDLAARNCLVT---ENLVVKISDFGLS---------RDIYEDDYYRKRGGGKL 166
Query: 238 -----APEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSS 290
APE L+ + +++D+WS GV+L+ + + G P+ G + + + + + G+
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR---L 223
Query: 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
N +++ + DP++R + +E++
Sbjct: 224 PRPENCPDELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 84/300 (28%), Positives = 129/300 (43%), Gaps = 52/300 (17%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE-DVRREVQIMHHLTGHRNIVEL 133
+G G +G+ Y + + A K + RD + RE+ ++ +L H NIVEL
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDN--ERDGIPISSLREITLLLNLR-HPNIVEL 71
Query: 134 KGAYEDRH--SVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
K +H S+ L+M+ C L D + +SE L Q++ + Y H +
Sbjct: 72 KEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHENFI 129
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL---VGSAYYVAPEVL--RR 244
+HRDLK N L + LK DFGL+ + G K + V + +Y APE+L
Sbjct: 130 IHRDLKVSNLLLTDKGC---LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGCT 184
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI--LRG----HI--DFSSDP---- 292
Y D+W+ G IL LL+ P G++E D I L G I FS P
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244
Query: 293 --------------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338
+P +S + ++ +L DPK+R +A E L + + +KPL
Sbjct: 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK------EKPL 298
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 68/265 (25%), Positives = 129/265 (48%), Gaps = 15/265 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y F R +G+G +G LV H+ +Q+ K ++ R R+ + +E Q++ L H
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLK-HP 59
Query: 129 NIVELKGAYEDRHS-VNLIMDLCAGGELFDRII-AKGH-YSERAAANLCRQMVTVVHYCH 185
NIV + ++E + ++M C GG+L+ ++ KG E Q+ + Y H
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVL-R 243
++HRDLK +N + + + +K D G++ V D+ L+G+ YY++PE+
Sbjct: 120 EKHILHRDLKTQNVFLTRT---NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176
Query: 244 RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKD 302
+ Y ++D+W+ G +Y + + F + S+ I+ G + P P + S +
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL----PPMPKDYSPELGE 232
Query: 303 IVKKMLHADPKERLSAAEVLNHPWM 327
++ ML P++R S +L P++
Sbjct: 233 LIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 85/318 (26%), Positives = 133/318 (41%), Gaps = 66/318 (20%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REV 118
P D + Y ++G+G FG + HK TKQ A K + + N + + RE+
Sbjct: 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV---LMENEKEGFPITALREI 62
Query: 119 QIMHHLTGHRNIVEL--------KGAYEDRHSVNLIMDLC----AGGELFDRIIAKGHYS 166
+I+ L H N+V L + S L+ + C AG L K S
Sbjct: 63 KILQLLK-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTLS 119
Query: 167 ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF----- 221
E + + ++ ++Y H ++HRD+K N L + +D LK DFGL+ F
Sbjct: 120 EIKK--VMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKN 174
Query: 222 -KPGDVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIF 278
KP + + + V + +Y PE+L R+YG D+W AG I+ + + P G TEQ
Sbjct: 175 SKP-NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL 233
Query: 279 DAI--LRGHIDFSSDPWPNI----------------------------SSSAKDIVKKML 308
I L G I + + WP + A D++ K+L
Sbjct: 234 TLISQLCGSI--TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291
Query: 309 HADPKERLSAAEVLNHPW 326
DP +R+ A LNH +
Sbjct: 292 VLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 82/284 (28%), Positives = 129/284 (45%), Gaps = 40/284 (14%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G G +GV HK+TK+ A K + N + E RE++++ L NIVELK
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELK 66
Query: 135 GAYEDRHSVNLIMDLCAGG--ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
A+ R + L+ + EL + + G E+ + + Q++ +H+CH ++HR
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYI-YQLIKAIHWCHKNDIVHR 124
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--VFKDLVGSAYYVAPEVLR-RNYGAE 249
D+KPEN L S + LK DFG + G + + V + +Y +PE+L YG
Sbjct: 125 DIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETE------------------QSIFDAILRGH-IDFSS 290
D+WS G IL L G P F GE+E +F + R H + F +
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPA 241
Query: 291 DPWPN---------ISSSAKDIVKKMLHADPKERLSAAEVLNHP 325
P +S D++K +L +P +R + LNHP
Sbjct: 242 VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 74/265 (27%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G +G+ Y T+ + A K I R + V+ + E+ + +L HRNIV+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYL 71
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMGVMH 191
G+ + + M+ GG L + +K +E+ +Q++ + Y H ++H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLS---VFFKPGDVFKDLVGSAYYVAPEVL---RRN 245
RD+K +N L ++ + +K +DFG S P + G+ Y+APEV+ R
Sbjct: 132 RDIKGDNVLVNTYS--GVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRG 187
Query: 246 YGAEADIWSAGVILYILLSGVPPFW--GETEQSIFD-AILRGHIDFSSDPWPNISSSAKD 302
YGA ADIWS G + + +G PPF GE + ++F + + H + +S+ AK+
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES----LSAEAKN 243
Query: 303 IVKKMLHADPKERLSAAEVLNHPWM 327
+ + DP +R SA ++L P++
Sbjct: 244 FILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 84/297 (28%), Positives = 120/297 (40%), Gaps = 66/297 (22%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED------VRREVQIMHHLTGHR 128
+G G +GV Y K T + A K I R + ED RE+ ++ L H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELN-HP 58
Query: 129 NIVELKGAYEDRHSVNLI-----------MDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
NIV L + + L+ MD L +I Y Q+
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY----------QL 108
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYY 236
+ + YCHS V+HRDLKP+N L + LK DFGL+ F P + V + +Y
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDR---EGALKLADFGLARAFGVPVRTYTHEVVTLWY 165
Query: 237 VAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAI--------- 281
APE+L R Y DIWS G I +++ P F G++E IF +
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225
Query: 282 -LRGHIDFSS-----------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
+ D+ PN+ D++ KML DP +R+SA L HP+
Sbjct: 226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 59/187 (31%), Positives = 83/187 (44%), Gaps = 29/187 (15%)
Query: 167 ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGD 225
+ + Q++ V +CH GVMHRDLKP+N L LK D GL F P
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG--LLKIADLGLGRAFSIPVK 166
Query: 226 VFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFD 279
+ + + +Y APEVL +Y DIWS G I + P F G++E IF
Sbjct: 167 SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226
Query: 280 AI-------------LRGHIDFS-------SDPWPNISSSAKDIVKKMLHADPKERLSAA 319
+ LR +F S P++S D+++KML DP +R+SA
Sbjct: 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK 286
Query: 320 EVLNHPW 326
L HP+
Sbjct: 287 AALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 8e-24
Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 19/256 (7%)
Query: 78 GQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM-HHLTG-HRNIVELKG 135
G+FG ++ HK T++ F K I ++ ++ M H L + N ++L
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNF----------NAIEPMVHQLMKDNPNFIKLYY 76
Query: 136 AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLK 195
+ LIMD G+LFD + +G SE + RQ+V ++ H ++H D+K
Sbjct: 77 SVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIK 136
Query: 196 PENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE-VLRRNYGAEADIWS 254
EN L+ + + + D+GL K G+ Y +PE + NY D W+
Sbjct: 137 LENVLYDRAKDR--IYLCDYGLC---KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWA 191
Query: 255 AGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKE 314
GV+ Y LL+G PF + ++ + L N+S +A D V+ ML +
Sbjct: 192 VGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINY 251
Query: 315 RLSA-AEVLNHPWMRV 329
RL+ E++ HP++++
Sbjct: 252 RLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 80/298 (26%), Positives = 123/298 (41%), Gaps = 66/298 (22%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED------VRREVQIMHHLTGH 127
++G G +GV Y +K T + A K I R D E RE+ ++ L H
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELN-H 58
Query: 128 RNIVELKGAYEDRHSVNLI-----------MDLCAGGELFDRIIAKGHYSERAAANLCRQ 176
NIV+L + + L+ MD + +I + Q
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK----------SYLFQ 108
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAY 235
++ + +CHS V+HRDLKP+N L + + +K DFGL+ F P + V + +
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLW 165
Query: 236 YVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR--GHIDFSSD 291
Y APE+L + Y DIWS G I +++ F G++E I R G D
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225
Query: 292 P--------------W---------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
P W P + +D++ +MLH DP +R+SA L HP+
Sbjct: 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 51/289 (17%)
Query: 96 ACKSISSRKLINRD--DVEDVRREVQIMHHLTGHRNIVELKGAY--------EDRHSVNL 145
K ++ +K++ D V+ RE++I+ L H NIV++ ED S+
Sbjct: 29 CDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSLTE 87
Query: 146 IMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLF 201
+ + E + ++ +G SE A Q++ + Y HS V+HRDLKP N
Sbjct: 88 LNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147
Query: 202 SSSAEDSPLKATDFGLSVFFKP-----GDVFKDLVGSAYYVAPEVL--RRNYGAEADIWS 254
++ ED LK DFGL+ P G + + LV + +Y +P +L NY D+W+
Sbjct: 148 NT--EDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWA 204
Query: 255 AGVILYILLSGVPPFWGETE----QSIFDAI------------------LRGHIDFSSDP 292
AG I +L+G P F G E Q I +++ +R P
Sbjct: 205 AGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRP 264
Query: 293 W----PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKP 337
P ++ A D ++++L +P +RL+A E L HP+M D+P
Sbjct: 265 LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEP 313
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 1e-23
Identities = 71/267 (26%), Positives = 123/267 (46%), Gaps = 17/267 (6%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSI---SSRKLINRDDVEDVRREVQIMHHLTGHR 128
G LG+G +G Y + Q A K + +S L + E ++ EV ++ L H
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HV 62
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
NIV+ G D +++++ M+ GG + + G E +Q++ V Y H+
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFG-------LSVFFKPGDVFKDLVGSAYYVAPEV 241
V+HRD+K N + + +K DFG + + ++ K + G+ Y++APEV
Sbjct: 123 VVHRDIKGNNVMLMPNG---IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ + YG ++DIWS G ++ + +G PP + I P + S++A
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP-DSFSAAA 238
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWM 327
D V L D ER SA ++L H ++
Sbjct: 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 2e-23
Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 15/257 (5%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
RE+G G FG Y T + A K +S + + +D+ +EV+ + + H N +E
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIE 89
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
KG Y H+ L+M+ C G + K E A + + + Y HS ++HR
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL----RRNYGA 248
D+K N L + E +K DFG + P + F VG+ Y++APEV+ Y
Sbjct: 150 DIKAGNILLT---EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYDG 203
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-DFSSDPWPNISSSAKDIVKKM 307
+ D+WS G+ L PP + S I + S+ W S ++ V
Sbjct: 204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRNFVDSC 260
Query: 308 LHADPKERLSAAEVLNH 324
L P++R ++ E+L H
Sbjct: 261 LQKIPQDRPTSEELLKH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-23
Identities = 74/266 (27%), Positives = 122/266 (45%), Gaps = 30/266 (11%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG V K+T + +ACK + ++L + + E +I+ + IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC---------- 184
A+E + + L+M L GG+L I + ER +M V+HY
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIY---NVGERGL-----EMERVIHYSAQITCGILHL 111
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
HSM +++RD+KPEN L + +D GL+V K G G+ Y+APE+L+
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGN---CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE 168
Query: 245 N-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR----GHIDFSSDPWPNISSS 299
Y D ++ G +Y +++G PF E+ + + R + F N +
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEE 225
Query: 300 AKDIVKKMLHADPKERLSAAEVLNHP 325
+KDI + L P++RL + E + P
Sbjct: 226 SKDICRLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 85/310 (27%), Positives = 129/310 (41%), Gaps = 81/310 (26%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSI--SSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
++LG+G +G+ + + TK+ A K I + R N D + RE+ + L H NI
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR---NATDAQRTFREIMFLQELGDHPNI 69
Query: 131 VELKGAYE----------------DRHSV---NLIMDLCAGGELFDRIIAKGHYSERAAA 171
V+L + D H+V N++ D+ R I Y
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV------HKRYIM---Y------ 114
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD------ 225
Q++ + Y HS V+HRDLKP N L +S D +K DFGL+ +
Sbjct: 115 ----QLLKALKYIHSGNVIHRDLKPSNILLNS---DCRVKLADFGLARSLSELEENPENP 167
Query: 226 VFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWG------------ 271
V D V + +Y APE+L Y D+WS G IL +L G P F G
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227
Query: 272 --------ETEQ-------SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL 316
+ E ++ D++ + P S A D++KK+L +P +RL
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287
Query: 317 SAAEVLNHPW 326
+A E L HP+
Sbjct: 288 TAEEALEHPY 297
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 7e-23
Identities = 84/305 (27%), Positives = 126/305 (41%), Gaps = 65/305 (21%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED------VRREVQIMHHLTGH 127
++G G +GV Y + T + A K I R + ED RE+ ++ + H
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKI-------RLEQEDEGVPSTAIREISLLKEMQ-H 60
Query: 128 RNIVELKGAYEDRHSVNLI-----------MDLCAGGELFDRIIAKGHYSERAAANLCRQ 176
NIV L+ + L+ MD R+I Y Q
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY----------Q 110
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAY 235
++ + YCHS V+HRDLKP+N L + LK DFGL+ F P F V + +
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIPVRTFTHEVVTLW 168
Query: 236 YVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293
Y APE+L R+Y DIWS G I +++ P F G++E I R + + W
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228
Query: 294 PNISS-------------------------SAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
P ++S + D++ KML DP +R++A L H + +
Sbjct: 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
Query: 329 VDGDA 333
GDA
Sbjct: 289 DLGDA 293
|
Length = 294 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-22
Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
P ED + + +G G +G Y + +T + A K I KL +D V++E+ I
Sbjct: 7 PQED----FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEI-I 58
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
M H NIV G+Y R + + M+ C GG L D G SE A + R+ +
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQG 118
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-FKDLVGSAYYVAP 239
++Y HS G MHRD+K N L + ++ +K DFG+S K +G+ Y++AP
Sbjct: 119 LYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 240 EVL----RRNYGAEADIWSAGVILYILLSGVPPFWG---------ETEQSIFDAILRGHI 286
EV + Y DIW+ G+ L PP + T+ + L+ +
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
W N S VK L +PK+R +A ++L HP+
Sbjct: 236 K-----WSN---SFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 78/288 (27%), Positives = 125/288 (43%), Gaps = 46/288 (15%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
++G G +G + +++T + A K + DD E V RE+ ++ L H+N
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLD-----DDDEGVPSSALREICLLKELK-HKN 60
Query: 130 IVELKGAYEDRHSVNLIMDLCAGG--ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM 187
IV L + L+ + C + FD G + Q++ + +CHS
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAPEVL--RR 244
V+HRDLKP+N L + + E LK DFGL+ F P + V + +Y P+VL +
Sbjct: 119 NVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 245 NYGAEADIWSAGVILYILL-SGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS------ 297
Y D+WSAG I L +G P F G I R + + WP +S
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235
Query: 298 -------------------SSAKDIVKKMLHADPKERLSAAEVLNHPW 326
S+ +D+++ +L +P +R+SA E L HP+
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 76/299 (25%), Positives = 127/299 (42%), Gaps = 31/299 (10%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
RE+G G FG Y + A K +S + + +D+ +EV+ + L H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 79
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
+G Y H+ L+M+ C G + K E A + + + Y HS ++HR
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL----RRNYGA 248
D+K N L S E +K DFG + P + F VG+ Y++APEV+ Y
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID-FSSDPWPNISSSAKDIVKKM 307
+ D+WS G+ L PP + S I + S W S ++ V
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250
Query: 308 LHADPKERLSAAEVLNHPWMRVDGDASDKPLDI--AVLTRMK---------QFRAMNKL 355
L P++R ++ +L H ++ ++P + ++ R K Q+R M K+
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVL-----RERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-22
Identities = 66/251 (26%), Positives = 124/251 (49%), Gaps = 14/251 (5%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+++GRGQF Y T A K + L++ D +E+ ++ L H N+++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIK 66
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRII-----AKGHYSERAAANLCRQMVTVVHYCHSM 187
++ + + +N++++L G+L R+I K E+ Q+ + + + HS
Sbjct: 67 YYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-FKDLVGSAYYVAPEVLRRN- 245
VMHRD+KP N +++ +K D GL FF LVG+ YY++PE + N
Sbjct: 126 RVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR-GHIDFSSDPWPNISSSAKDIV 304
Y ++DIWS G +LY + + PF+G+ + +++ + D+ P + S + +V
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241
Query: 305 KKMLHADPKER 315
++ DP++R
Sbjct: 242 NMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 70/251 (27%), Positives = 130/251 (51%), Gaps = 28/251 (11%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVEL 133
+GRG FG +V K T++ +A K ++ +++ R + R E ++ + G + I L
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVL--VNGDCQWITTL 66
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----QMVTVVHYCHSMGV 189
A++D + + L+MD GG+L +++K + +R ++ R +MV +H H +
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLHY 123
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDL-VGSAYYVAPEVLRR--- 244
+HRD+KP+N L + ++ DFG + + G V + VG+ Y++PE+L+
Sbjct: 124 VHRDIKPDNVLLDMNGH---IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 245 ---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP----NIS 297
YG E D WS GV +Y +L G PF+ E+ + I+ F +P ++S
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHITDVS 237
Query: 298 SSAKDIVKKML 308
AKD++++++
Sbjct: 238 EEAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 64/282 (22%), Positives = 118/282 (41%), Gaps = 52/282 (18%)
Query: 73 RELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
++LG G FG Y L + A K++ + ++ +D +E ++M L GH N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKL-GHPN 57
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA-------------AANLCRQ 176
+V L G + + L+++ GG+L D + A + +
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY 236
M Y S +HRDL N L ED +K +DFGLS +D+ YY
Sbjct: 118 M----EYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLS---------RDVYDDDYY 161
Query: 237 V------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL 282
APE L+ + +++D+WS GV+L+ + + G P+ G + + + + +
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221
Query: 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
+G+ P +++ DP++R + +E++
Sbjct: 222 KGY--RLPKP-EYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 3e-22
Identities = 68/250 (27%), Positives = 129/250 (51%), Gaps = 26/250 (10%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG +V K+ + FA K ++ +++ R + R E ++ + ++ I L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDNQWITTLH 67
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----QMVTVVHYCHSMGVM 190
A++D +++ L+MD GG+L +++K + +R ++ R +MV + H + +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLT-LLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDL-VGSAYYVAPEVL------ 242
HRD+KP+N L + ++ DFG + + G V + VG+ Y++PE+L
Sbjct: 125 HRDIKPDNILMDMNGH---IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 243 RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP----NISS 298
+ YG E D WS GV +Y +L G PF+ E+ + I+ F +P ++S
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQVTDVSE 238
Query: 299 SAKDIVKKML 308
AKD++++++
Sbjct: 239 DAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 83/317 (26%), Positives = 124/317 (39%), Gaps = 76/317 (23%)
Query: 76 GRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
GRG +G Y K+ +++A K K + + RE+ ++ L H N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDK----EQYTGISQSACREIALLRELK-HEN 63
Query: 130 IVELKGAYEDRH--SVNLIMDLCAGGELFD--RIIAKGHYSERAAA-------NLCRQMV 178
+V L + + SV L+ D D +II K H + + +L Q++
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAE----HDLWQII-KFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLS-VFFKPGDVFKDL---VGS 233
VHY HS V+HRDLKP N L E +K D GL+ +F P DL V +
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178
Query: 234 AYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE-------------QSIF 278
+Y APE+L R+Y DIW+ G I LL+ P F G + IF
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238
Query: 279 ------------------------DAILRGHIDFSS-----DPWPNISSSAKDIVKKMLH 309
+S + S D+++K+L
Sbjct: 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE 298
Query: 310 ADPKERLSAAEVLNHPW 326
DP +R++A E L HP+
Sbjct: 299 YDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-21
Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 18/212 (8%)
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA--KGH--YSERAAANLCRQMVTVVH 182
H IV+ ++ + LIM+ +GG+L +I K H + E L Q+V +
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD 183
Query: 183 YCHSMGVMHRDLKPEN-FLFSSSAEDSPLKATDFGLSVFFKPG---DVFKDLVGSAYYVA 238
HS +MHRDLK N FL + +K DFG S + DV G+ YY+A
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGI----IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 239 PEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NI 296
PE+ R+ Y +AD+WS GVILY LL+ PF G +++ I +L G DP+P +
Sbjct: 240 PELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY----DPFPCPV 295
Query: 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
SS K ++ +L +P R + ++L+ +++
Sbjct: 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 72/257 (28%), Positives = 124/257 (48%), Gaps = 16/257 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG Y TK+ A K I + D++ED+++E+ ++ I
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY-ITRYY 68
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
G+Y + +IM+ GG D ++ G E A + R+++ + Y HS +HRD+
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN-YGAEADI 252
K N L S E +K DFG++ + ++ VG+ +++APEV++++ Y +ADI
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP--WPNISSSAKDIVKKMLHA 310
WS G+ L G PP + I + +S P S K+ V+ L+
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVLFLIPK-----NSPPTLEGQYSKPFKEFVEACLNK 239
Query: 311 DPKERLSAAEVLNHPWM 327
DP+ R +A E+L H ++
Sbjct: 240 DPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 88/322 (27%), Positives = 139/322 (43%), Gaps = 59/322 (18%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
+ K + ++ Y +++G G +G K T ++ A K +S R + + RE
Sbjct: 6 VNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRE 64
Query: 118 VQIMHHLTGHRNIVEL------KGAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHYS 166
+ ++ H+ H N++ L + ++ L+M DL + I S
Sbjct: 65 LTLLKHMQ-HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL--------QKIMGHPLS 115
Query: 167 ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
E L QM+ + Y HS G++HRDLKP N + ED LK DFGL+ + D
Sbjct: 116 EDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLA---RHADA 169
Query: 227 -FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWG------------ 271
V + +Y APEV+ +Y DIWS G I+ +L+G F G
Sbjct: 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229
Query: 272 -------ETEQSIFDAILRGHI---------DFSSDPWPNISSSAKDIVKKMLHADPKER 315
E Q + D + +I DFS+ +P S A D+++KML D +R
Sbjct: 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKR 288
Query: 316 LSAAEVLNHPWMRVDGDASDKP 337
L+A E L HP+ DA ++
Sbjct: 289 LTATEALEHPYFDSFRDADEET 310
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 3e-21
Identities = 77/294 (26%), Positives = 130/294 (44%), Gaps = 48/294 (16%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHR 128
+LG G G V H T ++ ++K+++ VR RE+QIMH
Sbjct: 11 SDLGAGNGGSVSKVKHIPTG------TVMAKKVVHIGAKSSVRKQILRELQIMHECRSP- 63
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMV---TVVHYC 184
IV GA+ + +++ + M+ G L DRI K G + +V T ++
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS--VFFKPGDVFKDLVGSAYYVAPEVL 242
H +MHRD+KP N L +S + +K DFG+S + D F VG++ Y++PE +
Sbjct: 123 HR--IMHRDIKPSNILVNSRGQ---IKLCDFGVSGELINSIADTF---VGTSTYMSPERI 174
Query: 243 R-RNYGAEADIWSAGVILYILLSGVPPF-------WGETEQ-SIFDAILRGHIDFSSDPW 293
+ Y ++D+WS G+ + L G PF G+ + I D + + +P
Sbjct: 175 QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ----IVQEPP 230
Query: 294 PNISSS-----AKDIVKKMLHADPKERLSAAEVL-NHPWMRVDGDASDKPLDIA 341
P + SS +D V L DP ER + ++ P+++ +D+
Sbjct: 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL---RASNVDLQ 281
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-21
Identities = 71/269 (26%), Positives = 124/269 (46%), Gaps = 23/269 (8%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG + T + +ACK ++ ++L R E E +I+ + R IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLA 59
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGH----YSERAAANLCRQMVTVVHYCHSMGVM 190
A++ + + L+M + GG+L I + E A Q+++ + + H ++
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFKDLVGSAYYVAPEVLR-RNYGA 248
+RDLKPEN L D ++ +D GL+V K G K G+ ++APE+L+ Y
Sbjct: 120 YRDLKPENVLLD---NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 249 EADIWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
D ++ GV LY +++ PF E + + IL + + S ++K
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD----KFSPASKSFC 232
Query: 305 KKMLHADPKERL-----SAAEVLNHPWMR 328
+ +L DP++RL + + HP R
Sbjct: 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFR 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 74/316 (23%), Positives = 122/316 (38%), Gaps = 73/316 (23%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE----DVRREVQIMHHL 124
Y +LG G FG Y T + A K K++ ++ + RE++I+ L
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKKL 64
Query: 125 TGHRNIVEL--------KGAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHYSERAAA 171
H N+V L + R SV ++ DL G L + + +E
Sbjct: 65 K-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQIK 118
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFK-- 228
Q++ ++Y H ++HRD+K N L + LK DFGL+ + P K
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGI---LKIADFGLARPYDGPPPNPKGG 175
Query: 229 ---------DLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE--- 274
+LV + +Y PE+L R Y DIW G + + + P G+++
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235
Query: 275 -QSIFDAI----------------LRGHIDFSSDPWPNISSSAK-------DIVKKMLHA 310
IF G F++ P + D++ K+L
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEERFGKLGPEGLDLLSKLLSL 294
Query: 311 DPKERLSAAEVLNHPW 326
DP +RL+A++ L HP+
Sbjct: 295 DPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 8e-21
Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 25/264 (9%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ +G G +G Y + T + A K I KL DD +++E+ ++ H NIV
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECK-HCNIVA 70
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
G+Y R + + M+ C GG L D G SE A +CR+ + + Y HS G MHR
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-FKDLVGSAYYVAPEV--LRRN--YG 247
D+K N L + + + +K DFG++ K +G+ Y++APEV + +N Y
Sbjct: 131 DIKGANILLTDNGD---VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 248 AEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDPWPNI------SSSA 300
DIW+ G+ L PP + +++F L +F P + SS+
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQP---PKLKDKTKWSSTF 241
Query: 301 KDIVKKMLHADPKERLSAAEVLNH 324
+ VK L +PK+R +A +L H
Sbjct: 242 HNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 9e-21
Identities = 67/257 (26%), Positives = 125/257 (48%), Gaps = 16/257 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G FG + T+Q A K I + D++ED+++E+ ++ + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY-VTKYY 68
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
G+Y + +IM+ GG D ++ G + E A + ++++ + Y HS +HRD+
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN-YGAEADI 252
K N L S E +K DFG++ + ++ VG+ +++APEV++++ Y ++ADI
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW--PNISSSAKDIVKKMLHA 310
WS G+ L G PP + + I ++ P S K+ + L+
Sbjct: 185 WSLGITAIELAKGEPP-----NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239
Query: 311 DPKERLSAAEVLNHPWM 327
DP R +A E+L H ++
Sbjct: 240 DPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 67/256 (26%), Positives = 125/256 (48%), Gaps = 12/256 (4%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
++G+G FG + T++ A K I + D++ED+++E+ ++ + +
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY-VTKY 67
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
G+Y + +IM+ GG D ++ G E A + R+++ + Y HS +HRD
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 126
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN-YGAEAD 251
+K N L S E +K DFG++ + ++ VG+ +++APEV++++ Y ++AD
Sbjct: 127 IKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311
IWS G+ L G PP + I + + N S K+ V+ L+ +
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG---NYSKPLKEFVEACLNKE 240
Query: 312 PKERLSAAEVLNHPWM 327
P R +A E+L H ++
Sbjct: 241 PSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 3e-20
Identities = 68/273 (24%), Positives = 126/273 (46%), Gaps = 34/273 (12%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G G +G Y H T Q A K + + D+ E++++E+ ++ + HRNI
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHRNIATYY 69
Query: 135 GAYEDRH------SVNLIMDLCAGGELFDRII-AKGH-YSERAAANLCRQMVTVVHYCHS 186
GA+ ++ + L+M+ C G + D I KG+ E A +CR+++ + + H
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEVLR-- 243
V+HRD+K +N L + +AE +K DFG+S + +G+ Y++APEV+
Sbjct: 130 HKVIHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 244 ----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
Y ++D+WS G+ + G PP I R +P P + S
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------NPAPRLKSK 239
Query: 300 A-----KDIVKKMLHADPKERLSAAEVLNHPWM 327
+ ++ L + +R + +++ HP++
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 74/273 (27%), Positives = 106/273 (38%), Gaps = 50/273 (18%)
Query: 71 FGRELGRGQFGVTYLVTHK----DTKQQFACKSISSRKLINRDDVE----DVRREVQIMH 122
F ++LG G FG L + +T +Q A KS+ N E D RE++I+
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL------NHSGEEQHRSDFEREIEILR 61
Query: 123 HLTGHRNIVELKGAYEDRH--SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR---QM 177
L H NIV+ KG E S+ LIM+ G L R + H + L Q+
Sbjct: 62 TLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSSQI 118
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGS- 233
+ Y S +HRDL N L S + +K +DFGL+ K+ S
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVES---EDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 234 AYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292
++ APE LR + + +D+WS GV LY L + + D S P
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFT--------------------YGDPSQSP 215
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHP 325
+M+ E L E L P
Sbjct: 216 PAEFLRMIGIAQGQMIVTRLLELLKEGERLPRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 4e-20
Identities = 83/291 (28%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE-DVRREVQIMHHLTG--HRNI 130
E+G G +G Y + A KS+ R N D + REV ++ L H NI
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSV--RVQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 131 VEL----KGAYEDRHS-VNLIM-----DLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
V L + DR + V L+ DL D++ G +E +L RQ +
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQDLRT---YLDKVPPPGLPAETIK-DLMRQFLRG 120
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 240
+ + H+ ++HRDLKPEN L +S + +K DFGL+ + +V + +Y APE
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 241 V-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ----SIFDAI------------LR 283
V L+ Y D+WS G I + P F G +E IFD I
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237
Query: 284 GHIDFS-------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
FS P I S ++ +ML +P +R+SA L HP+
Sbjct: 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 85/303 (28%), Positives = 123/303 (40%), Gaps = 78/303 (25%)
Query: 91 TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150
T Q A K +S R N + RE+ +M L H+NI+ L + + S+ D+
Sbjct: 40 TGQNVAIKKLS-RPFQNVTHAKRAYRELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVY 97
Query: 151 AGGELFDRIIAKGHYSERAAANLCR----------------QMVTVVHYCHSMGVMHRDL 194
EL D ANLC+ QM+ + + HS G++HRDL
Sbjct: 98 LVMELMD-------------ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDL 144
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF--KDLVGSAYYVAPEV-LRRNYGAEAD 251
KP N + S D LK DFGL+ G F V + YY APEV L Y D
Sbjct: 145 KPSNIVVKS---DCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 199
Query: 252 IWSAGVILYILLSGVPPF--------W-------GETEQSIFDAI---LRGHID------ 287
IWS G I+ ++ G F W G + +R +++
Sbjct: 200 IWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYA 259
Query: 288 -------FSSDPWPNISSS--------AKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332
F +P S S A+D++ KML DP++R+S + L HP++ V D
Sbjct: 260 GYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319
Query: 333 ASD 335
S+
Sbjct: 320 PSE 322
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 85/315 (26%), Positives = 134/315 (42%), Gaps = 44/315 (13%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L K + +V Y +G G +G +Q+ A K +S R + RE
Sbjct: 6 LNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRE 64
Query: 118 VQIMHHLTGHRNIVELKGAY------EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA 171
++++ H+ H N++ L + E+ + V L+ +L G +L + I+ S+
Sbjct: 65 LRLLKHMK-HENVIGLLDVFTPATSIENFNEVYLVTNL-MGADL-NNIVKCQKLSDEHVQ 121
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
L Q++ + Y HS G++HRDLKP N + ED L+ DFGL+ + D V
Sbjct: 122 FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLAR--QADDEMTGYV 176
Query: 232 GSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289
+ +Y APE++ +Y DIWS G I+ LL G F G I+ S
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236
Query: 290 SDPWPNISSS---------------------------AKDIVKKMLHADPKERLSAAEVL 322
+ ISS A D+++KML D +R+SA+E L
Sbjct: 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296
Query: 323 NHPWMRVDGDASDKP 337
HP+ D D+P
Sbjct: 297 AHPYFSQYHDPEDEP 311
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 85/324 (26%), Positives = 131/324 (40%), Gaps = 66/324 (20%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISS---------RKLINRDDVEDV 114
DV + Y +G G +GV + ++ A K I R L
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL--------- 52
Query: 115 RREVQIMHHLTGHRNIVELKGAY----EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA 170
RE++I+ H H NI+ ++ D V ++MDL +L I + +E
Sbjct: 53 -RELKILRHFK-HDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHI 109
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL--SVFFKPGDV-- 226
Q++ + Y HS V+HRDLKP N L + E L+ DFG+ + P +
Sbjct: 110 RYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE---LRIGDFGMARGLSSSPTEHKY 166
Query: 227 -FKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVI-------------------LYILLS 264
+ V + +Y APE+L Y D+WS G I L ++LS
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS 226
Query: 265 --GVPPFWGETEQSIFDAILRGHI-DFSSD---PW----PNISSSAKDIVKKMLHADPKE 314
G P E I +R +I + PW P S A D++ +ML DP+E
Sbjct: 227 VLGSPS--EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEE 284
Query: 315 RLSAAEVLNHPWMRVDGDASDKPL 338
R++ + L HP++ D D+P
Sbjct: 285 RITVEQALQHPFLAQYHDPDDEPT 308
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 82/306 (26%), Positives = 132/306 (43%), Gaps = 53/306 (17%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G +GV T ++ A K I+ + D + RE++++ L H +IVE+K
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKIND-VFEHVSDATRILREIKLLRLLR-HPDIVEIK 65
Query: 135 G--------AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
++D + V +M+ +L I A + Q++ + Y H+
Sbjct: 66 HIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFK--PGDVF-KDLVGSAYYVAPEV- 241
V HRDLKP+N L ++ D LK DFGL+ V F P +F D V + +Y APE+
Sbjct: 122 ANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 242 --LRRNYGAEADIWSAGVILYILLSGVPPFWG-------------------ETEQSIFDA 280
Y DIWS G I +L+G P F G ET + +
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238
Query: 281 ILRGH---------IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331
R + + FS +PN A +++++L DPK+R +A E L P+ +
Sbjct: 239 KARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297
Query: 332 DASDKP 337
+P
Sbjct: 298 KVEREP 303
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 85/313 (27%), Positives = 122/313 (38%), Gaps = 82/313 (26%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHLT 125
TY +LG G + Y K T Q A K I + ++ RE ++ L
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR----LEHEEGAPFTAIREASLLKDLK 61
Query: 126 GHRNIVELKGAYEDRHSVNLI-----------MDLCAGG------ELFDRIIAKGHYSER 168
H NIV L + ++ L+ MD C GG LF
Sbjct: 62 -HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLF------------ 108
Query: 169 AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL----SVFFKPG 224
Q++ + YCH V+HRDLKP+N L S E LK DFGL SV P
Sbjct: 109 -----LFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSV---PS 157
Query: 225 DVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAI 281
+ + V + +Y P+VL Y D+W G I Y + +G P F G T+ + I
Sbjct: 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217
Query: 282 LRGHIDFSSDPWPNISS----------------------------SAKDIVKKMLHADPK 313
R + + WP +SS +++ K L +PK
Sbjct: 218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPK 277
Query: 314 ERLSAAEVLNHPW 326
+R+SAAE + HP+
Sbjct: 278 KRISAAEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 7e-19
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G G +G Y H T Q A K + + D+ E+++ E+ ++ + HRNI
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHRNIATYY 79
Query: 135 GAYEDRHSVN------LIMDLCAGGELFDRII-AKGH-YSERAAANLCRQMVTVVHYCHS 186
GA+ + L+M+ C G + D + KG+ E A +CR+++ + + H+
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA 139
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLR-- 243
V+HRD+K +N L + +AE +K DFG+S ++ +G+ Y++APEV+
Sbjct: 140 HKVIHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196
Query: 244 ----RNYGAEADIWSAGVILYILLSGVPPF 269
Y +DIWS G+ + G PP
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 78/282 (27%), Positives = 121/282 (42%), Gaps = 52/282 (18%)
Query: 102 SRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD---- 157
SR N+ + RE+ ++ H+NI+ L + + S+ D+ EL D
Sbjct: 55 SRPFQNQTHAKRAYREL-VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLC 113
Query: 158 RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217
++I ER + L QM+ + + HS G++HRDLKP N + S D LK DFGL
Sbjct: 114 QVIHMELDHERMSY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL 169
Query: 218 SVFFKPGDVFKDLVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQS 276
+ + V + YY APEV L Y DIWS G I+ L+ G F G
Sbjct: 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID 229
Query: 277 IFDAIL------------------RGHIDFSSDPWPNIS--------------------- 297
++ ++ R +++ + +P IS
Sbjct: 230 QWNKVIEQLGTPSAEFMNRLQPTVRNYVE-NRPQYPGISFEELFPDWIFPSESERDKLKT 288
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRV--DGDASDKP 337
S A+D++ KML DP +R+S E L HP++ V D ++ P
Sbjct: 289 SQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAP 330
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 79/301 (26%), Positives = 127/301 (42%), Gaps = 49/301 (16%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE-DVRREVQIMHHLTG 126
TYI +LG G + Y K T A K I +L + + REV ++ L
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK- 62
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-----GHYSERAAANL-CRQMVTV 180
H NIV L S+ L+ E D+ + + G+ L Q++
Sbjct: 63 HANIVTLHDIIHTEKSLTLVF------EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRG 116
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAP 239
++YCH V+HRDLKP+N L + E LK DFGL+ P + + V + +Y P
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
++L +Y + D+W G I Y + +G P F G T + I R + + WP I
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233
Query: 298 SSAK--------------------------DIVKKMLHADPKERLSAAEVLNHPWMRVDG 331
S+ + +++ K+L + ++R+SA E + HP+ G
Sbjct: 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293
Query: 332 D 332
+
Sbjct: 294 E 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 77/268 (28%), Positives = 125/268 (46%), Gaps = 24/268 (8%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN---IV 131
+GRG FG Y DT + +A K + +K I E + +IM L + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD-KKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+ A+ ++ I+DL GG+L + G +SE +++ + + H+ V++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFF---KPGDVFKDLVGSAYYVAPEVLRRN--Y 246
RDLKP N L E ++ +D GL+ F KP VG+ Y+APEVL++ Y
Sbjct: 121 RDLKPANILLD---EHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAY 173
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN-ISSSAKDIVK 305
+ AD +S G +L+ LL G PF + + I R + + + P+ S + +++
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVE-LPDSFSPELRSLLE 231
Query: 306 KMLHADPKERL-----SAAEVLNHPWMR 328
+L D RL A EV HP+ R
Sbjct: 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 72/271 (26%), Positives = 113/271 (41%), Gaps = 31/271 (11%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
E+G G G Y + K T A K + R+ N+++ + + ++ ++ IV+
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 134 KGAYEDRHSVNLIMDL---CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC-HSMGV 189
G + V + M+L C +L RI +G E + +V +HY GV
Sbjct: 80 YGYFITDSDVFICMELMSTCLD-KLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL-----RR 244
+HRD+KP N L +S +K DFG+S G A Y+APE +
Sbjct: 137 IHRDVKPSNILLDASGN---VKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNP 193
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDPWP------NIS 297
Y AD+WS G+ L L +G P+ +TE + IL + P S
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL-------QEEPPSLPPNEGFS 246
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
V L D ++R E+L HP++R
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-18
Identities = 66/252 (26%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
F +ELG GQFGV +L + K A K I + D +E E ++M L+ H N+
Sbjct: 8 FLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIE----EAKVMMKLS-HPNL 61
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGV 189
V+L G + + ++ + A G L + + KG ++C + + Y S G
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---APEVLRRN- 245
+HRDL N L ED+ +K +DFGL+ + D + G+ + V PEV +
Sbjct: 122 IHRDLAARNCLVG---EDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSR 177
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS-SAKDI 303
+ +++D+WS GV+++ + S G P+ + + +++ G+ P ++ I
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR----LYRPKLAPTEVYTI 233
Query: 304 VKKMLHADPKER 315
+ H P++R
Sbjct: 234 MYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 83/314 (26%), Positives = 136/314 (43%), Gaps = 46/314 (14%)
Query: 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ 119
K + +V + Y +++G G +G + T + A K + R + + RE++
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELR 66
Query: 120 IMHHLTGHRNIVELKGAY------EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL 173
++ H+ H N++ L + + H L+M G +++ SE L
Sbjct: 67 LLKHMK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFL 123
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
QM+ + Y H+ G++HRDLKP N + ED LK DFGL+ + V +
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLAR--QTDSEMTGYVVT 178
Query: 234 AYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGE--------------TEQSI 277
+Y APEV+ +Y DIWS G I+ +L+G P F G T
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238
Query: 278 FDAIL-----RGHI---------DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323
F L + ++ DF S PN + A ++++KML D + R++AAE L
Sbjct: 239 FVQKLQSEDAKNYVKKLPRFRKKDFRS-LLPNANPLAVNVLEKMLVLDAESRITAAEALA 297
Query: 324 HPWMRVDGDASDKP 337
HP+ D D+
Sbjct: 298 HPYFEEFHDPEDET 311
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 84/311 (27%), Positives = 129/311 (41%), Gaps = 59/311 (18%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ +G G G+ ++ A K +S R N+ + RE+ +M H+NI+
Sbjct: 30 KPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMK-CVNHKNIIG 87
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
L + + S+ D+ EL D ++I ER + L QM+ + + HS G
Sbjct: 88 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIKHLHSAG 146
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV-LRRNYG 247
++HRDLKP N + S D LK DFGL+ + V + YY APEV L Y
Sbjct: 147 IIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 248 AEADIWSAGVIL------YILLSGV----------------------------------- 266
DIWS G I+ +L G
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263
Query: 267 PPFWGETEQSIFDAILRGHIDFSSDPWPN--ISSSAKDIVKKMLHADPKERLSAAEVLNH 324
P + G + + +F +L F +D N +S A+D++ KML D +R+S E L H
Sbjct: 264 PKYAGYSFEKLFPDVL-----FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 325 PWMRVDGDASD 335
P++ V D S+
Sbjct: 319 PYINVWYDPSE 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 16/221 (7%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
+E+G GQFG+ +L + K++ A K+I + ED E Q+M L+ H +
Sbjct: 8 LVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSE----EDFIEEAQVMMKLS-HPKL 61
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGV 189
V+L G +R + L+ + G L D + A +G +S+ +C + + Y S V
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV 121
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---APEVLR-RN 245
+HRDL N L E+ +K +DFG++ F D + G+ + V +PEV
Sbjct: 122 IHRDLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
Y +++D+WS GV+++ + S G P+ + + + I G
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF 218
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 80/300 (26%), Positives = 123/300 (41%), Gaps = 49/300 (16%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE-DVRREVQIMHHLTG 126
TYI +LG G + + K T+ A K I +L + + REV ++ L
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKDLK- 62
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK------GHYSERAAANLCRQMVTV 180
H NIV L S+ L+ E D+ + + S Q++
Sbjct: 63 HANIVTLHDIVHTDKSLTLVF------EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRG 116
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAP 239
+ YCH V+HRDLKP+N L + E LK DFGL+ P + + V + +Y P
Sbjct: 117 LAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPP 173
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
+VL Y + D+W G I + + SG P F G T + I R + + WP IS
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233
Query: 298 SSAK--------------------------DIVKKMLHADPKERLSAAEVLNHPWMRVDG 331
S+ + +++ K L + K+R+SA E + H + R G
Sbjct: 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 81/307 (26%), Positives = 129/307 (42%), Gaps = 51/307 (16%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+ +G G G+ + A K +S R N+ + RE+ +M H+NI+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMK-CVNHKNIIS 80
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
L + + S+ D+ EL D ++I ER + L QM+ + + HS G
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIKHLHSAG 139
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV-LRRNYG 247
++HRDLKP N + S D LK DFGL+ + V + YY APEV L Y
Sbjct: 140 IIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 248 AEADIWSAGVIL------YILLSG-----------------VPPFWGETEQSIFDAILRG 284
DIWS G I+ IL G P F + + ++ + +
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV-EN 255
Query: 285 HIDFSSDPWPNI----------------SSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
++ +P + +S A+D++ KML DP +R+S E L HP++
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315
Query: 329 VDGDASD 335
V D ++
Sbjct: 316 VWYDPAE 322
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 77/300 (25%), Positives = 119/300 (39%), Gaps = 59/300 (19%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE-DVRREVQIMHHLTG 126
TY+ +LG G + + K T+ A K I +L + + REV ++ +L
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKNLK- 61
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV------ 180
H NIV L + L+ E D + Y + + V +
Sbjct: 62 HANIVTLHDIIHTERCLTLVF------EYLDSDLK--QYLDNCGNLMSMHNVKIFMFQLL 113
Query: 181 --VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL----SVFFKPGDVFKDLVGSA 234
+ YCH ++HRDLKP+N L + E LK DFGL SV P + + V +
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSV---PTKTYSNEVVTL 167
Query: 235 YYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292
+Y P+VL Y D+W G ILY + +G P F G T + I R + +
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227
Query: 293 WPNISSSAK--------------------------DIVKKMLHADPKERLSAAEVLNHPW 326
WP I+S+ + D++ +L + K R+SA L H +
Sbjct: 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 70/288 (24%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
D +T+ +G+G +G + V +K + A K + I+ E++ E I+
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKA 70
Query: 124 LTGHRNIVELKGAYEDRHSVN-----LIMDLCAGGELFDRIIAKG------HYSERAAAN 172
L+ H N+V+ G Y + N L+++LC GG + D + KG E A
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD--LVKGFLKRGERMEEPIIAY 128
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-V 231
+ + + + + H +HRD+K N L ++ + +K DFG+S + ++ V
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSV 185
Query: 232 GSAYYVAPEV------LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285
G+ +++APEV L Y A D+WS G+ L G PP + +R
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP------MRAL 238
Query: 286 IDFSSDPWPNI------SSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
+P P + S+ D ++K L D ++R + +++L H ++
Sbjct: 239 FKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 34/227 (14%)
Query: 74 ELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
+LG G FGV T A K + S KL D ++D +E IMH L H N+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLD-HENL 58
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRI--IAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+ L G H + ++ +L G L DR+ A GH+ + Q+ + Y S
Sbjct: 59 IRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV----------- 237
+HRDL N L +S D +K DFGL + +YV
Sbjct: 118 FIHRDLAARNILLAS---DDKVKIGDFGLMRALPQNE--------DHYVMEEHLKVPFAW 166
Query: 238 -APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI 281
APE LR R + +D+W GV L+ + + G P+ G + I I
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 83/316 (26%), Positives = 133/316 (42%), Gaps = 44/316 (13%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L K + +V Y +G G +G T + A K +S R + + RE
Sbjct: 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRE 66
Query: 118 VQIMHHLTGHRNIVEL------KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA 171
++++ H+ H N++ L + E+ + V L+ L G +L + I+ ++
Sbjct: 67 LRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQ 123
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
L Q++ + Y HS ++HRDLKP N + ED LK DFGL+ D V
Sbjct: 124 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLAR--HTDDEMTGYV 178
Query: 232 GSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289
+ +Y APE++ +Y DIWS G I+ LL+G F G ILR
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238
Query: 290 SDPWPNISSS---------------------------AKDIVKKMLHADPKERLSAAEVL 322
++ ISS A D+++KML D +R++AA+ L
Sbjct: 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298
Query: 323 NHPWMRVDGDASDKPL 338
H + D D+P+
Sbjct: 299 AHAYFAQYHDPDDEPV 314
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 81/310 (26%), Positives = 125/310 (40%), Gaps = 74/310 (23%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH 127
+Y G +G G FGV Y DT ++ A K + D + RE+ IM +L H
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKNRELLIMKNLN-H 118
Query: 128 RNIVELKGAY--------EDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAA------ 171
NI+ LK Y E +N++M E + + K HY+ A
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVM------EFIPQTVHKYMKHYARNNHALPLFLV 172
Query: 172 -----NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
LCR + Y HS + HRDLKP+N L + LK DFG + G
Sbjct: 173 KLYSYQLCRALA----YIHSKFICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQR 226
Query: 227 FKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR- 283
+ S +Y APE++ NY D+WS G I+ ++ G P F G QS D ++R
Sbjct: 227 SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG---QSSVDQLVRI 283
Query: 284 --------------GHIDFSSDPWPNISS-------------SAKDIVKKMLHADPKERL 316
+ +++ +P++ A + + + L +P +RL
Sbjct: 284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL 343
Query: 317 SAAEVLNHPW 326
+ E L P+
Sbjct: 344 NPIEALADPF 353
|
Length = 440 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 71/260 (27%), Positives = 112/260 (43%), Gaps = 34/260 (13%)
Query: 72 GRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
GR +G GQFG Y ++ ++ K A K+ + + E +E IM H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKT--CKNCTSPSVREKFLQEAYIMRQFD-HP 67
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL--------CRQMVTV 180
+IV+L G + + V ++M+L GEL Y + +L Q+ T
Sbjct: 68 HIVKLIGVITE-NPVWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQLSTA 119
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS--AYYVA 238
+ Y S +HRD+ N L SS +K DFGLS + + +K G ++A
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSSP---DCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 239 PEVLR-RNYGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-N 295
PE + R + + +D+W GV ++ IL+ GV PF G + I G P P N
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG----ERLPMPPN 232
Query: 296 ISSSAKDIVKKMLHADPKER 315
+ ++ K DP +R
Sbjct: 233 CPPTLYSLMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 75/300 (25%), Positives = 119/300 (39%), Gaps = 56/300 (18%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE-DVRREVQIMHHLTG 126
+Y+ +LG G + Y + Q A K IS + + V RE ++ L
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLK- 61
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR------QMVTV 180
H NIV L + ++ + E +A+ + Q++
Sbjct: 62 HANIVLLHDIIHTKETLTFVF------EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRG 115
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAP 239
+ Y H ++HRDLKP+N L S E LK DFGL+ P + V + +Y P
Sbjct: 116 LAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF---SSDPWP 294
+VL +Y + DIW AG I +L G P F G + +F+ + + + D WP
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS--DVFEQLEKIWTVLGVPTEDTWP 230
Query: 295 NISS----------------------------SAKDIVKKMLHADPKERLSAAEVLNHPW 326
+S A+D+ +ML PK+R+SA + L HP+
Sbjct: 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-16
Identities = 67/261 (25%), Positives = 126/261 (48%), Gaps = 25/261 (9%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
F +ELG GQFGV +L + + + A K+I+ + D +E E ++M L+ H +
Sbjct: 8 FMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIE----EAKVMMKLS-HPKL 61
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGV 189
V+L G + + ++ + G L + + + G S+ ++C+ + + Y
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---APEVLRRN- 245
+HRDL N L SS+ +K +DFG++ + D + G+ + V PEV +
Sbjct: 122 IHRDLAARNCLVSSTG---VVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 246 YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
Y +++D+WS GV+++ + G PF ++ + + I RG + P ++S +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----PKLAS--MTVY 231
Query: 305 KKML---HADPKERLSAAEVL 322
+ M H P+ R + AE+L
Sbjct: 232 EVMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 58/186 (31%), Positives = 85/186 (45%), Gaps = 37/186 (19%)
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL---VG 232
Q++ + Y HS G++HRD+KP N L +S + LK DFGL+ +P D K + V
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEP-DESKHMTQEVV 166
Query: 233 SAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL-------- 282
+ YY APE+L R+Y + DIWS G I LL F ++ D I
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226
Query: 283 ----------RGHIDFSSDPWPNISS----------SAKDIVKKMLHADPKERLSAAEVL 322
R HI P++ A ++ +ML DP +R+SAA+ L
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
Query: 323 NHPWMR 328
HP++
Sbjct: 287 AHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 71/289 (24%), Positives = 125/289 (43%), Gaps = 36/289 (12%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ D +T+ +G+G +G Y VT+K A K + D E++ E I+
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNIL 72
Query: 122 HHLTGHRNIVELKGA-YEDRHSVN----LIMDLCAGG---ELFDRIIAKGH-YSERAAAN 172
L H N+V+ G Y+ V L+++LC GG EL ++ G E +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-V 231
+ + + + H+ ++HRD+K N L ++ + +K DFG+S + ++ V
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 232 GSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285
G+ +++APEV+ +Y A D+WS G+ L G PP + I R
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR-- 247
Query: 286 IDFSSDPWPNISSSAK------DIVKKMLHADPKERLSAAEVLNHPWMR 328
+P P + K + + L D + R S +L HP+++
Sbjct: 248 -----NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 73/275 (26%), Positives = 116/275 (42%), Gaps = 52/275 (18%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRR----EVQIMHHLTGHR 128
++G+G FG Y K + A K+ S D++R E +I+ H
Sbjct: 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRS------TLPPDLKRKFLQEAEILKQYD-HP 52
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSM 187
NIV+L G + + ++M+L GG L + K + + + + Y S
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---------- 237
+HRDL N L E++ LK +DFG+S ++ G Y V
Sbjct: 113 NCIHRDLAARNCLVG---ENNVLKISDFGMS---------REEEGGIYTVSDGLKQIPIK 160
Query: 238 --APEVLRRNYG---AEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSD 291
APE L NYG +E+D+WS G++L+ S G P+ G + Q + I G+
Sbjct: 161 WTAPEAL--NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY------ 212
Query: 292 PWPNISSSAKDIVKKMLH---ADPKERLSAAEVLN 323
P ++I + ML DP+ R S +E+ N
Sbjct: 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 66/310 (21%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
ELG G GV V H+ + I +RKLI+ + +R RE++++H
Sbjct: 8 ELGAGNGGVVTKVLHRPSGL------IMARKLIHLEIKPAIRNQIIRELKVLHECNS-PY 60
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYC---H 185
IV GA+ +++ M+ GG L D+++ K G E + ++ + Y H
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----VGSAYYVAPEV 241
+MHRD+KP N L +S E +K DFG+S G + + VG+ Y++PE
Sbjct: 120 K--IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPER 169
Query: 242 LRRN-YGAEADIWSAGVILYILLSG---VPPFWGETEQSIF----------DAILRGHID 287
L+ Y ++DIWS G+ L + G +PP + +++F ++
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229
Query: 288 FSSDPWP--------NI-------------SSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
P P I S +D V K L +PKER E+ HP+
Sbjct: 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289
Query: 327 -MRVDGDASD 335
R + + D
Sbjct: 290 IKRAELEEVD 299
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 73/264 (27%), Positives = 122/264 (46%), Gaps = 16/264 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN---IV 131
+GRG FG Y DT + +A K + +K I E + +IM L + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD-KKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+ A+ + I+DL GG+L + G +SE+ +++ + + H+ V++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN--YGAE 249
RDLKP N L E ++ +D GL+ F VG+ Y+APEVL++ Y +
Sbjct: 121 RDLKPANILLD---EHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
AD +S G +L+ LL G PF + + I R + + + + S K +++ +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTVNVELPDSFSPELKSLLEGLLQ 235
Query: 310 ADPKERL-----SAAEVLNHPWMR 328
D +RL A EV H + +
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 68/308 (22%), Positives = 115/308 (37%), Gaps = 64/308 (20%)
Query: 70 IFGRELGRG--QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRR---EVQIMHHL 124
+G+ + +L HK T A K I+ ++ ED++ E+ L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN----LDSCSKEDLKLLQQEIITSRQL 56
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY----SERAAANLCRQMVTV 180
H NI+ ++ + ++ L A G D + K H+ E A A + + ++
Sbjct: 57 Q-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNA 113
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV---FFKPGDVFKDLVGSA--- 234
+ Y HS G +HR +K + L S K GL K G + +
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDG-----KVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 235 ----YYVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI- 286
+++PEVL++N Y ++DI+S G+ L +G PF + +RG +
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVP 228
Query: 287 -----------------DFSSDPWPNISSSAKDIVKKM------------LHADPKERLS 317
SS+ PN S + L DP+ R S
Sbjct: 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288
Query: 318 AAEVLNHP 325
A+++LNH
Sbjct: 289 ASQLLNHS 296
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 21/236 (8%)
Query: 104 KLINRDDVED------VRREVQIMHHLTGHRNIVEL--KGAYEDRHSVNLIMDLCAGGEL 155
KL+ D E+ RRE + L H NIV L G + + + G L
Sbjct: 9 KLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPPGL-LFAVFEYVPGRTL 66
Query: 156 FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
+ + A G L Q++ + H+ G++HRDLKP+N + S + K DF
Sbjct: 67 REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDF 126
Query: 216 GLSVF---FKPGDVFK-----DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGV 266
G+ + DV +++G+ Y APE LR +D+++ G+I L+G
Sbjct: 127 GIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
Query: 267 PPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
G + I L +D S PW +++K L+ DP++R ++A L
Sbjct: 187 RVVQGASVAEILYQQL-SPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 69/285 (24%), Positives = 114/285 (40%), Gaps = 41/285 (14%)
Query: 66 RNTYIFGRELGRGQFGVTY--LVTHKD---TKQQFACKSISSRKLINRDDVEDVRREVQI 120
R++ R LG G FG Y L +D + Q A K++ + + D D E I
Sbjct: 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALI 62
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA-------NL 173
M H+NIV L G +R ++++L AGG+L + ER ++
Sbjct: 63 MSKFN-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
R + Y +HRD+ N L + K DFG++ +D+ +
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRA 172
Query: 234 AYY------------VAPEV-LRRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFD 279
+YY + PE L + ++ D+WS GV+L+ + S G P+ G T Q + +
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
+ G DP I+ P++R + A +L
Sbjct: 233 FVTGGG---RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 74/291 (25%), Positives = 108/291 (37%), Gaps = 56/291 (19%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR-------REVQIMHHLT 125
R +G+G G YL ++ A K I R+D+ + RE +I L
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKI-------REDLSENPLLKKRFLREAKIAADLI 60
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--------RIIAKGHYSERAAANLCRQM 177
H IV + D V M G L ++K + +
Sbjct: 61 -HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 178 VTV---VHYCHSMGVMHRDLKPENFLF---------------SSSAEDSPLKATDFGL-- 217
+ + Y HS GV+HRDLKP+N L E+ L D
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 218 ---SVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEA-DIWSAGVILYILLSGVPPFWGET 273
S PG + VG+ Y+APE L +E+ DI++ GVILY +L+ P+ +
Sbjct: 180 ICYSSMTIPGKI----VGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
Query: 274 EQSIFDAILRGHIDFSSD--PWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
+ I R I + P+ I I K L DP ER S+ + L
Sbjct: 236 GRKI---SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 6e-15
Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 49/280 (17%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRR---E 117
++++ G +G+G+FG L ++ Q+ A K + +DD + E
Sbjct: 4 NSKELK----LGATIGKGEFGDVMLGDYR--GQKVAVKCL-------KDDSTAAQAFLAE 50
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+M L H N+V+L G + + ++ + A G L D + ++G RA L +Q+
Sbjct: 51 ASVMTTLR-HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG----RAVITLAQQL 105
Query: 178 VTVVHYCHSM------GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
+ C M +HRDL N L S ED K +DFGL+ + +
Sbjct: 106 GFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLA-----KEASQGQD 157
Query: 232 GSAYYV---APEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286
V APE LR + ++D+WS G++L+ + S G P+ + + + +G+
Sbjct: 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR 217
Query: 287 DFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLN 323
+ + P ++ K M DP +R + ++
Sbjct: 218 MEAPEGCP------PEVYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 27/223 (12%)
Query: 66 RNTYIFGRELGRGQFG-----VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
RN FG+ LG G FG Y ++ D + A K + + + E + E++I
Sbjct: 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKI 91
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMV 178
M HL H NIV L GA + +I + C G+L + + K + + Q+
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----LVGSA 234
+ + S +HRDL N L + +K DFGL+ D+ D + G+A
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHG---KIVKICDFGLA-----RDIMNDSNYVVKGNA 203
Query: 235 Y----YVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWG 271
++APE + Y E+D+WS G++L+ + S G P+ G
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 4/142 (2%)
Query: 77 RGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136
RG FG YL K+ + +A K + +IN++ V V+ E + L+ IV L +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPFIVHLYYS 72
Query: 137 YEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKP 196
+ ++V L+M+ GG++ + G++ E A ++ + Y H G++HRDLKP
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKP 132
Query: 197 ENFLFSSSAEDSPLKATDFGLS 218
+N L S+ +K TDFGLS
Sbjct: 133 DNMLISNEGH---IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 70/290 (24%), Positives = 121/290 (41%), Gaps = 33/290 (11%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT-----GHRN 129
LG G G Y H T++ A K +I D ++++ QIM L
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVK------VIPLDITVELQK--QIMSELEILYKCDSPY 60
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH---YCHS 186
I+ GA+ + +++ + GG L Y + L R V VV Y S
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLGRIAVAVVKGLTYLWS 113
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE-VLRRN 245
+ ++HRD+KP N L ++ + +K DFG+S + K VG+ Y+APE +
Sbjct: 114 LKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQ 169
Query: 246 YGAEADIWSAGVILYILLSG---VPPFWGETEQSIFDAILRGHIDFSSDPWP--NISSSA 300
YG +D+WS G+ L G P + +L+ +D P S
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFR 350
+ + + PKER + +++HP++ D + + + + V +++ R
Sbjct: 230 VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVVSMWVCRALEERR 279
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 73/306 (23%), Positives = 135/306 (44%), Gaps = 32/306 (10%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSIS-SRKLINRD----DVEDVRRE 117
E R G+ LG G FG + + K ++ + K++ D D+ D+ E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR-- 175
+++M + H+NI+ L GA + ++++ + G L + + A+ + + C+
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 176 --------------QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221
Q+ + Y S +HRDL N L + ED+ +K DFGL+
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDV 184
Query: 222 KPGDVFKDLVGS---AYYVAPEVL-RRNYGAEADIWSAGVILY-ILLSGVPPFWGETEQS 276
D +K ++APE L R Y ++D+WS GV+L+ I G P+ G +
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
Query: 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDK 336
+F + GH D N + I+++ HA P +R + +++ + ++D+
Sbjct: 245 LFKLLKEGH---RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDE 301
Query: 337 PLDIAV 342
LD++V
Sbjct: 302 YLDLSV 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 8e-14
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 73 RELGRGQFGVTYLVTHK----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
R+LG G FG L + +T +Q A KS+ + + D+++E++I+ +L H
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HE 66
Query: 129 NIVELKGAYEDR--HSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCH 185
NIV+ KG + + + LIM+ G L + + K + + Q+ + Y
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD----VFKDLVGSAYYVAPEV 241
S +HRDL N L S + +K DFGL+ + V DL ++ APE
Sbjct: 127 SRQYVHRDLAARNVLVES---EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 242 L-RRNYGAEADIWSAGVILYILLS 264
L + + +D+WS GV LY LL+
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 9e-14
Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 16/221 (7%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
F +ELG GQFGV + + A K I + + +E E ++M L+ H +
Sbjct: 8 FLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIE----EAKVMMKLS-HEKL 61
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA-ANLCRQMVTVVHYCHSMGV 189
V+L G + + ++ + + G L + + G + + +C+ + + Y S
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---APEVLRR-N 245
+HRDL N L +K +DFGLS + D + VGS + V PEVL
Sbjct: 122 IHRDLAARNCLVDD---QGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+ +++D+W+ GV+++ + S G P+ + + +G
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL 218
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 73 RELGRGQFGVTYLV----THKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
R LG G FG L + T + A K++ + + ++E+ I+ L H
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HE 66
Query: 129 NIVELKGAYEDR--HSVNLIMDLCAGGELFDRIIAKGHYSERAAANL------CRQMVTV 180
NIV+ KG ++ + LIM+ G L D Y + NL +Q+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD----VFKDLVGSAYY 236
+ Y HS +HRDL N L + D +K DFGL+ G V +D ++
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDN---DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 237 VAPEVLRRN-YGAEADIWSAGVILYILLS 264
A E L+ N + +D+WS GV LY LL+
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 55/175 (31%), Positives = 83/175 (47%), Gaps = 27/175 (15%)
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY 235
Q++ + + HS V+HRDLKP+N L +SS + +K DFGL+ + +V + +
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLW 174
Query: 236 YVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAI-LRGHID-- 287
Y APEV L+ +Y D+WS G I + P F G ++ I D I L G D
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 288 ---------FSSDPW-------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
F S +I KD++ K L +P +R+SA L+HP+
Sbjct: 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 68/279 (24%), Positives = 104/279 (37%), Gaps = 58/279 (20%)
Query: 75 LGRGQFGVTYLVTHKDT------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
LG G FG Y T D + A K++ RK + ++ +E +M + H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFN-HP 59
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA--------------NLC 174
NIV+L G +IM+L GG+L Y A ++C
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLL-------SYLRDARVERFGPPLLTLKELLDIC 112
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP--LKATDFGLSVFFKPGDVFKDLVG 232
+ Y M +HRDL N L S D+ +K DFGL+ +D+
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYK 163
Query: 233 SAYY------------VAPEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIF 278
S YY +APE L + ++D+WS GV+++ IL G P+ Q +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
Query: 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS 317
+ G N ++ DP ER +
Sbjct: 224 QHVTAGG---RLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 30/225 (13%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
ELG G GV + V+HK + I +RKLI+ + +R RE+Q++H
Sbjct: 12 ELGAGNGGVVFKVSHKPSG------LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY- 64
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSM- 187
IV GA+ +++ M+ GG L D+++ K G E+ + ++ + Y
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 123
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----VGSAYYVAPEVLR 243
+MHRD+KP N L +S E +K DFG+S G + + VG+ Y++PE L+
Sbjct: 124 KIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQ 175
Query: 244 -RNYGAEADIWSAGVILYILLSG---VPPFWGETEQSIFDAILRG 284
+Y ++DIWS G+ L + G +PP + + +F + G
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG 220
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 63/252 (25%), Positives = 108/252 (42%), Gaps = 36/252 (14%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTY-----LVTHKDTKQQFACKSISSRKLINRDDVEDVR 115
P+ VR F ELG G FG Y + + A K++ ++ ++ R
Sbjct: 3 PLSAVR----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL--KENAEPKVQQEFR 56
Query: 116 REVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA---- 171
+E ++M L H NIV L G ++ + A G+L + ++ +S+ A
Sbjct: 57 QEAELMSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 172 ------------NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219
++ Q+ + Y S +HRDL N L E +K +DFGLS
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSR 172
Query: 220 FFKPGDVFKDLVGSAY---YVAPE-VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETE 274
D ++ S ++ PE +L + E+DIWS GV+L+ + S G+ P++G +
Sbjct: 173 DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232
Query: 275 QSIFDAILRGHI 286
Q + + I +
Sbjct: 233 QEVIEMIRSRQL 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 36/287 (12%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
ELGRG +GV + H T A K I R +N + + + ++ I V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVT 64
Query: 133 LKGAYEDRHSVNLIMDLCAGG--ELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHS-MG 188
GA V + M++ + + ++ KG E + +V + Y HS +
Sbjct: 65 FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV-----GSAYYVAPEVL- 242
V+HRD+KP N L + + + +K DFG+S G + + G Y+APE +
Sbjct: 125 VIHRDVKPSNVLINRNGQ---VKLCDFGIS-----GYLVDSVAKTIDAGCKPYMAPERIN 176
Query: 243 ----RRNYGAEADIWSAGVILYILLSGVPPF--WGETEQSIFDAILRGHIDFSSDPWPNI 296
++ Y ++D+WS G+ + L +G P+ W Q L+ ++ S P
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-----LKQVVEEPSPQLPAE 231
Query: 297 SSSA--KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIA 341
S +D V K L + KER + E+L HP+ + K D+A
Sbjct: 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL---HLSKNTDVA 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 66/249 (26%), Positives = 99/249 (39%), Gaps = 46/249 (18%)
Query: 116 REVQIMHHLTGHRNIVELKGAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHYSERAA 170
RE ++ L H NIV L + ++ L+ DLC + D+ G
Sbjct: 52 REASLLKGLK-HANIVLLHDIIHTKETLTLVFEYVHTDLC---QYMDK--HPGGLHPENV 105
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKD 229
Q++ + Y H ++HRDLKP+N L S + E LK DFGL+ P + +
Sbjct: 106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSN 162
Query: 230 LVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHI 286
V + +Y P+VL Y D+W G I ++ GV F G + Q + I
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLG 222
Query: 287 DFSSDPWPNISS----------------------------SAKDIVKKMLHADPKERLSA 318
+ D WP + S A+D+ K+L PK RLSA
Sbjct: 223 TPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA 282
Query: 319 AEVLNHPWM 327
L+H +
Sbjct: 283 QAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 62/257 (24%), Positives = 109/257 (42%), Gaps = 20/257 (7%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + R+LG GQFG + +T A K++ + D +D E QIM L
Sbjct: 5 RTSIQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTM----DPKDFLAEAQIMKKLR 59
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHY 183
H +++L + ++ +L G L + + A ++ Q+ + + Y
Sbjct: 60 -HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPE 240
+ +HRDL N L E++ K DFGL+ K D+++ G+ + + APE
Sbjct: 119 LEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPE 174
Query: 241 VLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
N + ++D+WS G++L I+ G P+ G T + + +G + P
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG---YRMPCPPGCPK 231
Query: 299 SAKDIVKKMLHADPKER 315
DI+ DP +R
Sbjct: 232 ELYDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 38/282 (13%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLINRD----DVEDV 114
E R+ + G+ LG G FG + K+ + ++ K++ D D+ D+
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAV---KMLKSDATEKDLSDL 70
Query: 115 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK------------ 162
E+++M + H+NI+ L GA + +I++ + G L + + A+
Sbjct: 71 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130
Query: 163 ----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218
S + + Q+ + Y S +HRDL N L + ED+ +K DFGL+
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA 187
Query: 219 VFFKPGDVFKDLVGS---AYYVAPEVL-RRNYGAEADIWSAGVILY-ILLSGVPPFWGET 273
D +K ++APE L R Y ++D+WS GV+L+ I G P+ G
Sbjct: 188 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247
Query: 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER 315
+ +F + GH D N ++ +++ HA P +R
Sbjct: 248 VEELFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQR 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 48/234 (20%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRNI 130
LG+G FG + T KD K+ + K D ++++ E +I+ H NI
Sbjct: 3 LGKGNFGEVFKGTLKD-------KTPVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNI 54
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG---------HYSERAAANLCRQMVTVV 181
V+L G R + ++M+L GG+ + K ++ AAA +
Sbjct: 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMA------- 107
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS------VFFKPGDVFKDLVGSAY 235
Y S +HRDL N L E++ LK +DFG+S ++ G K +
Sbjct: 108 -YLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSG--LKQI--PIK 159
Query: 236 YVAPEVLRRNYG---AEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+ APE L NYG +E+D+WS G++L+ S GV P+ G T Q + + +G+
Sbjct: 160 WTAPEAL--NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 72 GRELGRGQFGVTYLVTHKDTK--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
G ++GRG +G Y KD K +++A K I + RE+ ++ L H N
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELK-HPN 59
Query: 130 IVELKG---AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA-----------AANLCR 175
++ L+ ++ DR V L+ D A +L+ I K H + +A +L
Sbjct: 60 VIALQKVFLSHSDR-KVWLLFDY-AEHDLWH--IIKFHRASKANKKPMQLPRSMVKSLLY 115
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFL-FSSSAEDSPLKATDFGLSVFF----KPGDVFKDL 230
Q++ +HY H+ V+HRDLKP N L E +K D G + F KP +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 231 VGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPF 269
V + +Y APE+L R+Y DIW+ G I LL+ P F
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 36/101 (35%), Positives = 57/101 (56%), Gaps = 10/101 (9%)
Query: 230 LVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288
++G+ Y+APE+L + +G D W+ GV L+ L+G+PPF ET Q +F IL I
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI-- 597
Query: 289 SSDPWPN----ISSSAKDIVKKMLHADPKERLSAAEVLNHP 325
PWP +S +A++ ++ +L DP +R E+ HP
Sbjct: 598 ---PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 82/322 (25%), Positives = 134/322 (41%), Gaps = 76/322 (23%)
Query: 72 GRELGRGQFGVTYLVTHKDTK--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
G ++GRG +G Y KD K + +A K I + RE+ ++ L H N
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELK-HPN 59
Query: 130 IVELKG---AYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA-----------AANLCR 175
++ L+ ++ DR V L+ D A +L+ I K H + +A +L
Sbjct: 60 VISLQKVFLSHADR-KVWLLFDY-AEHDLWH--IIKFHRASKANKKPVQLPRGMVKSLLY 115
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFL-FSSSAEDSPLKATDFGLSVFF----KPGDVFKDL 230
Q++ +HY H+ V+HRDLKP N L E +K D G + F KP +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 231 VGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVP-------------PFWGETEQ 275
V + +Y APE+L R+Y DIW+ G I LL+ P P+ +
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235
Query: 276 SIFDAI-------------LRGHI----DFSSDPWPNIS-------------SSAKDIVK 305
IF+ + + H DF + + N S S A +++
Sbjct: 236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 295
Query: 306 KMLHADPKERLSAAEVLNHPWM 327
K+L DP +R+++ + + P+
Sbjct: 296 KLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 25/231 (10%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + R+LG G FG + K+ + A K + S L+ + D + +EVQ + L
Sbjct: 5 REEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQ---KEVQALKRLR 60
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA--NLCRQMVTVVHY 183
H++++ L V +I +L G L + + A+ ++ Q+ + Y
Sbjct: 61 -HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY-------Y 236
+HRDL N L ED K DFGL+ + K+ V + +
Sbjct: 120 LEEQNSIHRDLAARNILV---GEDLVCKVADFGLA------RLIKEDVYLSSDKKIPYKW 170
Query: 237 VAPEVL-RRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + ++D+WS G++LY + + G P+ G ++D I G+
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY 221
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 62/269 (23%), Positives = 100/269 (37%), Gaps = 41/269 (15%)
Query: 73 RELGRGQFGVT---YLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
+ELG G FG + + + A K++ + ++ RE +M L H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA--GKKEFLREASVMAQLD-HPC 57
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
IV L G + + L+M+L G L + + L Q+ + Y S
Sbjct: 58 IVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-VGSAYY------------ 236
+HRDL N L + K +DFG+S + L GS YY
Sbjct: 117 VHRDLAARNVLLVN---RHQAKISDFGMS---------RALGAGSDYYRATTAGRWPLKW 164
Query: 237 VAPEVLRRNYG---AEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292
APE + NYG +++D+WS GV L+ S G P+ + + G
Sbjct: 165 YAPECI--NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE---RLPR 219
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEV 321
I+ P++R + +E+
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 65/276 (23%), Positives = 121/276 (43%), Gaps = 32/276 (11%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSIS-SRKLINRD----DVEDVRREVQI 120
R+ G+ LG G FG + + ++++ + K++ D D+ D+ E+++
Sbjct: 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 73
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----- 175
M + H+NI+ L GA + +I++ + G L + + A+ + ++ R
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 176 -----------QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
Q+ + Y S +HRDL N L + E++ +K DFGL+
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNI 190
Query: 225 DVFKDLVGS---AYYVAPEVL-RRNYGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFD 279
D +K ++APE L R Y ++D+WS GV+++ I G P+ G + +F
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER 315
+ GH D N ++ +++ HA P R
Sbjct: 251 LLKEGH---RMDKPANCTNELYMMMRDCWHAIPSHR 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 31/253 (12%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+G+G+FG L ++ K C + N + E +M L H N+V+L
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQLR-HSNLVQLL 65
Query: 135 GA-YEDRHSVNLIMDLCAGGELFD------RIIAKGHYSERAAANLCRQMVTVVHYCHSM 187
G E++ + ++ + A G L D R + G + + ++C M Y +
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM----EYLEAN 121
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG-SAYYVAPEVLR-RN 245
+HRDL N L S ED+ K +DFGL+ K +D + APE LR +
Sbjct: 122 NFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKK 175
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
+ ++D+WS G++L+ + S G P+ + + + +G+ + D P + D++
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPV---VYDVM 232
Query: 305 KKMLHADPKERLS 317
K+ H D R S
Sbjct: 233 KQCWHLDAATRPS 245
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 22/222 (9%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
+GRG FG + + A KS R+ + D +E +I+ + H NIV L
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKS--CRETLPPDLKAKFLQEARILKQYS-HPNIVRL 58
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHR 192
G + + ++M+L GG+ + +G + + + Y S +HR
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR 118
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLS------VFFKPGDVFKDLVGSAYYVAPEVLRRNY 246
DL N L + E + LK +DFG+S V+ G + + V + APE L NY
Sbjct: 119 DLAARNCLVT---EKNVLKISDFGMSREEEDGVYASTGGMKQIPVK---WTAPEAL--NY 170
Query: 247 G---AEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
G +E+D+WS G++L+ S G P+ + Q +AI +G
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTGH 127
F ++LG+G FG L + D Q + ++ +KL + + D RE++I+ L H
Sbjct: 7 KFIQQLGKGNFGSVELCRY-DPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-H 64
Query: 128 RNIVELKG-AYE-DRHSVNLIMDLCAGGELFDRIIAKGHYSERA-----AANLCRQMVTV 180
NIV+ KG Y R ++ L+M+ G L D + + A+ +C+ M
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM--- 121
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS----------VFFKPGDVFKDL 230
Y S +HRDL N L S ++ +K DFGL+ +PG+
Sbjct: 122 -EYLGSKRYVHRDLATRNILVES---ENRVKIGDFGLTKVLPQDKEYYKVREPGE----- 172
Query: 231 VGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS 264
++ APE L + + +D+WS GV+LY L +
Sbjct: 173 -SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 59/252 (23%), Positives = 110/252 (43%), Gaps = 48/252 (19%)
Query: 66 RNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R+T + RELG G FG +L ++ K+ A K++ ++ + D +D RE ++
Sbjct: 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL--KETASNDARKDFEREAEL 61
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN-------- 172
+ + H NIV+ G + ++ + G+L + + G + +
Sbjct: 62 LTNF-QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 173 ------LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
+ Q+ + + Y S +HRDL N L D +K DFG+S
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMS-------- 169
Query: 227 FKDLVGSAYY------------VAPE-VLRRNYGAEADIWSAGVILY-ILLSGVPPFWGE 272
+D+ + YY + PE ++ R + E+D+WS GV+L+ I G P++G
Sbjct: 170 -RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228
Query: 273 TEQSIFDAILRG 284
+ + + + I +G
Sbjct: 229 SNEEVIECITQG 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 44/203 (21%)
Query: 168 RAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
A + +Q++ + Y H+ ++HRD+K EN + D D G + F F
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND--VDQVCIG-DLGAAQFPVVAPAF 213
Query: 228 KDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI 286
L G+ APEVL R+ Y ++ADIWSAG++L+ +L+ + + + + + H
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273
Query: 287 --------------DFSSDP---------------------WP-----NISSSAKDIVKK 306
+F DP +P N+ + +V K
Sbjct: 274 HLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHK 333
Query: 307 MLHADPKERLSAAEVLNHPWMRV 329
ML D R SA E+LN+P
Sbjct: 334 MLTFDAAMRPSAEEILNYPMFAQ 356
|
Length = 357 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 72/303 (23%), Positives = 128/303 (42%), Gaps = 33/303 (10%)
Query: 66 RNTYIFGRELGRGQFGVTYLV----THKDTKQQFACKSISSRKLINRD-DVEDVRREVQI 120
R+ + G+ LG G FG K Q ++ K D D+ D+ E+++
Sbjct: 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMEL 70
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK----------------GH 164
M + H+NI+ L G + +I++ A G L + + A+
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
S + + Q+ + Y S +HRDL N L ED+ +K DFGL+
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLARGVHDI 187
Query: 225 DVFKDLVGS---AYYVAPEVL-RRNYGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFD 279
D +K ++APE L R Y ++D+WS G++++ I G P+ G + +F
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLD 339
+ GH D N + ++++ HA P +R + + L +V S++ LD
Sbjct: 248 LLREGH---RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQ-LVEALDKVLAAVSEEYLD 303
Query: 340 IAV 342
+++
Sbjct: 304 LSM 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 4e-12
Identities = 52/187 (27%), Positives = 86/187 (45%), Gaps = 25/187 (13%)
Query: 113 DVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAA 170
D E IM H NI+ L+G V ++ + G L D + K G ++
Sbjct: 51 DFLSEASIMGQFD-HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQL 108
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230
+ R + + + Y MG +HRDL N L +S+ K +DFGLS V +D
Sbjct: 109 VGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL---VCKVSDFGLS------RVLEDD 159
Query: 231 VGSAY----------YVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIF 278
+AY + APE + R + + +D+WS G++++ ++S G P+W + Q +
Sbjct: 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219
Query: 279 DAILRGH 285
AI G+
Sbjct: 220 KAIEEGY 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
ELG G GV V HK + I +RKLI+ + +R RE+Q++H
Sbjct: 12 ELGAGNGGVVTKVQHKPSGL------IMARKLIHLEIKPAIRNQIIRELQVLHECNSPY- 64
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-G 188
IV GA+ +++ M+ GG L + E + ++ + Y
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----VGSAYYVAPEVLR- 243
+MHRD+KP N L +S E +K DFG+S G + + VG+ Y++PE L+
Sbjct: 125 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 176
Query: 244 RNYGAEADIWSAGVILYILLSG---VPPFWGETEQSIF 278
+Y ++DIWS G+ L L G +PP + ++IF
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 60/293 (20%), Positives = 120/293 (40%), Gaps = 53/293 (18%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
E R RELG+G FG+ Y V + + + A K+++ + + + E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNE 59
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL---- 173
+M H ++V L G ++M+L A G+L + + E
Sbjct: 60 ASVMKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPP 116
Query: 174 --------CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225
++ + Y + +HRDL N + + ED +K DFG++
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT------- 166
Query: 226 VFKDLVGSAYY------------VAPEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWG 271
+D+ + YY +APE L+ + ++D+WS GV+L+ + P+ G
Sbjct: 167 --RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG 224
Query: 272 ETEQSIFDAIL-RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323
+ + + ++ GH+D + P+ ++++ +PK R + E+++
Sbjct: 225 LSNEEVLKFVIDGGHLDLPENC-PDK---LLELMRMCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 54/291 (18%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R + RELG G FG +L ++ K A K++ L R +D +RE ++
Sbjct: 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAEL 60
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELF--------DRII--------AKGH 164
+ +L H +IV+ G D + ++ + G+L D +I AKG
Sbjct: 61 LTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
++ Q+ + + Y S +HRDL N L ++ +K DFG+S
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL---VKIGDFGMS------ 170
Query: 225 DVFKDLVGSAYY------------VAPE-VLRRNYGAEADIWSAGVILY-ILLSGVPPFW 270
+D+ + YY + PE ++ R + E+D+WS GVIL+ I G P++
Sbjct: 171 ---RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
Query: 271 GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
+ + + I +G + P DI+ +P++RL+ E+
Sbjct: 228 QLSNTEVIECITQGRVLERPRVCPK---EVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 68/273 (24%), Positives = 117/273 (42%), Gaps = 30/273 (10%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
F +G G FG K + ++ ++DD D E++++ L H NI
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFD-----RIIAKG---HYSERAAANLCRQMVTV-- 180
+ L GA E R + L ++ G L D R++ + A+ L Q +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 181 ------VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-KDLVGS 233
+ Y +HRDL N L E+ K DFGLS + +V+ K +G
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RGQEVYVKKTMGR 184
Query: 234 --AYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFS 289
++A E L + Y +D+WS GV+L+ ++S G P+ G T +++ + +G +
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YR 241
Query: 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
+ N D++++ P ER S A++L
Sbjct: 242 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 5e-11
Identities = 20/44 (45%), Positives = 28/44 (63%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
L+E F+ D D GTI+ +ELKA L LG LSE E+ +++ V
Sbjct: 2 LREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIREV 45
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-11
Identities = 65/251 (25%), Positives = 107/251 (42%), Gaps = 34/251 (13%)
Query: 85 LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144
LV T+Q F K + +R+ + + V M L H+ IV ED SV
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCL--HKYIVS-----ED--SVF 61
Query: 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS 204
L++ GG+L+ I + E +MV + H G++ RDL P N L
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121
Query: 205 AEDSPLKATDFGLSVFFKP---GDVFKDLVGSAYYVAPEVLRRNYGAEA-DIWSAGVILY 260
++ T F + G+ +++ Y APEV + EA D WS G IL+
Sbjct: 122 GH---IQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAILF 173
Query: 261 ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAA- 319
LL+ G+T + + H + W +S A+ +++++L +P ERL A
Sbjct: 174 ELLT------GKTLVECHPSGINTHTTLNIPEW--VSEEARSLLQQLLQFNPTERLGAGV 225
Query: 320 ----EVLNHPW 326
++ +HP+
Sbjct: 226 AGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 26/225 (11%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKL-INRDDVEDVRREVQIMHHLTGHRNIVEL 133
+G G+FG + K ++ +I + K +D E IM + H NI+ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNIIRL 71
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+G +I + G L D+ + G +S + R + + Y M +H
Sbjct: 72 EGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY----------YVAPEV 241
RDL N L +S+ E K +DFGLS V +D Y + APE
Sbjct: 131 RDLAARNILVNSNLE---CKVSDFGLS------RVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 242 LR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
+ R + + +D+WS G++++ ++S G P+W + + AI G
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG 226
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 36/276 (13%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
E+GRG FG + HK + A K I S ++ + + + ++ ++ + IV+
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRS--TVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 134 KGAYEDRHSVNLIMDLCAGG-ELFDRII---AKGHYSERAAANLCRQMVTVVHYC-HSMG 188
GA + M+L + F + + K E + V ++Y +
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLS-----VFFKPGDVFKDLVGSAYYVAPEVL- 242
++HRD+KP N L + +K DFG+S K D G Y+APE +
Sbjct: 129 IIHRDVKPSNILLDRNGN---IKLCDFGISGQLVDSIAKTRDA-----GCRPYMAPERID 180
Query: 243 ---RRNYGAEADIWSAGVILYILLSGVPPF--WGETEQSIFDAILRGHID-----FSSDP 292
R Y +D+WS G+ LY + +G P+ W S+FD L + S+
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKW----NSVFDQ-LTQVVKGDPPILSNSE 235
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
S S + + L D +R E+L HP+++
Sbjct: 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 9e-11
Identities = 68/282 (24%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 63 EDVRNTYIFGRELGRGQFG--VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
ED++ F +G G FG + ++ K A K + ++ + +D D E+++
Sbjct: 2 EDIK----FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKML--KEFASENDHRDFAGELEV 55
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD-----RII------AKGH----- 164
+ L H NI+ L GA E+R + + ++ G L D R++ AK H
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
+ + + T + Y +HRDL N L E+ K DFGLS +
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLS---RGE 169
Query: 225 DVF-KDLVGS--AYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFD 279
+V+ K +G ++A E L + Y ++D+WS GV+L+ ++S G P+ G T +++
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
+ +G + + N +++++ P ER A++
Sbjct: 230 KLPQG---YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 48/283 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL---INRDDVEDVRREVQIMH 122
R+ G+ LG G FG +++ + L D+ D+ E+++M
Sbjct: 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMK 70
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR------- 175
+ H+NI+ L G + ++++ A G L D + A+ E A+ + R
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 176 ---------QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
Q+ + + S +HRDL N L + ED +K DFGL+
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA-------- 179
Query: 227 FKDLVGSAYY------------VAPEVL-RRNYGAEADIWSAGVILY-ILLSGVPPFWGE 272
+D+ YY +APE L R Y ++D+WS GV+L+ I G P+ G
Sbjct: 180 -RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238
Query: 273 TEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER 315
+ +F + G+ + N + +++ H P +R
Sbjct: 239 PVEELFKLLKEGY---RMEKPQNCTQELYHLMRDCWHEVPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 58/250 (23%), Positives = 114/250 (45%), Gaps = 42/250 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
R+ + RELG G FG +L + +Q ++ + K + + +D RE +++ +
Sbjct: 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN 63
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL--FDR-------IIAKGH----YSERAA 170
L H +IV+ G + + ++ + G+L F R ++A+G+ ++
Sbjct: 64 LQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230
++ +Q+ + Y S +HRDL N L E+ +K DFG+S +D+
Sbjct: 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMS---------RDV 170
Query: 231 VGSAYY------------VAPE-VLRRNYGAEADIWSAGVILY-ILLSGVPPFWGETEQS 276
+ YY + PE ++ R + E+D+WS GV+L+ I G P++ +
Sbjct: 171 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230
Query: 277 IFDAILRGHI 286
+ + I +G +
Sbjct: 231 VIECITQGRV 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 26/260 (10%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + R+LG GQFG ++ T T + A K++ + E +E QIM L
Sbjct: 5 RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTM----SPEAFLQEAQIMKKLR 59
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHY-SERAAANLCRQMVTVVHY 183
H +V+L + + ++ + + G L D + +G ++ Q+ + Y
Sbjct: 60 -HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPE 240
S +HRDL N L E+ K DFGL+ + D + G+ + + APE
Sbjct: 119 LESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIED-DEYTAREGAKFPIKWTAPE 174
Query: 241 VLRRNYGA---EADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-N 295
NYG ++D+WS G++L I+ G P+ G T + + + + RG+ P P N
Sbjct: 175 AA--NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY----RMPRPPN 228
Query: 296 ISSSAKDIVKKMLHADPKER 315
D++ + DP+ER
Sbjct: 229 CPEELYDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 65/258 (25%), Positives = 115/258 (44%), Gaps = 35/258 (13%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDV--EDVRREVQIMHHLTGHR 128
G +G G+FG + T Q+ A K+I DV + E +M L H+
Sbjct: 10 LGEIIGEGEFGAVLQGEY--TGQKVAVKNIKC-------DVTAQAFLEETAVMTKLH-HK 59
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM- 187
N+V L G + + ++M+L + G L + + +G RA ++ + + + M
Sbjct: 60 NLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGME 114
Query: 188 -----GVMHRDLKPENFLFSSSAEDSPLKATDFGL-SVFFKPGDVFKDLVGSAYYVAPEV 241
++HRDL N L S ED K +DFGL V D K V + APE
Sbjct: 115 YLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVK---WTAPEA 168
Query: 242 LRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
L+ + +++D+WS GV+L+ + S G P+ + + + + + +G + +P +
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPAD 225
Query: 300 AKDIVKKMLHADPKERLS 317
++ +PK+R S
Sbjct: 226 VYVLMTSCWETEPKKRPS 243
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 28/269 (10%)
Query: 69 YIFGRELGRGQFGV---TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ GR LG+G+FG L + + Q+ A K + + + + D+E+ RE M
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIFSSSDIEEFLREAACMKEFD 59
Query: 126 GHRNIVELKGAYEDRHSVN------LIMDLCAGGELFDRIIAKGHYSER---AAANLCRQ 176
H N+++L G + +I+ G+L ++ E L R
Sbjct: 60 -HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 177 MVTV---VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
M+ + + Y S +HRDL N + E+ + DFGLS GD ++ S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 234 AY---YVAPEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDF 288
++A E L N Y +D+W+ GV ++ I+ G P+ G I++ +++G +
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG--NR 233
Query: 289 SSDPWPNISSSAKDIVKKMLHADPKERLS 317
P P+ +++ + +PK R S
Sbjct: 234 LKQP-PDCLEDVYELMCQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 59/247 (23%), Positives = 107/247 (43%), Gaps = 36/247 (14%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTY----LVTHKDTKQQFACKSISSRKLINRDDVEDVRR 116
P+ VR F ELG FG Y + D Q A K++ + + N + ++
Sbjct: 3 PLSAVR----FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQ 56
Query: 117 EVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN---- 172
E +M L H NIV L G V ++ + G+L + +I + +S+ ++
Sbjct: 57 EASLMAELH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115
Query: 173 -------------LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219
+ Q+ + Y S +H+DL N L E +K +D GLS
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLSR 172
Query: 220 FFKPGDVFKDLVGSAY---YVAPE-VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETE 274
D ++ S ++ PE ++ + +++DIWS GV+L+ + S G+ P++G +
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232
Query: 275 QSIFDAI 281
Q + + +
Sbjct: 233 QEVIEMV 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 68/282 (24%), Positives = 110/282 (39%), Gaps = 46/282 (16%)
Query: 17 TTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATS--------SSVGRVLGKPMED---- 64
D + K D S T AT S V +P E
Sbjct: 27 GGTDTSDSKDTTGD--KFDDCDELGDSDDVTHATDYDADEESLSPQTDVCQEPCETTSSS 84
Query: 65 -----VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFAC--KSISSRKLINRDDVEDVRRE 117
VR Y L G G ++ T +Q+ K+++ K RE
Sbjct: 85 DPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGRE 136
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL--CAGGELFDRIIAKGHYSERAAANLCR 175
+ I+ ++ HR I+ L AY + +V ++M C +LF + G A + R
Sbjct: 137 IDILKTIS-HRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQR 192
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV-----FFKPGDVFKDL 230
+++ + Y H G++HRD+K EN +F E++ L DFG + P
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTEN-IFLDEPENAVLG--DFGAACKLDAHPDTPQCY--GW 247
Query: 231 VGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWG 271
G+ +PE+L + Y A+ DIWSAG++L+ + +G
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 16/218 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKL-INRDDVEDVRREVQIMHHLTGHRNIVEL 133
+G G+FG K ++ +I + K D E IM H NI+ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHL 70
Query: 134 KGAYEDRHSVNLIMDLCAGGEL--FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+G V +I + G L F R G ++ + R + + Y M +H
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS------AYYVAPEVLR-R 244
RDL N L +S+ K +DFGLS F + S + APE + R
Sbjct: 130 RDLAARNILVNSNL---VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 245 NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI 281
+ + +D+WS G++++ ++S G P+W + Q + +AI
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 62/253 (24%), Positives = 109/253 (43%), Gaps = 26/253 (10%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
++LG GQFG ++ + ++ + A K++ + V+ E +M L H +V
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM----SVQAFLEEANLMKTLQ-HDKLVR 65
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVM 190
L + +I + A G L D + + G + Q+ + Y +
Sbjct: 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPEVLRRNYG 247
HRDL+ N L S S K DFGL+ + + + G+ + + APE + N+G
Sbjct: 126 HRDLRAANVLVSESLM---CKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAI--NFG 179
Query: 248 A---EADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKD 302
+ ++D+WS G++LY I+ G P+ G + + A+ RG+ P N D
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY----RMPRMENCPDELYD 235
Query: 303 IVKKMLHADPKER 315
I+K +ER
Sbjct: 236 IMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 50/279 (17%)
Query: 75 LGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
LGRG+FG +L K + K++ K + + + RRE+ + L+ H+N
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKN 69
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGEL--FDRIIAKGHYSERAAANLCRQMVTVVH-YCHS 186
+V L G + +I++ G+L F R + +Q V +
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 187 MG------VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY---- 236
M +HRDL N L SS E +K + LS KD+ S YY
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLS---------KDVYNSEYYKLRN 177
Query: 237 -------VAPEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHID 287
+APE ++ + + ++D+WS GV+++ + G PF+G +++ + + + G ++
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE 237
Query: 288 FSSDPWPNISSSAKDIVKKMLH---ADPKERLSAAEVLN 323
P + K M +PK+R S +E+++
Sbjct: 238 -----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 62/287 (21%), Positives = 116/287 (40%), Gaps = 47/287 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLV--THKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
R + ELG G FG +L + +Q ++ + K + +D +RE +++
Sbjct: 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV 63
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL--FDR-------------IIAKGHYSER 168
L H++IV G + + ++ + G+L F R +A G +
Sbjct: 64 LQ-HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 169 AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK 228
+ Q+ + + Y S+ +HRDL N L + +K DFG+S +
Sbjct: 123 QMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMS---------R 170
Query: 229 DLVGSAYY------------VAPE-VLRRNYGAEADIWSAGVILY-ILLSGVPPFWGETE 274
D+ + YY + PE +L R + E+DIWS GV+L+ I G P++ +
Sbjct: 171 DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230
Query: 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
+ I +G P I++ +P++R+ ++
Sbjct: 231 TEAIECITQGRELERPRTCPP---EVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 66/270 (24%), Positives = 119/270 (44%), Gaps = 34/270 (12%)
Query: 75 LGRGQFG--VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
+G G FG + + + A K + ++ ++DD D E++++ L H NI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFD-----RII------AKGH-----YSERAAANLCRQ 176
L GA E R + L ++ G L D R++ A + S + +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-KDLVGS-- 233
+ + Y +HRDL N L E+ K DFGLS + +V+ K +G
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS---RGQEVYVKKTMGRLP 174
Query: 234 AYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSD 291
++A E L + Y +D+WS GV+L+ ++S G P+ G T +++ + +G + +
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLE 231
Query: 292 PWPNISSSAKDIVKKMLHADPKERLSAAEV 321
N D++++ P ER S A++
Sbjct: 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 67/291 (23%), Positives = 114/291 (39%), Gaps = 47/291 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVE-DVRREVQIMH 122
RN + R++G+G FG + + F ++ K D++ D +RE +M
Sbjct: 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 63
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL--FDRIIAKGHYSERAAANLCRQMVTV 180
H NIV+L G + L+ + A G+L F R H S RA +L +
Sbjct: 64 EFD-HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR-----HRSPRAQCSLSHSTSSA 117
Query: 181 VHY-------------CHSMGV------------MHRDLKPENFLFSSSAEDSPLKATDF 215
C + V +HRDL N L E+ +K DF
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADF 174
Query: 216 GLSVFFKPGDVFK----DLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLS-GVPPFW 270
GLS D +K D + + + Y E+D+W+ GV+L+ + S G+ P++
Sbjct: 175 GLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234
Query: 271 GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
G + + + G++ D N ++++ P +R S A +
Sbjct: 235 GMAHEEVIYYVRDGNVLSCPD---NCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 61/252 (24%), Positives = 113/252 (44%), Gaps = 27/252 (10%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
+LG+G FG ++ T T + A K++ + E +E Q+M L H +V+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQL 66
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSER----AAANLCRQMVTVVHYCHSMGV 189
+ + ++ + + G L D + KG + ++ Q+ + + Y M
Sbjct: 67 YAVVSEE-PIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPE-VLRRN 245
+HRDL+ N L E+ K DFGL+ + + + G+ + + APE L
Sbjct: 124 VHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGR 179
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKDI 303
+ ++D+WS G++L L + G P+ G + + D + RG+ P P S D+
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----RMPCPPECPESLHDL 235
Query: 304 VKKMLHADPKER 315
+ + +P+ER
Sbjct: 236 MCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQF--ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
ELG G FG +K K+Q A K + + + +++ RE +IMH L + IV
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIV 58
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVM 190
+ G E ++ L+M++ +GG L + K + L Q+ + Y +
Sbjct: 59 RMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-VFKDLVGSAY---YVAPE-VLRRN 245
HRDL N L K +DFGLS D +K + + APE + R
Sbjct: 118 HRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 246 YGAEADIWSAGVILYILLS-GVPPF 269
+ + +D+WS G+ ++ S G P+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 13/221 (5%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-DVEDVRREVQIMHHLTGHRNIV 131
+ +G G+FG K ++ +I + K + D D E IM H NI+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNII 68
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGV 189
L+G V +I + G L D+ + + G ++ + R + + + Y M
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG---SAYYVAPEVLR-RN 245
+HRDL N L +S + K +DFGLS + + G + APE + R
Sbjct: 128 VHRDLAARNILVNS---NLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+ + +D+WS G++++ ++S G P+W + Q + A+ G+
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 54/240 (22%), Positives = 108/240 (45%), Gaps = 30/240 (12%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDV---EDVRREVQIMHH 123
+T F ELG +FG Y T ++++ + L ++ + E+ + E +
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSR 64
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN----------- 172
L H NIV L G +++I C+ +L + ++ + +S+ + +
Sbjct: 65 LQ-HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123
Query: 173 -----LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
+ Q+ + + S V+H+DL N L +K +D GL D +
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGLFREVYAADYY 180
Query: 228 KDLVGSAY----YVAPE-VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI 281
K L+G++ +++PE ++ + ++DIWS GV+L+ + S G+ P+ G + Q + + I
Sbjct: 181 K-LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 64/282 (22%), Positives = 125/282 (44%), Gaps = 31/282 (10%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
E R RELG+G FG+ Y V + + + A K+++ + R+ +E + E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NE 59
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL---FDRIIAKGHYSERAAANLC 174
+M H ++V L G +IM+L G+L + + + A
Sbjct: 60 ASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118
Query: 175 RQMVTV-------VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
++M+ + + Y ++ +HRDL N + AED +K DFG++ D +
Sbjct: 119 KKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYY 175
Query: 228 ----KDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAI 281
K L+ +++PE L+ + +D+WS GV+L+ I P+ G + + + +
Sbjct: 176 RKGGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323
+ G + D P++ ++++ +PK R S E+++
Sbjct: 235 MEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 17/223 (7%)
Query: 72 GRELGRGQFGVTY---LVTHKDT-KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH 127
+ LG G FG + + D+ K A K+I R R +++ + M L H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLD-H 68
Query: 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHS 186
IV L G S+ L+ L G L D + + + N C Q+ ++Y
Sbjct: 69 AYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPE-VL 242
++HR+L N L S DS ++ DFG++ P D + + ++A E +L
Sbjct: 128 HRMVHRNLAARNILLKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 243 RRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
Y ++D+WS GV ++ ++S G P+ G + D + +G
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 67/296 (22%), Positives = 125/296 (42%), Gaps = 63/296 (21%)
Query: 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL---INRDDVEDVRREVQIMHHLTG 126
+ G+ LG G+FG T K + +++ + L + ++ D+ E ++ +
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN- 61
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGEL--FDRIIAK-----------------GHYSE 167
H ++++L GA + LI++ G L F R K + E
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 168 RA---------AANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218
RA A + R M Y M ++HRDL N L AE +K +DFGLS
Sbjct: 122 RALTMGDLISFAWQISRGM----QYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLS 174
Query: 219 VFFKPGDVFKDLVGSAY-----------YVAPEVLRRN-YGAEADIWSAGVILYILLS-G 265
DV+++ +Y ++A E L + Y ++D+WS GV+L+ +++ G
Sbjct: 175 -----RDVYEE---DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 226
Query: 266 VPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
P+ G + +F+ + G+ + N S +++ +P +R + A++
Sbjct: 227 GNPYPGIAPERLFNLLKTGY---RMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 59/232 (25%), Positives = 107/232 (46%), Gaps = 28/232 (12%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTH-KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
R + ++LG GQFG ++ T+ K TK A K++ + VE E +M L
Sbjct: 5 RESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSM----SVEAFLAEANVMKTL 58
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA----ANLCRQMVTV 180
H +V+L A + + +I + A G L D + K + + Q+
Sbjct: 59 Q-HDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEG 114
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YV 237
+ + +HRDL+ N L S+S K DFGL+ + + + G+ + +
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASL---VCKIADFGLARVIEDNE-YTAREGAKFPIKWT 170
Query: 238 APEVLRRNYGA---EADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + N+G+ ++D+WS G++L +++ G P+ G + + A+ RG+
Sbjct: 171 APEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 220
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 1e-07
Identities = 20/43 (46%), Positives = 24/43 (55%), Gaps = 3/43 (6%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGL 399
K ALK + E LSEEEI EM + +D D G I FEE +
Sbjct: 23 KAALKSLGEGLSEEEI---DEMIREVDKDGDGKIDFEEFLELM 62
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 60/251 (23%), Positives = 111/251 (44%), Gaps = 25/251 (9%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
+LG+G FG ++ T T + A K++ ++ E +E QIM L H +V L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMP----EAFLQEAQIMKKLR-HDKLVPL 66
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMGVM 190
+ + ++ + G L D + +G + ++ Q+ + Y M +
Sbjct: 67 YAVVSEE-PIYIVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPE-VLRRNY 246
HRDL+ N L ++ K DFGL+ + + + G+ + + APE L +
Sbjct: 125 HRDLRAANILV---GDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRF 180
Query: 247 GAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN-ISSSAKDIV 304
++D+WS G++L L++ G P+ G + + + + RG+ P P S +++
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY----RMPCPQGCPESLHELM 236
Query: 305 KKMLHADPKER 315
K DP ER
Sbjct: 237 KLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK---PGDVFKD 229
+ RQ+++ + Y H G++HRD+K EN + + ED L DFG + F +
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFARGSWSTPFHYG 321
Query: 230 LVGSAYYVAPEVLRRN-YGAEADIWSAGVILY 260
+ G+ APEVL + Y DIWSAG++++
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 49/195 (25%), Positives = 93/195 (47%), Gaps = 29/195 (14%)
Query: 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHY-CHSMGV------------MHRDLKPE 197
+ G + ++ ++ E +L ++++T+ C+S V +HRDL
Sbjct: 149 SSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAAR 208
Query: 198 NFLFSSSAEDSPLKATDFGLS--VFFKPGDVFK-DLVGSAYYVAPE-VLRRNYGAEADIW 253
N L S E++ +K DFGL+ ++ P V K D ++APE + R Y ++D+W
Sbjct: 209 NILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 265
Query: 254 SAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML---H 309
S GV+L+ + S G P+ G F L+ + P+ ++ ++ + ML H
Sbjct: 266 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTP--EMYQTMLDCWH 320
Query: 310 ADPKERLSAAEVLNH 324
+P +R + +E++ H
Sbjct: 321 GEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 63/258 (24%), Positives = 103/258 (39%), Gaps = 21/258 (8%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRN 129
ELG G FG +K K + K+++ + L N ++ ++ RE +M L +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSE---KTVAVKILKNDNNDPALKDELLREANVMQQLD-NPY 57
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
IV + G E S L+M+L G L + H +E+ L Q+ + Y
Sbjct: 58 IVRMIGICEAE-SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA----YYVAPEVLR-R 244
+HRDL N L + K +DFGLS + + + APE +
Sbjct: 117 VHRDLAARNVLLVTQHY---AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 245 NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303
+ +++D+WS GV+++ S G P+ G + I G + P D+
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG--ERMECP-QRCPPEMYDL 230
Query: 304 VKKMLHADPKERLSAAEV 321
+K ER A V
Sbjct: 231 MKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 27/260 (10%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R T ++LG GQFG ++ + + A KS+ + E E +M L
Sbjct: 5 RETLKLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSM----SPEAFLAEANLMKQLQ 59
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGH-YSERAAANLCRQMVTVVHY 183
H +V L A + + +I + G L D + +G + ++ Q+ + +
Sbjct: 60 -HPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPE 240
+HRDL+ N L S E K DFGL+ + + + G+ + + APE
Sbjct: 118 IERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 173
Query: 241 VLRRNYGA---EADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-N 295
+ NYG ++D+WS G++L I+ G P+ G T + + RG+ P P N
Sbjct: 174 AI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY----RMPRPDN 227
Query: 296 ISSSAKDIVKKMLHADPKER 315
++++ P+ER
Sbjct: 228 CPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 62/261 (23%), Positives = 114/261 (43%), Gaps = 23/261 (8%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
E R + ++LG GQFG ++ T + A K++ + E E QIM
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTM----SPESFLEEAQIMK 56
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRII-AKGHYSERAA-ANLCRQMVTV 180
L H +V+L A + ++ + + G L D + +G + ++ Q+
Sbjct: 57 KLR-HDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAG 114
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YV 237
+ Y M +HRDL+ N L K DFGL+ + + + G+ + +
Sbjct: 115 MAYIERMNYIHRDLRSANILVGDGL---VCKIADFGLARLIEDNE-YTARQGAKFPIKWT 170
Query: 238 APE-VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP- 294
APE L + ++D+WS G++L L++ G P+ G + + + + RG+ P P
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY----RMPCPQ 226
Query: 295 NISSSAKDIVKKMLHADPKER 315
+ S +++ + DP+ER
Sbjct: 227 DCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 95 FACKSISSRK--LINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152
FAC + + +I E I+ + H +I++LKG + LI+
Sbjct: 109 FACIDNKTCEHVVIKAGQRGGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCLILPRYKT 167
Query: 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212
+L+ + AK + + + R ++ + Y H ++HRD+K EN + + +
Sbjct: 168 -DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD---VCL 223
Query: 213 TDFGLSVFFKPGDV----FKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSG 265
DFG + F P D+ + G+ APE+L R+ YG DIWSAG++L+ + +
Sbjct: 224 GDFGAACF--PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 88/402 (21%), Positives = 146/402 (36%), Gaps = 105/402 (26%)
Query: 6 GLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGR---VLGKPM 62
S +T+ H A +++ PP + + A S G VLG+ +
Sbjct: 65 STDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVTYALPNQSREEGHFYVVLGEDI 124
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD------------- 109
+ + LG G FG + K+ A K + + RD
Sbjct: 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQ 184
Query: 110 -DVEDVRREVQIMHHL---TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY 165
D D ++I + TGH IV K G L D I+ G +
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPK----------------YGPCLLDWIMKHGPF 228
Query: 166 SERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
S R A + Q + Y H+ + +MH DLKPEN L +S + T+ L P
Sbjct: 229 SHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETS-DTVVDPVTNRAL-----PP 282
Query: 225 DVFK----DL-------------VGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSG- 265
D + DL V + +Y +PEV L + D+WS G I+Y L +G
Sbjct: 283 DPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
Query: 266 ---------------------VPPFWG-----ETEQSIFDAILRGHIDFSSDPWPNISSS 299
+P W E + ++++ G + +DP +++
Sbjct: 343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSA--GQLRPCTDP-KHLARI 399
Query: 300 AK--------------DIVKKMLHADPKERLSAAEVLNHPWM 327
A+ D++ +LH D ++RL+A ++ HP++
Sbjct: 400 ARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441
|
Length = 467 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 21/226 (9%)
Query: 71 FGRELGRGQFGVTY----LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ LG G FG Y + + K A K + R+ + +++ E +M +
Sbjct: 11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYVMASV-D 67
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCH 185
H ++V L G V LI L G L D + K + + N C Q+ + Y
Sbjct: 68 HPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA-----YYVAPE 240
++HRDL N L + +K TDFGL+ + K+ ++A E
Sbjct: 127 EKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLDVDE--KEYHAEGGKVPIKWMALE 181
Query: 241 -VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
+L R Y ++D+WS GV ++ L++ G P+ G I D + +G
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 62/280 (22%), Positives = 105/280 (37%), Gaps = 52/280 (18%)
Query: 70 IFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
G+ LG G+FG L ++ + A K++ + ++E+ E M
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL-DIHTYSEIEEFLSEAACMKDFD- 59
Query: 127 HRNIVELKGA---------------------YEDRHSVNLIMDLCAGGELFDRIIAKGHY 165
H N+++L G + D HS L L E
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKL--------- 110
Query: 166 SERAAANLCRQMVTV---VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
L + MV + + Y + +HRDL N + ED + DFGLS
Sbjct: 111 ---PLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIY 164
Query: 223 PGDVFKDLVGSAY---YVAPEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSI 277
GD ++ + ++A E L Y +++D+W+ GV ++ I G P+ G I
Sbjct: 165 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224
Query: 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS 317
+D + G+ P + D++ ADPK+R +
Sbjct: 225 YDYLRHGN--RLKQP-EDCLDELYDLMYSCWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 66/281 (23%), Positives = 124/281 (44%), Gaps = 49/281 (17%)
Query: 73 RELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH 127
RELG+G FG+ Y +D + + A K+++ + R+ +E + E +M T H
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASVMKGFTCH 69
Query: 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSE----RAAANLCRQMVTV--- 180
++V L G ++M+L A G+L + + +E R L ++M+ +
Sbjct: 70 -HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL-QEMIQMAAE 127
Query: 181 ----VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY 236
+ Y ++ +HRDL N + A D +K DFG++ +D+ + YY
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMV---AHDFTVKIGDFGMT---------RDIYETDYY 175
Query: 237 ------------VAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL 282
+APE L+ + +D+WS GV+L+ + S P+ G + + + ++
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235
Query: 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323
G D N D+++ +PK R + E++N
Sbjct: 236 DGG---YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL--VG 232
+Q++ V Y H ++HRD+K EN + D + DFG ++ F+ D VG
Sbjct: 274 KQLLCAVEYIHDKKLIHRDIKLENIFLNC---DGKIVLGDFGTAMPFEKEREAFDYGWVG 330
Query: 233 SAYYVAPEVLRRN-YGAEADIWSAGVILYILLS 264
+ +PE+L + Y DIWS G+IL +LS
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 40/231 (17%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQF---------------ACKSISSRKLINRDD 110
R +LG GQFG +L + +F A K + R + +
Sbjct: 4 RQQLRLKEKLGEGQFGEVHLC-EAEGLAEFLGEGAPEFDGQPVLVAVKML--RADVTKTA 60
Query: 111 VEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA 170
D +E++IM L + NI+ L G + +I + G+L + + S
Sbjct: 61 RNDFLKEIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 171 AN------------LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218
AN + Q+ + + Y S+ +HRDL N L + +K DFG+S
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT---IKIADFGMS 176
Query: 219 VFFKPGDVFKDLVGSAY----YVAPE-VLRRNYGAEADIWSAGVILYILLS 264
GD ++ + G A ++A E +L + +D+W+ GV L+ + +
Sbjct: 177 RNLYSGDYYR-IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 24/234 (10%)
Query: 71 FGRELGRGQFGVTY--LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
G+ LG G+FG + D+ + A K++ + R ++ED E M H
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKI-AICTRSEMEDFLSEAVCMKEFD-HP 60
Query: 129 NIVELKGA------YEDRHSVNLIMDLCAGGEL-----FDRIIAKGHY-SERAAANLCRQ 176
N++ L G E S +I+ G+L + R+ Y +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY- 235
+ + + Y S +HRDL N + + E+ + DFGLS GD ++ +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 236 --YVAPEVLR-RNYGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGH 285
++A E L R Y ++D+WS GV ++ I G P+ G I+D + +G+
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|197492 smart00054, EFh, EF-hand, calcium binding motif | Back alignment and domain information |
|---|
Score = 44.3 bits (106), Expect = 1e-06
Identities = 14/28 (50%), Positives = 15/28 (53%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKL 402
LKE F+ D D G I FEE K L L
Sbjct: 2 LKEAFRLFDKDGDGKIDFEEFKDLLKAL 29
|
EF-hands are calcium-binding motifs that occur at least in pairs. Links between disease states and genes encoding EF-hands, particularly the S100 subclass, are emerging. Each motif consists of a 12 residue loop flanked on either side by a 12 residue alpha-helix. EF-hands undergo a conformational change unpon binding calcium ions. Length = 29 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 9/149 (6%)
Query: 142 SVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200
+V L+ L G L D + K + N C Q+ + Y + ++HRDL N L
Sbjct: 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVL 141
Query: 201 FSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA----YYVAPEVLRRNYGAEADIWSAG 256
S +K TDFGL+ + G + +L R + ++D+WS G
Sbjct: 142 VKSPNH---VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYG 198
Query: 257 VILYILLS-GVPPFWGETEQSIFDAILRG 284
V ++ L++ G P+ G + I D + +G
Sbjct: 199 VTVWELMTFGAKPYDGIPAREIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 45/238 (18%)
Query: 66 RNTYIFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLI----------NRDDV 111
R +F +LG GQFG +L QF R L+ N++
Sbjct: 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR 63
Query: 112 EDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA 171
D +EV+I+ L NI+ L G D + +I + G+L ++ ++ H ++
Sbjct: 64 NDFLKEVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEEN 121
Query: 172 --------------------NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211
++ Q+ + + Y S+ +HRDL N L E+ +K
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIK 178
Query: 212 ATDFGLSVFFKPGDVFKDLVGSAY----YVAPE-VLRRNYGAEADIWSAGVILYILLS 264
DFG+S GD ++ + G A ++A E +L + +D+W+ GV L+ +L
Sbjct: 179 IADFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 26/153 (16%)
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----LV 231
Q+ + + S +HRDL N L S E++ +K DFGL+ D++KD
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLA-----RDIYKDPDYVRK 233
Query: 232 GSAY----YVAPE-VLRRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
GSA ++APE + + Y ++D+WS GV+L+ + S G P+ G F L+
Sbjct: 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK-- 291
Query: 286 IDFSSDPWPNISSSAKDIVKKML---HADPKER 315
D + P ++ I + ML DPKER
Sbjct: 292 -DGTRMRAPENATPE--IYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|200946 pfam00036, efhand, EF hand | Back alignment and domain information |
|---|
Score = 43.2 bits (103), Expect = 3e-06
Identities = 16/28 (57%), Positives = 17/28 (60%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKL 402
LKE FK D D G I+FEE K L KL
Sbjct: 2 LKEAFKEFDKDGDGKISFEEFKELLKKL 29
|
The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 40/167 (23%), Positives = 63/167 (37%), Gaps = 22/167 (13%)
Query: 166 SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225
+E +C Q + + H L + L G SV FK +
Sbjct: 15 NEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-----------DG-SVAFKTPE 62
Query: 226 VFKDLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS-IFDAILR 283
Y++APEV+ ++Y +ADI+S G+ LY L P+ E E S I + +L
Sbjct: 63 ---QSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119
Query: 284 GHIDFSSDPWPNISS-----SAKDIVKKMLHADPKERLSAAEVLNHP 325
G N+ S +D ++ P+ R +A L H
Sbjct: 120 GMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 70/298 (23%), Positives = 110/298 (36%), Gaps = 65/298 (21%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLIN----RDDV----- 111
R F +LG GQFG +L + K + + L+ R D
Sbjct: 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 112 EDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM------DLCAGGELFDRIIAKGHY 165
ED +EV+I+ L+ NI L G + +IM DL L +
Sbjct: 64 EDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQ--FLQKHVAETSGL 120
Query: 166 SERAAA-------NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218
+ + + + Q+ + + Y S+ +HRDL N L + +K DFG+S
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT---IKIADFGMS 177
Query: 219 VFFKPGDVFKDLVGSAYY------VAP-------EVLRRNYGAEADIWSAGVILY-IL-L 263
++L S YY P VL + ++D+W+ GV L+ IL L
Sbjct: 178 ---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228
Query: 264 SGVPPFWGETEQSIFDAILRGHIDFSSD---PWPNISSSAKDIVKKML---HADPKER 315
P+ T+Q + + D P P KDI + ML D ++R
Sbjct: 229 CREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCP--KDIYELMLECWRRDEEDR 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 37/164 (22%), Positives = 75/164 (45%), Gaps = 10/164 (6%)
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYC 184
H NIV L+G +++ ++ + + G L D + K G + + + + Y
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS--AYYVAPEVL 242
MG +H+ L L +S D K + F K ++ + G + APE +
Sbjct: 124 SEMGYVHKGLAAHKVLVNS---DLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 243 R-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
+ ++ + +D+WS G++++ ++S G P+W + Q + A+ G
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 30/105 (28%), Positives = 50/105 (47%), Gaps = 7/105 (6%)
Query: 66 RNTYIFGRELGRGQFG-----VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R+ FG+ LG G FG + + +D + A K + + + D+ E + E++I
Sbjct: 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKI 94
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY 165
+ HL H+NIV L GA V +I + C G+L + + K
Sbjct: 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAET 139
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 73 RELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
R +G+G FG Y L+ K A KS++ ++ + ++VE +E IM + H N
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN--RITDLEEVEQFLKEGIIMKDFS-HPN 57
Query: 130 IVELKG-AYEDRHSVNLIMDLCAGGELFDRIIAKGHY-SERAAANLCRQMVTVVHYCHSM 187
++ L G S +++ G+L + I ++ H + + Q+ + Y S
Sbjct: 58 VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY----------- 236
+HRDL N + E +K DFGL+ +D+ YY
Sbjct: 118 KFVHRDLAARNCMLD---ESFTVKVADFGLA---------RDIYDKEYYSVHNHTGAKLP 165
Query: 237 ---VAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPF 269
+A E L+ + + ++D+WS GV+L+ L++ G PP+
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|205583 pfam13405, EF_hand_4, EF-hand domain | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 2e-05
Identities = 14/29 (48%), Positives = 17/29 (58%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLG 403
L+E FK D D G I+ EEL+ L LG
Sbjct: 2 LREAFKLFDKDGDGYISAEELRKALRSLG 30
|
Length = 30 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 7/104 (6%)
Query: 66 RNTYIFGRELGRGQFG-----VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R+ + GR LG G FG + ++H + + A K + S + + + E++I
Sbjct: 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKI 93
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH 164
M HL H NIV L GA + +I + C G+L D + H
Sbjct: 94 MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 22/54 (40%), Positives = 30/54 (55%)
Query: 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419
L+EE+I LKE F+ D D+ G I EL L LG SE+E+ +L E +
Sbjct: 13 QLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEID 66
|
Length = 160 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 27/70 (38%), Positives = 37/70 (52%), Gaps = 5/70 (7%)
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG-- 232
RQ++T + H +G++HRD+KPEN L + D +K DFG +V G F L G
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFGAAVDMCTGINFNPLYGML 372
Query: 233 SAYYVAPEVL 242
Y PE L
Sbjct: 373 DPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 41/232 (17%)
Query: 66 RNTYIFGRELGRGQFGVTYLV----THKDTKQQFACKSISSRKLI----------NRDDV 111
R F +LG GQFG +L K + F+ ++ ++ N++
Sbjct: 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR 63
Query: 112 EDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA- 170
D +E++IM L NI+ L + +I + G+L ++ +++ E A
Sbjct: 64 NDFLKEIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEK 121
Query: 171 --------ANLC---RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219
+ L Q+ + + Y S+ +HRDL N L ++ +K DFG+S
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSR 178
Query: 220 FFKPGDVFKDLVGSAYYVAP-------EVLRRNYGAEADIWSAGVILYILLS 264
GD ++ + G A V P +L + +D+W+ GV L+ +L+
Sbjct: 179 NLYSGDYYR-IQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 9/149 (6%)
Query: 142 SVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200
+V LI L G L D + K + + N C Q+ ++Y ++HRDL N L
Sbjct: 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVL 141
Query: 201 FSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPE-VLRRNYGAEADIWSAG 256
+ +K TDFGL+ + G ++A E +L R Y ++D+WS G
Sbjct: 142 VKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 198
Query: 257 VILYILLS-GVPPFWGETEQSIFDAILRG 284
V ++ L++ G P+ G I + +G
Sbjct: 199 VTVWELMTFGSKPYDGIPASEISSILEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 18/92 (19%)
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----LVGSAY----YVAPE- 240
+HRDL N L S E++ +K DFGL+ D++KD G A ++APE
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLA-----RDIYKDPDYVRKGDARLPLKWMAPES 246
Query: 241 VLRRNYGAEADIWSAGVILYILLS-GVPPFWG 271
+ + Y ++D+WS GV+L+ + S G P+ G
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 15/219 (6%)
Query: 75 LGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
LG G FG Y V +T + I + + +VE E IM + H ++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMD-HPHLV 72
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVM 190
L G ++ L+ L G L D + K + + N C Q+ + Y ++
Sbjct: 73 RLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY---YVAPEVLR-RNY 246
HRDL N L S + +K TDFGL+ + + + G ++A E + R +
Sbjct: 132 HRDLAARNVLVKSP---NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 247 GAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
++D+WS GV ++ L++ G P+ G + I D + +G
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|205383 pfam13202, EF_hand_3, EF hand | Back alignment and domain information |
|---|
Score = 38.0 bits (90), Expect = 2e-04
Identities = 11/23 (47%), Positives = 16/23 (69%)
Query: 375 LKEMFKSMDTDNSGTITFEELKA 397
LK++F+ DT+ G I+ EELK
Sbjct: 1 LKDLFRQFDTNGDGKISKEELKR 23
|
Length = 25 |
| >gnl|CDD|222407 pfam13833, EF_hand_6, EF-hand domain pair | Back alignment and domain information |
|---|
Score = 38.6 bits (91), Expect = 2e-04
Identities = 18/43 (41%), Positives = 25/43 (58%), Gaps = 3/43 (6%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGL 399
K AL ++ +LSEEE+ +F+ DTD G I+FEE L
Sbjct: 11 KRALALLGISLSEEEV---DILFREFDTDGDGKISFEEFCVLL 50
|
Length = 53 |
| >gnl|CDD|185503 PTZ00183, PTZ00183, centrin; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 19/52 (36%), Positives = 31/52 (59%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
L+E++ ++E F DTD SGTI +ELK + LG + E++Q++ V
Sbjct: 11 LTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADV 62
|
Length = 158 |
| >gnl|CDD|222177 pfam13499, EF_hand_5, EF-hand domain pair | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 3e-04
Identities = 17/39 (43%), Positives = 24/39 (61%)
Query: 380 KSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
K +D D G I EEL+ L LG +L++ EV +L+EA
Sbjct: 1 KLLDKDGDGYIDVEELRKLLKALGLKLTDEEVEELIEAD 39
|
Length = 60 |
| >gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 21/56 (37%), Positives = 33/56 (58%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+A+ L+EE+I KE F D D GTIT +EL + LG +E+E++ ++ V
Sbjct: 1 MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 56
|
Length = 149 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 22/100 (22%), Positives = 36/100 (36%), Gaps = 6/100 (6%)
Query: 104 KLINRDDV-EDVRREVQIMHHLTGHRNIV-ELKGAYEDRHSVNLIMDLCAGGELFDRIIA 161
K+ + D REV I+ L V ++ + E L+M+ G L +
Sbjct: 27 KINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEE 86
Query: 162 KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLF 201
+ A L ++ H + + H DL P N L
Sbjct: 87 EKEDIAEQLAELLAKL----HQLPLLVLCHGDLHPGNILV 122
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 9e-04
Identities = 15/39 (38%), Positives = 22/39 (56%), Gaps = 3/39 (7%)
Query: 360 LKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAG 398
LK + E LS+EE+ +++ K D D G I +EE K
Sbjct: 118 LKSLGERLSDEEV---EKLLKEYDEDGDGEIDYEEFKKL 153
|
Length = 160 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 20/161 (12%)
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY----SERAAANLCRQMVT 179
L H NIV + + + + ++ A G D I H+ SE A A + + ++
Sbjct: 55 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMSELAIAYILQGVLK 112
Query: 180 VVHYCHSMGVMHRDLKPENFLFSS------SAEDSPLKATDFG--LSVFFKPGDVFKDLV 231
+ Y H MG +HR +K + L S S S L + G L V D K V
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH---DFPKYSV 169
Query: 232 GSAYYVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPF 269
+++PEVL++N Y A++DI+S G+ L +G PF
Sbjct: 170 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 25/102 (24%)
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY 235
Q+ + Y H GV+H+D+ N + E+ +K TD LS +DL Y
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALS---------RDLFPMDY 172
Query: 236 ------------YVAPEVLRRN-YGAEADIWSAGVILYILLS 264
++A E L Y + +D+WS GV+L+ L++
Sbjct: 173 HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.002
Identities = 22/51 (43%), Positives = 30/51 (58%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
EEE L+E FK D D+ G I+ EL+ L LG RLS+ EV +L++
Sbjct: 90 KEEE---LREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEY 137
|
Length = 160 |
| >gnl|CDD|185503 PTZ00183, PTZ00183, centrin; Provisional | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 15/59 (25%), Positives = 33/59 (55%), Gaps = 3/59 (5%)
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416
+ K + E EEI+ + F+ D D +G I+ + LK +LG +++ E++++++
Sbjct: 78 IMTKKLGERDPREEIL---KAFRLFDDDKTGKISLKNLKRVAKELGETITDEELQEMID 133
|
Length = 158 |
| >gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 20/51 (39%), Positives = 31/51 (60%), Gaps = 3/51 (5%)
Query: 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
+ SEEEI KE FK D D +G I+ EL+ + LG +L++ EV +++
Sbjct: 79 DTDSEEEI---KEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEEVDEMI 126
|
Length = 149 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 50/219 (22%), Positives = 93/219 (42%), Gaps = 36/219 (16%)
Query: 74 ELGRGQFGVT--YLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
E+GRG +T YL H T + I+ + + ++ ++ EV ++ H H NI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEV-VLSHFFRHPNIM 62
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM----VTVVHYCHSM 187
+ + +I A G + K ++ E + L + + ++Y H
Sbjct: 63 TSWTVFTTGSWLWVISPFMAYGSA--NSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN 120
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF---KPGDVFKDLVGSAY--------- 235
G +HR++K + L S D + + GLS + + G K Y
Sbjct: 121 GYIHRNIKASHILIS---GDGLVSLS--GLSHLYSLVRNGQKAK----VVYDFPQFSTSV 171
Query: 236 --YVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPF 269
+++PE+LR++ Y ++DI+S G+ L +G PF
Sbjct: 172 LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 70/269 (26%), Positives = 110/269 (40%), Gaps = 42/269 (15%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+ RG+ G +Y QF K I+ I ++ D+ + H NIV+L
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK--------LQHPNIVKLI 749
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH-YCHSMGVMHRD 193
G LI + G L + + R A + + +H C S V+ +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRC-SPAVVVGN 808
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVL-RRNYGAE 249
L PE + +D P LS+ PG + K + SAY VAPE ++ +
Sbjct: 809 LSPEKIIID--GKDEP----HLRLSL---PGLLCTDTKCFISSAY-VAPETRETKDITEK 858
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG--------HIDFSSDP--WPNISSS 299
+DI+ G+IL LL+G P + E + +I+ H+D DP ++S +
Sbjct: 859 SDIYGFGLILIELLTGKSP--ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916
Query: 300 AKDIVKKM---LHA---DPKERLSAAEVL 322
+IV+ M LH DP R A +VL
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVL 945
|
Length = 968 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 22/153 (14%)
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----LV 231
Q+ + + S +HRDL N L A+ +K DFGL+ D+ D
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLL---AQGKIVKICDFGLA-----RDIMHDSNYVSK 296
Query: 232 GSAY----YVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGE-TEQSIFDAILRG 284
GS + ++APE + N Y +D+WS G++L+ + S G P+ G + + ++ I G
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356
Query: 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERLS 317
+ D DI+ K +++P++R S
Sbjct: 357 YRMAKPDHATQ---EVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 19/68 (27%), Positives = 35/68 (51%), Gaps = 6/68 (8%)
Query: 154 ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213
E+F RI +++ N+ + M+T + Y H G+ H D+KPEN + + +
Sbjct: 115 EIFKRIKC---KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII--- 168
Query: 214 DFGLSVFF 221
D+G++ F
Sbjct: 169 DYGIASHF 176
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 420 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.6 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.45 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.42 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.23 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.16 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.05 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.04 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.82 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.75 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.65 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.52 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.51 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.48 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 98.46 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.37 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.35 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 98.28 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.24 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| PF00036 | 29 | EF-hand_1: EF hand; InterPro: IPR018248 Many calci | 98.14 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 98.13 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.12 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.06 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 98.04 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 98.02 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.0 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 97.96 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.91 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 97.91 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.87 | |
| PF13405 | 31 | EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J | 97.85 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 97.85 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.8 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.76 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 97.75 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.73 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.71 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.68 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.63 | |
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 97.61 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.6 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 97.56 | |
| cd00213 | 88 | S-100 S-100: S-100 domain, which represents the la | 97.53 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 97.52 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 97.51 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.47 | |
| PF13202 | 25 | EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ | 97.46 | |
| cd00052 | 67 | EH Eps15 homology domain; found in proteins implic | 97.44 | |
| KOG0041 | 244 | consensus Predicted Ca2+-binding protein, EF-Hand | 97.43 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-67 Score=477.76 Aligned_cols=268 Identities=41% Similarity=0.703 Sum_probs=248.3
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChh----hHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD----DVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
..+.+.|.+.+.||+|+||.|.+|..+.||+.||||++.++...... ....+.+|+++|++|+ |||||+++++|+
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFE 246 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeee
Confidence 44778899999999999999999999999999999999887654422 3345789999999999 999999999999
Q ss_pred eCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
..+..||||||++||+|++++..++.+.+...+.+++||+.|+.|||++||+||||||+|||++.+.++..+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999999999999999999999999999999999999999999999999998878899999999999
Q ss_pred cccCCCCceecccCCcccccchhhcc----cCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCCCCC
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPW 293 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 293 (420)
+....+..+.+.||||.|.|||++.. .+..++|+||+||+||.+++|.+||.+..... +.++|.++.+.+....|
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 99988888999999999999999853 25568999999999999999999998877665 89999999999999999
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
..+|.++.+||.+||.+||++|||+.|+|+||||+...
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 99999999999999999999999999999999998544
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-66 Score=435.79 Aligned_cols=300 Identities=37% Similarity=0.723 Sum_probs=275.6
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+.+.|.+.+.||+|.|+.||++.+..+|+.+|+|++...++ +....+.+.+|++|.+.|+ ||||+++.+.+...+..
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~-~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH 85 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh-ccccHHHHHHHHHHHHhcC-CCcEeehhhhhccccee
Confidence 356789999999999999999999999999999999987665 4447889999999999999 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+|+|++.|++|..-+..+..++|..+..+++||++||.|||.+||||||+||+|+++.+.+....+||+|||++..+..
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99999999999988888877899999999999999999999999999999999999999988888999999999999987
Q ss_pred CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
+......+|||.|||||++++ .|+..+|||+.|||||.|+.|++||++.+...+++.|+.+.++++.+.|+.+++++++
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 778888999999999999975 5999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcccHHHHHHHHHHHhhhhhHHHHHHHHHh
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAE 365 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~ 365 (420)
||++||..||.+|+|+.|+|+|||+..........-.......|++|....+|+-.++..+..
T Consensus 246 LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~s 308 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVIA 308 (355)
T ss_pred HHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHHh
Confidence 999999999999999999999999975443222223355788999999999999999887753
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-60 Score=452.97 Aligned_cols=322 Identities=61% Similarity=1.045 Sum_probs=297.5
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
...+...|.+++.||+|.||.||+++++.+|+.+|+|++.+.........+.+.+|+.+|+++.+|||||.++++|++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 45677889999999999999999999999999999999998877666677899999999999999999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC-CCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE-DSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~-~~~~kl~Dfg~~~~ 220 (420)
.+++|||+|.||+|++.+... .++|..+..+++|++.++.|||+.||+||||||+|+|+....+ +..+|++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999887 5999999999999999999999999999999999999987654 45899999999999
Q ss_pred cCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 221 FKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
...+......+||+.|+|||++. ..|+..+||||+||++|.|++|.+||++.+....+..|..+.+.|..+.|+.++..
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 98877888999999999999998 67999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcccHHHHHHHHHHHhhhhhHHHHHHHHHhhhhHHHHhhHHHHh
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMF 379 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F 379 (420)
+++||++||..||.+|+|+.++|+|||++.............+..++.++...+++++..+.......+ ...++.+|
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 345 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGLKEMF 345 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHHHHHH
Confidence 999999999999999999999999999988777777777777788888999999998887777776665 77788889
Q ss_pred hccCCCCC
Q 014704 380 KSMDTDNS 387 (420)
Q Consensus 380 ~~~D~~~~ 387 (420)
..+|.+++
T Consensus 346 ~~~~~~~~ 353 (382)
T KOG0032|consen 346 KLMDTDNN 353 (382)
T ss_pred Hhhccccc
Confidence 99988776
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-61 Score=455.21 Aligned_cols=256 Identities=35% Similarity=0.612 Sum_probs=242.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
.+|..++.||+|||+.||.+++..+|+.||+|++.+..+......+++.+||++.+.|+ |||||+++++|+|.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence 57999999999999999999999999999999999988878888899999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-C
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-D 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-~ 225 (420)
.|+|+.++|..+++.++.++|.+++.+++||+.||.|||+++|+|||||..|+++ +++.+|||+|||+|..+... .
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence 9999999999999989999999999999999999999999999999999999999 56778999999999998744 6
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
...+.||||.|.|||++.+ .++..+||||+||+||.||+|++||...+-.+.+..|....+.+|. .+|.++++||
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI 249 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI 249 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence 6678999999999999874 5999999999999999999999999999999999999999998887 6899999999
Q ss_pred HHhcccCcCCCCCHHHHhcCCccccc
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+||+.||.+|||++++|.|+||+..
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 99999999999999999999999543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-59 Score=422.26 Aligned_cols=264 Identities=36% Similarity=0.679 Sum_probs=241.3
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||+||+|+++.++..||||.+.+.++ .....+.+..|+++|+.++ |||||.+++++++++.+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEE
Confidence 44679999999999999999999999999999999988765 5667788999999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCC---CCeeEeeccccccc
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED---SPLKATDFGLSVFF 221 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~---~~~kl~Dfg~~~~~ 221 (420)
+|||||+||+|.+++..++.++|..++.++.||+.||++||+++||||||||+|||++....+ -.+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999875333 67999999999999
Q ss_pred CCCCceecccCCcccccchhh-cccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 222 KPGDVFKDLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
.++....+.||+|.|||||++ .++|+.|+|+||+|+|+|++++|+.||...+..+++..+.++....+... ..++...
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~ 244 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPL 244 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCch
Confidence 988888899999999999999 57899999999999999999999999999999999998888765444332 3467778
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.+|+...|+.+|.+|.+..+-+.|+++....
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8999999999999999999999999987544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-59 Score=444.31 Aligned_cols=274 Identities=34% Similarity=0.648 Sum_probs=251.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
+-|++++.||.|+.|.|.+|++..||+.+|||+|.+..-........+++||-+|+.+. ||||+++|++|++..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEE
Confidence 56999999999999999999999999999999998875556666788999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
.||++||.|++++..++++++.+++++++||+.|+.|||..+|+||||||+|+|+ +..++|||+|||+|..-.++..
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCcc
Confidence 9999999999999999999999999999999999999999999999999999999 4555699999999999888888
Q ss_pred eecccCCcccccchhhccc--CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~~--~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
..+.||+|+|.|||++.+. -+.++||||+|||||.||||++||++++...++.++.+|.+..+. .+|+++++||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~eaQdLL 243 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEAQDLL 243 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHHHHHH
Confidence 9999999999999999764 478999999999999999999999999999999999999999885 7899999999
Q ss_pred HHhcccCcCCCCCHHHHhcCCcccccCCCC------------------CCcccHHHHHHHHH
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMRVDGDAS------------------DKPLDIAVLTRMKQ 348 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~------------------~~~~~~~~~~~~~~ 348 (420)
++||.+||++|+|.+||++|||+....... ...++..+++.|.-
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s~ps~~~IDp~Il~~l~i 305 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILSIPSIQEIDPLILQHLCI 305 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceeecCCcccCCHHHHhhhhh
Confidence 999999999999999999999997543221 24566777777754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-58 Score=414.82 Aligned_cols=256 Identities=28% Similarity=0.429 Sum_probs=227.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-eEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-SVNL 145 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-~~~i 145 (420)
.+.+..+.||+|..|+||+++|+.|++.+|+|.|.. ..++...+++.+|+++++... ||+||++|+.|..++ .++|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCceEEe
Confidence 456778899999999999999999999999999943 335667789999999999997 999999999999999 4999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||+||+|.+.+...++++|.....++.++++||.|||+ ++||||||||+|||+++ .+.|||||||.+..+...
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs---kGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS---KGEVKICDFGVSGILVNS 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc---CCCEEeccccccHHhhhh
Confidence 99999999999999988999999999999999999999995 99999999999999964 566999999999887655
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE-----TEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
...+++||..|||||.+.+ .|+.++||||||+.++|+.+|+.||... ...+++..|..+..+-... ..+|+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS~ 309 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFSP 309 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCCH
Confidence 5678899999999999976 6999999999999999999999999774 5677888888754332221 14799
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
++++||..||++||.+|||+.|+|+|||++...
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999999999999999999999999998544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-58 Score=427.50 Aligned_cols=257 Identities=34% Similarity=0.657 Sum_probs=240.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
..+|.+++.||+|+|++|++|+++.+++.||||++.++.+..+...+.+.+|-.+|.+|.+||.|++|+-.|+|+..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 36799999999999999999999999999999999998887777888899999999999889999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|+||+++|+|.++|.+.+.|++..++.++.||+.||+|||++|||||||||+|||+ +.++++||+|||.|+.+.+..
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999 788999999999998875321
Q ss_pred c--------------eecccCCcccccchhhccc-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 014704 226 V--------------FKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS 290 (420)
Q Consensus 226 ~--------------~~~~~gt~~y~aPE~~~~~-~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 290 (420)
. ..+++||..|.+||++... .++.+|+|+||||+|.|+.|.+||.+.++-.++++|+...+.|+.
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~ 308 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE 308 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence 1 1458999999999999754 789999999999999999999999999999999999999998886
Q ss_pred CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 291 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
++++.+++||+++|..||.+|+|+.+|.+||||..
T Consensus 309 ----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 309 ----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred ----CCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 67899999999999999999999999999999964
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-58 Score=412.81 Aligned_cols=257 Identities=35% Similarity=0.671 Sum_probs=238.7
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||+||.++.+++++.||+|++++.......+.+...+|..+|..++ ||.||+++-.|++.+.+|+|
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEEE
Confidence 57999999999999999999999999999999999988887778899999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc-CCCC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~-~~~~ 225 (420)
+||+.||+|+-+|.+.+.++|..++-++..|+.||.|||++|||||||||+|||+ +.+++++|+|||+++.. ..+.
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCCC
Confidence 9999999999999999999999999999999999999999999999999999999 67889999999999854 4445
Q ss_pred ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
...++|||+.|||||++. ..|+.++|.||||+++|+|++|.+||.+.+...+.++|.++...... ..++.+++++|
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardll 257 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDLL 257 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHHH
Confidence 667789999999999986 46999999999999999999999999999999999999998854443 23799999999
Q ss_pred HHhcccCcCCCC----CHHHHhcCCccccc
Q 014704 305 KKMLHADPKERL----SAAEVLNHPWMRVD 330 (420)
Q Consensus 305 ~~~L~~dp~~R~----t~~e~l~h~~~~~~ 330 (420)
+++|+.||++|. ++.++-+||||...
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 999999999996 79999999999743
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-59 Score=400.43 Aligned_cols=263 Identities=36% Similarity=0.683 Sum_probs=243.2
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC-----ChhhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-----NRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
.+-..|.-.+.||.|..++|.++.++.+|+.+|+|++...... .....+.-..|+.+|+++.+||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3446788889999999999999999999999999998643221 11234566889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
.+..+++|+|.|+.|.|+|+|.+.-.++|....+|++|+++++.|||.++||||||||+|||+ +++.++||+|||++
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEecccee
Confidence 999999999999999999999999999999999999999999999999999999999999999 67778999999999
Q ss_pred cccCCCCceecccCCcccccchhhc-------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLR-------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 291 (420)
+.+.++......||||+|.|||.+. ..|+..+|+|++|||||.|+.|.+||+.....-++..|+.|.+.|..+
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 9999999999999999999999874 248899999999999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 292 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.|.++|.+.++||.+||++||.+|+|++|+|.||||..
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 99999999999999999999999999999999999954
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-57 Score=427.97 Aligned_cols=259 Identities=39% Similarity=0.724 Sum_probs=236.5
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCC--hhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN--RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
...+.|.+++.||+|+||+|+.|.+..++..||+|++.+..... ....+.+.+|+.+++++..||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45578999999999999999999999999999999877642221 1345678899999999999999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCC-CCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED-SPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~-~~~kl~Dfg~~~~ 220 (420)
.+|+|||||.||+|++++.+.+++.|..+..+++|+++|++|||++||+||||||+|||++ .+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEeccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999995 44 7899999999998
Q ss_pred c-CCCCceecccCCcccccchhhcc-c-C-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 221 F-KPGDVFKDLVGSAYYVAPEVLRR-N-Y-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 221 ~-~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
. ..+....+.+||+.|+|||++.+ . | +.++||||+||+||.|++|+.||.+.+...++..|.++.+.++. .+
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----~~ 246 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----YL 246 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----Cc
Confidence 8 46677889999999999999975 3 5 58899999999999999999999999999999999999888876 34
Q ss_pred -ChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 297 -SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 297 -~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
|+++++|+++||..||.+|+|+.++++||||+.
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-57 Score=391.80 Aligned_cols=253 Identities=33% Similarity=0.662 Sum_probs=239.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||.|+||.|.+++++.+|..+|+|++.+.........+...+|..+|+.+. ||+++++++.+.+.+++|+|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEE
Confidence 57899999999999999999999999999999999988888888899999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
|||++||.|+.++.+.+++++..++.++.||+.||+|||+++|++|||||+|||+ +.++.+||+|||+|+.+...
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc--
Confidence 9999999999999999999999999999999999999999999999999999999 67889999999999987643
Q ss_pred eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
..+.||||.|+|||++. ..|+.++|-|||||++|||+.|.+||.+.+..+++++|..+...|+. .+++++++||+
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl~ 273 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLLK 273 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHHH
Confidence 56789999999999986 46999999999999999999999999999999999999999999986 68999999999
Q ss_pred HhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 306 KMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
++|++|-.+|. ...++.+||||+.
T Consensus 274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHHhhhhHhhhcCcCCCccccccCccccc
Confidence 99999999994 5789999999974
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-56 Score=387.55 Aligned_cols=268 Identities=37% Similarity=0.708 Sum_probs=241.6
Q ss_pred cccccceeec-ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe--
Q 014704 63 EDVRNTYIFG-RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-- 139 (420)
Q Consensus 63 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-- 139 (420)
..+.++|.+. ++||-|-.|.|..+.++.||+.+|+|++.. ..+.++|++.--..++|||||.++++|++
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 4466788875 578999999999999999999999998742 25678999988888889999999999864
Q ss_pred --CCeEEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeec
Q 014704 140 --RHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (420)
Q Consensus 140 --~~~~~iv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Df 215 (420)
..++.+|||.++||+|+.++..++. ++|.++..|++||..|+.|||+.+|.||||||+|+|..+...+..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 5678899999999999999998876 999999999999999999999999999999999999998888999999999
Q ss_pred ccccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCC
Q 014704 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGET----EQSIFDAILRGHIDFSS 290 (420)
Q Consensus 216 g~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~ 290 (420)
|+|+.-.....+.+.+-||+|.|||++. ++|+..+|+||+||++|.|++|++||+... ...+...|..+.+.|+.
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 9999877666778889999999999996 569999999999999999999999998754 35677889999999999
Q ss_pred CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcc
Q 014704 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338 (420)
Q Consensus 291 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~ 338 (420)
+.|..+|++++++|+.+|..+|.+|.|+.++++|||+.........++
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl 336 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL 336 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence 999999999999999999999999999999999999987665555444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-56 Score=388.99 Aligned_cols=256 Identities=29% Similarity=0.551 Sum_probs=221.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
+.|+...++|+|+||+||+|++++||+.||||.+..+. .++...+-..|||++|++|+ |||+|.++++|.....+++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence 46888899999999999999999999999999986443 23344456789999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-CC
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PG 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~~ 224 (420)
+|||+. ++.+.|... ..+++..+..++.|++.|+.|||++++|||||||+|||+ ..++.+||||||+|+.+. ++
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCc
Confidence 999987 444555544 459999999999999999999999999999999999999 567789999999999987 88
Q ss_pred CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Q 014704 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI---------------- 286 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~---------------- 286 (420)
+.++..+.|.+|+|||.+.+ +|++.+||||+||++.||++|.+.|.+.++-+.+..|...-.
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 88999999999999999865 599999999999999999999999999988776666643211
Q ss_pred ---CCCC--------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 287 ---DFSS--------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 287 ---~~~~--------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.++. ..+++++.-+.+|+++||+.||++|++.+|+|+|+||.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 1111 12567788899999999999999999999999999994
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-55 Score=409.26 Aligned_cols=260 Identities=32% Similarity=0.568 Sum_probs=236.0
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+++.||+|+||.||+|+.+.||..+|+|++++.......+++.++.|=.+|.... +|+||+++-.|++..++||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEEEecCCCeeEE
Confidence 367999999999999999999999999999999999998888889999999999999966 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC--
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-- 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-- 223 (420)
||||++||++..+|...+.|++..++.++.+++.|+.-+|+.|+|||||||+|+|| +..+++||+|||++.-...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999 7889999999999853210
Q ss_pred --------------------CC-c-------------------------eecccCCcccccchhhcc-cCCCccchhhhH
Q 014704 224 --------------------GD-V-------------------------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAG 256 (420)
Q Consensus 224 --------------------~~-~-------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DvwslG 256 (420)
.+ . ..+.+|||.|||||++.+ .|+..||.||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 00 0 012489999999999865 599999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCC---HHHHhcCCccccc
Q 014704 257 VILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS---AAEVLNHPWMRVD 330 (420)
Q Consensus 257 vil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~~ 330 (420)
||+||||.|++||.+.+..+++.+|.+....+..+.-..++++++|||.+||. ||++|.. ++||.+||||+..
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 99999999999999999999999999988555555556789999999999999 9999985 9999999999854
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-55 Score=394.92 Aligned_cols=260 Identities=33% Similarity=0.651 Sum_probs=246.1
Q ss_pred ccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 60 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
.....++.+|.+.+.||+|.||.|-+|.....|+.||||.|++.+..+.+++-.+++||+||..|+ ||||+.+|++|++
T Consensus 46 hhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFEN 124 (668)
T KOG0611|consen 46 HHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFEN 124 (668)
T ss_pred CcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcC
Confidence 344567889999999999999999999999999999999999999999999999999999999999 9999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+.+.|||||..+|+|+|++..++.++|.++..+++||.+|+.|||+++++|||||.+|||+ +.++++||+|||++.
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSN 201 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999 677889999999999
Q ss_pred ccCCCCceecccCCcccccchhhccc--CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 220 FFKPGDVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.+.......++||+|.|.+||++++. -++.+|-|||||+||.|+.|..||++.+...++.+|.+|.+.-+. -+
T Consensus 202 ly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~P 276 (668)
T KOG0611|consen 202 LYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TP 276 (668)
T ss_pred hhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CC
Confidence 99888889999999999999999874 478999999999999999999999999999999999999876554 46
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.++.-||+.||.+||++|.|++++..|-|+.
T Consensus 277 SdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 277 SDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred chHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 7899999999999999999999999999986
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-54 Score=410.17 Aligned_cols=256 Identities=30% Similarity=0.570 Sum_probs=238.9
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|++.++||+|+||+|+++..+.+++.||||++++......++++..+.|.+++.....||.++.++..|+.++++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 36799999999999999999999999999999999999998999999999999999999889999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-CC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~~ 224 (420)
||||+.||++. ++...+.+++..+.-++..++.||.|||++||||||||.+|||+ +.++++||+|||+++... .+
T Consensus 447 vmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCCC
Confidence 99999999954 34456789999999999999999999999999999999999999 678899999999998754 56
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
...+++||||.|||||++.+ .|+.++|-|||||+|||||.|..||.++++++++..|+.....++. .+|.++.++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~i 598 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAI 598 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHH
Confidence 67788999999999999975 5999999999999999999999999999999999999998888775 689999999
Q ss_pred HHHhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 304 VKKMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 304 i~~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
++++|.++|++|.. +.+|..||||+.
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 99999999999995 589999999974
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-55 Score=401.93 Aligned_cols=262 Identities=31% Similarity=0.519 Sum_probs=228.0
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-e
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-S 142 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-~ 142 (420)
.+-++|.+.++||.|.||.||+|+.+.+|..||||.++++ +...++.- =.||++.|++|..||||+++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~K-f~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKK-FYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhh-hccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 3557899999999999999999999999999999998754 43444333 3589999999999999999999998887 9
Q ss_pred EEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+|+|||||+ .+|+++++.++ .+++..+..|+.||++||+|+|.+|+.|||+||+|||+. ....+||+|||+|+.+
T Consensus 85 L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEeccccccccc
Confidence 999999996 49999998764 499999999999999999999999999999999999994 4667999999999999
Q ss_pred CCCCceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------------
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG--------------- 284 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~--------------- 284 (420)
.+...++..+.|.+|+|||++. +.|+.+.|||++|||++|+.+-++.|.|.++-+.+.+|..-
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 9999999999999999999974 46999999999999999999999999999887777666431
Q ss_pred ----CCCCCC-------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 285 ----HIDFSS-------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 285 ----~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.+.++. ...+..+.++.++|.+||.+||++||||.|+|+||||+...
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 122221 11345789999999999999999999999999999998543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-54 Score=405.37 Aligned_cols=254 Identities=31% Similarity=0.576 Sum_probs=235.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+... ...++..+.+|+++++.|+ ||||+.++++|+...++++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence 479999999999999999999999999999999987654 4567888999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
.|||.| +|+.++...+.++|+.+..++.+++.||.|||+++|+|||+||.|||+ +..+.+|+||||+|+.+..+.
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence 999987 999999999999999999999999999999999999999999999999 678899999999999887654
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
..+...|||.|||||+..+ .|+..+|+||+|||+||+++|++||......++.+.|......++. .+|..+.+|+
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl 231 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFL 231 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHH
Confidence 4456789999999999875 5999999999999999999999999999999999999988776665 7899999999
Q ss_pred HHhcccCcCCCCCHHHHhcCCccccc
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
..+|.+||.+|+|..+++.|||.+..
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhh
Confidence 99999999999999999999998743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-53 Score=390.11 Aligned_cols=260 Identities=28% Similarity=0.507 Sum_probs=226.8
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--Ce
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HS 142 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--~~ 142 (420)
-.+.|+.+++||+|.||.||+|++..+|+.||+|.+..... .+.......+||.+|++|. ||||+++.++..+. ..
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCce
Confidence 34678899999999999999999999999999999986653 3445566789999999999 99999999988766 78
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+|+|+|||+. +|.-++... -.|++.+++.+++||+.||+|||++||+|||||.+|||| ++++.+||+|||+|+++
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeec
Confidence 9999999976 887777654 369999999999999999999999999999999999999 67888999999999977
Q ss_pred CCCC--ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC---
Q 014704 222 KPGD--VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP--- 294 (420)
Q Consensus 222 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--- 294 (420)
.... .++..+-|.+|.|||.+.+ .|+.++|+||+||||.||++|++.|.+.++.+.++.|.+-......+.|+
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 6543 5677889999999999865 59999999999999999999999999999999999987644333333333
Q ss_pred ----------------------CCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 295 ----------------------NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 295 ----------------------~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+++.+.+|+..||..||.+|.||.++|+|+||...
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 457888999999999999999999999999999543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-53 Score=387.03 Aligned_cols=261 Identities=34% Similarity=0.633 Sum_probs=228.2
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh-----------hhHHHHHHHHHHHHhccCCCCccE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-----------DDVEDVRREVQIMHHLTGHRNIVE 132 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~~hpniv~ 132 (420)
..-++|++++.||+|.||.|.+|++..+++.||||++.+..+... ..++.+.+||.+|++|. |||||+
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~ 172 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVK 172 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeE
Confidence 345789999999999999999999999999999999987554221 22468999999999999 999999
Q ss_pred EEEEEEeC--CeEEEEEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCC
Q 014704 133 LKGAYEDR--HSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209 (420)
Q Consensus 133 ~~~~~~~~--~~~~iv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~ 209 (420)
++++..+. +.+|||+|||..|.+.. ....+. +++.+++.+++.++.||+|||.+|||||||||+|+|+ +.+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCCc
Confidence 99999764 67999999999998844 333344 9999999999999999999999999999999999999 56789
Q ss_pred eeEeecccccccCCC------CceecccCCcccccchhhcc---c--CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Q 014704 210 LKATDFGLSVFFKPG------DVFKDLVGSAYYVAPEVLRR---N--YGAEADIWSAGVILYILLSGVPPFWGETEQSIF 278 (420)
Q Consensus 210 ~kl~Dfg~~~~~~~~------~~~~~~~gt~~y~aPE~~~~---~--~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~ 278 (420)
+||+|||.+.....+ ..+...+|||.|+|||.+.+ . .+.+.||||+||+||.|+.|+.||.++...+++
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 999999999876322 23455789999999998754 1 467899999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 279 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.+|.+..+.|+.. +.+.+++++||.+||.+||++|++..++..|||.....
T Consensus 329 ~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 329 DKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred HHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 9999998888875 36899999999999999999999999999999997653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-53 Score=361.14 Aligned_cols=258 Identities=32% Similarity=0.560 Sum_probs=222.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
.+|...+.||+|.||.||+|++..+|+.||||.|+.....+ .......|||+.|+.++ |+||+.++++|...+.+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence 47888999999999999999999999999999998765432 22345779999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
+||++ .+|...++.+. .++...++.++.+++.||+|||++.|+||||||+|+|+ +.++.+||+|||+|+.+.+..
T Consensus 80 fEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCC
Confidence 99996 48988887654 48999999999999999999999999999999999999 567889999999999876443
Q ss_pred -ceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC---------
Q 014704 226 -VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW--------- 293 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 293 (420)
.....+-|.+|+|||.+- +.|+..+||||.|||+.||+-|.+-|.|.++-+.+..|.+.-.....+.|
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 334447899999999874 46999999999999999999999999999988888887664333333333
Q ss_pred ---------------CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 294 ---------------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 294 ---------------~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+..+.++.||+.+||..||.+|+|+.|+|+|+||+..
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 3457788999999999999999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-54 Score=370.59 Aligned_cols=246 Identities=30% Similarity=0.556 Sum_probs=215.9
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEE-EEE-eCCeE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG-AYE-DRHSV 143 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~-~~~-~~~~~ 143 (420)
..+|.+.++||.|+||.||++++..+|..+|.|.+.-.. .+....+.+..|+.+|++|+ |||||++++ .+. +...+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhh
Confidence 357999999999999999999999999999999998443 35667788999999999999 999999998 444 44449
Q ss_pred EEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--CeeccCCCCcEEEecCCCCCCeeEeec
Q 014704 144 NLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHS--MG--VMHRDLKPENFLFSSSAEDSPLKATDF 215 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~--~~--ivH~Dlkp~Nill~~~~~~~~~kl~Df 215 (420)
+||||||++|+|.+.++. ++.++|..+++++.|++.||..||+ .. |+||||||.||++ +.++.+||+||
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDf 172 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDF 172 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccc
Confidence 999999999999887753 4569999999999999999999999 45 9999999999999 57788999999
Q ss_pred ccccccCCCCce-ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 014704 216 GLSVFFKPGDVF-KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (420)
Q Consensus 216 g~~~~~~~~~~~-~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 293 (420)
|+++.+...... .+.+|||+||+||.+.+ .|+.++||||+||++|||+.-++||.+.+-.++-.+|.++.++.-.+
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~-- 250 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD-- 250 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH--
Confidence 999998765543 46799999999999865 69999999999999999999999999999999999999996642211
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCH
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSA 318 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~ 318 (420)
...|.++..+|..|+.+||+.||+.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc
Confidence 3568999999999999999999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-54 Score=361.96 Aligned_cols=255 Identities=34% Similarity=0.645 Sum_probs=236.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
-++|.+++.||+|.||.||.|+.+.++-.||+|++.++.........++.+|+++-..|+ ||||+++|++|.|...+|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEE
Confidence 367999999999999999999999999999999998877666666788999999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRII--AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
++||..+|+|+..|. ...++++..++.++.|++.||.|||.++|+||||||+|+|++ ..+.+||+|||.+....
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCceeecC-
Confidence 999999999999998 567799999999999999999999999999999999999994 55669999999998765
Q ss_pred CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
.....+.|||..|.|||...+ .++..+|+|++|++.||++.|.+||...+..+.+..|.+..+.++. .++.+++|
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~is~~a~d 251 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----TISGGAAD 251 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----ccChhHHH
Confidence 455578899999999999875 5899999999999999999999999999999999999999888873 78999999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+|.+||.++|.+|.+..|++.|||+..
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999999864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-53 Score=372.90 Aligned_cols=264 Identities=37% Similarity=0.657 Sum_probs=235.4
Q ss_pred ccceee-cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 66 RNTYIF-GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 66 ~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
.+-|.+ .+.||+|+|+.|-.++...+|..||||+|.+.. .....++.+|++++.+.++|+||++++++|+++..+|
T Consensus 76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY 152 (463)
T KOG0607|consen 76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY 152 (463)
T ss_pred HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence 345665 468999999999999999999999999998763 2345789999999999999999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+|||.+.||.|..++.++..++|.++..+++.|+.||.|||.+||.||||||+|||....+.-..||||||.+...+...
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 99999999999999999999999999999999999999999999999999999999987666678999999887654322
Q ss_pred --------CceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCC---------------HH
Q 014704 225 --------DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGET---------------EQ 275 (420)
Q Consensus 225 --------~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~---------------~~ 275 (420)
....+.+|+..|||||+.. ..|+.+||.||||||+|.|++|++||.+.- .+
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 2234568999999999753 248999999999999999999999996532 36
Q ss_pred HHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 276 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
.+++.|..|.+.|+...|..+|.+++++|+.+|..|+.+|.++.++++|||++....
T Consensus 313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 799999999999999999999999999999999999999999999999999975443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-53 Score=396.33 Aligned_cols=255 Identities=30% Similarity=0.548 Sum_probs=225.2
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
-...|...++||+|+.|.||.|....+++.||+|.+..+.- ...+-+.+|+.+|+.++ |+|||.+++.|...+.+|
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhcc-chHHHHHHHHhcccceeE
Confidence 34568888999999999999999999999999999976542 33467899999999999 999999999999889999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||++||+|.|.+.. ..++|.+++.|++.++.||+|||.+||+|||||.+|||+ +.++.+||+|||++..+...
T Consensus 347 VVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeeccccc
Confidence 99999999999887754 469999999999999999999999999999999999999 56677999999999988765
Q ss_pred C-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCCCChHHH
Q 014704 225 D-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG-HIDFSSDPWPNISSSAK 301 (420)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~ 301 (420)
. ...+.+|||+|||||+..+ .|+++.||||||++++||+-|.+||...+....+..|... .+.+. .+..+|+.++
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk--~~~klS~~~k 500 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLK--NPEKLSPELK 500 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcC--CccccCHHHH
Confidence 4 5677899999999999975 5999999999999999999999999987776666666543 33333 3468999999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+||.+||+.|+++|++|.|+|+||||+.
T Consensus 501 dFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 501 DFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 9999999999999999999999999954
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=382.98 Aligned_cols=258 Identities=34% Similarity=0.565 Sum_probs=216.0
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--eEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH--SVN 144 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~--~~~ 144 (420)
.+|..++.||+|+||.||++.++++|...|||.+.... ....+.+.+|+.+|++|+ |||||++++...... .++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeE
Confidence 46888999999999999999999999999999986542 222678999999999999 999999999754444 699
Q ss_pred EEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 145 LIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+|||++||+|.+++.+.+ .++|..+..+.+||++||.|||++|||||||||+|||+... ++.+||+|||.+.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKKLES 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCcccccccc
Confidence 9999999999999999877 79999999999999999999999999999999999999531 57799999999987663
Q ss_pred ----CCceecccCCcccccchhhcccC--CCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 224 ----GDVFKDLVGSAYYVAPEVLRRNY--GAEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 224 ----~~~~~~~~gt~~y~aPE~~~~~~--~~~~DvwslGvil~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
........||+.|||||++.... .+++||||+||++.||+||..||.. ......+-.+..... .+ .....+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~-~P-~ip~~l 248 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS-LP-EIPDSL 248 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC-CC-CCCccc
Confidence 12234578999999999997443 3499999999999999999999976 333333344443331 11 223468
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
|.++++||.+||..||++||||.++|+|||.+....
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999999999999999999999999999976543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=375.79 Aligned_cols=269 Identities=32% Similarity=0.550 Sum_probs=228.6
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe---
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--- 139 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--- 139 (420)
-.+...|...+.||.|+||.|+.|.++.+|+.||+|.+.. .+......++..+|+++|+.++ |+||+.+.+++..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSR 95 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccccc
Confidence 3456678778999999999999999999999999999862 3445667789999999999999 9999999999865
Q ss_pred --CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 140 --RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 140 --~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
-+.+|+|+|+| +.+|...++....+++..+..++.||+.||+|+|+.||+||||||+|++++ .+..+||+|||+
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n---~~c~lKI~DFGL 171 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN---ADCDLKICDFGL 171 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec---cCCCEEeccccc
Confidence 45799999999 568888887777799999999999999999999999999999999999995 556699999999
Q ss_pred ccccCC---CCceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------
Q 014704 218 SVFFKP---GDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH------- 285 (420)
Q Consensus 218 ~~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~------- 285 (420)
|+.... ...++..+.|.+|.|||++. ..|+.+.||||+|||+.||++|++.|.|.+.-..+..|..-.
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 998753 44557789999999999874 469999999999999999999999999887665555543211
Q ss_pred ----------------CCCCC----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCc
Q 014704 286 ----------------IDFSS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKP 337 (420)
Q Consensus 286 ----------------~~~~~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~ 337 (420)
...+. ..+++.++.+.+|+.+||..||.+|+|++|+|.|||+..-....+++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 11111 12578899999999999999999999999999999998766655544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=376.69 Aligned_cols=260 Identities=30% Similarity=0.482 Sum_probs=229.2
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.+.|.+...||.|..++||+|+...++..||||++..++.. .+++.+.+|+..|+.++ ||||++++..|..+..+|+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLID-HPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcC-CCCcceEEEEEEecceeEE
Confidence 46799999999999999999999999999999999876653 34789999999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
||.||.+|++.+.+... ..++|..++.|+++++.||.|||.+|.||||||+.|||+ +.++.|||+|||.+..+..
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeecc
Confidence 99999999999999765 349999999999999999999999999999999999999 6788899999998765532
Q ss_pred -CC----ceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------CC
Q 014704 224 -GD----VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID------FS 289 (420)
Q Consensus 224 -~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~------~~ 289 (420)
+. .+..++||++|||||++.+ .|+.|+||||||++..||.+|..||......+++..-+++.++ ++
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 22 1256789999999999643 5999999999999999999999999998888887777777664 23
Q ss_pred CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 290 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.+.....+..++.+|..||.+||++|||+.++|+|+||+...
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 333456778899999999999999999999999999998654
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-52 Score=385.84 Aligned_cols=261 Identities=36% Similarity=0.626 Sum_probs=241.1
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
..+.+-|.+.+.||+|.|++|-+|++.-+|..||||+|.+.++ +.-....+..|++.|+.+. |||||++|++......
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTK 91 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhc-CcCeeeeeehhcccce
Confidence 4567789999999999999999999999999999999998876 3344567899999999999 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+|+|+|+-+||+|++++.+.. .+.|..+.+++.||+.|+.|||+..+|||||||+||.+. ..-+.|||.|||++..+
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccC
Confidence 999999999999999998764 599999999999999999999999999999999999886 45678999999999999
Q ss_pred CCCCceecccCCcccccchhhccc-C-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLRRN-Y-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
.++....+.||+..|.|||++.+. | .+++||||||||||.|++|++||...++.+.+..|+.+.+..+. .+|.+
T Consensus 170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~e 245 (864)
T KOG4717|consen 170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSKE 245 (864)
T ss_pred CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhHH
Confidence 999999999999999999998764 5 57899999999999999999999999999999999999988876 68999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
+++||..||..||.+|.|.++|..|+|++...
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 99999999999999999999999999998543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=390.11 Aligned_cols=253 Identities=33% Similarity=0.641 Sum_probs=227.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|+++.+++.||+|++...........+.+.+|+.+++.++ ||||+++++++.+++.+|+|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEEE
Confidence 67999999999999999999999999999999997654444455677899999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
|||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCCc-
Confidence 9999999999999988899999999999999999999999999999999999999 566789999999998764332
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.......+.+..+...++. .++..+++||+
T Consensus 173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~ 247 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLVK 247 (329)
T ss_pred -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHHHHHH
Confidence 34579999999999864 4889999999999999999999999998888888888887665543 47889999999
Q ss_pred HhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 306 KMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
+||+.||++|++ +.++++||||+.
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 999999999997 799999999974
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=383.80 Aligned_cols=253 Identities=30% Similarity=0.574 Sum_probs=226.0
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.++.+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEE
Confidence 36899999999999999999999999999999987544333345567899999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
|||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--
Confidence 9999999999999988899999999999999999999999999999999999999 45677999999998866432
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+..+...++. .++..+++||+
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~ 230 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIK 230 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHH
Confidence 234579999999999864 4889999999999999999999999999888888888887766553 46889999999
Q ss_pred HhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 306 KMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
+||+.||.+|++ +.++++||||..
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 999999999995 999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=387.31 Aligned_cols=249 Identities=33% Similarity=0.598 Sum_probs=222.0
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++++. ||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999997654444455677889999999998 99999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-CCCceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~ 231 (420)
++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.... ........+
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCccccee
Confidence 9999999888899999999999999999999999999999999999999 456779999999987532 223334567
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+..+...++. .+++++.+||++||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~ 232 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccC
Confidence 9999999999864 5899999999999999999999999998888888888877665543 6799999999999999
Q ss_pred CcCCCC-----CHHHHhcCCcccc
Q 014704 311 DPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 311 dp~~R~-----t~~e~l~h~~~~~ 329 (420)
||++|| ++.++++||||..
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999 8999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=363.61 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=219.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE--eCCeEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE--DRHSVN 144 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~--~~~~~~ 144 (420)
+.|.....|++|+||.||+|+++.|++.||+|.++...-.. ..--.-.+||.+|.+++ |||||.+-++.. +-+.+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcC-CCCeeeeEEEEeccccceee
Confidence 56899999999999999999999999999999997654211 11123579999999999 999999999875 446799
Q ss_pred EEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 145 LIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
||||||+. +|...+...+ ++...+++.++.|++.|++|||.+.|+||||||+|+|+ .+.+.+||+|||+|+.+..
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhcC
Confidence 99999975 8888887765 79999999999999999999999999999999999999 5677899999999998764
Q ss_pred C-CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC------
Q 014704 224 G-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP------ 294 (420)
Q Consensus 224 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~------ 294 (420)
. ..++..+-|.+|+|||.+.+ .|+.+.|+||+|||+.||+++++.|.+..+...+..|.+--.......|+
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 4 45677789999999999864 59999999999999999999999999999988888876532222222221
Q ss_pred ----------------------CCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 295 ----------------------NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 295 ----------------------~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.++....+|+..+|..||.+|.||.|+|+|.||...
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 145888999999999999999999999999999753
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=389.55 Aligned_cols=258 Identities=28% Similarity=0.503 Sum_probs=222.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++..++ ||||+++++.+.+...+|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999997654434455677899999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
||||+||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccccccc
Confidence 9999999999999988899999999999999999999999999999999999999 456789999999987543210
Q ss_pred -----------------------------------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCC
Q 014704 226 -----------------------------------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPF 269 (420)
Q Consensus 226 -----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf 269 (420)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0123579999999999864 5899999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcC---CCCCHHHHhcCCcccc
Q 014704 270 WGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPK---ERLSAAEVLNHPWMRV 329 (420)
Q Consensus 270 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~---~R~t~~e~l~h~~~~~ 329 (420)
.+.+....+..+.........+....+++++++||.+|+. +|. .||+++|+++||||+.
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 9988888888887754333333334678999999999875 444 4589999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=389.86 Aligned_cols=258 Identities=29% Similarity=0.556 Sum_probs=224.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|++..+|+.||||++.............+.+|+.++..++ ||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEE
Confidence 36999999999999999999999999999999997654434455677889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
||||.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecccccc
Confidence 9999999999999888889999999999999999999999999999999999999 567789999999987543211
Q ss_pred --------------------------------------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCC
Q 014704 226 --------------------------------------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGV 266 (420)
Q Consensus 226 --------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~ 266 (420)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0112469999999999864 5899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCC---HHHHhcCCcccc
Q 014704 267 PPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS---AAEVLNHPWMRV 329 (420)
Q Consensus 267 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~ 329 (420)
.||.+.+.......+......+..+....+++++++||++||. +|.+|++ +.++++||||+.
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9999988888888877655444443334679999999999996 9999998 999999999974
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=384.49 Aligned_cols=257 Identities=31% Similarity=0.505 Sum_probs=225.8
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..++ ||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEE
Confidence 36999999999999999999999999999999997654433445677899999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
|||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--c
Confidence 9999999999999888889999999999999999999999999999999999999 5567899999999986543 2
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC----CCCChHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW----PNISSSAK 301 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~~~~~~ 301 (420)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+..+.+ ..++.++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 345679999999999864 5899999999999999999999999998888877777654433322222 25789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+||.+||..+|++||++.++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=375.67 Aligned_cols=258 Identities=28% Similarity=0.484 Sum_probs=216.7
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
.|.+.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.+. |+||+++++++.+.+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEE
Confidence 3788899999999999999999999999999987654433344456789999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence 999999998877643 358999999999999999999999999999999999999 456779999999998765555
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.........+..............++.++.+||
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 5556689999999999864 689999999999999999999999987654332222222111112222346899999999
Q ss_pred HHhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 305 KKMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 305 ~~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
++||+.||++||+ ++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 9999999999997 999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=383.41 Aligned_cols=254 Identities=32% Similarity=0.594 Sum_probs=226.0
Q ss_pred ccceeecceecccCCeEEEEEEEcCCC-ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTK-QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
.++|.+.+.||+|+||.||+|.++.++ ..||+|.+.+.........+.+.+|+.+++.++ ||||+++++++.+.+.+|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEE
Confidence 357999999999999999999977654 689999987654444455677899999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCCC
Confidence 999999999999999988899999999999999999999999999999999999999 56778999999999875432
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.......+..+...++. .+++.++++
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l 258 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHL 258 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHH
Confidence 245679999999999864 5899999999999999999999999999888888888887765543 578999999
Q ss_pred HHHhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 304 VKKMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 304 i~~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
|++||+.||++|+ |++++++||||..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999996 8999999999974
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=379.44 Aligned_cols=247 Identities=30% Similarity=0.590 Sum_probs=219.7
Q ss_pred ecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCCC
Q 014704 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (420)
Q Consensus 75 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~~ 154 (420)
||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++ ||||+++++++.+.+.+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999999999999999997654444555677889999999998 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCceecccCC
Q 014704 155 LFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLVGS 233 (420)
Q Consensus 155 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~gt 233 (420)
|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......+||
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCC
Confidence 99999888889999999999999999999999999999999999999 5567899999999875432 2233456799
Q ss_pred cccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCc
Q 014704 234 AYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312 (420)
Q Consensus 234 ~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 312 (420)
+.|+|||++.+ .++.++||||+||++|+|++|..||.+....+.+..+......++. .+++++++||.+||..||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHcCCCH
Confidence 99999999865 5899999999999999999999999998888888888877665543 678999999999999999
Q ss_pred CCCC---CHHHHhcCCcccc
Q 014704 313 KERL---SAAEVLNHPWMRV 329 (420)
Q Consensus 313 ~~R~---t~~e~l~h~~~~~ 329 (420)
++|| ++.++|+||||..
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCC
Confidence 9997 5899999999974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-50 Score=363.02 Aligned_cols=260 Identities=32% Similarity=0.577 Sum_probs=235.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
+.|++.+.||.|.-|+||++..+.++..+|+|++.+..+.....+.++..|-+||+.++ ||.++.+|..|+.++..|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccceeEEE
Confidence 57889999999999999999999999999999999888777777888999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-
Q 014704 147 MDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP- 223 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~- 223 (420)
||||.||+|..+++++ +.+++..++.++..++-||+|||-.|||+|||||+|||+ .++++|.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence 9999999998877765 459999999999999999999999999999999999999 6788999999998643210
Q ss_pred --------------------------------C-C-----------------------ceecccCCcccccchhhccc-C
Q 014704 224 --------------------------------G-D-----------------------VFKDLVGSAYYVAPEVLRRN-Y 246 (420)
Q Consensus 224 --------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~-~ 246 (420)
. . ...+++||-.|.|||++.+. .
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 01235799999999999864 8
Q ss_pred CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCC----HHHHh
Q 014704 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS----AAEVL 322 (420)
Q Consensus 247 ~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l 322 (420)
+.++|.|+|||++|||+.|..||.+.+..+.+.+|......|+..+ .++..++|||+++|.+||.+|.. |.||-
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 9999999999999999999999999999999999999999998864 78999999999999999999998 99999
Q ss_pred cCCcccccCC
Q 014704 323 NHPWMRVDGD 332 (420)
Q Consensus 323 ~h~~~~~~~~ 332 (420)
+||||+..+.
T Consensus 391 ~HpFF~gVnW 400 (459)
T KOG0610|consen 391 RHPFFEGVNW 400 (459)
T ss_pred cCccccCCCh
Confidence 9999986543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=380.57 Aligned_cols=256 Identities=24% Similarity=0.411 Sum_probs=208.6
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+++++.++ |+||+++++++.+.+.+|+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEE
Confidence 467889999999999999999999999999999986432 2344567899999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
||||+++++|.+. ...++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceeccccc
Confidence 9999999998642 346788889999999999999999999999999999999 55678999999999876432
Q ss_pred CceecccCCcccccchhhcc------cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 225 DVFKDLVGSAYYVAPEVLRR------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~------~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
.......||..|+|||++.. ..+.++|||||||++|+|++|+.||...........+..............++.
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 22345679999999998742 235689999999999999999999974332222211111111112222346789
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
++++||.+||+.||++|||+.|+|+||||....
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 999999999999999999999999999997653
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-50 Score=387.61 Aligned_cols=258 Identities=30% Similarity=0.527 Sum_probs=220.7
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
.|.+.+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence 5889999999999999999999999999999997655545556778999999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC--
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-- 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~-- 225 (420)
|||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 456789999999875321000
Q ss_pred ----------------------------------------------ceecccCCcccccchhhcc-cCCCccchhhhHHH
Q 014704 226 ----------------------------------------------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVI 258 (420)
Q Consensus 226 ----------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvi 258 (420)
.....+||+.|+|||++.+ .++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0123579999999999864 58999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcc--cCcCCCCCHHHHhcCCcccc
Q 014704 259 LYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH--ADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 259 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~--~dp~~R~t~~e~l~h~~~~~ 329 (420)
+|+|++|..||...+.......+.........+.+..+++++++||.+||. .++..|+++.++++||||..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 999999999999888776666666544334444445689999999999664 45555999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=389.07 Aligned_cols=258 Identities=28% Similarity=0.532 Sum_probs=220.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.++.+++.||+|++.+.........+.+.+|+++++.++ ||||+++++++.+...+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEEE
Confidence 36899999999999999999999999999999987654434455678899999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
||||+||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeecccccccccccc
Confidence 9999999999999888889999999999999999999999999999999999999 456789999999986321100
Q ss_pred -----------------------------------------------ceecccCCcccccchhhcc-cCCCccchhhhHH
Q 014704 226 -----------------------------------------------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGV 257 (420)
Q Consensus 226 -----------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGv 257 (420)
.....+||+.|+|||++.+ .++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0012469999999999864 5899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCC---CCHHHHhcCCcccc
Q 014704 258 ILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER---LSAAEVLNHPWMRV 329 (420)
Q Consensus 258 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~t~~e~l~h~~~~~ 329 (420)
++|+|++|..||.+......+..+......+..+....++.++++||.+||. +|.+| +|+.+++.||||+.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9999999999999888877777777644333333334678999999999997 67765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-50 Score=380.22 Aligned_cols=249 Identities=31% Similarity=0.580 Sum_probs=220.8
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||++.++.+|+.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999997655444556678899999999998 99999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 231 (420)
++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......+
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccccccc
Confidence 9999999888889999999999999999999999999999999999999 4567799999999875432 22334567
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++. .++.++.+||++||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~ 232 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIK 232 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC----CCCHHHHHHHHHHcCC
Confidence 9999999999864 5899999999999999999999999988888888877776665543 6789999999999999
Q ss_pred CcCCCC-----CHHHHhcCCcccc
Q 014704 311 DPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 311 dp~~R~-----t~~e~l~h~~~~~ 329 (420)
||++|+ ++.++++||||..
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999997 8999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-50 Score=378.57 Aligned_cols=250 Identities=29% Similarity=0.556 Sum_probs=221.0
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|.++.+++.||+|++.+.........+.+..|+.++..+..||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999987654434455677888999998876699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-CCCceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~ 231 (420)
++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.... .........
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 9999999888899999999999999999999999999999999999999 556789999999987542 223334567
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+...++..+..+...++. .++.++.+||++||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccc
Confidence 9999999999864 5899999999999999999999999999988888888877665443 5789999999999999
Q ss_pred CcCCCCCH------HHHhcCCcccc
Q 014704 311 DPKERLSA------AEVLNHPWMRV 329 (420)
Q Consensus 311 dp~~R~t~------~e~l~h~~~~~ 329 (420)
||++|+++ +++++||||..
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 99999998 99999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=387.65 Aligned_cols=257 Identities=32% Similarity=0.581 Sum_probs=222.8
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
.|.+.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.+. ||||+++++.+.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEEE
Confidence 5889999999999999999999999999999997654434455678899999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC---
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG--- 224 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~--- 224 (420)
|||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccccc
Confidence 999999999999888889999999999999999999999999999999999999 56778999999997532100
Q ss_pred ---------------------------------------------CceecccCCcccccchhhcc-cCCCccchhhhHHH
Q 014704 225 ---------------------------------------------DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVI 258 (420)
Q Consensus 225 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvi 258 (420)
......+||+.|+|||++.+ .++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 00123479999999999864 58999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCC---HHHHhcCCcccc
Q 014704 259 LYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS---AAEVLNHPWMRV 329 (420)
Q Consensus 259 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~ 329 (420)
+|+|++|+.||.+.+.......+.........+....+++++.++|.+|+ .+|++|++ +.++++||||+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 99999999999988877777777765544444445678999999999987 59999997 999999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=378.62 Aligned_cols=249 Identities=33% Similarity=0.600 Sum_probs=220.8
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||++.++.+|+.||+|++.............+.+|+.+++.++ ||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence 47999999999999999999999999997654444455677889999999998 99999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 231 (420)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 4567899999999875322 22334567
Q ss_pred CCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 232 GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 232 gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
||+.|+|||++. +.++.++|||||||++|+|++|..||...+.......+......++. .+++++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~ 232 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccC
Confidence 999999999986 45899999999999999999999999988888888888776665543 6789999999999999
Q ss_pred CcCCCC-----CHHHHhcCCcccc
Q 014704 311 DPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 311 dp~~R~-----t~~e~l~h~~~~~ 329 (420)
||++|+ ++.++++|+||..
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCC
Confidence 999998 9999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=387.92 Aligned_cols=258 Identities=30% Similarity=0.549 Sum_probs=222.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.+. ||||+++++.+.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEE
Confidence 36999999999999999999999999999999987544333345577889999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC--
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-- 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-- 224 (420)
||||+||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccccccc
Confidence 9999999999999888889999999999999999999999999999999999999 56678999999997532100
Q ss_pred ------------------------------------------CceecccCCcccccchhhcc-cCCCccchhhhHHHHHH
Q 014704 225 ------------------------------------------DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYI 261 (420)
Q Consensus 225 ------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ 261 (420)
......+||+.|+|||++.+ .++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 00113479999999999864 58999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCC---CHHHHhcCCcccc
Q 014704 262 LLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAEVLNHPWMRV 329 (420)
Q Consensus 262 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~h~~~~~ 329 (420)
|++|+.||.+.........+...........+..+++++.++|.+|+ .+|.+|+ |+.++++||||+.
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999999988877777776665444444445578999999999987 5999999 9999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-52 Score=378.63 Aligned_cols=254 Identities=30% Similarity=0.491 Sum_probs=227.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
..|...+.||+|+||.||+|.+..+++.||+|++.... ...+++.+..|+.+|..++ ++||.++|+.|..+..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHHH
Confidence 45778899999999999999999999999999997654 3456788999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
||||.||++.+.+.....+.|..+.-++++++.||.|||.++.+|||||+.|||+. ..+.+||+|||.+........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechhh
Confidence 99999999999998877789999999999999999999999999999999999995 447799999999998866543
Q ss_pred e-ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 227 F-KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 227 ~-~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
. .+++|||.|||||++.+ .|+.++||||||++.+||++|.+|+....+..++-.|-+..++.-.. .+|+.+++||
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~---~~S~~~kEFV 243 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG---DFSPPFKEFV 243 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc---ccCHHHHHHH
Confidence 3 67899999999999976 69999999999999999999999998888766666665554433332 5788999999
Q ss_pred HHhcccCcCCCCCHHHHhcCCcccc
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
..||.+||+.||||.++|+|+|++.
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHh
Confidence 9999999999999999999999986
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=383.69 Aligned_cols=259 Identities=31% Similarity=0.520 Sum_probs=225.7
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+++.+|+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEEE
Confidence 468999999999999999999999999999999997544333444566889999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 9999999999988754 468999999999999999999999999999999999999 567789999999998764332
Q ss_pred --ceecccCCcccccchhhcc-----cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 226 --VFKDLVGSAYYVAPEVLRR-----NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 226 --~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
.....+||+.|+|||++.. .++.++|||||||++|+|++|..||.+.+....+..+......+..+....+|.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK 276 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence 2234679999999998853 378999999999999999999999999988888888887654444444456899
Q ss_pred HHHHHHHHhcccCcCC--CCCHHHHhcCCcccc
Q 014704 299 SAKDIVKKMLHADPKE--RLSAAEVLNHPWMRV 329 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~--R~t~~e~l~h~~~~~ 329 (420)
++++||++||+.+|.+ |+|+.++++||||+.
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 9999999999999988 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=376.37 Aligned_cols=255 Identities=28% Similarity=0.543 Sum_probs=224.9
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|+||.||+|.++.+++.||+|++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 48899999999999999999999999999999976544344556778899999999985667899999999999999999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-CCCc
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDV 226 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~~~~ 226 (420)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence 999999999999888889999999999999999999999999999999999999 456789999999987532 2233
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+....+..+......++. .++.++.++|+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~ 233 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICK 233 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence 345679999999999865 5899999999999999999999999999988888888877665543 57899999999
Q ss_pred HhcccCcCCCCCH-----HHHhcCCcccc
Q 014704 306 KMLHADPKERLSA-----AEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~t~-----~e~l~h~~~~~ 329 (420)
+||..||.+|+++ .++++||||..
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999986 89999999974
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=383.79 Aligned_cols=258 Identities=34% Similarity=0.631 Sum_probs=226.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.++..+. ||||+++++++.+++.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEE
Confidence 36999999999999999999999999999999997654434455678899999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
|||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCc
Confidence 9999999999999888889999999999999999999999999999999999999 566789999999988654332
Q ss_pred -----------------------------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Q 014704 226 -----------------------------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ 275 (420)
Q Consensus 226 -----------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~ 275 (420)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 2234579999999999865 5899999999999999999999999998888
Q ss_pred HHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCC-HHHHhcCCcccc
Q 014704 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS-AAEVLNHPWMRV 329 (420)
Q Consensus 276 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~e~l~h~~~~~ 329 (420)
.....+......+..+....+++++.+||.+||. ||.+|++ +.++++||||+.
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 8888877733333333334579999999999997 9999999 999999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=369.88 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=212.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++ ||||+++++++.+.+..|+|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence 469999999999999999999999999999999865432 223356789999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 147 MDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
|||+.| +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence 999975 8988887654 47899999999999999999999999999999999999 45677999999998765322
Q ss_pred CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------------
Q 014704 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID--------------- 287 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------------- 287 (420)
.......|++.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..+.+..+.+....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 22344578999999998853 4899999999999999999999999888776665554332111
Q ss_pred ----CCC-------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 288 ----FSS-------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 288 ----~~~-------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
++. ...+.++.++++||++||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 000 0123568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=375.57 Aligned_cols=250 Identities=27% Similarity=0.536 Sum_probs=221.2
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|.++.+++.||+|++.+...........+..|.+++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999997654444455677888999998876699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 231 (420)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence 9999999888889999999999999999999999999999999999999 5567899999999875432 22334567
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+......++. .++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcc
Confidence 9999999999864 5899999999999999999999999999999999888887655443 4789999999999999
Q ss_pred CcCCCC-------CHHHHhcCCcccc
Q 014704 311 DPKERL-------SAAEVLNHPWMRV 329 (420)
Q Consensus 311 dp~~R~-------t~~e~l~h~~~~~ 329 (420)
||++|+ ++.++++||||..
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 999999 9999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=381.78 Aligned_cols=261 Identities=30% Similarity=0.505 Sum_probs=224.1
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|++.+.||+|+||.||++.++.+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.++..+|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEE
Confidence 4578999999999999999999999999999999987544434445567889999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecccC
Confidence 99999999999998864 468999999999999999999999999999999999999 56678999999999876433
Q ss_pred Cc--eecccCCcccccchhhcc-----cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 225 DV--FKDLVGSAYYVAPEVLRR-----NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 225 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.. ....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+....+..+......+..+....++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 22 235679999999999853 27889999999999999999999999998888888887755444333334679
Q ss_pred hHHHHHHHHhcccCcCC--CCCHHHHhcCCccccc
Q 014704 298 SSAKDIVKKMLHADPKE--RLSAAEVLNHPWMRVD 330 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~--R~t~~e~l~h~~~~~~ 330 (420)
..++++|.+||..++.+ |+|+.++++||||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999999866554 8999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=374.31 Aligned_cols=255 Identities=28% Similarity=0.524 Sum_probs=225.5
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+..||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 48889999999999999999999999999999976544344455667888999988877999999999999999999999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCc
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDV 226 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~ 226 (420)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence 999999999999888889999999999999999999999999999999999999 5667899999999875432 223
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+......++. .++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~ 233 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICK 233 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHHHHHH
Confidence 345679999999999864 5899999999999999999999999999988888888887766553 57899999999
Q ss_pred HhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 306 KMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
+||+.||++|++ ..++++||||+.
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999999998 489999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=377.04 Aligned_cols=249 Identities=32% Similarity=0.595 Sum_probs=220.4
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||++.++.+|+.||+|++.+...........+.+|+++++.+. ||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999997654444455677889999999998 99999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-CCCceecc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDL 230 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~ 230 (420)
++|..++...+.+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||++.... ........
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccc
Confidence 9999999888889999999999999999999997 799999999999999 556789999999987543 22333456
Q ss_pred cCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcc
Q 014704 231 VGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (420)
Q Consensus 231 ~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 309 (420)
.||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++. .+++++.+||++||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~ 232 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhh
Confidence 79999999999864 5899999999999999999999999998888888888777665543 578999999999999
Q ss_pred cCcCCCC-----CHHHHhcCCcccc
Q 014704 310 ADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 310 ~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
.||++|+ ++.++++||||..
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 9999997 9999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=375.15 Aligned_cols=250 Identities=29% Similarity=0.566 Sum_probs=214.9
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++..+.+||||+++++++.+.+.+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999998654444455677889999999996699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc-CCCCceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~-~~~~~~~~~~ 231 (420)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++... .........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence 9999999888899999999999999999999999999999999999999 45678999999998753 2333445568
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCC---------CHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE---------TEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
||+.|+|||++.+ .++.++|+|||||++|+|++|+.||... ......+.+......++ ..++.++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~ 233 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAS 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHH
Confidence 9999999999864 5899999999999999999999999531 12334455555555443 35789999
Q ss_pred HHHHHhcccCcCCCCC------HHHHhcCCcccc
Q 014704 302 DIVKKMLHADPKERLS------AAEVLNHPWMRV 329 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t------~~e~l~h~~~~~ 329 (420)
++|++||+.||.+|+| +.++++||||..
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999999997 789999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=371.49 Aligned_cols=248 Identities=27% Similarity=0.434 Sum_probs=213.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCce-EEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-eEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQ-FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-SVN 144 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~-~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-~~~ 144 (420)
....+.+.||+|+||+||+|.++. .. ||+|++......... .+.+.+|+.+|.+++ |||||++++++.+.. .++
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceE
Confidence 345566779999999999999975 44 999999765543333 789999999999999 999999999998887 799
Q ss_pred EEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-CeeccCCCCcEEEecCCCCC-CeeEeecccccc
Q 014704 145 LIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMG-VMHRDLKPENFLFSSSAEDS-PLKATDFGLSVF 220 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~Nill~~~~~~~-~~kl~Dfg~~~~ 220 (420)
|||||+++|+|.+++.. ...++...+..++.||+.|+.|||+++ ||||||||+|||+ +.+. ++||+|||+++.
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCcccee
Confidence 99999999999999988 578999999999999999999999999 9999999999999 4554 899999999987
Q ss_pred cCCC-CceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 221 FKPG-DVFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 221 ~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
.... ...+...||+.|||||++.+ .|+.++|||||||++|||+||..||.+....++...+..+......+ ...
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~ 271 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KEC 271 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccC
Confidence 6654 33444789999999999984 39999999999999999999999999988877776666544433322 237
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
++.+..|+.+||..||.+||++.+++.
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 899999999999999999999999863
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=355.55 Aligned_cols=259 Identities=29% Similarity=0.476 Sum_probs=219.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCC-ccEEEEEEEeCC----
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN-IVELKGAYEDRH---- 141 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn-iv~~~~~~~~~~---- 141 (420)
..|...++||+|+||+||+|+.+.+|+.||+|.+...... +..-....+|+.+|+.|+ |+| |+.+++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence 4577888999999999999999999999999999754321 122345689999999999 999 999999998877
Q ss_pred --eEEEEEecCCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeec
Q 014704 142 --SVNLIMDLCAGGELFDRIIAKG----HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (420)
Q Consensus 142 --~~~iv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Df 215 (420)
.+++|+||++ .+|..++.... .++...++.+++||+.||+|||+++|+||||||+|||+ +..+.+||+||
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDF 164 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADF 164 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeecc
Confidence 8999999996 58999887755 47888999999999999999999999999999999999 45788999999
Q ss_pred ccccccC-CCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 014704 216 GLSVFFK-PGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 216 g~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 292 (420)
|+|+... +...++..++|.+|+|||++-+ .|+...||||+|||++||+++++.|.+.++.+.+..|.+-.-......
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9999776 4555777889999999999854 599999999999999999999999999998887777755322222222
Q ss_pred C--------------------------CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 293 W--------------------------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 293 ~--------------------------~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
| +..+++..+++.+||+.+|.+|.|+..+|.||||....
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 2 22345889999999999999999999999999997543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=377.41 Aligned_cols=258 Identities=30% Similarity=0.493 Sum_probs=224.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.++.+|+.||+|++.............+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEEE
Confidence 36899999999999999999999999999999997654434455677899999999988 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence 9999999999999876 679999999999999999999999999999999999999 566789999999998765433
Q ss_pred c--eecccCCcccccchhhc-------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 226 V--FKDLVGSAYYVAPEVLR-------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 226 ~--~~~~~gt~~y~aPE~~~-------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
. .....||+.|+|||++. ..++.++|||||||++|+|++|..||...+....+..+.........+..+.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 2 22347999999999875 24788999999999999999999999988888888877765433333333468
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.++.+||++||. +|++|||+.++++||||..
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999999998 9999999999999999974
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=367.45 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=212.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++...+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEE
Confidence 469999999999999999999999999999999875432 2344567889999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
|||+.++.+..+......+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccc
Confidence 9999987776555445679999999999999999999999999999999999999 456789999999998764322
Q ss_pred -ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------
Q 014704 226 -VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI----------------- 286 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~----------------- 286 (420)
......||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+.......+.....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2234578999999999864 589999999999999999999999988765544433322110
Q ss_pred --CCCC---------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 287 --DFSS---------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 287 --~~~~---------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.++. ..+..+|.++.+||++||+.||++|||++++|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 0112368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=380.84 Aligned_cols=258 Identities=30% Similarity=0.547 Sum_probs=222.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.++.+++.||+|++.............+.+|+.++..++ ||||+++++.+.+.+.+|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence 36889999999999999999999999999999997544434455678899999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
||||+||+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccccccc
Confidence 9999999999999888899999999999999999999999999999999999999 556789999999986542110
Q ss_pred -----------------------------------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCC
Q 014704 226 -----------------------------------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPF 269 (420)
Q Consensus 226 -----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf 269 (420)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0113479999999999864 5899999999999999999999999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCC---CHHHHhcCCcccc
Q 014704 270 WGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAEVLNHPWMRV 329 (420)
Q Consensus 270 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~h~~~~~ 329 (420)
.+.+....+..+.........+....+++++++||.+|+. ||.+|+ ++.++++||||+.
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 9988888888877644333322233578999999999874 999998 5899999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=371.80 Aligned_cols=250 Identities=28% Similarity=0.527 Sum_probs=217.5
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|.++.+|+.||+|++.+...........+..|..++..+.+||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999999999999999997644333345567788888888765599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 231 (420)
++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..... .......+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence 9999999888889999999999999999999999999999999999999 4567899999999875322 22334567
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.....+.+......++. .++.++++||++||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~ 233 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEKLFER 233 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHccC
Confidence 9999999999864 5899999999999999999999999998888888888766554432 4789999999999999
Q ss_pred CcCCCCCH-HHHhcCCcccc
Q 014704 311 DPKERLSA-AEVLNHPWMRV 329 (420)
Q Consensus 311 dp~~R~t~-~e~l~h~~~~~ 329 (420)
||++|+++ .++++||||..
T Consensus 234 dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred CHHHcCCChHHHHcCCCcCC
Confidence 99999998 58889999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=372.16 Aligned_cols=250 Identities=30% Similarity=0.573 Sum_probs=220.6
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++..+..||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999997654444455677889999999886699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 231 (420)
++|..++.+.+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .......+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence 9999999888889999999999999999999999999999999999999 5567899999999875322 22234457
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+......++. .++.++.+||++||..
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHccC
Confidence 9999999999864 5899999999999999999999999998888888888776655443 5789999999999999
Q ss_pred CcCCCCCH-----HHHhcCCcccc
Q 014704 311 DPKERLSA-----AEVLNHPWMRV 329 (420)
Q Consensus 311 dp~~R~t~-----~e~l~h~~~~~ 329 (420)
||++|||+ .++++||||+.
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99999999 99999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-49 Score=370.62 Aligned_cols=250 Identities=32% Similarity=0.573 Sum_probs=216.8
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+..||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999997654333445566777888887765699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-Cceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 231 (420)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ......+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 45678999999999764322 2334567
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++ ..++.++.+||.+||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 9999999999864 589999999999999999999999999988888888876554443 35789999999999999
Q ss_pred CcCCCCCH-HHHhcCCcccc
Q 014704 311 DPKERLSA-AEVLNHPWMRV 329 (420)
Q Consensus 311 dp~~R~t~-~e~l~h~~~~~ 329 (420)
||++||++ .++++||||..
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred CHHHcCCChHHHHcCcccCC
Confidence 99999986 58889999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=371.30 Aligned_cols=252 Identities=31% Similarity=0.548 Sum_probs=218.6
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHH---hccCCCCccEEEEEEEeCCeEEE
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH---HLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~---~l~~hpniv~~~~~~~~~~~~~i 145 (420)
|++.+.||+|+||.||+|.++.+++.||||++.+.........+.+.+|++++. .++ ||||+++++++.+.+.+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEEcCCEEEE
Confidence 678899999999999999999999999999997654334445567778877664 455 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-C
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-G 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~ 224 (420)
||||++|++|..++. .+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .
T Consensus 80 v~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 999999999988775 4579999999999999999999999999999999999999 5567899999999875432 2
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+..+...++. .++.++.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence 23345679999999999864 5899999999999999999999999999888888888877665443 578999999
Q ss_pred HHHhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 304 VKKMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 304 i~~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
|.+||+.||.+|| ++.++++||||+.
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999999999 7999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=370.56 Aligned_cols=250 Identities=29% Similarity=0.566 Sum_probs=214.1
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++.++.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999998654444556677889999998886699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-CCCceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~ 231 (420)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999 556789999999987532 233334567
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCC---------CCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWG---------ETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .........+......++ ..++..+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~ 233 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAA 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence 9999999999864 589999999999999999999999952 122334455555555444 35789999
Q ss_pred HHHHHhcccCcCCCCC------HHHHhcCCcccc
Q 014704 302 DIVKKMLHADPKERLS------AAEVLNHPWMRV 329 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t------~~e~l~h~~~~~ 329 (420)
+||++||+.||++||| +.++++||||+.
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999999998 589999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=376.25 Aligned_cols=261 Identities=30% Similarity=0.495 Sum_probs=223.8
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+...+|
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEE
Confidence 3478999999999999999999999999999999987544334444566889999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcC
Confidence 99999999999988865 468999999999999999999999999999999999999 45678999999999876433
Q ss_pred C--ceecccCCcccccchhhcc-----cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 225 D--VFKDLVGSAYYVAPEVLRR-----NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 225 ~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
. .....+||+.|+|||++.. .++.++|||||||++|+|++|..||.+.+....+..+......+..+....++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 2 2235679999999999853 27899999999999999999999999999888888888765444444445789
Q ss_pred hHHHHHHHHhcccCcCC--CCCHHHHhcCCccccc
Q 014704 298 SSAKDIVKKMLHADPKE--RLSAAEVLNHPWMRVD 330 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~--R~t~~e~l~h~~~~~~ 330 (420)
..++++|.+||..++.+ |+++.++++|+||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999999844443 7899999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=365.94 Aligned_cols=257 Identities=26% Similarity=0.434 Sum_probs=207.7
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|.++.+++.||+|++..... ......+.+|+.+++.++ ||||+++++++.+....|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEE
Confidence 3679999999999999999999999999999999865432 222346778999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-
Q 014704 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP- 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~- 223 (420)
||||+. ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVP 156 (303)
T ss_pred EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCC
Confidence 999996 5777777654 568999999999999999999999999999999999999 4567799999999875432
Q ss_pred CCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC-------------
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHID------------- 287 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~~------------- 287 (420)
........||+.|+|||++.+ .++.++||||+||++|+|++|..||.+... ...+..+......
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 222344578999999998853 478899999999999999999999987543 2333322211000
Q ss_pred -CCCCC------------C--CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 288 -FSSDP------------W--PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 288 -~~~~~------------~--~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.... | ...+.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 00000 0 123568899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=368.81 Aligned_cols=255 Identities=27% Similarity=0.531 Sum_probs=223.9
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 37788999999999999999999999999999876544344456678889999998886788999999999999999999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-Cc
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DV 226 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-~~ 226 (420)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCcc
Confidence 999999999999888889999999999999999999999999999999999999 45678999999998754322 22
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
.....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.........+......++. .++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHH
Confidence 344579999999999864 5899999999999999999999999999888888888877665543 57899999999
Q ss_pred HhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 306 KMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
+||+.||.+|++ ..++++||||+.
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 999999999997 579999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=367.19 Aligned_cols=250 Identities=29% Similarity=0.512 Sum_probs=216.5
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|.+..+++.||+|++................|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997654323344566778888888764599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 231 (420)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence 9999999888889999999999999999999999999999999999999 4567799999999875422 22334567
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+....++.+......++ ..++.++++||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence 9999999999864 589999999999999999999999999888888887776554433 24788999999999999
Q ss_pred CcCCCCCHH-HHhcCCcccc
Q 014704 311 DPKERLSAA-EVLNHPWMRV 329 (420)
Q Consensus 311 dp~~R~t~~-e~l~h~~~~~ 329 (420)
||++||++. ++++||||+.
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred CHhhcCCChHHHHcCcccCC
Confidence 999999996 8999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=372.40 Aligned_cols=255 Identities=31% Similarity=0.573 Sum_probs=215.1
Q ss_pred ceeecceecccCCeEEEEEEEc---CCCceEEEEEecCCcCC-ChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
+|.+.+.||+|+||.||++++. .+++.||+|++.+.... .....+.+.+|+.+++.+.+||||+++++++.+.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999999874 47899999998754322 2234567889999999997799999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+||||+.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence 9999999999999999888889999999999999999999999999999999999999 4567899999999876533
Q ss_pred CC--ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCCCCCCC
Q 014704 224 GD--VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGE----TEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 224 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||... ........+......++ ..
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~ 233 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SF 233 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----CC
Confidence 22 2234579999999999864 3788999999999999999999999643 23344444554443332 36
Q ss_pred CChHHHHHHHHhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 296 ISSSAKDIVKKMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
++..+.++|.+||+.||++|| +++++++||||+.
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 789999999999999999999 8899999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=368.39 Aligned_cols=249 Identities=35% Similarity=0.629 Sum_probs=217.4
Q ss_pred ceecccCCeEEEEEEEc---CCCceEEEEEecCCcCC-ChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 73 RELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
+.||+|+||.||++++. .+++.||+|++.+.... .......+.+|+.+++.++ ||||+++++++.+++.+|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEe
Confidence 68999999999999874 46889999998754321 2233456789999999999 9999999999999999999999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCce
Q 014704 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVF 227 (420)
Q Consensus 149 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~ 227 (420)
|+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcc
Confidence 99999999999888889999999999999999999999999999999999999 5567899999999875432 2223
Q ss_pred ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHH
Q 014704 228 KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306 (420)
Q Consensus 228 ~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 306 (420)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+..+...++ +.+++++.+||++
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~ 233 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKK 233 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence 44579999999999864 588999999999999999999999999888888888888766544 3578999999999
Q ss_pred hcccCcCCCC-----CHHHHhcCCcccc
Q 014704 307 MLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 307 ~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
||+.||++|| ++.++++||||..
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999 8999999999964
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=369.42 Aligned_cols=249 Identities=29% Similarity=0.584 Sum_probs=215.0
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHH-HHhccCCCCccEEEEEEEeCCeEEEEEecCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI-MHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~ 151 (420)
+.||+|+||+||+|.++.+|+.||+|++.+...........+..|... ++.++ ||||+++++++.+.+.+|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 479999999999999999999999999976543333344556666554 56677 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCceecc
Q 014704 152 GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDL 230 (420)
Q Consensus 152 g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 230 (420)
|++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccc
Confidence 99999999888889999999999999999999999999999999999999 5567899999999875422 2233456
Q ss_pred cCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcc
Q 014704 231 VGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (420)
Q Consensus 231 ~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 309 (420)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+........ +.++..+.++|++||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ 232 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence 79999999999864 589999999999999999999999999888888888887655443 3679999999999999
Q ss_pred cCcCCCCCH----HHHhcCCcccc
Q 014704 310 ADPKERLSA----AEVLNHPWMRV 329 (420)
Q Consensus 310 ~dp~~R~t~----~e~l~h~~~~~ 329 (420)
.||++||++ .++++||||..
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCC
Confidence 999999987 69999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=369.70 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=211.3
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC-----Ce
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-----HS 142 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-----~~ 142 (420)
+|.+.+.||+|+||.||+|+++.+|+.||+|.+.... ........+.+|+.+++.++ ||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence 5899999999999999999999999999999986432 22334467889999999999 99999999987543 35
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|+|||||. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence 899999995 6899999888889999999999999999999999999999999999999 567789999999987643
Q ss_pred CCC----ceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc------------
Q 014704 223 PGD----VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR------------ 283 (420)
Q Consensus 223 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~------------ 283 (420)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 2234579999999999753 589999999999999999999999987664333222111
Q ss_pred ---------------CCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 284 ---------------GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 284 ---------------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
.........++.+++++.++|.+||..||++|||+.++|+||||+....
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000111123567889999999999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=361.21 Aligned_cols=258 Identities=29% Similarity=0.497 Sum_probs=217.2
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++ ||||+++++++.+.+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEE
Confidence 4888999999999999999999999999999987544333333456788999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||+.|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ ++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 999999998887654 458999999999999999999999999999999999999 556789999999998765444
Q ss_pred ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
......|++.|+|||++. ..++.++||||+||++|+|++|..||.+.........+..............++..+.+||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 445567999999999986 4588999999999999999999999988765444333332222222222346789999999
Q ss_pred HHhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 305 KKMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 305 ~~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
.+||..||++|| ++.++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 9999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=382.43 Aligned_cols=258 Identities=23% Similarity=0.374 Sum_probs=205.0
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc-----CCCCccEEEEEEEe
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT-----GHRNIVELKGAYED 139 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpniv~~~~~~~~ 139 (420)
..++|.+.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.+. +|++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 4578999999999999999999999999999999986421 22345667888887775 24468899998876
Q ss_pred C-CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCC-----------
Q 014704 140 R-HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAE----------- 206 (420)
Q Consensus 140 ~-~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~----------- 206 (420)
+ .++|+|||++ |++|.+++.+.+.+++..+..++.||+.||.|||+ .|||||||||+|||+...+.
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4 5789999998 77999999888899999999999999999999998 59999999999999964321
Q ss_pred --CCCeeEeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Q 014704 207 --DSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR 283 (420)
Q Consensus 207 --~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~ 283 (420)
...+||+|||.+.... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..+..
T Consensus 282 ~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 1259999999876432 22345689999999999865 599999999999999999999999988776555444332
Q ss_pred CCCCCCCC------------------------------------CCC--CCChHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 014704 284 GHIDFSSD------------------------------------PWP--NISSSAKDIVKKMLHADPKERLSAAEVLNHP 325 (420)
Q Consensus 284 ~~~~~~~~------------------------------------~~~--~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 325 (420)
....++.. .+. ..++.+.+||.+||++||++|||+.|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 11111000 000 0135578999999999999999999999999
Q ss_pred cccc
Q 014704 326 WMRV 329 (420)
Q Consensus 326 ~~~~ 329 (420)
||..
T Consensus 440 ~~~~ 443 (467)
T PTZ00284 440 YVLK 443 (467)
T ss_pred cccc
Confidence 9975
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=371.83 Aligned_cols=258 Identities=35% Similarity=0.621 Sum_probs=239.1
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
-.+.|.+.+.||+|.|+.|.+|++..++..||+|+|.+... +......+.+|+++|+.|. |||||+++.+.+....+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLN-HPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcC-CcceeeeeeeeeecceeE
Confidence 34679999999999999999999999999999999988765 4445566999999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||+.||.+++++.+.++..+..+..++.|+.+|++|||+++|||||||++|||+ +.+.++||+|||++..+..+
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeeccc
Confidence 999999999999999999999999999999999999999999999999999999999 66777999999999999988
Q ss_pred CceecccCCcccccchhhccc--CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~~--~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
....+++|++.|.|||++.+. -++.+|+||+|+++|.|+.|.+||++.+..++-...+.+.+..+. .++.++++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce~ 284 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCED 284 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechhHH
Confidence 888999999999999999753 589999999999999999999999999998888888888887765 57899999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
+|+++|..+|.+|++.+++++|.|.....
T Consensus 285 lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 285 LLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred HHHHhhccCccccCCHHHhhhhcccchhh
Confidence 99999999999999999999999986443
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=371.90 Aligned_cols=249 Identities=31% Similarity=0.560 Sum_probs=216.3
Q ss_pred ecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc--CCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 75 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
||+|+||+||+|+++.+++.||+|++.+..............|..++..+. +||||+++++++.+...+|+||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999987544333344455667777777663 599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~ 231 (420)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999999888899999999999999999999999999999999999999 4567799999999875432 22334567
Q ss_pred CCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcc
Q 014704 232 GSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (420)
Q Consensus 232 gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 309 (420)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+..+...++. ..++.++++||++||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~ 234 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN 234 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence 9999999999853 4899999999999999999999999999888888888877766554 2478999999999999
Q ss_pred cCcCCCC----CHHHHhcCCcccc
Q 014704 310 ADPKERL----SAAEVLNHPWMRV 329 (420)
Q Consensus 310 ~dp~~R~----t~~e~l~h~~~~~ 329 (420)
.||++|| ++.++++||||..
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccC
Confidence 9999998 7999999999974
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=369.61 Aligned_cols=260 Identities=33% Similarity=0.622 Sum_probs=235.4
Q ss_pred cccceee--cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 65 VRNTYIF--GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 65 ~~~~y~~--~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+..-|.+ .+.||+|-||+||-|+++.+|+.||||+|.+..+... ....+++|+.||+.+. ||.||.+.-.|+..+.
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~-HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLH-HPGIVNLECMFETPER 637 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcC-CCCeeEEEEeecCCce
Confidence 3445555 4789999999999999999999999999998777544 4488999999999999 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 143 VNLIMDLCAGGELFDRII--AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+++|||.+.| ++.+.+. +++++++...+.++.||+.||.|||-+||+|+||||+|||+.+.+.-..+||||||+|+.
T Consensus 638 vFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 638 VFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 9999999965 5556554 457899999999999999999999999999999999999999877778899999999999
Q ss_pred cCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 221 FKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
+.+.....+.+|||.|+|||++.. .|...-|+||.|||+|.-++|..||.. ++++-++|.+..+-++..+|..++++
T Consensus 717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHH
Confidence 988777788899999999999964 599999999999999999999999954 35677889999999999999999999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.|||..+|++.-++|.|..+.|.|||++.
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 999999999999999999999999999974
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=366.23 Aligned_cols=259 Identities=27% Similarity=0.527 Sum_probs=219.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||++.++.+++.||+|++.+.........+.+.+|+.++..++ |+||+++++++.+++++|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEE
Confidence 46999999999999999999999999999999987543334445567889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||+.|++|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 999999999999976 4579999999999999999999999999999999999999 556789999999987654332
Q ss_pred ce--ecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCC
Q 014704 226 VF--KDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS-DPWPNI 296 (420)
Q Consensus 226 ~~--~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 296 (420)
.. ...+||+.|+|||++. +.++.++||||+||++|+|++|+.||.+....+....+......+.. .....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 21 2346999999999985 24788999999999999999999999988877777777654332221 123458
Q ss_pred ChHHHHHHHHhcccCcCC--CCCHHHHhcCCcccc
Q 014704 297 SSSAKDIVKKMLHADPKE--RLSAAEVLNHPWMRV 329 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~--R~t~~e~l~h~~~~~ 329 (420)
+.++++||++||..++++ |+++.++++||||..
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999999999765544 789999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=366.15 Aligned_cols=250 Identities=28% Similarity=0.538 Sum_probs=214.7
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|.++.+++.||+|++.+.........+.+.+|+.++.++.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999998655444556677899999999997799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc-CCCCceeccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~-~~~~~~~~~~ 231 (420)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++... .........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence 9999999888889999999999999999999999999999999999999 45677999999998753 2333445678
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE-------TEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
||+.|+|||++.+ .++.++|||||||++|+|++|..||... ........+......++ ..++..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l 233 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHV 233 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 9999999999864 5899999999999999999999999532 22344455555444433 3578999999
Q ss_pred HHHhcccCcCCCCC------HHHHhcCCcccc
Q 014704 304 VKKMLHADPKERLS------AAEVLNHPWMRV 329 (420)
Q Consensus 304 i~~~L~~dp~~R~t------~~e~l~h~~~~~ 329 (420)
|++||..||++|++ +.++++||||+.
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 99999999999998 579999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=353.26 Aligned_cols=256 Identities=31% Similarity=0.505 Sum_probs=216.1
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR---- 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~---- 140 (420)
..-.|.-.+++|+|+||.||+|....+++.||||.+..+... -.+|+.+|+.+. |||||++.-+|...
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~-HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLD-HPNIVRLLYFFSSSTESD 93 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcC-CcCeeeEEEEEEecCCCc
Confidence 444688889999999999999999999999999998654432 237999999998 99999999888532
Q ss_pred -CeEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeec
Q 014704 141 -HSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (420)
Q Consensus 141 -~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Df 215 (420)
-+..+||||++ .+|.+.+.. +.+++.-.++-+..||++||.|||+.||+||||||+|+|++ .+.+.+|||||
T Consensus 94 ~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDF 170 (364)
T KOG0658|consen 94 EVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDF 170 (364)
T ss_pred hhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccC
Confidence 24568999996 489888874 56789999999999999999999999999999999999996 45688999999
Q ss_pred ccccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------
Q 014704 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG--------- 284 (420)
Q Consensus 216 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~--------- 284 (420)
|.|+....+....+...|..|+|||.+-+ .|+.+.||||.||++.||+-|++.|.|.+....+..|.+.
T Consensus 171 GSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 171 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred CcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99999988887788889999999998754 6999999999999999999999999999887777666431
Q ss_pred ---CC--------CCCCCC-----CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 285 ---HI--------DFSSDP-----WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 285 ---~~--------~~~~~~-----~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.. .+.... ...+++++.+|+.++|..+|.+|.++.|+|.||||....
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 11 111111 235789999999999999999999999999999997443
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=359.05 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=208.8
Q ss_pred cceeecceecccCCeEEEEEEEcC-CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc--CCCCccEEEEEEE-----
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKD-TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYE----- 138 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpniv~~~~~~~----- 138 (420)
.+|.+.+.||+|+||.||+|.+.. +++.||+|.+..... .......+.+|+.+++.+. .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 468899999865432 2223345667888877763 3999999999885
Q ss_pred eCCeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
....+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEcccc
Confidence 3456899999996 5898888653 358999999999999999999999999999999999999 456789999999
Q ss_pred cccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS----- 290 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 290 (420)
++.............||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+..+.+..+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 998765544445567999999999985 45899999999999999999999999988877777666543211000
Q ss_pred ------------------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 291 ------------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 291 ------------------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
...+.++..+++||.+||+.||++|||+.++|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0123567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=358.81 Aligned_cols=251 Identities=28% Similarity=0.471 Sum_probs=207.5
Q ss_pred ecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCCC
Q 014704 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (420)
Q Consensus 75 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~~ 154 (420)
||+|+||+||++.++.+++.||+|.+...........+.+..|+.+++.++ ||||+++.+++.....+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999999999999999987654433344567789999999998 9999999999999999999999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc-eec
Q 014704 155 LFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-FKD 229 (420)
Q Consensus 155 L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 229 (420)
|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........ ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccc
Confidence 9877743 3468999999999999999999999999999999999999 4567799999999876644322 234
Q ss_pred ccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhc
Q 014704 230 LVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML 308 (420)
Q Consensus 230 ~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L 308 (420)
..||+.|+|||++.+ .++.++||||+||++|+|++|+.||...........+.......+......++.++.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 578999999999864 5889999999999999999999999765432222222221111122222467899999999999
Q ss_pred ccCcCCCC-----CHHHHhcCCcccc
Q 014704 309 HADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 309 ~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
+.||++|| |++++++||||+.
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 99999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=363.97 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=216.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||++++..++..+|+|.+.... .......+.+|+++++.++ ||||+++++++.+.+.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence 468999999999999999999999999999999986432 3344567999999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||++|++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence 999999999999998888899999999999999999999986 69999999999999 45677999999998765432
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------------
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID---------------- 287 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------------- 287 (420)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......++...+......
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2344579999999999864 5899999999999999999999999776654433222110000
Q ss_pred ----------------------------CCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 288 ----------------------------FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 288 ----------------------------~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+......+++++++||.+||+.||++|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000112467899999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=366.86 Aligned_cols=249 Identities=29% Similarity=0.566 Sum_probs=215.2
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHH-HHhccCCCCccEEEEEEEeCCeEEEEEecCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI-MHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~ 151 (420)
+.||+|+||.||+|.++.+|+.||+|++.+...........+..|..+ ++.++ ||||+++++++...+.+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEcCCC
Confidence 479999999999999999999999999976543334445566666654 56677 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCceecc
Q 014704 152 GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDL 230 (420)
Q Consensus 152 g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 230 (420)
|++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccc
Confidence 99999999888899999999999999999999999999999999999999 5567899999999875322 2233456
Q ss_pred cCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcc
Q 014704 231 VGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (420)
Q Consensus 231 ~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 309 (420)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+........ +.++..+.++|++||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence 79999999999864 589999999999999999999999999888888888877655443 3578999999999999
Q ss_pred cCcCCCCCH----HHHhcCCcccc
Q 014704 310 ADPKERLSA----AEVLNHPWMRV 329 (420)
Q Consensus 310 ~dp~~R~t~----~e~l~h~~~~~ 329 (420)
.||.+||++ .++++||||..
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCC
Confidence 999999976 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=366.17 Aligned_cols=248 Identities=31% Similarity=0.554 Sum_probs=217.1
Q ss_pred ceecccCCeEEEEEEEc---CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEec
Q 014704 73 RELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~ 149 (420)
+.||+|+||.||++.+. .+|+.||+|++..... .......+.+|++++++++ ||||+++++++.+++.+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence 67999999999999863 5789999999975432 2233456788999999998 99999999999999999999999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-Ccee
Q 014704 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFK 228 (420)
Q Consensus 150 ~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-~~~~ 228 (420)
+.|++|.+++.+...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...... ....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCcee
Confidence 9999999999888889999999999999999999999999999999999999 45677999999998765433 2334
Q ss_pred cccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHh
Q 014704 229 DLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307 (420)
Q Consensus 229 ~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 307 (420)
...||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+......++. .+++++.+||++|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHH
Confidence 5679999999999864 5889999999999999999999999998888888888877665443 5789999999999
Q ss_pred cccCcCCCCC-----HHHHhcCCcccc
Q 014704 308 LHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 308 L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
|+.||++||| +.++++||||..
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 9999999999 788999999974
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=378.80 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=207.9
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR---- 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~---- 140 (420)
...+|.+++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++ ||||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeeccccc
Confidence 3467999999999999999999999999999999885421 23457999999999 99999999987432
Q ss_pred ----CeEEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeE
Q 014704 141 ----HSVNLIMDLCAGGELFDRII----AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (420)
Q Consensus 141 ----~~~~iv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl 212 (420)
..+++||||+.+ +|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++. .+..+||
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--~~~~vkL 212 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--NTHTLKL 212 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--CCCceee
Confidence 257799999975 6766654 3456999999999999999999999999999999999999952 3346999
Q ss_pred eecccccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----
Q 014704 213 TDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH----- 285 (420)
Q Consensus 213 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~----- 285 (420)
+|||+++............||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99999987765555556688999999998753 58999999999999999999999999887665555543311
Q ss_pred ------------CCCCCCC--------CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 286 ------------IDFSSDP--------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 286 ------------~~~~~~~--------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
..++... ....+.++.+||.+||++||.+|||+.|+|+||||...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 1111100 11357899999999999999999999999999999643
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=365.98 Aligned_cols=254 Identities=33% Similarity=0.574 Sum_probs=230.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe-EEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS-VNL 145 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~-~~i 145 (420)
++|..++.+|+|+||.++.++++..++.+++|.|...... ........+|+.+++++. |||||.+.+.|..++. .+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t-~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT-EPERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC-chhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEE
Confidence 5799999999999999999999999999999999876653 344457889999999999 9999999999988888 999
Q ss_pred EEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
||+||+||+|.+.+.+.+ .++|+.+..|+.||+.|+.|||+++|+|||||+.||++ ..+..|||+|||+|+...+
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcCC
Confidence 999999999999987654 59999999999999999999999999999999999999 4566689999999999987
Q ss_pred CC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 GD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.. ...+.+||+.||+||++.+ .|+.|+|||||||++|||++-+++|.+.+...+..+|.++...... ...+.+++
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~ 235 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELR 235 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHH
Confidence 76 5677899999999999976 5999999999999999999999999999999999999998743332 35689999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.+|+.||..+|+.||++.++|.+|.+.
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 999999999999999999999998875
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=364.64 Aligned_cols=249 Identities=29% Similarity=0.563 Sum_probs=213.6
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHH-HHHhccCCCCccEEEEEEEeCCeEEEEEecCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ-IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~ 151 (420)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.++ ||||+++++++.+.+.+|+|||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999999999999999987644333334455666655 567777 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-CCCceecc
Q 014704 152 GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDL 230 (420)
Q Consensus 152 g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~ 230 (420)
|++|...+.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.... ........
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccc
Confidence 99999999888889999999999999999999999999999999999999 556789999999987532 22233456
Q ss_pred cCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcc
Q 014704 231 VGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (420)
Q Consensus 231 ~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 309 (420)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++ +..+..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH 232 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcc
Confidence 79999999999864 589999999999999999999999999888888888877655443 3568899999999999
Q ss_pred cCcCCCCCH----HHHhcCCcccc
Q 014704 310 ADPKERLSA----AEVLNHPWMRV 329 (420)
Q Consensus 310 ~dp~~R~t~----~e~l~h~~~~~ 329 (420)
.||.+|+++ .++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCC
Confidence 999999875 59999999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=363.51 Aligned_cols=259 Identities=25% Similarity=0.497 Sum_probs=220.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..+. |+||+++++++.+.+..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999987543333344566888999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||+.||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 999999999999977 4679999999999999999999999999999999999999 456779999999987664433
Q ss_pred ce--ecccCCcccccchhhcc------cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCC
Q 014704 226 VF--KDLVGSAYYVAPEVLRR------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS-DPWPNI 296 (420)
Q Consensus 226 ~~--~~~~gt~~y~aPE~~~~------~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 296 (420)
.. ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+.+..+......++. ..+..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 22 23579999999998853 4788999999999999999999999988888888777765433322 223567
Q ss_pred ChHHHHHHHHhcccCcCC--CCCHHHHhcCCcccc
Q 014704 297 SSSAKDIVKKMLHADPKE--RLSAAEVLNHPWMRV 329 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~--R~t~~e~l~h~~~~~ 329 (420)
+.+++++|.+||..++++ |++++++++|+||+.
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 899999999999876655 569999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=363.98 Aligned_cols=249 Identities=29% Similarity=0.580 Sum_probs=212.8
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHH-HHHhccCCCCccEEEEEEEeCCeEEEEEecCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ-IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~ 151 (420)
+.||+|+||.||+|+++.+++.||+|++.+...........+..|.. +++.+. ||||+++++++.+.+.+|+||||+.
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEeCCC
Confidence 47999999999999999999999999997543322333344555554 456677 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCceecc
Q 014704 152 GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDL 230 (420)
Q Consensus 152 g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 230 (420)
|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .......
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccc
Confidence 99999999888889999999999999999999999999999999999999 4567799999999875422 2233456
Q ss_pred cCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcc
Q 014704 231 VGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (420)
Q Consensus 231 ~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 309 (420)
+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+. +.++..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQ 232 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHHHHcc
Confidence 79999999999865 589999999999999999999999999888888888876654433 4689999999999999
Q ss_pred cCcCCCCCHH----HHhcCCcccc
Q 014704 310 ADPKERLSAA----EVLNHPWMRV 329 (420)
Q Consensus 310 ~dp~~R~t~~----e~l~h~~~~~ 329 (420)
.||.+|+++. ++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCC
Confidence 9999999876 8999999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-48 Score=369.03 Aligned_cols=261 Identities=29% Similarity=0.455 Sum_probs=218.1
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccC-----CCCccEEEEE
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG-----HRNIVELKGA 136 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----hpniv~~~~~ 136 (420)
.+.+..+|.+.+.||+|+||.|-+|.+..|++.||||+++..+ ....+...|+++|..|+. .-|||+++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 3456678999999999999999999999999999999997643 345667889999999983 3489999999
Q ss_pred EEeCCeEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEee
Q 014704 137 YEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (420)
Q Consensus 137 ~~~~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~D 214 (420)
|...+++|||+|++ +.+|+++++.++ .++...++.++.||+.||.+||+.||||+||||+|||+.... ...|||+|
T Consensus 257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~-r~~vKVID 334 (586)
T KOG0667|consen 257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK-RSRIKVID 334 (586)
T ss_pred cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC-cCceeEEe
Confidence 99999999999999 569999998764 488999999999999999999999999999999999998654 34899999
Q ss_pred cccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Q 014704 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH-------- 285 (420)
Q Consensus 215 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~-------- 285 (420)
||.|+.....- -+.+-+..|+|||++.+ .|+.+.||||||||++||++|.+.|.|.++.+.+..|..-.
T Consensus 335 FGSSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 335 FGSSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cccccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99999865432 26778899999999865 69999999999999999999999999999877776663210
Q ss_pred -------CCCCC-----------C---------------------CCC------------CCChHHHHHHHHhcccCcCC
Q 014704 286 -------IDFSS-----------D---------------------PWP------------NISSSAKDIVKKMLHADPKE 314 (420)
Q Consensus 286 -------~~~~~-----------~---------------------~~~------------~~~~~~~~li~~~L~~dp~~ 314 (420)
.-|.. . ..+ .-...+.+||++||..||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 00000 0 000 01235689999999999999
Q ss_pred CCCHHHHhcCCccccc
Q 014704 315 RLSAAEVLNHPWMRVD 330 (420)
Q Consensus 315 R~t~~e~l~h~~~~~~ 330 (420)
|+|+.++|+||||...
T Consensus 493 R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 493 RITPAQALNHPFLTGT 508 (586)
T ss_pred cCCHHHHhcCcccccc
Confidence 9999999999999843
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=363.08 Aligned_cols=259 Identities=25% Similarity=0.498 Sum_probs=219.7
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||++.++.+++.||+|++.+...........+.+|+.++..+. |+||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEE
Confidence 36899999999999999999999999999999986543333344556889999999988 99999999999999999999
Q ss_pred EecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||+.||+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence 999999999999976 4679999999999999999999999999999999999999 456789999999987653322
Q ss_pred c--eecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCC
Q 014704 226 V--FKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD-PWPNI 296 (420)
Q Consensus 226 ~--~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~ 296 (420)
. ....+||+.|+|||++. +.++.++|||||||++|+|++|+.||.+.+..+.+..+......+..+ ....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 2 22357999999999874 247899999999999999999999999988888888887654333221 23468
Q ss_pred ChHHHHHHHHhcccCcCC--CCCHHHHhcCCcccc
Q 014704 297 SSSAKDIVKKMLHADPKE--RLSAAEVLNHPWMRV 329 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~--R~t~~e~l~h~~~~~ 329 (420)
+.++++||++||..++.+ |+++.++++||||..
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999999765554 689999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-49 Score=344.55 Aligned_cols=255 Identities=32% Similarity=0.598 Sum_probs=240.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.++||+|.||.|-+++.+.+++.||+|++++.-....+++..-..|-++|+..+ ||.+..+--.|+..+++|+|
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEEE
Confidence 67899999999999999999999999999999999988888888889999999999999 99999999899999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc-cCCCC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF-FKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~-~~~~~ 225 (420)
|||..||.|+-+|.+...++|..++.+-..|+.||.|||+++||.||||.+|+|+ +.++++||+|||+++. +..+.
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcccccc
Confidence 9999999999999988899999999999999999999999999999999999999 7889999999999975 34567
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
..+++||||.|+|||++.. .|+.++|-|.+||++|||++|+.||+..+...+++.|+.+.+.|+. .++++++.|+
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktLL 399 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTLL 399 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHHH
Confidence 7889999999999999974 6999999999999999999999999999999999999999999886 7899999999
Q ss_pred HHhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 305 KKMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 305 ~~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
..+|.+||.+|. .+.|+.+|+||..
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 999999999998 4899999999974
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=369.29 Aligned_cols=252 Identities=22% Similarity=0.361 Sum_probs=206.1
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
..+|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.++++++ ||||+++++++......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEE
Confidence 4679999999999999999999999999999997532 34679999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
|||++. ++|..++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccc
Confidence 999995 6899999888889999999999999999999999999999999999999 45677999999998753221
Q ss_pred -CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCC----------
Q 014704 225 -DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET-------EQSIFDAILRGH---------- 285 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~-------~~~~~~~i~~~~---------- 285 (420)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ....+..+....
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22345679999999999864 58999999999999999999998875432 111111111100
Q ss_pred ----------------CC--CCCCCC---CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 286 ----------------ID--FSSDPW---PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 286 ----------------~~--~~~~~~---~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.. .....| ..++.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 00 000011 13467899999999999999999999999999997543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=353.94 Aligned_cols=255 Identities=29% Similarity=0.518 Sum_probs=213.6
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
.|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++ |+||+.+++.+.+.+.+|+||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEE
Confidence 3778899999999999999999999999999987654433444566788999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||+.|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence 999999999888654 358999999999999999999999999999999999999 456779999999987765444
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQS---IFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
......|+..|+|||++.+ .++.++||||+|+++|+|++|..||....... ....+... ........+++++.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 233 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---VQEEYSEKFSPDAR 233 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---hhhhcCccCCHHHH
Confidence 4445679999999999864 58999999999999999999999998654321 22222111 11112346788999
Q ss_pred HHHHHhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 302 DIVKKMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
+|+++||+.||++||| +.++++||||+.
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999999 999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=353.48 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=207.5
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc--CCCCccEEEEEEEe-----C
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYED-----R 140 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpniv~~~~~~~~-----~ 140 (420)
+|.+.+.||+|+||.||+|.++.+++.||+|.+..... .......+.+|+.+++.+. +||||+++++++.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 48899999999999999999999999999999875432 1222234567787777663 39999999998864 3
Q ss_pred CeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
..+++||||+.+ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcc
Confidence 468999999975 888888664 348999999999999999999999999999999999999 45677999999999
Q ss_pred cccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----CCC---
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-----DFS--- 289 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~-----~~~--- 289 (420)
.............||+.|+|||++. ..++.++||||+||++|+|++|.+||.+......+..+..... .++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 8765444445567899999999885 4589999999999999999999999988777665555443110 000
Q ss_pred ---------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 290 ---------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 290 ---------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
....+.++..+.++|.+||+.||++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01124567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=350.90 Aligned_cols=248 Identities=28% Similarity=0.507 Sum_probs=208.0
Q ss_pred ecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCCC
Q 014704 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (420)
Q Consensus 75 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~~ 154 (420)
||+|+||.||++.++.+|+.||+|.+.............+..|+++++.++ ||||+++++++.++..+|+||||+.|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999987544333333455677999999998 9999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecccC
Q 014704 155 LFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232 (420)
Q Consensus 155 L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g 232 (420)
|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.............|
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCC
Confidence 988876543 48899999999999999999999999999999999999 4567799999999987765554455679
Q ss_pred Ccccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHh
Q 014704 233 SAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307 (420)
Q Consensus 233 t~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 307 (420)
++.|+|||++.+ .++.++||||+||++|+|++|..||..... ..+...+......+. ...++.++++||++|
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~ 233 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLF 233 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHH
Confidence 999999999854 589999999999999999999999976433 233333333333322 236789999999999
Q ss_pred cccCcCCCCCH----HHHhcCCcccc
Q 014704 308 LHADPKERLSA----AEVLNHPWMRV 329 (420)
Q Consensus 308 L~~dp~~R~t~----~e~l~h~~~~~ 329 (420)
|+.||++||++ +++++|+||+.
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcC
Confidence 99999999999 77889999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=356.99 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=213.0
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.++.+++.||+|.+..... ......+.+|+.++++++ ||||+++++++.+++..|+|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence 569999999999999999999999999999999865432 223345778999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 147 MDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
|||+.+ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence 999975 8888776554 48999999999999999999999999999999999999 45677999999998764322
Q ss_pred CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Q 014704 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI---------------- 286 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~---------------- 286 (420)
.......+|+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..+.+..+.+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 22334568999999998753 478999999999999999999999988776555544432110
Q ss_pred ---CCCC-------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 287 ---DFSS-------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 287 ---~~~~-------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.++. ...+.++.++++||.+||+.||++|||+.|+|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0000 11235788999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=350.39 Aligned_cols=259 Identities=30% Similarity=0.504 Sum_probs=218.5
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
.|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++ |+||+.+++.+.+++..++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEE
Confidence 3777889999999999999999999999999987654433344556788999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.+..++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence 999999998887653 359999999999999999999999999999999999999 456679999999987655444
Q ss_pred ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
......|+..|+|||++. ..++.++|+||+|+++|+|++|..||.+.........+..............++.++.+|+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 444567999999999985 4589999999999999999999999988766544444433322222233356789999999
Q ss_pred HHhcccCcCCCCC-----HHHHhcCCccccc
Q 014704 305 KKMLHADPKERLS-----AAEVLNHPWMRVD 330 (420)
Q Consensus 305 ~~~L~~dp~~R~t-----~~e~l~h~~~~~~ 330 (420)
.+||..||++||| +.++++|+||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=326.78 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=220.8
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
..+...||+|+.|+|++++.+.+|...|||.+.+.. +.++.+++...+.++....++|+||+.+++|..+..++|.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 445677999999999999999999999999997643 567788999999998887778999999999999999999999
Q ss_pred cCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 149 LCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 149 ~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
.|. ..+..++.. +++++|..+.++...++.||.||.+ +||+|||+||+|||+ ++.+++||||||++..+.....
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecccc
Confidence 984 233333332 4679999999999999999999985 589999999999999 7788899999999998877777
Q ss_pred eecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 227 FKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.+...|.+.|||||.+. ..|+-++||||||++++||.||..||.+. ++.+++.++++...+ ..+.-.++|+++.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP-~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP-LLPGHMGFSPDFQ 326 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC-CCCcccCcCHHHH
Confidence 77789999999999884 35899999999999999999999999874 567788888885542 2333346899999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
+|+..||++|+.+||...++|+|||+.....
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 9999999999999999999999999976543
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=361.73 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=209.0
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-- 141 (420)
.+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++ ||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCc
Confidence 35578999999999999999999999999999999986542 23344567889999999998 999999999986543
Q ss_pred ----eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 142 ----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 142 ----~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
.+|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCC
Confidence 57999999975 5666553 358899999999999999999999999999999999999 4567899999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------------
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR------------- 283 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~------------- 283 (420)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 986554444455678999999999864 589999999999999999999999987765433322211
Q ss_pred ---------CCCCCCC----------------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 284 ---------GHIDFSS----------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 284 ---------~~~~~~~----------------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
....++. ......++++++||.+||..||++|||+.|+|+||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 1111100 001124678999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=348.87 Aligned_cols=254 Identities=37% Similarity=0.678 Sum_probs=213.7
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
|++++.||+|+||+||++.+..+++.||+|++..... .........+|+.++++++ ||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI-EEEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH-HHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc-cccccchhhhhhhcccccc-cccccccccccccccccccccc
Confidence 7899999999999999999999999999999976533 1222233456999999997 9999999999999999999999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc-CCCCce
Q 014704 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVF 227 (420)
Q Consensus 149 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~-~~~~~~ 227 (420)
|+.+++|.+++...+.+++..+..++.||+.||.+||++||+|+||||+||++ +.++.++|+|||.+... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence 99999999999878889999999999999999999999999999999999999 46677999999998863 333445
Q ss_pred ecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 228 KDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 228 ~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
....++..|+|||++. ..++.++||||+|+++|+|++|..||.... .......................+..+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 5678999999999987 468999999999999999999999998873 33333333332222222111223479999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+|.+||+.||++|||+.++++||||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=356.40 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=213.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||++.++.++..+|+|.+.... .......+.+|+++++.++ ||||+++++++.+.+.+|+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEE
Confidence 468999999999999999999999999999999886532 3344567899999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||+.|++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh
Confidence 999999999999998888899999999999999999999985 79999999999999 45667999999998765322
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---------------------
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL--------------------- 282 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~--------------------- 282 (420)
......||..|+|||++.+ .++.++|||||||++|+|++|+.||...........+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 2234578999999999865 58899999999999999999999997655433321110
Q ss_pred -----------------------cCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 283 -----------------------RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 283 -----------------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.... +......++.++++||.+||+.||++|||+.|++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 000011356789999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=371.00 Aligned_cols=253 Identities=28% Similarity=0.464 Sum_probs=219.3
Q ss_pred cceeecceecccCCeEEEEEEEcCC-CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDT-KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
..|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+++.++ ||||+++++++.+.+.+|+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEEE
Confidence 4599999999999999999998877 788999976432 3344567889999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 146 IMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceec
Confidence 9999999999887753 3468999999999999999999999999999999999999 45678999999999876
Q ss_pred CCCC---ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 222 KPGD---VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 222 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+..+..... ...++
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~s 296 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCPVS 296 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CccCC
Confidence 4332 2344579999999999864 589999999999999999999999999888888888877654321 13578
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.+++++|.+||..||++|||+.+++.|+|++.
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999999864
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=373.07 Aligned_cols=257 Identities=31% Similarity=0.524 Sum_probs=220.9
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC---
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH--- 141 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~--- 141 (420)
..++|.+.+.||+|+||+||+|.+..+|+.||||++..... +......+.+|+.++..+. |+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccccC
Confidence 44689999999999999999999999999999999876543 4455677899999999998 999999988764322
Q ss_pred -----eEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeE
Q 014704 142 -----SVNLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (420)
Q Consensus 142 -----~~~iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl 212 (420)
.+++||||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEE
Confidence 378999999999999988653 468999999999999999999999999999999999999 45678999
Q ss_pred eecccccccCCC---CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q 014704 213 TDFGLSVFFKPG---DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288 (420)
Q Consensus 213 ~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 288 (420)
+|||+++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+..+....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999998765432 22345679999999999865 58999999999999999999999999988888888877765432
Q ss_pred CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
. .+.+++++.+++.+||+.||.+||++.++++|||++.
T Consensus 265 ~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 265 L---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred C---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 2 2467899999999999999999999999999999864
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=360.07 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=211.3
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--- 140 (420)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL 98 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcC-CCCccccceeecccccc
Confidence 34578999999999999999999999999999999986532 23344567889999999998 99999999987543
Q ss_pred ---CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 141 ---~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
..+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~ 172 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 172 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCC
Confidence 457999999965 6777664 358899999999999999999999999999999999999 4567899999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID--------- 287 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 287 (420)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 987655444455689999999999864 5899999999999999999999999888766655554331110
Q ss_pred -------------CC----------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 288 -------------FS----------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 288 -------------~~----------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+. .......+.++++||.+||+.||.+|||+.++|+||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 0001123567899999999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=363.21 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=213.1
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-----e
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-----S 142 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-----~ 142 (420)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+... .........+.+|+.+++.++ ||||+++++++.+.+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccce
Confidence 377889999999999999999999999999998643 223344567889999999998 999999999998776 7
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
.|+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecc
Confidence 999999996 5888888888889999999999999999999999999999999999999 556789999999998654
Q ss_pred CCC--ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------
Q 014704 223 PGD--VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG-------------- 284 (420)
Q Consensus 223 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~-------------- 284 (420)
... ......+|+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 2234568999999999864 4789999999999999999999999888766555544321
Q ss_pred ---------CCCCCC-----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 285 ---------HIDFSS-----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 285 ---------~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
....+. ......++++.+||.+||+.||++|||+.++|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 111100 112345789999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=347.11 Aligned_cols=253 Identities=35% Similarity=0.686 Sum_probs=224.8
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||++.+..+++.||+|.+...........+.+.+|+++++++. ||||+++++++.+...+|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEE
Confidence 36999999999999999999999999999999987654444455678999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
|||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||+|+||++ +.++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--
Confidence 9999999999999888899999999999999999999999999999999999999 45677999999998876543
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
.....|++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+..+...++. .++..++++|.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~ 230 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIR 230 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHHHHHH
Confidence 234578999999998754 5788999999999999999999999888877777777766655443 46899999999
Q ss_pred HhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 306 KMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
+||..||.+|+ +++++++||||+.
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCccccc
Confidence 99999999999 9999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=358.97 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=209.6
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--- 140 (420)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccccc
Confidence 35578999999999999999999999999999999986532 23344567889999999998 99999999988643
Q ss_pred ---CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 141 ---~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
..+|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcc
Confidence 357999999975 6666664 358899999999999999999999999999999999999 4567899999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG------------ 284 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~------------ 284 (420)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+...
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 987655444455689999999999864 5899999999999999999999999887654433322211
Q ss_pred ----------CCCC----------------CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 285 ----------HIDF----------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 285 ----------~~~~----------------~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
...+ ........+.++++||.+||..||++|||+.|+|+||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 0000 00011224567899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=383.20 Aligned_cols=264 Identities=32% Similarity=0.546 Sum_probs=218.5
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED- 139 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~- 139 (420)
..+...++|.+.+.||+|+||+||+|.++.++..||+|.+..... .......+..|+.+++.|. ||||++++++|.+
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de 84 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNK 84 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEec
Confidence 345566789999999999999999999999999999999875543 3445678899999999999 9999999998854
Q ss_pred -CCeEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-------CCeeccCCCCcEEEecC---
Q 014704 140 -RHSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSM-------GVMHRDLKPENFLFSSS--- 204 (420)
Q Consensus 140 -~~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-------~ivH~Dlkp~Nill~~~--- 204 (420)
...+|||||||.+++|.++|.. .+.+++..++.|+.||+.||.|||+. +||||||||+|||+...
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4579999999999999998865 25699999999999999999999985 49999999999999642
Q ss_pred -----------CCCCCeeEeecccccccCCCCceecccCCcccccchhhc---ccCCCccchhhhHHHHHHHHhCCCCCC
Q 014704 205 -----------AEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR---RNYGAEADIWSAGVILYILLSGVPPFW 270 (420)
Q Consensus 205 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwslGvil~~ll~g~~pf~ 270 (420)
+....+||+|||++.............||+.|+|||++. ..++.++||||||||||+|++|..||.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 123458999999998765444445567999999999884 348899999999999999999999997
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 271 GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 271 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.......+.........++ ....+.++.+||..||..+|.+||++.|+|.|+|++.
T Consensus 245 ~~~~~~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 245 KANNFSQLISELKRGPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred cCCcHHHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 6654433333333222222 2456899999999999999999999999999999963
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=339.55 Aligned_cols=255 Identities=28% Similarity=0.475 Sum_probs=216.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCC--hhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN--RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
+.|.+.+.||+|++|.||.|.+..+++.||+|.+....... ......+.+|+.++++++ ||||+++++++.+....+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEE
Confidence 46899999999999999999999999999999986543221 223567899999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+|+||++|++|.+.+...+.+++..+..++.|++.||.|||+.||+||||+|+||++ +.++.++|+|||++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecccc
Confidence 999999999999999888889999999999999999999999999999999999999 45677999999998765432
Q ss_pred Cce----ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 225 DVF----KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 225 ~~~----~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
... ....|+..|+|||++.+ .++.++||||+|+++|++++|+.||...........+........ ....++..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ--LPSHVSPD 235 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC--CCccCCHH
Confidence 211 23467889999999864 488999999999999999999999987665555544444332222 12367899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+.++|++||..+|++|||+.++++|+||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=346.75 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=213.0
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++ ||||+++++++.+++.+++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence 579999999999999999999999999999999864432 223356778999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
|||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 158 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC
Confidence 99997 5888887654 468999999999999999999999999999999999999 45677999999998764322
Q ss_pred CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------------
Q 014704 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID--------------- 287 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------------- 287 (420)
.......+++.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22234467899999998754 4788999999999999999999999887766555444321110
Q ss_pred ----CCC-------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 288 ----FSS-------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 288 ----~~~-------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
++. ...+.+++++++||.+||+.||.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 01235788999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=356.38 Aligned_cols=259 Identities=28% Similarity=0.450 Sum_probs=211.1
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--- 140 (420)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccccc
Confidence 45678999999999999999999999999999999986532 12234466789999999999 99999999987543
Q ss_pred ---CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 141 ---~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
..+|++++++ |++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~ 164 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGL 164 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCcc
Confidence 4578999998 778877664 5679999999999999999999999999999999999999 5567799999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI--------- 286 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~--------- 286 (420)
+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 165 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 165 ARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9865432 345578999999999864 488999999999999999999999987765544444322110
Q ss_pred --------------CCCC----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 287 --------------DFSS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 287 --------------~~~~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
..+. ..+...++.+.+||.+||+.||++|||+.|+|+||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0000 01234567789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=363.42 Aligned_cols=257 Identities=29% Similarity=0.501 Sum_probs=224.9
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..+.|.|+..||.|+||.||+|+.+.++-..|.|+|.. ...+.++.+.-||.||..+. ||+||++++.|..++.++
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceE
Confidence 34678899999999999999999999998889998853 35677899999999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 145 LIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+.|||.||-....+..- ..+++..+..+++|++.||.|||+++|||||||..|||+. .++.|+|+|||.+.....
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccchh
Confidence 999999999998777664 4599999999999999999999999999999999999995 566699999998765433
Q ss_pred C-CceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 224 G-DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 224 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
. ....++.|||+|||||+.. ..|+.++||||||++|.+|..+.+|....+...++-+|.+..++-...+ ...
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP-S~W 261 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP-SHW 261 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc-chh
Confidence 2 2345789999999999863 3599999999999999999999999999999999888887665443322 356
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+..+.||+.+||.+||+.||++.++|+||||+.
T Consensus 262 s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 262 SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred hhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 889999999999999999999999999999973
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=350.27 Aligned_cols=249 Identities=27% Similarity=0.486 Sum_probs=193.8
Q ss_pred cceecccCCeEEEEEEEcC--CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCeEEEEE
Q 014704 72 GRELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHSVNLIM 147 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--~~~~~iv~ 147 (420)
+++||+|+||.||+|.++. +++.||+|.+..... ...+.+|+.++++++ ||||+++++++.. ...+|+||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence 5689999999999999763 678899999864322 245779999999999 9999999998854 56789999
Q ss_pred ecCCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecC-CCCCCeeEeeccc
Q 014704 148 DLCAGGELFDRIIAK---------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS-AEDSPLKATDFGL 217 (420)
Q Consensus 148 e~~~g~~L~~~l~~~---------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~~~~kl~Dfg~ 217 (420)
||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 9995 5887776532 248999999999999999999999999999999999999643 3456899999999
Q ss_pred ccccCCCC----ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHH---------HHHHHHH
Q 014704 218 SVFFKPGD----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQ---------SIFDAIL 282 (420)
Q Consensus 218 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~---------~~~~~i~ 282 (420)
+....... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.... ..+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98654321 2234678999999998854 4899999999999999999999999654321 1111111
Q ss_pred cCCC--------------------------CCC--------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 283 RGHI--------------------------DFS--------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 283 ~~~~--------------------------~~~--------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.... .+. .......+.++.+||++||+.||++|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1000 000 00011235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=348.98 Aligned_cols=248 Identities=27% Similarity=0.442 Sum_probs=212.9
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+.-+..+.+.+.||+|-||.||.|.+..+ ..||+|.++.... ..+.+.+|+++|++|+ |+|||++++++..++.
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM----SPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEP 275 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc----ChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCc
Confidence 33445677889999999999999999764 4799999875432 2356889999999999 9999999999999889
Q ss_pred EEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 143 VNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+||||||+..|+|.++|.. ...+.......++.||++|++||+++++|||||-..|||+ +++..+||+|||+|+.
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARL 352 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccc
Confidence 9999999999999999987 4569999999999999999999999999999999999999 6778999999999995
Q ss_pred cCCCCceeccc--CCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 221 FKPGDVFKDLV--GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 221 ~~~~~~~~~~~--gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
...+......- -...|.|||.+. +.++.+||||||||+|||++| |+.||.+.+..++++.+.+|..- +. ...+
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl-p~--P~~C 429 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL-PR--PEGC 429 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC-CC--CCCC
Confidence 54333222211 234699999986 569999999999999999999 99999999999999999887533 22 2478
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHh
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVL 322 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l 322 (420)
|+++.+++..||+.+|++|||++.+.
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999999999999998653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=381.57 Aligned_cols=259 Identities=31% Similarity=0.541 Sum_probs=231.2
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
-.++|.+.++||+|+||.|.+++++.+++.||+|++.+.......+..-|..|-.+|..-. .+.|+.++-.|+|+.++|
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceE
Confidence 3578999999999999999999999999999999998754444455567888888888777 899999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||++||+|..++.+..++++..++.++..|+-||.-||+.|+|||||||+|||+ +..|++||+|||.+..+..+
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCC
Confidence 999999999999999998899999999999999999999999999999999999999 67889999999999887643
Q ss_pred -Cc-eecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCC
Q 014704 225 -DV-FKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG--HIDFSSDPWP 294 (420)
Q Consensus 225 -~~-~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~ 294 (420)
.. ....+|||.|.+||++. +.|++.||.||+||++|||+.|..||+.++-.+.+.+|++. .+.|| .-.
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~ 306 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DET 306 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--ccc
Confidence 32 34568999999999984 35999999999999999999999999999999999999987 55565 334
Q ss_pred CCChHHHHHHHHhcccCcCCCCC---HHHHhcCCccccc
Q 014704 295 NISSSAKDIVKKMLHADPKERLS---AAEVLNHPWMRVD 330 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~~ 330 (420)
.+|.++++||+++|. +|+.|.. ++++-+||||...
T Consensus 307 ~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 699999999999995 7899998 9999999999743
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=346.05 Aligned_cols=258 Identities=34% Similarity=0.607 Sum_probs=222.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+++++.+. ||||+++++.+.+....|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEE
Confidence 36899999999999999999999999999999998665443345678999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 147 MDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
|||+.|++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence 9999999999988754 468999999999999999999999999999999999999 45677999999988754321
Q ss_pred C------------------------------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 014704 225 D------------------------------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET 273 (420)
Q Consensus 225 ~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~ 273 (420)
. ......||..|+|||++.+ .++.++||||||+++|+|++|..||.+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1 1113468899999999864 48899999999999999999999999888
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCC----HHHHhcCCccccc
Q 014704 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS----AAEVLNHPWMRVD 330 (420)
Q Consensus 274 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 330 (420)
....+..+......++.. ..++..+.++|.+||..||++||| ++++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred hHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 877777777655554432 237899999999999999999999 9999999999753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=353.32 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=206.3
Q ss_pred cccccceeecceecccCCeEEEEEEEcC--CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
..+..+|.+.+.||+|+||.||+|.... +++.||+|.+... ....+|+.+++.++ ||||+++++++...
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~ 158 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWK 158 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeC
Confidence 3456789999999999999999998643 4678999987542 23568999999999 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
..+|+|||++. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACK 234 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccc
Confidence 99999999995 6888988777889999999999999999999999999999999999999 5567899999999876
Q ss_pred cCCCC---ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHcC----CCCCC
Q 014704 221 FKPGD---VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE---QSIFDAILRG----HIDFS 289 (420)
Q Consensus 221 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~----~~~~~ 289 (420)
..... ......||+.|+|||++.. .++.++|||||||++|+|++|..||.+... ...+..+.+. ...++
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 54332 1234579999999999864 589999999999999999999999976532 1222222211 00111
Q ss_pred C-----------------------CC---CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 290 S-----------------------DP---WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 290 ~-----------------------~~---~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
. +. -..++.++.+||++||..||++|||+.++|+||||+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 0 00 0134678899999999999999999999999999974
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=340.28 Aligned_cols=256 Identities=28% Similarity=0.518 Sum_probs=213.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.++.+|+.||+|.+..... .....+.+.+|+.+++.+. ||||+++++++.+...+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence 469999999999999999999999999999999864432 2223456789999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
|||+++++|..++.....+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence 9999998887777666779999999999999999999999999999999999999 456779999999998765433
Q ss_pred ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------
Q 014704 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI----------------- 286 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~----------------- 286 (420)
......++..|+|||.+.+ .++.++||||+|+++|+|++|..||.+....+....+.....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2334567889999998754 478999999999999999999999987766544443322100
Q ss_pred --CCCC--------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 287 --DFSS--------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 287 --~~~~--------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
..+. ..++.++..+.+||.+||..||++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 0124568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=337.66 Aligned_cols=254 Identities=29% Similarity=0.476 Sum_probs=213.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++ ||||+++++++.+.+.+|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Confidence 457999999999999999999999999999999986432 233456889999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||||+++++|.+++...+.+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc
Confidence 99999999999999888899999999999999999999999999999999999999 456679999999987654321
Q ss_pred -ceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCCChH
Q 014704 226 -VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS-DPWPNISSS 299 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~ 299 (420)
......|++.|+|||++. +.++.++|+||+||++|+|++|..||...................+. .....++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 223457899999999873 34888999999999999999999999765544433333333322211 111246788
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPW 326 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~ 326 (420)
+.++|.+||..+|++|||+.++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=337.09 Aligned_cols=255 Identities=25% Similarity=0.476 Sum_probs=212.0
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--- 140 (420)
+..+.|.+.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++++.+||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 45678999999999999999999999999999999986432 23467889999999996699999999998653
Q ss_pred ---CeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeec
Q 014704 141 ---HSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (420)
Q Consensus 141 ---~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Df 215 (420)
..+|+||||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||++ ++++.++|+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Df 155 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDF 155 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccC
Confidence 4689999999999999988764 358999999999999999999999999999999999999 45677999999
Q ss_pred ccccccCCC-CceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q 014704 216 GLSVFFKPG-DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288 (420)
Q Consensus 216 g~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 288 (420)
|++...... .......|++.|+|||++. ..++.++||||+||++|+|++|..||...........+.....
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-- 233 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-- 233 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCC--
Confidence 998765432 1223457899999999874 2478899999999999999999999977665544444333221
Q ss_pred CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.......++.++.+|+.+||..||.+|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 111224578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=339.89 Aligned_cols=254 Identities=30% Similarity=0.462 Sum_probs=208.1
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|+||.||+|.++.+++.||+|.+..... .......+.+|+.+++.++ ||||+++++++.++..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence 48899999999999999999999999999999865322 2334467889999999999 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 148 DLCAGGELFDRIIAK---GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 148 e~~~g~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence 9997 5888877543 458999999999999999999999999999999999999 45677999999998765322
Q ss_pred -CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------------
Q 014704 225 -DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI--------------- 286 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~--------------- 286 (420)
.......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.+.........+.....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 12233467899999998754 478899999999999999999999987765433322211100
Q ss_pred ----------CCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 287 ----------DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 287 ----------~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
......+..++++++++|++||..||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00011134578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=350.73 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=200.8
Q ss_pred ccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
.++|.+.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.++..+.+||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999852 345689999986432 2344567899999999995599999999988754
Q ss_pred -CeEEEEEecCCCCChHHHHHhc---------------------------------------------------------
Q 014704 141 -HSVNLIMDLCAGGELFDRIIAK--------------------------------------------------------- 162 (420)
Q Consensus 141 -~~~~iv~e~~~g~~L~~~l~~~--------------------------------------------------------- 162 (420)
..+++||||++||+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999988653
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc---eecccCCc
Q 014704 163 -----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSA 234 (420)
Q Consensus 163 -----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~ 234 (420)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... .....+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 237778889999999999999999999999999999999 4567899999999986533221 12234567
Q ss_pred ccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccC
Q 014704 235 YYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311 (420)
Q Consensus 235 ~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 311 (420)
.|+|||++. ..++.++|||||||++|+|++ |..||.+..... ....+..+.. .. ....+++++.+++.+||..|
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-MR--APENATPEIYRIMLACWQGD 317 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-CC--CCCCCCHHHHHHHHHHccCC
Confidence 899999885 458999999999999999997 999998765433 3333333322 11 12467889999999999999
Q ss_pred cCCCCCHHHHhc
Q 014704 312 PKERLSAAEVLN 323 (420)
Q Consensus 312 p~~R~t~~e~l~ 323 (420)
|++|||+.++++
T Consensus 318 p~~RPs~~el~~ 329 (338)
T cd05102 318 PKERPTFSALVE 329 (338)
T ss_pred hhhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=352.10 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=199.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
..|.+.+.||+|+||.||+|.+..+++.||+|+.... ....|+.++++++ ||||+++++++......++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCeeEEE
Confidence 4699999999999999999999999999999985432 2346899999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||++. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc
Confidence 99995 588887765 4569999999999999999999999999999999999999 556779999999987644433
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCC-CCCCH---------HHHHHHHHcC-C---CCCCC
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPF-WGETE---------QSIFDAILRG-H---IDFSS 290 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf-~~~~~---------~~~~~~i~~~-~---~~~~~ 290 (420)
......||+.|+|||++.+ .++.++|||||||++|+|+++..|+ ..... ...+..+... . ..++.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 3445679999999999864 5899999999999999999855444 32211 0111111110 0 00110
Q ss_pred --------------------------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 291 --------------------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 291 --------------------------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.....++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 001245778889999999999999999999999999974
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=341.96 Aligned_cols=258 Identities=31% Similarity=0.568 Sum_probs=222.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||++.++.+++.||+|.+.............+.+|+.+++.++ ||||+++++.+..++.+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEE
Confidence 36899999999999999999999999999999987654333445567889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
|||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCcc
Confidence 9999999999999888889999999999999999999999999999999999999 456789999999886421000
Q ss_pred ---------------ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 014704 226 ---------------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (420)
Q Consensus 226 ---------------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 289 (420)
......|+..|+|||.+. ..++.++|+||||+++|+|++|..||.+....+....+..+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 011235788999999875 4589999999999999999999999998888888888777665554
Q ss_pred CCCCCCCChHHHHHHHHhcccCcCCCCC---HHHHhcCCcccc
Q 014704 290 SDPWPNISSSAKDIVKKMLHADPKERLS---AAEVLNHPWMRV 329 (420)
Q Consensus 290 ~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~ 329 (420)
.... .++.++.++|.+||+.||++||+ +.++|+||||..
T Consensus 237 ~~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 237 EGDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred Cccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 4332 57899999999999999999998 799999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=354.29 Aligned_cols=250 Identities=23% Similarity=0.391 Sum_probs=203.7
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|++++ ||||+++++++...+..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence 4579999999999999999999999999999996421 23568999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
|||++. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccc
Confidence 999995 6888888654 469999999999999999999999999999999999999 45667999999999865432
Q ss_pred C---ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCC---C-
Q 014704 225 D---VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET--------EQSIFDAILRGHID---F- 288 (420)
Q Consensus 225 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~---~- 288 (420)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ..++.+.+...... +
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 2 1224579999999999864 58999999999999999999876653321 23333333332211 0
Q ss_pred -----------------------CCCCC---CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 289 -----------------------SSDPW---PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 289 -----------------------~~~~~---~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
....| ..++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11112 245678999999999999999999999999999963
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=336.55 Aligned_cols=256 Identities=29% Similarity=0.503 Sum_probs=218.7
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. ||||+++++++.++..+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEE
Confidence 36889999999999999999999999999999986543 2344567889999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-C
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-D 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-~ 225 (420)
+||+.+++|.+++... .+++..+..++.|++.||.|||+.+++||||+|+||++ +.++.++|+|||++...... .
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence 9999999999988754 89999999999999999999999999999999999999 45677999999999876543 2
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
......|++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+......... ...++.++.+++
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 231 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFV 231 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHH
Confidence 2344578899999998864 5899999999999999999999999877766665555554322211 112788999999
Q ss_pred HHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.+||..||++|||++++++||||+...
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=334.46 Aligned_cols=253 Identities=30% Similarity=0.530 Sum_probs=214.4
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh------hhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR------DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
+|.+++.||+|+||.||+|.+..+++.+|+|.+........ ...+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence 47889999999999999999998899999998865433221 23467889999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
..++||||+.+++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||++ +.++.++|+|||.+...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCccc
Confidence 999999999999999999888889999999999999999999999999999999999999 55677999999998766
Q ss_pred CCCC-------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 014704 222 KPGD-------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (420)
Q Consensus 222 ~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 293 (420)
.... ......|+..|+|||.+.+ .++.++|+||+|+++|+|++|+.||...+.......+...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 233 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP---EIP 233 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCC---cCC
Confidence 4211 1123458889999998864 5888999999999999999999999877665555444442211 112
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
..++..+.++|++||+.||.+||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 3578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=336.64 Aligned_cols=252 Identities=24% Similarity=0.461 Sum_probs=216.5
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
.|.+..+||+|+||.||+|.++.+|+.+|+|.+... .+++.+..|+.+|+++. .|++|++|+.|-....+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEeeh
Confidence 478889999999999999999999999999998643 46788999999999999 999999999999999999999
Q ss_pred ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 148 DLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
|||..|++.+.+.. +++++|.++..+++..+.||+|||...-+|||||..|||++ .++..||+|||.+..+....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN---T~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN---TDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc---ccchhhhhhccccchhhhhHH
Confidence 99999999998865 46799999999999999999999999999999999999995 56779999999998765432
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCCCChHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH-IDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~l 303 (420)
..++..|||.|||||++.. .|+.++||||||++..||.-|++||.+-.....+-.|-... ..|.. ....|.++.||
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~K--PE~WS~~F~DF 262 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKK--PEEWSSEFNDF 262 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCC--hHhhhhHHHHH
Confidence 3356789999999999986 59999999999999999999999997765543332222221 11211 12458899999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
|++||.++|++|.|+.++++|||++..
T Consensus 263 i~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 999999999999999999999999743
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=337.35 Aligned_cols=252 Identities=32% Similarity=0.565 Sum_probs=218.9
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|++++++++ ||||+++++++.+....++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEE
Confidence 4889999999999999999999999999999997655444456788999999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCce
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~ 227 (420)
||+.|++|.+++.....+++..+..++.||++||.|||++|++|+||+|+||++ ++++.++|+|||++.........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCccc
Confidence 999999999999887789999999999999999999999999999999999999 45677999999998876554444
Q ss_pred ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 228 KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE---QSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 228 ~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
....|+..|+|||.+.. .++.++|+||+|+++|+|++|..||...+. .............+ ...++.++.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 232 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----PATWSTEAIDA 232 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccC----cccCcHHHHHH
Confidence 55678899999999864 479999999999999999999999987763 33333333222222 23578999999
Q ss_pred HHHhcccCcCCCCCH--HHHhcCCcc
Q 014704 304 VKKMLHADPKERLSA--AEVLNHPWM 327 (420)
Q Consensus 304 i~~~L~~dp~~R~t~--~e~l~h~~~ 327 (420)
|.+||..||.+||++ .|+++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=334.48 Aligned_cols=251 Identities=31% Similarity=0.532 Sum_probs=215.2
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|.+..+|+.||+|.+.+...........+..|..++....+||||+++++++...+.+|+||||+.|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999999999999999987544333333445566666665554599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecccC
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g 232 (420)
++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence 9999999888889999999999999999999999999999999999999 4567799999998876433 234568
Q ss_pred Ccccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccC
Q 014704 233 SAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311 (420)
Q Consensus 233 t~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 311 (420)
++.|+|||.+.+ .++.++||||+|+++|+|++|..||...+....+..+..+...++......++.++.++|.+||+.|
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 899999999864 4789999999999999999999999988888888888777666655555578999999999999999
Q ss_pred cCCCCC---HHHHhcCCcccc
Q 014704 312 PKERLS---AAEVLNHPWMRV 329 (420)
Q Consensus 312 p~~R~t---~~e~l~h~~~~~ 329 (420)
|++||+ ++|+|+||||+.
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHccCCCcHHHHHcChHhhc
Confidence 999994 579999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=342.12 Aligned_cols=256 Identities=26% Similarity=0.392 Sum_probs=212.8
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|++++++++ ||||+++++++.+++.+|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999886432 2344567889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||++|++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+||+++ .++.+||+|||++......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCccccccc-
Confidence 9999999999999888889999999999999999999997 5999999999999994 5667999999998765332
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------------
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF---------------- 288 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------------- 288 (420)
......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+.......
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 2244578999999999864 48899999999999999999999997655433322221111000
Q ss_pred ------------------CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 289 ------------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 289 ------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+..+...++.++++|+.+||..||++|||+.++++||||..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00011236778999999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=349.16 Aligned_cols=252 Identities=28% Similarity=0.493 Sum_probs=220.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
..|.=.+.||.|+||.||.|++..+.+.||||.+....-.+.+.-..+..|++.|+++. |||++.+-++|..+...|+|
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchHHHH
Confidence 34666789999999999999999999999999997665555555678999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRII-AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||||-| +-.|.+. .++++.+.+++.|+.+.+.||+|||+++.||||||..|||+ .+.+.|||+|||.|....+.
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcCch-
Confidence 999965 6666664 35679999999999999999999999999999999999999 67788999999999877654
Q ss_pred ceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCCCChHH
Q 014704 226 VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG-HIDFSSDPWPNISSSA 300 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~ 300 (420)
.+++|||+|||||++. +.|+-++||||||++..||.-.++|+...+....+..|..+ .+.+... ..|..+
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~---eWS~~F 254 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSN---EWSDYF 254 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCc---hhHHHH
Confidence 5679999999999873 67999999999999999999999999888877666666654 3444443 458899
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.||..||++-|.+|||.+++|+|+|+..
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 99999999999999999999999999864
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=334.35 Aligned_cols=255 Identities=29% Similarity=0.484 Sum_probs=217.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||.|+||+||+|....++..+|+|++..... ......+.+|+.+++.++ |+||+++++.+.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEE
Confidence 469999999999999999999998999999999865433 225678999999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 147 MDLCAGGELFDRIIAK---GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
||++.|++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||++ ++++.++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhcc
Confidence 9999999999998764 458999999999999999999999999999999999999 4567799999999876654
Q ss_pred CCc-----eecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCC
Q 014704 224 GDV-----FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD--PWP 294 (420)
Q Consensus 224 ~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~ 294 (420)
... .....|+..|+|||++.. .++.++|+||||+++|+|++|+.||...+....+..+.......... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence 322 133468999999998854 48899999999999999999999998877666666655543221111 124
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.+++.+.+++.+||..||++|||+.++++||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 678999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=331.10 Aligned_cols=252 Identities=24% Similarity=0.466 Sum_probs=218.7
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|+||.||+|.++.+++.|++|.+..... .......+.+|+.+++.++ ||||+++++++.+.+.+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEE
Confidence 47888999999999999999999999999999875443 3445678999999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||+.|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceeccCcc
Confidence 999999999998764 5689999999999999999999999999999999999994 56779999999988765432
Q ss_pred c-eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 226 V-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 226 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
. .....|++.|+|||++.+ .++.++|+||||+++|+|++|+.||...+.......+..+...... ..++.++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQL 232 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence 2 234568899999998864 5889999999999999999999999888877777777665433222 2568899999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCcc
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
|.+||+.+|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=335.93 Aligned_cols=255 Identities=28% Similarity=0.466 Sum_probs=212.2
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|.++.+++.||+|++.... ......+.+|+.+++.++ ||||+++++++...+.+|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLW 82 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEE
Confidence 3467999999999999999999999999999999986432 233456889999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeeccc
Confidence 999999999999999888889999999999999999999999999999999999999 45667999999998865432
Q ss_pred C-ceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCCCh
Q 014704 225 D-VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS-DPWPNISS 298 (420)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~ 298 (420)
. ......|++.|+|||.+. ..++.++||||+||++|+|++|..||...........+.......+. .....++.
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence 2 223456889999999873 23788999999999999999999999765543333222222222111 11124688
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPW 326 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~ 326 (420)
.+.+||++||..||++|||++++|+|+|
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=342.11 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=206.1
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
...|.+.+.||+||.+.||++...+. +.||+|.+.... .+...+..+.+|+..|.+|++|.+||++++|-..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 45699999999999999999987654 566777664333 3566778899999999999999999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||- ..+|...|.++.. .+...++.+..||+.|+.++|++||||.||||.|+|+. .+.+||+|||+|..+...
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCcc
Confidence 99986 4589888887765 34358889999999999999999999999999999995 567999999999988654
Q ss_pred C---ceecccCCcccccchhhcc------------cCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCC
Q 014704 225 D---VFKDLVGSAYYVAPEVLRR------------NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDF 288 (420)
Q Consensus 225 ~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~ 288 (420)
. ...+.+||+.||+||.+.. +.++++||||||||||+|+.|++||..-. ...-+..|.......
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI 592 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence 3 2345799999999998841 15688999999999999999999995433 223333444432222
Q ss_pred CCCCCCCCC--hHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 289 SSDPWPNIS--SSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 289 ~~~~~~~~~--~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+. +.++ .++.++++.||..||++|||+.++|+|||+..
T Consensus 593 ef---p~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 593 EF---PDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cc---cCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 22 2222 34899999999999999999999999999974
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=342.50 Aligned_cols=254 Identities=27% Similarity=0.521 Sum_probs=206.9
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++ ||||+++++++.+.+.+|+|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence 48899999999999999999999999999999865432 2233456788999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-C
Q 014704 148 DLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-D 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-~ 225 (420)
||+.+ +|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...... .
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC
Confidence 99975 78777765 4679999999999999999999999999999999999999 45677999999998865432 2
Q ss_pred ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCC--------------CC
Q 014704 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFW-GETEQSIFDAILRGHI--------------DF 288 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~-~~~~~~~~~~i~~~~~--------------~~ 288 (420)
......+++.|+|||++.+ .++.++|||||||++|+|++|..||. +.+....+..+.+... .+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2234567899999998754 37899999999999999999988854 4444444433322110 00
Q ss_pred ---C--------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 289 ---S--------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 289 ---~--------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+ ....+.+++++++||.+||..||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 01123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.97 Aligned_cols=241 Identities=18% Similarity=0.248 Sum_probs=207.5
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe----CCeEEEEEe
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----RHSVNLIMD 148 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~----~~~~~iv~e 148 (420)
..||+|++|.||+|.. +|+.||+|.+...........+.+.+|+.+|++++ ||||+++++++.+ ...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence 5789999999999988 57899999987654333334577889999999999 9999999999876 457899999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCce
Q 014704 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227 (420)
Q Consensus 149 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~ 227 (420)
|+.||+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+||++ +.++.+||+|||++.......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence 999999999998888899999999999999999999984 99999999999999 556789999999988654322
Q ss_pred ecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 228 KDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 228 ~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
....|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+......++.+ ...++.+++|+
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li 255 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV 255 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence 34568999999999864 68999999999999999999999999988888888776655444332 25789999999
Q ss_pred HHhcccCcCCCCCHHHHhc
Q 014704 305 KKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~ 323 (420)
.+||+.||++|||+.++++
T Consensus 256 ~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHhcCCcccCcCHHHHHH
Confidence 9999999999999999974
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=337.52 Aligned_cols=259 Identities=28% Similarity=0.493 Sum_probs=217.2
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
+...+|.+.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.+. ||||+++++.+.+....
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL 92 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCEE
Confidence 344689999999999999999999999999999999865432 23467889999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+||||+.|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred EEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhccc
Confidence 999999999999998754 468999999999999999999999999999999999999 4567899999999876543
Q ss_pred CC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 GD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.. ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||...........+...... .......++..+.
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 247 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFR 247 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC-CCCCccccCHHHH
Confidence 32 2234578999999998864 4789999999999999999999999887765444333332211 1112246788999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
++|.+||..||++|||+.++++||||....
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=337.54 Aligned_cols=251 Identities=31% Similarity=0.522 Sum_probs=210.4
Q ss_pred ecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCCC
Q 014704 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (420)
Q Consensus 75 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~~ 154 (420)
||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.++ ||||+++++++...+.+|+||||++|++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999999999999999987644333344556788999999999 9999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecccC
Q 014704 155 LFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232 (420)
Q Consensus 155 L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g 232 (420)
|.+++.+.. .+++..+..++.|++.||.|||++|++||||+|+||++ ++++.++|+|||.+.............+
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccC
Confidence 999987765 69999999999999999999999999999999999999 5567899999999877654434445568
Q ss_pred Ccccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccC
Q 014704 233 SAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311 (420)
Q Consensus 233 t~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 311 (420)
+..|+|||.+.+ .++.++||||+|+++|+|++|+.||...........+..............+++++.++|++||+.|
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 889999998754 4889999999999999999999999776542222233332222233333467899999999999999
Q ss_pred cCCCC-----CHHHHhcCCcccc
Q 014704 312 PKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 312 p~~R~-----t~~e~l~h~~~~~ 329 (420)
|++|| ++.++++||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=329.81 Aligned_cols=252 Identities=25% Similarity=0.539 Sum_probs=214.5
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-CCeEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-RHSVNLI 146 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-~~~~~iv 146 (420)
.|++.+.||+|++|.||++.++.+++.||+|.+..... .....+.+.+|+.++++++ |||++++++.+.. ...+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEE
Confidence 48999999999999999999999999999999865332 3345567899999999998 9999999998764 4568999
Q ss_pred EecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 147 MDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEeccc
Confidence 9999999999988763 458999999999999999999999999999999999999 45678999999998765432
Q ss_pred -CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 225 -DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
.......|++.|+|||++.+ .++.++||||+|+++|+|++|..||...+.......+..+.... ....+++.+.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGE 232 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHH
Confidence 22334568999999998864 58899999999999999999999998877766666666654322 12357899999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+|.+||..||++|||+.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=344.43 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=204.7
Q ss_pred ecceeccc--CCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 71 FGRELGRG--QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 71 ~~~~lG~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
+.++||+| +|++||++.++.+|+.||+|.+..... .......+.+|+.+++.++ ||||+++++++.+++..|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEe
Confidence 56789999 789999999999999999999865432 3344567889999999998 9999999999999999999999
Q ss_pred cCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-C
Q 014704 149 LCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-D 225 (420)
Q Consensus 149 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-~ 225 (420)
|+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.++++||+.+...... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhccccccc
Confidence 99999999988653 4589999999999999999999999999999999999994 5667999999865433211 0
Q ss_pred -------ceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------
Q 014704 226 -------VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS------ 289 (420)
Q Consensus 226 -------~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------ 289 (420)
......++..|+|||++.+ .++.++|||||||++|+|++|..||..............+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 1112356778999999863 488999999999999999999999987655444433332221100
Q ss_pred ------------------------------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 290 ------------------------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 290 ------------------------------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.+....+++++.+||++||+.||++|||+.++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0011234678999999999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=329.66 Aligned_cols=253 Identities=25% Similarity=0.455 Sum_probs=219.1
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|+.+++.++ ||||+++++.+...+..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence 58899999999999999999999999999999876543 3445678999999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||++|++|.+++... ..+++..+..++.|++.+|.|||++||+||||+|+||+++. ++..+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK--HKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEccCCCceecCCCc
Confidence 999999999999764 34899999999999999999999999999999999999952 34568999999998765544
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
......|+..|+|||.+.+ .++.++||||+|+++|+|++|..||.+.+.......+........ ...++.++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li 233 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI---SDRYSPDLRQLI 233 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC---CCCcCHHHHHHH
Confidence 4344678999999999864 478899999999999999999999988877777766665443211 235789999999
Q ss_pred HHhcccCcCCCCCHHHHhcCCcc
Q 014704 305 KKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.+||..+|++|||+.++++||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=334.28 Aligned_cols=257 Identities=29% Similarity=0.497 Sum_probs=216.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
+.|++.+.||+|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.+. ||||+++++++...+..|+|
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEE
Confidence 3478889999999999999999999999999998543 3345677889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
|||+.+++|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||++ +.++.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence 999999999887765 4569999999999999999999999999999999999999 45667999999998764322
Q ss_pred CceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 225 DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
.......|++.|+|||++. ..++.++||||+||++|+|++|.+||...+.......+......... ....++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCC-CccccCH
Confidence 1223457899999999873 23678999999999999999999999887776666666554332211 1235788
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
++++||.+||..||.+|||+.++++||||+...
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 999999999999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=336.34 Aligned_cols=257 Identities=30% Similarity=0.492 Sum_probs=216.5
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..+.|++.+.||.|+||.||+|.+..+++.+|+|.+... .....+.+.+|+.+++.+. ||||+++++.+..++.+|
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEE
Confidence 346799999999999999999999999999999998643 3455677889999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
+||||++|++|..++.+ ...+++..+..++.|++.+|.|||++||+||||||+||++ +.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccc
Confidence 99999999999887754 4568999999999999999999999999999999999999 4567799999998875432
Q ss_pred C-CceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 224 G-DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 224 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
. .......+++.|+|||++. ..++.++|||||||++|+|++|..||...+.......+........ .....+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 241 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-SQPSKW 241 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC-CCCccc
Confidence 2 1223456889999999873 2367899999999999999999999988776665555554332211 112357
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.++.++|.+||..||++||++.++++||||..
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 889999999999999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=331.76 Aligned_cols=249 Identities=33% Similarity=0.621 Sum_probs=215.7
Q ss_pred ecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCCC
Q 014704 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (420)
Q Consensus 75 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~~ 154 (420)
||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++ ||||+++++++.++..+|+||||++|++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 799999999999999989999999997655444455678999999999998 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecccCCc
Q 014704 155 LFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 234 (420)
Q Consensus 155 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~ 234 (420)
|.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++.............|++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCc
Confidence 99999888889999999999999999999999999999999999999 456789999999998765543334457899
Q ss_pred ccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccC
Q 014704 235 YYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET--EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311 (420)
Q Consensus 235 ~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 311 (420)
.|+|||.+.. .++.++|+||+|+++|+|++|..||.... .......+..+......+ ...+.++.++|.+||..+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHccCC
Confidence 9999998754 58899999999999999999999998776 566666666433222222 234889999999999999
Q ss_pred cCCCCC-----HHHHhcCCcccc
Q 014704 312 PKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 312 p~~R~t-----~~e~l~h~~~~~ 329 (420)
|++||+ +.|+++||||+.
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhC
Confidence 999999 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=335.65 Aligned_cols=257 Identities=33% Similarity=0.507 Sum_probs=218.9
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||.|+||.||++.+..++..+|+|.+... .....+.+.+|+.++++++ ||||+++++++.+...+|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEE
Confidence 35799999999999999999999988999999998643 3445677889999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||+++++|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccc
Confidence 99999999999988764 469999999999999999999999999999999999999 55678999999988765332
Q ss_pred C-ceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 225 D-VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
. ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+..+...... ....++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 235 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD-QPSKWS 235 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC-CcccCC
Confidence 2 223456899999999874 23678999999999999999999999888777766666655332211 123578
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.++.++|.+||+.+|.+|||+.++++||||...
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 899999999999999999999999999999743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=336.58 Aligned_cols=259 Identities=26% Similarity=0.409 Sum_probs=213.8
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||++.+..+++.||+|.+... ........+.+|+.+++++. ||||+++++.+...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEE
Confidence 3688999999999999999999999999999988643 23344578899999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 147 MDLCAGGELFDRIIAK---GHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|||++|++|..++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++ .++.+||+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCccccc
Confidence 9999999998887653 379999999999999999999997 5999999999999994 46779999999987653
Q ss_pred CCCceecccCCcccccchhhcc-------cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRR-------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
.. ......+++.|+|||.+.+ .++.++|+||+||++|+|++|..||...........+............+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 22 2234568889999998743 257899999999999999999999977655444443322111111122345
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
++.++.+||.+||..+|++||++.++++||||.....
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 7899999999999999999999999999999975543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=331.47 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=212.1
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcC---CChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL---INRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
+|.+++.||+|+||.||+|... +++.+|+|.+..... ........+.+|+.+++.++ |+||+++++++.+.+.++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence 4788999999999999999864 688999998864322 12234467899999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP- 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~- 223 (420)
+||||+.|++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhc
Confidence 999999999999999887889999999999999999999999999999999999999 4567799999999876421
Q ss_pred ------CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 224 ------GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 224 ------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
........|+..|+|||.+.+ .++.++||||||+++|+|++|..||...........+.......+. ....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 234 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR-LPDSF 234 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC-CCCCC
Confidence 112234568999999999864 4789999999999999999999999876655444444433221111 22357
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+.++.++|++||..+|++|||+.++++||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=336.53 Aligned_cols=255 Identities=31% Similarity=0.553 Sum_probs=213.7
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++++. ||||+++++++.+...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence 58899999999999999999999999999999875432 2334567899999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 148 DLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
||+ |++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---CCCcEEEeeeeecccccCCCC
Confidence 999 99999988653 5689999999999999999999999999999999999994 46779999999988765432
Q ss_pred -ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Q 014704 226 -VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI---------------- 286 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~---------------- 286 (420)
......|+..|+|||.+.+ .++.++||||+|+++|+|++|.+||.+......+..+.....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2344578999999998753 468999999999999999999999987776555554433110
Q ss_pred ---CCCC-------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 287 ---DFSS-------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 287 ---~~~~-------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.++. ..++..+..+.+||.+||..||++|||++++|+||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0110 11235678999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=337.21 Aligned_cols=262 Identities=28% Similarity=0.487 Sum_probs=217.4
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.+...+|.+.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++ ||||+++++++...+.
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDE 90 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCE
Confidence 3445789999999999999999999999999999999864332 33467889999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
.|+||||++|++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEcc
Confidence 9999999999999998754 568999999999999999999999999999999999999 556789999999987654
Q ss_pred CCCc-eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 223 PGDV-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 223 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
.... .....+++.|+|||.+.+ .++.++|+||+||++|++++|..||.+.+.......+..... ........++..+
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 245 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPERLSAVF 245 (297)
T ss_pred CCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC-CCCCCccccCHHH
Confidence 3322 234568899999998864 588999999999999999999999987665433332222211 1111224578889
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCcccccCCC
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDA 333 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 333 (420)
++|+.+||..||++|||+.++++||||+.....
T Consensus 246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 246 RDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 999999999999999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=333.28 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=207.6
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++++. ||||+++++++...+..++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEEEEE
Confidence 5788899999999999999999999999999986432 2344567899999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCce
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~ 227 (420)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++...... ..
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-IA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-cc
Confidence 99999998543 357899999999999999999999999999999999999 45678999999998765432 23
Q ss_pred ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 228 KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE-------QSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 228 ~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
....||..|+|||++.+ .++.++|+||||+++|+|++|..||..... ......+..... +.......+++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 228 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSEK 228 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCCcCCHH
Confidence 44578999999998864 589999999999999999999999965321 122222222211 11112356889
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+.++|.+||+.||++||++.++++||||...
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 9999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=361.45 Aligned_cols=252 Identities=29% Similarity=0.477 Sum_probs=212.1
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEE-EEEe--
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG-AYED-- 139 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~-~~~~-- 139 (420)
..-..++++.+.|.+|||+.||+|++...|..||+|++... ++..++.+.+||.+|+.|++|+|||.++| ....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 33456789999999999999999999988899999997543 67788999999999999999999999999 3321
Q ss_pred ----CCeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCCCCCCee
Q 014704 140 ----RHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 140 ----~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
.-.++|.||||.||.|.|++..+ ..|+|.++.+|+.|+++|+.+||... |||||||-+|||+ ..++.+|
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~K 186 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYK 186 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEE
Confidence 23578999999999999999753 45999999999999999999999998 9999999999999 5567899
Q ss_pred EeecccccccCCCC-ce---------ecccCCcccccchhhc---c-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH
Q 014704 212 ATDFGLSVFFKPGD-VF---------KDLVGSAYYVAPEVLR---R-NYGAEADIWSAGVILYILLSGVPPFWGETEQSI 277 (420)
Q Consensus 212 l~Dfg~~~~~~~~~-~~---------~~~~gt~~y~aPE~~~---~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~ 277 (420)
|||||.+....... .. -....|+.|+|||++. + ..+.|+|||+|||+||.|+....||.....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--- 263 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--- 263 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---
Confidence 99999886532211 00 0124699999999874 2 489999999999999999999999976543
Q ss_pred HHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCc
Q 014704 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326 (420)
Q Consensus 278 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 326 (420)
-.|+.+.+.++. ++..+..+++||+.||+.||++||++.|++.+-+
T Consensus 264 -laIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 264 -LAILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred -eeEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 346778877776 3688999999999999999999999999987644
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=350.72 Aligned_cols=246 Identities=35% Similarity=0.563 Sum_probs=215.8
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+...|.+...+|.|+|+.|..+.+..+++.+++|++.+... ...+|+.++....+||||+++.+.+.+..+.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 356789999999999999999999999999999999976532 2346777777887899999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+|||++.|+.+.+.+.....+. ..+..|+.+|+.|+.|||++|+|||||||+|||+. +..++++|+|||.++....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCch
Confidence 99999999999999988776666 78889999999999999999999999999999995 4567899999999998765
Q ss_pred CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
. ..+.+-|..|.|||++.. .|+++||+||||++||+||+|+.||...... ++...+..+.+. ..+|.+++
T Consensus 469 ~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AK 540 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAK 540 (612)
T ss_pred h--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHH
Confidence 4 345567889999999874 5999999999999999999999999877665 555555554443 47899999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+||+.||++||.+|+++.+++.||||
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999999
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=335.32 Aligned_cols=257 Identities=28% Similarity=0.514 Sum_probs=218.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
..+|.+.+.||.|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++ ||||+++++++.+.+.+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCceEEE
Confidence 357999999999999999999999999999999986432 234567889999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|+||+.|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccccc
Confidence 9999999999887754 468999999999999999999999999999999999999 456779999999987654433
Q ss_pred c-eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 226 V-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 226 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
. .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||.+.........+...... .......+++.+.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCcccCCHHHHHH
Confidence 2 234568899999998864 5889999999999999999999999887765555555443221 112234678999999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
|++||..||++|||+.++++||||+...
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=327.04 Aligned_cols=252 Identities=29% Similarity=0.519 Sum_probs=220.6
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|++.+.||.|+||.||.+.+..+++.+++|.+..... +......+.+|+.++++++ |+||+++++++.+.+..+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEE
Confidence 58999999999999999999999999999999865433 3445667889999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||++++|.+++... ..+++..+..++.|++.+|.|||+.|++||||+|+||+++ +++.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEccccc
Confidence 999999999998765 4589999999999999999999999999999999999994 56679999999988664433
Q ss_pred -ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 226 -VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......|++.|+|||.+.+ .++.++||||+|+++|+|++|..||......+....+..+...... ..++.++.++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISL 232 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence 2344578999999998754 4788999999999999999999999988888888887776554322 4678999999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCcc
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
|.+||..+|++|||+.++|+|+|+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=345.83 Aligned_cols=255 Identities=23% Similarity=0.426 Sum_probs=216.5
Q ss_pred ccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 60 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
..++...+...++..||+|.||+||+|.+-. .||||++..... +.+..+.|++|+.++++-+ |.||+-++|++..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTR-HENILLFMGACMN 459 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcc-hhhheeeehhhcC
Confidence 4556666778899999999999999999965 499999987654 5668899999999999999 9999999999988
Q ss_pred CCeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
+.. .||+.+|+|.+|+.+++-. ..|.-.....|++||++|+.|||.++|||||||..||++ .+++.|||+|||++
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLA 535 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccce
Confidence 877 9999999999999988654 458888999999999999999999999999999999999 56688999999998
Q ss_pred ccc---CCCCceecccCCcccccchhhcc----cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-
Q 014704 219 VFF---KPGDVFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS- 290 (420)
Q Consensus 219 ~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~- 290 (420)
... ..........|...|||||++.. .|++.+||||||+++|||++|..||.....++++-.+-+|......
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS 615 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence 653 23344555678899999999852 4999999999999999999999999977777777666666332221
Q ss_pred CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 291 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
....+.+.++++|+..||.+++++||.+.++|.
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 122456679999999999999999999999986
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=329.78 Aligned_cols=255 Identities=28% Similarity=0.484 Sum_probs=210.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC--ChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCe
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--NRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHS 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--~~~ 142 (420)
.+|...+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++ ||||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCE
Confidence 3688999999999999999999999999999998654321 2234567899999999998 9999999998875 467
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
++++|||+++++|.+++...+.+++.....++.|++.||.|||+++|+||||||+||++ +.++.+||+|||++....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence 89999999999999999888889999999999999999999999999999999999999 456679999999987653
Q ss_pred CC----CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 223 PG----DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 223 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.. .......++..|+|||.+.+ .++.++||||+||++|+|++|+.||...........+........ ....++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~ 235 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ--LPSHIS 235 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCC--CchhcC
Confidence 21 11223468889999999864 488999999999999999999999987665554444433221111 112467
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
+.++++| +||..+|++|||++|+++||||+
T Consensus 236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 8899999 57778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=351.62 Aligned_cols=254 Identities=24% Similarity=0.471 Sum_probs=224.1
Q ss_pred eecceecccCCeEEEEEEEcCCCceEEEEEecCCcC-CChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe--EEEE
Q 014704 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-INRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS--VNLI 146 (420)
Q Consensus 70 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~--~~iv 146 (420)
++...||+|+|-+||+|.+..+|..||.-.++.+.+ ..+...+++..|+.+|+.|+ ||||+++|++|.+... +.+|
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeee
Confidence 456889999999999999999999998765543332 34566799999999999999 9999999999987655 8899
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+|++..|+|..|+.+.++++...++.|++||+.||.|||++. |||||||.+||+|+ +..+.|||+|+|+|......
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhcc
Confidence 999999999999999999999999999999999999999986 99999999999997 67788999999999987654
Q ss_pred CceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFW-GETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
.. ...+|||.|||||++...|+..+||||||+.|+||+|+..||. +.+..++++++..|..+-.....+ .+++++|
T Consensus 200 ~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~--dPevr~f 276 (632)
T KOG0584|consen 200 HA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK--DPEVREF 276 (632)
T ss_pred cc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC--CHHHHHH
Confidence 33 3478999999999999999999999999999999999999995 566788899998887655443322 6899999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
|.+||.. .+.|+|+.|+|+||||..+
T Consensus 277 IekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 277 IEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHhcC-chhccCHHHHhhChhhccc
Confidence 9999999 9999999999999999875
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=337.36 Aligned_cols=256 Identities=27% Similarity=0.495 Sum_probs=213.0
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.++.+++.||+|.+..... .....+.+.+|+++++.++ ||||+++++++.+++..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEE
Confidence 468999999999999999999998999999999865432 2234567889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-C
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-D 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-~ 225 (420)
|||+++++|..+......+++..+..++.||+.||.|||+.||+||||+|+||++ +.++.++|+|||++...... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence 9999999888777666679999999999999999999999999999999999999 45678999999998865433 2
Q ss_pred ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------------
Q 014704 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID---------------- 287 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------------- 287 (420)
......++..|+|||++.+ .++.++||||||+++|+|++|++||...........+......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2334568899999998854 4788999999999999999999999876654443333321100
Q ss_pred ---CCC--------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 288 ---FSS--------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 288 ---~~~--------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.+. ..++.++..+.+|+.+||..+|++||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 1134678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=333.47 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=210.2
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE------
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE------ 138 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~------ 138 (420)
..+.|++.+.||.|+||.||+|.+..+++.+|+|++... ......+..|+.+++++.+||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 446899999999999999999999999999999998543 2344678899999999966999999999984
Q ss_pred eCCeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
....+|++|||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg 166 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFG 166 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCc
Confidence 356789999999999999988653 358899999999999999999999999999999999999 456779999999
Q ss_pred cccccCCC-CceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 014704 217 LSVFFKPG-DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (420)
Q Consensus 217 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 289 (420)
++...... .......|++.|+|||.+. ..++.++|||||||++|+|++|..||...........+.+... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~ 244 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--P 244 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--C
Confidence 98765322 2223457899999999874 2478899999999999999999999977665444444333221 1
Q ss_pred CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 290 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
......++.++.+||++||..||.+|||+.++|+||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 11123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=328.26 Aligned_cols=254 Identities=30% Similarity=0.517 Sum_probs=216.0
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||.|+||.||+|.+..+++.+++|.+.... ....+.+.+|+.++++++ ||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEE
Confidence 357999999999999999999999889999999986542 235678999999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+|||+.+++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||++ +.++.+||+|||++......
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhh
Confidence 99999999999988776 789999999999999999999999999999999999999 45677999999998765432
Q ss_pred C-ceecccCCcccccchhhcc----cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCCCh
Q 014704 225 D-VFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS-DPWPNISS 298 (420)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~~----~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~ 298 (420)
. ......++..|+|||.+.. .++.++|+||||+++|+|++|..||.+.........+......... ......+.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence 2 2234578889999998753 5788999999999999999999999887766555555444222211 11134578
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPW 326 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~ 326 (420)
++.++|++||..+|.+|||+.+++.|+|
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 8999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=330.45 Aligned_cols=256 Identities=27% Similarity=0.482 Sum_probs=213.7
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCC-------hhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-------RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+....... ....+.+.+|+.+++.++ ||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence 5889999999999999999999899999999885422111 112456889999999998 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+.+++||||+.|++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||++ +.++.++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccccc
Confidence 9999999999999999999888889999999999999999999999999999999999999 4567899999999876
Q ss_pred cCCCC---ceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCC
Q 014704 221 FKPGD---VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG--HIDFSSDP 292 (420)
Q Consensus 221 ~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~ 292 (420)
..... ......|+..|+|||.+.. .++.++|+||||+++|++++|..||...........+... ...++...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 43211 1233468899999998753 3789999999999999999999999766554444333322 22333333
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.+.++.++.++|.+||..+|++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 45678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=336.83 Aligned_cols=260 Identities=28% Similarity=0.476 Sum_probs=214.7
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC--ChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
+|.+.+.||+|+||.||+|.+..+++.||+|.+...... .......+.+|+.+++.++ |+||+++++++.+.+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence 488899999999999999999999999999999765432 1223456788999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++ .++.++|+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc---CCCCEEEccceeeeeccCC
Confidence 99999 889999997766 799999999999999999999999999999999999994 5677999999999876543
Q ss_pred -CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------------
Q 014704 225 -DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS------------ 289 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------ 289 (420)
.......+++.|+|||.+.+ .++.++||||+||++|+|++|.+||.+......+..+........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 22233457888999998743 478999999999999999999888887776555544432110000
Q ss_pred ------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 290 ------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 290 ------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
...+...+.++.++|.+||..||++|||+.++|+|+||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 0012345788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=337.93 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=211.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CeEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HSVN 144 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--~~~~ 144 (420)
++|.+.+.||.|+||.||+|.++.+|+.||+|.+..... .......+.+|+.++++++ |+||+++++++.+. +.++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeEE
Confidence 579999999999999999999999999999999865432 1222335678999999999 99999999998755 5689
Q ss_pred EEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||++ +.++.+||+|||++.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecCC
Confidence 99999965 78777765 3568999999999999999999999999999999999999 4567899999999987653
Q ss_pred C-CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------------
Q 014704 224 G-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-------------- 286 (420)
Q Consensus 224 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~-------------- 286 (420)
. .......+++.|+|||.+.+ .++.++||||+|+++|+|++|.+||.+.+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 3 22233356788999998853 478999999999999999999999998887777766554211
Q ss_pred -----CCCCCC-------CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 287 -----DFSSDP-------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 287 -----~~~~~~-------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
...... +...++++.+||.+||..||++|||+.+++.||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 111111 123578899999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=352.81 Aligned_cols=248 Identities=29% Similarity=0.520 Sum_probs=214.2
Q ss_pred eecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCC
Q 014704 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGG 153 (420)
Q Consensus 74 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~ 153 (420)
+||+|.||+||.|++..+....|||.|..+ +....+-+..||.+-++|+ |.|||+++|.+..++++-|.||.++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 599999999999999999999999999754 3455677999999999999 999999999999999999999999999
Q ss_pred ChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc-eec
Q 014704 154 ELFDRIIAK-GHY--SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV-FKD 229 (420)
Q Consensus 154 ~L~~~l~~~-~~~--~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 229 (420)
+|.++|..+ +++ +|.++..+.+||++||.|||++.|||||||-+|||++ .-.+.+||+|||.++.+..-.. ..+
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence 999999765 667 8999999999999999999999999999999999998 4578899999999988755433 356
Q ss_pred ccCCcccccchhhc---ccCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 230 LVGSAYYVAPEVLR---RNYGAEADIWSAGVILYILLSGVPPFWGET--EQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 230 ~~gt~~y~aPE~~~---~~~~~~~DvwslGvil~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
+.||..|||||++. +.|+.++|||||||++.||.||++||.... ...+++ -|.+....+....+|.+++.||
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---VGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---VGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---hcceecCCCCcHHHHHHHHHHH
Confidence 78999999999995 359999999999999999999999996433 333332 2333333333457889999999
Q ss_pred HHhcccCcCCCCCHHHHhcCCccccc
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+|+.+||.+||+|.++|.+||++..
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccC
Confidence 99999999999999999999999865
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=335.07 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=208.7
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe----
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS---- 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~---- 142 (420)
++|.+.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.+||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 468999999999999999999999999999998765322 223346788899999999868999999999887665
Q ss_pred -EEEEEecCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 143 -VNLIMDLCAGGELFDRIIAK-----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 143 -~~iv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
.|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++. .++.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~--~~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK--QKGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec--CCCeEEEeecc
Confidence 8999999986 788877643 35799999999999999999999999999999999999952 26779999999
Q ss_pred cccccCCC-CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----
Q 014704 217 LSVFFKPG-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS---- 289 (420)
Q Consensus 217 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---- 289 (420)
++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98765322 12223457889999998753 478999999999999999999999988776555444433110000
Q ss_pred --------------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 290 --------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 290 --------------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
....+.++.++.+||.+||..||.+|||+.++|.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 001245788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=327.10 Aligned_cols=252 Identities=26% Similarity=0.562 Sum_probs=217.8
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|++.+.||+|+||.||++.+..+|+.||+|.+..... .......+.+|+.++++++ ||||+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence 58899999999999999999999999999999865433 2344567899999999999 999999999999999999999
Q ss_pred ecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 148 DLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||+.+++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||++ +.+..++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence 9999999999887643 58899999999999999999999999999999999999 456679999999987654432
Q ss_pred c-eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 226 V-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 226 ~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
. .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||...........+..+...... ..++.++.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 232 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVS---SHYSYDLRNL 232 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCc---ccCCHHHHHH
Confidence 2 223468889999999864 5788999999999999999999999888877777777766543221 3578899999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCcc
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
|.+||+.+|++||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=331.63 Aligned_cols=256 Identities=27% Similarity=0.503 Sum_probs=211.4
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCC---hhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN---RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
+|..++.||+|+||.||++.+..+++.||+|.+....... ....+.+.+|++++++++ ||||+++++++.+.+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence 4788899999999999999999999999999986433211 223578899999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||+.|++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++. .+..+||+|||.+......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~--~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEEcccccccccccc
Confidence 99999999999999988888999999999999999999999999999999999999952 2346999999998765432
Q ss_pred C-----ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---HcCCCCCCCCCCCC
Q 014704 225 D-----VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI---LRGHIDFSSDPWPN 295 (420)
Q Consensus 225 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~ 295 (420)
. ......|+..|+|||.+.+ .++.++||||+|+++|+|++|..||...........+ ...... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 235 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA--PSIPEH 235 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC--CCCchh
Confidence 1 1123468889999998854 5889999999999999999999999754432222222 221111 112235
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
+++++.+++.+||..+|++|||+.++++||||+
T Consensus 236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 788999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=333.02 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=201.1
Q ss_pred eecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhc--cCCCCccEEEEEEEeCCeEEEEEecCC
Q 014704 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL--TGHRNIVELKGAYEDRHSVNLIMDLCA 151 (420)
Q Consensus 74 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~hpniv~~~~~~~~~~~~~iv~e~~~ 151 (420)
.||+|+||.||++.+..+++.+|+|.+.+.............+|..+++.+ .+||||+.+++++...+..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998765433222233344555444443 239999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceeccc
Q 014704 152 GGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231 (420)
Q Consensus 152 g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 231 (420)
|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcC
Confidence 99999999888889999999999999999999999999999999999999 556789999999987553322 23346
Q ss_pred CCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcc
Q 014704 232 GSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309 (420)
Q Consensus 232 gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 309 (420)
|++.|+|||.+.. .++.++||||+||++|+|++|..||........ ..+............+.++.+++++|++||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence 8999999998853 478999999999999999999999975432111 1111111122222234678999999999999
Q ss_pred cCcCCCC-----CHHHHhcCCcccc
Q 014704 310 ADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 310 ~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
.||++|+ |+.++++||||+.
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCccccC
Confidence 9999999 6999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=328.07 Aligned_cols=251 Identities=28% Similarity=0.479 Sum_probs=213.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.+..+++.+++|.+.... ..+.+.+|+.+++.++ ||||+++++++.+...+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcEEEE
Confidence 57999999999999999999999889999999986432 2578999999999997 99999999999999999999
Q ss_pred EecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
+||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||+|+||++ +.++.++|+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCc
Confidence 999999999999875 4568999999999999999999999999999999999999 456679999999988765433
Q ss_pred -ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 226 -VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......|+..|+|||++.+ .++.++||||+|+++|+|++|+.||...........+...... .......++.++.++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDF 232 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHHH
Confidence 2234458899999999864 5889999999999999999999999876655444433332211 111123567899999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCcc
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
|.+||+.||++|||+.++|.||||
T Consensus 233 i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=331.44 Aligned_cols=258 Identities=25% Similarity=0.417 Sum_probs=212.7
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-- 140 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-- 140 (420)
....++|.+.+.||+|+||.||+|..+.+++.+|+|.+.... .....+.+|+.+++++.+|||++++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 345678999999999999999999999999999999986432 22356789999999995599999999998643
Q ss_pred ---CeEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 141 ---HSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 141 ---~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
+.+|+||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEe
Confidence 468999999999999987753 3568999999999999999999999999999999999999 456679999
Q ss_pred ecccccccCCCC-ceecccCCcccccchhhcc------cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Q 014704 214 DFGLSVFFKPGD-VFKDLVGSAYYVAPEVLRR------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI 286 (420)
Q Consensus 214 Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 286 (420)
|||++....... ......|+..|+|||.+.. .++.++|||||||++|+|++|+.||...........+.+...
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 999988654332 2234568899999998742 268899999999999999999999988776555555554432
Q ss_pred CCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 287 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.... .....+..+.++|.+||+.+|++||++.++++||||+
T Consensus 251 ~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 PTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2111 1134677899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=332.09 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=210.2
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE--
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE-- 138 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~-- 138 (420)
......++|.+.+.||+|+||.||+|.++.+++.+|+|++.... .....+.+|+.+++.+.+||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34456688999999999999999999999999999999875422 223568899999999955999999999873
Q ss_pred ---eCCeEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCee
Q 014704 139 ---DRHSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 139 ---~~~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
+.+.+++||||++|++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+||++. .++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEE
Confidence 45679999999999999887653 34688999999999999999999999999999999999994 556799
Q ss_pred EeecccccccCCCC-ceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 014704 212 ATDFGLSVFFKPGD-VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG 284 (420)
Q Consensus 212 l~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~ 284 (420)
|+|||++....... ......|++.|+|||++. ..++.++||||+||++|+|++|..||........+..+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred EccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 99999987654322 223446899999999874 24788999999999999999999999876654444333332
Q ss_pred CCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
... ........+.++.++|.+||+.||++|||+.++++|+||
T Consensus 245 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 111 111112357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=327.38 Aligned_cols=255 Identities=29% Similarity=0.498 Sum_probs=211.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcC--CChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--Ce
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HS 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--~~ 142 (420)
.+|.+++.||+|+||.||+|.+..+++.||+|.+..... ......+.+.+|+.+++++. ||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence 468999999999999999999999999999998854321 12334578899999999998 99999999998763 56
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
++++|||++|++|.+++.+...+++..+..++.|++.||.|||+++|+|+||||+||++ +.++.++|+|||.+....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence 88999999999999999887889999999999999999999999999999999999999 456779999999987653
Q ss_pred CC----CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 223 PG----DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 223 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.. .......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||...........+...... ......++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 235 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PVLPPHVS 235 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC--CCCchhhC
Confidence 21 11233468899999998854 5889999999999999999999999876655544444432211 11123567
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
..+.++|++||. +|++||+++++++|||+.
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 889999999994 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=339.70 Aligned_cols=249 Identities=27% Similarity=0.479 Sum_probs=192.2
Q ss_pred cceecccCCeEEEEEEEcC--CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE--eCCeEEEEE
Q 014704 72 GRELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE--DRHSVNLIM 147 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~--~~~~~~iv~ 147 (420)
+.+||+|+||.||+|.++. ++..||+|.+.... ....+.+|+.+++.++ ||||+++++++. ....+++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence 4689999999999999764 56789999886432 2245789999999999 999999999885 456789999
Q ss_pred ecCCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecC-CCCCCeeEeeccc
Q 014704 148 DLCAGGELFDRIIAK---------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS-AEDSPLKATDFGL 217 (420)
Q Consensus 148 e~~~g~~L~~~l~~~---------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~~~~kl~Dfg~ 217 (420)
||+.+ +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+... +.++.+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99864 777776421 248899999999999999999999999999999999999543 3456899999999
Q ss_pred ccccCCCC----ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHH---------HHHHHHH
Q 014704 218 SVFFKPGD----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQ---------SIFDAIL 282 (420)
Q Consensus 218 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~---------~~~~~i~ 282 (420)
++...... ......||+.|+|||++.+ .++.++||||+||++|+|+||.+||...... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 98754322 2234578999999998854 4789999999999999999999999654321 1111111
Q ss_pred cCC--------------CCC-------C-------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 283 RGH--------------IDF-------S-------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 283 ~~~--------------~~~-------~-------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
... ..+ . .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 000 0 00001235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=331.61 Aligned_cols=254 Identities=26% Similarity=0.473 Sum_probs=215.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
..|...+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.+...+|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEEE
Confidence 46888899999999999999999999999999986432 2345678999999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
|||+.|++|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+||+++ .++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEcccccceeccCCcc
Confidence 999999999998864 5789999999999999999999999999999999999994 566799999999876544332
Q ss_pred -eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 227 -FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 227 -~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
.....++..|+|||++.+ .++.++|+||||+++|+|++|..||...........+...... .....++..+.+++
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li 233 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP---TLTGEFSKPFKEFI 233 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC---CCchhhhHHHHHHH
Confidence 223467889999999864 5789999999999999999999999887766655544333221 12235678899999
Q ss_pred HHhcccCcCCCCCHHHHhcCCccccc
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+||..+|++||++.++++|+||...
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 234 DACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred HHHcccCcccCcCHHHHHhChHhhhc
Confidence 99999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=325.91 Aligned_cols=254 Identities=28% Similarity=0.500 Sum_probs=214.7
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++ |+||+++++++.+.+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence 58899999999999999999998999999999875543 2446788999999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc-
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV- 226 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~- 226 (420)
||+++++|.+++.....+++..+..++.|++.||.|||++||+|+||+|+||++ +.++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence 999999999999887779999999999999999999999999999999999999 4567799999999887643322
Q ss_pred ----eecccCCcccccchhhcc-c---CCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCCCC
Q 014704 227 ----FKDLVGSAYYVAPEVLRR-N---YGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 227 ----~~~~~gt~~y~aPE~~~~-~---~~~~~DvwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.....+++.|+|||++.. . ++.++||||||+++|++++|+.||..... ......+.. ......+.+..++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS 234 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence 123567889999999853 2 78899999999999999999999976532 233323332 2222223344568
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
..+.++|.+||+.+|.+|||+.+++.|||+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=329.67 Aligned_cols=249 Identities=27% Similarity=0.468 Sum_probs=201.0
Q ss_pred ccceeeccee--cccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 66 RNTYIFGREL--GRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 66 ~~~y~~~~~l--G~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+.|.+.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.....+.+||||+++++.+...+.+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3567776666 99999999999999999999999986543211 1222222233599999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+||||++|++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||++..+ ...++|+|||++.....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~--~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRA--KDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCC--CCeEEEecCccceecCC
Confidence 9999999999999999887789999999999999999999999999999999999999532 22799999999876543
Q ss_pred CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSI-FDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
. ....|+..|+|||++.+ .++.++||||+|+++|+|++|..||........ ...+.... ......++.+++.+.
T Consensus 163 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 163 P---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNAN 238 (267)
T ss_pred C---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHH
Confidence 2 23468899999999864 588999999999999999999999976543322 11121111 222233456899999
Q ss_pred HHHHHhcccCcCCCCC-HHHHhcCCccc
Q 014704 302 DIVKKMLHADPKERLS-AAEVLNHPWMR 328 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t-~~e~l~h~~~~ 328 (420)
+||.+||+.||.+|++ ++++|+||||+
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhcCCccc
Confidence 9999999999999996 69999999996
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=356.09 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=195.1
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCC-ceEEEE--------------EecCCcCCChhhHHHHHHHHHHHHhccCC
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTK-QQFACK--------------SISSRKLINRDDVEDVRREVQIMHHLTGH 127 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~avK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~~h 127 (420)
..+.++|.+.+.||+|+||+||+|..+... ..++.| .+.+...........+.+|+.+|++++ |
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-H 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-C
Confidence 445678999999999999999998765432 222222 111111112234566889999999999 9
Q ss_pred CCccEEEEEEEeCCeEEEEEecCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEe
Q 014704 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFS 202 (420)
Q Consensus 128 pniv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~ 202 (420)
|||+++++++.+.+..|+|++++. ++|.+++... .......+..++.||+.||.|||++||+||||||+|||+
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl- 300 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL- 300 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-
Confidence 999999999999999999999995 5777776542 223466788999999999999999999999999999999
Q ss_pred cCCCCCCeeEeecccccccCCCCc--eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCC-C--CHHH
Q 014704 203 SSAEDSPLKATDFGLSVFFKPGDV--FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWG-E--TEQS 276 (420)
Q Consensus 203 ~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~-~--~~~~ 276 (420)
+.++.+||+|||++..+..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..++.+ . ....
T Consensus 301 --~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 --NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred --CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 4567799999999987654322 234579999999999864 589999999999999999998765432 2 1222
Q ss_pred HHHHHHcCC----CCCCCC------------------------CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 277 IFDAILRGH----IDFSSD------------------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 277 ~~~~i~~~~----~~~~~~------------------------~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.+..+.... ..++.. ....++.++.++|.+||+.||.+|||+.|+|.||||.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 222221110 001000 0013567788999999999999999999999999996
Q ss_pred c
Q 014704 329 V 329 (420)
Q Consensus 329 ~ 329 (420)
.
T Consensus 459 ~ 459 (501)
T PHA03210 459 A 459 (501)
T ss_pred c
Confidence 4
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=328.93 Aligned_cols=255 Identities=27% Similarity=0.480 Sum_probs=211.7
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC---
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH--- 141 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~--- 141 (420)
..++|.+.+.||.|+||.||+|.++.+++.+++|++.... ...+.+.+|+.+++++..||||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 3578999999999999999999999889999999986432 234678999999999955999999999997644
Q ss_pred ---eEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEee
Q 014704 142 ---SVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (420)
Q Consensus 142 ---~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~D 214 (420)
.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECC
Confidence 58999999999999988765 3579999999999999999999999999999999999999 4567799999
Q ss_pred cccccccCCC-CceecccCCcccccchhhcc------cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Q 014704 215 FGLSVFFKPG-DVFKDLVGSAYYVAPEVLRR------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID 287 (420)
Q Consensus 215 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 287 (420)
||++...... .......|+..|+|||++.. .++.++||||||+++|+|++|..||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 9998765432 22234568999999998742 3678999999999999999999999876655555555544322
Q ss_pred CCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 288 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
... .....+.++++||.+||..||++|||+.++++|||+
T Consensus 237 ~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 TLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 111 112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=331.58 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=207.1
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CeEEEE
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HSVNLI 146 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--~~~~iv 146 (420)
|++.+.||+|+||.||+|.+..+++.||+|.+..... . .......+|+.++.++.+||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-S-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-C-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999865321 2 22234457999999997799999999999987 899999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||+.+ +|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++ . +.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCC
Confidence 999975 787877654 5689999999999999999999999999999999999995 3 789999999998765544
Q ss_pred ceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------------
Q 014704 226 VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH------------------ 285 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~------------------ 285 (420)
......++..|+|||.+. +.++.++||||+||++|+|++|..||.+.+..+.+..+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 444567899999999764 347889999999999999999999998877655544443211
Q ss_pred CCCCCC-------CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 286 IDFSSD-------PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 286 ~~~~~~-------~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
..++.. ..+.++.++.++|.+||.++|++|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 111110 013568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=324.73 Aligned_cols=254 Identities=30% Similarity=0.493 Sum_probs=216.2
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcC--CChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
+|+..+.||+|+||.||+|....+++.|++|.+..... ...+..+.+.+|+.+++.++ ||||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence 47788999999999999999998899999999865332 22345678999999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
++||++|++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.+||+|||.+.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccccc
Confidence 99999999999999888889999999999999999999999999999999999999 456789999999988765444
Q ss_pred ceecccCCcccccchhhcc-c-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......|+..|+|||.+.. . ++.++|+||||+++|+|++|..||...........+..... .+ .....++.++.++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~l 234 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-LP-PIPDHLSDEAKDF 234 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-CC-CcCCCcCHHHHHH
Confidence 3445678999999998753 3 78999999999999999999999977665555444443111 11 1224578999999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCcc
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+++||..+|.+|||+.+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=338.16 Aligned_cols=261 Identities=29% Similarity=0.498 Sum_probs=228.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.+.|+.-++||+||||.||-++.+.||+.||+|.+.+.............+|-.+|.+++ .+.||.+--.|+..+.+++
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCL 262 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEE
Confidence 467888899999999999999999999999999987765555555567789999999999 8999999999999999999
Q ss_pred EEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+..|.||+|.-+|.+.+ .+++..+..++.+|+.||.+||+.+||+|||||+|||+ ++.++++|+|+|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCC
Confidence 999999999988887766 69999999999999999999999999999999999999 7889999999999999999
Q ss_pred CCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
+......+||.+|||||+++ +.|+...|-|||||++|+|+.|+.||.......-.+.+.+....-+......+|+++++
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks 419 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS 419 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence 88888889999999999996 45999999999999999999999999766544333333333333333333578999999
Q ss_pred HHHHhcccCcCCCC-----CHHHHhcCCccccc
Q 014704 303 IVKKMLHADPKERL-----SAAEVLNHPWMRVD 330 (420)
Q Consensus 303 li~~~L~~dp~~R~-----t~~e~l~h~~~~~~ 330 (420)
|.+.+|++||++|. ++.++-+||||+..
T Consensus 420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 99999999999998 47799999999853
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=325.33 Aligned_cols=252 Identities=29% Similarity=0.524 Sum_probs=217.1
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCeEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHSVNL 145 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--~~~~~i 145 (420)
+|.+.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++ ||||+++++++.. ....|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence 48889999999999999999999999999999875443 4455678899999999999 9999999998753 456899
Q ss_pred EEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 146 IMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCH-----SMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH-----~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
+|||+.+++|.+++.. ...+++..+..++.||+.||.||| +.+|+|+||||+||+++ .++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEEEeccc
Confidence 9999999999998865 357899999999999999999999 89999999999999994 56789999999
Q ss_pred cccccCCCCc-eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 217 LSVFFKPGDV-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 217 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
++........ .....|++.|+|||.+.. .++.++|+||||+++|+|++|..||...........+..+..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 232 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI---PY 232 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC---cc
Confidence 9987654443 344578999999999864 478899999999999999999999998887777777766544321 13
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
..+.++.+++.+||..+|++|||+.++++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=345.38 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=203.2
Q ss_pred ccceeecceecccCCeEEEEEEE-----cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTH-----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
.++|.+++.||+|+||.||+|.+ ..++..||+|++.... .....+.+.+|+.++..+..||||+++++++.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45799999999999999999974 3456789999986433 2334567889999999995599999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhcC---------------------------------------------------------
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKG--------------------------------------------------------- 163 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~--------------------------------------------------------- 163 (420)
+..++|||||+||+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886432
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 164 ------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 164 ------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
.+++..+..++.||+.||.|||++||+||||||+|||++ .+..+||+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCcc
Confidence 367888999999999999999999999999999999994 46679999999998664332
Q ss_pred ce---ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 226 VF---KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 226 ~~---~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
.. ....++..|+|||++.+ .++.++|||||||++|+|++ |..||........+............ ....+.++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 346 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS--PECAPSEM 346 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC--CCCCCHHH
Confidence 11 12234567999999864 58999999999999999998 89999776544333333332222221 13467899
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcC
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
++||.+||+.||++|||+.++++.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=332.58 Aligned_cols=254 Identities=29% Similarity=0.472 Sum_probs=208.2
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|++.+.||.|+||.||+|.++.+++.||+|.+..... .......+.+|++++++++ ||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEe
Confidence 48889999999999999999999999999998864432 2333467889999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||+. ++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||++ +.++.+||+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCc
Confidence 9996 5888887653 568999999999999999999999999999999999999 456779999999987654322
Q ss_pred -ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Q 014704 226 -VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI---------------- 286 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~---------------- 286 (420)
......+++.|+|||.+.+ .++.++||||||+++|+|+||+.||.+.+.......+.....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2233457889999998754 368899999999999999999999987765544433322110
Q ss_pred --CCC-------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 287 --DFS-------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 287 --~~~-------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.++ ....+.++.+++++|.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000 01123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=344.75 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=204.1
Q ss_pred ccceeecceecccCCeEEEEEEEcCC-----CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
.++|.+.+.||+|+||.||+|++..+ +..||+|.+.... .......+.+|+.+++.+..||||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 46799999999999999999986543 3579999986543 2334567899999999994499999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhc----------------------------------------------------------
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK---------------------------------------------------------- 162 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~---------------------------------------------------------- 162 (420)
+.+++|||||.+|+|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999988542
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCce---
Q 014704 163 ------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF--- 227 (420)
Q Consensus 163 ------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~--- 227 (420)
.++++..+..++.||+.||.|||++||+||||||+|||+ +++..+||+|||++.........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeec
Confidence 136788899999999999999999999999999999999 45677999999998765433211
Q ss_pred ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 228 KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 228 ~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
....+++.|+|||++. ..++.++|||||||++|+|++ |..||........+..+.......... ..+++++.+++.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~ 349 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMK 349 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHHHH
Confidence 1223456799999875 468999999999999999997 999998765544444444433332221 246899999999
Q ss_pred HhcccCcCCCCCHHHHhc
Q 014704 306 KMLHADPKERLSAAEVLN 323 (420)
Q Consensus 306 ~~L~~dp~~R~t~~e~l~ 323 (420)
+||+.||++|||+.++++
T Consensus 350 ~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 350 MCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=334.07 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=210.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CeEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HSVN 144 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--~~~~ 144 (420)
+.|.+.+.||.|+||.||+|.+..+++.+|+|.+..... .......+.+|+.++++++ ||||+++++++... ...|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc-cccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence 469999999999999999999999999999999875432 2223345778999999999 99999999998877 8999
Q ss_pred EEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 145 LIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
+||||+.+ +|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence 99999975 8988887644 58999999999999999999999999999999999999 4567799999999887654
Q ss_pred C-CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------------
Q 014704 224 G-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID------------- 287 (420)
Q Consensus 224 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~------------- 287 (420)
. .......+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...........+......
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 23344567889999998854 3688999999999999999999999887766555544321100
Q ss_pred -------------CCCCCCCC--CChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 288 -------------FSSDPWPN--ISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 288 -------------~~~~~~~~--~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.....++. ++..+.++|++||+.||++|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00011222 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=334.32 Aligned_cols=261 Identities=30% Similarity=0.535 Sum_probs=217.9
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..+.|.....||+|+||.||++.+..++..||||.+... .....+.+.+|+.+++.++ ||||+++++.+...+..|
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDELW 95 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeEE
Confidence 445666678899999999999999999999999998542 2344567899999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||+++++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++......
T Consensus 96 lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 96 VVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred EEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccc
Confidence 9999999999988774 4578999999999999999999999999999999999999 45678999999998754322
Q ss_pred C-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 225 D-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
. ......|+..|+|||.+.+ .++.++||||+|+++|+|++|..||........+..+..... ........++..+.+
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 250 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRVKDSHKVSSVLRG 250 (292)
T ss_pred cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CccccccccCHHHHH
Confidence 2 2234568999999999864 588999999999999999999999988777666655544322 111122356889999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcccccCCCC
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVDGDAS 334 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~ 334 (420)
++.+||..||.+|||++++++||||......+
T Consensus 251 li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 251 FLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 99999999999999999999999998655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=344.53 Aligned_cols=235 Identities=26% Similarity=0.442 Sum_probs=206.8
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+-||+|+.|.||+|+.+ ++.||||.++. .-+.+|+-|++|+ ||||+.+.++|...-++|||||||..
T Consensus 130 eWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeecccc
Confidence 44899999999999986 47899998742 2346889999999 99999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecccC
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g 232 (420)
|.|...|+....++......|..+|+.|+.|||.+.|||||||.-||||. .+..|||+|||.++........-.++|
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STkMSFaG 273 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTKMSFAG 273 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999995 455699999999998776666678899
Q ss_pred Ccccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccC
Q 014704 233 SAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHAD 311 (420)
Q Consensus 233 t~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 311 (420)
|..|||||++.. ..+.|+|||||||+|||||||..||.+-+...++.-+-.+.+.++.+ ..++..++-||+.||+-.
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP--stcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP--STCPDGFKLLLKQCWNSK 351 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc--ccCchHHHHHHHHHHhcC
Confidence 999999999975 58999999999999999999999998777666554444444444432 467889999999999999
Q ss_pred cCCCCCHHHHhcCC
Q 014704 312 PKERLSAAEVLNHP 325 (420)
Q Consensus 312 p~~R~t~~e~l~h~ 325 (420)
|..||++.++|.|-
T Consensus 352 pRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 352 PRNRPSFRQILLHL 365 (904)
T ss_pred CCCCccHHHHHHHH
Confidence 99999999999994
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=341.57 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=209.2
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--- 140 (420)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCc
Confidence 35678999999999999999999999999999999986432 23344567889999999998 99999999988643
Q ss_pred ---CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 141 ---~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
...|+||||+.+ +|.+.+... +++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~ 164 (353)
T cd07850 91 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 164 (353)
T ss_pred cccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCcc
Confidence 357999999964 888877543 8999999999999999999999999999999999999 4567799999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH----------- 285 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~----------- 285 (420)
+.............+++.|+|||.+.+ .++.++|||||||++|+|++|+.||...+....+..+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 987655444445578999999998864 58999999999999999999999998776544443332210
Q ss_pred -----------CCCCC---------C--------CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 286 -----------IDFSS---------D--------PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 286 -----------~~~~~---------~--------~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
..... . .....+..++++|.+||+.||++|||+.|+|+||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 00000 0 01124567899999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=331.43 Aligned_cols=254 Identities=35% Similarity=0.697 Sum_probs=222.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++++.+||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36999999999999999999999999999999987655544555678899999999997799999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
|||+.+++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCccc
Confidence 9999999999999888889999999999999999999999999999999999999 456779999999987654322
Q ss_pred --------------------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 014704 226 --------------------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG 284 (420)
Q Consensus 226 --------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~ 284 (420)
......|+..|+|||++.. .++.++|+||||++++++++|+.||........+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 1123457889999998754 5788999999999999999999999988877777777655
Q ss_pred CCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCH----HHHhcCCcc
Q 014704 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSA----AEVLNHPWM 327 (420)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~h~~~ 327 (420)
...++ ..+++.+.+||.+||+.+|.+|||+ .++++||||
T Consensus 238 ~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 54444 3568899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=327.35 Aligned_cols=266 Identities=26% Similarity=0.437 Sum_probs=215.7
Q ss_pred cccccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC-C----Ccc
Q 014704 57 VLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-R----NIV 131 (420)
Q Consensus 57 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-p----niv 131 (420)
.....++.+.++|.+.+.+|+|.||.|-.+.+..++..||||+++.-. ...+..+-|+++|.++..+ | -+|
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 344556677899999999999999999999999999999999986422 2345677899999999522 2 378
Q ss_pred EEEEEEEeCCeEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC----
Q 014704 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA---- 205 (420)
Q Consensus 132 ~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~---- 205 (420)
++.++|+-.++.+||+|.+ |.++++++..++ +++-..+..++.|++++++|||+.+++|.||||+|||+.+.+
T Consensus 155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence 9999999999999999998 779999998764 488899999999999999999999999999999999997432
Q ss_pred -------------CCCCeeEeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCC
Q 014704 206 -------------EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWG 271 (420)
Q Consensus 206 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~ 271 (420)
.+..|+|+|||.|....... +..+.|..|.|||++.+ .++.+|||||+||||+||.+|...|+.
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 23468999999998765443 66788999999999876 699999999999999999999999988
Q ss_pred CCHHH---HHHHHHc------------------CCCCCCCCCCCC------------------C---ChHHHHHHHHhcc
Q 014704 272 ETEQS---IFDAILR------------------GHIDFSSDPWPN------------------I---SSSAKDIVKKMLH 309 (420)
Q Consensus 272 ~~~~~---~~~~i~~------------------~~~~~~~~~~~~------------------~---~~~~~~li~~~L~ 309 (420)
....+ +++.|+. +.++++...-+. . -.++.|||++||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 77544 3333322 122222111000 0 1347799999999
Q ss_pred cCcCCCCCHHHHhcCCcccc
Q 014704 310 ADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 310 ~dp~~R~t~~e~l~h~~~~~ 329 (420)
.||.+|+|+.|+|.||||..
T Consensus 392 fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFFAR 411 (415)
T ss_pred cCccccccHHHHhcCHHhhc
Confidence 99999999999999999974
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=327.81 Aligned_cols=256 Identities=30% Similarity=0.532 Sum_probs=214.5
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc--CCCCccEEEEEEEeCCeEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpniv~~~~~~~~~~~~~i 145 (420)
.|.+.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. .|||++++++++.+...+|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788899999999999999999999999999986432 2345577889999999986 59999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||||+.|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++ .++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCc
Confidence 9999999999988755 5799999999999999999999999999999999999994 56779999999988765433
Q ss_pred -ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 226 -VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
......|+..|+|||.+.+ .++.++|+||||+++|+|++|..||.+.........+..... +.-....++.++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--PRLEDNGYSKLLRE 233 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCC--CCCCcccCCHHHHH
Confidence 2234578999999998854 368899999999999999999999987766554443333211 11111237889999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
++.+||+.||++||++.++++|+||+...
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999999997543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=331.83 Aligned_cols=256 Identities=33% Similarity=0.551 Sum_probs=212.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+++++++. |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEE
Confidence 369999999999999999999999999999998865332 3344578899999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
|||+.++.+..+..+...+++..+..++.||+.||.|||++|++||||+|+||++ ++++.+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCcc
Confidence 9999987776666666679999999999999999999999999999999999999 457789999999988765443
Q ss_pred -ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Q 014704 226 -VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI---------------- 286 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~---------------- 286 (420)
......++..|+|||++.+ .++.++||||+|+++|+|++|..||.+.........+.....
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 3345678899999998753 578999999999999999999999987665444333221100
Q ss_pred ---CCCCC--------CCC-CCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 287 ---DFSSD--------PWP-NISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 287 ---~~~~~--------~~~-~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.+... .++ .++.++.+||++||..+|++|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000 011 248889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=328.73 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=205.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|+++.+|+.||+|.+..... ......+..|+.++.+..+||||+++++++..++.+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 368999999999999999999999999999999865432 222345666777654544599999999999999999999
Q ss_pred EecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 147 MDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
|||++ ++|.+++.. ...+++..+..++.||+.||.|||++ +++||||||+||++ +.++.+||+|||++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeeccccccc
Confidence 99996 577776653 24689999999999999999999997 99999999999999 55678999999998876
Q ss_pred CCCCceecccCCcccccchhhcc-----cCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHcC-CCCCCCCCCC
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLRR-----NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRG-HIDFSSDPWP 294 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~-~~~~~~~~~~ 294 (420)
..........|+..|+|||.+.+ .++.++|+||+|+++|+|++|..||.... ..+.+..+..+ ...++. .
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 231 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA---E 231 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc---c
Confidence 44333334568899999998743 36889999999999999999999996432 22333333332 222221 3
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.+|.++.++|.+||..+|++|||+.++++||||....
T Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 5789999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=331.72 Aligned_cols=258 Identities=28% Similarity=0.497 Sum_probs=215.5
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.+....|.+.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~ 89 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHT 89 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCe
Confidence 344567999999999999999999999999999999986544444455577899999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.|+||||+.| ++.+.+.. ...+++..+..++.|++.||.|||+.||+||||+|+||++ +.++.++|+|||++...
T Consensus 90 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 90 AWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLV 165 (307)
T ss_pred EEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceec
Confidence 9999999974 66666653 4569999999999999999999999999999999999999 55678999999998765
Q ss_pred CCCCceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
... ....+++.|+|||++. +.++.++||||||+++|+|++|..||.+.........+....... .....++
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 240 (307)
T cd06607 166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT--LSSNDWS 240 (307)
T ss_pred CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--CCchhhC
Confidence 433 2346888999999873 358899999999999999999999998877665555544332211 1112467
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
..+.++|.+||..||++||++.+++.||||...
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 889999999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=330.61 Aligned_cols=258 Identities=28% Similarity=0.470 Sum_probs=210.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|++|.||+|.++.+|+.||+|.+..... .....+.+.+|++++++++ ||||+++++++.+...+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEE
Confidence 469999999999999999999999999999999865432 2233467889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 147 MDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
|||++ ++|.+.+..... +++..+..++.||+.||.|||++||+||||+|+||+++. .+..+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--RTNALKLADFGLARAFGIP 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--CCCEEEEcccccccccCCC
Confidence 99996 578887765443 578889999999999999999999999999999999953 3456999999998765322
Q ss_pred -CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------------
Q 014704 225 -DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF------------- 288 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------------- 288 (420)
.......+++.|+|||.+.+ .++.++||||+|+++|+|++|..||...+....+.++.......
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 22234467889999998754 47889999999999999999999998877655554433211000
Q ss_pred --------CC----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 289 --------SS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 289 --------~~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.. ...+.+++++.++|.+||+.+|++||++.++++||||..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 00 012457889999999999999999999999999999974
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=330.44 Aligned_cols=257 Identities=30% Similarity=0.554 Sum_probs=235.2
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
..+|.+..+||+|+||.|.+|..+.+.+.||||++++.-....++++--..|-++|.....-|.+++++.+|+..+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 35789999999999999999999999999999999988777777777778888888877767899999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc-CCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~-~~~ 224 (420)
||||+.||+|.-.+.+-+++.|..+..++..|+-||-+||++||++||||.+|||+ +.++++||+|||+++.- -.+
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999 67788999999999753 344
Q ss_pred CceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
....+++|||.|+|||++. +.|+..+|.||+||+||||+.|++||.+.++.++++.|......++. .+|.++.++
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~i 580 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAI 580 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHH
Confidence 5567889999999999986 67999999999999999999999999999999999999998888775 689999999
Q ss_pred HHHhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 304 VKKMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 304 i~~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
.+..|.+.|.+|.. -.++-.||||+.
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 99999999999985 468889999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=344.93 Aligned_cols=257 Identities=30% Similarity=0.540 Sum_probs=238.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
.++.+...||-||||.|-++..+.....+|+|++++....+....+.+..|-++|..++ .|.||++|..|.+..++|++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhh
Confidence 34566778999999999999987766679999999998888888999999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
||-|-||+|+..+..++.+++.++..++..+++|++|||++|||+|||||+|.++ +.++.+||.|||+|+.+..+..
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCc
Confidence 9999999999999999999999999999999999999999999999999999999 7788999999999999999998
Q ss_pred eecccCCcccccchhh-cccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~-~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
..++||||.|.|||++ +...+.++|.||||+++|||++|.+||.+.++...++.|+++.-.+..+ ..++..+.+||+
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik 653 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIK 653 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHH
Confidence 8999999999999986 5668999999999999999999999999999999999999986544443 478999999999
Q ss_pred HhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 306 KMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
++...+|.+|.. +.+|-+|.||..
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 999999999986 899999999964
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=329.93 Aligned_cols=254 Identities=30% Similarity=0.482 Sum_probs=204.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
+.|.+.+.||+|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++ ||||+++++++.+.+..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEE
Confidence 579999999999999999999998999999999865332 122245678999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
|||+.+ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPS 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCC
Confidence 999975 898888664 468999999999999999999999999999999999999 45667999999998754321
Q ss_pred CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCC---------------
Q 014704 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHI--------------- 286 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~--------------- 286 (420)
.......++..|+|||++.+ .++.++||||+|+++|+|++|+.||.+.. ..+.+..+.+...
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 12223356889999998753 47899999999999999999999997655 2232222211000
Q ss_pred ----CCC-------CCCCCCCC--hHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 287 ----DFS-------SDPWPNIS--SSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 287 ----~~~-------~~~~~~~~--~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.+. ...++.++ .++.++|.+||+.+|++|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 00112344 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=328.24 Aligned_cols=254 Identities=30% Similarity=0.460 Sum_probs=213.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.++.+++.+|+|.+.... .......+.+|+++++.+. ||||+++++++...+.++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEE
Confidence 35888899999999999999999999999999987543 2345577899999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||++ ++++.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHH
Confidence 9999999999998776 789999999999999999999999 999999999999999 45677999999998765432
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE-----TEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
.. ....++..|+|||.+.+ .++.++||||+|+++|+|++|..||... ........+....... .....++.
T Consensus 155 ~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 231 (265)
T cd06605 155 LA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR--LPSGKFSP 231 (265)
T ss_pred Hh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC--CChhhcCH
Confidence 22 12678899999999864 5889999999999999999999999654 2233333343332111 11112788
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
++.++|.+||..||++|||+.+++.||||+.
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=327.49 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=201.5
Q ss_pred eecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHH---HHhccCCCCccEEEEEEEeCCeEEEEEecC
Q 014704 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI---MHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (420)
Q Consensus 74 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~---l~~l~~hpniv~~~~~~~~~~~~~iv~e~~ 150 (420)
.||+|+||.||+|.+..+++.||+|.+.+..............|..+ ++... ||||+++++++.+.+.+|+||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCEEEEEEecC
Confidence 48999999999999999999999999876543222222233444433 33344 999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecc
Q 014704 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230 (420)
Q Consensus 151 ~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 230 (420)
.|++|.+++...+.+++..+..++.|++.||.|||+.+|+||||||+||++ +.++.+||+|||++....... ....
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~-~~~~ 155 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHAS 155 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-CcCc
Confidence 999999999888889999999999999999999999999999999999999 456779999999987654322 2345
Q ss_pred cCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 231 VGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 231 ~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
.|+..|+|||.+.+ .++.++||||+|+++|+|++|..||.+.. .......+......+ ...++.++.+++.
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~~li~ 231 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL----PDSFSPELRSLLE 231 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC----CCcCCHHHHHHHH
Confidence 78999999999853 48899999999999999999999997763 333333333222222 2356899999999
Q ss_pred HhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 306 KMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
+||..+|.+|| ++.++++||||+.
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 99999999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=331.43 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=202.5
Q ss_pred ccceeecceecccCCeEEEEEEEcC----------------CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKD----------------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 129 (420)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++.+++ |||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence 4689999999999999999998643 34479999986532 3444567899999999998 999
Q ss_pred ccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 014704 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG-------------------HYSERAAANLCRQMVTVVHYCHSMGVM 190 (420)
Q Consensus 130 iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~al~~lH~~~iv 190 (420)
|+++++++.+.+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886532 357788899999999999999999999
Q ss_pred eccCCCCcEEEecCCCCCCeeEeecccccccCCCCce---ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh--
Q 014704 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-- 264 (420)
Q Consensus 191 H~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-- 264 (420)
||||||+|||+ +.++.+||+|||++......... ....++..|+|||++. +.++.++||||||+++|+|++
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999 45677999999999866443321 2334578899999875 568999999999999999986
Q ss_pred CCCCCCCCCHHHHHHHHHcC----CCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHh
Q 014704 265 GVPPFWGETEQSIFDAILRG----HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322 (420)
Q Consensus 265 g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 322 (420)
|..||...+.......+... .........+.++..+.+|+.+||..||++|||+.++.
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 67888877666655543221 11111111235688999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=332.76 Aligned_cols=256 Identities=28% Similarity=0.473 Sum_probs=204.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC----
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH---- 141 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~---- 141 (420)
-++|.+.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++ ||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEeccccccc
Confidence 3579999999999999999999999999999999864322 2222345678999999998 999999999986543
Q ss_pred ----eEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 142 ----SVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 142 ----~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
..++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||++ +.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg 164 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFG 164 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCC
Confidence 45999999964 7877776543 68999999999999999999999999999999999999 556789999999
Q ss_pred cccccCCCC-----ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 014704 217 LSVFFKPGD-----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (420)
Q Consensus 217 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 289 (420)
++....... ......++..|+|||.+.+ .++.++||||+|+++|+|++|+.||.+.........+......++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 987653321 1123467889999998754 378899999999999999999999988776554444333111111
Q ss_pred CCCC----------------------------CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 290 SDPW----------------------------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 290 ~~~~----------------------------~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
...+ ...+..+.+||.+||..||++|||+.++|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 1000 0125678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=329.01 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=214.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|++.+.||+|+||+||++.+..+|+.||+|++.... .....+.+.+|+++++.++ ||||+++++++.+...+++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence 57999999999999999999999999999999886432 2344578899999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+||++ ++++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh-
Confidence 9999999999998887889999999999999999999997 699999999999999 45677999999988654322
Q ss_pred ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHcCCCCCCCCCC
Q 014704 226 VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ-----------SIFDAILRGHIDFSSDPW 293 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~ 293 (420)
......|+..|+|||++. ..++.++|+|||||++|++++|..||...... .....+...... ....
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 235 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP--RLPS 235 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC--CCCc
Confidence 123457899999999875 46889999999999999999999999765432 222333322111 1111
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
..++.++.+|+.+||..||++|||+.|+++|+||.....
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 236789999999999999999999999999999975443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=325.26 Aligned_cols=248 Identities=18% Similarity=0.336 Sum_probs=208.0
Q ss_pred cceeecceecccCCeEEEEEEEc---CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+|.+.+.||+|+||.||+|.++ ..+..||+|.+.... .......+.+|+.+++.++ ||||+++++++...+..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCCc
Confidence 56999999999999999999875 345689999986532 2344567899999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
++||||+++++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||++ +.+..++++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCccccccc
Confidence 9999999999999988764 578999999999999999999999999999999999999 456789999999876543
Q ss_pred CCCcee--cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 223 PGDVFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 223 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
...... ...++..|+|||.+. +.++.++||||+||++|++++ |..||.+.........+..+.. .+ ....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 235 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-LP--APRNCPN 235 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CC--CCCCCCH
Confidence 222111 223567899999875 468999999999999999775 9999999888877777765532 22 2346789
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+.+++.+||..+|++|||+.++++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=337.97 Aligned_cols=260 Identities=31% Similarity=0.519 Sum_probs=208.3
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR---- 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~---- 140 (420)
+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++ ||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFES 79 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccc
Confidence 4578999999999999999999999999999999985321 2234566889999999999 99999999987544
Q ss_pred -CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 141 -HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 141 -~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
...|+|+||+.+ +|.+.+. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECccccee
Confidence 358999999964 8877664 4579999999999999999999999999999999999999 556779999999987
Q ss_pred ccCCCC----ceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Q 014704 220 FFKPGD----VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH-------- 285 (420)
Q Consensus 220 ~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~-------- 285 (420)
...... ......||+.|+|||.+. ..++.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 654322 122357899999999864 358899999999999999999999997765433332221100
Q ss_pred --------------CCCC-C----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 286 --------------IDFS-S----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 286 --------------~~~~-~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
.... . ...+.++.++.++|.+||+.||++|||+.++++||||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000 0 012356888999999999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=328.78 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=211.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCC-----ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTK-----QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
++|.+.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++ ||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCC
Confidence 46889999999999999999986554 679999886432 3344567899999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC
Q 014704 142 SVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~ 205 (420)
..|++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++ +
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence 999999999999999998764 457889999999999999999999999999999999999 4
Q ss_pred CCCCeeEeecccccccCCCC---ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014704 206 EDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280 (420)
Q Consensus 206 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~ 280 (420)
+++.++|+|||++....... ......+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 56779999999987654322 123345688899999875 568999999999999999998 9999999888888877
Q ss_pred HHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 281 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+..+..... ...++.++.+|+.+||+.||.+||++.+++++
T Consensus 239 i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 776543322 24678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=323.60 Aligned_cols=253 Identities=26% Similarity=0.518 Sum_probs=215.5
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|+||.||++.++.+|..+|+|.+..... .....+.+.+|+.+++.++ |+||+++++.+.+....|+|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence 48899999999999999999999999999999875432 2334567889999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 148 DLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||+.+++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++. ++..+||+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC--CCCeEEecccccchhccCCc
Confidence 9999999999887643 4799999999999999999999999999999999999952 23457999999987664332
Q ss_pred -ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 226 -VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......|++.|+|||.+.. .++.++|+||+|+++|++++|..||...+.......+..+..... .+.++.++.++
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 233 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPI---SPNFSRDLRSL 233 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCC---CCCCCHHHHHH
Confidence 2223468999999998854 588999999999999999999999988777766666665443322 24578899999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCcc
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
|.+||..+|++|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.39 Aligned_cols=261 Identities=29% Similarity=0.484 Sum_probs=212.7
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR---- 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~---- 140 (420)
+.++|.+.+.||+|+||+||+|.+..+++.||+|.+.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence 4568999999999999999999999999999999986532 23334566789999999998 99999999987644
Q ss_pred -CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 141 -HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 141 -~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
...|+|+||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||++ +.++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccc
Confidence 35899999995 6898988888889999999999999999999999999999999999999 456779999999998
Q ss_pred ccCCC-CceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Q 014704 220 FFKPG-DVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH----------- 285 (420)
Q Consensus 220 ~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~----------- 285 (420)
..... .......++..|+|||.+. ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 76443 2233456889999999875 358899999999999999999999997765433332222100
Q ss_pred ------------CCCC----CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 286 ------------IDFS----SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 286 ------------~~~~----~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.... ...++.+++++.+||++||+.||++|||+.++++||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0000 011346789999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=321.45 Aligned_cols=248 Identities=30% Similarity=0.540 Sum_probs=213.5
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||.|+||.||++.++.+++.+|+|.+.... .....+.+.+|+.+++.++ ||||+++++.+.+.+.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence 4889999999999999999999999999999986433 2345577889999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 148 DLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||.+.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence 999999999988653 358999999999999999999999999999999999999 456779999999987654322
Q ss_pred -ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 226 -VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......|++.|+|||++.+ .++.++|+||+|+++|+|++|..||...+.......+..+...... ..++..+.+|
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 231 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSL 231 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHH
Confidence 2234578999999999864 5889999999999999999999999988877777777665543222 3578899999
Q ss_pred HHHhcccCcCCCCCHHHHhcC
Q 014704 304 VKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h 324 (420)
|.+||+.||++|||+.+++.-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=325.55 Aligned_cols=249 Identities=35% Similarity=0.628 Sum_probs=217.4
Q ss_pred ecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCCC
Q 014704 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (420)
Q Consensus 75 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~~ 154 (420)
||.|+||.||++++..+|+.+++|.+...........+.+.+|+.++++++ ||||+++++.+......|++|||+.|++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999999999999999987654434456678999999999999 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC---------
Q 014704 155 LFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--------- 225 (420)
Q Consensus 155 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~--------- 225 (420)
|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||++ +.++.++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccc
Confidence 99999887889999999999999999999999999999999999999 456789999999987643321
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
......++..|+|||.+.. .++.++||||||+++|+|++|..||...........+..+...++.. ..++..+.+++
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence 1233467889999998754 47889999999999999999999999888888888887766554432 23589999999
Q ss_pred HHhcccCcCCCCCH---HHHhcCCcccc
Q 014704 305 KKMLHADPKERLSA---AEVLNHPWMRV 329 (420)
Q Consensus 305 ~~~L~~dp~~R~t~---~e~l~h~~~~~ 329 (420)
++||+.+|++|||+ .++|+||||+.
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 99999999999999 99999999963
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=324.43 Aligned_cols=252 Identities=27% Similarity=0.497 Sum_probs=210.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|+++.+++.||+|.+.............+.+|+.+++.++ ||||+++++++.+.+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence 47999999999999999999999999999999887544445555677899999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 147 MDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence 999999999887753 3458999999999999999999999999999999999999 456779999999988764
Q ss_pred CCCc-eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 223 PGDV-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET--EQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 223 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
.... .....|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.... .......+.... ++.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE 235 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence 3321 233568899999998854 58889999999999999999999996653 234444444332 22222235678
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.+.+++.+||..+|++|||+.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 89999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=330.39 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=206.8
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|...+.||+|+||.||++.+..+++.||+|.+..... ......+.+|+.++.++.+||||+++++++.+++..+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 56677899999999999999999999999999875432 2445678899999999977999999999999999999999
Q ss_pred ecCCCCChHHH---HH--hcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 148 DLCAGGELFDR---II--AKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 148 e~~~g~~L~~~---l~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
||+.+ ++.++ +. ....+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+|||++...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQL 158 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---cCCcEEEeecchhHHh
Confidence 99864 54443 22 235799999999999999999999975 999999999999994 5667999999998765
Q ss_pred CCCCceecccCCcccccchhhcc----cCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCC-CCCCCCCCCC
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGH-IDFSSDPWPN 295 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~-~~~~~~~~~~ 295 (420)
..........|++.|+|||++.. .++.++||||+||++|+|++|+.||..... ......+..+. ..........
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 44333344568999999999853 488999999999999999999999975542 12222222222 1222222345
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
++.++.+||.+||+.||++|||+.++++||||+.
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 7899999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=327.96 Aligned_cols=258 Identities=28% Similarity=0.478 Sum_probs=217.3
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.+....|...+.||+|+||.||++.+..++..||+|.+.............+.+|+.+++.++ |||++++++++.++..
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHT 99 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCe
Confidence 344556889999999999999999999999999999987654444455677899999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.|+||||+.| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||++ +.++.++|+|||++...
T Consensus 100 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 100 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIA 175 (317)
T ss_pred EEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCcccc
Confidence 9999999975 77776654 4568999999999999999999999999999999999999 45677999999988754
Q ss_pred CCCCceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
... ....|++.|+|||.+. +.++.++||||+||++|+|++|..||...........+......... ...++
T Consensus 176 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 250 (317)
T cd06635 176 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWS 250 (317)
T ss_pred CCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC--Ccccc
Confidence 432 3456889999999873 35889999999999999999999999887766666666554332211 23567
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
..++++|.+||+.+|.+||++.++++|+|+...
T Consensus 251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 889999999999999999999999999999643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=331.12 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=213.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.+.|...+.||+|+||.||+|.+..+++.||+|.+.... .....+.+.+|+.++++++ ||||+++++++.+.+.+|+
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEE
Confidence 356888899999999999999999899999999986432 2334578999999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||||+++++|.+++. .+.+++..+..++.|++.|+.|||++|++|+||+|+||++. .++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEccccccccccCcc
Confidence 999999999988775 45789999999999999999999999999999999999994 56779999999987654332
Q ss_pred -ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 226 -VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......|+..|+|||.+.+ .++.++||||||+++|+|++|..||...........+....... ....++.++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 232 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT---LEGQYSKPFKEF 232 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC---CCcccCHHHHHH
Confidence 1223468889999999864 57889999999999999999999997666555444443332211 112467889999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
|.+||..+|++|||+.++++||||..
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHH
Confidence 99999999999999999999999964
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=330.95 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=204.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCce--EEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQ--FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
++|.+.+.||+|+||.||+|.++.++.. +|+|.+.. .........+.+|+.++.++.+||||+++++++.+.+.+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 4689999999999999999999877765 46666542 2234455678899999999955999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCC
Q 014704 145 LIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~ 208 (420)
+||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||+ +.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCC
Confidence 9999999999999987542 47899999999999999999999999999999999999 4567
Q ss_pred CeeEeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 014704 209 PLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286 (420)
Q Consensus 209 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 286 (420)
.+||+|||++.............++..|+|||.+.+ .++.++|||||||++|+|+| |..||.+.+..+....+..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~- 240 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY- 240 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-
Confidence 799999999864322111112234567999998864 47899999999999999998 999998887777666654432
Q ss_pred CCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 287 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.. .....+++++.+||.+||+.+|++||++.+++.+
T Consensus 241 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 RL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 1123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=328.51 Aligned_cols=253 Identities=30% Similarity=0.475 Sum_probs=208.7
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
|.+.+.||.|++|.||+|.++.+|..||+|++..... .......+.+|+.+++.++ ||||+++++++.+.+..|++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence 6778899999999999999999999999999875432 2233456889999999999 9999999999999999999999
Q ss_pred cCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-C
Q 014704 149 LCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-D 225 (420)
Q Consensus 149 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-~ 225 (420)
|+. ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++ .++.++|+|||++...... .
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCcc
Confidence 995 68999887765 689999999999999999999999999999999999994 4678999999998765322 2
Q ss_pred ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------
Q 014704 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI----------------- 286 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~----------------- 286 (420)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+.+...
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 2233456889999998754 468899999999999999999999987766444333322100
Q ss_pred --------CCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 287 --------DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 287 --------~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.......+.++..+.++|.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00011134677899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=321.70 Aligned_cols=254 Identities=29% Similarity=0.466 Sum_probs=218.0
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|++|.||+|.+..+++.|++|++..... ......+.+|+..+.+++ ||||+++++++......++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEE
Confidence 368899999999999999999999999999999865432 144578999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||++ +.++.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCC
Confidence 9999999999999888889999999999999999999999 999999999999999 456789999999988765433
Q ss_pred ce-ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCC-CChH
Q 014704 226 VF-KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE---TEQSIFDAILRGHIDFSSDPWPN-ISSS 299 (420)
Q Consensus 226 ~~-~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~-~~~~ 299 (420)
.. ....++..|+|||.+.. .++.++|+||||+++|+|++|..||... ...+....+........ ... ++..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL---PAEEFSPE 231 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCC---CcccCCHH
Confidence 22 24568899999998864 5788999999999999999999999776 44455555554322211 123 7889
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.++|.+||..+|++|||+.++++||||+.
T Consensus 232 l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 232 FRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=327.17 Aligned_cols=253 Identities=28% Similarity=0.513 Sum_probs=208.7
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||.|++|.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++ ||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence 48899999999999999999999999999999865432 233466788999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 148 DLCAGGELFDRIIAK---GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 148 e~~~g~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||+.+ +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCC
Confidence 99975 888877654 358999999999999999999999999999999999999 45677999999998765332
Q ss_pred -CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------
Q 014704 225 -DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID-------------- 287 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------------- 287 (420)
.......++..|+|||.+.+ .++.++||||||+++|+|++|+.||.+.+..+....+.+....
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 12234467889999998754 4788999999999999999999999887766555544321100
Q ss_pred CCC-----------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 288 FSS-----------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 288 ~~~-----------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+.. ...+.++..++++|.+||+.||++||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000 0012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=290.22 Aligned_cols=256 Identities=28% Similarity=0.538 Sum_probs=216.6
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
.|.-.++||+|.||+||+|+.+++++.||+|.++.... ++..-....+|+.+|+.|+ |.|||+++++...++.+.+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelk-hknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeH
Confidence 46667899999999999999999999999999975432 2223356789999999999 999999999999999999999
Q ss_pred ecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-C
Q 014704 148 DLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-D 225 (420)
Q Consensus 148 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-~ 225 (420)
|||+ .+|..+..+ ++.++.+.++.++.|++.+|.+||++++.||||||+|+|++ .++.+||+|||+++.+.-. .
T Consensus 81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin---~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN---RNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec---cCCcEEecccchhhhcCCceE
Confidence 9995 477777654 46799999999999999999999999999999999999994 5677999999999876532 2
Q ss_pred ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC--------
Q 014704 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP-------- 294 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-------- 294 (420)
.++..+-|.+|.+|.++-+ -|+...|+||.|||+.|+.. |++.|.+.+....+..|.+.-.....+.|+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 4455678999999999754 49999999999999999987 889999999888888886644333333333
Q ss_pred -----------------CCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 295 -----------------NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 295 -----------------~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+++..-+++++++|.-+|.+|++++++|+||||..
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 34556789999999999999999999999999964
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.18 Aligned_cols=256 Identities=31% Similarity=0.541 Sum_probs=216.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
..|...+.||+|++|.||++.+..+++.+++|.+... .....+.+.+|+.+++.+. ||||+++++++...+..++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEEE
Confidence 3455668999999999999999989999999987532 2234466889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
+||+.|++|.+++.. .++++..+..++.|++.||.|||++||+||||+|+||++ +.++.++|+|||.+.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc
Confidence 999999999998876 679999999999999999999999999999999999999 456789999999877543322
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
......|++.|+|||.+.+ .++.++||||+|+++|+|++|..||...+.......+......... ....++..+.+++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK-NLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCc-ccccCCHHHHHHH
Confidence 2233568999999999864 5889999999999999999999999887777666666655322221 1234788999999
Q ss_pred HHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.+||+.+|++|||+.++++||||+...
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=337.57 Aligned_cols=262 Identities=28% Similarity=0.455 Sum_probs=213.0
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE----eC
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE----DR 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~----~~ 140 (420)
+.++|.+.+.||.|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++ ||||+++++++. ..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCC
Confidence 34789999999999999999999999999999999875322 2334567889999999999 999999999875 34
Q ss_pred CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
..+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARG 156 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccccee
Confidence 57899999995 5898988877889999999999999999999999999999999999999 5677899999999876
Q ss_pred cCCCC-----ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------
Q 014704 221 FKPGD-----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG--------- 284 (420)
Q Consensus 221 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~--------- 284 (420)
..... ......|+..|+|||.+.+ .++.++||||+|+++|+|++|+.||.+.+....+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 53221 1234578999999998753 4889999999999999999999999876544333222210
Q ss_pred --------------CCCCCCC----CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 285 --------------HIDFSSD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 285 --------------~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
....... .++.++.++.++|++||+.+|++|||+.+++.||||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0000000 12457899999999999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=358.67 Aligned_cols=253 Identities=28% Similarity=0.367 Sum_probs=206.0
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.+..+|+.||+|++...........+++.+|+++++.+. ||||+++++++.+.+..|+|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence 57999999999999999999999999999999987544333444567999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeec
Q 014704 147 MDLCAGGELFDRIIAK-----------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Df 215 (420)
|||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence 9999999999988642 234566788999999999999999999999999999999 55677999999
Q ss_pred ccccccCCCC-------------------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Q 014704 216 GLSVFFKPGD-------------------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ 275 (420)
Q Consensus 216 g~~~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~ 275 (420)
|++....... .....+||+.|+|||++.+ .++.++||||+||++|+|++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998652110 0112469999999999864 5899999999999999999999999876544
Q ss_pred HHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 276 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
......... ......++..+++.+.+++.+||..||++|++..+.+.+
T Consensus 238 ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 238 KISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 333221111 111112235788999999999999999999987776654
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=323.70 Aligned_cols=253 Identities=24% Similarity=0.401 Sum_probs=210.9
Q ss_pred ccceeecceecccCCeEEEEEEEcC-----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
.+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++ |+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 4679999999999999999999987 67889999875432 2334467889999999998 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKG-------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
...++||||+.|++|.+++...+ .+++..+..++.||+.||.|||+++++||||||+||+++..+....+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999987653 48899999999999999999999999999999999999765555679999
Q ss_pred ecccccccCCCCcee---cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCC
Q 014704 214 DFGLSVFFKPGDVFK---DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDF 288 (420)
Q Consensus 214 Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 288 (420)
|||++.......... ...++..|+|||++. ..++.++|||||||++|+|++ |..||.+.+.......+..... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR-L 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-C
Confidence 999998763322211 223356799999985 469999999999999999997 9999998887777666654322 1
Q ss_pred CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
. ....++..+.+++.+||+.+|++|||+.++++|
T Consensus 241 ~--~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 D--PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 124678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=323.68 Aligned_cols=253 Identities=26% Similarity=0.461 Sum_probs=214.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
+-|.+.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++ ||||+++++++.++...|+|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEE
Confidence 45888899999999999999999889999999875432 2334567899999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
|||+++++|.+++. ...+++..+..++.|++.++.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh
Confidence 99999999998875 4568999999999999999999999999999999999999 456779999999987654332
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
......|+..|+|||.+.. .++.++|+||+||++|+|++|..||...........+....... ....++.++.++|
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i 233 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLKEFV 233 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---CCcccCHHHHHHH
Confidence 1233468889999998854 57889999999999999999999998777666665554433221 1135688999999
Q ss_pred HHhcccCcCCCCCHHHHhcCCcccc
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.+||..+|.+||++.++++||||..
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhh
Confidence 9999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=326.54 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=202.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
+.|.+.+.||+|+||.||+|.++.+|+.||+|.+..... ......+.+|+.+++.++ |+||+++++++.+++..|+|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEE
Confidence 579999999999999999999999999999999865432 222345778999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
|||+. ++|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCC
Confidence 99996 577666654 3568888999999999999999999999999999999999 45677999999998754322
Q ss_pred CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCC--------------CC
Q 014704 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGH--------------ID 287 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~--------------~~ 287 (420)
.......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.... +.+..+.... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 22234467899999998854 4788999999999999999999999765432 2222221100 00
Q ss_pred CCC------------CCCC--CCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 288 FSS------------DPWP--NISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 288 ~~~------------~~~~--~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+.. ..+. ..+.++.+++.+||..||++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 0011 125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=333.98 Aligned_cols=263 Identities=30% Similarity=0.435 Sum_probs=213.7
Q ss_pred cccccee-ecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChh-----------hHHHHHHHHHHHHhccCCCCcc
Q 014704 64 DVRNTYI-FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-----------DVEDVRREVQIMHHLTGHRNIV 131 (420)
Q Consensus 64 ~~~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~hpniv 131 (420)
.+.++|. +.+.||.|+||+||+|.++.+++.||+|.+......... ....+.+|+.+++.++ ||||+
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv 83 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIM 83 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Cccee
Confidence 3556786 467899999999999999999999999998654321100 1125779999999999 99999
Q ss_pred EEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCee
Q 014704 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 132 ~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
++++++..++..++||||+. ++|.+++.....+++..+..++.|++.||.|||++||+||||+|+||++ +.++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~k 159 (335)
T PTZ00024 84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICK 159 (335)
T ss_pred eeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCEE
Confidence 99999999999999999996 5899999888889999999999999999999999999999999999999 4567899
Q ss_pred EeecccccccCC---------------CCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCH
Q 014704 212 ATDFGLSVFFKP---------------GDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETE 274 (420)
Q Consensus 212 l~Dfg~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~ 274 (420)
|+|||.+..... ........+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999876541 111223356889999998854 378999999999999999999999988877
Q ss_pred HHHHHHHHcCCCCCCC------------------------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 275 QSIFDAILRGHIDFSS------------------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 275 ~~~~~~i~~~~~~~~~------------------------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
...+..+......... ...+..+.++.++|.+||..+|++|||++++|.||||+..
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 6665554331110000 0123457889999999999999999999999999999865
Q ss_pred C
Q 014704 331 G 331 (420)
Q Consensus 331 ~ 331 (420)
.
T Consensus 320 ~ 320 (335)
T PTZ00024 320 P 320 (335)
T ss_pred C
Confidence 4
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=318.68 Aligned_cols=254 Identities=28% Similarity=0.483 Sum_probs=212.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCc--CCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--Ce
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRK--LINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HS 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--~~ 142 (420)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+.... .........+.+|+.++++++ ||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence 47999999999999999999999999999999875321 122345678999999999998 99999999998764 56
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+++++||+.|++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence 89999999999999999887889999999999999999999999999999999999999 456679999999987653
Q ss_pred CC----CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 223 PG----DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 223 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.. .......|+..|+|||.+.+ .++.++|+|||||++|+|++|+.||...........+...... ......++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~p~~~~ 235 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK--PMLPDGVS 235 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCC--CCCCcccC
Confidence 21 12234568899999999864 4789999999999999999999999877665555554432221 11234678
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+.+.++|.+||. +|.+|||+.++++|||.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 999999999998 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=329.00 Aligned_cols=257 Identities=30% Similarity=0.557 Sum_probs=216.0
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
...|.....||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.+. ||||+++++++..++..|+
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEE
Confidence 345666778999999999999999899999999986432 233467889999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||||+++++|.+++. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 96 LMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEecCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhccccc
Confidence 999999999988664 4578999999999999999999999999999999999999 566789999999987554322
Q ss_pred -ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 226 -VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......|+..|+|||++.+ .++.++||||+|+++|+|++|+.||...........+...... ....+..++..+.++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~ 250 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRDF 250 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHHH
Confidence 2234568999999999864 5889999999999999999999999887766666555443322 222234678899999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
|++||+.+|++||++.++++||||....
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 9999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=324.74 Aligned_cols=248 Identities=25% Similarity=0.448 Sum_probs=210.9
Q ss_pred cceeecceecccCCeEEEEEEEcC-----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
++|.+.+.||+|+||.||+|.+.. +++.||+|.+.... .....+.+.+|+++++.+. ||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecCC
Confidence 568999999999999999998753 35789999986432 2334578999999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCC
Q 014704 142 SVNLIMDLCAGGELFDRIIAKG--------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~ 207 (420)
..++||||++|++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||++ +.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCC
Confidence 9999999999999999987542 37888999999999999999999999999999999999 456
Q ss_pred CCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014704 208 SPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL 282 (420)
Q Consensus 208 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~ 282 (420)
+.+||+|||++........ .....+++.|+|||++. +.++.++||||||+++|+|++ |..||.+.........+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 7899999999876533221 12334577899999886 458999999999999999998 999999888888888887
Q ss_pred cCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+...... ..++..+.+++++||..||++|||+.|+++
T Consensus 239 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66554332 357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=334.49 Aligned_cols=259 Identities=31% Similarity=0.496 Sum_probs=209.7
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR---- 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~---- 140 (420)
+..+|.+.+.||.|+||.||+|.++.+|+.||+|.+..... ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcC-CCcchhhHhhhccccccc
Confidence 45789999999999999999999999999999999865432 44577889999999998 99999999876543
Q ss_pred ----------CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCe
Q 014704 141 ----------HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (420)
Q Consensus 141 ----------~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~ 210 (420)
...|+||||+. ++|.+.+. .+.+++..+..++.||+.||.|||++||+||||||+||+++. .+..+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--EDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC--CCceE
Confidence 35899999997 58887775 457999999999999999999999999999999999999952 44568
Q ss_pred eEeecccccccCCCC----ceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 014704 211 KATDFGLSVFFKPGD----VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG 284 (420)
Q Consensus 211 kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~ 284 (420)
||+|||.+....... ......|+..|+|||.+. ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999987653221 112336788999999864 34788999999999999999999999877665544444322
Q ss_pred CCC----------------------CCC----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 285 HID----------------------FSS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 285 ~~~----------------------~~~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
... ... ...+.++.++.+||++||..||++|||+.++|+||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 100 000 01235788999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=316.81 Aligned_cols=252 Identities=31% Similarity=0.587 Sum_probs=218.9
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||.|+||.||++.+..++..||+|.+..... .......+.+|+++++.++ |||++++.+.+.+....++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence 48889999999999999999998999999999875433 3455677899999999999 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 148 DLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 148 e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeeccc
Confidence 999999999988764 679999999999999999999999999999999999999 4567799999999887654
Q ss_pred CC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 GD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.. ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...........+......... ..++.++.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 232 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP---SQYSSELR 232 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence 33 2334578999999998754 5889999999999999999999999888777777776655432221 25788999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+++.+||..+|++|||+.++|+||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=322.55 Aligned_cols=252 Identities=22% Similarity=0.374 Sum_probs=208.2
Q ss_pred ccccceeecceecccCCeEEEEEEEcC-----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
...++|++.+.||+|+||.||+|.++. ++..||+|.+.... .......+.+|+.+++.++ ||||+++++++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~ 79 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS 79 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc
Confidence 356789999999999999999998753 35679999875432 2234466889999999998 999999999999
Q ss_pred eCCeEEEEEecCCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCC
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAKG----------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~ 208 (420)
+....++||||+.+++|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+||++ +.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~ 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDF 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCC
Confidence 9999999999999999999886532 25678889999999999999999999999999999999 4567
Q ss_pred CeeEeecccccccCCCCce---ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Q 014704 209 PLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILR 283 (420)
Q Consensus 209 ~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~ 283 (420)
.++|+|||++......... ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 7999999998765433221 12345778999999864 58999999999999999999 7999988887777776666
Q ss_pred CCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
...... ...++..+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 543222 13578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=320.47 Aligned_cols=249 Identities=28% Similarity=0.481 Sum_probs=203.0
Q ss_pred ecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecC
Q 014704 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (420)
Q Consensus 71 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~ 150 (420)
....||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++ |+||+++++++..++.+++|+||+
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecC
Confidence 335899999999999999999999999988643 2345578899999999998 999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-c
Q 014704 151 AGGELFDRIIAK-GHY--SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-V 226 (420)
Q Consensus 151 ~g~~L~~~l~~~-~~~--~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~-~ 226 (420)
.+++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. .++.++|+|||.+....... .
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCeEEEecchhheecccCCCc
Confidence 999999988764 445 88889999999999999999999999999999999952 24579999999987654322 2
Q ss_pred eecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
.....|++.|+|||.+.+ .++.++||||+|+++|+|++|..||....... ....+... .........+++++++
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF--KIHPEIPESLSAEAKN 243 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh--ccCCCCCcccCHHHHH
Confidence 233468899999998853 37889999999999999999999997543221 11111110 1111112357889999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
|+++||..+|++|||+.+++.||||
T Consensus 244 li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=322.26 Aligned_cols=256 Identities=28% Similarity=0.473 Sum_probs=208.0
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCeEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHSVN 144 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--~~~~~ 144 (420)
++|...+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|++++++++ ||||+++++++.+ .+.+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEE
Confidence 36888999999999999999999999999999986532 2244577899999999998 9999999998864 44789
Q ss_pred EEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 145 LIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++ .+..++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---cCCeEEEeecccccc
Confidence 99999999999887643 34589999999999999999999999999999999999994 556799999999876
Q ss_pred cCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCCC-CCCCCCC
Q 014704 221 FKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGE-----TEQSIFDAILRGHI-DFSSDPW 293 (420)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~-----~~~~~~~~i~~~~~-~~~~~~~ 293 (420)
..... .....++..|+|||.+. ..++.++||||+|+++|+|++|..||... ...+....+..... .......
T Consensus 155 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 155 LVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 54322 12346788999999886 46899999999999999999999999765 22344444443221 1111111
Q ss_pred --CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 294 --PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 294 --~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
...++.+.+||.+||..+|.+|||+.|+++||||+.
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 134678999999999999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=324.66 Aligned_cols=253 Identities=30% Similarity=0.497 Sum_probs=210.9
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CeEEEE
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HSVNLI 146 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--~~~~iv 146 (420)
|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+. |||++++++++.+. +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence 678899999999999999999999999999997653 23334467889999999999 99999999999888 899999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||+.+ +|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||++ ++++.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCC
Confidence 999975 888887665 579999999999999999999999999999999999999 557789999999988765432
Q ss_pred --ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC---------
Q 014704 226 --VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP--------- 292 (420)
Q Consensus 226 --~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 292 (420)
......++..|+|||.+.+ .++.++||||||+++|+|++|+.||...+....+..+...........
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 2334467889999997653 478999999999999999999999988877666665544221111111
Q ss_pred -----------------CCC-CChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 293 -----------------WPN-ISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 293 -----------------~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+.. .+..+.++|++||..+|++||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 112 27889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=317.71 Aligned_cols=245 Identities=37% Similarity=0.712 Sum_probs=215.9
Q ss_pred ecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCCC
Q 014704 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (420)
Q Consensus 75 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~~ 154 (420)
||.|+||.||++.+..+++.+|+|.+.............+.+|+.+++.+. ||||+++++.++++..+|+||||+.+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999999889999999987765544456778999999999999 9999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-CceecccCC
Q 014704 155 LFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFKDLVGS 233 (420)
Q Consensus 155 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt 233 (420)
|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.++|+|||.+...... .......++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCCcccCCcCC
Confidence 999998888899999999999999999999999999999999999994 5667999999998876443 233455788
Q ss_pred cccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCc
Q 014704 234 AYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312 (420)
Q Consensus 234 ~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 312 (420)
..|+|||.+.+ ..+.++|+||||+++|++++|..||...........+......++. .++..+.++|++||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhcCCH
Confidence 99999998864 4788999999999999999999999888777777777765444433 458899999999999999
Q ss_pred CCCCCH---HHHhcCCcc
Q 014704 313 KERLSA---AEVLNHPWM 327 (420)
Q Consensus 313 ~~R~t~---~e~l~h~~~ 327 (420)
++|||+ .++++||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.37 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=204.5
Q ss_pred cccccceeecceecccCCeEEEEEEEcCC-----CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
+.-.++|.+++.||+|+||.||+|.+... +..||+|++.... .....+.+.+|+++++++..||||+++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34467899999999999999999987533 3469999986432 2344567999999999996699999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhc-------------------------------------------------------
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAK------------------------------------------------------- 162 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~------------------------------------------------------- 162 (420)
.+...+|+|||||++|+|.+++...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999999999887642
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE
Q 014704 163 -----------------------------------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLF 201 (420)
Q Consensus 163 -----------------------------------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill 201 (420)
..+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 136778889999999999999999999999999999999
Q ss_pred ecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH
Q 014704 202 SSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQS 276 (420)
Q Consensus 202 ~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~ 276 (420)
+ .+..+||+|||++........ .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.......
T Consensus 271 ~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 271 A---QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred e---CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 4 566799999999886543221 12335678899999875 458999999999999999997 999998765443
Q ss_pred HHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 277 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+............ ...++.++.+++.+||..||++|||+.++.+
T Consensus 348 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSGYRMAK--PDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcCCCCCC--CccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 33333333222222 2467889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=330.75 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=203.5
Q ss_pred ceeecceecccCCeEEEEEEEcC--CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CeE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HSV 143 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--~~~ 143 (420)
+|.+.+.||+|+||.||+|.++. +++.||+|.+.............+.+|+.+++.++ ||||+++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence 48889999999999999999988 89999999987643222333467789999999999 99999999999988 889
Q ss_pred EEEEecCCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEec-CCCCCCeeEeeccc
Q 014704 144 NLIMDLCAGGELFDRIIAK-----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS-SAEDSPLKATDFGL 217 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~-~~~~~~~kl~Dfg~ 217 (420)
++||||+.+ +|.+.+... ..+++..+..++.||+.||.|||+++|+||||||+||+++. ++.++.+||+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999999975 676666432 36899999999999999999999999999999999999954 12267899999999
Q ss_pred ccccCCCCc----eecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---------HHHHHH
Q 014704 218 SVFFKPGDV----FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQS---------IFDAIL 282 (420)
Q Consensus 218 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~---------~~~~i~ 282 (420)
+........ .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||.+..... .+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 886543221 223467899999998754 47899999999999999999999997654321 111110
Q ss_pred c--------------------------CCCCCCC-------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 283 R--------------------------GHIDFSS-------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 283 ~--------------------------~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
. ....++. ..+...+.++.++|.+||+.||++|||+.++++||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0 0000000 0011457789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=321.75 Aligned_cols=251 Identities=26% Similarity=0.496 Sum_probs=209.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.++.+++.+|+|.+.............+.+|+.+++.+. ||||+++++++.+++.++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEE
Confidence 46889999999999999999999999999999887544444455678899999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 147 MDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|||+.|++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence 999999999988763 3458999999999999999999999999999999999999 456779999999987654
Q ss_pred CCC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 223 PGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 223 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
... ......|+..|+|||.+.+ .++.++|+||||+++|+|++|..||.+... ......+.... ++......++.
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSE 235 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccH
Confidence 332 2234568999999999854 588899999999999999999999976543 23333333322 22222345788
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.++++|.+||..||++|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=325.85 Aligned_cols=256 Identities=29% Similarity=0.487 Sum_probs=214.4
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..+.|...+.||+|+||.||+|.+..+++.|++|.+.............+.+|+.+++.++ |||++++++++.+....|
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEE
Confidence 3445777889999999999999999999999999987654444455567889999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
+||||+. +++.+.+.. ...+++..+..++.||+.||.|||++||+||||+|+||++ +.++.+||+|||++.....
T Consensus 98 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP 173 (313)
T ss_pred EEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC
Confidence 9999996 577777754 4568999999999999999999999999999999999999 4567799999998865332
Q ss_pred CCceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 224 GDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
.....|+..|+|||.+. +.++.++||||||+++|+|++|..||...........+....... .....++..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 248 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT--LQSNEWTDS 248 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCccccCHH
Confidence 23457899999999873 458889999999999999999999998877655555554433221 122356788
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+++|+.+||+.+|.+||++.++++||||+..
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=325.30 Aligned_cols=256 Identities=30% Similarity=0.558 Sum_probs=213.0
Q ss_pred ceeecceecccCCeEEEEEEEc---CCCceEEEEEecCCcCC-ChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.|++.+.||.|+||.||+|.+. .+|+.||+|++...... .....+.+.+|+.+++.+.+|+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4888999999999999999875 47899999998653321 1233467889999999997799999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceeccc
Confidence 9999999999999999888889999999999999999999999999999999999999 4567899999999876543
Q ss_pred CC--ceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCCCCC
Q 014704 224 GD--VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGET----EQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 224 ~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 294 (420)
.. ......|+..|+|||.+.. .++.++||||+|+++|+|++|..||.... .......+......++ .
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~ 233 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----Q 233 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----c
Confidence 32 2234568999999998753 46789999999999999999999996433 2333344444333332 3
Q ss_pred CCChHHHHHHHHhcccCcCCCC-----CHHHHhcCCccccc
Q 014704 295 NISSSAKDIVKKMLHADPKERL-----SAAEVLNHPWMRVD 330 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~~ 330 (420)
.+++.+.+++++||..||++|| ++.+++.||||+..
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 5788999999999999999997 89999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=325.00 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=205.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCc--eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQ--QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
++|.+.+.||+|+||.||+|+.+.++. .+++|.+.. .......+.+.+|+.++.++.+||||+++++++.+.+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 479999999999999999999987764 468887653 2233445678999999999955999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCC
Q 014704 145 LIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~ 208 (420)
+||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||+ +.+.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCC
Confidence 9999999999999986532 47889999999999999999999999999999999999 4567
Q ss_pred CeeEeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 014704 209 PLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286 (420)
Q Consensus 209 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 286 (420)
.+||+|||++..............+..|+|||.+.. .++.++|||||||++|+|++ |..||.+.........+..+..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 799999999864322111111223457999998754 58999999999999999997 9999998888877777765422
Q ss_pred CCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 287 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
. .....++..+.+|+.+||..+|.+|||+.++++.
T Consensus 237 -~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 -M--EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred -C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 1123578999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=314.31 Aligned_cols=252 Identities=31% Similarity=0.540 Sum_probs=217.2
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|++|.||++.+..+++.|++|.+..... .....+.+.+|+++++++. |||++++++++.+.+.++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence 48889999999999999999999999999999876543 2355678999999999998 999999999999999999999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc-
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV- 226 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~- 226 (420)
||+++++|.+++.....+++..+..++.|++.||.|||++||+||||+|+||+++ .++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCccc
Confidence 9999999999998888899999999999999999999999999999999999994 467899999999987654332
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
.....++..|+|||.+.+ .++.++||||+|+++|+|++|..||...........+...... .....++..+.+++.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHHHHH
Confidence 234568899999998754 4788999999999999999999999876655544444432221 122467899999999
Q ss_pred HhcccCcCCCCCHHHHhcCCcc
Q 014704 306 KMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 306 ~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+||..+|++|||+.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=331.17 Aligned_cols=260 Identities=28% Similarity=0.445 Sum_probs=212.5
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH- 141 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~- 141 (420)
..+.++|.+.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++ ||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLS 88 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCcc
Confidence 346788999999999999999999999999999999986432 22334456889999999998 999999999987553
Q ss_pred -----eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 142 -----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 142 -----~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
.+++||||+ |++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+||+++ .++.++|+|||
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~dfg 163 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFG 163 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecc
Confidence 468999999 778877665 46799999999999999999999999999999999999994 56679999999
Q ss_pred cccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF------ 288 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------ 288 (420)
++...... .....+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+.+.......+.......
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 164 LARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98865432 234467899999998864 47889999999999999999999998776554444433211110
Q ss_pred -----------------C----CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 289 -----------------S----SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 289 -----------------~----~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
. ...++.++..+.++|.+||+.||++|||+.+++.||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0 011246788899999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=333.76 Aligned_cols=261 Identities=29% Similarity=0.473 Sum_probs=214.7
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe-
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS- 142 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~- 142 (420)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+. ||||+++.+++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASSL 89 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhccccc
Confidence 46678999999999999999999999999999999886432 22334566889999999998 9999999998866554
Q ss_pred -----EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 143 -----VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 143 -----~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
+|+|+||+ |++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~ 164 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGL 164 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEccccc
Confidence 89999999 6799887764 579999999999999999999999999999999999999 4567799999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS------ 289 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------ 289 (420)
+...... .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||.+......+..+.......+
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 8865432 344568889999998754 478899999999999999999999988776665555443211100
Q ss_pred -----------------C----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCC
Q 014704 290 -----------------S----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDA 333 (420)
Q Consensus 290 -----------------~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 333 (420)
. ..+...+.++.+||++||..||++|||+.++++||||......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0 0123468899999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=322.47 Aligned_cols=248 Identities=24% Similarity=0.447 Sum_probs=209.3
Q ss_pred ccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
+.+|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.+++++. ||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecC
Confidence 357999999999999999999863 34567899988542 2345667999999999998 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCC
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKG-------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~ 207 (420)
+.+++||||+.+++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||++ +.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence 99999999999999999987543 38999999999999999999999999999999999999 456
Q ss_pred CCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014704 208 SPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL 282 (420)
Q Consensus 208 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~ 282 (420)
+.+||+|||++........ .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 7899999999886543321 12234577899999886 458999999999999999998 999998888888888887
Q ss_pred cCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+...... ..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 237 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 76543221 357889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=326.41 Aligned_cols=257 Identities=28% Similarity=0.506 Sum_probs=214.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++ ||||+++++++...+..|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-HPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEEE
Confidence 468999999999999999999998889999999985432 233467899999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccccc
Confidence 9999999999998864 458899999999999999999999999999999999999 456779999999887654332
Q ss_pred -ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 226 -VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......|++.|+|||.+. +.++.++|+||||+++|++++|+.||...+.......+..... ........++..++++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHHHHHH
Confidence 223446889999999875 4588999999999999999999999987665444333332211 1111234567889999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
|++||..+|++||++.+++.|+||+...
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=313.46 Aligned_cols=264 Identities=29% Similarity=0.467 Sum_probs=208.1
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCc----eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-C
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-R 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-~ 140 (420)
...|++.+.||+|.||.||+|..++++. .+|+|.++.++..+. .....-+|+.+++.|+ |||++.+..++.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELK-HPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence 3569999999999999999998776543 689999876543222 2345679999999999 9999999998876 8
Q ss_pred CeEEEEEecCCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecC-CCCCCeeEee
Q 014704 141 HSVNLIMDLCAGGELFDRIIA-----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS-AEDSPLKATD 214 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~~~~kl~D 214 (420)
..+++++||.+. +|.+.+.- ...++...++.|+.||+.|+.|||++-|+||||||.|||+..+ .+.+.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999975 88887753 2458999999999999999999999999999999999999643 2358999999
Q ss_pred cccccccCCC----CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCH---------HHHHH
Q 014704 215 FGLSVFFKPG----DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETE---------QSIFD 279 (420)
Q Consensus 215 fg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~---------~~~~~ 279 (420)
||+++.+... ......+-|.+|.|||.+.+ .|+++.|||++|||+.||++-.+.|.+... ...+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999987532 12234567999999998854 699999999999999999999988866432 12233
Q ss_pred HHHcCCCCCCCCCCC---------------------------------CCChHHHHHHHHhcccCcCCCCCHHHHhcCCc
Q 014704 280 AILRGHIDFSSDPWP---------------------------------NISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326 (420)
Q Consensus 280 ~i~~~~~~~~~~~~~---------------------------------~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 326 (420)
.|..--.......|+ .-++...+|+.+||+.||.+|+|++++|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 333211111111121 12455889999999999999999999999999
Q ss_pred ccccCC
Q 014704 327 MRVDGD 332 (420)
Q Consensus 327 ~~~~~~ 332 (420)
|..+.-
T Consensus 340 F~~d~l 345 (438)
T KOG0666|consen 340 FTEDPL 345 (438)
T ss_pred cccCCC
Confidence 987643
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=316.14 Aligned_cols=245 Identities=24% Similarity=0.462 Sum_probs=207.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||++..+. +..+|+|.+.... .....+.+|+.+++.++ ||||+++++++.+...+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA----MSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC----ccHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEE
Confidence 468899999999999999998865 5679999876432 22357889999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++ +.+..+||+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCc
Confidence 9999999999988753 568999999999999999999999999999999999999 456779999999987654332
Q ss_pred cee--cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 226 VFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 226 ~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
... ...++..|+|||.+. ..++.++||||||+++|+|++ |+.||...+..+....+..+...... ...+..+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVY 231 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHH
Confidence 221 223556899999986 458899999999999999999 99999988888888888776433222 23578899
Q ss_pred HHHHHhcccCcCCCCCHHHHhc
Q 014704 302 DIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+++.+||..+|++|||+.++++
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=317.17 Aligned_cols=247 Identities=23% Similarity=0.407 Sum_probs=209.5
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
...|.+.+.||+|+||.||+|.++.+++.||+|.+... ......+.+|+.+++.++ ||||+++++++.....+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEE
Confidence 34688999999999999999999999999999998643 233567889999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++ ++++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCcccccccc
Confidence 99999999999988754 358899999999999999999999999999999999999 4567899999999887654
Q ss_pred CCcee--cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 224 GDVFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 224 ~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
..... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....+....+..+.. . .....++.+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~ 233 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR-M--ERPEGCPPK 233 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-C--CCCCCCCHH
Confidence 32211 123456799999876 458899999999999999998 9999988887777777665421 1 222467899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+.++|.+||..||++|||+.++++
T Consensus 234 ~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 234 VYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=314.46 Aligned_cols=253 Identities=33% Similarity=0.557 Sum_probs=215.5
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--CeEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HSVNL 145 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--~~~~i 145 (420)
+|.+.+.||+|++|.||+|.+..+++.|++|++..... .....+.+.+|+.+++++. ||||+++++.+.+. ..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEE
Confidence 47888999999999999999998999999999865432 2455688999999999999 99999999999988 89999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|+||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||++. .++.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccccc
Confidence 999999999999998888999999999999999999999999999999999999994 46779999999998776544
Q ss_pred c---eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 226 V---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 226 ~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
. .....++..|+|||.+.. .++.++||||||+++|+|++|..||.... .......+...... ......++..+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 233 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP--PEIPEHLSEEA 233 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCC--cCCCcccCHHH
Confidence 3 345678899999999865 48899999999999999999999997765 22233333221111 11223568899
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.++|.+||..||++||++.++++||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=332.86 Aligned_cols=261 Identities=31% Similarity=0.484 Sum_probs=218.5
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-----e
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-----S 142 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-----~ 142 (420)
+|.+.+.||.|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++ ||||+++++++.+.. .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence 5889999999999999999999889999999986532 22345577999999999999 999999999988775 7
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||.+....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence 899999997 5898888877789999999999999999999999999999999999999 456789999999998765
Q ss_pred CCC----ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-----
Q 014704 223 PGD----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD----- 291 (420)
Q Consensus 223 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----- 291 (420)
... ......+++.|+|||++.+ .++.++|+||+|+++|+|++|..||.+.+..+.+..+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 442 2344568899999998853 58899999999999999999999998888766666555422111100
Q ss_pred ----------------------CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCC
Q 014704 292 ----------------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDAS 334 (420)
Q Consensus 292 ----------------------~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~ 334 (420)
..+.++.++.++|.+||+.+|++|||+.+++.||||+.....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 1234688899999999999999999999999999997655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=321.25 Aligned_cols=257 Identities=23% Similarity=0.387 Sum_probs=210.2
Q ss_pred ccccceeecceecccCCeEEEEEEEcC-----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
...++|.+.+.||+|+||.||+|..+. .+..||+|.+.... .......+.+|+.+++.++ ||||+++++++.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 79 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVS 79 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEc
Confidence 345789999999999999999997653 34579999876432 2233456789999999998 999999999999
Q ss_pred eCCeEEEEEecCCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCC
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAKG----------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~ 208 (420)
+.+..|+||||+.+|+|.+++...+ .++...+..++.|++.||.|||++||+||||||+||++ +.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~ 156 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDF 156 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCC
Confidence 9999999999999999999997532 24567888999999999999999999999999999999 4567
Q ss_pred CeeEeecccccccCCCCce---ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHc
Q 014704 209 PLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILR 283 (420)
Q Consensus 209 ~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~ 283 (420)
.++|+|||+++........ ....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 7999999998765432211 1234567899999886 458999999999999999998 8999988887777776665
Q ss_pred CCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc------CCcccc
Q 014704 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN------HPWMRV 329 (420)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~------h~~~~~ 329 (420)
+..... ....++.+.+++.+||+.||++|||+.++++ ||||..
T Consensus 237 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 237 GGYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 433211 1346789999999999999999999999986 888863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=312.87 Aligned_cols=251 Identities=31% Similarity=0.547 Sum_probs=213.6
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
.|.+.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.+. ||||+++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEE
Confidence 47888999999999999999998899999999865432 35678999999999999 999999999999999999999
Q ss_pred ecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 148 DLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 148 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++ .++.++|+|||.+........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeecccccccccccc
Confidence 999999999988776 5799999999999999999999999999999999999994 567799999999887765433
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
.....++..|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+......... ....++..+.++|.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR-NPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcC-cccccCHHHHHHHH
Confidence 345578899999998864 4788999999999999999999999877555444444432221111 11224789999999
Q ss_pred HhcccCcCCCCCHHHHhcCCc
Q 014704 306 KMLHADPKERLSAAEVLNHPW 326 (420)
Q Consensus 306 ~~L~~dp~~R~t~~e~l~h~~ 326 (420)
+||+.||++|||+.++++|||
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=320.60 Aligned_cols=257 Identities=32% Similarity=0.527 Sum_probs=218.8
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
+..+.|.+.+.||+|+||.||+|.+..++..|++|++..... ..+.+.+|+.+++.++ |+||+++++++......
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEE
Confidence 456779999999999999999999998899999999864321 4567889999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhc
Confidence 99999999999999998876 89999999999999999999999999999999999999 456679999999887554
Q ss_pred CCC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 223 PGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 223 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
... ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+....... ......++.++
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 246 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP-LKNPEKWSPEF 246 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CcchhhCCHHH
Confidence 322 2233457889999998764 58899999999999999999999998877665555554433221 11223478899
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+++|++||+.+|.+|||+.++++|+||+.
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=355.14 Aligned_cols=149 Identities=29% Similarity=0.526 Sum_probs=137.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++ ||||+++++++.....+|+|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEE
Confidence 57999999999999999999999999999999997655555556678999999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
|||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999999999999888889999999999999999999999999999999999999 456789999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=315.20 Aligned_cols=242 Identities=25% Similarity=0.393 Sum_probs=201.2
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|.++.+++.||+|.+.... .......+.+|+++++.++ ||||+++++++.+...+++||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccC
Confidence 47999999999999999999999999875432 3445577999999999998 99999999999999999999999999
Q ss_pred CChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCcee---
Q 014704 153 GELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK--- 228 (420)
Q Consensus 153 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~--- 228 (420)
++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..........
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCC
Confidence 99999987644 58999999999999999999999999999999999999 456679999999987644321111
Q ss_pred cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHH
Q 014704 229 DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306 (420)
Q Consensus 229 ~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 306 (420)
...++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+...... . .....+..+.+|+.+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~ 231 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-P--CPELCPDAVYRLMER 231 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC-C--CcccCCHHHHHHHHH
Confidence 112245699999885 458999999999999999998 99999877776666655543221 1 123568899999999
Q ss_pred hcccCcCCCCCHHHHhc
Q 014704 307 MLHADPKERLSAAEVLN 323 (420)
Q Consensus 307 ~L~~dp~~R~t~~e~l~ 323 (420)
||..+|++|||+.++++
T Consensus 232 ~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=325.61 Aligned_cols=258 Identities=29% Similarity=0.515 Sum_probs=209.9
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-- 141 (420)
...++|.+.+.||+|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++ ||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchh
Confidence 345689999999999999999999999999999999865322 2233456788999999998 999999999987654
Q ss_pred --------eEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeE
Q 014704 142 --------SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (420)
Q Consensus 142 --------~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl 212 (420)
.+++|+||+++ ++.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||++ ++++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl 157 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKL 157 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEe
Confidence 79999999976 676766654 468999999999999999999999999999999999999 56678999
Q ss_pred eecccccccCCCC--ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q 014704 213 TDFGLSVFFKPGD--VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288 (420)
Q Consensus 213 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 288 (420)
+|||++....... ......++..|+|||.+.+ .++.++||||+||++|+|++|++||........+..+.......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999988664332 2223356788999998753 47899999999999999999999998777655555444321100
Q ss_pred C--------------------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 289 S--------------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 289 ~--------------------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
. ...+..++..+.++|.+||..||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0 01133578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=330.50 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=202.0
Q ss_pred cccceeecceecccCCeEEEEEEEcC-----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
-.++|++.+.||+|+||.||+|.+.. +++.||+|++.... .....+.+.+|+.++.++.+||||+++++++..
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 34689999999999999999997543 45789999986432 234456788999999999559999999998764
Q ss_pred -CCeEEEEEecCCCCChHHHHHhc--------------------------------------------------------
Q 014704 140 -RHSVNLIMDLCAGGELFDRIIAK-------------------------------------------------------- 162 (420)
Q Consensus 140 -~~~~~iv~e~~~g~~L~~~l~~~-------------------------------------------------------- 162 (420)
+..++++|||+++++|.+++...
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 46788999999999999888542
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc---eecccCCc
Q 014704 163 -----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSA 234 (420)
Q Consensus 163 -----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~ 234 (420)
..+++..+..++.||+.||.|||++||+||||||+|||++ .++.++|+|||++..+..... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 2578899999999999999999999999999999999994 567799999999987543221 12334567
Q ss_pred ccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCc
Q 014704 235 YYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312 (420)
Q Consensus 235 ~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 312 (420)
.|+|||++. ..++.++|||||||++|+|++ |..||.+....+.+............ ....++++.+++.+||+.+|
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCCh
Confidence 899999875 469999999999999999998 99999875543333333322222211 13567899999999999999
Q ss_pred CCCCCHHHHhcC
Q 014704 313 KERLSAAEVLNH 324 (420)
Q Consensus 313 ~~R~t~~e~l~h 324 (420)
++||++.++++|
T Consensus 318 ~~RPs~~ell~~ 329 (337)
T cd05054 318 EDRPTFSELVEI 329 (337)
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=320.42 Aligned_cols=254 Identities=29% Similarity=0.470 Sum_probs=208.3
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc--CCCCccEEEEEEEeCCe----
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYEDRHS---- 142 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpniv~~~~~~~~~~~---- 142 (420)
|.+.+.||+|+||.||+|.++.+++.||+|.+..... .......+.+|+.+++++. .||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6788999999999999999998899999999875432 2223345677888877764 39999999999988776
Q ss_pred -EEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 143 -VNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 143 -~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
++++|||+.+ +|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.+||+|||++.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~---~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc---cCCCEEEeccCcce
Confidence 9999999975 8888887643 489999999999999999999999999999999999994 55789999999988
Q ss_pred ccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----CC----
Q 014704 220 FFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID-----FS---- 289 (420)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~-----~~---- 289 (420)
............++..|+|||++.+ .++.++|+||+|+++|+|++|.+||.+.+..+.+..+...... ++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 7654444444568889999998864 5889999999999999999999999988877766665432110 00
Q ss_pred --------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 290 --------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 290 --------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
....+.++..+.++|.+||+.||++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00112456788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.81 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=201.6
Q ss_pred ceeccc--CCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecC
Q 014704 73 RELGRG--QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (420)
Q Consensus 73 ~~lG~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~ 150 (420)
..||+| +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++ ||||+++++++..++..++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence 456666 999999999999999999999865432 3345678999999999998 999999999999999999999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-c-
Q 014704 151 AGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-V- 226 (420)
Q Consensus 151 ~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~-~- 226 (420)
.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++. .++.++++||+.+....... .
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCccc
Confidence 999999988764 3489999999999999999999999999999999999994 56679999998654322110 0
Q ss_pred ------eecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--------
Q 014704 227 ------FKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS-------- 289 (420)
Q Consensus 227 ------~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------- 289 (420)
.....++..|+|||++.+ .++.++||||+||++|+|++|..||.+.........+.......+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 011234667999999864 378999999999999999999999987665444433332211000
Q ss_pred -----------------------------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 290 -----------------------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 290 -----------------------------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.......+..+.+||++||+.||++|||+.++|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00112356789999999999999999999999999999643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=315.47 Aligned_cols=243 Identities=25% Similarity=0.432 Sum_probs=210.0
Q ss_pred ceecccCCeEEEEEEEcCC---CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEec
Q 014704 73 RELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~ 149 (420)
+.||+|+||.||+|.+... +..|++|.+..... ....+.+.+|++.++.++ |+||+++++++.+...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence 4799999999999999866 88999999875432 224678999999999999 99999999999999999999999
Q ss_pred CCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 150 CAGGELFDRIIAK---------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 150 ~~g~~L~~~l~~~---------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence 9999999999875 679999999999999999999999999999999999999 4567899999999987
Q ss_pred cCCCC---ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 221 FKPGD---VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 221 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
..... ......+++.|+|||.+.. .++.++||||+|+++|+|++ |..||...........+..+... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL---PKPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence 65432 2234467889999998864 68999999999999999999 69999988888888877764321 11245
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
++.++.+++.+||..+|++|||+.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 68999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=320.23 Aligned_cols=249 Identities=22% Similarity=0.390 Sum_probs=207.5
Q ss_pred cceeecceecccCCeEEEEEEEc----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHK----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+.|++.+.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.+++.++ ||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence 46889999999999999999853 356789999986432 3344567899999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC
Q 014704 143 VNLIMDLCAGGELFDRIIAK-----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~ 205 (420)
.|+||||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence 99999999999999988532 237888899999999999999999999999999999999 4
Q ss_pred CCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014704 206 EDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280 (420)
Q Consensus 206 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~ 280 (420)
.+..+||+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+.....+.+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 567799999999976543321 22334567899999885 458999999999999999998 9999988877777666
Q ss_pred HHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 281 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+...... + ....+++.+.+++.+||+.||++||++.+++++
T Consensus 239 ~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQLL-P--CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCcC-C--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6654432 1 224678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=316.11 Aligned_cols=251 Identities=26% Similarity=0.508 Sum_probs=209.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|++++++++ |+||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEE
Confidence 57999999999999999999999899999999987544444455678999999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 147 MDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence 999999999988864 2458999999999999999999999999999999999999 456779999999987654
Q ss_pred CCC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 223 PGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET--EQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 223 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
... ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.... .......+..+... ..+...++.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP--PLPADHYSE 235 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC--CCChhhcCH
Confidence 322 2234568899999998764 58899999999999999999999996543 23344444443321 112235778
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
++.++|.+||..+|++|||+.++++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=333.90 Aligned_cols=257 Identities=23% Similarity=0.415 Sum_probs=218.7
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCc---e-EEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQ---Q-FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~-~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 136 (420)
.++-..++..+.++||+|+||.||+|..+..+. . ||+|............+..+.+|.++|+.++ |||||++||+
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGV 229 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGV 229 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEE
Confidence 344455667778999999999999999876432 3 8999987655557788899999999999999 9999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeec
Q 014704 137 YEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (420)
Q Consensus 137 ~~~~~~~~iv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Df 215 (420)
..+..-++||||+|.||+|.++|.+.+. ++..+...++.+.+.||+|||+++++||||-.+|+|+ ..+..+||+||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDF 306 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDF 306 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCcc
Confidence 9999999999999999999999998874 9999999999999999999999999999999999999 45566899999
Q ss_pred ccccccCCCCceecc-cCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 014704 216 GLSVFFKPGDVFKDL-VGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 216 g~~~~~~~~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 292 (420)
|+++.-......... .-...|+|||.+. +-|+.++|||||||++||+++ |..||.+....++...|....+..+.+.
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~ 386 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS 386 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC
Confidence 998764311111111 2346899999996 469999999999999999999 8999999999999999966655554432
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
..+.++..++.+|+..||++|||+.++.+
T Consensus 387 --~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 387 --KTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --CCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 66889999999999999999999999854
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=325.56 Aligned_cols=248 Identities=22% Similarity=0.322 Sum_probs=204.0
Q ss_pred cceeecceecccCCeEEEEEEEcCCCce----EEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQ----FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.+|++.+.||+|+||.||+|.+..++.. ||+|.+.... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence 4699999999999999999998766554 8999885422 3344567889999999998 99999999998765 5
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.+..+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccccc
Confidence 77999999999999999874 458899999999999999999999999999999999999 45677999999999876
Q ss_pred CCCCcee---cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 222 KPGDVFK---DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 222 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
....... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....+....+.. ...++.. +..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~ 236 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQP--PIC 236 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC-CCCCCCC--CCC
Confidence 5433211 223466899999885 468999999999999999998 9999988776665444333 3333322 356
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+.++.+++.+||..||++|||+.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=314.35 Aligned_cols=242 Identities=25% Similarity=0.358 Sum_probs=202.0
Q ss_pred ceecccCCeEEEEEEE--cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecC
Q 014704 73 RELGRGQFGVTYLVTH--KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~ 150 (420)
+.||+|+||.||+|.+ +.++..+|+|++.... ......+.+.+|+.+++.+. ||||+++++++.. ...++||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~~~lv~e~~ 77 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICEA-ESWMLVMELA 77 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-CCcEEEEecC
Confidence 3689999999999975 4567899999886432 23445678899999999998 9999999998764 5678999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCce---
Q 014704 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF--- 227 (420)
Q Consensus 151 ~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~--- 227 (420)
.+++|.+++.....+++..+..++.|++.||.|||++||+||||||+||++ +.+..+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeee
Confidence 999999999888889999999999999999999999999999999999999 45677999999999876433221
Q ss_pred -ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 228 -KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 228 -~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
....++..|+|||.+.. .++.++|+||||+++|+|++ |..||.+.........+..+.. .+ ....+++++.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~li 231 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-ME--CPQRCPPEMYDLM 231 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-CC--CCCCCCHHHHHHH
Confidence 12234578999998864 58889999999999999998 9999988888777777776542 11 1236789999999
Q ss_pred HHhcccCcCCCCCHHHHhc
Q 014704 305 KKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~ 323 (420)
.+||+.||++||++.+|..
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 9999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=348.50 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=207.9
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-----
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----- 139 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~----- 139 (420)
...+|+..+.||+||||.||+++.+-+|+.||||+|.... +......+.+|+..|.+|+ |||||+++..|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCcc
Confidence 3456888899999999999999999999999999997644 4556688999999999999 9999999865400
Q ss_pred -------------------------------------------------------------------------C------
Q 014704 140 -------------------------------------------------------------------------R------ 140 (420)
Q Consensus 140 -------------------------------------------------------------------------~------ 140 (420)
.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred -----------------------------------CeEEEEEecCCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHH
Q 014704 141 -----------------------------------HSVNLIMDLCAGGELFDRIIAKGHY-SERAAANLCRQMVTVVHYC 184 (420)
Q Consensus 141 -----------------------------------~~~~iv~e~~~g~~L~~~l~~~~~~-~~~~~~~i~~qi~~al~~l 184 (420)
..+||-||||+..+|.+.+..+... ....+++++++|++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 1367889999886666655544333 4778899999999999999
Q ss_pred HHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-------------------CCCceecccCCcccccchhhcc-
Q 014704 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-------------------PGDVFKDLVGSAYYVAPEVLRR- 244 (420)
Q Consensus 185 H~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~- 244 (420)
|+.|||||||||.||++ +.+..|||+|||+|.... .....++.+||..|+|||++.+
T Consensus 714 H~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99999999999999999 567779999999998721 0113356789999999999852
Q ss_pred ---cCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHH
Q 014704 245 ---NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAE 320 (420)
Q Consensus 245 ---~~~~~~DvwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 320 (420)
.|+.|+|+||||||++||+. ||....+ ..++..+.++.++.+.+.+..--+.-..+|+.||+.||.+||||.|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 59999999999999999995 6765543 4566677777777764444444567789999999999999999999
Q ss_pred HhcCCccc
Q 014704 321 VLNHPWMR 328 (420)
Q Consensus 321 ~l~h~~~~ 328 (420)
+|++.||.
T Consensus 868 LL~s~llp 875 (1351)
T KOG1035|consen 868 LLNSELLP 875 (1351)
T ss_pred HhhccCCC
Confidence 99999996
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=315.27 Aligned_cols=249 Identities=22% Similarity=0.400 Sum_probs=209.2
Q ss_pred cceeecceecccCCeEEEEEEEcCC---CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
++|.+.+.||+|+||.||+|.++.+ ...||+|.+.... .......+.+|+.+++.++ ||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence 5799999999999999999998754 4579999886432 3344567889999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
++||||+.+++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence 9999999999999998764 468999999999999999999999999999999999999 456779999999998764
Q ss_pred CC-Ccee--cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 223 PG-DVFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 223 ~~-~~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.. .... ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+..+... + .....+
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-P--PPMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-C--CCCCCC
Confidence 21 1111 223457899999886 458999999999999999998 99999888877777777654322 1 123578
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=321.03 Aligned_cols=258 Identities=26% Similarity=0.375 Sum_probs=209.8
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
-.+.|.+.+.||+|+||.||+|.+..+++.||||.+..... ......+..|+.++.++.+||||+++++++.+....|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 34679999999999999999999998899999999865432 2334566778887777767999999999999999999
Q ss_pred EEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+||||+. ++|.+.+.. ...+++..+..++.|++.||.|||+ .||+||||+|+||++ ++++.+||+|||++....
T Consensus 91 ~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 91 ICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhcc
Confidence 9999985 467666654 4568999999999999999999997 599999999999999 456789999999987765
Q ss_pred CCCceecccCCcccccchhhcc-----cCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCC
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRR-----NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
.........++..|+|||.+.+ .++.++||||||+++|+|++|+.||.... ..+.+..+........ .....+
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 245 (296)
T cd06618 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGF 245 (296)
T ss_pred CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCCC
Confidence 4433344568889999998853 37889999999999999999999997633 2344444444332211 111246
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.++.+|+.+||..||++|||+.+++.||||..
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 889999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=326.49 Aligned_cols=258 Identities=29% Similarity=0.485 Sum_probs=207.9
Q ss_pred ceeecceecccCCeEEEEEEEcCC--CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe----CC
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDT--KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----RH 141 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~----~~ 141 (420)
+|.+.+.||+|+||.||++.+..+ +..||+|.+.... ........+.+|+.+++++.+||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488899999999999999999888 8999999986422 1223346688999999999669999999986432 25
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.+|+++||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence 6789999985 6899998888889999999999999999999999999999999999999 45677999999999865
Q ss_pred CCCC-----ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------
Q 014704 222 KPGD-----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-------- 286 (420)
Q Consensus 222 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~-------- 286 (420)
.... ......||+.|+|||.+.+ .++.++||||+|+++|+|++|.+||........+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 4321 1233578999999998753 488999999999999999999999987665444433222100
Q ss_pred ---------------CCC----CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 287 ---------------DFS----SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 287 ---------------~~~----~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
..+ ...++..+..+.+|+.+||+.||++|||+.+++.|||+..-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 000 11234568899999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=321.05 Aligned_cols=253 Identities=31% Similarity=0.509 Sum_probs=209.5
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
|.+.+.||+|+||.||+|....+++.|++|.+..... ........+|+..++++.+||||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999998899999999864322 12233456799999999889999999999999999999999
Q ss_pred cCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 149 LCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 149 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
|+ +++|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||++ +.++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC
Confidence 99 789999887765 78999999999999999999999999999999999999 5577899999999987665444
Q ss_pred eecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Q 014704 227 FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS--------------- 289 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------- 289 (420)
.....++..|+|||++.+ .++.++|+||||+++|+|++|++||...........+........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 455678999999998743 478999999999999999999999987765554443322100000
Q ss_pred -----------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 290 -----------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 290 -----------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
....+..+.++.++|++||+.||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 01122346889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=313.93 Aligned_cols=251 Identities=27% Similarity=0.484 Sum_probs=216.9
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+|.+.+.||+|+||.||++.++.+++.+|+|.+..... .......+.+|+.+++.++ ||||+++++++.+....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence 48899999999999999999999999999999875433 3344567889999999999 999999999999999999999
Q ss_pred ecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 148 DLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 148 e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++ .+..+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhcc
Confidence 99999999988866 35689999999999999999999999999999999999995 466799999999887654
Q ss_pred CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
. ......+++.|+|||.+.+ .++.++|+||+|+++|+|++|+.||...+.......+..+...... ...+.++++
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIYSQDLQN 231 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhhCHHHHH
Confidence 4 3334568899999999864 4788999999999999999999999988877776666655443222 256889999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
++.+||..+|++|||+.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=320.40 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=208.1
Q ss_pred ccceeecceecccCCeEEEEEEEcCCC----------------ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTK----------------QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 129 (420)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+++++.++ |||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCC
Confidence 357999999999999999999876543 458999886542 2345678999999999998 999
Q ss_pred ccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCc
Q 014704 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG-----------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (420)
Q Consensus 130 iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 198 (420)
|+++++++.++...+++|||+.+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999987765 68999999999999999999999999999999999
Q ss_pred EEEecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh--CCCCCCCC
Q 014704 199 FLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS--GVPPFWGE 272 (420)
Q Consensus 199 ill~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~--g~~pf~~~ 272 (420)
|++ +.++.++|+|||++........ .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||...
T Consensus 161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999 4557899999999876543321 123456778999998764 68999999999999999998 78899877
Q ss_pred CHHHHHHHHHcC----CCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 273 TEQSIFDAILRG----HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 273 ~~~~~~~~i~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+....+..+... ...........++.++.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 776666665432 111111122356789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=325.45 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=205.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC-----
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR----- 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~----- 140 (420)
.++|.+.+.||+|+||.||+|.++.+++.+|+|.+..... .......+.+|+++++.++ ||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence 4789999999999999999999999999999999865432 1222345678999999998 99999999987443
Q ss_pred ---CeEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 141 ---HSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 141 ---~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
..+++||||+.+ +|...+.. ...+++..+..++.|+++||.|||++||+||||||+||++ +.++.++|+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCc
Confidence 357999999965 67666654 3479999999999999999999999999999999999999 556789999999
Q ss_pred cccccCCCCc------------eecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014704 217 LSVFFKPGDV------------FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL 282 (420)
Q Consensus 217 ~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 282 (420)
++........ .....|++.|+|||.+.+ .++.++||||+|+++|+|++|++||.+.+.....+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9876532211 122356888999998753 47899999999999999999999998887766555543
Q ss_pred cCCCCCCC--------------------------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 283 RGHIDFSS--------------------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 283 ~~~~~~~~--------------------------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
........ ..+..+++++.+||.+||..||++|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 31110000 0123455788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=313.30 Aligned_cols=246 Identities=22% Similarity=0.410 Sum_probs=207.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||.|.+.. +..+|+|.+..... ..+.+.+|+.++++++ ||||+++++++.+...+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence 468999999999999999998765 45699998864322 2356889999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||++ +.++.+||+|||.+.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCc
Confidence 9999999999988764 468999999999999999999999999999999999999 456779999999987654332
Q ss_pred cee--cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 226 VFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 226 ~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+..+...... ...+..+.
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVY 231 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence 211 223556799999986 458899999999999999998 99999888777777777765443322 24578999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+++.+||..||++|||+.+++++
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=325.97 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=205.0
Q ss_pred cccccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE
Q 014704 57 VLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (420)
Q Consensus 57 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 136 (420)
+.........++|.-...||+|+||.||+|...++ ..||||.+...... . ..+|.+|+.++.+++ |||+|+++||
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~--~-~~eF~~Ei~~ls~l~-H~Nlv~LlGy 139 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQ--G-EREFLNEVEILSRLR-HPNLVKLLGY 139 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCc--c-hhHHHHHHHHHhcCC-CcCcccEEEE
Confidence 44445556678898899999999999999998764 88999987643321 1 455999999999999 9999999999
Q ss_pred EEeCC-eEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CeeccCCCCcEEEecCCCCCCe
Q 014704 137 YEDRH-SVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMG---VMHRDLKPENFLFSSSAEDSPL 210 (420)
Q Consensus 137 ~~~~~-~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~~~~ 210 (420)
|.+.+ ..++|+||+.+|+|.++|.... .++|....+|+.+++.||+|||+.. |||||||++|||+ +++...
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~a 216 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNA 216 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCE
Confidence 99988 5999999999999999998765 8999999999999999999999864 9999999999999 678889
Q ss_pred eEeecccccccCC-CCceecc-cCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHH----HH
Q 014704 211 KATDFGLSVFFKP-GDVFKDL-VGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGET---EQSIF----DA 280 (420)
Q Consensus 211 kl~Dfg~~~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~---~~~~~----~~ 280 (420)
||+|||+|+.... ....... .||..|+|||++. +..+.++|||||||+|.||+||+.+..... ...+. ..
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999976654 3333333 8999999999985 679999999999999999999998876432 11111 12
Q ss_pred HHcCCCC-CCCCCC--CCCC-----hHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 281 ILRGHID-FSSDPW--PNIS-----SSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 281 i~~~~~~-~~~~~~--~~~~-----~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+..+... +..+.+ ...+ ..+..+..+|++.+|..||++.|+++
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 2222111 111111 1222 22557788999999999999999743
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=322.65 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=213.3
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
....|...+.||+|+||.||+|+++.++..+|+|.+.............+.+|+.+++.++ |+|++++++++......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeE
Confidence 3456888899999999999999999999999999986543334445567889999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
+||||+. ++|.+.+.. ...+++..+..++.|++.||.|||+++++||||+|+||++ +.++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecC
Confidence 9999996 577776654 4568999999999999999999999999999999999999 4567799999999876543
Q ss_pred CCceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 224 GDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
. ....|++.|+|||.+. +.++.++|||||||++|+|++|..||...........+..+...... ...++..
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 242 (308)
T cd06634 168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEY 242 (308)
T ss_pred c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcC--cccccHH
Confidence 3 3346889999999873 35788999999999999999999999876655555555444332211 2356888
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.+||++||..+|++||++.++++|||+..
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=319.90 Aligned_cols=255 Identities=29% Similarity=0.526 Sum_probs=213.5
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
|.....||+|+||.||++..+.+++.||+|.+... .......+.+|+.+++.++ |+||+++++++...+..++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEEe
Confidence 44457899999999999999999999999987532 2334567899999999998 9999999999999999999999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-ce
Q 014704 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-VF 227 (420)
Q Consensus 149 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~-~~ 227 (420)
|+++++|.+++. ...+++..+..++.|++.||+|||+.|++||||+|+||++ +.++.++|+|||++....... ..
T Consensus 98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccccc
Confidence 999999988764 4578999999999999999999999999999999999999 456779999999887654322 22
Q ss_pred ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHH
Q 014704 228 KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306 (420)
Q Consensus 228 ~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 306 (420)
....|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+.........+...... .......++..+.+++.+
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 252 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-KLKNLHKVSPSLKGFLDR 252 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-ccCCcccCCHHHHHHHHH
Confidence 33568899999998854 5789999999999999999999999887766665555443221 122234678999999999
Q ss_pred hcccCcCCCCCHHHHhcCCcccccCC
Q 014704 307 MLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 307 ~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
||..||.+||++.++++||||.....
T Consensus 253 ~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 253 LLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHhCCcccCcCHHHHhcChHHhccCC
Confidence 99999999999999999999986553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=329.15 Aligned_cols=262 Identities=30% Similarity=0.487 Sum_probs=211.7
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--C
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--H 141 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--~ 141 (420)
.+.++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++++.+||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 45678999999999999999999999899999999886432 22334466788999999993399999999988643 4
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.+|+||||+. ++|.+++... .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhcc
Confidence 6899999997 4898888655 78899999999999999999999999999999999999 56778999999998765
Q ss_pred CCCC------ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Q 014704 222 KPGD------VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH-------- 285 (420)
Q Consensus 222 ~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~-------- 285 (420)
.... ......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||.+.........+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 4322 2234568999999998743 47889999999999999999999998766544433332211
Q ss_pred -------------------CCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 286 -------------------IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 286 -------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
........+.++.++.++|.+||+.||++|||+.++++|||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0111112345788999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=320.62 Aligned_cols=252 Identities=24% Similarity=0.425 Sum_probs=209.6
Q ss_pred cccceeecceecccCCeEEEEEEEcCC-----CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
-.++|.+.+.||+|+||.||++.++.. ...+|+|.+.... .......+.+|+.+++++.+||||+++++++..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 346799999999999999999998643 3689999986432 334456788999999999449999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEec
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS 203 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~ 203 (420)
.+.++++|||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~-- 165 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-- 165 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE--
Confidence 99999999999999999998642 458899999999999999999999999999999999999
Q ss_pred CCCCCCeeEeecccccccCCCCce---ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHH
Q 014704 204 SAEDSPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIF 278 (420)
Q Consensus 204 ~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~ 278 (420)
+.++.+||+|||++......... ....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 166 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 166 -TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred -cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 45678999999999876543221 1223456799999875 458999999999999999997 99999988877777
Q ss_pred HHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 279 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..+..+.. .. .....+.++.+|+.+||..||++|||+.+++++
T Consensus 245 ~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 245 KLLKEGYR-ME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHcCCc-CC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 76665432 11 123568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=315.97 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=203.5
Q ss_pred eeecceecccCCeEEEEEEEcCCCc--eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC------
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQ--QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR------ 140 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~------ 140 (420)
|.+++.||+|+||.||+|++..++. .+|+|.+.... ......+.+.+|+.+++.++ ||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCC
Confidence 3577899999999999999987765 68999886532 24455678899999999998 99999999976422
Q ss_pred CeEEEEEecCCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEee
Q 014704 141 HSVNLIMDLCAGGELFDRIIA------KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~D 214 (420)
...+++|||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.+..+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECC
Confidence 357899999999999887742 2348899999999999999999999999999999999999 4567899999
Q ss_pred cccccccCCCCce---ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCC
Q 014704 215 FGLSVFFKPGDVF---KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFS 289 (420)
Q Consensus 215 fg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 289 (420)
||++......... ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+.........+..+....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~- 234 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK- 234 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 9999876443221 12245678999999864 58999999999999999999 899998888777777777654321
Q ss_pred CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 290 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..+.++..+.++|.+||+.||++|||+.+++++
T Consensus 235 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 --QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 123678899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=316.34 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=208.8
Q ss_pred cccceeecceecccCCeEEEEEEEcCC-----CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
..++|.+.+.||+|+||.||+|.++.. +..||+|.+.... .......+.+|+.+++.+. ||||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~ 80 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVST 80 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcC
Confidence 456899999999999999999998754 3789999975432 2334567889999999998 9999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCC
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAKG----------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~ 209 (420)
....++||||+.+++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+||++ +.++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~ 157 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLT 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCC
Confidence 999999999999999999886532 36788899999999999999999999999999999999 55678
Q ss_pred eeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC
Q 014704 210 LKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284 (420)
Q Consensus 210 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~ 284 (420)
+||+|||+++....... .....++..|+|||.+. +.++.++|||||||++|++++ |..||.+.+.......+..+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 99999999876543321 12345678899999875 468999999999999999998 99999888887777777644
Q ss_pred CCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
... .. ....+.++.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~-~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 238 GHL-DL--PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCC-CC--CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 321 11 1346899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=315.76 Aligned_cols=248 Identities=22% Similarity=0.361 Sum_probs=205.0
Q ss_pred eeecceecccCCeEEEEEEEcCC---CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe---
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS--- 142 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~--- 142 (420)
|.+++.||+|+||.||+|....+ +..||+|.+..... .......+.+|+..++.++ ||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence 56789999999999999998653 47899999875332 3445678999999999998 9999999998765443
Q ss_pred ---EEEEEecCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 143 ---VNLIMDLCAGGELFDRIIAK------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 143 ---~~iv~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
.+++|||+.+++|..++... ..+++..+..++.|++.||.|||++||+||||||+||++ +++..+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence 79999999999998887543 358999999999999999999999999999999999999 456779999
Q ss_pred ecccccccCCCCce---ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCC
Q 014704 214 DFGLSVFFKPGDVF---KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDF 288 (420)
Q Consensus 214 Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 288 (420)
|||+++........ ....++..|+|||.+.. .++.++||||||+++|+|++ |..||.+....+....+..+....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99998876433221 11234678999998864 58999999999999999999 999998888877777776653221
Q ss_pred CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
....++.++.+++.+||..||++|||+.+++++
T Consensus 236 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 ---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 123678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=316.84 Aligned_cols=245 Identities=29% Similarity=0.493 Sum_probs=201.5
Q ss_pred eecceecccCCeEEEEEEEc----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 70 IFGRELGRGQFGVTYLVTHK----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 70 ~~~~~lG~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.+.+.||.|+||.||+|.+. ..+..|+||.+... ......+.+.+|++.+++++ ||||+++++++...+.+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccc-ccccccccccccccccccc
Confidence 45689999999999999998 34578999998542 24455788999999999997 9999999999998888999
Q ss_pred EEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|||||.+|+|.+++... ..+++..+..|+.||+.||.|||+++|+|+||+++||+++ .++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---SNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---TTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccc
Confidence 99999999999999887 6799999999999999999999999999999999999995 466899999999987632
Q ss_pred CCce---ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 224 GDVF---KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 224 ~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
.... ....+...|+|||.+.. .++.++||||||+++||+++ |+.||...+...+...+..+..... ...++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhH
Confidence 2221 22346778999999864 48999999999999999999 7899998888888888866544221 235789
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+.++|..||..||++|||+.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=313.52 Aligned_cols=246 Identities=23% Similarity=0.402 Sum_probs=207.7
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|++.++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++ ||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEE
Confidence 467999999999999999999975 45679999876432 23567899999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
+|||+.+++|.+++... ..+++..+..++.|++.||+|||+++++||||||+||++ +.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIED 155 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCC
Confidence 99999999999988653 458889999999999999999999999999999999999 4567899999999987643
Q ss_pred CCce--ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 224 GDVF--KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 224 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
.... ....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+..+. .. +....++.+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~ 232 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RM--PRMENCPDE 232 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CC--CCCCCCCHH
Confidence 3211 2234567899999885 458889999999999999998 999998888777777776542 22 223467899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+.+++.+||..+|++|||++++++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=341.63 Aligned_cols=248 Identities=27% Similarity=0.503 Sum_probs=217.7
Q ss_pred cccceeecceecccCCeEEEEEEEcC-----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
-+.+..+.+.||+|+||.||+|+... ....||||.++... +.+....|++|++++..|+ |||||+++|+|..
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCRE 560 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEcc
Confidence 34567788999999999999998643 34679999987543 4446789999999999999 9999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAKG--------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~ 205 (420)
++-+|+|+|||..|+|.++|.... +++..+...|+.||+.|+.||-++.+|||||-..|+|| +
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---g 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---G 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---c
Confidence 999999999999999999997532 27889999999999999999999999999999999999 6
Q ss_pred CCCCeeEeecccccccCCCCceecc---cCCcccccchhh-cccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014704 206 EDSPLKATDFGLSVFFKPGDVFKDL---VGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280 (420)
Q Consensus 206 ~~~~~kl~Dfg~~~~~~~~~~~~~~---~gt~~y~aPE~~-~~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~ 280 (420)
++..|||+|||+++.+...+.+.-. .-..+|||||.+ .++|+.+|||||+||+|||+++ |..||.+.+.+++++.
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 7889999999999987665544322 234689999976 5789999999999999999998 9999999999999999
Q ss_pred HHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHH
Q 014704 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321 (420)
Q Consensus 281 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 321 (420)
|..+.. ++.+ .+.|.++.+|+..||+.+|.+||++.||
T Consensus 718 i~~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 718 IRAGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHcCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 999987 4443 4789999999999999999999999998
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=318.79 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=208.9
Q ss_pred cceeecceecccCCeEEEEEEEcCC-----CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.+|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... .....+.+.+|+.++..++ ||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCC
Confidence 4588899999999999999987543 5789999986432 2334567889999999999 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC
Q 014704 142 SVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~ 205 (420)
..++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ .
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---F 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---c
Confidence 999999999999999988532 347888899999999999999999999999999999999 4
Q ss_pred CCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014704 206 EDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280 (420)
Q Consensus 206 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~ 280 (420)
++..+||+|||+++....... .....+++.|+|||.+. +.++.++||||||+++|+|++ |..||.+....+....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 566799999999876543322 12334678899999875 568999999999999999998 8999998888888888
Q ss_pred HHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 281 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+........ ...++..+.+|+.+||+.+|++||++.+++..
T Consensus 239 i~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 877654322 13678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.61 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=206.5
Q ss_pred cccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
..++|.+.+.||+|+||.||++.+. .++..||+|.+.... .....+.+.+|+.+++++.+||||+++++++..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 3467999999999999999999863 345689999886432 234456789999999999449999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
.+..|+||||+.+++|.+++.... .+++..+..++.|++.||.|||+++|+|+||||+||++ +.+..++|+|||+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCcc
Confidence 999999999999999999987643 38999999999999999999999999999999999999 4567799999999
Q ss_pred ccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 014704 218 SVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 218 ~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 292 (420)
+........ .....++..|+|||.+. ..++.++||||+||++|+|++ |..||........+............
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 265 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ-- 265 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC--
Confidence 886543321 11234577899999875 458999999999999999998 99999877665555444443322221
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
....+.++.+++.+||..+|++|||+.++++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=327.92 Aligned_cols=258 Identities=30% Similarity=0.485 Sum_probs=208.8
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR---- 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~---- 140 (420)
+.++|.+.+.||+|+||.||+|++..+|+.||+|.+.... ........+.+|+.+++.+. ||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGD 90 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcC-CCCccchhheecccccCC
Confidence 4578999999999999999999999999999999986532 22333456889999999998 99999999998654
Q ss_pred --CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 141 --HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 141 --~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
..+|+|+||+.+ +|...+ ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~ 164 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLA 164 (342)
T ss_pred CCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCC
Confidence 356999999964 676554 3468999999999999999999999999999999999999 45678999999998
Q ss_pred cccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH----------- 285 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~----------- 285 (420)
...... .....+++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 165 RHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred cCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 765322 234567889999998754 48899999999999999999999998877555444433211
Q ss_pred ------------CCCCCC----CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 286 ------------IDFSSD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 286 ------------~~~~~~----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
...+.. .++..+.++.+||++||+.||++||++.+++.||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000110 12456788999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=321.10 Aligned_cols=252 Identities=26% Similarity=0.443 Sum_probs=208.0
Q ss_pred cccceeecceecccCCeEEEEEEEcC-------CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKD-------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
..++|.+++.||+|+||.||+|.+.. +...+|+|.+.... .......+.+|+.+++.+.+||||+++++++
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34689999999999999999998743 23569999986532 3344567889999999995599999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLF 201 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill 201 (420)
.+.+..|+||||+.+++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 99999999999999999999997642 47889999999999999999999999999999999999
Q ss_pred ecCCCCCCeeEeecccccccCCCCce---ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH
Q 014704 202 SSSAEDSPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQS 276 (420)
Q Consensus 202 ~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~ 276 (420)
+.++.+||+|||++......... ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.....
T Consensus 174 ---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 174 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred ---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 45678999999998765432211 11234568999998864 58999999999999999998 899998888777
Q ss_pred HHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 277 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
....+..... . +....++.++.+|+.+||..+|++|||+.+++++
T Consensus 251 ~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCC-C--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7776655432 1 1224678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=308.24 Aligned_cols=265 Identities=29% Similarity=0.498 Sum_probs=218.6
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE--
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE-- 138 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~-- 138 (420)
|.-+..+.|.-..+||+|.||.||+|+.+++|+.||+|++....-. ...-....+|+++|..|+ |+|++.++++|.
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lk-Henv~nliEic~tk 88 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLK-HENVVNLIEICRTK 88 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhc
Confidence 3344456788889999999999999999999999999876542211 111244679999999999 999999998774
Q ss_pred ------eCCeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCee
Q 014704 139 ------DRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 139 ------~~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
+...+|+||.+|+. +|.-.|... .+++..++.+++++++.||.|+|.+.|+|||+|++|+|+ +.++.+|
T Consensus 89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilk 164 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILK 164 (376)
T ss_pred cCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEE
Confidence 33459999999975 888888765 569999999999999999999999999999999999999 6788999
Q ss_pred EeecccccccCCCC-----ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 014704 212 ATDFGLSVFFKPGD-----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG 284 (420)
Q Consensus 212 l~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~ 284 (420)
|+|||+++.+.... .++..+-|.+|.+||.+.+ .|+++.|||..|||+.+|++|.+.|.++++++.+..|..-
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 99999997654221 2344567999999998854 5999999999999999999999999999999888888654
Q ss_pred CCCCCCCCCCCC-------------------------------ChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 285 HIDFSSDPWPNI-------------------------------SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 285 ~~~~~~~~~~~~-------------------------------~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
...+..+.|+++ .+++.+|+.+||..||.+|+++.++|+|.||..+.
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 444444444432 34778999999999999999999999999998654
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=320.73 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=207.4
Q ss_pred cccceeecceecccCCeEEEEEEEcC-------CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKD-------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
-.++|.+.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.+.+||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 34689999999999999999998642 34579999876432 2345677889999999996699999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLF 201 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill 201 (420)
.+.+.+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 9999999999999999999998753 247888999999999999999999999999999999999
Q ss_pred ecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH
Q 014704 202 SSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQS 276 (420)
Q Consensus 202 ~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~ 276 (420)
+.++.+||+|||+++....... .....++..|+|||++. +.++.++||||||+++|+|++ |..||.+.....
T Consensus 168 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 168 ---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred ---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 4567799999999986543221 11223456799999875 458999999999999999999 999998888877
Q ss_pred HHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 277 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+..+..+... .....++.++++++.+||..||++|||+.++++
T Consensus 245 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 245 LFKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 77777654321 112457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=327.35 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=210.2
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-- 140 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-- 140 (420)
..+.++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARS 90 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeeccc
Confidence 346688999999999999999999999999999999986432 12233466889999999999 99999999988643
Q ss_pred ----CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 141 ----HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 141 ----~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
..+|++++++ |++|.+.+. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg 165 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFG 165 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEeccc
Confidence 3478888887 779977665 4569999999999999999999999999999999999999 456779999999
Q ss_pred cccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-------- 286 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~-------- 286 (420)
++..... ......|+..|+|||.+.+ .++.++||||+||++|+|++|+.||........+..+.....
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 166 LARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred ccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 9876532 2234578899999998754 478899999999999999999999987665544443322110
Q ss_pred ---------------CCCC----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 287 ---------------DFSS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 287 ---------------~~~~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
..+. +.+...++++.+||.+||+.||.+|||+.++++||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0000 112245788999999999999999999999999999985443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=319.27 Aligned_cols=253 Identities=32% Similarity=0.550 Sum_probs=210.2
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
|.+.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.++++++ ||||+++++++.++..+++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence 5677899999999999999998999999999865432 2234567889999999999 9999999999999999999999
Q ss_pred cCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-c
Q 014704 149 LCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-V 226 (420)
Q Consensus 149 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~-~ 226 (420)
|+.+ +|.+.+... ..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||.+....... .
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc
Confidence 9975 888877664 579999999999999999999999999999999999999 456779999999987765443 2
Q ss_pred eecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----------------
Q 014704 227 FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID----------------- 287 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~----------------- 287 (420)
.....++..|+|||.+.+ .++.++|+||+|+++|+|++|+.||.+.+..+.+..+......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 334568889999998753 5789999999999999999999999887765554443321110
Q ss_pred --CC-------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 288 --FS-------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 288 --~~-------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
++ ...++.++.++.++|.+||..||.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00 01123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=364.70 Aligned_cols=257 Identities=28% Similarity=0.489 Sum_probs=219.8
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
+.-++.-+..||.|.||.||.|.+.++|...|+|.+.-.... ......+.+|+.+|..+. |||+|+++++-.+.+.++
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeecHHHHH
Confidence 444677778999999999999999999999999998754432 455677899999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
|.||||+||+|.+.+...+..+|.....+..|++.|+.|||++|||||||||+||++ +.++.+|++|||.|+.+...
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCc
Confidence 999999999999998877778888889999999999999999999999999999999 56678999999999987654
Q ss_pred C-----ceecccCCcccccchhhcc----cCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCC-CCCCCCCC
Q 014704 225 D-----VFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGH-IDFSSDPW 293 (420)
Q Consensus 225 ~-----~~~~~~gt~~y~aPE~~~~----~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~-~~~~~~~~ 293 (420)
. .....+||+.|||||++.+ ....++||||+||++.||+||+.||..-+ +-+++..+-.+. ++++.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~--- 1464 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE--- 1464 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch---
Confidence 2 2346789999999999964 35678999999999999999999996543 344444454443 33333
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+|++.++||.+||..||++|+++.|+|+|.|-+..
T Consensus 1465 -~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1465 -RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred -hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 489999999999999999999999999999997643
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.85 Aligned_cols=247 Identities=24% Similarity=0.424 Sum_probs=207.1
Q ss_pred cceeecceecccCCeEEEEEEEcC-----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.+|.+.+.||+|+||.||+|.+.. ++..+++|.+... .....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCC
Confidence 468999999999999999998643 4556889987532 2334467899999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC
Q 014704 142 SVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~ 205 (420)
..++||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---G 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---c
Confidence 9999999999999999987542 37899999999999999999999999999999999999 4
Q ss_pred CCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014704 206 EDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280 (420)
Q Consensus 206 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~ 280 (420)
.++.++|+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.........+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 567899999999876543321 12345678899999876 458899999999999999998 9999988888777777
Q ss_pred HHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 281 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+..+..... ....+..+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 238 ITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 766544322 2346889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=311.48 Aligned_cols=247 Identities=23% Similarity=0.360 Sum_probs=207.1
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|++.+.||+|+||.||+|.+.. ++.||+|.+..... ..+.+.+|+.++++++ ||||+++++++...+..|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCC-CCCccceeEEEecCCCee
Confidence 34679999999999999999999764 57899999865332 3466889999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 145 LIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+||||+.+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEcc
Confidence 9999999999999987654 68999999999999999999999999999999999999 456779999999998765
Q ss_pred CCCce--ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 223 PGDVF--KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 223 ~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
..... ....++..|+|||.+.. .++.++||||||+++|+|++ |+.||.+.+.......+..... .+ ....++.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 231 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-MP--CPPGCPK 231 (261)
T ss_pred CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC--CCCcCCH
Confidence 32211 11122457999998764 58899999999999999999 9999998887777777665422 22 1235789
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=301.58 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=206.6
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-----C
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-----R 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-----~ 140 (420)
.++|++.+.||+|||+-||+++...+++.||+|.+... ..++.+...+|++..++++ |||+++++++... .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCc
Confidence 47899999999999999999999999999999998654 3567788999999999999 9999999887533 3
Q ss_pred CeEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCCCCCCeeEee
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATD 214 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~~~~kl~D 214 (420)
...||++.|...|+|.+.+... ..++|..+..|+.++++||.+||+.. ++||||||.|||+. +.+.++|.|
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D 172 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMD 172 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEe
Confidence 4599999999999999988643 36999999999999999999999999 99999999999995 467799999
Q ss_pred cccccccCCCC----------ceecccCCcccccchhhcc----cCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHH
Q 014704 215 FGLSVFFKPGD----------VFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGETEQ--SIF 278 (420)
Q Consensus 215 fg~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~DvwslGvil~~ll~g~~pf~~~~~~--~~~ 278 (420)
||.+....-.- .+.....|..|.|||.+.- ..+.++|||||||+||.|+.|..||...-.+ .+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 99987653110 1122357899999999852 3789999999999999999999999432111 111
Q ss_pred HHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 279 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
-.+.++.+.++... ..|+.+.++|+.||++||.+||++.+++.+
T Consensus 253 LAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 22445566666553 489999999999999999999999999864
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=314.22 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=210.5
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
...+|.+.+.||.|+||.||+|.++. +..+|+|.+.... ......+.+|+.+++.++ ||||+++++++.+...++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeE
Confidence 34679999999999999999999988 8899999986532 234567899999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 145 LIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ ++++.+||+|||.+....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIK 155 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcC
Confidence 999999999999998753 458999999999999999999999999999999999999 456779999999987664
Q ss_pred CCCc-eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 223 PGDV-FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 223 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
.... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+.+..+..+. ..+ .....++.
T Consensus 156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~ 232 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY-RMP--CPAKCPQE 232 (261)
T ss_pred CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-cCC--CCCCCCHH
Confidence 3221 12334567899999875 458899999999999999998 899998888777777776542 222 12467899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 233 IYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=318.25 Aligned_cols=253 Identities=31% Similarity=0.530 Sum_probs=211.0
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
|.+.+.||+|+||.||+|....+++.||+|.+.... ......+.+.+|+.+++.+. |+||+++++++.+...+++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence 567789999999999999999999999999987643 22334567889999999999 9999999999999999999999
Q ss_pred cCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-c
Q 014704 149 LCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-V 226 (420)
Q Consensus 149 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~-~ 226 (420)
|+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||++ ++++.++|+|||.+....... .
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc
Confidence 997 5899998876 579999999999999999999999999999999999999 457789999999987664332 2
Q ss_pred eecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------------C
Q 014704 227 FKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH------------------I 286 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~------------------~ 286 (420)
.....++..|+|||.+.+ .++.++||||||+++|++++|..||.+.+....+..+.... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 233456788999998753 58899999999999999999999998877655554443210 0
Q ss_pred CCC-------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 287 DFS-------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 287 ~~~-------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.++ ...++.++..+.++|++||..||++||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 000 01234567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=321.64 Aligned_cols=263 Identities=33% Similarity=0.531 Sum_probs=211.7
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-CCe
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-RHS 142 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-~~~ 142 (420)
.+.++|.+.+.||.|+||.||+|.++.+++.||+|.+.+... .....+.+.+|+.+++.++ ||||+++++++.. ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCc
Confidence 467889999999999999999999999999999998865322 2334567889999999999 9999999999865 567
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|+||||+ +++|.+++. ...+++..+..++.|++.||.|||++||+||||+|+||++ +.++.++|+|||.+....
T Consensus 85 ~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccC
Confidence 89999999 568877665 4568899999999999999999999999999999999999 456789999999987643
Q ss_pred CCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------------
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG---------------- 284 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~---------------- 284 (420)
.. .....+++.|+|||.+.+ .++.++||||+|+++|+|++|+.||...........+.+.
T Consensus 160 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 160 PQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred CC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 22 234567889999998754 5899999999999999999999999776643322221110
Q ss_pred ----------CCCCC-CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCC
Q 014704 285 ----------HIDFS-SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASD 335 (420)
Q Consensus 285 ----------~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~ 335 (420)
....+ ....+.++..+.++|++||+.+|++|||+.+++.||||........
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~ 299 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD 299 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcc
Confidence 00000 0112457889999999999999999999999999999976554433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=314.04 Aligned_cols=247 Identities=22% Similarity=0.325 Sum_probs=204.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCc----eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQ----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.+|.+.+.||+|+||+||+|.+..++. .||+|.+.... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLTS-T 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcCC-C
Confidence 578999999999999999999877766 48999886432 3344567899999999998 99999999998754 4
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.++++||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++ ++++.+||+|||++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceeec
Confidence 78999999999999998764 569999999999999999999999999999999999999 45667999999999876
Q ss_pred CCCCce---ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 222 KPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 222 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
...... ....+++.|+|||.+. ..++.++|||||||++|+|++ |..||...........+..+... + .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~ 236 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL-P--QPPIC 236 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-C--CCccC
Confidence 433221 1223467899999875 458999999999999999998 99999877766666655554322 2 12467
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+.++.+++.+||..||++||++.++++
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=318.63 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=209.3
Q ss_pred ccccceeecceecccCCeEEEEEEEc-------CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHK-------DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 136 (420)
...++|.+.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+.+||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 34578999999999999999999753 234579999876432 334567899999999999559999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 014704 137 YEDRHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200 (420)
Q Consensus 137 ~~~~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil 200 (420)
+......|+||||+.+++|.+++... ..++...+..++.||+.||.|||++||+||||||+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 99999999999999999999998764 24677889999999999999999999999999999999
Q ss_pred EecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHH
Q 014704 201 FSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQ 275 (420)
Q Consensus 201 l~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~ 275 (420)
+ +.++.+||+|||++........ .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..
T Consensus 170 i---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 170 V---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred E---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 9 4567799999999987643221 122345678999998854 58999999999999999998 89999988888
Q ss_pred HHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 276 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+....+..+.... ....++.++.+||.+||..+|++|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 247 ELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8877776553221 124678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=319.64 Aligned_cols=255 Identities=31% Similarity=0.552 Sum_probs=209.3
Q ss_pred ceeecceecccCCeEEEEEEEc---CCCceEEEEEecCCcCCC-hhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLIN-RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
+|.+.+.||+|+||.||++.+. .++..||+|.+.+..... ......+.+|+.++.++.+||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999999864 457889999986543221 233467889999999997799999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+||||+.+++|.+++.....+++..+..++.|++.+|.|||+.|++||||||+||++ +.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECcccccccc
Confidence 9999999999999999887889999999999999999999999999999999999999 4567799999999876543
Q ss_pred CCc--eecccCCcccccchhhccc---CCCccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCCCCC
Q 014704 224 GDV--FKDLVGSAYYVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPFWGET----EQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 224 ~~~--~~~~~gt~~y~aPE~~~~~---~~~~~DvwslGvil~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 294 (420)
... .....|+..|+|||.+.+. .+.++||||+|+++|+|++|..||.... .......+....... ..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~ 233 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF----PK 233 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC----Cc
Confidence 321 1234689999999987542 6889999999999999999999996432 233333343333222 23
Q ss_pred CCChHHHHHHHHhcccCcCCCCC---HHHHhcCCcccc
Q 014704 295 NISSSAKDIVKKMLHADPKERLS---AAEVLNHPWMRV 329 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~ 329 (420)
.++..+.++|.+||+.||++||| +.++|+||||+.
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 57889999999999999999998 567799999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=313.26 Aligned_cols=243 Identities=26% Similarity=0.377 Sum_probs=198.7
Q ss_pred ceecccCCeEEEEEEEcCCCc--eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQ--QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~ 150 (420)
+.||+|+||.||+|.++.++. .+++|.+... ......+.+.+|+.++.++.+||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999988775 4678877532 233455678899999999955999999999999999999999999
Q ss_pred CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEee
Q 014704 151 AGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (420)
Q Consensus 151 ~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~D 214 (420)
.+++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||++ +.+..+||+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECC
Confidence 9999999987543 47889999999999999999999999999999999999 5567899999
Q ss_pred cccccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 014704 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 215 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 292 (420)
||++..............+..|+|||++. ..++.++||||||+++|+|++ |..||.+.+.......+..+.. . ..
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~--~~ 232 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-L--EK 232 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC-C--CC
Confidence 99986432111111123356799999885 458899999999999999997 9999988877777776655321 1 12
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
...++.++.+++.+||..||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=311.09 Aligned_cols=246 Identities=25% Similarity=0.454 Sum_probs=205.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
.+|++.+.||+|+||.||+|.++. +..+|+|.+..... ....+.+|+.+++.++ ||||+++++++.+.+..|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEE
Confidence 358899999999999999998864 56899998864322 2356788999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccc
Confidence 9999999999998764 468999999999999999999999999999999999999 456779999999987654322
Q ss_pred cee--cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 226 VFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 226 ~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
... ...++..|+|||.+. ..++.++||||||+++|++++ |..||...+..+....+..+.. .. .....+.++.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~ 231 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-LY--RPKLAPTEVY 231 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-CC--CCCCCCHHHH
Confidence 111 122345799999886 468999999999999999999 8999988877777776665422 11 1235789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+++.+||..+|++|||+.++++.
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=310.97 Aligned_cols=245 Identities=23% Similarity=0.416 Sum_probs=203.7
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+.+++.++ ||||+++++++.+ ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCcEE
Confidence 46799999999999999999998765 4699999865332 2357889999999998 9999999998754 56899
Q ss_pred EEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
||||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||++ ++++.++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED 154 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccc
Confidence 99999999999999753 358899999999999999999999999999999999999 4567799999999976543
Q ss_pred CCce--ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 224 GDVF--KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 224 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
.... ....++..|+|||... ..++.++||||||+++|+|++ |..||.+.........+..+.. .+. ...++..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~ 231 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPC--PPECPES 231 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-CCC--ccccCHH
Confidence 3211 2234667899999875 458999999999999999999 8999988877777776655432 111 2357899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+.+++.+||+.||++|||+.++++
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=311.71 Aligned_cols=248 Identities=22% Similarity=0.414 Sum_probs=207.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCc---eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+|++.+.||+|+||.||+|.++.++. .+|+|.+.... .....+.+.+|+.+++.++ ||||+++++++.+++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence 578999999999999999999875443 69999886432 2344578899999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|+||||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++ +.+..++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence 9999999999999998765 468999999999999999999999999999999999999 456779999999988764
Q ss_pred CCCc--e--ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 223 PGDV--F--KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 223 ~~~~--~--~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
.... . ....++..|+|||.+. +.++.++|+||||+++|++++ |..||......+....+..+. ..+ ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLP--APMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCC--CCCCC
Confidence 3321 1 1122356799999986 468999999999999999886 999998887777777666542 222 22357
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
++.+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=314.42 Aligned_cols=247 Identities=22% Similarity=0.413 Sum_probs=206.7
Q ss_pred cceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.+|.+.++||+|+||.||++... .++..+|+|.+... .......+.+|+++++.+. ||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecCC
Confidence 56888999999999999999753 34668999987542 3445678999999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC
Q 014704 142 SVNLIMDLCAGGELFDRIIAKG---------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~ 206 (420)
..+++|||+.+++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||++ ++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cC
Confidence 9999999999999999987643 47889999999999999999999999999999999999 45
Q ss_pred CCCeeEeecccccccCCCCce---ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014704 207 DSPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI 281 (420)
Q Consensus 207 ~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i 281 (420)
+..+||+|||++......... ....+++.|+|||.+. ..++.++|||||||++|+|++ |.+||...........+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 678999999998765433211 2234567899999876 458999999999999999998 99999887777777776
Q ss_pred HcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
..+.... ....+++.+.++|.+||+.||.+||++.++++
T Consensus 238 ~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6654321 12367899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.09 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=199.7
Q ss_pred ccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED- 139 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~- 139 (420)
.++|++.+.||+|+||.||+|.+. .+++.||||.+.... .......+.+|+.++.++.+||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 468999999999999999999853 457889999986432 233456788999999999769999999998764
Q ss_pred CCeEEEEEecCCCCChHHHHHhc---------------------------------------------------------
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAK--------------------------------------------------------- 162 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~--------------------------------------------------------- 162 (420)
...+++|||||++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45689999999999999988643
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc---eec
Q 014704 163 ----------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKD 229 (420)
Q Consensus 163 ----------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~ 229 (420)
..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........ ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCC
Confidence 135777888999999999999999999999999999999 4567899999999876532221 112
Q ss_pred ccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCCCChHHHHHHHH
Q 014704 230 LVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKDIVKK 306 (420)
Q Consensus 230 ~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 306 (420)
..+++.|+|||.+. ..++.++||||||+++|+|++ |..||....... ....+..+. ....+ ...++++.+++.+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~ 317 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-RMRAP--DYTTPEMYQTMLD 317 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC-CCCCC--CCCCHHHHHHHHH
Confidence 34567799999875 458999999999999999997 999997654333 333333332 22221 2367889999999
Q ss_pred hcccCcCCCCCHHHHhcC
Q 014704 307 MLHADPKERLSAAEVLNH 324 (420)
Q Consensus 307 ~L~~dp~~R~t~~e~l~h 324 (420)
||+.||++|||+.++++|
T Consensus 318 cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 318 CWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.37 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=199.4
Q ss_pred eecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEec
Q 014704 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (420)
Q Consensus 70 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~ 149 (420)
.+++.+|.| |.||.++.+.+++.||+|++.... ........+.+|+.+++.++ ||||+++++++.+.+.++++|||
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEec
Confidence 344444444 556666667789999999987543 24456788999999999999 99999999999999999999999
Q ss_pred CCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC--
Q 014704 150 CAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-- 225 (420)
Q Consensus 150 ~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~-- 225 (420)
+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+|||.+.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeecccccc
Confidence 9999999988753 4589999999999999999999999999999999999994 55679999999886543211
Q ss_pred ------ceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------
Q 014704 226 ------VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS------- 289 (420)
Q Consensus 226 ------~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------- 289 (420)
......++..|+|||++.. .++.++||||+||++|+|++|..||..............+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence 1123457788999999854 488999999999999999999999987654433322222111000
Q ss_pred -----------------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 290 -----------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 290 -----------------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
......++.++.+|+.+||..||++|||+.++|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00001234678899999999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=308.47 Aligned_cols=241 Identities=23% Similarity=0.360 Sum_probs=201.3
Q ss_pred ceecccCCeEEEEEEEcCCC---ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEec
Q 014704 73 RELGRGQFGVTYLVTHKDTK---QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~ 149 (420)
+.||+|+||.||+|.+..++ ..+|+|.+...... ...+.+.+|+.+++.+. ||||+++++++. ...+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence 47999999999999876554 78999998754432 34567899999999998 999999999876 4568999999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCce-e
Q 014704 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-K 228 (420)
Q Consensus 150 ~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~-~ 228 (420)
+.+++|.+++.....+++..+..++.|++.||.|||+++++||||||+||++ +.++.+||+|||++......... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccc
Confidence 9999999999888889999999999999999999999999999999999999 45677999999998866433321 1
Q ss_pred ---cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 229 ---DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 229 ---~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
...++..|+|||.+. ..++.++||||||+++|++++ |..||...+..+....+...... .....++..++++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l 230 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYSI 230 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHHH
Confidence 112346799999885 458999999999999999998 99999888777777776655322 2224678899999
Q ss_pred HHHhcccCcCCCCCHHHHhc
Q 014704 304 VKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~ 323 (420)
|.+||..+|++|||+.++++
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=312.51 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=201.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCce----EEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQ----FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
++|++.+.||+|+||+||+|.+..++.. +++|.+... ........+..|+..+..+. ||||+++++++. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP-GAS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-CCc
Confidence 5788999999999999999999877764 666766422 12234467888998999998 999999999875 455
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.++++||+.+|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+||++ +++..+||+|||+++..
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence 78899999999999999764 568999999999999999999999999999999999999 55678999999999865
Q ss_pred CCCC---ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 222 KPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 222 ~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
.... ......++..|+|||.+. +.++.++||||||+++|++++ |..||.+.........+..+...... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 236 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP---QIC 236 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---CCC
Confidence 4332 122345677899999885 468999999999999999998 99999888776665555544332211 235
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+.++.+++.+||..||++|||+.++++
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 778999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=312.41 Aligned_cols=252 Identities=30% Similarity=0.536 Sum_probs=209.5
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcC--CChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
+|.+.+.||+|+||.||++.+..++..+++|+++.... ........+.+|+.+++.++ ||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence 58899999999999999999988777777777654222 12233456778999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 146 IMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
||||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||++. ++.++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence 9999999999887753 35689999999999999999999999999999999999994 245999999998765
Q ss_pred CCCC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 222 KPGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 222 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
.... ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+.........+..+..... ...++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---PETYSRQ 232 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---cchhcHH
Confidence 4332 2334568899999998754 578899999999999999999999987777666666655432221 1356889
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+.++|.+||..||++||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=320.98 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=209.1
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCC-------CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEE
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDT-------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 134 (420)
.+....+|.+++.||+|+||.||+|.+... +..||+|.+... ........+.+|+.+++++.+||||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 344556899999999999999999986432 236899987643 23345678999999999995599999999
Q ss_pred EEEEeCCeEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCc
Q 014704 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (420)
Q Consensus 135 ~~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 198 (420)
+++...+.++++|||+.+++|.+++.... .++...+..++.|++.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 99999999999999999999999987532 36778889999999999999999999999999999
Q ss_pred EEEecCCCCCCeeEeecccccccCCCCce---ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 014704 199 FLFSSSAEDSPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGET 273 (420)
Q Consensus 199 ill~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~ 273 (420)
|++ +.++.+||+|||+++........ ....++..|+|||++.+ .++.++||||||+++|+|++ |..||.+.+
T Consensus 165 ill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 165 VLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred EEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999 45677999999998765432211 12234567999998854 58899999999999999998 899999888
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 274 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.......+...... +.....+.++.+++.+||+.+|++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 88877777654321 1123568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=314.59 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=203.9
Q ss_pred ceeecceecccCCeEEEEEEEcC-----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+|++.+.||+|+||.||+|.... ....+++|.+.... .......+.+|+.+++.+. ||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCC
Confidence 47888999999999999998753 23568888876432 2344577899999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCc
Q 014704 143 VNLIMDLCAGGELFDRIIAK------------------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 198 (420)
.+++|||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999987642 247788999999999999999999999999999999
Q ss_pred EEEecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 014704 199 FLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGET 273 (420)
Q Consensus 199 ill~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~ 273 (420)
|++ ++++.+||+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+..
T Consensus 158 ill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999 4567899999999876533221 12234567899999875 458999999999999999998 999998888
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 274 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
...+...+.... ..+ ....++.++.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~-~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGY-RME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCC-CCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 777776665432 222 22467899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=310.55 Aligned_cols=248 Identities=23% Similarity=0.412 Sum_probs=207.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCc---eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
..|++.+.||+|+||.||+|.++.+++ .||+|.+... ........+.+|+.+++.+. ||||+++++++.++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCce
Confidence 468999999999999999999987665 5999998643 23445678999999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
++||||+.+++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||++ +.+..+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence 9999999999999988764 568999999999999999999999999999999999999 456789999999987654
Q ss_pred CCCce---eccc---CCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 223 PGDVF---KDLV---GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 223 ~~~~~---~~~~---gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
..... .... .+..|+|||.+. ..++.++||||+|+++|++++ |..||...........+... ... +...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~--~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRL--PPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcC--CCcc
Confidence 32211 1111 235799999986 458999999999999999886 99999988877777776543 222 2224
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.++..+.+++.+||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=314.18 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=207.8
Q ss_pred ccceeecceecccCCeEEEEEEEcC-----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC
Confidence 4679999999999999999998753 57889999986432 2344567899999999998 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKG----------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 198 (420)
...++||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999987432 36788899999999999999999999999999999
Q ss_pred EEEecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 014704 199 FLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGET 273 (420)
Q Consensus 199 ill~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~ 273 (420)
|++ +.++.++|+|||++........ .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+..
T Consensus 161 il~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999 4567799999999876543221 11223466799999875 468999999999999999997 889998888
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 274 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
..+....+..+..... ...++.++.+||.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 8887777776554211 1356889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=307.88 Aligned_cols=242 Identities=23% Similarity=0.398 Sum_probs=206.7
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||.|+||.||+|... |+.||+|.+.... ...+.+.+|+.+++.++ |+||+++++++.+....++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS----TAAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccch----hHHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEE
Confidence 57899999999999999999875 6889999986432 14678999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 147 MDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
|||+.+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccccccc
Confidence 99999999999997765 69999999999999999999999999999999999999 45677999999999876332
Q ss_pred CceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
. ....++..|+|||.+. +.++.++||||||+++|++++ |..||...+.......+..+.. . .....+++.+.+
T Consensus 156 ~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~ 230 (256)
T cd05039 156 Q--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-M--EAPEGCPPEVYK 230 (256)
T ss_pred c--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-C--CCccCCCHHHHH
Confidence 2 1234466799999875 468889999999999999997 9999988887777666655422 1 112357899999
Q ss_pred HHHHhcccCcCCCCCHHHHhc
Q 014704 303 IVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~ 323 (420)
+|.+||..+|++|||+.++++
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=307.41 Aligned_cols=245 Identities=27% Similarity=0.481 Sum_probs=209.6
Q ss_pred eecceecccCCeEEEEEEEcCCC----ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 70 IFGRELGRGQFGVTYLVTHKDTK----QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 70 ~~~~~lG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.+.+.||.|+||.||++.+...+ ..||+|.+.... .....+.+..|+.+++.+. |+||+++++++.+.+..|+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeEE
Confidence 56789999999999999998766 889999986432 2225678999999999997 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
+|||+.+++|.+++..... +++..+..++.|++.||+|||+.|++||||||+||++ +.++.++|+|||++.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceeccc
Confidence 9999999999999876554 9999999999999999999999999999999999999 4566899999999987654
Q ss_pred CCceec--ccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 224 GDVFKD--LVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 224 ~~~~~~--~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
...... ..+++.|+|||.+. ..++.++||||+|+++|+|++ |.+||...+.....+.+......... ...+.+
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 232 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP---ENCPPE 232 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC---CcCCHH
Confidence 422221 33678999999885 458999999999999999998 89999888888888877766543222 347899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+.+++.+||..||++|||+.++++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=327.47 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=204.5
Q ss_pred ccccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
.-.++|.+++.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+|.++..||||+++++++.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34467899999999999999999964 345689999996532 23334578899999999977999999999999
Q ss_pred eCCeEEEEEecCCCCChHHHHHhcC-------------------------------------------------------
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAKG------------------------------------------------------- 163 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~~------------------------------------------------------- 163 (420)
..+..++|||||.+|+|.+++...+
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999886432
Q ss_pred -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 014704 164 -------------------------------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200 (420)
Q Consensus 164 -------------------------------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil 200 (420)
.+++..+..++.||+.||.|||+.+|+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 2566678889999999999999999999999999999
Q ss_pred EecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHH
Q 014704 201 FSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQ 275 (420)
Q Consensus 201 l~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~ 275 (420)
++ .+..+||+|||++........ .....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||......
T Consensus 272 l~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 272 IC---EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred Ee---CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 94 567799999999876532221 123356788999998864 58899999999999999998 89999776554
Q ss_pred HHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 276 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+............. ....++.++.+|+.+||..+|++||++.++++.
T Consensus 349 ~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 349 EQFYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44434333332222 223578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=315.42 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=202.9
Q ss_pred ccceeecceecccCCeEEEEEEEcCC--------------CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCcc
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDT--------------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~--------------~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 131 (420)
.++|++.+.||+|+||.||+|++..+ ...||+|.+.... .......+.+|++++++++ ||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcC
Confidence 36899999999999999999987543 2358999986432 3344567999999999999 99999
Q ss_pred EEEEEEEeCCeEEEEEecCCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 014704 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (420)
Q Consensus 132 ~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 199 (420)
++++++......++||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999886532 367888999999999999999999999999999999
Q ss_pred EEecCCCCCCeeEeecccccccCCCCce---ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh--CCCCCCCCC
Q 014704 200 LFSSSAEDSPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS--GVPPFWGET 273 (420)
Q Consensus 200 ll~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~--g~~pf~~~~ 273 (420)
+++ .+..+||+|||++......... ....++..|+|||.+. +.++.++|||||||++|+|++ |..||...+
T Consensus 161 ll~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 161 LVG---NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EEc---CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 994 5667999999998765433211 2234567899999875 568999999999999999988 778998777
Q ss_pred HHHHHHHHHcC----CCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 274 EQSIFDAILRG----HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 274 ~~~~~~~i~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.......+... .........+..++.+.+|+.+||..||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66655544321 111111122356889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=307.70 Aligned_cols=240 Identities=24% Similarity=0.379 Sum_probs=197.8
Q ss_pred eecccCCeEEEEEEEc--CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCC
Q 014704 74 ELGRGQFGVTYLVTHK--DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (420)
Q Consensus 74 ~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~ 151 (420)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++ ||||++++++++. ...++||||+.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~-~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCEA-EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEcC-CCeEEEEEeCC
Confidence 4899999999999875 445679999886432 3344567999999999998 9999999998864 57899999999
Q ss_pred CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCce---
Q 014704 152 GGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF--- 227 (420)
Q Consensus 152 g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~--- 227 (420)
+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||++ +.+..+||+|||++.........
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceec
Confidence 9999998875 4568999999999999999999999999999999999999 45677999999998765433211
Q ss_pred -ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 228 -KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 228 -~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
....+++.|+|||.+. +.++.++||||||+++|++++ |..||.+.........+..+... . .....++++.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li 231 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL-D--CPAECPPEMYALM 231 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-C--CCCCCCHHHHHHH
Confidence 1122357899999876 458899999999999999996 99999988877777766665422 1 1235689999999
Q ss_pred HHhcccCcCCCCCHHHHhc
Q 014704 305 KKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~ 323 (420)
.+||..||++||++.++++
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=307.77 Aligned_cols=245 Identities=22% Similarity=0.393 Sum_probs=203.3
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+.++++++ ||||+++++++. ....|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEEC-CCCcE
Confidence 4567999999999999999999876 456799999865332 2356899999999998 999999999875 45688
Q ss_pred EEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 145 LIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
++|||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++ +++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeecc
Confidence 999999999999988753 3589999999999999999999999999999999999994 56779999999997654
Q ss_pred CCCce--ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 223 PGDVF--KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 223 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
..... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+.+..+....+..+.. .+ .....+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 230 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR-MP--CPQDCPI 230 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CC--CCCcCCH
Confidence 33211 1233556799999875 458899999999999999999 9999988887777777765422 11 1235788
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHh
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVL 322 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l 322 (420)
.+.+|+.+||..+|++|||+.+++
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHH
Confidence 999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=307.01 Aligned_cols=248 Identities=24% Similarity=0.403 Sum_probs=208.4
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...++|.+.+.||+|+||.||+|.+.. ++.||+|.+.... ...+.+.+|+.+++.+. ||||+++++++.+....
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT----MSPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc----cCHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCce
Confidence 345789999999999999999999764 5789999986533 23467899999999999 99999999999998999
Q ss_pred EEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 144 NLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||++ +.++.+||+|||++...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLI 153 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceec
Confidence 99999999999999987643 68999999999999999999999999999999999999 55678999999998765
Q ss_pred CCCCc--eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 222 KPGDV--FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 222 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
..... .....++..|+|||.+.+ .++.++||||+|+++|++++ |+.||.+.........+..+.. .+ .....+
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~ 230 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR-MP--RPPNCP 230 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCCC
Confidence 43211 112234568999998864 58899999999999999998 9999988888777777765422 11 123568
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.++.+++.+||..+|++||++.++++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 231 EELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHH
Confidence 89999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=308.38 Aligned_cols=248 Identities=22% Similarity=0.410 Sum_probs=207.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCc---eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
++|...+.||+|+||.||+|.++.++. .+|+|.+.... .....+.+.+|+++++.++ ||||+++.+++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCc
Confidence 578889999999999999999876654 79999886432 2344567899999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|+||||+.+++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||++ +.+..+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceecc
Confidence 9999999999999988764 568999999999999999999999999999999999999 456779999999987654
Q ss_pred CCCc--eec--ccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 223 PGDV--FKD--LVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 223 ~~~~--~~~--~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
.... ... ...+..|+|||++. +.++.++||||||+++|++++ |..||...+.......+..+.. .+ ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~-~~--~~~~~ 235 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR-LP--APMDC 235 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC-CC--CCCCC
Confidence 3221 111 12345799999886 458999999999999999997 9999988888777777765422 11 12357
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+..+.+++.+||..+|++||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=306.88 Aligned_cols=242 Identities=26% Similarity=0.424 Sum_probs=203.3
Q ss_pred ceecccCCeEEEEEEEcC-CC--ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEec
Q 014704 73 RELGRGQFGVTYLVTHKD-TK--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~-~~--~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~ 149 (420)
+.||+|+||.||+|.+.. .+ ..||+|.+...... ...+.+.+|+.++++++ ||||+++++++.+ ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence 468999999999999865 33 36999998765432 55678999999999999 9999999999988 889999999
Q ss_pred CCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc-
Q 014704 150 CAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV- 226 (420)
Q Consensus 150 ~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~- 226 (420)
+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++ .++.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccccccc
Confidence 99999999997764 689999999999999999999999999999999999994 557899999999887643221
Q ss_pred ---eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 227 ---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 227 ---~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.....++..|+|||.+.. .++.++||||||+++|+|++ |..||...+..+....+......... ....+..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER--PEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCC--CccCCHHHH
Confidence 112356788999998864 58999999999999999998 99999888877777776653332222 135688999
Q ss_pred HHHHHhcccCcCCCCCHHHHhc
Q 014704 302 DIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+++.+||..+|++|||+.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=306.92 Aligned_cols=247 Identities=21% Similarity=0.359 Sum_probs=205.3
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...+.|.+.++||+|+||.||+|..+. ++.||+|.+..... ....+.+|+.++++++ ||||+++++++. .+.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM----SPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEPI 75 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC----cHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cCCc
Confidence 356789999999999999999998754 67899999864332 3467889999999998 999999999874 4568
Q ss_pred EEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 144 NLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+++|||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||++ +.++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLI 152 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeec
Confidence 9999999999999988653 358899999999999999999999999999999999999 45677999999998766
Q ss_pred CCCCc--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 222 KPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 222 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
..... .....++..|+|||++. ..++.++||||||+++|++++ |+.||.+.+.......+..+.. . ......+
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 229 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR-M--PRPDNCP 229 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-C--CCCCCCC
Confidence 52221 12234567899999886 458899999999999999999 9999988887777666655422 1 1224578
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.++.+++.+||..+|++|||++++++
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 89999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=306.69 Aligned_cols=241 Identities=24% Similarity=0.400 Sum_probs=202.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE-EeCCeEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY-EDRHSVNL 145 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~-~~~~~~~i 145 (420)
.+|.+.+.||+|+||.||++... |..||+|.+... ...+.+.+|+.++++++ |+|++++++++ .+.+..|+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence 46899999999999999999765 678999987532 23467889999999998 99999999975 45667999
Q ss_pred EEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
||||+++++|.+++.+.. .+++..+..++.|++.||+|||++||+||||||+||++ ++++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence 999999999999987654 38899999999999999999999999999999999999 5567899999999876433
Q ss_pred CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.. ....++..|+|||++.. .++.++||||||+++|+|++ |+.||...........+..+... ...+.+++.+.
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 229 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPVVY 229 (256)
T ss_pred cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCHHHH
Confidence 22 23345668999998864 58899999999999999997 99999888777777766554221 22346789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhc
Q 014704 302 DIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+++.+||+.+|++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.41 Aligned_cols=245 Identities=23% Similarity=0.390 Sum_probs=203.1
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.+. |||++++++++. .+..++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCCcEE
Confidence 46799999999999999999988765 4699998764322 2356889999999998 999999999875 456889
Q ss_pred EEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
||||+.+++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||++ ++++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIED 154 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccC
Confidence 999999999999987643 47899999999999999999999999999999999999 5567799999999976543
Q ss_pred CCc--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 224 GDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 224 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||.+.........+..+.. . .....++..
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~ 231 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-M--PCPQGCPES 231 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCcccCHH
Confidence 321 12234567899999875 458899999999999999999 9999998887777777665422 1 122467899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+.+++++||..||++||+++++++
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 232 LHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=327.26 Aligned_cols=257 Identities=32% Similarity=0.560 Sum_probs=223.6
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
-|..++.||-|+||.|.++...+|...||.|.+.+........+..++.|-.||..-. .+.||+||-.|+|++++|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEEEE
Confidence 4667788999999999999999999999999999887777788889999999999988 899999999999999999999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-----
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK----- 222 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~----- 222 (420)
+|++||++..+|.+.+-|.|..++.++..+..|+++.|..|+|||||||+|||| +.+++|||.|||++.-+.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceecccc
Confidence 999999999999999999999999999999999999999999999999999999 778899999999986431
Q ss_pred ----CCCc----------------------------------eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHH
Q 014704 223 ----PGDV----------------------------------FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILL 263 (420)
Q Consensus 223 ----~~~~----------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll 263 (420)
.++. ....+||+.|+|||++. ..|+..||.||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 1100 01247999999999986 46999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCC---CHHHHhcCCcccc
Q 014704 264 SGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL---SAAEVLNHPWMRV 329 (420)
Q Consensus 264 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~h~~~~~ 329 (420)
.|++||...+..+.-.++.+..-.+......++|.++.++|.++. -+++.|. .++|+-.||||+.
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 999999988876665555554444444445689999999999977 4788888 4778999999974
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=308.40 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=206.7
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCc----eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
..+|.+.+.||+|+||.||+|.++.+|. .+|+|.+.... .......+.+|+.++++++ ||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-C
Confidence 3579999999999999999999877664 58999876443 2345577899999999998 9999999999887 7
Q ss_pred eEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
..++||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||.+..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccccc
Confidence 889999999999999998764 468999999999999999999999999999999999999 4566799999999987
Q ss_pred cCCCCcee---cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 221 FKPGDVFK---DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 221 ~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
........ ...++..|+|||.+. ..++.++|+||||+++|++++ |..||.+....++...+..+.. ++.+ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LPQP--PI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CCCC--CC
Confidence 65332211 122356799999875 468899999999999999998 9999998888777777765432 2221 24
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+.++.+++.+||..||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6788999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=333.08 Aligned_cols=247 Identities=29% Similarity=0.463 Sum_probs=200.8
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-----
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH----- 141 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~----- 141 (420)
..|...+.||+||||.||+++++.+|+.||||.+.... .....+..-+|+++|++|+ |||||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccc
Confidence 34666789999999999999999999999999997654 3455688999999999999 999999999865443
Q ss_pred -eEEEEEecCCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC-CCCCeeEeecc
Q 014704 142 -SVNLIMDLCAGGELFDRIIAK---GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFG 216 (420)
Q Consensus 142 -~~~iv~e~~~g~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~~~~kl~Dfg 216 (420)
...+|||||.||+|...+.+. ..++|.+...++..+..||.|||++||+||||||.||++.... .....||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 467999999999999999754 4599999999999999999999999999999999999987644 44568999999
Q ss_pred cccccCCCCceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHcC------
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAILRG------ 284 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~~----~~~~~~i~~~------ 284 (420)
.|+....+..+.+.+||+.|.+||++. +.|+..+|.|||||++|++.||..||..... .++...+...
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 999999888999999999999999987 5689999999999999999999999954322 2233333221
Q ss_pred ---------CCCCCCC--CCCCCC----hHHHHHHHHhcccCcCCCC
Q 014704 285 ---------HIDFSSD--PWPNIS----SSAKDIVKKMLHADPKERL 316 (420)
Q Consensus 285 ---------~~~~~~~--~~~~~~----~~~~~li~~~L~~dp~~R~ 316 (420)
.+.+... ....++ ..+...+..+|..+|++|.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1111110 011222 3355778899999999999
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.18 Aligned_cols=256 Identities=27% Similarity=0.545 Sum_probs=232.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
.+|.+.++||+|+|+.|..++++.|.+.||+|++++..+...++++-+..|-.+..+.++||.+|-++.+|+.+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 57999999999999999999999999999999999988877888888999999999998999999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc-cCCCC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF-FKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~-~~~~~ 225 (420)
.||++||+|.-++.+...++|+.+..+...|+-||.|||++||+.||||.+|||+ +..+++||.|+|.++. +.+++
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCCc
Confidence 9999999998888888899999999999999999999999999999999999999 5678899999999875 46778
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCC--------CCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFW--------GETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~--------~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
..+++||||.|.|||++.+ .|+..+|.|+|||+++||+.|+.||. .+++.-+++-|+...+..+. .+
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----sl 482 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----SL 482 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----ee
Confidence 8889999999999999986 59999999999999999999999994 23455677778877776664 56
Q ss_pred ChHHHHHHHHhcccCcCCCC------CHHHHhcCCcccc
Q 014704 297 SSSAKDIVKKMLHADPKERL------SAAEVLNHPWMRV 329 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~------t~~e~l~h~~~~~ 329 (420)
|-.+..+++..|.+||.+|. .+.++-.|+||+.
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 77889999999999999997 4789999999974
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=309.89 Aligned_cols=250 Identities=22% Similarity=0.437 Sum_probs=210.4
Q ss_pred cceeecceecccCCeEEEEEEEcCC-----CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
++|.+.+.||+|+||.||+|..+.+ .+.|++|.+.... .....+.+.+|++++++++ ||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence 5788999999999999999997643 4679999875432 2234577999999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeE
Q 014704 142 SVNLIMDLCAGGELFDRIIAKG---------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl 212 (420)
..|+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence 9999999999999999997665 68999999999999999999999999999999999999 45677999
Q ss_pred eecccccccCCCC--ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCC
Q 014704 213 TDFGLSVFFKPGD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDF 288 (420)
Q Consensus 213 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 288 (420)
+|||++....... ......++..|+|||.+. ..++.++||||||+++|++++ |..||...........+..+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999987543221 122345677899999875 457889999999999999998 889998877777777777665544
Q ss_pred CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
... ..++..+.+++.+||..+|++|||+.+++.+
T Consensus 239 ~~~--~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PVP--EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCC--CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 332 3578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=310.48 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=195.3
Q ss_pred cce-eecceecccCCeEEEEEEE----cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe--
Q 014704 67 NTY-IFGRELGRGQFGVTYLVTH----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-- 139 (420)
Q Consensus 67 ~~y-~~~~~lG~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-- 139 (420)
++| .+.+.||+|+||+||++.. ..++..||+|.+.... .......+.+|+.+++.++ ||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 455 8999999999999988653 3567899999986432 2234567889999999998 9999999998765
Q ss_pred CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
...+++||||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~ 155 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccc
Confidence 3468999999999999998865 469999999999999999999999999999999999999 456789999999988
Q ss_pred ccCCCCc----eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HH------------HHH
Q 014704 220 FFKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ--SI------------FDA 280 (420)
Q Consensus 220 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~--~~------------~~~ 280 (420)
....... .....++..|+|||.+. ..++.++||||||+++|+|++|..||...... .. +..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 6643321 11234566799999886 45899999999999999999999998543321 00 000
Q ss_pred HHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 281 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
........+ ....++..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111111111 12356789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.24 Aligned_cols=246 Identities=26% Similarity=0.489 Sum_probs=206.7
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
.+|.+.+.||+|+||.||++.+.. +..+|+|.+..... ....+.+|+++++.+. ||||+++++++.....+++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC----CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEE
Confidence 468899999999999999998864 67899998864332 2356889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||+.+++|.+++... +.+++..+..++.|++.+|.|||++|++||||||+||++ +.++.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCc
Confidence 9999999999988764 468999999999999999999999999999999999999 456679999999987653322
Q ss_pred c--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 226 V--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 226 ~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
. .....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+..+...+.. ...+..+.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVY 231 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHH
Confidence 1 11223456899999886 468899999999999999998 99999888877777777665332222 23578999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+|+.+||..+|++|||+.+++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=302.06 Aligned_cols=241 Identities=26% Similarity=0.398 Sum_probs=200.3
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.+. ||||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCC
Confidence 47899999999999865 57889999886432 2334457889999999998 99999999999999999999999999
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCce--ec
Q 014704 153 GELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF--KD 229 (420)
Q Consensus 153 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~--~~ 229 (420)
++|.+++... ..+++..+..++.|++.+|.|||++|++||||||+||++ +.++.+||+|||++......... ..
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCC
Confidence 9999988654 458999999999999999999999999999999999999 45677999999998764332211 11
Q ss_pred ccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHh
Q 014704 230 LVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307 (420)
Q Consensus 230 ~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 307 (420)
..++..|+|||++. +.++.++||||||+++|++++ |..||.+.........+..+... .....++..+.+++.+|
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHH
Confidence 23456799999986 458899999999999999998 99999888777766666554221 12235789999999999
Q ss_pred cccCcCCCCCHHHHhc
Q 014704 308 LHADPKERLSAAEVLN 323 (420)
Q Consensus 308 L~~dp~~R~t~~e~l~ 323 (420)
|..+|++|||+.++++
T Consensus 231 l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 231 WDYKPENRPKFSELQK 246 (250)
T ss_pred cccCcccCCCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=308.49 Aligned_cols=249 Identities=21% Similarity=0.293 Sum_probs=206.6
Q ss_pred ccceeecceecccCCeEEEEEEEcC----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-C
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKD----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-R 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-~ 140 (420)
.++|.+.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+++.+. ||||+++++++.. .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence 4689999999999999999999876 3578999987532 24455678899999999998 9999999998765 5
Q ss_pred CeEEEEEecCCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeE
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK--------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl 212 (420)
...+++++|+.+++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||++ +.+..+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence 7789999999999999988653 358899999999999999999999999999999999999 45678999
Q ss_pred eecccccccCCCCce---ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCC
Q 014704 213 TDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHID 287 (420)
Q Consensus 213 ~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 287 (420)
+|||+++.+...... ....++..|+|||.+.+ .++.++||||||+++|++++ |+.||...+.......+..+. .
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-R 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C
Confidence 999999865433211 12345678999998854 58999999999999999999 999998887777666555532 2
Q ss_pred CCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 288 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+.. ...+++++.+++.+||..||++|||+.++++
T Consensus 238 ~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 LAQ--PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 222 2356889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=310.41 Aligned_cols=240 Identities=18% Similarity=0.300 Sum_probs=193.3
Q ss_pred ceecccCCeEEEEEEEcCCCc-------eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 73 RELGRGQFGVTYLVTHKDTKQ-------QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~-------~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
+.||+|+||.||+|.++..+. .+|+|.+... .....+.+.+|+.+++.+. ||||+++++++..+...++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence 469999999999999876543 3888876432 2334567889999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC-----CCCeeEeeccccc
Q 014704 146 IMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE-----DSPLKATDFGLSV 219 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~-----~~~~kl~Dfg~~~ 219 (420)
||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++. ...++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999987654 5899999999999999999999999999999999999975322 1247999999987
Q ss_pred ccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 220 FFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
..... ....++..|+|||++.+ .++.++||||||+++|+|++| ..||.......... +......++. ..
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~----~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPA----PK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCC----CC
Confidence 65432 23467889999999864 478999999999999999998 46665554443332 3333333332 34
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+.++.++|.+||+.||++|||+.++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=300.45 Aligned_cols=256 Identities=22% Similarity=0.309 Sum_probs=211.1
Q ss_pred ecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecC
Q 014704 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (420)
Q Consensus 71 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~ 150 (420)
-...||.|+||+|++-.++.+|+..|||.|..... ..+..++..|.....+-.+.||||++|+..-.++..||.||+|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 34679999999999999999999999999976543 4566889999998888877999999999999999999999999
Q ss_pred CCCChHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 151 AGGELFDRI-----IAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 151 ~g~~L~~~l-----~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+ .+|..+. .++..++|..+..|....+.||.||-. ..|||||+||+|||+ +..+.+||||||.+..+..+
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHH
Confidence 5 3553222 235679999999999999999999975 589999999999999 56777999999999877655
Q ss_pred CceecccCCcccccchhhc--c-cCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCCCCC--CCCCh
Q 014704 225 DVFKDLVGSAYYVAPEVLR--R-NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFSSDPW--PNISS 298 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~--~-~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~--~~~~~ 298 (420)
-..+.-+|...|||||.+. . .|+-++||||||++|||+.||..||.+-+ ..+.+..+..+.++...... -..+.
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 4445568999999999985 2 49999999999999999999999996543 33444555555544332221 24788
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
.+..||..||.+|...||...+++++||++....
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 9999999999999999999999999999975543
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=306.55 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=205.5
Q ss_pred ccceeecceecccCCeEEEEEEEcCC---CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.++|.+.+.||+|+||.||+|.+... ...||+|.+.... .....+.+.+|+.+++.+. ||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CC
Confidence 45689999999999999999997654 3468999875432 2345578999999999998 9999999999876 45
Q ss_pred EEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.|+||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++ .++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeec
Confidence 789999999999999997644 589999999999999999999999999999999999994 4667999999998866
Q ss_pred CCCCcee--cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 222 KPGDVFK--DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 222 ~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
....... ...++..|+|||.+. ..++.++||||||+++|++++ |..||.+....+....+.++... .....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~ 234 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCP 234 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCC
Confidence 4432222 223456799999875 458899999999999999986 99999888877777666655322 1234678
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..+.+++.+||..+|++|||+.+++..
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.38 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=201.1
Q ss_pred ccceeecceecccCCeEEEEEEEcC----------------CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKD----------------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 129 (420)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+.... .......+.+|+.+++.++ |||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence 3579999999999999999986532 34569999886432 2344567899999999998 999
Q ss_pred ccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCc
Q 014704 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG-----------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (420)
Q Consensus 130 iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 198 (420)
|+++++++.+.+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999887642 36678899999999999999999999999999999
Q ss_pred EEEecCCCCCCeeEeecccccccCCCCce---ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh--CCCCCCCC
Q 014704 199 FLFSSSAEDSPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS--GVPPFWGE 272 (420)
Q Consensus 199 ill~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~--g~~pf~~~ 272 (420)
|+++ .++.++|+|||++......... ....+++.|+|||... +.++.++|||||||++|+|++ |..||...
T Consensus 161 ili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLVG---KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEEc---CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9994 5677999999998865433211 1223467899999764 568999999999999999998 78999877
Q ss_pred CHHHHHHHHHc----CCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 273 TEQSIFDAILR----GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 273 ~~~~~~~~i~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+..+....... .......+....++..+.+|+.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66555543321 1011111112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=315.45 Aligned_cols=264 Identities=27% Similarity=0.463 Sum_probs=222.9
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChh----hHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD----DVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
..+.++|.+..+||+|||+.||+|-+....+.||||+-...+.+..+ ..+...+|.+|-+.|. ||.||++|++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyfs 537 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYFS 537 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeeee
Confidence 44667899999999999999999999988999999987654443332 2456789999999999 999999999985
Q ss_pred -eCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCCCCCCeeEeec
Q 014704 139 -DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDF 215 (420)
Q Consensus 139 -~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~~~~kl~Df 215 (420)
|.+.+|-|+|||+|.+|.-+|...+.++|.++..|+.||+.||.||.+.. |||-||||.|||+.+...-+.+||.||
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 66778999999999999889998899999999999999999999999874 999999999999988777889999999
Q ss_pred ccccccCCCC--------ceecccCCcccccchhhc-c----cCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHH-
Q 014704 216 GLSVFFKPGD--------VFKDLVGSAYYVAPEVLR-R----NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDA- 280 (420)
Q Consensus 216 g~~~~~~~~~--------~~~~~~gt~~y~aPE~~~-~----~~~~~~DvwslGvil~~ll~g~~pf~~~~~-~~~~~~- 280 (420)
|+++.+.... ..+...||.+|++||.+- + +.+.++||||+|||+|.++.|+.||..+-. +.+++.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 9999875432 234568999999999863 2 478899999999999999999999976543 333332
Q ss_pred -HH-cCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 281 -IL-RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 281 -i~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
|+ .....|+.. +.+++++++||++||.+.-++|....++..||||.-
T Consensus 698 TIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 698 TILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred chhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 22 234555554 478999999999999999999999999999999953
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=304.51 Aligned_cols=244 Identities=21% Similarity=0.336 Sum_probs=193.2
Q ss_pred ceecccCCeEEEEEEEcC--CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecC
Q 014704 73 RELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~ 150 (420)
+.||+|+||.||+|.... ++..+|+|.+.... .......+.+|+.+++.++ ||||+++++++.+...+++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence 468999999999998653 45679999886443 2233457889999999998 999999999999999999999999
Q ss_pred CCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 151 AGGELFDRIIAKG-----HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 151 ~g~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
++|+|.+++.... ..++..+..++.|++.||.|||++|++||||||+||++ +.+..+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence 9999999886532 35677888999999999999999999999999999999 456789999999987543322
Q ss_pred ce---ecccCCcccccchhhcc--------cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHH-HcCCCCCCCCC
Q 014704 226 VF---KDLVGSAYYVAPEVLRR--------NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI-LRGHIDFSSDP 292 (420)
Q Consensus 226 ~~---~~~~gt~~y~aPE~~~~--------~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i-~~~~~~~~~~~ 292 (420)
.. ....|+..|+|||++.+ .++.++||||||+++|+|++ |..||......+..... .......+.+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 11 22457788999998753 25789999999999999996 99999776655544332 22223333222
Q ss_pred C-CCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 293 W-PNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 293 ~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
. ...+..+.+++++|+ .+|++|||+.+++.
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 2 245788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=309.60 Aligned_cols=249 Identities=25% Similarity=0.415 Sum_probs=199.0
Q ss_pred cceeecceecccCCeEEEEEEE----cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--
Q 014704 67 NTYIFGRELGRGQFGVTYLVTH----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-- 140 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-- 140 (420)
..|.+.+.||+|+||.||+|.. +.++..||+|.+.... .......+.+|+.+++.+. ||||+++++++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCC
Confidence 3578899999999999999984 4568899999986432 3344577999999999998 99999999998775
Q ss_pred CeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
..+++||||++|++|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+||++ +.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCcccc
Confidence 6789999999999999988664 358999999999999999999999999999999999999 456779999999988
Q ss_pred ccCCCCc----eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCH---------------HHHHH
Q 014704 220 FFKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETE---------------QSIFD 279 (420)
Q Consensus 220 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~---------------~~~~~ 279 (420)
....... .....++..|+|||++. +.++.++||||||+++|+|+++..|+..... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 6643321 12345677899999875 4588999999999999999998776532211 11111
Q ss_pred HHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 280 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.+..+. .. +.+..++..+.+|+.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VLEEGK-RL--PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHcCc-cC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 122221 11 2234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=301.97 Aligned_cols=247 Identities=22% Similarity=0.380 Sum_probs=204.7
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...++|.+.+.||+|+||.||++.+.. +..+|+|.+... ....+.+.+|+.+++.+. |+||+++++++.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG----SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPI 75 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC----hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCe
Confidence 356789999999999999999998654 567999987643 223567889999999998 9999999999887 778
Q ss_pred EEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 144 NLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+++|||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++ +.+..+||+|||.+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVI 152 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeec
Confidence 9999999999999998763 357888999999999999999999999999999999999 45678999999998765
Q ss_pred CCCCc--eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 222 KPGDV--FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 222 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
..... .....++..|+|||++.. .++.++|+||||+++|++++ |..||.+.+.......+..+.. . ......+
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~ 229 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-M--PRPENCP 229 (260)
T ss_pred cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-C--CCcccCC
Confidence 43221 112345677999999864 58889999999999999999 9999988877777766655422 1 2224678
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.++.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 230 EELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 89999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=340.73 Aligned_cols=249 Identities=26% Similarity=0.429 Sum_probs=215.0
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCc-----eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ-----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
.....+.+.||+|+||.||.|....... .||+|.+.+ ..+.+....|.+|..+|+.++ |||||++++++.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCC
Confidence 4567788999999999999999875433 388888754 446778899999999999999 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK-------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
...+|++|||+||+|..+|.+. ..++-.....++.||+.|+.||+++++|||||..+|+|+ +....+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEc
Confidence 9999999999999999999876 248889999999999999999999999999999999999 566899999
Q ss_pred ecccccccCCCCceec-c--cCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCC
Q 014704 214 DFGLSVFFKPGDVFKD-L--VGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDF 288 (420)
Q Consensus 214 Dfg~~~~~~~~~~~~~-~--~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 288 (420)
|||+|+.+...+.+.. . .-...|||||.+. +.++.++|||||||++||++| |..||.+.+..+++...+++. .+
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence 9999996544333221 1 2235799999987 679999999999999999999 999999999999998777766 33
Q ss_pred CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+. ...++..+.+++..||+.+|++||++..+++
T Consensus 924 ~~--P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DP--PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CC--CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 33 3578999999999999999999999999987
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=303.11 Aligned_cols=228 Identities=25% Similarity=0.365 Sum_probs=188.3
Q ss_pred cCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCCChHH
Q 014704 78 GQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD 157 (420)
Q Consensus 78 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~~L~~ 157 (420)
|.||.||+++++.+++.||+|.+.... ...+|...+.... ||||+++++++.+...+++||||+.|++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999999999999999986532 1234444455555 9999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecccCCcccc
Q 014704 158 RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237 (420)
Q Consensus 158 ~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~ 237 (420)
++.+...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||.+...... .....++..|+
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCcccc
Confidence 99888889999999999999999999999999999999999999 45667999999987665432 23345677899
Q ss_pred cchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCC
Q 014704 238 APEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL 316 (420)
Q Consensus 238 aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 316 (420)
|||.+.. .++.++|+||+|+++|+|++|+.||...... + .....+.. .+.+++.++++|.+||+.||++||
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTLNI--PEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccccCC--cccCCHHHHHHHHHHccCCHHHhc
Confidence 9998864 5889999999999999999999987543221 0 00111111 135788999999999999999999
Q ss_pred CH-----HHHhcCCcc
Q 014704 317 SA-----AEVLNHPWM 327 (420)
Q Consensus 317 t~-----~e~l~h~~~ 327 (420)
++ +++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 85 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=300.69 Aligned_cols=241 Identities=27% Similarity=0.401 Sum_probs=201.1
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.||.|+||.||+|.+.. ++.||+|.+..... ......+.+|+++++++. ||||+++++++.+....++||||+.|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 479999999999999987 89999998865432 235578999999999999 99999999999999999999999999
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCcee---
Q 014704 153 GELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK--- 228 (420)
Q Consensus 153 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~--- 228 (420)
++|.+++... ..+++..+..++.|++.+|.|||++|++||||||+||++ +.++.+||+|||++..........
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccc
Confidence 9999998664 468999999999999999999999999999999999999 456779999999987654222111
Q ss_pred cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHH
Q 014704 229 DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306 (420)
Q Consensus 229 ~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 306 (420)
...++..|+|||.+. +.++.++|+||||+++|+|++ |..||...........+.... ... ....++.++.+++.+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~ 230 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMP--APQLCPEEIYRLMLQ 230 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCC--CCccCCHHHHHHHHH
Confidence 122356799999875 458999999999999999999 899998877666666655432 111 123578899999999
Q ss_pred hcccCcCCCCCHHHHhc
Q 014704 307 MLHADPKERLSAAEVLN 323 (420)
Q Consensus 307 ~L~~dp~~R~t~~e~l~ 323 (420)
||..+|++|||+.++++
T Consensus 231 ~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 231 CWAYDPENRPSFSEIYN 247 (251)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=288.02 Aligned_cols=253 Identities=28% Similarity=0.566 Sum_probs=210.2
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--eE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH--SV 143 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~--~~ 143 (420)
.++|.+.+++|+|.|+.||.|....+++.++||+++.- ..+.+.+|+.+|..|.+||||++++++..+.. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 47899999999999999999999999999999998643 34789999999999999999999999987654 57
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
.+|+||+++.+...+. ..++...+..++.+++.||.|||+.||+|||+||.|++++ .+...++|+|+|+|.+..+
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCC
Confidence 7999999887664433 4578889999999999999999999999999999999996 4456799999999999999
Q ss_pred CCceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHH-------------cCCCC
Q 014704 224 GDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFW-GETEQSIFDAIL-------------RGHID 287 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~-~~~~~~~~~~i~-------------~~~~~ 287 (420)
+...+-.+.+..|--||.+. +.|+..-|+|||||++..|+..+.||. |.+....+-+|. +-.+.
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 98888888999999999885 468999999999999999999998884 333322222221 11111
Q ss_pred CC-----------CCCCC---------CCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 288 FS-----------SDPWP---------NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 288 ~~-----------~~~~~---------~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
++ ...|. -+++++.||+.++|..|..+|+||.|++.||||..
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 11 11121 24699999999999999999999999999999964
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=306.56 Aligned_cols=239 Identities=17% Similarity=0.232 Sum_probs=191.3
Q ss_pred eecccCCeEEEEEEEcCC------------------------CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCC
Q 014704 74 ELGRGQFGVTYLVTHKDT------------------------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129 (420)
Q Consensus 74 ~lG~G~~g~V~~~~~~~~------------------------~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 129 (420)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++ |||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~-h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVS-HIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCC-CCC
Confidence 699999999999985321 2358888875422 233456888999999998 999
Q ss_pred ccEEEEEEEeCCeEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC---
Q 014704 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--- 205 (420)
Q Consensus 130 iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--- 205 (420)
|+++++++.+....++||||+++++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++..+
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888865 46789999999999999999999999999999999999996422
Q ss_pred -CCCCeeEeecccccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHH-hCCCCCCCCCHHHHHHHH
Q 014704 206 -EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILL-SGVPPFWGETEQSIFDAI 281 (420)
Q Consensus 206 -~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll-~g~~pf~~~~~~~~~~~i 281 (420)
....+|++|||++...... ....++..|+|||.+.+ .++.++||||||+++|+++ +|..||...........+
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 2235899999987654322 23457888999998854 4889999999999999984 699999877655443322
Q ss_pred HcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
. .....+. ..++++.++|.+||+.+|++|||+.++|++
T Consensus 235 ~-~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 E-KKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred H-hccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2 2222222 346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=303.35 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=209.4
Q ss_pred ceeecceecccCCeEEEEEEEcC-CCceEEEEEecCCcC-------CChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKD-TKQQFACKSISSRKL-------INRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
.|.+.+.||+|+||.||+|.++. +++.+|+|.+..... ........+.+|+.++.+..+||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37888999999999999999987 678999998864321 1233456678899988764349999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEee
Q 014704 140 RHSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATD 214 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~D 214 (420)
.+..++||||++|++|.+++.. ...+++..++.++.|++.+|.|||+ .|++|+||+|+||++ +.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence 9999999999999999887743 3468999999999999999999996 789999999999999 4567799999
Q ss_pred cccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 014704 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (420)
Q Consensus 215 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 293 (420)
||.+.............|+..|+|||.+.+ .++.++||||||+++|+|++|..||...........+......... .
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 235 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP--E 235 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC--c
Confidence 999987655444455678999999999864 4889999999999999999999999887777666666655433211 1
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..++.++.++|++||+.||++||++.|+..+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 2568899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=303.01 Aligned_cols=240 Identities=18% Similarity=0.268 Sum_probs=191.2
Q ss_pred ceecccCCeEEEEEEEcCC------------CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 73 RELGRGQFGVTYLVTHKDT------------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~------------~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
+.||+|+||.||+|..... ...+|+|.+... .......+.+|+.+++.++ ||||+++++++.+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVS-HKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence 4689999999999985422 235888886543 2234457888999999998 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC----CCCeeEeec
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE----DSPLKATDF 215 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~----~~~~kl~Df 215 (420)
...++||||+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||+..++. ...++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999998887654 56899999999999999999999999999999999999964321 123899999
Q ss_pred ccccccCCCCceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 014704 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILL-SGVPPFWGETEQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 216 g~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 292 (420)
|++...... ....++..|+|||.+. ..++.++|||||||++|+|+ +|..||......+.. ..........
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~--- 229 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLV--- 229 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCC---
Confidence 998765322 2346788999999885 45899999999999999997 588898766544332 2222222221
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
...+.++.+||.+||+.||++||++.+++++
T Consensus 230 -~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 230 -TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 2346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=302.29 Aligned_cols=244 Identities=21% Similarity=0.353 Sum_probs=193.3
Q ss_pred ceecccCCeEEEEEEEcC--CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecC
Q 014704 73 RELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~ 150 (420)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++ ||||+++++.+.+...+|+||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeC
Confidence 469999999999997543 34578888765332 3344567889999999998 999999999999999999999999
Q ss_pred CCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 151 AGGELFDRIIAKG-----HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 151 ~g~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
.+|+|.+++.... ..++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccch
Confidence 9999999987643 24677889999999999999999999999999999999 456789999999986543322
Q ss_pred c---eecccCCcccccchhhcc--------cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHc-CCCCCCCCC
Q 014704 226 V---FKDLVGSAYYVAPEVLRR--------NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILR-GHIDFSSDP 292 (420)
Q Consensus 226 ~---~~~~~gt~~y~aPE~~~~--------~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~ 292 (420)
. .....+++.|+|||++.. .++.++|||||||++|+|++ |..||........+..+.. ....++.+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1 122345678999998742 36789999999999999999 8889987776665555443 333333322
Q ss_pred C-CCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 293 W-PNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 293 ~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+ ..++..+.+++..|+ .||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 2 356788899999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=300.85 Aligned_cols=240 Identities=25% Similarity=0.425 Sum_probs=201.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||++.. +++.||+|.+... .....+.+|+.+++.++ ||||+++++++... ..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-----chHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-CcEEE
Confidence 5699999999999999999864 5788999998542 12357889999999998 99999999998765 47999
Q ss_pred EecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 147 MDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
|||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc
Confidence 99999999999987653 47899999999999999999999999999999999999 45667999999998764322
Q ss_pred CceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
......+..|+|||.+. +.++.++|+||||+++|+|++ |..||...........+.++.. . .....++..+.+
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~ 228 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-M--EPPEGCPADVYV 228 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-C--CCCCcCCHHHHH
Confidence 12234466899999886 468899999999999999998 9999988887777776665422 1 123467899999
Q ss_pred HHHHhcccCcCCCCCHHHHhc
Q 014704 303 IVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~ 323 (420)
++.+||..+|++||++.+++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=300.67 Aligned_cols=243 Identities=24% Similarity=0.375 Sum_probs=194.5
Q ss_pred ceecccCCeEEEEEEEcC---CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE-eCCeEEEEEe
Q 014704 73 RELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE-DRHSVNLIMD 148 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~-~~~~~~iv~e 148 (420)
+.||+|+||.||+|.+.. .+..+|+|.+... ......+.+.+|+.+++.++ ||||+++++++. .++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence 468999999999998753 3457999987532 23345678889999999998 999999999765 4566899999
Q ss_pred cCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc-
Q 014704 149 LCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV- 226 (420)
Q Consensus 149 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~- 226 (420)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+ +.++.+||+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence 99999999998764 346778888999999999999999999999999999999 4567799999999876532211
Q ss_pred ----eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 227 ----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 227 ----~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
.....++..|+|||.+. ..++.++||||||+++|+|++ |.+||...........+..+..... ...++..+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence 11234567899999875 458899999999999999999 5677777666666666555432211 12467899
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcC
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.+++.+||..+|++||++.++++.
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=328.68 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=177.4
Q ss_pred cccceeecceecccCCeEEEEEEEcCC----CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE----
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDT----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA---- 136 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~---- 136 (420)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .+...+| .++... +.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~-~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRAC-PNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhc-hhhHHHHHHhhhcc
Confidence 346899999999999999999999988 89999998753221 1111111 111212 2233222211
Q ss_pred --EEeCCeEEEEEecCCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCeeccC
Q 014704 137 --YEDRHSVNLIMDLCAGGELFDRIIAKGH--------------------YSERAAANLCRQMVTVVHYCHSMGVMHRDL 194 (420)
Q Consensus 137 --~~~~~~~~iv~e~~~g~~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~al~~lH~~~ivH~Dl 194 (420)
......+++||||+.+++|.+++..... ..+..+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2456779999999999999998865421 123446789999999999999999999999
Q ss_pred CCCcEEEecCCCCCCeeEeecccccccCCC--CceecccCCcccccchhhcc-----------------------cCCCc
Q 014704 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPG--DVFKDLVGSAYYVAPEVLRR-----------------------NYGAE 249 (420)
Q Consensus 195 kp~Nill~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-----------------------~~~~~ 249 (420)
||+|||++. .++.+||+|||++.....+ .......+|+.|+|||.+.. +++.+
T Consensus 282 KP~NILl~~--~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 282 KPQNIIFSE--GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CHHHEEEeC--CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999952 3467999999999865432 22345688999999996521 23456
Q ss_pred cchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-----------CC------CCCCCCChHHHHHHHHhcccCc
Q 014704 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF-----------SS------DPWPNISSSAKDIVKKMLHADP 312 (420)
Q Consensus 250 ~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----------~~------~~~~~~~~~~~~li~~~L~~dp 312 (420)
+||||+||++|+|+++..|+... .......+......+ .. +.+........+||.+||+.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 79999999999999977665322 111111222111110 00 0011123345699999999999
Q ss_pred CCCCCHHHHhcCCcccccC
Q 014704 313 KERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 313 ~~R~t~~e~l~h~~~~~~~ 331 (420)
++|||+.++|+||||+...
T Consensus 439 ~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 439 RQRISAKAALAHPYFDREG 457 (566)
T ss_pred ccCCCHHHHhCCcCcCCCC
Confidence 9999999999999997544
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=302.18 Aligned_cols=237 Identities=19% Similarity=0.254 Sum_probs=190.9
Q ss_pred ceecccCCeEEEEEEEcCCC----------ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 73 RELGRGQFGVTYLVTHKDTK----------QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~----------~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+|+.+++.++ ||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence 47999999999999998766 347778765332 11577899999999998 9999999999887 77
Q ss_pred EEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC----CCCCeeEeeccc
Q 014704 143 VNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA----EDSPLKATDFGL 217 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~----~~~~~kl~Dfg~ 217 (420)
.++||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 899999999999999998766 799999999999999999999999999999999999996432 112699999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 293 (420)
+..... .....++..|+|||++.. .++.++||||||+++|+|++ |..||...+........... ...+.
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~--- 227 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLPM--- 227 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCCC---
Confidence 886543 223456788999999864 48899999999999999999 68888766543333322211 11111
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.....+.++|.+||..+|.+|||+.++++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 228 -PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=304.05 Aligned_cols=245 Identities=24% Similarity=0.399 Sum_probs=200.1
Q ss_pred ceecccCCeEEEEEEEcCCC------ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 73 RELGRGQFGVTYLVTHKDTK------QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
+.||+|+||.||+|.++... +.+|+|.+.... .......+.+|+.+++.++ ||||+++++++.+....++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence 46899999999999986543 679999875432 2234567889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC--CCCCeeEeeccc
Q 014704 147 MDLCAGGELFDRIIAK-------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGL 217 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~~~~kl~Dfg~ 217 (420)
|||++|++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ ....++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999988642 2378899999999999999999999999999999999996533 223799999999
Q ss_pred ccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 014704 218 SVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 218 ~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 292 (420)
+........ .....++..|+|||.+. +.++.++||||||+++|+|++ |..||...+.......+..+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CC
Confidence 876543221 12234567899999886 458999999999999999998 99999887776666665543211 12
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
...++..+.++|.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2467899999999999999999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=303.61 Aligned_cols=248 Identities=25% Similarity=0.415 Sum_probs=196.3
Q ss_pred cceeecceecccCCeEEEEEEE----cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe--C
Q 014704 67 NTYIFGRELGRGQFGVTYLVTH----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--R 140 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--~ 140 (420)
.+|++.+.||+|+||.||+|.. ..++..||+|.+... .....+.+.+|+++++.++ ||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCC
Confidence 4789999999999999999984 456889999998643 3345678899999999998 9999999997643 4
Q ss_pred CeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
..+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccc
Confidence 5689999999999999998764 468999999999999999999999999999999999999 456779999999998
Q ss_pred ccCCCCce----ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---------------HHH
Q 014704 220 FFKPGDVF----KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQS---------------IFD 279 (420)
Q Consensus 220 ~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~---------------~~~ 279 (420)
........ ....++..|+|||.+.+ .++.++||||||+++|+|++|..|+....... .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 76433211 11223456999998864 58899999999999999999877764332110 011
Q ss_pred HHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 280 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+......++ ....++.++.+||.+||..+|++|||+.++++
T Consensus 237 ~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1122222221 12467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=307.37 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=201.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCc----eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQ----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
++|+..+.||+|+||.||+|.+..+|. .+|+|.+.... .......+.+|+.+++.+. ||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-C
Confidence 568889999999999999999987775 46888875432 2333456889999999998 99999999998754 4
Q ss_pred EEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.++++||+.+|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccccc
Confidence 678999999999999987654 58999999999999999999999999999999999999 45667999999999865
Q ss_pred CCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 222 KPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 222 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
..... .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+.........+..+. .++. .+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~ 236 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQ--PPIC 236 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCCC--CCCC
Confidence 43322 12234567899999886 458899999999999999997 999998876665555444432 2222 2356
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+.++.+++.+||..+|++||++.++++.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=304.76 Aligned_cols=249 Identities=16% Similarity=0.206 Sum_probs=187.0
Q ss_pred cccceeecceecccCCeEEEEEEEcCC---CceEEEEEecCCcCCChhhH--------HHHHHHHHHHHhccCCCCccEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDV--------EDVRREVQIMHHLTGHRNIVEL 133 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~~hpniv~~ 133 (420)
..++|.+.+.||+|+||.||+|.+..+ +..+|+|+............ .....+...+..+. |+||+++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~ 88 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPKY 88 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCcE
Confidence 447899999999999999999999877 66778876432221100000 11122333445566 9999999
Q ss_pred EEEEEeCC----eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCC
Q 014704 134 KGAYEDRH----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209 (420)
Q Consensus 134 ~~~~~~~~----~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~ 209 (420)
++++.... ..+++++++. .++.+.+......++..+..++.|++.||.|||+++|+||||||+|||+ +.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~~~ 164 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGNNR 164 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCc
Confidence 99765443 3468888874 4666666655567899999999999999999999999999999999999 45677
Q ss_pred eeEeecccccccCCCC--------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCH-HH---
Q 014704 210 LKATDFGLSVFFKPGD--------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE-QS--- 276 (420)
Q Consensus 210 ~kl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~-~~--- 276 (420)
++|+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ..
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999997653211 1123469999999999865 589999999999999999999999977632 22
Q ss_pred -----HHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 277 -----IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 277 -----~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
....+..+... .+..+..+.++++.|+..+|++||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22223332222 2456889999999999999999999999874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=322.42 Aligned_cols=257 Identities=26% Similarity=0.446 Sum_probs=220.9
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE-----
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE----- 138 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~----- 138 (420)
+-.+.|+|.+.||.|.+|.||+++++.+++.+|+|+.... .+..+.++.|.++|+.+.+|||++.++++|.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3456799999999999999999999999999999997643 3445778999999999999999999999985
Q ss_pred eCCeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
.++.+|+|||||.||+..|+++.. .++.|..++.|++.++.|+.+||.+.++|||||=.|||++ .++.|||+|||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDFG 168 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDFG 168 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeeee
Confidence 357899999999999999988753 5699999999999999999999999999999999999995 56669999999
Q ss_pred cccccCCCC-ceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 014704 217 LSVFFKPGD-VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (420)
Q Consensus 217 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 289 (420)
.+..+.... ...+.+|||.|||||++. ..|+..+|+||||++..||--|.+|+.+......+-.|-+... ..
T Consensus 169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP-Pk 247 (953)
T KOG0587|consen 169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP-PK 247 (953)
T ss_pred eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC-cc
Confidence 998876543 345678999999999984 2478899999999999999999999988777666555544322 22
Q ss_pred CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 290 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
...+...+.++.+||..||.+|-++||+..++|+|||++
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 233567789999999999999999999999999999998
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=300.59 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=201.1
Q ss_pred eeecceecccCCeEEEEEEEcC---CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC----
Q 014704 69 YIFGRELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH---- 141 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~---- 141 (420)
|.+.+.||+|+||.||+|.++. +++.||+|++.... ......+.+.+|+++++.+. ||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 6778899999999999998653 57889999986543 24445677899999999998 999999999886432
Q ss_pred --eEEEEEecCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 142 --SVNLIMDLCAGGELFDRIIAK------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 142 --~~~iv~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
..+++++|+.+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++ +.+..+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence 247889999999998877532 247889999999999999999999999999999999999 456779999
Q ss_pred ecccccccCCCCc---eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCC
Q 014704 214 DFGLSVFFKPGDV---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDF 288 (420)
Q Consensus 214 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 288 (420)
|||++........ .....+++.|++||.+.. .++.++||||||+++|+|++ |.+||.+.........+..+....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9999886543321 122345678999998864 57889999999999999999 899998887777766666543211
Q ss_pred CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
. .+..+..+.+++.+||..+|++|||+.+++.+
T Consensus 236 -~--~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 236 -Q--PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -C--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 13567899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=297.03 Aligned_cols=244 Identities=18% Similarity=0.307 Sum_probs=192.2
Q ss_pred ceecccCCeEEEEEEEcCC--CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecC
Q 014704 73 RELGRGQFGVTYLVTHKDT--KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~ 150 (420)
+.||+|+||.||++..... ...+++|.+.... .....+.+.+|+.+++.++ ||||+++++.+.+....|+||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecC
Confidence 3699999999999976443 2356677665432 2334578999999999998 999999999999999999999999
Q ss_pred CCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 151 AGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 151 ~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
++++|.+++.+. ...++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchh
Confidence 999999998754 235677788999999999999999999999999999999 456779999999876432211
Q ss_pred --ceecccCCcccccchhhcc--------cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC-CCCCCCC-
Q 014704 226 --VFKDLVGSAYYVAPEVLRR--------NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH-IDFSSDP- 292 (420)
Q Consensus 226 --~~~~~~gt~~y~aPE~~~~--------~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~- 292 (420)
......++..|+|||++.. .++.++||||||+++|+|++ |..||......+.+..+.++. .....+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 1134567889999998742 25778999999999999997 677888777776666654432 2222221
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
...+++.+.+++..|| .+|++||++.++++
T Consensus 235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 2346888999999999 68999999999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=300.86 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=200.4
Q ss_pred cceeecceecccCCeEEEEEEEcC----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe--C
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKD----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--R 140 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--~ 140 (420)
..|.+.+.||+|+||.||+|.... ++..+|+|.+..... ......+.+|+++++.+. ||||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence 467888999999999999998653 478999999875432 134678999999999998 9999999999877 5
Q ss_pred CeEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
...++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||.+.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence 67999999999999999987654 58999999999999999999999999999999999999 456789999999998
Q ss_pred ccCCCCce----ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--------------HHHH
Q 014704 220 FFKPGDVF----KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQS--------------IFDA 280 (420)
Q Consensus 220 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~--------------~~~~ 280 (420)
........ ....++..|+|||.+. ..++.++||||||+++|+|++|..||....... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532211 1223456799999875 458899999999999999999999986543211 1122
Q ss_pred HHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 281 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.......++. ...++.++.+++.+||..+|++|||+.++++
T Consensus 238 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2222222222 2356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=295.82 Aligned_cols=262 Identities=28% Similarity=0.527 Sum_probs=199.6
Q ss_pred ccccc-cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC-------CCccEE
Q 014704 62 MEDVR-NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-------RNIVEL 133 (420)
Q Consensus 62 ~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-------pniv~~ 133 (420)
++.+. ++|.+.++||+|-|++||+|.+....+.||+|+++... ...+....||++|++++.+ ..||++
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 45566 89999999999999999999999999999999987533 2345678999999998632 369999
Q ss_pred EEEEE----eCCeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCC-
Q 014704 134 KGAYE----DRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSA- 205 (420)
Q Consensus 134 ~~~~~----~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~- 205 (420)
++.|. .+.++++|+|++ |.+|..+|... +.++...++.|++||+.||.|||. .||||.||||+|||+...+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~ 226 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEI 226 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecccc
Confidence 99986 467899999999 78999988765 449999999999999999999996 5999999999999986321
Q ss_pred --------------------------------------------------------------------------------
Q 014704 206 -------------------------------------------------------------------------------- 205 (420)
Q Consensus 206 -------------------------------------------------------------------------------- 205 (420)
T Consensus 227 ~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~ 306 (590)
T KOG1290|consen 227 DPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNE 306 (590)
T ss_pred chhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccc
Confidence
Q ss_pred ------------------------------C-------------------------------------------------
Q 014704 206 ------------------------------E------------------------------------------------- 206 (420)
Q Consensus 206 ------------------------------~------------------------------------------------- 206 (420)
.
T Consensus 307 ~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~ 386 (590)
T KOG1290|consen 307 PRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPL 386 (590)
T ss_pred cCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCC
Confidence 0
Q ss_pred ---CCCeeEeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC------HHH
Q 014704 207 ---DSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET------EQS 276 (420)
Q Consensus 207 ---~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~------~~~ 276 (420)
+..+||+|||-|+... ..++.-..|..|+|||++-+ .|++.+||||++|++|||+||...|.... ++.
T Consensus 387 ~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 387 PECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred CccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 0024666666665532 22334456889999998764 69999999999999999999999995432 122
Q ss_pred HHHHHH------------cCCCC--C-----------CCCCCC---------CC----ChHHHHHHHHhcccCcCCCCCH
Q 014704 277 IFDAIL------------RGHID--F-----------SSDPWP---------NI----SSSAKDIVKKMLHADPKERLSA 318 (420)
Q Consensus 277 ~~~~i~------------~~~~~--~-----------~~~~~~---------~~----~~~~~~li~~~L~~dp~~R~t~ 318 (420)
.+..|. .|... | ...+|+ .+ ..++.+||.-||+.+|++||||
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA 544 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTA 544 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccH
Confidence 222221 11110 0 001122 11 3467899999999999999999
Q ss_pred HHHhcCCccccc
Q 014704 319 AEVLNHPWMRVD 330 (420)
Q Consensus 319 ~e~l~h~~~~~~ 330 (420)
.++|+|||+...
T Consensus 545 ~~cl~hPwLn~~ 556 (590)
T KOG1290|consen 545 AQCLKHPWLNPV 556 (590)
T ss_pred HHHhcCccccCC
Confidence 999999999743
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=303.19 Aligned_cols=252 Identities=22% Similarity=0.370 Sum_probs=209.5
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
.+....+.++||+|-||.|.+|.-.. +..||+|.++... +......|.+|+++|.+|+ ||||++++++|..++.++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLC 611 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchH
Confidence 34667889999999999999998754 6899999987543 3445688999999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 145 LIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|+||++.|+|.+++..+. .+.......|+.||++|++||.+.++|||||.+.|+|+ +.+.++||+|||.++.+.
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccc
Confidence 9999999999999998773 23455567799999999999999999999999999999 788999999999999776
Q ss_pred CCCcee---cccCCcccccchhh-cccCCCccchhhhHHHHHHHHh--CCCCCCCCCHHHHHHHHHcCCCCC----CCCC
Q 014704 223 PGDVFK---DLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLS--GVPPFWGETEQSIFDAILRGHIDF----SSDP 292 (420)
Q Consensus 223 ~~~~~~---~~~gt~~y~aPE~~-~~~~~~~~DvwslGvil~~ll~--g~~pf~~~~~~~~~~~i~~~~~~~----~~~~ 292 (420)
.++... ..+-...|||||.+ .++++.++|||+||+++||+++ ...||...+.+++.++.-.-...- -...
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence 665433 33556789999965 6889999999999999999764 889998888887777643311111 1111
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+-++..+.+++.+||..|.++|||++++-.
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 2456888999999999999999999999843
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.90 Aligned_cols=261 Identities=23% Similarity=0.393 Sum_probs=217.9
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccC-----CCCccEEEE
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG-----HRNIVELKG 135 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----hpniv~~~~ 135 (420)
-++.+.++|.+....|+|-|++|..|.+...|..||||+|.... ...+.=..|+++|++|.. .-|+++++.
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 45667789999999999999999999999999999999997532 334556789999999972 348999999
Q ss_pred EEEeCCeEEEEEecCCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeE
Q 014704 136 AYEDRHSVNLIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (420)
Q Consensus 136 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl 212 (420)
.|...+++|+|+|-+ ..+|.+.|.+.+. |....+..++.|++-||..|-..||+|.||||+|||++ .....+||
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKL 578 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKL 578 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeee
Confidence 999999999999988 4589999987664 78889999999999999999999999999999999997 45678999
Q ss_pred eecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 014704 213 TDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291 (420)
Q Consensus 213 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 291 (420)
||||.|........ +.+.-+..|.|||++.+ .|+...|+||.||+||||+||+..|.|.+..+++...+.....|+..
T Consensus 579 CDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 579 CDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred ccCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 99999988765443 44555778999999876 59999999999999999999999999999887776655433333321
Q ss_pred CC-------------------------------------------------CCC-------ChHHHHHHHHhcccCcCCC
Q 014704 292 PW-------------------------------------------------PNI-------SSSAKDIVKKMLHADPKER 315 (420)
Q Consensus 292 ~~-------------------------------------------------~~~-------~~~~~~li~~~L~~dp~~R 315 (420)
.+ +.+ -..+++||.+||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 00 001 1357899999999999999
Q ss_pred CCHHHHhcCCcccc
Q 014704 316 LSAAEVLNHPWMRV 329 (420)
Q Consensus 316 ~t~~e~l~h~~~~~ 329 (420)
.|..++|.||||+.
T Consensus 738 it~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 738 ITVNQALKHPFITE 751 (752)
T ss_pred CCHHHHhcCCcccC
Confidence 99999999999963
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=308.91 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=188.7
Q ss_pred cccceeecceecccCCeEEEEEEEc----------------CCCceEEEEEecCCcCCCh-----------hhHHHHHHH
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHK----------------DTKQQFACKSISSRKLINR-----------DDVEDVRRE 117 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E 117 (420)
-.++|.+.++||+|+||+||+|... ..++.||||.+........ ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4578999999999999999999752 2356799999864321000 011223457
Q ss_pred HHHHHhccCCCC-----ccEEEEEEEe--------CCeEEEEEecCCCCChHHHHHhcC---------------------
Q 014704 118 VQIMHHLTGHRN-----IVELKGAYED--------RHSVNLIMDLCAGGELFDRIIAKG--------------------- 163 (420)
Q Consensus 118 ~~~l~~l~~hpn-----iv~~~~~~~~--------~~~~~iv~e~~~g~~L~~~l~~~~--------------------- 163 (420)
+.++.++. |.+ +++++++|.. .+..++||||+.+++|.+++....
T Consensus 223 ~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 77777777 443 4667776642 356899999999999999886421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecc--cCCccccc
Q 014704 164 ---HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL--VGSAYYVA 238 (420)
Q Consensus 164 ---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~--~gt~~y~a 238 (420)
.+++..+..++.|++.+|.|||+.+|+||||||+|||+ +.+..+||+|||++.....+...... .+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 23566788999999999999999999999999999999 45677999999999765443322222 34789999
Q ss_pred chhhccc---------------------CC--CccchhhhHHHHHHHHhCCC-CCCCCC-----------HHHHHHHHHc
Q 014704 239 PEVLRRN---------------------YG--AEADIWSAGVILYILLSGVP-PFWGET-----------EQSIFDAILR 283 (420)
Q Consensus 239 PE~~~~~---------------------~~--~~~DvwslGvil~~ll~g~~-pf~~~~-----------~~~~~~~i~~ 283 (420)
||.+... |+ .+.||||+||++|+|++|.. ||.+.. ....+..+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 9987421 11 34799999999999999876 764321 1111222223
Q ss_pred CCCCCCCCCCCCCChHHHHHHHHhcccCc---CCCCCHHHHhcCCccc
Q 014704 284 GHIDFSSDPWPNISSSAKDIVKKMLHADP---KERLSAAEVLNHPWMR 328 (420)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~R~t~~e~l~h~~~~ 328 (420)
..+.+ ..+..+++.+++|+.+||..+| .+|+|+.|+|+||||.
T Consensus 459 ~~~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 459 QKYDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred cCCCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 33333 3467789999999999999866 6899999999999995
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=282.93 Aligned_cols=242 Identities=43% Similarity=0.758 Sum_probs=207.7
Q ss_pred CCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCCChHHH
Q 014704 79 QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDR 158 (420)
Q Consensus 79 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~~L~~~ 158 (420)
+||.||+|.+..+|+.+|+|++....... ..+.+.+|++.+++++ |+||+++++++......++++||+.+++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999999889999999986543321 1578999999999997 99999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecccCCccccc
Q 014704 159 IIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVA 238 (420)
Q Consensus 159 l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~a 238 (420)
+.....+++..+..++.+++.++.|||+.+++|+||+|+||+++ .++.++|+|||.+.............++..|+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccccccccCCcCCCC
Confidence 88776689999999999999999999999999999999999994 457899999999988765544556678999999
Q ss_pred chhhc-ccCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCC
Q 014704 239 PEVLR-RNYGAEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL 316 (420)
Q Consensus 239 PE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 316 (420)
||.+. ..++.++||||+|+++|++++|..||.. .......+.+......... .+..++.++.+++.+||..+|++||
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-ccccCCHHHHHHHHHHccCCchhcc
Confidence 99886 4688899999999999999999999987 5555555555554444322 1122788999999999999999999
Q ss_pred CHHHHhcCCcc
Q 014704 317 SAAEVLNHPWM 327 (420)
Q Consensus 317 t~~e~l~h~~~ 327 (420)
++.++++||||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=307.59 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=213.2
Q ss_pred cceeecceecccCCeEEEEEEEcCC-C--ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDT-K--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~-~--~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
+...+.++||+|+||.|++|.++.. | -.||||++...... .....|.+|+.+|.+|. |||++++|++..+ .-.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chh
Confidence 3456789999999999999999753 3 35999999866543 26789999999999999 9999999999887 667
Q ss_pred EEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 144 NLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.+|||++.+|+|.++|.+ +..|.......++.||+.|+.||.++++|||||-..|+|+. ....|||+|||+.+.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceecc
Confidence 899999999999999987 34588889999999999999999999999999999999995 4667999999999988
Q ss_pred CCCCceeccc----CCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 222 KPGDVFKDLV----GSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 222 ~~~~~~~~~~----gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
..++.+..+. -...|+|||.++ +.++.++|||++||++|||+| |..||.+....+++++|..+.. ++. .+.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-LpR--Pk~ 339 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-LPR--PKY 339 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-CCC--CCC
Confidence 7655433322 235699999997 579999999999999999998 8999999999999999885433 322 246
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
+++++.+++..||..+|.+|||+..+.+.-+.
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 89999999999999999999999998654433
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=302.34 Aligned_cols=247 Identities=28% Similarity=0.462 Sum_probs=209.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCC--C--ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDT--K--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~--~--~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
+....+.+.||.|-||.||+|+...- | --||||..+.. .+.+..+.|..|..+|+.++ ||||++++|++.+ .
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfd-HphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVE-Q 463 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCC-Ccchhheeeeeec-c
Confidence 34455678899999999999997543 3 34888887643 34556789999999999999 9999999999865 4
Q ss_pred eEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
-.|||||++.-|.|..+|..+ ..++......++.||+.||.|||+.+.|||||-..|||+. ....|||+|||+++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhh
Confidence 589999999999999999865 4589999999999999999999999999999999999995 456799999999999
Q ss_pred cCCCCceecccCC--cccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 221 FKPGDVFKDLVGS--AYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 221 ~~~~~~~~~~~gt--~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
+.....+....|. ..|||||-++ +.++.++|||-|||.+||+++ |..||.+-...+++-.|.+|.... . .+++
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP-~--P~nC 617 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP-C--PPNC 617 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC-C--CCCC
Confidence 8877666555543 4699999987 579999999999999999887 999999988888887777765432 2 2578
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHh
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVL 322 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l 322 (420)
++.+..|+.+||.+||.+||++.++.
T Consensus 618 Pp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 618 PPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ChHHHHHHHHHhccCcccCCcHHHHH
Confidence 99999999999999999999988764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=282.85 Aligned_cols=255 Identities=29% Similarity=0.495 Sum_probs=209.6
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR---- 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~---- 140 (420)
+..+|.-.+.+|.|+- .|..|-+.-+++.||+|..... +.+....++..+|...+..+. |+||++++.+|...
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHH
Confidence 4457888899999998 7888888888999999987654 555566688899999999999 99999999998543
Q ss_pred --CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 141 --HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 141 --~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
..+|+|||+++. +|.+.+. -.++-..+..++.|++.|++|||+.||+||||||+||++ ..+..+||.|||+|
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLA 165 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhh
Confidence 468999999964 8877776 457888999999999999999999999999999999999 56778999999999
Q ss_pred cccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH------------ 285 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~------------ 285 (420)
+.....-..+..+.|..|.|||++.+ .|...+||||+|||+.||++|...|.|.+.-..+.++...-
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 98766556677899999999998754 59999999999999999999999998876544444432100
Q ss_pred ---------------C----CCCCCCCCC-------CChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 286 ---------------I----DFSSDPWPN-------ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 286 ---------------~----~~~~~~~~~-------~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
. .|+...|+. -+..+++++.+||..||++|.|++++|+|||++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 111112211 135689999999999999999999999999997
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.49 Aligned_cols=248 Identities=30% Similarity=0.467 Sum_probs=200.0
Q ss_pred eeecceecccCCeE-EEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 69 YIFGRELGRGQFGV-TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 69 y~~~~~lG~G~~g~-V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
|.-.+.+|.|+-|+ ||+|... |+.||||.+.. +......+||..|+.-+.|||||++++.-.+....||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 44456789998876 8999884 68999998753 334678899999999999999999999999999999999
Q ss_pred ecCCCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC--CCCCeeEeeccccccc
Q 014704 148 DLCAGGELFDRIIAKGH----YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGLSVFF 221 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~~~~kl~Dfg~~~~~ 221 (420)
|.|. .+|.+++..... ........++.|+++||++||+.+||||||||+||||...+ ....++|+|||+++.+
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9995 599999987411 11134578899999999999999999999999999998642 3457999999999988
Q ss_pred CCCCc----eecccCCcccccchhhccc-CCCccchhhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 222 KPGDV----FKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 222 ~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~DvwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
..+.. .....||.+|+|||++... -+.++||||+||++|+.++| .+||.+.... -.+|+.+......-. +.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~-~~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLE-PL 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeec-cC
Confidence 76542 3456799999999999753 56789999999999999985 9999665443 235677665543311 11
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
...++++||.+||++||..||+|.++|+||+|-
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 112899999999999999999999999999995
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=294.72 Aligned_cols=245 Identities=24% Similarity=0.442 Sum_probs=212.0
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
+.+.....+||.|-||.||.|.++.-.-.||||.++.. .-.++.|..|..+|+.++ |||+|+++++|..+--+||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEE
Confidence 34455667899999999999999998889999998653 346788999999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+|||..|+|.++|.+..+ ++.-....++.||.+|+.||..+++|||||-..|+|+ +++..||++|||+++.+..
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcC
Confidence 9999999999999987644 7777788999999999999999999999999999999 7888999999999998864
Q ss_pred CCceecccCC---cccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 224 GDVFKDLVGS---AYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 224 ~~~~~~~~gt---~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
+.++...|. ..|.|||-+. ..++.++|||+|||+|||+.| |-.||.+.+..+++..+.++ +... ...++++
T Consensus 418 -DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM~--~PeGCPp 493 (1157)
T KOG4278|consen 418 -DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRMD--GPEGCPP 493 (1157)
T ss_pred -CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-cccc--CCCCCCH
Confidence 344444443 5699999886 458999999999999999988 99999999888887766654 3333 2358999
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHh
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVL 322 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l 322 (420)
.+..|++.||+.+|.+||++.|+-
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHH
Confidence 999999999999999999999983
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=277.99 Aligned_cols=254 Identities=27% Similarity=0.460 Sum_probs=206.2
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-----eE
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-----SV 143 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-----~~ 143 (420)
..-.+.||-|+||.||.+.+..+|+.||+|.+.. .+.+-...+++.+|+++|..++ |.|++..+++.+..+ .+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHH
Confidence 3445789999999999999999999999998753 2223344578999999999999 999999998876543 46
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+++|++. .+|...+.+...++...++-++.||+.||+|||+.||.||||||.|+|++ .+..+||||||+++....
T Consensus 133 YV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN---SNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN---SNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec---cCceEEecccccccccch
Confidence 78899985 58888888888899999999999999999999999999999999999994 577899999999987654
Q ss_pred CC--ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------------
Q 014704 224 GD--VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL----------------- 282 (420)
Q Consensus 224 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~----------------- 282 (420)
.+ .++..+-|.+|.|||++.+ .|+.+.||||.|||+.||+..+..|...+.-+.++.|.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 33 3455577899999999864 69999999999999999999999998777655555442
Q ss_pred ------cCCCCCCCCC-------CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 283 ------RGHIDFSSDP-------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 283 ------~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
++....+.-. ...-..+..+++..||..||++|++..+++.|++..
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 2222111110 012235678999999999999999999999999974
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=304.64 Aligned_cols=249 Identities=23% Similarity=0.432 Sum_probs=215.7
Q ss_pred cceeecceecccCCeEEEEEEEcCCC---ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTK---QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
....|.++||.|.||.|++|+.+..| ..||||.++.- .++.....|..|..||-+++ ||||+++.++.....-+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCcee
Confidence 45678899999999999999998766 46999998643 35666788999999999999 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
.||.|||++|+|..+|..+ +.++..+..-+++.|+.|++||-+.|+|||||-..|||+ +.+..+|++|||+++.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecc
Confidence 9999999999999999765 679999999999999999999999999999999999999 557789999999999775
Q ss_pred CCC--ceecccC--Ccccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 223 PGD--VFKDLVG--SAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 223 ~~~--~~~~~~g--t~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
.+. ..++.-| ...|.|||.+. ++++.++||||+||+|||.++ |..||++.+.+++++.|..+-. ++ +..++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR-LP--pPmDC 859 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR-LP--PPMDC 859 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC-CC--CCCCC
Confidence 433 2222223 35799999986 679999999999999999876 9999999999999999988632 22 23578
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+..+..|+..||++|-.+||.+.|++.+
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999999999999764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=253.97 Aligned_cols=216 Identities=24% Similarity=0.355 Sum_probs=180.3
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+.-.+...-+..||+|+||.|-+.++..+|...|+|.+..+- +.+..+++.+|+.+..+...+|.+|.+|+.+.++..
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 334455666788999999999999999999999999997543 456678899999999888889999999999999999
Q ss_pred EEEEEecCCCCChHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 143 VNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~----~l~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
++|.||.++ .+|.. .+.+.+.++|..+.+|+..++.||.|||++ .++|||+||+|||+ +.++.+|+||||.
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGI 195 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGI 195 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEccccc
Confidence 999999995 36643 334457799999999999999999999976 89999999999999 5678899999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc-----cCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcC
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-----NYGAEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRG 284 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DvwslGvil~~ll~g~~pf~~-~~~~~~~~~i~~~ 284 (420)
+..+..+-..+-..|...|||||.+.. .|+-++||||||+++.||.+++.||.. .++.+.+.++...
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 987765443333578899999998852 589999999999999999999999953 4555666665543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=277.76 Aligned_cols=257 Identities=27% Similarity=0.472 Sum_probs=203.1
Q ss_pred ccccccceeecceecccCCeEEEEEEEcC---CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
...+.+.|...++||+|.|++||++.+.. .++.||+|.+.... ...++.+|+++|..+.++.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 44566789999999999999999999887 77899999986433 23679999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
.++.+.+|+||++..+..++.. .++...+..+++.++.||.++|.+|||||||||+|+|++. ..+.-.|+|||+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~--~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR--RTQRGVLVDFGLA 180 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc--ccCCceEEechhH
Confidence 9999999999999888777664 4678899999999999999999999999999999999974 4456789999998
Q ss_pred cccC-----------------C--CC----------------c----------eecccCCcccccchhhc--ccCCCccc
Q 014704 219 VFFK-----------------P--GD----------------V----------FKDLVGSAYYVAPEVLR--RNYGAEAD 251 (420)
Q Consensus 219 ~~~~-----------------~--~~----------------~----------~~~~~gt~~y~aPE~~~--~~~~~~~D 251 (420)
.... + +. . .-...||++|.|||++. ...+++.|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7210 0 00 0 01136999999999985 45789999
Q ss_pred hhhhHHHHHHHHhCCCCCCCCCHH-HHHHHH--------------HcCC-------------------CCC---------
Q 014704 252 IWSAGVILYILLSGVPPFWGETEQ-SIFDAI--------------LRGH-------------------IDF--------- 288 (420)
Q Consensus 252 vwslGvil~~ll~g~~pf~~~~~~-~~~~~i--------------~~~~-------------------~~~--------- 288 (420)
|||.|||+..++++..||...... ..+..| .-+. ..+
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999999543211 000000 0000 000
Q ss_pred ----CCCCC-CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 289 ----SSDPW-PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 289 ----~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
....| ...+..+.+|+.+||+.||.+|+|++++|+||||.
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 00011 22355789999999999999999999999999997
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=295.76 Aligned_cols=260 Identities=27% Similarity=0.488 Sum_probs=223.7
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
+-+++|.+...+|+|.||.||+++++.+++..|+|+++.. ...+..-+..|+-+++..+ |||||.+++.|......
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL 87 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence 4567899999999999999999999999999999999643 3456778899999999999 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
+|.||||.||+|.+...-.++++|.++..+++..+.+|+|||+.|-+|||||=.||+++ +.+.+||+|||.+..+..
T Consensus 88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhhh
Confidence 99999999999999888889999999999999999999999999999999999999995 456699999999877643
Q ss_pred C-CceecccCCcccccchhh----cccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCCC
Q 014704 224 G-DVFKDLVGSAYYVAPEVL----RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS-DPWPNIS 297 (420)
Q Consensus 224 ~-~~~~~~~gt~~y~aPE~~----~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~ 297 (420)
. ....++.||++|||||+- .+.|...||||++|+...|+---++|..+......+....+..++.+. ..-...+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 2 234567999999999975 356999999999999999998888887777666666555554443332 1123467
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+.+-+|++.+|.++|++|||++.+|.|||+...
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 889999999999999999999999999998653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=323.11 Aligned_cols=240 Identities=23% Similarity=0.297 Sum_probs=182.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
..|...+.||+|+||.||+|+++.++..||+|.+..... ....|++.+++++ |||||++++++.+.+..|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCEEE
Confidence 345566789999999999999998999999998854221 1235688899998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH---SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|||+++|+|.+++. .+++..+..++.|++.||+||| +.+|+||||||+||+++ .+...++. ||.......
T Consensus 762 ~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-ecccccccc
Confidence 99999999999885 3889999999999999999999 66999999999999994 34445554 555443221
Q ss_pred CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHH---HHHcC-C------CCCCC
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE--QSIFD---AILRG-H------IDFSS 290 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~--~~~~~---~i~~~-~------~~~~~ 290 (420)
. ....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..... ..... . .....
T Consensus 835 ~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 D---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred C---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1 23368899999999864 599999999999999999999999854211 11111 10000 0 00000
Q ss_pred C--CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 291 D--PWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 291 ~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
. .......++.+++.+||+.||++|||+.|+++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0 000112356789999999999999999999765
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=295.46 Aligned_cols=254 Identities=24% Similarity=0.426 Sum_probs=210.8
Q ss_pred ccccccceeecceecccCCeEEEEEEEcC-------CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEE
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKD-------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 134 (420)
++...++..+.+.||+|+||.|++|.... ....||||..+... ...+.+.+..|+++|+.+..||||+.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 33344555777899999999999998542 14579999986543 3367789999999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCc
Q 014704 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (420)
Q Consensus 135 ~~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 198 (420)
+++...+.+++|+|||..|+|.+++...+ .++......++.||+.|++||++..++||||-..|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998765 38889999999999999999999999999999999
Q ss_pred EEEecCCCCCCeeEeecccccccCCCCcee--cccCCc--ccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 014704 199 FLFSSSAEDSPLKATDFGLSVFFKPGDVFK--DLVGSA--YYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGE 272 (420)
Q Consensus 199 ill~~~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~gt~--~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~ 272 (420)
||+ ..+..+||+|||+++......... ...|+. .|||||.+.. .|+.++||||+||+|||++| |..||.+-
T Consensus 449 VLi---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 449 VLI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred EEe---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999 567889999999999765544332 223333 4999999875 69999999999999999999 99999885
Q ss_pred C-HHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 273 T-EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 273 ~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
. ...+++.+..|... ..+ ..++.++.++++.||+.+|++||++.++.+
T Consensus 526 ~~~~~l~~~l~~G~r~-~~P--~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 526 PPTEELLEFLKEGNRM-EQP--EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CcHHHHHHHHhcCCCC-CCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 5 56666666665432 221 356899999999999999999999999854
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=283.76 Aligned_cols=201 Identities=31% Similarity=0.547 Sum_probs=178.7
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC-----ChhhHHHHHHHHHHHHhcc--CCCCccEEEEEEEe
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-----NRDDVEDVRREVQIMHHLT--GHRNIVELKGAYED 139 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--~hpniv~~~~~~~~ 139 (420)
..|...+.||+|+||.|++|.++.....|+||.|.+.... +...+-.+-.||.||..|+ .|+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4589999999999999999999999999999999876542 2233445778999999996 59999999999999
Q ss_pred CCeEEEEEecC-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 140 RHSVNLIMDLC-AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 140 ~~~~~iv~e~~-~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
++++||+||-. +|-+|++++.-+.+++|.++..|++|+..|+++||+.||||||||-+||.+ +.++.+||+|||.+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence 99999999976 457999999999999999999999999999999999999999999999999 66788999999999
Q ss_pred cccCCCCceecccCCcccccchhhccc--CCCccchhhhHHHHHHHHhCCCCCCC
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWG 271 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DvwslGvil~~ll~g~~pf~~ 271 (420)
.....+ .+..++||..|.|||++.+. .+..-|||++|++||.++....||+.
T Consensus 718 a~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 887654 45678999999999999764 47889999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=266.32 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=186.2
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc-CCCCccEEEEEEEeCC----e
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT-GHRNIVELKGAYEDRH----S 142 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hpniv~~~~~~~~~~----~ 142 (420)
...+.++||+|.||.||+|+..+ +.||||++. .++.+.+.+|-+|.+... .|+||++++++-+... .
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred chhhHHHhhcCccceeehhhccC--ceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 35567899999999999999864 899999984 345577888877776542 3999999998865444 7
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM---------GVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---------~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
++||++|.+.|+|.++|.. ..+++....+++.-|++||+|||+. .|+|||||..|||+ .++.+..|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEee
Confidence 9999999999999999975 4689999999999999999999963 59999999999999 678889999
Q ss_pred ecccccccCCCCce---ecccCCcccccchhhccc--CC-----CccchhhhHHHHHHHHhCCC------------CCC-
Q 014704 214 DFGLSVFFKPGDVF---KDLVGSAYYVAPEVLRRN--YG-----AEADIWSAGVILYILLSGVP------------PFW- 270 (420)
Q Consensus 214 Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~--~~-----~~~DvwslGvil~~ll~g~~------------pf~- 270 (420)
|||+|..+.++... -..+||.+|||||++.+. +. .+.||||+|.+|||+++... ||.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 99999988765432 236899999999999764 22 35899999999999998533 332
Q ss_pred ----CCCHHHHHHHHHc--CCCCCCCCCCCCC--ChHHHHHHHHhcccCcCCCCCHHHH
Q 014704 271 ----GETEQSIFDAILR--GHIDFSSDPWPNI--SSSAKDIVKKMLHADPKERLSAAEV 321 (420)
Q Consensus 271 ----~~~~~~~~~~i~~--~~~~~~~~~~~~~--~~~~~~li~~~L~~dp~~R~t~~e~ 321 (420)
..+.+++...+.+ .++.++. .|... ..-+++.+..||..||+.|.|+.=+
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~-~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPD-AWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChh-hhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 1122333333332 2333332 23222 2457899999999999999998644
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=262.40 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=189.3
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHh--ccCCCCccEEEEEEEe
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH--LTGHRNIVELKGAYED 139 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~hpniv~~~~~~~~ 139 (420)
.+.+..+..+.+.||+|.||.||+|.++ |+.||||++..+ +.....+|.++.+. |+ |+||+.+++.=..
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLR-HENILgFIaaD~~ 276 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLR-HENILGFIAADNK 276 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhc-cchhhhhhhcccc
Confidence 3567788999999999999999999996 678999998542 33567777777664 57 9999999886432
Q ss_pred C----CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeccCCCCcEEEecCCCC
Q 014704 140 R----HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM--------GVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 140 ~----~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~ivH~Dlkp~Nill~~~~~~ 207 (420)
+ ..+|+|++|.+.|+|+|+|.. ..++.....+++.-+++||++||-. .|.|||||..|||+ ..+
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn 352 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKN 352 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccC
Confidence 2 368999999999999999976 6799999999999999999999942 49999999999999 677
Q ss_pred CCeeEeecccccccCCCC-----ceecccCCcccccchhhcccCC-------CccchhhhHHHHHHHHhC----------
Q 014704 208 SPLKATDFGLSVFFKPGD-----VFKDLVGSAYYVAPEVLRRNYG-------AEADIWSAGVILYILLSG---------- 265 (420)
Q Consensus 208 ~~~kl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-------~~~DvwslGvil~~ll~g---------- 265 (420)
+...|+|+|+|....... ..+..+||.+|||||++..... ..+||||||.++||+...
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 889999999998765432 2345689999999999965432 358999999999998752
Q ss_pred CCCCCCCC-----HHHHHHHHHcCCCCC-CCCCCCCCC--hHHHHHHHHhcccCcCCCCCHHHH
Q 014704 266 VPPFWGET-----EQSIFDAILRGHIDF-SSDPWPNIS--SSAKDIVKKMLHADPKERLSAAEV 321 (420)
Q Consensus 266 ~~pf~~~~-----~~~~~~~i~~~~~~~-~~~~~~~~~--~~~~~li~~~L~~dp~~R~t~~e~ 321 (420)
++||++-. .+++.+-+--..+.. ....|...+ ..+..+++.||..+|.-|.||-.+
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 57875422 223222221122221 122333222 346688999999999999998766
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=279.61 Aligned_cols=243 Identities=25% Similarity=0.382 Sum_probs=204.6
Q ss_pred ecceecccCCeEEEEEEEcCCC----ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 71 FGRELGRGQFGVTYLVTHKDTK----QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 71 ~~~~lG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
..++||+|+||+||+|.+-..| -+||+|++.... .......+.+|+-+|.+++ |||++++++++.... +-||
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HHHH
Confidence 4578999999999999987655 468889876433 3445678999999999999 999999999997766 7899
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
++|+++|+|.++++.. ..+.......|..||++|+.|||+++++||||-..|||+ .....+|+.|||+++......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCccc
Confidence 9999999999999764 568889999999999999999999999999999999999 456679999999999876543
Q ss_pred c-eecc--cCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 226 V-FKDL--VGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 226 ~-~~~~--~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
. +... .-.+.|||=|.+. ..|+.++||||+||++||++| |..|+.+....++-..+..+.. ++.+ +..+-++
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqP--piCtiDV 929 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQP--PICTIDV 929 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCC--CCccHHH
Confidence 2 2222 2245688888775 569999999999999999999 9999999998888777777654 4443 4678899
Q ss_pred HHHHHHhcccCcCCCCCHHHHhc
Q 014704 301 KDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.-++.+||..|+..||+++++..
T Consensus 930 y~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 930 YMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHhccCcccCccHHHHHH
Confidence 99999999999999999998753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=251.23 Aligned_cols=258 Identities=24% Similarity=0.405 Sum_probs=207.2
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE-EEeCC
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA-YEDRH 141 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~-~~~~~ 141 (420)
-++.+.|.+.+.||+|.||.+.++.|+.++..+++|.+.... .....|.+|...--.|..|.||+.-|++ |+..+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 356688999999999999999999999999999999987532 3457899999887788889999998874 77888
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.+++++||++-|+|..-+.. ..+.|.....++.|+++|+.|+|++++||||||.+|||+-..+ ...|||||||.+...
T Consensus 96 ~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTRKV 173 (378)
T ss_pred eEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeeccccccc
Confidence 89999999999999877654 4588999999999999999999999999999999999997643 458999999998764
Q ss_pred CCCCceecccCCcccccchhhc----cc--CCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCCC
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLR----RN--YGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHIDFSSD 291 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~----~~--~~~~~DvwslGvil~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~ 291 (420)
.. .....--+..|.+||... +. ..+.+|+|.||+++|.++||.+||..... ---+.+...+...-...
T Consensus 174 g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 174 GT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred Cc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 32 222223456799999763 22 47889999999999999999999964321 12223333333333344
Q ss_pred CCCCCChHHHHHHHHhcccCcCCC---CCHHHHhcCCccc
Q 014704 292 PWPNISSSAKDIVKKMLHADPKER---LSAAEVLNHPWMR 328 (420)
Q Consensus 292 ~~~~~~~~~~~li~~~L~~dp~~R---~t~~e~l~h~~~~ 328 (420)
.+..+++.+..+.++-|..++++| .++.......|..
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 566789999999999999999999 7777777778864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=238.60 Aligned_cols=211 Identities=42% Similarity=0.732 Sum_probs=184.5
Q ss_pred ecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCCC
Q 014704 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGE 154 (420)
Q Consensus 75 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~~ 154 (420)
||+|++|.||++....+++.+++|++....... ....+.+|+..++.+. |++|+++++++......++++|++.|++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999998889999999987543211 3577999999999999 9999999999999999999999999999
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-ceecccC
Q 014704 155 LFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-VFKDLVG 232 (420)
Q Consensus 155 L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g 232 (420)
|.+++... ..++...+..++.+++.++.+||+.|++|+||+|.||+++.. +..++|+|||.+....... ......+
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccC
Confidence 99988765 578999999999999999999999999999999999999531 5679999999988765432 1234567
Q ss_pred Ccccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 233 SAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 233 t~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
...|++||.+.. .++.+.|+|++|++++++ ..+.+++.+|+..
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence 889999999865 678899999999999999 5689999999999
Q ss_pred CcCCCCCHHHHhcCC
Q 014704 311 DPKERLSAAEVLNHP 325 (420)
Q Consensus 311 dp~~R~t~~e~l~h~ 325 (420)
||++||++.++++|+
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-31 Score=238.86 Aligned_cols=211 Identities=43% Similarity=0.739 Sum_probs=181.8
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
|.+.+.||+|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.++ |+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEe
Confidence 56788999999999999999988999999998754321 25678999999999998 9999999999999999999999
Q ss_pred cCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC--
Q 014704 149 LCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-- 225 (420)
Q Consensus 149 ~~~g~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~-- 225 (420)
++.+++|.+++..... +++..+..++.+++.++.+||+++++|+||+|.||+++ .+..++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEecCcccc
Confidence 9999999999987766 89999999999999999999999999999999999994 45789999999988765442
Q ss_pred ceecccCCcccccchhh-c-ccCCCccchhhhHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCC
Q 014704 226 VFKDLVGSAYYVAPEVL-R-RNYGAEADIWSAGVILYILLSGVPPFWG--ETEQSIFDAILRGH 285 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~-~-~~~~~~~DvwslGvil~~ll~g~~pf~~--~~~~~~~~~i~~~~ 285 (420)
......++..|++||.+ . ..++.++|+|+||+++++|++|+.||.. .....+.+.+..+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 33455788899999987 3 3477899999999999999999999977 44446666676654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=290.01 Aligned_cols=196 Identities=19% Similarity=0.237 Sum_probs=147.0
Q ss_pred CCccEEEEEE-------EeCCeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 014704 128 RNIVELKGAY-------EDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (420)
Q Consensus 128 pniv~~~~~~-------~~~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 199 (420)
+||+++++++ .....++.++|++ +++|.+++... ..+++..+..+++||+.||.|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777777776 2334677888987 66999999653 4599999999999999999999999999999999999
Q ss_pred EEecC----------------CCCCCeeEeecccccccCCCC-----------------ceecccCCcccccchhhc-cc
Q 014704 200 LFSSS----------------AEDSPLKATDFGLSVFFKPGD-----------------VFKDLVGSAYYVAPEVLR-RN 245 (420)
Q Consensus 200 ll~~~----------------~~~~~~kl~Dfg~~~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~ 245 (420)
|+... +.+..+|++|||+++...... .....+||+.|||||++. ..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 99531 234568888888876432100 011246899999999875 46
Q ss_pred CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 014704 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHP 325 (420)
Q Consensus 246 ~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 325 (420)
|+.++|||||||+||||++|.+|+.... ..+..+..... +.. +....+...+++.+||++||.+|||+.|+|+||
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQ-ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Chh-hhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 9999999999999999999998875322 22222322211 111 111245678999999999999999999999999
Q ss_pred cccc
Q 014704 326 WMRV 329 (420)
Q Consensus 326 ~~~~ 329 (420)
||..
T Consensus 267 ~~~~ 270 (793)
T PLN00181 267 FINE 270 (793)
T ss_pred hhhh
Confidence 9975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=234.60 Aligned_cols=249 Identities=20% Similarity=0.269 Sum_probs=203.7
Q ss_pred cccceeecceecccCCeEEEEEEEcCC-----CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE-
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE- 138 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~- 138 (420)
-+.++++.-.+-+|.||.||.|.+++. .+.|-+|.++.. .++-....+..|--.+..+. |||+..+.++..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie 358 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIE 358 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCc-CCCccceeEEEee
Confidence 356788888999999999999987643 245667776543 24556778899999999998 999999999874
Q ss_pred eCCeEEEEEecCCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCe
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAK--------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~ 210 (420)
+....++++.+..-|+|..++... ..++..+...++.|+..|++|||++||||.||-..|+++ ++...+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeE
Confidence 455677888898889999888722 236777888899999999999999999999999999999 566889
Q ss_pred eEeecccccccCCCCcee---cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 014704 211 KATDFGLSVFFKPGDVFK---DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285 (420)
Q Consensus 211 kl~Dfg~~~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~ 285 (420)
||+|=.+++...+.+..- ..-....||+||.+. ..|+.++|||||||+||||+| |+.|+..-++.++...++.|.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc
Confidence 999999998876654321 112345799999986 469999999999999999998 999999999988888887764
Q ss_pred CCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHh
Q 014704 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322 (420)
Q Consensus 286 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 322 (420)
. ...+ -++++++..++..||..+|++||+++|+.
T Consensus 516 R-laQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 516 R-LAQP--FNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred e-ecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 3 2221 37899999999999999999999999974
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=260.01 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=199.0
Q ss_pred eecceecccCCeEEEEEEEcCCCceEEEEEecCC--cCCChhh-HHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSR--KLINRDD-VEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 70 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~-~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
.....+|.|++|.|+.+........++.|.+... ....... ...+..|+.+-..+. |||++..+..+.+....+-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhcccchhh
Confidence 4567899999999998888777776777765422 1111211 222667788888888 99998888877766666666
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC--
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-- 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-- 224 (420)
||||++ +|+.++...+.++..++..+++|++.|++|+|+.||.|||||++|+++ ..++.+||+|||.+......
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeeccCcc
Confidence 999999 999999888889999999999999999999999999999999999999 46678999999998765432
Q ss_pred ---CceecccCCcccccchhhcc-cCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHc----CCCCCCCCCCC
Q 014704 225 ---DVFKDLVGSAYYVAPEVLRR-NYG-AEADIWSAGVILYILLSGVPPFWGETEQSIF-DAILR----GHIDFSSDPWP 294 (420)
Q Consensus 225 ---~~~~~~~gt~~y~aPE~~~~-~~~-~~~DvwslGvil~~ll~g~~pf~~~~~~~~~-~~i~~----~~~~~~~~~~~ 294 (420)
......+|+..|+|||++.+ .|. ...||||.|+++..|.+|+.||......+.. ..... ....-+...+.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 23356789999999999865 465 4689999999999999999999654432211 11111 11111222345
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.++...+.+|.+||++||.+|.|+++|++.+||+...
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 6788999999999999999999999999999998543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=214.54 Aligned_cols=161 Identities=27% Similarity=0.351 Sum_probs=127.3
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceeccc
Q 014704 153 GELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231 (420)
Q Consensus 153 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 231 (420)
|+|.+++... ..+++..+..++.|++.||.|||+++ ||+|||+ +.++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 6899999874 45999999999999999999999999 9999999 55677888 99988754322 36
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCC---CCCCCCCh--HHHHHH
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSS---DPWPNISS--SAKDIV 304 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~---~~~~~~~~--~~~~li 304 (420)
||+.|||||++.+ .++.++||||+||++|+|++|..||..... ...+..+......... .....++. +++++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 8999999999864 589999999999999999999999976543 2333333332222111 01112333 699999
Q ss_pred HHhcccCcCCCCCHHHHhcCCccc
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.+||..||++|||+.++++|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-26 Score=219.68 Aligned_cols=255 Identities=37% Similarity=0.593 Sum_probs=209.5
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCC-CccEEEEEEEeCCeEEEEE
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-niv~~~~~~~~~~~~~iv~ 147 (420)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.++..+. |+ +|+++.+.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence 778899999999999999987 678999987665443335678999999999999 66 8999999998888889999
Q ss_pred ecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCC-CeeEeecccccccCC
Q 014704 148 DLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS-PLKATDFGLSVFFKP 223 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~-~~kl~Dfg~~~~~~~ 223 (420)
+++.++++.+.+.... .+++..+..++.|++.++.|+|+.+++|||+||+||++. ... .++++|||.+.....
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCC
Confidence 9999999997776664 799999999999999999999999999999999999995 344 699999999886544
Q ss_pred CC-------ceecccCCcccccchhhcc----cCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCC-
Q 014704 224 GD-------VFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHID- 287 (420)
Q Consensus 224 ~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DvwslGvil~~ll~g~~pf~~~~~----~~~~~~i~~~~~~- 287 (420)
.. ......||..|+|||.+.. .+....|+||+|++++++++|..||..... ......+......
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 32 2456789999999998864 578899999999999999999999877663 4555555554433
Q ss_pred CCCCCCCCC----ChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 288 FSSDPWPNI----SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 288 ~~~~~~~~~----~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
......... ...+.+++..++..+|..|.+..+...++|....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 222221111 2578999999999999999999999998776543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=228.58 Aligned_cols=178 Identities=19% Similarity=0.228 Sum_probs=135.8
Q ss_pred cccccccceeecceecccCCeEEEEEEEcC-CCceEEEEEecCCcC--CChhhHHHHHHHHHHHHhccCCCCccE-EEEE
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKD-TKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTGHRNIVE-LKGA 136 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~-~~~~ 136 (420)
+...+.+.|.+.+.||+|+||+||+|.++. +++.||||.+..... ........+.+|+++|+.+. |+|++. ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~ 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc
Confidence 345566789999999999999999999876 677889998753211 12234567999999999999 999884 5442
Q ss_pred EEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccC-CCCcEEEecCCCCCCeeEeec
Q 014704 137 YEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL-KPENFLFSSSAEDSPLKATDF 215 (420)
Q Consensus 137 ~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dl-kp~Nill~~~~~~~~~kl~Df 215 (420)
+..|+|||||+|++|.. +. ... ...++.|++.+|.|||++||+|||| ||+|||+ +.++.+||+||
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDF 156 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDF 156 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEEC
Confidence 45799999999999963 21 111 2568899999999999999999999 9999999 44567999999
Q ss_pred ccccccCCCC---------ceecccCCcccccchhhccc-------CCCccchh
Q 014704 216 GLSVFFKPGD---------VFKDLVGSAYYVAPEVLRRN-------YGAEADIW 253 (420)
Q Consensus 216 g~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-------~~~~~Dvw 253 (420)
|+++...... ......+++.|+|||.+... .+...|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9998764322 11345688899999998532 23446766
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=212.23 Aligned_cols=212 Identities=25% Similarity=0.415 Sum_probs=177.6
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
+.-.|+++++||+|+||..+.|...-+++.||||.-... .+..++..|.+..+.|.+.++|..+|-+...+.+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 345799999999999999999999999999999985432 234678999999999999999999998888888888
Q ss_pred EEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC--CCCCeeEeeccccccc
Q 014704 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGLSVFF 221 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~~~~kl~Dfg~~~~~ 221 (420)
+|+|++ |.+|.|++.- ..+++..+++.++.||+.-++|+|++.+|.|||||+|+||...+ +...|.++|||+|+.+
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999998 8899887764 45699999999999999999999999999999999999997532 3457999999999987
Q ss_pred CCCC--------ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHH
Q 014704 222 KPGD--------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAIL 282 (420)
Q Consensus 222 ~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~---~~~~~~~i~ 282 (420)
.... ...+..||..||+-.... +.-+.+.|+-|||-+++++|-|.+||.+.. ..+-+++|-
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 5332 234568999999977644 447889999999999999999999998743 444555553
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-27 Score=222.40 Aligned_cols=253 Identities=24% Similarity=0.309 Sum_probs=191.8
Q ss_pred ceeecceecccCCeEEEEEEEcCCC-ceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc---CCCCccEEEEEE-EeCCe
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTK-QQFACKSISSRKLINRDDVEDVRREVQIMHHLT---GHRNIVELKGAY-EDRHS 142 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~---~hpniv~~~~~~-~~~~~ 142 (420)
+|.+.+.||+|+||.||.|.+..++ ..+|+|.......... ..+..|+.++..+. +-+++..+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 7999999999999999999998764 6789998764322111 26788899998887 246999999999 58888
Q ss_pred EEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC--CCCCeeEeecccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGLS 218 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~~~~kl~Dfg~~ 218 (420)
.||||+.+ |.+|.++.... +.++..++..++.|++.+|.++|+.|++||||||+|+++.... +...+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 88999977544 5799999999999999999999999999999999999997543 2257999999999
Q ss_pred cccC---CCC-------c-eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Q 014704 219 VFFK---PGD-------V-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI 286 (420)
Q Consensus 219 ~~~~---~~~-------~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 286 (420)
+... ... . .....||..|+++.+..+ ..+++.|+||++.++.+++.|..||.+...............
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8322 110 1 123569999999998865 589999999999999999999999976553222222222111
Q ss_pred CCCCC-CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 287 DFSSD-PWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 287 ~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..... .....+.++..+...+-..+...+|....+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 11111 122345677777777777788888887776543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=203.91 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=200.1
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
..+.+.|.+.++||+|+||.+|.|....+|..||||+-.... ....+..|.++.+.|++-..|+.+..+..+..+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 345688999999999999999999999999999999865432 224578899999999988899999999989999
Q ss_pred EEEEEecCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRII-AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
-.+||+++ |.+|.+++. ....++-.++.-++-|++.-++|+|.++++||||||+|+|+.-+.....+.|+|||+|+.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999998 889988775 3466999999999999999999999999999999999999977666778999999999876
Q ss_pred CCCC--------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCC
Q 014704 222 KPGD--------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAILRGHIDFS 289 (420)
Q Consensus 222 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~ 289 (420)
.... ......||..|.+--...+ ..+.+.|+-|+|.+|.++.-|..||.+.. ..+-+++|.......+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 4322 2234679999998766543 35778999999999999999999998754 3455566665544433
Q ss_pred CC-CCCCCChHHHHHHHHhcccCcCCCCC
Q 014704 290 SD-PWPNISSSAKDIVKKMLHADPKERLS 317 (420)
Q Consensus 290 ~~-~~~~~~~~~~~li~~~L~~dp~~R~t 317 (420)
.. ...++|.++.-.+.-|=..--++-|.
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 22 23567888888888776655555554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-28 Score=235.24 Aligned_cols=240 Identities=28% Similarity=0.511 Sum_probs=208.0
Q ss_pred eecccCCeEEEEEEE---cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecC
Q 014704 74 ELGRGQFGVTYLVTH---KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (420)
Q Consensus 74 ~lG~G~~g~V~~~~~---~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~ 150 (420)
.+|.|+||.|+++.. .+.|.-+|+|+..+......... ....|-.++..++.||.++++...++.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999987653 34577899999877655443333 56677788888888999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecc
Q 014704 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230 (420)
Q Consensus 151 ~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 230 (420)
.||.|+..+.+...+++.....+...++-+++++|+.+|+|||+|++||++ +.++++++.|||+++..-.....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---
Confidence 999999999988889999999999999999999999999999999999999 67888999999999876544332
Q ss_pred cCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 231 VGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 231 ~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
|||..|||||+++ ....++|-||+|+++++|+||..||.+ ++...|.+..+.++. .++..+++++..++..
T Consensus 154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKR 224 (612)
T ss_pred ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhh
Confidence 9999999999998 567899999999999999999999987 677788887776665 5688999999999999
Q ss_pred CcCCCCC-----HHHHhcCCcccc
Q 014704 311 DPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 311 dp~~R~t-----~~e~l~h~~~~~ 329 (420)
+|..|.- +.++++|+||..
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred CHHHHhccCcchhHHHhccchhee
Confidence 9999985 579999999964
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=195.56 Aligned_cols=175 Identities=15% Similarity=0.165 Sum_probs=134.8
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHH------HHHHHHHHHhccCCCCccEEEEEE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED------VRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~------~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
-+.++|++.+.||.|+||.||++.. ++..+|+|++.......+..... +++|+..+.++. ||+|..+.+++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~ 104 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFY 104 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEee
Confidence 3578999999999999999999655 36689999997654433333333 689999999998 99999999987
Q ss_pred EeC--------CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCC
Q 014704 138 EDR--------HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209 (420)
Q Consensus 138 ~~~--------~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~ 209 (420)
.+. +..++||||++|.+|.+.. .+++ ....+++.+|..||+.|++|||+||+||+++ .++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~~g- 172 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---KNG- 172 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---CCC-
Confidence 643 3578999999999997763 2333 3466999999999999999999999999995 344
Q ss_pred eeEeecccccccCCCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHH
Q 014704 210 LKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILL 263 (420)
Q Consensus 210 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll 263 (420)
++|+|||............. =++...|..++|+||||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 99999998765432211100 123455778999999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=202.49 Aligned_cols=234 Identities=25% Similarity=0.395 Sum_probs=154.4
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccC---------CCCccEEEEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG---------HRNIVELKGAYE 138 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---------hpniv~~~~~~~ 138 (420)
.+..++.||.|+++.||.+.+..||+.+|+|++...........+.+++|.-....+.+ |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 56778999999999999999999999999999876554455567788887765554332 223443344332
Q ss_pred ---------eC---C-----eEEEEEecCCCCChHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHHcCCeeccC
Q 014704 139 ---------DR---H-----SVNLIMDLCAGGELFDRII---AKGHY----SERAAANLCRQMVTVVHYCHSMGVMHRDL 194 (420)
Q Consensus 139 ---------~~---~-----~~~iv~e~~~g~~L~~~l~---~~~~~----~~~~~~~i~~qi~~al~~lH~~~ivH~Dl 194 (420)
.. . +.+++|+-+. ++|.+.+. ..... .......+..|++..+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 2356777774 57766543 22222 12223456689999999999999999999
Q ss_pred CCCcEEEecCCCCCCeeEeecccccccCCCCceecccCCcccccchhhcc---------cCCCccchhhhHHHHHHHHhC
Q 014704 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR---------NYGAEADIWSAGVILYILLSG 265 (420)
Q Consensus 195 kp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DvwslGvil~~ll~g 265 (420)
+|+|+++ +.++.+.|+||+....... .......+..|.|||.... .++.+.|.|+||+++|.|++|
T Consensus 172 ~~~nfll---~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLL---DQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE----TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEE---cCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999 5678899999988775432 2222345678999997632 378899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCC
Q 014704 266 VPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER 315 (420)
Q Consensus 266 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 315 (420)
..||........... .|. ...++++.++.||+.+|+.||++|
T Consensus 247 ~lPf~~~~~~~~~~~------~f~--~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------DFS--RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------GGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------cch--hcCCcCHHHHHHHHHHccCCcccC
Confidence 999975543221111 122 223678999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=190.90 Aligned_cols=142 Identities=20% Similarity=0.213 Sum_probs=111.5
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhh-----------------------HHHHHHHHHHHHhccCCC
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD-----------------------VEDVRREVQIMHHLTGHR 128 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~~hp 128 (420)
...||+|+||.||+|.+. +|+.||+|+++......... .....+|++++.++. ++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence 468999999999999997 89999999997542111110 123346999999998 77
Q ss_pred CccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeccCCCCcEEEecCCCC
Q 014704 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC-HSMGVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 129 niv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~l-H~~~ivH~Dlkp~Nill~~~~~~ 207 (420)
++.....+... ..+|||||++|+++.......+.+++..+..++.|++.+|.|+ |+.||+||||||+|||++ +
T Consensus 80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~ 153 (190)
T cd05147 80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----D 153 (190)
T ss_pred CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----C
Confidence 77544333222 2389999999987766555567899999999999999999999 799999999999999995 2
Q ss_pred CCeeEeeccccccc
Q 014704 208 SPLKATDFGLSVFF 221 (420)
Q Consensus 208 ~~~kl~Dfg~~~~~ 221 (420)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 56999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=224.76 Aligned_cols=219 Identities=34% Similarity=0.633 Sum_probs=174.8
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
..|..++.|..|+||.||.++|+.+.+++|+| +.+.++. +++ ++.... .|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn---ilt~a~-npfvv--------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN---ILTFAG-NPFVV--------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc---cccccC-Cccee---------------
Confidence 56888999999999999999999999999995 4443321 111 222222 44444
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC----
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK---- 222 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~---- 222 (420)
|+-...+...+.++... +.+++|||+.||+|||+||+|.++ ..-+++|+.|||+++...
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhcc
Confidence 44445555556665444 778999999999999999999999 456779999999987531
Q ss_pred ----CCC--------ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 014704 223 ----PGD--------VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (420)
Q Consensus 223 ----~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 289 (420)
.+. .....+|||.|.|||++. +.|+..+|.|++|+|+|+++.|..||.+++.++++.......+.++
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 111 113458999999999875 5699999999999999999999999999999999999999888888
Q ss_pred CCCCCCCChHHHHHHHHhcccCcCCCC---CHHHHhcCCccccc
Q 014704 290 SDPWPNISSSAKDIVKKMLHADPKERL---SAAEVLNHPWMRVD 330 (420)
Q Consensus 290 ~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~h~~~~~~ 330 (420)
+.. ..++++++++|.++|+.+|..|. .+-++.+|+||+..
T Consensus 279 E~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 279 EED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred ccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 875 46789999999999999999996 57788899999753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=182.86 Aligned_cols=188 Identities=22% Similarity=0.278 Sum_probs=140.6
Q ss_pred ecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChh-hHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEec
Q 014704 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-DVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (420)
Q Consensus 71 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~ 149 (420)
+...|++|+||+||.+.. .+.+++.+.+......... ....+.+|+++|++|.+|++|++++++ +..|++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 457899999999997765 5677887776544332111 123578999999999868999999986 346999999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccC-CCCcEEEecCCCCCCeeEeecccccccCCCCce-
Q 014704 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL-KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF- 227 (420)
Q Consensus 150 ~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dl-kp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~- 227 (420)
+.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++ .++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCCcchHH
Confidence 999998654321 1 2357889999999999999999999 79999994 5567999999999865433211
Q ss_pred -----e--------cccCCcccccchhhc--ccCC-CccchhhhHHHHHHHHhCCCCCCCCCH
Q 014704 228 -----K--------DLVGSAYYVAPEVLR--RNYG-AEADIWSAGVILYILLSGVPPFWGETE 274 (420)
Q Consensus 228 -----~--------~~~gt~~y~aPE~~~--~~~~-~~~DvwslGvil~~ll~g~~pf~~~~~ 274 (420)
. ....++.|++|+... ...+ ...+.++.|.-+|.++||..+++++.+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 113577888887532 2222 567888999999999999999877653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=224.45 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=180.0
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCc-CCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRK-LINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
.|...+.||++.|=.|.+|++.+ | .|+||++.+.. ..+-....+...|++ ....+ |||++.+..+.+.....|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~-~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMK-APNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhc-CCcccchHHHHHhhHHHHHH
Confidence 68888999999999999999876 4 49999987654 233333444455555 44445 99999999888888888999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc--CCC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF--KPG 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~--~~~ 224 (420)
-+|.. -+|+|++.-+..+..-+.+.|+.|++.||.-||..||+|||||.+|||+++ -+-+.|+||-.-+.. ..+
T Consensus 100 Rqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS---WNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS---WNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee---echhhhhcccccCCccCCCC
Confidence 99985 499999988888889999999999999999999999999999999999964 345889999755432 111
Q ss_pred C------ceecccCCcccccchhhcc------------cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 014704 225 D------VFKDLVGSAYYVAPEVLRR------------NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285 (420)
Q Consensus 225 ~------~~~~~~gt~~y~aPE~~~~------------~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~ 285 (420)
+ .+.+...-..|.|||.+.. ..+++.||||+||+++||++ |++||.- .+++ ...++.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~-aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLL-AYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHH-hHhccC
Confidence 1 1122233457999997732 14688999999999999988 7999831 1111 111111
Q ss_pred CCCCCCCCCCC-ChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 286 IDFSSDPWPNI-SSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 286 ~~~~~~~~~~~-~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
-..+......+ +..++.||..|++.||++|.+|++.|+.
T Consensus 252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00000000011 2368999999999999999999999976
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=182.86 Aligned_cols=144 Identities=17% Similarity=0.173 Sum_probs=113.7
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChh-----------------------hHHHHHHHHHHHHhccCCC
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-----------------------DVEDVRREVQIMHHLTGHR 128 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~~hp 128 (420)
.+.||+|+||.||+|.+. +|+.||||++......... ....+.+|...+.++. |+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence 578999999999999987 8999999998764211000 0123468999999998 89
Q ss_pred CccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCC
Q 014704 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 129 niv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~ 207 (420)
++.....+.... .|+||||++|+++.........+++..+..++.|++.++.++|+ .||+||||||+||+++ +
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~----~ 153 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH----D 153 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----C
Confidence 875544443332 48999999988665444445678889999999999999999999 9999999999999995 4
Q ss_pred CCeeEeecccccccCC
Q 014704 208 SPLKATDFGLSVFFKP 223 (420)
Q Consensus 208 ~~~kl~Dfg~~~~~~~ 223 (420)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 6799999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=189.84 Aligned_cols=190 Identities=27% Similarity=0.405 Sum_probs=140.3
Q ss_pred CCCCccEEEEEEEe---------------------------CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 014704 126 GHRNIVELKGAYED---------------------------RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV 178 (420)
Q Consensus 126 ~hpniv~~~~~~~~---------------------------~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~ 178 (420)
.|||||++..+|.+ +..+|+||.... .+|.+++..+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 49999999887632 236889998875 4898888654 467778888999999
Q ss_pred HHHHHHHHcCCeeccCCCCcEEEecCCCC-CCeeEeecccccccCC-------CCceecccCCcccccchhhcccC----
Q 014704 179 TVVHYCHSMGVMHRDLKPENFLFSSSAED-SPLKATDFGLSVFFKP-------GDVFKDLVGSAYYVAPEVLRRNY---- 246 (420)
Q Consensus 179 ~al~~lH~~~ivH~Dlkp~Nill~~~~~~-~~~kl~Dfg~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~---- 246 (420)
+|+.|||++||.|||+|.+|||+.-+++. ..+.|+|||.+-.-.. .....+.-|....||||+.....
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999999765433 4578899997643221 11122345788899999986321
Q ss_pred ---CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHH
Q 014704 247 ---GAEADIWSAGVILYILLSGVPPFWGETEQSIFDA-ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAE 320 (420)
Q Consensus 247 ---~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 320 (420)
-.++|.|+.|.+.||++....||++..+..+-.. ...... +. ....+++.+++++..+|+.||.+|+++.-
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL--Pa-lp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL--PA-LPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC--CC-CcccCChHHHHHHHHHhcCCccccCCccH
Confidence 2479999999999999999999988443221111 111111 11 12367899999999999999999998543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=175.61 Aligned_cols=138 Identities=22% Similarity=0.283 Sum_probs=108.8
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc----CCCCccEEEEEEEeCC---eEE
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT----GHRNIVELKGAYEDRH---SVN 144 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hpniv~~~~~~~~~~---~~~ 144 (420)
.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+. .||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 7666655 689886532 224467999999999994 2899999999998874 434
Q ss_pred -EEEec--CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCCeeccCCCCcEEEecCC-CCCCeeEeecccc
Q 014704 145 -LIMDL--CAGGELFDRIIAKGHYSERAAANLCRQMVTVV-HYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLS 218 (420)
Q Consensus 145 -iv~e~--~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al-~~lH~~~ivH~Dlkp~Nill~~~~-~~~~~kl~Dfg~~ 218 (420)
+|+|| +.+++|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||+...+ .+..++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 557999999965 456666 36688888887 999999999999999999997543 3447999995433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=180.62 Aligned_cols=239 Identities=18% Similarity=0.242 Sum_probs=189.8
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
..+..+|.+...|..|+|++.. ..+++|++..+.. +......|..|.-.|+.+. ||||+.+++.+..+.++.++..
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG--NDIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhccCCCcccccccccC--cchhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEeee
Confidence 4566788899999999999975 4578888876554 3334466888999998888 9999999999999999999999
Q ss_pred cCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCCCCCCeeE--eecccccccC
Q 014704 149 LCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKA--TDFGLSVFFK 222 (420)
Q Consensus 149 ~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~~~~kl--~Dfg~~~~~~ 222 (420)
|++-|+|+..+..... .+..++.+++..|+.|++|||+.. |.--.|+...+++ +++.+.+| +|--++...
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfqe- 343 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQE- 343 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeeec-
Confidence 9999999999987654 677899999999999999999875 5556788999999 45554444 443333221
Q ss_pred CCCceecccCCcccccchhhccc----CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRRN----YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
....-.|.||+||.+++. .-.++|+|||++++|||.|...||.+-...+.-.+|.-..+.... .++++.
T Consensus 344 -----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i--ppgis~ 416 (448)
T KOG0195|consen 344 -----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI--PPGISR 416 (448)
T ss_pred -----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC--CCCccH
Confidence 122457889999999753 346799999999999999999999988877766666544443333 358999
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHh
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVL 322 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l 322 (420)
.+..|+.-|+..||.+||.+..++
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999987763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-22 Score=203.82 Aligned_cols=197 Identities=22% Similarity=0.330 Sum_probs=159.7
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
...|.|.+.||+|+||.||+|.+.+ |+.||+|+-+....+.-....+++.-++ +. --+.|..+...+.-.+.-++
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~---~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ---MLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh---hhcchHHHHHHHccCCccee
Confidence 3578899999999999999999988 9999999876544332222222322222 11 13566777777777777899
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecC----CCCCCeeEeeccccccc
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS----AEDSPLKATDFGLSVFF 221 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~----~~~~~~kl~Dfg~~~~~ 221 (420)
|+||.+-|+|.+++...+.+++..+..+..||+..++.||..+|||+||||+|+||... .+..-++|+|||.+..+
T Consensus 772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 99999999999999988889999999999999999999999999999999999999642 23456999999998765
Q ss_pred ---CCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCC
Q 014704 222 ---KPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVP 267 (420)
Q Consensus 222 ---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~ 267 (420)
..+..+...++|-.+-.+|+..+ .|+...|.|.++.++|.||.|+.
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 34456777889999999999876 59999999999999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=174.13 Aligned_cols=147 Identities=16% Similarity=0.130 Sum_probs=115.3
Q ss_pred cceeecceecccCCeEEEEEE-EcCCCceEEEEEecCCcCCC-------------------hh--hHHHHHHHHHHHHhc
Q 014704 67 NTYIFGRELGRGQFGVTYLVT-HKDTKQQFACKSISSRKLIN-------------------RD--DVEDVRREVQIMHHL 124 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~-~~~~~~~~avK~~~~~~~~~-------------------~~--~~~~~~~E~~~l~~l 124 (420)
..|.+.+.||+|+||.||+|. +..+|+.||+|++....... .. ....+.+|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999999 66789999999987542110 00 113467899999999
Q ss_pred cCCC--CccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-CeeccCCCCcEEE
Q 014704 125 TGHR--NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG-VMHRDLKPENFLF 201 (420)
Q Consensus 125 ~~hp--niv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~-ivH~Dlkp~Nill 201 (420)
. +. .+++++++ ...++||||+.|.+|.........+.+..+..++.||+.++.+||++| |+||||||+||++
T Consensus 108 ~-~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 108 Y-EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred H-hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 8 43 34455543 235899999999888766544556677778899999999999999999 9999999999999
Q ss_pred ecCCCCCCeeEeecccccccC
Q 014704 202 SSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 202 ~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+ ++.++|+|||.+....
T Consensus 183 ~----~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H----DGKVVIIDVSQSVELD 199 (237)
T ss_pred E----CCCEEEEEChhhhccC
Confidence 5 4569999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-22 Score=186.45 Aligned_cols=244 Identities=24% Similarity=0.366 Sum_probs=165.1
Q ss_pred eeecceecccCCeEEEEEEEcCC---CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEE------EEE--
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK------GAY-- 137 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~------~~~-- 137 (420)
+.+.+..+.++++.+...+-... ...++-+..... .........+++-.+.....|++.+..- ..+
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~ 322 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKR 322 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchhhhccc
Confidence 34445555666666555443332 222333322211 1122334445555555555344433221 011
Q ss_pred ---EeCCeEEEEEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCee
Q 014704 138 ---EDRHSVNLIMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 138 ---~~~~~~~iv~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
....++||.|++|.-.+|.+++..+. ..+....+.++.|+..++.| +|.+|||+||.||++. .+..+|
T Consensus 323 ~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~k 396 (516)
T KOG1033|consen 323 NKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLK 396 (516)
T ss_pred cccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhh
Confidence 12346899999999999999997553 36677889999999999999 9999999999999994 455799
Q ss_pred EeecccccccCCCC-------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014704 212 ATDFGLSVFFKPGD-------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL 282 (420)
Q Consensus 212 l~Dfg~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~ 282 (420)
|.|||+........ ..+..+||..||+||.+.+ .|+.++||||||+||+||+. =..+| .....+..+.
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r 473 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIR 473 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhh
Confidence 99999987765444 4456789999999999974 69999999999999999997 22222 1234455566
Q ss_pred cCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
.+.++.. .+.+ -++-..|+.+||...|.+||++.+.--|+|.
T Consensus 474 ~g~ip~~--~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 474 DGIIPPE--FLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cCCCChH--Hhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 6655411 1112 2456799999999999999988887777764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-22 Score=203.09 Aligned_cols=258 Identities=31% Similarity=0.520 Sum_probs=208.9
Q ss_pred ceeecceecccCCeEEEEEEEcCC-CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDT-KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
.|.+.+.||+|+|+.|-.+....+ ...+|.|.+.... ........+..|..+-+.+..|+|++.+++...+....+++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 467777899999999998877543 4457777665433 23444566777888888887799999999999999999999
Q ss_pred EecCCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCCeeccCCCCcEEEecCCCCC-CeeEeecccccccC
Q 014704 147 MDLCAGGELFDRI-IAKG-HYSERAAANLCRQMVTVVHYCH-SMGVMHRDLKPENFLFSSSAEDS-PLKATDFGLSVFFK 222 (420)
Q Consensus 147 ~e~~~g~~L~~~l-~~~~-~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~Nill~~~~~~~-~~kl~Dfg~~~~~~ 222 (420)
++|..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.|||+||+|.+++ ..+ .++++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhcccc
Confidence 9999999999988 4444 5788889999999999999999 99999999999999995 444 79999999998765
Q ss_pred C--C--CceecccC-Ccccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCC
Q 014704 223 P--G--DVFKDLVG-SAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSI-FDAILRGHIDFSSDPWP 294 (420)
Q Consensus 223 ~--~--~~~~~~~g-t~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 294 (420)
. + ......+| ++.|+|||...+ ...+..|+||+|+++.-+++|..|+........ +.........+....|.
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 4 2 23455688 999999999865 467889999999999999999999865543321 12222222334456788
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccccccccc
Confidence 99999999999999999999999999999999976
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-19 Score=160.48 Aligned_cols=137 Identities=25% Similarity=0.348 Sum_probs=113.4
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChh-----hHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-----DVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
+.||+|++|.||+|.+ .|..+++|........... ....+.+|+.++..+. |++|+....++.+....++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999987 5678999986543321111 1246789999999998 899887777777778889999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
||++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.||++. ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 99999999988865432 7789999999999999999999999999999995 45699999998865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=157.39 Aligned_cols=134 Identities=21% Similarity=0.280 Sum_probs=106.5
Q ss_pred eecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh-----hhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-----DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 74 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
.||+|+||.||+|.. +|..+++|.......... .....+.+|++++..+. |+++....-++.+....++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence 489999999999985 467899998654332211 12366789999999998 7766554445556667799999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 149 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
|++|++|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++...
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 9999999887754321 7899999999999999999999999999995 466999999988753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=173.51 Aligned_cols=198 Identities=24% Similarity=0.354 Sum_probs=156.7
Q ss_pred HhccCCCCccEEEEEEEeCCeEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCC-eeccCCCCcE
Q 014704 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGV-MHRDLKPENF 199 (420)
Q Consensus 122 ~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i-vH~Dlkp~Ni 199 (420)
+.+. |.|+.++++.+.++..+++|.+||..|+|.|.+.. .-.+++.-...+++.|+.||.|||...| .|+.|+..|+
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4566 99999999999999999999999999999999987 3458888889999999999999998876 9999999999
Q ss_pred EEecCCCCCCeeEeecccccccCCC---CceecccCCcccccchhhccc--------CCCccchhhhHHHHHHHHhCCCC
Q 014704 200 LFSSSAEDSPLKATDFGLSVFFKPG---DVFKDLVGSAYYVAPEVLRRN--------YGAEADIWSAGVILYILLSGVPP 268 (420)
Q Consensus 200 ll~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DvwslGvil~~ll~g~~p 268 (420)
++ +....+||.|||+....... .......-...|.|||.+... .+.+.||||+|++++|+++...|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 56788999999998766321 111112234579999998642 46789999999999999999999
Q ss_pred CCCCC----HHHHHHHHHc-CCCCCCCCCC--CCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 269 FWGET----EQSIFDAILR-GHIDFSSDPW--PNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 269 f~~~~----~~~~~~~i~~-~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
|.... ..++...+.+ +...+....+ ..+.+++..+++.||..+|++||+++++-.
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 96522 2355555666 3322222222 145667999999999999999999999853
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-19 Score=156.42 Aligned_cols=140 Identities=16% Similarity=0.201 Sum_probs=108.3
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh-------------------hhHHHHHHHHHHHHhccCCC
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-------------------DDVEDVRREVQIMHHLTGHR 128 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~~hp 128 (420)
.|.+.+.||+|+||.||++... +|+.||||++........ .......+|+.++..+. |+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-Hc
Confidence 4888899999999999999875 689999998764321000 01123678999999997 66
Q ss_pred --CccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC
Q 014704 129 --NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206 (420)
Q Consensus 129 --niv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~ 206 (420)
.++..++ ....++||||++|++|..... ......++.+++.++.++|+.||+||||||+||+++ .
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---~ 160 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---D 160 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc---C
Confidence 4455544 244589999999999865432 134568899999999999999999999999999994 5
Q ss_pred CCCeeEeecccccccC
Q 014704 207 DSPLKATDFGLSVFFK 222 (420)
Q Consensus 207 ~~~~kl~Dfg~~~~~~ 222 (420)
++.++|+|||.+....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 6789999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=174.48 Aligned_cols=141 Identities=21% Similarity=0.265 Sum_probs=112.5
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCC-----hhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-----RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
...|...+.||+|+||.||++.+... .+++|......... ....+.+.+|+++++.+. |++++....++.+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~ 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDP 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeC
Confidence 34567789999999999999987543 34555432221111 122356889999999999 99999888777777
Q ss_pred CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
...++||||++|++|.+++. ....++.|++.+|.+||+.||+||||||+|||+. +..++|+|||+++.
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGla~~ 476 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGLGKY 476 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCccccc
Confidence 78899999999999988775 3567899999999999999999999999999993 45699999999876
Q ss_pred c
Q 014704 221 F 221 (420)
Q Consensus 221 ~ 221 (420)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=150.05 Aligned_cols=142 Identities=16% Similarity=0.199 Sum_probs=100.5
Q ss_pred ecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHH---------------------HHHHHHHHHHhccCC-C
Q 014704 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE---------------------DVRREVQIMHHLTGH-R 128 (420)
Q Consensus 71 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~~h-p 128 (420)
+++.||+|+||+||+|.+. +++.||||++............ ....|...+..+..+ -
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999987 7899999998653221111111 114677777777622 2
Q ss_pred CccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCC
Q 014704 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 129 niv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~ 207 (420)
.+.+.+++ ...++||||+.|+.+........... ..+..++.+++.++.++|. .||+||||||+||+++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~ 150 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----D 150 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----C
Confidence 35555543 23589999999854321111111111 6678999999999999999 9999999999999995 5
Q ss_pred CCeeEeecccccccC
Q 014704 208 SPLKATDFGLSVFFK 222 (420)
Q Consensus 208 ~~~kl~Dfg~~~~~~ 222 (420)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 679999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3e-18 Score=165.06 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=202.1
Q ss_pred cccceeecceecc--cCCeEEEEEEE--cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 65 VRNTYIFGRELGR--GQFGVTYLVTH--KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~--G~~g~V~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
+...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+. .......-..=.+|+...+++..|+|.++.+..++..
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCcccccC
Confidence 4456777889999 99999999998 88899999997322 1111222234457788888888899999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHcCCeeccCCCCcEEEecCCCC-CCeeEee
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVT----VVHYCHSMGVMHRDLKPENFLFSSSAED-SPLKATD 214 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~qi~~----al~~lH~~~ivH~Dlkp~Nill~~~~~~-~~~kl~D 214 (420)
+..++-+|+| |.+|..+...... ++...++..+.+... ||.++|+.+|+|-|+||.||++. .+ ...+++|
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~d 266 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTD 266 (524)
T ss_pred Ccceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCC
Confidence 9999999999 4788888776655 889999999999999 99999999999999999999995 44 7799999
Q ss_pred cccccccCCCCce------ecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q 014704 215 FGLSVFFKPGDVF------KDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288 (420)
Q Consensus 215 fg~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 288 (420)
||+...+..+... ....|...|++||..++-++...|+|++|.+..+-.+|..++...... .+..+..+. .
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~~r~~~--i 343 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQLRQGY--I 343 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC-Ccccccccc--C
Confidence 9999887655421 222577889999999999999999999999999988887766443111 111122211 2
Q ss_pred CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.+.....+.++...+..|+..+|..|++++.+++|+++..
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 23333456777788999999999999999999999999863
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.2e-17 Score=147.58 Aligned_cols=138 Identities=18% Similarity=0.251 Sum_probs=103.9
Q ss_pred ceec-ccCCeEEEEEEEcCCCceEEEEEecCCcC----------CChhhHHHHHHHHHHHHhccCCCCc--cEEEEEEEe
Q 014704 73 RELG-RGQFGVTYLVTHKDTKQQFACKSISSRKL----------INRDDVEDVRREVQIMHHLTGHRNI--VELKGAYED 139 (420)
Q Consensus 73 ~~lG-~G~~g~V~~~~~~~~~~~~avK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~~hpni--v~~~~~~~~ 139 (420)
..|| .||.|+||.+... +..++||.+..... .+......+.+|+.++.+|. |++| ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeee
Confidence 4677 7888889888764 67899998853221 11223467889999999998 8775 677776433
Q ss_pred C-Ce---EEEEEecCCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEee
Q 014704 140 R-HS---VNLIMDLCAG-GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (420)
Q Consensus 140 ~-~~---~~iv~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~D 214 (420)
. .. .++|||+++| .+|.+++.. ..+++. .+.||+.+|.+||++||+||||||+|||++ .++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEE
Confidence 2 22 2599999997 688877654 456554 367899999999999999999999999995 345799999
Q ss_pred ccccccc
Q 014704 215 FGLSVFF 221 (420)
Q Consensus 215 fg~~~~~ 221 (420)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.4e-18 Score=171.33 Aligned_cols=259 Identities=28% Similarity=0.430 Sum_probs=205.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
+.+.+.+-+-+|+++.++.+.-..+|...+.|...........+.+.+..+-.++-... +|-++...-.+......+++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCCcchh
Confidence 34566678888999999988888888777777665443333334444444444443333 56666554445556778999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC---
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP--- 223 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~--- 223 (420)
++|..|++|...+...+..++..+...+..+..+++|||...+.|||++|.|++. ..++..++.|||.......
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccccccccC
Confidence 9999999999999988888999999999999999999999999999999999999 5677899999984322100
Q ss_pred ------------------C-----------CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 014704 224 ------------------G-----------DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET 273 (420)
Q Consensus 224 ------------------~-----------~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~ 273 (420)
. .......||+.|.+||.+.+ .....+|.|+.|+++++.++|.+||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 01123468999999998754 57889999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHH---HHhcCCccccc
Q 014704 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAA---EVLNHPWMRVD 330 (420)
Q Consensus 274 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~---e~l~h~~~~~~ 330 (420)
.+++++.|.++...++... ...+.++++++..+|..+|.+|..+. ++-.|+||+..
T Consensus 1040 pq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 9999999999988887654 35789999999999999999999988 88899999754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=132.92 Aligned_cols=133 Identities=24% Similarity=0.317 Sum_probs=110.9
Q ss_pred ecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC-CCccEEEEEEEeCCeEEEEEec
Q 014704 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKGAYEDRHSVNLIMDL 149 (420)
Q Consensus 71 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pniv~~~~~~~~~~~~~iv~e~ 149 (420)
+.+.||+|.++.||++.... ..+++|....... ...+.+|+.+++.+..+ .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 35789999999999999854 6799998754321 45788999999999833 6899999998888889999999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM---GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 150 ~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+.|+.+... +......++.+++.++.++|.. +++|+|++|+||+++ ..+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence 998877543 5566678899999999999985 799999999999995 356799999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=3e-15 Score=147.96 Aligned_cols=156 Identities=21% Similarity=0.312 Sum_probs=101.9
Q ss_pred cccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcC--------------------------CCh----
Q 014704 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--------------------------INR---- 108 (420)
Q Consensus 59 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------------------------~~~---- 108 (420)
+.+.+.+-..|.. +.||+|++|+||+|+.+++|+.||||++.+.-. .+.
T Consensus 112 G~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v 190 (537)
T PRK04750 112 GGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVV 190 (537)
T ss_pred CCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHH
Confidence 4455555556776 789999999999999998899999999874310 000
Q ss_pred -hhHHH------HHHHHHHHHhcc---CCCCccEEEEEEEe-CCeEEEEEecCCCCChHHH--HHhcC----CCCHHHHH
Q 014704 109 -DDVED------VRREVQIMHHLT---GHRNIVELKGAYED-RHSVNLIMDLCAGGELFDR--IIAKG----HYSERAAA 171 (420)
Q Consensus 109 -~~~~~------~~~E~~~l~~l~---~hpniv~~~~~~~~-~~~~~iv~e~~~g~~L~~~--l~~~~----~~~~~~~~ 171 (420)
+..+. +.+|+..+.++. .+.+.+.+-++|.+ .+..++||||++|+.+.+. +...+ .+.+..+.
T Consensus 191 ~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~ 270 (537)
T PRK04750 191 AEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE 270 (537)
T ss_pred HHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH
Confidence 11122 344444444443 13333333333332 4556899999999999763 33333 24444555
Q ss_pred HHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC-CCCCeeEeecccccccC
Q 014704 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLSVFFK 222 (420)
Q Consensus 172 ~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~~~~kl~Dfg~~~~~~ 222 (420)
.++.|++ ..|++|+|+||.||++..++ ..+.++++|||++..+.
T Consensus 271 ~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 271 VFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 5555554 58999999999999996432 22379999999987664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.4e-14 Score=120.73 Aligned_cols=143 Identities=15% Similarity=0.161 Sum_probs=104.5
Q ss_pred cceecccCCeEEEEEEEcC------CCceEEEEEecCCcC--------C--C---------hhhHHHHH----HHHHHHH
Q 014704 72 GRELGRGQFGVTYLVTHKD------TKQQFACKSISSRKL--------I--N---------RDDVEDVR----REVQIMH 122 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~------~~~~~avK~~~~~~~--------~--~---------~~~~~~~~----~E~~~l~ 122 (420)
...||.|.-+.||.|.... .+..+|||+.+.... . + ......+. +|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998653 357899998753211 0 0 11123333 8999999
Q ss_pred hccCC-CCccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeccCCCCcEE
Q 014704 123 HLTGH-RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC-HSMGVMHRDLKPENFL 200 (420)
Q Consensus 123 ~l~~h-pniv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~l-H~~~ivH~Dlkp~Nil 200 (420)
++... -++++++++ ..-+|||||+.+..+.....+...+++..+..+..+++.+|..| |+.|||||||++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 99732 467788865 44689999997654432222333466667788899999999998 8999999999999999
Q ss_pred EecCCCCCCeeEeecccccccC
Q 014704 201 FSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 201 l~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+. ++.+.|+|||.+....
T Consensus 158 ~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE----CCcEEEEECCCceeCC
Confidence 95 3459999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.6e-14 Score=137.98 Aligned_cols=142 Identities=18% Similarity=0.222 Sum_probs=95.6
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCC--------------------------Ch-hh----------HHHHH
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--------------------------NR-DD----------VEDVR 115 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--------------------------~~-~~----------~~~~~ 115 (420)
+.||+|++|+||+|+.+ +|+.||||+....-.. +. .. .-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999986 5899999997543100 00 00 00244
Q ss_pred HHHHHHHhcc----CCCCccEEEEEE-EeCCeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHcC
Q 014704 116 REVQIMHHLT----GHRNIVELKGAY-EDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVT-VVHYCHSMG 188 (420)
Q Consensus 116 ~E~~~l~~l~----~hpniv~~~~~~-~~~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~-al~~lH~~~ 188 (420)
+|.+.+.++. +++++ .+-.+| ...+..++||||++|++|.+..... ...+ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 5555555553 23443 222222 2234568999999999998765432 1222 3345566655 467899999
Q ss_pred CeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 189 ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
++|+|+||.||++ ..++.++++|||++..+.
T Consensus 278 ~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 9999999999999 456779999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.1e-14 Score=130.09 Aligned_cols=236 Identities=17% Similarity=0.233 Sum_probs=158.0
Q ss_pred EEEEEEEcCCCceEEEEEecCCcCCCh-hhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-----eEEEEEecCCCCCh
Q 014704 82 VTYLVTHKDTKQQFACKSISSRKLINR-DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-----SVNLIMDLCAGGEL 155 (420)
Q Consensus 82 ~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-----~~~iv~e~~~g~~L 155 (420)
.||++.+...|.+|+--.+......+. ...+..+.-...|-.+. |.|||+++.|+.+.. ...++.||++.|+|
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 467777777776665544332111111 11223333344455666 999999999986544 47889999999999
Q ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCCCCCCeeEeecccccc---cCCCC-
Q 014704 156 FDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSVF---FKPGD- 225 (420)
Q Consensus 156 ~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~---~~~~~- 225 (420)
..+|++. ..+......+|+.||+.||.|||+.. |+|+++..+-|++ ..++.||+.---.... .....
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~ 236 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTRE 236 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCccccchhhhhhhH
Confidence 9998754 34788889999999999999999885 9999999999999 4566677642111110 00011
Q ss_pred -ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 226 -VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPF-WGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
......+.++|.+||.-. .+.+.++|||++|+...+|..|..-- .+......-..+.+..+.... .--++
T Consensus 237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len-------~lqr~ 309 (458)
T KOG1266|consen 237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLEN-------GLQRG 309 (458)
T ss_pred hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccC-------ccccC
Confidence 111224678899999754 45678999999999999998876542 222222222233333322221 22468
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
++.+||+-.|..||++.++|.||.+-
T Consensus 310 ~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 310 SITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred cCcccccCCCCCCcchhhhhcCceee
Confidence 99999999999999999999999863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.9e-15 Score=141.58 Aligned_cols=252 Identities=21% Similarity=0.219 Sum_probs=186.9
Q ss_pred cccceeecceecccCCeEEEEEEEc-CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHK-DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...+|.....||.|.|+.|+.+... .++..|++|.+.........+ ..-..|+-+...+.-|.+++.++..|......
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456778889999999999998765 677889999876543322222 23356777777777799999998888877888
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+--|||+++++.....-...+.+...+.+..|++.++.++|+..++|+|+||+||++..++ ...++.|||....+.-
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLAF 419 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccccce
Confidence 89999999999877765556688999999999999999999999999999999999996432 6789999998764221
Q ss_pred CCceecccCCcccc-cchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 224 GDVFKDLVGSAYYV-APEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 224 ~~~~~~~~gt~~y~-aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
.. ......-+++ .+|++.. .+..+.|++|||.-+.+.++|...-+... ....|..+..... +....++
T Consensus 420 ~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p~~----~~~~~~~ 490 (524)
T KOG0601|consen 420 SS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTPNL----PGLKLQL 490 (524)
T ss_pred ec--ccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeecccccCC----CchHHhh
Confidence 11 1122333444 3566544 47889999999999999999865432221 2223344433222 2445778
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
..+.+.++..++..|+.+.++..|.-|.
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhh
Confidence 8999999999999999999998887653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.3e-12 Score=125.92 Aligned_cols=183 Identities=15% Similarity=0.165 Sum_probs=133.1
Q ss_pred eeecceecccCCeEEE-EEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 69 YIFGRELGRGQFGVTY-LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~-~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
|.+ ...+-++.+ +| .|..+.++.+|.|..++.+.- .....+.+-++.|+.++ ||||+++++.++.++.+|||+
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEe
Confidence 444 333344444 34 466777888999988765432 44567889999999999 999999999999999999999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH-SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
|.+. -|..++.+. ....+..-+.||+.||.||| ..+++|++|..+.|++ +..+..||++|.++........
T Consensus 89 ErV~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~ 160 (690)
T KOG1243|consen 89 ERVR--PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNA 160 (690)
T ss_pred eccc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCc
Confidence 9985 455566543 37778888999999999998 6689999999999999 5667799999988765432211
Q ss_pred -eecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCC
Q 014704 227 -FKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGV 266 (420)
Q Consensus 227 -~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~ 266 (420)
.....---.|..|+.+... +-..|.|-||+++++++.|.
T Consensus 161 ~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 161 PAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCcc
Confidence 0011111234555543211 12469999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-13 Score=117.40 Aligned_cols=128 Identities=18% Similarity=0.188 Sum_probs=95.5
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+.|+.|.++.||++... +..|++|....... ....+.+|+.+++.+.....+++++.+. ....++||||++|
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G 75 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG 75 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence 57899999999999864 67899998754321 1234678999999987333345666553 3345799999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGV-----MHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i-----vH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
.++.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 887543 11123467899999999999985 9999999999995 34599999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.1e-12 Score=107.03 Aligned_cols=148 Identities=17% Similarity=0.186 Sum_probs=111.9
Q ss_pred ecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh-----hhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-----DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 71 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
....|-+|+-+.|+++.+ .|+.++||.=......-+ -...+..+|+++|.++. --.|.-..=++.|...-.|
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence 456788999999999987 467777775333222111 12456789999999987 5566555556667777789
Q ss_pred EEecCCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 146 IMDLCAG-GELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 146 v~e~~~g-~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+|||++| .++.+++.... .........++++|-+.+.-||.++|+|+||..+||++.+.+....+.++|||++...
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999988 46777776542 2333344789999999999999999999999999999998777777899999998653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.5e-12 Score=105.04 Aligned_cols=135 Identities=21% Similarity=0.283 Sum_probs=100.5
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChh-----hHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEE
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-----DVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~ 147 (420)
..+++|+-+.+|.+.+. |..+++|.=.++..-.++ ...+-.+|.+++.++. -..|.-.+=+..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence 46789999999999774 345667653332222221 1245678999999987 455554444455777788999
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
||++|..|.+.+... ...+++.+-.-+.-||..||+|+||.++||++.. ..+.++|||++...
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~----~~i~~IDfGLg~~s 141 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG----GRIYFIDFGLGEFS 141 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC----CcEEEEECCccccc
Confidence 999998888888654 2567788888889999999999999999999952 33999999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.31 E-value=8e-10 Score=105.23 Aligned_cols=288 Identities=18% Similarity=0.229 Sum_probs=189.1
Q ss_pred CCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE----eCCeEEEEEecCCC-C
Q 014704 79 QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE----DRHSVNLIMDLCAG-G 153 (420)
Q Consensus 79 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~----~~~~~~iv~e~~~g-~ 153 (420)
--.+.|++....+|..|++|++.-...... .....-+++++++. |+|||++.+++. .+..+++|++|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 346789999999999999999944332222 23445678899999 999999999886 35578999999986 6
Q ss_pred ChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 154 ELFDRIIAK---------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 154 ~L~~~l~~~---------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
+|.++.... ...+|..++.++.|+..||.++|+.|+.-+-|.|.+|++. .+.+++|...|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccce
Confidence 787755321 2467899999999999999999999999999999999994 4447888888876
Q ss_pred cccCCCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCC-CCCHHHH-HHHHHcCCCCCCCCCCCCC
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFW-GETEQSI-FDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~-~~~~~~~-~~~i~~~~~~~~~~~~~~~ 296 (420)
.....+. + |.+.+ -.+-|.=.||.+++.|.||..--+ ....++. +..|. +..
T Consensus 441 Dvl~~d~------~-------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~y 494 (655)
T KOG3741|consen 441 DVLQEDP------T-------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTY 494 (655)
T ss_pred eeecCCC------C-------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhh
Confidence 6554432 0 11111 135688899999999999965422 2222222 33333 256
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcC---CcccccCCCCCCcccHHHHH-HHHHHHhhhhhHHHHHHHH--Hhhh---
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNH---PWMRVDGDASDKPLDIAVLT-RMKQFRAMNKLKKVALKVI--AENL--- 367 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h---~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~i--~~~~--- 367 (420)
|.+++++|.-+...++++ -++.+++.| .||........+ ...++ .+-+--...+|-++++++. .++.
T Consensus 495 S~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q~~---~d~mE~~Ls~emENGRLfRll~Kln~I~dR~e~~ 570 (655)
T KOG3741|consen 495 STDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQLK---TDVMETELSREMENGRLFRLLLKLNFIDDRPEYV 570 (655)
T ss_pred hHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHHHH---HHHHHHHHHHHHhcchHHHHHHHHhhhccCcccc
Confidence 889999999999999987 788888876 334322111000 00000 0101011122223332222 1111
Q ss_pred -----hHHH----HhhH-HHHhhccCCCCCCcccHHHHHhhhhhhC
Q 014704 368 -----SEEE----IMGL-KEMFKSMDTDNSGTITFEELKAGLPKLG 403 (420)
Q Consensus 368 -----~~~~----~~~l-~~~F~~~D~~~~G~i~~~el~~~l~~lg 403 (420)
++.. +.-+ .-+|...|.|+.-.++...+-++|.+|.
T Consensus 571 ~D~~WSesG~~fmi~LFRDYlFHqvtedg~p~lDlaHvl~CLNKLD 616 (655)
T KOG3741|consen 571 DDPDWSESGDRFMIKLFRDYLFHQVTEDGKPWLDLAHVLQCLNKLD 616 (655)
T ss_pred cCCcchhccceehHHHHHHhhheEeccCCChhhhHHHHHHHhhhcc
Confidence 1111 1111 2357778888888899999999998875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.3e-11 Score=108.64 Aligned_cols=143 Identities=25% Similarity=0.393 Sum_probs=104.2
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccC-CCCccEEEEEEEeC---CeEEEEEe
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG-HRNIVELKGAYEDR---HSVNLIMD 148 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-hpniv~~~~~~~~~---~~~~iv~e 148 (420)
+.||.|.++.||++...+ |+.+++|........ .....+.+|+++++.+.. +.++++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998754 678999987543221 134568899999999973 23467788776553 36789999
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 014704 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS------------------------------------------ 186 (420)
Q Consensus 149 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~------------------------------------------ 186 (420)
|++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888664421 346666666777777777777763
Q ss_pred --------------cCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 187 --------------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 187 --------------~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
..++|+|++|.||+++.+ .+..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236999999999999532 145688999997764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.8e-10 Score=104.87 Aligned_cols=238 Identities=18% Similarity=0.209 Sum_probs=157.5
Q ss_pred eecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE------EEeC-Ce
Q 014704 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA------YEDR-HS 142 (420)
Q Consensus 70 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~------~~~~-~~ 142 (420)
..++.||+|+-+.+|..-...+ .+.|++..... .. -...+..|...-.||-+-.=+.+ .-+. ..
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Ppp---a~---~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPP---AA---QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchhhc---hhheeecCCCc---hH---HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 3467899999999997654332 35587764332 11 11223344444446654331111 0122 23
Q ss_pred EEEEEecCCCCChHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeec
Q 014704 143 VNLIMDLCAGGELFDRII-------AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~-------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Df 215 (420)
..++|..+.|..--..+. +.....+..+.+.++.++.+.+.||+.|.+-+|++++|+|+ .+++.+.|+|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEcc
Confidence 678888888753222221 12336788899999999999999999999999999999999 45677999986
Q ss_pred ccccccCCCCceecccCCcccccchhhc-c-----cCCCccchhhhHHHHHHHHhC-CCCCCCCCH----HHHHH-HHHc
Q 014704 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLR-R-----NYGAEADIWSAGVILYILLSG-VPPFWGETE----QSIFD-AILR 283 (420)
Q Consensus 216 g~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DvwslGvil~~ll~g-~~pf~~~~~----~~~~~-~i~~ 283 (420)
..-.....+......+|.+.|.+||.-+ + .-+...|.|.|||++++++.| ++||.+-.. ..-.+ .|..
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 5444444566667788999999999754 2 246789999999999999886 999965321 00111 2322
Q ss_pred CCCC------------CCCCCCCCCChHHHHHHHHhcccC--cCCCCCHH
Q 014704 284 GHID------------FSSDPWPNISSSAKDIVKKMLHAD--PKERLSAA 319 (420)
Q Consensus 284 ~~~~------------~~~~~~~~~~~~~~~li~~~L~~d--p~~R~t~~ 319 (420)
+.+. ....+|.-+++++..|..+|+... +.-|||++
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 2211 122345668899999999999763 56899865
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.3e-09 Score=99.28 Aligned_cols=136 Identities=21% Similarity=0.165 Sum_probs=95.4
Q ss_pred EEEEEEEcCCCceEEEEEecCCcCC----C----hhhHHHHHHHHHHHHhccCCCCc--cEEEEEEEe-----CCeEEEE
Q 014704 82 VTYLVTHKDTKQQFACKSISSRKLI----N----RDDVEDVRREVQIMHHLTGHRNI--VELKGAYED-----RHSVNLI 146 (420)
Q Consensus 82 ~V~~~~~~~~~~~~avK~~~~~~~~----~----~~~~~~~~~E~~~l~~l~~hpni--v~~~~~~~~-----~~~~~iv 146 (420)
.|.++.. .|+.|.||........ + ........+|...+.+|. .-+| +.++.+.+. ...-++|
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3555544 4567888876432210 0 011124778999998885 3333 344555543 2357899
Q ss_pred EecCCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecC----CCCCCeeEeeccccc
Q 014704 147 MDLCAGG-ELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS----AEDSPLKATDFGLSV 219 (420)
Q Consensus 147 ~e~~~g~-~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~----~~~~~~kl~Dfg~~~ 219 (420)
||++++. +|.+++.. ....++.....++.++...+.-||..||+|+|+++.|||+... +++..+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999885 78888753 3446677788999999999999999999999999999999741 345679999999875
Q ss_pred c
Q 014704 220 F 220 (420)
Q Consensus 220 ~ 220 (420)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 3
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.2e-10 Score=96.76 Aligned_cols=130 Identities=17% Similarity=0.171 Sum_probs=82.4
Q ss_pred EEEEEEEcCCCceEEEEEecCCcC------------CC-----------hhhHHHHHHHHHHHHhccCC-CCccEEEEEE
Q 014704 82 VTYLVTHKDTKQQFACKSISSRKL------------IN-----------RDDVEDVRREVQIMHHLTGH-RNIVELKGAY 137 (420)
Q Consensus 82 ~V~~~~~~~~~~~~avK~~~~~~~------------~~-----------~~~~~~~~~E~~~l~~l~~h-pniv~~~~~~ 137 (420)
.||.|... .|..+|+|+.+.... .. ........+|.+.|.++... -++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888875 467999998753211 00 01134578899999999832 2577787653
Q ss_pred EeCCeEEEEEecCC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCeeccCCCCcEEEecCCCCCCeeEee
Q 014704 138 EDRHSVNLIMDLCA--GGELFDRIIAKGHYSERAAANLCRQMVTVVHY-CHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (420)
Q Consensus 138 ~~~~~~~iv~e~~~--g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~-lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~D 214 (420)
.-+|||||++ |..+.. +... .++......++.+++..+.. +|..||+|+||.+.||++.. +.+.++|
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~----~~~~iID 149 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD----GKVYIID 149 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET----TCEEE--
T ss_pred ----CCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec----ceEEEEe
Confidence 2379999998 655533 3322 12244567788888885555 68999999999999999952 2699999
Q ss_pred cccccccC
Q 014704 215 FGLSVFFK 222 (420)
Q Consensus 215 fg~~~~~~ 222 (420)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-10 Score=114.61 Aligned_cols=150 Identities=19% Similarity=0.321 Sum_probs=108.5
Q ss_pred HHHHHHHHHHc-CCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCcee----------cccCCcccccchhhcc-
Q 014704 177 MVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK----------DLVGSAYYVAPEVLRR- 244 (420)
Q Consensus 177 i~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~gt~~y~aPE~~~~- 244 (420)
+..|+.|+|.. ++||++|.|++|.+ +..+.+||+.|+++....+...+. ...-...|.|||++..
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred ccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 33899999965 89999999999999 566779999999987765422111 1123557999999865
Q ss_pred cCCCccchhhhHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCCCCCCC-CCCCCCChHHHHHHHHhcccCcCCCCCHHHHh
Q 014704 245 NYGAEADIWSAGVILYILL-SGVPPFWGETEQSIFDAILRGHIDFSS-DPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322 (420)
Q Consensus 245 ~~~~~~DvwslGvil~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 322 (420)
..+.++|+||+|+++|.+. .|+.-+......... ........... ..-.++++++++=+.++|..++..||++..++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 4788999999999999998 455555444322111 11111111111 11147899999999999999999999999999
Q ss_pred cCCccccc
Q 014704 323 NHPWMRVD 330 (420)
Q Consensus 323 ~h~~~~~~ 330 (420)
..|||...
T Consensus 264 ~~~ff~D~ 271 (700)
T KOG2137|consen 264 SIPFFSDP 271 (700)
T ss_pred cccccCCc
Confidence 99999743
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.5e-09 Score=94.64 Aligned_cols=140 Identities=17% Similarity=0.226 Sum_probs=104.3
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCc--C---------------CC--hhhHHHHHHHHHHHHhccCC-
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRK--L---------------IN--RDDVEDVRREVQIMHHLTGH- 127 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~---------------~~--~~~~~~~~~E~~~l~~l~~h- 127 (420)
-+.++..||-|.-+.||.|.+. .|.++|||+-+.-. + .+ .-.....++|.++|.+|..+
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 4668899999999999999987 47899999643110 0 00 01234568999999999744
Q ss_pred CCccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCC
Q 014704 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 128 pniv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~ 207 (420)
-.+++.+++ +.-.+|||+++|-.|... +++...+..++..|++-+..+-..||||+|+++-||++ +++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~d 238 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TED 238 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecC
Confidence 367777765 456899999999777432 22455666777777777777779999999999999999 566
Q ss_pred CCeeEeecccccc
Q 014704 208 SPLKATDFGLSVF 220 (420)
Q Consensus 208 ~~~kl~Dfg~~~~ 220 (420)
+.+.++||-.+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 7799999976554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.6e-09 Score=92.62 Aligned_cols=110 Identities=21% Similarity=0.257 Sum_probs=87.2
Q ss_pred HHHHHHHHHHHHhccCCCC--ccEEEEEEEeC----CeEEEEEecCCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 014704 111 VEDVRREVQIMHHLTGHRN--IVELKGAYEDR----HSVNLIMDLCAGG-ELFDRIIAKGHYSERAAANLCRQMVTVVHY 183 (420)
Q Consensus 111 ~~~~~~E~~~l~~l~~hpn--iv~~~~~~~~~----~~~~iv~e~~~g~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~ 183 (420)
.....+|...+..|. .-+ +++.+.+.+.. ...++|+|+++|. +|.+++......+......++.++...+.-
T Consensus 55 ~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 356788888888876 333 45666665542 2458999999984 788888775557778889999999999999
Q ss_pred HHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 184 lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
||.+||+|+|+++.|||+..++....+.|+||+-+...
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999976555567999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.4e-10 Score=110.18 Aligned_cols=241 Identities=17% Similarity=0.192 Sum_probs=167.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCC-ccEEEEEEEeCCeEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN-IVELKGAYEDRHSVNL 145 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn-iv~~~~~~~~~~~~~i 145 (420)
..|.....+++|+++.+++.+...+...+ .+++... ....-++++|.+++ ||| .+..++-++.+...++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCcccccch
Confidence 34556677899999999999877654433 6665322 44667889999999 999 7777787888889999
Q ss_pred EEecCCCC-C-hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGG-E-LFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~-~-L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
+|++|.++ + ........-.+.+-....+.+.-+.+++++|+..=+||| ||+.. ....++.||+....+..
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQLTR 383 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcccCc
Confidence 99999887 2 211111112244555667778888899999998879999 88874 35589999999888776
Q ss_pred CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCC-CCCCCCChH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH--IDFSS-DPWPNISSS 299 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~-~~~~~~~~~ 299 (420)
........+|+.++|||+..+ .+....|+|++|+--.++.-|.+|-.... .....+-.+. ..... ..|... .
T Consensus 384 ~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~--~ 459 (829)
T KOG0576|consen 384 TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPV--F 459 (829)
T ss_pred ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcc--c
Confidence 666677889999999998764 58889999999987667766766643211 0000000000 00000 111111 1
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
-.++...|+...|..|+....++.|.+|..
T Consensus 460 ~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 460 HRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred ccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 125788899999999999999999988853
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.6e-07 Score=81.45 Aligned_cols=141 Identities=13% Similarity=0.119 Sum_probs=101.0
Q ss_pred ecccCCeEEEEEEEcCCCceEEEEEecCC---cCCChhhHHHHHHHHHHHHhccCCCC--ccEEEEEEE---e--CCeEE
Q 014704 75 LGRGQFGVTYLVTHKDTKQQFACKSISSR---KLINRDDVEDVRREVQIMHHLTGHRN--IVELKGAYE---D--RHSVN 144 (420)
Q Consensus 75 lG~G~~g~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~~~~E~~~l~~l~~hpn--iv~~~~~~~---~--~~~~~ 144 (420)
-|+||-+-|+..... |+.+-+|.-... .+.-+.....+.+|...+.+|. .-+ ++++. ++. . ...-+
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~-~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELE-RAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHH-HcCCCCCccc-eeeeeccCCceEEE
Confidence 466888889987664 346888876421 1111335678999999999986 322 44544 332 1 12367
Q ss_pred EEEecCCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 145 LIMDLCAG-GELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 145 iv~e~~~g-~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
||+|-+.| .+|.+++.+. .+.++.....++.++..++.-||+.|+.|+|+.+.||++...+ ...++++||.-++.
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~ 179 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR 179 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence 99998865 5888877653 3457777789999999999999999999999999999996432 34599999986654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.8e-08 Score=83.25 Aligned_cols=141 Identities=19% Similarity=0.220 Sum_probs=90.1
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHH------HHHHHHHHHHhcc--CCCCccEEEEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE------DVRREVQIMHHLT--GHRNIVELKGA 136 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~------~~~~E~~~l~~l~--~hpniv~~~~~ 136 (420)
+.++|.+.+.+-......|.+..- .|+.+++|.........+.... ...+++..+.++. +-.....++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 456788888887777766666554 4688999987654321111111 2344555555554 12222232222
Q ss_pred E-----EeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCee
Q 014704 137 Y-----EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 137 ~-----~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
. .-....+++|||++|..|.+... +++ .+...+.+++.-||+.|+.|+|.+|.|+++. ++.++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~i~ 174 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNGIR 174 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCcEE
Confidence 2 22244568999999988865431 333 3456677889999999999999999999995 23399
Q ss_pred Eeeccccc
Q 014704 212 ATDFGLSV 219 (420)
Q Consensus 212 l~Dfg~~~ 219 (420)
++||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.6e-07 Score=97.77 Aligned_cols=206 Identities=22% Similarity=0.272 Sum_probs=146.7
Q ss_pred hHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE----EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 014704 110 DVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV----NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH 185 (420)
Q Consensus 110 ~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~----~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH 185 (420)
.+...+-|+..+.++. |+|++.++.|....... .+..++|.+.++...+...+..+....+.+..++++||.|+|
T Consensus 225 ~i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 3455667888888888 99999999987544333 345689999999999999899999999999999999999999
Q ss_pred HcCCeeccCCCCcEEEecCCCCCCeeEe--ecccccccCCCCceecccCCcccccchhhcccC---CCccchhhhHHHHH
Q 014704 186 SMGVMHRDLKPENFLFSSSAEDSPLKAT--DFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNY---GAEADIWSAGVILY 260 (420)
Q Consensus 186 ~~~ivH~Dlkp~Nill~~~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~DvwslGvil~ 260 (420)
+....|.-|..+-..-...+..+.+... ||+.+.............-+..+.++|....+. ....|+|.+|..+.
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 9966555555443332223445556666 888877665443333334556678888776542 33469999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC-hHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 261 ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS-SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 261 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+..|..+-.. ......++. ..+ ....+++.+|+.-++++|+++.+++.|+|.+..
T Consensus 384 ~~~~~~~i~~~---~~~~~~~l~-----------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 384 QLSQGEDISEK---SAVPVSLLD-----------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhcCccccc---ccchhhhhc-----------cccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 99887654211 111111111 112 167899999999999999999999999998644
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.63 E-value=8.8e-07 Score=79.12 Aligned_cols=73 Identities=21% Similarity=0.250 Sum_probs=55.7
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCC-CccEEEEEEEeCCeEEEEEecCC
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGAYEDRHSVNLIMDLCA 151 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-niv~~~~~~~~~~~~~iv~e~~~ 151 (420)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+.... .+++.+++..+.+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 47899999999983 24568889875321 2355789999999987332 25788888888888899999999
Q ss_pred CCC
Q 014704 152 GGE 154 (420)
Q Consensus 152 g~~ 154 (420)
|.+
T Consensus 78 G~~ 80 (226)
T TIGR02172 78 GKR 80 (226)
T ss_pred Ccc
Confidence 963
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.5e-07 Score=89.67 Aligned_cols=144 Identities=19% Similarity=0.215 Sum_probs=90.4
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcC--------------------------CCh-hhH----H------HHH
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--------------------------INR-DDV----E------DVR 115 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------------------------~~~-~~~----~------~~~ 115 (420)
+-|+.++-|+||+|+.+. |+.||||+..+.-. .+. ... + .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999986 89999998753211 000 000 1 234
Q ss_pred HHHHHHHhcc----CCCCccEEEEEEEeCCeEEEEEecCCCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 014704 116 REVQIMHHLT----GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI--IAKGHYSERAAANLCRQMVTVVHYCHSMGV 189 (420)
Q Consensus 116 ~E~~~l~~l~----~hpniv~~~~~~~~~~~~~iv~e~~~g~~L~~~l--~~~~~~~~~~~~~i~~qi~~al~~lH~~~i 189 (420)
+|...+.++. +.|+|.-..=+++-.+.-.++|||++|-.+.+.. .. ...+...+.....++. +..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 4555555443 2344322222233345567999999998887763 33 3355333332222211 223334899
Q ss_pred eeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 190 vH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
.|.|.+|.||++. .++.+.+.|||......+
T Consensus 287 fHaDpHpGNi~v~---~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVR---SDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEe---cCCcEEEEcCcceecCCH
Confidence 9999999999994 557899999999877654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.3e-06 Score=79.32 Aligned_cols=75 Identities=19% Similarity=0.183 Sum_probs=55.0
Q ss_pred ecccCC-eEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCC
Q 014704 75 LGRGQF-GVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGG 153 (420)
Q Consensus 75 lG~G~~-g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~ 153 (420)
|-.|.+ +.||++... +..+.+|+..... ...+.+|+++++.+..+--+++++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 334444 789998653 3678888864321 2457789999999976656778888887777789999999997
Q ss_pred ChHH
Q 014704 154 ELFD 157 (420)
Q Consensus 154 ~L~~ 157 (420)
+|..
T Consensus 78 ~l~~ 81 (244)
T cd05150 78 PAAA 81 (244)
T ss_pred cHhH
Confidence 7653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.2e-06 Score=77.02 Aligned_cols=139 Identities=17% Similarity=0.157 Sum_probs=93.9
Q ss_pred eecccCCeEEEEEEEcCCCceEEEEEecCCcCCChh----------------hH-----HHHHHHHHHHHhcc-CCCCcc
Q 014704 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD----------------DV-----EDVRREVQIMHHLT-GHRNIV 131 (420)
Q Consensus 74 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----------------~~-----~~~~~E~~~l~~l~-~hpniv 131 (420)
.|.+|.-+.||+|... ++..+|+|++......-.. .. .=...|...|+++. .+-.++
T Consensus 55 ~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 5667888889999864 4789999998643221110 01 11356888888775 134556
Q ss_pred EEEEEEEeCCeEEEEEecCCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCC
Q 014704 132 ELKGAYEDRHSVNLIMDLCAGGEL-FDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSP 209 (420)
Q Consensus 132 ~~~~~~~~~~~~~iv~e~~~g~~L-~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~ 209 (420)
+.+.+.. -.+||||+..... .-.|.. -.+....+..+..++++.+.-|-. .++||+||+.-|||+. ++.
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----~~~ 204 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----DGE 204 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----CCe
Confidence 6666543 3699999954311 111111 123334678888999999888766 8999999999999994 566
Q ss_pred eeEeecccccccC
Q 014704 210 LKATDFGLSVFFK 222 (420)
Q Consensus 210 ~kl~Dfg~~~~~~ 222 (420)
+.++|||.|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999887654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.48 E-value=6.3e-06 Score=70.96 Aligned_cols=129 Identities=20% Similarity=0.251 Sum_probs=92.0
Q ss_pred cceeecceecccCC-eEEEEEEEcCCCceEEEEEecCCcCCCh------------------hhHHHHHHHHHHHHhccC-
Q 014704 67 NTYIFGRELGRGQF-GVTYLVTHKDTKQQFACKSISSRKLINR------------------DDVEDVRREVQIMHHLTG- 126 (420)
Q Consensus 67 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~~avK~~~~~~~~~~------------------~~~~~~~~E~~~l~~l~~- 126 (420)
..+++.+.||.|.- |.||++... |+.||+|++..-..... .....|..|.+...+|+.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57899999999999 999999874 67999999322111000 123457889998888862
Q ss_pred -CCCc--cEEEEEEEeC------------------CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 014704 127 -HRNI--VELKGAYEDR------------------HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH 185 (420)
Q Consensus 127 -hpni--v~~~~~~~~~------------------~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH 185 (420)
+.++ |+.++|..-. ....||.||.+... .+ ...-+.+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHHHHH
Confidence 4445 8999986321 12357788776543 11 2234578888899999
Q ss_pred HcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 186 ~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
..||+-+|+++.|..= -||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccC--------CEEEecccC
Confidence 9999999999999863 389999864
|
|
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.7e-07 Score=72.75 Aligned_cols=56 Identities=29% Similarity=0.459 Sum_probs=52.0
Q ss_pred HHhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhc
Q 014704 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 363 i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~ 418 (420)
+-..+++.++.+++++|..+|.|+||.|..++|+..+..+|...+++||++||+++
T Consensus 22 vFamf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~~~d~elDaM~~Ea 77 (171)
T KOG0031|consen 22 VFAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKIASDEELDAMMKEA 77 (171)
T ss_pred HHHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHhC
Confidence 33456889999999999999999999999999999999999999999999999986
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.7e-06 Score=76.31 Aligned_cols=78 Identities=27% Similarity=0.320 Sum_probs=57.1
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC-CCccEEEEEE---EeCCeEEEEEe
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKGAY---EDRHSVNLIMD 148 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pniv~~~~~~---~~~~~~~iv~e 148 (420)
+.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+..+ ..+++++.+. ......+++|+
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 578999999999999866 48999986432 3457788999999998733 2356777644 23345789999
Q ss_pred cCCCCChHH
Q 014704 149 LCAGGELFD 157 (420)
Q Consensus 149 ~~~g~~L~~ 157 (420)
+++|..+..
T Consensus 76 ~i~g~~~~~ 84 (239)
T PF01636_consen 76 YIPGRPLDD 84 (239)
T ss_dssp EESSEEHHH
T ss_pred Eeccccccc
Confidence 999987766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.8e-06 Score=70.72 Aligned_cols=132 Identities=23% Similarity=0.265 Sum_probs=92.9
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
-...+.||+|.+|.||++.++. ..+|+|+-... .....+..|+++|..+.+----.+++.+-++ .+.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRG--GEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeeccC--ceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence 3456789999999999999864 58999985432 3346799999999999854444677766443 45599
Q ss_pred cCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCC-CC-cEEEecCCCCCCeeEeecccccccC
Q 014704 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLK-PE-NFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 149 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk-p~-Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|++|-.|.+.-... + .+-+..++++---|-..||-|+.|. |. ||+++ +..+.|+||..|....
T Consensus 93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~----~~~~~iIDFd~At~k~ 157 (201)
T COG2112 93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN----DRDVYIIDFDSATFKK 157 (201)
T ss_pred hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec----CCcEEEEEccchhhcc
Confidence 99998886644321 1 2334455555556778899999997 44 55552 3369999999887543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.9e-06 Score=88.52 Aligned_cols=81 Identities=21% Similarity=0.343 Sum_probs=58.5
Q ss_pred cceecccCCeEEEEEEEcCCC--ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCc--cEEEEEEEeC---CeEE
Q 014704 72 GRELGRGQFGVTYLVTHKDTK--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI--VELKGAYEDR---HSVN 144 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpni--v~~~~~~~~~---~~~~ 144 (420)
.+.++.|.++.+|+......+ ..+++|+....... .....+.+|+++|+.+..|+++ ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 467899999999998765432 46788876432211 1235688999999999645654 7888887664 4678
Q ss_pred EEEecCCCCC
Q 014704 145 LIMDLCAGGE 154 (420)
Q Consensus 145 iv~e~~~g~~ 154 (420)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.6e-05 Score=69.08 Aligned_cols=134 Identities=19% Similarity=0.270 Sum_probs=95.2
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcC-------------CChhhHHHHHHHHHHHHhcc-----CCCCccEEE
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-------------INRDDVEDVRREVQIMHHLT-----GHRNIVELK 134 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~-----~hpniv~~~ 134 (420)
..||+|+.-.||.--+ .....||+...... ..........+|+.....+. .+.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5789999999995432 34468898876540 01122455667776665554 377899999
Q ss_pred EEEEeCCeEEEEEecCCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCC
Q 014704 135 GAYEDRHSVNLIMDLCAG------GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (420)
Q Consensus 135 ~~~~~~~~~~iv~e~~~g------~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~ 208 (420)
|+.+++....+|+|.+.. .+|.+++. .+.+++ .+...+-+-..||-+++|+.+|++|.||++...++..
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998643 46777774 344655 3334444555688999999999999999998766555
Q ss_pred -CeeEee
Q 014704 209 -PLKATD 214 (420)
Q Consensus 209 -~~kl~D 214 (420)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 678887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.7e-06 Score=71.17 Aligned_cols=60 Identities=37% Similarity=0.572 Sum_probs=51.7
Q ss_pred HHHHHhhh-hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 360 LKVIAENL-SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 360 l~~i~~~~-~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
+.+|.... .....++++.+|+.||.|++|+|+.+||+.+++.+|.+++++|+++|++.+|
T Consensus 78 l~~ms~~~~~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d 138 (160)
T COG5126 78 LTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYD 138 (160)
T ss_pred HHHHHHHhccCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcC
Confidence 44454444 3344678999999999999999999999999999999999999999999987
|
|
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.5e-06 Score=68.67 Aligned_cols=50 Identities=26% Similarity=0.454 Sum_probs=46.9
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+++.+|+.+|.|.+|+||..+|+.++++||.+++++|+.+||+++|.
T Consensus 104 t~eEi~~afrl~D~D~~Gkis~~~lkrvakeLgenltD~El~eMIeEAd~ 153 (172)
T KOG0028|consen 104 TKEEIKKAFRLFDDDKTGKISQRNLKRVAKELGENLTDEELMEMIEEADR 153 (172)
T ss_pred cHHHHHHHHHcccccCCCCcCHHHHHHHHHHhCccccHHHHHHHHHHhcc
Confidence 45678999999999999999999999999999999999999999999983
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.3e-05 Score=79.34 Aligned_cols=143 Identities=15% Similarity=0.171 Sum_probs=87.8
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCC-h---------------------------hhHHH------HHHHH
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-R---------------------------DDVED------VRREV 118 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~---------------------------~~~~~------~~~E~ 118 (420)
+.||.-+.|+||+|+.++ |+.||||+-++.--.. . +..+. +.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999987 9999999864321100 0 00111 22233
Q ss_pred HHHHhcc---CCCC------ccEEEEEEEeCCeEEEEEecCCCCChHH--HHHhcCCCCHHHHHHHHHHHHHHH-HHHHH
Q 014704 119 QIMHHLT---GHRN------IVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVV-HYCHS 186 (420)
Q Consensus 119 ~~l~~l~---~hpn------iv~~~~~~~~~~~~~iv~e~~~g~~L~~--~l~~~~~~~~~~~~~i~~qi~~al-~~lH~ 186 (420)
+...+.. .|-+ |++++-.+ ...-.++||||+|..+.| .+.+.+ ++...+ +..+.++. .-+=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i---~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-ISPHDI---LNKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-CCHHHH---HHHHHHHHHHHHHh
Confidence 3222221 1444 44444332 234579999999977654 444433 444433 33333332 22335
Q ss_pred cCCeeccCCCCcEEEecC-CCCCCeeEeecccccccC
Q 014704 187 MGVMHRDLKPENFLFSSS-AEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 187 ~~ivH~Dlkp~Nill~~~-~~~~~~kl~Dfg~~~~~~ 222 (420)
.|++|+|-+|.||++..+ ..+..+.+.|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 789999999999999743 346789999999987654
|
|
| >PF00036 EF-hand_1: EF hand; InterPro: IPR018248 Many calcium-binding proteins belong to the same evolutionary family and share a type of calcium-binding domain known as the EF-hand | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.7e-06 Score=49.63 Aligned_cols=29 Identities=48% Similarity=0.772 Sum_probs=26.4
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
+++++|+.+|+|+||+|+.+|+..++++|
T Consensus 1 E~~~~F~~~D~d~dG~I~~~Ef~~~~~~L 29 (29)
T PF00036_consen 1 ELKEAFREFDKDGDGKIDFEEFKEMMKKL 29 (29)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHT
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHhC
Confidence 46889999999999999999999999864
|
This type of domain consists of a twelve residue loop flanked on both sides by a twelve residue alpha-helical domain. In an EF-hand loop the calcium ion is coordinated in a pentagonal bipyramidal configuration. The six residues involved in the binding are in positions 1, 3, 5, 7, 9 and 12; these residues are denoted by X, Y, Z, -Y, -X and -Z. The invariant Glu or Asp at position 12 provides two oxygens for liganding Ca (bidentate ligand).; PDB: 1BJF_A 1XFW_R 1XFV_O 2K0J_A 2F3Z_A 3BYA_A 1XFU_Q 2R28_B 1ZOT_B 3G43_D .... |
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.5e-06 Score=68.69 Aligned_cols=56 Identities=39% Similarity=0.536 Sum_probs=53.0
Q ss_pred HhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 364 ~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
...++++++.+++++|..+|.|++|.|+..||..+|+.+|..+++.++.+||+.+|
T Consensus 11 ~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d 66 (160)
T COG5126 11 FTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEID 66 (160)
T ss_pred cccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhcc
Confidence 34678999999999999999999999999999999999999999999999999987
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.12 E-value=0.0001 Score=70.95 Aligned_cols=80 Identities=13% Similarity=0.177 Sum_probs=57.2
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCC--C--hhhHHHHHHHHHHHHhccCC--CCccEEEEEEEeCCeEEEE
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--N--RDDVEDVRREVQIMHHLTGH--RNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~--~~~~~~~~~E~~~l~~l~~h--pniv~~~~~~~~~~~~~iv 146 (420)
+.||.|.+..||++.....++.++||.-...... . +-..++...|.+.|+.+..+ .++++++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998754468999985421110 1 12456778888888887533 467888877 55667899
Q ss_pred EecCCCCC
Q 014704 147 MDLCAGGE 154 (420)
Q Consensus 147 ~e~~~g~~ 154 (420)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998744
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.5e-05 Score=70.38 Aligned_cols=73 Identities=16% Similarity=0.150 Sum_probs=46.9
Q ss_pred ceecccCCe-EEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCC--CccEEEEEEEeC---CeEEEE
Q 014704 73 RELGRGQFG-VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR--NIVELKGAYEDR---HSVNLI 146 (420)
Q Consensus 73 ~~lG~G~~g-~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp--niv~~~~~~~~~---~~~~iv 146 (420)
+.|+.|+.. .||+. +..+++|+.... .....+.+|.+++..+..+- -+.++++..... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457766666 48876 235788875431 12357899999999887431 345555544332 235889
Q ss_pred EecCCCCCh
Q 014704 147 MDLCAGGEL 155 (420)
Q Consensus 147 ~e~~~g~~L 155 (420)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999766
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.2e-06 Score=68.39 Aligned_cols=50 Identities=34% Similarity=0.577 Sum_probs=47.1
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+++++|+.+|.|++|+|+.+||+.+|..+|..++.+++++|++++|.
T Consensus 83 ~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~~~~e~~~mi~~~d~ 132 (151)
T KOG0027|consen 83 SSEELKEAFRVFDKDGDGFISASELKKVLTSLGEKLTDEECKEMIREVDV 132 (151)
T ss_pred cHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcCCHHHHHHHHHhcCC
Confidence 35689999999999999999999999999999999999999999999884
|
|
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=98.02 E-value=8.1e-06 Score=60.88 Aligned_cols=51 Identities=18% Similarity=0.262 Sum_probs=46.1
Q ss_pred HHHhhHHHHhhccCC-CCCCcccHHHHHhhhhh-hCCCCCH-HHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDT-DNSGTITFEELKAGLPK-LGTRLSE-SEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~-~~~G~i~~~el~~~l~~-lg~~~~~-~e~~~~~~~~d~ 420 (420)
..+..+..+|..+|. +++|+|+.+||+.+++. +|..++. +++++||+.+|.
T Consensus 5 ~ai~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~ 58 (89)
T cd05022 5 KAIETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDV 58 (89)
T ss_pred HHHHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCC
Confidence 345678999999999 99999999999999998 9988888 999999999884
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.2e-05 Score=66.98 Aligned_cols=75 Identities=19% Similarity=0.294 Sum_probs=50.0
Q ss_pred ceecccCCeEEEEEEEcC-CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCC
Q 014704 73 RELGRGQFGVTYLVTHKD-TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~ 151 (420)
+.|..|-...+|++.... .++.|++|+...... ..-...+|+.+++.+..+.-.++++.... + .+||||++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~ 75 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIP 75 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeC
Confidence 567788889999987553 356789997653211 11234579999999874444566665433 2 37999999
Q ss_pred CCCh
Q 014704 152 GGEL 155 (420)
Q Consensus 152 g~~L 155 (420)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 9765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.9e-05 Score=58.97 Aligned_cols=51 Identities=18% Similarity=0.298 Sum_probs=45.9
Q ss_pred HHHhhHHHHhhccC-CCCCC-cccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMD-TDNSG-TITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..++++|+.+| .|++| .|+.+||+.+|+. +|...++++++++|+.+|.
T Consensus 5 ~~~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~ 62 (88)
T cd05027 5 KAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDS 62 (88)
T ss_pred HHHHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCC
Confidence 34567899999998 79999 5999999999999 8999999999999999874
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=1.3e-05 Score=73.07 Aligned_cols=139 Identities=17% Similarity=0.191 Sum_probs=97.9
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCC-----------------cCCChhhH--HHHHHHHHHHHhccCCC
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSR-----------------KLINRDDV--EDVRREVQIMHHLTGHR 128 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~-----------------~~~~~~~~--~~~~~E~~~l~~l~~hp 128 (420)
-|.+++.||-|.-+.||.+.+.. |++.++|+-..- ...+.-.+ -...+|...|+.|..|-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 46788999999999999998865 778888853210 00011111 23467899999887443
Q ss_pred -CccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCC
Q 014704 129 -NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 129 -niv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~ 207 (420)
-+++.+++ +..++|||++.|..|...-. ...+..+...++.-+.-|-.+|+||+|.+-=||++ .++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd 238 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDD 238 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence 24555554 45689999999988854321 12334556667777778889999999999999999 456
Q ss_pred CCeeEeecccccc
Q 014704 208 SPLKATDFGLSVF 220 (420)
Q Consensus 208 ~~~kl~Dfg~~~~ 220 (420)
..++++||-.+..
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 7799999976544
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=2.1e-05 Score=65.57 Aligned_cols=53 Identities=45% Similarity=0.695 Sum_probs=49.5
Q ss_pred hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+..+..+++++|..||+|++|+|+..||..+++.+|..++++|+..++.++|.
T Consensus 3 ~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~ 55 (151)
T KOG0027|consen 3 SEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDL 55 (151)
T ss_pred CHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 45677889999999999999999999999999999999999999999999884
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=3.5e-06 Score=90.14 Aligned_cols=208 Identities=17% Similarity=0.084 Sum_probs=138.9
Q ss_pred HHHHHHHHHHHhccCCCCccEEEEEEEe--CCeEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH
Q 014704 112 EDVRREVQIMHHLTGHRNIVELKGAYED--RHSVNLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCH 185 (420)
Q Consensus 112 ~~~~~E~~~l~~l~~hpniv~~~~~~~~--~~~~~iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH 185 (420)
+....|..-++... |+++.....-..+ ...-|.+++||.+|.+++.+.+. ..+.+..+....++.+.+..-+|
T Consensus 1274 emll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1274 EMLLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred Hhhhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 33445555555566 8888776654432 34468899999999999988754 33555555555556577777777
Q ss_pred HcC-----CeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CCceecccCCcccccchhhcc-cCCCccchhhhHHH
Q 014704 186 SMG-----VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVI 258 (420)
Q Consensus 186 ~~~-----ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvi 258 (420)
+.. .+|++||+-|.++. .+..+|+.++|+.+...+ .......++++.|+.|++.++ .++.++|+|..|+-
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIV---tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIV---TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred hcccCCccchhhhhhhhcccee---cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 542 78999999999994 456799999999984333 234455678889999998876 47778999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-CCCCC-ChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 259 LYILLSGVPPFWGETEQSIFDAILRGHIDFSSD-PWPNI-SSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 259 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~-~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
+|.+..|..+| ....+.+.++..+-... ..+.+ |.++......+|-..-..||.-...+..+.+-
T Consensus 1430 ly~rs~~n~~f-----i~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1430 LYLRSDGNAYF-----IFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHhcccHHH-----HHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 99999888887 23333344433221110 01111 33444444444545556788877777766653
|
|
| >PF13405 EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J_B 1OE9_B 1W7I_B 1KFU_S 1KFX_S 2BL0_B 1Y1X_B 3MSE_B | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.2e-05 Score=47.22 Aligned_cols=30 Identities=53% Similarity=0.782 Sum_probs=26.5
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhh-hhC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLP-KLG 403 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~-~lg 403 (420)
+++.+|+.+|.|++|+|+.+||..+++ ++|
T Consensus 1 ~l~~~F~~~D~d~dG~I~~~el~~~l~~~lG 31 (31)
T PF13405_consen 1 RLREAFKMFDKDGDGFIDFEELRAILRKSLG 31 (31)
T ss_dssp HHHHHHHHH-TTSSSEEEHHHHHHHHHHHTT
T ss_pred CHHHHHHHHCCCCCCcCcHHHHHHHHHHhcC
Confidence 367899999999999999999999999 676
|
... |
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=97.85 E-value=3.2e-05 Score=59.02 Aligned_cols=51 Identities=25% Similarity=0.414 Sum_probs=46.2
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
++.++...++++|..+|.|++|.|+.+|++.+++.+| ++++++++|+..+|
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~--~~~~ev~~i~~~~d 54 (96)
T smart00027 4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG--LPQTLLAKIWNLAD 54 (96)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC--CCHHHHHHHHHHhc
Confidence 4567888999999999999999999999999999876 68999999999887
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.80 E-value=8.5e-05 Score=64.19 Aligned_cols=100 Identities=17% Similarity=0.221 Sum_probs=78.1
Q ss_pred HHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 014704 115 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD---RIIAKGHYSERAAANLCRQMVTVVHYCHS---MG 188 (420)
Q Consensus 115 ~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~~L~~---~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ 188 (420)
.+|.-+++.+.+.+++++++|+|-. ++|.||...+++.. .+..-...++....+|+.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 4588889999866799999999832 56889998765532 12222346899999999999999999997 45
Q ss_pred CeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 189 ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+.-.|++++|+-++ +++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~---~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVN---DDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEe---CCCcEEEEechhcchh
Confidence 88899999999995 5567999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00026 Score=64.67 Aligned_cols=134 Identities=16% Similarity=0.140 Sum_probs=75.9
Q ss_pred eecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCCC
Q 014704 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGG 153 (420)
Q Consensus 74 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g~ 153 (420)
.+..|-.+.+|+.. .+++.+++|....... ...-...+|..+++.+..+.-.++++... . -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence 35568888999887 3466788997543211 10012578999999987442334555443 2 26899999986
Q ss_pred ChHHH----------H-------HhcC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------cCCeeccC
Q 014704 154 ELFDR----------I-------IAKG----HYSE-RAAANLCRQM---------VTVVHYCHS--------MGVMHRDL 194 (420)
Q Consensus 154 ~L~~~----------l-------~~~~----~~~~-~~~~~i~~qi---------~~al~~lH~--------~~ivH~Dl 194 (420)
.+... + +... +++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 65311 1 1111 1111 1112222111 111222222 24899999
Q ss_pred CCCcEEEecCCCCCCeeEeecccccc
Q 014704 195 KPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 195 kp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
.|.||+++. ++ +.|+||..+..
T Consensus 154 ~~~Nil~~~---~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTP---QG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeC---CC-CEEEeccccCc
Confidence 999999953 33 78999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=97.75 E-value=3.8e-05 Score=54.04 Aligned_cols=46 Identities=37% Similarity=0.603 Sum_probs=38.9
Q ss_pred HHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHH----HHhcCC
Q 014704 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQL----MEAVSL 420 (420)
Q Consensus 375 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~----~~~~d~ 420 (420)
++++|..+|+|++|+|+.+||..++..++...+.++++++ ++.+|.
T Consensus 2 l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~ 51 (66)
T PF13499_consen 2 LKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDT 51 (66)
T ss_dssp HHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCC
Confidence 6789999999999999999999999999977766655555 777763
|
... |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00038 Score=65.02 Aligned_cols=138 Identities=17% Similarity=0.185 Sum_probs=82.3
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCC-CccEEEEE------EEeCCeEE
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGA------YEDRHSVN 144 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-niv~~~~~------~~~~~~~~ 144 (420)
.+.|..|....+|+.... +..+++|+... .....+..|+.++..|..+- .+++++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 356777888899998653 34689998753 12356778888888886221 24555442 23445678
Q ss_pred EEEecCCCCChHH----HH----------Hhc-CCC----------CH--HHH--------HHHHHHHHHHHHHHHH---
Q 014704 145 LIMDLCAGGELFD----RI----------IAK-GHY----------SE--RAA--------ANLCRQMVTVVHYCHS--- 186 (420)
Q Consensus 145 iv~e~~~g~~L~~----~l----------~~~-~~~----------~~--~~~--------~~i~~qi~~al~~lH~--- 186 (420)
+|+++++|..+.. .. +.. ..+ .+ ... ......+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 01 100 000 00 000 0111223334445543
Q ss_pred ----cCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 187 ----MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 187 ----~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
.+++|+|+.|.||+++ ++..+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFD---GDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEe---CCceEEEeehhhhcC
Confidence 4799999999999994 445568999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00053 Score=64.74 Aligned_cols=78 Identities=13% Similarity=0.125 Sum_probs=52.2
Q ss_pred eecccCCeEEEEEEEcCCCceEEEEEecCCcCC----ChhhHHHHHHHHHHHHhccCC-C-CccEEEEEEEeCCeEEEEE
Q 014704 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI----NRDDVEDVRREVQIMHHLTGH-R-NIVELKGAYEDRHSVNLIM 147 (420)
Q Consensus 74 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~E~~~l~~l~~h-p-niv~~~~~~~~~~~~~iv~ 147 (420)
.||.|....||++.....++.++||.-...... -+-..++..-|...|+..... | .+++++.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998644468999975321110 123456667788888776532 3 46666654 666677999
Q ss_pred ecCCCC
Q 014704 148 DLCAGG 153 (420)
Q Consensus 148 e~~~g~ 153 (420)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00036 Score=65.42 Aligned_cols=76 Identities=16% Similarity=0.221 Sum_probs=50.2
Q ss_pred ceecccCCeEEEEEEEcC------CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 73 RELGRGQFGVTYLVTHKD------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
+.|..|-...||++.... .++.+++|+..... .......+|.+++..+..+--.++++.++.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 456677778899887643 25789999865421 1223567898899888743334566665542 358
Q ss_pred EecCCCCChH
Q 014704 147 MDLCAGGELF 156 (420)
Q Consensus 147 ~e~~~g~~L~ 156 (420)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0005 Score=64.12 Aligned_cols=142 Identities=19% Similarity=0.227 Sum_probs=95.3
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCC-------------------ChhhHH----HHHHHHHHHHhccCCC
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-------------------NRDDVE----DVRREVQIMHHLTGHR 128 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------------------~~~~~~----~~~~E~~~l~~l~~hp 128 (420)
-..|..|.-+.||.|... +|..+|||+++.+-+. .....+ =.+.|++.|.++. ..
T Consensus 149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~a 226 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-NA 226 (520)
T ss_pred ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-hc
Confidence 345778888999998865 4788999988532110 001111 1357888898887 55
Q ss_pred CccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeccCCCCcEEEecCCCC
Q 014704 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC-HSMGVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 129 niv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~l-H~~~ivH~Dlkp~Nill~~~~~~ 207 (420)
.|+-.--+.. ..-.|||+|+.+...-.-..+.-.++...+..+-.|++.-+.-| |..++||.||+--|+|+. +
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh----d 300 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH----D 300 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE----C
Confidence 5432222211 22368999995432222222334577788888888888888776 567899999999999993 6
Q ss_pred CCeeEeeccccccc
Q 014704 208 SPLKATDFGLSVFF 221 (420)
Q Consensus 208 ~~~kl~Dfg~~~~~ 221 (420)
+.+.++|.+.+...
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 77999999877654
|
|
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00011 Score=55.79 Aligned_cols=50 Identities=22% Similarity=0.280 Sum_probs=43.5
Q ss_pred HHhhHHHHhhccCC-CC-CCcccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDT-DN-SGTITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~-~~-~G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
....+.++|..+|. |+ +|.|+.+||+.++.. +|..+++++++++|+.+|.
T Consensus 6 ~~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~ 62 (94)
T cd05031 6 AMESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQ 62 (94)
T ss_pred HHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCC
Confidence 35678899999997 97 699999999999986 5778899999999999873
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00063 Score=63.93 Aligned_cols=138 Identities=18% Similarity=0.246 Sum_probs=79.5
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC-CCccEEEEE------EEeCCeEE
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKGA------YEDRHSVN 144 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pniv~~~~~------~~~~~~~~ 144 (420)
.+.++.|....+|++... +..+++|+..... ..+.+..|++++..|..+ -.+++++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEeC--CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 456778877899988643 3368889864321 124566778888877521 124444432 12345678
Q ss_pred EEEecCCCCChH----H----------HHHhc-CCC--------CHHH-----HH----------HHHHHHHHHHHHHHH
Q 014704 145 LIMDLCAGGELF----D----------RIIAK-GHY--------SERA-----AA----------NLCRQMVTVVHYCHS 186 (420)
Q Consensus 145 iv~e~~~g~~L~----~----------~l~~~-~~~--------~~~~-----~~----------~i~~qi~~al~~lH~ 186 (420)
++++|++|..+. . .++.. ..+ .... .. .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999985431 1 01110 001 0000 00 011122334555542
Q ss_pred -------cCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 187 -------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 187 -------~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+++|+|+++.||+++ ++..+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 5799999999999995 34456899999765
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00017 Score=54.52 Aligned_cols=49 Identities=18% Similarity=0.304 Sum_probs=42.0
Q ss_pred HhhHHHHhhccC-CCCCC-cccHHHHHhhhhh-hC----CCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMD-TDNSG-TITFEELKAGLPK-LG----TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~-lg----~~~~~~e~~~~~~~~d~ 420 (420)
+..++++|..|| .|++| .|+.+||+.+|+. +| ..++++++++||+.+|.
T Consensus 8 ~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~ 63 (92)
T cd05025 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDE 63 (92)
T ss_pred HHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCC
Confidence 466899999997 99999 5999999999985 55 35689999999999874
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00015 Score=54.32 Aligned_cols=52 Identities=23% Similarity=0.356 Sum_probs=44.3
Q ss_pred HHHHhhHHHHhhccCC--CCCCcccHHHHHhhhhh-hCCCC----CHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDT--DNSGTITFEELKAGLPK-LGTRL----SESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~--~~~G~i~~~el~~~l~~-lg~~~----~~~e~~~~~~~~d~ 420 (420)
++++..++.+|..+|. |++|.|+.+||..+++. +|..+ +.++++.||..+|.
T Consensus 4 ~~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~ 62 (88)
T cd00213 4 EKAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDV 62 (88)
T ss_pred HHHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhcc
Confidence 4567789999999999 89999999999999986 56444 59999999998863
|
Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th |
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00011 Score=57.87 Aligned_cols=52 Identities=21% Similarity=0.335 Sum_probs=47.0
Q ss_pred hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
.+++..+++++|..||..+||+|+..+...+|+.+|.++|+.|+.+.+.+.+
T Consensus 6 ~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~nPT~aeV~k~l~~~~ 57 (152)
T KOG0030|consen 6 TPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQNPTNAEVLKVLGQPK 57 (152)
T ss_pred CcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcCCCcHHHHHHHHcCcc
Confidence 4566789999999999999999999999999999999999999998876653
|
|
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0002 Score=53.39 Aligned_cols=51 Identities=25% Similarity=0.444 Sum_probs=43.6
Q ss_pred HHHhhHHHHhhccCC-CC-CCcccHHHHHhhhh---hhCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDT-DN-SGTITFEELKAGLP---KLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~-~~-~G~i~~~el~~~l~---~lg~~~~~~e~~~~~~~~d~ 420 (420)
+.+..+-.+|..+|. |+ +|+|+.+||+.+++ .+|..++++|+++||+.+|.
T Consensus 7 ~~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~ 62 (88)
T cd05029 7 QAIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDR 62 (88)
T ss_pred HHHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcC
Confidence 345667888999997 77 89999999999996 37999999999999998874
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0045 Score=58.44 Aligned_cols=75 Identities=15% Similarity=0.189 Sum_probs=45.9
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC-CCccEEEE------EEEeCCeEEE
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKG------AYEDRHSVNL 145 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pniv~~~~------~~~~~~~~~i 145 (420)
+.|+.|....+|...... ..+++|++. . .. .+.+..|+.++..|..+ -.+++++. +....+..++
T Consensus 28 ~~l~~G~~n~~y~v~t~~--g~~vLK~~~-~--~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQ--GEYVLTLFE-R--LT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred chhccccccceEEEEeCC--CcEEEEEec-c--CC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 456778888999987543 368999874 1 11 23455566666666411 12344442 2233566889
Q ss_pred EEecCCCCCh
Q 014704 146 IMDLCAGGEL 155 (420)
Q Consensus 146 v~e~~~g~~L 155 (420)
+++|++|..+
T Consensus 100 l~~~l~G~~~ 109 (319)
T PRK05231 100 IVTFLEGKWP 109 (319)
T ss_pred EEEecCCCCC
Confidence 9999998643
|
|
| >PF13202 EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ_B 1UHI_A 1UHH_B 1EJ3_B 1UHK_A 2ZFD_A 1UHN_A | Back alignment and domain information |
|---|
Probab=97.46 E-value=8.7e-05 Score=40.91 Aligned_cols=25 Identities=44% Similarity=0.786 Sum_probs=22.0
Q ss_pred HHHHhhccCCCCCCcccHHHHHhhh
Q 014704 375 LKEMFKSMDTDNSGTITFEELKAGL 399 (420)
Q Consensus 375 l~~~F~~~D~~~~G~i~~~el~~~l 399 (420)
|+.+|..+|.|+||.|+.+|+...+
T Consensus 1 l~~~F~~~D~d~DG~is~~E~~~~~ 25 (25)
T PF13202_consen 1 LKDAFQQFDTDGDGKISFEEFQRLV 25 (25)
T ss_dssp HHHHHHHHTTTSSSEEEHHHHHHHH
T ss_pred CHHHHHHHcCCCCCcCCHHHHHHHC
Confidence 4678999999999999999998753
|
... |
| >cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00019 Score=50.53 Aligned_cols=42 Identities=29% Similarity=0.445 Sum_probs=38.0
Q ss_pred HHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 376 KEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 376 ~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
+++|..+|.|++|.|+.+|+..++..+|. +.++++++++.+|
T Consensus 2 ~~~F~~~D~~~~G~i~~~el~~~l~~~g~--~~~~~~~i~~~~d 43 (67)
T cd00052 2 DQIFRSLDPDGDGLISGDEARPFLGKSGL--PRSVLAQIWDLAD 43 (67)
T ss_pred hHHHHHhCCCCCCcCcHHHHHHHHHHcCC--CHHHHHHHHHHhc
Confidence 56899999999999999999999998875 8899999998876
|
The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. |
| >KOG0041 consensus Predicted Ca2+-binding protein, EF-Hand protein superfamily [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00022 Score=59.75 Aligned_cols=54 Identities=30% Similarity=0.493 Sum_probs=49.5
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
.++..++..+..+|+.+|.+.||+|++.||+.+|.+||..-|---++.||.++|
T Consensus 92 eFsrkqIk~~~~~Fk~yDe~rDgfIdl~ELK~mmEKLgapQTHL~lK~mikeVd 145 (244)
T KOG0041|consen 92 EFSRKQIKDAESMFKQYDEDRDGFIDLMELKRMMEKLGAPQTHLGLKNMIKEVD 145 (244)
T ss_pred HHHHHHHHHHHHHHHHhcccccccccHHHHHHHHHHhCCchhhHHHHHHHHHhh
Confidence 457778889999999999999999999999999999999888888999999887
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 420 | ||||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-66 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-65 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-65 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-65 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-63 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-62 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-61 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-60 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-59 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-59 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-59 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-59 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-59 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-59 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-58 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-57 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-56 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-56 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-56 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-56 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-55 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-54 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-54 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-54 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-54 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-54 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-53 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-53 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-53 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-52 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-51 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-50 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-50 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-50 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-50 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-50 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-50 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-50 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-50 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-50 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-50 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-50 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-50 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-50 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-50 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-49 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-49 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-49 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-49 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-48 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-48 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-47 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-47 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-47 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-47 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-47 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-47 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-46 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-46 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-46 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-46 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-46 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-46 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-46 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-46 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-46 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-46 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-45 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-45 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-45 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-44 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-43 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-43 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-43 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-41 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-41 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-41 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-40 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-39 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-39 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-39 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-39 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-39 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-39 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-39 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-39 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-39 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-39 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-39 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-39 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-39 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-38 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-38 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-38 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-38 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-38 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-38 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-38 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-38 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-38 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-38 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-38 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-38 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-38 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-38 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-38 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-38 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-38 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-38 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-38 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-38 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-38 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-38 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-38 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-37 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-37 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-37 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-37 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-37 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-37 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-37 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-37 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-37 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-37 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-37 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-37 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-37 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-37 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-37 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-37 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-37 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-37 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-37 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-37 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-37 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-37 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-37 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-37 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-37 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-37 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-37 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-36 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-36 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-36 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-36 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-36 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-36 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-36 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-36 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-36 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-36 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-35 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-35 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-35 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-35 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-35 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-35 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-35 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-34 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-34 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-34 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-33 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-32 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-32 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-32 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-32 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-32 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-32 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-32 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-32 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-32 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-32 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-32 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-32 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-32 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-32 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-32 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-32 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-32 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-32 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-32 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-32 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-32 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-32 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-32 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-32 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-32 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-32 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-32 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-32 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-32 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-32 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-32 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-32 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-32 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-32 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-32 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-32 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-32 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-32 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-32 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-32 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-32 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-32 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-32 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-32 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-32 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-32 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-32 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-32 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-32 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-31 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-31 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-31 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-31 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-31 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-31 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-31 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-31 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-31 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-31 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-31 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-31 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-31 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-31 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-31 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-31 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-31 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-31 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-31 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-31 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-31 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-31 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-31 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-31 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-31 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-31 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-31 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-31 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-30 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-30 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-30 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-30 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-30 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-30 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-30 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-30 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-29 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-29 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-29 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-29 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-29 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-29 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-29 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-29 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-29 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-29 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-29 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-29 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-29 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-29 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-29 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-29 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-29 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-29 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-29 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-29 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-29 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-29 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-29 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-29 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-29 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-29 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-29 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-29 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-29 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-28 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-28 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-28 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-28 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-28 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-28 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-28 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-27 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-27 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-27 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-27 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-27 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-27 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-27 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-27 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-27 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-26 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-26 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-26 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-26 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-26 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-26 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-26 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-26 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-26 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-26 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-26 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-25 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-25 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-25 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-25 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-25 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-25 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-25 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-25 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-25 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-25 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-24 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-24 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-24 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-24 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-24 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-24 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-24 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-24 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-24 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-24 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-24 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-24 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-24 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-24 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-24 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-24 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-24 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-24 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-24 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-24 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-23 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-23 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-23 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-23 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-23 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-23 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-23 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-23 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-22 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-22 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-22 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-22 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-22 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-22 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-21 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-21 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-20 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-20 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-20 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-20 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-20 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-20 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-20 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-20 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-19 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-19 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-19 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-19 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-19 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-19 | ||
| 2aao_A | 166 | Regulatory Apparatus Of Calcium Dependent Protein K | 4e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-19 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-19 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-19 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-19 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-19 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-19 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-19 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-19 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-19 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-19 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-19 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-19 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-19 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-18 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-18 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-18 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-18 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-18 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-18 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-18 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-17 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-17 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-17 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-17 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-17 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-17 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-17 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-17 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-17 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-16 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-15 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-15 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-15 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-15 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-15 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-15 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-15 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-15 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-15 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-15 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-15 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-15 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-15 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-15 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-15 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-15 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-15 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-15 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-15 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-15 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-15 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-15 | ||
| 1s6j_A | 87 | N-Terminal Region Of The Ca2+-Saturated Calcium Reg | 4e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-15 | ||
| 1s6i_A | 188 | Ca2+-Regulatory Region (Cld) From Soybean Calcium-D | 7e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-13 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-13 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-12 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-11 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-11 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-11 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-11 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 7e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-10 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 1e-10 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 1e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-09 | ||
| 3pm8_A | 197 | Cad Domain Of Pff0520w, Calcium Dependent Protein K | 1e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 5e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 6e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 9e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 |
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2AAO|A Chain A, Regulatory Apparatus Of Calcium Dependent Protein Kinase From Arabidopsis Thaliana Length = 166 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1S6J|A Chain A, N-Terminal Region Of The Ca2+-Saturated Calcium Regulatory Domain (Cld) From Soybean Calcium-Dependent Protein Kinase- Alpha (Cdpk) Length = 87 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1S6I|A Chain A, Ca2+-Regulatory Region (Cld) From Soybean Calcium-Dependent Protein Kinase-Alpha (Cdpk) In The Presence Of Ca2+ And The Junction Domain (Jd) Length = 188 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3PM8|A Chain A, Cad Domain Of Pff0520w, Calcium Dependent Protein Kinase Length = 197 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 614 bits (1584), Expect = 0.0
Identities = 143/397 (36%), Positives = 209/397 (52%), Gaps = 22/397 (5%)
Query: 37 PGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFA 96
PG AT G + + Y R LG+G FG L K T Q+ A
Sbjct: 2 PGSMMDHLHATP------GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECA 55
Query: 97 CKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELF 156
K IS R++ + D E + REVQ++ L H NI++L +ED+ L+ ++ GGELF
Sbjct: 56 VKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114
Query: 157 DRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216
D II++ +SE AA + RQ+++ + Y H ++HRDLKPEN L S ++D+ ++ DFG
Sbjct: 115 DEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 174
Query: 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQS 276
LS F+ KD +G+AYY+APEVL Y + D+WS GVILYILLSG PPF G E
Sbjct: 175 LSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYD 234
Query: 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV---DGDA 333
I + +G F W +S SAKD+++KML P R+SA + L+H W++ + +
Sbjct: 235 ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS 294
Query: 334 SDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENL-SEEEIMGLKEMFKSMDTDNSGTITF 392
D P + ++QF+ KL + AL + L S++E L +F MD + G +
Sbjct: 295 VDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDR 354
Query: 393 EELKAGLPK-----------LGTRLSESEVRQLMEAV 418
EL G + L E EV Q+++AV
Sbjct: 355 AELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAV 391
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 610 bits (1575), Expect = 0.0
Identities = 124/405 (30%), Positives = 201/405 (49%), Gaps = 23/405 (5%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
+ + + G + K + +Y R+LG G +G L K+ +
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 96 ACKSISSRKLIN----------RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145
A K I + E++ E+ ++ L H NI++L +ED+ L
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYFYL 123
Query: 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205
+ + GGELF++II + + E AAN+ +Q+++ + Y H ++HRD+KPEN L +
Sbjct: 124 VTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN 183
Query: 206 EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSG 265
+K DFGLS FF +D +G+AYY+APEVL++ Y + D+WS GVI+YILL G
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCG 243
Query: 266 VPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHP 325
PPF G+ +Q I + +G F + W NIS AK+++K ML D +R +A E LN
Sbjct: 244 YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303
Query: 326 WMR---VDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSE-EEIMGLKEMFKS 381
W++ + + SD+ L+ M++F KL + A+ I L+ EE L ++FK
Sbjct: 304 WIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKK 363
Query: 382 MDTDNSGTITFEELKAGLPKLGT--------RLSESEVRQLMEAV 418
+D + G + +EL G L + E EV +++ V
Sbjct: 364 LDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEV 408
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 607 bits (1566), Expect = 0.0
Identities = 136/375 (36%), Positives = 199/375 (53%), Gaps = 21/375 (5%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
Y LG+G FG + T+Q++A K I+ N+D + REV+++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLK 76
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
L H NI++L ED S ++ +L GGELFD II + +SE AA + +Q+ + +
Sbjct: 77 KL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
Y H ++HRDLKPEN L S +D +K DFGLS F+ KD +G+AYY+APEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 243 RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302
R Y + D+WSAGVILYILLSG PPF+G+ E I + G F W IS AKD
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 303 IVKKMLHADPKERLSAAEVLNHPWMR----VDGDASDKPLDIAVLTRMKQFRAMNKLKKV 358
+++KML P R++A + L HPW++ SD P + +T ++QF+A KL +
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQA 315
Query: 359 ALKVIAENLSE-EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL--------------G 403
AL +A L+ +E L E+F+ +DT+N G + +EL G +
Sbjct: 316 ALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNE 375
Query: 404 TRLSESEVRQLMEAV 418
E ++ LM +
Sbjct: 376 GSTIEDQIDSLMPLL 390
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 12/44 (27%), Positives = 22/44 (50%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
++ FK D D SG I+ +EL + + + E+ ++E V
Sbjct: 419 MERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQV 462
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 605 bits (1562), Expect = 0.0
Identities = 133/395 (33%), Positives = 207/395 (52%), Gaps = 15/395 (3%)
Query: 37 PGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFA 96
R + ++ G + + Y ++LG G +G L K T + A
Sbjct: 7 HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERA 66
Query: 97 CKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELF 156
K I + + + EV ++ L H NI++L +ED+ + L+M+ GGELF
Sbjct: 67 IKIIRKTSVSTSSN-SKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 157 DRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216
D II + ++E AA + +Q+++ V Y H ++HRDLKPEN L S +D+ +K DFG
Sbjct: 125 DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQS 276
LS F+ K+ +G+AYY+APEVLR+ Y + D+WS GVIL+ILL+G PPF G+T+Q
Sbjct: 185 LSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244
Query: 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDAS-- 334
I + +G F S W N+S AKD++K+ML D + R+SA + L HPW++
Sbjct: 245 ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKES 304
Query: 335 --DKPLDIAVLTRMKQFRAMNKLKKVALKVIAENL-SEEEIMGLKEMFKSMDTDNSGTIT 391
+ P + M++F+ KL + AL +A L S+EE L ++F+ +D + G +
Sbjct: 305 GIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLD 364
Query: 392 FEELKAGLPKLGT--------RLSESEVRQLMEAV 418
+EL G KL ESEV ++ A
Sbjct: 365 RQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAA 399
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 571 bits (1473), Expect = 0.0
Identities = 119/362 (32%), Positives = 185/362 (51%), Gaps = 8/362 (2%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
Y ELG+G F V Q++A I+++KL + D + + RE +I
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARI 63
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
L H NIV L + + LI DL GGELF+ I+A+ +YSE A++ +Q++
Sbjct: 64 CRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAP 239
V +CH MGV+HR+LKPEN L +S + + +K DFGL++ + + G+ Y++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 240 EVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
EVLR++ YG D+W+ GVILYILL G PPFW E + ++ I G DF S W ++
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKV 358
AKD++ KML +P +R++AAE L HPW+ + + +K+F A KLK
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA 302
Query: 359 ALKVIAEN--LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416
L V+ S + +K + ++ ++G E T + L+E
Sbjct: 303 ILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDF--ESYTKMCDPGMTAFEPEALGNLVE 360
Query: 417 AV 418
+
Sbjct: 361 GL 362
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 567 bits (1463), Expect = 0.0
Identities = 113/359 (31%), Positives = 179/359 (49%), Gaps = 6/359 (1%)
Query: 40 PRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKS 99
P +S + + Y ELG+G F V HK T +FA K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 100 ISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI 159
I+++KL RD + + RE +I L H NIV L + ++ L+ DL GGELF+ I
Sbjct: 62 INTKKLSARD-FQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 119
Query: 160 IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219
+A+ YSE A++ +Q++ + YCHS G++HR+LKPEN L +S A+ + +K DFGL++
Sbjct: 120 VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 220 FFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIF 278
+ + G+ Y++PEVL+++ Y DIW+ GVILYILL G PPFW E + ++
Sbjct: 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 239
Query: 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338
I G D+ S W ++ AK ++ ML +PK+R++A + L PW+ +
Sbjct: 240 AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIH 299
Query: 339 DIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKA 397
+ +K+F A KLK L + + L + + E ++
Sbjct: 300 RQDTVDCLKKFNARRKLKGAILTTMIAT---RNLSNLGRNLLNKKEQGPPSTIKESSES 355
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 560 bits (1445), Expect = 0.0
Identities = 111/352 (31%), Positives = 181/352 (51%), Gaps = 12/352 (3%)
Query: 46 ATSATSSSVGRVLGKPMEDV--RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSR 103
+ S G +L +DV + Y +G+G F V +++T QQFA K +
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 104 KLINRD--DVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA 161
K + ED++RE I H L H +IVEL Y + ++ + G +L I+
Sbjct: 61 KFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK 119
Query: 162 KGH----YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217
+ YSE A++ RQ++ + YCH ++HRD+KP L +S +P+K FG+
Sbjct: 120 RADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179
Query: 218 SV-FFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQ 275
++ + G V VG+ +++APEV++R YG D+W GVIL+ILLSG PF+G T++
Sbjct: 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKE 238
Query: 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASD 335
+F+ I++G + W +IS SAKD+V++ML DP ER++ E LNHPW++ +
Sbjct: 239 RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAY 298
Query: 336 KPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNS 387
K + ++++F A KLK L ++ + E D +
Sbjct: 299 KIHLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEELPDFSEDPT 350
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 535 bits (1380), Expect = 0.0
Identities = 122/340 (35%), Positives = 189/340 (55%), Gaps = 10/340 (2%)
Query: 29 PNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTH 88
L S++ +A+ + G + + + + ELGRG + Y
Sbjct: 15 TENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQ 74
Query: 89 KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148
K T++ +A K + D + VR E+ ++ L+ H NI++LK +E ++L+++
Sbjct: 75 KGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLE 128
Query: 149 LCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208
L GGELFDRI+ KG+YSER AA+ +Q++ V Y H G++HRDLKPEN L+++ A D+
Sbjct: 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA 188
Query: 209 PLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVP 267
PLK DFGLS + + K + G+ Y APE+LR YG E D+WS G+I YILL G
Sbjct: 189 PLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE 248
Query: 268 PFWGET-EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
PF+ E +Q +F IL F S W +S +AKD+V+K++ DPK+RL+ + L HPW
Sbjct: 249 PFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308
Query: 327 MRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAEN 366
+ G A++ ++++F A KLK V+A +
Sbjct: 309 VT--GKAANFVHMDTAQKKLQEFNARRKLKAAVKAVVASS 346
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 533 bits (1375), Expect = 0.0
Identities = 115/329 (34%), Positives = 175/329 (53%), Gaps = 16/329 (4%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQ 119
E+V + Y G ELG GQF V K T Q+A K I R+ + ED+ REV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
I+ + H N++ L YE++ V LI++L AGGELFD + K +E A +Q++
Sbjct: 67 ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 180 VVHYCHSMGVMHRDLKPENFLFSS-SAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVA 238
V+Y HS+ + H DLKPEN + + +K DFGL+ G+ FK++ G+ +VA
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 239 PEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
PE++ G EAD+WS GVI YILLSG PF G+T+Q + + +F + + N S
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
+ AKD ++++L DPK+R++ + L HPW++ L+R M K KK
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ-------QALSRKASAVNMEKFKK 298
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDN 386
A + + N S GL ++F++ +
Sbjct: 299 FAARKKSNNGSGG---GLNDIFEAQKIEW 324
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 531 bits (1369), Expect = 0.0
Identities = 106/406 (26%), Positives = 178/406 (43%), Gaps = 23/406 (5%)
Query: 7 LPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVR 66
L +SQ Q P P PP P P + K +
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ + + LG G G + +K T+++FA K + D RREV++ +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQ 113
Query: 127 HRNIVELKGAYED----RHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTV 180
+IV + YE+ R + ++M+ GGELF RI +G ++ER A+ + + +
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 240
+ Y HS+ + HRD+KPEN L++S ++ LK TDFG + + + YYVAPE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 241 VL-RRNYGAEADIWSAGVILYILLSGVPPFWGE----TEQSIFDAILRGHIDFSSDPWPN 295
VL Y D+WS GVI+YILL G PPF+ + I G +F + W
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKL 355
+S K +++ +L +P +R++ E +NHPW+ PL + + + + R +
Sbjct: 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVK 353
Query: 356 KKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPK 401
+++ + + E+I ++ K D N + + L
Sbjct: 354 EEMTSALATMRVDYEQI----KIKKIEDASNPLLLKRRKKARALEA 395
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 514 bits (1326), Expect = 0.0
Identities = 85/317 (26%), Positives = 159/317 (50%), Gaps = 6/317 (1%)
Query: 48 SATSSSVGRVLGKPMEDVRNTY-IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI 106
S + + ME+ N Y + +ELGRG+F V K T Q++A K + R+
Sbjct: 9 SGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR- 67
Query: 107 NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK--GH 164
+D ++ E+ ++ ++ L YE+ + LI++ AGGE+F + +
Sbjct: 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM 127
Query: 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
SE L +Q++ V+Y H ++H DLKP+N L SS +K DFG+S
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 225 DVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR 283
++++G+ Y+APE+L + D+W+ G+I Y+LL+ PF GE Q + I +
Sbjct: 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
Query: 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR-VDGDASDKPLDIAV 342
++D+S + + ++S A D ++ +L +P++R +A L+H W++ D + P + +
Sbjct: 248 VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSS 307
Query: 343 LTRMKQFRAMNKLKKVA 359
++ + + K +
Sbjct: 308 SSQTQDHSVRSSEDKTS 324
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 511 bits (1317), Expect = 0.0
Identities = 106/343 (30%), Positives = 169/343 (49%), Gaps = 20/343 (5%)
Query: 51 SSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD 110
S+ + L + + Y ++G G + V HK T +FA K I K
Sbjct: 6 VHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------ 59
Query: 111 VEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAA 170
D E++I+ H NI+ LK Y+D V ++ +L GGEL D+I+ + +SER A
Sbjct: 60 -RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA 118
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED-SPLKATDFGLSVFFKPGD-VFK 228
+ + + V Y H+ GV+HRDLKP N L+ + + ++ DFG + + + +
Sbjct: 119 SAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 229 DLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWG---ETEQSIFDAILRG 284
+A +VAPEVL R Y A DIWS GV+LY +L+G PF +T + I I G
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238
Query: 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLT 344
S W ++S +AKD+V KMLH DP +RL+AA VL HPW+ L+
Sbjct: 239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAP 298
Query: 345 RMKQ------FRAMNKLKKVALKVIAENLSEEEIMGLKEMFKS 381
+ + + A+N+ + L+ + + + G+K++ +
Sbjct: 299 HLVKGAMAATYSALNRNQSPVLEPVGRSTLAQR-RGIKKITST 340
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 511 bits (1317), Expect = 0.0
Identities = 110/346 (31%), Positives = 170/346 (49%), Gaps = 10/346 (2%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD---DVEDVRREVQ 119
+ V + Y G ELG GQF + K T ++A K I R+ E++ REV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
I+ + H NI+ L YE+R V LI++L +GGELFD + K SE A + +Q++
Sbjct: 68 ILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSP-LKATDFGLSVFFKPGDVFKDLVGSAYYVA 238
V+Y H+ + H DLKPEN + P +K DFGL+ + G FK++ G+ +VA
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 239 PEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
PE++ G EAD+WS GVI YILLSG PF G+T+Q I DF + + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG--DASDKPLDIAVLTRMKQFRAMNKL 355
AKD ++K+L + ++RL+ E L HPW+ A + + L K+ +
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRW 306
Query: 356 KK-VALKVIAENLSEEEIMGLK-EMFKSMDTDNSGTITFEELKAGL 399
K ++ + +L+ + + + + S T + L
Sbjct: 307 KLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKAL 352
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 508 bits (1311), Expect = 0.0
Identities = 86/318 (27%), Positives = 158/318 (49%), Gaps = 12/318 (3%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+++ Y+ +LGRG+FG+ + +K+ + K + + D V++E+ I++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVV 181
HRNI+ L ++E + +I + +G ++F+RI +ER + Q+ +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
+ HS + H D++PEN ++ + S +K +FG + KPGD F+ L + Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ + D+WS G ++Y+LLSG+ PF ET Q I + I+ F + + IS A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVAL 360
D V ++L + K R++A+E L HPW++ + + V+ +K R + L K L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLK----QKIERVSTKVIRTLKHRRYYHTLIKKDL 290
Query: 361 KVIAENLSEEEIMGLKEM 378
++ ++
Sbjct: 291 NMVVSAARISCGGAIRSQ 308
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 507 bits (1307), Expect = 0.0
Identities = 108/280 (38%), Positives = 163/280 (58%), Gaps = 4/280 (1%)
Query: 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
G D+ Y +GRG +G + K T+ + A K I + +DV+ ++E+
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEI 57
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV 178
+IM L H NI+ L +ED + L+M+LC GGELF+R++ K + E AA + + ++
Sbjct: 58 EIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVA 238
+ V YCH + V HRDLKPENFLF + + DSPLK DFGL+ FKPG + + VG+ YYV+
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 239 PEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
P+VL YG E D WSAGV++Y+LL G PPF T+ + I G F W N+S
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236
Query: 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338
A+ +++++L PK+R+++ + L H W +S + L
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 504 bits (1299), Expect = e-180
Identities = 107/324 (33%), Positives = 159/324 (49%), Gaps = 25/324 (7%)
Query: 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ 119
P + + + LG G F + HK + Q FA K IS R + ++E+
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEIT 57
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
+ GH NIV+L + D+ L+M+L GGELF+RI K H+SE A+ + R++V+
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GDVFKDLVGSAYYVA 238
V + H +GV+HRDLKPEN LF+ ++ +K DFG + P K + +Y A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 239 PEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQS-------IFDAILRGHIDFSS 290
PE+L +N Y D+WS GVILY +LSG PF I I +G F
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL---------DIA 341
+ W N+S AKD+++ +L DP +RL + + + W++ S PL A
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297
Query: 342 VLTRMK-QFRAMNKLKKVALKVIA 364
V T +K F A NK K+ +
Sbjct: 298 VHTCVKATFHAFNKYKREGFCLQN 321
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 494 bits (1274), Expect = e-177
Identities = 109/266 (40%), Positives = 153/266 (57%), Gaps = 2/266 (0%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
Y LG+G FG + T+Q++A K I+ N+D + REV+++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLK 76
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
L H NI++L ED S ++ +L GGELFD II + +SE AA + +Q+ + +
Sbjct: 77 KLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
Y H ++HRDLKPEN L S +D +K DFGLS F+ KD +G+AYY+APEVL
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 243 RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302
R Y + D+WSAGVILYILLSG PPF+G+ E I + G F W IS AKD
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 303 IVKKMLHADPKERLSAAEVLNHPWMR 328
+++KML P R++A + L HPW++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 495 bits (1276), Expect = e-177
Identities = 104/309 (33%), Positives = 162/309 (52%), Gaps = 9/309 (2%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQ 119
+ V + Y G ELG GQF + K T ++A K I R+ E++ REV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
I+ + H N++ L YE+R V LI++L +GGELFD + K SE A + +Q++
Sbjct: 68 ILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSP-LKATDFGLSVFFKPGDVFKDLVGSAYYVA 238
V+Y H+ + H DLKPEN + P +K DFGL+ + G FK++ G+ +VA
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 239 PEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
PE++ G EAD+WS GVI YILLSG PF G+T+Q I DF + + + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMR--VDGDASDKPLDIAVLTRMKQFRAMNKL 355
AKD ++K+L + ++RL+ E L HPW+ + A + + L ++ +
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRW 306
Query: 356 KKVALKVIA 364
K + +++
Sbjct: 307 KL-SFSIVS 314
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 490 bits (1265), Expect = e-175
Identities = 102/275 (37%), Positives = 157/275 (57%), Gaps = 3/275 (1%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ Y ELG+G F V HK T +FA K I+++KL RD + + RE +I
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICR 60
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
L H NIV L + ++ L+ DL GGELF+ I+A+ YSE A++ +Q++ +
Sbjct: 61 KLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
YCHS G++HR+LKPEN L +S A+ + +K DFGL++ + + G+ Y++PEVL
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 243 RRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
+++ Y DIW+ GVILYILL G PPFW E + ++ I G D+ S W ++ AK
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDK 336
++ ML +PK+R++A + L PW+ +
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 493 bits (1272), Expect = e-175
Identities = 97/331 (29%), Positives = 157/331 (47%), Gaps = 15/331 (4%)
Query: 9 SSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNT 68
+ + S DP K++ P + + ++
Sbjct: 36 QRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK 95
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-----RDDVEDVRREVQIMHH 123
Y +GRG V H+ T +FA K + + E RRE I+
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
+ GH +I+ L +YE + L+ DL GELFD + K SE+ ++ R ++ V +
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR 243
H+ ++HRDLKPEN L ++ ++ +DFG S +PG+ ++L G+ Y+APE+L+
Sbjct: 216 LHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272
Query: 244 -------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296
YG E D+W+ GVIL+ LL+G PPFW + + I+ G FSS W +
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332
Query: 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
SS+ KD++ ++L DP+ RL+A + L HP+
Sbjct: 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 485 bits (1251), Expect = e-173
Identities = 103/283 (36%), Positives = 157/283 (55%), Gaps = 6/283 (2%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD---DVEDVRREVQI 120
V + Y G ELG GQF + K T +++A K I R+L + E++ REV I
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
+ + H NI+ L +E++ V LI++L +GGELFD + K +E A +Q++
Sbjct: 62 LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 181 VHYCHSMGVMHRDLKPENFLFSS-SAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
VHY HS + H DLKPEN + + + +K DFG++ + G+ FK++ G+ +VAP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 240 EVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
E++ G EAD+WS GVI YILLSG PF GET+Q I + DF + + N S
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIA 341
AKD ++++L DPK R++ A+ L H W++ + + D
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG 283
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 487 bits (1256), Expect = e-173
Identities = 100/369 (27%), Positives = 167/369 (45%), Gaps = 28/369 (7%)
Query: 27 HHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLV 86
K D P V + + V + Y ELG G FGV +
Sbjct: 11 GSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRC 70
Query: 87 THKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146
K T + F K I++ + D V+ E+ IM+ L H ++ L A+ED++ + LI
Sbjct: 71 VEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLI 126
Query: 147 MDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205
++ +GGELFDRI A+ + SE N RQ + + H ++H D+KPEN + +
Sbjct: 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK- 185
Query: 206 EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS 264
+ S +K DFGL+ P ++ K +A + APE++ R G D+W+ GV+ Y+LLS
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
Query: 265 GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
G+ PF GE + + R +F D + ++S AKD +K +L +P++RL+ + L H
Sbjct: 246 GLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305
Query: 325 PWMRVDGDASDKPLD---------------------IAVLTRMKQFRAMNKLKKVALKVI 363
PW++ D + + R+ F ++ K + ++
Sbjct: 306 PWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIY 365
Query: 364 AENLSEEEI 372
+E
Sbjct: 366 DSYFDRKEA 374
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 484 bits (1247), Expect = e-172
Identities = 106/319 (33%), Positives = 154/319 (48%), Gaps = 18/319 (5%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-----NRDDVEDVRRE 117
+ +R+ YI + LG G G L + T ++ A K IS RK D +V E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
++I+ L H I+++K ++ ++++L GGELFD+++ E QM
Sbjct: 66 IEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
+ V Y H G++HRDLKPEN L SS ED +K TDFG S + + L G+ Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 238 APEVL----RRNYGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFDAILRGHIDFSSDP 292
APEVL Y D WS GVIL+I LSG PPF T+ S+ D I G +F +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAM 352
W +S A D+VKK+L DPK R + E L HPW++ D+ + + +
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ------DEDMKRKFQDLLSEENES 297
Query: 353 NKLKKVALKVIAENLSEEE 371
L +V + E
Sbjct: 298 TALPQVLAQPSTSRKRPRE 316
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 481 bits (1240), Expect = e-172
Identities = 98/280 (35%), Positives = 163/280 (58%), Gaps = 8/280 (2%)
Query: 53 SVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVE 112
S GR + + +IF R+LG G FG +LV + + + K+I+ + + +E
Sbjct: 8 SSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPME 65
Query: 113 DVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK----GHYSER 168
+ E++++ L H NI+++ +ED H++ ++M+ C GGEL +RI++ SE
Sbjct: 66 QIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 169 AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK 228
A L +QM+ + Y HS V+H+DLKPEN LF ++ SP+K DFGL+ FK +
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 229 DLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288
+ G+A Y+APEV +R+ + DIWSAGV++Y LL+G PF G + + + ++
Sbjct: 185 NAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY 244
Query: 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
+ + P ++ A D++K+ML DP+ R SAA+VL+H W +
Sbjct: 245 AVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 480 bits (1239), Expect = e-171
Identities = 95/292 (32%), Positives = 144/292 (49%), Gaps = 16/292 (5%)
Query: 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN------RDDVE 112
Y LGRG V HK T +++A K I + ++ E
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 113 DVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAAN 172
+EV I+ ++GH NI++LK YE L+ DL GELFD + K SE+
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232
+ R ++ V+ H + ++HRDLKPEN L +D +K TDFG S PG+ +++ G
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCG 185
Query: 233 SAYYVAPEVLR-------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285
+ Y+APE++ YG E D+WS GVI+Y LL+G PPFW + + I+ G+
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245
Query: 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKP 337
F S W + S + KD+V + L P++R +A E L HP+ + +
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 490 bits (1264), Expect = e-171
Identities = 110/413 (26%), Positives = 170/413 (41%), Gaps = 18/413 (4%)
Query: 8 PSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVG-----RVLGKPM 62
P T D + + SS + + +
Sbjct: 93 PCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ V + Y ELG G FGV + VT + T FA K + + D E VR+E+Q M
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMS 209
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVV 181
L H +V L A+ED + + +I + +GGELF+++ + SE A RQ+ +
Sbjct: 210 VLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 268
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
+ H +H DLKPEN +F++ + LK DFGL+ P K G+A + APEV
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ G D+WS GV+ YILLSG+ PF GE + + + + IS
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRV-DGDASDKPLDIAVLTRMKQFRAMNKLKKVA 359
KD ++K+L ADP R++ + L HPW+ + D + + R + R K K
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS---RYTKIRDSIKTKY-- 442
Query: 360 LKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVR 412
I + K + S F + P+ + +EV
Sbjct: 443 DAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVG 495
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 475 bits (1224), Expect = e-169
Identities = 101/313 (32%), Positives = 151/313 (48%), Gaps = 36/313 (11%)
Query: 64 DVRNTYIFGRE-LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ Y + LG G + T Q++A K I + V REV++++
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLY 65
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
GHRN++EL +E+ L+ + GG + I + H++E A+ + + + + +
Sbjct: 66 QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL--------VGSA 234
+ H+ G+ HRDLKPEN L + SP+K DF L K + GSA
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 235 YYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGE---------------T 273
Y+APEV+ Y D+WS GVILYILLSG PPF G
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
Query: 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDA 333
+ +F++I G +F W +IS +AKD++ K+L D K+RLSAA+VL HPW++ G A
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ--GCA 303
Query: 334 SDKPLDIA-VLTR 345
+ L VL R
Sbjct: 304 PENTLPTPMVLQR 316
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-169
Identities = 106/339 (31%), Positives = 162/339 (47%), Gaps = 25/339 (7%)
Query: 48 SATSSSVGRVLGKPMEDVRNTYIFGRE-LGRGQFGVTYLVTHKDTKQQFACKSISSRKLI 106
S+ + + V + Y ++ LG G G H+ T Q+ A K +
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL------ 62
Query: 107 NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH----SVNLIMDLCAGGELFDRIIAK 162
D R+EV +G +IV + YE+ H + +IM+ GGELF RI +
Sbjct: 63 --YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120
Query: 163 GH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220
G ++ER AA + R + T + + HS + HRD+KPEN L++S +D+ LK TDFG +
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 221 FKPGDVFKDLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQ---- 275
+ + YYVAPEVL Y D+WS GVI+YILL G PPF+ T Q
Sbjct: 181 TTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239
Query: 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASD 335
+ I G F + W +S AK +++ +L DP ERL+ + +NHPW+
Sbjct: 240 GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299
Query: 336 KPLDIA-VLTRMKQFRAMNKLKKVALKVIAEN-LSEEEI 372
PL A VL K +++K+ +A + +++
Sbjct: 300 TPLHTARVLQEDKDH--WDEVKEEMTSALATMRVDYDQV 336
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 466 bits (1202), Expect = e-165
Identities = 103/356 (28%), Positives = 173/356 (48%), Gaps = 25/356 (7%)
Query: 8 PSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRN 67
+ + ++ + + L +D P PP P R++ V +
Sbjct: 38 EAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDH----------RIVTAKQGAVNS 87
Query: 68 TYIFGR--ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
Y + LG G+FG + T + A K I +R + D E+V+ E+ +M+ L
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQL- 143
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYC 184
H N+++L A+E ++ + L+M+ GGELFDRII + + +E +Q+ + +
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
H M ++H DLKPEN L + + +K DFGL+ +KP + K G+ ++APEV+
Sbjct: 204 HQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY 262
Query: 245 N-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303
+ D+WS GVI Y+LLSG+ PF G+ + + IL D + + +IS AK+
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEF 322
Query: 304 VKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVA 359
+ K+L + R+SA+E L HPW+ SD L + + K+ R + V
Sbjct: 323 ISKLLIKEKSWRISASEALKHPWL------SDHKLHSRLSAQKKKNRGSDAQDFVT 372
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 460 bits (1187), Expect = e-163
Identities = 86/315 (27%), Positives = 145/315 (46%), Gaps = 39/315 (12%)
Query: 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ 119
K + + + + LG G G + +K T+++FA K + D RREV+
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 62
Query: 120 IMHHLTGHRNIVELKGAYED----RHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANL 173
+ + +IV + YE+ R + ++M+ GGELF RI +G ++ER A+ +
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
+ + + Y HS+ + HRD+KPEN L++S ++ LK TDFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 234 AYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGE----TEQSIFDAILRGHIDFS 289
A E Y D+WS GVI+YILL G PPF+ + I G +F
Sbjct: 167 ----AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222
Query: 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQF 349
+ W +S K +++ +L +P +R++ E +NHPW+ PL + + + +
Sbjct: 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 282
Query: 350 RAMNKLKKVALKVIA 364
R +K+ +A
Sbjct: 283 R-WEDVKEEMTSALA 296
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 442 bits (1140), Expect = e-155
Identities = 105/288 (36%), Positives = 149/288 (51%), Gaps = 13/288 (4%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-----DDVEDVRRE 117
+ +R+ YI + LG G G L + T ++ A + IS RK D +V E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
++I+ L H I+++K ++ ++++L GGELFD+++ E QM
Sbjct: 191 IEILKKLN-HPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
+ V Y H G++HRDLKPEN L SS ED +K TDFG S + + L G+ Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 238 APEVL----RRNYGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFDAILRGHIDFSSDP 292
APEVL Y D WS GVIL+I LSG PPF T+ S+ D I G +F +
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDI 340
W +S A D+VKK+L DPK R + E L HPW++ D D K D+
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ-DEDMKRKFQDL 415
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 438 bits (1129), Expect = e-154
Identities = 98/339 (28%), Positives = 155/339 (45%), Gaps = 52/339 (15%)
Query: 48 SATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-- 105
++ G + +++ Y +G+G +GV + T+ A K ++ K+
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 106 INRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH- 164
IN DVE ++ EV++M L H NI L YED + L+M+LC GG L D++
Sbjct: 67 INPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 165 ---------------------------------------YSERAAANLCRQMVTVVHYCH 185
E+ +N+ RQ+ + +HY H
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-----VFKDLVGSAYYVAPE 240
+ G+ HRD+KPENFLFS++ + +K DFGLS F + G+ Y+VAPE
Sbjct: 186 NQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
Query: 241 VLR---RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
VL +YG + D WSAGV+L++LL G PF G + +L + F + + +S
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLS 304
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDK 336
A+D++ +L+ + ER A L HPW+ D K
Sbjct: 305 PLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-107
Identities = 79/366 (21%), Positives = 145/366 (39%), Gaps = 38/366 (10%)
Query: 41 RPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSI 100
PS + ++GK ++ LG G G + A K I
Sbjct: 4 SPSLEQDDGDEETSVVIVGK------ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRI 56
Query: 101 SSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRII 160
+ REVQ++ H N++ +DR + ++LC L + +
Sbjct: 57 ------LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE 109
Query: 161 AKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA--TDFGL 217
K + L +Q + + + HS+ ++HRDLKP N L S +KA +DFGL
Sbjct: 110 QKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169
Query: 218 SVFFKPGD----VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLS-GVPP 268
G + G+ ++APE+L N DI+SAG + Y ++S G P
Sbjct: 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
Query: 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
F ++ + +D P + A+++++KM+ DP++R SA VL HP+
Sbjct: 230 FGKSLQRQANILLGACSLDCLH-PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
Query: 329 VDGDASDKPLDIAVLTRMKQFR----AMNKLKKVALKVIAEN----LSEEEIMGLKEMFK 380
V R+++ + +L++ V+ + ++ L++ F+
Sbjct: 289 --SLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRK-FR 345
Query: 381 SMDTDN 386
+ +
Sbjct: 346 TYKGGS 351
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 322 bits (826), Expect = e-107
Identities = 75/349 (21%), Positives = 136/349 (38%), Gaps = 48/349 (13%)
Query: 56 RVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR 115
+ + ++N + + LG G G + A K + D +
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRM------LIDFCDIAL 56
Query: 116 REVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA------ 169
E++++ H N++ + + + ++LC L D + +K E
Sbjct: 57 MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEY 115
Query: 170 -AANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS----------AEDSPLKATDFGLS 218
+L RQ+ + V + HS+ ++HRDLKP+N L S+S AE+ + +DFGL
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 219 VFFKPGDV-----FKDLVGSAYYVAPEVLR--------RNYGAEADIWSAGVILYILLS- 264
G + G++ + APE+L R DI+S G + Y +LS
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 265 GVPPFWGETEQSIFDAILRGHIDFS---SDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
G PF + + I+RG ++ + A D++ +M+ DP +R +A +V
Sbjct: 236 GKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
Query: 322 LNHPWMRVDGDASDKPLDIA----VLTRMKQFRAMNKLKKVALKVIAEN 366
L HP + L ++ + R + K + VI
Sbjct: 294 LRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSG 342
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 5e-96
Identities = 73/295 (24%), Positives = 123/295 (41%), Gaps = 41/295 (13%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ + LG+G FG + + +A K I + + + + EV ++ L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLN 60
Query: 126 GHRNIVELKGAYEDRHSVN-------------LIMDLCAGGELFDRIIAKGHYSER-AAA 171
H+ +V A+ +R + + M+ C G L+D I ++ +R
Sbjct: 61 -HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK--------- 222
L RQ++ + Y HS G++HRDLKP N E +K DFGL+
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 223 ------PGDVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE 274
D +G+A YVA EVL +Y + D++S G+I + ++ P G
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMER 234
Query: 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329
+I + I+F D N K I++ ++ DP +R A +LN W+ V
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 2e-95
Identities = 68/299 (22%), Positives = 119/299 (39%), Gaps = 43/299 (14%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
++ LG+G + HK T FA K ++ V+ RE +++ L H+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HK 67
Query: 129 NIVELKGAYEDRHSVN--LIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHY 183
NIV+L E+ + + LIM+ C G L+ + + E + R +V +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 184 CHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
G++HR++KP N + S K TDFG + + + F L G+ Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 243 RR---------NYGAEADIWSAGVILYILLSGVPPFW----GETEQSIFDAILRG----- 284
R YGA D+WS GV Y +G PF + + I+ G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 285 ----------HIDFSSD--PWPNISSSAKDIVK----KMLHADPKERLSAAEVLNHPWM 327
ID+S D ++S + ++ +L AD ++ +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 5e-95
Identities = 93/309 (30%), Positives = 143/309 (46%), Gaps = 13/309 (4%)
Query: 24 GPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVT 83
GP + K PG P + A + + + VL P R Y+ GR LG+G F
Sbjct: 1 GP-APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRS--RRRYVRGRFLGKGGFAKC 57
Query: 84 YLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143
+ ++ DTK+ FA K + L+ E + E+ I L H+++V G +ED V
Sbjct: 58 FEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFV 116
Query: 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS 203
++++LC L + + +E A RQ+V Y H V+HRDLK N +
Sbjct: 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 176
Query: 204 SAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN-YGAEADIWSAGVILYI 261
E +K DFGL+ + K L G+ Y+APEVL + + E D+WS G I+Y
Sbjct: 177 DLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233
Query: 262 LLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
LL G PPF + + I + ++S I+ A +++KML DP R + E+
Sbjct: 234 LLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLIQKMLQTDPTARPTINEL 289
Query: 322 LNHPWMRVD 330
LN +
Sbjct: 290 LNDEFFTSG 298
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 8e-93
Identities = 84/283 (29%), Positives = 145/283 (51%), Gaps = 19/283 (6%)
Query: 49 ATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR 108
+ ++ +G + + G LG+G F Y T + A K I + +
Sbjct: 1 SLATCIGEKIED--------FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKA 52
Query: 109 DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSE 167
V+ V+ EV+I L H +I+EL +ED + V L++++C GE+ + + +SE
Sbjct: 53 GMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE 111
Query: 168 RAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
A + Q++T + Y HS G++HRDL N L + + +K DFGL+ K
Sbjct: 112 NEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEK 168
Query: 228 KD-LVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285
L G+ Y++PE+ R+ +G E+D+WS G + Y LL G PPF +T ++ + ++
Sbjct: 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD 228
Query: 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
+ P +S AKD++ ++L +P +RLS + VL+HP+M
Sbjct: 229 YEM---P-SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 1e-92
Identities = 82/264 (31%), Positives = 126/264 (47%), Gaps = 10/264 (3%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y+ GR LG+G F + ++ DTK+ FA K + L+ E + E+ I L H+
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQ 75
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
++V G +ED V ++++LC L + + +E A RQ+V Y H
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN-Y 246
V+HRDLK N + E +K DFGL+ + K L G+ Y+APEVL + +
Sbjct: 136 VIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306
E D+WS G I+Y LL G PPF + + I + P +I+ A +++K
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---P-KHINPVAASLIQK 248
Query: 307 MLHADPKERLSAAEVLNHPWMRVD 330
ML DP R + E+LN +
Sbjct: 249 MLQTDPTARPTINELLNDEFFTSG 272
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 3e-91
Identities = 86/272 (31%), Positives = 137/272 (50%), Gaps = 10/272 (3%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ GR LG+G+FG YL K K A K + +L +RRE++I HL H
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 74
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
NI+ + + DR + L+++ GEL+ + G + E+ +A ++ +HYCH
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL-RRNYG 247
V+HRD+KPEN L E LK DFG SV P + + G+ Y+ PE++ + +
Sbjct: 135 VIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
+ D+W AGV+ Y L G+PPF + I+ + F P P +S +KD++ K+
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF---P-PFLSDGSKDLISKL 246
Query: 308 LHADPKERLSAAEVLNHPWMRVDGDASDKPLD 339
L P +RL V+ HPW++ + P+
Sbjct: 247 LRYHPPQRLPLKGVMEHPWVKANSRRVLPPVY 278
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 1e-90
Identities = 76/328 (23%), Positives = 136/328 (41%), Gaps = 32/328 (9%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
Y +++G G + V ++ KQ +A K ++ + + ++ R E+ ++ L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN-LEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 127 H-RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH 185
H I+ L + ++M+ C +L + K + + M+ VH H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVL 242
G++H DLKP NFL D LK DFG++ +P V VG+ Y+ PE +
Sbjct: 126 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 243 ------------RRNYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFS 289
+ ++D+WS G ILY + G PF Q S AI+ + +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI- 240
Query: 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIA------VL 343
+ +D++K L DPK+R+S E+L HP++++ ++ VL
Sbjct: 241 -EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 299
Query: 344 TRMKQFRAMNKLKKVALKVIAENLSEEE 371
++ + N + K A + E
Sbjct: 300 GQLVGLNSPNSILKAAKTLYEHYSGGES 327
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 1e-90
Identities = 89/261 (34%), Positives = 130/261 (49%), Gaps = 10/261 (3%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ GR LG+G+FG YL K +K A K + +L +RREV+I HL H
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
NI+ L G + D V LI++ G ++ + + E+ A ++ + YCHS
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL-RRNYG 247
V+HRD+KPEN L LK DFG SV P DL G+ Y+ PE++ R +
Sbjct: 130 VIHRDIKPENLLLG---SAGELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
+ D+WS GV+ Y L G PPF T Q + I R F P ++ A+D++ ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---P-DFVTEGARDLISRL 241
Query: 308 LHADPKERLSAAEVLNHPWMR 328
L +P +R EVL HPW+
Sbjct: 242 LKHNPSQRPMLREVLEHPWIT 262
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 8e-90
Identities = 72/317 (22%), Positives = 130/317 (41%), Gaps = 26/317 (8%)
Query: 43 SSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISS 102
+S + + M Y +++G G + V ++ KQ +A K ++
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN- 61
Query: 103 RKLINRDDVEDVRREVQIMHHLTGH-RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA 161
+ + ++ R E+ ++ L H I+ L + ++M+ C +L +
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 120
Query: 162 KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221
K + + M+ VH H G++H DLKP NFL D LK DFG++
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQM 176
Query: 222 KPGD---VFKDLVGSAYYVAPEVL------------RRNYGAEADIWSAGVILYILLSGV 266
+P V VG+ Y+ PE + + ++D+WS G ILY + G
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 267 PPFWGETEQ-SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHP 325
PF Q S AI+ + + + +D++K L DPK+R+S E+L HP
Sbjct: 237 TPFQQIINQISKLHAIIDPNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294
Query: 326 WMRVDGDASDKPLDIAV 342
++++ ++
Sbjct: 295 YVQIQTHPVNQMAKGTT 311
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 2e-89
Identities = 84/384 (21%), Positives = 152/384 (39%), Gaps = 39/384 (10%)
Query: 10 SQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTY 69
+ L + +D P S++++ V G+ Y
Sbjct: 6 HSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRI-------Y 58
Query: 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-R 128
+++G G + V ++ KQ +A K ++ + + ++ R E+ ++ L H
Sbjct: 59 SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVN-LEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
I+ L + ++M+ C +L + K + + M+ VH H G
Sbjct: 117 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG--DVFKD-LVGSAYYVAPEVL--- 242
++H DLKP NFL D LK DFG++ +P V KD VG+ Y+ PE +
Sbjct: 176 IVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 243 ---------RRNYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDP 292
+ ++D+WS G ILY + G PF Q S AI+ + + +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--EF 289
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIA------VLTRM 346
+D++K L DPK+R+S E+L HP++++ ++ VL ++
Sbjct: 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQL 349
Query: 347 KQFRAMNKLKKVALKVIAENLSEE 370
+ N + K A + E
Sbjct: 350 VGLNSPNSILKAAKTLYEHYSGGE 373
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 275 bits (704), Expect = 3e-89
Identities = 70/322 (21%), Positives = 127/322 (39%), Gaps = 47/322 (14%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
++ LG+G + HK T FA K ++ + V+ RE +++ L H+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLN-HK 67
Query: 129 NIVELKGAYEDRHSVN--LIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHY 183
NIV+L E+ + + LIM+ C G L+ + + E + R +V +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 184 CHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
G++HR++KP N + S K TDFG + + + F L G+ Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 243 RRN---------YGAEADIWSAGVILYILLSGVPPFW----GETEQSIFDAILRG----- 284
R YGA D+WS GV Y +G PF + + I+ G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 285 ----------HIDFSSD--PWPNISSSAKDIVK----KMLHADPKERLSAAEVLNHPWMR 328
ID+S D ++S + ++ +L AD ++ +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307
Query: 329 VDGDASDKPLDIAVLTRMKQFR 350
+ + + L +M +
Sbjct: 308 L----HRMVIHVFSLQQMTAHK 325
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 1e-88
Identities = 93/264 (35%), Positives = 133/264 (50%), Gaps = 10/264 (3%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y+ G LG G FG + H+ T + A K ++ +K+ + D V ++RE+Q + H
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HP 71
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+I++L ++M+ +GGELFD I G E A L +Q+++ V YCH
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNY- 246
V+HRDLKPEN L K DFGLS G+ + GS Y APEV+ R Y
Sbjct: 132 VVHRDLKPENVLLD---AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306
G E DIWS GVILY LL G PF E ++F I G F + ++ S ++
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLMH 244
Query: 307 MLHADPKERLSAAEVLNHPWMRVD 330
ML DP +R + ++ H W + D
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQD 268
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 272 bits (696), Expect = 2e-88
Identities = 49/349 (14%), Positives = 99/349 (28%), Gaps = 67/349 (19%)
Query: 33 KIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVR---------NTYIFGRELGRGQFGVT 83
+I S SA S V L + R T + G LG+
Sbjct: 30 RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAY 89
Query: 84 YLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL------------------- 124
T ++T + F + + ++ ++ EV + L
Sbjct: 90 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149
Query: 125 -----TGHRNIVELKGAYEDRHSVN--LIMDLCA------GGELFDRIIAKGHYSERAAA 171
+ ++ ++ D ++ + G L A
Sbjct: 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 209
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
L Q++ ++ H G++H L+P + + + + T F V
Sbjct: 210 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFEHLV---RDGARVVSS 263
Query: 232 GSAYYVAPEVLRRN------------YGAEADIWSAGVILYILLSGVPPFWGETEQSIFD 279
S + PE+ R D W+ G+++Y + P + +
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE 323
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
I R NI + +++ L ++RL + + P
Sbjct: 324 WIFRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 4e-88
Identities = 48/300 (16%), Positives = 82/300 (27%), Gaps = 44/300 (14%)
Query: 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL--- 124
L G V +LV + + FA K + +R ++E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 125 --------------------TGHRNIVELKGAYEDRHSVN--LIMDLCAG------GELF 156
+L +D N L+M + L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 157 DRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216
+ +G A L Q++ + S G++H P+N D L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVS 239
Query: 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPFWGET 273
K G Y E L + + + W G+ +Y + PF T
Sbjct: 240 ALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 274 EQSIFDAIL-----RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
G + + K ++ + L+ D + RL E + P
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 5e-88
Identities = 93/314 (29%), Positives = 152/314 (48%), Gaps = 28/314 (8%)
Query: 47 TSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI 106
+ A+ + +G Y + +G+G F L H T ++ A K I + +
Sbjct: 3 SIASCADEQPHIGN--------YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-L 53
Query: 107 NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYS 166
N ++ + REV+IM L H NIV+L E ++ LIM+ +GGE+FD ++A G
Sbjct: 54 NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK 112
Query: 167 ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
E+ A + RQ+V+ V YCH ++HRDLK EN L D +K DFG S F G
Sbjct: 113 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD---ADMNIKIADFGFSNEFTVGGK 169
Query: 227 FKDLVGSAYYVAPEVLR-RNY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG 284
G+ Y APE+ + + Y G E D+WS GVILY L+SG PF G+ + + + +LRG
Sbjct: 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229
Query: 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD---------GDASD 335
+ + +S+ ++++K+ L +P +R + +++ W+ +
Sbjct: 230 --KYRIPFY--MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPEL 285
Query: 336 KPLDIAVLTRMKQF 349
D + M
Sbjct: 286 DISDQKRIDIMVGM 299
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 8e-88
Identities = 78/275 (28%), Positives = 133/275 (48%), Gaps = 14/275 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ + LG G +G L ++ T++ A K + ++ + D E++++E+ I L H
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 65
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
N+V+ G + + L ++ C+GGELFDRI E A Q++ V Y H +G
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL---VGSAYYVAPEVL-RR 244
+ HRD+KPEN L E LK +DFGL+ F+ + + L G+ YVAPE+L RR
Sbjct: 126 ITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 245 NY-GAEADIWSAGVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKD 302
+ D+WS G++L +L+G P+ ++ + +PW I S+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLA 240
Query: 303 IVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKP 337
++ K+L +P R++ ++ W K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 2e-87
Identities = 104/360 (28%), Positives = 159/360 (44%), Gaps = 25/360 (6%)
Query: 48 SATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN 107
+ G + M D Y F +++G G FGV L+ K TK+ A K I I+
Sbjct: 2 DRAPVTTGPLDMPIMHDSDR-YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID 60
Query: 108 RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSE 167
E+V+RE+ L H NIV K + +IM+ +GGEL++RI G +SE
Sbjct: 61 ----ENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE 115
Query: 168 RAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
A +Q+++ V YCHSM + HRDLK EN L S LK DFG S
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPR-LKICDFGYSKSSVLHSQP 174
Query: 228 KDLVGSAYYVAPEVL-RRNY-GAEADIWSAGVILYILLSGVPPFWGETEQSIF----DAI 281
K VG+ Y+APEVL R+ Y G AD+WS GV LY++L G PF E + I
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD----------G 331
L D IS ++ ++ ADP R+S E+ H W +
Sbjct: 235 LSVKYSIPDDIR--ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNT 292
Query: 332 DASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTIT 391
+ + + + + + +++ A++ + + + L + D+++ I
Sbjct: 293 GSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDID 352
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 9e-87
Identities = 94/307 (30%), Positives = 152/307 (49%), Gaps = 13/307 (4%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
YI LG G FG L TH T+Q+ A K IS + L D V RE+ + L H
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK-LLRHP 69
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+I++L + ++++ AGGELFD I+ K +E +Q++ + YCH
Sbjct: 70 HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNY- 246
++HRDLKPEN L ++ +K DFGLS G+ K GS Y APEV+ + Y
Sbjct: 129 IVHRDLKPENLLLD---DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306
G E D+WS G++LY++L G PF E ++F + + + +S A+ ++++
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIRR 241
Query: 307 MLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTR--MKQFRAMNKLKKVALKVIA 364
M+ ADP +R++ E+ PW V+ +P++ + + + + + I
Sbjct: 242 MIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIV 301
Query: 365 ENLSEEE 371
E L +E
Sbjct: 302 EALRSDE 308
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 2e-86
Identities = 79/269 (29%), Positives = 134/269 (49%), Gaps = 16/269 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ + LG G +G L ++ T++ A K + ++ + D E++++E+ I L H
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 65
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
N+V+ G + + L ++ C+GGELFDRI E A Q++ V Y H +G
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL---VGSAYYVAPEVL-RR 244
+ HRD+KPEN L E LK +DFGL+ F+ + + L G+ YVAPE+L RR
Sbjct: 126 ITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 245 NY-GAEADIWSAGVILYILLSGVPPF--WGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
+ D+WS G++L +L+G P+ ++ Q D + +PW I S+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---TYLNPWKKIDSAPL 239
Query: 302 DIVKKMLHADPKERLSAAEVLNHPWMRVD 330
++ K+L +P R++ ++ W
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 7e-86
Identities = 102/329 (31%), Positives = 159/329 (48%), Gaps = 19/329 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
YI G LG G FG + H+ T + A K ++ +K+ + D V +RRE+Q + H
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HP 76
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+I++L + ++M+ +GGELFD I G E+ + L +Q+++ V YCH
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNY- 246
V+HRDLKPEN L K DFGLS G+ + GS Y APEV+ R Y
Sbjct: 137 VVHRDLKPENVLLD---AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306
G E DIWS+GVILY LL G PF + ++F I G F + + ++ S ++K
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLKH 249
Query: 307 MLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAEN 366
ML DP +R + ++ H W + D P D + + M A+ ++
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEV------CEKFE 303
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEEL 395
SEEE++ + + + + + +
Sbjct: 304 CSEEEVL---SCLYNRNHQDPLAVAYHLI 329
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 1e-85
Identities = 72/313 (23%), Positives = 125/313 (39%), Gaps = 34/313 (10%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ LG G FG H+DT +Q A K R+ ++ + E E+QIM L H
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKLN-HP 72
Query: 129 NIVELKGAYEDRHSVN------LIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVT 179
N+V + + + L M+ C GG+L + + E L + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ Y H ++HRDLKPEN + + K D G + G++ + VG+ Y+AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 240 EVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR--------------G 284
E+L + Y D WS G + + ++G PF + + +R G
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 285 HIDFSSD--PWPNISSSAKDIVKK----MLHADPKERLSAAEVLNHPWMR-VDGDASDKP 337
+ FSS ++S +++ ML ++R + + N + +D S K
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312
Query: 338 LDIAVLTRMKQFR 350
L + + +
Sbjct: 313 LSVMNMVSGRVHT 325
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 2e-85
Identities = 86/300 (28%), Positives = 136/300 (45%), Gaps = 20/300 (6%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
PR S A + GK E + + Y G LG G FG Y
Sbjct: 12 SGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 71
Query: 96 ACKSISSRKLINRDDVED---VRREVQIMHHLT-GHRNIVELKGAYEDRHSVNLIMDLCA 151
A K + ++ + ++ + V EV ++ ++ G ++ L +E S LI++
Sbjct: 72 AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131
Query: 152 G-GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210
+LFD I +G E A + Q++ V +CH+ GV+HRD+K EN L + + L
Sbjct: 132 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--L 189
Query: 211 KATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNY-GAEADIWSAGVILYILLSGVPP 268
K DFG K V+ D G+ Y PE +R Y G A +WS G++LY ++ G P
Sbjct: 190 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
Query: 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
F + E I+RG + F +SS + +++ L P +R + E+ NHPWM+
Sbjct: 249 FEHDEE------IIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 3e-85
Identities = 77/306 (25%), Positives = 122/306 (39%), Gaps = 22/306 (7%)
Query: 41 RPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSI 100
+P + + GK E Y G LG+G FG + + Q A K I
Sbjct: 5 KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64
Query: 101 SSRKLINRDDVED---VRREVQIM---HHLTGHRNIVELKGAYEDRHSVNLIMDL-CAGG 153
+++ + D EV ++ GH ++ L +E + L+++
Sbjct: 65 PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124
Query: 154 ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213
+LFD I KG E + Q+V + +CHS GV+HRD+K EN L K
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKLI 182
Query: 214 DFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNY-GAEADIWSAGVILYILLSGVPPFWG 271
DFG + D G+ Y PE + Y A +WS G++LY ++ G PF
Sbjct: 183 DFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
Query: 272 ETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331
+ E IL + F ++S ++++ L P R S E+L PWM+
Sbjct: 242 DQE------ILEAELHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291
Query: 332 DASDKP 337
+
Sbjct: 292 EDVPLN 297
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 8e-85
Identities = 77/311 (24%), Positives = 119/311 (38%), Gaps = 17/311 (5%)
Query: 24 GPGHHPNGLKIDPPGPPRPSSSA----TSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQ 79
G L +P + S T S G +P + ++ LG G
Sbjct: 10 GVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGS 69
Query: 80 FGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139
+G + V K+ + +A K S D EV + H V L+ A+E+
Sbjct: 70 YGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128
Query: 140 RHSVNLIMDLCAGGELFDRIIAKGHY-SERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198
+ L +LC G L A G E R + + + HS G++H D+KP N
Sbjct: 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPAN 187
Query: 199 FLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVI 258
K DFGL V + G Y+APE+L+ +YG AD++S G+
Sbjct: 188 IFLGPRGR---CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLT 244
Query: 259 LYILLSGVP-PFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS 317
+ + + P GE Q + L +SS + ++ ML DPK R +
Sbjct: 245 ILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSELRSVLVMMLEPDPKLRAT 298
Query: 318 AAEVLNHPWMR 328
A +L P +R
Sbjct: 299 AEALLALPVLR 309
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 1e-83
Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 37/292 (12%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-------------------- 106
N Y E+G+G +GV L +++ +A K +S +KLI
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 107 ---NRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHSVNLIMDLCAGGELFDRIIA 161
R +E V +E+ I+ L H N+V+L +D + ++ +L G + + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130
Query: 162 KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221
SE A + ++ + Y H ++HRD+KP N L ED +K DFG+S F
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEF 187
Query: 222 KPGDVF-KDLVGSAYYVAPEVL---RRNY-GAEADIWSAGVILYILLSGVPPFWGETEQS 276
K D + VG+ ++APE L R+ + G D+W+ GV LY + G PF E
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
+ I P+I+ KD++ +ML +P+ R+ E+ HPW+
Sbjct: 248 LHSKIKSQ--ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 5e-83
Identities = 62/325 (19%), Positives = 121/325 (37%), Gaps = 49/325 (15%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSIS--------------SRKLINRDDVE 112
N Y R L +G+F L + +A K + K+ + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 113 DVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-------- 164
D + E+QI+ + + + +G + V +I + +
Sbjct: 89 DFKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 165 YSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223
+ + + ++ Y H+ + HRD+KP N L + +K +DFG S +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR---VKLSDFGESEYM-V 203
Query: 224 GDVFKDLVGSAYYVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFD 279
K G+ ++ PE GA+ DIWS G+ LY++ V PF + + +F+
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 280 AILRGHIDF---------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
I +I++ S+ +S+ D +K L +P ER+++ + L H
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323
Query: 325 PWMRVDGDASDKPLDIAVLTRMKQF 349
W+ + + + K+
Sbjct: 324 EWLADTNIEDLREFSKELYKKRKKL 348
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 6e-83
Identities = 78/309 (25%), Positives = 132/309 (42%), Gaps = 30/309 (9%)
Query: 39 PPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACK 98
P + ++ G K Y LG G FG + K+ ++ K
Sbjct: 4 EEPPKAVELEGLAACEGEYSQK--------YSTMSPLGSGAFGFVWTAVDKEKNKEVVVK 55
Query: 99 SISSRKLINRDDVED-----VRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL-CAG 152
I K++ +ED V E+ I+ + H NI+++ +E++ L+M+ +G
Sbjct: 56 FIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSG 114
Query: 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212
+LF I E A+ + RQ+V+ V Y ++HRD+K EN + AED +K
Sbjct: 115 LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKL 171
Query: 213 TDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN-Y-GAEADIWSAGVILYILLSGVPPFW 270
DFG + + + G +F G+ Y APEVL N Y G E ++WS GV LY L+ PF
Sbjct: 172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
Query: 271 GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330
+ + +S +V +L P+ R + +++ PW+
Sbjct: 232 E------LEETVEA--AIHPPYL--VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281
Query: 331 GDASDKPLD 339
+ +D +
Sbjct: 282 VNLADYTWE 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 1e-79
Identities = 71/281 (25%), Positives = 117/281 (41%), Gaps = 23/281 (8%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
M Y +G G +G + K + K + + + + + EV ++
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLL 59
Query: 122 HHLTGHRNIVELKGAYEDRHS--VNLIMDLCAGGELFDRII----AKGHYSERAAANLCR 175
L H NIV DR + + ++M+ C GG+L I + + E +
Sbjct: 60 RELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 176 QMVTVVHYCHSMG-----VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-KD 229
Q+ + CH V+HRDLKP N +K DFGL+ F K
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDG---KQNVKLGDFGLARILNHDTSFAKT 175
Query: 230 LVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288
VG+ YY++PE + +Y ++DIWS G +LY L + +PPF +++ + I G
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-- 233
Query: 289 SSDPWPNI-SSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
P S +I+ +ML+ R S E+L +P +
Sbjct: 234 --RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 1e-79
Identities = 79/299 (26%), Positives = 143/299 (47%), Gaps = 21/299 (7%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-VRREVQIMHHLTGH 127
Y+ G LG G +G V +T + A K + +KL + E V++E+Q++ L H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-H 65
Query: 128 RNIVELKG--AYEDRHSVNLIMDLCAGG--ELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
+N+++L E++ + ++M+ C G E+ D + + + A Q++ + Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEY 124
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF---FKPGDVFKDLVGSAYYVAPE 240
HS G++H+D+KP N L + LK + G++ F D + GS + PE
Sbjct: 125 LHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 241 VLR--RNY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
+ + G + DIWSAGV LY + +G+ PF G+ +F+ I +G ++
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--CG 237
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMK-QFRAMNKL 355
D++K ML +P +R S ++ H W R ++ P+ I K ++R+M +
Sbjct: 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVV 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 1e-78
Identities = 69/292 (23%), Positives = 139/292 (47%), Gaps = 18/292 (6%)
Query: 42 PSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSIS 101
+S + + ME Y+ +++G G FG LV + +Q+ K I+
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN 58
Query: 102 SRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA 161
++ + + E+ RREV ++ ++ H NIV+ + ++E+ S+ ++MD C GG+LF RI A
Sbjct: 59 ISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA 116
Query: 162 --KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219
+ E + Q+ + + H ++HRD+K +N + D ++ DFG++
Sbjct: 117 QKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK---DGTVQLGDFGIAR 173
Query: 220 FFKPGDVF-KDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
+ +G+ YY++PE+ Y ++DIW+ G +LY L + F + +++
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233
Query: 278 FDAILRGHIDFSSDPWP-NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
I+ G P + S + +V ++ +P++R S +L ++
Sbjct: 234 VLKIISGSF----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 3e-75
Identities = 69/301 (22%), Positives = 127/301 (42%), Gaps = 18/301 (5%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
G P + + + + + +++GRGQF Y
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL 155
A K + L++ D +E+ ++ L H N+++ ++ + + +N++++L G+L
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDL 119
Query: 156 FDRI----IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211
I K ER Q+ + + + HS VMHRD+KP N ++ +K
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TGVVK 176
Query: 212 ATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPF 269
D GL F LVG+ YY++PE + N Y ++DIWS G +LY + + PF
Sbjct: 177 LGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
Query: 270 WGETE--QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
+G+ S+ I + D+ P + S + +V ++ DP++R V +
Sbjct: 237 YGDKMNLYSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294
Query: 328 R 328
Sbjct: 295 M 295
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 4e-73
Identities = 63/282 (22%), Positives = 106/282 (37%), Gaps = 38/282 (13%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ +G G FG + H+ + + K + E REV+ + L
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62
Query: 126 GHRNIVELKGAYEDR----------------HSVNLIMDLCAGGELFDRIIAK--GHYSE 167
H NIV G ++ + + M+ C G L I + +
Sbjct: 63 -HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 168 RAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
A L Q+ V Y HS +++RDLKP N + +K DFGL K
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKR 178
Query: 228 KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI 286
G+ Y++PE + ++YG E D+++ G+IL LL F + G I
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTDLRDGII 236
Query: 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
K +++K+L P++R + +E+L +
Sbjct: 237 S------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-69
Identities = 86/301 (28%), Positives = 133/301 (44%), Gaps = 23/301 (7%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
PRP + + +P ED + FG+ LG G F L T +++
Sbjct: 4 TAAEPRPGAGSLQHAQPPPQPRKKRP-ED----FKFGKILGEGSFSTVVLARELATSREY 58
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL 155
A K + R +I + V V RE +M L H V+L ++D + + GEL
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGEL 117
Query: 156 FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
I G + E ++V+ + Y H G++HRDLKPEN L + D ++ TDF
Sbjct: 118 LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE---DMHIQITDF 174
Query: 216 GLS---VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWG 271
G + VG+A YV+PE+L +D+W+ G I+Y L++G+PPF
Sbjct: 175 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234
Query: 272 ETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL------SAAEVLNHP 325
E IF I++ DF A+D+V+K+L D +RL + HP
Sbjct: 235 GNEYLIFQKIIKLEYDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 290
Query: 326 W 326
+
Sbjct: 291 F 291
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 1e-67
Identities = 61/313 (19%), Positives = 102/313 (32%), Gaps = 34/313 (10%)
Query: 38 GPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFAC 97
G +S + G + Y+F ++LG G F LV +A
Sbjct: 2 GSSHHHHHHSSGRENL--YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYAL 59
Query: 98 KSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR----HSVNLIMDLCAGG 153
K I + D E+ +RE + H NI+ L H L++ G
Sbjct: 60 KRI---LCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRG 115
Query: 154 ELFDRI----IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209
L++ I +E L + + H+ G HRDLKP N L +
Sbjct: 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD---EGQ 172
Query: 210 LKATDFGLSVFFKPG----------DVFKDLVGSAYYVAPEVL----RRNYGAEADIWSA 255
D G + + Y APE+ D+WS
Sbjct: 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232
Query: 256 GVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKE 314
G +LY ++ G P+ ++ ++ + P SS+ ++ M+ DP +
Sbjct: 233 GCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI--PQSPRHSSALWQLLNSMMTVDPHQ 290
Query: 315 RLSAAEVLNHPWM 327
R +L+
Sbjct: 291 RPHIPLLLSQLEA 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-66
Identities = 73/300 (24%), Positives = 119/300 (39%), Gaps = 46/300 (15%)
Query: 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
G+ + D + + LGRG FGV + +K +A K I R E V REV
Sbjct: 1 GRYLTD----FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREV 54
Query: 119 QIMHHLTGHRNIVELKGAYEDRHS------------VNLIMDLCAGGELFDRIIAKGHYS 166
+ + L H IV A+ ++++ + + M LC L D + +
Sbjct: 55 KALAKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 167 ---ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223
++ Q+ V + HS G+MHRDLKP N F+ D +K DFGL
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQ 170
Query: 224 GDVFKDL-------------VGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPF 269
+ + + VG+ Y++PE + +Y + DI+S G+IL+ LL PF
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF 227
Query: 270 WGETEQS-IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
+ E+ + + +V+ ML P ER A ++ +
Sbjct: 228 STQMERVRTLTDVRNLKF---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 1e-66
Identities = 48/347 (13%), Positives = 99/347 (28%), Gaps = 64/347 (18%)
Query: 33 KIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVR---------NTYIFGRELGRGQFGVT 83
+I S SA S V L + R T + G LG+
Sbjct: 35 RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAY 94
Query: 84 YLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL------------------- 124
T ++T + F + + ++ ++ EV + L
Sbjct: 95 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154
Query: 125 -----TGHRNIVELKGAYEDRHSVN--LIMDLCAG------GELFDRIIAKGHYSERAAA 171
+ ++ ++ D ++ + L A
Sbjct: 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 214
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
L Q++ ++ H G++H L+P + + + + T F V + G +
Sbjct: 215 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFEHLV--RDGASAVSPI 269
Query: 232 GSAY----YVAPEVLRRN------YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI 281
G + A +L D W+ G+ +Y + P + + I
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI 329
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
R NI + +++ L ++RL + + P
Sbjct: 330 FRS--------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-66
Identities = 75/321 (23%), Positives = 120/321 (37%), Gaps = 47/321 (14%)
Query: 37 PGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFA 96
GP ++ S VG+ + E R L G F Y + +++A
Sbjct: 2 AGPGSLGGASGRDQSDFVGQTV----ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYA 57
Query: 97 CKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN--------LIMD 148
K + S + + +EV M L+GH NIV+ A + L+ +
Sbjct: 58 LKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE 114
Query: 149 LCAGGELFDRII---AKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSS 203
LC G+L + + ++G S + Q V + H ++HRDLK EN L S+
Sbjct: 115 LC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173
Query: 204 SAEDSPLKATDFGLSVFFKPGDVFKDL-------------VGSAYYVAPEVL----RRNY 246
+K DFG + + + Y PE++
Sbjct: 174 ---QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230
Query: 247 GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKK 306
G + DIW+ G ILY+L PF E I+ G P + +++
Sbjct: 231 GEKQDIWALGCILYLLCFRQHPF----EDGAKLRIVNGKYSIP--PHDTQYTVFHSLIRA 284
Query: 307 MLHADPKERLSAAEVLNHPWM 327
ML +P+ERLS AEV++
Sbjct: 285 MLQVNPEERLSIAEVVHQLQE 305
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-64
Identities = 62/283 (21%), Positives = 111/283 (39%), Gaps = 34/283 (12%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ ++G G+FG + + +A K S + L D ++ REV L H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRI----IAKGHYSERAAANLCRQMVTVVHYC 184
++V A+ + + + + C GG L D I ++ E +L Q+ + Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 185 HSMGVMHRDLKPENFLFSSS----------------AEDSPLKATDFGLSVFFKPGDVFK 228
HSM ++H D+KP N S + + K D G V
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE- 190
Query: 229 DLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI 286
G + ++A EVL+ N + +ADI++ + + P + I +G +
Sbjct: 191 --EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQGRL 245
Query: 287 DFSSDPWP-NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
P +S +++K M+H DP+ R SA ++ H +
Sbjct: 246 ----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-62
Identities = 71/264 (26%), Positives = 124/264 (46%), Gaps = 16/264 (6%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
R +G+G FG +V DTK+ +A K ++ +K + R++V +V +E+QIM L H +V
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVN 79
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L +++D + +++DL GG+L + H+ E ++V + Y + ++HR
Sbjct: 80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHR 139
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN----YGA 248
D+KP+N L E + TDF ++ + G+ Y+APE+ Y
Sbjct: 140 DMKPDNILLD---EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSF 196
Query: 249 EADIWSAGVILYILLSGVPPFWG---ETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305
D WS GV Y LL G P+ + + I + + S ++K
Sbjct: 197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEMVSLLK 252
Query: 306 KMLHADPKERL-SAAEVLNHPWMR 328
K+L +P +R ++V N P+M
Sbjct: 253 KLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-62
Identities = 46/286 (16%), Positives = 95/286 (33%), Gaps = 36/286 (12%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIM 121
LG G F Y T D KQ+F K + + ++ +
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERL 121
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY-----SERAAANLCRQ 176
++ A+ ++ L+ +L + G L + I + + + +
Sbjct: 122 KPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP--------LKATDFGLSV---FFKPGD 225
M+ ++ H ++H D+KP+NF+ + + L D G S+ F G
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 226 VFKDLVGSAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSI-FDAILR 283
+F ++ + E+L + + + D + +Y +L G + + R
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
Query: 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329
D W + ML+ L + ++L +V
Sbjct: 301 RL--PHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 9e-62
Identities = 80/303 (26%), Positives = 143/303 (47%), Gaps = 29/303 (9%)
Query: 43 SSSATSATSSSVGRVLGKPMEDVRNTYI-------------FGRELGRGQFGVTYLVTHK 89
+++ + SV L K ED + + LG G FG LV HK
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK 63
Query: 90 DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149
++ +A K + +K++ +E E +I+ + +V+L+ +++D ++ ++M+
Sbjct: 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEY 122
Query: 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209
AGGE+F + G +SE A Q+V Y HS+ +++RDLKPEN L
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ---QGY 179
Query: 210 LKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPP 268
++ TDFG + + L G+ +APE++ Y D W+ GV++Y + +G PP
Sbjct: 180 IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL-----SAAEVLN 323
F+ + I++ I+ G + F + SS KD+++ +L D +R ++ N
Sbjct: 238 FFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
Query: 324 HPW 326
H W
Sbjct: 294 HKW 296
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 5e-60
Identities = 79/262 (30%), Positives = 126/262 (48%), Gaps = 16/262 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG LV HK T++ +A K +S ++I R D E IM +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLF 135
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++D + ++M+ GG+L +++ E+ A ++V + HSMG +HRD+
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 194
Query: 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD--LVGSAYYVAPEVLRR-----NYG 247
KP+N L S LK DFG + + + VG+ Y++PEVL+ YG
Sbjct: 195 KPDNMLLDKSGH---LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 251
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
E D WS GV LY +L G PF+ ++ + I+ + +IS AK+++
Sbjct: 252 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAF 311
Query: 308 LHADPKERL---SAAEVLNHPW 326
L D + RL E+ H +
Sbjct: 312 LT-DREVRLGRNGVEEIKRHLF 332
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-59
Identities = 75/264 (28%), Positives = 124/264 (46%), Gaps = 16/264 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ R LG G FG +L+ + + +A K + ++ VE E ++ +T H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 66
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
I+ + G ++D + +IMD GGELF + + A ++ + Y HS
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YG 247
+++RDLKPEN L + +K TDFG + DV L G+ Y+APEV+ Y
Sbjct: 127 IIYRDLKPENILLDK---NGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 181
Query: 248 AEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKM 307
D WS G+++Y +L+G PF+ ++ IL + F P + KD++ ++
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSRL 237
Query: 308 LHADPKERL-----SAAEVLNHPW 326
+ D +RL +V NHPW
Sbjct: 238 ITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-57
Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 20/272 (7%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH--HL 124
N + R +GRG FG Y DT + +A K + +++ + E ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
IV + A+ ++ I+DL GG+L + G +SE +++ + +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
H+ V++RDLKP N L E ++ +D GL+ F VG+ Y+APEVL++
Sbjct: 309 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQK 364
Query: 245 N--YGAEADIWSAGVILYILLSGVPPFWGETEQS---IFDAILRGHIDFSSDPWPNISSS 299
Y + AD +S G +L+ LL G PF + I L ++ + S
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPE 420
Query: 300 AKDIVKKMLHADPKERL-----SAAEVLNHPW 326
+ +++ +L D RL A EV P+
Sbjct: 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 9e-57
Identities = 67/267 (25%), Positives = 121/267 (45%), Gaps = 20/267 (7%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG F +V K T Q +A K ++ ++ R +V R E ++ + R I +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLH 127
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
A++D + + L+M+ GG+L + G A ++V + H +G +HRD
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD--LVGSAYYVAPEVLRR------- 244
+KP+N L ++ DFG + + + VG+ Y++PE+L+
Sbjct: 188 IKPDNILLDR---CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 245 -NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP-NISSSAKD 302
+YG E D W+ GV Y + G PF+ ++ + I+ S + A+D
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARD 304
Query: 303 IVKKMLHADPKERL---SAAEVLNHPW 326
++++L P+ RL A + HP+
Sbjct: 305 FIQRLLC-PPETRLGRGGAGDFRTHPF 330
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-56
Identities = 79/297 (26%), Positives = 133/297 (44%), Gaps = 21/297 (7%)
Query: 40 PRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKS 99
P+ SS + + LG +++ + F R LG+G FG L K+T +A K
Sbjct: 2 PKESSKEGNGIGVNSSNRLG--IDN----FEFIRVLGKGSFGKVMLARVKETGDLYAVKV 55
Query: 100 ISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI 159
+ ++ DDVE E +I+ H + +L ++ + +M+ GG+L I
Sbjct: 56 LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115
Query: 160 IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS- 218
+ E A ++++ + + H G+++RDLK +N L + K DFG+
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH---EGHCKLADFGMCK 172
Query: 219 VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
G G+ Y+APE+L+ YG D W+ GV+LY +L G PF E E +
Sbjct: 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
Query: 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL------SAAEVLNHPWMR 328
F+AIL + + P + A I+K + +P RL +L HP+ +
Sbjct: 233 FEAILNDEVVY---P-TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-56
Identities = 71/257 (27%), Positives = 123/257 (47%), Gaps = 10/257 (3%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG +L K T Q FA K++ ++ DDVE E +++ H + +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + ++ +M+ GG+L I + + A +++ + + HS G+++RDL
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 195 KPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
K +N L D +K DFG+ G+ Y+APE+L Y D
Sbjct: 145 KLDNILLDK---DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
WS GV+LY +L G PF G+ E+ +F +I + + P + AKD++ K+ +P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEAKDLLVKLFVREP 257
Query: 313 KERL-SAAEVLNHPWMR 328
++RL ++ HP R
Sbjct: 258 EKRLGVRGDIRQHPLFR 274
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-55
Identities = 70/265 (26%), Positives = 126/265 (47%), Gaps = 18/265 (6%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG FG +V K+ + FA K ++ +++ R + R E ++ + + I L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLH 140
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRII-AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
A++D +++ L+MD GG+L + + E A +MV + H + +HRD
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200
Query: 194 LKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKD-LVGSAYYVAPEVLRRN------ 245
+KP+N L + ++ DFG + G V VG+ Y++PE+L+
Sbjct: 201 IKPDNILMDM---NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW-PNISSSAKDIV 304
YG E D WS GV +Y +L G PF+ E+ + I+ F ++S +AKD++
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLI 317
Query: 305 KKMLHADPKERL---SAAEVLNHPW 326
++++ + RL + HP+
Sbjct: 318 RRLIC-SREHRLGQNGIEDFKKHPF 341
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-55
Identities = 75/302 (24%), Positives = 139/302 (46%), Gaps = 16/302 (5%)
Query: 34 IDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNT---YIFGRELGRGQFGVTYLVTHKD 90
I P P ++ + + ++ P + + F + +G+G FG L HK
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61
Query: 91 TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150
+ +A K + + ++ + + + + E ++ H +V L +++ + ++D
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 121
Query: 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210
GGELF + + + E A ++ + + Y HS+ +++RDLKPEN L S +
Sbjct: 122 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS---QGHI 178
Query: 211 KATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPP 268
TDFGL + G+ Y+APEVL + Y D W G +LY +L G+PP
Sbjct: 179 VLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
Query: 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERL----SAAEVLNH 324
F+ ++D IL + PNI++SA+ +++ +L D +RL E+ +H
Sbjct: 239 FYSRNTAEMYDNILNKPLQL---K-PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294
Query: 325 PW 326
+
Sbjct: 295 VF 296
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-55
Identities = 71/261 (27%), Positives = 122/261 (46%), Gaps = 14/261 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG L K T + +A K + +I DDVE E +++ + +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + +M+ GG+L I G + E A ++ + + S G+++RDL
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 195 KPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
K +N + S + +K DFG+ G K G+ Y+APE++ YG D
Sbjct: 148 KLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 204
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W+ GV+LY +L+G PF GE E +F +I+ ++ + P ++S A I K ++ P
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKGLMTKHP 260
Query: 313 KERL-----SAAEVLNHPWMR 328
+RL ++ H + R
Sbjct: 261 GKRLGCGPEGERDIKEHAFFR 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-55
Identities = 75/334 (22%), Positives = 125/334 (37%), Gaps = 30/334 (8%)
Query: 5 NGLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMED 64
+ S Q ++ A + L P + + + V + E+
Sbjct: 3 GSVSSGQAHSLASLAKTWSSGSAKLQRL------GPETEDNEGVLLTEKLKPVDYEYREE 56
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR-REVQIMHH 123
V +GRG FG + + K T Q A K + +E R E+
Sbjct: 57 VHW-MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV---------RLEVFRVEELVACAG 106
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
L+ IV L GA + VN+ M+L GG L I G E A Q + + Y
Sbjct: 107 LS-SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEY 165
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV------FKDLVGSAYYV 237
H+ ++H D+K +N L SS S DFG ++ +P + + G+ ++
Sbjct: 166 LHTRRILHGDVKADNVLLSSDG--SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 238 APEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWPN 295
APEV+ A+ DIWS+ ++ +L+G P+ I P P+
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KIASEPPPIREIP-PS 281
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329
+ +++ L +P R SA E+ +
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 4e-55
Identities = 83/261 (31%), Positives = 131/261 (50%), Gaps = 15/261 (5%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LG+G FG LV K T + +A K + +I +D+V E +++ + T H + LK
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
A++ + +M+ GGELF + + ++E A ++V+ + Y HS V++RD+
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 195 KPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
K EN + D +K TDFGL G K G+ Y+APEVL N YG D
Sbjct: 132 KLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 253 WSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADP 312
W GV++Y ++ G PF+ + + +F+ IL I F +S AK ++ +L DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDP 244
Query: 313 KERL-----SAAEVLNHPWMR 328
K+RL A EV+ H +
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL 265
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-54
Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 20/272 (7%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
NT+ R LG+G FG + T + +ACK + +++ R E QI+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL-EKVN 242
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI--IAKGHYSERAAANLCRQMVTVVHYC 184
R +V L AYE + ++ L++ L GG+L I + + + E A ++ +
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
H +++RDLKPEN L ++ +D GL+V G K VG+ Y+APEV++
Sbjct: 303 HRERIVYRDLKPENILLDD---HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 245 N-YGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAILRGHIDFSSDPWPNISSS 299
Y D W+ G +LY +++G PF ++ + + ++S S
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQ 415
Query: 300 AKDIVKKMLHADPKERL-----SAAEVLNHPW 326
A+ + ++L DP ERL SA EV HP
Sbjct: 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 8e-54
Identities = 78/326 (23%), Positives = 140/326 (42%), Gaps = 31/326 (9%)
Query: 27 HHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRE-------LGRGQ 79
HH + D P + + E + + G + +GRG
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64
Query: 80 FGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139
+ LV K T + +A + + + + +D++ V+ E + + H +V L ++
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 124
Query: 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199
+ +++ GG+L + + E A ++ ++Y H G+++RDLK +N
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 200 LFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGV 257
L S + +K TD+G+ +PGD G+ Y+APE+LR YG D W+ GV
Sbjct: 185 LLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 241
Query: 258 ILYILLSGVPPFW---------GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML 308
+++ +++G PF TE +F IL I ++S A ++K L
Sbjct: 242 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFL 297
Query: 309 HADPKERL------SAAEVLNHPWMR 328
+ DPKERL A++ HP+ R
Sbjct: 298 NKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 9e-54
Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 24/271 (8%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
+GRG + LV K T + +A K + + + +D++ V+ E + + H +V L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 135 GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194
++ + +++ GG+L + + E A ++ ++Y H G+++RDL
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136
Query: 195 KPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADI 252
K +N L S + +K TD+G+ +PGD G+ Y+APE+LR YG D
Sbjct: 137 KLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193
Query: 253 WSAGVILYILLSGVPPFW---------GETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303
W+ GV+++ +++G PF TE +F IL I ++S A +
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASV 249
Query: 304 VKKMLHADPKERL------SAAEVLNHPWMR 328
+K L+ DPKERL A++ HP+ R
Sbjct: 250 LKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 58/267 (21%), Positives = 115/267 (43%), Gaps = 14/267 (5%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
F E+GRG F Y +T + A + RKL + + + + E +++ L H NI
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNI 87
Query: 131 VELKGAYED----RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
V ++E + + L+ +L G L + + + CRQ++ + + H+
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 187 MG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
++HRDLK +N + +K D GL+ K K ++G+ ++APE+
Sbjct: 148 RTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMYEE 204
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWPNISSSAKDI 303
Y D+++ G+ + + + P+ I+ + G S K+I
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIPEVKEI 262
Query: 304 VKKMLHADPKERLSAAEVLNHPWMRVD 330
++ + + ER S ++LNH + + +
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-53
Identities = 67/273 (24%), Positives = 124/273 (45%), Gaps = 24/273 (8%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
LG+G +G+ Y + + A K I + + + E+ + HL H+NIV
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLK-HKNIV 82
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMG 188
+ G++ + + + M+ GG L + +K +E+ +Q++ + Y H
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-- 245
++HRD+K +N L ++ LK +DFG S + G+ Y+APE++ +
Sbjct: 143 IVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 246 -YGAEADIWSAGVILYILLSGVPPFW--GETEQSIFDAILRGHIDFSSDPWP---NISSS 299
YG ADIWS G + + +G PPF+ GE + ++F + ++S+
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF------KVGMFKVHPEIPESMSAE 254
Query: 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332
AK + K DP +R A ++L +++V
Sbjct: 255 AKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-53
Identities = 75/329 (22%), Positives = 136/329 (41%), Gaps = 19/329 (5%)
Query: 8 PSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKP-MEDVR 66
+ ++ + KI +A + + + + D
Sbjct: 285 EYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD-- 342
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ F LG+G FG L K T + +A K + +I DDVE E +++
Sbjct: 343 --FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
+ +L ++ + +M+ GG+L I G + E A ++ + + S
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN 245
G+++RDLK +N + S + +K DFG+ G K G+ Y+APE++
Sbjct: 461 KGIIYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 246 -YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
YG D W+ GV+LY +L+G PF GE E +F +I+ ++ + ++S A I
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAIC 573
Query: 305 KKMLHADPKERL-----SAAEVLNHPWMR 328
K ++ P +RL ++ H + R
Sbjct: 574 KGLMTKHPGKRLGCGPEGERDIKEHAFFR 602
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 3e-53
Identities = 88/331 (26%), Positives = 148/331 (44%), Gaps = 22/331 (6%)
Query: 8 PSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKP--MEDV 65
+ + + TTA G PS ++ + M +
Sbjct: 91 ETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE- 149
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ + + LG+G FG LV K T + +A K + ++ +D+V E +++ + +
Sbjct: 150 ---FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-S 205
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH 185
H + LK +++ + +M+ GGELF + + +SE A ++V+ + Y H
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 186 S-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLR 243
S V++RDLK EN + D +K TDFGL K G K G+ Y+APEVL
Sbjct: 266 SEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 244 RN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302
N YG D W GV++Y ++ G PF+ + + +F+ IL I F + AK
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKS 378
Query: 303 IVKKMLHADPKERL-----SAAEVLNHPWMR 328
++ +L DPK+RL A E++ H +
Sbjct: 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-53
Identities = 72/275 (26%), Positives = 125/275 (45%), Gaps = 23/275 (8%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ ++ R LGRG FG + K T + +ACK ++ ++L R + E +I+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVH 243
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH----YSERAAANLCRQMVTVVH 182
R IV L A+E + + L+M + GG++ I + E A Q+V+ +
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV-FFKPGDVFKDLVGSAYYVAPEV 241
+ H +++RDLKPEN L D ++ +D GL+V K G+ ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLLDD---DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHIDFSSDPWPNI 296
L Y D ++ GV LY +++ PF E + + +L + +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKF 416
Query: 297 SSSAKDIVKKMLHADPKERL-----SAAEVLNHPW 326
S ++KD + +L DP++RL S + HP
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 5e-53
Identities = 82/265 (30%), Positives = 135/265 (50%), Gaps = 19/265 (7%)
Query: 75 LGRGQFGVTYLVTH---KDTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNI 130
LG+G +G + V +T + FA K + ++ N D + E I+ + H I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFI 83
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
V+L A++ + LI++ +GGELF ++ +G + E A ++ + + H G++
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGII 143
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGA 248
+RDLKPEN + + +K TDFGL G V G+ Y+APE+L R+ +
Sbjct: 144 YRDLKPENIMLNH---QGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 249 EADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKML 308
D WS G ++Y +L+G PPF GE + D IL+ ++ P P ++ A+D++KK+L
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEARDLLKKLL 256
Query: 309 HADPKERL-----SAAEVLNHPWMR 328
+ RL A EV HP+ R
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFR 281
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 9e-52
Identities = 77/262 (29%), Positives = 126/262 (48%), Gaps = 19/262 (7%)
Query: 75 LGRGQFGVTYLVTH---KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
LG+G FG +LV D +Q +A K + L RD V + E I+ H IV
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVE-VNHPFIV 89
Query: 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+L A++ + LI+D GG+LF R+ + ++E ++ + + HS+G+++
Sbjct: 90 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 149
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAE 249
RDLKPEN L + +K TDFGLS G+ Y+APEV+ R +
Sbjct: 150 RDLKPENILLDE---EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 206
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
AD WS GV+++ +L+G PF G+ + IL+ + P +S A+ +++ +
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQSLLRMLFK 262
Query: 310 ADPKERL-----SAAEVLNHPW 326
+P RL E+ H +
Sbjct: 263 RNPANRLGAGPDGVEEIKRHSF 284
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-51
Identities = 85/325 (26%), Positives = 149/325 (45%), Gaps = 38/325 (11%)
Query: 35 DPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRE-------------LGRGQFG 81
+ G ++ TSA G L ++R + G LG G +G
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYG 68
Query: 82 VTYLVTH---KDTKQQFACKSISSRKLINRD-DVEDVRREVQIMHHLTGHRNIVELKGAY 137
+LV DT + +A K + ++ + E R E Q++ H+ +V L A+
Sbjct: 69 KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128
Query: 138 EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPE 197
+ ++LI+D GGELF + + ++E ++V + + H +G+++RD+K E
Sbjct: 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 188
Query: 198 NFLFSSSAEDSPLKATDFGLS--VFFKPGDVFKDLVGSAYYVAPEVLRRN---YGAEADI 252
N L S + + TDFGLS + D G+ Y+AP+++R + D
Sbjct: 189 NILLDS---NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 245
Query: 253 WSAGVILYILLSGVPPFWGETEQS----IFDAILRGHIDFSSDPWPNISSSAKDIVKKML 308
WS GV++Y LL+G PF + E++ I IL+ + +S+ AKD+++++L
Sbjct: 246 WSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDLIQRLL 301
Query: 309 HADPKERL-----SAAEVLNHPWMR 328
DPK+RL A E+ H + +
Sbjct: 302 MKDPKKRLGCGPRDADEIKEHLFFQ 326
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-50
Identities = 31/100 (31%), Positives = 57/100 (57%), Gaps = 1/100 (1%)
Query: 320 EVLNHPWMRVD-GDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEM 378
+H R + L +L +K F+ N+LKK+AL +IA++L + EI L+ +
Sbjct: 3 HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNI 62
Query: 379 FKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
F ++D DNSGT++ +E+ GL K+G + ++ Q++ +
Sbjct: 63 FIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDI 102
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-47
Identities = 85/322 (26%), Positives = 149/322 (46%), Gaps = 27/322 (8%)
Query: 27 HHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLV 86
HH +G+ + S T + R++ D R ++G G G+ L
Sbjct: 6 HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQ-GDPRLLLDSYVKIGEGSTGIVCLA 64
Query: 87 THKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146
K + +Q A K + L + E + EV IM H N+VE+ +Y + ++
Sbjct: 65 REKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVL 120
Query: 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206
M+ GG L D I+++ +E A +C ++ + Y H+ GV+HRD+K ++ L +
Sbjct: 121 MEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR 179
Query: 207 DSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS 264
+K +DFG + LVG+ Y++APEV+ R+ Y E DIWS G+++ ++
Sbjct: 180 ---VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD 236
Query: 265 GVPPFWGETEQSIFDAI-------LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS 317
G PP++ ++ + L+ S +D +++ML DP+ER +
Sbjct: 237 GEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPV--------LRDFLERMLVRDPQERAT 288
Query: 318 AAEVLNHPWMRVDGDASD-KPL 338
A E+L+HP++ G PL
Sbjct: 289 AQELLDHPFLLQTGLPECLVPL 310
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-47
Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 1/97 (1%)
Query: 322 LNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKS 381
++H G + I VL K + + K +K+A+ +IA+ ++ ++ LK F
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60
Query: 382 MDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+D D G IT E+LK GL K G +L L++ +
Sbjct: 61 LDEDGKGYITKEQLKKGLEKDGLKLPY-NFDLLLDQI 96
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 6e-06
Identities = 15/66 (22%), Positives = 29/66 (43%), Gaps = 8/66 (12%)
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLS-----ESEVR 412
+A + + LS++ + F+ D DN G IT EL L + + + V+
Sbjct: 110 IAAALDRKQLSKKL---IYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVK 166
Query: 413 QLMEAV 418
+++ V
Sbjct: 167 RMIRDV 172
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-47
Identities = 70/305 (22%), Positives = 127/305 (41%), Gaps = 50/305 (16%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
E+G G G + + + T A K + R+ N+++ + + ++ ++ IV+
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHR 192
G + V + M+L + +G ER + +V ++Y GV+HR
Sbjct: 90 FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR 149
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-----VGSAYYVAPEVLRRN-- 245
D+KP N L + +K DFG+S G + D G A Y+APE +
Sbjct: 150 DVKPSNILLDERGQ---IKLCDFGIS-----GRLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 246 ----YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI----------LRGHIDFSSD 291
Y AD+WS G+ L L +G P+ + ++ F+ + L GH+ FS D
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259
Query: 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIA-----VLTRM 346
+ VK L D ++R ++L H +++ +D+A V+ +
Sbjct: 260 --------FQSFVKDCLTKDHRKRPKYNKLLEHSFIK---RYETLEVDVASWFKDVMAKT 308
Query: 347 KQFRA 351
+ R+
Sbjct: 309 ESPRS 313
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-47
Identities = 75/330 (22%), Positives = 129/330 (39%), Gaps = 23/330 (6%)
Query: 13 QLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFG 72
+ D N P A S V + K +D +
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFK--DDPEKLFSDL 59
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE 132
RE+G G FG Y + A K +S + + +D+ +EV+ + L H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQ 118
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
+G Y H+ L+M+ C G + K E A + + + Y HS ++HR
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL----RRNYGA 248
D+K N L S +K DFG + P + F VG+ Y++APEV+ Y
Sbjct: 179 DVKAGNILLSEPGL---VKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDG 232
Query: 249 EADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDP---WPNISSSAKDIV 304
+ D+WS G+ L PP + +++ HI + P + S ++ V
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNESPALQSGHWSEYFRNFV 286
Query: 305 KKMLHADPKERLSAAEVLNHPWMRVDGDAS 334
L P++R ++ +L H ++ + +
Sbjct: 287 DSCLQKIPQDRPTSEVLLKHRFVLRERPPT 316
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-46
Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 22/284 (7%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
D + Y ++G+G G Y T Q+ A + + L + E + E+ +M
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMR 72
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
+ NIV +Y + ++M+ AGG L D ++ + E A +CR+ + +
Sbjct: 73 ENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEV 241
+ HS V+HRD+K +N L +K TDFG P + +VG+ Y++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDP----WPN 295
+ R YG + DIWS G++ ++ G PP+ E ++++ I + P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTPELQNPEK 241
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASD-KPL 338
+S+ +D + + L D ++R SA E+L H ++++ S PL
Sbjct: 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPL 285
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 68/289 (23%), Positives = 121/289 (41%), Gaps = 38/289 (13%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
E+GRG +G + HK + Q A K I R ++ + + + ++ ++ + IV+
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAK------GHYSERAAANLCRQMVTVVHYCHSM 187
GA + M+L + FD+ E + V +++
Sbjct: 87 YGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 188 G-VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-----VGSAYYVAPEV 241
++HRD+KP N L S +K DFG+S G + + G Y+APE
Sbjct: 145 LKIIHRDIKPSNILLDRSGN---IKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPER 196
Query: 242 L-----RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDA---ILRGHI-DFSSDP 292
+ R+ Y +D+WS G+ LY L +G P+ S+FD +++G S+
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQLSNSE 254
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIA 341
S S + V L D +R E+L HP++ ++ +++A
Sbjct: 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL---MYEERAVEVA 300
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 80/329 (24%), Positives = 129/329 (39%), Gaps = 49/329 (14%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQF 95
P + + V GK E Y + +G G FGV + ++ +
Sbjct: 9 PLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVES-DEV 67
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK------GAYEDRHSVNLIMDL 149
A K + D RE+QIM + H N+V+LK G +D +NL+++
Sbjct: 68 AIKKV-------LQDKRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 150 CAGGELFDRIIAKGHYSERAAANLCR----QMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205
++ + L + Q++ + Y HS+G+ HRD+KP+N L
Sbjct: 120 V-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--P 176
Query: 206 EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILL 263
LK DFG + G+ + S YY APE++ NY DIWS G ++ L+
Sbjct: 177 PSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236
Query: 264 SGVPPFWGETE----QSIFD-----------AILRGHIDFS-----SDPW-----PNISS 298
G P F GE+ I + +++ P+ P
Sbjct: 237 QGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPP 296
Query: 299 SAKDIVKKMLHADPKERLSAAEVLNHPWM 327
A D++ ++L P RL+A E L HP+
Sbjct: 297 DAIDLISRLLEYTPSARLTAIEALCHPFF 325
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-46
Identities = 71/294 (24%), Positives = 137/294 (46%), Gaps = 14/294 (4%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
D + ++G+G FG + T++ A K I + D++ED+++E+ ++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLS 75
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
+ + G+Y + +IM+ GG D ++ G E A + R+++ +
Sbjct: 76 QCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLD 133
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPEV 241
Y HS +HRD+K N L S E +K DFG++ + ++ VG+ +++APEV
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
++++ Y ++ADIWS G+ L G PP + I + + + S
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY---SKPL 247
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNK 354
K+ V+ L+ +P R +A E+L H + + +A ++ R K+++A
Sbjct: 248 KEFVEACLNKEPSFRPTAKELLKHKF--ILRNAKKTSYLTELIDRYKRWKAEQS 299
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-45
Identities = 73/325 (22%), Positives = 141/325 (43%), Gaps = 27/325 (8%)
Query: 44 SSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSR 103
S A+ + + S+ + + D + +G G +G Y H T Q A K +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-- 58
Query: 104 KLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN------LIMDLCAGGELFD 157
+ D+ E++++E+ ++ + HRNI GA+ ++ L+M+ C G + D
Sbjct: 59 --VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 158 --RIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
+ E A +CR+++ + + H V+HRD+K +N L + +AE +K DF
Sbjct: 117 LIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE---VKLVDF 173
Query: 216 GLSVFFKPGDVFKD-LVGSAYYVAPEVLRRN------YGAEADIWSAGVILYILLSGVPP 268
G+S ++ +G+ Y++APEV+ + Y ++D+WS G+ + G PP
Sbjct: 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
Query: 269 FWGETEQSIFDAILRGHI-DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
I R S W S + ++ L + +R + +++ HP++
Sbjct: 234 LCDMHPMRALFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290
Query: 328 RVDGDASD-KPLDIAVLTRMKQFRA 351
R + + + R K+ R
Sbjct: 291 RDQPNERQVRIQLKDHIDRTKKKRG 315
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-45
Identities = 78/305 (25%), Positives = 130/305 (42%), Gaps = 43/305 (14%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHL 124
Y ++G G +GV + ++DT Q A K D V RE++++ L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDPVIKKIALREIRMLKQL 59
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTVVH 182
H N+V L + + ++L+ + C DR + E ++ Q + V+
Sbjct: 60 K-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVN 116
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEV 241
+CH +HRD+KPEN L + + +K DFG + + P D + D V + +Y +PE+
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
Query: 242 L--RRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAI-------------L 282
L YG D+W+ G + LLSGVP + G+++ I +
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 283 RGHIDFSSDPW----------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332
+ PNIS A ++K LH DP ERL+ ++L+HP+ +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 333 ASDKP 337
D
Sbjct: 294 IEDLA 298
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-45
Identities = 80/353 (22%), Positives = 129/353 (36%), Gaps = 56/353 (15%)
Query: 12 TQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIF 71
T + + P P +K+ ++ + P +Y
Sbjct: 7 TTSFAESCKPVQQPSAF-GSMKVSRDKDGSKVTTVVATPGQG-------PDRPQEVSYTD 58
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIV 131
+ +G G FGV Y D+ + A K + D RE+QIM L H NIV
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLD-HCNIV 110
Query: 132 ELK------GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----QMVTVV 181
L+ G +D +NL++D ++ + + Q+ +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
Y HS G+ HRD+KP+N L LK DFG + G+ + S YY APE+
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAV--LKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 242 L--RRNYGAEADIWSAGVILYILLSGVPPFWGETE---------------QSIFDAILRG 284
+ +Y + D+WSAG +L LL G P F G++ + +
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287
Query: 285 HIDFS-----SDPW-----PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
+ +F + PW P A + ++L P RL+ E H +
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-45
Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 36/286 (12%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
ELGRG +GV + H + Q A K I R +N + + + ++ I V
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 134 KGAYEDRHSVNLIMDLCAGG--ELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHS-MGV 189
GA V + M+L + + ++I K E + +V + + HS + V
Sbjct: 72 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-----VGSAYYVAPEVLR- 243
+HRD+KP N L ++ + +K DFG+S G + D+ G Y+APE +
Sbjct: 132 IHRDVKPSNVLINALGQ---VKMCDFGIS-----GYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 244 ----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFD---AILRGHI-DFSSDPWPN 295
+ Y ++DIWS G+ + L P+ ++ + F ++ +D +
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKF-- 239
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIA 341
S+ D + L + KER + E++ HP+ K D+A
Sbjct: 240 -SAEFVDFTSQCLKKNSKERPTYPELMQHPFFT---LHESKGTDVA 281
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-44
Identities = 79/284 (27%), Positives = 129/284 (45%), Gaps = 24/284 (8%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
D + ELG G FG Y +K+T A K I + +++ED E++I+
Sbjct: 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILA 71
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVV 181
H IV+L GAY + ++++ C GG + + +E +CRQM+ +
Sbjct: 72 TCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD-LVGSAYYVAPE 240
++ HS ++HRDLK N L + + ++ DFG+S +D +G+ Y++APE
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 241 VLRRN------YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP-- 292
V+ Y +ADIWS G+ L + PP E + +L I S P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLL--KIAKSDPPTL 242
Query: 293 --WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDAS 334
S +D +K L +P+ R SAA++L HP++
Sbjct: 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 55/259 (21%), Positives = 102/259 (39%), Gaps = 28/259 (10%)
Query: 88 HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIM 147
++ + + + L + ++ +++ M + +N V + + + M
Sbjct: 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQLQPSSPKVYLYIQM 140
Query: 148 DLCAGGELFDRIIAKGHYSER---AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS 204
LC L D + + +R ++ Q+ V + HS G+MHRDLKP N F+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM- 199
Query: 205 AEDSPLKATDFGLSVFFKPGDVFKDL-------------VGSAYYVAPEVLR-RNYGAEA 250
D +K DFGL + + + VG+ Y++PE + NY +
Sbjct: 200 --DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 251 DIWSAGVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLH 309
DI+S G+IL+ LL F + E+ I + + +V+ ML
Sbjct: 258 DIFSLGLILFELLY---SFSTQMERVRIITDVRNLKF---PLLFTQKYPQEHMMVQDMLS 311
Query: 310 ADPKERLSAAEVLNHPWMR 328
P ER A +++ +
Sbjct: 312 PSPTERPEATDIIENAIFE 330
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-44
Identities = 79/305 (25%), Positives = 134/305 (43%), Gaps = 47/305 (15%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMH 122
Y +G G +G+ +KDT + A K K + DD + V+ RE++++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLK 79
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTV 180
L H N+V L + + L+ + + + + Q++
Sbjct: 80 QLR-HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIING 136
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAP 239
+ +CHS ++HRD+KPEN L S S +K DFG + PG+V+ D V + +Y AP
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR--GHID------FS 289
E+L YG D+W+ G ++ + G P F G+++ I+ G++ F+
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253
Query: 290 SDPW-------------------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330
+P P +S D+ KK LH DP +R AE+L+H + ++D
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313
Query: 331 GDASD 335
G A
Sbjct: 314 GFAER 318
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-43
Identities = 92/334 (27%), Positives = 136/334 (40%), Gaps = 51/334 (15%)
Query: 26 GHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYL 85
HH L+ GP S SA + +S ++ Y +LG G +G Y
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPSATS---------IDR----YRRITKLGEGTYGEVYK 52
Query: 86 VTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHLTGHRNIVELKGAYEDRHSV 143
T + A K I +L + ++ REV ++ L HRNI+ELK H +
Sbjct: 53 AIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRL 108
Query: 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS 203
+LI + +L + S R + Q++ V++CHS +HRDLKP+N L S
Sbjct: 109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167
Query: 204 SAEDSP--LKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVI 258
S LK DFGL+ F P F + + +Y PE+L R+Y DIWS I
Sbjct: 168 SDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACI 227
Query: 259 LYILLSGVPPFWGETEQSIFDAILR--GHID------FSSDPW----------------- 293
+L P F G++E I G D ++ P
Sbjct: 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL 287
Query: 294 -PNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
+ D++ ML DP +R+SA L HP+
Sbjct: 288 GALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 74/339 (21%), Positives = 134/339 (39%), Gaps = 47/339 (13%)
Query: 33 KIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTK 92
+ PPR S + + + +LG G +G Y HK+T
Sbjct: 4 TVQLRNPPRRQLKKLDEDSLT---------KQPEEVFDVLEKLGEGSYGSVYKAIHKETG 54
Query: 93 QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152
Q A K + D++++ +E+ IM ++V+ G+Y + ++M+ C
Sbjct: 55 QIVAIKQVP-----VESDLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDLWIVMEYCGA 108
Query: 153 GELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211
G + D I + +E A + + + + Y H M +HRD+K N L ++ K
Sbjct: 109 GSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH---AK 165
Query: 212 ATDFG----LSVFFKPGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGV 266
DFG L+ + +G+ +++APEV++ Y ADIWS G+ + G
Sbjct: 166 LADFGVAGQLTDTMAKRNTV---IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
Query: 267 PPFWGETEQSIFDAI-------LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAA 319
PP+ I R +S + D VK+ L P++R +A
Sbjct: 223 PPYADIHPMRAIFMIPTNPPPTFRKPELWSDN--------FTDFVKQCLVKSPEQRATAT 274
Query: 320 EVLNHPWMRVDGDASD-KPLDIAVLTRMKQFRAMNKLKK 357
++L HP++R S + L + + + +
Sbjct: 275 QLLQHPFVRSAKGVSILRDL----INEAMDVKLKRQESQ 309
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 71/292 (24%), Positives = 124/292 (42%), Gaps = 28/292 (9%)
Query: 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
P R+ Y +G G V K++ A K I+ K + ++++ +E+
Sbjct: 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEI 64
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--------RIIAKGHYSERAA 170
Q M H NIV ++ + + L+M L +GG + D G E
Sbjct: 65 QAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF-FKPGDVFKD 229
A + R+++ + Y H G +HRD+K N L ++ DFG+S F GD+ ++
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADFGVSAFLATGGDITRN 180
Query: 230 L-----VGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL 282
VG+ ++APEV+ + Y +ADIWS G+ L +G P+ + L
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240
Query: 283 RG------HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
+ + S + ++ L DP++R +AAE+L H + +
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 78/355 (21%), Positives = 129/355 (36%), Gaps = 67/355 (18%)
Query: 33 KIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTK 92
+++ R A VG + +D + ELG G GV + V+HK +
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGEL---KDDD----FEKISELGAGNGGVVFKVSHKPSG 58
Query: 93 QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152
A K I I + RE+Q++H IV GA+ +++ M+ G
Sbjct: 59 LVMARKLI--HLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG-VMHRDLKPENFLFSSSAEDSPLK 211
G L + G E+ + ++ + Y +MHRD+KP N L +S E +K
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IK 172
Query: 212 ATDFGLSVFFKPGDVFKDL----VGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGV 266
DFG+S G + + VG+ Y++PE L+ Y ++DIWS G+ L + G
Sbjct: 173 LCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
Query: 267 PPF--------------------WGETEQSIFDAILRGHIDFSSDPWPNI---------- 296
P + S P I
Sbjct: 228 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287
Query: 297 ----------SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIA 341
S +D V K L +P ER +++ H +++ + + +D A
Sbjct: 288 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK---RSDAEEVDFA 339
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 75/294 (25%), Positives = 122/294 (41%), Gaps = 43/294 (14%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-----VRREVQIM 121
Y LG GQF Y K+T Q A K I KL +R + +D RE++++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLL 66
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVT 179
L+ H NI+ L A+ + +++L+ D + + +
Sbjct: 67 QELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQ 123
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVA 238
+ Y H ++HRDLKP N L + LK DFGL+ F P + V + +Y A
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180
Query: 239 PEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAI----------- 281
PE+L R YG D+W+ G IL LL VP G+++ IF+ +
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 282 --LRGHIDFSSDP-------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
L ++ F S P + D+++ + +P R++A + L +
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 77/305 (25%), Positives = 118/305 (38%), Gaps = 58/305 (19%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-----VRREVQIM 121
+ + +LG G + Y +K T A K + + D E+ RE+ +M
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAIREISLM 57
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHYSERAAANLCRQ 176
L H NIV L + + L+ DL + Q
Sbjct: 58 KELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAY 235
++ + +CH ++HRDLKP+N L + + LK DFGL+ F P + F V + +
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVTLW 173
Query: 236 YVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAI-------- 281
Y AP+VL R Y DIWS G IL +++G P F G ++ IFD +
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 282 --------------------LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEV 321
LR + + D + +L +P RLSA +
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQV--LQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291
Query: 322 LNHPW 326
L+HPW
Sbjct: 292 LHHPW 296
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 66/369 (17%), Positives = 128/369 (34%), Gaps = 64/369 (17%)
Query: 63 EDVRNTYIFGRELGRGQ--FGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
Y +G+G L +K T + + I+ + + V ++ E+ +
Sbjct: 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHV 79
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMV 178
H NIV + + + + ++ A G D +E A A + + ++
Sbjct: 80 SKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF--------KPGDVFKDL 230
+ Y H MG +HR +K + L S + + + ++ D K
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGK---VYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 231 VGSAYYVAPEVLRRN---YGAEADIWSAGVILYILLSGVPPF------------------ 269
V +++PEVL++N Y A++DI+S G+ L +G PF
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255
Query: 270 ------------------WGETEQSIFDAILRGHIDFSSDPWPNI------SSSAKDIVK 305
+ D++ S+ P+ S V+
Sbjct: 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315
Query: 306 KMLHADPKERLSAAEVLNHPWMRVDGDASDKPLD--IAVLTRMKQFRAMNKLKKVALKVI 363
+ L +P R SA+ +LNH + + + + L + +T + F + +
Sbjct: 316 QCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGL 375
Query: 364 AENLSEEEI 372
NL E E+
Sbjct: 376 VTNLEELEV 384
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-41
Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 42/285 (14%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHLTGHRNIVE 132
+G G +G + +++T + A K + +L + D+ RE+ ++ L H+NIV
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELK-HKNIVR 65
Query: 133 LKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
L + L+ + C + FD G + Q++ + +CHS V+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVL--RRNYG 247
HRDLKP+N L + + E LK +FGL+ F P + V + +Y P+VL + Y
Sbjct: 124 HRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 248 AEADIWSAGVILYILLS-GVPPFWGETE----QSIFDAI-------------LRGHIDFS 289
D+WSAG I L + G P F G + IF + L + +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 290 SDP--------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
P P ++++ +D+++ +L +P +R+SA E L HP+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 76/303 (25%), Positives = 118/303 (38%), Gaps = 63/303 (20%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED-----VRREVQIM 121
TYI +LG G + Y K T A K I R + E+ REV ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLL 54
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLC---------AGGELFDRIIAKGHYSERAAAN 172
L H NIV L S+ L+ + G + + K
Sbjct: 55 KDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVK---------L 104
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLV 231
Q++ + YCH V+HRDLKP+N L + E LK DFGL+ P + + V
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEV 161
Query: 232 GSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IF------- 278
+ +Y P++L +Y + D+W G I Y + +G P F G T + IF
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221
Query: 279 DAILRGHIDFS---------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323
+ G + P + S D++ K+L + + R+SA + +
Sbjct: 222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281
Query: 324 HPW 326
HP+
Sbjct: 282 HPF 284
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 80/290 (27%), Positives = 125/290 (43%), Gaps = 42/290 (14%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHLTG 126
Y ++G G +GV Y + + FA K I +L D+ RE+ I+ L
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALKKI---RLEKEDEGIPSTTIREISILKELK- 58
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
H NIV+L + + L+ + +L D +G A + Q++ + YC
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYC 116
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVL- 242
H V+HRDLKP+N L + E LK DFGL+ F P + + + +Y AP+VL
Sbjct: 117 HDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 243 -RRNYGAEADIWSAGVILYILLSGVPPFWGETE----QSIFDAI-------------LRG 284
+ Y DIWS G I +++G P F G +E IF + L
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 285 -HIDFSSDP-------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
+F+ + S D++ KML DP +R++A + L H +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 67/308 (21%), Positives = 121/308 (39%), Gaps = 61/308 (19%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
++ Y R+LGRG++ + + ++ + K++ + ++RE++I+ +
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV---V---KILKPVKKKKIKREIKILEN 86
Query: 124 LTGHRNIVELKGAYEDRHSVNLI--------MDLCAGGELFDRIIAKGHYSERAAANLCR 175
L G NI+ L +D S D ++ ++
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF-------KQLYQT--LTDYDIRFYMY 137
Query: 176 QMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY 235
+++ + YCHSMG+MHRD+KP N + L+ D+GL+ F+ PG + V S Y
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 236 YVAPEVL--RRNYGAEADIWSAGVILYILLSGVPP-FWGETEQSIFDAILR--------- 283
+ PE+L + Y D+WS G +L ++ P F G I +
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255
Query: 284 --GHID----------------------FSSDPWPNISSSAKDIVKKMLHADPKERLSAA 319
+ S+ +S A D + K+L D + RL+A
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315
Query: 320 EVLNHPWM 327
E + HP+
Sbjct: 316 EAMEHPYF 323
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 76/293 (25%), Positives = 118/293 (40%), Gaps = 43/293 (14%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHL 124
Y ++G G +GV Y + A K I +L D+ RE+ ++ L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI---RLDAEDEGIPSTAIREISLLKEL 76
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAANLCRQMVTVVH 182
H NIV L + L+ + ++ D K + Q++ V
Sbjct: 77 H-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVA 133
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEV 241
+CH ++HRDLKP+N L +S LK DFGL+ F P + V + +Y AP+V
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 242 L--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAI-------------L 282
L + Y DIWS G I +++G P F G T+ IF + L
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250
Query: 283 RGHIDFSSDPW---------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
+ + P D++ ML DP +R+SA + +NHP+
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-39
Identities = 81/325 (24%), Positives = 120/325 (36%), Gaps = 55/325 (16%)
Query: 48 SATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN 107
S S + + + + R G+G FG L K T A K +
Sbjct: 4 SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV------- 56
Query: 108 RDDVEDVRREVQIMHHLT--GHRNIVELK-----GAYEDRHSV--NLIMDLCAGGELFDR 158
D RE+QIM L H NIV+L+ DR + N++M+ L
Sbjct: 57 IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRC 115
Query: 159 IIAKGHYSERAAANLCR----QMVTVVHYCH--SMGVMHRDLKPENFLFSSSAEDSPLKA 212
L + Q++ + H S+ V HRD+KP N L + + D LK
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKL 173
Query: 213 TDFGLSVFFKPGDVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFW 270
DFG + P + + S YY APE++ ++Y DIWS G I ++ G P F
Sbjct: 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233
Query: 271 GETEQSIFDAILR---------------GHIDFS-----SDPW--------PNISSSAKD 302
G+ I+R H D PW + A D
Sbjct: 234 GDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYD 293
Query: 303 IVKKMLHADPKERLSAAEVLNHPWM 327
++ +L P+ER+ E L HP+
Sbjct: 294 LLSALLQYLPEERMKPYEALCHPYF 318
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-39
Identities = 75/300 (25%), Positives = 115/300 (38%), Gaps = 49/300 (16%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR-----REVQIM 121
+ Y E+G G +G Y + A KS+ ++ N REV ++
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALL 65
Query: 122 HHL--TGHRNIVELK-----GAYEDRHSVNLIMDLCAG--GELFDRIIAKGHYSERAAAN 172
L H N+V L + V L+ + D+ G +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKD 124
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232
L RQ + + + H+ ++HRDLKPEN L +S +K DFGL+ + +V
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSYQMALTPVVV 181
Query: 233 SAYYVAPEVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAILRGHID 287
+ +Y APEVL + Y D+WS G I + P F G +E IFD L G
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD--LIGLPP 239
Query: 288 ------FSSDPW---------------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
S P P + S ++ +ML +P +R+SA L H +
Sbjct: 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-39
Identities = 65/270 (24%), Positives = 117/270 (43%), Gaps = 25/270 (9%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD----VEDVRREVQIMHHLTG 126
+ +++G+G FG+ + K A KS+ + ++ +REV IM +L
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN- 81
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCH 185
H NIV+L G + ++M+ G+L+ R++ K H L + + Y
Sbjct: 82 HPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 186 SMG--VMHRDLKPENFLFSSSAEDSP--LKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
+ ++HRDL+ N S E++P K DFGLS L+G+ ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMAPET 197
Query: 242 LR---RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
+ +Y +AD +S +ILY +L+G PF + I + P I
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR----PTIPE 253
Query: 299 SA----KDIVKKMLHADPKERLSAAEVLNH 324
+++++ DPK+R + ++
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-39
Identities = 62/306 (20%), Positives = 123/306 (40%), Gaps = 34/306 (11%)
Query: 42 PSSSATSATSSSVGRVLGKPMEDVRNTYI------FGRELGRGQFGVTYLVTHKDTKQQF 95
P + + ++ S R + ++ I G +G+G+FG Y +
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH---GEV 58
Query: 96 ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL 155
A + I + N D ++ +REV H N+V GA + +I LC G L
Sbjct: 59 AIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 156 FDRI-IAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214
+ + AK + +++V + Y H+ G++H+DLK +N + ++ + TD
Sbjct: 117 YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITD 172
Query: 215 FGLSVFFKP------GDVFKDLVGSAYYVAPEVLRRN----------YGAEADIWSAGVI 258
FGL D + G ++APE++R+ + +D+++ G I
Sbjct: 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
Query: 259 LYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSA 318
Y L + PF + ++I + G + + DI+ + +ER +
Sbjct: 233 WYELHAREWPFKTQPAEAIIWQMGTGMK--PNLSQIGMGKEISDILLFCWAFEQEERPTF 290
Query: 319 AEVLNH 324
++++
Sbjct: 291 TKLMDM 296
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 32/266 (12%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
+GRG FGV + + A K ++ + + + E++ + + H NI
Sbjct: 12 VEEVVGRGAFGVVCKAKWRA--KDVAIK-----QIESESERKAFIVELRQLSRVN-HPNI 63
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSM 187
V+L GA + L+M+ GG L++ + +Y+ A + C Q V Y HSM
Sbjct: 64 VKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 188 ---GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
++HRDLKP N L + + LK DFG + + + GSA ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAG--GTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEG 177
Query: 245 N-YGAEADIWSAGVILYILLSGVPPFWG--ETEQSIFDAILRGH---IDFSSDPWPNISS 298
+ Y + D++S G+IL+ +++ PF I A+ G + N+
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI------KNLPK 231
Query: 299 SAKDIVKKMLHADPKERLSAAEVLNH 324
+ ++ + DP +R S E++
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 86/326 (26%), Positives = 139/326 (42%), Gaps = 64/326 (19%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
D+ + Y+ + LG G G+ + D ++ A K I V+ RE++I+
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRR 64
Query: 124 LTGHRNIVELK--------------GAYEDRHSVNLIM-----DLCAGGELFDRIIAKGH 164
L H NIV++ G+ + +SV ++ DL ++ +G
Sbjct: 65 L-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA-------NVLEQGP 116
Query: 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
E A Q++ + Y HS V+HRDLKP N ++ ED LK DFGL+ P
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDPH 174
Query: 225 DVFKDL----VGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETE---- 274
K + + +Y +P +L NY D+W+AG I +L+G F G E
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
Query: 275 QSIFDAI------------------LRGHIDFSSDPW----PNISSSAKDIVKKMLHADP 312
Q I ++I +R + P P IS A D ++++L P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 313 KERLSAAEVLNHPWMRVDGDASDKPL 338
+RL+A E L+HP+M + D+P+
Sbjct: 295 MDRLTAEEALSHPYMSIYSFPMDEPI 320
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-36
Identities = 72/307 (23%), Positives = 123/307 (40%), Gaps = 40/307 (13%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
+VR Y + +G G +G T + A K + R + + RE++++ H
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKH 80
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVT 179
+ H N++ L + +++ D +++ E L QM+
Sbjct: 81 MR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK 139
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ Y H+ G++HRDLKP N + D LK DFGL+ V + +Y AP
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNE---DCELKILDFGLARQADSE--MTGYVVTRWYRAP 194
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWG-------------------ETEQSIF 278
EV+ Y DIWS G I+ +++G F G E Q +
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254
Query: 279 DAILRGHID----FSSDPW----PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330
+ ++ + N S A ++++KML D ++R++A E L HP+
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
Query: 331 GDASDKP 337
D D+P
Sbjct: 315 HDTEDEP 321
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 77/310 (24%), Positives = 128/310 (41%), Gaps = 46/310 (14%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
+V Y +G G +G T + A K +S R + + RE++++ H
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKH 84
Query: 124 LTGHRNIVELK------GAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQM 177
+ H N++ L + E+ + V L+ L G +L + I+ ++ L Q+
Sbjct: 85 MK-HENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQFLIYQI 141
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK-DLVGSAYY 236
+ + Y HS ++HRDLKP N + D LK DFGL+ + V + +Y
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNE---DCELKILDFGLA---RHTADEMTGYVATRWY 195
Query: 237 VAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWG-------------------ETEQ 275
APE++ +Y DIWS G I+ LL+G F G E +
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 276 SIFDAILRGHID----FSSDPW----PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
I R +I + + A D+++KML D +R++AA+ L H +
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
Query: 328 RVDGDASDKP 337
D D+P
Sbjct: 316 AQYHDPDDEP 325
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 77/310 (24%), Positives = 128/310 (41%), Gaps = 78/310 (25%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR----REVQIMHHLTGHRNI 130
+G+G FG + H+ T Q+ A K K++ ++ E RE++I+ L H N+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQLLK-HENV 78
Query: 131 VELKG--------AYEDRHSVNLIMDLC----AGGELFDRIIAKGHYSERAAANLCRQMV 178
V L + S+ L+ D C AG L + ++ + + ++
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSEIKRVMQMLL 134
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAY--- 235
++Y H ++HRD+K N L + LK DFGL+ F + K+ + Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAF---SLAKNSQPNRYTNR 188
Query: 236 -----YVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAILRG 284
Y PE+L R+YG D+W AG I+ + + P G TEQ I L G
Sbjct: 189 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ--LCG 246
Query: 285 HIDFSSDPWPNISS----------------------------SAKDIVKKMLHADPKERL 316
I + + WPN+ + A D++ K+L DP +R+
Sbjct: 247 SI--TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 317 SAAEVLNHPW 326
+ + LNH +
Sbjct: 305 DSDDALNHDF 314
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 73/348 (20%), Positives = 125/348 (35%), Gaps = 86/348 (24%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSI---SSRKLINRDDVEDVRREVQ 119
E Y G+ LG G FG+ V ++ ++FA K + K RE+
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN----------RELD 52
Query: 120 IMHHLTGHRNIVELK--------------------------------------GAYEDRH 141
IM L H NI++L
Sbjct: 53 IMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111
Query: 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----QMVTVVHYCHSMGVMHRDLKPE 197
+N+IM+ L + + NL Q+ V + HS+G+ HRD+KP+
Sbjct: 112 YLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQ 170
Query: 198 NFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL--RRNYGAEADIWSA 255
N L +++D+ LK DFG + P + + S +Y APE++ Y D+WS
Sbjct: 171 NLLV--NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 256 GVILYILLSGVPPFWGETE---------------QSIFDAILRGHIDFSSDPWPNIS--- 297
G + L+ G P F GET + + + +
Sbjct: 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288
Query: 298 -------SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338
S A D+++++L +P R++ E + HP+ ++ + +
Sbjct: 289 ILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEV 336
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 80/317 (25%), Positives = 128/317 (40%), Gaps = 49/317 (15%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
V Y + +G G G+ ++ A K +S R N+ + RE+ +M
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKC 80
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVT 179
+ H+NI+ L + + S+ D+ EL D ++I ER + L QM+
Sbjct: 81 V-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-YLLYQMLC 138
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ + HS G++HRDLKP N + S LK DFGL+ + V + YY AP
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 240 EV-LRRNYGAEADIWSAGVILYILLSGVPPFWGE----------------TEQSI----- 277
EV L Y DIWS G I+ ++ G F G + +
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 278 ----------------FDAILRGHIDFSSDPWPNISSS-AKDIVKKMLHADPKERLSAAE 320
F+ + + + + +S A+D++ KML D +R+S E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315
Query: 321 VLNHPWMRVDGDASDKP 337
L HP++ V D S+
Sbjct: 316 ALQHPYINVWYDPSEAE 332
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 80/307 (26%), Positives = 127/307 (41%), Gaps = 41/307 (13%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
++ TY+ +G G +G K + ++ A K +S R + + RE+ ++ H
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKH 79
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVT 179
+ H N++ L + S+ D +I+ +SE L QM+
Sbjct: 80 MQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM-GLKFSEEKIQYLVYQMLK 137
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ Y HS GV+HRDLKP N + D LK DFGL+ V + +Y AP
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNE---DCELKILDFGLARHADAE--MTGYVVTRWYRAP 192
Query: 240 EVL--RRNYGAEADIWSAGVILYILLSGVPPFWG-------------------ETEQSIF 278
EV+ +Y DIWS G I+ +L+G F G E Q +
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252
Query: 279 DAILRGHID----FSSDPW----PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330
D + +I + P S A D+++KML D +RL+AA+ L HP+
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312
Query: 331 GDASDKP 337
D ++
Sbjct: 313 RDPEEET 319
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 53/293 (18%)
Query: 75 LGRGQFGVTYLVTH-KDTKQQFACKSISSRKLINRDDVEDVR--REVQIMHHL--TGHRN 129
+G G +G + K+ + A K + ++ ++ + REV ++ HL H N
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 130 IVELK-----GAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
+V L + + L+ DL D++ + ++ Q++
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQDL---TTYLDKV-PEPGVPTETIKDMMFQLLR 131
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ + HS V+HRDLKP+N L +SS + +K DFGL+ + +V + +Y AP
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 240 EVL-RRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAILRGHID------F 288
EVL + +Y D+WS G I + P F G ++ I D I G
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI--GLPGEEDWPRD 246
Query: 289 SSDPW---------------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
+ P +I KD++ K L +P +R+SA L+HP+
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-35
Identities = 82/320 (25%), Positives = 125/320 (39%), Gaps = 62/320 (19%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR---REVQI 120
DV Y +G G +G+ K + A K K+ + + RE++I
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKI 78
Query: 121 MHHLTGHRNIVELK-----GAYEDRHSVNLIM-----DLCAGGELFDRIIAKGHYSERAA 170
+ H NI+ + E V ++ DL +++ H S
Sbjct: 79 LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-------KLLKTQHLSNDHI 130
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230
Q++ + Y HS V+HRDLKP N L ++ LK DFGL+ P
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLARVADPDHDHTGF 187
Query: 231 ----VGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWG------------- 271
V + +Y APE++ + Y DIWS G IL +LS P F G
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247
Query: 272 ------ETEQSIFDAILRGHID----FSSDPW----PNISSSAKDIVKKMLHADPKERLS 317
E I + R ++ + PW PN S A D++ KML +P +R+
Sbjct: 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307
Query: 318 AAEVLNHPWMRVDGDASDKP 337
+ L HP++ D SD+P
Sbjct: 308 VEQALAHPYLEQYYDPSDEP 327
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 76/317 (23%), Positives = 126/317 (39%), Gaps = 49/317 (15%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
V Y + +G G G+ + A K +S R N+ + RE+ +M
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKC 117
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAANLCRQMVT 179
+ H+NI+ L + + ++ D+ EL D ++I + + L QM+
Sbjct: 118 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-QMELDHERMSYLLYQMLC 175
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ + HS G++HRDLKP N + S D LK DFGL+ + V + YY AP
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 240 EV-LRRNYGAEADIWSAGVILYILLSGVPPFWGE----------------TEQSI----- 277
EV L Y DIWS G I+ ++ F G + +
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 278 ----------------FDAILRGHIDFSSDPWPNISSS-AKDIVKKMLHADPKERLSAAE 320
F + + + + +S A+D++ KML DP +R+S +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 321 VLNHPWMRVDGDASDKP 337
L HP++ V D ++
Sbjct: 353 ALQHPYINVWYDPAEVE 369
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-35
Identities = 49/72 (68%), Positives = 57/72 (79%)
Query: 347 KQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRL 406
KQF AMNK KK+AL+VIAE+LSEEEI GLKEMF +D D SG ITFEELKAGL ++G L
Sbjct: 1 KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANL 60
Query: 407 SESEVRQLMEAV 418
ESE+ LM+A
Sbjct: 61 KESEILDLMQAA 72
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 4e-06
Identities = 15/56 (26%), Positives = 25/56 (44%), Gaps = 5/56 (8%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + E+ L F D D SG IT +EL+ + G + + + +LM V
Sbjct: 92 LNKIEREDH---LFAAFTYFDKDGSGYITPDELQQACEEFG--VEDVRIEELMRDV 142
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 24/95 (25%), Positives = 44/95 (46%), Gaps = 12/95 (12%)
Query: 336 KPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSE-EEIMGLKEMFKSMDTDNSGTITFEE 394
K L MK+F++ KL + A+ + L+ EE L ++F+ +D + G + +E
Sbjct: 2 KHALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKE 61
Query: 395 LKAGLPK-----------LGTRLSESEVRQLMEAV 418
L G K L + E+EV ++++V
Sbjct: 62 LIEGYRKLMQWKGDTVSDLDSSQIEAEVDHILQSV 96
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 15/54 (27%), Positives = 22/54 (40%), Gaps = 5/54 (9%)
Query: 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
LS E L F+ D+D SG IT EEL + + Q+++
Sbjct: 118 LLLSRER---LLAAFQQFDSDGSGKITNEELGRLFGVTE--VDDETWHQVLQEC 166
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 61/265 (23%), Positives = 111/265 (41%), Gaps = 24/265 (9%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
++G G FG + A K + + + + V + REV IM L H NI
Sbjct: 41 IKEKIGAGSFGTVHRAEWHG--SDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNI 96
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRII---AKGHYSERAAANLCRQMVTVVHYCHSM 187
V GA +++++ + + G L+ + A+ ER ++ + ++Y H+
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 188 G--VMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSAYYVAPEVLRR 244
++HR+LK N L + +K DFGLS + K G+ ++APEVLR
Sbjct: 157 NPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 245 N-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA--- 300
++D++S GVIL+ L + P+ + A+ I +
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------LEIPRNLNPQ 267
Query: 301 -KDIVKKMLHADPKERLSAAEVLNH 324
I++ +P +R S A +++
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 21/266 (7%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD-VEDVRREVQIMHHLTGHRN 129
+G G FG Y + A K+ + +E+VR+E ++ L H N
Sbjct: 11 LEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPN 67
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG- 188
I+ L+G ++ L+M+ GG L +++ N Q+ ++Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 189 --VMHRDLKPENFLFSSSAEDSP-----LKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
++HRDLK N L E+ LK TDFGL+ G+ ++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTKMSAAGAYAWMAPEV 185
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI--DFSSDPWPNISS 298
+R + + +D+WS GV+L+ LL+G PF G ++ + + S
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF-- 243
Query: 299 SAKDIVKKMLHADPKERLSAAEVLNH 324
+++ + DP R S +L+
Sbjct: 244 --AKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 17/83 (20%), Positives = 46/83 (55%), Gaps = 4/83 (4%)
Query: 338 LDIAVLTRMKQFRAMNKLKKVALKVIAENLS--EEEIMGLKEMFKSMDTDNSGTITFEEL 395
+ VL MK + + ++ + + ++A LS I + E+F +DT+++G+++ E+
Sbjct: 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61
Query: 396 KAGLPKLGTRLSESEVRQLMEAV 418
L +G + + ++ ++++A+
Sbjct: 62 YTVLASVG--IKKWDINRILQAL 82
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-05
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 5/61 (8%)
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
+A +N+ LK F +D D G I+ ++ + + L +++ +
Sbjct: 96 MAGCYRWKNIESTF---LKAAFNKIDKDEDGYISKSDIVSLVHDKV--LDNNDIDNFFLS 150
Query: 418 V 418
V
Sbjct: 151 V 151
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 24/217 (11%)
Query: 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN 129
I G LG+G FG VTH++T + K + + + +EV++M L H N
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPN 68
Query: 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+++ G +N I + GG L I Y + + + + + Y HSM
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLS---------------VFFKPGDVFKDLVGS 233
++HRDL N L E+ + DFGL+ + +VG+
Sbjct: 129 IIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 234 AYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPF 269
Y++APE++ R+Y + D++S G++L ++ V
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 65/323 (20%), Positives = 114/323 (35%), Gaps = 60/323 (18%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-----DDVEDVR--- 115
+++ Y R + G +G A K + + R D +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 116 REVQIMHHLTGHRNIVELK-----GAYEDRHSVNLIMDLCAGGELFD----RIIAKGHY- 165
RE+++++H H NI+ L+ H + L+ EL ++I
Sbjct: 78 REIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVT------ELMRTDLAQVIHDQRIV 130
Query: 166 -SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
S + ++ +H H GV+HRDL P N L + ++ + DF L+
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD---NNDITICDFNLAREDTAD 187
Query: 225 DVFKDLVGSAYYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWG----------- 271
V +Y APE++ + + D+WSAG ++ + + F G
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247
Query: 272 --------ETEQSIFDAILRGHIDFS-----SDPW----PNISSSAKDIVKKMLHADPKE 314
E R ++ S + W P A D++ KML +P+
Sbjct: 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
Query: 315 RLSAAEVLNHPWMRVDGDASDKP 337
R+S + L HP+ D D
Sbjct: 308 RISTEQALRHPYFESLFDPLDLT 330
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 61/264 (23%), Positives = 111/264 (42%), Gaps = 19/264 (7%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
G+ +G G FG Y A K ++ ++ + EV ++ H NI
Sbjct: 28 VGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNI 82
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSMGV 189
+ G + ++ C G L+ + ++ + + ++ RQ + Y H+ +
Sbjct: 83 LLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLS---VFFKPGDVFKDLVGSAYYVAPEVLRRN- 245
+HRDLK N ED+ +K DFGL+ + F+ L GS ++APEV+R
Sbjct: 142 IHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 246 ---YGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFSSDPWP-NISSSA 300
Y ++D+++ G++LY L++G P+ I + + RG + N
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 301 KDIVKKMLHADPKERLSAAEVLNH 324
K ++ + L ER S +L
Sbjct: 259 KRLMAECLKKKRDERPSFPRILAE 282
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 71/328 (21%), Positives = 114/328 (34%), Gaps = 71/328 (21%)
Query: 63 EDVRNTY-IFGRELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVED-VRREV 118
E V + + G ++GRG +G Y KD + +A K I + RE+
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI------EGTGISMSACREI 69
Query: 119 QIMHHLTGHRNIVELKGAYEDR--HSVNLIMD--------LCAGGELFDRIIAKGHYSER 168
++ L H N++ L+ + V L+ D +
Sbjct: 70 ALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 169 AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS-PLKATDFGLS-VFFKPGDV 226
+L Q++ +HY H+ V+HRDLKP N L + +K D G + +F P
Sbjct: 129 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 227 FKDLVGSA---YYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI 281
DL +Y APE+L R+Y DIW+ G I LL+ P F E
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 282 LRG----HI-------------DFSSDPW--------------------------PNISS 298
I D P S
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308
Query: 299 SAKDIVKKMLHADPKERLSAAEVLNHPW 326
A +++K+L DP +R+++ + + P+
Sbjct: 309 KAFHLLQKLLTMDPIKRITSEQAMQDPY 336
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 48/268 (17%), Positives = 96/268 (35%), Gaps = 31/268 (11%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
F +L G + + K + R R D E + + H N+
Sbjct: 14 FLTKLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRK-SRDFNEECPRLRIFS-HPNV 69
Query: 131 VELKGAYEDRHSVNL--IMDLCAGGELFDRIIAKGHY--SERAAANLCRQMVTVVHYCHS 186
+ + GA + + + I G L++ + ++ + A M + + H+
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 187 MG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
+ + L + + ED + + + F+ + + +VAPE L++
Sbjct: 130 LEPLIPRHALNSRSVMID---EDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQK 182
Query: 245 ----NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI----LRGHIDFSSDPWPNI 296
AD+WS V+L+ L++ PF + I + LR I P P I
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI-----P-PGI 236
Query: 297 SSSAKDIVKKMLHADPKERLSAAEVLNH 324
S ++K ++ DP +R ++
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 70/309 (22%), Positives = 123/309 (39%), Gaps = 37/309 (11%)
Query: 24 GPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVT 83
HH + G S S G G Y R +GRG G
Sbjct: 3 SSHHHHH----HSSGLVPRGSHMDGTAESREGTQFGP--------YRLRRLVGRGGMGDV 50
Query: 84 YLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143
Y ++ A K +S + ++RE + L ++V + E +
Sbjct: 51 YEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQL 109
Query: 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS 203
+ M L G +L + +G + A + RQ+ + + H+ G HRD+KPEN L S
Sbjct: 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS- 168
Query: 204 SAEDSPLKATDFGL------SVFFKPGDVFKDLVGSAYYVAPEVLRRNY-GAEADIWSAG 256
D DFG+ + G+ VG+ YY+APE ++ ADI++
Sbjct: 169 --ADDFAYLVDFGIASATTDEKLTQLGNT----VGTLYYMAPERFSESHATYRADIYALT 222
Query: 257 VILYILLSGVPPFWGETEQSIFDAILRGHIDFS----SDPWPNISSSAKDIVKKMLHADP 312
+LY L+G PP+ G+ +++ HI+ + S P I + ++ + + +P
Sbjct: 223 CVLYECLTGSPPYQGDQL-----SVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNP 277
Query: 313 KER-LSAAE 320
++R ++ +
Sbjct: 278 EDRYVTCGD 286
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 81/327 (24%), Positives = 131/327 (40%), Gaps = 68/327 (20%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR---REVQI 120
++ + + LG G +GV THK T + A K K+ D RE++I
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKI 62
Query: 121 MHHLTGHRNIVELK-----GAYEDRHSVNLIMDLCAGGELFD----RIIAKGHYSERAAA 171
+ H H NI+ + ++E+ + V +I EL R+I+ S+
Sbjct: 63 LKHFK-HENIITIFNIQRPDSFENFNEVYIIQ------ELMQTDLHRVISTQMLSDDHIQ 115
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKDL 230
Q + V H V+HRDLKP N L +S + LK DFGL+ + + +
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGLARIIDESAADNSEP 172
Query: 231 VGSA----------YYVAPEVL--RRNYGAEADIWSAGVILYILLSGVPPFWGE------ 272
G +Y APEV+ Y D+WS G IL L P F G
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232
Query: 273 ----------TEQSIFDAI--------LRGHIDFSSDPW----PNISSSAKDIVKKMLHA 310
+ I ++ + + P P ++ D++++ML
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292
Query: 311 DPKERLSAAEVLNHPWMRVDGDASDKP 337
DP +R++A E L HP+++ D +D+P
Sbjct: 293 DPAKRITAKEALEHPYLQTYHDPNDEP 319
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 28/132 (21%), Positives = 47/132 (35%), Gaps = 13/132 (9%)
Query: 293 WPNISSSAKDIVKKMLHADPK------ERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRM 346
I+ ++ K+ D K R A D A + L +
Sbjct: 43 EAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARG--DAAAEKQRLASLLKDLE 100
Query: 347 KQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRL 406
N+L+ LSEE+ L+++F S SG +F++LK L K +
Sbjct: 101 DDASGYNRLR-----PSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTI 155
Query: 407 SESEVRQLMEAV 418
E +++L V
Sbjct: 156 PEGPLKKLFVMV 167
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 9/45 (20%), Positives = 18/45 (40%), Gaps = 1/45 (2%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTR-LSESEVRQLMEAV 418
L+ ++ D D SG ++ EE++ L + + V
Sbjct: 255 LRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVV 299
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 20/277 (7%)
Query: 54 VGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED 113
+G+++ Y +LG G YL + A K+I + ++
Sbjct: 5 IGKIIN-------ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR 57
Query: 114 VRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL 173
REV L+ H+NIV + E+ L+M+ G L + I + G S A N
Sbjct: 58 FEREVHNSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINF 116
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD--LV 231
Q++ + + H M ++HRD+KP+N L + LK DFG++ + + ++
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQTNHVL 173
Query: 232 GSAYYVAPEVLRRNY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF-- 288
G+ Y +PE + DI+S G++LY +L G PPF GET SI AI
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSVPN 231
Query: 289 -SSDPWPNISSSAKDIVKKMLHADPKER-LSAAEVLN 323
++D +I S +++ + D R + E+ +
Sbjct: 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKD 268
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 79/353 (22%), Positives = 135/353 (38%), Gaps = 85/353 (24%)
Query: 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
G+ V Y ++LG+G +G+ + + T + A K I N D + RE+
Sbjct: 1 GRVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREI 59
Query: 119 QIMHHLTGHRNIVELKGAY--EDRHSVNLIM-----DLCAGGELFDRIIAKGHYSERAAA 171
I+ L+GH NIV L ++ V L+ DL +I
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLH-------AVIRANILEPVHKQ 112
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
+ Q++ V+ Y HS G++HRD+KP N L ++ + +K DFGLS F + +
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 232 GSA----------------------YYVAPEVL--RRNYGAEADIWSAGVILYILLSGVP 267
+ +Y APE+L Y D+WS G IL +L G P
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
Query: 268 PFWGE----------------TEQSI--------------------------FDAILRGH 285
F G + + + D +
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWK 289
Query: 286 IDFSS-DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKP 337
+P + + A D++ K+L +P +R+SA + L HP++ + + +++P
Sbjct: 290 NLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEP 342
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 16/95 (16%), Positives = 36/95 (37%)
Query: 324 HPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMD 383
P + + +P+ + + ++ ++ + + ++ + + F +D
Sbjct: 2 QPPVANFCLWNLQPIQGSWMGAACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVD 61
Query: 384 TDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
D SGT+ EL G G RLS ++M
Sbjct: 62 RDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIF 96
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 8e-29
Identities = 60/293 (20%), Positives = 109/293 (37%), Gaps = 42/293 (14%)
Query: 40 PRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKD-TKQQFACK 98
P S + + G ++ Y + G G YL ++ + K
Sbjct: 60 PYCGSPYSFLPQLNPGDIVA-------GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK 112
Query: 99 SISSRKLINRDDVEDV---RREVQIMHHLTGHRNIVEL--KGAYEDRHSVN---LIMDLC 150
L++ D E E Q + + H +IV++ + DRH ++M+
Sbjct: 113 G-----LVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYV 166
Query: 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210
G L A +++ + Y HS+G+++ DLKPEN + + + L
Sbjct: 167 GGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQL 220
Query: 211 KATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFW 270
K D G + F L G+ + APE++R DI++ G L L +P
Sbjct: 221 KLIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRN 277
Query: 271 GETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER-LSAAEVL 322
G + + DP S ++++ + DP++R +A E+
Sbjct: 278 GRYVDGLPE----------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS 320
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 64/325 (19%), Positives = 115/325 (35%), Gaps = 72/325 (22%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--- 125
YI R+LG G F +L A K + K E E++++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDAD 76
Query: 126 -------GHRNIVELKGAYEDRHSVN----LIMDLCAGGELFDRIIAKGH--YSERAAAN 172
G +I++L + + ++ ++ G L I H
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 173 LCRQMVTVVHYCHSM-GVMHRDLKPENFLFS---SSAEDSPLKATDFGLSVFFKPGDVFK 228
+ +Q++ + Y H G++H D+KPEN L S +K D G + + + +
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYT 193
Query: 229 DLVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----------- 276
+ + + Y +PEV L +G ADIWS +++ L++G F + S
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 277 --------------------IFDAILRGHIDFSSDPWPNISSSAK-------------DI 303
F++ WP + D
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 304 VKKMLHADPKERLSAAEVLNHPWMR 328
+ ML DP++R A ++NHPW++
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLK 338
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 115 RREVQIMHHLTGHRNIV------ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSER 168
RRE Q L H IV E + ++M+ G L D + +G + +
Sbjct: 60 RREAQNAAALN-HPAIVAVYDTGEAETPAGPLPY--IVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 169 AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF- 227
A + +++ H G++HRD+KP N + S + +K DFG++
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSV 173
Query: 228 ---KDLVGSAYYVAPEVLRRNY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI-- 281
++G+A Y++PE R + A +D++S G +LY +L+G PPF G++ S+ A
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQH 231
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKER-LSAAEVLN 323
+R S +S+ +V K L +P+ R +AAE+
Sbjct: 232 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 23/88 (26%), Positives = 34/88 (38%), Gaps = 8/88 (9%)
Query: 331 GDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTI 390
G PL + M KL+ L A I GL F+ +D D S ++
Sbjct: 3 GLVPRGPLGSHMD---AVDATMEKLRAQCLSRGAS-----GIQGLARFFRQLDRDGSRSL 54
Query: 391 TFEELKAGLPKLGTRLSESEVRQLMEAV 418
+E + GL KLG L ++E +
Sbjct: 55 DADEFRQGLAKLGLVLDQAEAEGVCRKW 82
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 57/297 (19%), Positives = 106/297 (35%), Gaps = 59/297 (19%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH-HLTGHRN 129
+G+G++G + + + + A K SSR D + RE ++ + + H N
Sbjct: 12 LLECVGKGRYGEVWRGSWQG--ENVAVKIFSSR------DEKSWFRETELYNTVMLRHEN 63
Query: 130 IVELKGAYEDRHSVN------LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
I+ + D S + LI G L+D + + + + + + +
Sbjct: 64 ILGFIAS--DMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGLAH 120
Query: 184 CHS--------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----- 230
H + HRDLK +N L ++ D GL+V D+
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVK---KNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 231 VGSAYYVAPEVLR-------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSI-FDAIL 282
VG+ Y+APEVL + DIW+ G++L+ + + + F ++
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 283 RGHIDFSSD-----------PWPNISSSA------KDIVKKMLHADPKERLSAAEVL 322
F PN S ++K+ + +P RL+A +
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 70/367 (19%), Positives = 129/367 (35%), Gaps = 107/367 (29%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR--REVQIM 121
V + YI +GRG +G YL K+T++ A K ++ + D ++ R RE+ I+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITIL 79
Query: 122 HHLTGHRNIVELK--------GAYEDRHSVNLIM--DLCAGGELFDRIIAKGHY-SERAA 170
+ L I+ L +++ + V I DL ++ + +E
Sbjct: 80 NRL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLK-------KLFKTPIFLTEEHI 131
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS-VFFKPGDVFKD 229
+ ++ ++ H G++HRDLKP N L + D +K DFGL+ D
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLLNQ---DCSVKVCDFGLARTINSEKDTNIV 188
Query: 230 LVGSA----------------------YYVAPEVL--RRNYGAEADIWSAGVILYILLS- 264
+Y APE++ + NY DIWS G I LL+
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 265 ----------------GVPPFWGETEQSIFDAILRGHID-------------------FS 289
G F +++ + + D +
Sbjct: 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN 308
Query: 290 SD---------------PW----PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330
P+IS ++++ ML +P +R++ + L+HP+++
Sbjct: 309 KPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368
Query: 331 GDASDKP 337
+
Sbjct: 369 RKKKLEN 375
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 77/405 (19%), Positives = 132/405 (32%), Gaps = 113/405 (27%)
Query: 33 KIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTK 92
+ ++ + + + Y +G G +G K K
Sbjct: 19 TVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEK 78
Query: 93 QQFACKSISSRKLINRDDVEDVR--REVQIMHHLTGHRNIVELK-----GAYEDRHSVNL 145
+ A K I + D ++ R RE+ I++ L H ++V++ E + +
Sbjct: 79 RVVAIKKIL---RVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 146 IMDLCAGGELFD----RIIAKGHY-SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200
++ E+ D ++ Y +E L ++ V Y HS G++HRDLKP N L
Sbjct: 135 VL------EIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL 188
Query: 201 FSSSAEDSPLKATDFGLS-VFFKPGDVFKDLVGSA------------------------- 234
+ D +K DFGL+ P + L S
Sbjct: 189 VNQ---DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245
Query: 235 --YYVAPEVL--RRNYGAEADIWSAGVILYILL--------------------SGVPPFW 270
+Y APE++ + NY D+WS G I LL S P
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSP 305
Query: 271 GETEQSIFDAILRGHID-----F------SSDPWPNISSS-------------------- 299
+ + F RG+ D F S + +
Sbjct: 306 DQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365
Query: 300 -------AKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKP 337
A ++K+ML +P +R++ E L HP+ + A +
Sbjct: 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVET 410
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 63/341 (18%), Positives = 119/341 (34%), Gaps = 64/341 (18%)
Query: 35 DPPGPPRPSSSATSAT------SSSVGRVLGKPMEDVR---NTYIFGRELGRGQFGVTYL 85
+ P RP S + ++ G G P+ R T + +G+G+FG +
Sbjct: 1 EDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWR 60
Query: 86 VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH-HLTGHRNIVELKGAYEDRHSVN 144
+ ++ A K SSR + RE +I + H NI+ A +
Sbjct: 61 GKWRG--EEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112
Query: 145 ----LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS--------MGVMHR 192
L+ D G LFD + + + L + + + H + HR
Sbjct: 113 TQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-----VGSAYYVAPEVLRRNYG 247
DLK +N L ++ D GL+V D+ VG+ Y+APEVL +
Sbjct: 172 DLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 228
Query: 248 AE-------ADIWSAGVILYILLSGVPPFWGETEQSI-FDAILRGHIDFSS--------- 290
+ ADI++ G++ + + + + + ++
Sbjct: 229 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288
Query: 291 ------DPWPNISSSA--KDIVKKMLHADPKERLSAAEVLN 323
+ W + + I+++ +A+ RL+A +
Sbjct: 289 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 67/332 (20%), Positives = 118/332 (35%), Gaps = 74/332 (22%)
Query: 63 EDVRNTYIFGRELGRGQFG-VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ ++ Y LG G FG V + H K Q A K I + E R E+ ++
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVL 70
Query: 122 HHL-----TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY---SERAAANL 173
+ V + + + + +L G F+ + + ++ ++
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE-FLKENNFQPYPLPHVRHM 128
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA----------------EDSPLKATDFGL 217
Q+ + + H + H DLKPEN LF +S +++ ++ DFG
Sbjct: 129 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 218 SVFFKPGDVFKDLVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQS 276
+ F + +V + +Y PEV L + D+WS G IL+ G F +
Sbjct: 189 ATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 277 IFDAILR--GHID------------FSSD--PWPNISSSAK------------------- 301
+ + G I F W SS +
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306
Query: 302 -----DIVKKMLHADPKERLSAAEVLNHPWMR 328
D++++ML DP +R++ AE L HP+
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 68/330 (20%), Positives = 116/330 (35%), Gaps = 73/330 (22%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ V Y + +G+G FG Q A K + + K E++I+
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILE 148
Query: 123 HL-----TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY---SERAAANLC 174
HL N++ + + R+ + + +L L++ +I K + S
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFA 206
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSA 234
++ + H ++H DLKPEN L S +K DFG S ++ V+ + S
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDFG-SSCYEHQRVYTYIQ-SR 263
Query: 235 YYVAPEV-LRRNYGAEADIWSAGVILYILLS---------------------GVPPFW-- 270
+Y APEV L YG D+WS G IL LL+ G+P
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 271 --GETEQSIFD--AILRGHIDFSSDPWPNISSSAK------------------------- 301
+ ++ R + + + +
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 302 ---DIVKKMLHADPKERLSAAEVLNHPWMR 328
D +K+ L DP R++ + L HPW+R
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 4e-25
Identities = 38/58 (65%), Positives = 48/58 (82%)
Query: 361 KVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
K +AE LSEEEI GLKE+FK +DTDNSGTITF+ELK GL ++G+ L ESE++ LM+A
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 68
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 7e-06
Identities = 15/38 (39%), Positives = 20/38 (52%), Gaps = 3/38 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
K LK + L E EI K++ + D D SGTI + E
Sbjct: 46 KDGLKRVGSELMESEI---KDLMDAADIDKSGTIDYGE 80
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 41/295 (13%), Positives = 76/295 (25%), Gaps = 43/295 (14%)
Query: 32 LKIDPPGPPRPSSSATSATSSSV--GRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHK 89
+ D P SSA V R+ Y G +
Sbjct: 1 IAFDALREPDRESSAPPDDVQLVPGARIAN-------GRYRLLIFHGGVPPLQFWQALDT 53
Query: 90 DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149
+Q A + + ++ D +++ + + + + R ++ +
Sbjct: 54 ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGGLVVAEW 112
Query: 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209
GG L + +A S A + + H GV P S
Sbjct: 113 IRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID----- 165
Query: 210 LKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPF 269
GDV ++ + + DI G LY LL P
Sbjct: 166 --------------GDV---VLAYPATMPDA------NPQDDIRGIGASLYALLVNRWPL 202
Query: 270 WGETEQSIFDAILRGHIDFSSDPW---PNISSSAKDIVKKMLHADPKERLSAAEV 321
+S R +P +I + + + D R ++ +
Sbjct: 203 PEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 69/334 (20%), Positives = 110/334 (32%), Gaps = 74/334 (22%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ N ++ R++G G FG L H D K+ +A K + + K + E I+
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILK 86
Query: 123 HL----TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQ 176
+ + NIV+ G + + LI + G L++ I + + C +
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV----- 231
++ ++Y M + H DLKPEN L + L K
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 232 -GSA--------------YYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ 275
G A Y APEV L + +D+WS G +L L +G F
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 276 SIFDAILR--GHID---------------FSSDP----WPNISSSAK------------- 301
+ I + D WP +SS
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 302 --------DIVKKMLHADPKERLSAAEVLNHPWM 327
D + +L DP R S AE+L H ++
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 65/332 (19%), Positives = 115/332 (34%), Gaps = 59/332 (17%)
Query: 36 PPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYI-FGRELGRGQFGVTYLVTHKDTKQQ 94
PPG S +S S G L ++ I +++G+G++G ++ + ++
Sbjct: 6 PPGESLRDLIEQSQSSGS-GSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRG--EK 62
Query: 95 FACKSISSRKLINRDDVEDVRREVQIMH-HLTGHRNIVELKGAYEDRHSVN----LIMDL 149
A K + + RE +I L H NI+ A LI D
Sbjct: 63 VAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116
Query: 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS--------MGVMHRDLKPENFLF 201
G L+D + ++ L V+ + + H+ + HRDLK +N L
Sbjct: 117 HENGSLYD-YLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 202 SSSAEDSPLKATDFGLSVFFKPGDVFKDL-----VGSAYYVAPEVLRRNYGAE------- 249
++ D GL+V F D+ VG+ Y+ PEVL +
Sbjct: 176 K---KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232
Query: 250 ADIWSAGVILYILLSGV----------PPFWGET-EQSIFDAI--------LRGHIDFSS 290
AD++S G+IL+ + P+ ++ + LR +
Sbjct: 233 ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP-NR 291
Query: 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
++ + +P RL+A V
Sbjct: 292 WSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 59/277 (21%), Positives = 106/277 (38%), Gaps = 41/277 (14%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ G ++GRG FG + + A KS R+ + D +E +I+ +
Sbjct: 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQYS 170
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA-----AANLCRQMVTV 180
H NIV L G + + ++M+L GG+ + +G + M
Sbjct: 171 -HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME-- 227
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
Y S +HRDL N L + E + LK +DFG+S ++ Y
Sbjct: 228 --YLESKCCIHRDLAARNCLVT---EKNVLKISDFGMS---------REEADGVYAASGG 273
Query: 238 ---------APEVLRRN-YGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHI 286
APE L Y +E+D+WS G++L+ G P+ + Q + + +G
Sbjct: 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR 333
Query: 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323
+ ++++ +P +R S + +
Sbjct: 334 ---LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 76/329 (23%), Positives = 120/329 (36%), Gaps = 72/329 (21%)
Query: 63 EDVRNTYIFGRELGRGQFG-VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ + Y LG G FG V + HK + A K + + E R E+Q++
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVL 65
Query: 122 HHL-----TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLC 174
HL V++ +E + ++ +L G +D I G + +
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 175 RQMVTVVHYCHSMGVMHRDLKPENFLFSSSA----------------EDSPLKATDFGLS 218
Q+ V++ HS + H DLKPEN LF S + +K DFG +
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 219 VFFKPGDVFKDLVGSAYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
+ + LV + +Y APEV L + D+WS G IL G F +
Sbjct: 185 TY--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242
Query: 278 FDAILR--GHID------------FSSD--PWPNISSSAK-------------------- 301
+ R G + F D W SS+ +
Sbjct: 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH 302
Query: 302 ----DIVKKMLHADPKERLSAAEVLNHPW 326
D+++KML DP +R++ E L HP+
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPF 331
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 67/375 (17%), Positives = 118/375 (31%), Gaps = 114/375 (30%)
Query: 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ 119
K + Y R+LG G F +L K+ A K + S E E++
Sbjct: 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIR 85
Query: 120 IMHHLT-------GHRNIVELKGAYE-----DRHSVNLIMDLCAGGELFDRIIAKGH--Y 165
++ + +V+L ++ H ++ ++ G L II +
Sbjct: 86 LLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC-MVFEV-LGHHLLKWIIKSNYQGL 143
Query: 166 SERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSS-------------------- 204
+ +Q++ + Y H+ ++H D+KPEN L S +
Sbjct: 144 PLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 205 --------------------------AEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVA 238
AE +K D G + + F + + + Y +
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRS 261
Query: 239 PEV-LRRNYGAEADIWSAGVILYILLSGVPPF--WGETEQSIFDAILRGHID-------- 287
EV + Y ADIWS + + L +G F E + + + I+
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRK 321
Query: 288 -----------FSSD----------PWPNISSSAK-------------DIVKKMLHADPK 313
F+ PW + D + ML P+
Sbjct: 322 LIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPE 381
Query: 314 ERLSAAEVLNHPWMR 328
+R +AAE L HPW+
Sbjct: 382 KRATAAECLRHPWLN 396
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-23
Identities = 20/88 (22%), Positives = 34/88 (38%), Gaps = 4/88 (4%)
Query: 334 SDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFE 393
+D + + F A + + L ++ +K++F +D D SG I +
Sbjct: 3 TDLLSAEDIKKAIGAFTAADSFDHKKFFQMV-GLKKKSADDVKKVFHILDKDKSGFIEED 61
Query: 394 ELKAGLPKL---GTRLSESEVRQLMEAV 418
EL + L LS E + LM A
Sbjct: 62 ELGSILKGFSSDARDLSAKETKTLMAAG 89
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 27/222 (12%)
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
V Y GR +G G FGV + T+ QQ A K R D +R E + L
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLL 62
Query: 125 TGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFD-RIIAKGHYSERAAANLCRQMVTVVH 182
G I + E H+V L++DL G L D + +S + A +QM+ V
Sbjct: 63 AGCTGIPNVYYFGQEGLHNV-LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 183 YCHSMGVMHRDLKPENFLF--SSSAEDSPLKATDFGLSVFFK--------PGDVFKDLVG 232
H +++RD+KP+NFL +S + + DFG+ F++ P K+L G
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 233 SAYYVAPEVLRRNYGAEA----DIWSAGVILYILLSGVPPFW 270
+A Y++ + + G E D+ + G + L G P W
Sbjct: 181 TARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
V N + GR++G G FG YL T+ T ++ A K + + + E +I L
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKTKHPQLLYESKIYRIL 59
Query: 125 TGHRNIVELKGA-YEDRHSVNLIMDLCAG---GELFDRIIAKGHYSERAAANLCRQMVTV 180
G I ++ E ++V L+MDL G +LF+ S + L QM+
Sbjct: 60 QGGTGIPNVRWFGVEGDYNV-LVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINR 115
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK--------PGDVFKDLVG 232
V + HS +HRD+KP+NFL + + DFGL+ ++ P K+L G
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 233 SAYYVAPEVLRRNYGAEA----DIWSAGVILYILLSGVPPFW 270
+A Y + + + G E D+ S G +L L G P W
Sbjct: 176 TARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-23
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
V N Y GR++G G FG YL T ++ A K + + E +I +
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKIYKMM 61
Query: 125 TGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFD-RIIAKGHYSERAAANLCRQMVTVVH 182
G I ++ E ++V ++M+L G L D +S + L QM++ +
Sbjct: 62 QGGVGIPTIRWCGAEGDYNV-MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK--------PGDVFKDLVGSA 234
Y HS +HRD+KP+NFL + + + DFGL+ ++ P K+L G+A
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 235 YYVAPEVLRRNYGAEA----DIWSAG-VILYILLSGVP 267
Y + + + G E D+ S G V++Y L +P
Sbjct: 180 RYAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 60/296 (20%), Positives = 101/296 (34%), Gaps = 57/296 (19%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
RG+FG + + + A K + EV + + H NI
Sbjct: 28 LLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HENI 80
Query: 131 VELKGAYEDRHSVN------LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
++ GA ++ + LI G L D + S ++ M + Y
Sbjct: 81 LQFIGA--EKRGTSVDVDLWLITAFHEKGSLSD-FLKANVVSWNELCHIAETMARGLAYL 137
Query: 185 HSM----------GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD---LV 231
H + HRD+K +N L + DFGL++ F+ G D V
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 232 GSAYYVAPEVLRRNYGAE------ADIWSAGVILYILLSGVPPFWGETE--QSIFDAILR 283
G+ Y+APEVL + D+++ G++L+ L S G + F+ +
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 284 GHIDFSS---------------DPWPNISSSAK--DIVKKMLHADPKERLSAAEVL 322
H D W + A + +++ D + RLSA V
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-22
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 33/238 (13%)
Query: 66 RNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ + LG G FG ++ + K A K + R+ + +++ E +M
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTV 180
+ + ++ L G +V LI L G L D + K + + N C Q+
Sbjct: 72 ASVD-NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
++Y ++HRDL N L + +K TDFGL+ + Y
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLGAEE--------KEYHAEG 178
Query: 238 --------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
A E + R Y ++D+WS GV ++ L++ G P+ G I + +G
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-22
Identities = 37/55 (67%), Positives = 46/55 (83%)
Query: 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
AE LSEEEI GLKE+FK +DTDNSGTITF+ELK GL ++G+ L ESE++ LM+A
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 55
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 6e-06
Identities = 13/56 (23%), Positives = 24/56 (42%), Gaps = 5/56 (8%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + EE L F D D SG IT +E++ G L + + +++ +
Sbjct: 75 LNKLEREEN---LVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEI 125
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 18/57 (31%), Positives = 24/57 (42%), Gaps = 3/57 (5%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQ 413
K LK + L E EI K++ + D D SGTI + E A L E +
Sbjct: 33 KDGLKRVGSELMESEI---KDLMDAADIDKSGTIDYGEFIAATVHLNKLEREENLVS 86
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 47/220 (21%), Positives = 91/220 (41%), Gaps = 27/220 (12%)
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
V + G+++G G FG L + T + A K + K + E + L
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMK----SRAPQLHLEYRFYKQL 61
Query: 125 TGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFD-RIIAKGHYSERAAANLCRQMVTVVH 182
I ++ +++ ++++L G L D + +S + + Q+++ +
Sbjct: 62 GSGDGIPQVYYFGPCGKYNA-MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 183 YCHSMGVMHRDLKPENFLF--SSSAEDSPLKATDFGLSVFFK--------PGDVFKDLVG 232
Y HS +++RD+KPENFL + + DF L+ + P K L G
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 233 SAYYVAPEVLRRNYGAEA----DIWSAG-VILYILLSGVP 267
+A Y++ + + G E D+ + G + +Y L +P
Sbjct: 180 TARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-22
Identities = 21/88 (23%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 334 SDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFE 393
+D + ++ +A + I+ +S++ LKE+F+ +D D SG I +
Sbjct: 3 TDILSPSDIAAALRDCQAPDSFSPKKFFQISG-MSKKSSSQLKEIFRILDNDQSGFIEED 61
Query: 394 ELKAGLPKLGT---RLSESEVRQLMEAV 418
ELK L + + L+ SE + + A
Sbjct: 62 ELKYFLQRFESGARVLTASETKTFLAAA 89
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 58/238 (24%), Positives = 101/238 (42%), Gaps = 20/238 (8%)
Query: 59 GKPMEDV----RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDV 114
G P D R +LG GQ+G Y K A K++ + +VE+
Sbjct: 1 GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEF 56
Query: 115 RREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAAN 172
+E +M + H N+V+L G +I + G L D R + S
Sbjct: 57 LKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115
Query: 173 LCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVG 232
+ Q+ + + Y +HRDL N L E+ +K DFGLS GD + G
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAG 171
Query: 233 SAYYV---APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+ + + APE L + ++D+W+ GV+L+ + + G+ P+ G +++ + + +
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 18/223 (8%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
E + Y +G+G FG + ++ A K I ++K + EV+++
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ----AQIEVRLLE 105
Query: 123 HL-----TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCR 175
+ IV LK + R+ + L+ ++ L+D + S +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQ 164
Query: 176 QMVTVVHYCHS--MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
QM T + + + + ++H DLKPEN L + + S +K DFG S +++ + S
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNP-KRSAIKIVDFG-SSCQLGQRIYQYIQ-S 221
Query: 234 AYYVAPEV-LRRNYGAEADIWSAGVILYILLSGVPPFWGETEQ 275
+Y +PEV L Y D+WS G IL + +G P F G E
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 66/305 (21%), Positives = 113/305 (37%), Gaps = 48/305 (15%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R R LG G FG Y + + + Q A K++ ++ + D D E I
Sbjct: 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALI 86
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
+ H+NIV G ++M+L AGG+L + + ++ ++ V
Sbjct: 87 ISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 181 V-------HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
Y +HRD+ N L + K DFG++ +D+ +
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIYRA 196
Query: 234 AYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFD 279
+YY PE + ++ D WS GV+L+ + S G P+ ++ Q + +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLNH-PWMRVDGDASD 335
+ G DP N I M P++R + A +L + D D +
Sbjct: 257 FVTSGGR---MDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 310
Query: 336 KPLDI 340
L I
Sbjct: 311 TALPI 315
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 5e-21
Identities = 73/316 (23%), Positives = 113/316 (35%), Gaps = 40/316 (12%)
Query: 21 PDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDV----RNTYIFGRELG 76
+ P N + S + A P R GR +G
Sbjct: 340 LPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIG 399
Query: 77 RGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
GQFG + ++ ++ A K+ + + E +E M H +IV+L
Sbjct: 400 EGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQFD-HPHIVKL 456
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
G + V +IM+LC GEL + K + Q+ T + Y S +HR
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV-----------APEV 241
D+ N L S + +K DFGLS + + S YY APE
Sbjct: 516 DIAARNVLVS---SNDCVKLGDFGLS---------RYMEDSTYYKASKGKLPIKWMAPES 563
Query: 242 LR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
+ R + + +D+W GV ++ +L GV PF G + I G PN +
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNCPPT 620
Query: 300 AKDIVKKMLHADPKER 315
++ K DP R
Sbjct: 621 LYSLMTKCWAYDPSRR 636
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-21
Identities = 61/237 (25%), Positives = 93/237 (39%), Gaps = 33/237 (13%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
R + R LG G FG Y HK K A K+ +K D+ E E IM
Sbjct: 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMK 68
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVV 181
+L H +IV+L G E +IM+L GEL + K Q+ +
Sbjct: 69 NLD-HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---- 237
Y S+ +HRD+ N L + +K DFGLS + + YY
Sbjct: 127 AYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS---------RYIEDEDYYKASVT 174
Query: 238 -------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+PE + R + +D+W V ++ +LS G PF+ + + + +G
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD 231
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-21
Identities = 53/238 (22%), Positives = 92/238 (38%), Gaps = 33/238 (13%)
Query: 66 RNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ + LG G FG ++ + K A K + R+ + +++ E +M
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTV 180
+ + ++ L G +V LI L G L D + K + + N C Q+
Sbjct: 72 ASVD-NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
++Y ++HRDL N L +K TDFGL+ + Y
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEE--------KEYHAEG 178
Query: 238 --------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
A E + R Y ++D+WS GV ++ L++ G P+ G I + +G
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-21
Identities = 15/68 (22%), Positives = 29/68 (42%), Gaps = 5/68 (7%)
Query: 356 KKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAG-----LPKLGTRLSESE 410
K A+K+ + + I K MF +D + +G IT +E+ + KL +++
Sbjct: 3 SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62
Query: 411 VRQLMEAV 418
Q+
Sbjct: 63 RHQVCVEA 70
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-08
Identities = 18/68 (26%), Positives = 23/68 (33%)
Query: 351 AMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESE 410
+L LK A N +F D D SGTIT +E KA G S+ +
Sbjct: 91 GWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQED 150
Query: 411 VRQLMEAV 418
Sbjct: 151 CEATFRHC 158
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 10/38 (26%), Positives = 19/38 (50%), Gaps = 3/38 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
K K+ + S+E+ + F+ D DN+G + +E
Sbjct: 136 KAYGKISGISPSQEDC---EATFRHCDLDNAGDLDVDE 170
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 9e-21
Identities = 53/307 (17%), Positives = 101/307 (32%), Gaps = 68/307 (22%)
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH-HLTGHRN 129
+GRG++G Y + + + A K S + ++ E I L H N
Sbjct: 17 LLELIGRGRYGAVYKGSLDE--RPVAVKVFSFA------NRQNFINEKNIYRVPLMEHDN 68
Query: 130 IVELKGAYEDRHSVN------LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
I ++R + + L+M+ G L ++ ++ L + + Y
Sbjct: 69 IARFIVG-DERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVTRGLAY 126
Query: 184 CHSM---------GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----- 229
H+ + HRDL N L D +DFGLS+ + +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVK---NDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 230 ----LVGSAYYVAPEVLR--------RNYGAEADIWSAGVILYILLSGV----------- 266
VG+ Y+APEVL + + D+++ G+I + +
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 267 --PPFWGETEQSIFDAILRGHIDFS------SDPWPNISSSAKDIVKKML---HADPKER 315
F E ++ + + W S + + + + + D + R
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 316 LSAAEVL 322
L+A
Sbjct: 304 LTAQXAE 310
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 40/239 (16%), Positives = 74/239 (30%), Gaps = 29/239 (12%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSIS----SRKLINRDDVEDVRREVQIM 121
IF LG+G F + ++ +R+ E +M
Sbjct: 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTV 180
L+ H+++V G L+ + G L + K + + +Q+
Sbjct: 67 SKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPL-----KATDFGLSVFFKPGDVFKDLVGSAY 235
+H+ ++H ++ +N L + K +D G+S ++
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---------ITVLPKDI 176
Query: 236 Y------VAPEVL--RRNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
V PE + +N D WS G L+ + S G P Q H
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 51/250 (20%), Positives = 88/250 (35%), Gaps = 35/250 (14%)
Query: 55 GRVLGKPMEDVRNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDD 110
G + + LG G FG ++ + K K I R
Sbjct: 1 GAMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQS 58
Query: 111 VEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERA 169
+ V + + L H +IV L G S+ L+ G L D + +G +
Sbjct: 59 FQAVTDHMLAIGSLD-HAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQL 116
Query: 170 AANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD 229
N Q+ ++Y G++HR+L N L S ++ DFG++
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVA---------DL 164
Query: 230 LVGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQ 275
L + A E + Y ++D+WS GV ++ L++ G P+ G
Sbjct: 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224
Query: 276 SIFDAILRGH 285
+ D + +G
Sbjct: 225 EVPDLLEKGE 234
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 56/257 (21%), Positives = 107/257 (41%), Gaps = 19/257 (7%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R +LG GQ+G Y K A K++ + +VE+ +E +M +
Sbjct: 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK 274
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHY 183
H N+V+L G +I + G L D R + S + Q+ + + Y
Sbjct: 275 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---APE 240
+HR+L N L E+ +K DFGLS GD + G+ + + APE
Sbjct: 334 LEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 389
Query: 241 VLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
L + ++D+W+ GV+L+ + + G+ P+ G +++ + + + +
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCPE 446
Query: 299 SAKDIVKKMLHADPKER 315
++++ +P +R
Sbjct: 447 KVYELMRACWQWNPSDR 463
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 59/235 (25%), Positives = 89/235 (37%), Gaps = 29/235 (12%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+LG G FGV A K + L + ++D REV MH
Sbjct: 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVV 181
L HRN++ L G + ++ +L G L DR+ +GH+ + Q+ +
Sbjct: 77 SLD-HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---- 237
Y S +HRDL N L ++ +K DFGL D Y +
Sbjct: 135 GYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALPQND-------DHYVMQEHR 184
Query: 238 -------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILR 283
APE L+ R + +D W GV L+ + + G P+ G I I +
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 65/305 (21%), Positives = 112/305 (36%), Gaps = 48/305 (15%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R R LG G FG Y + + + Q A K++ ++ + D D E I
Sbjct: 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALI 127
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
+ H+NIV G ++++L AGG+L + + ++ ++ V
Sbjct: 128 ISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 181 V-------HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
Y +HRD+ N L + K DFG++ +D+ +
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIYRA 237
Query: 234 AYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFD 279
YY PE + ++ D WS GV+L+ + S G P+ ++ Q + +
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297
Query: 280 AILRGHIDFSSDPWPNISSSAKDIVKKML---HADPKERLSAAEVLNH-PWMRVDGDASD 335
+ G DP N I M P++R + A +L + D D +
Sbjct: 298 FVTSGGR---MDPPKNCPGPVYRI---MTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351
Query: 336 KPLDI 340
L I
Sbjct: 352 TALPI 356
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 62/237 (26%), Positives = 96/237 (40%), Gaps = 33/237 (13%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
R GR +G GQFG + ++ ++ A K+ + + E +E M
Sbjct: 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMR 71
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVV 181
H +IV+L G + V +IM+LC GEL + K + Q+ T +
Sbjct: 72 QFD-HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---- 237
Y S +HRD+ N L S + +K DFGLS + + S YY
Sbjct: 130 AYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---------RYMEDSTYYKASKG 177
Query: 238 -------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + R + + +D+W GV ++ +L GV PF G + I G
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 234
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-20
Identities = 21/88 (23%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 334 SDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFE 393
+D + +++ + + + LS+ +K++F+ +D D SG + +
Sbjct: 3 TDILSAEDIAAALQECQDPDTFEPQKF-FQTSGLSKMSASQVKDIFRFIDNDQSGYLDGD 61
Query: 394 ELKAGLPKLGT---RLSESEVRQLMEAV 418
ELK L K + L+ESE + LM+A
Sbjct: 62 ELKYFLQKFQSDARELTESETKSLMDAA 89
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 2e-04
Identities = 12/42 (28%), Positives = 17/42 (40%), Gaps = 5/42 (11%)
Query: 355 LKKV--ALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
LK + A L+E E K + + D D G I +E
Sbjct: 63 LKYFLQKFQSDARELTESET---KSLMDAADNDGDGKIGADE 101
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 6e-20
Identities = 18/68 (26%), Positives = 32/68 (47%), Gaps = 1/68 (1%)
Query: 352 MNKLKK-VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESE 410
M+K + + + L EE+ + E F D +N G + + ELK + LG L + E
Sbjct: 1 MSKNRSSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKRE 60
Query: 411 VRQLMEAV 418
+ L++
Sbjct: 61 ILDLIDEY 68
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 4e-07
Identities = 15/51 (29%), Positives = 28/51 (54%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+EI K F+ D D++G I+ + L+ +LG L++ E+R ++E
Sbjct: 94 PLDEI---KRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEF 141
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 1e-04
Identities = 14/40 (35%), Positives = 21/40 (52%), Gaps = 4/40 (10%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
L++V K + E L++EE L+ M + D D G I E
Sbjct: 118 LRRV-AKELGETLTDEE---LRAMIEEFDLDGDGEINENE 153
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 2e-04
Identities = 10/58 (17%), Positives = 26/58 (44%), Gaps = 4/58 (6%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE-LKAGLPKLGTRLSESEVRQ 413
KVA+K + L + E + ++ D++ + +++ K+ R E+++
Sbjct: 46 KVAMKALGFELPKRE---ILDLIDEYDSEGRHLMKYDDFYIVMGEKILKRDPLDEIKR 100
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 1e-19
Identities = 16/68 (23%), Positives = 31/68 (45%), Gaps = 5/68 (7%)
Query: 352 MNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTD-NSGTITFEELKAGLPKLGTRLSESE 410
M+ + K E L+EE+ K F G+I+ +EL + LG + E
Sbjct: 1 MDDIYKA----AVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEE 56
Query: 411 VRQLMEAV 418
++++++ V
Sbjct: 57 LQEMIDEV 64
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 3e-07
Identities = 18/54 (33%), Positives = 29/54 (53%), Gaps = 3/54 (5%)
Query: 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ SEEE L ++F+ D + G I EELK L G ++E ++ +LM+
Sbjct: 90 KGKSEEE---LSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDG 140
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 3e-05
Identities = 15/62 (24%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE-LKAGLPKLGTRLSESEVRQLM 415
++++ +N + EE L+EM +D D SGT+ F+E L + + +L
Sbjct: 42 GKVMRMLGQNPTPEE---LQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELS 98
Query: 416 EA 417
+
Sbjct: 99 DL 100
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 39.8 bits (94), Expect = 4e-04
Identities = 12/40 (30%), Positives = 24/40 (60%), Gaps = 4/40 (10%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
LK + L+ E ++E++ ++E+ K D +N G I ++E
Sbjct: 117 LKIM-LQATGETITEDD---IEELMKDGDKNNDGRIDYDE 152
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-19
Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 40/238 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R +ELG GQFGV L K + A K I ++ +E Q M L+
Sbjct: 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKE----GSMSEDEFFQEAQTMMKLS 61
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERA-----AANLCRQMVTV 180
H +V+ G + + ++ + + G L + + + G E + ++C M
Sbjct: 62 -HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA-- 118
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
+ S +HRDL N L D +K +DFG++ + ++ Y
Sbjct: 119 --FLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMT---------RYVLDDQYVSSVG 164
Query: 238 --------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APEV Y +++D+W+ G++++ + S G P+ T + + +GH
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 30/232 (12%)
Query: 70 IFGRELGRGQFGVTY--LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH 127
+ +ELG G FG K + A K + + + +++ E +M L +
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-N 77
Query: 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM 187
IV + G E S L+M++ G L + H ++ L Q+ + Y
Sbjct: 78 PYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---------- 237
+HRDL N L K +DFGLS + + YY
Sbjct: 137 NFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADE--------NYYKAQTHGKWPVK 185
Query: 238 --APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + + +++D+WS GV+++ S G P+ G + + +G
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 237
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 57/236 (24%), Positives = 101/236 (42%), Gaps = 36/236 (15%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ F +E+G GQFG+ +L + K + A K+I ED E ++M L+
Sbjct: 7 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE----GAMSEEDFIEEAEVMMKLS 61
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL---CRQMVTVVH 182
H +V+L G ++ + L+ + G L D + + AA L C + +
Sbjct: 62 -HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMA 118
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV----- 237
Y V+HRDL N L E+ +K +DFG++ + ++ Y
Sbjct: 119 YLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMT---------RFVLDDQYTSSTGTK 166
Query: 238 ------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+PEV Y +++D+WS GV+++ + S G P+ + + + I G
Sbjct: 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 222
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 28/230 (12%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDV--EDVRREVQIMHH 123
+ +G+G+FG L ++ K A K I ++D + E +M
Sbjct: 20 MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-------KNDATAQAFLAEASVMTQ 70
Query: 124 LTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTV 180
L H N+V+L G E++ + ++ + A G L D R + +
Sbjct: 71 LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
+ Y +HRDL N L S ED+ K +DFGL+ + V
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT-----KEASSTQDTGKLPVKWT 181
Query: 238 APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE LR + + ++D+WS G++L+ + S G P+ + + + +G+
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 231
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 44/247 (17%), Positives = 87/247 (35%), Gaps = 49/247 (19%)
Query: 59 GKPMED-VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
GK ++D N ++ G+++G G FG+ YL + ++ A + + + + E
Sbjct: 28 GKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK----VEYQENGPLFSE 83
Query: 118 VQIMHHLTGHRNIVELKGAY-------------------EDRHSVNLIMDLCAGGELFDR 158
++ + I + + ++M+ G +L
Sbjct: 84 LKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRF-MVMERL-GIDLQKI 141
Query: 159 IIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218
G + + L +M+ V+ Y H +H D+K N L D + D+GLS
Sbjct: 142 SGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VYLADYGLS 200
Query: 219 VFFKPG--------DVFKDLVGSAYYVA------PEVLRRNYGAEADIWSAG-VILYILL 263
+ P + K G+ + + + RR +D+ G +L L
Sbjct: 201 YRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-----SDVEILGYCMLRWLC 255
Query: 264 SGVPPFW 270
+P W
Sbjct: 256 GKLP--W 260
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 61/261 (23%), Positives = 100/261 (38%), Gaps = 51/261 (19%)
Query: 61 PMEDVRNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRR 116
P + R+LG G FG Y +T +Q A KS+ + + + D+++
Sbjct: 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKK 72
Query: 117 EVQIMHHLTGHRNIVELKGA--YEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANL 173
E++I+ +L H NIV+ KG + + + LIM+ G L + + K + +
Sbjct: 73 EIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-VG 232
Q+ + Y S +HRDL N L + +K DFGL+ K +
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLT---------KAIETD 179
Query: 233 SAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS--------------- 264
YY APE L + +D+WS GV L+ LL+
Sbjct: 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
Query: 265 GVPPFWGETEQSIFDAILRGH 285
P T + + + G
Sbjct: 240 IGPTHGQMTVTRLVNTLKEGK 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 54/234 (23%), Positives = 97/234 (41%), Gaps = 32/234 (13%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
F +ELG GQFGV + A K I ++ E ++M +L+
Sbjct: 23 PKDLTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIKE----GSMSEDEFIEEAKVMMNLS 77
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYC 184
H +V+L G + + +I + A G L + + + + + +C+ + + Y
Sbjct: 78 -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV------- 237
S +HRDL N L + + +K +DFGLS + ++ Y
Sbjct: 137 ESKQFLHRDLAARNCLVN---DQGVVKVSDFGLS---------RYVLDDEYTSSVGSKFP 184
Query: 238 ----APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
PEVL + +++DIW+ GV+++ + S G P+ T + I +G
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 238
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 56/288 (19%), Positives = 110/288 (38%), Gaps = 47/288 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R RELG+G FG+ Y V + + + A K++ + + + + E +
Sbjct: 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASV 81
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
M ++V L G +IM+L G+L + + + +
Sbjct: 82 MKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 181 VHYCH----------SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230
+ + +HRDL N + + ED +K DFG++ +D+
Sbjct: 141 IQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------RDI 188
Query: 231 VGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-ILLSGVPPFWGETEQS 276
+ YY +PE L+ + +D+WS GV+L+ I P+ G + +
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248
Query: 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
+ ++ G + D N ++++ +PK R S E+++
Sbjct: 249 VLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 59/243 (24%), Positives = 89/243 (36%), Gaps = 38/243 (15%)
Query: 66 RNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ +LG+G FG Y +T A K + + D D +RE+QI+
Sbjct: 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQIL 78
Query: 122 HHLTGHRNIVELKG--AYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMV 178
L IV+ +G R S+ L+M+ G L D + + Q+
Sbjct: 79 KAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-VGSAYYV 237
+ Y S +HRDL N L ++ +K DFGL+ K L + YYV
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLA---------KLLPLDKDYYV 185
Query: 238 ------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILR 283
APE L + ++D+WS GV+LY L + E R
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245
Query: 284 GHI 286
Sbjct: 246 DVP 248
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 54/234 (23%), Positives = 95/234 (40%), Gaps = 36/234 (15%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDV--EDVRREVQIMHH 123
+ +G+G+FG L ++ K A K I ++D + E +M
Sbjct: 192 MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-------KNDATAQAFLAEASVMTQ 242
Query: 124 LTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTV 180
L H N+V+L G E++ + ++ + A G L D R + +
Sbjct: 243 LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
+ Y +HRDL N L S ED+ K +DFGL+ K+ +
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---------KEASSTQDTGKLP 349
Query: 238 ----APEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE LR + ++D+WS G++L+ + S G P+ + + + +G+
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 403
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 62/298 (20%), Positives = 100/298 (33%), Gaps = 60/298 (20%)
Query: 25 PGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGV-- 82
HH + + ++ P + F ++LG+G FG
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSAFEDR-------DPTQFEERHLKFLQQLGKGNFGSVE 58
Query: 83 --TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA--YE 138
Y +T + A K + + + + D RE++I+ L H NIV+ KG
Sbjct: 59 MCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA 114
Query: 139 DRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPE 197
R ++ LIM+ G L D + K Q+ + Y + +HRDL
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 174
Query: 198 NFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-VGSAYYV------------APEVLR- 243
N L ++ +K DFGL+ K L YY APE L
Sbjct: 175 NILVE---NENRVKIGDFGLT---------KVLPQDKEYYKVKEPGESPIFWYAPESLTE 222
Query: 244 RNYGAEADIWSAGVILYILLS----------------GVPPFWGETEQSIFDAILRGH 285
+ +D+WS GV+LY L + G + + +
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 82.5 bits (205), Expect = 4e-19
Identities = 24/56 (42%), Positives = 34/56 (60%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+++NL+EE+I KE F D DNSG+I+ EL + LG SE+EV LM +
Sbjct: 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEI 56
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 49.4 bits (119), Expect = 2e-07
Identities = 18/51 (35%), Positives = 30/51 (58%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
SE+E+ E FK D + G I+ ELK L +G +L+++EV +++ V
Sbjct: 82 SEQEL---LEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREV 129
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 39.8 bits (94), Expect = 3e-04
Identities = 13/57 (22%), Positives = 24/57 (42%), Gaps = 4/57 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE-LKAGLPKLGTRLSESEVR 412
++ + + SE E + ++ +D D + I F E L +L SE E+
Sbjct: 34 ATVMRSLGLSPSEAE---VADLMNEIDVDGNHAIEFSEFLALMSRQLKCNDSEQELL 87
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 57/257 (22%), Positives = 92/257 (35%), Gaps = 53/257 (20%)
Query: 66 RNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
F ++LG+G FG Y +T + A K + + + + D RE++I+
Sbjct: 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEIL 65
Query: 122 HHLTGHRNIVELKGA--YEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMV 178
L H NIV+ KG R ++ LIM+ G L D + K Q+
Sbjct: 66 KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 179 TVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-VGSAYYV 237
+ Y + +HRDL N L ++ +K DFGL+ K L ++
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLT---------KVLPQDKEFFK 172
Query: 238 ------------APEVLR-RNYGAEADIWSAGVILYILLS----------------GVPP 268
APE L + +D+WS GV+LY L + G
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 269 FWGETEQSIFDAILRGH 285
+ + +
Sbjct: 233 QGQMIVFHLIELLKNNG 249
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-19
Identities = 12/70 (17%), Positives = 29/70 (41%), Gaps = 2/70 (2%)
Query: 349 FRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSE 408
+ + L + EE+ L+ +F + D + SG + EE +A +L +
Sbjct: 3 HHHHHSSGRENLYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRP 60
Query: 409 SEVRQLMEAV 418
++ + + +
Sbjct: 61 ADAEAVFQRL 70
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 6e-19
Identities = 74/292 (25%), Positives = 113/292 (38%), Gaps = 36/292 (12%)
Query: 15 HSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVR----NTYI 70
D G+ P +I P PRP TS S + + N I
Sbjct: 280 PQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLI 339
Query: 71 FGRELGRGQFGVTYLVTHKDTKQQF--ACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
ELG G FG ++ K+Q A K + ++ + D E++ RE QIMH L +
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD-NP 396
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSM 187
IV L G + ++ L+M++ GG L ++ + A L Q+ + Y
Sbjct: 397 YIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---------- 237
+HR+L N L K +DFGLS D +YY
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADD--------SYYTARSAGKWPLK 504
Query: 238 --APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + R + + +D+WS GV ++ LS G P+ + I +G
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 7e-19
Identities = 16/56 (28%), Positives = 28/56 (50%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ +L EEI L+E F+ D D G I +L + +G +E E+ +L + +
Sbjct: 1 MDRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQI 56
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 4e-06
Identities = 13/56 (23%), Positives = 30/56 (53%), Gaps = 4/56 (7%)
Query: 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPK-LGTRLSESEVRQLMEAV 418
A+ + +E L++ F+ DT+ G I+ EL+ + LG ++ ++ +++ V
Sbjct: 82 ADMIGVKE---LRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDV 134
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 44.4 bits (106), Expect = 8e-06
Identities = 8/40 (20%), Positives = 20/40 (50%), Gaps = 3/40 (7%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
L++ ++ + +I +E+ + +D + G + FEE
Sbjct: 110 LREAMRALLGHQVGHRDI---EEIIRDVDLNGDGRVDFEE 146
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 2e-04
Identities = 11/63 (17%), Positives = 29/63 (46%), Gaps = 5/63 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE-LKAGLPKLGTRLSESEVRQ-L 414
++ + +E E L E+ + ++ + G + F++ ++ PKL ++ + L
Sbjct: 34 GNCMRTMGYMPTEME---LIELSQQINMNLGGHVDFDDFVELMGPKLLAETADMIGVKEL 90
Query: 415 MEA 417
+A
Sbjct: 91 RDA 93
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-19
Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 36/241 (14%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
F +GRG FG Y L+ + K A KS+ ++ + +V E IM
Sbjct: 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 81
Query: 123 HLTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTV 180
+ H N++ L G S +++ G+L + I + + + Q+
Sbjct: 82 DFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 140
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
+ Y S +HRDL N + E +K DFGL+ +D+ YY
Sbjct: 141 MKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---------RDMYDKEYYSVHN 188
Query: 238 -----------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRG 284
A E L+ + + ++D+WS GV+L+ L++ G PP+ I +L+G
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
Query: 285 H 285
Sbjct: 249 R 249
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 8e-19
Identities = 19/77 (24%), Positives = 37/77 (48%), Gaps = 3/77 (3%)
Query: 345 RMKQFRAMNKLKKVAL---KVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPK 401
+ +Q ++++ K L K ++ ++ G KE + D + +G I LK L K
Sbjct: 1 KAQQEERLDEINKQFLDDPKYSSDEDLPSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK 60
Query: 402 LGTRLSESEVRQLMEAV 418
LG + E+++L+ V
Sbjct: 61 LGVPKTHLELKKLIGEV 77
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-05
Identities = 6/38 (15%), Positives = 17/38 (44%), Gaps = 3/38 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
K L+ + + E LK++ + + + T ++ +
Sbjct: 55 KRMLEKLGVPKTHLE---LKKLIGEVSSGSGETFSYPD 89
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 49/235 (20%), Positives = 91/235 (38%), Gaps = 34/235 (14%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R T LG GQFG ++ + + A KS+ + E +M L
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQ----GSMSPDAFLAEANLMKQLQ 66
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHY 183
H+ +V L + + +I + G L D + + + ++ Q+ + +
Sbjct: 67 -HQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV------ 237
+HRDL+ N L S + K DFGL+ + + + Y
Sbjct: 125 IEERNYIHRDLRAANILVS---DTLSCKIADFGLA---------RLIEDNEYTAREGAKF 172
Query: 238 -----APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + + ++D+WS G++L +++ G P+ G T + + RG+
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 2e-18
Identities = 21/56 (37%), Positives = 33/56 (58%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+A+ L+EE+I KE F D D GTIT +EL + LG +E+E++ ++ V
Sbjct: 1 MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 56
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 49.4 bits (119), Expect = 2e-07
Identities = 17/56 (30%), Positives = 32/56 (57%), Gaps = 3/56 (5%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + SEEE ++E F+ D D +G I+ EL+ + LG +L++ EV +++
Sbjct: 77 MKDTDSEEE---IREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREA 129
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 1e-04
Identities = 16/62 (25%), Positives = 28/62 (45%), Gaps = 8/62 (12%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE----LKAGLPKLGTRLSESE 410
L+ V + + E L++EE+ EM + D D G + +EE + A G +
Sbjct: 106 LRHV-MTNLGEKLTDEEV---DEMIREADIDGDGQVNYEEFVQMMTAKGGGGGAAARKEV 161
Query: 411 VR 412
+R
Sbjct: 162 IR 163
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 3e-04
Identities = 18/57 (31%), Positives = 29/57 (50%), Gaps = 4/57 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE-LKAGLPKLGTRLSESEVR 412
++ + +N +E E L++M +D D +GTI F E L K+ SE E+R
Sbjct: 34 GTVMRSLGQNPTEAE---LQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIR 87
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 32/230 (13%)
Query: 73 RELGRGQFGVTY--LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
ELG G FG + + + A K + ++ + D E++ RE QIMH L + I
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLD-NPYI 72
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGV 189
V L G + ++ L+M++ GG L ++ + A L Q+ + Y
Sbjct: 73 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 190 MHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV------------ 237
+HRDL N L K +DFGLS D +YY
Sbjct: 132 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADD--------SYYTARSAGKWPLKWY 180
Query: 238 APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + R + + +D+WS GV ++ LS G P+ + I +G
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 230
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 62/269 (23%), Positives = 106/269 (39%), Gaps = 45/269 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + +LG+G FG ++ T T + A K++ E +E Q+M L
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKLR 237
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERA-----AANLCRQMVT 179
H +V+L + + ++ + + G L D + G Y AA + M
Sbjct: 238 -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA- 294
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV-- 237
Y M +HRDL+ N L E+ K DFGL+ + + + Y
Sbjct: 295 ---YVERMNYVHRDLRAANILVG---ENLVCKVADFGLA---------RLIEDNEYTARQ 339
Query: 238 ---------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286
APE + ++D+WS G++L L + G P+ G + + D + RG+
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399
Query: 287 DFSSDPWPNISSSAKDIVKKMLHADPKER 315
P S D++ + +P+ER
Sbjct: 400 ---MPCPPECPESLHDLMCQCWRKEPEER 425
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 51/235 (21%), Positives = 94/235 (40%), Gaps = 34/235 (14%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + ++LG GQFG ++ T+ + A K++ VE E +M L
Sbjct: 187 RESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKP----GSMSVEAFLAEANVMKTLQ 241
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHY 183
H +V+L + + +I + A G L D + + Q+ + +
Sbjct: 242 -HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV------ 237
+HRDL+ N L S K DFGL+ + + + Y
Sbjct: 300 IEQRNYIHRDLRAANILVS---ASLVCKIADFGLA---------RVIEDNEYTAREGAKF 347
Query: 238 -----APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + ++ ++D+WS G++L +++ G P+ G + + A+ RG+
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 402
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77 | Back alignment and structure |
|---|
Score = 77.5 bits (192), Expect = 4e-18
Identities = 19/52 (36%), Positives = 30/52 (57%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
LSEE+ +KE F DT+ +G+I + ELK + LG + + E+ +LM
Sbjct: 1 LSEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEY 52
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 1e-05
Identities = 10/38 (26%), Positives = 21/38 (55%), Gaps = 3/38 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
KVA++ + ++ + EI E+ D + +G I F++
Sbjct: 30 KVAMRALGFDVKKPEI---LELMNEYDREGNGYIGFDD 64
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 53/249 (21%), Positives = 93/249 (37%), Gaps = 43/249 (17%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ GR LG+G+FG L + + A K + + +I D+E+ RE M
Sbjct: 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-DIIASSDIEEFLREAACMK 80
Query: 123 HLTGHRNIVELKGA------YEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANL--- 173
H ++ +L G +I+ G+L ++A L
Sbjct: 81 EFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 174 ---CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230
+ + Y S +HRDL N + + ED + DFGLS + +
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLS---------RKI 187
Query: 231 VGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQS 276
YY A E L Y +D+W+ GV ++ +++ G P+ G
Sbjct: 188 YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 277 IFDAILRGH 285
I++ ++ G+
Sbjct: 248 IYNYLIGGN 256
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 5e-18
Identities = 20/74 (27%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 345 RMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGT 404
+ K + + +K L+EE+ ++E F DTD SGTI +ELK + LG
Sbjct: 4 KAKTVVSARRDQKKG----RVGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGF 59
Query: 405 RLSESEVRQLMEAV 418
+ E+++++ +
Sbjct: 60 EPKKEEIKKMISEI 73
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 20/56 (35%), Positives = 33/56 (58%), Gaps = 3/56 (5%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ E S EEI + F+ D DNSGTIT ++L+ +LG L+E E+++++
Sbjct: 94 MGERDSREEI---LKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEA 146
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 7e-05
Identities = 22/58 (37%), Positives = 32/58 (55%), Gaps = 4/58 (6%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE-LKAGLPKLGTRLSESEVRQ 413
KVA++ + +EE +K+M +D D SGTI FEE L K+G R S E+ +
Sbjct: 51 KVAMRALGFEPKKEE---IKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDSREEILK 105
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 3e-04
Identities = 14/40 (35%), Positives = 23/40 (57%), Gaps = 4/40 (10%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
L++V K + ENL+EEE+ +EM D ++ I +E
Sbjct: 123 LRRV-AKELGENLTEEEL---QEMIAEADRNDDNEIDEDE 158
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 8e-18
Identities = 56/248 (22%), Positives = 98/248 (39%), Gaps = 42/248 (16%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
RN I G+ LG G+FG L T + A K++ ++ ++E+ E M
Sbjct: 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMK 91
Query: 123 HLTGHRNIVELKGAYEDRHSVN-----LIMDLCAGGELFDRIIAKGHYSERAAANL---- 173
+ H N++ L G + S +I+ G+L ++ + L
Sbjct: 92 DFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 174 --CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
+ + Y + +HRDL N + +D + DFGLS K +
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLS---------KKIY 198
Query: 232 GSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSI 277
YY A E L R Y +++D+W+ GV ++ + + G+ P+ G +
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258
Query: 278 FDAILRGH 285
+D +L GH
Sbjct: 259 YDYLLHGH 266
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 59/299 (19%), Positives = 107/299 (35%), Gaps = 36/299 (12%)
Query: 8 PSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRN 67
S + + T + G ++ V V +
Sbjct: 30 GSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSL 89
Query: 68 TYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
F +GRG FG Y L+ + K A KS+ ++ + +V E IM
Sbjct: 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 147
Query: 125 TGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVH 182
+ H N++ L G S +++ G+L + I + + + Q+ +
Sbjct: 148 S-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV----- 237
+ S +HRDL N + E +K DFGL+ +D+ +
Sbjct: 207 FLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---------RDMYDKEFDSVHNKT 254
Query: 238 ---------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
A E L+ + + ++D+WS GV+L+ L++ G PP+ I +L+G
Sbjct: 255 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 313
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 49/239 (20%), Positives = 87/239 (36%), Gaps = 34/239 (14%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ + +G G G L A K++ + D E IM
Sbjct: 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMG 105
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVV 181
H NI+ L+G ++ + G L + G ++ + R + +
Sbjct: 106 QFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---- 237
Y +G +HRDL N L + K +DFGLS + L
Sbjct: 165 RYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLS---------RVLEDDPDAAYTTT 212
Query: 238 ---------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + R + + +D+WS GV+++ +L+ G P+W T + + ++ G+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY 271
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 59/255 (23%), Positives = 94/255 (36%), Gaps = 51/255 (20%)
Query: 66 RNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ R+LG G FG Y T+ T + A K++ + ++E+ I+
Sbjct: 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDIL 87
Query: 122 HHLTGHRNIVELKGA--YEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
L H +I++ KG S+ L+M+ G L D + + +Q+
Sbjct: 88 RTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICE 145
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL-VGSAYYV- 237
+ Y H+ +HRDL N L D +K DFGL+ K + G YY
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGLA---------KAVPEGHEYYRV 193
Query: 238 -----------APEVLR-RNYGAEADIWSAGVILYILLS---------------GVPPFW 270
APE L+ + +D+WS GV LY LL+
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253
Query: 271 GETEQSIFDAILRGH 285
T + + + RG
Sbjct: 254 QMTVLRLTELLERGE 268
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 51/238 (21%), Positives = 92/238 (38%), Gaps = 31/238 (13%)
Query: 66 RNTYIFGRELGRGQFGV----TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ + +G G+FG + + A K++ + D E IM
Sbjct: 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIM 100
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTV 180
+ H NI+ L+G + +I + G L + G +S + R +
Sbjct: 101 GQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV--- 237
+ Y +M +HRDL N L + + K +DFGLS + A Y
Sbjct: 160 MKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDP-------EATYTTSG 209
Query: 238 --------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + R + + +D+WS G++++ +++ G P+W + + AI G
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF 267
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-17
Identities = 20/86 (23%), Positives = 33/86 (38%), Gaps = 5/86 (5%)
Query: 336 KPLDIAVL--TRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTD--NSGTIT 391
K L +VL + ++ L L S EI L E+FK + + + G I
Sbjct: 9 KHLCTSVLGCFDLDLYKQSGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLIN 68
Query: 392 FEELKAGLPKLGTRLSESEVRQLMEA 417
EE + L K + S ++ +
Sbjct: 69 KEEFQLALFKTNKKESL-FADRVFDL 93
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 7e-04
Identities = 11/51 (21%), Positives = 23/51 (45%), Gaps = 1/51 (1%)
Query: 352 MNKLKKVALKVIAENLSEEEIMGL-KEMFKSMDTDNSGTITFEELKAGLPK 401
+ ++ L NL + I + + F+ DT + G I EE ++ + +
Sbjct: 144 VKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVLR 194
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 44/245 (17%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
R R +G+G FGV Y + + Q A KS+ ++ VE RE +M
Sbjct: 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMR 77
Query: 123 HLTGHRNIVELKGAYEDRHSVNL-IMDLCAGGELFDRIIAKGHYSERA-----AANLCRQ 176
L H N++ L G + ++ G+L I + + R
Sbjct: 78 GLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 177 MVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY 236
M Y +HRDL N + E +K DFGL+ +D++ YY
Sbjct: 137 ME----YLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA---------RDILDREYY 180
Query: 237 V--------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280
A E L+ + ++D+WS GV+L+ LL+ G PP+ +
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240
Query: 281 ILRGH 285
+ +G
Sbjct: 241 LAQGR 245
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 48/254 (18%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
RN FG+ LG G FG + +D + A K + + + D+ E + E++I
Sbjct: 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKI 102
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD------RIIAKGHYSERAAANL- 173
M HL H NIV L GA V +I + C G+L + R++ A +
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 174 -------CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226
Q+ + + S +HRD+ N L + K DFGL+
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLA-------- 211
Query: 227 FKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-ILLSGVPPFWG- 271
+D++ + Y+ APE + Y ++D+WS G++L+ I G+ P+ G
Sbjct: 212 -RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270
Query: 272 ETEQSIFDAILRGH 285
+ + G+
Sbjct: 271 LVNSKFYKLVKDGY 284
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-17
Identities = 18/54 (33%), Positives = 26/54 (48%)
Query: 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
LSEE I K F D D G I+ +EL + LG ++ E+ ++E V
Sbjct: 12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEV 65
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-07
Identities = 17/51 (33%), Positives = 24/51 (47%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
SEEE L F+ D + G I EEL L G ++E ++ LM+
Sbjct: 94 SEEE---LANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDS 141
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 3e-05
Identities = 15/62 (24%), Positives = 29/62 (46%), Gaps = 4/62 (6%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE-LKAGLPKLGTRLSESEVRQLM 415
++++ +N ++EE L + + +D D SGTI FEE L + ++ +L
Sbjct: 43 GTVMRMLGQNPTKEE---LDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELA 99
Query: 416 EA 417
Sbjct: 100 NC 101
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 2e-04
Identities = 12/40 (30%), Positives = 25/40 (62%), Gaps = 4/40 (10%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
L ++ L+ E+++EE+ ++++ K D +N G I F+E
Sbjct: 118 LGEI-LRATGEHVTEED---IEDLMKDSDKNNDGRIDFDE 153
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 42/239 (17%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + +LG+G FG ++ T T + A K++ E +E Q+M L
Sbjct: 266 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKLR 320
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERA-----AANLCRQMVT 179
H +V+L + + ++ + + G L D + G Y AA + M
Sbjct: 321 -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA- 377
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV-- 237
Y M +HRDL+ N L E+ K DFGL+ + + + Y
Sbjct: 378 ---YVERMNYVHRDLRAANILVG---ENLVCKVADFGLA---------RLIEDNEYTARQ 422
Query: 238 ---------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
APE + ++D+WS G++L L + G P+ G + + D + RG+
Sbjct: 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 481
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-17
Identities = 14/56 (25%), Positives = 31/56 (55%), Gaps = 1/56 (1%)
Query: 364 AENLSEEEIMGLKEMFKSMDT-DNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
LS ++ L+ F+ +T + SG ++ +++ L LG + ++S +RQL++
Sbjct: 4 VSKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEF 59
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 5e-07
Identities = 11/51 (21%), Positives = 28/51 (54%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
++E L+E F+ D + +G I+ + ++ L +L LS ++ +++ +
Sbjct: 89 MQQE---LREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEI 136
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 4e-05
Identities = 13/63 (20%), Positives = 29/63 (46%), Gaps = 5/63 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE-LKAGLPKLGTRLSESEVRQ-L 414
+ L+V+ ++ ++++ D +G I F+ G LG ++ +++Q L
Sbjct: 37 GIILEVLGIQQTKST---IRQLIDEFDPFGNGDIDFDSFKIIGARFLGEEVNPEQMQQEL 93
Query: 415 MEA 417
EA
Sbjct: 94 REA 96
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 2e-04
Identities = 15/40 (37%), Positives = 23/40 (57%), Gaps = 4/40 (10%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
++++ L + E LS E+ L M +D D SGT+ FEE
Sbjct: 113 MREI-LAELDETLSSED---LDAMIDEIDADGSGTVDFEE 148
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 60/243 (24%), Positives = 98/243 (40%), Gaps = 31/243 (12%)
Query: 66 RNTYIFGRELGRGQFGVTY--LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
N F +G G FG + + A K + ++ ++DD D E++++
Sbjct: 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCK 81
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD---RIIAKGHYSERAAANLCRQMVTV 180
L H NI+ L GA E R + L ++ G L D + A AN ++
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 181 ---VHYCH----------SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF 227
+H+ +HRDL N L E+ K DFGLS + +V+
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVY 195
Query: 228 KDLVGSAYYV---APEVLR-RNYGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAIL 282
V A E L Y +D+WS GV+L+ I+ G P+ G T +++ +
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 283 RGH 285
+G+
Sbjct: 256 QGY 258
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 77.1 bits (191), Expect = 3e-17
Identities = 15/51 (29%), Positives = 29/51 (56%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+EE+ ++E F D D +GTI +ELK + LG + E+++++ +
Sbjct: 1 TEEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEI 51
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 49.4 bits (119), Expect = 1e-07
Identities = 17/56 (30%), Positives = 34/56 (60%), Gaps = 3/56 (5%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
++E ++EEI + FK D D +G I+F+ LK +LG L++ E++++++
Sbjct: 72 MSEKDTKEEI---LKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEA 124
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 41.7 bits (99), Expect = 6e-05
Identities = 13/58 (22%), Positives = 30/58 (51%), Gaps = 4/58 (6%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE-LKAGLPKLGTRLSESEVRQ 413
KVA++ + +EE +K+M +D + +G + F + L K+ + ++ E+ +
Sbjct: 29 KVAMRALGFEPKKEE---IKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEILK 83
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 40.9 bits (97), Expect = 1e-04
Identities = 15/40 (37%), Positives = 24/40 (60%), Gaps = 4/40 (10%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
LK+V K + ENL++EE+ +EM D D G ++ +E
Sbjct: 101 LKRV-AKELGENLTDEEL---QEMIDEADRDGDGEVSEQE 136
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 63/333 (18%), Positives = 118/333 (35%), Gaps = 54/333 (16%)
Query: 26 GHHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYL 85
G +G + P + S + R + ELG G FG +L
Sbjct: 1 GAMGSGSSLSPT-EGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFL 59
Query: 86 -----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140
+ + K A K++ K + +D +RE +++ L H++IV G +
Sbjct: 60 AECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG 115
Query: 141 HSVNLIMDLCAGGEL--FDRIIAKGHYSERAAANLCRQMVTVVH-------------YCH 185
+ ++ + G+L F R ++ + + Y
Sbjct: 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV-------- 237
+ +HRDL N L + +K DFG+S +D+ + YY
Sbjct: 176 GLHFVHRDLATRNCLVG---QGLVVKIGDFGMS---------RDIYSTDYYRVGGRTMLP 223
Query: 238 ----APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSD 291
PE + R + E+D+WS GV+L+ + + G P++ + D I +G +
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE---LE 280
Query: 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
I++ +P++R S +V
Sbjct: 281 RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 65/304 (21%), Positives = 109/304 (35%), Gaps = 69/304 (22%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
RN FG+ LG G FG + D A K + + + + E + E+++
Sbjct: 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKV 79
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL-----------FDRIIAKGHYSERA 169
+ +L H NIV L GA +I + C G+L + +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 170 AANLCRQMVTVVH-------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
A +++ + + S +HRDL N L + K DFGL+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA---- 192
Query: 223 PGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPP 268
+D+ + YV APE + Y E+D+WS G+ L+ L S G P
Sbjct: 193 -----RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 269 FWG-ETEQSIFDAILRGHI----DFSSDPWPNISSSAKDIVKKML---HADPKERLSAAE 320
+ G + + I G + + +I M ADP +R + +
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDI----------MKTCWDADPLKRPTFKQ 297
Query: 321 VLNH 324
++
Sbjct: 298 IVQL 301
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 59/257 (22%), Positives = 101/257 (39%), Gaps = 51/257 (19%)
Query: 66 RNTYIFGRELGRGQFGVTY-------LVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
R+ G+ LG G FG A K + + D+ D+ E+
Sbjct: 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEM 91
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV 178
++M + H+NI+ L GA + +I++ + G L + + A+ + ++ R
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 179 TVVH----------------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
+ Y S +HRDL N L + E++ +K DFGL+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---- 204
Query: 223 PGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-ILLSGVPP 268
+D+ YY APE L R Y ++D+WS GV+++ I G P
Sbjct: 205 -----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 269 FWGETEQSIFDAILRGH 285
+ G + +F + GH
Sbjct: 260 YPGIPVEELFKLLKEGH 276
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 1e-16
Identities = 22/55 (40%), Positives = 32/55 (58%)
Query: 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
AE L+EE+I KE F D D GTIT +EL + LG +E+E++ ++ V
Sbjct: 1 AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 55
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 1e-07
Identities = 19/56 (33%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ E SEEE+ E FK D D +G I+ EL+ + LG +L++ EV +++
Sbjct: 76 MKEQDSEEEL---IEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREA 128
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 40.5 bits (96), Expect = 2e-04
Identities = 17/57 (29%), Positives = 29/57 (50%), Gaps = 4/57 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE-LKAGLPKLGTRLSESEVR 412
++ + +N +E E L++M +D D +GTI F E L K+ + SE E+
Sbjct: 33 GTVMRSLGQNPTEAE---LQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSEEELI 86
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 39.4 bits (93), Expect = 4e-04
Identities = 13/40 (32%), Positives = 22/40 (55%), Gaps = 4/40 (10%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
L+ V + + E L+++E+ EM + D D G I +EE
Sbjct: 105 LRHV-MTNLGEKLTDDEV---DEMIREADIDGDGHINYEE 140
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 56/255 (21%), Positives = 100/255 (39%), Gaps = 50/255 (19%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
+ F ELG +FG Y + Q A K++ + E+ R E +
Sbjct: 8 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAML 65
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCR----- 175
L H N+V L G +++I C+ G+L + ++ + +S+ + + R
Sbjct: 66 RARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 176 -QMVTVVHYCH----------SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
+ VH S V+H+DL N L + +K +D GL
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF------ 175
Query: 225 DVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFW 270
+++ + YY APE + + ++DIWS GV+L+ + S G+ P+
Sbjct: 176 ---REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 232
Query: 271 GETEQSIFDAILRGH 285
G + Q + + I
Sbjct: 233 GYSNQDVVEMIRNRQ 247
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 59/257 (22%), Positives = 101/257 (39%), Gaps = 51/257 (19%)
Query: 66 RNTYIFGRELGRGQFGVTY-------LVTHKDTKQQFACKSISSRKLINRDDVEDVRREV 118
R+ G+ LG G FG A K + + D+ D+ E+
Sbjct: 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEM 137
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV 178
++M + H+NI+ L GA + +I++ + G L + + A+ + ++ R
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 179 TVVH----------------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
+ Y S +HRDL N L + E++ +K DFGL+
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---- 250
Query: 223 PGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-ILLSGVPP 268
+D+ YY APE L R Y ++D+WS GV+++ I G P
Sbjct: 251 -----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 269 FWGETEQSIFDAILRGH 285
+ G + +F + GH
Sbjct: 306 YPGIPVEELFKLLKEGH 322
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 2e-16
Identities = 18/93 (19%), Positives = 35/93 (37%), Gaps = 5/93 (5%)
Query: 331 GDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMG----LKEMFKSMDTDN 386
G K + K +K A + I + + E+ E+FK D +
Sbjct: 2 GACGSKGSTSDKGLASDKDGKKAKDRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNE 61
Query: 387 SGTITFEELKAGLPK-LGTRLSESEVRQLMEAV 418
+G + ++E+ +G + L S VR + +
Sbjct: 62 TGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRA 94
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 12/53 (22%), Positives = 19/53 (35%), Gaps = 4/53 (7%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG-TRLSESEVRQLMEAV 418
E L MF +D + + EE K +PKL + L + +
Sbjct: 127 YDFFE---LTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKEL 176
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 74.8 bits (185), Expect = 2e-16
Identities = 12/50 (24%), Positives = 26/50 (52%)
Query: 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
++++ KE F+ D++ +G IT E L+ L + G R+ + ++
Sbjct: 2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEA 51
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 49.0 bits (118), Expect = 2e-07
Identities = 13/51 (25%), Positives = 24/51 (47%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
SE+ + ++ F++ D + +G I L+ L LG RL E + +
Sbjct: 77 SEDIL---RQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGIT 124
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 39.8 bits (94), Expect = 3e-04
Identities = 14/57 (24%), Positives = 20/57 (35%), Gaps = 4/57 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE-LKAGLPKLGTRLSESEVR 412
+ LK + EMF D +G I F E L ++ SE +R
Sbjct: 29 QTVLKQFGVRVEPAA---FNEMFNEADATGNGKIQFPEFLSMMGRRMKQTTSEDILR 82
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 51/237 (21%), Positives = 91/237 (38%), Gaps = 30/237 (12%)
Query: 66 RNTYIFGRELGRGQFGVTY---LVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ +G G+FG L + A K++ + D E IM
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMG 101
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVV 181
H NI+ L+G V ++ + G L + ++ + R + + +
Sbjct: 102 QFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV---- 237
Y MG +HRDL N L + + K +DFGL + A Y
Sbjct: 161 KYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDP-------EAAYTTRGG 210
Query: 238 -------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285
+PE + R + + +D+WS G++L+ ++S G P+W + Q + A+ G+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 62/257 (24%), Positives = 102/257 (39%), Gaps = 51/257 (19%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQF-------ACKSISSRKLINRDDVEDVRREV 118
R+ + G+ LG G FG L + A K + + D+ D+ E+
Sbjct: 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEM 125
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMV 178
++M + H+NI+ L GA + +I++ + G L + + A+ + N
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 179 TVVH----------------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
+ Y S +HRDL N L + ED+ +K DFGL+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA---- 238
Query: 223 PGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-ILLSGVPP 268
+D+ YY APE L R Y ++D+WS GV+L+ I G P
Sbjct: 239 -----RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 269 FWGETEQSIFDAILRGH 285
+ G + +F + GH
Sbjct: 294 YPGVPVEELFKLLKEGH 310
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 44/274 (16%), Positives = 87/274 (31%), Gaps = 44/274 (16%)
Query: 27 HHPNGLKIDPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLV 86
HH + S TS + G VL + R G+ Y
Sbjct: 5 HHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDK---SGRQWKLKSFQTRDNQGILYEA 61
Query: 87 THKDT--------KQQFACK--SISSRKLINRDDVEDVRREVQI----MHHLTGHRNIVE 132
T KQ+F+ K + R ++ + + +Q+ + T I
Sbjct: 62 APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121
Query: 133 LK--GAYEDRHSVNLIMDLCAGGELFD--RIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
G ++D++ L++ G L + K SER+ + +++ + + H
Sbjct: 122 CMGFGVHQDKYRF-LVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE 179
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG--------DVFKDLVGSAYYVA-- 238
+H ++ EN + + +G + + P G +++
Sbjct: 180 YVHGNVTAENIFVDPEDQSQ-VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMD 238
Query: 239 ----PEVLRRNYGAEADIWSAG-VILYILLSGVP 267
RR +D+ S G +L L +P
Sbjct: 239 LHKGCGPSRR-----SDLQSLGYCMLKWLYGFLP 267
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 59/257 (22%), Positives = 100/257 (38%), Gaps = 51/257 (19%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R+ G+ LGRG FG + T + A K + ++ + + E++I
Sbjct: 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKI 83
Query: 121 MHHLTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFD--------RIIAKGHYSERAAA 171
+ H+ H N+V L GA + + +I++ C G L + K +
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 172 NLC-RQMVTVVH-------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223
L ++ + S +HRDL N L S E + +K DFGL+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA----- 195
Query: 224 GDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-ILLSGVPPF 269
+D+ YV APE + R Y ++D+WS GV+L+ I G P+
Sbjct: 196 ----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 270 WG-ETEQSIFDAILRGH 285
G + ++ + G
Sbjct: 252 PGVKIDEEFCRRLKEGT 268
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 5e-16
Identities = 10/44 (22%), Positives = 26/44 (59%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ +FK +D + G +++EE+KA + K +E ++ + +++
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSI 45
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-07
Identities = 10/41 (24%), Positives = 18/41 (43%), Gaps = 3/41 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKA 397
K + +E+ + + +FKS+D D +G I E
Sbjct: 23 KAFVSKKRAIKNEQLL---QLIFKSIDADGNGEIDQNEFAK 60
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 5e-16
Identities = 10/44 (22%), Positives = 26/44 (59%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ +FK +D + G +++EE+KA + K +E ++ + +++
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSI 45
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 4e-06
Identities = 16/62 (25%), Positives = 25/62 (40%), Gaps = 5/62 (8%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE-LKAGLPKLGTRLSESEVRQLM 415
K + +E+ L+ +FKS+D D +G I E K G LS+ + L
Sbjct: 23 KAFVSKKRAIKNEQL---LQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDK-IGLK 78
Query: 416 EA 417
Sbjct: 79 VL 80
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 3e-05
Identities = 13/51 (25%), Positives = 22/51 (43%), Gaps = 7/51 (13%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ LK ++K MD D G +T EE+ + K G +V + +
Sbjct: 73 DKIG---LKVLYKLMDVDGDGKLTKEEVTSFFKKHG----IEKVAEQVMKA 116
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 6e-16
Identities = 15/61 (24%), Positives = 31/61 (50%)
Query: 359 ALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
A + L +++I +KE F +D D G ++ E++KA +LG + E+ +++
Sbjct: 4 AASGVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKEA 63
Query: 419 S 419
Sbjct: 64 P 64
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 9e-08
Identities = 12/56 (21%), Positives = 23/56 (41%), Gaps = 3/56 (5%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
++ SEE I + F D + + E +K L +G ++ E+R +
Sbjct: 80 LSGTDSEETI---RNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEA 132
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-16
Identities = 59/256 (23%), Positives = 103/256 (40%), Gaps = 51/256 (19%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R + RELG G FG +L ++ K A K++ K +D +RE ++
Sbjct: 14 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAEL 70
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFD---------RIIAKGHYSERAAA 171
+ +L H +IV+ G D + ++ + G+L I+ G +
Sbjct: 71 LTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 172 NLCRQMVTVVH-------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224
QM+ + Y S +HRDL N L + +K DFG+S
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS------ 180
Query: 225 DVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFW 270
+D+ + YY PE + R + E+D+WS GVIL+ + + G P++
Sbjct: 181 ---RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237
Query: 271 GETEQSIFDAILRGHI 286
+ + + I +G +
Sbjct: 238 QLSNTEVIECITQGRV 253
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 42/271 (15%), Positives = 88/271 (32%), Gaps = 50/271 (18%)
Query: 35 DPPGPPRPSSSATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQ 94
+ S+ A +VG ++ + G +G+G FG YL ++ +
Sbjct: 6 AAQAGRQSSAKRHLAEQFAVGEIITD---MAAAAWKVGLPIGQGGFGCIYLA-DMNSSES 61
Query: 95 FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK-------------------G 135
+ K + D + E++ I +
Sbjct: 62 VGSDAPCVVK-VEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120
Query: 136 AYEDRHSVNLIMDLCAGG----ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMH 191
+ +IMD G ++++ +S + L +++ ++ Y H +H
Sbjct: 121 KNGKSYRF-MIMDRF--GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHEYVH 175
Query: 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF--------KDLVGSAYYVAPEVLR 243
D+K N L + D + D+GL+ + P V + G+ + + +
Sbjct: 176 GDIKASNLLLNYKNPDQ-VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS---ID 231
Query: 244 RNYGAEA----DIWSAGVILYILLSGVPPFW 270
+ G D+ G + L+G P W
Sbjct: 232 AHNGVAPSRRGDLEILGYCMIQWLTGHLP-W 261
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 9e-16
Identities = 62/309 (20%), Positives = 118/309 (38%), Gaps = 75/309 (24%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R + G+ LG G+FG + + A K + ++ + ++ D+ E +
Sbjct: 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNV 79
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL-----------FDRIIAKGHYSERA 169
+ + H ++++L GA + LI++ G L + + G + +
Sbjct: 80 LKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 170 AANLCRQMVTV---VHYCH----------SMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216
+ + +T+ + + M ++HRDL N L + E +K +DFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFG 195
Query: 217 LSVFFKPGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILY-IL 262
LS +D+ YV A E L Y ++D+WS GV+L+ I+
Sbjct: 196 LS---------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 263 LSGVPPFWGETEQSIFDAILRGHI----DFSSDPWPNISSSAKDIVKKML---HADPKER 315
G P+ G + +F+ + GH D S+ + ML +P +R
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRL----------MLQCWKQEPDKR 296
Query: 316 LSAAEVLNH 324
A++
Sbjct: 297 PVFADISKD 305
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-15
Identities = 17/56 (30%), Positives = 30/56 (53%), Gaps = 1/56 (1%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+A + ++I + +FK DT+ G I+ EL L LG ++ EVR++M +
Sbjct: 1 MAAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEI 55
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86 | Back alignment and structure |
|---|
Score = 38.0 bits (89), Expect = 4e-04
Identities = 9/29 (31%), Positives = 18/29 (62%), Gaps = 3/29 (10%)
Query: 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
+++ +E ++ M +DTD G I+F+E
Sbjct: 42 SVTPDE---VRRMMAEIDTDGDGFISFDE 67
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 61/263 (23%), Positives = 100/263 (38%), Gaps = 57/263 (21%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R FG+ LG G FG ++ Q A K + ++ + + E + E+++
Sbjct: 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSELKM 101
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL---------------FDRIIAKGHY 165
M L H NIV L GA + LI + C G+L + K
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 166 SERAAANLC-RQMVTVVH-------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217
E L ++ + + +HRDL N L + +K DFGL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGL 218
Query: 218 SVFFKPGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILLS 264
+ +D++ + YV APE L Y ++D+WS G++L+ + S
Sbjct: 219 A---------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
Query: 265 -GVPPFWG-ETEQSIFDAILRGH 285
GV P+ G + + + I G
Sbjct: 270 LGVNPYPGIPVDANFYKLIQNGF 292
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 54/264 (20%), Positives = 99/264 (37%), Gaps = 58/264 (21%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
RN + R++G G FG + + + A K + ++ + D D +RE +
Sbjct: 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAAL 103
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL-----------FDRIIAKGHYSERA 169
M + NIV+L G + L+ + A G+L + +
Sbjct: 104 MAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 170 AANLCRQMVTVVH-------------YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216
++ ++ Y +HRDL N L E+ +K DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFG 219
Query: 217 LSVFFKPGDVFKDLVGSAYYV------------APEVLR-RNYGAEADIWSAGVILYILL 263
LS +++ + YY PE + Y E+D+W+ GV+L+ +
Sbjct: 220 LS---------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 264 S-GVPPFWGETEQSIFDAILRGHI 286
S G+ P++G + + + G+I
Sbjct: 271 SYGLQPYYGMAHEEVIYYVRDGNI 294
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 4e-14
Identities = 11/83 (13%), Positives = 30/83 (36%), Gaps = 2/83 (2%)
Query: 333 ASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITF 392
+ L+ +V ++ ++ + + L +++E+ L FK+ SG +
Sbjct: 27 LIEAGLEDSVEDELEMATVRHRPEALELLEAQSKFTKKELQILYRGFKNE--CPSGVVNE 84
Query: 393 EELKAGLPKLGTRLSESEVRQLM 415
E K + + + +
Sbjct: 85 ETFKEIYSQFFPQGDSTTYAHFL 107
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 8e-14
Identities = 16/83 (19%), Positives = 34/83 (40%), Gaps = 5/83 (6%)
Query: 341 AVLTRMKQFRAMNKLKKVALKVIAE--NLSEEEIMGLKEMFKSMDTD--NSGTITFEELK 396
+++ K+ AM +++A + EE+ L E+FK + + + G I EE +
Sbjct: 3 CSVSKKKKKNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQ 62
Query: 397 AGLPKLGTRLSESEVRQLMEAVS 419
L + R ++ +
Sbjct: 63 LALFRNRNR-RNLFADRIFDVFD 84
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-13
Identities = 11/60 (18%), Positives = 30/60 (50%), Gaps = 2/60 (3%)
Query: 361 KVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRL--SESEVRQLMEAV 418
+ E+L + + L + F + D D+ G + +E+ ++ + ++ +V ++ +AV
Sbjct: 24 QFNVEDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAV 83
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-06
Identities = 12/116 (10%), Positives = 38/116 (32%), Gaps = 10/116 (8%)
Query: 304 VKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFR-AMNKLKKVALKV 362
++++++A ++ + + ++ + + L R + + A + +
Sbjct: 65 MRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNG------LLR-EDWVEANRVFAEAERER 117
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + +D D GT+ +ELK + + + E
Sbjct: 118 ERRGEPSLIALLSNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQEAAYTFFEKA 171
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-13
Identities = 13/66 (19%), Positives = 28/66 (42%), Gaps = 3/66 (4%)
Query: 356 KKVALKVIAENLSE---EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVR 412
A + I L + + + F++ DT + TI+ EE +A + L++ +
Sbjct: 4 MATADRDILARLHKAVTSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFD 63
Query: 413 QLMEAV 418
+L +
Sbjct: 64 RLWNEM 69
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 2e-04
Identities = 13/101 (12%), Positives = 41/101 (40%), Gaps = 21/101 (20%)
Query: 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMN 353
P+++++ +DI+ ++ A + + + D ++ ++R ++FRA
Sbjct: 2 PHMATADRDILARLHKAVTSHYHAITQEFEN----FDTMKTNT------ISR-EEFRA-- 48
Query: 354 KLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
+ L++E+ ++ M + G + + +
Sbjct: 49 -----ICNRRVQILTDEQF---DRLWNEMPVNAKGRLKYPD 81
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 5e-13
Identities = 17/83 (20%), Positives = 33/83 (39%)
Query: 336 KPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEEL 395
K + + ++ +NK K + ++ K + D + +G I L
Sbjct: 11 KAFGLLKAQQEERLEGINKQFLDDPKYSNDEDLPSKLEAFKVKYMEFDLNGNGDIDIMSL 70
Query: 396 KAGLPKLGTRLSESEVRQLMEAV 418
K L KLG + E+++L+ V
Sbjct: 71 KRMLEKLGVPKTHLELKRLIREV 93
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 2e-04
Identities = 6/38 (15%), Positives = 17/38 (44%), Gaps = 3/38 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
K L+ + + E LK + + + + + T ++ +
Sbjct: 71 KRMLEKLGVPKTHLE---LKRLIREVSSGSEETFSYSD 105
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-13
Identities = 16/53 (30%), Positives = 24/53 (45%)
Query: 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ L E F+++DTD SG I+ EL A L G S + +L+
Sbjct: 20 ARHMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMY 72
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-08
Identities = 13/48 (27%), Positives = 24/48 (50%)
Query: 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419
I+ ++E F+ D+ G + E++A L G ++SE + LM
Sbjct: 92 ILSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFD 139
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 9e-13
Identities = 19/79 (24%), Positives = 37/79 (46%), Gaps = 3/79 (3%)
Query: 343 LTRMKQFRAMNKLKKVAL---KVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGL 399
+ + +Q R + ++ + L K E E++ KE + D +N G I LK +
Sbjct: 17 ILKARQERRLAEINREFLCDQKYSDEENLPEKLTAFKEKYMEFDLNNEGEIDLMSLKRMM 76
Query: 400 PKLGTRLSESEVRQLMEAV 418
KLG + E+++++ V
Sbjct: 77 EKLGVPKTHLEMKKMISEV 95
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 4e-04
Identities = 7/38 (18%), Positives = 17/38 (44%), Gaps = 3/38 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
K ++ + + E +K+M + S TI++ +
Sbjct: 73 KRMMEKLGVPKTHLE---MKKMISEVTGGVSDTISYRD 107
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 2e-12
Identities = 6/44 (13%), Positives = 19/44 (43%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
K +F+ D + G ++ +E + ++ ++ + E +
Sbjct: 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEI 46
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 6e-06
Identities = 7/38 (18%), Positives = 18/38 (47%), Gaps = 3/38 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
+ + ++E+I + F+ +D D +G + +E
Sbjct: 24 REVALAFSPYFTQEDI---VKFFEEIDVDGNGELNADE 58
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 3e-12
Identities = 11/65 (16%), Positives = 26/65 (40%), Gaps = 5/65 (7%)
Query: 359 ALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPK-----LGTRLSESEVRQ 413
K+ ++ + I K MF +D +++G I+ +E+ LG +++ +
Sbjct: 2 NSKLTSDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHK 61
Query: 414 LMEAV 418
Sbjct: 62 DAVEA 66
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 5e-10
Identities = 25/124 (20%), Positives = 40/124 (32%), Gaps = 8/124 (6%)
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQF-RAMNK 354
+ A DIV L A P++ + + G D + K
Sbjct: 38 MVYKASDIVINNLGATPEQA-KRHKDAVEAFFGGAGMKYGVETDW------PAYIEGWKK 90
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQL 414
L L+ A+N + +F +D D +G IT +E KA G S + +
Sbjct: 91 LATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEET 150
Query: 415 MEAV 418
Sbjct: 151 FRVC 154
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 1e-04
Identities = 11/40 (27%), Positives = 17/40 (42%), Gaps = 3/40 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELK 396
K K S E+ +E F+ D D SG + +E+
Sbjct: 132 KAYTKAAGIIQSSEDC---EETFRVCDIDESGQLDVDEMT 168
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-12
Identities = 18/54 (33%), Positives = 26/54 (48%)
Query: 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
LSEE I K F D D G I+ +EL + LG ++ E+ ++E V
Sbjct: 12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEV 65
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-05
Identities = 13/38 (34%), Positives = 23/38 (60%), Gaps = 3/38 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
++++ +N ++EE L + + +D D SGTI FEE
Sbjct: 43 GTVMRMLGQNPTKEE---LDAIIEEVDEDGSGTIDFEE 77
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-12
Identities = 13/53 (24%), Positives = 22/53 (41%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
+ E EI KE F +D + G I ++L+ +G ++E M
Sbjct: 15 VFSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAM 67
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 5e-08
Identities = 14/56 (25%), Positives = 23/56 (41%), Gaps = 3/56 (5%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ E+ I FK +D D G+I L+ L G R + E++ + A
Sbjct: 88 LKGADPEDVI---MGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAF 140
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 2e-04
Identities = 9/43 (20%), Positives = 20/43 (46%), Gaps = 4/43 (9%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKA 397
L+++ L + EEI K M+ + D +G + ++ +
Sbjct: 117 LEEL-LTTGGGRFTPEEI---KNMWAAFPPDVAGNVDYKNICY 155
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 5e-12
Identities = 12/53 (22%), Positives = 22/53 (41%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419
+ +I KE F +D + G I E+L L +G ++ + +M
Sbjct: 1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSEAP 53
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 5e-08
Identities = 13/51 (25%), Positives = 23/51 (45%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
E+ I + F D + SG I + L+ L +G R ++ EV ++
Sbjct: 74 PEDVI---RNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREA 121
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 9/40 (22%), Positives = 20/40 (50%), Gaps = 4/40 (10%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
L+++ L + + ++EE+ EM++ D G + E
Sbjct: 98 LREL-LTTMGDRFTDEEV---DEMYREAPIDKKGNFNYVE 133
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 6e-12
Identities = 16/50 (32%), Positives = 29/50 (58%), Gaps = 4/50 (8%)
Query: 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+EI L + FK +D DNSG+++ EE + LP+L V+++++
Sbjct: 2 ADEIKRLGKRFKKLDLDNSGSLSVEEFMS-LPELQ---QNPLVQRVIDIF 47
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 3e-04
Identities = 11/41 (26%), Positives = 21/41 (51%), Gaps = 1/41 (2%)
Query: 355 LKKVALKVIAENLSEEEIMG-LKEMFKSMDTDNSGTITFEE 394
L +V ++ NL + ++ + + + D D G I+FEE
Sbjct: 97 LFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEE 137
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 7e-04
Identities = 13/50 (26%), Positives = 27/50 (54%), Gaps = 4/50 (8%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL-GTRLSESEVRQLME 416
E++ L+ F+ D D G I+ EL L + G L +++++Q+++
Sbjct: 73 KEQK---LRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVD 119
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 13/149 (8%), Positives = 36/149 (24%), Gaps = 15/149 (10%)
Query: 270 WGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329
E ++ G++ P + + R W+
Sbjct: 4 TKEAVKASD-----GNLLGDPGRIPLSKRESIKWQRPRFTRQALMR-----CCLIKWILS 53
Query: 330 DGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGT 389
+ L L ++ + +++E+ L FK+ +G
Sbjct: 54 SAAPQGSDSSDSELELSTVRHQPEGLDQLQAQ---TKFTKKELQSLYRGFKNE--CPTGL 108
Query: 390 ITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + K + + + +
Sbjct: 109 VDEDTFKLIYSQFFPQGDATTYAHFLFNA 137
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-11
Identities = 13/50 (26%), Positives = 22/50 (44%), Gaps = 1/50 (2%)
Query: 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG-TRLSESEVRQLMEAV 418
+ L +F+ +D D SG I+ EL+ L T + VR ++
Sbjct: 4 PDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMF 53
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-08
Identities = 17/44 (38%), Positives = 23/44 (52%)
Query: 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
I + +F++ D DNSG I ELK L G RLS+ L+
Sbjct: 73 ITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILI 116
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-11
Identities = 10/53 (18%), Positives = 23/53 (43%), Gaps = 2/53 (3%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTR--LSESEVRQLMEAV 418
S+ + +K F +D D G IT + ++ + + + LM+++
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSL 53
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-06
Identities = 17/117 (14%), Positives = 37/117 (31%), Gaps = 16/117 (13%)
Query: 304 VKKMLHADPKERLSAAEVLNHPWMRVDGDAS-DKPLDIAVLTRMKQFRAMNKLKKVALKV 362
K + + L W + K +D F ++
Sbjct: 35 FAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDET------TFINS------MKEM 82
Query: 363 IAENLSEEEIMG-LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ ++ + G L F+++DT+ I+ +E LG L ++ +A+
Sbjct: 83 VKNPEAKSVVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFDAI 137
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 4e-11
Identities = 8/46 (17%), Positives = 20/46 (43%)
Query: 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEV 411
+ + G ++++ D D++G I +EL + +L +
Sbjct: 4 AFANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDK 49
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 21/116 (18%), Positives = 42/116 (36%), Gaps = 6/116 (5%)
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVAL 360
+ ++KK+ D ++ D + L I L M + +
Sbjct: 38 RHMLKKLQPKDKITDERVQQIKKSFMSAYDATFDGR-LQIEELANM--ILPQEENFLLIF 94
Query: 361 KVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416
+ A + E M ++++ D D+SG I+ ELK L L + + ++
Sbjct: 95 RREAPLDNSVEFM---KIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLD 147
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 40.0 bits (93), Expect = 8e-04
Identities = 21/138 (15%), Positives = 39/138 (28%), Gaps = 17/138 (12%)
Query: 284 GHIDFS--SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIA 341
G + ++ + I ++ D W + D D+S + A
Sbjct: 72 GRLQIEELANMILPQEENFLLIFRREAPLDNSVEFMKI------WRKYDADSSGY-ISAA 124
Query: 342 VLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPK 401
L + L K I N +E M K D + G + +L L
Sbjct: 125 ELKN-----FLKDLFLQHKKKIPPNKLDEYT---DAMMKIFDKNKDGRLDLNDLARILAL 176
Query: 402 LGTRLSESEVRQLMEAVS 419
L + ++ +
Sbjct: 177 QENFLLQFKMDASSQVER 194
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 6e-11
Identities = 23/95 (24%), Positives = 39/95 (41%), Gaps = 16/95 (16%)
Query: 333 ASDKPLDIAVLTRMKQFRAMNK------LKKVALKVIAENLSEEEIMGLKEMFKSMDTDN 386
A D + + +A V LK +S + +K++FK++D D
Sbjct: 3 AKDLLKADDIKKALDAVKAEGSFNHKKFFALVGLKA----MSAND---VKKVFKAIDADA 55
Query: 387 SGTITFEELK---AGLPKLGTRLSESEVRQLMEAV 418
SG I EELK G L+++E + ++A
Sbjct: 56 SGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAA 90
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110 | Back alignment and structure |
|---|
Score = 38.7 bits (91), Expect = 4e-04
Identities = 12/42 (28%), Positives = 17/42 (40%), Gaps = 5/42 (11%)
Query: 355 LKKVA--LKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
LK V +L++ E K K+ D D G I +E
Sbjct: 64 LKFVLKSFAADGRDLTDAET---KAFLKAADKDGDGKIGIDE 102
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 16/64 (25%), Positives = 29/64 (45%), Gaps = 3/64 (4%)
Query: 350 RAMNKLKKVALKVIAE--NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLS 407
RA L+ L+ I + S +I L F S+D +GT++ E+ + +P+L
Sbjct: 4 RASTLLRDEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDFQR-IPELAINPL 62
Query: 408 ESEV 411
+
Sbjct: 63 GDRI 66
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 12/48 (25%), Positives = 22/48 (45%), Gaps = 1/48 (2%)
Query: 355 LKKVALKVIAENLSEEEIMGL-KEMFKSMDTDNSGTITFEELKAGLPK 401
L +V ++ N+S+E++ + + D D I+F E L K
Sbjct: 135 LLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAISFTEFVKVLEK 182
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 Length = 204 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 5e-10
Identities = 10/55 (18%), Positives = 19/55 (34%), Gaps = 1/55 (1%)
Query: 365 ENLSEEEIMGLKEMFKS-MDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + L+E +K ++ SGT+ E K + V + A
Sbjct: 14 GAVGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAF 68
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-10
Identities = 9/53 (16%), Positives = 19/53 (35%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419
EE++ + + G I+ + KLG S + +++ E
Sbjct: 9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYG 61
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-08
Identities = 13/51 (25%), Positives = 25/51 (49%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ EE++ +MF D + +G +T ++K L G L++ E + A
Sbjct: 82 NVEELI---KMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF 129
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 37/189 (19%), Positives = 70/189 (37%), Gaps = 22/189 (11%)
Query: 66 RNTYIFGRELGRGQFGVTYL-----VTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R+ G+ LGRG FG + T + A K + ++ + + E++I
Sbjct: 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKI 78
Query: 121 MHHLTGHRNIVELKGAY-EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
+ H+ H N+V L GA + + +I++ C G L + +K + +
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN----EFVPYKTKGAR 134
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSS--------AEDSPLKATDFGLSVFFKPGDVF--KD 229
+G + DLK +SS E+ L + + D +
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 230 LVGSAYYVA 238
L+ ++ VA
Sbjct: 195 LICYSFQVA 203
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 44/227 (19%), Positives = 81/227 (35%), Gaps = 35/227 (15%)
Query: 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVEL 133
E + TYL + ++ + K R +D V + +++
Sbjct: 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFR--QGKDYVGAIPVDLKRRLDSITSSQSSAS 164
Query: 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193
G E++ ++ + + K + Q+ + + S +HRD
Sbjct: 165 SGFVEEKSLSDVEEEEA------PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 218
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV------------APEV 241
L N L S E + +K DFGL+ +D+ YV APE
Sbjct: 219 LAARNILLS---EKNVVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 242 LRRN-YGAEADIWSAGVILY-ILLSGVPPFWG-ETEQSIFDAILRGH 285
+ Y ++D+WS GV+L+ I G P+ G + ++ + G
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 313
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 10/58 (17%), Positives = 23/58 (39%), Gaps = 6/58 (10%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSES------EVRQLMEAV 418
S E++ D D SG + +EL+ + +L ++ E++ ++
Sbjct: 10 SSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQY 67
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 24/116 (20%), Positives = 48/116 (41%), Gaps = 8/116 (6%)
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVAL 360
+++++++L A K L + + + K + I L + + + L
Sbjct: 39 QNLIQELLQARKKAGLELSPEMKTFVDQYGQRDDGK-IGIVELAHVLP----TEENFLLL 93
Query: 361 KVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416
+ S EE M + ++ DTD+SG I EELK L L + +++ +
Sbjct: 94 FRCQQLKSCEEFM---KTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLA 146
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 14/67 (20%), Positives = 24/67 (35%), Gaps = 3/67 (4%)
Query: 350 RAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSES 409
R + + LK + +E + F+ D D +G I EL A L L + +
Sbjct: 171 RLLPVQENFLLKFQGIKMCGKE---FNKAFELYDQDGNGYIDENELDALLKDLCEKNKQE 227
Query: 410 EVRQLME 416
+
Sbjct: 228 LDINNIS 234
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-09
Identities = 9/68 (13%), Positives = 24/68 (35%), Gaps = 4/68 (5%)
Query: 350 RAMNKLKKVALKVIAE--NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLS 407
++ +KL + L+ + ++E+ + F SG + E + +
Sbjct: 3 KSQSKLSQDQLQDLVRSTRFDKKELQQWYKGFF--KDCPSGHLNKSEFQKIYKQFFPFGD 60
Query: 408 ESEVRQLM 415
S + +
Sbjct: 61 PSAFAEYV 68
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 11/61 (18%), Positives = 20/61 (32%), Gaps = 3/61 (4%)
Query: 359 ALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG-TRLSESEVRQLMEA 417
++ + + +E F M SG T E K L G + + + Q+
Sbjct: 8 SIAGDQKAVPTQETHVWYRTF--MMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQVYNT 65
Query: 418 V 418
Sbjct: 66 F 66
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 2e-09
Identities = 13/51 (25%), Positives = 25/51 (49%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + L+ F++ D D G IT +EL+ + LG L + E+ ++
Sbjct: 1 ARAGLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREA 51
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71 | Back alignment and structure |
|---|
Score = 39.0 bits (92), Expect = 1e-04
Identities = 11/38 (28%), Positives = 19/38 (50%), Gaps = 3/38 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
+ A+ + + L +EE L M + D D G + +EE
Sbjct: 29 RRAMAGLGQPLPQEE---LDAMIREADVDQDGRVNYEE 63
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 5e-09
Identities = 17/53 (32%), Positives = 30/53 (56%)
Query: 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
++ + LKE FK D D +G I+ EL+ + LG +L++ EV Q+++
Sbjct: 2 HMDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEA 54
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-05
Identities = 12/61 (19%), Positives = 26/61 (42%), Gaps = 3/61 (4%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416
+ + + E L++EE+ ++M K D D G + +EE + + + +L
Sbjct: 32 RHVMINLGEKLTDEEV---EQMIKEADLDGDGQVNYEEFVKMMMTVRGGGGGNGWSRLRR 88
Query: 417 A 417
Sbjct: 89 K 89
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 9/58 (15%), Positives = 23/58 (39%), Gaps = 2/58 (3%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGT--RLSESEVRQLMEAV 418
I E+ + +K + +D G I+ E+ + ++ +LS + + +
Sbjct: 4 ITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEF 61
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 11/50 (22%), Positives = 22/50 (44%)
Query: 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
++ M+ +DTD G ++ E KA L +G L++ + +
Sbjct: 98 AMAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTL 147
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 6e-05
Identities = 8/41 (19%), Positives = 21/41 (51%), Gaps = 3/41 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKA 397
K L+ + +L++++ F ++D + +G I+ +E
Sbjct: 125 KAFLQAVGPDLTDDK---AITCFNTLDFNKNGQISRDEFLV 162
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} Length = 94 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-08
Identities = 17/56 (30%), Positives = 32/56 (57%), Gaps = 3/56 (5%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + SEEE ++E F+ D D +G I+ EL+ + LG +L++ EV +++
Sbjct: 22 MKDTDSEEE---IREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREA 74
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} Length = 94 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 3e-04
Identities = 13/40 (32%), Positives = 22/40 (55%), Gaps = 4/40 (10%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
L+ V + + E L++EE + EM + D D G + +EE
Sbjct: 51 LRHV-MTNLGEKLTDEE---VDEMIREADIDGDGQVNYEE 86
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-08
Identities = 10/52 (19%), Positives = 24/52 (46%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+++++ KE F+ D G I + + + LG + +EV +++
Sbjct: 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNP 55
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-08
Identities = 13/51 (25%), Positives = 25/51 (49%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ E+ E F+ D + +G + EL+ L LG +++E EV ++
Sbjct: 85 TYEDY---LEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGH 132
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 Length = 193 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 13/70 (18%), Positives = 25/70 (35%), Gaps = 5/70 (7%)
Query: 353 NKLKKVALKVIAE--NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESE 410
+KL+ ++ + E + +E EI + F SG ++ EE K S+
Sbjct: 6 SKLRPEVMQDLLESTDFTEHEIQEWYKGFL--RDCPSGHLSMEEFKKIYGNFFPYGDASK 63
Query: 411 -VRQLMEAVS 419
+
Sbjct: 64 FAEHVFRTFD 73
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 12/53 (22%), Positives = 26/53 (49%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419
++ ++ KE F+ +D D G I+ +++A LG +E E+ ++
Sbjct: 51 FTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEAP 103
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 16/56 (28%), Positives = 21/56 (37%), Gaps = 4/56 (7%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
IA E+ I F D + G E LK L G + S+ EV Q +
Sbjct: 119 IAGTDEEDVI---VNAFNLFD-EGDGKCKEETLKRSLTTWGEKFSQDEVDQALSEA 170
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 9/41 (21%), Positives = 17/41 (41%), Gaps = 4/41 (9%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEEL 395
LK+ L E S++E+ + D +G I ++
Sbjct: 147 LKRS-LTTWGEKFSQDEV---DQALSEAPIDGNGLIDIKKF 183
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 2e-08
Identities = 14/53 (26%), Positives = 28/53 (52%), Gaps = 1/53 (1%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG-TRLSESEVRQLMEAV 418
+ +++ + FK D + G I F+E K + K+G L+++EV + M+
Sbjct: 2 VRQDDEEEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEA 54
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81 | Back alignment and structure |
|---|
Score = 37.5 bits (88), Expect = 5e-04
Identities = 13/40 (32%), Positives = 19/40 (47%), Gaps = 3/40 (7%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
K + KV E L++ E+ +E K D D +G I E
Sbjct: 30 FKFIMQKVGEEPLTDAEV---EEAMKEADEDGNGVIDIPE 66
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-08
Identities = 18/61 (29%), Positives = 31/61 (50%), Gaps = 3/61 (4%)
Query: 358 VALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
+ +E+ + F+++D + +GTI EL+ L LG L+ SEV +LM+
Sbjct: 64 YRKPIKTPTEQSKEM---LDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKE 120
Query: 418 V 418
V
Sbjct: 121 V 121
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-06
Identities = 13/49 (26%), Positives = 24/49 (48%)
Query: 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
++E F+ D DN G ++ EEL + L LG + +E+ + +
Sbjct: 2 ASADQIQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQL 50
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 2e-04
Identities = 12/50 (24%), Positives = 23/50 (46%), Gaps = 8/50 (16%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE----LKAGLP 400
L+++ L + + L+ E+ +E+ K + G I +E L G P
Sbjct: 98 LRQL-LLNLGDALTSSEV---EELMKEVSVSGDGAINYESFVDMLVTGYP 143
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-08
Identities = 11/57 (19%), Positives = 22/57 (38%), Gaps = 9/57 (15%)
Query: 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTR--------LSESEVRQLMEAV 418
EE+ + +F + D+ ++ EL L K+ TR R ++ +
Sbjct: 1 EEVRQFRRLFAQLAGDD-MEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVM 56
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 13/48 (27%), Positives = 19/48 (39%)
Query: 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
I + ++K D D SGTI EL G L+E ++
Sbjct: 74 NNIKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRR 121
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 3e-08
Identities = 39/283 (13%), Positives = 78/283 (27%), Gaps = 65/283 (22%)
Query: 60 KPMEDVRNTYIFG--RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-----DVE 112
P T ++G G FG + T A K I+ + E
Sbjct: 11 VPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFE 68
Query: 113 DVRREVQIMHHLTG--------HRNIVELKGAY--------------------------- 137
++ E+ I L+ + L +
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 138 ---EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH-SMGVMHRD 193
+ ++++ GG +++ K S A ++ Q+ + S+ HRD
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRD 187
Query: 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIW 253
L N L ++ L T G S + +V +Y
Sbjct: 188 LHWGNVLLKKTS-LKKLHYTLNGKSSTIPSCGL-------------QVSIIDYTLSRLER 233
Query: 254 SAGVILYILLSGVPPFWGETEQS--IFDAILRGHIDFSSDPWP 294
V+ + F G+ + I+ + + + + + P
Sbjct: 234 DGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHP 276
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 20/54 (37%), Positives = 31/54 (57%)
Query: 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ L+EE+I KE F D D GTIT +EL + LG +E+E++ ++ V
Sbjct: 304 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 357
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 18/56 (32%), Positives = 32/56 (57%), Gaps = 3/56 (5%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + SEEEI +E F+ D D +G I+ EL+ + LG +L++ EV +++
Sbjct: 378 MKDTDSEEEI---REAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREA 430
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 7/46 (15%), Positives = 20/46 (43%), Gaps = 1/46 (2%)
Query: 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEV 411
S+ ++ L F+++D + G ++ +L+ + L +
Sbjct: 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQ-IGALAVNPLGDRI 66
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-05
Identities = 10/48 (20%), Positives = 22/48 (45%), Gaps = 1/48 (2%)
Query: 355 LKKVALKVIAENLSEEEIMGL-KEMFKSMDTDNSGTITFEELKAGLPK 401
+ +V ++ ++EE++ + + D D G ++F E L K
Sbjct: 136 MLQVLRLMVGVQVTEEQLENIADRTVQEADEDGDGAVSFVEFTKSLEK 183
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 12/77 (15%), Positives = 26/77 (33%), Gaps = 1/77 (1%)
Query: 343 LTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL 402
+ + FR + L F+ D D G I+ E+ L +
Sbjct: 84 VRVLAHFRPVEDEDTETQDPKKPEPLNSRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLM 143
Query: 403 -GTRLSESEVRQLMEAV 418
G +++E ++ + +
Sbjct: 144 VGVQVTEEQLENIADRT 160
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-08
Identities = 11/54 (20%), Positives = 20/54 (37%), Gaps = 4/54 (7%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL----GTRLSESEVRQLMEA 417
+ LK+ F D D +G + + + + G +EV+ L A
Sbjct: 2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNA 55
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-06
Identities = 12/54 (22%), Positives = 22/54 (40%), Gaps = 2/54 (3%)
Query: 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + +K + D + G I +E A L LG +S++E + V
Sbjct: 94 ASFNRVLGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQV 145
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-08
Identities = 17/58 (29%), Positives = 30/58 (51%), Gaps = 3/58 (5%)
Query: 361 KVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ E + + M E FK+ D + G I+ EL+ L LG RLS+ +V ++++
Sbjct: 75 LMDCEQGTFADYM---EAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLT 129
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-06
Identities = 13/52 (25%), Positives = 22/52 (42%), Gaps = 2/52 (3%)
Query: 367 LSEEEIMGLKEMFKSMD--TDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416
LS++EI LK++F+ D G + +L LG +V +
Sbjct: 3 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGG 54
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-08
Identities = 10/52 (19%), Positives = 19/52 (36%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
S+ KE F D IT ++ LG + +E+ +++
Sbjct: 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNP 53
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 6e-08
Identities = 15/51 (29%), Positives = 28/51 (54%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ E+ + E + D + +GT+ EL+ L LG +++E EV +LM+
Sbjct: 83 TFEDFV---EGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKGQ 130
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 8e-08
Identities = 17/51 (33%), Positives = 27/51 (52%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
EE + + F+ D D +G I EL+ L LG +LS E+ +L++ V
Sbjct: 74 DPEEFV---KGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGV 121
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140 | Back alignment and structure |
|---|
Score = 40.9 bits (97), Expect = 1e-04
Identities = 8/47 (17%), Positives = 17/47 (36%)
Query: 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416
+ K+ F D +G I + L G + +E+ ++
Sbjct: 2 TDDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES 48
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-08
Identities = 9/50 (18%), Positives = 23/50 (46%), Gaps = 1/50 (2%)
Query: 362 VIAENLSEEEIMGLKEMFKSM-DTDNSGTITFEELKAGLPKLGTRLSESE 410
+ A LS+ + + +F + D ++ G I +++ + + K+ S
Sbjct: 1 MAAHQLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPT 50
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} Length = 191 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-06
Identities = 13/71 (18%), Positives = 23/71 (32%), Gaps = 3/71 (4%)
Query: 348 QFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLS 407
++ M + V E+L E + MF DT I E G +
Sbjct: 85 EWLKMWA-ECVKSVEKGESLPEWLTKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IP 141
Query: 408 ESEVRQLMEAV 418
+S+ + +
Sbjct: 142 KSDCDAAFDTL 152
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 Length = 109 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-07
Identities = 14/54 (25%), Positives = 26/54 (48%), Gaps = 6/54 (11%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELK---AGLPKLGTRLSESEVRQLMEAV 418
S ++ +K+ F +D D SG I +ELK L+++E + ++A
Sbjct: 40 SADD---IKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAG 90
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} PDB: 2kqy_A Length = 109 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-07
Identities = 14/54 (25%), Positives = 27/54 (50%), Gaps = 6/54 (11%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGT---RLSESEVRQLMEAV 418
+ ++ +K++F +D D SG I EEL+ L + L+ +E + + A
Sbjct: 40 TPDQ---IKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAG 90
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-07
Identities = 13/55 (23%), Positives = 30/55 (54%), Gaps = 3/55 (5%)
Query: 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
E+ + F+ D +++G ++ +L+ L LG +L+++EV +L++ V
Sbjct: 77 TTKAKTED---FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGV 128
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 6e-06
Identities = 10/47 (21%), Positives = 18/47 (38%)
Query: 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
K++F D G I + L L +G + V+ ++ A
Sbjct: 2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINA 48
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 4e-04
Identities = 10/40 (25%), Positives = 24/40 (60%), Gaps = 4/40 (10%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
L+ + L + E L++ E+ E+ K ++ D++G I +++
Sbjct: 105 LRYM-LTGLGEKLTDAEV---DELLKGVEVDSNGEIDYKK 140
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 Length = 78 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-07
Identities = 14/50 (28%), Positives = 28/50 (56%), Gaps = 4/50 (8%)
Query: 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
++ ++ +FK DT+ G I+ EL L LG+ ++ EV+++M +
Sbjct: 2 ADD---MERIFKRFDTNGDGKISLSELTDALRTLGSTSAD-EVQRMMAEI 47
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 Length = 78 | Back alignment and structure |
|---|
Score = 37.5 bits (88), Expect = 5e-04
Identities = 11/38 (28%), Positives = 18/38 (47%), Gaps = 4/38 (10%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
AL+ + ++E ++ M +DTD G I F E
Sbjct: 26 TDALRTLGSTSADE----VQRMMAEIDTDGDGFIDFNE 59
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 15/56 (26%), Positives = 20/56 (35%), Gaps = 3/56 (5%)
Query: 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESE-VRQLMEAV 418
E LS E + F M SG +T E K S ++ V Q+ E
Sbjct: 8 VEELSATECHQWYKKF--MTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETF 61
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A Length = 108 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-07
Identities = 16/61 (26%), Positives = 28/61 (45%), Gaps = 6/61 (9%)
Query: 361 KVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEA 417
KV + S ++ +K+ F +D D SG I +ELK L L+++E + +
Sbjct: 32 KVGLASKSLDD---VKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLAD 88
Query: 418 V 418
Sbjct: 89 G 89
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-07
Identities = 7/51 (13%), Positives = 15/51 (29%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
E + F + D D +G I + + + +A+
Sbjct: 2 YERR---IAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQAL 49
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A Length = 166 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-06
Identities = 13/54 (24%), Positives = 19/54 (35%), Gaps = 2/54 (3%)
Query: 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ +E L DTD G +T + L G + E RQ A+
Sbjct: 90 DRFAEMARPFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAAL 141
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 110 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 8e-07
Identities = 13/52 (25%), Positives = 23/52 (44%), Gaps = 2/52 (3%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
++EE+ F+S+ D S I+ K K ++LS E+ + E
Sbjct: 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTK--SKLSIPELSYIWELS 65
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 Length = 109 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 9e-07
Identities = 18/54 (33%), Positives = 30/54 (55%), Gaps = 6/54 (11%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELK---AGLPKLGTRLSESEVRQLMEAV 418
++ + +KE+F+ +D D SG I EELK G G L+++E + L+ A
Sbjct: 39 TDAQ---VKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAG 89
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 11/93 (11%)
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKA--TDFGLSVFFKPGD---VFKDLVGSAYY 236
HY H+ ++HRD+K N L D TDFG+S D + + G+ Y
Sbjct: 153 HYLHTRAIIHRDVKSINILL-----DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 237 VAPEVLRRNYGAE-ADIWSAGVILYILLSGVPP 268
+ PE + E +D++S GV+L+ +L
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A Length = 165 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 14/44 (31%), Positives = 24/44 (54%)
Query: 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
+ KE F ++D D SGT+ EL+ + +G RLS + ++
Sbjct: 69 LNAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIV 112
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A Length = 165 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 7e-04
Identities = 9/49 (18%), Positives = 19/49 (38%), Gaps = 6/49 (12%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLG-----TRLSESEVRQLMEAV 418
+ F ++ G + EEL+ L + G + S R ++ +
Sbjct: 2 VYTYFSAV-AGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAML 49
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 Length = 95 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-06
Identities = 11/52 (21%), Positives = 20/52 (38%), Gaps = 2/52 (3%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+S E E+F D D G ++ E++ K T L + + +
Sbjct: 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLK--TGLPSTLLAHIWSLC 53
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A Length = 83 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-06
Identities = 10/58 (17%), Positives = 24/58 (41%), Gaps = 6/58 (10%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLS------ESEVRQLMEAV 418
++ + L+ FK +D + G +T EL+ + L + + +L++
Sbjct: 1 MACKVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMA 58
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A Length = 198 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 17/44 (38%), Positives = 25/44 (56%)
Query: 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
+ G ++ F S DTD SGT+ +EL+ L +G RLS V +
Sbjct: 102 LNGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIA 145
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-06
Identities = 15/61 (24%), Positives = 27/61 (44%), Gaps = 2/61 (3%)
Query: 360 LKVIAENLSEEEIMG-LKEMFKSMDTDNSGTITFEELKAGLPKLGT-RLSESEVRQLMEA 417
L V+AE + EE + L + F + IT E L+ LG +S+ + + ++
Sbjct: 26 LPVMAEKMDVEEFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVRE 85
Query: 418 V 418
Sbjct: 86 G 86
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} Length = 135 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-05
Identities = 13/64 (20%), Positives = 28/64 (43%), Gaps = 3/64 (4%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQL 414
L++ + + E +S+E+ + M + D D G + E + +L + E L
Sbjct: 62 LRRNSGILGIEGMSKED---AQGMVREGDLDGDGALNQTEFCVLMVRLSPEMMEDAETWL 118
Query: 415 MEAV 418
+A+
Sbjct: 119 EKAL 122
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 4e-06
Identities = 56/391 (14%), Positives = 123/391 (31%), Gaps = 119/391 (30%)
Query: 88 HKDT---KQQFACKSISS--RKLINRD----DVEDVRREVQIMHHLTGHRNIVELKGAYE 138
H D + Q+ K I S + DV+D+ + + L+ E+
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSI-----LSKE----EIDHIIM 56
Query: 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPE- 197
+ +V+ + LF +++K + ++ V V L+
Sbjct: 57 SKDAVSGTL------RLFWTLLSKQ-------EEMVQKFVEEV------------LRINY 91
Query: 198 NFLFSSSAEDS--PLKATD---------FGLSVFFKPGDV-----FKDLVGSAYYVAPE- 240
FL S + P T + + F +V + L + + P
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAK 151
Query: 241 --VLRRNYG---------AEADIWSAGVILYILLSGVPPFW---GE--TEQSIFDAI--L 282
++ G A D+ + + + + FW + +++ + + L
Sbjct: 152 NVLI---DGVLGSGKTWVA-LDVCLSYKVQCKMDFKI--FWLNLKNCNSPETVLEMLQKL 205
Query: 283 RGHIDFSSDPWPNISS-------SAKDIVKKMLHADPKER--LSAAEVLNHPWMRVDGDA 333
ID + + SS S + ++++L + P E L VL + +A
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL----VLLNVQ-----NA 256
Query: 334 SD-KPLDIA----VLTRMKQ---FRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTD 385
+++ + TR KQ F + ++L + L+ +E+ L +
Sbjct: 257 KAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ 316
Query: 386 NSGTITFEELKAGLPKL----GTRLSESEVR 412
+ E+ P+ + +
Sbjct: 317 DLP----REVLTTNPRRLSIIAESIRDGLAT 343
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 3e-04
Identities = 66/477 (13%), Positives = 127/477 (26%), Gaps = 157/477 (32%)
Query: 1 MGNCN---GLPSSQTQLHSTTADPDTGPGHHPNGLKIDPPGPPRPSSSATSATSSSVGRV 57
+ NCN + +L +IDP R S+
Sbjct: 189 LKNCNSPETVLEMLQKLL----------------YQIDPNWTSRSDHSSN---------- 222
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVR-- 115
+ + ++ EL R L+ K + L+ +V++ +
Sbjct: 223 IKLRIHSIQA------ELRR-------LLKSKPYE----------NCLLVLLNVQNAKAW 259
Query: 116 -------------REVQIMHHLTG----HRNIVELKGAYEDRHSVNLIMDLCAGGELFDR 158
R Q+ L+ H ++ L
Sbjct: 260 NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK----------SLL-- 307
Query: 159 IIAKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLK--PENFLFSSSAEDSPLKATDF 215
K Y + +L R+++T S+ RD +N+ + D +
Sbjct: 308 --LK--YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC--DKLTTIIES 361
Query: 216 GLSVFFKPGDV---FKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGE 272
L+V +P + F L V P A I + L ++ W +
Sbjct: 362 SLNV-LEPAEYRKMFDRLS-----VFPP--------SAHI-PTIL-LSLI-------WFD 398
Query: 273 TEQSIFDAILRGHIDFSS-DPWPN----------ISSSAKDIVKKMLHADPKERLSAAEV 321
+S ++ +S + P + K + LH + + +
Sbjct: 399 VIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKT 458
Query: 322 LNHPWMRVDGDASDKPLD------IAV-LTRMKQFRAMNKLKKVAL-------KVIAENL 367
D LD I L ++ M + V L K+ ++
Sbjct: 459 F-DSD-----DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 368 SEEEIMGLK------EMFKSMDTDNSGTIT--FEELKAGLPKLGTRLSESEVRQLME 416
+ + + +K DN + LPK+ L S+ L+
Sbjct: 513 AWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLR 569
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 6e-06
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 16/95 (16%)
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKA--TDFGLSVFFKPGDVFKD------LVGSA 234
+ H +HRD+K N L D A +DFGL+ + + F +VG+
Sbjct: 148 FLHENHHIHRDIKSANILL-----DEAFTAKISDFGLA---RASEKFAQTVMTSRIVGTT 199
Query: 235 YYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPF 269
Y+APE LR ++DI+S GV+L +++G+P
Sbjct: 200 AYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 234
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 Length = 92 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 7e-06
Identities = 11/52 (21%), Positives = 22/52 (42%), Gaps = 2/52 (3%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+++E+ FK++ D +G I K K ++L E+ + E
Sbjct: 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTK--SKLPILELSHIWELS 52
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 Length = 167 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 10/49 (20%), Positives = 18/49 (36%), Gaps = 6/49 (12%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLG-----TRLSESEVRQLMEAV 418
L F S+ G I +EL+ L + G + R ++ +
Sbjct: 4 LYGYFASV-AGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSML 51
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 Length = 167 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-05
Identities = 16/48 (33%), Positives = 27/48 (56%)
Query: 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419
+ G ++ F S D+D SGT+ +EL+ L +G RL+ V + + S
Sbjct: 71 LNGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRYS 118
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 Length = 185 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 28/160 (17%), Positives = 57/160 (35%), Gaps = 18/160 (11%)
Query: 265 GVPPFWGETEQSIFDAIL----RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAA- 319
G+ F + + FD L G I + + ++ + K++ K L + + A+
Sbjct: 1 GLNDFQKQKIKFTFDFFLDMNHDGSIQD--NDFEDMMTRYKEVNKGSLSDADYKSMQASL 58
Query: 320 -EVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEM 378
+ R D + D + ++ AM + K +A +L + +
Sbjct: 59 EDEWRDLKGRADINK-DDVVSWE------EYLAMWE-KTIATCKSVADLPAWCQNRIPFL 110
Query: 379 FKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
FK MD G + EE + L ++V + +
Sbjct: 111 FKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVI 148
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A Length = 76 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-05
Identities = 18/53 (33%), Positives = 27/53 (50%), Gaps = 3/53 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRL--SESEVRQLMEAV 418
S EEI G E+F + + I+ EELK + LG L S + +++E V
Sbjct: 3 SPEEIKGAFEVF-AAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEV 54
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} Length = 111 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 4e-05
Identities = 8/52 (15%), Positives = 24/52 (46%), Gaps = 2/52 (3%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + + +++F S D SG +T + + L + + L ++++ +
Sbjct: 8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILMQ--SSLPQAQLASIWNLS 57
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A Length = 624 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 8e-05
Identities = 8/55 (14%), Positives = 24/55 (43%), Gaps = 2/55 (3%)
Query: 366 NLSEEEIMG--LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
++ + + + + + D + + F+ELK L +L ++ + R++
Sbjct: 2 SMDQRQKLQHWIHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFREC 56
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 Length = 224 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 11/82 (13%), Positives = 26/82 (31%), Gaps = 2/82 (2%)
Query: 334 SDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFE 393
+P + ++ ++ + + N ++ E+ L FK+ SG + E
Sbjct: 15 QRRPSKDKIEDELEMTMVCHRPEGLEQLEAQTNFTKRELQVLYRGFKNE--CPSGVVNEE 72
Query: 394 ELKAGLPKLGTRLSESEVRQLM 415
K + S +
Sbjct: 73 TFKQIYAQFFPHGDASTYAHYL 94
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 54/224 (24%), Positives = 82/224 (36%), Gaps = 55/224 (24%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134
LGRG FG Y D A K + + + + EV+++ HRN++ L+
Sbjct: 38 LGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGEL--QFQTEVEMISMAV-HRNLLRLR 93
Query: 135 G----------AYE-------DRHSVNLIMDLCAGGELFD---RI-IAKGHYSERAAANL 173
G Y + + D R IA G +A L
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASC----LRERPESQPPLDWPKRQRIALG-----SARGL 144
Query: 174 CRQMVTVVHYCH---SMGVMHRDLKPENFLFSSSAEDSPLKA--TDFGLSVFFKPGD--V 226
Y H ++HRD+K N L D +A DFGL+ D V
Sbjct: 145 A--------YLHDHCDPKIIHRDVKAANILL-----DEEFEAVVGDFGLAKLMDYKDTHV 191
Query: 227 FKDLVGSAYYVAPEVLRRNYGAE-ADIWSAGVILYILLSGVPPF 269
+ G+ ++APE L +E D++ GV+L L++G F
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 Length = 863 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 3e-04
Identities = 17/69 (24%), Positives = 36/69 (52%)
Query: 350 RAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSES 409
R +N+++ L A+ +S+E++ + F D +G + E+ +A L +G + E+
Sbjct: 702 RTINEVENQILTRDAKGISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEA 761
Query: 410 EVRQLMEAV 418
E ++M V
Sbjct: 762 EFARIMSIV 770
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A Length = 207 | Back alignment and structure |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 13/65 (20%), Positives = 23/65 (35%), Gaps = 4/65 (6%)
Query: 353 NKLKKVALKVIAE--NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESE 410
L K L+ + SEEE+ + F +G IT ++ ++ K
Sbjct: 14 GALSKEILEELQLNTKFSEEELCSWYQSFL--KDCPTGRITQQQFQSIYAKFFPDTDPKA 71
Query: 411 VRQLM 415
Q +
Sbjct: 72 YAQHV 76
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A Length = 190 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 6e-04
Identities = 12/67 (17%), Positives = 20/67 (29%), Gaps = 4/67 (5%)
Query: 354 KLKKVALKVIAE--NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEV 411
KL K L + + EI + F SG + E+ + S +
Sbjct: 7 KLSKDDLTCLKQSTYFDRREIQQWHKGFL--RDCPSGQLAREDFVKIYKQFFPFGSPEDF 64
Query: 412 RQLMEAV 418
+ V
Sbjct: 65 ANHLFTV 71
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* Length = 183 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 7e-04
Identities = 10/48 (20%), Positives = 19/48 (39%), Gaps = 1/48 (2%)
Query: 355 LKKVALKVIAENLSEEEIMGL-KEMFKSMDTDNSGTITFEELKAGLPK 401
+ + + LS E+ L + + D D GTI E + + +
Sbjct: 124 VNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISR 171
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A Length = 214 | Back alignment and structure |
|---|
Score = 39.5 bits (92), Expect = 8e-04
Identities = 10/48 (20%), Positives = 19/48 (39%), Gaps = 1/48 (2%)
Query: 355 LKKVALKVIAENLSEEEIMGL-KEMFKSMDTDNSGTITFEELKAGLPK 401
+ + + LS E+ L + + D D GTI E + + +
Sbjct: 155 VNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISR 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 420 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.51 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.22 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 99.04 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.83 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.82 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 98.67 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 98.59 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.53 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 98.47 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.4 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 98.39 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 98.39 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 98.37 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.36 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 98.35 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 98.31 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 98.29 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 98.22 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 98.2 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 98.19 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.18 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.17 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 98.16 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 98.15 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 98.15 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 98.14 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 98.13 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 98.11 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 98.11 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 98.11 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 98.1 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 98.1 | |
| 2d58_A | 107 | Allograft inflammatory factor 1; EF-hand, metal bi | 98.08 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 98.04 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.04 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 98.04 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 98.03 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 98.02 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 98.0 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 97.99 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 97.99 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 97.98 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 97.96 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 97.95 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 97.95 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 97.95 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 97.93 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 97.93 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 97.92 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 97.92 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 97.89 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 97.88 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 97.88 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 97.87 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 97.87 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 97.87 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 97.87 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 97.86 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 97.86 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 97.86 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 97.85 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 97.85 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 97.84 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 97.84 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 97.84 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 97.82 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 97.81 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 97.8 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 97.8 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.8 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 97.8 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 97.78 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 97.78 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 97.77 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 97.76 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 97.76 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 97.75 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.74 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 97.73 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 97.73 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 97.73 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.72 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 97.7 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 97.7 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 97.7 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 97.69 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 97.67 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.66 | |
| 1k8u_A | 90 | S100A6, calcyclin, CACY; calcium regulatory protei | 97.65 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 97.64 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 97.64 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.64 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 97.63 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.63 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 97.63 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 97.62 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 97.62 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 97.61 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 97.6 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 97.6 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.6 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 97.6 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 97.59 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 97.59 | |
| 1psr_A | 100 | Psoriasin, S100A7; EF-hand protein, MAD phasing, p | 97.57 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 97.56 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.56 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 97.56 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 97.56 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.54 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.53 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 97.53 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 97.53 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 97.52 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 97.52 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.51 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.51 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 97.49 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 97.48 | |
| 1h8b_A | 75 | ACT-EF34, alpha-actinin 2, skeletal muscle isoform | 97.47 | |
| 1cb1_A | 78 | Calbindin D9K; calcium-binding protein; NMR {Sus s | 97.47 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 97.46 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 97.46 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 97.45 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.45 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 97.41 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 97.41 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 97.4 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 97.39 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 97.38 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.38 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 97.37 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 97.36 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 97.35 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.35 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 97.35 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 97.34 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 97.34 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.31 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 97.29 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 97.28 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 97.27 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 97.24 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 97.24 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 97.23 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 97.23 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 97.22 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 97.2 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 97.19 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.19 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.19 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 97.19 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 97.17 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.15 | |
| 3fia_A | 121 | Intersectin-1; EH 1 domain, NESG, structural genom | 97.15 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 97.13 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 97.11 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 97.08 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 97.07 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 97.07 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 97.07 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 97.06 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 97.06 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 97.06 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 97.05 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 97.04 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 97.03 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 97.03 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 97.02 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 96.97 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 96.97 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 96.95 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 96.94 | |
| 1snl_A | 103 | Nucleobindin 1, calnuc; EF-hand, calcium-binding, | 96.88 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 96.87 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 96.82 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 96.79 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 96.79 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 96.79 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 96.74 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 96.73 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 96.72 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 96.7 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 96.69 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 96.67 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 96.66 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 96.66 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 96.66 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 96.61 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 96.58 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 96.55 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 96.55 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 96.53 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 96.5 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 96.42 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.4 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.37 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 96.36 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 96.33 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 96.29 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 96.27 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 96.27 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 96.24 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 96.22 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 96.21 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 96.19 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 96.19 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 96.17 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 96.16 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 96.16 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 96.1 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 96.06 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 96.03 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 95.96 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 95.92 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 95.89 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 95.84 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 95.83 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 95.8 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 95.77 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 95.74 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 95.73 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 95.72 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 95.72 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 95.62 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 95.61 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 95.57 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 95.55 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 95.47 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 95.43 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 95.4 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 95.38 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 95.37 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 95.18 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 95.15 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 95.08 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 95.06 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-69 Score=497.96 Aligned_cols=256 Identities=32% Similarity=0.599 Sum_probs=234.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++|+ |||||+++++|++++.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999998655444556788999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC--
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-- 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-- 224 (420)
||||+||+|.+++.+.+.++|..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCC
Confidence 9999999999999999999999999999999999999999999999999999999 56778999999999987533
Q ss_pred -CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 225 -DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
....+.+||+.|||||++.+ .|+.++||||+||++|+|++|++||.+.+..+++..|.++.+.++. .+|+++++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~d 263 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPKARD 263 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCHHHHH
Confidence 23456799999999999975 5999999999999999999999999999999999999998887654 68999999
Q ss_pred HHHHhcccCcCCCCCHHH------HhcCCccccc
Q 014704 303 IVKKMLHADPKERLSAAE------VLNHPWMRVD 330 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e------~l~h~~~~~~ 330 (420)
||++||++||++|||++| +++||||+..
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 999999999999999988 5899999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-68 Score=498.27 Aligned_cols=258 Identities=29% Similarity=0.518 Sum_probs=230.6
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
....|.+.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++ |||||+++++|.+++.+|
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 45679999999999999999999999999999999975543 23456889999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||||+||+|.+++.+ +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCC
Confidence 99999999999998865 679999999999999999999999999999999999999 56778999999999877543
Q ss_pred -CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 225 -DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
....+.+||+.|||||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..|..... .....+..+|+++++
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG 302 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHH
Confidence 34567899999999999874 599999999999999999999999999999998888877533 233445678999999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
||.+||++||++|||+.|+|+||||+...
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999998543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-67 Score=482.64 Aligned_cols=255 Identities=35% Similarity=0.643 Sum_probs=216.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+++|++++ |||||++++++++++.+|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence 57999999999999999999999999999999998766655566788999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
|||| +|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence 9999 67999999999999999999999999999999999999999999999999 5667899999999988776666
Q ss_pred eecccCCcccccchhhccc--CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~~--~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
..+.+||+.|||||++.+. ++.++||||+||++|+|++|+.||.+.+...++..+.++.+.++. .+|+++++||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li 243 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLI 243 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence 6778999999999999754 468999999999999999999999999999999999998876653 6899999999
Q ss_pred HHhcccCcCCCCCHHHHhcCCccccc
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
++||++||++|||+.|+|+||||+.+
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHccCChhHCcCHHHHHcCcccccC
Confidence 99999999999999999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-66 Score=515.39 Aligned_cols=358 Identities=39% Similarity=0.658 Sum_probs=320.6
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
...+.++|.+.+.||+|+||.||+|.++.+|+.||||++.+.........+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence 3457789999999999999999999999999999999998765544556788999999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.+|+|||||.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++...
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999999999899999999999999999999999999999999999999976666788999999999887
Q ss_pred CCCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.........+||+.|+|||++.+.|+.++||||+||++|+|++|.+||.+.+....+..+..+...+..+.|..+|++++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred ccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 76666667789999999999988899999999999999999999999999999999999999998888888889999999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccccCC---CCCCcccHHHHHHHHHHHhhhhhHHHHHHHHHhhh-hHHHHhhHHH
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDGD---ASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENL-SEEEIMGLKE 377 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~-~~~~~~~l~~ 377 (420)
+||++||+.||++|||+.|+|+||||+.... ....+.....+.++++|...+++++.++.+++..+ ++++...+++
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~~ 339 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTA 339 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHHH
Confidence 9999999999999999999999999975433 12334446678899999999999999999998776 7788899999
Q ss_pred HhhccCCCCCCcccHHHH----HhhhhhhCCCCC-------HHHHHHHHHhcCC
Q 014704 378 MFKSMDTDNSGTITFEEL----KAGLPKLGTRLS-------ESEVRQLMEAVSL 420 (420)
Q Consensus 378 ~F~~~D~~~~G~i~~~el----~~~l~~lg~~~~-------~~e~~~~~~~~d~ 420 (420)
+|..+|.|++|.|+.+|| ...++.+|...+ +++++++|+.+|.
T Consensus 340 ~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~ 393 (484)
T 3nyv_A 340 IFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDF 393 (484)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTC
T ss_pred HHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCC
Confidence 999999999999999999 555566787777 8999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-66 Score=515.84 Aligned_cols=360 Identities=34% Similarity=0.616 Sum_probs=318.6
Q ss_pred ccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh----------hhHHHHHHHHHHHHhccCCCC
Q 014704 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR----------DDVEDVRREVQIMHHLTGHRN 129 (420)
Q Consensus 60 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~hpn 129 (420)
.....+.++|.+.+.||+|+||+||+|.++.+++.||+|++.+...... ...+.+.+|+.++++++ |||
T Consensus 29 ~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn 107 (504)
T 3q5i_A 29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPN 107 (504)
T ss_dssp EECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTT
T ss_pred ccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCC
Confidence 3445678899999999999999999999999999999999976543211 34578999999999998 999
Q ss_pred ccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCC
Q 014704 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209 (420)
Q Consensus 130 iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~ 209 (420)
|+++++++.+...+|+|||||.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..++....
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999999999998899999999999999999999999999999999999999976554457
Q ss_pred eeEeecccccccCCCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 014704 210 LKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (420)
Q Consensus 210 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 289 (420)
+||+|||++............+||+.|+|||++.+.++.++||||+||++|+|++|..||.+.+...++..+..+...++
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999999998776666677789999999999988899999999999999999999999999999999999999988888
Q ss_pred CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCC---cccHHHHHHHHHHHhhhhhHHHHHHHHHhh
Q 014704 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDK---PLDIAVLTRMKQFRAMNKLKKVALKVIAEN 366 (420)
Q Consensus 290 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~ 366 (420)
...|..+|+++++||++||+.||.+|||+.|+|+||||+........ ......+.++++|...+++++.++.++...
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~ 347 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSK 347 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHH
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 77788999999999999999999999999999999999865443221 122456778899999999999999999877
Q ss_pred h-hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhh--------CCCCCHHHHHHHHHhcCC
Q 014704 367 L-SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL--------GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~-~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l--------g~~~~~~e~~~~~~~~d~ 420 (420)
+ ++++..+++++|..+|.|++|.|+.+||..++..+ |...++++++++|+.+|.
T Consensus 348 ~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~ 410 (504)
T 3q5i_A 348 LTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDF 410 (504)
T ss_dssp TSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCT
T ss_pred CCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCC
Confidence 6 88889999999999999999999999999999988 667889999999999884
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-66 Score=517.03 Aligned_cols=362 Identities=36% Similarity=0.637 Sum_probs=317.9
Q ss_pred cccccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE
Q 014704 57 VLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (420)
Q Consensus 57 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 136 (420)
+.......+.++|.+.+.||+|+||+||+|+++.++..||+|++.+... .......+.+|+.+++.++ ||||++++++
T Consensus 27 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~ 104 (494)
T 3lij_A 27 FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLD-HPNIMKLYDF 104 (494)
T ss_dssp GCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEE
T ss_pred eeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHhCC-CCCCCeEEEE
Confidence 3344455677899999999999999999999999999999999976543 2334577899999999998 9999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 137 YEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 137 ~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
+.+...+|+|||||.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++..+.+..+||+|||
T Consensus 105 ~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 99999999999999999999999988899999999999999999999999999999999999999766667789999999
Q ss_pred cccccCCCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
++............+||+.|+|||++.+.|+.++||||+||++|+|++|..||.+.+..+++..+..+...++.+.|..+
T Consensus 185 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 264 (494)
T 3lij_A 185 LSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV 264 (494)
T ss_dssp TCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTS
T ss_pred CCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccC
Confidence 99887766666677899999999999888999999999999999999999999999999999999999999888888899
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC----CCCCcccHHHHHHHHHHHhhhhhHHHHHHHHHhhh-hHHH
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD----ASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENL-SEEE 371 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~-~~~~ 371 (420)
++++++||++||+.||.+|||+.++|+||||+.... ....+.....+.++++|...+++++.++.+++..+ ++++
T Consensus 265 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~ 344 (494)
T 3lij_A 265 SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEE 344 (494)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHH
T ss_pred CHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHH
Confidence 999999999999999999999999999999975311 11223334567889999999999999999998876 7888
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCC--------CCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGT--------RLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~--------~~~~~e~~~~~~~~d~ 420 (420)
..+++++|..+|.|++|.|+.+||..++..+|. ..++++++++|+.+|.
T Consensus 345 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~ 401 (494)
T 3lij_A 345 TKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADF 401 (494)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCC
Confidence 999999999999999999999999999999864 4558899999999873
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-66 Score=488.92 Aligned_cols=256 Identities=25% Similarity=0.539 Sum_probs=225.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|++.+.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|++|+ |||||++++++++++.+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence 589999999999999999999999999999999986554 4556788999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 147 MDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||+||+|.+++...+ .+++..++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence 99999999999997653 47999999999999999999999999999999999999 56778999999999876543
Q ss_pred C-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 225 D-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 225 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
. .....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..+++..|..+.+.. .+..+|+++++
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~ 255 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYDLRS 255 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHHHHH
Confidence 2 2345689999999999975 59999999999999999999999999999999999999887542 23578999999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
||.+||++||++|||+.|+|+||||+..
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999999743
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-65 Score=511.11 Aligned_cols=355 Identities=38% Similarity=0.671 Sum_probs=314.8
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+.++|.+.+.||+|+||+||+|.++.+++.||||++.+... .......+.+|+.++++++ ||||+++++++.+...+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCEE
Confidence 466789999999999999999999999999999999865432 2234578999999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+|||||.|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++..+.+..+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999999888999999999999999999999999999999999999997766677899999999988766
Q ss_pred CCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
.......+||+.|+|||++.+.|+.++||||+||++|+|++|..||.+.+....+..+..+...+..+.|..+|+++++|
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 66666778999999999999889999999999999999999999999999999999999999888888888999999999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCcccccCCCCCC----cccHHHHHHHHHHHhhhhhHHHHHHHHHhhh-hHHHHhhHHHH
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWMRVDGDASDK----PLDIAVLTRMKQFRAMNKLKKVALKVIAENL-SEEEIMGLKEM 378 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~-~~~~~~~l~~~ 378 (420)
|++||+.||++|||+.++|+||||+........ +.....+.++++|...+++++.++.+++..+ +.++..+++++
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~ 336 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEI 336 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHHH
Confidence 999999999999999999999999865443321 1224467789999999999999999999877 78889999999
Q ss_pred hhccCCCCCCcccHHHHHhhh----hhhCCCCC----------HHHHHHHHHhcCC
Q 014704 379 FKSMDTDNSGTITFEELKAGL----PKLGTRLS----------ESEVRQLMEAVSL 420 (420)
Q Consensus 379 F~~~D~~~~G~i~~~el~~~l----~~lg~~~~----------~~e~~~~~~~~d~ 420 (420)
|..+|.|++|.|+.+||..++ +.+|...+ +++++++|+.+|.
T Consensus 337 F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~ 392 (486)
T 3mwu_A 337 FRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDM 392 (486)
T ss_dssp HHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCT
T ss_pred HHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcC
Confidence 999999999999999996555 44576655 8899999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-65 Score=495.22 Aligned_cols=259 Identities=30% Similarity=0.522 Sum_probs=231.3
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
+....|.+.+.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++ |||||+++++|.+++.+
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~ 223 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDEL 223 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEE
Confidence 345679999999999999999999999999999999976533 33456889999999999 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|||||||+||+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 224 ~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp EEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCC
Confidence 999999999999998864 579999999999999999999999999999999999999 5677899999999987754
Q ss_pred C-CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 G-DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
. ......+||+.|||||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..|..... .....+..+|++++
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~ 378 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLK 378 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHH
T ss_pred CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHH
Confidence 3 34567899999999999975 599999999999999999999999999999999888877543 23344568999999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
+||.+||++||++|||+.|+|+||||+...
T Consensus 379 dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 379 GFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 999999999999999999999999998543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-65 Score=470.49 Aligned_cols=254 Identities=22% Similarity=0.427 Sum_probs=221.4
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe----CCeEE
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----RHSVN 144 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~----~~~~~ 144 (420)
|++.+.||+|+||+||+|.++.++..||+|++..... .....+.+.+|+++|++|+ |||||+++++|++ +..+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEE
Confidence 4788899999999999999999999999999976543 4556788999999999999 9999999999875 45689
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
||||||+||+|.+++.+.+.+++..+..|+.||+.||+|||++| |+||||||+|||++ +.++.+||+|||+|+...
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEeCC
Confidence 99999999999999999899999999999999999999999999 99999999999995 245789999999998654
Q ss_pred CCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
. ....+.+||+.|||||++.+.|+.++|||||||++|+|+||+.||.+.. ...+...+..+..+.. ....++++++
T Consensus 184 ~-~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~ 260 (290)
T 3fpq_A 184 A-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIPEVK 260 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--GGGCCCHHHH
T ss_pred C-CccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCC--CCccCCHHHH
Confidence 3 3456779999999999998889999999999999999999999997654 4555555555433222 2245789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+||.+||+.||++|||+.|+|+||||+.
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-65 Score=475.72 Aligned_cols=254 Identities=30% Similarity=0.537 Sum_probs=221.7
Q ss_pred cceeecceecccCCeEEEEEEEc---CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
++|++.+.||+|+||+||+|++. .+++.||+|++.+... .......+.+|+.+|++++ |||||++++++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-KVRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEE-EEEECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHc-ChHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence 57999999999999999999984 4678999999976543 2223346889999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|||||||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccC
Confidence 9999999999999999999999999999999999999999999999999999999999 5677899999999986543
Q ss_pred -CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 -GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.....+.+||+.|||||++.+ .|+.++||||+||++|+|+||++||.+.+..+++..|.++.+.++. .+|++++
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 254 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQ 254 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCCHHHH
Confidence 334456789999999999864 5999999999999999999999999999999999999998776653 6899999
Q ss_pred HHHHHhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 302 DIVKKMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
+||++||++||++||| ++|+++||||+.
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 9999999999999998 589999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-63 Score=467.61 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=221.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
+.|.+.++||+|+||.||+|+++.+|+.||||++..... ..+|+.+|+.|+ |||||++++++.+++.+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~-HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLS-SPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEE
Confidence 568999999999999999999999999999999976433 247999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCC-CeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS-PLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~-~~kl~Dfg~~~~~~~~~ 225 (420)
||||+||+|.+++.+.+.+++..+..++.||+.||.|||++|||||||||+|||++ .++ .+||+|||+|+......
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCCC
Confidence 99999999999999999999999999999999999999999999999999999995 343 69999999998765432
Q ss_pred c------eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 226 V------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 226 ~------~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
. ....+||+.|||||++.+ .|+.++|||||||++|+|++|++||.+.+...++..|......+. ..++.+|+
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~ 284 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAP 284 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCH
Confidence 1 223589999999999875 599999999999999999999999998887778888887765433 23467899
Q ss_pred HHHHHHHHhcccCcCCCCCHHHH-------------hcCCcccccC
Q 014704 299 SAKDIVKKMLHADPKERLSAAEV-------------LNHPWMRVDG 331 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~-------------l~h~~~~~~~ 331 (420)
++++||.+||++||++|||+.|+ |+|||+....
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 99999999999999999999997 6799997543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-63 Score=477.12 Aligned_cols=262 Identities=28% Similarity=0.432 Sum_probs=225.6
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe----
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED---- 139 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~---- 139 (420)
.+.++|.+++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+++|+.|+ |||||++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPY 128 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccccc
Confidence 356789999999999999999999999999999999975432 4455678899999999999 9999999998764
Q ss_pred --CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 140 --RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 140 --~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
.+.+|||||||+ |+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGl 204 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGM 204 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecce
Confidence 367999999996 6899999988999999999999999999999999999999999999999 5677899999999
Q ss_pred ccccCCC-----CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 014704 218 SVFFKPG-----DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS 290 (420)
Q Consensus 218 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 290 (420)
|+.+... ....+.+||+.|||||++.+ .|+.++||||+||++|+|++|++||.+.+....+..|......++.
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9876432 23456799999999999754 4799999999999999999999999999998888887654322221
Q ss_pred C---------------------------CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 291 D---------------------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 291 ~---------------------------~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
. .++.+++++++||.+||++||++|||+.|+|+||||+...
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 1 1346789999999999999999999999999999998543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-60 Score=479.66 Aligned_cols=263 Identities=35% Similarity=0.628 Sum_probs=242.2
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+.++|.+++.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|+.+|+.|+ |||||+++++|++.+.+
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence 44578999999999999999999999999999999987542 345678999999999999 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|||||||+||+|++++.. .+.+++..+..+++||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+|+.+.
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEECC
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEcc
Confidence 999999999999999864 4679999999999999999999999999999999999999642 34689999999999988
Q ss_pred CCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
........+||+.|||||++.+ .|+.++||||+||++|+|++|.+||.+.+..+.+..|..+...++...+..+|++++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 8777788899999999999875 599999999999999999999999999999999999999998888888889999999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
+||++||+.||++|||+.|+|+||||+...
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 999999999999999999999999998544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-60 Score=451.68 Aligned_cols=257 Identities=25% Similarity=0.460 Sum_probs=211.7
Q ss_pred cccccceeecceecccCCeEEEEEEEc---CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
..+.++|++.+.||+|+||+||+|+++ .+++.||+|.+.+. .....+.+|+++|+.+.+||||++++++|.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 356788999999999999999999875 45789999998643 2345788999999999779999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+++|+|||||+||+|.+++ +.+++..++.++.||+.||+|||++||+||||||+|||++. +.+.+||+|||+|+
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~--~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR--RLKKYALVDFGLAQ 166 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred CCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC--CCCeEEECcCCCCc
Confidence 99999999999999999988 46999999999999999999999999999999999999963 33679999999997
Q ss_pred ccCCCC-----------------------------ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCC
Q 014704 220 FFKPGD-----------------------------VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPP 268 (420)
Q Consensus 220 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~p 268 (420)
...... .....+||+.|||||++.+ .|+.++||||+||++|+|++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 653221 1234589999999999864 489999999999999999999999
Q ss_pred CCCC-CHHHHHHHHHcC--------------------------------------C------------CCCCCCCCCCCC
Q 014704 269 FWGE-TEQSIFDAILRG--------------------------------------H------------IDFSSDPWPNIS 297 (420)
Q Consensus 269 f~~~-~~~~~~~~i~~~--------------------------------------~------------~~~~~~~~~~~~ 297 (420)
|.+. +....+..|... . .......|..+|
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 9654 344444333210 0 001123466789
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
++++|||++||+.||++|+|++|+|+||||+.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-60 Score=439.83 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=200.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-----
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH----- 141 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~----- 141 (420)
++|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+++|++|+ |||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence 46999999999999999999999999999999996543 3445678999999999998 999999999987544
Q ss_pred -------eEEEEEecCCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCee
Q 014704 142 -------SVNLIMDLCAGGELFDRIIAKGHY---SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 142 -------~~~iv~e~~~g~~L~~~l~~~~~~---~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
++|||||||+||+|.+++.....+ ++..+..++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEE
Confidence 479999999999999999876653 456788999999999999999999999999999999 5567899
Q ss_pred EeecccccccCCCCc-------------eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHH-H
Q 014704 212 ATDFGLSVFFKPGDV-------------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ-S 276 (420)
Q Consensus 212 l~Dfg~~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~-~ 276 (420)
|+|||+|+....... ....+||+.|||||++.+ .|+.++|||||||++|||++ ||.+.... .
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 999999987654321 234589999999999875 59999999999999999996 88654322 2
Q ss_pred HHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 277 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.+..+.....+ +.+...++.+.+||++||+.||++|||+.|+|+||||+.
T Consensus 236 ~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 236 TLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 33344443321 112345677899999999999999999999999999974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-59 Score=434.96 Aligned_cols=251 Identities=22% Similarity=0.436 Sum_probs=216.7
Q ss_pred ccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
+++|.+.+.||+|+||+||+|++. .++..||||++... +....+.+.+|+++|++|+ |||||++++++.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC
Confidence 468999999999999999999875 35788999998643 4456678999999999999 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCC
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK-------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~ 207 (420)
+.+|||||||+||+|.++|.+. ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCC
Confidence 9999999999999999999764 369999999999999999999999999999999999999 556
Q ss_pred CCeeEeecccccccCCCCce---ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014704 208 SPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL 282 (420)
Q Consensus 208 ~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~ 282 (420)
+.+||+|||+|+........ ....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..+++..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 78999999999876544322 2346899999999986 569999999999999999998 999999999999999998
Q ss_pred cCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.+..... ...+|+++.+|+.+||+.||++|||+.++ |+|++
T Consensus 245 ~~~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 245 QGRVLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred cCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 8764321 24689999999999999999999999999 34553
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=470.79 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=221.8
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHH---HHHHHhccCCCCccEEEEEEEeCCe
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE---VQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
-++|.+++.||+|+||.||+|+++.+|+.||||++.+...........+.+| +.+++.++ |||||+++++|++.+.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEEECCE
Confidence 3679999999999999999999999999999999976543323333444444 55555666 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||+ +.++++||+|||+|+...
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999 567889999999998875
Q ss_pred CCCceecccCCcccccchhhc-c-cCCCccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 223 PGDVFKDLVGSAYYVAPEVLR-R-NYGAEADIWSAGVILYILLSGVPPFWGE---TEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwslGvil~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
... ..+.+||+.|||||++. + .|+.++|+|||||++|+|++|.+||.+. ....+...+....+.++ ..+|
T Consensus 344 ~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S 418 (689)
T 3v5w_A 344 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFS 418 (689)
T ss_dssp SCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSC
T ss_pred CCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCC
Confidence 443 35679999999999985 3 5999999999999999999999999764 34556667777666554 4689
Q ss_pred hHHHHHHHHhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 298 SSAKDIVKKMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
+++++||.+||++||++|++ ++|+++||||+.
T Consensus 419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 99999999999999999998 799999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=442.61 Aligned_cols=301 Identities=36% Similarity=0.690 Sum_probs=268.0
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
...+.++|.+.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEES 101 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence 34567889999999999999999999999999999999976543 4456678999999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
..|+|||||.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+..+||+|||++...
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999999999988888999999999999999999999999999999999999976656678999999999887
Q ss_pred CCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
.........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+..+...++...|..+++++
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 76655566789999999999875 59999999999999999999999999999999999999999888888888899999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcccHHHHHHHHHHHhhhhhHHHHHHHHH
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIA 364 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~ 364 (420)
++||.+||+.||++|||+.++|+||||...............+..+++|....+++..++..+.
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 325 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMI 325 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999997533222223345667888999999999888776654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-59 Score=432.28 Aligned_cols=253 Identities=22% Similarity=0.402 Sum_probs=207.5
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+.-.+++.+++.||+|+||+||+|+++. .||||+++... .+....+.+.+|+.+|++++ |||||++++++.+ +.
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DN 105 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SS
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-Ce
Confidence 4445688999999999999999998753 59999986543 35566788999999999999 9999999998754 56
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+|||||||+||+|.+++... +.+++..+..|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+..
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVK 182 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceec
Confidence 89999999999999999764 579999999999999999999999999999999999999 45678999999999875
Q ss_pred CCC---CceecccCCcccccchhhcc----cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--CCC
Q 014704 222 KPG---DVFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS--SDP 292 (420)
Q Consensus 222 ~~~---~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~ 292 (420)
... ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.+....+..+.......+ ...
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 432 23355689999999999852 489999999999999999999999988665544444443332222 233
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
++.+++++.+|+.+||+.||++|||+.|++++
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 46789999999999999999999999987543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-59 Score=456.13 Aligned_cols=300 Identities=37% Similarity=0.680 Sum_probs=266.2
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
..+.++|.+.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEEGH 84 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSSE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECCE
Confidence 4567889999999999999999999999999999999976543 3445678999999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|+|||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++....++.+||+|||++....
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999999999999999999999999999999999999999999999999999765567889999999998765
Q ss_pred CCC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 223 PGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 223 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+....+..+..+...++.+.|+.+++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 433 3356789999999999875 59999999999999999999999999999999999999999999998899999999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcccHHHHHHHHHHHhhhhhHHHHHHHHH
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIA 364 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~ 364 (420)
++||.+||+.||++|||+.|+|+||||+..............+..+++|...++++..++..+.
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~~ 308 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVML 308 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEEC
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999997543322333345678889999999999988877663
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=434.09 Aligned_cols=249 Identities=22% Similarity=0.393 Sum_probs=210.2
Q ss_pred ccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
..+|.+.++||+|+||+||+|+++ .+++.||||++... +....+.+.+|+++|++|+ |||||++++++.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEEC
Confidence 467899999999999999999875 35789999999643 4456678999999999998 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK---------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA 205 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~---------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~ 205 (420)
+.+|||||||+||+|.+++.+. +++++..+..|+.||+.||.|||+++||||||||+|||+ +
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---G 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---E
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---C
Confidence 9999999999999999998753 358999999999999999999999999999999999999 4
Q ss_pred CCCCeeEeecccccccCCCC---ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014704 206 EDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280 (420)
Q Consensus 206 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~ 280 (420)
.+..+||+|||+++...... .....+||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+.+..+++..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 56789999999998764432 2234679999999999864 69999999999999999999 9999999999999988
Q ss_pred HHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 281 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+..+... + ....+++++.+|+.+||+.||++|||+.|++++
T Consensus 273 i~~g~~~-~--~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGREL-E--RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCCC-C--CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCCC-C--CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8876432 1 224689999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-58 Score=428.90 Aligned_cols=250 Identities=22% Similarity=0.378 Sum_probs=216.2
Q ss_pred ccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
...+++.+.||+|+||+||+|.+. .+++.||||++.... .....+.+.+|+.+|++++ |||||++++++.++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKD 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEEC
Confidence 356889999999999999999864 357889999986432 3345678999999999999 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecC
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS 204 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~ 204 (420)
+.+|||||||++|+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl--- 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--- 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---
Confidence 9999999999999999999653 358999999999999999999999999999999999999
Q ss_pred CCCCCeeEeecccccccCCCC---ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHH
Q 014704 205 AEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFD 279 (420)
Q Consensus 205 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~ 279 (420)
++++.+||+|||+++...... .....+||+.|||||++. +.|+.++|||||||++|||+| |..||.+.+..++..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 566789999999998764332 234568999999999986 569999999999999999998 899999999999999
Q ss_pred HHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 280 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.+..+.... ..+.+++++.+|+.+||+.||++|||+.|++++
T Consensus 259 ~i~~~~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 888765422 224789999999999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=429.67 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=213.9
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCC-----CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 136 (420)
++.-.++|++++.||+|+||+||+|.+..+ ++.||||.+.... .....+.+.+|+++|.++.+|||||+++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 344568899999999999999999998754 3679999986533 345567899999999999867999999999
Q ss_pred EEe-CCeEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 014704 137 YED-RHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (420)
Q Consensus 137 ~~~-~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 199 (420)
|.+ .+.+|||||||+||+|.++|... ..+++..+..++.||+.||.|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 45789999999999999999753 3489999999999999999999999999999999999
Q ss_pred EEecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCH
Q 014704 200 LFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETE 274 (420)
Q Consensus 200 ll~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~ 274 (420)
|+ +.++.+||+|||+|+....... ....+||+.|||||++. +.|+.++|||||||++|||+| |..||.+...
T Consensus 217 Ll---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 217 LL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp EE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 99 5567899999999987654332 23457999999999986 469999999999999999998 9999988654
Q ss_pred -HHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 275 -QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 275 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..+...+..+. .++. ...+++++.+|+.+||+.||++|||+.|+++|
T Consensus 294 ~~~~~~~i~~g~-~~~~--p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 294 DEEFCRRLKEGT-RMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp SHHHHHHHHHTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCC-CCCC--CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 44555555543 2222 24679999999999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-56 Score=423.49 Aligned_cols=296 Identities=39% Similarity=0.692 Sum_probs=240.4
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
..+.+.++|.+.+.||+|+||.||+|.++.+++.||||++.... ..+.+.+|+.+++++. ||||+++++++.+.
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETP 120 (349)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECS
T ss_pred ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecC
Confidence 34567788999999999999999999999999999999987532 3356889999999999 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+.+++||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++..
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999999999998888899999999999999999999999999999999999997655578899999999987
Q ss_pred cCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 221 FKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+..+......+....+..++.
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 765555556789999999999865 589999999999999999999999977654 447778888877777777788999
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcccHHHHHHHHHHHhhhhhHHHHHHHHH
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIA 364 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~ 364 (420)
++.+||++||..||++|||+.|+|+||||....... ........++++|....++++.....++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF--VHMDTAQKKLQEFNARRKLKAAVKAVVA 344 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCC--SCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCccch--hhhcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999997543322 2235566788888888888887776654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=427.45 Aligned_cols=267 Identities=38% Similarity=0.638 Sum_probs=241.5
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh---hhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
...+.++|.+++.||+|+||.||+|.++.+|+.||+|++.+...... ...+.+.+|+.+|+.+. ||||+++++++.
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~ 85 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYE 85 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEE
Confidence 35677899999999999999999999999999999999986543221 24578999999999999 999999999999
Q ss_pred eCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC-CCCeeEeeccc
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE-DSPLKATDFGL 217 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~-~~~~kl~Dfg~ 217 (420)
+...+|+|||||.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..++. ...+||+|||+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999999999988888999999999999999999999999999999999999964321 22799999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
+............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..+...++...|..+
T Consensus 166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (361)
T 2yab_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245 (361)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred ceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence 998776666667789999999999875 6999999999999999999999999999999999999999888877777889
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
++++++||.+||..||++|||+.|+|+||||+.
T Consensus 246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 999999999999999999999999999999974
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=417.25 Aligned_cols=258 Identities=35% Similarity=0.636 Sum_probs=235.5
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|.+..+|+.||||++..... +....+.+.+|+++++.++ ||||+++++++.+.+.+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEE
Confidence 44689999999999999999999999999999999976543 4556778999999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....+
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCC
Confidence 999999999999999988999999999999999999999999999999999999999 56678999999999887766
Q ss_pred CceecccCCcccccchhhccc-C-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRRN-Y-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
......+||+.|+|||++.+. + +.++||||+||++|+|++|..||.+.+.......+..+...++. .+++++.+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 243 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCEN 243 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHH
Confidence 666778999999999998653 4 57899999999999999999999999999999999998776654 57999999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
||++||..||.+|||+.|+|+||||+...
T Consensus 244 li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999997543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-56 Score=427.26 Aligned_cols=299 Identities=34% Similarity=0.643 Sum_probs=245.5
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC--ChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.+.++|.+.+.||+|+||.||+|.++.+|+.||||++...... .....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence 4567899999999999999999999999999999998643221 1124578999999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
.+|+|||||+|++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999998877643 3589999999999999999999999999999999999997655566799999999
Q ss_pred ccccCCCCc-eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 218 SVFFKPGDV-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 218 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
+........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. ....+..+..+...+....|..
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccccc
Confidence 987654432 345689999999999864 5899999999999999999999999875 4567777888777766656678
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcccHHHHHHHHHHHhhhhhHHHHHHHHH
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIA 364 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~ 364 (420)
++.++++||.+||+.||++|||+.++|+||||+..............+.++++|....+++..++..++
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 327 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVS 327 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC----------
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999997543212222234556788888888888887776665
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-56 Score=430.44 Aligned_cols=263 Identities=33% Similarity=0.646 Sum_probs=220.1
Q ss_pred ccccceeec-ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe---
Q 014704 64 DVRNTYIFG-RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--- 139 (420)
Q Consensus 64 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--- 139 (420)
.+.++|.+. +.||+|+||+||+|.++.+|+.||||++... ..+.+|+.++.++.+||||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 344567766 7899999999999999999999999998532 4577899998776669999999999876
Q ss_pred -CCeEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 140 -RHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 140 -~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
...+|+|||||+||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++..+.++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 677999999999999999998754 59999999999999999999999999999999999999765457889999999
Q ss_pred cccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCCC
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ----SIFDAILRGHIDFSSD 291 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~ 291 (420)
+++...........+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.... .....+..+.+.++..
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 998776555556778999999999986 46999999999999999999999999776532 2556677788888877
Q ss_pred CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCC
Q 014704 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDAS 334 (420)
Q Consensus 292 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~ 334 (420)
.|..++.++++||++||+.||++|||+.++|+||||.......
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~ 332 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSC
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCC
Confidence 7889999999999999999999999999999999998654433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=419.97 Aligned_cols=262 Identities=31% Similarity=0.629 Sum_probs=238.9
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
++.++|.+.+.||+|+||.||+|.++.+++.||+|++... ......+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEE
Confidence 4668999999999999999999999999999999998643 344567899999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|+|||||+|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.. .++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECC
Confidence 99999999999999997653 69999999999999999999999999999999999999642 26789999999999887
Q ss_pred CCCceecccCCcccccchhhccc-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.+.......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+....+..+..+...++...|+.++.++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 77767778899999999998754 79999999999999999999999999999999999999988887777788999999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
+||.+||..||++|||+.|+|+||||+...
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 999999999999999999999999997543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=419.42 Aligned_cols=257 Identities=28% Similarity=0.535 Sum_probs=228.1
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..+++.+.+||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 36799999999999999999999999999999999765443445667889999999998669999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-C
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-G 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~ 224 (420)
|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... .
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccCC
Confidence 99999999999999988999999999999999999999999999999999999999 5667899999999986432 3
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+++..|..+...++. .+++++.+|
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l 254 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGI 254 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Confidence 34456789999999999865 5999999999999999999999999999999999999998877654 579999999
Q ss_pred HHHhcccCcCCCCCH------HHHhcCCcccc
Q 014704 304 VKKMLHADPKERLSA------AEVLNHPWMRV 329 (420)
Q Consensus 304 i~~~L~~dp~~R~t~------~e~l~h~~~~~ 329 (420)
|++||+.||++||++ .++++||||+.
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 999999999999999 89999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=416.47 Aligned_cols=258 Identities=36% Similarity=0.569 Sum_probs=210.7
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|+++.+++.||+|++..... ..+.+.+|+.+++.++ ||||+++++++.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEE
Confidence 45689999999999999999999999999999999975432 2256889999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+|||||.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ ....+||+|||++......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-SSCCEEECCCCCC------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCceEEEeecCcccccccc
Confidence 999999999999999888899999999999999999999999999999999999999532 2345999999999865444
Q ss_pred CceecccCCcccccchhhcc-cCCC-ccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGA-EADIWSAGVILYILLSGVPPFWGETE----QSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~-~~DvwslGvil~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
......+||+.|+|||++.+ .+.. ++|||||||++|+|++|+.||.+... ......+......++. ...+++
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~ 249 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIRISP 249 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSCCCH
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCCCCH
Confidence 44456789999999999854 4544 48999999999999999999987543 4555666665554443 346899
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
++++||.+||+.||++|||+.|+++||||...
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 99999999999999999999999999999643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=411.73 Aligned_cols=255 Identities=32% Similarity=0.591 Sum_probs=230.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|+|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999997643333445678899999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-CCC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~~~ 225 (420)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... .+.
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCCC
Confidence 9999999999999988899999999999999999999999999999999999999 566789999999998643 333
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+...+...+......++. .+++++++||
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li 236 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence 4556789999999999864 5899999999999999999999999999999999999888776653 6799999999
Q ss_pred HHhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 305 KKMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 305 ~~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
.+||+.||++|| ++.++++||||+.
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 999999999999 9999999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=411.25 Aligned_cols=267 Identities=39% Similarity=0.679 Sum_probs=238.9
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh---hhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
.+.+.++|.+.+.||+|+||.||+|.++.+|+.||+|++........ ...+.+.+|+.+++.++ ||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 84 (326)
T 2y0a_A 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE 84 (326)
T ss_dssp CSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred cCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence 34577889999999999999999999999999999999976543221 24678999999999999 999999999999
Q ss_pred eCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC-CCCCeeEeeccc
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGL 217 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~~~~kl~Dfg~ 217 (420)
+...+|+|||||+|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..++ ....+||+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999999998888899999999999999999999999999999999999996432 223799999999
Q ss_pred ccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+..+......++...+..+
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (326)
T 2y0a_A 165 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244 (326)
T ss_dssp CEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred CeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence 98876655556678999999999986 45899999999999999999999999999998898888888777766656788
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+..+.+||++||+.||++|||+.++|+||||+.
T Consensus 245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 999999999999999999999999999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=396.67 Aligned_cols=266 Identities=38% Similarity=0.752 Sum_probs=244.2
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+.++|.+.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH 80 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEE
Confidence 466899999999999999999999999999999999976543 4556678999999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
++||||+.|++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.++....+||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999999999999888999999999999999999999999999999999999997666666799999999988776
Q ss_pred CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+...++...+..+++++.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence 666566789999999999865 5899999999999999999999999999999999999999888888888899999999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
||.+||+.||++|||+.|+|+||||+...
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 241 LIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 99999999999999999999999997543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=400.01 Aligned_cols=265 Identities=40% Similarity=0.803 Sum_probs=242.5
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
..+.++|.+.+.||+|+||.||+|.++.++..||+|.+..... ...+.+.+|+.++++++ ||||+++++++.+...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTD 80 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCe
Confidence 3567889999999999999999999999999999999875432 34578999999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
.++||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++..++.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999999999988899999999999999999999999999999999999999665667889999999998877
Q ss_pred CCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
.........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.........+..+...++...+..+++.+.+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 66666677899999999999888999999999999999999999999999999999999998887776666688999999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
||.+||+.||++|||+.++|+||||+...
T Consensus 241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999999997543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=415.35 Aligned_cols=256 Identities=28% Similarity=0.558 Sum_probs=225.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..++.++.+||||+++++++.+.+.+|+|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 57999999999999999999999999999999998765555555667889999999885599999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc-CCCC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~-~~~~ 225 (420)
||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.. ....
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccCCC
Confidence 9999999999999988899999999999999999999999999999999999999 56778999999999863 3444
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCC---------CHHHHHHHHHcCCCCCCCCCCCC
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE---------TEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||... ....+...+......++. .
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~ 284 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----S 284 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT----T
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC----c
Confidence 5567799999999999865 5899999999999999999999999632 344567777777766654 5
Q ss_pred CChHHHHHHHHhcccCcCCCCCH------HHHhcCCcccc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSA------AEVLNHPWMRV 329 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~------~e~l~h~~~~~ 329 (420)
++.++++||++||+.||++||++ .|+++||||+.
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 79999999999999999999985 89999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=412.96 Aligned_cols=264 Identities=35% Similarity=0.631 Sum_probs=238.5
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+.++|.+.+.||+|+||.||+|.++.+|+.||+|++.... ......+.+|+.+|+.++ ||||+++++++.+...+
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEM 123 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCEE
Confidence 45678999999999999999999999999999999986532 334567899999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|+|||||.|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEecccceecC
Confidence 99999999999999887654 69999999999999999999999999999999999999532 34679999999999877
Q ss_pred CCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......++...+..++++++
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 6666666789999999999864 589999999999999999999999999999899999999888888877888999999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
+||.+||+.||++|||+.|+|+||||+....
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 9999999999999999999999999986544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-54 Score=410.04 Aligned_cols=262 Identities=37% Similarity=0.661 Sum_probs=231.7
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
...+.++|.+.+.||+|+||.||+|.++.+|+.||+|++.+... ...+|++++.++.+||||+++++++.+.+
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 34567889999999999999999999999999999999976432 23478888988856999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC-CCCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~~~~kl~Dfg~~~~ 220 (420)
.+|+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+...+ ....+||+|||++..
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999999999999888999999999999999999999999999999999999985432 224599999999987
Q ss_pred cCCC-CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCC---CCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 221 FKPG-DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWG---ETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 221 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
.... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+.+.++...|..
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 6543 33456789999999999865 489999999999999999999999986 456788889999998888888889
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+++++++||++||+.||++|||+.++|+||||...
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 99999999999999999999999999999999643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-54 Score=409.85 Aligned_cols=257 Identities=28% Similarity=0.507 Sum_probs=230.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..++..+..||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 36799999999999999999999999999999999764332334567788999999988459999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-C
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-G 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~ 224 (420)
|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... .
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcccCC
Confidence 99999999999999988899999999999999999999999999999999999999 5567899999999986432 2
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+...++..+..+...++. .+++++++|
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 248 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDL 248 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHHHHHH
Confidence 33456789999999999865 5899999999999999999999999999999999999888766543 579999999
Q ss_pred HHHhcccCcCCCCCHH-HHhcCCcccc
Q 014704 304 VKKMLHADPKERLSAA-EVLNHPWMRV 329 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~-e~l~h~~~~~ 329 (420)
|.+||+.||++||++. ++++||||+.
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccC
Confidence 9999999999999998 9999999974
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-54 Score=403.08 Aligned_cols=253 Identities=29% Similarity=0.590 Sum_probs=229.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+...+|+|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEEE
Confidence 57999999999999999999999999999999997643323345677889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..... .
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--V 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS--C
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC--c
Confidence 9999999999999988899999999999999999999999999999999999999 5677899999999987543 2
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......++. .+++++++||+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~ 235 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLS 235 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHH
Confidence 345689999999999864 5899999999999999999999999999999999999988776653 67999999999
Q ss_pred HhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 306 KMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
+||..||++|| +++++++||||+.
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 99999999999 9999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=404.32 Aligned_cols=257 Identities=28% Similarity=0.551 Sum_probs=228.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.++.++.+||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 36799999999999999999999999999999999876665666678899999999998559999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-CC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~~ 224 (420)
||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... ..
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccCCC
Confidence 99999999999999988899999999999999999999999999999999999999 566789999999998643 33
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCC---------CCHHHHHHHHHcCCCCCCCCCCC
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWG---------ETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .....+...+......++.
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~---- 240 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 240 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT----
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC----
Confidence 44566789999999999864 589999999999999999999999965 3445566777777666553
Q ss_pred CCChHHHHHHHHhcccCcCCCCCH------HHHhcCCcccc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSA------AEVLNHPWMRV 329 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~------~e~l~h~~~~~ 329 (420)
.++.++++||.+||+.||++||++ .++++||||+.
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 679999999999999999999995 89999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-54 Score=411.16 Aligned_cols=256 Identities=28% Similarity=0.569 Sum_probs=219.9
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHH-HhccCCCCccEEEEEEEeCCeEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM-HHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l-~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
.++|.+.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|..++ +.++ ||||+++++++.+.+.+|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCEEE
Confidence 46799999999999999999999999999999999876655555566777888774 5566 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-C
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-P 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~ 223 (420)
+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... .
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccccC
Confidence 999999999999999988899999999999999999999999999999999999999 567789999999998643 3
Q ss_pred CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
.......+||+.|+|||++.+ .|+.++|+|||||++|+|++|..||.+.+..+++..+......++ +.++.++++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ 268 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARH 268 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHH
Confidence 334456789999999999865 589999999999999999999999999999999999998876654 368999999
Q ss_pred HHHHhcccCcCCCCCH----HHHhcCCcccc
Q 014704 303 IVKKMLHADPKERLSA----AEVLNHPWMRV 329 (420)
Q Consensus 303 li~~~L~~dp~~R~t~----~e~l~h~~~~~ 329 (420)
||++||+.||++||++ .++++||||+.
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 9999999999999986 69999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-54 Score=408.99 Aligned_cols=257 Identities=27% Similarity=0.515 Sum_probs=231.1
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..++..+..||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 36799999999999999999999999999999999765433334567889999999988569999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-CC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~~ 224 (420)
||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.... ..
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccccCC
Confidence 99999999999999988899999999999999999999999999999999999999 566789999999998643 23
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+...++..+......++. .+++++++|
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 251 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAI 251 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence 34456789999999999864 5899999999999999999999999999999999999988776653 689999999
Q ss_pred HHHhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 304 VKKMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 304 i~~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
|++||+.||++|| ++.++++||||+.
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999999 4799999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=393.23 Aligned_cols=262 Identities=36% Similarity=0.687 Sum_probs=226.6
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+.++|.+.+.||+|+||.||+|.++.++..||+|++.... .....+.+.+|+++++.++ ||||+++++++.+...+
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCC-CchHHhHHHheecCCeE
Confidence 45678999999999999999999999999999999987643 2344678999999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 144 NLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++...+.++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999999988543 679999999999999999999999999999999999999765566789999999998
Q ss_pred ccCCCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 220 FFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
............||+.|+|||++.+.++.++||||||+++|+|++|..||.+.........+......+.... ..++++
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 254 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC-RPLTPQ 254 (285)
T ss_dssp C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc-CcCCHH
Confidence 7766555566789999999999988899999999999999999999999999988888877776655544332 357899
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-54 Score=417.93 Aligned_cols=261 Identities=30% Similarity=0.503 Sum_probs=228.7
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++ ||||+++++++.+...+|
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEE
Confidence 3478999999999999999999999999999999987533222223355889999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccC
Confidence 99999999999998865 579999999999999999999999999999999999999 56778999999999876554
Q ss_pred Cc--eecccCCcccccchhhccc-----CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 225 DV--FKDLVGSAYYVAPEVLRRN-----YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 225 ~~--~~~~~gt~~y~aPE~~~~~-----~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.. ....+||+.|+|||++.+. |+.++|||||||++|+|++|..||.+.+....+..|..+...+..+.+..++
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 32 2367899999999998532 7899999999999999999999999999999999998765444444456789
Q ss_pred hHHHHHHHHhcccCcCC--CCCHHHHhcCCccccc
Q 014704 298 SSAKDIVKKMLHADPKE--RLSAAEVLNHPWMRVD 330 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~--R~t~~e~l~h~~~~~~ 330 (420)
.++++||++||+.+|.+ |++++|+++||||+..
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999999999 9999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-55 Score=412.88 Aligned_cols=257 Identities=34% Similarity=0.639 Sum_probs=223.7
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEE
Confidence 3468999999999999999999999999999999987543322233467899999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||+ +|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....+
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccCC
Confidence 999999 78999999988999999999999999999999999999999999999999 56678999999999887766
Q ss_pred CceecccCCcccccchhhccc-C-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRRN-Y-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.........+..+...++ ..+++++.+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 237 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQS 237 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSCHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCCHHHHH
Confidence 666777899999999998754 3 7899999999999999999999987665444433333333322 357999999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
||++||+.||.+|||+.|+++||||+..
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=402.96 Aligned_cols=281 Identities=29% Similarity=0.537 Sum_probs=242.0
Q ss_pred CCCcccccccccccccccceeec-ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCC
Q 014704 50 TSSSVGRVLGKPMEDVRNTYIFG-RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128 (420)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp 128 (420)
.+++...+.....+.+.++|.+. +.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.+.+||
T Consensus 11 ~~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~ 89 (327)
T 3lm5_A 11 VDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCP 89 (327)
T ss_dssp -----CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCT
T ss_pred ccccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCC
Confidence 34445556667788899999998 899999999999999999999999999876443 3345678999999999998789
Q ss_pred CccEEEEEEEeCCeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC
Q 014704 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206 (420)
Q Consensus 129 niv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~ 206 (420)
||+++++++.+.+.+|+||||+.|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++....
T Consensus 90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTT
T ss_pred CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCC
Confidence 9999999999999999999999999999988543 66999999999999999999999999999999999999965444
Q ss_pred CCCeeEeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q 014704 207 DSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285 (420)
Q Consensus 207 ~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 285 (420)
++.+||+|||++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+....
T Consensus 170 ~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 249 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249 (327)
T ss_dssp BCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Confidence 67899999999998766555566789999999999864 58999999999999999999999999999999988898888
Q ss_pred CCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 286 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
..++...+..+++.+.+||.+||+.||++|||+.++|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 250 VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 8888887888999999999999999999999999999999997543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=406.20 Aligned_cols=255 Identities=30% Similarity=0.593 Sum_probs=231.3
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+...+|
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEE
Confidence 3468999999999999999999999999999999997654333345678899999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccCC
Confidence 999999999999999988899999999999999999999999999999999999999 56678999999999876433
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+..+...++. .+++++.+|
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l 268 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDL 268 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHH
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Confidence 245689999999999864 5899999999999999999999999999999999999988776653 679999999
Q ss_pred HHHhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 304 VKKMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 304 i~~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
|.+||+.||++||+ +.++++||||+.
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 99999999999998 999999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=408.42 Aligned_cols=257 Identities=28% Similarity=0.537 Sum_probs=229.6
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+|+.++ ||||+++++++.+.+.+|
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEE
Confidence 3478999999999999999999999999999999997654434455678999999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeeccCC
Confidence 999999999999999988899999999999999999999999999999999999999 56778999999999987766
Q ss_pred CceecccCCcccccchhhcc----cCCCccchhhhHHHHHHHHhCCCCCCC---CCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 225 DVFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWG---ETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwslGvil~~ll~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
......+||+.|+|||++.. .|+.++|||||||++|+|++|..||.. .........+......++. .++
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~----~~s 244 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWS 244 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT----TSC
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC----cCC
Confidence 66677899999999999852 489999999999999999999999974 3455666666666655543 679
Q ss_pred hHHHHHHHHhcccCcCCCCC-HHHHhcCCcccc
Q 014704 298 SSAKDIVKKMLHADPKERLS-AAEVLNHPWMRV 329 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t-~~e~l~h~~~~~ 329 (420)
.++.+||.+||+.||++||+ +.++++||||+.
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 99999999999999999998 999999999963
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=401.72 Aligned_cols=268 Identities=36% Similarity=0.667 Sum_probs=215.2
Q ss_pred cccceeec---ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 65 VRNTYIFG---RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 65 ~~~~y~~~---~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
+.++|.+. +.||+|+||.||+|.++.+++.||||++.+. ....+.+|+.+++.+.+||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 34567764 7899999999999999999999999998642 34678899999999988999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
..|+|||||+|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999999999889999999999999999999999999999999999999976555557999999999866
Q ss_pred CCC-CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCCCC
Q 014704 222 KPG-DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET-------EQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 222 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~ 292 (420)
... ......+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.. ..+....+..+...++...
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 443 23455678999999999864 58999999999999999999999997643 3567788888888777766
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~ 338 (420)
|..+++++++||.+||+.||++|||+.++++||||+.....+..++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~ 285 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPL 285 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCC
Confidence 7789999999999999999999999999999999987655544444
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-53 Score=393.10 Aligned_cols=259 Identities=28% Similarity=0.489 Sum_probs=224.5
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...++|.+.+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCC-CCCCCeEeEEEEECCEE
Confidence 456789999999999999999999999999999999865432 33467899999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+|||||+|++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCC
Confidence 9999999999999988754 69999999999999999999999999999999999999 5567899999999887654
Q ss_pred CC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 GD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+........ .....++..+.
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 247 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAIFR 247 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SCGGGSCHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-CCccccCHHHH
Confidence 33 3345689999999999864 589999999999999999999999998887766666554332211 12246889999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
+||.+||+.||++|||+.|+|+||||+...
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 999999999999999999999999998644
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=408.48 Aligned_cols=260 Identities=35% Similarity=0.618 Sum_probs=227.7
Q ss_pred cccceee--cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 65 VRNTYIF--GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 65 ~~~~y~~--~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+.+.|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD-HANLIQLYDAFESKND 160 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence 3445555 678999999999999999999999999987543 245678999999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+++||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||++...
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceec
Confidence 99999999999999988764 46999999999999999999999999999999999999954 23567999999999987
Q ss_pred CCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
.........+||+.|+|||++.. .++.++|||||||++|+|++|..||.+.+....+..+......++...+..+++++
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 76665666789999999999864 58899999999999999999999999999999999999988877777778899999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
++||.+||+.||++|||+.|+|+||||+.
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999999999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=398.89 Aligned_cols=247 Identities=21% Similarity=0.283 Sum_probs=192.1
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC----
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH---- 141 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~---- 141 (420)
..+|.+.+.||+|+||+||+|++ +|+.||||++.... ......+.|+..+.+++ |||||++++++.+++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCce
Confidence 45799999999999999999988 47899999986432 22223445666677888 999999999997654
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM--------GVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
.+|||||||+||+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~ 150 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred EEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEE
Confidence 58999999999999999975 4699999999999999999999987 99999999999999 567889999
Q ss_pred ecccccccCCCCc-----eecccCCcccccchhhcc-------cCCCccchhhhHHHHHHHHhCCCCCCCC---------
Q 014704 214 DFGLSVFFKPGDV-----FKDLVGSAYYVAPEVLRR-------NYGAEADIWSAGVILYILLSGVPPFWGE--------- 272 (420)
Q Consensus 214 Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DvwslGvil~~ll~g~~pf~~~--------- 272 (420)
|||+|+....... ....+||+.|||||++.+ .|+.++|||||||++|||+||.+||...
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 9999987654332 224579999999999854 3678999999999999999997765321
Q ss_pred ------CHHHHHHHHHcCCCCCCCCC-C--CCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 273 ------TEQSIFDAILRGHIDFSSDP-W--PNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 273 ------~~~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
....+...+.........+. + ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 22334444444333222111 1 112346889999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-53 Score=396.75 Aligned_cols=264 Identities=36% Similarity=0.628 Sum_probs=223.6
Q ss_pred ccccceeec-ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 64 DVRNTYIFG-RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 64 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.+.++|.+. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++.++.+||||+++++++.+.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 355789985 78999999999999999999999999997542 23457889999999996559999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999999988899999999999999999999999999999999999999755444569999999987653
Q ss_pred CCC--------ceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCC---------------
Q 014704 223 PGD--------VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGET--------------- 273 (420)
Q Consensus 223 ~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~--------------- 273 (420)
... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 211 123456999999999985 348999999999999999999999997754
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 274 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
...+...+..+...++...+..++.++++||++||+.||++|||+.|+|+||||+..
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 345677788877777665556789999999999999999999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-53 Score=397.86 Aligned_cols=266 Identities=38% Similarity=0.648 Sum_probs=236.4
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh---hhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
..+.++|.+.+.||+|+||.||+|.++.+|+.||+|++........ ...+.+.+|+.+++.+. ||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence 4567889999999999999999999999999999999976543221 24678999999999999 9999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC-CCCeeEeecccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE-DSPLKATDFGLS 218 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~-~~~~kl~Dfg~~ 218 (420)
.+.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999988888999999999999999999999999999999999999953221 127999999999
Q ss_pred cccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+......++...+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 88766555566789999999999864 58999999999999999999999999999999998888877766654456789
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
..+.+||.+||..||++|||+.++|+||||+.
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 99999999999999999999999999999964
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=416.28 Aligned_cols=261 Identities=26% Similarity=0.509 Sum_probs=227.0
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...++|.+.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..++ ||||+++++++.+.+.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEE
Confidence 34578999999999999999999999999999999997533222223345889999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|+|||||.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcc
Confidence 999999999999999987 4679999999999999999999999999999999999999 567789999999998765
Q ss_pred CCCce--ecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCCCC
Q 014704 223 PGDVF--KDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH--IDFSSDP 292 (420)
Q Consensus 223 ~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~ 292 (420)
..... ...+||+.|+|||++. +.|+.++|||||||++|+|++|+.||.+.+..+.+..|.... +.++. .
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~ 305 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT-Q 305 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-S
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc-c
Confidence 44322 3468999999999985 358999999999999999999999999999998888887643 33332 2
Q ss_pred CCCCChHHHHHHHHhcccCcCC--CCCHHHHhcCCcccc
Q 014704 293 WPNISSSAKDIVKKMLHADPKE--RLSAAEVLNHPWMRV 329 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~h~~~~~ 329 (420)
+..+++++++||++||..+|++ |++++|+++||||+.
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 3568999999999999999988 999999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=419.45 Aligned_cols=259 Identities=35% Similarity=0.616 Sum_probs=233.5
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...++|.+++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence 34578999999999999999999999999999999997543323344678999999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+|||||+|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhccc
Confidence 9999999999999999888889999999999999999999999999999999999999 5567899999999998776
Q ss_pred CCceecccCCcccccchhhccc--CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
+......+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......+..+..+....+ ..+++++.
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 244 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVI 244 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHH
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHH
Confidence 6666677899999999998754 37899999999999999999999999988888999988766544 35789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+||++||+.||++|||+.++++||||+..
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 99999999999999999999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=416.46 Aligned_cols=257 Identities=31% Similarity=0.581 Sum_probs=220.3
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|.++.+|+.||+|++.............+.+|+.+++.++ ||||+++++++.+.+.+|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEE
Confidence 3468999999999999999999999999999999997654444455677889999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK- 222 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~- 222 (420)
+||||++|++|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||++....
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceeccC
Confidence 999999999999999988899999999999999999999998 999999999999999 556789999999998643
Q ss_pred CCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 223 PGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
........+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+.......+......++. .+++++.
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~ 377 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAK 377 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHH
Confidence 233445678999999999986 45999999999999999999999999999999999999888776653 5799999
Q ss_pred HHHHHhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 302 DIVKKMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 302 ~li~~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
+||.+||+.||++|| |+.|+++||||+.
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999999 9999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=387.92 Aligned_cols=257 Identities=26% Similarity=0.500 Sum_probs=215.8
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|++.+.||+|+||+||+|.++.+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+++.+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence 479999999999999999999999999999999976543 3445577889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
|||+++ +|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc
Confidence 999976 55555544 6789999999999999999999999999999999999999 55678999999999876432
Q ss_pred CceecccCCcccccchhhcc-c-CCCccchhhhHHHHHHHHhCCCC-CCCCCHHHHHHHHHcCCCCCCC-----------
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPP-FWGETEQSIFDAILRGHIDFSS----------- 290 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwslGvil~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~----------- 290 (420)
.......||+.|+|||++.+ . ++.++||||+||++|+|++|..| |.+.+....+..+.+.......
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 33455689999999999854 3 89999999999999999988777 5566666666665442111111
Q ss_pred --------------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 291 --------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 291 --------------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
...+.+++++++||++||+.||++|||+.|+|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 112357899999999999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=390.71 Aligned_cols=265 Identities=26% Similarity=0.399 Sum_probs=217.4
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC--ChhhHHHHHHHHHHHHhcc--CCCCccEEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--NRDDVEDVRREVQIMHHLT--GHRNIVELKGAYE 138 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~~l~~l~--~hpniv~~~~~~~ 138 (420)
..+.++|++.+.||+|+||+||+|++..+++.||+|++...... .......+.+|+.+++.+. .||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34567899999999999999999999999999999998743321 1112345677887777665 3999999999998
Q ss_pred eCC-----eEEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCee
Q 014704 139 DRH-----SVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 139 ~~~-----~~~iv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
+.. .+++||||+. ++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~k 160 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVK 160 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEE
Confidence 765 5899999997 599999987654 9999999999999999999999999999999999999 5567899
Q ss_pred EeecccccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 014704 212 ATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS 290 (420)
Q Consensus 212 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 290 (420)
|+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+.......+.
T Consensus 161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred EeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99999998776655556778999999999985 56999999999999999999999999999988877777553222221
Q ss_pred CC-----------------------CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 291 DP-----------------------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 291 ~~-----------------------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.. .+.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 11 235789999999999999999999999999999998543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=403.92 Aligned_cols=263 Identities=35% Similarity=0.693 Sum_probs=235.5
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC-Ch----hhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-NR----DDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~----~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
..+.++|.+.+.||+|+||.||+|.++.+|+.||||++...... .. ...+.+.+|+.+++.+.+||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 34557899999999999999999999999999999998754311 11 22456889999999995599999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
......|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGF 246 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCc
Confidence 9999999999999999999999888889999999999999999999999999999999999999 5667899999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc-------cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS 290 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 290 (420)
+............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+..+...+..
T Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred ccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 988776666667789999999998852 4788999999999999999999999999988888888888877766
Q ss_pred CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 291 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
+.|..++..+.+||.+||+.||++|||+.++|+||||+
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 66678899999999999999999999999999999996
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=393.95 Aligned_cols=257 Identities=32% Similarity=0.565 Sum_probs=217.5
Q ss_pred cccceeecceecccCCeEEEEEEEc---CCCceEEEEEecCCcCC-ChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
..++|.+.+.||+|+||.||+|++. .+|+.||+|++.+.... .......+.+|+.+++.++ ||||+++++++.+.
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcC
Confidence 3478999999999999999999985 67899999999765432 2234566889999999999 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKE 170 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC--
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCcccc
Confidence 9999999999999999999988899999999999999999999999999999999999999 4567899999999876
Q ss_pred cCC-CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 221 FKP-GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 221 ~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
... .......+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+......++. .++.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~ 246 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQ 246 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----TSCH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCH
Confidence 432 233445689999999999864 5899999999999999999999999999998899999887766543 6799
Q ss_pred HHHHHHHHhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 299 SAKDIVKKMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
++++||.+||..||++|| ++.++++||||+.
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 999999999999999999 8999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=389.94 Aligned_cols=264 Identities=41% Similarity=0.746 Sum_probs=235.1
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
..+.++|.+.+.||+|+||.||+|.++.+|+.||+|++..... ...+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIK-HENIVTLEDIYESTTH 80 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCC-CCCeeehhhhcccCCE
Confidence 4567899999999999999999999999999999999975432 23356889999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++...+.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999999999888899999999999999999999999999999999999999655567889999999987654
Q ss_pred CCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+...++...+..+++++.
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 161 NG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp CB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred CC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 32 2344579999999999864 589999999999999999999999999999999999999888877777788999999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
+||.+||..||++|||+.++|+||||+...
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999997644
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=396.93 Aligned_cols=263 Identities=30% Similarity=0.480 Sum_probs=213.9
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++ ||||+++++++.+.+.+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEEE
Confidence 44689999999999999999999999999999999975432 3334566789999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC--CCCCeeEeecccccccC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGLSVFFK 222 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~~~~kl~Dfg~~~~~~ 222 (420)
+||||+.| +|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+..++ ....+||+|||++....
T Consensus 110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999975 9999999888999999999999999999999999999999999999996432 34569999999998764
Q ss_pred CC-CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC-----
Q 014704 223 PG-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP----- 294 (420)
Q Consensus 223 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----- 294 (420)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+...........|+
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 32 23345678999999999864 48999999999999999999999999988877777665432111111111
Q ss_pred ---------------------CCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 295 ---------------------NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 295 ---------------------~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 167899999999999999999999999999999854
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=389.07 Aligned_cols=266 Identities=41% Similarity=0.736 Sum_probs=241.0
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
..+.++|.+.+.||+|+||.||+|.++.+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCCe
Confidence 4466899999999999999999999999999999999875433 3345678999999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|+||||+.+++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++..+.+..+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999999888899999999999999999999999999999999999999765556789999999998776
Q ss_pred CCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
.........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+.......+..+...++.+.+..+++++.+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 55544556789999999999888999999999999999999999999999998888999888877776667789999999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
||++||..||++|||+.++|+||||+..
T Consensus 256 li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999743
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=409.65 Aligned_cols=262 Identities=26% Similarity=0.478 Sum_probs=225.4
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..++..+. ||||+++++++.+.+.+
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYL 136 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEE
Confidence 34578999999999999999999999999999999997543322334456889999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|+||||++||+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheecc
Confidence 99999999999999998754 79999999999999999999999999999999999999 567789999999998765
Q ss_pred CCCce--ecccCCcccccchhhc--------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-
Q 014704 223 PGDVF--KDLVGSAYYVAPEVLR--------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD- 291 (420)
Q Consensus 223 ~~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~- 291 (420)
..... ...+||+.|+|||++. +.|+.++|||||||++|+|++|+.||.+.+..+.+..|......+..+
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence 54332 3468999999999986 358999999999999999999999999999988888887643222211
Q ss_pred CCCCCChHHHHHHHHhcccCcCCC---CCHHHHhcCCccccc
Q 014704 292 PWPNISSSAKDIVKKMLHADPKER---LSAAEVLNHPWMRVD 330 (420)
Q Consensus 292 ~~~~~~~~~~~li~~~L~~dp~~R---~t~~e~l~h~~~~~~ 330 (420)
....+|+++++||++||. +|++| ++++|+++||||+..
T Consensus 294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 124689999999999999 99998 599999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-52 Score=392.92 Aligned_cols=260 Identities=32% Similarity=0.534 Sum_probs=233.0
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeE
Confidence 34578999999999999999999999999999999998765555666788999999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceeccc
Confidence 9999999999999999888899999999999999999999999999999999999999 4567799999999987643
Q ss_pred C-CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 G-DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
. .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......++. .++.++.
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 269 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAA 269 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHH
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHH
Confidence 2 33345679999999999864 5899999999999999999999999998888888888877665543 5789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
+||.+||+.||++|||+.|+|+||||....
T Consensus 270 ~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 270 SLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999997543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=391.51 Aligned_cols=262 Identities=27% Similarity=0.446 Sum_probs=215.7
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.+.+.++|++.+.||+|+||+||+|.+.. |+.||+|++..... .......+.+|+.++++++ ||||+++++++.+++
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIHSER 92 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSS
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCC
Confidence 45677899999999999999999999964 89999999865432 3334577889999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
.+++||||++| +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARA 168 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCcee
Confidence 99999999975 787877665 459999999999999999999999999999999999999 4567899999999987
Q ss_pred cCCC-CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC------
Q 014704 221 FKPG-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD------ 291 (420)
Q Consensus 221 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------ 291 (420)
.... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+......+..+..........
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 6432 33445679999999999854 58999999999999999999999998877666555554311111100
Q ss_pred --------------------CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 292 --------------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 292 --------------------~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
..+.+++++.+||++||+.||++|||+.|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 123567899999999999999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=384.23 Aligned_cols=259 Identities=33% Similarity=0.615 Sum_probs=226.7
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEE
Confidence 3468999999999999999999999999999999986543323334567899999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC---
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCcc
Confidence 999999999999999988899999999999999999999999999999999999999 56678999999998665432
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......++. .++.++.+|
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l 237 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDL 237 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHH
T ss_pred -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHHHHHH
Confidence 2345679999999999865 5789999999999999999999999999988888888887665543 578999999
Q ss_pred HHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
|.+||+.||++|||+.|+|+||||+....
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 99999999999999999999999986543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=382.69 Aligned_cols=264 Identities=36% Similarity=0.667 Sum_probs=236.6
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC--C----hhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--N----RDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~----~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
.+.++|.+.+.||+|+||.||+|.++.+|+.||+|++...... . ....+.+.+|+.+++++.+||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 3557899999999999999999999999999999999754321 1 123467889999999997799999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
.+.+..++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecccc
Confidence 9999999999999999999999988899999999999999999999999999999999999999 5567799999999
Q ss_pred ccccCCCCceecccCCcccccchhhc-------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLR-------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS 290 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 290 (420)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+..+...++.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 98876666566678999999999874 24788999999999999999999999999988888889888888777
Q ss_pred CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 291 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+.+..++..+.+||.+||+.||++|||+.++|+||||+..
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 7777899999999999999999999999999999999753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-53 Score=412.61 Aligned_cols=264 Identities=38% Similarity=0.681 Sum_probs=220.3
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCC-----hhhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-----RDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
.+.++|.+.+.||+|+||.||+|.++.+++.||+|++.+..... ......+.+|+.+|++++ ||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 45688999999999999999999999999999999997654321 122335889999999998 999999999985
Q ss_pred eCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
. +.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++..+.+..+||+|||++
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4 558999999999999999988888999999999999999999999999999999999999976666678999999999
Q ss_pred cccCCCCceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCCCCC
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSSDPW 293 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~ 293 (420)
............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ......+..+...+....+
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 9876655556778999999999974 3578899999999999999999999976543 3455666777666665556
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
..+++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 788999999999999999999999999999999963
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=385.19 Aligned_cols=256 Identities=29% Similarity=0.486 Sum_probs=213.3
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.+ .+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++.+.+.+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence 4799999999999999999998 5689999999865432 2233467889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
|||+.+ +|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc
Confidence 999976 898888764 679999999999999999999999999999999999999 55678999999999875432
Q ss_pred CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC------------
Q 014704 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS------------ 290 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------ 290 (420)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+.+.......
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 23345578999999999854 4899999999999999999999999998877776666542110000
Q ss_pred -------------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 291 -------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 291 -------------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.....+++++.+||++||+.||++|||+.|+|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012357899999999999999999999999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=387.95 Aligned_cols=256 Identities=31% Similarity=0.608 Sum_probs=218.2
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCC-----------------------hhhHHHHHHHHHHHH
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-----------------------RDDVEDVRREVQIMH 122 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~ 122 (420)
.++|.+.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999999999999999997654221 112456899999999
Q ss_pred hccCCCCccEEEEEEEe--CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 014704 123 HLTGHRNIVELKGAYED--RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200 (420)
Q Consensus 123 ~l~~hpniv~~~~~~~~--~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil 200 (420)
+++ ||||+++++++.+ ...+|+||||+++++|.+++ ..+.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 92 ~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 998 9999999999987 67899999999999997754 4467999999999999999999999999999999999999
Q ss_pred EecCCCCCCeeEeecccccccCCCC-ceecccCCcccccchhhccc----CCCccchhhhHHHHHHHHhCCCCCCCCCHH
Q 014704 201 FSSSAEDSPLKATDFGLSVFFKPGD-VFKDLVGSAYYVAPEVLRRN----YGAEADIWSAGVILYILLSGVPPFWGETEQ 275 (420)
Q Consensus 201 l~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DvwslGvil~~ll~g~~pf~~~~~~ 275 (420)
+ +.++.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....
T Consensus 170 ~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 170 V---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp E---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred E---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9 556789999999998765433 34556899999999998643 377899999999999999999999998888
Q ss_pred HHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 276 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.....+......++. .+.+++++.+||.+||+.||++|||+.|+|+||||+
T Consensus 247 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 247 CLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 888888777665543 357899999999999999999999999999999995
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=412.52 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=200.7
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe----
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED---- 139 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~---- 139 (420)
.+.++|.+.+.||+|+||+||+|+++.+++.||||++... .......+.+.+|+.+|+.++ ||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCcc
Confidence 4567899999999999999999999999999999998653 334556678999999999998 9999999999843
Q ss_pred -CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 140 -RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 140 -~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
...+|+||||+ +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla 203 (458)
T 3rp9_A 128 KFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLA 203 (458)
T ss_dssp TCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccc
Confidence 35799999998 56999999888889999999999999999999999999999999999999 56678999999999
Q ss_pred cccCCC----------------------------CceecccCCcccccchhh-c-ccCCCccchhhhHHHHHHHHh----
Q 014704 219 VFFKPG----------------------------DVFKDLVGSAYYVAPEVL-R-RNYGAEADIWSAGVILYILLS---- 264 (420)
Q Consensus 219 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~-~-~~~~~~~DvwslGvil~~ll~---- 264 (420)
+..... ......+||+.|+|||++ . ..|+.++|||||||++|+|++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 875421 123456889999999976 3 459999999999999999998
Q ss_pred -------CCCCCCCCCH--------------------HHHHHHHHc-----------------------CCC----CCCC
Q 014704 265 -------GVPPFWGETE--------------------QSIFDAILR-----------------------GHI----DFSS 290 (420)
Q Consensus 265 -------g~~pf~~~~~--------------------~~~~~~i~~-----------------------~~~----~~~~ 290 (420)
|.++|.+... ...+..|.. ... ....
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 7777766431 111221111 000 0001
Q ss_pred CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 291 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
..++.+++++.+||++||..||++|||+.|+|+||||+..
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 1245679999999999999999999999999999999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=404.14 Aligned_cols=263 Identities=31% Similarity=0.517 Sum_probs=212.0
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
...+.++|.+.+.||+|+||.||+|.++.+|+.||||++... .........+.+|+.+++.+.+||||+++++++...+
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 345668999999999999999999999999999999998643 3345567788999999999988999999999997544
Q ss_pred --eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 142 --SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 142 --~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+|+|||||. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSR 157 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccc
Confidence 7999999997 589888765 579999999999999999999999999999999999999 566789999999998
Q ss_pred ccCC----------------------CCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Q 014704 220 FFKP----------------------GDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQ 275 (420)
Q Consensus 220 ~~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~ 275 (420)
.... .......+||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 6532 112345689999999999854 5899999999999999999999999999887
Q ss_pred HHHHHHHcCCCCCC------------------------------C-------------CCCCCCChHHHHHHHHhcccCc
Q 014704 276 SIFDAILRGHIDFS------------------------------S-------------DPWPNISSSAKDIVKKMLHADP 312 (420)
Q Consensus 276 ~~~~~i~~~~~~~~------------------------------~-------------~~~~~~~~~~~~li~~~L~~dp 312 (420)
..+..+........ . .....+++++.+||++||+.||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 77776653110000 0 0122678999999999999999
Q ss_pred CCCCCHHHHhcCCccccc
Q 014704 313 KERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 313 ~~R~t~~e~l~h~~~~~~ 330 (420)
++|||+.|+|+||||+..
T Consensus 318 ~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 318 NKRISANDALKHPFVSIF 335 (388)
T ss_dssp GGSCCHHHHTTSTTTTTT
T ss_pred ccCCCHHHHhCCHHHHHh
Confidence 999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=384.01 Aligned_cols=264 Identities=39% Similarity=0.703 Sum_probs=230.3
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh---hhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
+.++|.+.+.||+|+||.||+|.++.+++.||+|++........ ...+.+.+|+.++++++ ||||+++++++.+..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCC
Confidence 45789999999999999999999999999999999876543221 24678999999999999 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC-CCCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA-EDSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~~~~kl~Dfg~~~~ 220 (420)
..++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999998888899999999999999999999999999999999999996432 233799999999988
Q ss_pred cCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 221 FKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
...........||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+......++...+..++..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 76555556678999999999986 45899999999999999999999999999988888888887766655555678999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.+||.+||..||++|||+.++|+||||+.
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 999999999999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=415.05 Aligned_cols=257 Identities=30% Similarity=0.530 Sum_probs=227.9
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|+.++ ||||+++++++.+.+.+|
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEEE
Confidence 4578999999999999999999999999999999997644333345577899999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 145 LIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+||||++||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceecc
Confidence 99999999999999987544 9999999999999999999999999999999999999 566789999999999877
Q ss_pred CCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET----EQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.+......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. ...+...+......++ ..++
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s 413 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFS 413 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSC
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCC
Confidence 6666677799999999999865 59999999999999999999999998753 4556666666555443 4689
Q ss_pred hHHHHHHHHhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 298 SSAKDIVKKMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
+++++||++||+.||++|| ++.|+++||||+.
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 9999999999999999999 8999999999974
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=389.22 Aligned_cols=258 Identities=26% Similarity=0.446 Sum_probs=206.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.++.+|+.||+|++.... .......+.+|+.+++.++ ||||+++++++.+++.+|+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEEE
Confidence 57999999999999999999999999999999987543 2233467889999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 147 MDLCAGGELFDRIIAK------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
|||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCcccee
Confidence 99998 5999988754 358999999999999999999999999999999999999 5567899999999987
Q ss_pred cCCC-CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC------
Q 014704 221 FKPG-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD------ 291 (420)
Q Consensus 221 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------ 291 (420)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+..........
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 6432 23445689999999999864 58999999999999999999999999988887777665421110000
Q ss_pred ------------------------CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 292 ------------------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 292 ------------------------~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
....++.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 1125688999999999999999999999999999998543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=392.87 Aligned_cols=258 Identities=29% Similarity=0.576 Sum_probs=217.9
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
+.++|.+.+.||+|+||.||+|.++.+++.||+|++..... ....+.+.+|+.+++.++ ||||+++++++.+.+..|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence 45789999999999999999999999999999999865432 223466889999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+|||||+|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceeccC
Confidence 999999999999999877789999999999999999999999999999999999999 55678999999999865422
Q ss_pred C---ceecccCCcccccchhhccc--CCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCCCh
Q 014704 225 D---VFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 225 ~---~~~~~~gt~~y~aPE~~~~~--~~~~~DvwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
. .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.... ..+......... ...+..+++
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDS 236 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--STTGGGSCH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--CCccccCCH
Confidence 2 23456899999999998643 477899999999999999999999876543 333333333222 223567899
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
++.+||.+||..||++|||+.|+++||||+..
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 99999999999999999999999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=398.95 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=217.5
Q ss_pred cccceeecceeccc--CCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 65 VRNTYIFGRELGRG--QFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 65 ~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
..++|.+.+.||+| +||.||+|+++.+|+.||||++..... .....+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCE
Confidence 34689999999999 999999999999999999999976543 4456678999999999999 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+|+|||||+|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.+..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEccccccee
Confidence 99999999999999999876 679999999999999999999999999999999999999 5567899999998765
Q ss_pred cCCC--------CceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-
Q 014704 221 FKPG--------DVFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF- 288 (420)
Q Consensus 221 ~~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~- 288 (420)
.... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+..+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 4221 11123478999999999865 58999999999999999999999998766544444333222110
Q ss_pred -----------------------------------------CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 289 -----------------------------------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 289 -----------------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
....+..+++++.+||++||+.||++|||+.|+|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 011234578999999999999999999999999999999
Q ss_pred cccC
Q 014704 328 RVDG 331 (420)
Q Consensus 328 ~~~~ 331 (420)
+...
T Consensus 338 ~~~~ 341 (389)
T 3gni_B 338 KQIK 341 (389)
T ss_dssp GGC-
T ss_pred HHHh
Confidence 8644
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=394.84 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=215.8
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-- 140 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-- 140 (420)
-.+.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.+++.++ ||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDET 98 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSS
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCc
Confidence 456788999999999999999999999999999999986532 34455678899999999999 99999999999765
Q ss_pred ----CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 141 ----HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 141 ----~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
..+|+||||+ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg 173 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFG 173 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeee
Confidence 3569999999 8899888865 679999999999999999999999999999999999999 456789999999
Q ss_pred cccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID------- 287 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~------- 287 (420)
+++.... .....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+....+..+......
T Consensus 174 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 174 LARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp TCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9987543 2355689999999998854 5899999999999999999999999998877766665432111
Q ss_pred ----------------CCC----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 288 ----------------FSS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 288 ----------------~~~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
... ..++.+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 011 12356789999999999999999999999999999997543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=426.17 Aligned_cols=257 Identities=27% Similarity=0.519 Sum_probs=233.0
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|+++.+++.||||++.+.........+.+.+|..++..+.+||+|+++++++++.+.+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 46799999999999999999999999999999999764333344567788999999998779999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC-CC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~-~~ 224 (420)
||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... .+
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccCC
Confidence 99999999999999988899999999999999999999999999999999999999 567789999999998643 33
Q ss_pred CceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+..+++..|......++. .+++++++|
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 572 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAI 572 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHH
Confidence 4456678999999999986 46999999999999999999999999999999999999998877764 689999999
Q ss_pred HHHhcccCcCCCCCH-----HHHhcCCcccc
Q 014704 304 VKKMLHADPKERLSA-----AEVLNHPWMRV 329 (420)
Q Consensus 304 i~~~L~~dp~~R~t~-----~e~l~h~~~~~ 329 (420)
|++||+.||++||++ +|+++||||+.
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 999999999999997 99999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=396.37 Aligned_cols=257 Identities=26% Similarity=0.481 Sum_probs=217.8
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccC-CCCccEEEEEEEeCCeEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG-HRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-hpniv~~~~~~~~~~~~~ 144 (420)
..+|.+.+.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+|+++.+ ||||+++++++...+.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 4569999999999999999999875 89999999976543 45567889999999999984 699999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||| +.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+. ++.+||+|||++......
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccccccCC
Confidence 9999 56889999999988999999999999999999999999999999999999993 367999999999876543
Q ss_pred C---ceecccCCcccccchhhcc------------cCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCC
Q 014704 225 D---VFKDLVGSAYYVAPEVLRR------------NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDF 288 (420)
Q Consensus 225 ~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~ 288 (420)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ....+..+......+
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 2 2345689999999999853 58899999999999999999999998754 345566666655444
Q ss_pred CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
..+. ..+.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 288 ~~~~--~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 288 EFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCCc--cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 3332 3478999999999999999999999999999997543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=378.83 Aligned_cols=261 Identities=32% Similarity=0.527 Sum_probs=233.2
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCEE
Confidence 35578999999999999999999999999999999998765555666788999999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
++||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceeccc
Confidence 9999999999999999888899999999999999999999999999999999999999 4567899999999987643
Q ss_pred C-CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 G-DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
. .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......++. .+++.+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 243 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAA 243 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHH
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc----ccCHHHH
Confidence 2 23345679999999999865 5889999999999999999999999998888888888777655443 6789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
++|.+||+.||++|||+.++++||||.....
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 9999999999999999999999999975543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=396.95 Aligned_cols=268 Identities=35% Similarity=0.661 Sum_probs=228.7
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcC--CChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL--INRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
...+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYED 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhcc
Confidence 35677899999999999999999999999999999999865422 13455678999999999998 9999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHH
Q 014704 140 RHSVNLIMDLCAGGELFDRIIA----------------------------------------KGHYSERAAANLCRQMVT 179 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~ 179 (420)
.+.+++|||||+||+|.+++.. ...+++..+..++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999998741 112367888999999999
Q ss_pred HHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-----ceecccCCcccccchhhc---ccCCCccc
Q 014704 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-----VFKDLVGSAYYVAPEVLR---RNYGAEAD 251 (420)
Q Consensus 180 al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~D 251 (420)
||.|||++||+||||||+||+++.+ ....+||+|||++....... ......||+.|+|||++. ..++.++|
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999999999999999999999532 23379999999998653211 234567999999999985 45899999
Q ss_pred hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 252 IWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 252 vwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
|||||+++|+|++|..||.+.........+......+....+..+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999999999999999999998888777776677899999999999999999999999999999997543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=379.76 Aligned_cols=258 Identities=32% Similarity=0.645 Sum_probs=228.8
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++ ||||+++++++.+.+.+|+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEEE
Confidence 368999999999999999999999999999999986543222234567899999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECSSS-
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCccc-
Confidence 99999999999999988899999999999999999999999999999999999999 45677999999998765432
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......++ +.++.++++||
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li 243 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLI 243 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHH
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHH
Confidence 2345679999999999865 589999999999999999999999999888888888887766544 36789999999
Q ss_pred HHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
.+||..||.+|||+.++++||||+....
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 9999999999999999999999986544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=392.54 Aligned_cols=265 Identities=38% Similarity=0.690 Sum_probs=223.4
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC-----ChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-----NRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
..+.++|.+.+.||+|+||.||+|.++.+++.||||++...... .......+.+|+.+++.+. ||||+++++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 84 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF 84 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEE
Confidence 34668899999999999999999999999999999998754321 1123346889999999998 99999999998
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
..+. +|+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+..+||+|||+
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 7665 899999999999999998888899999999999999999999999999999999999997655566799999999
Q ss_pred ccccCCCCceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCC
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDP 292 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 292 (420)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+..+...+....
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 98876554445567999999999873 45889999999999999999999999765432 34555666655554444
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+..++.++.+||.+||..||++|||+.++|+||||+.
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 5678999999999999999999999999999999963
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=385.55 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=213.9
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
+...+.++|.+.+.||+|+||+||+|.++.+|+.||||++..... ..........|+..+.++..||||+++++++.+.
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 344566889999999999999999999999999999999865432 3344556667777777774599999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
+.+|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLV 205 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCE
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeee
Confidence 9999999999 66888887765 459999999999999999999999999999999999999 456779999999998
Q ss_pred ccCCCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 220 FFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
............||+.|+|||++.+.++.++|||||||++|+|++|..||.+.. ....+..+.. +......++++
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~ 280 (311)
T 3p1a_A 206 ELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYL--PPEFTAGLSSE 280 (311)
T ss_dssp ECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCC--CHHHHTTSCHH
T ss_pred ecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCC--CcccccCCCHH
Confidence 876555555667999999999998889999999999999999999977775532 2333333322 11123467999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 281 l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=384.32 Aligned_cols=261 Identities=28% Similarity=0.521 Sum_probs=216.9
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.++++++ ||||+++++++.+.+..++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEE
Confidence 368999999999999999999999999999999986543 23444677889999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence 99999999999988888889999999999999999999999999999999999999 55678999999999876532
Q ss_pred CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------------
Q 014704 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH----------------- 285 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~----------------- 285 (420)
.......||+.|+|||++.+ .++.++||||+|+++|+|++|..||.+.........+....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 33455689999999999854 58999999999999999999999999888776655543311
Q ss_pred --CCCCCC--------CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 286 --IDFSSD--------PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 286 --~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
...+.. .++.++.++.+||++||+.||++|||+.|+|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 011110 1246789999999999999999999999999999997543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=393.62 Aligned_cols=270 Identities=24% Similarity=0.429 Sum_probs=225.9
Q ss_pred CcccccccccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc----CC
Q 014704 52 SSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT----GH 127 (420)
Q Consensus 52 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h 127 (420)
.....+....+..+.++|.+.+.||+|+||.||+|++..+++.||||++.. .......+..|+.+++.+. .|
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h 95 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINN 95 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTG
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCC
Confidence 334445566777888999999999999999999999999999999999863 2344567888999999986 49
Q ss_pred CCccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecC-
Q 014704 128 RNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS- 204 (420)
Q Consensus 128 pniv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~- 204 (420)
|||+++++++...+.+|+||||+ |++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++..
T Consensus 96 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174 (360)
T ss_dssp GGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTT
T ss_pred CCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccc
Confidence 99999999999999999999999 899999998764 49999999999999999999999999999999999999531
Q ss_pred ---------------------CCCCCeeEeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHH
Q 014704 205 ---------------------AEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYIL 262 (420)
Q Consensus 205 ---------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~l 262 (420)
..+..+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 1267899999999986543 2345689999999999864 699999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------------CCC---------------------CCChHH
Q 014704 263 LSGVPPFWGETEQSIFDAILRGHIDFSSD---------------------PWP---------------------NISSSA 300 (420)
Q Consensus 263 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~~~~~ 300 (420)
++|..||.+......+..+......++.. .|+ ..++.+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 99999999988777766665432222110 000 123677
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.+||.+||+.||++|||+.|+|+||||+
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 8999999999999999999999999995
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=378.85 Aligned_cols=260 Identities=35% Similarity=0.616 Sum_probs=221.3
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
....++|.+.+.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTD 85 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCe
Confidence 334578999999999999999999999999999999986543323344678999999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccccC
Confidence 99999999999999999888899999999999999999999999999999999999999 456779999999998876
Q ss_pred CCCceecccCCcccccchhhccc-C-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRRN-Y-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
.........||+.|+|||++.+. + +.++||||||+++|+|++|..||...........+..+...++ ..++..+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l 238 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSV 238 (276)
T ss_dssp C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHH
Confidence 65555566899999999998754 3 6799999999999999999999999888888888887765543 3578999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.++|.+||+.||++|||+.++++||||+..
T Consensus 239 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 999999999999999999999999999754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=409.05 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=210.7
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--- 140 (420)
.+.++|.+.+.||+|+||.||+|.+..+|+.||||++... .......+.+.+|+.+|+.++ ||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCcc
Confidence 4568899999999999999999999999999999999754 234556678999999999998 99999999999654
Q ss_pred ---CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 141 ---~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
..+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEe
Confidence 467999999976 5666663 459999999999999999999999999999999999999 5567899999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID--------- 287 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 287 (420)
++...........+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+....+..+......
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 988766656667899999999999864 6999999999999999999999999998877777666542110
Q ss_pred -------------CCCCCC----CC------------CChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 288 -------------FSSDPW----PN------------ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 288 -------------~~~~~~----~~------------~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+....+ +. .++++++||++||+.||++|||+.|+|+||||+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 000000 00 1467899999999999999999999999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=393.74 Aligned_cols=259 Identities=28% Similarity=0.464 Sum_probs=211.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.++.+++.||+|++..... ......+.+|+.+++.++ ||||+++++++.+.+.+++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence 579999999999999999999999999999999864331 111123557999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 147 MDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
|||+.| +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC----
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc
Confidence 999974 8888887654 59999999999999999999999999999999999999 45678999999999865432
Q ss_pred CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC----------
Q 014704 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP---------- 292 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------- 292 (420)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.+.........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 23345678999999999854 589999999999999999999999999988877777655322221111
Q ss_pred ----------------CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 293 ----------------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 293 ----------------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
++.+++++.+||.+||+.||++|||+.|+|+||||.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 2356889999999999999999999999999999986544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=388.83 Aligned_cols=261 Identities=27% Similarity=0.481 Sum_probs=220.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe------
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED------ 139 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~------ 139 (420)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccc
Confidence 4689999999999999999999999999999999865543 2333456789999999999 9999999999987
Q ss_pred --CCeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 140 --RHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 140 --~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
.+.+|+||||+.| +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg 169 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFG 169 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCT
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccch
Confidence 4578999999975 777777654 569999999999999999999999999999999999999 556789999999
Q ss_pred cccccCCC-----CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 014704 217 LSVFFKPG-----DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (420)
Q Consensus 217 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 289 (420)
++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......++
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99876421 22345678999999998854 489999999999999999999999999998888777766444444
Q ss_pred CCCCCCC----------------------------ChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 290 SDPWPNI----------------------------SSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 290 ~~~~~~~----------------------------~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
...|+.+ ++++.+||.+||+.||++|||+.|+|+||||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 4333332 677999999999999999999999999999986443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=407.68 Aligned_cols=257 Identities=28% Similarity=0.505 Sum_probs=226.1
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|.+.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.++++++ ||||+++++++.+...+|
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEE
Confidence 3478999999999999999999999999999999997654333345678899999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 145 LIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceeee
Confidence 999999999999998764 369999999999999999999999999999999999999 5677899999999987
Q ss_pred cCCCCc-eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCCCCCC
Q 014704 221 FKPGDV-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE----TEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 221 ~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
...... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+. ....+...+......++ .
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~ 414 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----D 414 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----T
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----c
Confidence 765443 344589999999999865 5999999999999999999999999875 34667777777766554 3
Q ss_pred CCChHHHHHHHHhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 295 NISSSAKDIVKKMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
.+++++++||++||+.||++||+ +.++++||||+.
T Consensus 415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 68999999999999999999996 589999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=390.05 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=223.9
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH- 141 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~- 141 (420)
..+.++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++ ||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP 86 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEET
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCC
Confidence 456789999999999999999999999999999999998765555566678999999999998 999999999987654
Q ss_pred ---eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 142 ---SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 142 ---~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a 163 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIA 163 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEECCCSCC
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEeeccCc
Confidence 3499999999999999999888999999999999999999999999999999999999994 4567999999999
Q ss_pred cccCCCC----ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 014704 219 VFFKPGD----VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (420)
Q Consensus 219 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 293 (420)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+.......+...+
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 8654322 2234569999999999864 5899999999999999999999999999888877777766554444444
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
..++.++.+||.+||+.||++||++.++|.|+|++..
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 5789999999999999999999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=374.62 Aligned_cols=257 Identities=22% Similarity=0.418 Sum_probs=220.5
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe----CC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----RH 141 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~----~~ 141 (420)
...|.+.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.++ ||||+++++++.. ..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCc
Confidence 4568999999999999999999999999999999876443 4556788999999999998 9999999999875 46
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+++||||+++++|.+++...+.+++..+..++.||+.||.|||++| |+||||||+||+++ ..++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcc
Confidence 68999999999999999998889999999999999999999999999 99999999999995 256689999999997
Q ss_pred ccCCCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 220 FFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
..... ......||+.|+|||++.+.++.++||||||+++|+|++|..||.... .......+..+..... .....++
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 257 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIP 257 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--GGGCCCH
T ss_pred ccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc--cCCCCCH
Confidence 65433 334567999999999998889999999999999999999999998754 4444444444332221 1235678
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
++.+||.+||+.||++|||+.++|+||||+.
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=385.60 Aligned_cols=257 Identities=26% Similarity=0.462 Sum_probs=222.8
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...+.|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTA 129 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeE
Confidence 44567999999999999999999999999999999997654444455678999999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRII-AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|+||||+. |+|.+.+. ....+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSS
T ss_pred EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCceecC
Confidence 99999997 57877775 456799999999999999999999999999999999999995 56779999999998764
Q ss_pred CCCceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 223 PGDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
.. ....||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+.......+......... ...+++
T Consensus 206 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 280 (348)
T 1u5q_A 206 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSE 280 (348)
T ss_dssp SB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC--CTTSCH
T ss_pred CC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCH
Confidence 32 3467999999999873 45899999999999999999999999988877777766665433221 246789
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+.+||.+||+.||++|||+.++|+||||...
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 99999999999999999999999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=379.10 Aligned_cols=255 Identities=29% Similarity=0.517 Sum_probs=222.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
..|...+.||+|+||.||+|.++.+|+.||||++.... ....+.+.+|+.+++.++ ||||+++++++...+..|+|
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEE
Confidence 35888889999999999999999999999999986543 234577899999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
|||++|++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 121 ~e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 121 MEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp ECCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC
T ss_pred EecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc
Confidence 99999999998775 4579999999999999999999999999999999999999 456789999999988765432
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+........ .....+++.+.+||
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 275 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLRDFL 275 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHHHHH
Confidence 3345689999999999864 589999999999999999999999999888887777766543221 12245789999999
Q ss_pred HHhcccCcCCCCCHHHHhcCCccccc
Q 014704 305 KKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+||+.||++|||+.++|+||||...
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHccCChhhCcCHHHHhcChhhccC
Confidence 99999999999999999999999754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=394.45 Aligned_cols=263 Identities=25% Similarity=0.472 Sum_probs=212.1
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-- 140 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-- 140 (420)
-.+.++|.+.+.||+|+||.||+|.++.+++.||||++... .......+.+.+|+.+|+.++ ||||+++++++...
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCC
Confidence 45678999999999999999999999999999999999653 334556678999999999999 99999999999776
Q ss_pred ---CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 141 ---~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
..+|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGl 175 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGL 175 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCC
Confidence 67999999996 5999999888889999999999999999999999999999999999999 5667899999999
Q ss_pred ccccCCCC-----------------------ceecccCCcccccchhh-c-ccCCCccchhhhHHHHHHHHhC-------
Q 014704 218 SVFFKPGD-----------------------VFKDLVGSAYYVAPEVL-R-RNYGAEADIWSAGVILYILLSG------- 265 (420)
Q Consensus 218 ~~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~DvwslGvil~~ll~g------- 265 (420)
++...... .....+||+.|+|||++ . ..|+.++||||+||++|+|++|
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 98764322 23567899999999986 3 4599999999999999999984
Q ss_pred ----CCCCCCCC-----------------HHHHHHHHH------------------------cCCCCCCC---CCCCCCC
Q 014704 266 ----VPPFWGET-----------------EQSIFDAIL------------------------RGHIDFSS---DPWPNIS 297 (420)
Q Consensus 266 ----~~pf~~~~-----------------~~~~~~~i~------------------------~~~~~~~~---~~~~~~~ 297 (420)
.++|.+.+ ....+..+. ......+. ..++.++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 44444432 111111111 11111000 0135689
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
+++.+||++||+.||++|||+.|+|+||||+...
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999999999998543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=377.61 Aligned_cols=257 Identities=32% Similarity=0.581 Sum_probs=198.6
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++ ||||+++++++.+.+..|+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEEE
Confidence 357999999999999999999999999999999986543322334578999999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCC
Confidence 99999999999998865 569999999999999999999999999999999999999 45677999999999876432
Q ss_pred -CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 225 -DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+....... ...++.++.+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 241 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM----PSFLSIEAKD 241 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC----CTTSCHHHHH
T ss_pred CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC----ccccCHHHHH
Confidence 22334679999999999864 58899999999999999999999998776555444443333222 2357899999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
||.+||+.||++|||+.++|+||||...
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 9999999999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=388.55 Aligned_cols=253 Identities=30% Similarity=0.539 Sum_probs=219.0
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh-----hhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR-----DDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
.+.++|.+.+.||+|+||.||+|+++.+++.||||++........ .....+.+|+.++++++ ||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 466889999999999999999999999999999999986543222 13446788999999998 999999999999
Q ss_pred eCCeEEEEEecCCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 139 DRHSVNLIMDLCAGG-ELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~-~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
+.+.+++||||+.+| +|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence 999999999999766 999999988899999999999999999999999999999999999999 5567899999999
Q ss_pred ccccCCCCceecccCCcccccchhhccc-C-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRRN-Y-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
+............+||+.|+|||++.+. + +.++||||||+++|+|++|..||..... ...... .....
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~----~~~~~ 246 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI----HPPYL 246 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCC----CCSSC
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhcc----CCCcc
Confidence 9987766666677899999999998643 4 7899999999999999999999975321 111111 12235
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+++++.+||.+||+.||++|||+.++++||||+..
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 79999999999999999999999999999999753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=376.53 Aligned_cols=264 Identities=26% Similarity=0.414 Sum_probs=223.3
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
+..+.++|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDD 84 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCC
Confidence 3456789999999999999999999999999999999987665555666788999999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.+|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcccc
Confidence 999999999999999999988899999999999999999999999999999999999999 55678999999999876
Q ss_pred CCCC--ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCCCC
Q 014704 222 KPGD--VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID-FSSDPWPNIS 297 (420)
Q Consensus 222 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~ 297 (420)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.+.............. ......+.++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP 241 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC
Confidence 4332 2234579999999999865 5889999999999999999999999998877666555554332 2222345789
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+.+.++|.+||+.||++||+..+.+.+.|...
T Consensus 242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 242 QSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 99999999999999999997777777777654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=401.69 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=211.5
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
..+....+|.+.+.||+|+||.||+|.+..+++ ||+|.+..... ...+|+.+++.++ ||||+++++++...
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~-h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVK-HPNVVDLKAFFYSN 104 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEE
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCC-CCCcceEEEEEEec
Confidence 345566789999999999999999999987765 88887754332 1237999999998 99999999998554
Q ss_pred C------eEEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCe
Q 014704 141 H------SVNLIMDLCAGGELFDRII----AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (420)
Q Consensus 141 ~------~~~iv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~ 210 (420)
+ .+++||||+.++ +.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++ ..++.+
T Consensus 105 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~ 181 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVL 181 (394)
T ss_dssp SSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEE
T ss_pred CCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcE
Confidence 3 388999999875 433332 356799999999999999999999999999999999999995 246679
Q ss_pred eEeecccccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---
Q 014704 211 KATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH--- 285 (420)
Q Consensus 211 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~--- 285 (420)
||+|||+++....+.......||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+....+..+.+..
T Consensus 182 kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261 (394)
T ss_dssp EECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999988766665667789999999998854 58999999999999999999999999988777666654310
Q ss_pred --------------CCCCC--------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 286 --------------IDFSS--------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 286 --------------~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
..++. ...+.+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 01110 0123478999999999999999999999999999999754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=380.42 Aligned_cols=255 Identities=26% Similarity=0.512 Sum_probs=213.4
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCe
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHS 142 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--~~~ 142 (420)
..++|.+.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+.+||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 357899999999999999999999999999999998632 346789999999999889999999999988 678
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
.++||||+.+++|.+++. .+++..+..++.||+.||.|||++||+||||||+|||++. ++..+||+|||++....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--CCCEEEEEeCCCceEcC
Confidence 999999999999988773 4899999999999999999999999999999999999963 33479999999998877
Q ss_pred CCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHH-------------HHcCCC
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDA-------------ILRGHI 286 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~-------------i~~~~~ 286 (420)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ....+.. +.....
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 6666667789999999999854 58999999999999999999999995432 2222222 122111
Q ss_pred CCC--------------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 287 DFS--------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 287 ~~~--------------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
... ......+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 111 11112378999999999999999999999999999999743
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=383.87 Aligned_cols=260 Identities=27% Similarity=0.474 Sum_probs=217.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++ ||||+++++++.+.+.+|+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEEE
Confidence 468999999999999999999999999999999986543 24445567889999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-C
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-G 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~ 224 (420)
||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..... .
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCCc
Confidence 99999999998887777889999999999999999999999999999999999999 5567899999999976543 2
Q ss_pred CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Q 014704 225 DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI---------------- 286 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~---------------- 286 (420)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+.....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 33455679999999999865 589999999999999999999999998887666655432110
Q ss_pred ---CCCC--------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 287 ---DFSS--------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 287 ---~~~~--------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
..+. ..++.+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0000 0123678999999999999999999999999999999753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=382.58 Aligned_cols=266 Identities=37% Similarity=0.668 Sum_probs=194.7
Q ss_pred ccccceeecc-eecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe---
Q 014704 64 DVRNTYIFGR-ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--- 139 (420)
Q Consensus 64 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--- 139 (420)
.+.++|.+.+ .||+|+||.||+|.++.+|+.||||++... ....+|+..+.++.+||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 4667899955 699999999999999999999999998642 1233444443333349999999999976
Q ss_pred -CCeEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 140 -RHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 140 -~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
...+++|||||+||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.+..+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 556899999999999999998764 69999999999999999999999999999999999999766667789999999
Q ss_pred cccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCCC
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSI----FDAILRGHIDFSSD 291 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~ 291 (420)
++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+...... ...+......++..
T Consensus 177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred cceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 99875432 334567899999999985 4588999999999999999999999977665443 33444455566666
Q ss_pred CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcc
Q 014704 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338 (420)
Q Consensus 292 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~ 338 (420)
.+..+++++.+||.+||+.||++|||+.|+|+||||+........+.
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~ 302 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBC
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCcc
Confidence 67789999999999999999999999999999999986554444333
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=380.24 Aligned_cols=259 Identities=27% Similarity=0.478 Sum_probs=213.7
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC-CCccEEEEEEEeCCe
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKGAYEDRHS 142 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pniv~~~~~~~~~~~ 142 (420)
...++|.+.+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++.+.+| |||+++++++.+...
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 34678999999999999999999985 588999999875432 455667899999999999832 999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|+||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC-
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccC
Confidence 999999 55889999999999999999999999999999999999999999999999995 3569999999998765
Q ss_pred CCC---ceecccCCcccccchhhc------------ccCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC
Q 014704 223 PGD---VFKDLVGSAYYVAPEVLR------------RNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHI 286 (420)
Q Consensus 223 ~~~---~~~~~~gt~~y~aPE~~~------------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~ 286 (420)
... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||..... ...+..+.....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 432 223567999999999984 3578899999999999999999999987543 344445554433
Q ss_pred CCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 287 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
....+ ...+.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 239 ~~~~~--~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 239 EIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ccCCc--ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 33222 34578899999999999999999999999999998543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=388.59 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=207.2
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-- 141 (420)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.++ ||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCST
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccccc
Confidence 45678999999999999999999999999999999987533 34455678899999999998 999999999997665
Q ss_pred ----eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 142 ----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 142 ----~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
.+|+||||++| +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 173 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC
T ss_pred ccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeec
Confidence 78999999975 7888775 469999999999999999999999999999999999999 4567899999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC------
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS------ 290 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 290 (420)
+............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+.........
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 987665544556789999999999864 5899999999999999999999999998887777776653221100
Q ss_pred -----------CCC--------------C-------CCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 291 -----------DPW--------------P-------NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 291 -----------~~~--------------~-------~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
..+ + ..+.++++||++||+.||++|||+.|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 000 0 01467899999999999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=384.27 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=213.6
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCC--hhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN--RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
...++|.+.+.||+|+||.||+|.+..+|+.||+|++....... ......+.+|+.+++.++ ||||+++++++.+.+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKS 85 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTT
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCC
Confidence 34578999999999999999999999999999999987533211 111246789999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
..++||||+++ +|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKS 161 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGST
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEeccccee
Confidence 99999999986 888877654 358999999999999999999999999999999999999 5567899999999987
Q ss_pred cCCC-CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC-----
Q 014704 221 FKPG-DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP----- 292 (420)
Q Consensus 221 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----- 292 (420)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+..+...........
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 6432 33455689999999999853 488999999999999999999999999988877777765321111111
Q ss_pred -------------------CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 293 -------------------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 293 -------------------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+..++.++.+||++||+.||++|||+.|+|+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 14567899999999999999999999999999999754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=369.23 Aligned_cols=256 Identities=23% Similarity=0.326 Sum_probs=215.3
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+..+..+..||||+++++++.+.+.+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 356789999999999999999999999999999999875433 3345677889999999994499999999999999999
Q ss_pred EEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC--------------
Q 014704 144 NLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA-------------- 205 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-------------- 205 (420)
++||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999999765 6799999999999999999999999999999999999996433
Q ss_pred --CCCCeeEeecccccccCCCCceecccCCcccccchhhccc--CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014704 206 --EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAI 281 (420)
Q Consensus 206 --~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i 281 (420)
....+||+|||.+....... ...||+.|+|||++.+. ++.++||||||+++|+|++|.+|+.... ....+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~ 240 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI 240 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence 45579999999998765432 34699999999998654 5679999999999999999998875543 34445
Q ss_pred HcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
..+..... ...+++++.+||.+||+.||++|||+.++++||||+.
T Consensus 241 ~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 241 RQGRLPRI---PQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HTTCCCCC---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HcCCCCCC---CcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 55443221 2467999999999999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=388.30 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=203.1
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-- 140 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-- 140 (420)
-.+.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARS 102 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCc
Confidence 456689999999999999999999999999999999986532 34455678899999999999 99999999998654
Q ss_pred ----CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 141 ----HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 141 ----~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
..+|+|||++ +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG 177 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFG 177 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC--
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecc
Confidence 5689999999 7899887765 679999999999999999999999999999999999999 556789999999
Q ss_pred cccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID------- 287 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~------- 287 (420)
+++.... .....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+....+..+.+....
T Consensus 178 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 178 LARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9986543 2345689999999999864 5899999999999999999999999998877766665432110
Q ss_pred ----------------CCCC----CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 288 ----------------FSSD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 288 ----------------~~~~----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.+.. .++.+++++.+||++||+.||++|||+.|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0110 1245788999999999999999999999999999997543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=391.12 Aligned_cols=265 Identities=26% Similarity=0.417 Sum_probs=217.7
Q ss_pred cccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc-----CCCCccEE
Q 014704 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT-----GHRNIVEL 133 (420)
Q Consensus 59 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpniv~~ 133 (420)
..+...+..+|.+.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+. +|+||+++
T Consensus 89 ~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 89 QVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp CCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred ccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 344566788999999999999999999999999999999998642 344567888999999884 37799999
Q ss_pred EEEEEeCCeEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCee
Q 014704 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 134 ~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
++++...+.+++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ ...+|
T Consensus 165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~-~~~vk 242 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-RSGIK 242 (429)
T ss_dssp EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT-SCCEE
T ss_pred EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC-CcceE
Confidence 999999999999999996 58999887754 499999999999999999999999999999999999995321 13399
Q ss_pred EeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-
Q 014704 212 ATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS- 289 (420)
Q Consensus 212 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~- 289 (420)
|+|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+....+..+.......+
T Consensus 243 L~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 243 VIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp ECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred EeecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 999999976543 2345689999999999864 599999999999999999999999999888777665543100000
Q ss_pred -------------------------------------------------CCC-----CCCCChHHHHHHHHhcccCcCCC
Q 014704 290 -------------------------------------------------SDP-----WPNISSSAKDIVKKMLHADPKER 315 (420)
Q Consensus 290 -------------------------------------------------~~~-----~~~~~~~~~~li~~~L~~dp~~R 315 (420)
... ....++++.+||++||+.||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 000 01236789999999999999999
Q ss_pred CCHHHHhcCCcccccC
Q 014704 316 LSAAEVLNHPWMRVDG 331 (420)
Q Consensus 316 ~t~~e~l~h~~~~~~~ 331 (420)
||+.|+|+||||+...
T Consensus 401 pta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 401 MTPGQALRHPWLRRRL 416 (429)
T ss_dssp CCHHHHHTSTTTC---
T ss_pred CCHHHHhCChhhccCC
Confidence 9999999999998543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=387.79 Aligned_cols=255 Identities=28% Similarity=0.481 Sum_probs=212.0
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe----
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED---- 139 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~---- 139 (420)
...++|.+.+.||+|+||.||+|.+..+|+.||+|++..... ...+|+.+++.++ ||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLD-HVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCC-CTTBCCEEEEEEEC---
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcC-CCCccchhheeeecCcc
Confidence 345789999999999999999999999999999999865422 2237999999998 9999999999843
Q ss_pred ----------------------------------CCeEEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHH
Q 014704 140 ----------------------------------RHSVNLIMDLCAGGELFDRII----AKGHYSERAAANLCRQMVTVV 181 (420)
Q Consensus 140 ----------------------------------~~~~~iv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~qi~~al 181 (420)
...+++||||++| +|.+.+. ....+++..+..++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 3458999999985 7766554 356799999999999999999
Q ss_pred HHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHH
Q 014704 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVIL 259 (420)
Q Consensus 182 ~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil 259 (420)
.|||++||+||||||+|||++. .++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEET--TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcC--CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999999999999999999952 456799999999998766666667789999999998754 489999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcC-----------------CCCCCC---C-----CCCCCChHHHHHHHHhcccCcCC
Q 014704 260 YILLSGVPPFWGETEQSIFDAILRG-----------------HIDFSS---D-----PWPNISSSAKDIVKKMLHADPKE 314 (420)
Q Consensus 260 ~~ll~g~~pf~~~~~~~~~~~i~~~-----------------~~~~~~---~-----~~~~~~~~~~~li~~~L~~dp~~ 314 (420)
|+|++|..||.+.+..+.+..+... ...++. . ....+++++.+||.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999998887777666431 011111 0 11247889999999999999999
Q ss_pred CCCHHHHhcCCcccc
Q 014704 315 RLSAAEVLNHPWMRV 329 (420)
Q Consensus 315 R~t~~e~l~h~~~~~ 329 (420)
|||+.|+|+||||+.
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=389.48 Aligned_cols=256 Identities=29% Similarity=0.466 Sum_probs=211.1
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--- 140 (420)
....+|.+.+.||+|+||.||+|+++.+|+.||||++..... ...+|+++|+.++ ||||+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETT
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCCC
Confidence 345679999999999999999999999999999999865321 2347999999998 99999999988532
Q ss_pred ---CeEEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 141 ---HSVNLIMDLCAGGELFDRII----AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 141 ---~~~~iv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
..+++||||+.+ +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++. +...+||+
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~--~~~~~kl~ 199 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLC 199 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET--TTTEEEEC
T ss_pred CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC--CCCeEEec
Confidence 247799999976 6655553 3467999999999999999999999999999999999999962 34568999
Q ss_pred ecccccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------
Q 014704 214 DFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG------- 284 (420)
Q Consensus 214 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~------- 284 (420)
|||+++....+......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+....+..+.+.
T Consensus 200 DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 200 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp CCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999998765555566789999999999853 5899999999999999999999999998876666555431
Q ss_pred ----------CCCCCC---CC-----CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 285 ----------HIDFSS---DP-----WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 285 ----------~~~~~~---~~-----~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+.++. .. .+.+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 111111 01 13568999999999999999999999999999999754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=373.65 Aligned_cols=261 Identities=25% Similarity=0.462 Sum_probs=217.1
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED- 139 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~- 139 (420)
......++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.+++++..||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34556789999999999999999999999999999999986532 2346789999999999559999999999977
Q ss_pred -----CCeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeE
Q 014704 140 -----RHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212 (420)
Q Consensus 140 -----~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl 212 (420)
.+.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEE
Confidence 56899999999999999999764 569999999999999999999999999999999999999 45677999
Q ss_pred eecccccccCCCC-ceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q 014704 213 TDFGLSVFFKPGD-VFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285 (420)
Q Consensus 213 ~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 285 (420)
+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+....
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 9999988754322 234457999999999984 358899999999999999999999999888777666666543
Q ss_pred CCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 286 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.... ....++..+.+||.+||..||++|||+.++++||||+..
T Consensus 251 ~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 251 APRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 3221 224678999999999999999999999999999999743
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=381.02 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=207.8
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC---
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH--- 141 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~--- 141 (420)
+.++|.+.+.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence 3468999999999999999999999999999999997543 3345678999999999998 999999999986543
Q ss_pred ------------------------------------------------------eEEEEEecCCCCChHHHHHhcCC---
Q 014704 142 ------------------------------------------------------SVNLIMDLCAGGELFDRIIAKGH--- 164 (420)
Q Consensus 142 ------------------------------------------------------~~~iv~e~~~g~~L~~~l~~~~~--- 164 (420)
.+++|||||+|++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999987644
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-------------ceeccc
Q 014704 165 YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-------------VFKDLV 231 (420)
Q Consensus 165 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~ 231 (420)
.++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... ......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 5566789999999999999999999999999999999 456789999999998765432 223457
Q ss_pred CCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 232 gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
||+.|+|||++.+ .++.++||||||+++|+|++|..|+.. .......+....... .+...++++.+||.+||+.
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPL---LFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCH---HHHHHCHHHHHHHHHHHCS
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCc---ccccCChhHHHHHHHHccC
Confidence 9999999999864 589999999999999999998777522 222333333332211 1234567889999999999
Q ss_pred CcCCCCCHHHHhcCCcccc
Q 014704 311 DPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 311 dp~~R~t~~e~l~h~~~~~ 329 (420)
||++|||+.|+|+||||+.
T Consensus 313 ~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 313 SPTERPEATDIIENAIFEN 331 (332)
T ss_dssp SGGGSCCHHHHHHSTTCCC
T ss_pred CCCcCCCHHHHhhchhhhc
Confidence 9999999999999999963
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=387.05 Aligned_cols=257 Identities=30% Similarity=0.553 Sum_probs=217.8
Q ss_pred ccceeecceecccCCeEEEEEEEc---CCCceEEEEEecCCcCC-ChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.++|.+.+.||+|+||.||+|++. .+++.||||++...... .....+.+.+|+.+++.+.+||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 368999999999999999999984 57899999998653321 11233567789999999966999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCeec
Confidence 999999999999999999988899999999999999999999999999999999999999 55678999999999865
Q ss_pred CCCC--ceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCCCCCCCCC
Q 014704 222 KPGD--VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGE----TEQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 222 ~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~ 292 (420)
.... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||... ....+...+......++
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 286 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--- 286 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC---
Confidence 4322 2334679999999999863 3789999999999999999999999643 34455555555544433
Q ss_pred CCCCChHHHHHHHHhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
..++..+.+||.+||..||++|| |+.++++||||+.
T Consensus 287 -~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 287 -QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred -cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 46789999999999999999999 9999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=395.61 Aligned_cols=249 Identities=16% Similarity=0.190 Sum_probs=204.5
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc--CCCCccEEE-------E
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELK-------G 135 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpniv~~~-------~ 135 (420)
..++|.+.+.||+|+||.||+|.++.+|+.||||++...........+.+.+|+.+++.+. .||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3578999999999999999999999999999999998655555566788999995554443 399999998 7
Q ss_pred EEEeCCe-----------------EEEEEecCCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCCee
Q 014704 136 AYEDRHS-----------------VNLIMDLCAGGELFDRIIAKGHYSE-------RAAANLCRQMVTVVHYCHSMGVMH 191 (420)
Q Consensus 136 ~~~~~~~-----------------~~iv~e~~~g~~L~~~l~~~~~~~~-------~~~~~i~~qi~~al~~lH~~~ivH 191 (420)
++++.+. .|+||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 7776643 88999999 6799999987655655 788889999999999999999999
Q ss_pred ccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecccCCcccccchhhcc------------cCCCccchhhhHHHH
Q 014704 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR------------NYGAEADIWSAGVIL 259 (420)
Q Consensus 192 ~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~DvwslGvil 259 (420)
|||||+|||+ +.++.+||+|||+++... ......+| +.|+|||++.+ .++.++|||||||++
T Consensus 230 rDikp~NIll---~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 230 TYLRPVDIVL---DQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp SCCCGGGEEE---CTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred CCCCHHHEEE---cCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999 456789999999998643 34456678 99999999864 589999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 260 YILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 260 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
|+|++|+.||.+.........+. ..+..+++++.+||.+||+.||++|||+.++|+||||+
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred HHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 99999999997655433322222 22357899999999999999999999999999999996
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=378.29 Aligned_cols=261 Identities=24% Similarity=0.399 Sum_probs=216.5
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH- 141 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~- 141 (420)
....++|.+.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTT 81 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTT
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCC
Confidence 3456789999999999999999999999999999999875432 234577889999999999 999999999998765
Q ss_pred -eEEEEEecCCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEec-CCCCCCeeEeecc
Q 014704 142 -SVNLIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS-SAEDSPLKATDFG 216 (420)
Q Consensus 142 -~~~iv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~-~~~~~~~kl~Dfg 216 (420)
.+++||||++|++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||+.. .+.+..+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 78999999999999999976543 999999999999999999999999999999999999743 2345569999999
Q ss_pred cccccCCCCceecccCCcccccchhhc---------ccCCCccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHc
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR---------RNYGAEADIWSAGVILYILLSGVPPFWGET----EQSIFDAILR 283 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DvwslGvil~~ll~g~~pf~~~~----~~~~~~~i~~ 283 (420)
++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.... ....+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 999877666666778999999999874 458999999999999999999999996432 3455555554
Q ss_pred CCCCC-------------------C--CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCc
Q 014704 284 GHIDF-------------------S--SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326 (420)
Q Consensus 284 ~~~~~-------------------~--~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 326 (420)
+.... + ......++..+.+||++||+.||++|||+.|+|+||-
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 43211 0 0111223467889999999999999999999999963
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=367.11 Aligned_cols=258 Identities=26% Similarity=0.458 Sum_probs=225.1
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...+.|.+.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.+. ||||+++++++.+...+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeE
Confidence 345679999999999999999999999999999999875432 345678999999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+||||++|++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBT
T ss_pred EEEEEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCc
Confidence 99999999999998875 4679999999999999999999999999999999999999 4567899999999987654
Q ss_pred CC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 GD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+....... ....++..+.
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~ 248 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLK 248 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CCSSCCHHHH
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---CccccCHHHH
Confidence 33 2345679999999999864 58999999999999999999999999888877777766654322 2246789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
+||.+||+.||++|||+.++++||||....
T Consensus 249 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 249 EFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 999999999999999999999999997543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=369.19 Aligned_cols=258 Identities=23% Similarity=0.297 Sum_probs=199.5
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+..+...++.+. ||||+++++++.+.+..
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSSE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCC-CCeEEEEeeeeeccCCE
Confidence 445789999999999999999999999999999999865422 2222333444444566666 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 144 NLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
++||||++| +|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||++
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC---
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCc
Confidence 999999975 87766643 46799999999999999999999998 99999999999999 45678999999999
Q ss_pred cccCCCCceecccCCcccccchhhc-----ccCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcC-CCCCCCC
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLR-----RNYGAEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRG-HIDFSSD 291 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwslGvil~~ll~g~~pf~~-~~~~~~~~~i~~~-~~~~~~~ 291 (420)
.............||+.|+|||++. ..++.++||||+|+++|+|++|..||.. ............. ....+
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 235 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP-- 235 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC--
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc--
Confidence 8776555545568999999999962 3588999999999999999999999976 3344444444433 22222
Q ss_pred CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 292 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
...+++++.+||.+||+.||++|||+.|+++||||+..
T Consensus 236 -~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 236 -ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp -TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 24679999999999999999999999999999999754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=367.55 Aligned_cols=258 Identities=29% Similarity=0.582 Sum_probs=220.0
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
+.++|.+.+.||+|+||.||+|.++.+++.||+|++..... ....+.+.+|+.+++.++ ||||+++++++.+.+..|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEE
Confidence 34689999999999999999999999999999999865432 234578999999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCC
Confidence 999999999999998777789999999999999999999999999999999999999 45677999999999765432
Q ss_pred C---ceecccCCcccccchhhcc-c-CCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCCCh
Q 014704 225 D---VFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 225 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
. ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||.+.... ..+..+....... ..+..+++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKIDS 236 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS--TTGGGSCH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc--CchhhcCH
Confidence 2 2345679999999999864 3 477899999999999999999999876543 2333444332222 23457899
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+.+||.+||+.||++|||+.|+++||||+..
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 99999999999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=388.92 Aligned_cols=262 Identities=27% Similarity=0.488 Sum_probs=198.4
Q ss_pred cccccceee-cceecccCCeEEEEEEEc--CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 63 EDVRNTYIF-GRELGRGQFGVTYLVTHK--DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 63 ~~~~~~y~~-~~~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
+.+.+.|.+ +++||+|+||.||+|.++ .+++.||+|++..... ...+.+|+.+|+.++ ||||+++++++.+
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~-hpniv~~~~~~~~ 89 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFLS 89 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCC-CTTBCCCCEEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcC-CCCeeeEeeEEec
Confidence 456677887 668999999999999976 4688999999865432 246889999999999 9999999999954
Q ss_pred --CCeEEEEEecCCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecC-CCC
Q 014704 140 --RHSVNLIMDLCAGGELFDRIIAK---------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS-AED 207 (420)
Q Consensus 140 --~~~~~iv~e~~~g~~L~~~l~~~---------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~ 207 (420)
...+|+||||+.| +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+... +.+
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 7789999999964 887777532 249999999999999999999999999999999999999643 356
Q ss_pred CCeeEeecccccccCCC----CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHH------
Q 014704 208 SPLKATDFGLSVFFKPG----DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQ------ 275 (420)
Q Consensus 208 ~~~kl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~------ 275 (420)
+.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 78999999999876432 22345689999999999864 4899999999999999999999999776542
Q ss_pred ---HHHHHHHcCCCCCCCCCCC----------------------------------CCChHHHHHHHHhcccCcCCCCCH
Q 014704 276 ---SIFDAILRGHIDFSSDPWP----------------------------------NISSSAKDIVKKMLHADPKERLSA 318 (420)
Q Consensus 276 ---~~~~~i~~~~~~~~~~~~~----------------------------------~~~~~~~~li~~~L~~dp~~R~t~ 318 (420)
..+..+...........|. ..++.+.+||++||+.||++|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 3333333221111111121 227789999999999999999999
Q ss_pred HHHhcCCcccccC
Q 014704 319 AEVLNHPWMRVDG 331 (420)
Q Consensus 319 ~e~l~h~~~~~~~ 331 (420)
.|+|+||||+...
T Consensus 329 ~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 329 EQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHTSGGGTSSS
T ss_pred HHHhcChhhccCC
Confidence 9999999997543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=380.95 Aligned_cols=259 Identities=26% Similarity=0.387 Sum_probs=218.9
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+...++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCE
Confidence 445678999999999999999999999999999999987542 4455678999999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+|+||||++|++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+||++ +.++.+||+|||++...
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCccc
Confidence 999999999999999999888999999999999999999999996 99999999999999 45677999999998754
Q ss_pred CCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--------------------
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDA-------------------- 280 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~-------------------- 280 (420)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........
T Consensus 183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 183 IDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 321 2244579999999999865 589999999999999999999999987665443221
Q ss_pred ----------------------HHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 281 ----------------------ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 281 ----------------------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+..... +......++.++.+||++||+.||++|||+.|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 222111 111123478899999999999999999999999999999753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=381.78 Aligned_cols=259 Identities=29% Similarity=0.471 Sum_probs=217.0
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC---
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--- 140 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--- 140 (420)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++... ........+.+|++++++++ ||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE 100 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCcc
Confidence 4557899999999999999999999999999999998642 23445678999999999998 99999999999765
Q ss_pred --CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 141 --HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 141 --~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
..+|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA 175 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred ccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcce
Confidence 47899999997 489888865 579999999999999999999999999999999999999 55677999999999
Q ss_pred cccCCCCc----eecccCCcccccchhhc-c-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----
Q 014704 219 VFFKPGDV----FKDLVGSAYYVAPEVLR-R-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF---- 288 (420)
Q Consensus 219 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---- 288 (420)
........ ....+||+.|+|||++. . .++.++|||||||++|+|++|..||.+......+..+.......
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 87643321 24458999999999864 3 48999999999999999999999999887666665554211000
Q ss_pred ----------------C---C----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 289 ----------------S---S----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 289 ----------------~---~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+ . ..++.+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0 0 0124678999999999999999999999999999999754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=368.97 Aligned_cols=263 Identities=24% Similarity=0.382 Sum_probs=213.0
Q ss_pred cccccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE
Q 014704 57 VLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (420)
Q Consensus 57 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 136 (420)
..+...+...++|.+.+.||+|+||+||+|.+ +|+.||+|++..... .....+.+.+|+.++++++ ||||++++++
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~ 102 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGA 102 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEE
Confidence 33444555678999999999999999999987 478899999875543 4555678999999999999 9999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCCCCCCee
Q 014704 137 YEDRHSVNLIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 137 ~~~~~~~~iv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
+.+...+++||||++|++|.+++...+. +++..+..++.||+.||.|||++| |+||||||+||++ +.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~k 179 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVK 179 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEE
T ss_pred EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEE
Confidence 9999999999999999999999986553 999999999999999999999999 9999999999999 5667899
Q ss_pred EeecccccccCCCC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 014704 212 ATDFGLSVFFKPGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (420)
Q Consensus 212 l~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 289 (420)
|+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+........
T Consensus 180 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 180 VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259 (309)
T ss_dssp ECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred ECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 99999997654332 2345679999999999865 589999999999999999999999999888887777754443332
Q ss_pred CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc--CCccc
Q 014704 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN--HPWMR 328 (420)
Q Consensus 290 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~ 328 (420)
. ...+++++.+||.+||+.||++|||+.++++ ++|++
T Consensus 260 ~--~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 260 I--PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp C--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred C--CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 2 2468999999999999999999999999987 44544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=370.43 Aligned_cols=258 Identities=28% Similarity=0.553 Sum_probs=219.4
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC-ChhhHHHHHHHHHHHHhccCCCCccEEEEEE--EeCC
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAY--EDRH 141 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~--~~~~ 141 (420)
+.++|.+.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++ ||||+++++++ .+..
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence 457899999999999999999999999999999998754321 1234578999999999998 99999999998 4556
Q ss_pred eEEEEEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+|+||||+.++ |.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeecccccc
Confidence 899999999876 7777765 3569999999999999999999999999999999999999 456789999999998
Q ss_pred ccCC---CCceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 014704 220 FFKP---GDVFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (420)
Q Consensus 220 ~~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 293 (420)
.... ........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+...++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--- 234 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG--- 234 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS---
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC---
Confidence 7643 223345679999999999864 2477999999999999999999999999988888888887665543
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.+++.+.+||.+||..||++|||+.++++||||+...
T Consensus 235 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 235 -DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp -SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred -ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 6789999999999999999999999999999997543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=368.00 Aligned_cols=260 Identities=28% Similarity=0.476 Sum_probs=218.2
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGK 90 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-C
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCe
Confidence 45668899999999999999999999999999999998643 2345678999999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCccc
Confidence 9999999999999998875 4669999999999999999999999999999999999999 45677999999987543
Q ss_pred CCC-CceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 222 KPG-DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 222 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
... .......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......... ...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 246 (302)
T 2j7t_A 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL-TPS 246 (302)
T ss_dssp HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS-SGG
T ss_pred cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccC-Ccc
Confidence 211 1123457899999999873 35789999999999999999999999998887777777665433221 124
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.++.++.+||.+||..||++|||+.++++||||+..
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 578899999999999999999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=380.55 Aligned_cols=264 Identities=26% Similarity=0.418 Sum_probs=218.4
Q ss_pred cccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCC-----ccEE
Q 014704 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN-----IVEL 133 (420)
Q Consensus 59 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn-----iv~~ 133 (420)
....+.+.++|.+.+.||+|+||+||+|.++.+++.||||++... ......+.+|+.+++.+..|++ |+++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 345566788999999999999999999999999999999998642 3445678889999998875664 9999
Q ss_pred EEEEEeCCeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCCeeccCCCCcEEEecCCCCCC
Q 014704 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCH--SMGVMHRDLKPENFLFSSSAEDSP 209 (420)
Q Consensus 134 ~~~~~~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nill~~~~~~~~ 209 (420)
++++...+.+|+||||+.| +|.+++... +.+++..+..++.||+.||.||| +.||+||||||+|||+.. +.++.
T Consensus 122 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~ 199 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSA 199 (382)
T ss_dssp EEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCC
T ss_pred eeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCc
Confidence 9999999999999999964 999998875 45999999999999999999999 579999999999999953 23567
Q ss_pred eeEeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Q 014704 210 LKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDF 288 (420)
Q Consensus 210 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 288 (420)
+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+....+..+.......
T Consensus 200 ~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp EEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999999987643 2345689999999999865 58999999999999999999999999988877777665421100
Q ss_pred C------------------CCCC-----------------CC-------------------------CChHHHHHHHHhc
Q 014704 289 S------------------SDPW-----------------PN-------------------------ISSSAKDIVKKML 308 (420)
Q Consensus 289 ~------------------~~~~-----------------~~-------------------------~~~~~~~li~~~L 308 (420)
+ ...| .. .++++.+||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 0 0000 00 0137899999999
Q ss_pred ccCcCCCCCHHHHhcCCccccc
Q 014704 309 HADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 309 ~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+.||++|||+.|+|+||||+..
T Consensus 358 ~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGGCC-
T ss_pred CCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=377.77 Aligned_cols=253 Identities=24% Similarity=0.395 Sum_probs=216.1
Q ss_pred ccccceeecceecccCCeEEEEEEEc-------CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHK-------DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 136 (420)
...++|.+++.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+..||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 34578999999999999999999975 245679999986542 345567899999999999449999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 014704 137 YEDRHSVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200 (420)
Q Consensus 137 ~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil 200 (420)
+.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 999999999999999999999998653 4789999999999999999999999999999999999
Q ss_pred EecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHH
Q 014704 201 FSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQ 275 (420)
Q Consensus 201 l~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~ 275 (420)
+ +.++.+||+|||++........ .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....
T Consensus 236 l---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 236 V---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp E---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred E---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9 5667899999999987654322 233467889999998864 58999999999999999999 99999998888
Q ss_pred HHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 276 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
++...+..+.... ....++.++.++|.+||+.||++|||+.|++++
T Consensus 313 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 313 ELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GHHHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8887777654321 224678999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=379.05 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=222.6
Q ss_pred cccccceeecceecccCCeEEEEEEE-----cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTH-----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
+...++|.+.+.||+|+||.||+|.+ ..+++.||||++... ........+.+|+.++++++ ||||+++++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~ 143 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVS 143 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCC-CCCCCeEEEEE
Confidence 34467899999999999999999994 456789999998642 24555677899999999998 99999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCe
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKG-------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~ 210 (420)
.+....|+|||||+||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+..+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999997653 48999999999999999999999999999999999999765566779
Q ss_pred eEeecccccccCC---CCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 014704 211 KATDFGLSVFFKP---GDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285 (420)
Q Consensus 211 kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~ 285 (420)
||+|||+++.... ........||+.|+|||++. ..++.++|||||||++|+|++ |..||.+.........+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999975421 12233456899999999885 568999999999999999998 999999999988888888765
Q ss_pred CCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 286 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.... ...++..+.+||.+||+.||++|||+.+++++.|+.
T Consensus 304 ~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 RMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3322 246789999999999999999999999999987764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=362.72 Aligned_cols=257 Identities=26% Similarity=0.477 Sum_probs=221.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCeE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHSV 143 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--~~~~ 143 (420)
.++|++.+.||+|+||.||+|.++.+++.||+|.+..... .....+.+.+|+.++++++ ||||+++++++.+ ...+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceE
Confidence 4689999999999999999999999999999999976543 4456678999999999998 9999999998754 6789
Q ss_pred EEEEecCCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeccCCCCcEEEecCCCCCCeeEee
Q 014704 144 NLIMDLCAGGELFDRIIAK----GHYSERAAANLCRQMVTVVHYCHSMG-----VMHRDLKPENFLFSSSAEDSPLKATD 214 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~Nill~~~~~~~~~kl~D 214 (420)
|+||||++|++|.+++... ..+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEec
Confidence 9999999999999998753 34999999999999999999999999 9999999999999 5567899999
Q ss_pred cccccccCCCCc-eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 014704 215 FGLSVFFKPGDV-FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 215 fg~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 292 (420)
||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--- 236 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI--- 236 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC---
Confidence 999987654322 234578999999999864 589999999999999999999999999888888888887765322
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
...++.++.++|.+||+.||++|||+.++|+|+|+...
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 23678999999999999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=379.04 Aligned_cols=259 Identities=30% Similarity=0.475 Sum_probs=215.2
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
..-.+.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+++.++ ||||+++++++...
T Consensus 36 ~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 113 (371)
T 4exu_A 36 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPA 113 (371)
T ss_dssp EEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred ceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheecc
Confidence 33457789999999999999999999999999999999987543 24455678899999999999 99999999999877
Q ss_pred CeE------EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEee
Q 014704 141 HSV------NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (420)
Q Consensus 141 ~~~------~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~D 214 (420)
+.. |+||||+. ++|.+.+ ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~D 187 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILD 187 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECS
T ss_pred CCcccceeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEe
Confidence 654 99999997 5887766 3459999999999999999999999999999999999999 5667899999
Q ss_pred cccccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----
Q 014704 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID----- 287 (420)
Q Consensus 215 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~----- 287 (420)
||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 188 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 188 FGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp TTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 999986543 2345689999999999864 5899999999999999999999999998877766665431100
Q ss_pred ------------------CCC----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 288 ------------------FSS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 288 ------------------~~~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
... ..++.+++++.+||++||+.||++|||+.|+|+||||+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 000 012467899999999999999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=369.52 Aligned_cols=263 Identities=25% Similarity=0.406 Sum_probs=217.7
Q ss_pred ccccceeecceecccCCeEEEEEEEc-CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc--CCCCccEEEEEEE--
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHK-DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYE-- 138 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpniv~~~~~~~-- 138 (420)
...++|.+.+.||+|+||.||+|.+. .+|+.||+|++..... .......+.+|+.+++.+. .||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc-cccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34578999999999999999999995 6788999999875432 1222235667888887773 3999999999987
Q ss_pred ---eCCeEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 139 ---DRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 139 ---~~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
....+++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEe
Confidence 5677999999997 59999988754 49999999999999999999999999999999999999 456789999
Q ss_pred ecccccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----C
Q 014704 214 DFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI-----D 287 (420)
Q Consensus 214 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~-----~ 287 (420)
|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+......+..+..... .
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 999998765444455678999999999986 4589999999999999999999999999888777776654210 0
Q ss_pred CC------------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 288 FS------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 288 ~~------------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
++ ...++.++..+++||.+||..||++|||+.++|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 00 012346789999999999999999999999999999997543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=369.17 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=215.5
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCc---eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
+...++|.+.+.||+|+||.||+|.+..+++ .||||++.... .....+.+.+|+.+++.++ ||||+++++++.+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 121 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTR 121 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 3445789999999999999999999986655 49999986432 4455678999999999998 9999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
.+.+|+||||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcc
Confidence 99999999999999999999755 579999999999999999999999999999999999999 56678999999999
Q ss_pred cccCCCC----ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 014704 219 VFFKPGD----VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 219 ~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 292 (420)
....... ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..+.... .
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 275 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---A 275 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---C
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---C
Confidence 8765332 112334678899999986 468999999999999999999 999999999988888887763221 2
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
...+++.+.+||.+||..||++|||+.++++
T Consensus 276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2468999999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=384.85 Aligned_cols=258 Identities=17% Similarity=0.195 Sum_probs=198.0
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc-CCCCccEEE-------EEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT-GHRNIVELK-------GAY 137 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~hpniv~~~-------~~~ 137 (420)
...|.+.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.|. .||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345999999999999999999999999999999998765444556678888966555554 399988755 555
Q ss_pred EeC-----------------CeEEEEEecCCCCChHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHHcCCeecc
Q 014704 138 EDR-----------------HSVNLIMDLCAGGELFDRIIAKG-HYSERAA------ANLCRQMVTVVHYCHSMGVMHRD 193 (420)
Q Consensus 138 ~~~-----------------~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~------~~i~~qi~~al~~lH~~~ivH~D 193 (420)
... ..+|+|||||+ ++|.+++...+ .+.+... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 543 33899999998 79999997642 3444444 57779999999999999999999
Q ss_pred CCCCcEEEecCCCCCCeeEeecccccccCCCCceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCC
Q 014704 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFW 270 (420)
Q Consensus 194 lkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~ 270 (420)
|||+|||+ +.++.+||+|||+++.... ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.
T Consensus 220 ikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFI---MPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEE---CTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEE---CCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999 5567899999999987642 2235567899999999864 58999999999999999999999997
Q ss_pred CCCHHHH--HHH---HHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 271 GETEQSI--FDA---ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 271 ~~~~~~~--~~~---i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+...... +.. .......+....++.+++++.+||.+||+.||++|||+.++|+||||+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 7643210 000 1111223333344678999999999999999999999999999999963
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=382.93 Aligned_cols=260 Identities=23% Similarity=0.450 Sum_probs=223.3
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChh--------------hHHHHHHHHHHHHhccCCC
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD--------------DVEDVRREVQIMHHLTGHR 128 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~~hp 128 (420)
....++|.+.+.||+|+||.||+|.+ +|+.||+|++......... ..+.+.+|+.++++++ ||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ 103 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NE 103 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CC
Confidence 34557899999999999999999999 7899999998754322211 1278999999999998 99
Q ss_pred CccEEEEEEEeCCeEEEEEecCCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcE
Q 014704 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDR------IIA--KGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENF 199 (420)
Q Consensus 129 niv~~~~~~~~~~~~~iv~e~~~g~~L~~~------l~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Ni 199 (420)
||+++++++.+.+.+|+||||++|++|.++ +.. ...+++..+..++.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999887 655 5679999999999999999999999 9999999999999
Q ss_pred EEecCCCCCCeeEeecccccccCCCCceecccCCcccccchhhccc--CCC-ccchhhhHHHHHHHHhCCCCCCCCCH-H
Q 014704 200 LFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRRN--YGA-EADIWSAGVILYILLSGVPPFWGETE-Q 275 (420)
Q Consensus 200 ll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DvwslGvil~~ll~g~~pf~~~~~-~ 275 (420)
++ +.++.+||+|||++...... ......||+.|+|||++.+. ++. ++||||||+++|+|++|..||..... .
T Consensus 184 l~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 99 55678999999999876443 44566899999999998643 555 99999999999999999999988776 7
Q ss_pred HHHHHHHcCCCCCCCCC---------------CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 276 SIFDAILRGHIDFSSDP---------------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 276 ~~~~~i~~~~~~~~~~~---------------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.....+..+...++... ...++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 77788877766555321 1468899999999999999999999999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=365.03 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=215.2
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...++|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ..+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence 35578999999999999999999999999999999986532 3467899999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRII-AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|+||||+++++|.+++. ....+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhh
Confidence 99999999999999986 45679999999999999999999999999999999999999 456779999999997764
Q ss_pred CCC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 223 PGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 223 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+....... ......++..+
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 255 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT-FRKPELWSDNF 255 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGGSCHHH
T ss_pred hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc-cCCcccCCHHH
Confidence 432 2345579999999999864 58999999999999999999999998887766665555443211 11123568999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.+||.+||..||.+|||+.++|+||||+..
T Consensus 256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 256 TDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 999999999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=369.29 Aligned_cols=263 Identities=28% Similarity=0.479 Sum_probs=199.1
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.....++|.+.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKD 86 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSS
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecC
Confidence 34456789999999999999999999998999999999865432 234567889999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 142 SVNLIMDLCAGGELFDRIIA--------KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~--------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
..++||||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEE
Confidence 99999999999999998874 4569999999999999999999999999999999999999 456789999
Q ss_pred ecccccccCCCC------ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q 014704 214 DFGLSVFFKPGD------VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285 (420)
Q Consensus 214 Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 285 (420)
|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||................
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 999987654321 1234579999999999863 58999999999999999999999998877665555554433
Q ss_pred CCCC------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 286 IDFS------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 286 ~~~~------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.... ...+..++.++.+||.+||+.||++|||+.++++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 2211 12235678999999999999999999999999999999743
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=369.81 Aligned_cols=262 Identities=26% Similarity=0.423 Sum_probs=217.3
Q ss_pred ccccccccceeecceecccCCeEEEEEEE-cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCC------CccE
Q 014704 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTH-KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR------NIVE 132 (420)
Q Consensus 60 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp------niv~ 132 (420)
..++.+.++|.+.+.||+|+||.||+|.+ +.+++.||+|++... ....+.+.+|+.+++.+. |+ +|++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~ 81 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLN-TTDPNSTFRCVQ 81 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHH-HHCTTCTTCBCC
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhh-hcCCCCceeeEe
Confidence 45567788999999999999999999998 567899999998642 344577899999999987 55 5999
Q ss_pred EEEEEEeCCeEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC----
Q 014704 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE---- 206 (420)
Q Consensus 133 ~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~---- 206 (420)
+++++.+.+.+++||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++..+.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 889999998765 6899999999999999999999999999999999999964221
Q ss_pred ------------CCCeeEeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 014704 207 ------------DSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET 273 (420)
Q Consensus 207 ------------~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~ 273 (420)
+..+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred CCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 56799999999986543 2345689999999999865 58999999999999999999999999888
Q ss_pred HHHHHHHHHcCCCCCCC----------------CCC------------------------CCCChHHHHHHHHhcccCcC
Q 014704 274 EQSIFDAILRGHIDFSS----------------DPW------------------------PNISSSAKDIVKKMLHADPK 313 (420)
Q Consensus 274 ~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~~~~~~~li~~~L~~dp~ 313 (420)
.......+......++. ..| ...++++.+||.+||+.||+
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 76655544322111110 001 11246788999999999999
Q ss_pred CCCCHHHHhcCCcccc
Q 014704 314 ERLSAAEVLNHPWMRV 329 (420)
Q Consensus 314 ~R~t~~e~l~h~~~~~ 329 (420)
+|||+.|+|+||||+.
T Consensus 319 ~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 319 KRITLREALKHPFFDL 334 (339)
T ss_dssp TSCCHHHHTTSGGGGG
T ss_pred cccCHHHHhcCHHHHH
Confidence 9999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=370.61 Aligned_cols=263 Identities=30% Similarity=0.483 Sum_probs=214.2
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE--
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE-- 138 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~-- 138 (420)
++..+.++|.+.+.||+|+||.||+|.+..+++.||+|++... +....+.+.+|+.+++.++ ||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPS 80 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTT
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEecccc
Confidence 3456778999999999999999999999999999999998643 3456678999999999998 999999999873
Q ss_pred ------------eCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC
Q 014704 139 ------------DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206 (420)
Q Consensus 139 ------------~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~ 206 (420)
+...+|+||||+. ++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+||+++. +
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~ 156 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--E 156 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--T
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--C
Confidence 4468899999997 59988875 467999999999999999999999999999999999999962 4
Q ss_pred CCCeeEeecccccccCCC----CceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 014704 207 DSPLKATDFGLSVFFKPG----DVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDA 280 (420)
Q Consensus 207 ~~~~kl~Dfg~~~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~ 280 (420)
+..+||+|||++...... .......+|+.|+|||++. ..++.++||||||+++|+|++|..||.+.........
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 236 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL 236 (320)
T ss_dssp TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 567999999999876432 1223456799999999874 4589999999999999999999999999887777666
Q ss_pred HHcCCCCC----------------------CC----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 281 ILRGHIDF----------------------SS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 281 i~~~~~~~----------------------~~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
+....... +. ..++.++.++.+||++||+.||++|||+.++|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 65432111 00 01246899999999999999999999999999999998543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=370.70 Aligned_cols=261 Identities=28% Similarity=0.448 Sum_probs=216.5
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR-- 140 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-- 140 (420)
..+.++|.+.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFK-HENIITIFNIQRPDSF 83 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCS
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCc-CCCcCCeeeeeccccc
Confidence 45678999999999999999999999999999999998642 23445677889999999998 99999999988654
Q ss_pred ---CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 141 ---HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 141 ---~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
...|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGL 158 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTT
T ss_pred CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEeccc
Confidence 67999999997 589888765 579999999999999999999999999999999999999 4567799999999
Q ss_pred ccccCCCC-----------ceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Q 014704 218 SVFFKPGD-----------VFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG 284 (420)
Q Consensus 218 ~~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~ 284 (420)
+....... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 98764321 122357899999999874 45899999999999999999999999988876655544321
Q ss_pred --CC----------------------CCCCC----CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 285 --HI----------------------DFSSD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 285 --~~----------------------~~~~~----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.. ..+.. .++.+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00 00000 1246789999999999999999999999999999997644
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=375.37 Aligned_cols=259 Identities=27% Similarity=0.362 Sum_probs=203.2
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe--
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS-- 142 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~-- 142 (420)
..++|.+.+.||+|+||.||+|.++.+|+.||||++..... ......++++.+..++ ||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcC-CCCcccHHHhhhcccccc
Confidence 34689999999999999999999999999999999865432 2235667888888888 9999999999865443
Q ss_pred -----EEEEEecCCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--HcCCeeccCCCCcEEEecCCCCCCee
Q 014704 143 -----VNLIMDLCAGGELFDRII----AKGHYSERAAANLCRQMVTVVHYCH--SMGVMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 143 -----~~iv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
+++||||+.+ +|.+.+. ....+++..+..++.|++.||.||| ++||+||||||+|||++. .++.+|
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE--ADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET--TTTEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC--CCCcEE
Confidence 8899999986 4444333 4567999999999999999999999 999999999999999952 356799
Q ss_pred EeecccccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Q 014704 212 ATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS 289 (420)
Q Consensus 212 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 289 (420)
|+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+.+.....+
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 999999998776665566789999999998853 489999999999999999999999999888777776654211000
Q ss_pred ----------------------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 290 ----------------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 290 ----------------------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.......++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 001122567899999999999999999999999999998653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=362.85 Aligned_cols=254 Identities=28% Similarity=0.496 Sum_probs=211.4
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-----
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----- 139 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~----- 139 (420)
+.++|.+.+.||+|+||.||+|.+..+++.||+|++.. .....+.+.+|+.+++.++ ||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence 45789999999999999999999999999999999854 2345678999999999998 9999999998865
Q ss_pred --------CCeEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCe
Q 014704 140 --------RHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (420)
Q Consensus 140 --------~~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~ 210 (420)
...+|+||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~ 155 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV 155 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCE
Confidence 457899999999999999998654 57889999999999999999999999999999999999 556779
Q ss_pred eEeecccccccCCC---------------CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCC-C
Q 014704 211 KATDFGLSVFFKPG---------------DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWG-E 272 (420)
Q Consensus 211 kl~Dfg~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~-~ 272 (420)
||+|||++...... .......||+.|+|||++.+ .++.++||||||+++|+|++ ||.. .
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 99999999865421 12234579999999999864 58999999999999999998 5543 2
Q ss_pred CHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 273 TEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 273 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
........+......++.......+..+.++|++||+.||.+|||+.++++||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 344556666666666666555677888999999999999999999999999999974
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=371.73 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=219.0
Q ss_pred cccccceeecceecccCCeEEEEEEEcCC-------CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDT-------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKG 135 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 135 (420)
+...++|.+++.||+|+||.||+|.+..+ +..||+|++... ........+.+|+++++++..||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 45568999999999999999999997543 357999998654 245566789999999999944999999999
Q ss_pred EEEeCCeEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 014704 136 AYEDRHSVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (420)
Q Consensus 136 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 199 (420)
++.+.+.+++||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998754 499999999999999999999999999999999999
Q ss_pred EEecCCCCCCeeEeecccccccCCCC---ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCH
Q 014704 200 LFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETE 274 (420)
Q Consensus 200 ll~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~ 274 (420)
|+ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+...
T Consensus 223 ll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 223 LV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp EE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99 556789999999998765432 2234467889999998864 58999999999999999999 9999999998
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 275 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.++...+..+..... ...+++++.+||.+||+.||++|||+.+++++
T Consensus 300 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 300 EELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 888888777643222 24689999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=363.38 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=198.5
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.....++|.+.+.||+|+||.||+|.++.+|+.||||++..... .....+.+..+..+++.+. ||||+++++++.+.+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHD-CPYIVQCFGTFITNT 97 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSS
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCC
Confidence 33445789999999999999999999999999999999975432 2222333444555667776 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+|+||||+ ++.+...... .+.+++..+..++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||++.
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISG 173 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC-
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCch
Confidence 999999999 5555554443 46799999999999999999999995 99999999999999 556789999999998
Q ss_pred ccCCCCceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCCCC
Q 014704 220 FFKPGDVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWG-ETEQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~ 292 (420)
............||+.|+|||++. ..++.++||||||+++|+|++|..||.. ......+..+......... .
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 252 (318)
T 2dyl_A 174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP-G 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC-S
T ss_pred hccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC-c
Confidence 765555455667999999999984 3488999999999999999999999987 4455666666665433222 2
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
...+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 3468999999999999999999999999999999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=379.44 Aligned_cols=262 Identities=24% Similarity=0.425 Sum_probs=209.2
Q ss_pred ccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccC-------CCCccE
Q 014704 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG-------HRNIVE 132 (420)
Q Consensus 60 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-------hpniv~ 132 (420)
..++.+.++|.+.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.+.+ ||||++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 33455678999999999999999999999999999999998642 3455778999999999962 788999
Q ss_pred EEEEEE----eCCeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEecCC
Q 014704 133 LKGAYE----DRHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSA 205 (420)
Q Consensus 133 ~~~~~~----~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~ 205 (420)
+++++. +...+|+||||+ +++|.+.+... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 999987 566899999999 56777777654 4699999999999999999999998 999999999999996322
Q ss_pred ----------------------------------------------CCCCeeEeecccccccCCCCceecccCCcccccc
Q 014704 206 ----------------------------------------------EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239 (420)
Q Consensus 206 ----------------------------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aP 239 (420)
....+||+|||++...... ....+||+.|+||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aP 262 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCH
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCC
Confidence 1137999999999876432 3456899999999
Q ss_pred hhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHc------------CCCC---CCC-------
Q 014704 240 EVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET------EQSIFDAILR------------GHID---FSS------- 290 (420)
Q Consensus 240 E~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~------~~~~~~~i~~------------~~~~---~~~------- 290 (420)
|++.+ .++.++|||||||++|+|++|..||.+.+ ....+..+.. +... +..
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 99864 58999999999999999999999997654 2222222211 0000 000
Q ss_pred ----------------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 291 ----------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 291 ----------------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
......+..+.+||.+||+.||++|||+.|+|+||||+
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 00012245688999999999999999999999999996
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=370.01 Aligned_cols=256 Identities=30% Similarity=0.487 Sum_probs=212.9
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe-
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS- 142 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~- 142 (420)
.+.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+++.++ ||||+++++++.+...
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL 98 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccccc
Confidence 45688999999999999999999999999999999986533 24445678899999999999 9999999999987654
Q ss_pred -----EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 143 -----VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 143 -----~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
+|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGL 172 (353)
T ss_dssp GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTC
T ss_pred ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccc
Confidence 599999997 58877663 459999999999999999999999999999999999999 5567899999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH---------- 285 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~---------- 285 (420)
+...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+....+..+.+..
T Consensus 173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 9865432 345678999999998864 58999999999999999999999999888766666554310
Q ss_pred -------------CCC----CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 286 -------------IDF----SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 286 -------------~~~----~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
... ....++.+++++.+||.+||+.||++|||+.++|+||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 000 01123567899999999999999999999999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=367.02 Aligned_cols=260 Identities=24% Similarity=0.394 Sum_probs=199.9
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCc---eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
....++|.+.+.||+|+||.||+|.+..++. .||+|++..... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 96 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGVSLR 96 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEEC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhceeec
Confidence 3445789999999999999999999887765 899999875433 3455688999999999998 9999999999987
Q ss_pred CCeE------EEEEecCCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCC
Q 014704 140 RHSV------NLIMDLCAGGELFDRIIAKG------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 140 ~~~~------~iv~e~~~g~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~ 207 (420)
.... ++||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCC
Confidence 7655 99999999999999886543 59999999999999999999999999999999999999 456
Q ss_pred CCeeEeecccccccCCCCce---ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014704 208 SPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAIL 282 (420)
Q Consensus 208 ~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~ 282 (420)
+.+||+|||++......... ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 78999999999876443322 23456788999999864 58999999999999999999 999999988888888777
Q ss_pred cCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCC-------HHHHhcCCccccc
Q 014704 283 RGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLS-------AAEVLNHPWMRVD 330 (420)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-------~~e~l~h~~~~~~ 330 (420)
.+..... .+.+++++.+||.+||+.||++||| ++++++|+|+...
T Consensus 254 ~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 254 GGNRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp TTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred cCCCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 6553222 2467899999999999999999999 8888999999754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=372.93 Aligned_cols=263 Identities=23% Similarity=0.385 Sum_probs=208.5
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC--------ChhhHHHHHHHHHHHHhccCCCCccEE
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI--------NRDDVEDVRREVQIMHHLTGHRNIVEL 133 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~~hpniv~~ 133 (420)
...+.++|.+.+.||+|+||.||+|.+.. |+.||||++...... .....+.+.+|+.++++++ ||||+++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~ 94 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGL 94 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCC
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccce
Confidence 45577899999999999999999999876 899999998653221 2223478999999999998 9999999
Q ss_pred EEEEEe-----CCeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCC
Q 014704 134 KGAYED-----RHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 134 ~~~~~~-----~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~ 207 (420)
++++.. ...+|+||||+. |+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||++ +.+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~ 170 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADN 170 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTT
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCC
Confidence 999843 346899999997 5888877654 369999999999999999999999999999999999999 556
Q ss_pred CCeeEeecccccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Q 014704 208 SPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH 285 (420)
Q Consensus 208 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 285 (420)
+.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 171 NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp CCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 7799999999987655555566789999999998864 58999999999999999999999999988777666654311
Q ss_pred C------------------------CCCCC----CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 286 I------------------------DFSSD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 286 ~------------------------~~~~~----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
. ..+.. ..+..++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 0 11111 123568889999999999999999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=369.45 Aligned_cols=266 Identities=23% Similarity=0.382 Sum_probs=217.4
Q ss_pred cccccccccccceeecceecccCCeEEEEEEEcCCC-ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCC------
Q 014704 57 VLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTK-QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN------ 129 (420)
Q Consensus 57 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn------ 129 (420)
.....+..+.++|.+.+.||+|+||.||+|.+..++ +.||+|++... ....+.+.+|+.+++.+. |++
T Consensus 9 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-~~~~~~~~~ 83 (355)
T 2eu9_A 9 LVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIK-EKDKENKFL 83 (355)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHH-HHCTTSCSC
T ss_pred cccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHh-hcCCCCcee
Confidence 344556677889999999999999999999998776 68999998642 344577889999999998 655
Q ss_pred ccEEEEEEEeCCeEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecC---
Q 014704 130 IVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS--- 204 (420)
Q Consensus 130 iv~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~--- 204 (420)
++.+++++...+.+++||||+ +++|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||+...
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 84 CVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEE
T ss_pred EEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccc
Confidence 999999999999999999999 667777776654 69999999999999999999999999999999999999532
Q ss_pred -------------CCCCCeeEeecccccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCC
Q 014704 205 -------------AEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFW 270 (420)
Q Consensus 205 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~ 270 (420)
+.+..+||+|||++...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 24678999999999865432 34568999999999986 468999999999999999999999999
Q ss_pred CCCHHHHHHHHHcCCCCCCC----------------CCCC------------------------CCChHHHHHHHHhccc
Q 014704 271 GETEQSIFDAILRGHIDFSS----------------DPWP------------------------NISSSAKDIVKKMLHA 310 (420)
Q Consensus 271 ~~~~~~~~~~i~~~~~~~~~----------------~~~~------------------------~~~~~~~~li~~~L~~ 310 (420)
+.........+.......+. ..|+ ..+.++.+||++||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 88876655544332111110 0011 1234788999999999
Q ss_pred CcCCCCCHHHHhcCCccccc
Q 014704 311 DPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 311 dp~~R~t~~e~l~h~~~~~~ 330 (420)
||++|||+.|+|+||||+..
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGC
T ss_pred ChhhCcCHHHHhcChhhcCC
Confidence 99999999999999999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=361.57 Aligned_cols=262 Identities=26% Similarity=0.467 Sum_probs=214.8
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccC-CCCccEEEEEEEe
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG-HRNIVELKGAYED 139 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-hpniv~~~~~~~~ 139 (420)
......++|.+.+.||+|+||.||+|.+.. ++.||+|++..... .....+.+.+|+.+++++.+ ||||+++++++.+
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 344556789999999999999999999864 88999999875433 45567889999999999984 6999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+.+|+||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN 174 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSC
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccc
Confidence 999999999 56889999999888999999999999999999999999999999999999994 3679999999998
Q ss_pred ccCCCC---ceecccCCcccccchhhcc------------cCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHc
Q 014704 220 FFKPGD---VFKDLVGSAYYVAPEVLRR------------NYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILR 283 (420)
Q Consensus 220 ~~~~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~ 283 (420)
...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ....+..+..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 764332 1234579999999999853 57889999999999999999999997654 3344445554
Q ss_pred CCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
....... ....+.++.+||.+||+.||++|||+.++|+||||+...
T Consensus 255 ~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 255 PNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp TTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred cccccCC--cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 4333322 234578999999999999999999999999999997543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=373.05 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=211.4
Q ss_pred ccccccceeecceecccCCeEEEEEE-----EcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 136 (420)
.+...++|.+.+.||+|+||.||+|. +..+++.||||++.... .....+.+.+|+.++.++.+||||++++++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 34556899999999999999999999 45567899999996432 345567899999999999669999999999
Q ss_pred EEeCCe-EEEEEecCCCCChHHHHHhcCC---------------------------------------------------
Q 014704 137 YEDRHS-VNLIMDLCAGGELFDRIIAKGH--------------------------------------------------- 164 (420)
Q Consensus 137 ~~~~~~-~~iv~e~~~g~~L~~~l~~~~~--------------------------------------------------- 164 (420)
+.+.+. +++|||||+||+|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 987554 8999999999999999976543
Q ss_pred ---------------CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC---c
Q 014704 165 ---------------YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---V 226 (420)
Q Consensus 165 ---------------~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~---~ 226 (420)
+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... .
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccchh
Confidence 8999999999999999999999999999999999999 456679999999998664332 2
Q ss_pred eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
.....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+..... ....+..+. .... ...+++++.++
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~l~~l 328 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-RMRA--PDYTTPEMYQT 328 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC-CCCC--CTTCCHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC-CCCC--CCCCCHHHHHH
Confidence 23456889999999885 468999999999999999998 999998876443 333344332 2222 24578999999
Q ss_pred HHHhcccCcCCCCCHHHHhcC
Q 014704 304 VKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h 324 (420)
|.+||+.||++|||+.++++|
T Consensus 329 i~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHH
Confidence 999999999999999999876
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=368.56 Aligned_cols=257 Identities=29% Similarity=0.543 Sum_probs=205.9
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh---hhHHHHHHHHHHHHhcc---CCCCccEEE
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQIMHHLT---GHRNIVELK 134 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~---~hpniv~~~ 134 (420)
..+.+.++|.+.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++++. .||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 345677899999999999999999999999999999999975443221 12344678999999992 399999999
Q ss_pred EEEEeCCeEEEEEec-CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 135 GAYEDRHSVNLIMDL-CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 135 ~~~~~~~~~~iv~e~-~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
+++.+.+..++|||+ +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++ ..++.+||+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~ 182 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLI 182 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEEC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEE
Confidence 999999999999999 78999999999888899999999999999999999999999999999999995 245679999
Q ss_pred ecccccccCCCCceecccCCcccccchhhcc-cC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 014704 214 DFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NY-GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291 (420)
Q Consensus 214 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 291 (420)
|||++...... ......||+.|+|||++.+ .+ +.++||||||+++|+|++|+.||.... .+......++
T Consensus 183 dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~-- 253 (312)
T 2iwi_A 183 DFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP-- 253 (312)
T ss_dssp CCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC--
T ss_pred EcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc--
Confidence 99999876543 3355679999999998864 33 458999999999999999999996532 2333333333
Q ss_pred CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 292 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
..++.++.+||.+||+.||++|||+.|+++||||+..
T Consensus 254 --~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 254 --AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred --ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 3679999999999999999999999999999999754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=359.69 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=208.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++ ||||+++++++.+.+.+|+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeEEE
Confidence 367999999999999999999999999999999997654444455678999999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccccccc
Confidence 99999999999999988889999999999999999999999999999999999999 456789999999987664432
Q ss_pred --ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 226 --VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 226 --~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+. ..........+.++.++.+
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~ 267 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPRPSTVRPGIPVAFDA 267 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-SCCCCGGGTSTTCCTHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-cCCCCccccCCCCCHHHHH
Confidence 2234579999999999864 58999999999999999999999998877654444443 3333333344678999999
Q ss_pred HHHHhcccCcCCCC-CHHHHhc
Q 014704 303 IVKKMLHADPKERL-SAAEVLN 323 (420)
Q Consensus 303 li~~~L~~dp~~R~-t~~e~l~ 323 (420)
+|.+||+.||++|| |++++++
T Consensus 268 li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 268 VIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999 7887764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=367.28 Aligned_cols=257 Identities=31% Similarity=0.550 Sum_probs=216.4
Q ss_pred ccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh---hhHHHHHHHHHHHHhcc-CCCCccEEEE
Q 014704 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---DDVEDVRREVQIMHHLT-GHRNIVELKG 135 (420)
Q Consensus 60 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~~l~~l~-~hpniv~~~~ 135 (420)
...+.+.++|.+.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++++. +||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 4456677899999999999999999999999999999999976543221 12245778999999997 3799999999
Q ss_pred EEEeCCeEEEEEecCCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEee
Q 014704 136 AYEDRHSVNLIMDLCAG-GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (420)
Q Consensus 136 ~~~~~~~~~iv~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~D 214 (420)
++.+.+.+++|||++.+ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .+++.+||+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~D 193 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLID 193 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEee
Confidence 99999999999999986 89999999888999999999999999999999999999999999999995 2456799999
Q ss_pred cccccccCCCCceecccCCcccccchhhcc-c-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 014704 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 215 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 292 (420)
||++...... ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||.... .+......++
T Consensus 194 fg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~--- 263 (320)
T 3a99_A 194 FGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--- 263 (320)
T ss_dssp CTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS---
T ss_pred Cccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc---
Confidence 9999876543 3345679999999998864 3 4678999999999999999999996532 2333333332
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
..+++++.+||.+||+.||++|||+.++++||||+.
T Consensus 264 -~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 264 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp -SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred -ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 367999999999999999999999999999999974
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=350.57 Aligned_cols=249 Identities=23% Similarity=0.394 Sum_probs=216.2
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...++|.+.+.||+|+||.||+|.++. +..||+|++..... ..+.+.+|+.++++++ ||||+++++++.+.+.+
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSE
T ss_pred echhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC----cHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCce
Confidence 345789999999999999999998874 67899999875432 3467899999999999 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
++||||++|++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecc
Confidence 99999999999999997754 49999999999999999999999999999999999999 566789999999998765
Q ss_pred CCCce--ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 223 PGDVF--KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 223 ~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
..... ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||...........+..+...... ...++
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 232 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASD 232 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCH
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChH
Confidence 44322 23356778999999865 68999999999999999999 99999999888888887776543332 35689
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.+.++|.+||+.||++|||+.+++++
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=367.30 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=218.0
Q ss_pred cccccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
+...++|.+.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.++++++ ||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE
Confidence 445688999999999999999999997 345889999987542 3455678999999999998 99999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecc
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAK------------------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRD 193 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~D 193 (420)
.+.+.+|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999999764 5689999999999999999999999999999
Q ss_pred CCCCcEEEecCCCCCCeeEeecccccccCCCC---ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCC
Q 014704 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPP 268 (420)
Q Consensus 194 lkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~p 268 (420)
|||+||++ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++ |..|
T Consensus 200 lkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 200 LATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999 456679999999997654322 223456889999999886 468999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 269 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
|.+.........+..+..... ...++.++.++|.+||+.||++|||+.+++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 277 YYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 999998888888887654322 24678999999999999999999999999764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=357.09 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=207.2
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEe
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMD 148 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e 148 (420)
|.....||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++ ||||+++++++.+.+.+++|||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEE
Confidence 334458999999999999999999999999987542 334577999999999998 9999999999999999999999
Q ss_pred cCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 149 LCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 149 ~~~g~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++. .++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTCCEEECCTTTCEESCC--
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--CCCCEEEeecccccccCCCC
Confidence 999999999987652 4678999999999999999999999999999999999963 25679999999998765432
Q ss_pred -ceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 226 -VFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 226 -~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .......... ........++.++
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 255 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--VHPEIPESMSAEA 255 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--CCCCCCTTSCHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--ccccccccCCHHH
Confidence 2345579999999999854 3789999999999999999999999754322 2222211111 1112234679999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.+||.+||+.||++|||+.++|+||||+...
T Consensus 256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 256 KAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999999997543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=354.59 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=213.2
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+...++|.+.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRP 93 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCC
Confidence 334578999999999999999999887 467899999975432 3467899999999999 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+++||||+.|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGB
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEccccccccc
Confidence 9999999999999999976 4679999999999999999999999999999999999999 56678999999999876
Q ss_pred CCCCc--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 222 KPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 222 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
..... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+...... ...+
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 247 (283)
T 3gen_A 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLAS 247 (283)
T ss_dssp CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCC
T ss_pred cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCC
Confidence 43221 12335678899999986 468999999999999999998 99999999988888888776433332 3568
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+.+.++|.+||+.||++|||+.++++|
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999999876
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=351.96 Aligned_cols=247 Identities=24% Similarity=0.456 Sum_probs=214.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|.+.. ++.||+|++..... ..+.+.+|+.++++++ ||||+++++++.+.+.+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc----CHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEE
Confidence 4689999999999999999999874 67899999875432 3467899999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccccc
Confidence 99999999999999654 458999999999999999999999999999999999999 45567999999999866432
Q ss_pred C--ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 225 D--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 225 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
. ......+|+.|+|||++. ..++.++||||+|+++|+|++ |..||.+.........+..+...... ..+++++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 236 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHV 236 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---CcCCHHH
Confidence 2 112345678899999986 468999999999999999999 99999999998888888776433222 3578999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcC
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.++|.+||+.||++|||+.++++|
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=364.10 Aligned_cols=260 Identities=22% Similarity=0.306 Sum_probs=218.4
Q ss_pred cccccceeecceecccCCeEEEEEE-----EcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
+...++|.+.+.||+|+||.||+|. +..+++.||+|.+... ........+.+|+.+++++. ||||+++++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 102 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFN-HQNIVRCIGVS 102 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCC-CCCCCeEEEEE
Confidence 3456789999999999999999999 5567889999998643 24455678999999999998 99999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCe
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKG-------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~ 210 (420)
.+....|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++..+.+..+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999998753 48999999999999999999999999999999999999765566789
Q ss_pred eEeecccccccCCCC---ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 014704 211 KATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285 (420)
Q Consensus 211 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~ 285 (420)
||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..+.
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999987553322 223456889999999885 468999999999999999998 999999988888888877764
Q ss_pred CCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 286 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.... ...++..+.++|.+||+.||.+|||+.++++|.|+.
T Consensus 263 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 263 RMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 3322 246789999999999999999999999999998864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=358.75 Aligned_cols=245 Identities=25% Similarity=0.429 Sum_probs=206.8
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+++.||+|+||.||+|.+..+++.||+|.+.. .+....+.+.+|+.++++++ ||||+++++++.+++..++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEE
Confidence 4689999999999999999999999999999998853 24566788999999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceecccc
Confidence 9999999999999987 4679999999999999999999999999999999999999 56677999999999876433
Q ss_pred Cce---------------ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHc
Q 014704 225 DVF---------------KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQS-----IFDAILR 283 (420)
Q Consensus 225 ~~~---------------~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~-----~~~~i~~ 283 (420)
... ...+||+.|+|||++.+ .++.++||||||+++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 211 14579999999999865 58999999999999999999999986532110 0111111
Q ss_pred CCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.. ..+.+++.+.++|.+||+.||++|||+.++++
T Consensus 242 ~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 RY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 12467889999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=364.29 Aligned_cols=252 Identities=19% Similarity=0.251 Sum_probs=207.7
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.+++.+.+||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 45789999999999999999999999999999999865432 2358899999999944999999999999999999
Q ss_pred EEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC--CCCeeEeeccccccc
Q 014704 145 LIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE--DSPLKATDFGLSVFF 221 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~~~~kl~Dfg~~~~~ 221 (420)
+||||+ |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 99999999864 67999999999999999999999999999999999999954321 123999999999876
Q ss_pred CCCCc--------eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCC
Q 014704 222 KPGDV--------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE---TEQSIFDAILRGHIDFS 289 (420)
Q Consensus 222 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~ 289 (420)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. ...+.+..+.......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 43321 245689999999999865 5899999999999999999999999874 34445555544333222
Q ss_pred CCC-CCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 290 SDP-WPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 290 ~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
... ...++ ++.++|..||..||.+||++.++++
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 211 12234 9999999999999999999998875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=359.58 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=217.0
Q ss_pred cccccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
+...++|.+.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++ ||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 95 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGAC 95 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEEE
Confidence 334578999999999999999999983 455889999986432 4556688999999999998 99999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCCeecc
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKGH------------------------YSERAAANLCRQMVTVVHYCHSMGVMHRD 193 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~al~~lH~~~ivH~D 193 (420)
.+.+.+++||||++|++|.+++..... +++..+..++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999987543 89999999999999999999999999999
Q ss_pred CCCCcEEEecCCCCCCeeEeecccccccCCCCce---ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCC
Q 014704 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPP 268 (420)
Q Consensus 194 lkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~p 268 (420)
|||+||+++ .++.+||+|||++......... ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..|
T Consensus 176 ikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 176 LAARNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CSGGGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cchheEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999995 4567999999999876543322 23457888999998864 58999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 269 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
|.+.........+..+.... ....+++++.++|.+||+.||++|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGHRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp STTCCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHhhcCCcCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99988877777776654321 224689999999999999999999999999865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=350.11 Aligned_cols=252 Identities=25% Similarity=0.419 Sum_probs=204.2
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCC-hhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
.++|.+.+.||+|+||.||+|.+. ++.||+|++....... ....+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceE
Confidence 468999999999999999999985 7889999987543222 234578999999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CeeccCCCCcEEEecCC-----CCCCeeEeecc
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG---VMHRDLKPENFLFSSSA-----EDSPLKATDFG 216 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~-----~~~~~kl~Dfg 216 (420)
+||||++|++|.+++. .+.+++..+..++.|++.||.|||++| |+||||||+||+++... .++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999988774 567999999999999999999999999 89999999999996422 26679999999
Q ss_pred cccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
++........ ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+.......+. ...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 238 (271)
T 3dtc_A 162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PST 238 (271)
T ss_dssp C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CTT
T ss_pred cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--Ccc
Confidence 9986544322 34579999999999864 5899999999999999999999999998888777777766554433 246
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+++.+.++|.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 78999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=363.65 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=192.1
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHH-HHHhccCCCCccEEEEEEEeCCe
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ-IMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
...++|.+.+.||+|+||.||+|.++.+|+.||||++.... .......+..|+. +++.+. ||||+++++++.+.+.
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~-h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSD-CPYIVQFYGALFREGD 95 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCC-CTTBCCEEEEEECSSE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCC-CCcEeeeeeEEEeCCc
Confidence 34578999999999999999999999999999999997542 3344456667776 555555 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 143 VNLIMDLCAGGELFDRIIA-----KGHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
.++||||+.| +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+||+++ .++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccCC
Confidence 9999999976 78777653 56799999999999999999999999 999999999999994 56679999999
Q ss_pred cccccCCCCceecccCCcccccchhhc-----ccCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCC-CCCC
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR-----RNYGAEADIWSAGVILYILLSGVPPFWGETEQ-SIFDAILRGH-IDFS 289 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~-~~~~ 289 (420)
++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+.... ..+..+..+. ..+.
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCC
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence 998765544444557999999999983 34899999999999999999999999764421 2222222221 1222
Q ss_pred CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 290 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
...+..+++++.+||.+||..||++|||+.++++||||...
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 33335689999999999999999999999999999999743
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=354.86 Aligned_cols=254 Identities=26% Similarity=0.476 Sum_probs=204.2
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEE
Confidence 3467999999999999999999999999999999997655555666788999999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 145 LIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccceee
Confidence 99999999999998864 4569999999999999999999999999999999999999 4567899999999886
Q ss_pred cCCCC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCCC
Q 014704 221 FKPGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET--EQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 221 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.. .......+...... ......+
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 263 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLPSDHY 263 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--CCCTTTS
T ss_pred ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--CCccccc
Confidence 54332 2234578999999999864 58999999999999999999999997643 34455555554432 2223568
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+.++.+||.+||..||++|||+.+++++
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=369.16 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=215.2
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
..-.++|.+.+.||+|+||.||+|.++.+++.||||++... ......+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQP 186 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCC
Confidence 33457899999999999999999999989999999998643 23444567889999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREE 263 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceec
Confidence 999999999999999997654 59999999999999999999999999999999999999 55678999999999865
Q ss_pred CCCCcee---cccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 222 KPGDVFK---DLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 222 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
....... ...+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.........+..+... +. ...+
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~ 340 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-PC--PELC 340 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC-CC--CTTC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-CC--CCCC
Confidence 4332111 123567899999986 468999999999999999998 99999998888877777665322 21 2357
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
++++.+||.+||+.||++|||+.++++
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999999999999999999964
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=351.86 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=208.4
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhh----HHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD----VEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~----~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.......... .+.+.+|+.++++++ ||||+++++++.+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNP 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCC
Confidence 3468999999999999999999999999999999987544322221 267899999999998 99999999998766
Q ss_pred CeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCCC--CCCeeEeec
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAE--DSPLKATDF 215 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~--~~~~kl~Df 215 (420)
. ++||||+++++|.+.+... ..+++..+..++.|++.||.|||++| |+||||||+||+++..+. ...+||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 6999999999999888755 46999999999999999999999999 999999999999954321 224999999
Q ss_pred ccccccCCCCceecccCCcccccchhhc---ccCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCCCCC
Q 014704 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLR---RNYGAEADIWSAGVILYILLSGVPPFWGETEQ--SIFDAILRGHIDFSS 290 (420)
Q Consensus 216 g~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~ 290 (420)
|++..... ......||+.|+|||++. ..++.++||||||+++|+|++|..||...... .....+........
T Consensus 174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 250 (287)
T 4f0f_A 174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT- 250 (287)
T ss_dssp TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC-
T ss_pred Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC-
Confidence 99985433 345678999999999983 34789999999999999999999999765533 33444444433322
Q ss_pred CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 291 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
....+++++.+||.+||+.||++|||+.++++
T Consensus 251 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 251 -IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 23478999999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=354.57 Aligned_cols=256 Identities=22% Similarity=0.287 Sum_probs=212.3
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
...+.++|.+.+.||+|+||.||+|.+..+|+.||+|++..... .+.+.+|+.+++.+.+|+|++++++++.+..
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 34567889999999999999999999999999999999864322 2457899999999966999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC--CCCCeeEeecccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGLS 218 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~~~~kl~Dfg~~ 218 (420)
..++||||+ |++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 999999998754 599999999999999999999999999999999999996432 2345999999999
Q ss_pred cccCCCCc--------eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCC
Q 014704 219 VFFKPGDV--------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE---TEQSIFDAILRGHI 286 (420)
Q Consensus 219 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~---~~~~~~~~i~~~~~ 286 (420)
........ .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+. .....+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 87654321 245679999999999864 5899999999999999999999999874 34444444443322
Q ss_pred CCCC-CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 287 DFSS-DPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 287 ~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
..+. ...+.+++++.++|.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1111 112367899999999999999999999999965
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=352.27 Aligned_cols=252 Identities=26% Similarity=0.368 Sum_probs=203.7
Q ss_pred cccccceeecceecccCCeEEEEEEEcCC---CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
+...++|.+.+.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.++++++ ||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~- 86 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT- 86 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-
Confidence 44567999999999999999999998754 456999988643 23455678999999999998 999999999984
Q ss_pred CCeEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
.+..|+||||+.+++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS 163 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC----
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECccccc
Confidence 567899999999999999997654 699999999999999999999999999999999999995 4567999999999
Q ss_pred cccCCCCc--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 219 VFFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 219 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..+.... ..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~ 240 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPP 240 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCT
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CCC
Confidence 87654332 22345678999999986 468999999999999999996 999999888888887777654321 234
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.+++++.++|.+||+.||++|||+.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 789999999999999999999999999754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=357.62 Aligned_cols=256 Identities=22% Similarity=0.372 Sum_probs=219.3
Q ss_pred ccccccccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEE
Q 014704 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELK 134 (420)
Q Consensus 60 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 134 (420)
...+...++|.+.+.||+|+||.||+|.++ .+++.||+|.+.... .......+.+|+.+++.+. ||||++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~ 94 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLL 94 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeeeE
Confidence 344566789999999999999999999887 357889999986432 3445567899999999998 99999999
Q ss_pred EEEEeCCeEEEEEecCCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecC
Q 014704 135 GAYEDRHSVNLIMDLCAGGELFDRIIAK----------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS 204 (420)
Q Consensus 135 ~~~~~~~~~~iv~e~~~g~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~ 204 (420)
+++.+.+..++||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli--- 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--- 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---
Confidence 9999999999999999999999988753 357999999999999999999999999999999999999
Q ss_pred CCCCCeeEeecccccccCCCCce---ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHH
Q 014704 205 AEDSPLKATDFGLSVFFKPGDVF---KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFD 279 (420)
Q Consensus 205 ~~~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~ 279 (420)
+.++.+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+........
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 45678999999999865433221 2345688999999986 458999999999999999999 899999998888888
Q ss_pred HHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 280 AILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 280 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.+..+..... ...++..+.+||.+||..||++|||+.++++|
T Consensus 252 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 252 FVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8877654322 24678999999999999999999999999976
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=357.07 Aligned_cols=252 Identities=24% Similarity=0.412 Sum_probs=215.4
Q ss_pred cccceeecceecccCCeEEEEEEEc-------CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHK-------DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
..++|.+++.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++++..||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 4578999999999999999999986 356789999986432 4456678999999999994499999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLF 201 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill 201 (420)
.+.+.+|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 99999999999999999999998654 38999999999999999999999999999999999999
Q ss_pred ecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH
Q 014704 202 SSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQS 276 (420)
Q Consensus 202 ~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~ 276 (420)
+.++.+||+|||++........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+
T Consensus 191 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 191 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp ---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 5567899999999987654332 22345788999999885 458999999999999999999 999999998888
Q ss_pred HHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 277 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
....+..+.... ....++.++.++|.+||..||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 888777664322 224678999999999999999999999999865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=351.17 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=217.8
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
..+...++|.+.+.||+|+||.||+|.++.++..||+|++... ....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTRE 81 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccC
Confidence 3445668899999999999999999999999999999998643 335678999999999999 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
+.+|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLS 158 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccc
Confidence 9999999999999999999874 349999999999999999999999999999999999999 45667999999999
Q ss_pred cccCCCCc--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 219 VFFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 219 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 235 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPE 235 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCT
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCC
Confidence 87654332 22345788899999986 468999999999999999999 99999988877777766654322 2224
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+++.+.+||.+||..||++|||+.++++
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 68999999999999999999999999964
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=373.27 Aligned_cols=259 Identities=24% Similarity=0.412 Sum_probs=213.5
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH- 141 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~- 141 (420)
....++|.+.+.||+|+||.||+|.++.+|+.||||++..... ....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTT 81 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTT
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCC
Confidence 3456789999999999999999999999999999999875432 234577889999999999 999999999998765
Q ss_pred -eEEEEEecCCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEec-CCCCCCeeEeecc
Q 014704 142 -SVNLIMDLCAGGELFDRIIAKGH---YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS-SAEDSPLKATDFG 216 (420)
Q Consensus 142 -~~~iv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~-~~~~~~~kl~Dfg 216 (420)
..|+|||||+|++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||+.. .+.+..+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 78999999999999999875433 999999999999999999999999999999999999843 2345569999999
Q ss_pred cccccCCCCceecccCCcccccchhhc---------ccCCCccchhhhHHHHHHHHhCCCCCCC----CCHHHHHHHHHc
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR---------RNYGAEADIWSAGVILYILLSGVPPFWG----ETEQSIFDAILR 283 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DvwslGvil~~ll~g~~pf~~----~~~~~~~~~i~~ 283 (420)
++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+ ....+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 998876665556678999999999875 3578899999999999999999999964 334556666665
Q ss_pred CCCCCC---------------------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 284 GHIDFS---------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 284 ~~~~~~---------------------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+..... ......++..+.++|++||+.||++|||+.+++++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 543210 00011234578899999999999999999998543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=362.31 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=212.1
Q ss_pred cccccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
+...++|.+.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++..||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 445678999999999999999999973 356789999997432 2334578999999999994499999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccC
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKG-----------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dl 194 (420)
.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 99999999999999999999997653 2789999999999999999999999999999
Q ss_pred CCCcEEEecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCC
Q 014704 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPF 269 (420)
Q Consensus 195 kp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf 269 (420)
||+||+++ .++.+||+|||++........ .....||+.|+|||++. +.++.++||||||+++|+|++ |..||
T Consensus 199 kp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 199 AARNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp SGGGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ChhhEEEc---CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999994 566799999999986643321 23345788999999885 468999999999999999998 99999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCc
Q 014704 270 WGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326 (420)
Q Consensus 270 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 326 (420)
.+......+..+......... ...+++++.+||.+||..||.+|||+.++++|..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp TTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 887755555555544433332 2467899999999999999999999999998743
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=360.28 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=210.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceE--EEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQF--ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~--avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
++|.+.+.||+|+||.||+|.++.++..+ |+|.+... ......+.+.+|+.+++++..||||+++++++.+.+.+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 67999999999999999999999888765 99988642 233455678999999999944999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCC
Q 014704 145 LIMDLCAGGELFDRIIAKG----------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~ 208 (420)
+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||++ +.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence 9999999999999997654 69999999999999999999999999999999999999 4566
Q ss_pred CeeEeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCC
Q 014704 209 PLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHI 286 (420)
Q Consensus 209 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 286 (420)
.+||+|||++.............+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+..+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 259 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence 799999999875433222334467889999999864 58999999999999999998 9999999988888777766532
Q ss_pred CCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 287 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
. .....+++++.+||.+||..||++|||+.+++++
T Consensus 260 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 L---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp C---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 1224678999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=356.06 Aligned_cols=255 Identities=27% Similarity=0.381 Sum_probs=213.3
Q ss_pred cccccceeecceecccCCeEEEEEEE-----cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTH-----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
+...++|.+.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++.+||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 34557899999999999999999985 4567899999987542 3345678999999999994499999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKG------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 199 (420)
.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 99999999999999999999998654 489999999999999999999999999999999999
Q ss_pred EEecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCH
Q 014704 200 LFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETE 274 (420)
Q Consensus 200 ll~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~ 274 (420)
+++ .++.+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+...
T Consensus 177 l~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 177 LLT---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEE---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEc---CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 994 566799999999987654432 22345788999999875 468999999999999999999 9999987765
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 275 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
................ ...++.++.++|.+||..||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SHHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 4444444333322222 24678999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=353.64 Aligned_cols=248 Identities=18% Similarity=0.304 Sum_probs=206.2
Q ss_pred cccceeecceecccCCeEEEEEEEcCCC-------ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTK-------QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
..++|.+.+.||+|+||.||+|.++.++ ..||+|++... .....+.+.+|+.++++++ ||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLS-HKHLVLNYGVC 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSC-CTTBCCEEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEE
Confidence 3578999999999999999999998877 46999998643 2345678999999999999 99999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCC-----CCee
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAED-----SPLK 211 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~-----~~~k 211 (420)
.+.+..++||||++|++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.. ..+|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987655 9999999999999999999999999999999999999653321 1299
Q ss_pred EeecccccccCCCCceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCC-CCCCCCCHHHHHHHHHcCCCCC
Q 014704 212 ATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGV-PPFWGETEQSIFDAILRGHIDF 288 (420)
Q Consensus 212 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~ 288 (420)
|+|||++...... ....||+.|+|||++. ..++.++||||||+++|+|++|. +||......... .+......+
T Consensus 162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~~~ 237 (289)
T 4fvq_A 162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRHQL 237 (289)
T ss_dssp ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCCC
T ss_pred eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccCCC
Confidence 9999998765432 3346889999999986 45899999999999999999955 455444444433 333333333
Q ss_pred CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 289 SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 289 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+ ...++++.+||.+||+.||++|||+.++++|
T Consensus 238 ~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 238 P----APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp C----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred C----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 2457889999999999999999999999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=367.34 Aligned_cols=258 Identities=23% Similarity=0.442 Sum_probs=206.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccC----------CCCccEEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG----------HRNIVELKG 135 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~----------hpniv~~~~ 135 (420)
.++|.+.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++++.. ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 46899999999999999999999999999999998642 3345678899999998862 789999999
Q ss_pred EEEeCC----eEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeeccCCCCcEEEecCC---
Q 014704 136 AYEDRH----SVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSM-GVMHRDLKPENFLFSSSA--- 205 (420)
Q Consensus 136 ~~~~~~----~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~--- 205 (420)
++...+ .+++||||+ |++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++..+
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 987654 789999999 88999999764 4599999999999999999999998 999999999999996432
Q ss_pred CCCCeeEeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHH
Q 014704 206 EDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE------QSIF 278 (420)
Q Consensus 206 ~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~------~~~~ 278 (420)
....+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 3347999999999876432 345689999999999865 589999999999999999999999976542 2222
Q ss_pred HHHHcCCCCCCC--------------------------------------CCCCCCChHHHHHHHHhcccCcCCCCCHHH
Q 014704 279 DAILRGHIDFSS--------------------------------------DPWPNISSSAKDIVKKMLHADPKERLSAAE 320 (420)
Q Consensus 279 ~~i~~~~~~~~~--------------------------------------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 320 (420)
..+.......+. .....++.++.+||.+||+.||++|||+.|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 222210000000 000133567899999999999999999999
Q ss_pred HhcCCccccc
Q 014704 321 VLNHPWMRVD 330 (420)
Q Consensus 321 ~l~h~~~~~~ 330 (420)
+|+||||+..
T Consensus 331 ll~hp~f~~~ 340 (373)
T 1q8y_A 331 LVNHPWLKDT 340 (373)
T ss_dssp HHTCGGGTTC
T ss_pred HhhChhhhcc
Confidence 9999999854
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=352.86 Aligned_cols=251 Identities=22% Similarity=0.371 Sum_probs=203.0
Q ss_pred cccccceeecceecccCCeEEEEEE----EcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
....++|++.+.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.++++++ ||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 81 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCY 81 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence 3456789999999999999999998 5668899999998643 3455678999999999999 999999999985
Q ss_pred e--CCeEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeec
Q 014704 139 D--RHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215 (420)
Q Consensus 139 ~--~~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Df 215 (420)
. ...+++||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+||
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Df 158 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDF 158 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccC
Confidence 4 456899999999999999998754 499999999999999999999999999999999999995 4567999999
Q ss_pred ccccccCCCC----ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHH---------------
Q 014704 216 GLSVFFKPGD----VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ--------------- 275 (420)
Q Consensus 216 g~~~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~--------------- 275 (420)
|++....... ......++..|+|||++. ..++.++||||||+++|+|++|..||......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 9998764432 122345778899999986 45899999999999999999999998643221
Q ss_pred -HHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 276 -SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 276 -~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.....+..+. ..+ ....+++++.+||.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 239 FHLIELLKNNG-RLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHTTC-CCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccC-cCC--CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1222222222 222 23468999999999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=358.08 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=203.8
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceE----EEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQF----ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.++|.+.+.||+|+||.||+|.+..+++.+ |+|.+.... .....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence 468999999999999999999998877654 777764322 3345678999999999998 999999999998765
Q ss_pred eEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
.++|+||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCcceeE
Confidence 78899999999999999874 5699999999999999999999999999999999999995 456799999999987
Q ss_pred cCCCCc---eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 221 FKPGDV---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 221 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..+.... ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 243 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPI 243 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCcc
Confidence 654322 223456889999998864 58999999999999999999 999999888777776666654222 1246
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
++.++.+++.+||+.||++|||+.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 78999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=362.43 Aligned_cols=250 Identities=21% Similarity=0.379 Sum_probs=203.5
Q ss_pred cccceeecceecccCCeEEEEEEEc---CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHK---DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
..++|.+.+.||+|+||.||+|+++ .++..||||++.... .....+.+.+|+.++++++ ||||+++++++.+.+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSK 119 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCC
Confidence 4468999999999999999999987 457789999986432 4455678999999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
.+++||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccccc
Confidence 9999999999999999997654 69999999999999999999999999999999999999 5667899999999987
Q ss_pred cCCCCc----eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 221 FKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 221 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
...... .....+|+.|+|||++. +.++.++||||||+++|+|++ |..||.+.........+..+... + ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~-~--~~~ 273 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL-P--PPM 273 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-C--CCT
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCc
Confidence 643321 11234577899999986 468999999999999999998 99999999888888777665321 1 124
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.++..+.++|.+||+.||++|||+.++++
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 67899999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=360.11 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=208.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCce----EEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQ----FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.++|++.+.||+|+||.||+|.+..+++. ||+|.+.... .......+.+|+.+++.++ ||||+++++++. ..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-CC
Confidence 46899999999999999999999888876 6777764332 2223356778999999998 999999999986 45
Q ss_pred eEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
..++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence 689999999999999999764 579999999999999999999999999999999999999 4567799999999987
Q ss_pred cCCCC---ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 221 FKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 221 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
..... ......||+.|+|||++. +.++.++||||||+++|+|++ |..||.+.........+..+...... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---Cc
Confidence 65432 234456888999999986 568999999999999999999 99999988877777777765432222 34
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
++.++.++|.+||..||++|||+.++++|
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 67889999999999999999999999876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=371.55 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=201.3
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++.+.+||||+++++++.+.+.
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence 3456778889999999999998754 456899999998542 235678999999987559999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecC----------C
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYS-------ERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS----------A 205 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~-------~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~----------~ 205 (420)
+|+|||||. |+|.+++....... +..+..++.||+.||.|||++||+||||||+|||++.. +
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 999999996 59999997654332 33457899999999999999999999999999999743 2
Q ss_pred CCCCeeEeecccccccCCCCc-----eecccCCcccccchhhcc--------cCCCccchhhhHHHHHHHHh-CCCCCCC
Q 014704 206 EDSPLKATDFGLSVFFKPGDV-----FKDLVGSAYYVAPEVLRR--------NYGAEADIWSAGVILYILLS-GVPPFWG 271 (420)
Q Consensus 206 ~~~~~kl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~--------~~~~~~DvwslGvil~~ll~-g~~pf~~ 271 (420)
.+..+||+|||++........ ....+||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 455799999999987654321 234579999999999853 48899999999999999999 9999976
Q ss_pred CCHHHHHHHHHcCCCCCCCCC---CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 272 ETEQSIFDAILRGHIDFSSDP---WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 272 ~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
..... ..+..+....+... ...+++++.+||.+||+.||++|||+.++++||||..
T Consensus 243 ~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred chhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 65433 34455544433221 1134578999999999999999999999999999963
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=346.93 Aligned_cols=247 Identities=32% Similarity=0.656 Sum_probs=199.3
Q ss_pred ccccceeec-ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe---
Q 014704 64 DVRNTYIFG-RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--- 139 (420)
Q Consensus 64 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--- 139 (420)
.+.++|.+. +.||+|+||.||+|.++.+++.||+|++... ..+.+|+.++.++..||||+++++++.+
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 344567776 8899999999999999999999999998532 4577899998666559999999999987
Q ss_pred -CCeEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 140 -RHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 140 -~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
...+|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++..+.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 778999999999999999998764 69999999999999999999999999999999999999765447889999999
Q ss_pred cccccCCCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----cCCCCCCCCC
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL----RGHIDFSSDP 292 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~ 292 (420)
++..... ..++.++|||||||++|+|++|..||.+.........+. .....++...
T Consensus 166 ~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 166 FAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp TCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 9865431 346789999999999999999999998765543322111 1122222222
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~ 338 (420)
+..+++++.+||.+||+.||++|||+.|+|+||||+........+.
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ 271 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBC
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCC
Confidence 3568999999999999999999999999999999986655444443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=348.31 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=210.7
Q ss_pred ccceeecc-eecccCCeEEEEEEE--cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 66 RNTYIFGR-ELGRGQFGVTYLVTH--KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 66 ~~~y~~~~-~lG~G~~g~V~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.++|.+.+ .||+|+||.||+|.+ ..+++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++ ..+.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCCC
Confidence 46799988 999999999999954 56678999999875432 3344678999999999998 99999999999 5677
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+++||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCcceeec
Confidence 899999999999999999888899999999999999999999999999999999999995 45679999999998765
Q ss_pred CCCce----ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 223 PGDVF----KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 223 ~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
..... ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+..+.... ....+
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 245 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGC 245 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCC
Confidence 43322 22346788999999864 58899999999999999999 999999998888887777654321 12467
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
++++.++|.+||+.||++|||+.++++
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=343.20 Aligned_cols=247 Identities=24% Similarity=0.444 Sum_probs=213.8
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|.+.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++ ||||+++++++.+.+.+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEE
Confidence 468999999999999999999987 467899999875432 3467899999999998 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||++|++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccc
Confidence 99999999999999765 568999999999999999999999999999999999999 45667999999999876432
Q ss_pred C--ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 225 D--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 225 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
. ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..+..... ....+..+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l 234 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV 234 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHHH
Confidence 1 112345778899999986 468999999999999999999 9999999988888888877643322 23578999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcC
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.++|.+||+.||++|||+.+++++
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 235 YQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=350.27 Aligned_cols=248 Identities=25% Similarity=0.440 Sum_probs=212.3
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe---
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--- 139 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--- 139 (420)
..+..+|.+.+.||+|+||.||+|.+..+++.||+|++.... +.+.+|+.++++++ ||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEE
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEecccc
Confidence 346678999999999999999999999999999999986432 35678999999998 9999999998864
Q ss_pred -------------CCeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecC
Q 014704 140 -------------RHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSS 204 (420)
Q Consensus 140 -------------~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~ 204 (420)
...+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-- 156 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV-- 156 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc--
Confidence 45689999999999999999764 5799999999999999999999999999999999999995
Q ss_pred CCCCCeeEeecccccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Q 014704 205 AEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR 283 (420)
Q Consensus 205 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~ 283 (420)
.++.+||+|||++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .......+..
T Consensus 157 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~ 233 (284)
T 2a19_B 157 -DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRD 233 (284)
T ss_dssp -ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHT
T ss_pred -CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhc
Confidence 456799999999988766555556689999999999864 589999999999999999999998743 2334444444
Q ss_pred CCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+... ..++.++.++|.+||..||++|||+.++++|.|.-.
T Consensus 234 ~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 GIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cccc------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 3321 357899999999999999999999999999988643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=372.99 Aligned_cols=254 Identities=27% Similarity=0.380 Sum_probs=197.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
.+|.+.+.||+|+||+||. ....+++.||||++..... ..+.+|+.+|+.+.+||||+++++++.+...+|+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 4699999999999999764 3445689999999864322 23568999999995599999999999999999999
Q ss_pred EecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC--CCCCeeEeecccccccCC
Q 014704 147 MDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~~~~kl~Dfg~~~~~~~ 223 (420)
||||. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++..+ ....+||+|||++.....
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 99996 59999987654 356667789999999999999999999999999999996432 234578999999987654
Q ss_pred CC----ceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 224 GD----VFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 224 ~~----~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
.. .....+||+.|+|||++. ..++.++|||||||++|+|++ |..||...........+........ ....
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~ 254 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL-HPEK 254 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS-CTTC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc-Cccc
Confidence 32 234567999999999985 347789999999999999999 9999976654443322222111111 1112
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
..+..+.+||.+||+.||++|||+.++++||||..
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 33566899999999999999999999999999963
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=354.68 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=210.8
Q ss_pred cccccceeecceecccCCeEEEEEEE-----cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTH-----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
+...++|.+.+.||+|+||.||+|.+ ..+++.||+|++.... .......+.+|+.+++++.+||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 34467899999999999999999985 3567899999986542 3445678999999999996699999999998
Q ss_pred EeCC-eEEEEEecCCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 014704 138 EDRH-SVNLIMDLCAGGELFDRIIAKGH----------------YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200 (420)
Q Consensus 138 ~~~~-~~~iv~e~~~g~~L~~~l~~~~~----------------~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil 200 (420)
...+ .+++||||++|++|.+++..... +++..+..++.||+.||.|||++||+||||||+||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7654 59999999999999999987654 899999999999999999999999999999999999
Q ss_pred EecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCH-
Q 014704 201 FSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETE- 274 (420)
Q Consensus 201 l~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~- 274 (420)
++ .++.+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+...
T Consensus 181 ~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 181 LS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp EC---GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred EC---CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 94 566799999999987643322 22346788999999885 458999999999999999998 9999987664
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 275 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
......+..+.. ... ...+++++.++|.+||+.||.+|||+.++++|
T Consensus 258 ~~~~~~~~~~~~-~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 258 EEFCRRLKEGTR-MRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHHTCC-CCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhccCcc-CCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 334444444332 111 23578999999999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=361.67 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=207.3
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.+...++|.+.+.||+|+||.||+|.++ +++.||+|++... .....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---SSQGIEEFETEIETLSFCR-HPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTT
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCC
Confidence 4456688999999999999999999975 5889999987653 2345678999999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKG----HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
..++||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccc
Confidence 9999999999999999886543 48999999999999999999999999999999999999 5677899999999
Q ss_pred ccccCCC---CceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCC
Q 014704 218 SVFFKPG---DVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIF-------DAILRGHI 286 (420)
Q Consensus 218 ~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~-------~~i~~~~~ 286 (420)
+...... .......||+.|+|||++. +.++.++||||||+++|+|++|+.||.+....... .....+..
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 9865322 1223456899999999885 56899999999999999999999999765432111 11111111
Q ss_pred CC------CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 014704 287 DF------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHP 325 (420)
Q Consensus 287 ~~------~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 325 (420)
.. .....+..+..+.+++.+||+.||++|||+.+++++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 10 0111122356789999999999999999999998763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=352.47 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=209.4
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCC----ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTK----QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
+....+|.+.+.||+|+||.||+|.++.++ ..||+|++.... .......+.+|+.+++.++ ||||+++++++.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 116 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVIS 116 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEe
Confidence 445578999999999999999999987653 359999986432 3445667999999999998 999999999999
Q ss_pred eCCeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
+.+.+++||||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGL 193 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCc
Confidence 999999999999999999999765 579999999999999999999999999999999999999 4567899999999
Q ss_pred ccccCCCC----ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCC
Q 014704 218 SVFFKPGD----VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSD 291 (420)
Q Consensus 218 ~~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 291 (420)
+....... ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..+... +
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-~-- 270 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-P-- 270 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-C--
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-C--
Confidence 98764322 112235678899999986 468999999999999999999 99999998888888877765321 1
Q ss_pred CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 292 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
....++..+.++|.+||+.||++|||+.+++++
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 124678999999999999999999999999764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=344.13 Aligned_cols=246 Identities=18% Similarity=0.267 Sum_probs=211.4
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC--Ce
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR--HS 142 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--~~ 142 (420)
..++|.+.+.||+|+||.||+|.+. ++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+. ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCC
Confidence 3468999999999999999999985 78899999876432 4455678999999999998 99999999999877 78
Q ss_pred EEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 143 VNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
+++||||++|++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+||++ +.++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVK 160 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSC
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccce
Confidence 999999999999999998765 4899999999999999999999999 9999999999999 55677999998887
Q ss_pred cccCCCCceecccCCcccccchhhccc-C---CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLRRN-Y---GAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~---~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
..... ....||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.........+......... ..
T Consensus 161 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 234 (271)
T 3kmu_A 161 FSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI--PP 234 (271)
T ss_dssp CTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC--CT
T ss_pred eeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC--CC
Confidence 65332 335789999999998643 3 34799999999999999999999998888877777665444332 34
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+++++.++|.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 68999999999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=347.89 Aligned_cols=254 Identities=25% Similarity=0.465 Sum_probs=201.1
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
+.+...++|++.+.||+|+||.||+|.+.. .||+|++.... ......+.+.+|+.+++.++ ||||++++++. ..
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TA 91 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cC
Confidence 345566789999999999999999998653 59999987543 34556788999999999999 99999999964 56
Q ss_pred CeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
...++||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT 168 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC---
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceecc
Confidence 6789999999999999988543 5699999999999999999999999999999999999995 45679999999997
Q ss_pred ccCC---CCceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCCCC-
Q 014704 220 FFKP---GDVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILRGHIDFSS- 290 (420)
Q Consensus 220 ~~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~- 290 (420)
.... ........||+.|+|||++. ..++.++||||||+++|+|++|..||.+... ......+..+......
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh
Confidence 6542 22334567999999999984 3478899999999999999999999987554 4455555555443332
Q ss_pred CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 291 DPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 291 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.....+++++.+||.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 223467899999999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=372.62 Aligned_cols=251 Identities=22% Similarity=0.387 Sum_probs=216.4
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.+....+|.+.+.||+|+||.||+|.++.++..||||++.... ...+.+.+|+.+|++++ ||||+++++++.+..
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREP 289 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcC-CCCEeeEEEEEecCC
Confidence 3445678999999999999999999999989999999986532 24578999999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSR 366 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEE
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccce
Confidence 999999999999999999864 458999999999999999999999999999999999999 456789999999998
Q ss_pred ccCCCCce--ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 220 FFKPGDVF--KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 220 ~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
........ ....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.+...+...+..+.. . .....
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~ 443 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-M--ERPEG 443 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-C--CCCTT
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCCC
Confidence 76543221 2234677899999986 468999999999999999999 9999998887777776665432 2 22346
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+++++.+||.+||+.||++|||+.++++
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 8999999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=344.87 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=213.1
Q ss_pred cccceeecc-eecccCCeEEEEEEEc--CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 65 VRNTYIFGR-ELGRGQFGVTYLVTHK--DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 65 ~~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
..++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++ ||||+++++++ ..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAE 82 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESS
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCC
Confidence 346677766 9999999999999864 467889999987542 4456788999999999998 99999999999 556
Q ss_pred eEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
.+++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKA 159 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceee
Confidence 689999999999999988654 4599999999999999999999999999999999999995 456799999999987
Q ss_pred cCCCCce----ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 221 FKPGDVF----KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 221 ~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
....... ....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..+.... ..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~---~~~ 236 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPP 236 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC---CCC
Confidence 6543321 2335688999999986 468999999999999999998 999999888888887777754321 124
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhcCCc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 326 (420)
.+++++.++|.+||..||++|||+.+++++.+
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 78999999999999999999999999998744
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=346.98 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=205.6
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCC-ccEEEEEEEeCCe
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN-IVELKGAYEDRHS 142 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn-iv~~~~~~~~~~~ 142 (420)
.+.++|.+.+.||+|+||.||+|++..+|+.||+|++..... ...+.+|+.+++.+. |++ +..+..++.+...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHT-TSTTCCCEEEEEEETTE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhh-cCCCCCccccccCCCCc
Confidence 456889999999999999999999999999999999865432 235889999999999 555 4555555577888
Q ss_pred EEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999999 8999999874 457999999999999999999999999999999999999964445678999999999876
Q ss_pred CCCCc--------eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCC
Q 014704 222 KPGDV--------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAILRGHIDFS 289 (420)
Q Consensus 222 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~ 289 (420)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. ....+..+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 54322 245579999999999865 58999999999999999999999997633 2223333333222222
Q ss_pred C-CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 290 S-DPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 290 ~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
. .....+++++.++|.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1 112467899999999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=363.51 Aligned_cols=256 Identities=16% Similarity=0.210 Sum_probs=194.9
Q ss_pred cccceeecceecccCCeEEEEEEEcCC-----CceEEEEEecCCcCCChhh--------HHHHHHHHHHHHhccCCCCcc
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDT-----KQQFACKSISSRKLINRDD--------VEDVRREVQIMHHLTGHRNIV 131 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~~hpniv 131 (420)
..++|.+.+.||+|+||.||+|.+..+ ++.||+|++.........+ ...+..|+..++.+. ||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCCC
Confidence 456899999999999999999999765 5789999986532100000 012233444555555 99999
Q ss_pred EEEEEEEeC----CeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC
Q 014704 132 ELKGAYEDR----HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206 (420)
Q Consensus 132 ~~~~~~~~~----~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~ 206 (420)
++++++... ...|+||||| |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++. ..
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-SC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-CC
Confidence 999998764 5689999999 99999999876 67999999999999999999999999999999999999963 24
Q ss_pred CCCeeEeecccccccCCCCc--------eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHH-H
Q 014704 207 DSPLKATDFGLSVFFKPGDV--------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ-S 276 (420)
Q Consensus 207 ~~~~kl~Dfg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~-~ 276 (420)
++.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... .
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 67899999999977543211 133459999999999875 4899999999999999999999999853321 1
Q ss_pred HHHHHHc---CCC-CCCC--CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 277 IFDAILR---GHI-DFSS--DPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 277 ~~~~i~~---~~~-~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
....... ... .+.. -....++.++.+++..||..||++||++.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111110 000 0000 001367899999999999999999999999865
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=353.65 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=212.4
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCc-----eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQ-----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
+...++|.+.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+.+|+.+++.+..||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4445789999999999999999999987654 79999986532 3455678999999999994499999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEec
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAK--------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS 203 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~ 203 (420)
.+.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~- 198 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT- 198 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE-
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC-
Confidence 9999999999999999999998753 3579999999999999999999999999999999999995
Q ss_pred CCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHH
Q 014704 204 SAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIF 278 (420)
Q Consensus 204 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~ 278 (420)
.++.+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+......+
T Consensus 199 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 199 --NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp --GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred --CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 456799999999986543321 22345788999999885 468999999999999999998 99999887655555
Q ss_pred HHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 279 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..+......... ....+..+.++|.+||+.||.+|||+.+++++
T Consensus 277 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 277 YKLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 554444333322 23568999999999999999999999999763
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=355.40 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=191.9
Q ss_pred cccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 59 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
+...+....+|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++++.+||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 344445567899999999999999999999999999999998543 34556788999999999977999999999984
Q ss_pred --------eCCeEEEEEecCCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCC
Q 014704 139 --------DRHSVNLIMDLCAGGELFDRIIA---KGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSA 205 (420)
Q Consensus 139 --------~~~~~~iv~e~~~g~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~ 205 (420)
....+++||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||+ +
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~ 172 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---S 172 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---C
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---C
Confidence 3456899999996 688888765 467999999999999999999999999 9999999999999 4
Q ss_pred CCCCeeEeecccccccCCCCce-------------ecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCC
Q 014704 206 EDSPLKATDFGLSVFFKPGDVF-------------KDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPP 268 (420)
Q Consensus 206 ~~~~~kl~Dfg~~~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~p 268 (420)
.++.+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++|..|
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 252 (337)
T 3ll6_A 173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252 (337)
T ss_dssp TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 5678999999999876543211 1446899999999973 3478899999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCc
Q 014704 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326 (420)
Q Consensus 269 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 326 (420)
|.+....... ......+ .....+..+.+||++||+.||++|||+.|+++|-+
T Consensus 253 ~~~~~~~~~~----~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 253 FEDGAKLRIV----NGKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp C----------------CCCC--TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CcchhHHHhh----cCcccCC--cccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9765543332 2222222 23456788999999999999999999999998744
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=379.20 Aligned_cols=243 Identities=23% Similarity=0.330 Sum_probs=205.8
Q ss_pred cceecccCCeEEEEEEE--cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEec
Q 014704 72 GRELGRGQFGVTYLVTH--KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~ 149 (420)
.+.||+|+||.||+|.+ +.+++.||||++.... ......+.+.+|+.+|++++ ||||+++++++.+ +.+++||||
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~lv~E~ 450 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM 450 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEEEEEEc
Confidence 35899999999999955 4567899999987543 24455688999999999999 9999999999865 458899999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc---
Q 014704 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV--- 226 (420)
Q Consensus 150 ~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~--- 226 (420)
|.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 451 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 451 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC------
T ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccCccccc
Confidence 99999999999888899999999999999999999999999999999999995 456799999999987654321
Q ss_pred -eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 227 -FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 227 -~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
.....+|+.|+|||++.. .++.++|||||||++|+|++ |..||.+....++...+..+..... ...++.++.+|
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~l 604 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDL 604 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHH
Confidence 223356788999999864 69999999999999999998 9999999999888888887653221 24689999999
Q ss_pred HHHhcccCcCCCCCHHHHhc
Q 014704 304 VKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~ 323 (420)
|.+||+.||++|||+.++++
T Consensus 605 i~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 605 MNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999964
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=343.49 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=208.6
Q ss_pred ccccceeecceecccCCeEEEEEEEcCC---CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
...++|.+.+.||+|+||.||+|.+... +..||+|.+.... .....+.+.+|+.+++.++ ||||+++++++.++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEEE 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECSS
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcCC
Confidence 3457899999999999999999997643 3469999986542 3455678999999999998 99999999998754
Q ss_pred CeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
..|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSR 161 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGGG
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCCc
Confidence 568999999999999999765 4599999999999999999999999999999999999995 45679999999998
Q ss_pred ccCCCCc--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 220 FFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 220 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+..... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 238 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PDL 238 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CTT
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CCC
Confidence 7654322 23345788999999986 468999999999999999998 9999988777777766666533221 245
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+++.+.++|.+||..||++|||+.+++++
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 78999999999999999999999999765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=355.54 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=198.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC----
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH---- 141 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~---- 141 (420)
.++|.+.+.||+|+||.||+|++. ++.||||++... ........+|+.++++++ ||||+++++++.+..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----chHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCc
Confidence 468999999999999999999875 689999998643 233455677999999998 999999999998754
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeeccCCCCcEEEecCCCCCCee
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM----------GVMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~----------~ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
.+++|||||++|+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||+ +.++.+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~k 171 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTAC 171 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEE
T ss_pred eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEE
Confidence 47999999999999999865 4699999999999999999999999 99999999999999 5667899
Q ss_pred EeecccccccCCCCc---eecccCCcccccchhhcc------cCCCccchhhhHHHHHHHHhCCCCCCCCC---------
Q 014704 212 ATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLRR------NYGAEADIWSAGVILYILLSGVPPFWGET--------- 273 (420)
Q Consensus 212 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~DvwslGvil~~ll~g~~pf~~~~--------- 273 (420)
|+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999987654332 233579999999999864 46678999999999999999999997542
Q ss_pred -------HHHHHHHHHcCCCCCCCC-CCC--CCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 274 -------EQSIFDAILRGHIDFSSD-PWP--NISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 274 -------~~~~~~~i~~~~~~~~~~-~~~--~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.......+.......... .+. ..++++.+||.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222222232222211111 010 12345999999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=346.08 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=203.8
Q ss_pred cccceeecceecccCCeEEEEEE----EcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
....|++.+.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTED 95 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC-
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecC
Confidence 34679999999999999999999 56788999999987543 3345678999999999998 99999999999876
Q ss_pred --CeEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 141 --HSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 141 --~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGL 172 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECcccc
Confidence 678999999999999999954 45799999999999999999999999999999999999995 456799999999
Q ss_pred ccccCCCCc----eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCC--------------CH-HHH
Q 014704 218 SVFFKPGDV----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGE--------------TE-QSI 277 (420)
Q Consensus 218 ~~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~--------------~~-~~~ 277 (420)
+........ .....||..|+|||++. ..++.++||||||+++|+|++|..|+... .. ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 987654432 23456888899999885 45889999999999999999999876322 11 222
Q ss_pred HHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 278 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
...+..+. ..+ ....+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 253 VNTLKEGK-RLP--CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTTC-CCC--CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHhccC-CCC--CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 23333322 222 23478999999999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=350.54 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=204.1
Q ss_pred cccceeecceecccCCeEEEEEEEcC---CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+.+|+.++++++ ||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMS 109 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC--
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeecc
Confidence 45789999999999999999998865 456899999875432 4455678999999999999 999999999997655
Q ss_pred -----eEEEEEecCCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCe
Q 014704 142 -----SVNLIMDLCAGGELFDRIIA------KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPL 210 (420)
Q Consensus 142 -----~~~iv~e~~~g~~L~~~l~~------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~ 210 (420)
..++||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcE
Confidence 35999999999999999853 3569999999999999999999999999999999999999 456789
Q ss_pred eEeecccccccCCCCc---eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCC
Q 014704 211 KATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGH 285 (420)
Q Consensus 211 kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~ 285 (420)
||+|||++........ .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+..+.
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 9999999987644321 223457889999999864 58999999999999999999 999999888887777777654
Q ss_pred CCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 286 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
... ....+++++.++|.+||..||++|||+.+++++
T Consensus 267 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 RLK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 322 224688999999999999999999999999865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=352.75 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=203.8
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceE----EEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQF----ACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.++|++.+.||+|+||.||+|.+..+++.+ |+|.+... ........+.+|+.+++.++ ||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence 468999999999999999999998888765 56655432 23445678999999999998 999999999998765
Q ss_pred eEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
.++|++|+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCcceeE
Confidence 78899999999999999774 5699999999999999999999999999999999999995 456799999999987
Q ss_pred cCCCCc---eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 221 FKPGDV---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 221 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+..+..... ...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 243 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPI 243 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence 643321 223456889999999864 58999999999999999999 9999999888777777666543222 246
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
++.++.++|.+||..||.+|||+.++++
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7899999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=364.97 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=208.4
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC-e
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-S 142 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-~ 142 (420)
...++|.+.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+|++++ ||||+++++++.+.. .
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTSC
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCCc
Confidence 34578999999999999999999885 6799999986532 3467899999999998 999999999987655 7
Q ss_pred EEEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+|+|||||++|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCccc
Confidence 9999999999999999987654 7999999999999999999999999999999999999 5567899999999986
Q ss_pred cCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCCh
Q 014704 221 FKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298 (420)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 298 (420)
.... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+....++...+..+.. . .....+++
T Consensus 339 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~--~~p~~~~~ 413 (450)
T 1k9a_A 339 ASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-M--DAPDGCPP 413 (450)
T ss_dssp CC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-C--CCCTTCCH
T ss_pred cccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcCCH
Confidence 5432 22346788999999986 468999999999999999998 9999998887777777776532 1 12246899
Q ss_pred HHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 299 SAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 299 ~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
++.+||.+||+.||++|||+.++++
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=347.30 Aligned_cols=252 Identities=23% Similarity=0.387 Sum_probs=205.2
Q ss_pred ccceeecceecccCCeEEEEEEEcC-CCc--eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKD-TKQ--QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~--~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.++|.+.+.||+|+||.||+|.+.. +++ .||+|++...........+.+.+|+.++++++ ||||+++++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence 4689999999999999999998753 333 68999987654444556788999999999998 999999999998765
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEccccccccc
Confidence 88999999999999998764 5699999999999999999999999999999999999995 4567999999999876
Q ss_pred CCCCc----eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 222 KPGDV----FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 222 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
..... .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+......++. ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcC
Confidence 54332 123457888999999864 58899999999999999999 99999999988888888776554443 247
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
++.++.++|.+||..||++|||+.+++++
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 89999999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=365.27 Aligned_cols=249 Identities=22% Similarity=0.388 Sum_probs=213.3
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.+...++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|+.++ ||||+++++++. ..
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KE 255 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS----BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SS
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC----ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-CC
Confidence 45556789999999999999999999864 6789999987532 34678999999999998 999999999986 56
Q ss_pred eEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLAR 332 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGG
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCce
Confidence 789999999999999999754 368999999999999999999999999999999999999 556789999999998
Q ss_pred ccCCCCc--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 220 FFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 220 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
....... .....+|+.|+|||++. +.++.++|||||||++|+|++ |..||.+.+..++...+..+.. .+ ....
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~--~~~~ 409 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-MP--RPEN 409 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-CC--CCTT
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCC
Confidence 7643221 12334678899999986 569999999999999999999 9999999998888888876532 22 2246
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+++++.+||.+||..||++|||+.++++
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 8999999999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=340.45 Aligned_cols=250 Identities=20% Similarity=0.347 Sum_probs=212.8
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
..+...++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++ ||||+++++++.+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ- 79 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCC-CcCcceEEEEEcC-
Confidence 34556689999999999999999999976 46789999986532 23567899999999998 9999999999864
Q ss_pred CeEEEEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
+..++||||+.|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLA 156 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCccc
Confidence 55899999999999999886543 69999999999999999999999999999999999999 46678999999999
Q ss_pred cccCCCCce--ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 219 VFFKPGDVF--KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 219 ~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
......... ....+++.|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+..+.... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 233 (279)
T 1qpc_A 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPD 233 (279)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCT
T ss_pred ccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---Ccc
Confidence 876543321 2345678899999986 458999999999999999999 999999988888888777653322 224
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.++.++.++|.+||..||++|||+.++++
T Consensus 234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 234 NCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 67899999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=375.89 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=205.4
Q ss_pred ccceeecc-eecccCCeEEEEEEEcC--CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 66 RNTYIFGR-ELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 66 ~~~y~~~~-~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.+++.+.+ .||+|+||.||+|.++. ++..||||++.... .....+.+.+|+++|++++ ||||+++++++.+ +.
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EA 409 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SS
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CC
Confidence 44566655 89999999999998763 45679999987542 3345688999999999998 9999999999976 56
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+|+|||||.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTTTC
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCcccc
Confidence 89999999999999998654 4599999999999999999999999999999999999995 4567999999999876
Q ss_pred CCCCce----ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 222 KPGDVF----KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 222 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
...... ....+|+.|+|||++. +.++.++|||||||++|+|++ |..||.+.+..++...+..+.... ....
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~ 563 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPE 563 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC---CCTT
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCCc
Confidence 433211 1234568899999986 569999999999999999998 999999988888888887764321 1246
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHh
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVL 322 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l 322 (420)
+++++.+||.+||+.||++|||+.+++
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 899999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=346.61 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=200.3
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+.+|+++..+..++.+....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 456789999999999999999999999999999998764332 134788999999999444455555556788899
Q ss_pred EEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999 9999999875 4579999999999999999999999999999999999999544566789999999998765
Q ss_pred CCCc--------eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCC
Q 014704 223 PGDV--------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETE---QSIFDAILRGHIDFSS 290 (420)
Q Consensus 223 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~ 290 (420)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+..+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 4322 234579999999999865 589999999999999999999999976432 1222222222222111
Q ss_pred -CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 291 -DPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 291 -~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.....+++++.+||.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 112357899999999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=350.76 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=203.5
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE----eC
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE----DR 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~----~~ 140 (420)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.++ ||||+++++++. ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCC
Confidence 457899999999999999999999999999999998642 3456678999999999998 999999999986 34
Q ss_pred CeEEEEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 141 HSVNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
...|+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecC
Confidence 578999999999999998876 4679999999999999999999999999999999999999 556779999999
Q ss_pred cccccCCCC----------ceecccCCcccccchhhcc----cCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHH
Q 014704 217 LSVFFKPGD----------VFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGET--EQSIFDA 280 (420)
Q Consensus 217 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~DvwslGvil~~ll~g~~pf~~~~--~~~~~~~ 280 (420)
++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.... .......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 887653211 0123457999999999853 36899999999999999999999995311 0111222
Q ss_pred HHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 281 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+.. ...++ ..+.++.++.++|.+||+.||.+|||+.+++++
T Consensus 260 ~~~-~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 VQN-QLSIP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHC-C--CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhc-cCCCC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 222 22222 235689999999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=350.22 Aligned_cols=249 Identities=23% Similarity=0.388 Sum_probs=206.8
Q ss_pred ccceeecceecccCCeEEEEEE----EcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE--e
Q 014704 66 RNTYIFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE--D 139 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~--~ 139 (420)
.++|++.+.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.++++++ ||||+++++++. +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence 3689999999999999999999 4678899999998653 3455677999999999998 999999999886 5
Q ss_pred CCeEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
...+|+||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccc
Confidence 6679999999999999999976 45699999999999999999999999999999999999995 4567999999999
Q ss_pred cccCCCCc----eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHH---------------HHH
Q 014704 219 VFFKPGDV----FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ---------------SIF 278 (420)
Q Consensus 219 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~---------------~~~ 278 (420)
........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 87654332 123468888999999864 5899999999999999999999998654322 222
Q ss_pred HHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 279 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..+..+. ..+ ....+++++.+||.+||+.||++|||+.+++++
T Consensus 255 ~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQ-RLP--APPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhccc-CCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2233322 222 234789999999999999999999999999654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=343.22 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=206.8
Q ss_pred ccceeecceecccCCeEEEEEEEcCCC---ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE-EeCC
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTK---QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY-EDRH 141 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~-~~~~ 141 (420)
..+|.+.+.||+|+||.||+|.+..++ ..+|+|.+... ......+.+.+|+.++++++ ||||+++++++ .+++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCC
Confidence 457999999999999999999976433 35899988642 24456678999999999998 99999999985 5567
Q ss_pred eEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
..++||||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECccccccc
Confidence 889999999999999999764 458999999999999999999999999999999999999 5667899999999986
Q ss_pred cCCCC-----ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 014704 221 FKPGD-----VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (420)
Q Consensus 221 ~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 293 (420)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++ |.+||.+.........+..+......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP--- 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence 64322 2234567889999999864 58999999999999999999 67778777776677777766544332
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
..++..+.++|.+||+.||++|||+.++++
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 357899999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=341.30 Aligned_cols=243 Identities=23% Similarity=0.383 Sum_probs=200.0
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-CCeE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-RHSV 143 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-~~~~ 143 (420)
..++|.+.+.||+|+||.||+|.+. |+.||+|++... ...+.+.+|+.++++++ ||||+++++++.+ .+.+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-----hHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCce
Confidence 4578999999999999999999874 789999998643 24567899999999998 9999999998754 4578
Q ss_pred EEEEecCCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 144 NLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
|+||||+++++|.+++...+. +++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccc
Confidence 999999999999999976543 8999999999999999999999999999999999999 45678999999998765
Q ss_pred CCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+.. ......+++.
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 242 (278)
T 1byg_A 168 SST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPA 242 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHH
T ss_pred ccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHH
Confidence 432 23346788999999986 458999999999999999998 9999998887777776655422 1223468999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+.++|.+||+.||++|||+.++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 243 VYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCCCHHHHHH
Confidence 999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=384.57 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=212.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe------C
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED------R 140 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~------~ 140 (420)
++|.+.+.||+|+||.||+|.+..+|+.||||++... ......+.+.+|+.++++++ ||||+++++++.+ .
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccCC
Confidence 6799999999999999999999999999999998653 24556678999999999998 9999999998765 6
Q ss_pred CeEEEEEecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
+..|+|||||+|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++....+||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 77899999999999999998654 589999999999999999999999999999999999997655555699999999
Q ss_pred ccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--------------HH
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDA--------------IL 282 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~--------------i~ 282 (420)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+......+.. ..
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 99877666666778999999999986 4689999999999999999999999977543321100 01
Q ss_pred cCCCCCCC------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 283 RGHIDFSS------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 283 ~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.+...+.. .....+++.+.+||.+||..||++|||+.++++||||+
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~ 302 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence 11111111 11223568899999999999999999999999999995
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=351.41 Aligned_cols=261 Identities=20% Similarity=0.278 Sum_probs=206.4
Q ss_pred cccccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 59 GKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 59 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
........++|.+.+.||+|+||.||+|.+. +|+.||+|++..... ......+.+|+.+++.+. ||||+++++++.
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 97 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCM 97 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEEC
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccC--chHHHHHHHHHHHHHhcc-CCCccceEEEEe
Confidence 3445566789999999999999999999864 588999999875432 122236899999999999 999999999999
Q ss_pred eCCeEEEEEecCCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCeeccCCCCcEEEecCCCCCCee
Q 014704 139 DRHSVNLIMDLCAGGELFDRIIAKG----HYSERAAANLCRQMVTVVHYCHSM---GVMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 139 ~~~~~~iv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
+.+..++||||+.|++|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||+ +.++.+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~k 174 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAV 174 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEE
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEE
Confidence 9999999999999999999997643 399999999999999999999999 99999999999999 5667899
Q ss_pred EeecccccccCCCC--ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHcC
Q 014704 212 ATDFGLSVFFKPGD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGE----TEQSIFDAILRG 284 (420)
Q Consensus 212 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~----~~~~~~~~i~~~ 284 (420)
|+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||... ............
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999998764332 334456999999999985 46899999999999999999999999521 111111111111
Q ss_pred CCCCC-----------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCc
Q 014704 285 HIDFS-----------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326 (420)
Q Consensus 285 ~~~~~-----------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 326 (420)
..... .......+..+.+++.+||+.||++|||+.++++|-+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 11000 0001122367899999999999999999999998854
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=340.42 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=206.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCc---eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
..|.+.+.||+|+||.||+|.+..++. .||+|.+... ......+.+.+|+.+++.++ ||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCC
Confidence 467788999999999999999765544 7999998642 24456678999999999998 99999999999876655
Q ss_pred -EEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 144 -NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 144 -~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDI 174 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTT
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccc
Confidence 999999999999999976 3568999999999999999999999999999999999999 56678999999999765
Q ss_pred CCCC-----ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 222 KPGD-----VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 222 ~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
.... ......+|+.|+|||.+.+ .++.++||||||+++|+|++ |.+||...........+..+..... ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 251 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---PE 251 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---CT
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---Cc
Confidence 4322 2234567899999999865 58999999999999999999 5555666666666666665543222 24
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+++.+.++|.+||+.||.+|||+.++++
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 67899999999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=357.59 Aligned_cols=257 Identities=17% Similarity=0.203 Sum_probs=198.0
Q ss_pred cccceeecceecccCCeEEEEEEEcC---CCceEEEEEecCCcCCChh--------hHHHHHHHHHHHHhccCCCCccEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRD--------DVEDVRREVQIMHHLTGHRNIVEL 133 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~~hpniv~~ 133 (420)
..++|.+.+.||+|+||.||+|.+.. ++..+|+|++......... ....+.+|+..++.+. ||||+++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~ 113 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLF 113 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCccee
Confidence 45789999999999999999999987 7889999998754211000 1134667888888888 9999999
Q ss_pred EEEEEe----CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCC
Q 014704 134 KGAYED----RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSP 209 (420)
Q Consensus 134 ~~~~~~----~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~ 209 (420)
++++.+ ...+|+||||+ |++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ ...
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~ 191 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQ 191 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TTS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CCc
Confidence 999987 78899999999 999999998777899999999999999999999999999999999999996432 238
Q ss_pred eeEeecccccccCCCC--------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCC--CHHHHH
Q 014704 210 LKATDFGLSVFFKPGD--------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGE--TEQSIF 278 (420)
Q Consensus 210 ~kl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~--~~~~~~ 278 (420)
+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. ......
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999998764221 1234579999999999875 4899999999999999999999999652 222222
Q ss_pred HHHHcCCCCCCC-----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 279 DAILRGHIDFSS-----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 279 ~~i~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..........+. .....++.++.++|.+||..||++|||+.++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 211111111110 0012678999999999999999999999999753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=346.47 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=203.4
Q ss_pred cccce-eecceecccCCeEEEEEEE----cCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 65 VRNTY-IFGRELGRGQFGVTYLVTH----KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 65 ~~~~y-~~~~~lG~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
+.++| ++.+.||+|+||.||++.. ..+++.||+|++... ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCED 104 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCC-CcchhhEEEEEec
Confidence 44555 9999999999999988764 457889999999754 24455678999999999999 9999999999987
Q ss_pred --CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 140 --RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 140 --~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
...+++||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGL 180 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGG
T ss_pred CCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCccc
Confidence 46889999999999999988654 59999999999999999999999999999999999999 5667899999999
Q ss_pred ccccCCCCc----eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHH---------------HH
Q 014704 218 SVFFKPGDV----FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ---------------SI 277 (420)
Q Consensus 218 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~---------------~~ 277 (420)
+........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ..
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 988755432 234568889999999864 5889999999999999999999999654321 11
Q ss_pred HHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 278 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
...+..+ ...+ ....++.++.+||++||+.||++|||+.++++
T Consensus 261 ~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 261 TELLERG-ERLP--RPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHTT-CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcc-cCCC--CCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2222222 2222 22468999999999999999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=360.89 Aligned_cols=254 Identities=22% Similarity=0.389 Sum_probs=210.2
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.+...++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|++++ ||||+++++++.+ +
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E 251 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-C
Confidence 44556789999999999999999999976 4679999987543 23467899999999998 9999999999876 6
Q ss_pred eEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccce
Confidence 789999999999999999643 569999999999999999999999999999999999999 456779999999998
Q ss_pred ccCCCC--ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 220 FFKPGD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 220 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
...... ......+++.|+|||++. +.++.++||||||+++|+|++ |..||.+....++...+..+.. .+ ....
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~--~~~~ 405 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP--CPPE 405 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CC--CCTT
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCC
Confidence 764332 122345678899999886 568999999999999999999 9999999988888888876532 12 1246
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhc--CCccc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLN--HPWMR 328 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~ 328 (420)
+++.+.+||.+||+.||++|||+.++++ ..++.
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 8899999999999999999999999986 34554
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=343.33 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=196.0
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHh--ccCCCCccEEEEEEEe-
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH--LTGHRNIVELKGAYED- 139 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~hpniv~~~~~~~~- 139 (420)
..+.++|.+.+.||+|+||.||+|.+ +++.||||++... ....+.+|.+++.. ++ ||||+++++++.+
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLR-HENILGFIASDMTS 74 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCC-CTTBCCEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhcc-CcCeeeEEEeeccc
Confidence 34668999999999999999999988 5789999998532 34566677777777 66 9999999998654
Q ss_pred ---CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeeccCCCCcEEEecCCCCC
Q 014704 140 ---RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH--------SMGVMHRDLKPENFLFSSSAEDS 208 (420)
Q Consensus 140 ---~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH--------~~~ivH~Dlkp~Nill~~~~~~~ 208 (420)
...+|+||||+++|+|.+++. ...+++..+..++.||+.||.||| ++||+||||||+|||+ +.++
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~ 150 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNG 150 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTS
T ss_pred cCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCC
Confidence 356899999999999999884 457999999999999999999999 9999999999999999 4567
Q ss_pred CeeEeecccccccCCCCce-----ecccCCcccccchhhccc-------CCCccchhhhHHHHHHHHhC----------C
Q 014704 209 PLKATDFGLSVFFKPGDVF-----KDLVGSAYYVAPEVLRRN-------YGAEADIWSAGVILYILLSG----------V 266 (420)
Q Consensus 209 ~~kl~Dfg~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-------~~~~~DvwslGvil~~ll~g----------~ 266 (420)
.+||+|||++......... ....||+.|+|||++.+. ++.++|||||||++|+|++| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 8999999999765433221 234799999999998643 45789999999999999999 8
Q ss_pred CCCCCCC----HHHHHHHHHcCCCCCCCCC----CCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 267 PPFWGET----EQSIFDAILRGHIDFSSDP----WPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 267 ~pf~~~~----~~~~~~~i~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.||.... ...............+..+ ....+.++.+||.+||+.||++|||+.++++
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 8885532 2223333322211111110 0123467999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=362.61 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=209.7
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.+.+|++|..+..++.+.+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 456889999999999999999999999999999998765432 134789999999999667888888888889999
Q ss_pred EEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|||||+ |++|.+++.. .+.+++..+..|+.||+.||.|||++||+||||||+|||+...+.++.+||+|||+++...
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 9999999975 4679999999999999999999999999999999999999654467789999999998765
Q ss_pred CCCc--------eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCC
Q 014704 223 PGDV--------FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAILRGHIDFSS 290 (420)
Q Consensus 223 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~ 290 (420)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ....+..+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 4322 125679999999999865 58999999999999999999999997643 33344443332211111
Q ss_pred -CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 291 -DPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 291 -~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.....++.++.+||..||..||++||++.++++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111367899999999999999999999998864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=355.59 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=199.8
Q ss_pred cceeecceecccCCeEEEEEEEcCCC---ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE-eCCe
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTK---QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE-DRHS 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~-~~~~ 142 (420)
..|.+.+.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+.++++++ ||||+++++++. .++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCC
Confidence 45889999999999999999986433 46899988642 24456788999999999998 999999999864 4568
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccc
Confidence 89999999999999999765 458999999999999999999999999999999999999 56678999999999865
Q ss_pred CCCC-----ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 222 KPGD-----VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 222 ~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
.... ......+|+.|+|||++. ..++.++||||||+++|+|++ |.+||.+.+..+....+..+...... .
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p---~ 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---E 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC---T
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC---C
Confidence 4322 123345788999999986 468999999999999999999 78888877766666666665433222 4
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.++..+.++|.+||+.||++|||+.+++++
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 678999999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=353.40 Aligned_cols=245 Identities=16% Similarity=0.212 Sum_probs=201.1
Q ss_pred ccceeecceecccCCeEEEEEEEcCC--------CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccE-----
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDT--------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVE----- 132 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~----- 132 (420)
.++|.+.+.||+|+||.||+|.+..+ ++.||+|++... +.+.+|+.+++++. ||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence 47899999999999999999999874 889999998643 35789999999998 999887
Q ss_pred ----------EEEEEEe-CCeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcE
Q 014704 133 ----------LKGAYED-RHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENF 199 (420)
Q Consensus 133 ----------~~~~~~~-~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 199 (420)
+++++.. ...+|+||||+ |++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6777766 78899999999 99999999876 7799999999999999999999999999999999999
Q ss_pred EEecCCCCC--CeeEeecccccccCCCC--------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCC
Q 014704 200 LFSSSAEDS--PLKATDFGLSVFFKPGD--------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPP 268 (420)
Q Consensus 200 ll~~~~~~~--~~kl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~p 268 (420)
|++ .++ .+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..|
T Consensus 191 l~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 191 FVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 995 344 79999999997654321 1234579999999999875 689999999999999999999999
Q ss_pred CCCCC--HHHHHHHH---HcCCCCCC--CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 269 FWGET--EQSIFDAI---LRGHIDFS--SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 269 f~~~~--~~~~~~~i---~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
|.+.. ...+.... ......+. ...+..+++++.+||.+||..||++|||+.++++
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 98753 33333222 22222221 1223467899999999999999999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=345.21 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=204.0
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcC-CChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-INRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
.|..++.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++ ||||+++++++.+.+..++|
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEE
Confidence 455669999999999999986 578999999875432 23345678999999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 147 MDLCAGGELFDRIIA---KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEK 185 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeeccccccccc
Confidence 999999999999874 3459999999999999999999999999999999999999 5667899999999887543
Q ss_pred CC---ceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCC-------C
Q 014704 224 GD---VFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQS----IFDAILRGHIDF-------S 289 (420)
Q Consensus 224 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~-------~ 289 (420)
.. ......||+.|+|||++.+.++.++||||||+++|+|++|..||....... +...+......+ .
T Consensus 186 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 186 FAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp CSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred ccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 22 123457999999999998889999999999999999999999997654322 222222221110 0
Q ss_pred CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 290 SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 290 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.......+..+.+++.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01112234678999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=348.74 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=210.6
Q ss_pred cccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
..+...++|.+.+.||+|+||.||+|.+.. .+|+|++..... .....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMSP 101 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecC
Confidence 334456789999999999999999999864 499999875432 2333456789999999998 99999999999999
Q ss_pred CeEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
..+++||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFS 177 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcc
Confidence 99999999999999999987654 699999999999999999999999999999999999994 4579999999987
Q ss_pred ccCC------CCceecccCCcccccchhhcc----------cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Q 014704 220 FFKP------GDVFKDLVGSAYYVAPEVLRR----------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILR 283 (420)
Q Consensus 220 ~~~~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~ 283 (420)
.... ........||+.|+|||++.. .++.++||||||+++|+|++|..||.+.........+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 257 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 5431 122234568999999999853 368899999999999999999999999988888877776
Q ss_pred CCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 284 GHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+...... ...++.++.++|.+||..||++|||+.++++.
T Consensus 258 ~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 258 GMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp TCCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 6443222 23578899999999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=340.13 Aligned_cols=241 Identities=29% Similarity=0.466 Sum_probs=194.7
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||.||+|.+. ++.||+|.+.. ....+.+.+|+.++++++ ||||+++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS-----TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC-----hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--CcEEE
Confidence 57999999999999999999885 68899999853 234578999999999998 9999999998764 47999
Q ss_pred EecCCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 147 MDLCAGGELFDRIIAKG---HYSERAAANLCRQMVTVVHYCHS---MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
|||++|++|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+||+++. +...+||+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA--GGTVLKICDFGTACD 155 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEET--TTTEEEECCCCC---
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeC--CCCEEEEcccccccc
Confidence 99999999999998665 37899999999999999999999 89999999999999953 223489999999976
Q ss_pred cCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 221 FKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET--EQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 221 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... .......+..+... .....++
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 230 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP---PLIKNLP 230 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC---CCBTTCC
T ss_pred cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC---CcccccC
Confidence 5432 234569999999999865 58999999999999999999999997543 33344444443221 2235789
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..+.++|.+||+.||++|||+.+++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=351.65 Aligned_cols=249 Identities=18% Similarity=0.249 Sum_probs=198.4
Q ss_pred cccccceeecceecccCCeEEEEEE-----EcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccC--CCCccEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG--HRNIVELKG 135 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--hpniv~~~~ 135 (420)
+...++|.+.+.||+|+||.||+|. +..+++.||+|++... ....+.+|+.+++.+.. |+||+++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3445789999999999999999994 6678899999998643 23567788888887753 899999999
Q ss_pred EEEeCCeEEEEEecCCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEec-------
Q 014704 136 AYEDRHSVNLIMDLCAGGELFDRIIA-----KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSS------- 203 (420)
Q Consensus 136 ~~~~~~~~~iv~e~~~g~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~------- 203 (420)
++...+..|+|||||+||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999999974 456999999999999999999999999999999999999964
Q ss_pred -CCCCCCeeEeecccccccC---CCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Q 014704 204 -SAEDSPLKATDFGLSVFFK---PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIF 278 (420)
Q Consensus 204 -~~~~~~~kl~Dfg~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~ 278 (420)
...++.+||+|||+++... ........+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 1226789999999996543 3344566789999999999865 489999999999999999999999965432100
Q ss_pred HHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 014704 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHP 325 (420)
Q Consensus 279 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 325 (420)
.....+.. ...++.+.+++..||+.+|.+|++..+.+.+.
T Consensus 294 ----~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 294 ----KPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp ----EECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ----eechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 00001111 12367889999999999999997665555443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=340.18 Aligned_cols=229 Identities=15% Similarity=0.101 Sum_probs=189.8
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.++..+. ||||+++++++.+.+..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcE
Confidence 46678999999999999999999999999999999998765555566788999999999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+||||++|++|.+++.. + .....+..++.||+.||.|||++||+||||||+|||++ .++.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC-------
T ss_pred EEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc-------
Confidence 999999999999998843 3 46667899999999999999999999999999999995 56678887543
Q ss_pred CCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---HHHcCCCCCCCCCCCCCChHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFD---AILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~ 300 (420)
|++| ++.++|||||||++|+|++|+.||.+.+....+. ....+.........+.+++++
T Consensus 175 ------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 ------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred ------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 3333 6789999999999999999999998765432110 111111111112235689999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcC
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.+||.+||+.||++| |+.++++.
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHH
Confidence 999999999999999 99999763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=363.50 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=214.6
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.+...++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|++++ ||||+++++++.+ +
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-E 334 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEee-c
Confidence 44556789999999999999999999976 4679999987543 23467899999999999 9999999999876 6
Q ss_pred eEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+||||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 411 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTT
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccce
Confidence 789999999999999999643 569999999999999999999999999999999999999 456779999999998
Q ss_pred ccCCCCc--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 220 FFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 220 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
....... .....++..|+|||++. +.++.++|||||||++|+|++ |..||.+....+++..+..+.. .+ ....
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~--~~~~ 488 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP--CPPE 488 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-CC--CCTT
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCC
Confidence 7643211 12335678899999885 568999999999999999999 9999999988888888876532 21 1246
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcC--Cccc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNH--PWMR 328 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h--~~~~ 328 (420)
++.++.+||.+||+.||++|||+.++++. .++.
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 88999999999999999999999999863 4443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=347.17 Aligned_cols=250 Identities=21% Similarity=0.329 Sum_probs=194.6
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhc--cCCCCccEEEEEEEe
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL--TGHRNIVELKGAYED 139 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~hpniv~~~~~~~~ 139 (420)
...+.++|.+.+.||+|+||.||+|.+. ++.||||++... ......+|.+++..+ . ||||+++++++.+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMR-HENILGFIAADIK 102 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEE
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhc-CCCeeeEEEEEcc
Confidence 3556789999999999999999999885 789999998532 234455566666554 5 9999999999988
Q ss_pred C----CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeccCCCCcEEEecCCCC
Q 014704 140 R----HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM--------GVMHRDLKPENFLFSSSAED 207 (420)
Q Consensus 140 ~----~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~ivH~Dlkp~Nill~~~~~~ 207 (420)
. ..+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++ ||+||||||+|||+ +.+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~ 178 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKN 178 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTT
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCC
Confidence 7 789999999999999999865 4799999999999999999999999 99999999999999 456
Q ss_pred CCeeEeecccccccCCCCce-----ecccCCcccccchhhccc-CCCc------cchhhhHHHHHHHHhC----------
Q 014704 208 SPLKATDFGLSVFFKPGDVF-----KDLVGSAYYVAPEVLRRN-YGAE------ADIWSAGVILYILLSG---------- 265 (420)
Q Consensus 208 ~~~kl~Dfg~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~------~DvwslGvil~~ll~g---------- 265 (420)
+.+||+|||++......... ....||+.|+|||++.+. ++.. +|||||||++|+|++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 78999999999766433221 245799999999998653 3443 8999999999999999
Q ss_pred CCCCCCCC-----HHHHHHHHHcCCCCCCCCC---CCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 266 VPPFWGET-----EQSIFDAILRGHIDFSSDP---WPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 266 ~~pf~~~~-----~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..||.... .......+.........+. ...+++++.+||.+||+.||++|||+.++++|
T Consensus 259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 77775421 1222222222221111110 01345679999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=343.42 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=202.3
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHh--ccCCCCccEEEEEEEeC
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH--LTGHRNIVELKGAYEDR 140 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~hpniv~~~~~~~~~ 140 (420)
..+.++|.+.+.||+|+||.||+|.+ +|+.||||++.. .....+.+|++++.. ++ ||||+++++++...
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~------~~~~~~~~e~~~~~~~~l~-h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS------REERSWFREAEIYQTVMLR-HENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG------GGHHHHHHHHHHHHHSCCC-CTTBCCEEEEEECC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc------hhHHHHHHHHHHHHHhhcC-CCcEEEEEeeeccc
Confidence 45678999999999999999999998 478999999853 234678889999988 56 99999999999877
Q ss_pred C----eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeeccCCCCcEEEecCCCCC
Q 014704 141 H----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCH--------SMGVMHRDLKPENFLFSSSAEDS 208 (420)
Q Consensus 141 ~----~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH--------~~~ivH~Dlkp~Nill~~~~~~~ 208 (420)
. .+|+||||+++|+|.+++.+ ..+++..+..++.|++.||.||| ++||+||||||+|||+ +.++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~ 184 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNG 184 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTS
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCC
Confidence 6 89999999999999999865 46999999999999999999999 8999999999999999 5567
Q ss_pred CeeEeecccccccCCCCc-----eecccCCcccccchhhccc-------CCCccchhhhHHHHHHHHhC----------C
Q 014704 209 PLKATDFGLSVFFKPGDV-----FKDLVGSAYYVAPEVLRRN-------YGAEADIWSAGVILYILLSG----------V 266 (420)
Q Consensus 209 ~~kl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DvwslGvil~~ll~g----------~ 266 (420)
.+||+|||++........ .....||+.|+|||++.+. ++.++||||||+++|+|++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 899999999987654332 2345799999999998653 33689999999999999999 7
Q ss_pred CCCCCCC-----HHHHHHHHHcCCCCCCCCC-C--CCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 267 PPFWGET-----EQSIFDAILRGHIDFSSDP-W--PNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 267 ~pf~~~~-----~~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.||.... .......+........... + ...+..+.+||.+||+.||++|||+.++++|
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 8986642 3344444433332221110 0 1233578999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=339.21 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=203.5
Q ss_pred cccceeecceecccCCeEEEEEE----EcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVT----HKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
..++|.+.+.||+|+||.||+|. +..+++.||+|++... .....+.+.+|+.++++++ ||||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA 114 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC-
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEec
Confidence 45679999999999999999998 4567899999998653 3455678999999999998 99999999998654
Q ss_pred C--eEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 141 H--SVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 141 ~--~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
+ .+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcc
Confidence 3 789999999999999999876 4599999999999999999999999999999999999995 456799999999
Q ss_pred ccccCCCCce----ecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHH----------------H
Q 014704 218 SVFFKPGDVF----KDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQ----------------S 276 (420)
Q Consensus 218 ~~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~----------------~ 276 (420)
+......... ....++..|+|||++.+ .++.++||||||+++|+|++|..||...... .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 9876544321 23457788999999864 5889999999999999999999998543111 1
Q ss_pred HHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 277 IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 277 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
+...+..+ ...+ ....++.++.++|.+||..||++|||+.++++
T Consensus 272 ~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNN-GRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTT-CCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcC-CCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11222222 1122 23468999999999999999999999999974
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=351.23 Aligned_cols=251 Identities=16% Similarity=0.218 Sum_probs=198.9
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC-----ChhhHHHHHHHHHHHHhcc--------CCCCccE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-----NRDDVEDVRREVQIMHHLT--------GHRNIVE 132 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~hpniv~ 132 (420)
.++|.+.+.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ .||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999998 6799999999765321 2344578999999999986 5888888
Q ss_pred EEEEEE------------------------------eCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 014704 133 LKGAYE------------------------------DRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182 (420)
Q Consensus 133 ~~~~~~------------------------------~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~ 182 (420)
+.+++. +.+.+|+|||||++|++.+.+.+ +.+++..+..++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 887653 26889999999999987776643 67899999999999999999
Q ss_pred HHH-HcCCeeccCCCCcEEEecCCC-----------------CCCeeEeecccccccCCCCceecccCCcccccchhhcc
Q 014704 183 YCH-SMGVMHRDLKPENFLFSSSAE-----------------DSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244 (420)
Q Consensus 183 ~lH-~~~ivH~Dlkp~Nill~~~~~-----------------~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 244 (420)
||| ++||+||||||+|||++.++. ...+||+|||+++..... ..+||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 999999999999999975431 127999999999876543 3479999999999987
Q ss_pred cCCCccchhhhHHH-HHHHHhCCCCCCCCCH-HHHHHHHHcCC-CC--CCCCCCCCCChHHHHHHHHhcccCcCCCCCHH
Q 014704 245 NYGAEADIWSAGVI-LYILLSGVPPFWGETE-QSIFDAILRGH-ID--FSSDPWPNISSSAKDIVKKMLHADPKERLSAA 319 (420)
Q Consensus 245 ~~~~~~DvwslGvi-l~~ll~g~~pf~~~~~-~~~~~~i~~~~-~~--~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 319 (420)
..+.++||||+|++ .+++++|..||.+... ......+.... .. .....++.+++++++||++||+.| |+.
T Consensus 252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 77889999998776 7789999999843211 12233333221 11 111112357889999999999977 999
Q ss_pred HHh-cCCccc
Q 014704 320 EVL-NHPWMR 328 (420)
Q Consensus 320 e~l-~h~~~~ 328 (420)
|+| +||||+
T Consensus 327 e~l~~Hp~f~ 336 (336)
T 2vuw_A 327 DLLCQHSLFK 336 (336)
T ss_dssp HHHHHCGGGC
T ss_pred HHHhcCCCcC
Confidence 999 999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=357.30 Aligned_cols=247 Identities=16% Similarity=0.185 Sum_probs=193.0
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC-CCc--------------
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNI-------------- 130 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pni-------------- 130 (420)
...|.+++.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+. | .|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccchh
Confidence 345889999999999999999999999999999987544444445678999999999987 5 321
Q ss_pred -------cEEEEEEEe-----CCeEEEEEecCCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 014704 131 -------VELKGAYED-----RHSVNLIMDLCAGGELFDRIIA-------KGHYSERAAANLCRQMVTVVHYCHSMGVMH 191 (420)
Q Consensus 131 -------v~~~~~~~~-----~~~~~iv~e~~~g~~L~~~l~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH 191 (420)
..+..++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 111121221 23467788876 6799887741 234778889999999999999999999999
Q ss_pred ccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecccCCcccccchhh----------cc-cCCCccchhhhHHHHH
Q 014704 192 RDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL----------RR-NYGAEADIWSAGVILY 260 (420)
Q Consensus 192 ~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~DvwslGvil~ 260 (420)
|||||+|||+ +.++.+||+|||+++.... .....+| +.|+|||++ .. .++.++|||||||++|
T Consensus 235 rDiKp~NILl---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEE---CTTCCEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CCcccceEEE---ecCCeEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999 5566799999999886543 2455678 999999988 32 3788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 261 ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 261 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
+|++|+.||.+.........+. ..+..+++++.+||.+||+.||++|||+.++++||||+
T Consensus 309 elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred HHHHCCCCCCCcchhhhHHHHH--------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 9999999998765443332222 22346889999999999999999999999999999996
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=363.32 Aligned_cols=251 Identities=26% Similarity=0.368 Sum_probs=210.5
Q ss_pred cccccceeecceecccCCeEEEEEEEcCC---CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDT---KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
+...++|.+++.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.++++++ ||||+++++++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~- 461 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT- 461 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-
Confidence 44567899999999999999999998654 457999987643 23455678999999999998 999999999985
Q ss_pred CCeEEEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
++..|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS 538 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCC
Confidence 466899999999999999998654 699999999999999999999999999999999999995 4567999999999
Q ss_pred cccCCCCc--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 219 VFFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 219 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+.... ..+
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~ 615 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPP 615 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCT
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCc
Confidence 87654332 22345778999999986 458999999999999999997 999999999888888887764322 224
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.+++.+.+||.+||..||++|||+.++++
T Consensus 616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 616 NCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 68899999999999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.50 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=188.8
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHH--HHhccCCCCccEEEEEEEe----
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI--MHHLTGHRNIVELKGAYED---- 139 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~--l~~l~~hpniv~~~~~~~~---- 139 (420)
.++|.+.+.||+|+||.||+|.+ +++.||||++.... ...+..|..+ +..+. ||||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLME-HDNIARFIVGDERVTAD 82 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECTT
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhcc-CcchhhheecccccccC
Confidence 36899999999999999999976 57899999986422 2334444444 44567 9999999986542
Q ss_pred -CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeeccCCCCcEEEecCCCCCC
Q 014704 140 -RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM---------GVMHRDLKPENFLFSSSAEDSP 209 (420)
Q Consensus 140 -~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---------~ivH~Dlkp~Nill~~~~~~~~ 209 (420)
...+|+|||||+||+|.+++... ..++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCc
Confidence 33678999999999999998654 458999999999999999999999 99999999999999 45678
Q ss_pred eeEeecccccccCCCC---------ceecccCCcccccchhhcc--------cCCCccchhhhHHHHHHHHhCCCCCCCC
Q 014704 210 LKATDFGLSVFFKPGD---------VFKDLVGSAYYVAPEVLRR--------NYGAEADIWSAGVILYILLSGVPPFWGE 272 (420)
Q Consensus 210 ~kl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~DvwslGvil~~ll~g~~pf~~~ 272 (420)
+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999998764321 2234579999999999864 4677899999999999999997776432
Q ss_pred CH-----------------HHHHHHHH-cCCC--CCCCC--CCCCCChHHHHHHHHhcccCcCCCCCHHHHh------cC
Q 014704 273 TE-----------------QSIFDAIL-RGHI--DFSSD--PWPNISSSAKDIVKKMLHADPKERLSAAEVL------NH 324 (420)
Q Consensus 273 ~~-----------------~~~~~~i~-~~~~--~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l------~h 324 (420)
.. ........ .... .++.. ....+++++.+||.+||+.||++|||+.|++ .+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 11 11111111 1111 11110 1112345799999999999999999999994 46
Q ss_pred Cccccc
Q 014704 325 PWMRVD 330 (420)
Q Consensus 325 ~~~~~~ 330 (420)
+|-+..
T Consensus 319 ~~~~~~ 324 (336)
T 3g2f_A 319 IWERNK 324 (336)
T ss_dssp CCCC--
T ss_pred HHHhcc
Confidence 676543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=371.25 Aligned_cols=246 Identities=22% Similarity=0.335 Sum_probs=204.4
Q ss_pred cccccccceeecceecccCCeEEEEEEEcC-CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKD-TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 61 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
+++.+.++|.+.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.++++++ ||||+++++++..
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEH 150 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEee
Confidence 345677899999999999999999999976 78999999986432 3455677899999999998 9999999999987
Q ss_pred CCe-----EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEee
Q 014704 140 RHS-----VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATD 214 (420)
Q Consensus 140 ~~~-----~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~D 214 (420)
.+. .||||||++|++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++. ..+||+|
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~----~~~kl~D 224 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE----EQLKLID 224 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS----SCEEECC
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC----CcEEEEe
Confidence 665 7999999999999887654 7999999999999999999999999999999999999953 3799999
Q ss_pred cccccccCCCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 215 FGLSVFFKPGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 215 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
||++...... ....||+.|+|||++.+.++.++|||||||++|+|++|..||.+.... ... ......
T Consensus 225 FG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~-~~~~~~ 291 (681)
T 2pzi_A 225 LGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLP-EDDPVL 291 (681)
T ss_dssp CTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCC-TTCHHH
T ss_pred cccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc---------ccc-cccccc
Confidence 9999876543 456799999999999877899999999999999999999998653210 000 001111
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
..++.+.+||.+||+.||++||+..+++.|+|+.
T Consensus 292 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 292 KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 2467899999999999999999999999998874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=316.01 Aligned_cols=234 Identities=14% Similarity=0.103 Sum_probs=163.0
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCC-------hhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN-------RDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
....+.|++|.+..++....|+.||+|++.+..... ....+.+.+|+++|+++..|+||+++++++++++.+|
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 345788888888888888889999999997653321 2334679999999999977999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||||+|++|.+++...+++++. .|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC--
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCC
Confidence 999999999999999998888875 588999999999999999999999999999 56778999999999876543
Q ss_pred -CceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 -DVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
....+.+||+.|||||++.+.+..++|+||+|++++++.+|..++ ...+.. .. .. ...+..+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~-~~---~~-----~~~~~~l 455 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQ-EP---VE-----RWNFVLL 455 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHT-SC---GG-----GCSHHHH
T ss_pred CccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhc-CC---CC-----CCcHHHH
Confidence 234567899999999999988889999999999999887765443 111111 11 00 1125566
Q ss_pred HHHhcccCcCCCCCHHHHhcCCccc
Q 014704 304 VKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
...+...+|..|+.......++|..
T Consensus 456 ~~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 456 LALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HHHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred HHHHhCCCCCCCCChhhhccchhHH
Confidence 7777777787777766666666653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=259.46 Aligned_cols=184 Identities=18% Similarity=0.173 Sum_probs=143.4
Q ss_pred eecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChh-----hHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 70 IFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD-----DVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 70 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
...+.||+|+||.||+|.. .++.+++|........... ..+.+.+|++++++++ ||||+++..++.+.+..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccE
Confidence 4467899999999999943 4688999987654332221 2355899999999998 999996555555777789
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+|||||+|++|.+++.. +..++.|++.||.|||++||+||||||+|||++ . .+||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCCc
Confidence 99999999999998864 668999999999999999999999999999995 3 7999999999987543
Q ss_pred Cc--------eecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCC
Q 014704 225 DV--------FKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPF 269 (420)
Q Consensus 225 ~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf 269 (420)
.. ....+||+.|||||++.. .|+..+|+||..+-..+-+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21 135689999999999864 5888899999988888777766665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-27 Score=215.06 Aligned_cols=159 Identities=20% Similarity=0.245 Sum_probs=123.0
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh---------------hhHHHHHHHHHHHHhccCCCCcc
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR---------------DDVEDVRREVQIMHHLTGHRNIV 131 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~~hpniv 131 (420)
..|.+++.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+++++. |++++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~ 167 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVP 167 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSC
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcC
Confidence 3466679999999999999999 7899999999864321110 13567899999999998 55555
Q ss_pred EEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCee
Q 014704 132 ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLK 211 (420)
Q Consensus 132 ~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~k 211 (420)
.+ +.. +..|+||||++|++|.+ +. ......++.|++.||.|||++||+||||||+|||++ ++.+|
T Consensus 168 ~~---~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~vk 232 (282)
T 1zar_A 168 KV---YAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIW 232 (282)
T ss_dssp CE---EEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEE
T ss_pred eE---Eec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcEE
Confidence 54 433 45699999999999987 31 234557999999999999999999999999999995 56799
Q ss_pred EeecccccccCCCCceecccCCcccccchhhcc-----------cCCCccchhh
Q 014704 212 ATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR-----------NYGAEADIWS 254 (420)
Q Consensus 212 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~Dvws 254 (420)
|+|||+++. +..++|||++.+ .|+..+|+|.
T Consensus 233 l~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 233 IIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp ECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999864 445889998753 3555666665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.2e-24 Score=192.64 Aligned_cols=141 Identities=13% Similarity=0.117 Sum_probs=109.0
Q ss_pred ceeecceecccCCeEEEEEEEcCCCce--EEEEEecCCcCC--C-------------------hhhHHHHHHHHHHHHhc
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQ--FACKSISSRKLI--N-------------------RDDVEDVRREVQIMHHL 124 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~--~-------------------~~~~~~~~~E~~~l~~l 124 (420)
.|.+.+.||+|+||.||+|.+..+|+. ||||++...... . ......+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478899999999999999999778889 999987543211 0 01123688999999999
Q ss_pred cCCCCc--cEEEEEEEeCCeEEEEEecCCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeeccCCC
Q 014704 125 TGHRNI--VELKGAYEDRHSVNLIMDLCAG-G----ELFDRIIAKGHYSERAAANLCRQMVTVVHYCH-SMGVMHRDLKP 196 (420)
Q Consensus 125 ~~hpni--v~~~~~~~~~~~~~iv~e~~~g-~----~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp 196 (420)
. |+++ +.++++ +..++||||+.+ | +|.+.... .++..+..++.|++.+|.||| +.||+||||||
T Consensus 128 ~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 K-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp H-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred H-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8 7754 445543 356899999942 3 66655422 235577899999999999999 99999999999
Q ss_pred CcEEEecCCCCCCeeEeeccccccc
Q 014704 197 ENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 197 ~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+|||++ . .++|+|||+|...
T Consensus 200 ~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEES---S--SEEECCCTTCEET
T ss_pred HHEEEc---C--cEEEEECcccccC
Confidence 999994 3 7999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5.3e-20 Score=174.19 Aligned_cols=142 Identities=17% Similarity=0.203 Sum_probs=102.1
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC-----------ChhhH--------HHHHHHHHHHHhccCCC
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-----------NRDDV--------EDVRREVQIMHHLTGHR 128 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----------~~~~~--------~~~~~E~~~l~~l~~hp 128 (420)
.|.+++.||.|+||.||+|.+. +|+.||||+++..... ..... -...+|...|.++. ++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~ 173 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE 173 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence 4899999999999999999985 5899999987532110 00000 11246778888886 55
Q ss_pred Ccc--EEEEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC
Q 014704 129 NIV--ELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206 (420)
Q Consensus 129 niv--~~~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~ 206 (420)
++. ..+++ .. .+|||||++|++|.+.. ....+..++.||+.+|.|||++|||||||||.|||+..+++
T Consensus 174 gv~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 174 GFPVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp TCSCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 443 33332 22 37999999998885432 22345678999999999999999999999999999975432
Q ss_pred C-------CCeeEeeccccccc
Q 014704 207 D-------SPLKATDFGLSVFF 221 (420)
Q Consensus 207 ~-------~~~kl~Dfg~~~~~ 221 (420)
. ..+.|+||+.+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 1 13789999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.2e-13 Score=125.49 Aligned_cols=141 Identities=18% Similarity=0.174 Sum_probs=112.0
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
+.|.+...+|.|+++.||++... ++.+++|+...... .....+.+|+.+++.+..+..++++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 45888889999999999999753 57899999864211 11235889999999997678899999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS---------------------------------------- 186 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---------------------------------------- 186 (420)
|||++|.+|.+.+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999876521 223345788999999999998
Q ss_pred -------------------cCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 187 -------------------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 187 -------------------~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
..++|+|++|.||+++ ++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence 4589999999999994 334467999987653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.36 E-value=2.2e-12 Score=116.82 Aligned_cols=135 Identities=13% Similarity=0.136 Sum_probs=98.4
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCC-ccEEEEEEEeCCeEEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN-IVELKGAYEDRHSVNLI 146 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn-iv~~~~~~~~~~~~~iv 146 (420)
.|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+..+.- +++++.+..+.+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 455544445667799999965 45778999987542 12457899999999984422 56799988888889999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG-------------------------------------- 188 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~-------------------------------------- 188 (420)
|||++|.+|. . ...+ ...++.++...|..||+..
T Consensus 94 ~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999998883 1 1122 2356677777777777643
Q ss_pred --------------------CeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 189 --------------------VMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 189 --------------------ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
++|+|++|.||+++ ++..+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence 99999999999994 334467999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=3.4e-11 Score=114.53 Aligned_cols=142 Identities=21% Similarity=0.353 Sum_probs=104.5
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEec--CCcCCChhhHHHHHHHHHHHHhccC-CCCccEEEEEEEeC---CeEEE
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSIS--SRKLINRDDVEDVRREVQIMHHLTG-HRNIVELKGAYEDR---HSVNL 145 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~--~~~~~~~~~~~~~~~E~~~l~~l~~-hpniv~~~~~~~~~---~~~~i 145 (420)
.+.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+++.|.. +..+++++.++.+. +..|+
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 467899999999998764 4678999765 3221 1123468899999999973 34578999988776 45899
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS--------------------------------------- 186 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~--------------------------------------- 186 (420)
||||++|..+.+.. ...++......++.++...|..||+
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999998774311 2346788888999999999999997
Q ss_pred -------------------cCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 187 -------------------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 187 -------------------~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
.+++|+|+++.||++..++ ...+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECcccccc
Confidence 3589999999999995321 13368999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-11 Score=113.79 Aligned_cols=181 Identities=17% Similarity=0.242 Sum_probs=124.1
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCC--ccEEEEEEEeCC---eEEEEE
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRN--IVELKGAYEDRH---SVNLIM 147 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn--iv~~~~~~~~~~---~~~iv~ 147 (420)
+.++.|.+..||++. ..+++|+... ......+.+|..+|+.+..+.. +++++....+.. ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 568999999999863 4689998542 2345779999999999853433 445555543333 358899
Q ss_pred ecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 014704 148 DLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS----------------------------------------- 186 (420)
Q Consensus 148 e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~----------------------------------------- 186 (420)
++++|.+|.+... ..++......++.|+...+..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999988865433 346777888888999998888886
Q ss_pred -----------------cCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecccCCccc---ccchhhc---
Q 014704 187 -----------------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYY---VAPEVLR--- 243 (420)
Q Consensus 187 -----------------~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y---~aPE~~~--- 243 (420)
..++|+|++|.||+++.+ ....+.|+||+.+....+.. .......+ ..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHH
Confidence 137999999999999632 14567899999887543221 11111111 2333221
Q ss_pred ccCCC------------ccchhhhHHHHHHHHhCCCCC
Q 014704 244 RNYGA------------EADIWSAGVILYILLSGVPPF 269 (420)
Q Consensus 244 ~~~~~------------~~DvwslGvil~~ll~g~~pf 269 (420)
..|.. ..+.|++|.++|.+.+|..+|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12222 258999999999999998876
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=99.04 E-value=2.2e-10 Score=99.18 Aligned_cols=97 Identities=30% Similarity=0.493 Sum_probs=76.5
Q ss_pred cCCcccccCCCCCCcccHHHHHHHHHHHhhhhhHHHHHHHHHhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 323 NHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 323 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
.|||.+... ....++...++.++++|...+++++.++..++..++.+++..++++|..+|.|++|.|+.+||..++..+
T Consensus 8 ~~~~~~~~~-~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~ 86 (197)
T 3pm8_A 8 SSGRENLYF-QGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKI 86 (197)
T ss_dssp ----------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred cchHhhhcc-CCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHh
Confidence 489997655 4556777889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCC
Q 014704 403 GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 403 g~~~~~~e~~~~~~~~d~ 420 (420)
|..++..++..+++.+|.
T Consensus 87 g~~~~~~~~~~l~~~~D~ 104 (197)
T 3pm8_A 87 GYQKIPPDIHQVLRDIDS 104 (197)
T ss_dssp C----CHHHHHHHHC---
T ss_pred CCCCCHHHHHHHHHHhCC
Confidence 999999999999998873
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=99.00 E-value=4.3e-10 Score=96.82 Aligned_cols=96 Identities=28% Similarity=0.399 Sum_probs=79.9
Q ss_pred cCCcccccCCCCCCcccHHHHHHHHHHHhhhhhHHHHHHHHHhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 323 NHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 323 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
.|||+... .....++...++.++++|...+++++.++..++..++.+++..++++|..+|.|++|.|+.+|+..+++.+
T Consensus 3 ~~~~~~~~-~~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~ 81 (191)
T 3k21_A 3 HHHHHSSG-RENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKD 81 (191)
T ss_dssp ------------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred CCccccCC-ccccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHc
Confidence 57777532 34556677889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhcCC
Q 014704 403 GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 403 g~~~~~~e~~~~~~~~d~ 420 (420)
|..++ .++..+++.+|.
T Consensus 82 g~~~~-~~~~~l~~~~D~ 98 (191)
T 3k21_A 82 GLKLP-YNFDLLLDQIDS 98 (191)
T ss_dssp TCCCC-TTHHHHHHHHCT
T ss_pred CCCcH-HHHHHHHHHhCC
Confidence 99988 899999998873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=8.3e-08 Score=88.90 Aligned_cols=136 Identities=19% Similarity=0.287 Sum_probs=94.8
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCC--CccEEEEEEE-eCCeEEEEEec
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR--NIVELKGAYE-DRHSVNLIMDL 149 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp--niv~~~~~~~-~~~~~~iv~e~ 149 (420)
+.++.|....||+. |..+++|+.. .......+.+|..+|+.|..|- .+.+++.+.. ..+..++|||+
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 45788998999988 4678999842 2234578999999999998432 3567777664 45567899999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------------
Q 014704 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM------------------------------------------ 187 (420)
Q Consensus 150 ~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~------------------------------------------ 187 (420)
++|..+.+... ..++......++.++...|..||+.
T Consensus 95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99988865322 2345555555556666655555532
Q ss_pred ------------------CCeeccCCCCcEEEecCCCCCC-eeEeecccccc
Q 014704 188 ------------------GVMHRDLKPENFLFSSSAEDSP-LKATDFGLSVF 220 (420)
Q Consensus 188 ------------------~ivH~Dlkp~Nill~~~~~~~~-~kl~Dfg~~~~ 220 (420)
.++|+|++|.||++..++.++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999964222344 48999997764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=5.1e-08 Score=88.50 Aligned_cols=134 Identities=19% Similarity=0.240 Sum_probs=97.1
Q ss_pred eecccCCe-EEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCCC
Q 014704 74 ELGRGQFG-VTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 74 ~lG~G~~g-~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
.+..|..| .||+......+..+++|+-.. .....+.+|...|+.|..+--+.+++.++.+.+..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445544 699988877788899998642 23467889999999997665678999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------------
Q 014704 153 GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSM--------------------------------------------- 187 (420)
Q Consensus 153 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~--------------------------------------------- 187 (420)
.++.+..... ......+..++...|.-||+.
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8887654321 122234555555555555531
Q ss_pred -------------CCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 188 -------------GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 188 -------------~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
.++|+|+.+.|||+. ++..+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence 178999999999995 344567999987754
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.67 E-value=1.2e-08 Score=77.64 Aligned_cols=54 Identities=28% Similarity=0.524 Sum_probs=50.7
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+++++..+++++|+.+|.|++|+|+.+||+.+|+.+|..++++|+++||+++|.
T Consensus 30 l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~ 83 (100)
T 2lv7_A 30 IPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDM 83 (100)
T ss_dssp CCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCS
T ss_pred CCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCC
Confidence 467788889999999999999999999999999999999999999999999984
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=98.59 E-value=1.7e-07 Score=79.52 Aligned_cols=81 Identities=21% Similarity=0.513 Sum_probs=73.9
Q ss_pred ccHHHHHHHHHHHhhhhhHHHHHHHHHhhhh--HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHH
Q 014704 338 LDIAVLTRMKQFRAMNKLKKVALKVIAENLS--EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415 (420)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~~--~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~ 415 (420)
+...++.++++|...+++++.++..++..++ +++...++++|..+|.|++|.|+.+|+..+++.+|. +..++..++
T Consensus 2 ~~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~--~~~~~~~~~ 79 (180)
T 3mse_B 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGI--KKWDINRIL 79 (180)
T ss_dssp CCHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--CHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC--CHHHHHHHH
Confidence 3467899999999999999999999999887 888999999999999999999999999999999986 478999999
Q ss_pred HhcCC
Q 014704 416 EAVSL 420 (420)
Q Consensus 416 ~~~d~ 420 (420)
..+|.
T Consensus 80 ~~~D~ 84 (180)
T 3mse_B 80 QALDI 84 (180)
T ss_dssp HHHCT
T ss_pred HHhCC
Confidence 98873
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=3.4e-07 Score=87.99 Aligned_cols=81 Identities=11% Similarity=0.150 Sum_probs=52.4
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcC-CC---hhhHHHHHHHHHHHHhccCC-C-CccEEEEEEEeCCeEEE
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-IN---RDDVEDVRREVQIMHHLTGH-R-NIVELKGAYEDRHSVNL 145 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~---~~~~~~~~~E~~~l~~l~~h-p-niv~~~~~~~~~~~~~i 145 (420)
.+.||.|.++.||++....+++.+++|....... .. ....+++..|.++++.+..+ | .+++++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4578999999999998766678899998653211 00 11235677899999988633 3 34466643 4555689
Q ss_pred EEecCCCCC
Q 014704 146 IMDLCAGGE 154 (420)
Q Consensus 146 v~e~~~g~~ 154 (420)
|||+++|..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998743
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.47 E-value=3.6e-07 Score=76.03 Aligned_cols=74 Identities=66% Similarity=0.957 Sum_probs=65.4
Q ss_pred HHHHhhhhhHHHHHHHHHhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 347 KQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 347 ~~~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++|...+.+++.++..++..++++++..++.+|..+|.|++|.|+.+|+..++..+|..++..++..+++.+|.
T Consensus 1 ~~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~ 74 (166)
T 2aao_A 1 KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAADV 74 (166)
T ss_dssp -----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCCHHHHHHHHHHHCT
T ss_pred CchhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 35777889999999999999999999999999999999999999999999999999999999999999998873
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.39 E-value=9.3e-08 Score=81.69 Aligned_cols=84 Identities=27% Similarity=0.467 Sum_probs=76.0
Q ss_pred cccHHHHHHHHHHHhhhhhHHHHHHHHHhhh-hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhh-----------CC
Q 014704 337 PLDIAVLTRMKQFRAMNKLKKVALKVIAENL-SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL-----------GT 404 (420)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~-~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l-----------g~ 404 (420)
++...++.++++|...+++++.++..++..+ ++++...++++|..+|.|++|.|+.+|+..++..+ |.
T Consensus 3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~ 82 (191)
T 3khe_A 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDS 82 (191)
T ss_dssp CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccc
Confidence 3456788999999999999999999999888 78888999999999999999999999999999987 77
Q ss_pred CCCHHHHHHHHHhcCC
Q 014704 405 RLSESEVRQLMEAVSL 420 (420)
Q Consensus 405 ~~~~~e~~~~~~~~d~ 420 (420)
..+.+++..+++.+|.
T Consensus 83 ~~~~~~~~~~~~~~D~ 98 (191)
T 3khe_A 83 SQIEAEVDHILQSVDF 98 (191)
T ss_dssp HHHHHHHHHHHHHTCT
T ss_pred hhhHHHHHHHHHHhCC
Confidence 7889999999998873
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=98.39 E-value=3.6e-07 Score=67.14 Aligned_cols=56 Identities=30% Similarity=0.525 Sum_probs=49.1
Q ss_pred HhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 364 ~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+..+++++...++.+|..+|.|++|.|+.+|+..++..+| .++.++++++++.+|.
T Consensus 2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~ 57 (86)
T 2opo_A 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDT 57 (86)
T ss_dssp ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCT
T ss_pred CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC-CCCHHHHHHHHHHhCC
Confidence 4456777888999999999999999999999999999999 9999999999999874
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=98.37 E-value=5.7e-07 Score=66.70 Aligned_cols=58 Identities=31% Similarity=0.428 Sum_probs=52.7
Q ss_pred HHhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 363 i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+...+++++...++.+|..+|.|++|.|+.+||..+++.+|..++.+++++++..+|.
T Consensus 10 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D~ 67 (90)
T 1avs_A 10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDE 67 (90)
T ss_dssp HHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred HHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 3445677888899999999999999999999999999999999999999999999873
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=3.2e-07 Score=86.81 Aligned_cols=85 Identities=8% Similarity=0.091 Sum_probs=56.9
Q ss_pred eccee-cccCCeEEEEEEEc--C----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC--CCccEEEEEEEeC-
Q 014704 71 FGREL-GRGQFGVTYLVTHK--D----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH--RNIVELKGAYEDR- 140 (420)
Q Consensus 71 ~~~~l-G~G~~g~V~~~~~~--~----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--pniv~~~~~~~~~- 140 (420)
..+.| +.|..+.+|++... . ++..+++|+..............+.+|+.+++.|..+ -.+.+++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34677 88989999988754 1 1567999986532200000013577899999988744 3577888887655
Q ss_pred --CeEEEEEecCCCCCh
Q 014704 141 --HSVNLIMDLCAGGEL 155 (420)
Q Consensus 141 --~~~~iv~e~~~g~~L 155 (420)
+..++|||+++|..+
T Consensus 104 ~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTSSCEEEEECCCCBCC
T ss_pred ccCCceEEEEecCCCCh
Confidence 356899999998654
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=98.35 E-value=2.2e-08 Score=93.38 Aligned_cols=120 Identities=21% Similarity=0.302 Sum_probs=80.3
Q ss_pred CCChHHHHHHHHhc---ccCcCCCCCHHHHhcC------CcccccCCCC-----------------C------CcccHHH
Q 014704 295 NISSSAKDIVKKML---HADPKERLSAAEVLNH------PWMRVDGDAS-----------------D------KPLDIAV 342 (420)
Q Consensus 295 ~~~~~~~~li~~~L---~~dp~~R~t~~e~l~h------~~~~~~~~~~-----------------~------~~~~~~~ 342 (420)
.++.++.+|.++++ ..+|+.|.+.++.+.| +|+....+.. . ......+
T Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~v 95 (323)
T 1ij5_A 16 KVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASL 95 (323)
T ss_dssp HHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHHH
Confidence 45678899999988 8899999999999988 8876431100 0 0001123
Q ss_pred HHHHH-HHHhhhhhHHHHHHHHHhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 343 LTRMK-QFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 343 ~~~~~-~~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
+.+++ +|...+.+++ ++..++.+++..++.+|..+|.|++|.|+.+||..+|..+|..++..++..++..+|
T Consensus 96 l~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~~~~~~~i~~l~~~~D 168 (323)
T 1ij5_A 96 LKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVE 168 (323)
T ss_dssp HHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhc
Confidence 33444 4444455444 345678888999999999999999999999999999999999999999999998775
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=98.31 E-value=4.1e-07 Score=66.80 Aligned_cols=55 Identities=18% Similarity=0.203 Sum_probs=50.5
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHH---HHHHHHhcCC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESE---VRQLMEAVSL 420 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e---~~~~~~~~d~ 420 (420)
.+++++...++.+|..+|.|++|.|+.+||..+++.+|..++..+ +.+++..+|.
T Consensus 7 ~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~~d~ 64 (86)
T 1j7q_A 7 ALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKG 64 (86)
T ss_dssp CCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSC
T ss_pred cCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCCHHHHHHHHHHHHHhCC
Confidence 456677888999999999999999999999999999999999999 9999998873
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=98.29 E-value=6.3e-07 Score=64.18 Aligned_cols=53 Identities=34% Similarity=0.564 Sum_probs=48.9
Q ss_pred hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++++...++.+|..+|.|++|.|+.+|+..+++.+|..++.+++++++..+|.
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~ 54 (77)
T 2joj_A 2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDR 54 (77)
T ss_dssp CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCC
Confidence 45677889999999999999999999999999999999999999999999873
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.22 E-value=1.4e-06 Score=64.89 Aligned_cols=51 Identities=22% Similarity=0.212 Sum_probs=46.4
Q ss_pred hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+.++...++++|..+|.|++|+|+.+|++.+++.+| ++++++.+|++.+|.
T Consensus 4 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~ 54 (92)
T 1fi6_A 4 TDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDF 54 (92)
T ss_dssp CHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCT
T ss_pred CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCC
Confidence 466788899999999999999999999999999987 689999999999874
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=98.20 E-value=1.7e-06 Score=71.25 Aligned_cols=54 Identities=30% Similarity=0.516 Sum_probs=50.5
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
.++++++.+++++|..+|.|++|.|+.+||..+++.+|..+++.++..++...+
T Consensus 9 ~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~~ 62 (153)
T 3i5g_B 9 KLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGRVPPDDELNAMLKECP 62 (153)
T ss_dssp TCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTSCCCHHHHHHHHHTSS
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCccHHHHHHHHHhcc
Confidence 468899999999999999999999999999999999999999999999987654
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.19 E-value=2.2e-06 Score=63.66 Aligned_cols=55 Identities=20% Similarity=0.371 Sum_probs=49.0
Q ss_pred HhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 364 ~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...++.++...++.+|..+|.|++|.|+.+||..++..+| ++.++++++|+.+|.
T Consensus 18 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g--~~~~~~~~~~~~~D~ 72 (91)
T 2pmy_A 18 GADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRPADAEAVFQRLDA 72 (91)
T ss_dssp -CHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT--CCHHHHHHHHHHHCT
T ss_pred hccCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC--cCHHHHHHHHHHhCC
Confidence 3456777888999999999999999999999999999998 689999999999873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.3e-05 Score=77.58 Aligned_cols=77 Identities=13% Similarity=0.097 Sum_probs=46.8
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcC-CCh-----hhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL-INR-----DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~-----~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.+.||.|..+.||++.. +++.++||....... ... .....++.|+..+..-.....+++++.+. ....++
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 45789999999999954 467899995432111 011 12233444444333222134567777664 566789
Q ss_pred EEecC-CC
Q 014704 146 IMDLC-AG 152 (420)
Q Consensus 146 v~e~~-~g 152 (420)
|||++ +|
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 77
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.18 E-value=1.6e-06 Score=65.08 Aligned_cols=51 Identities=22% Similarity=0.255 Sum_probs=46.2
Q ss_pred hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+.++..+++++|..+|.|++|+|+.+|++.+++.+| +++++++++++.+|.
T Consensus 5 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~ 55 (95)
T 1c07_A 5 SPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDT 55 (95)
T ss_dssp CSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCT
T ss_pred CHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC--CCHHHHHHHHHHHCC
Confidence 456778899999999999999999999999999987 689999999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.17 E-value=2.1e-05 Score=73.46 Aligned_cols=74 Identities=11% Similarity=0.087 Sum_probs=43.8
Q ss_pred ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC-CCccEEEE------EEEeCCeEEE
Q 014704 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKG------AYEDRHSVNL 145 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pniv~~~~------~~~~~~~~~i 145 (420)
+.|+.|..+.||++... +..+++|+.... ...+..|+.+++.|..+ -.+++++. +..+.+..++
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 45666788999998764 345899988541 13445566666666421 12344443 2245677899
Q ss_pred EEecCCCCCh
Q 014704 146 IMDLCAGGEL 155 (420)
Q Consensus 146 v~e~~~g~~L 155 (420)
||+|++|.++
T Consensus 109 l~~~i~G~~~ 118 (346)
T 2q83_A 109 VYDWIEGRPF 118 (346)
T ss_dssp EEECCCCBCC
T ss_pred EEEeecCccC
Confidence 9999998653
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.16 E-value=3e-06 Score=59.39 Aligned_cols=49 Identities=27% Similarity=0.567 Sum_probs=45.5
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...++.+|..+|.|++|.|+.+||..++..+|..++.++++++++.+|.
T Consensus 5 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~ 53 (71)
T 2b1u_A 5 LEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADV 53 (71)
T ss_dssp HHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 4568899999999999999999999999999999999999999999873
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=98.15 E-value=2.1e-06 Score=70.71 Aligned_cols=48 Identities=25% Similarity=0.403 Sum_probs=45.4
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
...++.+|+.||.|++|+|+.+||+.+|..+|..++++|+++||+.+|
T Consensus 84 ~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D 131 (153)
T 3i5g_B 84 EDALRNAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAP 131 (153)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCC
T ss_pred HHHHHHHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhC
Confidence 356889999999999999999999999999999999999999999987
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=98.15 E-value=2.2e-06 Score=63.69 Aligned_cols=53 Identities=34% Similarity=0.552 Sum_probs=48.2
Q ss_pred hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+.+....++.+|..+|.|++|.|+.+||..++..+|..++.+++.++|..+|.
T Consensus 4 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~ 56 (92)
T 2kn2_A 4 DTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADL 56 (92)
T ss_dssp CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred CccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 34566788999999999999999999999999999999999999999999873
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=98.14 E-value=1.7e-06 Score=81.51 Aligned_cols=56 Identities=36% Similarity=0.580 Sum_probs=52.9
Q ss_pred hhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 365 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+.++++++.+++++|..+|.|++|.|+.+||..+|+.+|..++++|+++||+.+|.
T Consensus 294 E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D~ 349 (440)
T 3u0k_A 294 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA 349 (440)
T ss_dssp BCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred hhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 45688999999999999999999999999999999999999999999999999884
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.13 E-value=2.6e-06 Score=58.94 Aligned_cols=47 Identities=13% Similarity=0.451 Sum_probs=44.1
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.++.+|..+|.|++|.|+.+|+..++..+|..++.+++..+++.+|.
T Consensus 2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~ 48 (67)
T 1tiz_A 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDV 48 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCC
Confidence 46789999999999999999999999999999999999999999873
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.11 E-value=3.8e-06 Score=62.81 Aligned_cols=50 Identities=26% Similarity=0.518 Sum_probs=46.1
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|..+|.|++|.|+.+||..+++.+|..+++++++++|+.+|.
T Consensus 27 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~ 76 (94)
T 2kz2_A 27 SEEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADI 76 (94)
T ss_dssp CHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 44568899999999999999999999999999999999999999999873
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.11 E-value=6.5e-07 Score=65.83 Aligned_cols=58 Identities=64% Similarity=0.976 Sum_probs=50.6
Q ss_pred HHhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 363 i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+...++.++...++.+|..+|.|++|.|+.+|+..+++.+|..++.++++++++.+|.
T Consensus 13 ~~~~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~ 70 (87)
T 1s6j_A 13 MAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADI 70 (87)
T ss_dssp SSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCT
T ss_pred HHHHCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 3344555566778999999999999999999999999999999999999999999873
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=98.11 E-value=3.5e-06 Score=65.14 Aligned_cols=52 Identities=23% Similarity=0.366 Sum_probs=46.4
Q ss_pred HHHHhhHHHHhhccC-CCCCC-cccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMD-TDNSG-TITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+++++|..|| .|++| +|+.+||+.+++. +|..++++++++||+++|.
T Consensus 18 ~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~ 76 (113)
T 2lnk_A 18 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDS 76 (113)
T ss_dssp HHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCS
T ss_pred hhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCC
Confidence 456778999999999 89997 9999999999986 7778899999999999884
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=98.10 E-value=2.3e-06 Score=64.77 Aligned_cols=51 Identities=20% Similarity=0.253 Sum_probs=44.9
Q ss_pred HHHHhhHHHHhhccC-CCCC-CcccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcC
Q 014704 369 EEEIMGLKEMFKSMD-TDNS-GTITFEELKAGLPK-----LGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D-~~~~-G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d 419 (420)
+..+.++.++|..|| .|++ |+|+.+||+.+++. +|..++++++++||+++|
T Consensus 6 e~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D 63 (101)
T 3nso_A 6 EQAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLD 63 (101)
T ss_dssp HHHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhC
Confidence 345678999999997 8987 99999999999986 467899999999999987
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=98.10 E-value=2.6e-06 Score=70.64 Aligned_cols=49 Identities=24% Similarity=0.459 Sum_probs=45.7
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...++++|+.||.|++|+|+.+||+.+|..+|..++++|+++||+.+|.
T Consensus 84 ~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~ 132 (159)
T 3i5g_C 84 ADEFMEAFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDI 132 (159)
T ss_dssp HHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCc
Confidence 4568899999999999999999999999999999999999999999873
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.1e-05 Score=61.75 Aligned_cols=52 Identities=31% Similarity=0.475 Sum_probs=48.6
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+++...++.+|..+|.|++|.|+.+|+..++..+|..++++++.+++..+|.
T Consensus 28 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~D~ 79 (107)
T 2d58_A 28 PSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKKLIGEVSS 79 (107)
T ss_dssp HHHHHHHHHHHTTSCCCTTSCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 5677889999999999999999999999999999999999999999999873
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.04 E-value=3.3e-05 Score=71.31 Aligned_cols=76 Identities=14% Similarity=0.116 Sum_probs=60.8
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC--CCccEEEEEEEeCCeEEEEEec
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH--RNIVELKGAYEDRHSVNLIMDL 149 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--pniv~~~~~~~~~~~~~iv~e~ 149 (420)
.+.|+.|....+|+... ++..+++|+... .....+..|...|+.|..+ ..+++++.+....+..++||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINER------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEG------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCc------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 35789999999999875 467899998643 2356789999999998633 5688899988888899999999
Q ss_pred CCCCCh
Q 014704 150 CAGGEL 155 (420)
Q Consensus 150 ~~g~~L 155 (420)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.04 E-value=5.7e-06 Score=63.93 Aligned_cols=52 Identities=15% Similarity=0.293 Sum_probs=46.5
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+++++...++++|..+|.|++|+|+.+||+.++. |..++++++.+||+.+|.
T Consensus 8 ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~--~~~~~~~~~~~i~~~~D~ 59 (111)
T 2kgr_A 8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQARTILM--QSSLPQAQLASIWNLSDI 59 (111)
T ss_dssp SCHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHH--TTCCCHHHHHHHHHHHCS
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHH--hCCCCHHHHHHHHHHHCC
Confidence 3566778899999999999999999999999998 677899999999999874
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=98.03 E-value=1.4e-05 Score=65.09 Aligned_cols=52 Identities=27% Similarity=0.408 Sum_probs=48.6
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.++...++.+|..+|.|++|.|+.+||..++..+|..++++++++++..+|.
T Consensus 44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~ 95 (147)
T 1wy9_A 44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKRLIREVSS 95 (147)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 5677889999999999999999999999999999999999999999999873
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=98.02 E-value=4.6e-06 Score=67.55 Aligned_cols=52 Identities=29% Similarity=0.549 Sum_probs=48.3
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+++..+++++|..+|.|++|.|+.+||..+++.+|..++..++.+|++.+|.
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~ 53 (143)
T 2obh_A 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDK 53 (143)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 4567889999999999999999999999999999999999999999998873
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=98.00 E-value=2.2e-06 Score=70.00 Aligned_cols=53 Identities=30% Similarity=0.530 Sum_probs=50.0
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
++++++.+++++|..+|.|++|.|+.+||..+++.+|..++++++..++..+|
T Consensus 4 lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d 56 (148)
T 2lmt_A 4 LTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAE 56 (148)
T ss_dssp CCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcc
Confidence 56788999999999999999999999999999999999999999999998876
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=97.99 E-value=1.1e-05 Score=61.44 Aligned_cols=49 Identities=20% Similarity=0.297 Sum_probs=45.7
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
....++.+|..+|.|++|.|+.+||..++..+|..++++++++++..+|
T Consensus 22 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~e~~~l~~~~d 70 (105)
T 1wlz_A 22 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMP 70 (105)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSC
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcC
Confidence 3467889999999999999999999999999999999999999999887
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=97.99 E-value=9.5e-06 Score=62.01 Aligned_cols=51 Identities=16% Similarity=0.233 Sum_probs=46.1
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++.++..+++++|..+|. ++|+|+.+|++.++..+| ++++++.+|++.+|.
T Consensus 9 ls~~e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~ 59 (106)
T 1eh2_A 9 VKPEDKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDI 59 (106)
T ss_dssp SCHHHHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTT--CCHHHHHHHHHHHCS
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcC
Confidence 356778889999999999 999999999999999987 689999999999884
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=97.98 E-value=7.4e-06 Score=61.84 Aligned_cols=52 Identities=19% Similarity=0.250 Sum_probs=45.7
Q ss_pred HHHHhhHHHHhhccC-CCCCC-cccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMD-TDNSG-TITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
+.+..+++++|..|| .|++| +|+.+||+.+++. +|..++++++++||+++|.
T Consensus 6 ~~~~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~ 64 (99)
T 2y5i_A 6 EGAMDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDS 64 (99)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCC
Confidence 345678999999997 89998 9999999999986 6788899999999999884
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=97.96 E-value=4.1e-06 Score=60.51 Aligned_cols=49 Identities=33% Similarity=0.515 Sum_probs=45.2
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhC-CCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG-TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg-~~~~~~e~~~~~~~~d~ 420 (420)
....++ +|..+|.|++|.|+.+||..++..+| ..++++++.++++.+|.
T Consensus 7 ~~~~l~-~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~D~ 56 (81)
T 1c7v_A 7 EEEILR-AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADE 56 (81)
T ss_dssp CHHHHH-HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCS
T ss_pred HHHHHH-HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCC
Confidence 456788 99999999999999999999999999 99999999999999873
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=97.95 E-value=4.4e-06 Score=63.09 Aligned_cols=49 Identities=14% Similarity=0.213 Sum_probs=43.9
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++...++++|..+|.|++|+|+.+|++.+++.+| ++++++.+||+.+|.
T Consensus 8 ~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~--l~~~~l~~i~~~~D~ 56 (99)
T 1qjt_A 8 SGNPVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADT 56 (99)
T ss_dssp TTCTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCC
T ss_pred hhHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcC--CCHHHHHHHHHHHCC
Confidence 3456789999999999999999999999999887 689999999999884
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=97.95 E-value=2.6e-05 Score=62.96 Aligned_cols=49 Identities=27% Similarity=0.518 Sum_probs=45.7
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...++.+|+.+|.|++|+|+.+||+.++..+|..++++++++||+++|.
T Consensus 78 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~ 126 (143)
T 2obh_A 78 KEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADR 126 (143)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 4568899999999999999999999999999999999999999999874
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=97.95 E-value=6.6e-06 Score=58.91 Aligned_cols=47 Identities=32% Similarity=0.586 Sum_probs=43.2
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..++.+|..+|.|++|.|+.+|+..+++.+| .++.++++.++..+|.
T Consensus 3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~ 49 (78)
T 1k9u_A 3 DDMERIFKRFDTNGDGKISLSELTDALRTLG-STSADEVQRMMAEIDT 49 (78)
T ss_dssp CHHHHHHHHHCTTCSSEECHHHHHHHHHHHH-TCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhC-CCCHHHHHHHHHHhCC
Confidence 3578899999999999999999999999999 9999999999999873
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=97.93 E-value=6.7e-06 Score=61.58 Aligned_cols=52 Identities=21% Similarity=0.316 Sum_probs=40.0
Q ss_pred HHHHhhHHHHhhccC-CCC-CCcccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMD-TDN-SGTITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D-~~~-~G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
+++..+++++|..|| .|+ +|+|+.+||+.+++. +|..++++++++||+.+|.
T Consensus 5 ~~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~ 63 (95)
T 1j55_A 5 ETAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDA 63 (95)
T ss_dssp HHHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCC
Confidence 345678999999999 788 589999999999987 5677899999999999874
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=97.93 E-value=1.6e-06 Score=66.89 Aligned_cols=51 Identities=25% Similarity=0.180 Sum_probs=45.3
Q ss_pred hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+.++..+++++|..||.|++|+|+.+|++.+++.+| ++++++.+||+.+|.
T Consensus 17 s~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~ 67 (110)
T 1iq3_A 17 TEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDA 67 (110)
T ss_dssp SSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCS
T ss_pred CHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcC
Confidence 455677899999999999999999999999999887 578899999999874
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=97.92 E-value=5.2e-06 Score=62.22 Aligned_cols=52 Identities=19% Similarity=0.321 Sum_probs=45.8
Q ss_pred HHHHhhHHHHhhccC-CCCCC-cccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMD-TDNSG-TITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
+.+..+++++|..|| .|++| +|+.+||+.+++. +|..++++++++||+++|.
T Consensus 8 e~~~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~ 66 (95)
T 2wcb_A 8 EEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDA 66 (95)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSS
T ss_pred HHHHHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcC
Confidence 445678999999999 89998 9999999999986 6778899999999999874
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=97.92 E-value=1e-05 Score=65.78 Aligned_cols=55 Identities=36% Similarity=0.571 Sum_probs=50.2
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.+++++..+++++|..+|.|++|.|+.+|+..+++.+|..++..++..++..+|.
T Consensus 3 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~ 57 (148)
T 1exr_A 3 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA 57 (148)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCT
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHCC
Confidence 3566778889999999999999999999999999999999999999999998873
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.89 E-value=1.5e-05 Score=60.66 Aligned_cols=52 Identities=21% Similarity=0.287 Sum_probs=43.9
Q ss_pred HHHHhhHHHHhhccC-CCCC-CcccHHHHHhhhhh-hC----CCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMD-TDNS-GTITFEELKAGLPK-LG----TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D-~~~~-G~i~~~el~~~l~~-lg----~~~~~~e~~~~~~~~d~ 420 (420)
+..+.+++++|..|| .|++ |+|+.+||+.+|+. +| ..++++++++||+++|.
T Consensus 9 e~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~ 67 (104)
T 3zwh_A 9 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDS 67 (104)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcC
Confidence 445678999999997 7775 89999999999985 55 45689999999999984
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=97.88 E-value=1.5e-05 Score=59.20 Aligned_cols=50 Identities=20% Similarity=0.340 Sum_probs=44.9
Q ss_pred HHHhhHHHHhhccCCCCCC---cccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDTDNSG---TITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G---~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+.++|..+| +++| +|+.+||+.+++. +|..++++++++||+.+|.
T Consensus 6 ~~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~ 63 (92)
T 3rm1_A 6 KAVVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDS 63 (92)
T ss_dssp HHHHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcC
Confidence 45678899999999 7766 9999999999999 9999999999999999884
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=97.88 E-value=9.7e-06 Score=66.08 Aligned_cols=48 Identities=25% Similarity=0.510 Sum_probs=45.3
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..++.+|+.+|.|++|+|+.+||+.++..+|..++.+++++||+.+|.
T Consensus 83 ~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~ 130 (148)
T 2lmt_A 83 EEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADF 130 (148)
T ss_dssp HHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCC
Confidence 457889999999999999999999999999999999999999999884
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=97.87 E-value=2.5e-06 Score=70.68 Aligned_cols=52 Identities=25% Similarity=0.366 Sum_probs=46.9
Q ss_pred hhhHHHHhhHHHHhhccCC--CCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHh
Q 014704 366 NLSEEEIMGLKEMFKSMDT--DNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~--~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~ 417 (420)
.++++++.+++++|..||. |++|.|+.+||..+|+.||..++++|+.+|+..
T Consensus 2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~~~t~~el~~~~~~ 55 (159)
T 3i5g_C 2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGMNPTEAQVHQHGGT 55 (159)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTCCCCHHHHHTTTCC
T ss_pred CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHcc
Confidence 3578899999999999995 899999999999999999999999999987643
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=97.87 E-value=2e-05 Score=60.34 Aligned_cols=50 Identities=26% Similarity=0.383 Sum_probs=45.6
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhh---CCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|..+|.|++|+|+.+||..++..+ |..+++++++++++.+|.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~ 91 (108)
T 2pvb_A 39 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDK 91 (108)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCCHHHHHHHHHHhCC
Confidence 34568899999999999999999999999999 888999999999999873
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=97.87 E-value=1.4e-05 Score=64.60 Aligned_cols=57 Identities=42% Similarity=0.625 Sum_probs=51.4
Q ss_pred HhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 364 ~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+..+++++...++.+|..+|.|++|.|+.+|+..++..+|..++..++..+++.+|.
T Consensus 2 ~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~ 58 (147)
T 4ds7_A 2 SQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDV 58 (147)
T ss_dssp --CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred CCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhcc
Confidence 456778889999999999999999999999999999999999999999999998873
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=97.87 E-value=1.4e-05 Score=67.40 Aligned_cols=49 Identities=35% Similarity=0.539 Sum_probs=45.2
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
....++.+|+.||.|++|+|+.+||+.+|..+|..++++|+++||+++|
T Consensus 82 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d 130 (176)
T 2lhi_A 82 SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS 130 (176)
T ss_dssp HHHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc
Confidence 3456889999999999999999999999999999999999999999875
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.86 E-value=1.4e-05 Score=62.49 Aligned_cols=51 Identities=22% Similarity=0.317 Sum_probs=45.9
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
+..+..+..+|+.+|.| +|+|+.+||+.+|+. +|...+++++++||+++|.
T Consensus 11 E~~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~ 66 (121)
T 4drw_A 11 EHAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQ 66 (121)
T ss_dssp HHHHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcC
Confidence 34567899999999988 899999999999987 8999999999999999984
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=97.86 E-value=2.1e-05 Score=64.35 Aligned_cols=51 Identities=27% Similarity=0.498 Sum_probs=47.6
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
.++...++.+|..+|.|++|.|+.+||..++..+|..++++++++++..+|
T Consensus 46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~~D 96 (150)
T 2jjz_A 46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVT 96 (150)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHC
Confidence 456778999999999999999999999999999999999999999999886
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=97.86 E-value=1.1e-05 Score=59.90 Aligned_cols=51 Identities=20% Similarity=0.327 Sum_probs=46.2
Q ss_pred HHHHhhHHHHhhccC-CCCCC-cccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcC
Q 014704 369 EEEIMGLKEMFKSMD-TDNSG-TITFEELKAGLPK-----LGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d 419 (420)
+.+...++.+|..+| .|++| .|+.+||..++.. +|..++++++++++..+|
T Consensus 5 ~~~~~~l~~~F~~~D~~d~~G~~I~~~el~~~l~~~~~~~~g~~~~~~~~~~~~~~~D 62 (93)
T 1k2h_A 5 ETAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELD 62 (93)
T ss_dssp HHHHHHHHHHHHHHHTTSSCCSSCCHHHHHHHHHHHTHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCcCccCHHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Confidence 345677899999999 79999 9999999999998 999999999999999876
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=97.85 E-value=2.8e-06 Score=58.64 Aligned_cols=46 Identities=22% Similarity=0.442 Sum_probs=40.1
Q ss_pred HHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 375 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++.+|..+|.|++|.|+.+|+..+++.+|..+++++++++++.+|.
T Consensus 2 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~ 47 (66)
T 3li6_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDA 47 (66)
T ss_dssp CCHHHHHHCTTCSSSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHccCCCcHHHHHHHHHHHCC
Confidence 3568899999999999999999999998888888999999988873
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=97.85 E-value=3.1e-06 Score=61.49 Aligned_cols=50 Identities=26% Similarity=0.383 Sum_probs=45.1
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhC--CCCCHHHHHH----HHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG--TRLSESEVRQ----LMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg--~~~~~~e~~~----~~~~~d~ 420 (420)
....++.+|..+|.|++|.|+.+|+..++..+| ..++.+++.+ +++.+|.
T Consensus 5 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~D~ 60 (83)
T 1yx7_A 5 VKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADK 60 (83)
T ss_dssp SCTHHHHHHHHHSSSCSSSCSHHHHHHHHHHHTTCTTTTTTTTHHHHHHHHTTTCS
T ss_pred HHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHccccCCCHHHHHHHHHHHHHHhCC
Confidence 345688999999999999999999999999999 8899999999 9988873
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=1.8e-05 Score=58.95 Aligned_cols=52 Identities=21% Similarity=0.287 Sum_probs=42.6
Q ss_pred HHHHhhHHHHhhccC-CCCC-CcccHHHHHhhhhh-hC----CCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMD-TDNS-GTITFEELKAGLPK-LG----TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D-~~~~-G~i~~~el~~~l~~-lg----~~~~~~e~~~~~~~~d~ 420 (420)
+..+..++++|+.+| .|++ |+|+.+||+.+++. +| ...+++++++||+++|.
T Consensus 6 e~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~ 64 (93)
T 4eto_A 6 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDS 64 (93)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCC
Confidence 345678999999997 6885 89999999999985 65 45689999999999984
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=97.84 E-value=2.3e-05 Score=60.07 Aligned_cols=50 Identities=34% Similarity=0.520 Sum_probs=45.6
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhh---CCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|..+|.|++|+|+.+||..++..+ |..+++++++++++.+|.
T Consensus 40 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~d~ 92 (110)
T 1pva_A 40 SANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADK 92 (110)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCT
T ss_pred hHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCCHHHHHHHHHHhCC
Confidence 35568899999999999999999999999999 788999999999999873
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=97.84 E-value=1.2e-05 Score=70.47 Aligned_cols=74 Identities=19% Similarity=0.260 Sum_probs=62.9
Q ss_pred HHHHhhhhhHHHHHHHHHhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 347 KQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 347 ~~~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+.....+++.....+...++.++...++++|..+|.|++|.|+.+|+..+++.+|..++.++++.+++.+|.
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~ 98 (220)
T 3sjs_A 25 CIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDT 98 (220)
T ss_dssp HHHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGBCCCHHHHHHHHHHHCT
T ss_pred hccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 34444555555555566777889999999999999999999999999999999999999999999999998873
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=97.82 E-value=2.5e-05 Score=59.82 Aligned_cols=49 Identities=29% Similarity=0.360 Sum_probs=45.1
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh---CCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~ 420 (420)
...++.+|..+|.|++|+|+.+|+..++..+ |..+++++++++++.+|.
T Consensus 41 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~D~ 92 (109)
T 3fs7_A 41 PDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGDT 92 (109)
T ss_dssp HHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccCCHHHHHHHHHHhCC
Confidence 4567889999999999999999999999999 889999999999999874
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=97.81 E-value=2.3e-05 Score=60.01 Aligned_cols=50 Identities=28% Similarity=0.367 Sum_probs=45.6
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhh---CCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|..+|.|++|.|+.+||..++..+ |..+++++++++++.+|.
T Consensus 40 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~ 92 (109)
T 1bu3_A 40 SADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGDS 92 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCCHHHHHHHHHHHCT
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCCHHHHHHHHHHhCC
Confidence 34568899999999999999999999999999 888999999999999873
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=97.80 E-value=2.3e-05 Score=60.00 Aligned_cols=49 Identities=37% Similarity=0.492 Sum_probs=45.1
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh---CCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~ 420 (420)
...++.+|+.+|.|++|.|+.+|+..++..+ |..+++++++++++.+|.
T Consensus 40 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~ 91 (109)
T 5pal_A 40 DAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDS 91 (109)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 4467889999999999999999999999999 999999999999999874
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.80 E-value=3.2e-05 Score=61.95 Aligned_cols=50 Identities=20% Similarity=0.229 Sum_probs=45.7
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCC-CCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGT-RLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~ 420 (420)
....++.+|..+|.|++|+|+.+||..++..+|. .+++++++++|+.+|.
T Consensus 38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~~~D~ 88 (135)
T 3h4s_E 38 FVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVREGDL 88 (135)
T ss_dssp HHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHHHHCS
T ss_pred hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCC
Confidence 3467889999999999999999999999999994 9999999999999873
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=97.80 E-value=2e-05 Score=65.31 Aligned_cols=53 Identities=23% Similarity=0.485 Sum_probs=49.1
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCC-CCCHHHHHHHHHhc
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGT-RLSESEVRQLMEAV 418 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~ 418 (420)
.+++++...++.+|..+|.|++|.|+.+||..++..+|. .++..++..++...
T Consensus 18 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~ 71 (166)
T 2mys_B 18 MFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEA 71 (166)
T ss_pred hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHC
Confidence 567788899999999999999999999999999999999 99999999998764
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=97.80 E-value=2.5e-05 Score=64.21 Aligned_cols=57 Identities=25% Similarity=0.381 Sum_probs=51.9
Q ss_pred HhhhhHHHHhhHHHHhhccCCCC-CCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 364 AENLSEEEIMGLKEMFKSMDTDN-SGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 364 ~~~~~~~~~~~l~~~F~~~D~~~-~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+++++...++++|..+|.|+ +|.|+.+|+..++..+|..++.+++..+++.+|.
T Consensus 9 ~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~ 66 (161)
T 1dtl_A 9 VEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDE 66 (161)
T ss_dssp GGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred HhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 34567888899999999999999 9999999999999999999999999999998873
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=97.78 E-value=2.6e-05 Score=59.68 Aligned_cols=50 Identities=32% Similarity=0.390 Sum_probs=45.6
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhh---CCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|..+|.|++|+|+.+||..++..+ |..+++++++++++.+|.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~ 91 (109)
T 1rwy_A 39 SADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDK 91 (109)
T ss_dssp CHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCT
T ss_pred hHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCCHHHHHHHHHHHCC
Confidence 45668899999999999999999999999999 788999999999999873
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.78 E-value=2.2e-05 Score=63.03 Aligned_cols=52 Identities=23% Similarity=0.484 Sum_probs=46.4
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+++...++.+|..+|.|++|.|+.+|+..++..+|..++..++..+++.+|.
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~ 53 (142)
T 2bl0_C 2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADA 53 (142)
T ss_dssp CHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCc
Confidence 4567788999999999999999999999999999999999999999988773
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=97.77 E-value=2.3e-05 Score=62.71 Aligned_cols=48 Identities=17% Similarity=0.243 Sum_probs=43.4
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++...++++|..|| |++|+|+.+|++.+|..+| ++++++.+||+.+|.
T Consensus 48 ~e~~~l~~~F~~fD-d~dG~Is~~El~~~l~~~g--l~~~el~~I~~~~D~ 95 (139)
T 2jq6_A 48 KDKPTYDEIFYTLS-PVNGKITGANAKKEMVKSK--LPNTVLGKIWKLADV 95 (139)
T ss_dssp GTHHHHHHHHHHSC-CSSSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHhC-CCCCeECHHHHHHHHHHhC--cCHHHHHHHHHHhCC
Confidence 45677899999999 9999999999999999977 789999999999884
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=97.76 E-value=3e-05 Score=59.31 Aligned_cols=50 Identities=36% Similarity=0.509 Sum_probs=45.1
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhh---CCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|..+|.|++|+|+.+||..++..+ |..+++++++++++.+|.
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~ 91 (108)
T 1rro_A 39 SASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADN 91 (108)
T ss_dssp CHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCC
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999 688999999999999873
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=97.76 E-value=1e-05 Score=57.44 Aligned_cols=49 Identities=27% Similarity=0.378 Sum_probs=44.8
Q ss_pred HhhHHHHhhcc-CCCCC-CcccHHHHHhhhhhhCCCC--CHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSM-DTDNS-GTITFEELKAGLPKLGTRL--SESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~-D~~~~-G~i~~~el~~~l~~lg~~~--~~~e~~~~~~~~d~ 420 (420)
...++.+|..+ |.|++ |.|+.+||..++..+|..+ +.++++++++.+|.
T Consensus 4 ~~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~l~~~~D~ 56 (76)
T 1qx2_A 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDK 56 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCT
T ss_pred HHHHHHHHHHHcccCCCcCeECHHHHHHHHHHhCCCcCCCHHHHHHHHHHhCC
Confidence 35678899999 99999 9999999999999999999 99999999998873
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=97.75 E-value=8.3e-05 Score=60.26 Aligned_cols=50 Identities=30% Similarity=0.525 Sum_probs=45.8
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....+..+|..+|.|++|.|+.+||+.++..+|..+++++++++++.+|.
T Consensus 81 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~ 130 (148)
T 1exr_A 81 SEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADI 130 (148)
T ss_dssp HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999999999999999999873
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.0001 Score=67.67 Aligned_cols=72 Identities=7% Similarity=-0.020 Sum_probs=46.6
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecC-
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC- 150 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~- 150 (420)
.+.|+.|....+|++ ..+++|+...... ..-...+|+.+++.+..+.-..+++.+ +...-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 578889999999998 4589998754211 111235688888888633323566654 343447899999
Q ss_pred CCCCh
Q 014704 151 AGGEL 155 (420)
Q Consensus 151 ~g~~L 155 (420)
+|.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 76554
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=97.73 E-value=1.1e-05 Score=65.74 Aligned_cols=55 Identities=29% Similarity=0.480 Sum_probs=51.0
Q ss_pred hhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 365 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
..++++++..++++|..+|.|++|.|+.+|+..++..+|..++..++..++..+|
T Consensus 3 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d 57 (153)
T 3ox6_A 3 RSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQIN 57 (153)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC
Confidence 4567888899999999999999999999999999999999999999999998876
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=97.73 E-value=3.8e-05 Score=63.13 Aligned_cols=58 Identities=31% Similarity=0.428 Sum_probs=53.4
Q ss_pred HHhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 363 i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+...++++++..++++|..+|.|++|.|+.+|+..++..+|..++.+++..++..+|.
T Consensus 10 ~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~ 67 (162)
T 1top_A 10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDE 67 (162)
T ss_dssp HHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred hhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcC
Confidence 4456788899999999999999999999999999999999999999999999998873
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=97.73 E-value=3.8e-05 Score=62.94 Aligned_cols=55 Identities=24% Similarity=0.459 Sum_probs=50.7
Q ss_pred hhhHHHHhhHHHHhhccC-CCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 366 NLSEEEIMGLKEMFKSMD-TDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D-~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.++++++..++++|..+| .|++|.|+.+|+..+++.+|..++..++..+++.+|.
T Consensus 6 ~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~ 61 (158)
T 2jnf_A 6 KLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDP 61 (158)
T ss_dssp TSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCSHHHHHHHHHHHCT
T ss_pred hCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 456778889999999999 9999999999999999999999999999999998873
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=97.72 E-value=4.1e-05 Score=61.90 Aligned_cols=52 Identities=19% Similarity=0.277 Sum_probs=48.6
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhc
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~ 418 (420)
++++++..++.+|..+|.|++|.|+.+|+..++..+|..++.+++..+++.+
T Consensus 2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~ 53 (149)
T 2mys_C 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNP 53 (149)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHh
Confidence 4567888899999999999999999999999999999999999999999887
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=97.70 E-value=4e-05 Score=62.87 Aligned_cols=56 Identities=29% Similarity=0.482 Sum_probs=51.2
Q ss_pred hhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 365 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+++++...++++|..+|.|++|.|+.+|+..+++.+|..++.+++..+++.+|.
T Consensus 15 ~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~ 70 (161)
T 3fwb_A 15 SELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDS 70 (161)
T ss_dssp TTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCc
Confidence 34677888999999999999999999999999999999999999999999998873
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=97.70 E-value=1.7e-05 Score=59.00 Aligned_cols=51 Identities=27% Similarity=0.451 Sum_probs=44.0
Q ss_pred HHHHhhHHHHhhccC-CCCCC-cccHHHHHhhhhh---hCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMD-TDNSG-TITFEELKAGLPK---LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~---lg~~~~~~e~~~~~~~~d~ 420 (420)
+++...++++|..+| .|++| +|+.+||+.+++. +|. +++.+++++|+.+|.
T Consensus 6 ~~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~-~~~~~i~~~~~~~D~ 61 (92)
T 2kax_A 6 EKALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGE-MKESSIDDLMKSLDK 61 (92)
T ss_dssp HHHHHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTT-TCCTTHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCC-CCHHHHHHHHHHhCC
Confidence 345678999999999 99999 9999999999987 334 889999999999874
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=97.70 E-value=4e-05 Score=63.54 Aligned_cols=55 Identities=33% Similarity=0.556 Sum_probs=50.9
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.+++++...++++|..+|.|++|.|+.+|+..+++.+|..++..++..++..+|.
T Consensus 21 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~ 75 (169)
T 3qrx_A 21 GLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDK 75 (169)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHCS
T ss_pred CCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcC
Confidence 4567888999999999999999999999999999999999999999999998873
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=4.1e-05 Score=59.30 Aligned_cols=51 Identities=18% Similarity=0.205 Sum_probs=44.5
Q ss_pred HHHhhHHHHhhccCC-CCCC-cccHHHHHhhhh-hhCCC-----CCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDT-DNSG-TITFEELKAGLP-KLGTR-----LSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~-~~~G-~i~~~el~~~l~-~lg~~-----~~~~e~~~~~~~~d~ 420 (420)
+++..++++|..+|. |++| +|+.+||+.+++ .+|.. ++++++++||+.+|.
T Consensus 9 ~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~ 67 (113)
T 1xk4_C 9 RNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDT 67 (113)
T ss_dssp HHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCC
Confidence 456788999999995 9999 999999999999 78853 689999999999874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00037 Score=59.68 Aligned_cols=122 Identities=16% Similarity=0.089 Sum_probs=77.4
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCceecc
Q 014704 153 GELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL 230 (420)
Q Consensus 153 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 230 (420)
-+|.+.|... .+++|++++.++.|.+.+|.-+-. ..-..+=+.|..|++. .++.|...+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc-----------
Confidence 4788888764 579999999999999999877622 2222333456888884 445555442 1110
Q ss_pred cCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhccc
Q 014704 231 VGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHA 310 (420)
Q Consensus 231 ~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 310 (420)
.....+.|||......+.+.=|||||+++|.-+-=..| .+.-..+|+++..||..|..-
T Consensus 98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence 12335678887755556788999999999988752221 122247899999999999866
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A | Back alignment and structure |
|---|
Probab=97.65 E-value=2.1e-05 Score=57.93 Aligned_cols=50 Identities=28% Similarity=0.487 Sum_probs=45.1
Q ss_pred HHHhhHHHHhhccC-CCCCC-cccHHHHHhhhhh---hCCCCCHHHHHHHHHhcC
Q 014704 370 EEIMGLKEMFKSMD-TDNSG-TITFEELKAGLPK---LGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 370 ~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~---lg~~~~~~e~~~~~~~~d 419 (420)
.....++.+|..+| .|++| .|+.+||..+++. +|..+++++++++++.+|
T Consensus 7 ~~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D 61 (90)
T 1k8u_A 7 QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLD 61 (90)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHhcccCCCCCHHHHHHHHHHhC
Confidence 34567899999999 59999 9999999999997 999999999999999876
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.64 E-value=5.9e-05 Score=60.37 Aligned_cols=49 Identities=31% Similarity=0.483 Sum_probs=45.4
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+|+..++..+|..+++++++++++.+|.
T Consensus 75 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~ 123 (140)
T 1ggw_A 75 PEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV 123 (140)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhccC
Confidence 3567889999999999999999999999999999999999999999874
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=97.64 E-value=5.6e-05 Score=61.85 Aligned_cols=55 Identities=25% Similarity=0.459 Sum_probs=48.0
Q ss_pred HhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhc
Q 014704 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 364 ~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~ 418 (420)
...+++++...++.+|..+|.|++|.|+.+||..+++.+|..++..++..++...
T Consensus 9 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~ 63 (156)
T 1wdc_B 9 LTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKEA 63 (156)
T ss_dssp ---CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHTTS
T ss_pred hccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHhC
Confidence 3456778889999999999999999999999999999999999999999988653
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=97.63 E-value=2.3e-05 Score=59.81 Aligned_cols=52 Identities=17% Similarity=0.301 Sum_probs=42.9
Q ss_pred HHHHhhHHHHhhccC-CCCC-CcccHHHHHhhhhh-hCCCC-CHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMD-TDNS-GTITFEELKAGLPK-LGTRL-SESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D-~~~~-G~i~~~el~~~l~~-lg~~~-~~~e~~~~~~~~d~ 420 (420)
+.+..+++++|..|| .|++ |+|+.+||+.+++. +|... +++++++||+++|.
T Consensus 18 e~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~ 73 (106)
T 2h2k_A 18 EESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDV 73 (106)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCC
Confidence 345678999999999 7986 79999999999986 77554 35789999999874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00013 Score=68.06 Aligned_cols=139 Identities=14% Similarity=0.107 Sum_probs=71.7
Q ss_pred ceecccCCeE-EEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCC-CccEEEEEEEeCCeEEEEEecC
Q 014704 73 RELGRGQFGV-TYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGAYEDRHSVNLIMDLC 150 (420)
Q Consensus 73 ~~lG~G~~g~-V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-niv~~~~~~~~~~~~~iv~e~~ 150 (420)
+.|+.|+... +|+... .+|..+++|....... ..+..|+.+++.+..+. .+++++.+..+.+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 3565555444 666653 2256788886543210 23456788888776332 3566776533333 6899999
Q ss_pred CCCChHHHHHhc--------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHH
Q 014704 151 AGGELFDRIIAK--------------------------GHYSERAAA-------NLC-------------RQMVTVVHYC 184 (420)
Q Consensus 151 ~g~~L~~~l~~~--------------------------~~~~~~~~~-------~i~-------------~qi~~al~~l 184 (420)
.|..+.+.+... ..++..... .+. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 776665433211 012221110 000 0111222333
Q ss_pred ------HHcCCeeccCCCCcEEEecCCC-CCCeeEeecccccc
Q 014704 185 ------HSMGVMHRDLKPENFLFSSSAE-DSPLKATDFGLSVF 220 (420)
Q Consensus 185 ------H~~~ivH~Dlkp~Nill~~~~~-~~~~kl~Dfg~~~~ 220 (420)
+...++|||+.+.||++..+.. ...+.|+||+.+..
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1246999999999999953211 14689999997764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.63 E-value=7.9e-05 Score=69.04 Aligned_cols=139 Identities=17% Similarity=0.164 Sum_probs=77.6
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCC-CccEEEEE------EEeCCeEE
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGA------YEDRHSVN 144 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-niv~~~~~------~~~~~~~~ 144 (420)
.+.|+.|....+|++.... | .+++|+..... ..+.+..|+.+++.|..+. .+++++.. ....+..+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEeCC-c-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 3567788889999987643 3 68999876421 1234667888888876331 13344321 23346678
Q ss_pred EEEecCCCCChH--------------HHHHhc-CCC--------CHHHHHH---------------HHHHHHHHHHHHHH
Q 014704 145 LIMDLCAGGELF--------------DRIIAK-GHY--------SERAAAN---------------LCRQMVTVVHYCHS 186 (420)
Q Consensus 145 iv~e~~~g~~L~--------------~~l~~~-~~~--------~~~~~~~---------------i~~qi~~al~~lH~ 186 (420)
++|+|++|..+. ..++.. ..+ ....-.. +...+...+.++.+
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 999999986431 011111 010 1000000 00113344555553
Q ss_pred -------cCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 187 -------MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 187 -------~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
.+++|+|+++.|||+. ++..+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEe---CCceEEEecchhccC
Confidence 3699999999999995 233457999987653
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00011 Score=55.37 Aligned_cols=52 Identities=19% Similarity=0.241 Sum_probs=42.5
Q ss_pred HHHHhhHHHHhhccCCCC---CCcccHHHHHhhhhhh-CCCCC----HHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDTDN---SGTITFEELKAGLPKL-GTRLS----ESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~---~G~i~~~el~~~l~~l-g~~~~----~~e~~~~~~~~d~ 420 (420)
+..+.+++++|..||.++ +|+|+.+||+.+++.+ |..++ ++++++||+++|.
T Consensus 7 e~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~ 66 (100)
T 3nxa_A 7 EKAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDA 66 (100)
T ss_dssp HHHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCC
Confidence 345678999999999964 7999999999999874 43343 7899999999984
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=97.62 E-value=5.9e-05 Score=71.20 Aligned_cols=49 Identities=27% Similarity=0.551 Sum_probs=45.9
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.+.++++|+.+|.|++|+|+.+||+.+|..+|..++++|+++||+++|.
T Consensus 374 eeeLreAFk~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D~ 422 (440)
T 3u0k_A 374 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADI 422 (440)
T ss_dssp CHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 3568899999999999999999999999999999999999999999984
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=97.62 E-value=4.7e-05 Score=61.17 Aligned_cols=49 Identities=22% Similarity=0.431 Sum_probs=45.5
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+||..++..+|..+++++++++++.+|.
T Consensus 75 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~ 123 (143)
T 3j04_B 75 EDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPI 123 (143)
T ss_dssp HHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCC
Confidence 3567889999999999999999999999999999999999999999874
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=97.61 E-value=6e-05 Score=60.93 Aligned_cols=49 Identities=24% Similarity=0.541 Sum_probs=45.4
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+||..++..+|..++++++.++++.+|.
T Consensus 82 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~ 130 (148)
T 1m45_A 82 TEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEV 130 (148)
T ss_dssp THHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 3567889999999999999999999999999999999999999999874
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=97.60 E-value=4.4e-05 Score=61.34 Aligned_cols=50 Identities=24% Similarity=0.436 Sum_probs=45.5
Q ss_pred hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHh
Q 014704 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~ 417 (420)
+++++..++++|..+|.|++|.|+.+|+..+++.+|..++.+++..++..
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~ 51 (143)
T 3j04_B 2 DQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSE 51 (143)
T ss_dssp CHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSCCCCHHHHHTTTTT
T ss_pred CHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHh
Confidence 56788899999999999999999999999999999999999999887653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00014 Score=68.98 Aligned_cols=141 Identities=14% Similarity=0.135 Sum_probs=84.4
Q ss_pred cceecccCCeEEEEEEEcC-------CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 72 GRELGRGQFGVTYLVTHKD-------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
.+.|..|-...+|++.... .++.+++|+.-.. ......+.+|..+++.|..+.-..++++++.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567788889999998742 3578999985321 12345667999999998755445777776543 2
Q ss_pred EEEecCCCCChHH----------HH-------Hhc----C-CC--CHHHHHHHHHHHHH-------------------HH
Q 014704 145 LIMDLCAGGELFD----------RI-------IAK----G-HY--SERAAANLCRQMVT-------------------VV 181 (420)
Q Consensus 145 iv~e~~~g~~L~~----------~l-------~~~----~-~~--~~~~~~~i~~qi~~-------------------al 181 (420)
+||||++|.+|.. .+ +.. + .. -+..+..+..++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999999855421 11 111 1 11 23455666655432 23
Q ss_pred HHHH----H----cCCeeccCCCCcEEEecC-CCCCCeeEeecccccc
Q 014704 182 HYCH----S----MGVMHRDLKPENFLFSSS-AEDSPLKATDFGLSVF 220 (420)
Q Consensus 182 ~~lH----~----~~ivH~Dlkp~Nill~~~-~~~~~~kl~Dfg~~~~ 220 (420)
..|. . ..++|+|+.+.||++..+ +..+.+.++||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3333 2 248999999999999643 1235799999987653
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=97.60 E-value=1.2e-05 Score=59.78 Aligned_cols=51 Identities=6% Similarity=0.155 Sum_probs=43.1
Q ss_pred HHHhhHHHHhhccCC-CCCC-cccHHHHHhhh-hhhCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDT-DNSG-TITFEELKAGL-PKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~-~~~G-~i~~~el~~~l-~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+....++.+|..+|. |++| .|+.+||..++ +.+|..++..+++++|+.+|.
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~g~~~~~~~~~~l~~~~D~ 60 (93)
T 1xk4_A 7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDI 60 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHhhcCCCcCeECHHHHHHHHHHHCcccCCHHHHHHHHHHhCC
Confidence 345678899999999 9999 99999999999 778876777888999988873
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=97.59 E-value=1.9e-05 Score=64.21 Aligned_cols=53 Identities=19% Similarity=0.371 Sum_probs=44.2
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
++++++..++.+|..+|.|++|.|+.+|+..+++.+|..++..++..++..+|
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d 56 (151)
T 1w7j_B 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPK 56 (151)
T ss_dssp -------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC
Confidence 46778889999999999999999999999999999999999999999998876
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00022 Score=58.44 Aligned_cols=50 Identities=26% Similarity=0.397 Sum_probs=46.0
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....+..+|..+|.|++|.|+.+|+..++..+|..++++++.+++..+|.
T Consensus 94 ~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~ 143 (162)
T 1top_A 94 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDK 143 (162)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCT
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 44568899999999999999999999999999999999999999999873
|
| >1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A | Back alignment and structure |
|---|
Probab=97.57 E-value=1.6e-05 Score=60.14 Aligned_cols=51 Identities=18% Similarity=0.296 Sum_probs=43.9
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhh-----hCC--CCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPK-----LGT--RLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-----lg~--~~~~~e~~~~~~~~d~ 420 (420)
++++.+++++|..||.+ +|+|+.+||+.+++. +|. .++++++++||+++|.
T Consensus 6 ~~~~~~l~~~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D~ 63 (100)
T 1psr_A 6 ERSIIGMIDMFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDK 63 (100)
T ss_dssp HHHHHHHHHHHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCT
T ss_pred HHHHHHHHHHHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhCC
Confidence 45677899999999977 799999999999987 565 6788899999999884
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=97.56 E-value=8.8e-05 Score=60.62 Aligned_cols=47 Identities=17% Similarity=0.372 Sum_probs=44.5
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
..+..+|..+|.|++|.|+.+||..++..+|..+++++++++|+.+|
T Consensus 87 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d 133 (156)
T 1wdc_B 87 ETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAP 133 (156)
T ss_dssp HHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcC
Confidence 46788999999999999999999999999999999999999999987
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00014 Score=59.55 Aligned_cols=50 Identities=28% Similarity=0.560 Sum_probs=46.1
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....+..+|..+|.|++|.|+.+||..++..+|..++++++.++++.+|.
T Consensus 94 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~ 143 (161)
T 3fwb_A 94 PLDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFDL 143 (161)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCS
T ss_pred cHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999999999999999999873
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00024 Score=58.78 Aligned_cols=50 Identities=30% Similarity=0.507 Sum_probs=45.9
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....+..+|..+|.|++|.|+.+|+..++..+|..+++++++++++.+|.
T Consensus 99 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D~ 148 (169)
T 3qrx_A 99 SREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADR 148 (169)
T ss_dssp HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCC
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999999999999999999874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00039 Score=64.46 Aligned_cols=75 Identities=11% Similarity=0.151 Sum_probs=49.1
Q ss_pred eecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCC-CccEEEEE-----EEeCCeEEEEE
Q 014704 74 ELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR-NIVELKGA-----YEDRHSVNLIM 147 (420)
Q Consensus 74 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp-niv~~~~~-----~~~~~~~~iv~ 147 (420)
.|+ |....||++... +|+.+++|+...... ....+..|..+++.|..+. .+++++.. ....+..+++|
T Consensus 33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEC-CSSSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred eec-CcccceEEEEcC-CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 466 788899987653 466799999853211 2356778888888886321 23444432 23356678999
Q ss_pred ecCCCCC
Q 014704 148 DLCAGGE 154 (420)
Q Consensus 148 e~~~g~~ 154 (420)
++++|..
T Consensus 107 ~~i~G~~ 113 (328)
T 1zyl_A 107 PSVGGRQ 113 (328)
T ss_dssp ECCCCEE
T ss_pred EecCCCC
Confidence 9998854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00028 Score=68.19 Aligned_cols=75 Identities=11% Similarity=0.120 Sum_probs=51.7
Q ss_pred cceecccCCeEEEEEEEcC-------CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 72 GRELGRGQFGVTYLVTHKD-------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
.+.|+.|....||++.... .+..+++|+.... ...+.+.+|..+++.|..+.-.+++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4578889999999998653 2578999987321 1114455899999998744434677776542 3
Q ss_pred EEEecCCCCCh
Q 014704 145 LIMDLCAGGEL 155 (420)
Q Consensus 145 iv~e~~~g~~L 155 (420)
+|+||++|.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987443
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0001 Score=59.04 Aligned_cols=48 Identities=25% Similarity=0.420 Sum_probs=44.6
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
...+..+|..+|.|++|.|+.+|+..++..+|..+++++++++|+.+|
T Consensus 78 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d 125 (142)
T 2bl0_C 78 EDILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE 125 (142)
T ss_dssp HHHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC
Confidence 446788999999999999999999999999999999999999999876
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=97.53 E-value=7.6e-05 Score=62.94 Aligned_cols=51 Identities=22% Similarity=0.300 Sum_probs=45.4
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhh-hhCCC-C------CHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLP-KLGTR-L------SESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~-~lg~~-~------~~~e~~~~~~~~d~ 420 (420)
.....++.+|..+|.|++|+|+.+||..++. .+|.. + +++++++||+.+|.
T Consensus 95 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~ 153 (179)
T 3a8r_A 95 GFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDP 153 (179)
T ss_dssp CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHST
T ss_pred CHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCC
Confidence 3456789999999999999999999999999 88876 6 88999999999884
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.52 E-value=7.8e-05 Score=59.92 Aligned_cols=50 Identities=36% Similarity=0.561 Sum_probs=45.9
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|..+|.|++|.|+.+|+..++..+|..+++++++++++.+|.
T Consensus 74 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~ 123 (145)
T 2bl0_B 74 QSKEMLDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSV 123 (145)
T ss_dssp GHHHHHHHHHHHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCCC
T ss_pred cHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCC
Confidence 44567889999999999999999999999999999999999999999873
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00024 Score=57.03 Aligned_cols=48 Identities=35% Similarity=0.554 Sum_probs=44.6
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
...+..+|..+|.|++|.|+.+|+..++..+|..++++++.++++.+|
T Consensus 83 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d 130 (147)
T 4ds7_A 83 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS 130 (147)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS
T ss_pred HHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc
Confidence 456788999999999999999999999999999999999999999876
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00012 Score=59.69 Aligned_cols=49 Identities=31% Similarity=0.504 Sum_probs=45.3
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHh--cCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA--VSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~--~d~ 420 (420)
...++.+|..+|.|++|.|+.+||..++..+|..++++++.++|+. +|.
T Consensus 83 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D~ 133 (156)
T 1wdc_C 83 FADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQE 133 (156)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCC
Confidence 4567889999999999999999999999999999999999999999 773
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=97.51 E-value=9.5e-05 Score=61.11 Aligned_cols=49 Identities=24% Similarity=0.305 Sum_probs=45.4
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+||..++..+|..++++++.++|+.+|.
T Consensus 94 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~ 142 (166)
T 2mys_B 94 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPP 142 (166)
T ss_pred HHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcCC
Confidence 3567889999999999999999999999999999999999999999873
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=97.49 E-value=6.1e-05 Score=61.15 Aligned_cols=49 Identities=24% Similarity=0.415 Sum_probs=43.7
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
....+..+|..+|.|++|.|+.+||..++..+|..+++++++++++.+|
T Consensus 85 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d 133 (151)
T 1w7j_B 85 TYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE 133 (151)
T ss_dssp ---CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc
Confidence 3456788999999999999999999999999999999999999999876
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=97.48 E-value=4e-05 Score=57.40 Aligned_cols=51 Identities=20% Similarity=0.300 Sum_probs=43.4
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
+++..+++++|..||. .+|+|+.+||+.+++. +|..++++++++||+.+|.
T Consensus 5 ~~~~~~l~~~F~~fD~-~dg~Is~~El~~~l~~~~~~~lg~~~~~~ev~~l~~~~D~ 60 (96)
T 1a4p_A 5 EHAMETMMFTFHKFAG-DKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQ 60 (96)
T ss_dssp HHHHHHHHHHHHHHHG-GGCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHcC-CCCeECHHHHHHHHHHHcccccccccCHHHHHHHHHHhCC
Confidence 3456789999999994 5679999999999986 6777899999999999874
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 | Back alignment and structure |
|---|
Probab=97.47 E-value=1.4e-05 Score=56.99 Aligned_cols=50 Identities=18% Similarity=0.286 Sum_probs=43.9
Q ss_pred HHhhHHHHhhccCC-CCCC-cccHHHHHhhhhh-hCCCC-CHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDT-DNSG-TITFEELKAGLPK-LGTRL-SESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~-~~~G-~i~~~el~~~l~~-lg~~~-~~~e~~~~~~~~d~ 420 (420)
+...++.+|..+|. |++| .|+.+||..++.. +|..+ +.+++++++..+|.
T Consensus 5 ~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~D~ 58 (78)
T 1cb1_A 5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDK 58 (78)
T ss_dssp CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCC
T ss_pred HHHHHHHHHHHHhccCCCcCEeCHHHHHHHHHHHhhhhcccHHHHHHHHHHhcC
Confidence 35678899999999 9999 9999999999986 88777 88899999998873
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.46 E-value=8e-05 Score=62.50 Aligned_cols=46 Identities=13% Similarity=0.234 Sum_probs=42.9
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh----CCCCCHHHHHHHHHhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL----GTRLSESEVRQLMEAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g~~~~~~e~~~~~~~~d 419 (420)
..++.+|+.+| |++|+|+.+||+.+++.+ |..++++++++|++.+|
T Consensus 76 ~~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~~l~~~~d 125 (174)
T 2i7a_A 76 VHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYS 125 (174)
T ss_dssp HHHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHHHHHHHHS
T ss_pred HHHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHHHHHHHHc
Confidence 35788999999 999999999999999999 99999999999999876
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=97.46 E-value=3.8e-05 Score=62.08 Aligned_cols=53 Identities=17% Similarity=0.192 Sum_probs=48.3
Q ss_pred hHHHHhhHHHHhhccCCCC-CCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 368 SEEEIMGLKEMFKSMDTDN-SGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~-~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..++...++.+|..+|.|+ +|.|+.+|+..+++.+|..++..++..++..+|.
T Consensus 9 ~~~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~ 62 (146)
T 2qac_A 9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYGD 62 (146)
T ss_dssp HHHHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 3456778999999999999 9999999999999999999999999999998873
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=97.45 E-value=2.4e-05 Score=59.81 Aligned_cols=49 Identities=35% Similarity=0.476 Sum_probs=44.9
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh---CCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~ 420 (420)
...++.+|..+|.|++|+|+.+||..++..+ |..+++++++++++.+|.
T Consensus 40 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~ 91 (108)
T 2kyc_A 40 SSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARVLTASETKTFLAAADH 91 (108)
T ss_dssp SSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCCCCTTTTHHHHTTTCC
T ss_pred HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCC
Confidence 4567899999999999999999999999999 888999999999999873
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0019 Score=58.70 Aligned_cols=80 Identities=15% Similarity=0.028 Sum_probs=55.8
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCC--CccEEEEEEEeCCeEEE
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR--NIVELKGAYEDRHSVNL 145 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp--niv~~~~~~~~~~~~~i 145 (420)
...-.+.+|.|..+.||++... +|+.|++|+...... .....+..|...|+.|.... -+++++.+ +. -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence 3455678999999999999875 578999998653321 22245789999999986332 34556654 22 378
Q ss_pred EEecCCCCCh
Q 014704 146 IMDLCAGGEL 155 (420)
Q Consensus 146 v~e~~~g~~L 155 (420)
||||++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987643
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00018 Score=58.92 Aligned_cols=50 Identities=28% Similarity=0.476 Sum_probs=43.9
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....+..+|..+|.|++|.|+.+|+..++..+|..++++++..+|+.+|.
T Consensus 93 ~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D~ 142 (161)
T 1dtl_A 93 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDK 142 (161)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999999999999999999873
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00019 Score=58.11 Aligned_cols=49 Identities=24% Similarity=0.607 Sum_probs=45.4
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhh-hCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPK-LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+||..++.. +|..+++++++++++.+|.
T Consensus 87 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~ 136 (153)
T 3ox6_A 87 VKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDL 136 (153)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCC
Confidence 456888999999999999999999999999 8999999999999999874
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00013 Score=59.58 Aligned_cols=49 Identities=20% Similarity=0.424 Sum_probs=45.5
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...++.+|..+|.|++|.|+.+||..++..+|..++++++.++++.+|.
T Consensus 90 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~ 138 (158)
T 2jnf_A 90 QQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEIDA 138 (158)
T ss_dssp SSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhCC
Confidence 4568899999999999999999999999999999999999999999873
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=5.2e-05 Score=64.53 Aligned_cols=57 Identities=21% Similarity=0.284 Sum_probs=49.5
Q ss_pred HhhhhHHHHhhHHHHhhccCCCCCCcccHHHHH-----hhhhhhCCCCCHH-----HHHHHHHhcCC
Q 014704 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELK-----AGLPKLGTRLSES-----EVRQLMEAVSL 420 (420)
Q Consensus 364 ~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~-----~~l~~lg~~~~~~-----e~~~~~~~~d~ 420 (420)
...++++++..++++|..+|.|++|.|+.+|+. .+++.+|..++.. ++..+++.+|.
T Consensus 11 ~~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~ 77 (195)
T 1qv0_A 11 TDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGM 77 (195)
T ss_dssp CCTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTC
T ss_pred cccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHHcCC
Confidence 344578889999999999999999999999999 7889999888877 68889988873
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00012 Score=62.68 Aligned_cols=53 Identities=23% Similarity=0.468 Sum_probs=48.0
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhc
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~ 418 (420)
.++.+++..++.+|..+|.|++|.|+.+||..+|..+|..++..++..++..+
T Consensus 50 ~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~l~~~~ 102 (196)
T 3dtp_E 50 MFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEA 102 (196)
T ss_dssp SSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSCCCCHHHHHHHHTTS
T ss_pred hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc
Confidence 34667778899999999999999999999999999999999999999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00038 Score=65.79 Aligned_cols=75 Identities=11% Similarity=0.162 Sum_probs=46.0
Q ss_pred cceecccCCeEEEEEEEcC--------CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 72 GRELGRGQFGVTYLVTHKD--------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
.+.|+.|....+|++.... .+..+++|+..... ........|..+++.|..+.-+++++... .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4567888889999998653 13678999864321 11112467888888887443345777554 22
Q ss_pred EEEEecCCCCC
Q 014704 144 NLIMDLCAGGE 154 (420)
Q Consensus 144 ~iv~e~~~g~~ 154 (420)
++||||++|.+
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998854
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0002 Score=57.74 Aligned_cols=47 Identities=26% Similarity=0.410 Sum_probs=43.4
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhc
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~ 418 (420)
...++.+|..+|.|++|.|+.+||..++..+|..++++++++++..+
T Consensus 83 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~ 129 (146)
T 2qac_A 83 VEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF 129 (146)
T ss_dssp HHHHHHHHHTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHc
Confidence 45688899999999999999999999999999999999999999865
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00043 Score=57.81 Aligned_cols=50 Identities=26% Similarity=0.541 Sum_probs=43.7
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....+..+|..+|.|++|.|+.+|+..++..+|..++++++.++|+.+|.
T Consensus 82 ~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~ 131 (179)
T 2f2o_A 82 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADI 131 (179)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHCT
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCC
Confidence 34567889999999999999999999999999999999999999999873
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0002 Score=61.19 Aligned_cols=47 Identities=15% Similarity=0.137 Sum_probs=43.9
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
...+..+|..+|.|++|+|+.+||..++ .+|..++++++..||..+|
T Consensus 125 ~~~l~~~F~~~D~d~~G~Is~~El~~~l-~~g~~~~~~~~~~l~~~~D 171 (196)
T 3dtp_E 125 EDVIVNAFNLFDEGDGKCKEETLKRSLT-TWGEKFSQDEVDQALSEAP 171 (196)
T ss_dssp HHHHHHHHHTTCSSSSCCBHHHHHHHHH-HSSSCCCHHHHHHHHHSSC
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCCHHHHHHHHHHcC
Confidence 3467889999999999999999999999 9999999999999999987
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00021 Score=57.54 Aligned_cols=49 Identities=29% Similarity=0.466 Sum_probs=44.8
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....+..+|..+|.|++|.|+.+|+..++..+|..++++++.++++. |.
T Consensus 83 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d~ 131 (149)
T 2mys_C 83 TFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QE 131 (149)
T ss_pred hHHHHHHHHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-CC
Confidence 45568889999999999999999999999999999999999999988 63
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=97.35 E-value=3.7e-05 Score=62.25 Aligned_cols=48 Identities=23% Similarity=0.333 Sum_probs=43.7
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhc-C
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV-S 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~-d 419 (420)
+..++++|..+|.|++|.|+.+|+..+++.+|..++..++..++..+ |
T Consensus 3 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~~D 51 (148)
T 1m45_A 3 TRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSS 51 (148)
T ss_dssp CCCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--C
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHhhC
Confidence 45678899999999999999999999999999999999999999988 6
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00012 Score=54.84 Aligned_cols=51 Identities=18% Similarity=0.255 Sum_probs=44.0
Q ss_pred HHHhhHHHHhhccC-CCCCC-cccHHHHHhhhh-hh----CCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMD-TDNSG-TITFEELKAGLP-KL----GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~-~l----g~~~~~~e~~~~~~~~d~ 420 (420)
.....+..+|..+| .|++| .|+.+||..++. .+ |..+++.+++++++.+|.
T Consensus 10 ~~~~~l~~~F~~~Dd~d~~G~~I~~~el~~~l~~~~~~~~~~~~~~~~~~~l~~~~D~ 67 (99)
T 1qls_A 10 RCIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDL 67 (99)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHhcCCCcCeeCHHHHHHHHHHHcchhccccCCHHHHHHHHHHhCC
Confidence 34567899999998 99999 999999999998 45 367899999999999873
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00016 Score=61.92 Aligned_cols=52 Identities=29% Similarity=0.509 Sum_probs=42.9
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..++..++++|..+|.|++|.|+.+|+..++..+|..++.+++..+++.+|.
T Consensus 33 ~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~ 84 (204)
T 3e3r_A 33 ASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWDR 84 (204)
T ss_dssp -------CHHHHHHCTTCCSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCT
T ss_pred chhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhcc
Confidence 4567789999999999999999999999999999999999999999998873
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=97.31 E-value=7.4e-05 Score=61.04 Aligned_cols=52 Identities=25% Similarity=0.323 Sum_probs=43.7
Q ss_pred hhHHHHhhHHHHhhccCC--CCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 367 LSEEEIMGLKEMFKSMDT--DNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~--~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
++++++..++++|..+|. |++|.|+.+||..+++.+|..++..++..+ ..+|
T Consensus 3 ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D 56 (156)
T 1wdc_C 3 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTH 56 (156)
T ss_dssp CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCS
T ss_pred CCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhC
Confidence 456777888888999998 899999999999999888888888888888 7665
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00022 Score=60.20 Aligned_cols=45 Identities=24% Similarity=0.406 Sum_probs=42.5
Q ss_pred HHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 376 KEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 376 ~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+|..+|.|++|.|+.+|+..++..+|..++++++.++|+.+|.
T Consensus 112 ~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~ 156 (191)
T 1uhk_A 112 DALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDI 156 (191)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCC
T ss_pred HHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 389999999999999999999999999999999999999999874
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00013 Score=62.98 Aligned_cols=56 Identities=16% Similarity=0.303 Sum_probs=45.0
Q ss_pred hhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCC--CCCHHHHHHHH-------HhcCC
Q 014704 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGT--RLSESEVRQLM-------EAVSL 420 (420)
Q Consensus 365 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~--~~~~~e~~~~~-------~~~d~ 420 (420)
..++++++..++++|..+|.|++|.|+.+|+..++..+|. .++.+++..++ +.+|.
T Consensus 28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~ 92 (208)
T 2hpk_A 28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGV 92 (208)
T ss_dssp --------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTC
T ss_pred HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCC
Confidence 3456777889999999999999999999999999999998 89999999999 87763
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00035 Score=59.23 Aligned_cols=45 Identities=31% Similarity=0.386 Sum_probs=38.6
Q ss_pred HHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 376 KEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 376 ~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+|..+|.|++|.|+.+||..++..+|..+++++++++|+.+|.
T Consensus 116 ~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~ 160 (195)
T 1qv0_A 116 DAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDL 160 (195)
T ss_dssp HHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCC
T ss_pred HHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 389999999999999999999999999999999999999999874
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0002 Score=60.49 Aligned_cols=54 Identities=20% Similarity=0.353 Sum_probs=47.9
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHH-----hhhhhhCCCCCHH-----HHHHHHHhcCC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELK-----AGLPKLGTRLSES-----EVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~-----~~l~~lg~~~~~~-----e~~~~~~~~d~ 420 (420)
.++++...++++|..+|.|++|.|+.+|+. .+++.+|..++.. +++.+++.+|.
T Consensus 10 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~ 73 (191)
T 1uhk_A 10 DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGM 73 (191)
T ss_dssp TCHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTC
T ss_pred CCHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHHHhCc
Confidence 356778889999999999999999999999 8899999988887 68889998873
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00034 Score=59.46 Aligned_cols=48 Identities=25% Similarity=0.449 Sum_probs=44.1
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..++.+|..+|.|++|.|+.+|+..++..+|..+++++++++++.+|.
T Consensus 93 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D~ 140 (191)
T 1y1x_A 93 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDR 140 (191)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 457788999999999999999999999999999999999999999873
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00046 Score=59.07 Aligned_cols=50 Identities=20% Similarity=0.333 Sum_probs=45.6
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhhhh-CCCCCHHHHHHHHHh----cC
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL-GTRLSESEVRQLMEA----VS 419 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l-g~~~~~~e~~~~~~~----~d 419 (420)
.....++.+|..+|.|++|.|+.+||..++..+ |..++++++.++++. +|
T Consensus 111 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~D 165 (202)
T 2bec_A 111 SRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGVQVTEEQLENIADRTVQEAD 165 (202)
T ss_dssp SHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHSCCSCCCHHHHHHHHHHHHHHHC
T ss_pred cHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHcC
Confidence 345678899999999999999999999999999 999999999999988 76
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00028 Score=61.60 Aligned_cols=47 Identities=19% Similarity=0.188 Sum_probs=44.3
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
..++.+|..+|.|++|+|+.+||..++..+|..+++++++++++.+|
T Consensus 117 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d 163 (220)
T 3sjs_A 117 ELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA 163 (220)
T ss_dssp HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc
Confidence 45788999999999999999999999999999999999999999876
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00021 Score=56.27 Aligned_cols=44 Identities=23% Similarity=0.480 Sum_probs=22.9
Q ss_pred HHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 376 KEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 376 ~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
+++|..+|.|++|.|+.+|+..++..+|..++.+++..+++.+|
T Consensus 3 ~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D 46 (134)
T 1jfj_A 3 EALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSID 46 (134)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHC
T ss_pred HHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHc
Confidence 44455555555555555555555555555555555555555444
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00043 Score=57.49 Aligned_cols=48 Identities=33% Similarity=0.475 Sum_probs=44.5
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..++.+|..+|.|++|.|+.+|+..++..+|..++++++..+++.+|.
T Consensus 74 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~ 121 (172)
T 2znd_A 74 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDR 121 (172)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 467889999999999999999999999999999999999999998873
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00012 Score=61.82 Aligned_cols=51 Identities=14% Similarity=0.228 Sum_probs=45.6
Q ss_pred hhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhh------CCCCCHHHHHHHH
Q 014704 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL------GTRLSESEVRQLM 415 (420)
Q Consensus 365 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l------g~~~~~~e~~~~~ 415 (420)
..+++++...++++|..+|.|++|.|+.+||..+++.+ |..++.+++.+++
T Consensus 6 ~~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~~~~~~~~~~l~ 62 (186)
T 2hps_A 6 ESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFL 62 (186)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCCCCCcHHHHHHH
Confidence 45577788999999999999999999999999999876 8888899999885
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0026 Score=61.83 Aligned_cols=76 Identities=12% Similarity=0.140 Sum_probs=49.5
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecCC
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCA 151 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~~ 151 (420)
.+.|+.|-...+|++.....+..+++|+..... .. .-...+|..+++.|..+.-.+++++++. + .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 356888889999999876545789999874321 11 1112589999999984443467777763 2 25999998
Q ss_pred CCCh
Q 014704 152 GGEL 155 (420)
Q Consensus 152 g~~L 155 (420)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8544
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00039 Score=59.86 Aligned_cols=50 Identities=20% Similarity=0.317 Sum_probs=44.7
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhh-CCCCCHHHHHHH----HHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKL-GTRLSESEVRQL----MEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l-g~~~~~~e~~~~----~~~~d~ 420 (420)
....++.+|..+|.|++|+|+.+||..++..+ |..+++++++++ |+.+|.
T Consensus 111 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D~ 165 (208)
T 2ct9_A 111 RSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQ 165 (208)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCC
Confidence 44567889999999999999999999999997 999999999988 888773
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00037 Score=56.25 Aligned_cols=47 Identities=19% Similarity=0.191 Sum_probs=37.3
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhC--------CCCCHHHHHHHH----HhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLG--------TRLSESEVRQLM----EAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg--------~~~~~~e~~~~~----~~~d 419 (420)
..++.+|+.+|.|++|+|+.+||..++..++ ..++.+++.+++ +.+|
T Consensus 68 ~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s~~e~~~~~~~~f~~~D 126 (143)
T 3a4u_B 68 ELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDELINIIDGVLRDDD 126 (143)
T ss_dssp HHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------CCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCCHHHHHHHHHHHHHHcC
Confidence 4577889999999999999999999999884 578999998777 7666
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0028 Score=59.06 Aligned_cols=69 Identities=12% Similarity=0.069 Sum_probs=44.1
Q ss_pred cccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccC--CCCccEEEEE------EEeCCeEEEEE
Q 014704 76 GRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG--HRNIVELKGA------YEDRHSVNLIM 147 (420)
Q Consensus 76 G~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--hpniv~~~~~------~~~~~~~~iv~ 147 (420)
|.|....||++.... | .+++|+..... ...|+.+++.|.. -|++++++.. ....+..+++|
T Consensus 32 G~g~~N~vy~v~~~~-g-~~vLK~~~~~~---------~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~ 100 (339)
T 3i1a_A 32 GADTNAFAYQADSES-K-SYFIKLKYGYH---------DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY 100 (339)
T ss_dssp TSCSSCEEEEEECSS-C-EEEEEEEECSS---------CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred cCccccceEEEEeCC-C-CEEEEEecCcc---------chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence 444468899987543 4 89999875432 1356666666642 2335555432 23457789999
Q ss_pred ecCCCCCh
Q 014704 148 DLCAGGEL 155 (420)
Q Consensus 148 e~~~g~~L 155 (420)
+|++|..+
T Consensus 101 ~~i~G~~~ 108 (339)
T 3i1a_A 101 PFIHAPNG 108 (339)
T ss_dssp ECCCCCBT
T ss_pred eccCCCcC
Confidence 99998755
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00059 Score=52.82 Aligned_cols=51 Identities=22% Similarity=0.264 Sum_probs=44.9
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++.++...+.++|..+|. ++|+|+.+|++.++.+.| ++.+++.+|++.+|.
T Consensus 27 it~ee~~~y~~iF~~lD~-~dG~Isg~elr~~~~~sg--Lp~~~L~~Iw~laD~ 77 (121)
T 3fia_A 27 ITVEERAKHDQQFHSLKP-ISGFITGDQARNFFFQSG--LPQPVLAQIWALADM 77 (121)
T ss_dssp CCHHHHHHHHHHHHHTCC-BTTBEEHHHHHHHHGGGC--CCHHHHHHHHHHHCT
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeECHHHHHHHHHHcC--CCHHHHHHHHHHHcC
Confidence 357788889999999998 899999999999998874 689999999999884
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0013 Score=53.81 Aligned_cols=47 Identities=26% Similarity=0.317 Sum_probs=43.0
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+|+..++..+| ++++++.++++.+|.
T Consensus 97 ~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~--~~~~~~~~~~~~~D~ 143 (166)
T 3akb_A 97 RPFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAALDT 143 (166)
T ss_dssp HHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTT--CCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--CCHHHHHHHHHHhCC
Confidence 34588999999999999999999999999998 899999999999873
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00033 Score=56.13 Aligned_cols=43 Identities=30% Similarity=0.579 Sum_probs=40.8
Q ss_pred HHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHh
Q 014704 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417 (420)
Q Consensus 375 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~ 417 (420)
++++|..+|.|++|.|+.+|+..+++.+|..++.+++..++..
T Consensus 7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~ 49 (145)
T 2bl0_B 7 IQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ 49 (145)
T ss_dssp HHHHHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh
Confidence 8899999999999999999999999999999999999998864
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0006 Score=56.20 Aligned_cols=46 Identities=30% Similarity=0.497 Sum_probs=42.7
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhc
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~ 418 (420)
..++.+|..+|.|++|.|+.+|+..++..+|..+++++++++++.+
T Consensus 70 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~ 115 (165)
T 1k94_A 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRY 115 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHHHh
Confidence 4678899999999999999999999999999999999999999865
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00022 Score=62.07 Aligned_cols=53 Identities=23% Similarity=0.377 Sum_probs=45.8
Q ss_pred HhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhh-hCCCCCHHHHHHHHH
Q 014704 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPK-LGTRLSESEVRQLME 416 (420)
Q Consensus 364 ~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-lg~~~~~~e~~~~~~ 416 (420)
...++++++..++++|..+|.|++|.|+.+||..++.. +|..++.+++.+++.
T Consensus 39 ~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~ 92 (219)
T 3cs1_A 39 PREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITK 92 (219)
T ss_dssp CCSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHH
Confidence 34567888999999999999999999999999999987 898888777777654
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00033 Score=61.00 Aligned_cols=49 Identities=22% Similarity=0.355 Sum_probs=44.6
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCC-CCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGT-RLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|+|+.+||..++..+|. .+++++++++|+.+|.
T Consensus 129 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~ 178 (219)
T 3cs1_A 129 FFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDK 178 (219)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCT
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCC
Confidence 356889999999999999999999999999987 7899999999999873
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00044 Score=58.73 Aligned_cols=47 Identities=34% Similarity=0.519 Sum_probs=38.7
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
..++++|..+|.|++|.|+.+|+..++..+|..++++++..+++.+|
T Consensus 27 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~l~~~~D 73 (191)
T 1y1x_A 27 QELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYD 73 (191)
T ss_dssp SCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC
Confidence 45777888888888888888888888877777888888888888776
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00072 Score=54.75 Aligned_cols=48 Identities=25% Similarity=0.418 Sum_probs=43.7
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhhh-hCCCCCHHHHHHHHHh
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPK-LGTRLSESEVRQLMEA 417 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-lg~~~~~~e~~~~~~~ 417 (420)
.....++.+|..+|.|++|.|+.+|+..++.. +|..++++++.++++.
T Consensus 72 ~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~ 120 (155)
T 3ll8_B 72 DKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDK 120 (155)
T ss_dssp CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHHH
Confidence 34467889999999999999999999999999 6999999999999988
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00055 Score=65.87 Aligned_cols=55 Identities=36% Similarity=0.574 Sum_probs=46.7
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.++.++...++++|..+|.|++|.|+.+||..++..+|..++.+++++|++.+|.
T Consensus 305 ~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D~ 359 (450)
T 3sg6_A 305 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA 359 (450)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCT
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhcc
Confidence 3456667788889999999999999999999999999988999999999988873
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00081 Score=55.71 Aligned_cols=48 Identities=21% Similarity=0.271 Sum_probs=43.1
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|..+|.|++|+|+.+|+..++..+| +++++++++|+.+|.
T Consensus 92 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g--~~~~~~~~~~~~~D~ 139 (174)
T 1q80_A 92 VEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFDAIDT 139 (174)
T ss_dssp HHTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHT--CCGGGHHHHHHHHCT
T ss_pred HHHHHHHHHHHhCCCCCCcccHHHHHHHHHHcC--CCHHHHHHHHHHhCC
Confidence 346788999999999999999999999999997 789999999999873
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00041 Score=57.75 Aligned_cols=47 Identities=28% Similarity=0.388 Sum_probs=43.6
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
..++.+|..+|.|++|.|+.+|+..++..+|..+++++++.+++.+|
T Consensus 77 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d 123 (173)
T 1alv_A 77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS 123 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc
Confidence 46788999999999999999999999999999999999999998765
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00084 Score=55.66 Aligned_cols=47 Identities=26% Similarity=0.325 Sum_probs=43.0
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...++.+|..+|.|++|.|+.+|+..++..+| +++++++.+|+.+|.
T Consensus 101 ~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g--~~~~~~~~~~~~~D~ 147 (176)
T 1nya_A 101 GPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDT 147 (176)
T ss_dssp HHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhC--CCHHHHHHHHHHhCC
Confidence 35578899999999999999999999999998 899999999999874
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00082 Score=56.77 Aligned_cols=47 Identities=19% Similarity=0.212 Sum_probs=42.8
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+|+..++..+| +++++++++|+.+|.
T Consensus 108 ~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g--~~~~~~~~~~~~~D~ 154 (191)
T 2ccm_A 108 TKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IPKSDCDAAFDTLSD 154 (191)
T ss_dssp HHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTT--CCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC--CCHHHHHHHHHHhCC
Confidence 45688899999999999999999999999998 899999999999874
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00047 Score=54.98 Aligned_cols=45 Identities=18% Similarity=0.223 Sum_probs=41.0
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHH
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~ 416 (420)
...++++|..+|.|++|.|+.+|+..+++.+|..++.+++.+++.
T Consensus 4 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~ 48 (140)
T 1ggw_A 4 DSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES 48 (140)
T ss_dssp CTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHh
Confidence 356788999999999999999999999999999999999998875
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00024 Score=60.82 Aligned_cols=48 Identities=29% Similarity=0.342 Sum_probs=42.2
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh--CCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL--GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l--g~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|+|+.+||..++..+ |..+++++++++|+.+|.
T Consensus 129 ~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~l~~~~D~ 178 (197)
T 3pm8_A 129 EVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVDL 178 (197)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHC----CCHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCCHHHHHHHHHHHcC
Confidence 467889999999999999999999999998 778899999999999874
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.00077 Score=55.67 Aligned_cols=46 Identities=33% Similarity=0.539 Sum_probs=42.8
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhc
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~ 418 (420)
..++.+|..+|.|++|.|+.+|+..++..+|..+++++++++++.+
T Consensus 72 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~ 117 (167)
T 1gjy_A 72 NGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRY 117 (167)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHh
Confidence 4678899999999999999999999999999999999999999875
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0005 Score=59.14 Aligned_cols=44 Identities=18% Similarity=0.393 Sum_probs=41.3
Q ss_pred HHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 375 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+..+|..+|.|++|.|+.+|+..++..+| +++++++++|..+|.
T Consensus 130 ~~~~F~~~D~d~~G~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~ 173 (208)
T 2hpk_A 130 SNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQEAAYTFFEKADT 173 (208)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHTT--SCTTHHHHHHHHHCT
T ss_pred HHHHHHHhCCCCCCcCCHHHHHHHHHHhC--cCHHHHHHHHHHhCC
Confidence 78899999999999999999999999999 899999999999873
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00095 Score=56.91 Aligned_cols=46 Identities=37% Similarity=0.556 Sum_probs=43.0
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhc
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~ 418 (420)
..++.+|..+|.|++|.|+.+|+..++..+|..+++++++++++.+
T Consensus 103 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~ 148 (198)
T 1juo_A 103 NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRY 148 (198)
T ss_dssp HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHh
Confidence 4678899999999999999999999999999999999999999875
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00091 Score=56.38 Aligned_cols=46 Identities=28% Similarity=0.347 Sum_probs=42.4
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|.|+.+|+..++. |..++++++.++++.+|.
T Consensus 123 ~~~~~~F~~~D~d~~G~I~~~E~~~~l~--~~~~~~~~~~~~~~~~D~ 168 (191)
T 3khe_A 123 ERLLAAFQQFDSDGSGKITNEELGRLFG--VTEVDDETWHQVLQECDK 168 (191)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHTT--SSCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHCCCCcCcCCHHHHHHHHc--cCCCCHHHHHHHHHHhCC
Confidence 4578899999999999999999999998 888999999999999874
|
| >1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00078 Score=50.88 Aligned_cols=47 Identities=23% Similarity=0.299 Sum_probs=38.5
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhh-----hCCCCCH-----------HHHHHHHHhcCC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPK-----LGTRLSE-----------SEVRQLMEAVSL 420 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~-----lg~~~~~-----------~e~~~~~~~~d~ 420 (420)
.++.+|..+|.|++|+|+.+||..++.. +|...+. ..+..+|+.+|.
T Consensus 21 ~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~g~~~~~~~~~~~~e~~~~~~~~~~~~~D~ 83 (103)
T 1snl_A 21 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDT 83 (103)
T ss_dssp CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCS
T ss_pred CHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHHhccCCCCccHHHHHHHHHHHHHHHHHHcCC
Confidence 4678899999999999999999999986 5765543 348889998874
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00078 Score=56.50 Aligned_cols=46 Identities=20% Similarity=0.320 Sum_probs=41.8
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|+|+.+||..++. +..++++++.++|+.+|.
T Consensus 108 ~~~~~~F~~~D~d~~G~I~~~El~~~l~--~~~~~~~~~~~~~~~~d~ 153 (180)
T 3mse_B 108 TFLKAAFNKIDKDEDGYISKSDIVSLVH--DKVLDNNDIDNFFLSVHS 153 (180)
T ss_dssp CHHHHHHHHHCTTCSSCBCHHHHHHHTT--TSSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHc--CCCCCHHHHHHHHHHhhh
Confidence 5678899999999999999999999998 678899999999998873
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0013 Score=63.25 Aligned_cols=49 Identities=27% Similarity=0.551 Sum_probs=45.4
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...++.+|..+|.|++|.|+.+||+.++..+|..+++++++++++.+|.
T Consensus 384 ~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D~ 432 (450)
T 3sg6_A 384 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADI 432 (450)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCT
T ss_pred hhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 3467889999999999999999999999999999999999999999873
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0015 Score=54.86 Aligned_cols=49 Identities=20% Similarity=0.443 Sum_probs=42.3
Q ss_pred HhhHHHHh--hccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMF--KSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F--~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+...| ..||.|++|.|+.+||..++..+|..+++++++++|+.+|.
T Consensus 99 ~~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~ 149 (186)
T 2hps_A 99 MAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDF 149 (186)
T ss_dssp HTTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcC
Confidence 34445555 66799999999999999999999999999999999999873
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.00041 Score=60.72 Aligned_cols=56 Identities=20% Similarity=0.287 Sum_probs=47.7
Q ss_pred HHhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHh-hhhhhCCCCCHHHHHHHHHhc
Q 014704 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKA-GLPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 363 i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~-~l~~lg~~~~~~e~~~~~~~~ 418 (420)
+...+++++...++++|..+|.|++|.|+.+||.. +++.+|..++..++..+++.+
T Consensus 41 l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~ 97 (226)
T 2lvv_A 41 IPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRA 97 (226)
T ss_dssp SCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHH
T ss_pred hchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHH
Confidence 33456788899999999999999999999999998 667789888888888887765
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0003 Score=60.12 Aligned_cols=52 Identities=15% Similarity=0.197 Sum_probs=45.8
Q ss_pred hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCC-----CCCHHHHHHHHHhcCC
Q 014704 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGT-----RLSESEVRQLMEAVSL 420 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-----~~~~~e~~~~~~~~d~ 420 (420)
+..+..++++ |..+|.|++|.|+.+||..+++.+|. .++.++++.+++.+|.
T Consensus 28 ~~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~ 84 (198)
T 1juo_A 28 PGQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDR 84 (198)
T ss_dssp TTCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCT
T ss_pred CccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCC
Confidence 3446677888 99999999999999999999999986 6799999999998873
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0012 Score=56.46 Aligned_cols=47 Identities=23% Similarity=0.294 Sum_probs=36.1
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
..+..+|..+|.|++|.|+++|+..++..++...+.+++..+|+.+|
T Consensus 59 ~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D 105 (204)
T 1jba_A 59 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYD 105 (204)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHHHHHHHHhC
Confidence 35667777888888888888888888877777777777888887776
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0013 Score=56.02 Aligned_cols=51 Identities=14% Similarity=0.316 Sum_probs=44.0
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhhh-------hCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPK-------LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-------lg~~~~~~e~~~~~~~~d~ 420 (420)
.....+..+|..+|.|++|.|+.+||..++.. +|...++++++++|+.+|.
T Consensus 106 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~ 163 (204)
T 3e3r_A 106 AREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDS 163 (204)
T ss_dssp HHHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSC
T ss_pred hHHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhc
Confidence 34567889999999999999999999999984 5677888999999999873
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.00062 Score=57.67 Aligned_cols=46 Identities=24% Similarity=0.495 Sum_probs=41.1
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|+|+.+||..++..+| +++++++++|+.+|.
T Consensus 82 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~ 127 (188)
T 1s6i_A 82 ENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQ 127 (188)
T ss_dssp CSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCS
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCC
Confidence 3567899999999999999999999999988 688899999999873
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0016 Score=57.06 Aligned_cols=48 Identities=19% Similarity=0.230 Sum_probs=39.9
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh------------CCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL------------GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l------------g~~~~~~e~~~~~~~~d~ 420 (420)
..++.+|+.+|.|++|+|+.+|+..++..+ +...++++++++|+.+|.
T Consensus 138 ~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~ 197 (229)
T 3dd4_A 138 EKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDK 197 (229)
T ss_dssp HHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCS
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcC
Confidence 467889999999999999999999999887 566788999999999874
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=96.69 E-value=0.00076 Score=58.47 Aligned_cols=49 Identities=31% Similarity=0.422 Sum_probs=42.3
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCC-----CCCHHHHHH----HHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGT-----RLSESEVRQ----LMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-----~~~~~e~~~----~~~~~d~ 420 (420)
...++.+|+.+|.|++|+|+.+||..++..+|. .++++++++ +|+.+|.
T Consensus 128 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~~D~ 185 (214)
T 2l4h_A 128 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDI 185 (214)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHHhCC
Confidence 356888999999999999999999999999875 788888876 8888773
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=96.67 E-value=0.00048 Score=54.02 Aligned_cols=46 Identities=17% Similarity=0.429 Sum_probs=37.9
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+++++|+.|| |+|+.+||+.+++.+|. +++|+++||+++|.
T Consensus 46 ~~~~~~l~~aF~~fD----G~I~~~El~~~l~~lG~--t~~ei~~~~~~~D~ 91 (123)
T 2kld_A 46 KNTVDDISESLRQGG----GKLNFDELRQDLKGKGH--TDAEIEAIFTKYDQ 91 (123)
T ss_dssp -----CCSCSSTTTT----TCEEHHHHHHHTTTCCS--SHHHHHHHHHHHSS
T ss_pred hhHHHHHHHHHHHhC----CCCCHHHHHHHHHHhCC--CHHHHHHHHHHHcC
Confidence 344567888999998 99999999999999997 99999999999874
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0032 Score=54.18 Aligned_cols=49 Identities=27% Similarity=0.337 Sum_probs=41.6
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhC-----CCCCHHH-HHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLG-----TRLSESE-VRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg-----~~~~~~e-~~~~~~~~d~ 420 (420)
...++.+|..+|.|++|.|+.+||..++..++ ...+.++ ++++|+.+|.
T Consensus 92 ~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~~~f~~~D~ 146 (211)
T 2ggz_A 92 EQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDI 146 (211)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHHHHHHHhCC
Confidence 34678899999999999999999999999886 5666654 8999999874
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0021 Score=54.52 Aligned_cols=49 Identities=24% Similarity=0.312 Sum_probs=41.5
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhh--hCCCCCH---HHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPK--LGTRLSE---SEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~--lg~~~~~---~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|+|+.+||..++.. .|..+++ +++.++|+.+|.
T Consensus 121 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~~~~~~~~~~~~~~D~ 174 (191)
T 3k21_A 121 KKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVDK 174 (191)
T ss_dssp HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCHHHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCHhHHHHHHHHHHHhcC
Confidence 346788999999999999999999999988 5667776 468999998874
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.00067 Score=56.94 Aligned_cols=48 Identities=31% Similarity=0.457 Sum_probs=42.5
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCC-----CCCHHHHHH----HHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGT-----RLSESEVRQ----LMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-----~~~~~e~~~----~~~~~d~ 420 (420)
..++.+|..+|.|++|.|+.+||..++..+|. .++++++.+ +|..+|.
T Consensus 98 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~ 154 (183)
T 1dgu_A 98 IKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDI 154 (183)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCC
Confidence 46888999999999999999999999999986 688899886 8888773
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.61 E-value=0.00075 Score=56.46 Aligned_cols=47 Identities=19% Similarity=0.318 Sum_probs=41.7
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+|+..++..+| ++++++.++|+.+|.
T Consensus 104 ~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g--~~~~~~~~~~~~~D~ 150 (185)
T 2sas_A 104 QNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITD 150 (185)
T ss_dssp HHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHT
T ss_pred HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhC--CCHHHHHHHHHHhcC
Confidence 35688899999999999999999999999888 678899999998763
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0013 Score=56.21 Aligned_cols=50 Identities=16% Similarity=0.311 Sum_probs=43.3
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
.++++++..++++|..+|.|++|.|+.+||..+ ..+|...+ +..+++.+|
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~~~---~~~l~~~~D 71 (202)
T 2bec_A 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVNPL---GDRIIESFF 71 (202)
T ss_dssp CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHSTT---HHHHHHTTS
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCCcc---HHHHHHHhC
Confidence 457778889999999999999999999999999 88887665 777888776
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0035 Score=52.37 Aligned_cols=49 Identities=20% Similarity=0.270 Sum_probs=39.4
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh----CCC----CC----HHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL----GTR----LS----ESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g~~----~~----~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+|+..++..+ |.. ++ .+++.++|+.+|.
T Consensus 91 ~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 151 (183)
T 1s6c_A 91 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDK 151 (183)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCC
Confidence 3567889999999999999999999999886 643 44 3889999999873
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=96.55 E-value=0.00048 Score=61.42 Aligned_cols=55 Identities=18% Similarity=0.209 Sum_probs=46.7
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCH------HHHHHHHHhcCC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSE------SEVRQLMEAVSL 420 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~------~e~~~~~~~~d~ 420 (420)
.+++.+..+++++|..+|.|++|.|+.+||..+++.+|..++. .++..++..+|.
T Consensus 9 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~l~~~~~~~~~~~~~~~~~l~~~~D~ 69 (263)
T 2f33_A 9 QSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYGQ 69 (263)
T ss_dssp TTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHTT
T ss_pred hcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHHHhhcCCCccchHHHHHHHHHHhCC
Confidence 3456667789999999999999999999999999998866555 788899988773
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.004 Score=52.88 Aligned_cols=49 Identities=20% Similarity=0.302 Sum_probs=41.2
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhC------CCCCHHH-HHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLG------TRLSESE-VRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg------~~~~~~e-~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+||..++..++ ...+.++ +..+|+.+|.
T Consensus 87 ~~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~ 142 (198)
T 2r2i_A 87 DQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKIDI 142 (198)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHhCC
Confidence 34577899999999999999999999999886 5566655 8999999874
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0013 Score=53.98 Aligned_cols=46 Identities=30% Similarity=0.449 Sum_probs=34.5
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|.|+.+|+..++..+| +++++++++++.+|.
T Consensus 99 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~--~~~~~~~~~~~~~d~ 144 (166)
T 2aao_A 99 DHLFAAFTYFDKDGSGYITPDELQQACEEFG--VEDVRIEELMRDVDQ 144 (166)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHTCC----------CCHHHHHCT
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHhCC
Confidence 4578899999999999999999999999887 578889999998873
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0053 Score=60.12 Aligned_cols=48 Identities=23% Similarity=0.338 Sum_probs=42.5
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....+..+|+.+|.|++|+|+.+||..++.. ..+++++++++|+++|.
T Consensus 416 ~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~--~~~~~~~~~~~~~~~D~ 463 (484)
T 3nyv_A 416 SRERLERAFRMFDSDNSGKISSTELATIFGV--SDVDSETWKSVLSEVDK 463 (484)
T ss_dssp HHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH--TTCCHHHHHHHHHHHCT
T ss_pred cHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhcC
Confidence 3456888999999999999999999999987 46799999999999984
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0074 Score=57.60 Aligned_cols=32 Identities=28% Similarity=0.428 Sum_probs=25.7
Q ss_pred CeeccCCCCcEEEecC---CCCCCeeEeecccccc
Q 014704 189 VMHRDLKPENFLFSSS---AEDSPLKATDFGLSVF 220 (420)
Q Consensus 189 ivH~Dlkp~Nill~~~---~~~~~~kl~Dfg~~~~ 220 (420)
++|+|+.+.|||+... +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999542 3456799999987753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.006 Score=58.52 Aligned_cols=76 Identities=11% Similarity=0.173 Sum_probs=50.4
Q ss_pred cceecccCCeEEEEEEEcCC-------CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 72 GRELGRGQFGVTYLVTHKDT-------KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
.+.|..|-...+|++..... ++.+++|+..... ...-...+|..+++.|..+.-.+++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 45677888899999987531 5789999864321 11112457888888887444456777543 22 6
Q ss_pred EEEecCCCCCh
Q 014704 145 LIMDLCAGGEL 155 (420)
Q Consensus 145 iv~e~~~g~~L 155 (420)
.||||++|.+|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 88999998653
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=96.36 E-value=0.004 Score=52.28 Aligned_cols=49 Identities=27% Similarity=0.310 Sum_probs=41.2
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh----C--------CCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL----G--------TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g--------~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+|+..++..+ | ...+++++.++|+.+|.
T Consensus 98 ~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 158 (190)
T 1g8i_A 98 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDK 158 (190)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcC
Confidence 3467889999999999999999999999873 3 35778999999999873
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0052 Score=54.54 Aligned_cols=48 Identities=25% Similarity=0.409 Sum_probs=43.3
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh----CCCCCHHHHHH----HHHhcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL----GTRLSESEVRQ----LMEAVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g~~~~~~e~~~----~~~~~d 419 (420)
...++.+|..+|.|++|.|+.+||..++..+ |..++.+++.+ +++.+|
T Consensus 102 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d 157 (263)
T 2f33_A 102 CEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFD 157 (263)
T ss_dssp HHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcC
Confidence 3458899999999999999999999999988 99999999887 888776
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.0061 Score=54.24 Aligned_cols=49 Identities=24% Similarity=0.298 Sum_probs=41.9
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh----C--------CCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL----G--------TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g--------~~~~~~e~~~~~~~~d~ 420 (420)
...++.+|..+|.|++|.|+.+||..++..+ | ...++++++++|+.+|.
T Consensus 164 ~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 224 (256)
T 2jul_A 164 HEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDR 224 (256)
T ss_dssp HHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCC
Confidence 3467789999999999999999999999876 5 34578899999999884
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0042 Score=52.15 Aligned_cols=47 Identities=28% Similarity=0.343 Sum_probs=41.9
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.+..+|..+|.|++|.|+.+|+..++..++...+.+++..+|+.+|.
T Consensus 64 ~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~ 110 (190)
T 1fpw_A 64 FANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDL 110 (190)
T ss_dssp HHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCS
T ss_pred HHHHHHHHHCCCCCCcEeHHHHHHHHHHHccCCcHHHHHHHHHHhcC
Confidence 46788999999999999999999999999888889999999998873
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0045 Score=53.99 Aligned_cols=46 Identities=30% Similarity=0.590 Sum_probs=39.7
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh---CCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|+|+.+||..++..+ |...+ ++.++|+.+|.
T Consensus 133 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~--e~~~~~~~~D~ 181 (226)
T 2lvv_A 133 FELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDIT--DATTVFNEIDT 181 (226)
T ss_dssp HHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCC--SCHHHHHHHCC
T ss_pred HHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHH--HHHHHHHHhCC
Confidence 567889999999999999999999999987 65544 58999998874
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=96.24 E-value=0.0073 Score=52.53 Aligned_cols=49 Identities=16% Similarity=0.240 Sum_probs=41.7
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhh----hhCCCCCHHHHHHHHH----hcC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLP----KLGTRLSESEVRQLME----AVS 419 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~----~lg~~~~~~e~~~~~~----~~d 419 (420)
....++.+|..+|.|++|.|+.+||..++. .+|..+++++++++++ .+|
T Consensus 120 ~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D 176 (226)
T 2zfd_A 120 IDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEAD 176 (226)
T ss_dssp HHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhC
Confidence 345678899999999999999999999995 6799999999877765 665
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=96.22 E-value=0.0024 Score=67.45 Aligned_cols=54 Identities=24% Similarity=0.497 Sum_probs=49.7
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++.++...++.+|..||.|++|.|+.+||..++..+|..+++++++.+|..+|.
T Consensus 719 l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~ 772 (863)
T 1sjj_A 719 ISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVDP 772 (863)
T ss_dssp SSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTCCCCTHHHHHHHHHHCT
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 456678889999999999999999999999999999999999999999999873
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=96.21 E-value=0.00068 Score=66.66 Aligned_cols=48 Identities=25% Similarity=0.382 Sum_probs=25.4
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|.|+.+||..++..+|..+++++++++|+++|.
T Consensus 417 ~~~~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~ 464 (486)
T 3mwu_A 417 ERMERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDN 464 (486)
T ss_dssp HHHHHHHHHHCSSCSSSBCSSCC--------------------CCCCS
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 467889999999999999999999999999999999999999999884
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0062 Score=53.01 Aligned_cols=49 Identities=20% Similarity=0.272 Sum_probs=40.7
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh----CCC----C----CHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL----GTR----L----SESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g~~----~----~~~e~~~~~~~~d~ 420 (420)
...++.+|+.+|.|++|+|+.+|+..++..+ |.. + +.++++++|+.+|.
T Consensus 124 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 184 (224)
T 1s1e_A 124 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDK 184 (224)
T ss_dssp HHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCC
Confidence 3467889999999999999999999999876 643 3 34889999999874
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0051 Score=51.70 Aligned_cols=48 Identities=19% Similarity=0.236 Sum_probs=42.1
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|.|+.+|+..++..++...+.+++..+|+.+|.
T Consensus 63 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~ 110 (190)
T 2l2e_A 63 AFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAFQLYDL 110 (190)
T ss_dssp HHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHhHccC
Confidence 356778999999999999999999999988888889999999988873
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=96.17 E-value=0.0053 Score=52.09 Aligned_cols=51 Identities=20% Similarity=0.284 Sum_probs=45.1
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.....+..+|..+|.|++|.|+++|+..++..++...+.+++..+|+.+|.
T Consensus 49 ~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~ 99 (198)
T 2r2i_A 49 SANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYDV 99 (198)
T ss_dssp HHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHHHHHHCT
T ss_pred chHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHHHHHhcC
Confidence 334557889999999999999999999999999988889999999998874
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0036 Score=55.91 Aligned_cols=49 Identities=12% Similarity=0.287 Sum_probs=43.2
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCC----CCCHHHHHH----HHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGT----RLSESEVRQ----LMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~----~~~~~e~~~----~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+||..++..+|. .++++++++ +|..+|.
T Consensus 195 ~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~D~ 251 (272)
T 2be4_A 195 KRDFEKIFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDM 251 (272)
T ss_dssp HHHHHHHHHHHCTTCCSEEETHHHHHHHHHHHHHHSSSCCHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHhCCCCCCeecHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCC
Confidence 345788999999999999999999999998876 899999887 9988873
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0021 Score=59.57 Aligned_cols=47 Identities=19% Similarity=0.248 Sum_probs=44.0
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhh-hhhCCCCCHHHHHHHHHhcCC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGL-PKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l-~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.+..+|..+|.|++|+|+.+||..++ ..+|..++++++..||..+|.
T Consensus 254 ~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~ls~~e~~~l~~~~D~ 301 (323)
T 1ij5_A 254 VLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDV 301 (323)
T ss_dssp HHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTT
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHHHcCCCCCHHHHHHHHHHHCC
Confidence 67889999999999999999999999 999999999999999999873
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=96.10 E-value=0.0071 Score=51.62 Aligned_cols=48 Identities=27% Similarity=0.259 Sum_probs=40.9
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhh----hhCCCCCHHHHHHHHH----hcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLP----KLGTRLSESEVRQLME----AVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~----~lg~~~~~~e~~~~~~----~~d 419 (420)
...+..+|..+|.|++|.|+.+|+..++. .+|..+++++++++++ .+|
T Consensus 110 ~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D 165 (207)
T 2ehb_A 110 HEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQAD 165 (207)
T ss_dssp HHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhC
Confidence 45678899999999999999999999985 5699999999877764 665
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=96.06 E-value=0.0056 Score=60.33 Aligned_cols=46 Identities=30% Similarity=0.352 Sum_probs=41.4
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..++.+|+.+|.|++|+|+.+||..++... .++++++++||+++|.
T Consensus 435 ~~~~~~F~~~D~d~dG~Is~~El~~~l~~~--~~~~~~~~~~~~~~D~ 480 (504)
T 3q5i_A 435 ERLRRAFNLFDTDKSGKITKEELANLFGLT--SISEKTWNDVLGEADQ 480 (504)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHHHTTCS--CCCHHHHHHHHHTTCS
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHhhC--CCCHHHHHHHHHHhCC
Confidence 567899999999999999999999999874 4799999999999984
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0079 Score=50.49 Aligned_cols=48 Identities=23% Similarity=0.365 Sum_probs=41.0
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh----C--------CCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL----G--------TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g--------~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|.|+.+|+..++..+ | ...+++++.++|+.+|.
T Consensus 99 ~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 158 (190)
T 2l2e_A 99 DKLIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDK 158 (190)
T ss_dssp HHHHHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTC
T ss_pred HHHHHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCC
Confidence 457788999999999999999999999873 3 35789999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=95.96 E-value=0.0046 Score=60.77 Aligned_cols=47 Identities=19% Similarity=0.370 Sum_probs=40.9
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|+.+|.|++|+|+.+||..++.. ..++++++++||+++|.
T Consensus 425 ~~~~~~~F~~~D~d~~G~Is~~El~~~l~~--~~~~~~~~~~~~~~~D~ 471 (494)
T 3lij_A 425 KDKLESAFQKFDQDGNGKISVDELASVFGL--DHLESKTWKEMISGIDS 471 (494)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHC-C--CSCCCHHHHHHHHTTCS
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhCC
Confidence 356788999999999999999999999976 56789999999999884
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=95.92 E-value=0.0049 Score=63.44 Aligned_cols=47 Identities=19% Similarity=0.382 Sum_probs=44.3
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
..++.+|+.+|.|++|.|+.+||+.++..+|..++++++++|+..+|
T Consensus 605 ~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~~~D 651 (714)
T 3bow_A 605 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA 651 (714)
T ss_dssp HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHHHHS
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhC
Confidence 56889999999999999999999999999999999999999999876
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=95.89 E-value=0.0077 Score=51.42 Aligned_cols=44 Identities=18% Similarity=0.314 Sum_probs=23.5
Q ss_pred HHHhhccCCCCCCcccHHHHHhhhhhhCCC-CCHHHHHHHHHhcC
Q 014704 376 KEMFKSMDTDNSGTITFEELKAGLPKLGTR-LSESEVRQLMEAVS 419 (420)
Q Consensus 376 ~~~F~~~D~~~~G~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d 419 (420)
..+|..+|.|++|.|+++|+..++..++.. ...+++..+|+.+|
T Consensus 77 ~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D 121 (207)
T 2ehb_A 77 DRIFDVFDVKRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYD 121 (207)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHGGGSTTSCHHHHHHHHHHHHC
T ss_pred HHHHHHhcCCCCCeEeHHHHHHHHHHHccCCCHHHHHHHHHHHhC
Confidence 345555566666666666665555554432 23444555555554
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=95.84 E-value=0.0055 Score=52.32 Aligned_cols=48 Identities=21% Similarity=0.230 Sum_probs=40.7
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh----C----CCCC------HHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL----G----TRLS------ESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g----~~~~------~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|.|+.+||..++..+ | ..++ +++++++|+.+|.
T Consensus 107 ~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~l~~~~~~~~~~~~~~f~~~D~ 168 (207)
T 2d8n_A 107 QKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGK 168 (207)
T ss_dssp TTHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHHTSCTTTSSHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHhcCCCCCeEcHHHHHHHHHHHHHHhccccCCCcccccccHHHHHHHHHHHcCC
Confidence 457789999999999999999999999886 7 5555 3679999999874
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.83 E-value=0.008 Score=51.65 Aligned_cols=51 Identities=14% Similarity=0.273 Sum_probs=44.7
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.....+..+|..+|.|++|.|+++|+..++..++...+++++..+|+.+|.
T Consensus 54 ~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~F~~~D~ 104 (211)
T 2ggz_A 54 KANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYFKLYDA 104 (211)
T ss_dssp HHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSHHHHHHHHHHHHCT
T ss_pred chHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCchHHHHHHHHHHhcC
Confidence 344567889999999999999999999999998888888999999998874
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=95.80 E-value=0.005 Score=52.64 Aligned_cols=48 Identities=17% Similarity=0.274 Sum_probs=43.6
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|.|+.+|+..++..++...++++++.+|+.+|.
T Consensus 71 ~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~ 118 (207)
T 2d8n_A 71 AYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDV 118 (207)
T ss_dssp HHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHHHHHCT
T ss_pred HHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHHHhcC
Confidence 457889999999999999999999999999988889999999998873
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.77 E-value=0.0074 Score=50.75 Aligned_cols=45 Identities=20% Similarity=0.367 Sum_probs=25.6
Q ss_pred HHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 375 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
+..+|..+|.|++|.|+++|+..++..++...+.+++..+|+.+|
T Consensus 65 ~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D 109 (193)
T 1bjf_A 65 AEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYD 109 (193)
T ss_dssp HHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHC
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCHHHHHHHHHhhcC
Confidence 344555556666666666666655555555555555555555554
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=95.74 E-value=0.0077 Score=50.52 Aligned_cols=48 Identities=23% Similarity=0.395 Sum_probs=40.5
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhh----hCC--------CCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPK----LGT--------RLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~----lg~--------~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|.|+.+|+..++.. +|. ..+++++.++|+.+|.
T Consensus 99 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 158 (190)
T 1fpw_A 99 EKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDK 158 (190)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCC
Confidence 35677899999999999999999999987 352 3678899999999874
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.73 E-value=0.0087 Score=50.98 Aligned_cols=30 Identities=33% Similarity=0.360 Sum_probs=23.5
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
..+..+|..+|.|++|.|+.+||..++..+
T Consensus 95 ~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~ 124 (204)
T 1jba_A 95 HKLKWTFKIYDKDRNGCIDRQELLDIVESI 124 (204)
T ss_dssp HHHHHHHHHHCSSCSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 356778888888888888888888887654
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=95.72 E-value=0.0055 Score=51.12 Aligned_cols=48 Identities=19% Similarity=0.328 Sum_probs=42.2
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|.|+.+|+..++..++...+.+++..+|+.+|.
T Consensus 56 ~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~ 103 (183)
T 1s6c_A 56 TYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDI 103 (183)
T ss_dssp HHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCHHHHHHHHHHHhCC
Confidence 456778999999999999999999999988777788899999998873
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=95.72 E-value=0.0055 Score=47.80 Aligned_cols=42 Identities=33% Similarity=0.468 Sum_probs=36.4
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
++..+|..+|.|++|.|+.+|+..++..+|... +.++|..+|
T Consensus 76 ~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~----~~~~~~~~D 117 (134)
T 1jfj_A 76 GLKVLYKLMDVDGDGKLTKEEVTSFFKKHGIEK----VAEQVMKAD 117 (134)
T ss_dssp HHHHHHHHHCCSSSSEEEHHHHHHHHTTTTCHH----HHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCccCHHHHHHHHHHhCHHH----HHHHHHHhC
Confidence 378899999999999999999999999887644 788888776
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.0089 Score=50.01 Aligned_cols=55 Identities=11% Similarity=0.285 Sum_probs=41.9
Q ss_pred HHHHHhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 360 LKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 360 l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
+.+++......++.++++.|..+| ++|.|+.+||..+ +|...+..++.++++.+|
T Consensus 15 l~~~~~~~~~~~~~~~~~~F~~~D--~dG~I~~~el~~~---lg~~~~~~~~~~i~~~~d 69 (179)
T 3a8r_A 15 LQFVTAKVGNDGWAAVEKRFNQLQ--VDGVLLRSRFGKC---IGMDGSDEFAVQMFDSLA 69 (179)
T ss_dssp HHHHHHHHCCCCHHHHHHHHHHHC--BTTBEEGGGHHHH---HTCCSCHHHHHHHHHHHH
T ss_pred HHHHHhccchhhHHHHHHHHhccC--CCCCCcHHHHHHH---HCCCCcHHHHHHHHHHHH
Confidence 445555544455678889999999 7999999999985 477778888888887654
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=95.61 E-value=0.0081 Score=52.25 Aligned_cols=43 Identities=19% Similarity=0.356 Sum_probs=22.2
Q ss_pred HHhhccCCCCCCcccHHHHHhhhhhhCC-CCCHHHHHHHHHhcC
Q 014704 377 EMFKSMDTDNSGTITFEELKAGLPKLGT-RLSESEVRQLMEAVS 419 (420)
Q Consensus 377 ~~F~~~D~~~~G~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d 419 (420)
.+|..+|.|++|.|+++|+..++..++. ....+++..+|+.+|
T Consensus 89 ~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D 132 (226)
T 2zfd_A 89 RVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYD 132 (226)
T ss_dssp HHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHC
T ss_pred HHHHHHcCCCCCcCcHHHHHHHHHHHccCCCHHHHHHHHHHHhC
Confidence 3555555555555555555555554432 223444555555554
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.57 E-value=0.015 Score=48.90 Aligned_cols=49 Identities=18% Similarity=0.274 Sum_probs=39.1
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh----C--CCCC------HHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL----G--TRLS------ESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g--~~~~------~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|.|+.+|+..++..+ | ..++ ++++.++|+.+|.
T Consensus 98 ~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~ 158 (193)
T 1bjf_A 98 EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDT 158 (193)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCT
T ss_pred HHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccccHHHHHHHHHHHhCC
Confidence 3457789999999999999999999999764 5 2344 3559999999873
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=95.55 E-value=0.0093 Score=53.13 Aligned_cols=48 Identities=23% Similarity=0.428 Sum_probs=42.2
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh----CCCCCHHHHHH----HHHhcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL----GTRLSESEVRQ----LMEAVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g~~~~~~e~~~----~~~~~d 419 (420)
...++.+|..+|.|++|.|+.+|+..++..+ |..++.+++.+ +++.+|
T Consensus 103 ~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D 158 (272)
T 2be4_A 103 SVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFD 158 (272)
T ss_dssp HHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHhc
Confidence 3467889999999999999999999999988 88999998865 777776
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=95.47 E-value=0.015 Score=46.76 Aligned_cols=46 Identities=20% Similarity=0.411 Sum_probs=33.7
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCC-CCHHHHHHHHHhcC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTR-LSESEVRQLMEAVS 419 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d 419 (420)
.+..+|..+|.|++|.|+++|+..++..+... ...+++..+|+.+|
T Consensus 39 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D 85 (155)
T 3ll8_B 39 LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYD 85 (155)
T ss_dssp THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhC
Confidence 46677888888888888888888887766433 44567777887776
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=95.43 E-value=0.013 Score=62.19 Aligned_cols=48 Identities=19% Similarity=0.356 Sum_probs=44.9
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
...++.+|..+|.|++|.|+.+||+.+++.+|..+++++++++++.+|
T Consensus 606 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~l~~~~~~~l~~~~d 653 (900)
T 1qxp_A 606 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA 653 (900)
T ss_dssp HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTS
T ss_pred HHHHHHHHHhhCCCCCCeECHHHHHHHHHHhCCCCCHHHHHHHHHHhC
Confidence 367899999999999999999999999999999999999999999875
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=95.40 E-value=0.0077 Score=50.51 Aligned_cols=47 Identities=19% Similarity=0.272 Sum_probs=42.2
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.+..+|..+|.|++|.|+.+|+..++..++...+.+++..+|+.+|.
T Consensus 64 ~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~ 110 (190)
T 1g8i_A 64 FATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDL 110 (190)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhcCCCCeEeHHHHHHHHHHhcCCCHHHHHHHHHHhhcC
Confidence 47788999999999999999999999988877788999999998873
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.38 E-value=0.0094 Score=51.83 Aligned_cols=48 Identities=19% Similarity=0.328 Sum_probs=42.2
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|.|+++|+..++..++...++++++.+|+.+|.
T Consensus 89 ~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~ 136 (224)
T 1s1e_A 89 TYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDI 136 (224)
T ss_dssp HHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHCCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhcCCCCCcEeHHHHHHHHHHHccCCHHHHHHHHHHHHcC
Confidence 456778999999999999999999999988777788899999998873
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=95.37 E-value=0.01 Score=52.75 Aligned_cols=48 Identities=21% Similarity=0.355 Sum_probs=43.1
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|.|+++|+..++..++...+.+++..+|+.+|.
T Consensus 129 ~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~ 176 (256)
T 2jul_A 129 TYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLKWAFNLYDI 176 (256)
T ss_dssp HHHHHHHHHSSCSCCSEECSHHHHHHHHHHHSCCHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHHHHHHHhccChHHHHHHHHHHhCC
Confidence 356788999999999999999999999998888889999999998874
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=95.18 E-value=0.0087 Score=51.21 Aligned_cols=50 Identities=22% Similarity=0.322 Sum_probs=40.3
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
.++++++..++++|..+|.|++|.|+.+||..++ .+|...+.++ +++.+|
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~~-~lg~~~~~~~---l~~~~d 71 (208)
T 2ct9_A 22 GFSHSQITRLYSRFTSLDKGENGTLSREDFQRIP-ELAINPLGDR---IINAFF 71 (208)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECTGGGGGCH-HHHTSTTHHH---HHHTTS
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCcHHH---HHHHHc
Confidence 4577888999999999999999999999999965 6787776544 455544
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=95.15 E-value=0.0081 Score=61.80 Aligned_cols=53 Identities=17% Similarity=0.301 Sum_probs=47.5
Q ss_pred hhHHH-HhhHHHHhhccCCCCCCcccHHHHHhhhhhh--------CCCCCHHHHHHHHHhcCC
Q 014704 367 LSEEE-IMGLKEMFKSMDTDNSGTITFEELKAGLPKL--------GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~-~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l--------g~~~~~~e~~~~~~~~d~ 420 (420)
+++++ ..+++++|..+| |++|.|+.+||..+|..+ |..++.++++.|+..+|.
T Consensus 525 ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~~~s~~~~~~l~~~~D~ 586 (714)
T 3bow_A 525 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDE 586 (714)
T ss_dssp CSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCSCCCHHHHHHHHHHHCC
T ss_pred CChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCCCCCHHHHHHHHHHhCC
Confidence 45556 778999999999 999999999999999997 788999999999999874
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.08 E-value=0.032 Score=45.75 Aligned_cols=46 Identities=15% Similarity=0.143 Sum_probs=37.4
Q ss_pred HHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCH--------HHHHHHHHhcCC
Q 014704 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSE--------SEVRQLMEAVSL 420 (420)
Q Consensus 375 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~--------~e~~~~~~~~d~ 420 (420)
+..+|..+|.|++|.|+++|+..++..+...... ..+..+|+.+|.
T Consensus 60 ~~~lf~~~D~d~dg~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~ 113 (176)
T 1nya_A 60 FDYLAKEAGVGSDGSLTEEQFIRVTENLIFEQGEASFNRVLGPVVKGIVGMCDK 113 (176)
T ss_dssp HHHHHHHHTSCTTCCBCHHHHHHHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCS
T ss_pred HHHHHHHhCCCCCCeEcHHHHHHHHHHHhcCCchhhHHHHHHHHHHHHHHHhcC
Confidence 3478999999999999999999999876555443 568888888873
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=95.06 E-value=0.022 Score=47.39 Aligned_cols=42 Identities=10% Similarity=0.200 Sum_probs=19.9
Q ss_pred HhhccCCCCCCc-ccHHHHHhhhhhhCCC-CCHHHHHHHHHhcC
Q 014704 378 MFKSMDTDNSGT-ITFEELKAGLPKLGTR-LSESEVRQLMEAVS 419 (420)
Q Consensus 378 ~F~~~D~~~~G~-i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d 419 (420)
+|..+|.|++|. |+++|+..++..+... ..++++..+|+.+|
T Consensus 65 l~~~~D~d~~G~~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D 108 (183)
T 1dgu_A 65 ICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFD 108 (183)
T ss_dssp HHHHHSCSSSSCCCCHHHHHHHHHHHSTTCCHHHHHHHHHHHHC
T ss_pred HHHHhCCCCCCCEecHHHHHHHHHHhcCCCCHHHHHHHHHHHhC
Confidence 444455555555 5555555555443322 12334555555544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 420 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-98 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-90 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-90 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-88 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-88 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-86 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-85 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-85 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-84 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-83 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-82 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-81 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-81 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-79 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-78 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-74 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-73 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-73 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-72 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-72 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-70 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-69 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-67 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-67 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-67 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-66 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-66 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-65 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-65 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-65 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-64 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-63 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-63 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-62 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-61 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-57 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-56 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-43 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-42 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-22 | |
| d1ij5a_ | 321 | a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind | 3e-15 | |
| d1ij5a_ | 321 | a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind | 6e-04 | |
| d1ij5a_ | 321 | a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind | 0.003 | |
| d1s6ja_ | 87 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 2e-13 | |
| d1f54a_ | 77 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 1e-11 | |
| d1s6ia_ | 182 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 4e-11 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 1e-09 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 2e-04 | |
| d2pq3a1 | 73 | a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T | 2e-09 | |
| d1wrka1 | 82 | a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens) | 2e-08 | |
| d1avsa_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 3e-08 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 4e-08 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 4e-04 | |
| d1dtla_ | 156 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 7e-08 | |
| d1qv0a_ | 189 | a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr | 1e-07 | |
| d1qv0a_ | 189 | a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr | 0.003 | |
| d1exra_ | 146 | a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr | 1e-07 | |
| d1exra_ | 146 | a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr | 0.002 | |
| d1jbaa_ | 189 | a.39.1.5 (A:) Guanylate cyclase activating protein | 1e-07 | |
| d2opoa1 | 81 | a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che | 2e-07 | |
| d1bjfa_ | 181 | a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId | 3e-07 | |
| d1bjfa_ | 181 | a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId | 0.001 | |
| d1oqpa_ | 77 | a.39.1.5 (A:) Caltractin (centrin 2) {Green algae | 3e-07 | |
| d1oqpa_ | 77 | a.39.1.5 (A:) Caltractin (centrin 2) {Green algae | 5e-04 | |
| d2zfda1 | 183 | a.39.1.5 (A:32-214) Calcineurin B-like protein 2 { | 5e-07 | |
| d1auib_ | 165 | a.39.1.5 (B:) Calcineurin regulatory subunit (B-ch | 6e-07 | |
| d1m45a_ | 146 | a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's ye | 7e-07 | |
| d1wdcb_ | 142 | a.39.1.5 (B:) Myosin Essential Chain {Bay scallop | 8e-07 | |
| d2scpa_ | 174 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 8e-07 | |
| d1w7jb1 | 139 | a.39.1.5 (B:11-149) Myosin Essential Chain {Human | 1e-06 | |
| d1w7jb1 | 139 | a.39.1.5 (B:11-149) Myosin Essential Chain {Human | 7e-04 | |
| d1fi5a_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), | 1e-06 | |
| d1rroa_ | 108 | a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) | 1e-06 | |
| d1df0a1 | 186 | a.39.1.8 (A:515-700) Calpain large subunit, C-term | 2e-06 | |
| d1fw4a_ | 65 | a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: | 2e-06 | |
| d1uhka1 | 187 | a.39.1.5 (A:3-189) Calcium-regulated photoprotein | 2e-06 | |
| d1y1xa_ | 182 | a.39.1.8 (A:) Programmed cell death 6 protein-like | 3e-06 | |
| d1jc2a_ | 75 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 4e-06 | |
| d1topa_ | 162 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 4e-06 | |
| d1topa_ | 162 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 2e-04 | |
| d2sasa_ | 185 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 4e-06 | |
| d1jfja_ | 134 | a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histoly | 6e-06 | |
| d2obha1 | 141 | a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien | 7e-06 | |
| d2obha1 | 141 | a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien | 6e-04 | |
| d2obha1 | 141 | a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien | 0.001 | |
| d1pvaa_ | 109 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 7e-06 | |
| d1pvaa_ | 109 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 0.003 | |
| d1qx2a_ | 76 | a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [Tax | 7e-06 | |
| d1wdcc_ | 152 | a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop | 8e-06 | |
| d1g8ia_ | 187 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 1e-05 | |
| d1nyaa_ | 176 | a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth | 1e-05 | |
| d1cb1a_ | 78 | a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [Tax | 2e-05 | |
| d1s6ca_ | 178 | a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera | 2e-05 | |
| d1s6ca_ | 178 | a.39.1.5 (A:) Kchip1, Kv4 potassium channel-intera | 0.002 | |
| d1snla_ | 99 | a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo | 2e-05 | |
| d1snla_ | 99 | a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo | 0.002 | |
| d5pala_ | 109 | a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis | 2e-05 | |
| d1alva_ | 173 | a.39.1.8 (A:) Calpain small (regulatory) subunit ( | 2e-05 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 2e-05 | |
| d1tiza_ | 67 | a.39.1.5 (A:) Calmodulin-related protein T21P5.17 | 3e-05 | |
| d1tiza_ | 67 | a.39.1.5 (A:) Calmodulin-related protein T21P5.17 | 0.004 | |
| d2hf5a1 | 33 | a.39.1.5 (A:81-113) Troponin C {Human (Homo sapien | 4e-05 | |
| d2fcea1 | 61 | a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [ | 5e-05 | |
| d1hqva_ | 181 | a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mous | 5e-05 | |
| d1rwya_ | 109 | a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta | 6e-05 | |
| d1qxpa2 | 188 | a.39.1.8 (A:515-702) Calpain large subunit, C-term | 9e-05 | |
| d1qxpa2 | 188 | a.39.1.8 (A:515-702) Calpain large subunit, C-term | 0.001 | |
| d1wlza1 | 83 | a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {H | 1e-04 | |
| d2pvba_ | 107 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 1e-04 | |
| d2pvba_ | 107 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 0.003 | |
| d1juoa_ | 172 | a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: | 2e-04 | |
| d3c1va1 | 93 | a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sa | 2e-04 | |
| d1yuta1 | 98 | a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sa | 6e-04 | |
| d1omra_ | 201 | a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: | 0.001 | |
| d1fpwa_ | 190 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 0.002 | |
| d1fpwa_ | 190 | a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1 | 0.003 | |
| d1a4pa_ | 92 | a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien | 0.002 | |
| d1a4pa_ | 92 | a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapien | 0.004 | |
| d1xo5a_ | 180 | a.39.1.5 (A:) Calcium- and integrin-binding protei | 0.002 | |
| d1ggwa_ | 140 | a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharo | 0.004 | |
| d2jxca1 | 95 | a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [ | 0.004 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 294 bits (753), Expect = 2e-98
Identities = 123/299 (41%), Positives = 172/299 (57%), Gaps = 5/299 (1%)
Query: 60 KPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQ 119
K ED+R+ Y F LG G F L K T++ A K I+ + L + E+
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIA 59
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
++H + H NIV L YE + LIM L +GGELFDRI+ KG Y+ER A+ L Q++
Sbjct: 60 VLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
V Y H +G++HRDLKPEN L+ S EDS + +DFGLS PG V G+ YVAP
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178
Query: 240 EVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
EVL + Y D WS GVI YILL G PPF+ E + +F+ IL+ +F S W +IS
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
SAKD ++ ++ DP++R + + L HPW+ D A DK + +V ++K+ A +K K+
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD-TALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 275 bits (704), Expect = 2e-90
Identities = 97/331 (29%), Positives = 164/331 (49%), Gaps = 28/331 (8%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
V + Y ELG G FGV + K T + F K I++ +++ V+ E+ IM+
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQ 82
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVH 182
L H ++ L A+ED++ + LI++ +GGELFDRI A+ + SE N RQ +
Sbjct: 83 LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
+ H ++H D+KPEN + + + S +K DFGL+ P ++ K +A + APE++
Sbjct: 142 HMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200
Query: 243 RRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
R G D+W+ GV+ Y+LLSG+ PF GE + + R +F D + ++S AK
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 302 DIVKKMLHADPKERLSAAEVLNHPWMRVDGD---------------------ASDKPLDI 340
D +K +L +P++RL+ + L HPW++ D +D P
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQ 320
Query: 341 AVLTRMKQFRAMNKLKKVALKVIAENLSEEE 371
+ R+ F ++ K + ++ +E
Sbjct: 321 PAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 351
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 273 bits (699), Expect = 4e-90
Identities = 86/305 (28%), Positives = 156/305 (51%), Gaps = 12/305 (3%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+++ Y+ +LGRG+FG+ + +K+ + K + + D V++E+ I++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILN 56
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVV 181
HRNI+ L ++E + +I + +G ++F+RI +ER + Q+ +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
+ HS + H D++PEN ++ + S +K +FG + KPGD F+ L + Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ + D+WS G ++Y+LLSG+ PF ET Q I + I+ F + + IS A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVAL 360
D V ++L + K R++A+E L HPW++ + + V+ +K R + L K L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIE----RVSTKVIRTLKHRRYYHTLIKKDL 290
Query: 361 KVIAE 365
++
Sbjct: 291 NMVVS 295
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 268 bits (685), Expect = 1e-88
Identities = 95/273 (34%), Positives = 143/273 (52%), Gaps = 16/273 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN------RDDVEDVRREVQIMH 122
Y LGRG V HK T +++A K I + ++ E +EV I+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
++GH NI++LK YE L+ DL GELFD + K SE+ + R ++ V+
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
H + ++HRDLKPEN L +D +K TDFG S PG+ +++ G+ Y+APE++
Sbjct: 125 ALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181
Query: 243 -------RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295
YG E D+WS GVI+Y LL+G PPFW + + I+ G+ F S W +
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
S + KD+V + L P++R +A E L HP+ +
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 269 bits (689), Expect = 3e-88
Identities = 100/297 (33%), Positives = 150/297 (50%), Gaps = 9/297 (3%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+ V + Y ELG G FGV + VT + T FA K + + + D E VR+E+Q M
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMS 78
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVV 181
L H +V L A+ED + + +I + +GGELF+++ + SE A RQ+ +
Sbjct: 79 VLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
+ H +H DLKPEN +F++ + LK DFGL+ P K G+A + APEV
Sbjct: 138 CHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ G D+WS GV+ YILLSG+ PF GE + + + + IS
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
KD ++K+L ADP R++ + L HPW+ G+A + I +R + R K K
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEHPWLT-PGNAPGRDSQIPS-SRYTKIRDSIKTKY 311
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (668), Expect = 3e-86
Identities = 91/274 (33%), Positives = 135/274 (49%), Gaps = 16/274 (5%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ED + GR LG+G+FG YL K +K A K + +L +RREV+I
Sbjct: 5 LED----FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
HL H NI+ L G + D V LI++ G ++ + + E+ A ++ +
Sbjct: 61 SHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 119
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
YCHS V+HRD+KPEN L S LK DFG SV P L G+ Y+ PE+
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEM 175
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ R + + D+WS GV+ Y L G PPF T Q + I R F ++ A
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGA 231
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDAS 334
+D++ ++L +P +R EVL HPW+ ++S
Sbjct: 232 RDLISRLLKHNPSQRPMLREVLEHPWIT--ANSS 263
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (669), Expect = 2e-85
Identities = 91/315 (28%), Positives = 156/315 (49%), Gaps = 19/315 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ + LG G G + +K T+++FA K + D RREV++ +
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQCP 65
Query: 129 NIVELKGAYEDRHSVN----LIMDLCAGGELFDRIIAKGH--YSERAAANLCRQMVTVVH 182
+IV + YE+ ++ ++M+ GGELF RI +G ++ER A+ + + + +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
Y HS+ + HRD+KPEN L++S ++ LK TDFG + + + YYVAPEVL
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185
Query: 243 R-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDA----ILRGHIDFSSDPWPNIS 297
Y D+WS GVI+YILL G PPF+ +I I G +F + W +S
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKK 357
K +++ +L +P +R++ E +NHPW+ PL + + + + R + ++
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 305
Query: 358 VALKVIAENLSEEEI 372
+ + + E+I
Sbjct: 306 MTSALATMRVDYEQI 320
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (661), Expect = 8e-85
Identities = 104/271 (38%), Positives = 155/271 (57%), Gaps = 6/271 (2%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD---VEDVRREVQ 119
E+V + Y G ELG GQF V K T Q+A K I R+ + ED+ REV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 120 IMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
I+ + H N++ L YE++ V LI++L AGGELFD + K +E A +Q++
Sbjct: 66 ILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSP-LKATDFGLSVFFKPGDVFKDLVGSAYYVA 238
V+Y HS+ + H DLKPEN + P +K DFGL+ G+ FK++ G+ +VA
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184
Query: 239 PEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297
PE++ G EAD+WS GVI YILLSG PF G+T+Q + + +F + + N S
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
+ AKD ++++L DPK+R++ + L HPW++
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 257 bits (657), Expect = 6e-84
Identities = 73/312 (23%), Positives = 134/312 (42%), Gaps = 18/312 (5%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
+D + RE+G G FG Y + A K +S + + +D+ +EV+ +
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
L H N ++ +G Y H+ L+M+ C G + K E A + + +
Sbjct: 71 KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
Y HS ++HRD+K N L S E +K DFG + P + F VG+ Y++APEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVI 183
Query: 243 R----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
Y + D+WS G+ L PP + S I + + + + S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSE 241
Query: 299 SAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKV 358
++ V L P++R ++ +L H ++ ++P + + + A+ +L +
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVL-----RERPPTVIMDLIQRTKDAVRELDNL 296
Query: 359 ALKVIAENLSEE 370
+ + + L +E
Sbjct: 297 QYRKMKKILFQE 308
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (647), Expect = 9e-83
Identities = 77/283 (27%), Positives = 138/283 (48%), Gaps = 16/283 (5%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
+ + + ELG G FG Y +K+T A K I ++ + +++ED E+ I+
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 65
Query: 124 LTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRII-AKGHYSERAAANLCRQMVTVVH 182
H NIV+L A+ +++ ++++ CAGG + ++ + +E +C+Q + ++
Sbjct: 66 CD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEV 241
Y H ++HRDLK N LF+ D +K DFG+S + +G+ Y++APEV
Sbjct: 125 YLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181
Query: 242 L------RRNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295
+ R Y +AD+WS G+ L + PP + I + + P
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SR 240
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338
SS+ KD +KK L + R + +++L HP++ VD + + L
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (644), Expect = 4e-82
Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 12/279 (4%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMH 122
D + Y ++G+G G Y T Q+ A + + L + E + E+ +M
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMR 72
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
+ NIV +Y + ++M+ AGG L D ++ + E A +CR+ + +
Sbjct: 73 EN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK-PGDVFKDLVGSAYYVAPEV 241
+ HS V+HRD+K +N L D +K TDFG +VG+ Y++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 242 LRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ R YG + DIWS G++ ++ G PP+ E I +P +S+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIF 246
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASD-KPL 338
+D + + L D ++R SA E+L H ++++ S PL
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPL 285
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (640), Expect = 1e-81
Identities = 83/270 (30%), Positives = 129/270 (47%), Gaps = 18/270 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ FG+ LG G F L T +++A K + R +I + V V RE +M L H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HP 68
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
V+L ++D + + GEL I G + E ++V+ + Y H G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-R 244
++HRDLKPEN L + ED ++ TDFG + P VG+A YV+PE+L +
Sbjct: 129 IIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 245 NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
+ +D+W+ G I+Y L++G+PPF E IF I++ DF A+D+V
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKARDLV 241
Query: 305 KKMLHADPKERLSAAE------VLNHPWMR 328
+K+L D +RL E + HP+
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 2e-81
Identities = 74/265 (27%), Positives = 133/265 (50%), Gaps = 12/265 (4%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
+ + LG G +G L ++ T++ A K + ++ + D E++++E+ I L H
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 63
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
N+V+ G + + L ++ C+GGELFDRI E A Q++ V Y H +G
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLRRN 245
+ HRD+KPEN L LK +DFGL+ F+ + + + G+ YVAPE+L+R
Sbjct: 124 ITHRDIKPENLLLDE---RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 246 --YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303
+ D+WS G++L +L+G P+ ++ + + + +PW I S+ +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAPLAL 239
Query: 304 VKKMLHADPKERLSAAEVLNHPWMR 328
+ K+L +P R++ ++ W
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYN 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (624), Expect = 8e-79
Identities = 75/270 (27%), Positives = 132/270 (48%), Gaps = 14/270 (5%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
+ED +I + LG+G FG +L K T Q FA K++ ++ DDVE E +++
Sbjct: 1 IED----FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 56
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
H + + ++ + ++ +M+ GG+L I + + A +++ +
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 116
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-VFKDLVGSAYYVAPE 240
+ HS G+++RDLK +N L +D +K DFG+ GD G+ Y+APE
Sbjct: 117 QFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 241 VLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
+L + Y D WS GV+LY +L G PF G+ E+ +F +I + + +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKE 229
Query: 300 AKDIVKKMLHADPKERLSAA-EVLNHPWMR 328
AKD++ K+ +P++RL ++ HP R
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 7e-78
Identities = 57/267 (21%), Positives = 114/267 (42%), Gaps = 14/267 (5%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
F E+GRG F Y +T + A + RKL + + + + E +++ L H
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HP 68
Query: 129 NIVELKGAYED----RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
NIV ++E + + L+ +L G L + + + CRQ++ + +
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 185 HSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVL 242
H+ ++HRDLK +N + +K D GL+ K K ++G+ ++APE+
Sbjct: 129 HTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY 185
Query: 243 RRNYGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFDAILRGHIDFSSDPWPNISSSAK 301
Y D+++ G+ + + + P+ I+ + G + K
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVK 243
Query: 302 DIVKKMLHADPKERLSAAEVLNHPWMR 328
+I++ + + ER S ++LNH + +
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 231 bits (591), Expect = 2e-74
Identities = 62/269 (23%), Positives = 112/269 (41%), Gaps = 7/269 (2%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ Y G LG G +L + A K + + + RRE Q L
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-N 65
Query: 127 HRNIVELKGAYEDRHSVN----LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVH 182
H IV + E ++M+ G L D + +G + + A + ++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 183 YCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG-LSVFFKPGDVFKDLVGSAYYVAPEV 241
+ H G++HRD+KP N + S++ + ++ ++G+A Y++PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
R + A +D++S G +LY +L+G PPF G++ S+ +R S +S+
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 301 KDIVKKMLHADPKERLSAAEVLNHPWMRV 329
+V K L +P+ R A + +RV
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 4e-74
Identities = 71/309 (22%), Positives = 118/309 (38%), Gaps = 49/309 (15%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
ME + + ELG G GV + V+HK + A K I I + RE+Q++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVL 58
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
H IV GA+ +++ M+ GG L + G E+ + ++ +
Sbjct: 59 HECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 182 HYCHSM-GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPE 240
Y +MHRD+KP N L +S +K DFG+S + VG+ Y++PE
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPE 173
Query: 241 VLR-RNYGAEADIWSAGVILYILLSGVPPFWGETE---QSIFDAILRGHIDFSSD----- 291
L+ +Y ++DIWS G+ L + G P + +F + G +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 292 --------------------------------PWPNISSSAKDIVKKMLHADPKERLSAA 319
P S +D V K L +P ER
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 320 EVLNHPWMR 328
+++ H +++
Sbjct: 294 QLMVHAFIK 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 231 bits (589), Expect = 1e-73
Identities = 76/273 (27%), Positives = 131/273 (47%), Gaps = 20/273 (7%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
++D + R LG G FG +L+ + + +A K + ++ VE E ++
Sbjct: 3 LQD----FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 58
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
+T H I+ + G ++D + +IMD GGELF + + A ++ +
Sbjct: 59 SIVT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
Y HS +++RDLKPEN L ++ +K TDFG + + DV L G+ Y+APEV
Sbjct: 118 EYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEV 172
Query: 242 LR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ + Y D WS G+++Y +L+G PF+ ++ IL + F P +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDV 228
Query: 301 KDIVKKMLHADPKERL-----SAAEVLNHPWMR 328
KD++ +++ D +RL +V NHPW +
Sbjct: 229 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 3e-73
Identities = 70/271 (25%), Positives = 114/271 (42%), Gaps = 21/271 (7%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y +G G +G + K + K + + + + + EV ++ L H
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELK-HP 63
Query: 129 NIVELKGAYEDRHS--VNLIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVH 182
NIV DR + + ++M+ C GG+L I + + E + Q+ +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 183 YCHSMG-----VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF-KDLVGSAYY 236
CH V+HRDLKP N +K DFGL+ F K VG+ YY
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180
Query: 237 VAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295
++PE + R Y ++DIWS G +LY L + +PPF +++ + I G
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYR 237
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
S +I+ +ML+ R S E+L +P
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 229 bits (584), Expect = 3e-72
Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 14/271 (5%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT- 125
N + R +GRG FG Y DT + +A K + +++ + E ++ ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 126 -GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
IV + A+ ++ I+DL GG+L + G +SE +++ + +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLRR 244
H+ V++RDLKP N L E ++ +D GL+ F VG+ Y+APEVL++
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQK 179
Query: 245 N--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302
Y + AD +S G +L+ LL G PF + I R + + + + S +
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRS 238
Query: 303 IVKKMLHADPKERLS-----AAEVLNHPWMR 328
+++ +L D RL A EV P+ R
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 4e-72
Identities = 79/267 (29%), Positives = 125/267 (46%), Gaps = 20/267 (7%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVED---VRREVQIMHHL- 124
Y G LG G FG Y A K + ++ + ++ + V EV ++ +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGG-ELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
+G ++ L +E S LI++ +LFD I +G E A + Q++ V +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR 243
CH+ GV+HRD+K EN L LK DFG K V+ D G+ Y PE +R
Sbjct: 126 CHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIR 182
Query: 244 --RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301
R +G A +WS G++LY ++ G PF + E I+RG + F +SS +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFF----RQRVSSECQ 232
Query: 302 DIVKKMLHADPKERLSAAEVLNHPWMR 328
+++ L P +R + E+ NHPWM+
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 2e-70
Identities = 83/269 (30%), Positives = 135/269 (50%), Gaps = 15/269 (5%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
N + + + LG+G FG LV K T + +A K + +I +D+V E +++ +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR- 63
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
H + LK A++ + +M+ GGELF + + ++E A ++V+ + Y HS
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEVLRRN 245
V++RD+K EN + +D +K TDFGL G K G+ Y+APEVL N
Sbjct: 124 RDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 246 -YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
YG D W GV++Y ++ G PF+ + + +F+ IL I F +S AK ++
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLL 236
Query: 305 KKMLHADPKERLS-----AAEVLNHPWMR 328
+L DPK+RL A EV+ H +
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 4e-69
Identities = 88/355 (24%), Positives = 138/355 (38%), Gaps = 51/355 (14%)
Query: 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH 123
DV Y +G G +G+ K + A K I ++ + RE++I+
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLR 62
Query: 124 LTGHRNIVELKGAYEDRHSVNL----IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVT 179
H NI+ + + ++ G +L+ ++ H S Q++
Sbjct: 63 FR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILR 120
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG----DVFKDLVGSAY 235
+ Y HS V+HRDLKP N L + LK DFGL+ P + V + +
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 236 YVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293
Y APE++ + Y DIWS G IL +LS P F G+ + IL S +
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 294 ---------------------------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPW 326
PN S A D++ KML +P +R+ + L HP+
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297
Query: 327 MRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKS 381
+ D SD+P+ A K ++ L K LK L EE + ++S
Sbjct: 298 LEQYYDPSDEPIAEAPF---KFDMELDDLPKEKLK----ELIFEETARFQPGYRS 345
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 1e-67
Identities = 60/269 (22%), Positives = 108/269 (40%), Gaps = 19/269 (7%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
G+ +G G FG Y A K ++ ++ + EV ++
Sbjct: 7 DGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR 62
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVVHYC 184
H NI+ G Y + ++ C G L+ + I + + ++ RQ + Y
Sbjct: 63 -HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEV 241
H+ ++HRDLK N ED +K DFGL+ F+ L GS ++APEV
Sbjct: 121 HAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 242 LRRN----YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS--SDPWPN 295
+R Y ++D+++ G++LY L++G P+ + ++ S N
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLNH 324
+ K ++ + L ER ++L
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-67
Identities = 69/292 (23%), Positives = 110/292 (37%), Gaps = 33/292 (11%)
Query: 75 LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDD--VEDVRREVQIMHHLTGHRNIVE 132
LG GQF Y K+T Q A K I D RE++++ L+ H NI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIG 64
Query: 133 LKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHR 192
L A+ + +++L+ D + + + Y H ++HR
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 193 DLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPEVLR--RNYGAE 249
DLKP N L E+ LK DFGL+ F P + V + +Y APE+L R YG
Sbjct: 125 DLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 250 ADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP--------------- 294
D+W+ G IL LL VP G+++ I + + WP
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 295 ---------NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKP 337
D+++ + +P R++A + L + +
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 9e-67
Identities = 76/274 (27%), Positives = 135/274 (49%), Gaps = 17/274 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTH---KDTKQQFACKSISSRKLINR-DDVEDVRREVQIMHHL 124
+ + LG G +G +LV DT + +A K + ++ + E R E Q++ H+
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
+V L A++ ++LI+D GGELF + + ++E ++V + +
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 145
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP--GDVFKDLVGSAYYVAPEVL 242
H +G+++RD+K EN L + + TDFGLS F + D G+ Y+AP+++
Sbjct: 146 HKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 243 R---RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
R + D WS GV++Y LL+G PF + E++ I R + +S+
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262
Query: 300 AKDIVKKMLHADPKERLS-----AAEVLNHPWMR 328
AKD+++++L DPK+RL A E+ H + +
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 2e-66
Identities = 73/313 (23%), Positives = 124/313 (39%), Gaps = 40/313 (12%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
+ K +VR Y + +G G +G T + A K + R + + RE
Sbjct: 9 VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRE 67
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGEL----FDRIIAKGHYSERAAANL 173
++++ H+ H N++ L + +++ D +++ E L
Sbjct: 68 LRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 126
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
QM+ + Y H+ G++HRDLKP N + ED LK DFGL+ V +
Sbjct: 127 VYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ--ADSEMTGYVVT 181
Query: 234 AYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD 291
+Y APEV+ Y DIWS G I+ +++G F G I++ ++
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 292 PW---------------------------PNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
N S A ++++KML D ++R++A E L H
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301
Query: 325 PWMRVDGDASDKP 337
P+ D D+P
Sbjct: 302 PYFESLHDTEDEP 314
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (539), Expect = 7e-66
Identities = 75/268 (27%), Positives = 136/268 (50%), Gaps = 16/268 (5%)
Query: 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG 126
+ + + LG G FG LV HK++ +A K + +K++ +E E +I+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS 186
+V+L+ +++D ++ ++M+ AGGE+F + G +SE A Q+V Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 187 MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RN 245
+ +++RDLKPEN L + ++ TDFG + K L G+ +APE++ +
Sbjct: 160 LDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKG 214
Query: 246 YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305
Y D W+ GV++Y + +G PPF+ + I++ I+ G + F + SS KD+++
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLR 270
Query: 306 KMLHADPKERL-----SAAEVLNHPWMR 328
+L D +R ++ NH W
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 3e-65
Identities = 81/341 (23%), Positives = 128/341 (37%), Gaps = 49/341 (14%)
Query: 45 SATSATSSSVGRVLGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRK 104
S + ++ G+ +P E +Y + +G G FGV Y D+ + A K +
Sbjct: 1 SKVTTVVATPGQGPDRPQEV---SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---- 53
Query: 105 LINRDDVEDVRREVQIMHHLTGHRNIVELKGAY------EDRHSVNLIMDLCAGG---EL 155
D RE+QIM L H NIV L+ + +D +NL++D
Sbjct: 54 ---LQDKRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 156 FDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDF 215
AK Q+ + Y HS G+ HRD+KP+N L + + LK DF
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDF 167
Query: 216 GLSVFFKPGDVFKDLVGSAYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGET 273
G + G+ + S YY APE++ Y + D+WSAG +L LL G P F G++
Sbjct: 168 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227
Query: 274 EQSIFDAILRG-------------------------HIDFSSDPWPNISSSAKDIVKKML 308
I++ ++ P A + ++L
Sbjct: 228 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 287
Query: 309 HADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQF 349
P RL+ E H + D + K + + F
Sbjct: 288 EYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNF 328
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-65
Identities = 73/310 (23%), Positives = 123/310 (39%), Gaps = 48/310 (15%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
Y ++G+G FG + H+ T Q+ A K + RE++I+ L H
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLL-KHE 69
Query: 129 NIVELKGAYED--------RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTV 180
N+V L + S+ L+ D C ++ + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-----DVFKDLVGSAY 235
++Y H ++HRD+K N L + D LK DFGL+ F + + + V + +
Sbjct: 130 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 236 YVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293
Y PE+L R+YG D+W AG I+ + + P G TEQ I + + + W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 294 PNI----------------------------SSSAKDIVKKMLHADPKERLSAAEVLNHP 325
PN+ A D++ K+L DP +R+ + + LNH
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 326 WMRVDGDASD 335
+ D SD
Sbjct: 307 FFWSDPMPSD 316
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 209 bits (532), Expect = 5e-65
Identities = 68/301 (22%), Positives = 129/301 (42%), Gaps = 49/301 (16%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
++ Y R+LGRG++ + + ++ K++ + ++RE++I+ +L
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVV------KILKPVKKKKIKREIKILENLR 87
Query: 126 GHRNIVELKGAYEDR--HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHY 183
G NI+ L +D + L+ + + ++ +++ + Y
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 144
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR 243
CHSMG+MHRD+KP N + E L+ D+GL+ F+ PG + V S Y+ PE+L
Sbjct: 145 CHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 202
Query: 244 --RNYGAEADIWSAGVILYILLSGVPPFWGETE--------------QSIFDAILRGHID 287
+ Y D+WS G +L ++ PF+ + + ++D I + +I+
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 288 --------------------FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327
S+ +S A D + K+L D + RL+A E + HP+
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
Query: 328 R 328
Sbjct: 323 Y 323
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 205 bits (523), Expect = 3e-64
Identities = 80/295 (27%), Positives = 124/295 (42%), Gaps = 38/295 (12%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
ME Y ++G G +GV Y + + FA K I K + RE+ I+
Sbjct: 1 MEK----YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISIL 54
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
L H NIV+L + + L+ + + +G A + Q++ +
Sbjct: 55 KELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPE 240
YCH V+HRDLKP+N L + + LK DFGL+ F P + + + +Y AP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINR---EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
Query: 241 VLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNI-- 296
VL + Y DIWS G I +++G P F G +E I R +S WPN+
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 297 -----------------------SSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
S D++ KML DP +R++A + L H + +
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-63
Identities = 69/296 (23%), Positives = 120/296 (40%), Gaps = 38/296 (12%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
M+ Y ++G G +G + +++T + A K + + RE+ ++
Sbjct: 1 MQK----YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLL 55
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
L H+NIV L + L+ + C G + Q++ +
Sbjct: 56 KELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAPE 240
+CHS V+HRDLKP+N L + + LK +FGL+ F P + V + +Y P+
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINR---NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
Query: 241 VL--RRNYGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAILRGHIDFSSDPW---- 293
VL + Y D+WSAG I L + P F G I R + + W
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 294 ---------------------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
P ++++ +D+++ +L +P +R+SA E L HP+
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-63
Identities = 68/293 (23%), Positives = 116/293 (39%), Gaps = 37/293 (12%)
Query: 69 YIFGRELGRGQFGVTYLVTH-KDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTG- 126
Y E+G G +G + K+ + A K + + REV ++ HL
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLETF 67
Query: 127 -HRNIVELKGAYEDRHS-----VNLIMDLCAGGEL-FDRIIAKGHYSERAAANLCRQMVT 179
H N+V L + + L+ + + + + ++ Q++
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 180 VVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAP 239
+ + HS V+HRDLKP+N L +S +K DFGL+ + +V + +Y AP
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 240 EVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP---- 294
EVL ++ Y D+WS G I + P F G ++ IL + WP
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 295 -------------------NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
+I KD++ K L +P +R+SA L+HP+ +
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-62
Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 40/314 (12%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
L K + +V Y +G G +G T + A K +S R + + RE
Sbjct: 9 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRE 67
Query: 118 VQIMHHLTGHRNIVELKGAYEDRHSV----NLIMDLCAGGELFDRIIAKGHYSERAAANL 173
++++ H+ H N++ L + S+ ++ + G + I+ ++ L
Sbjct: 68 LRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGS 233
Q++ + Y HS ++HRDLKP N + ED LK DFGL+ D V +
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHT--DDEMTGYVAT 181
Query: 234 AYYVAPEVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS-- 289
+Y APE++ Y DIWS G I+ LL+G F G ILR
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 290 -------------------------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
++ + + A D+++KML D +R++AA+ L H
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 325 PWMRVDGDASDKPL 338
+ D D+P+
Sbjct: 302 AYFAQYHDPDDEPV 315
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-61
Identities = 74/296 (25%), Positives = 119/296 (40%), Gaps = 38/296 (12%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
ME+ + ++G G +GV Y +K T + A K I RE+ ++
Sbjct: 1 MEN----FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLL 55
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCA-GGELFDRIIAKGHYSERAAANLCRQMVTV 180
L H NIV+L + + L+ + + F A + Q++
Sbjct: 56 KEL-NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF-KPGDVFKDLVGSAYYVAP 239
+ +CHS V+HRDLKP+N L + + +K DFGL+ F P + V + +Y AP
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 240 EVLRRN--YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW---- 293
E+L Y DIWS G I +++ F G++E I R W
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 294 ---------------------PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
P + + ++ +MLH DP +R+SA L HP+ +
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 2e-61
Identities = 59/294 (20%), Positives = 104/294 (35%), Gaps = 24/294 (8%)
Query: 64 DVR--NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIM 121
++R N Y GR++G G FG YL T ++ A K + + E +I
Sbjct: 2 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIY 56
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
+ G I ++ + ++M+L +S + L QM++ +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF--------KDLVGS 233
Y HS +HRD+KP+NFL + + + DFGL+ ++ K+L G+
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 234 AYYVAPEVLRRN-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292
A Y + D+ S G +L G P+ G + R S P
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236
Query: 293 ----WPNISSSAKDIVKKMLHADPKERLSAAEV---LNHPWMRVDGDASDKPLD 339
S + ++ + + + + R G + D D
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR-QGFSYDYVFD 289
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-61
Identities = 63/277 (22%), Positives = 108/277 (38%), Gaps = 24/277 (8%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
N F +G G FG K + ++ ++DD D E++++ L
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI----------------IAKGHYSERA 169
H NI+ L GA E R + L ++ G L D + S +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 170 AANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD 229
+ + + Y +HRDL N L E+ K DFGLS +
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTM 185
Query: 230 LVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHID 287
++A E L + Y +D+WS GV+L+ ++S G P+ G T +++ + +G
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG--- 242
Query: 288 FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
+ + N D++++ P ER S A++L
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-60
Identities = 61/290 (21%), Positives = 108/290 (37%), Gaps = 36/290 (12%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKL---INRDDVEDVRREVQIMH 122
R FG+ LG G FG T + ++ + L + + E + E+++M
Sbjct: 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH------------------ 164
L H NIV L GA + LI + C G+L + + +K
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 165 -----YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219
+ Q+ + + +HRDL N L + +K DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLAR 212
Query: 220 FFKPGD---VFKDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETE 274
V + ++APE L Y ++D+WS G++L+ + S GV P+ G
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 275 QSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
+ F +++ D + I++ D ++R S + +
Sbjct: 273 DANFYKLIQNGFKM--DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-60
Identities = 65/275 (23%), Positives = 108/275 (39%), Gaps = 23/275 (8%)
Query: 66 RNTYIFG-RELGRGQFGVTYLVTHKDTKQQ--FACKSISSRKLINRDDVEDVRREVQIMH 122
R+ + ELG G FG ++ K+Q A K + ++ + D E++ RE QIMH
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMH 64
Query: 123 HLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVV 181
L + IV L G + ++ L+M++ GG L ++ K A L Q+ +
Sbjct: 65 QLD-NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL----VGSAYYV 237
Y +HRDL N L K +DFGLS D + +
Sbjct: 123 KYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 238 APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295
APE + R + + +D+WS GV ++ LS G P+ + I +G + P
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPE 236
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEV---LNHPWM 327
++ ++R V + +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 4e-60
Identities = 60/269 (22%), Positives = 109/269 (40%), Gaps = 25/269 (9%)
Query: 61 PMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
M++ + +G+G+FG L ++ K A K I N + E +
Sbjct: 5 NMKE----LKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIK-----NDATAQAFLAEASV 53
Query: 121 MHHLTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFDRIIAKGH--YSERAAANLCRQM 177
M L H N+V+L G E++ + ++ + A G L D + ++G +
Sbjct: 54 MTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 178 VTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYV 237
+ Y +HRDL N L S ED+ K +DFGL+ +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQ--DTGKLPVKWT 167
Query: 238 APEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295
APE LR + + ++D+WS G++L+ + S G P+ + + + +G + D
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDG 224
Query: 296 ISSSAKDIVKKMLHADPKERLSAAEVLNH 324
+ +++K H D R S ++
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 8e-60
Identities = 57/268 (21%), Positives = 103/268 (38%), Gaps = 20/268 (7%)
Query: 73 RELGRGQFGVTYLVTHKDTK--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI 130
+ELG G FG ++ K + A K + + + +++ E +M L + I
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLD-NPYI 70
Query: 131 VELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVM 190
V + G E S L+M++ G L + H ++ L Q+ + Y +
Sbjct: 71 VRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 191 HRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD----LVGSAYYVAPEVLRRN- 245
HRDL N L + K +DFGLS + + + + APE +
Sbjct: 130 HRDLAARNVLLVT---QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 246 YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304
+ +++D+WS GV+++ S G P+ G + + +G D++
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLM 243
Query: 305 KKMLHADPKERLSAAEV---LNHPWMRV 329
D + R A V L + + V
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-58
Identities = 60/266 (22%), Positives = 101/266 (37%), Gaps = 17/266 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQ---FACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+LG G FGV + A K + L + ++D REV MH L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYC 184
HRN++ L G + ++ +L G L DR+ GH+ + Q+ + Y
Sbjct: 70 -HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD----VFKDLVGSAYYVAPE 240
S +HRDL N L + +K DFGL D + + + APE
Sbjct: 128 ESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 241 VLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISS 298
L+ R + +D W GV L+ + + G P+ G I I + +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPEDCPQ 242
Query: 299 SAKDIVKKMLHADPKERLSAAEVLNH 324
+++ + P++R + + +
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (482), Expect = 5e-58
Identities = 58/272 (21%), Positives = 108/272 (39%), Gaps = 17/272 (6%)
Query: 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISS-RKLINRDDVEDVRREVQIM 121
E + + +G G+FG K ++ +I + + D E IM
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTV 180
H N++ L+G V +I + G L + G ++ + R +
Sbjct: 82 GQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDL------VGSA 234
+ Y M +HRDL N L + + K +DFGLS F +
Sbjct: 141 MKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 235 YYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDP 292
+ APE ++ R + + +D+WS G++++ ++S G P+W T Q + +AI + D+ P
Sbjct: 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPP 254
Query: 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
+ S+ ++ D R +++N
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-57
Identities = 67/265 (25%), Positives = 108/265 (40%), Gaps = 14/265 (5%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSI-SSRKLINRDDVEDVRREVQIMHHL 124
R GR +G GQFG + + + +I + + + E +E M
Sbjct: 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 65
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHY 183
H +IV+L G + V +IM+LC GEL + + + Q+ T + Y
Sbjct: 66 -DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK--DLVGSAYYVAPEV 241
S +HRD+ N L SS+ +K DFGLS + + +K ++APE
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180
Query: 242 LR-RNYGAEADIWSAGVILY-ILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
+ R + + +D+W GV ++ IL+ GV PF G + I G PN +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPT 237
Query: 300 AKDIVKKMLHADPKERLSAAEVLNH 324
++ K DP R E+
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-57
Identities = 59/261 (22%), Positives = 110/261 (42%), Gaps = 17/261 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHR 128
F +ELG GQFGV + A K I + ++ E ++M +L+ H
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSE----DEFIEEAKVMMNLS-HE 59
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRI-IAKGHYSERAAANLCRQMVTVVHYCHSM 187
+V+L G + + +I + A G L + + + + + +C+ + + Y S
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 188 GVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--VFKDLVGSAYYVAPEVLRRN 245
+HRDL N L + + +K +DFGLS + + + PEVL +
Sbjct: 120 QFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 246 -YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303
+ +++DIW+ GV+++ + S G P+ T + I +G + S I
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASEKVYTI 233
Query: 304 VKKMLHADPKERLSAAEVLNH 324
+ H ER + +L++
Sbjct: 234 MYSCWHEKADERPTFKILLSN 254
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-57
Identities = 76/326 (23%), Positives = 127/326 (38%), Gaps = 53/326 (16%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
+G V Y + +G G G+ + A K +S R N+ + RE
Sbjct: 8 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRE 66
Query: 118 VQIMHHLTGHRNIVELKGAY------EDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAA 171
+ +M + H+NI+ L + E+ V L+M+L + +
Sbjct: 67 LVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMS 122
Query: 172 NLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLV 231
L QM+ + + HS G++HRDLKP N + S D LK DFGL+ + V
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 179
Query: 232 GSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG------ 284
+ YY APEV+ Y DIWS G I+ ++ F G ++ ++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 285 ----------------HIDFSSDPWPNI----------------SSSAKDIVKKMLHADP 312
++ +P + +S A+D++ KML DP
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 313 KERLSAAEVLNHPWMRVDGDASDKPL 338
+R+S + L HP++ V D ++
Sbjct: 300 AKRISVDDALQHPYINVWYDPAEVEA 325
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-56
Identities = 57/270 (21%), Positives = 111/270 (41%), Gaps = 21/270 (7%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R + +LG+G FG ++ T T + A K++ + E +E Q+M L
Sbjct: 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKL- 69
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHY 183
H +V+L + + ++ + + G L D + + + ++ Q+ + + Y
Sbjct: 70 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD--LVGSAYYVAPEV 241
M +HRDL+ N L E+ K DFGL+ + + + APE
Sbjct: 129 VERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185
Query: 242 LRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
+ ++D+WS G++L L + G P+ G + + D + RG + P S
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 242
Query: 300 AKDIVKKMLHADPKERLSAAEVLN--HPWM 327
D++ + +P+ER + + +
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-56
Identities = 59/264 (22%), Positives = 113/264 (42%), Gaps = 17/264 (6%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
+ F +E+G GQFG+ +L + + A K+I + ED E ++M L+
Sbjct: 4 PSELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAM----SEEDFIEEAEVMMKLS 58
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH-YSERAAANLCRQMVTVVHYC 184
H +V+L G ++ + L+ + G L D + + ++ +C + + Y
Sbjct: 59 -HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 185 HSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--VFKDLVGSAYYVAPEVL 242
V+HRDL N L E+ +K +DFG++ F + +PEV
Sbjct: 118 EEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 243 RRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
+ Y +++D+WS GV+++ + S G P+ + + + I G F S+
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHV 231
Query: 301 KDIVKKMLHADPKERLSAAEVLNH 324
I+ P++R + + +L
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 185 bits (471), Expect = 2e-56
Identities = 59/292 (20%), Positives = 98/292 (33%), Gaps = 22/292 (7%)
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
V Y GR +G G FGV + T+ QQ A K R D +R E + L
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLL 57
Query: 125 TGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYC 184
G I + ++ L++DL + +S + A +QM+ V
Sbjct: 58 AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 185 HSMGVMHRDLKPENFLFSS--SAEDSPLKATDFGLSVFFKPGDV--------FKDLVGSA 234
H +++RD+KP+NFL S + + DFG+ F++ K+L G+A
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 235 YYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP- 292
Y++ R D+ + G + L G P+ G + R S P
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 293 ---WPNISSSAKDIVKKMLHADPKERLSAAEVLN--HPWMRVDGDASDKPLD 339
+ + + + D+ D
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (465), Expect = 1e-55
Identities = 58/263 (22%), Positives = 106/263 (40%), Gaps = 17/263 (6%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R +LG GQ+G Y K A K++ + +VE+ +E +M +
Sbjct: 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK 71
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY--SERAAANLCRQMVTVVHY 183
H N+V+L G +I + G L D + S + Q+ + + Y
Sbjct: 72 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD--VFKDLVGSAYYVAPEV 241
+HRDL N L E+ +K DFGLS + APE
Sbjct: 131 LEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 242 LRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
L N + ++D+W+ GV+L+ + + G+ P+ G +++ + + D+ +
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEK 244
Query: 300 AKDIVKKMLHADPKERLSAAEVL 322
++++ +P +R S AE+
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIH 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-55
Identities = 51/264 (19%), Positives = 100/264 (37%), Gaps = 19/264 (7%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT 125
R T LG GQFG ++ + + A KS+ + + E +M L
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 66
Query: 126 GHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHY 183
H+ +V L + +I + G L D + + ++ Q+ + +
Sbjct: 67 -HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 184 CHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKD--LVGSAYYVAPEV 241
+HRDL+ N L S + K DFGL+ + + + APE
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 242 LRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299
+ + ++D+WS G++L +++ G P+ G T + + RG + N
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEE 238
Query: 300 AKDIVKKMLHADPKERLSAAEVLN 323
+++ P++R + + +
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 9e-55
Identities = 66/285 (23%), Positives = 108/285 (37%), Gaps = 35/285 (12%)
Query: 66 RNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
RN FG+ LG G FG T D A K + + + E + E+++
Sbjct: 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKV 79
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH---------------- 164
+ +L H NIV L GA +I + C G+L + + K
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 165 --YSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
+ Q+ + + S +HRDL N L + K DFGL+ K
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIK 196
Query: 223 PGD---VFKDLVGSAYYVAPEVLRRNY-GAEADIWSAGVILYILLS-GVPPFWGETEQSI 277
V + ++APE + E+D+WS G+ L+ L S G P+ G S
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 278 FDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
F +++ + + DI+K ADP +R + +++
Sbjct: 257 FYKMIKEGFRM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-54
Identities = 57/284 (20%), Positives = 110/284 (38%), Gaps = 30/284 (10%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ-------QFACKSISSRKLINRDDVEDVRREV 118
R+ + G+ LG G FG L + + A K + + D+ D+ E+
Sbjct: 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEM 69
Query: 119 QIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRI----------------IAK 162
++M + H+NI+ L GA + +I++ + G L + + +
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 163 GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222
S + + Q+ + Y S +HRDL N L +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 223 PGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDA 280
+ ++APE L R Y ++D+WS GV+L+ + + G P+ G + +F
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 281 ILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
+ GH D N ++ +++ HA P +R + +++
Sbjct: 250 LKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (453), Expect = 1e-53
Identities = 63/295 (21%), Positives = 113/295 (38%), Gaps = 43/295 (14%)
Query: 62 MEDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRR 116
+E RN + R++G G FG + + A K + + D D +R
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQR 65
Query: 117 EVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHY----------- 165
E +M + NIV+L G + L+ + A G+L + + + +
Sbjct: 66 EAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 166 -------------SERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKA 212
S + RQ+ + Y +HRDL N L E+ +K
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKI 181
Query: 213 TDFGLSVFFKPGDVFK---DLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVP 267
DFGLS D +K + ++ PE + N Y E+D+W+ GV+L+ + S G+
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 268 PFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322
P++G + + + G+I N ++++ P +R S +
Sbjct: 242 PYYGMAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-52
Identities = 56/264 (21%), Positives = 99/264 (37%), Gaps = 16/264 (6%)
Query: 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSI--SSRKLINRDDVEDVRREVQIMHHLTG 126
+ + LG G FG Y ++ R+ + +++ E +M +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69
Query: 127 HRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCH 185
+ ++ L G V LI L G L D + K + + N C Q+ ++Y
Sbjct: 70 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 186 SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVL 242
++HRDL N L +K TDFGL+ + + ++A E +
Sbjct: 129 DRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 243 R-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300
R Y ++D+WS GV ++ L++ G P+ G I + +G P +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTIDV 242
Query: 301 KDIVKKMLHADPKERLSAAEVLNH 324
I+ K D R E++
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-49
Identities = 62/283 (21%), Positives = 114/283 (40%), Gaps = 29/283 (10%)
Query: 62 MEDVRNTYI--------FGRELGRGQFGVTYLVTHKD---TKQQFACKSISSRKLINRDD 110
++ V++ I F +GRG FG Y T D K A KS+ ++ + +
Sbjct: 14 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGE 71
Query: 111 VEDVRREVQIMHHLTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFDRIIAKGH-YSER 168
V E IM + H N++ L G S +++ G+L + I + H + +
Sbjct: 72 VSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 169 AAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK 228
Q+ + + S +HRDL N + E +K DFGL+ +
Sbjct: 131 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDS 187
Query: 229 DL-----VGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAI 281
++A E L+ + ++D+WS GV+L+ L++ G PP+ I +
Sbjct: 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247
Query: 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
L+G + +++ K H + R S +E+++
Sbjct: 248 LQGRRLLQPE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-49
Identities = 57/269 (21%), Positives = 108/269 (40%), Gaps = 20/269 (7%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQ----FACKSISSRKLINRDDVEDVRREVQIM 121
+ + +G G+FG Y K + + A K++ + D E IM
Sbjct: 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIM 63
Query: 122 HHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTV 180
H NI+ L+G + +I + G L + K G +S + R +
Sbjct: 64 GQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 181 VHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD----VFKDLVGSAYY 236
+ Y +M +HRDL N L +S+ K +DFGLS + +
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 237 VAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWP 294
APE + R + + +D+WS G++++ +++ G P+W + + AI G F
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPM 236
Query: 295 NISSSAKDIVKKMLHADPKERLSAAEVLN 323
+ S+ ++ + + R A++++
Sbjct: 237 DCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 1e-48
Identities = 57/289 (19%), Positives = 117/289 (40%), Gaps = 35/289 (12%)
Query: 66 RNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R RELG+G FG+ Y K + + + A K++ + + + + E +
Sbjct: 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASV 76
Query: 121 MHHLTGHRNIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGH----------YSERAA 170
M ++V L G +IM+L G+L + + S
Sbjct: 77 MKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 171 ANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFK-- 228
+ ++ + Y ++ +HRDL N + + ED +K DFG++ D ++
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 229 -DLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGV-PPFWGETEQSIFDAILRGH 285
+ +++PE L+ + +D+WS GV+L+ + + P+ G + + + ++ G
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252
Query: 286 IDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN------HPWMR 328
+ D N ++++ +PK R S E+++ P R
Sbjct: 253 LL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 6e-46
Identities = 61/286 (21%), Positives = 109/286 (38%), Gaps = 34/286 (11%)
Query: 66 RNTYIFGRELGRGQFGVTYLVT-----HKDTKQQFACKSISSRKLINRDDVEDVRREVQI 120
R+ G+ LGRG FG T + A K + ++ + + E++I
Sbjct: 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKI 69
Query: 121 MHHLTGHRNIVELKGA-YEDRHSVNLIMDLCAGGELFDRI----------------IAKG 163
+ H+ H N+V L GA + + +I++ C G L + + K
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 164 HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223
+ Q+ + + S +HRDL N L S E + +K DFGL+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYK 186
Query: 224 GDVF---KDLVGSAYYVAPEVLRRN-YGAEADIWSAGVILYILLSGV-PPFWGETEQSIF 278
+ D ++APE + Y ++D+WS GV+L+ + S P+ G F
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246
Query: 279 DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324
L+ + + H +P +R + +E++ H
Sbjct: 247 CRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-43
Identities = 55/299 (18%), Positives = 100/299 (33%), Gaps = 51/299 (17%)
Query: 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHL 124
+ T + +G+G+FG + K ++ A K SSR+ + E+ L
Sbjct: 1 IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSRE----ERSWFREAEIYQTVML 54
Query: 125 TGHRNIVELKGAYEDRHSVN----LIMDLCAGGELFDRIIAKGHYSERA-------AANL 173
H NI+ A + L+ D G LFD + E A+ L
Sbjct: 55 R-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 113
Query: 174 CRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD-----VFK 228
+ +V + HRDLK +N L ++ D GL+V
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAPN 170
Query: 229 DLVGSAYYVAPEVLRRN-------YGAEADIWSAGVILYILLSGVPPFWGETE------- 274
VG+ Y+APEVL + ADI++ G++ + + +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 275 --------QSIFDAILRGHIDFSSDPW---PNISSSAKDIVKKMLHADPKERLSAAEVL 322
+ + + + + I+++ +A+ RL+A +
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (381), Expect = 1e-42
Identities = 60/335 (17%), Positives = 111/335 (33%), Gaps = 72/335 (21%)
Query: 58 LGKPMEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE 117
G+P +D R YI R+LG G F +L A K + K+ E E
Sbjct: 6 KGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDE 59
Query: 118 VQIMHHL----------TGHRNIVELKGAYEDRHSVNLIMDL-----CAGGELFDRIIAK 162
++++ + G +I++L + + + + + +
Sbjct: 60 IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH 119
Query: 163 GHYSERAAANLCRQMVTVVHYC-HSMGVMHRDLKPENFLFSSS---AEDSPLKATDFGLS 218
+ +Q++ + Y G++H D+KPEN L +K D G +
Sbjct: 120 RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 179
Query: 219 VFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSI 277
++ + Y +PEVL +G ADIWS +++ L++G F + S
Sbjct: 180 CWYDEHYTNSI--QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237
Query: 278 FDAI--------------------------------------------LRGHIDFSSDPW 293
L +
Sbjct: 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297
Query: 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328
+ + D + ML DP++R A ++NHPW++
Sbjct: 298 KDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.8 bits (227), Expect = 2e-22
Identities = 37/201 (18%), Positives = 69/201 (34%), Gaps = 25/201 (12%)
Query: 72 GRELGRGQFGVTYLVTHKDTKQQFACK-----SISSRKLINRDDVEDVR-REVQIMHHLT 125
G+ +G G+ + + + K S +K+ + D D+ + I
Sbjct: 5 GKLMGEGKESAVFNCYSEKF-GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 126 GHRNIVELKGAYEDRH----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVV 181
R + +L+G + ++M+L EL+ + ++ V
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELY-------RVRVENPDEVLDMILEEV 116
Query: 182 HYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEV 241
+ G++H DL N L S + + DF SV +++++
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEG-WREILERDVRNIITY 171
Query: 242 LRRNYGAEADIWSAGVILYIL 262
R Y E DI S I IL
Sbjct: 172 FSRTYRTEKDINS--AIDRIL 190
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Score = 73.9 bits (180), Expect = 3e-15
Identities = 28/147 (19%), Positives = 50/147 (34%), Gaps = 1/147 (0%)
Query: 272 ETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331
E Q D H + I+ ++ K+ D K + R
Sbjct: 22 EELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAA 81
Query: 332 DASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTIT 391
+ + +K + L+ LSEE+ L+++F S SG +
Sbjct: 82 RGDAAAEKQRLASLLKDLED-DASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFS 140
Query: 392 FEELKAGLPKLGTRLSESEVRQLMEAV 418
F++LK L K + E +++L V
Sbjct: 141 FQDLKQVLAKYADTIPEGPLKKLFVMV 167
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Score = 39.2 bits (90), Expect = 6e-04
Identities = 7/45 (15%), Positives = 21/45 (46%), Gaps = 3/45 (6%)
Query: 353 NKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKA 397
+++KV + ++ + F +D D+S +++++E
Sbjct: 273 EEVQKVLEDAHIPESARKKF---EHQFSVVDVDDSKSLSYQEFVM 314
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Score = 36.9 bits (84), Expect = 0.003
Identities = 8/43 (18%), Positives = 16/43 (37%), Gaps = 1/43 (2%)
Query: 377 EMFKSMDTDNSGTITFEELKAGLPKLG-TRLSESEVRQLMEAV 418
++ D D SG ++ EE++ L + + V
Sbjct: 257 ILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVV 299
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 63.0 bits (153), Expect = 2e-13
Identities = 38/58 (65%), Positives = 48/58 (82%)
Query: 361 KVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
K +AE LSEEEI GLKE+FK +DTDNSGTITF+ELK GL ++G+ L ESE++ LM+A
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 68
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 58.1 bits (140), Expect = 1e-11
Identities = 23/55 (41%), Positives = 32/55 (58%)
Query: 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ NL+EE+I KE F D DN+G+I+ EL + LG SE+EV LM +
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEI 55
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 59.7 bits (143), Expect = 4e-11
Identities = 30/40 (75%), Positives = 35/40 (87%)
Query: 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG 403
AE LSEEEI GLKE+FK +DTDNSGTITF+ELK GL ++G
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVG 40
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 54.5 bits (130), Expect = 1e-09
Identities = 23/55 (41%), Positives = 32/55 (58%)
Query: 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ NL+EE+I KE F D DN+G+I+ EL + LG SE+EV LM +
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEI 55
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 39.1 bits (90), Expect = 2e-04
Identities = 15/43 (34%), Positives = 24/43 (55%)
Query: 376 KEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
E FK D + G I+ ELK L +G +L+++EV ++ V
Sbjct: 86 LEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREV 128
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Score = 51.9 bits (124), Expect = 2e-09
Identities = 20/52 (38%), Positives = 30/52 (57%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
L+EE+I KE F D D GTIT +EL + LG +E+E++ ++ V
Sbjct: 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 53
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Score = 49.2 bits (117), Expect = 2e-08
Identities = 15/59 (25%), Positives = 28/59 (47%), Gaps = 1/59 (1%)
Query: 361 KVIAENLSEEEIMGLKEMFKSMDTDNS-GTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
K E L+EE+ K F G+I+ +EL + LG + E++++++ V
Sbjct: 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEV 61
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 48.4 bits (115), Expect = 3e-08
Identities = 18/52 (34%), Positives = 26/52 (50%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
LSEE I K F D D G I+ +EL + LG ++ E+ ++E V
Sbjct: 8 LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEV 59
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 47.9 bits (114), Expect = 4e-08
Identities = 17/51 (33%), Positives = 27/51 (52%), Gaps = 4/51 (7%)
Query: 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG-TRLSESEVRQLMEAV 418
EEE + FK D + G I F+E K + K+G L+++EV + M+
Sbjct: 1 EEE---ILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEA 48
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 36.4 bits (84), Expect = 4e-04
Identities = 13/40 (32%), Positives = 19/40 (47%), Gaps = 3/40 (7%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
K + KV E L++ E+ +E K D D +G I E
Sbjct: 24 FKFIMQKVGEEPLTDAEV---EEAMKEADEDGNGVIDIPE 60
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 49.6 bits (117), Expect = 7e-08
Identities = 14/56 (25%), Positives = 26/56 (46%), Gaps = 1/56 (1%)
Query: 361 KVIAENLSEEEIMGLKEMFKSMDTD-NSGTITFEELKAGLPKLGTRLSESEVRQLM 415
K E L+EE+ K F G+I+ +EL + LG + E+++++
Sbjct: 2 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMI 57
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Score = 49.2 bits (116), Expect = 1e-07
Identities = 10/46 (21%), Positives = 20/46 (43%)
Query: 360 LKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTR 405
+K+ + + I K MF +D + +G IT +E+ +
Sbjct: 1 VKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICA 46
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Score = 36.5 bits (83), Expect = 0.003
Identities = 17/111 (15%), Positives = 28/111 (25%), Gaps = 8/111 (7%)
Query: 285 HIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLT 344
F A L +R GDA D
Sbjct: 63 EAFFRGCGMEYGKEIAFPQFLDGWKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGSG 122
Query: 345 RMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEEL 395
+ K + S+E+ + F+ D DN+G + +E+
Sbjct: 123 TITLDEWKAYGKI-----SGISPSQEDC---EATFRHCDLDNAGDLDVDEM 165
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Score = 48.4 bits (114), Expect = 1e-07
Identities = 21/54 (38%), Positives = 31/54 (57%)
Query: 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
E L+EE+I KE F D D GTIT +EL + LG +E+E++ ++ V
Sbjct: 1 EQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 54
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Score = 36.0 bits (82), Expect = 0.002
Identities = 15/44 (34%), Positives = 25/44 (56%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
L E FK D D +G I+ EL+ + LG +L++ EV +++
Sbjct: 84 LIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREA 127
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 49.1 bits (116), Expect = 1e-07
Identities = 10/55 (18%), Positives = 18/55 (32%), Gaps = 1/55 (1%)
Query: 365 ENLSEEEIMGLKEMFKSMDTD-NSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + L+E +K + SGT+ E K + V + A
Sbjct: 13 GAVGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAF 67
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Score = 46.5 bits (110), Expect = 2e-07
Identities = 15/51 (29%), Positives = 27/51 (52%), Gaps = 1/51 (1%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ ++I + +FK DT+ G I+ EL L L ++ EVR++M +
Sbjct: 1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTL-GSVTPDEVRRMMAEI 50
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Score = 47.9 bits (113), Expect = 3e-07
Identities = 13/64 (20%), Positives = 25/64 (39%), Gaps = 4/64 (6%)
Query: 354 KLKKVALKVIAE--NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEV 411
KL+ ++ + E + +E EI + F SG ++ EE K S+
Sbjct: 3 KLRPEVMQDLLESTDFTEHEIQEWYKGFL--RDCPSGHLSMEEFKKIYGNFFPYGDASKF 60
Query: 412 RQLM 415
+ +
Sbjct: 61 AEHV 64
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Score = 37.9 bits (87), Expect = 0.001
Identities = 14/67 (20%), Positives = 32/67 (47%), Gaps = 2/67 (2%)
Query: 335 DKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEE 394
D I+ ++ +A+ K+ +K+ + + E+ +++F+ MDT+ G ++ EE
Sbjct: 107 DGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKR--TEKIFRQMDTNRDGKLSLEE 164
Query: 395 LKAGLPK 401
G
Sbjct: 165 FIRGAKS 171
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 45.2 bits (107), Expect = 3e-07
Identities = 18/51 (35%), Positives = 31/51 (60%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
S EE + + F+ D DNSGTIT ++L+ +LG L+E E+++++
Sbjct: 7 SREE---ILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEA 54
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 36.4 bits (84), Expect = 5e-04
Identities = 12/41 (29%), Positives = 19/41 (46%), Gaps = 3/41 (7%)
Query: 357 KVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKA 397
+ K + ENL+EEE+ EM D ++ I +E
Sbjct: 32 RRVAKELGENLTEEELQ---EMIAEADRNDDNEIDEDEFIR 69
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 183 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 47.2 bits (111), Expect = 5e-07
Identities = 14/55 (25%), Positives = 23/55 (41%), Gaps = 3/55 (5%)
Query: 366 NLSEEEIMGLKEMFKSMDTD--NSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
S EI L E+FK + + + G I EE + L K + S ++ +
Sbjct: 10 VFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKKESL-FADRVFDLF 63
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} Length = 165 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 6e-07
Identities = 13/56 (23%), Positives = 27/56 (48%), Gaps = 4/56 (7%)
Query: 363 IAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ + +EI L + FK +D DNSG+++ EE + V+++++
Sbjct: 6 MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPEL----QQNPLVQRVIDIF 57
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.2 bits (108), Expect = 7e-07
Identities = 9/41 (21%), Positives = 17/41 (41%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
K++F D G I + L L +G + V+ ++
Sbjct: 4 NKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDII 44
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 142 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 46.2 bits (108), Expect = 8e-07
Identities = 14/49 (28%), Positives = 28/49 (57%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
L +++I +KE F +D D G ++ E++KA +LG + E+ ++
Sbjct: 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAML 49
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Score = 46.6 bits (109), Expect = 8e-07
Identities = 8/48 (16%), Positives = 17/48 (35%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
S+ + +K F +D D G IT + ++ + +
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKV 48
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (106), Expect = 1e-06
Identities = 10/41 (24%), Positives = 19/41 (46%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
KE F+ D G I + + + LG + +EV +++
Sbjct: 2 FKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVL 42
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 7e-04
Identities = 12/49 (24%), Positives = 23/49 (46%)
Query: 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
+ E F+ D + +G + EL+ L LG +++E EV ++
Sbjct: 73 QGTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG 121
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Score = 43.8 bits (103), Expect = 1e-06
Identities = 18/59 (30%), Positives = 32/59 (54%), Gaps = 3/59 (5%)
Query: 360 LKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+K ++ +EEE L ++F+ D + G I EELK L G ++E ++ +LM+
Sbjct: 5 MKDDSKGKTEEE---LSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDG 60
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.6 bits (105), Expect = 1e-06
Identities = 20/55 (36%), Positives = 31/55 (56%), Gaps = 3/55 (5%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAV 418
LS+ +K++F+ +D D SG + +ELK L K L+ESE + LM+A
Sbjct: 35 LSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAA 89
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} Length = 186 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 10/71 (14%), Positives = 27/71 (38%), Gaps = 10/71 (14%)
Query: 357 KVALKVIAENLSEEEIM-GLKEMFKSMDTDNSGTITFEELKAGLPKLG--------TRLS 407
++ + +EE+I G + +F + I+ EL+ L ++ S
Sbjct: 1 EIEANIEEIEANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFS 59
Query: 408 ESEVRQLMEAV 418
+ +++ +
Sbjct: 60 IETCKIMVDML 70
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 65 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.7 bits (100), Expect = 2e-06
Identities = 18/51 (35%), Positives = 30/51 (58%), Gaps = 3/51 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
SEEEI +E F+ D D +G I+ EL+ + LG +L++ EV +++
Sbjct: 1 SEEEI---REAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREA 48
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Score = 45.4 bits (106), Expect = 2e-06
Identities = 9/47 (19%), Positives = 19/47 (40%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQ 413
+ I K MF +D +++G I+ +E+ + + Q
Sbjct: 6 DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQ 52
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Score = 45.4 bits (106), Expect = 3e-06
Identities = 17/52 (32%), Positives = 29/52 (55%), Gaps = 2/52 (3%)
Query: 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
A ++++ + L E F+++DTD SG I+ EL A L G S + +L+
Sbjct: 11 ARHMNDNQ--ELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLL 60
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 75 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 42.2 bits (99), Expect = 4e-06
Identities = 18/55 (32%), Positives = 25/55 (45%), Gaps = 3/55 (5%)
Query: 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
A+ SEEE L F+ D + G I EEL L G + E ++ LM+
Sbjct: 3 AKGKSEEE---LANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDS 54
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 44.5 bits (104), Expect = 4e-06
Identities = 18/52 (34%), Positives = 26/52 (50%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
LSEE I K F D D G I+ +EL + LG ++ E+ ++E V
Sbjct: 14 LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEV 65
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 39.5 bits (91), Expect = 2e-04
Identities = 13/44 (29%), Positives = 20/44 (45%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
L F+ D + G I EEL L G ++E ++ LM+
Sbjct: 98 LANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDS 141
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 44.6 bits (104), Expect = 4e-06
Identities = 7/51 (13%), Positives = 19/51 (37%), Gaps = 1/51 (1%)
Query: 367 LSEEEIMGLKEMFKSM-DTDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416
L++ + +K F D ++ G+I + + + + S +
Sbjct: 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYK 52
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} Length = 134 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Score = 43.6 bits (101), Expect = 6e-06
Identities = 10/39 (25%), Positives = 22/39 (56%)
Query: 377 EMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
+FK +D + G +++EE+KA + K +E ++ +
Sbjct: 4 ALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIF 42
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 7e-06
Identities = 15/50 (30%), Positives = 28/50 (56%)
Query: 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
EE+ ++E F D D +GTI +ELK + LG + E+++++ +
Sbjct: 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEI 51
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 6e-04
Identities = 13/43 (30%), Positives = 26/43 (60%)
Query: 376 KEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ FK D D +G I+F+ LK +LG L++ E++++++
Sbjct: 82 LKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEA 124
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.001
Identities = 12/39 (30%), Positives = 20/39 (51%), Gaps = 3/39 (7%)
Query: 359 ALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKA 397
K + ENL++EE+ +EM D D G ++ +E
Sbjct: 104 VAKELGENLTDEEL---QEMIDEADRDGDGEVSEQEFLR 139
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 42.6 bits (100), Expect = 7e-06
Identities = 23/75 (30%), Positives = 38/75 (50%), Gaps = 15/75 (20%)
Query: 347 KQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL---G 403
K+F A+ LK +S + +K++FK++D D SG I EELK L G
Sbjct: 27 KKFFALVGLKA---------MSAND---VKKVFKAIDADASGFIEEEELKFVLKSFAADG 74
Query: 404 TRLSESEVRQLMEAV 418
L+++E + ++A
Sbjct: 75 RDLTDAETKAFLKAA 89
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 34.9 bits (80), Expect = 0.003
Identities = 9/38 (23%), Positives = 15/38 (39%), Gaps = 3/38 (7%)
Query: 360 LKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKA 397
+L++ E K K+ D D G I +E +
Sbjct: 70 FAADGRDLTDAET---KAFLKAADKDGDGKIGIDEFET 104
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} Length = 76 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.5 bits (97), Expect = 7e-06
Identities = 17/53 (32%), Positives = 26/53 (49%), Gaps = 3/53 (5%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG--TRLSESEVRQLMEAV 418
S EEI G E+F + + I+ EELK + LG S + +++E V
Sbjct: 3 SPEEIKGAFEVF-AAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEV 54
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 152 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 43.5 bits (101), Expect = 8e-06
Identities = 13/51 (25%), Positives = 22/51 (43%), Gaps = 2/51 (3%)
Query: 367 LSEEEIMGLKEMFKSMDT--DNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
LS++EI LK++F+ D G + +L LG +V +
Sbjct: 1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVG 51
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 1e-05
Identities = 8/64 (12%), Positives = 21/64 (32%), Gaps = 4/64 (6%)
Query: 354 KLKKVALKVIAE--NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEV 411
KLK ++ + +E+E+ + F SG + + + ++
Sbjct: 4 KLKPEVVEELTRKTYFTEKEVQQWYKGFI--KDCPSGQLDAAGFQKIYKQFFPFGDPTKF 61
Query: 412 RQLM 415
+
Sbjct: 62 ATFV 65
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Score = 43.1 bits (100), Expect = 1e-05
Identities = 10/55 (18%), Positives = 21/55 (38%), Gaps = 7/55 (12%)
Query: 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL----GTRLSESEVRQLME 416
++ + LK+ F D D +G + + + + G +EV+ L
Sbjct: 3 AIASDR---LKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKN 54
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} Length = 78 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Score = 40.6 bits (95), Expect = 2e-05
Identities = 9/55 (16%), Positives = 21/55 (38%), Gaps = 4/55 (7%)
Query: 368 SEEEIMGLKEMFKSMDT--DNSGTITFEELKAGLPKLGTRL--SESEVRQLMEAV 418
+++ LK +F+ + ++ EELK + L + L + +
Sbjct: 2 AQKSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQEL 56
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.9 bits (100), Expect = 2e-05
Identities = 10/50 (20%), Positives = 17/50 (34%), Gaps = 2/50 (4%)
Query: 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
N ++ E+ L FK + SG + E K + S +
Sbjct: 9 NFTKRELQVLYRGFK--NECPSGVVNEETFKQIYAQFFPHGDASTYAHYL 56
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 178 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.1 bits (85), Expect = 0.002
Identities = 10/79 (12%), Positives = 25/79 (31%), Gaps = 9/79 (11%)
Query: 324 HPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMG-LKEMFKSM 382
++ D + + + + + + K L E+ + F+ M
Sbjct: 93 FNLYDINKDGY--------INKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKM 144
Query: 383 DTDNSGTITFEELKAGLPK 401
D + G +T +E +
Sbjct: 145 DKNKDGIVTLDEFLESCQE 163
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} Length = 99 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (96), Expect = 2e-05
Identities = 9/49 (18%), Positives = 20/49 (40%), Gaps = 1/49 (2%)
Query: 365 ENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQ 413
+ L K F D ++ G + +EL+A K ++ + + +
Sbjct: 9 DGLDPNR-FNPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEE 56
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} Length = 99 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.0 bits (80), Expect = 0.002
Identities = 7/27 (25%), Positives = 14/27 (51%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPK 401
+ + K++DT+ +T EE A +
Sbjct: 70 REHVMKNVDTNQDRLVTLEEFLASTQR 96
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Score = 41.1 bits (96), Expect = 2e-05
Identities = 22/75 (29%), Positives = 36/75 (48%), Gaps = 15/75 (20%)
Query: 347 KQFRAMNKLKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL---G 403
K+F + LK ++ + +KE+F+ +D D SG I EELK L G
Sbjct: 27 KRFFHLVGLKG---------KTDAQ---VKEVFEILDKDQSGFIEEEELKGVLKGFSAHG 74
Query: 404 TRLSESEVRQLMEAV 418
L+++E + L+ A
Sbjct: 75 RDLNDTETKALLAAG 89
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} Length = 173 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Score = 42.6 bits (99), Expect = 2e-05
Identities = 10/47 (21%), Positives = 20/47 (42%), Gaps = 1/47 (2%)
Query: 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416
EE+ + +F + D+ ++ EL L K+ TR + +
Sbjct: 1 EEVRQFRRLFAQLAGDD-MEVSATELMNILNKVVTRHPDLKTDGFGI 46
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 43.6 bits (102), Expect = 2e-05
Identities = 15/147 (10%), Positives = 47/147 (31%), Gaps = 4/147 (2%)
Query: 73 RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD----DVEDVRREVQIMHHLTGHR 128
+E+G G + + ++ + K + + ++ R E + H
Sbjct: 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91
Query: 129 NIVELKGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG 188
+ + Y D +M+ + ++ + + +G + ++ + + Y
Sbjct: 92 PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151
Query: 189 VMHRDLKPENFLFSSSAEDSPLKATDF 215
+ + K F++ + F
Sbjct: 152 LEPKVKKQLVKQFTNPELCDITERLVF 178
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 39.5 bits (92), Expect = 3e-05
Identities = 6/44 (13%), Positives = 19/44 (43%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
K +F+ D + G ++ +E + ++ ++ + E +
Sbjct: 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEI 46
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 33.4 bits (76), Expect = 0.004
Identities = 6/27 (22%), Positives = 15/27 (55%)
Query: 376 KEMFKSMDTDNSGTITFEELKAGLPKL 402
+ F+ +D D +G + +E + + K+
Sbjct: 40 VKFFEEIDVDGNGELNADEFTSCIEKM 66
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 33 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Score = 38.3 bits (90), Expect = 4e-05
Identities = 15/36 (41%), Positives = 21/36 (58%), Gaps = 3/36 (8%)
Query: 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG 403
SEEEI +E F+ D D +G I+ EL+ + LG
Sbjct: 1 SEEEI---REAFRVFDKDGNGYISAAELRHVMTNLG 33
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 61 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Score = 38.9 bits (90), Expect = 5e-05
Identities = 12/44 (27%), Positives = 28/44 (63%)
Query: 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418
+ F+ D +++G ++ +L+ L LG +L+++EV +L++ V
Sbjct: 3 FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGV 46
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 41.6 bits (96), Expect = 5e-05
Identities = 14/53 (26%), Positives = 24/53 (45%), Gaps = 1/53 (1%)
Query: 364 AENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG-TRLSESEVRQLM 415
A + + L +F+ +D D SG I+ EL+ L T + VR ++
Sbjct: 10 AAGAALPDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSII 62
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Score = 40.0 bits (93), Expect = 6e-05
Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 3/56 (5%)
Query: 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG---TRLSESEVRQLMEAV 418
L ++ +K++F +D D SG I +EL + L LS E + LM A
Sbjct: 34 GLKKKSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAG 89
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Score = 40.9 bits (95), Expect = 9e-05
Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 10/63 (15%)
Query: 365 ENLSEEEIM-GLKEMFKSMDTDNSGTITFEELKAGLPKLGTR--------LSESEVRQLM 415
+ LSEEEI K +F + D+ I+ +EL+ L ++ ++ S R ++
Sbjct: 11 KVLSEEEIDDNFKTLFSKLAGDD-MEISVKELQTILNRIISKHKDLRTNGFSLESCRSMV 69
Query: 416 EAV 418
+
Sbjct: 70 NLM 72
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} Length = 188 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Score = 37.8 bits (87), Expect = 0.001
Identities = 8/45 (17%), Positives = 20/45 (44%)
Query: 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417
+F+ D D SG+++ E++ + G +L + ++
Sbjct: 93 RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVAR 137
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} Length = 83 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 1e-04
Identities = 10/47 (21%), Positives = 22/47 (46%)
Query: 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLM 415
+ + F++ DT + TI+ EE +A + L++ + +L
Sbjct: 16 TSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLW 62
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 107 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 38.8 bits (90), Expect = 1e-04
Identities = 14/55 (25%), Positives = 26/55 (47%), Gaps = 3/55 (5%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAV 418
L+ + + +K+ F +D D SG I +ELK L L+++E + +
Sbjct: 34 LASKSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADG 88
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 107 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 34.9 bits (80), Expect = 0.003
Identities = 9/39 (23%), Positives = 12/39 (30%), Gaps = 3/39 (7%)
Query: 359 ALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKA 397
A L++ E D D G I +E A
Sbjct: 68 NFSPSARALTDAETK---AFLADGDKDGDGMIGVDEFAA 103
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} Length = 172 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (92), Expect = 2e-04
Identities = 9/57 (15%), Positives = 19/57 (33%), Gaps = 6/57 (10%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG-----TRLSESEVRQLMEAV 418
+ L F ++ G I +EL+ L + G + R ++ +
Sbjct: 1 FPGQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSML 56
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} Length = 93 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Score = 37.9 bits (88), Expect = 2e-04
Identities = 9/57 (15%), Positives = 19/57 (33%), Gaps = 7/57 (12%)
Query: 369 EEEIMGLKEMFKSMDT--DNSGTITFEELKAGLPKLGTRL-----SESEVRQLMEAV 418
E+ + + F + + ELK L + E+ ++LM +
Sbjct: 5 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNL 61
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Score = 36.8 bits (85), Expect = 6e-04
Identities = 10/61 (16%), Positives = 23/61 (37%), Gaps = 6/61 (9%)
Query: 364 AENLS--EEEIMGLKEMF-KSMDTD-NSGTITFEELKAGLPKLG--TRLSESEVRQLMEA 417
AE L+ EE I + F + +++ E K + + + + M++
Sbjct: 3 AEPLTELEESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKS 62
Query: 418 V 418
+
Sbjct: 63 L 63
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} Length = 201 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Score = 37.9 bits (87), Expect = 0.001
Identities = 14/67 (20%), Positives = 22/67 (32%), Gaps = 4/67 (5%)
Query: 351 AMNKLKKVALKVIAE--NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSE 408
L K L+ + +EEE+ + F SG IT +E + K
Sbjct: 4 KSGALSKEILEELQLNTKFTEEELSSWYQSFL--KECPSGRITRQEFQTIYSKFFPEADP 61
Query: 409 SEVRQLM 415
Q +
Sbjct: 62 KAYAQHV 68
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 190 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 37.1 bits (85), Expect = 0.002
Identities = 11/64 (17%), Positives = 20/64 (31%), Gaps = 4/64 (6%)
Query: 354 KLKKVALKVIAE--NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEV 411
KL K L + + EI + F + SG + E+ + S +
Sbjct: 7 KLSKDDLTCLKQSTYFDRREIQQWHKGF--LRDCPSGQLAREDFVKIYKQFFPFGSPEDF 64
Query: 412 RQLM 415
+
Sbjct: 65 ANHL 68
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 190 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 36.3 bits (83), Expect = 0.003
Identities = 15/79 (18%), Positives = 30/79 (37%), Gaps = 9/79 (11%)
Query: 324 HPWMRVDGDASDKPLDIAVLTRMKQFRAMNKLKKVALKVIAENLSEEEIMG-LKEMFKSM 382
++ D +T + + + K+ ++ N E +K++FK M
Sbjct: 105 FELYDLNHDG--------YITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLM 156
Query: 383 DTDNSGTITFEELKAGLPK 401
D + G IT +E + G
Sbjct: 157 DKNEDGYITLDEFREGSKV 175
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} Length = 92 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Score = 35.3 bits (81), Expect = 0.002
Identities = 7/60 (11%), Positives = 21/60 (35%), Gaps = 3/60 (5%)
Query: 355 LKKVALKVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQL 414
++K + + ++ K +D G + F+ + + L ++ V +
Sbjct: 34 MEKEFPGFLENQKDPLAVD---KIMKDLDQCRDGKVGFQSFFSLIAGLTIACNDYFVVHM 90
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} Length = 92 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Score = 34.2 bits (78), Expect = 0.004
Identities = 10/55 (18%), Positives = 21/55 (38%), Gaps = 6/55 (10%)
Query: 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG-----TRLSESEVRQLMEAV 418
E + + F D G +T E+L+ + K + V ++M+ +
Sbjct: 5 EHAMETMMFTFHKFAGDK-GYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDL 58
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} Length = 180 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.002
Identities = 10/51 (19%), Positives = 19/51 (37%), Gaps = 1/51 (1%)
Query: 352 MNKLKKVALKVIAENLSEEEIMGL-KEMFKSMDTDNSGTITFEELKAGLPK 401
+ + + LS E+ L + + D D GTI E + + +
Sbjct: 118 SRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVISR 168
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 140 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 35.4 bits (80), Expect = 0.004
Identities = 6/27 (22%), Positives = 9/27 (33%)
Query: 376 KEMFKSMDTDNSGTITFEELKAGLPKL 402
K+ F D +G I + L
Sbjct: 8 KQAFSLFDRHGTGRIPKTSIGDLLRAC 34
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} Length = 95 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Score = 34.2 bits (78), Expect = 0.004
Identities = 8/53 (15%), Positives = 21/53 (39%), Gaps = 3/53 (5%)
Query: 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419
+ E+ +F S+ +G ++ +++K L L + ++ E
Sbjct: 4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSD 53
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 420 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.84 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.81 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.78 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.74 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 98.74 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 98.69 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 98.65 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.65 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 98.63 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.57 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.49 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 98.48 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 98.48 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 98.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.43 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 98.41 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 98.25 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 98.2 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.19 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.18 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 98.09 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.07 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 98.06 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.04 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 98.03 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 97.94 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 97.93 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 97.92 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 97.87 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 97.87 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 97.86 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.83 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 97.83 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 97.79 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 97.78 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.75 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.73 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 97.7 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 97.69 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 97.68 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 97.67 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 97.66 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 97.65 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 97.63 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 97.62 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 97.62 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.61 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 97.57 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 97.55 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 97.54 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 97.54 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 97.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.5 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 97.46 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 97.41 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 97.4 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 97.36 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 97.32 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 97.32 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 97.21 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.2 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 97.19 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 97.18 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 97.15 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 97.15 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 97.14 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 97.13 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 97.05 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 97.04 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 97.03 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 97.02 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 96.99 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 96.89 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 96.84 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 96.74 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 96.64 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 96.61 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 96.5 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 96.34 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.28 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 96.27 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 96.15 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 96.15 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 96.12 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 96.12 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 96.11 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 95.86 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 95.85 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 95.75 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 95.75 | |
| d1j7qa_ | 86 | Calcium vector protein {Amphioxus (Branchiostoma l | 95.38 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 95.35 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 95.15 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 95.09 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 94.94 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 94.79 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 94.75 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 94.71 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 94.63 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 94.59 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 94.49 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 94.48 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 94.23 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 94.1 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 94.06 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 94.05 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 93.96 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 93.7 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 93.7 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 93.46 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 93.39 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 93.06 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 93.02 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 92.73 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 92.68 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 92.66 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 92.57 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 92.22 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 91.85 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 91.82 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 91.7 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 91.7 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 91.63 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 91.59 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 91.5 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 91.43 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 91.4 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 91.24 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 91.19 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 90.94 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 90.73 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 90.67 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 90.54 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 90.23 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 90.23 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 90.02 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 89.75 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 89.61 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 89.54 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 89.33 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 89.26 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 89.24 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 89.03 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 88.87 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 88.86 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 88.63 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 88.42 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 88.39 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 87.61 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 86.7 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 86.18 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 85.99 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 85.8 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 85.55 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 85.04 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 83.15 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 82.79 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 82.62 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 82.15 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-66 Score=483.61 Aligned_cols=290 Identities=41% Similarity=0.738 Sum_probs=236.7
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
.+++.+.|++.+.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|++++ ||||+++++++.+++
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIK-HPNIVALDDIYESGG 80 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence 467888999999999999999999999999999999999765432 23466889999999998 999999999999999
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.+|+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+...++++.+||+|||+++..
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999999999999889999999999999999999999999999999999999987667789999999999987
Q ss_pred CCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 222 KPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 222 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
.........+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.........+.++...++.+.++.+|+++
T Consensus 161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 76666677889999999999865 59999999999999999999999999999999999999999888888888999999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcccHHHHHHHHHHHhhhhh
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMNKL 355 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (420)
++||.+||++||++|||+.|+|+||||+.... ....+...+..+++++...+++
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 294 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA-LDKNIHQSVSEQIKKNFAKSKW 294 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCC-CCCCCHHHHHHHHHHHSCCCTT
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCCCc-cccccchhHHHHHHHHHHHhhh
Confidence 99999999999999999999999999975432 2333444444455544433333
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-65 Score=465.71 Aligned_cols=254 Identities=33% Similarity=0.620 Sum_probs=232.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|++++++++ ||||+++++++.+++.+|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence 57999999999999999999999999999999997654433445678999999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
||||+||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...... .
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~-~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS-R 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCC-C
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCC-c
Confidence 9999999999999988999999999999999999999999999999999999999 55678999999999876543 3
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++. .+|+++++||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~ 236 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLIS 236 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHHH
Confidence 456789999999999975 4899999999999999999999999999999999999988776653 68999999999
Q ss_pred HhcccCcCCCCCHHHHhcCCcccc
Q 014704 306 KMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+||+.||++|||+.|+|+||||+.
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-64 Score=463.75 Aligned_cols=266 Identities=39% Similarity=0.677 Sum_probs=242.3
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCC---hhhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLIN---RDDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
+++.++|.+++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|++++ |||||++++++.+
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN 84 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE
Confidence 457788999999999999999999999999999999997654422 224678999999999998 9999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC-CCCeeEeecccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE-DSPLKATDFGLS 218 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~-~~~~kl~Dfg~~ 218 (420)
++.+|||||||+||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++. ...+||+|||++
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999999999998889999999999999999999999999999999999999965432 336999999999
Q ss_pred cccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.....+.......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.+..+..+...++...++.+|
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 98877766677889999999999975 59999999999999999999999999999999999999988887766667899
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+++++||++||+.||++|||++|+|+||||+.
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-64 Score=459.65 Aligned_cols=256 Identities=29% Similarity=0.583 Sum_probs=218.2
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|++.+.||+|+||+||+|+++.+|+.||||++..... .+..+.+.+|+++|++++ ||||+++++++.+++.+|+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeEE
Confidence 4679999999999999999999999999999999976532 233467899999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCC
Confidence 99999999999999888889999999999999999999999999999999999999 456779999999998764332
Q ss_pred ---ceecccCCcccccchhhcc-c-CCCccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCCCChH
Q 014704 226 ---VFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPPFWGETEQS-IFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 226 ---~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwslGvil~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
.....+||+.|||||++.+ . ++.++||||+||++|+|++|++||....... .+..+..... ....++.+|++
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~ 235 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSA 235 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT--TSTTGGGSCHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCCHH
Confidence 2355689999999999864 3 4678999999999999999999997765433 3333333222 22345678999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+++||.+||+.||++|||++|+|+||||+.
T Consensus 236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 236 PLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 999999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-64 Score=461.12 Aligned_cols=256 Identities=32% Similarity=0.603 Sum_probs=229.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++++ ||||+++++++.+++.+|+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEE
Confidence 367999999999999999999999999999999997654434455678999999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||||+||+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+|+.+....
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccCC
Confidence 99999999999999999999999999999999999999999999999999999999 566789999999998765332
Q ss_pred ---ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 226 ---VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 226 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.....+||+.|+|||++.+ .|+.++||||+||++|+|++|..||.+.+..+++..|.++.+.++. .++++++
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~ 238 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKAR 238 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCHHHH
Confidence 3345689999999999865 5899999999999999999999999999999999999998776653 6899999
Q ss_pred HHHHHhcccCcCCCCCHHH------HhcCCcccc
Q 014704 302 DIVKKMLHADPKERLSAAE------VLNHPWMRV 329 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e------~l~h~~~~~ 329 (420)
+||++||+.||++|||++| +++||||+.
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 9999999999999999988 588999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.4e-63 Score=468.77 Aligned_cols=263 Identities=35% Similarity=0.632 Sum_probs=240.5
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
+.++|++.+.||+|+||.||+|+++.+|+.||||++.... ......+.+|+.+|++++ |||||+++++|.+++.+|
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 4467999999999999999999999999999999987542 344567899999999998 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 145 LIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
||||||+||+|.+++...+ ++++..+..++.||+.||.|||++||+||||||+|||++. ..++.+||+|||+|.....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCC
Confidence 9999999999998876554 6999999999999999999999999999999999999953 2457899999999999887
Q ss_pred CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
........||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+....+..+.++...++...++.+|+++++
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 777777899999999999865 5999999999999999999999999999999999999999998888888899999999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
||.+||+.||++|||+.|+|+||||+....
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 999999999999999999999999986543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-63 Score=456.08 Aligned_cols=257 Identities=28% Similarity=0.492 Sum_probs=225.5
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
..++|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|++++ |||||++++++.+++.+|
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEE
Confidence 34689999999999999999999999999999999875433 33577999999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+|||||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccc
Confidence 99999999999987654 579999999999999999999999999999999999999 45678999999999887543
Q ss_pred -CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 225 -DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
......+||+.|+|||++.+ .|+.++||||+||++|+|++|..||.+.+....+..+...... ....++.+|+++++
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD 248 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHH
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHH
Confidence 34456789999999999875 5899999999999999999999999998877777666554322 11223578999999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
||.+||+.||++|||+.|+|+||||+..
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-63 Score=468.44 Aligned_cols=262 Identities=35% Similarity=0.630 Sum_probs=239.5
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
+-++|.+.+.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+.+|++++ |||||++++++.+++.+|
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence 456899999999999999999999999999999999654 2345678999999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 145 LIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
+|||||+||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||+..+ .++.+||+|||+++....
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchheeccc
Confidence 99999999999999854 4679999999999999999999999999999999999999642 356899999999998877
Q ss_pred CCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKD 302 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 302 (420)
........||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..+.+..+..+...++...++.+|+++++
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 777777899999999999865 5899999999999999999999999999999999999999888887777889999999
Q ss_pred HHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 303 IVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 303 li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
||.+||+.||++|||+.|+|+||||+...
T Consensus 259 li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999997543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-62 Score=448.76 Aligned_cols=253 Identities=23% Similarity=0.431 Sum_probs=220.5
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe----CCeEE
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----RHSVN 144 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~----~~~~~ 144 (420)
|++.+.||+|+||+||+|.++.+++.||+|.+..... .....+.+.+|+++|++++ |||||++++++.+ ...+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEE
Confidence 4788899999999999999999999999999876543 4556678999999999999 9999999999875 45689
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMG--VMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+|||||+||+|.+++.+.+.+++..+..++.||+.||+|||++| |+||||||+|||++ ++++.+||+|||+++...
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceecc
Confidence 99999999999999998889999999999999999999999999 99999999999995 345679999999998654
Q ss_pred CCCceecccCCcccccchhhcccCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRRNYGAEADIWSAGVILYILLSGVPPFWGET-EQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DvwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
. ......+||+.|||||++.+.|+.++|||||||++|+|++|+.||.+.. ...+...+..+..... .....+++++
T Consensus 167 ~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~ 243 (270)
T d1t4ha_ 167 A-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKVAIPEVK 243 (270)
T ss_dssp T-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG--GGGCCCHHHH
T ss_pred C-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc--cCccCCHHHH
Confidence 3 3345678999999999999889999999999999999999999997654 4555566655433222 2245789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
+||.+||+.||++|||+.|+|+||||+
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.9e-62 Score=448.47 Aligned_cols=261 Identities=36% Similarity=0.670 Sum_probs=239.0
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh------hhHHHHHHHHHHHHhccCCCCccEEEEEEEe
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR------DDVEDVRREVQIMHHLTGHRNIVELKGAYED 139 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 139 (420)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.++++++.||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4789999999999999999999999999999999987554321 1235688999999999889999999999999
Q ss_pred CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 140 RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 140 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
++.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhee
Confidence 99999999999999999999999999999999999999999999999999999999999999 567789999999999
Q ss_pred ccCCCCceecccCCcccccchhhcc-------cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q 014704 220 FFKPGDVFKDLVGSAYYVAPEVLRR-------NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDP 292 (420)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 292 (420)
....+......+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+..+...++...
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 8877666677889999999998742 368899999999999999999999999999999999999988888777
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
++.+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 7889999999999999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-62 Score=460.70 Aligned_cols=255 Identities=32% Similarity=0.593 Sum_probs=234.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|++++ ||||+++++++.+.+.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccc
Confidence 57999999999999999999999999999999998654444456788999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC-CC
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP-GD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~-~~ 225 (420)
||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.... ..
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCCc
Confidence 9999999999999999999999999999999999999999999999999999999 5667899999999987643 34
Q ss_pred ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 226 VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
.....+||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+.+..+++..+..+.+.++. .+|+++++||
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli 236 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHH
Confidence 4566789999999999864 5999999999999999999999999999999999999998877654 6899999999
Q ss_pred HHhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 305 KKMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 305 ~~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
++||++||++|++ ++|+++||||+.
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhccCCchhhcccccccHHHHHcCccccc
Confidence 9999999999994 999999999964
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-62 Score=457.40 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=229.7
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
....|.+.+.||+|+||+||+|+++.+|+.||||++...........+.+.+|+.+|++++ |||||++++++.+++.+|
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEE
Confidence 3456999999999999999999999999999999998766555566678999999999999 999999999999999999
Q ss_pred EEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 145 LIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
+|||||.||+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccccccCCC
Confidence 9999999999988888888999999999999999999999999999999999999994 5677999999999876432
Q ss_pred CceecccCCcccccchhhc----ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 225 DVFKDLVGSAYYVAPEVLR----RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~----~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
...+||+.|||||++. +.|+.++|||||||++|+|++|..||.+.+..+.+..+..+...... ...+|+++
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~ 243 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYF 243 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHHH
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHHH
Confidence 4568999999999984 34899999999999999999999999999888888888776554332 24679999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
++||.+||+.||++|||+.|+|+||||...
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999999999743
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-63 Score=454.23 Aligned_cols=257 Identities=29% Similarity=0.505 Sum_probs=225.9
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.+.|++.+.||+|+||+||+|+++.+|+.||+|++.... ....+.+.+|+++|++++ |||||++++++.+++.+|+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEE
Confidence 457999999999999999999999999999999997542 345577899999999999 9999999999999999999
Q ss_pred EEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
|||||+||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|......
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCC
Confidence 9999999999998765 4569999999999999999999999999999999999999 45678999999999765322
Q ss_pred -CceecccCCcccccchhhc------ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 225 -DVFKDLVGSAYYVAPEVLR------RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~------~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
......+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.++...... ....+|
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~s 242 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPSRWS 242 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-SGGGSC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-ccccCC
Confidence 1234568999999999973 34889999999999999999999999999888888888887643322 235789
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+++++||++||+.||++|||+.|+|+||||+..
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999743
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-62 Score=460.11 Aligned_cols=261 Identities=31% Similarity=0.631 Sum_probs=239.3
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
++.++|.+++.||+|+||+||+|.++.+|+.||||++.... .....+.+|+++|+.++ ||||+++++++++++.+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence 46688999999999999999999999999999999997542 33456889999999999 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|+|||||+||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+ +...+||+|||++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhhccc
Confidence 99999999999999997665 69999999999999999999999999999999999999642 34679999999999887
Q ss_pred CCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.........||+.|+|||.+.+ .|+.++||||+||++|+|++|..||.+.+...++..|.++...++...++.+|++++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 7777777889999999999864 589999999999999999999999999999999999999998888777788999999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 302 DIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
+||++||..||++|||+.|+|+||||+..
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-62 Score=445.83 Aligned_cols=253 Identities=27% Similarity=0.496 Sum_probs=214.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCeEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHSVN 144 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--~~~~~ 144 (420)
++|++.+.||+|+||+||+|+++.+|+.||+|++..... +....+.+.+|+++|++++ |||||++++++.+ .+.+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence 679999999999999999999999999999999976544 4556778999999999999 9999999999865 46689
Q ss_pred EEEecCCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeccCCCCcEEEecCCCCCCeeEeec
Q 014704 145 LIMDLCAGGELFDRIIA----KGHYSERAAANLCRQMVTVVHYCHSMG-----VMHRDLKPENFLFSSSAEDSPLKATDF 215 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~-----ivH~Dlkp~Nill~~~~~~~~~kl~Df 215 (420)
+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence 99999999999998854 467999999999999999999999976 9999999999999 55678999999
Q ss_pred ccccccCCCC-ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 014704 216 GLSVFFKPGD-VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (420)
Q Consensus 216 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 293 (420)
|+++...... .....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+..++...+..+..... .
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~ 235 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P 235 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---C
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence 9998875443 3456789999999999865 599999999999999999999999999999999999988765432 2
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcc
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNHPWM 327 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 327 (420)
..+|+++++||++||+.||++|||+.|+|+|||+
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 4689999999999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-61 Score=452.54 Aligned_cols=253 Identities=29% Similarity=0.591 Sum_probs=231.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++ ||||+++++++.+++.+|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence 46999999999999999999999999999999997654434455688999999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
||||.||+|..++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc--
Confidence 9999999999999999999999999999999999999999999999999999999 56778999999999876533
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
....+||+.|||||++.+ .|+.++||||+||++|+|++|+.||.+.+..++...+.++...++ +.+|++++++|.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 233 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS 233 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 346789999999999975 599999999999999999999999999999999999998877654 368999999999
Q ss_pred HhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 306 KMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
+||..||.+|+ |++++|+||||+.
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHhhhCHHhccccchhhHHHHHcCccccc
Confidence 99999999996 9999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-61 Score=454.22 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=216.8
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
...++|.+.+.||+|+||+||+|+++.+|+.||+|++.... .....+.+.+|+.+|++++ |||||+++++|.+++.+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence 34678999999999999999999999999999999997543 3445678999999999999 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
|+|||||+||+|.+++.+.+.+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHH
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccC
Confidence 9999999999999999988999999999999999999999997 599999999999999 556789999999998764
Q ss_pred CCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-----------------------
Q 014704 223 PGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIF----------------------- 278 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~----------------------- 278 (420)
.. ...+.+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+.....
T Consensus 157 ~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 157 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp HH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred CC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 32 2345789999999999865 6999999999999999999999999775532211
Q ss_pred -------------------HHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 279 -------------------DAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 279 -------------------~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
..+..... +..+...+|.++++||.+||+.||++|||++|+|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCC--CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCC--ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00111000 00111236889999999999999999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-61 Score=455.15 Aligned_cols=267 Identities=33% Similarity=0.644 Sum_probs=226.9
Q ss_pred ccccceeec-ceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe---
Q 014704 64 DVRNTYIFG-RELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--- 139 (420)
Q Consensus 64 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--- 139 (420)
.+-++|.+. +.||+|+||+||+|+++.+|+.||||++... ..+.+|+.++.++.+|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 345679876 5699999999999999999999999998532 4578999998776559999999999976
Q ss_pred -CCeEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 140 -RHSVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 140 -~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
...+|+|||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||+|||++..++.+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 46799999999999999999875 369999999999999999999999999999999999999876667889999999
Q ss_pred cccccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCCCC
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFD----AILRGHIDFSSD 291 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~----~i~~~~~~~~~~ 291 (420)
+++...........+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+.+...... .+..+...++..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 9998877666677899999999999875 59999999999999999999999998766444333 344455556555
Q ss_pred CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcc
Q 014704 292 PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPL 338 (420)
Q Consensus 292 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~ 338 (420)
.+..+|+++++||++||+.||++|||+.|+|+||||+........++
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~ 286 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 286 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCEE
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCCc
Confidence 55678999999999999999999999999999999976554444443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-61 Score=454.00 Aligned_cols=253 Identities=30% Similarity=0.600 Sum_probs=231.4
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+++|+.++ ||||+++++++.+...+|+|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence 68999999999999999999999999999999997654434455678999999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCc
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDV 226 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~ 226 (420)
|||+.||+|.+++.+.+.+++..+..++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc--
Confidence 9999999999999999999999999999999999999999999999999999999 55678999999999987543
Q ss_pred eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHH
Q 014704 227 FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVK 305 (420)
Q Consensus 227 ~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 305 (420)
....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+...++..+..+...++ ..+++++.+||+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR 270 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHHH
Confidence 345689999999999865 589999999999999999999999999999999999998876654 368999999999
Q ss_pred HhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 306 KMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 306 ~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
+||+.||.+|+ |++++++||||+.
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhhCHHhccccccccHHHHHcCccccC
Confidence 99999999995 9999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-60 Score=445.73 Aligned_cols=255 Identities=28% Similarity=0.529 Sum_probs=228.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHh-ccCCCCccEEEEEEEeCCeEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHH-LTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~-l~~hpniv~~~~~~~~~~~~~i 145 (420)
++|.+++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++.+ ++ ||||+++++++.+++.+|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~-hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-HPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT-CTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCC-CCcEEEEEEEEccCCceeE
Confidence 579999999999999999999999999999999976543334556777888887764 66 9999999999999999999
Q ss_pred EEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-
Q 014704 146 IMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG- 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~- 224 (420)
|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence 99999999999999999999999999999999999999999999999999999999 56678999999999876533
Q ss_pred CceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHH
Q 014704 225 DVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDI 303 (420)
Q Consensus 225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 303 (420)
......+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+..+++..+..+.+.++. .+|+++++|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dl 233 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDL 233 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHH
Confidence 33455689999999999865 6999999999999999999999999999999999999988766553 689999999
Q ss_pred HHHhcccCcCCCCCHH-HHhcCCcccc
Q 014704 304 VKKMLHADPKERLSAA-EVLNHPWMRV 329 (420)
Q Consensus 304 i~~~L~~dp~~R~t~~-e~l~h~~~~~ 329 (420)
|++||+.||++|||+. ++++||||+.
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 9999999999999996 8999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.4e-60 Score=449.85 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=216.7
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHH---HHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRRE---VQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
++|.+.+.||+|+||.||+|+++.+|+.||||++.+...........+.+| +++++.+. |||||++++++.+.+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEECCEE
Confidence 579999999999999999999999999999999875443222333344444 56666666 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|+|||||+||+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence 9999999999999999999999999999999999999999999999999999999999 5667899999999987654
Q ss_pred CCceecccCCcccccchhhc-c-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 224 GDVFKDLVGSAYYVAPEVLR-R-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
.. ....+||+.|+|||++. + .|+.++|||||||++|+|+||+.||.+........ +.+.........+..+|++++
T Consensus 160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCCSSSCHHHH
T ss_pred Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCCCCCCHHHH
Confidence 43 34568999999999985 3 48999999999999999999999998765432222 222223333333457899999
Q ss_pred HHHHHhcccCcCCCCC-----HHHHhcCCcccc
Q 014704 302 DIVKKMLHADPKERLS-----AAEVLNHPWMRV 329 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t-----~~e~l~h~~~~~ 329 (420)
+||.+||++||++||| ++|+++||||+.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999 899999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-59 Score=435.31 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=214.2
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCCCh--hhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEec
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINR--DDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDL 149 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~ 149 (420)
+++||+|+||+||+|+++.+|+.||||++........ ...+.+.+|+.+|++++ |||||++++++.+++++|+||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEEC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhhh
Confidence 5789999999999999999999999999975433211 12356889999999999 99999999999999999999999
Q ss_pred CCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC-Ccee
Q 014704 150 CAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG-DVFK 228 (420)
Q Consensus 150 ~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~-~~~~ 228 (420)
|.|+++.........+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..... ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCccccc
Confidence 9998877666666779999999999999999999999999999999999999 56778999999999876543 2344
Q ss_pred cccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC---------------
Q 014704 229 DLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD--------------- 291 (420)
Q Consensus 229 ~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------------- 291 (420)
..+||+.|+|||++. ..|+.++||||+||++|+|++|.+||.+.+..+.+..|.+........
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 568999999999875 348999999999999999999999999999888887776421111110
Q ss_pred ---------CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccC
Q 014704 292 ---------PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDG 331 (420)
Q Consensus 292 ---------~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 331 (420)
.++.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0235688999999999999999999999999999998543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-59 Score=428.16 Aligned_cols=252 Identities=31% Similarity=0.560 Sum_probs=217.2
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChh---hHHHHHHHHHHHHhcc-CCCCccEEEEEEEeC
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRD---DVEDVRREVQIMHHLT-GHRNIVELKGAYEDR 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~~E~~~l~~l~-~hpniv~~~~~~~~~ 140 (420)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+....... ...++.+|+.+|++++ .||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 457899999999999999999999999999999999765443221 1234678999999996 489999999999999
Q ss_pred CeEEEEEecCCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 141 HSVNLIMDLCAG-GELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 141 ~~~~iv~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
+.+|+||||+.+ +++.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. +++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec--CCCeEEECccccce
Confidence 999999999986 688888888889999999999999999999999999999999999999962 34679999999998
Q ss_pred ccCCCCceecccCCcccccchhhcc-c-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 220 FFKPGDVFKDLVGSAYYVAPEVLRR-N-YGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.... ......+||+.|+|||++.+ . ++.++||||+||++|+|++|+.||.+. ..+.++...++ +.+|
T Consensus 160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~----~~~s 228 (273)
T d1xwsa_ 160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRVS 228 (273)
T ss_dssp ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCS----SCCC
T ss_pred eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCC----CCCC
Confidence 7543 33456789999999999864 3 567899999999999999999999753 23555555544 3689
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
+++++||++||+.||++|||++|+|+||||+.
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-58 Score=426.29 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=223.5
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-- 141 (420)
.+.++|.+.+.||+|+||+||+|+++.+|+.||||++.+....+......+.+|+.+++.++ ||||+++++++.+.+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA 82 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence 45688999999999999999999999999999999998766656666788999999999999 999999999987654
Q ss_pred --eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 142 --SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 142 --~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+|+|||||+|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.++|+|||.+.
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIAR 159 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCCTTCE
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehhhhhh
Confidence 4899999999999999999999999999999999999999999999999999999999994 56679999999887
Q ss_pred ccCCCC----ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Q 014704 220 FFKPGD----VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWP 294 (420)
Q Consensus 220 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 294 (420)
...... .....+||+.|+|||++.+ .|+.++||||+||++|+|+||++||.+.+..+.+..+.+.....+...++
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 653322 3345689999999999875 58999999999999999999999999999988888888877766666677
Q ss_pred CCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 295 NISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 295 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
.+|+++.+||.+||++||++||+..+.|.|+|.+
T Consensus 240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 8999999999999999999999544555677765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-58 Score=424.69 Aligned_cols=258 Identities=27% Similarity=0.422 Sum_probs=214.9
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|++.+.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+++|++++ |||||++++++.+++.+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence 579999999999999999999999999999999965432 3334578899999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 147 MDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
||||.++.+ +++.. .+.+++..+..++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 80 ~e~~~~~~~-~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 80 FEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EECCSEEHH-HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCC
T ss_pred EeecCCchh-hhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCC
Confidence 999976544 44433 3569999999999999999999999999999999999999 45678999999999876543
Q ss_pred -CceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC----------
Q 014704 225 -DVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSD---------- 291 (420)
Q Consensus 225 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 291 (420)
.......||+.|+|||++.. .++.++||||+||++|+|++|+.||.+.+....+..+.+........
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 33445689999999998753 36889999999999999999999999988877777665421111111
Q ss_pred ---------------CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 292 ---------------PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 292 ---------------~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.++.+|+++++||++||+.||++|||+.|+|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 123568899999999999999999999999999999743
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-57 Score=421.36 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=215.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCC-CceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc--CCCCccEEEEEEEe---
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDT-KQQFACKSISSRKLINRDDVEDVRREVQIMHHLT--GHRNIVELKGAYED--- 139 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~hpniv~~~~~~~~--- 139 (420)
.++|++.+.||+|+||+||+|++..+ ++.||||++..... .......+.+|+.+|+.|. .||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc-cchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999999765 56799999875432 2222334667888887773 39999999999853
Q ss_pred --CCeEEEEEecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecc
Q 014704 140 --RHSVNLIMDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFG 216 (420)
Q Consensus 140 --~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg 216 (420)
...+|++||||.++.+...... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence 3578999999998777544433 3569999999999999999999999999999999999999 566789999999
Q ss_pred cccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----C--
Q 014704 217 LSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID-----F-- 288 (420)
Q Consensus 217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~-----~-- 288 (420)
++.............||+.|+|||++. ..|+.++||||+||++|+|++|++||.+.+..+.+..+...... +
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 998776666667789999999999885 46999999999999999999999999999988887776542110 0
Q ss_pred ----------------CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 289 ----------------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 289 ----------------~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
....+..+++.+++||++||++||++|||+.|+|+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 001234678999999999999999999999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.7e-57 Score=416.77 Aligned_cols=256 Identities=29% Similarity=0.469 Sum_probs=216.0
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.+|++++ ||||+++++++.+++..|++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence 58999999999999999999986 689999999976543 3344578999999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
|||+.++.+..+....+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||.+.......
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc
Confidence 9999887777776667889999999999999999999999999999999999999 556789999999998765432
Q ss_pred ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-------------
Q 014704 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS------------- 290 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------- 290 (420)
......|++.|+|||.+.+ .++.++||||+||++|+|++|+.||.+.+..+.+..+.........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 3345579999999999853 4799999999999999999999999998887777766432111110
Q ss_pred ------------CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccc
Q 014704 291 ------------DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMR 328 (420)
Q Consensus 291 ------------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 328 (420)
...+.+++++++||++||++||++|||+.|+|+||||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 11345788999999999999999999999999999997
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-57 Score=412.99 Aligned_cols=253 Identities=24% Similarity=0.432 Sum_probs=207.5
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+.-.++|.+++.||+|+||+||+|+.+ ..||||++..... +....+.+.+|+.+|++++ |||||++++++. ...
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQ 77 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSS
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-ccE
Confidence 334578999999999999999999764 3599999875443 4556788999999999998 999999999865 456
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+++|||||+||+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVK 154 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSCC-
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEccccceeec
Confidence 89999999999999999765 5699999999999999999999999999999999999994 5678999999999876
Q ss_pred CCC---CceecccCCcccccchhhcc----cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHcCCCCCC-CCC
Q 014704 222 KPG---DVFKDLVGSAYYVAPEVLRR----NYGAEADIWSAGVILYILLSGVPPFWGETEQSIF-DAILRGHIDFS-SDP 292 (420)
Q Consensus 222 ~~~---~~~~~~~gt~~y~aPE~~~~----~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~-~~i~~~~~~~~-~~~ 292 (420)
... .......||+.|||||++.. .|+.++|||||||++|||+||+.||.+.+....+ ..+.++..... ...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 432 23345689999999999852 4789999999999999999999999886655444 44444432221 223
Q ss_pred CCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 293 WPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 293 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
...+++++.+||.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 45789999999999999999999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-56 Score=412.94 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=213.4
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+.-.++|++.+.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+++|++++ |||||++++++.+++.
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPP 87 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCC-CCCEecCCccEeeCCe
Confidence 444578999999999999999999999999999999986532 34577999999999999 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
+|+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceee
Confidence 99999999999999998764 568999999999999999999999999999999999999 4567899999999987
Q ss_pred cCCCCc--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 221 FKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPF-WGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 221 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
...... .....||+.|+|||++. +.|+.++|||||||++|||++|..|| .+.+...+.+.+..+ ... +....+
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~--~~~~~~ 241 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRM--ERPEGC 241 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCC--CCCTTC
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCC--CCCccc
Confidence 654432 22345889999999886 56999999999999999999966554 555566666555554 222 223578
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
++++++||.+||+.||++|||+.|+++
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999999965
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=421.00 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=213.9
Q ss_pred cccccceeecceecccCCeEEEEEEEcCCCc-----eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKDTKQ-----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
+.-.++|.+++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|.++.+|||||++++++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 3345789999999999999999999876543 69999886543 2344567899999999995599999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccC
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKG-----------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDL 194 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dl 194 (420)
.+.+.+|+|||||+||+|.+++.... .+++..+..++.||+.||+|||++||+||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 99999999999999999999997542 4889999999999999999999999999999
Q ss_pred CCCcEEEecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCC
Q 014704 195 KPENFLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPF 269 (420)
Q Consensus 195 kp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf 269 (420)
||+|||++ .++.+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |..||
T Consensus 191 Kp~Nill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 191 AARNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp SGGGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred chhccccc---cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999994 567899999999987654332 23456899999999885 569999999999999999998 89999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 270 WGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 270 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.+.+....+..+......++. ...+|+++++||.+||+.||++|||++|+++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 887766666666666554433 34689999999999999999999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-56 Score=411.79 Aligned_cols=250 Identities=23% Similarity=0.388 Sum_probs=205.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCc---eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQ---QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.++|++.+.||+|+||+||+|.++.+++ .||||.+.... .....+.+.+|+++|++++ |||||++++++.+++.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCE
Confidence 4679999999999999999999987664 58888875432 4456678999999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence 99999999999999988764 469999999999999999999999999999999999999 56778999999999876
Q ss_pred CCCCce------ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q 014704 222 KPGDVF------KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPW 293 (420)
Q Consensus 222 ~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 293 (420)
...... ....||+.|||||++. +.|+.++|||||||++|||+| |..||.+.+..++...+..+... +..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL---PPP 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence 543221 1245789999999986 469999999999999999998 89999999998888888775432 123
Q ss_pred CCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 294 PNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 294 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
..+++++.+||.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 4689999999999999999999999999764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-56 Score=415.46 Aligned_cols=260 Identities=27% Similarity=0.450 Sum_probs=215.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe------
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED------ 139 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~------ 139 (420)
-++|.+.+.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|++++ ||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence 3789999999999999999999999999999999876543 3345577889999999998 9999999998754
Q ss_pred --CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 140 --RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 140 --~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
++.+|+|||||.++.+.........+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecce
Confidence 45689999999887776655566789999999999999999999999999999999999999 5667899999999
Q ss_pred ccccCCCC-----ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Q 014704 218 SVFFKPGD-----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSS 290 (420)
Q Consensus 218 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 290 (420)
+....... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+.......+.+....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 97664322 2234579999999998753 5899999999999999999999999998888777776654333332
Q ss_pred CCCCC----------------------------CChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 291 DPWPN----------------------------ISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 291 ~~~~~----------------------------~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
..+.. .++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 22211 26778999999999999999999999999999853
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=408.91 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=207.8
Q ss_pred ceecccCCeEEEEEEEcC--CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEEEecC
Q 014704 73 RELGRGQFGVTYLVTHKD--TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLIMDLC 150 (420)
Q Consensus 73 ~~lG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv~e~~ 150 (420)
+.||+|+||+||+|.++. +++.||||++.... .+....+.+.+|+++|++++ |||||++++++.++ ..|+|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC-CEEEEEEcC
Confidence 479999999999998653 45789999986543 24455678999999999998 99999999998654 578999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCCce---
Q 014704 151 AGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGDVF--- 227 (420)
Q Consensus 151 ~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~~~--- 227 (420)
+||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++........
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhhhhcccccccccc
Confidence 9999999999989999999999999999999999999999999999999995 4667999999999876544322
Q ss_pred -ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHH
Q 014704 228 -KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIV 304 (420)
Q Consensus 228 -~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 304 (420)
....||+.|||||++. +.++.++|||||||++|||+| |..||.+.+..++...+.++.... ....+|+++.+||
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~~~~li 243 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYDLM 243 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHH
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHHHH
Confidence 2346899999999985 468999999999999999998 999999999888888888764321 1246899999999
Q ss_pred HHhcccCcCCCCCHHHH---hcCCcc
Q 014704 305 KKMLHADPKERLSAAEV---LNHPWM 327 (420)
Q Consensus 305 ~~~L~~dp~~R~t~~e~---l~h~~~ 327 (420)
.+||+.||++|||+.++ |+|+|+
T Consensus 244 ~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 99999999999999998 456554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-56 Score=403.82 Aligned_cols=246 Identities=24% Similarity=0.440 Sum_probs=204.7
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+.+.||+|+||+||+|.++. ++.||||++.... ...+.+.+|++++++++ ||||+++++++.+++.+|+|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc----CcHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence 579999999999999999999874 6789999987533 23467999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC---------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCC
Confidence 9999999999988765 558999999999999999999999999999999999999 556789999999998765433
Q ss_pred c--eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 226 V--FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 226 ~--~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
. .....||+.|+|||++.+ .|+.++|||||||++|||+| |.+||...+..++...+..+..... ....++++.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~ 232 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVY 232 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHH
Confidence 2 234578999999999874 69999999999999999999 6777888888888888887644322 245789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+||.+||+.||++|||++|+++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-56 Score=407.76 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=215.2
Q ss_pred ccceeecce-ecccCCeEEEEEEEcCC--CceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 66 RNTYIFGRE-LGRGQFGVTYLVTHKDT--KQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 66 ~~~y~~~~~-lG~G~~g~V~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+++|.+.+. ||+|+||+||+|.++.+ +..||||++... ......+.+.+|+++|++++ |||||++++++.++ .
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~-~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAE-A 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeeccC-e
Confidence 357888885 99999999999987643 457999998653 24556788999999999998 99999999998754 5
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhcc
Confidence 89999999999999987654 5799999999999999999999999999999999999995 4567999999999877
Q ss_pred CCCCce----ecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 222 KPGDVF----KDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 222 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
...... ....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.+..++...+.++.... ..+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~ 236 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPE 236 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTT
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCc
Confidence 544322 2346899999999986 569999999999999999998 999999988888888888765322 2257
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHH---hcCCcccc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEV---LNHPWMRV 329 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~---l~h~~~~~ 329 (420)
+|+++.+||.+||+.||++|||+.++ |+|+|+..
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 89999999999999999999999888 56777753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=418.09 Aligned_cols=253 Identities=29% Similarity=0.439 Sum_probs=211.6
Q ss_pred ceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe------CC
Q 014704 68 TYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED------RH 141 (420)
Q Consensus 68 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~------~~ 141 (420)
+|...++||+|+||+||+|+++.+|+.||||++..... ...+|+.+|++++ ||||++++++|.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCce
Confidence 69999999999999999999999999999999975432 2347999999998 9999999999853 34
Q ss_pred eEEEEEecCCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 142 SVNLIMDLCAGGELFDR---IIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~---l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
++|+|||||+++.+... ......+++..++.++.||+.||+|||++||+||||||+|||++. +...+||+|||++
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~--~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TTCCEEECCCTTC
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec--CCCceeEecccch
Confidence 58999999987643322 234567999999999999999999999999999999999999952 3357999999999
Q ss_pred cccCCCCceecccCCcccccchhhc--ccCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLR--RNYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRG------------ 284 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~------------ 284 (420)
............+||+.|+|||.+. ..|+.++||||+||++|+|++|..||.+.+....+..+.+.
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 9887776667789999999999874 35899999999999999999999999988877776665431
Q ss_pred -----CCCCC--------CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 285 -----HIDFS--------SDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 285 -----~~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
...++ ....+.+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 01111 11134578999999999999999999999999999999754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-56 Score=406.76 Aligned_cols=254 Identities=20% Similarity=0.342 Sum_probs=215.6
Q ss_pred ccccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH 141 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 141 (420)
++.-.++|++.+.||+|+||.||+|.++ +++.||||++.... ...+.+.+|+.++++++ |||||++++++.+ +
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCC-CCCEeEEEeeecc-C
Confidence 3445678999999999999999999986 46789999986532 23467999999999998 9999999998754 5
Q ss_pred eEEEEEecCCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 142 SVNLIMDLCAGGELFDRIIAK--GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ ++++.+||+|||+|+
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLAR 157 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceE
Confidence 679999999999999876533 359999999999999999999999999999999999999 567789999999999
Q ss_pred ccCCCCc--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 220 FFKPGDV--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 220 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
....... .....||+.|+|||++. +.++.++|||||||++|||+| |.+||...+..+++..+..+..... ...
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~ 234 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDN 234 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTT
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---ccc
Confidence 8765432 23457899999999986 469999999999999999999 5666777778888888877643322 246
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhc--CCccc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLN--HPWMR 328 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~ 328 (420)
+++++.+||.+||+.||++|||+.++++ |+||.
T Consensus 235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 8999999999999999999999999987 77775
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=399.19 Aligned_cols=246 Identities=24% Similarity=0.412 Sum_probs=216.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|.+++.||+|+||+||+|+++ +++.||||++++... ..+.+.+|+.++++++ ||||+++++++.+++.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence 57899999999999999999985 678999999976433 3467999999999998 99999999999999999999
Q ss_pred EecCCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC
Q 014704 147 MDLCAGGELFDRIIA-KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~ 225 (420)
|||+++|+|.+++.. ...+++..+..++.||++||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCC
Confidence 999999999988665 4569999999999999999999999999999999999999 567789999999998765433
Q ss_pred c--eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHH
Q 014704 226 V--FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSAK 301 (420)
Q Consensus 226 ~--~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 301 (420)
. .....||+.|+|||++. ..++.++|||||||++|||+| |+.||.+.+..++...+..+..... ....++++.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~ 231 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY 231 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---cccccHHHH
Confidence 2 23457899999999986 469999999999999999998 8999999999999988887643322 246789999
Q ss_pred HHHHHhcccCcCCCCCHHHHhcC
Q 014704 302 DIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 302 ~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+||++||+.||++|||+.++++|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=418.92 Aligned_cols=258 Identities=28% Similarity=0.447 Sum_probs=213.3
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-- 141 (420)
++.++|++.+.||+|+||+||+|.++.+|+.||||++.+.. .+....+.+.+|+.+|+.++ |||||+++++|...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL 92 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCccc
Confidence 46789999999999999999999999999999999997543 35556778999999999998 999999999997654
Q ss_pred ----eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccc
Q 014704 142 ----SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGL 217 (420)
Q Consensus 142 ----~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~ 217 (420)
.+|+||||| |.+|...+ +.+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGL 167 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred cccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccc
Confidence 579999999 66676654 56789999999999999999999999999999999999999 5677899999999
Q ss_pred ccccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------
Q 014704 218 SVFFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHI--------- 286 (420)
Q Consensus 218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~--------- 286 (420)
++.... ......||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+....+..+.....
T Consensus 168 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 168 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 987643 3456789999999998854 478999999999999999999999998887666554433111
Q ss_pred --------------CCCC----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCccccc
Q 014704 287 --------------DFSS----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVD 330 (420)
Q Consensus 287 --------------~~~~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 330 (420)
.... ...+.+++++.+||++||+.||++|||+.|+|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1111 1234678999999999999999999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-56 Score=416.76 Aligned_cols=260 Identities=29% Similarity=0.526 Sum_probs=218.5
Q ss_pred cceeecceecccCCeEEEEEEE---cCCCceEEEEEecCCcCC-ChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 67 NTYIFGRELGRGQFGVTYLVTH---KDTKQQFACKSISSRKLI-NRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~---~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
++|++++.||+|+||+||+|.+ +.+|+.||||++.+.... +....+.+.+|+++++++++||||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999997 447899999998754332 223346788999999999956999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 143 VNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+++||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999 556789999999998764
Q ss_pred CC--CceecccCCcccccchhhcc---cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 223 PG--DVFKDLVGSAYYVAPEVLRR---NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 223 ~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.. .......|++.|+|||.+.+ .++.++|||||||+||+|++|..||.+.........+.+............+|
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 32 23345679999999999853 47889999999999999999999998765444444443332222223334689
Q ss_pred hHHHHHHHHhcccCcCCCC-----CHHHHhcCCcccc
Q 014704 298 SSAKDIVKKMLHADPKERL-----SAAEVLNHPWMRV 329 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~ 329 (420)
+++.+||++||++||++|| |++|+|+||||+.
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999999 5899999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-55 Score=413.56 Aligned_cols=253 Identities=26% Similarity=0.525 Sum_probs=212.0
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe--CCeE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED--RHSV 143 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~--~~~~ 143 (420)
.++|++.+.||+|+||+||+|+++.+|+.||||++... ..+.+.+|+.+|+.+.+||||+++++++.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 46899999999999999999999999999999998642 246789999999999779999999999974 4569
Q ss_pred EEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 144 NLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
++|||||.+++|... .+.+++..+..++.||+.||.|||++||+||||||+|||++. ++..+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--CCCeeeecccccceeccC
Confidence 999999999999765 357999999999999999999999999999999999999963 344699999999998877
Q ss_pred CCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHc-------------CCCC
Q 014704 224 GDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETE-QSIFDAILR-------------GHID 287 (420)
Q Consensus 224 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~-------------~~~~ 287 (420)
.......+||+.|+|||.+.+ .++.++||||+||++|+|++|..||..... ......+.. ....
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 666677889999999998754 489999999999999999999999976543 222221110 0000
Q ss_pred --------------------CCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 288 --------------------FSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 288 --------------------~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.....+..+++++.+||++||+.||++|||++|+|+||||+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011122347899999999999999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=401.07 Aligned_cols=258 Identities=25% Similarity=0.453 Sum_probs=220.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
++|++.+.||+|+||+||+|+++.+|+.||||+++.... .......+.+|+.+|+.++ ||||+++++++.+...+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence 479999999999999999999999999999999976543 4456788999999999999 99999999999999999999
Q ss_pred EecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCCC-
Q 014704 147 MDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPGD- 225 (420)
Q Consensus 147 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~- 225 (420)
++++.|++|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++ .+..+||+|||.+.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~---~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc---cCCceeeeecchhhcccCCCc
Confidence 99999999988888888999999999999999999999999999999999999994 56679999999998765433
Q ss_pred ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCC--------------
Q 014704 226 VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPF-WGETEQSIFDAILRGHIDF-------------- 288 (420)
Q Consensus 226 ~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~-------------- 288 (420)
......+++.|+|||++.. .++.++||||+||++|+|++|+.|| .+.+..+.+..+.......
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 3344567889999998854 3789999999999999999999885 4555565555553311110
Q ss_pred -----------CCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 289 -----------SSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 289 -----------~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
.....+.+++.+.+||++||+.||++|||++|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 11123457889999999999999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-55 Score=414.31 Aligned_cols=262 Identities=29% Similarity=0.469 Sum_probs=212.0
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC--
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH-- 141 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-- 141 (420)
++.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|++++ ||||+++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecccc
Confidence 35578999999999999999999999999999999996533 3455678899999999998 999999999987653
Q ss_pred --eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 142 --SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 142 --~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
..+++++|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLAR 157 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred ccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCcee
Confidence 23344455668999998865 579999999999999999999999999999999999999 456789999999998
Q ss_pred ccCCCC----ceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------
Q 014704 220 FFKPGD----VFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHID------ 287 (420)
Q Consensus 220 ~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~------ 287 (420)
...... .....+||+.|+|||++.. .++.++||||+||++|+|++|..||.+.+..............
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 754322 2345679999999999843 4789999999999999999999999888765555443221000
Q ss_pred --------------CC---C----CCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 288 --------------FS---S----DPWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 288 --------------~~---~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
.+ . ..++.+++++++||.+||+.||++|||+.|+|+||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 00 0 124567899999999999999999999999999999985443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=396.84 Aligned_cols=251 Identities=26% Similarity=0.366 Sum_probs=204.5
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCC---ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTK---QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR 140 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 140 (420)
.-.++|.+++.||+|+||.||+|++..++ ..||||.+... ......+.+.+|+.+|++++ ||||+++++++. +
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-E 79 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-S
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-c
Confidence 34578999999999999999999987543 46888887543 24555678999999999998 999999999985 4
Q ss_pred CeEEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 141 HSVNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 141 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
+.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSR 156 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-----
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchhhe
Confidence 6789999999999999887654 5699999999999999999999999999999999999995 45679999999998
Q ss_pred ccCCCC--ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 220 FFKPGD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 220 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
...... ......||+.|+|||++. +.|+.++|||||||++|||++ |.+||.+.+..++...+..+... +.++.
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~ 233 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPN 233 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTT
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCC
Confidence 765432 223456899999999986 469999999999999999998 89999999988888888876532 23457
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+|+++.+||.+||..||++|||+.|+++|
T Consensus 234 ~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=411.34 Aligned_cols=260 Identities=27% Similarity=0.409 Sum_probs=215.0
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeC----
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDR---- 140 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~---- 140 (420)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.+.. .+....+.+.+|+.+|++++ ||||+++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE 93 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTT
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccccc
Confidence 4578999999999999999999999999999999997543 34555678999999999998 99999999998633
Q ss_pred -CeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccc
Q 014704 141 -HSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSV 219 (420)
Q Consensus 141 -~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~ 219 (420)
...+++|+|+.||+|.+++. .+++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|++|||++.
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR 169 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----
T ss_pred cCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhc
Confidence 33456677778999998774 4679999999999999999999999999999999999999 566789999999987
Q ss_pred ccCCCCceecccCCcccccchhhcc--cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--------
Q 014704 220 FFKPGDVFKDLVGSAYYVAPEVLRR--NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGHIDFS-------- 289 (420)
Q Consensus 220 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------- 289 (420)
... .......||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+.......+.+......
T Consensus 170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 643 33455689999999998654 478999999999999999999999999888777776654322111
Q ss_pred ---------------CC----CCCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCC
Q 014704 290 ---------------SD----PWPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGD 332 (420)
Q Consensus 290 ---------------~~----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 332 (420)
.. .+..+++++++||++||+.||++|||+.|+|+||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 00 13467899999999999999999999999999999985443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=392.56 Aligned_cols=248 Identities=22% Similarity=0.376 Sum_probs=204.1
Q ss_pred cceeecceecccCCeEEEEEEEcCCC----ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTK----QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
+.|.+.++||+|+||.||+|.++.++ ..||||++.... .......+.+|+++|++++ |||||++++++.+.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence 56999999999999999999987654 469999986432 4455667899999999998 9999999999999999
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.++|||||.++++.+.+... +.+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhcc
Confidence 99999999999999877655 569999999999999999999999999999999999999 56778999999999876
Q ss_pred CCCC----ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCC
Q 014704 222 KPGD----VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAILRGHIDFSSDPWPN 295 (420)
Q Consensus 222 ~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 295 (420)
.... ......||+.|||||++. +.++.++|||||||++|||++| .+||...+..+++..+..+... + ....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~--~~~~ 237 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-P--TPMD 237 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-C--CCTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC-C--Cchh
Confidence 4432 223356899999999986 4699999999999999999995 5556667777787777765332 2 2246
Q ss_pred CChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 296 ISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 296 ~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
++.++.+||.+||+.||++|||+.|+++
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 8899999999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=392.21 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=209.3
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~i 145 (420)
.++|++++.||+|+||+||+|+++.+ +.||||++.... ...+.+.+|+.++++++ |||||++++++.+ +.+|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc----CCHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCeEE
Confidence 46899999999999999999999765 579999986543 23467999999999999 9999999999854 56789
Q ss_pred EEecCCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 146 IMDLCAGGELFDRIIA--KGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
|||||++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED 165 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC----
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccC
Confidence 9999999999888754 3569999999999999999999999999999999999999 4567899999999987654
Q ss_pred CC--ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChH
Q 014704 224 GD--VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAILRGHIDFSSDPWPNISSS 299 (420)
Q Consensus 224 ~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 299 (420)
.. ......||+.|+|||++. +.++.++|||||||++|||++| .+||.+....+++..+.++... +..+.++++
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---~~~~~~~~~ 242 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPES 242 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTSCHH
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---CCCcccCHH
Confidence 33 223457899999999986 5699999999999999999995 5566677777788877765322 223578999
Q ss_pred HHHHHHHhcccCcCCCCCHHHHhc--CCcccccC
Q 014704 300 AKDIVKKMLHADPKERLSAAEVLN--HPWMRVDG 331 (420)
Q Consensus 300 ~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~~ 331 (420)
+++||.+||+.||++|||+.++++ ++||....
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 999999999999999999999988 88997544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=409.23 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=203.4
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-----
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED----- 139 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~----- 139 (420)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.+.. .+......+.+|+.+|++++ ||||++++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEecccccc
Confidence 4468999999999999999999999999999999997654 35566678999999999998 9999999999953
Q ss_pred -CCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccc
Q 014704 140 -RHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLS 218 (420)
Q Consensus 140 -~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~ 218 (420)
..++|+|||||.|+.+ +.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|++|||++
T Consensus 93 ~~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 93 EFQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 166 (355)
T ss_dssp TCCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-
T ss_pred cCceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhh
Confidence 4789999999976544 444 4579999999999999999999999999999999999999 55677999999999
Q ss_pred cccCCCCceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------
Q 014704 219 VFFKPGDVFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAILRGH------------ 285 (420)
Q Consensus 219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~------------ 285 (420)
+...........+||+.|+|||++.+ .+++++||||+||++|+|++|++||.+.+.......+....
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 88776666677789999999999864 58999999999999999999999999888766665553211
Q ss_pred ----------CCCCCCC----------------CCCCChHHHHHHHHhcccCcCCCCCHHHHhcCCcccc
Q 014704 286 ----------IDFSSDP----------------WPNISSSAKDIVKKMLHADPKERLSAAEVLNHPWMRV 329 (420)
Q Consensus 286 ----------~~~~~~~----------------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 329 (420)
....... ....++++.+||++||..||++||||+|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 1111000 0113567899999999999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=401.09 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=210.6
Q ss_pred cceeecceecccCCeEEEEEEEcCCCce--EEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQ--FACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
++|++.+.||+|+||.||+|.++.+|.. ||||.+... ......+.+.+|+++|+++.+|||||++++++.+++.+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 5799999999999999999999988865 667776432 233455679999999999955999999999999999999
Q ss_pred EEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCC
Q 014704 145 LIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDS 208 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~ 208 (420)
+|||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.+.
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence 999999999999998654 569999999999999999999999999999999999999 4567
Q ss_pred CeeEeecccccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCC-CCCCCCCHHHHHHHHHcCCC
Q 014704 209 PLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGV-PPFWGETEQSIFDAILRGHI 286 (420)
Q Consensus 209 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~-~pf~~~~~~~~~~~i~~~~~ 286 (420)
.+||+|||+++............||+.|+|||.+. +.|+.++|||||||++|||++|. +||.+.+..++...+.++..
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 79999999998765444444567999999999986 46999999999999999999964 67888888888888776532
Q ss_pred CCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 287 DFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 287 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
.+.+..+++++++||.+||+.||++|||+.++++|
T Consensus 245 ---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22235789999999999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-54 Score=391.44 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=204.1
Q ss_pred cceeecceecccCCeEEEEEEEcCC-C--ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDT-K--QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~-~--~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
++|++.+.||+|+||.||+|++..+ + ..||||++.+.........+.+.+|+.+|++++ ||||+++++++.+ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cch
Confidence 5699999999999999999987533 3 368999987765555566788999999999998 9999999999976 467
Q ss_pred EEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 144 NLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 144 ~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
++|||||++|++.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++. +..+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~---~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE---TTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc---ccceeeccchhhhhcc
Confidence 8999999999999877654 56999999999999999999999999999999999999954 5679999999999875
Q ss_pred CCCc----eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 223 PGDV----FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 223 ~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
.... .....|+..|+|||++.+ .++.++|||||||++|||+| |..||.+.+..+....+.+....++. .+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--cccc
Confidence 4332 123467889999999864 58999999999999999998 89999999999999998887655433 3578
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
|+++++||.+||..||++|||+.++++
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=397.92 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=206.2
Q ss_pred cceeecceecccCCeEEEEEEEcCCCc----eEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCe
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQ----QFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHS 142 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 142 (420)
.+|++.+.||+|+||+||+|.+..+|+ .||+|.+... .+....+.+.+|+.++++++ |||||++++++.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-C
Confidence 469999999999999999999988876 5788877533 23445678999999999998 99999999999865 4
Q ss_pred EEEEEecCCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeeccccccc
Q 014704 143 VNLIMDLCAGGELFDRIIAK-GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFF 221 (420)
Q Consensus 143 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~ 221 (420)
.+++|||+.+++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeeccccceec
Confidence 67888999999999887764 5699999999999999999999999999999999999995 4567999999999876
Q ss_pred CCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCC
Q 014704 222 KPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNI 296 (420)
Q Consensus 222 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 296 (420)
..... .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+.+..++...+..+.... ..+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~p~~~ 238 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPIC 238 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC---CCTTB
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCccc
Confidence 54332 23346899999999885 469999999999999999998 899999888888877777764321 12468
Q ss_pred ChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 297 SSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 297 ~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
++++.+||.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=395.61 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=200.8
Q ss_pred ccccceeecceecccCCeEEEEEEEcC-----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE 138 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 138 (420)
.-.++|.+++.||+|+||.||+|.+.. +++.||||++.... .....+.+.+|+.++.++.+|+||+.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 345789999999999999999999764 34689999986432 34556778899999999877999999999876
Q ss_pred e-CCeEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEE
Q 014704 139 D-RHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLF 201 (420)
Q Consensus 139 ~-~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill 201 (420)
. ...+++|||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 5 45689999999999999999753 248899999999999999999999999999999999999
Q ss_pred ecCCCCCCeeEeecccccccCCCC---ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhC-CCCCCCCCHHH
Q 014704 202 SSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSG-VPPFWGETEQS 276 (420)
Q Consensus 202 ~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g-~~pf~~~~~~~ 276 (420)
+.++.+||+|||+|+...... ......||+.|+|||++.+ .++.++|||||||++|||++| .+||.+.....
T Consensus 168 ---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 168 ---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp ---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 456789999999998654332 2234579999999999864 589999999999999999986 56787765444
Q ss_pred -HHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 277 -IFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 277 -~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
....+..+. .+. ....+++++++||.+||+.||++|||+.|+++|
T Consensus 245 ~~~~~~~~~~-~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLKEGT-RMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCC-CCC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 344444432 222 224689999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-53 Score=392.24 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=216.0
Q ss_pred cccccceeecceecccCCeEEEEEEEcC-----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEE
Q 014704 63 EDVRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAY 137 (420)
Q Consensus 63 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 137 (420)
+.-+++|.+.+.||+|+||+||+|+++. +++.||||++.... .....+.+.+|+.+|++++ ||||+++++++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~ 85 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVC 85 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEE
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeee
Confidence 4446789999999999999999999763 56789999986433 3455678999999999998 99999999999
Q ss_pred EeCCeEEEEEecCCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecc
Q 014704 138 EDRHSVNLIMDLCAGGELFDRIIAKG------------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRD 193 (420)
Q Consensus 138 ~~~~~~~iv~e~~~g~~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~D 193 (420)
.+.+..++||||+.+|+|.+++.... .+++..+..++.|++.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999986532 378899999999999999999999999999
Q ss_pred CCCCcEEEecCCCCCCeeEeecccccccCCCC---ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCC-CC
Q 014704 194 LKPENFLFSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGV-PP 268 (420)
Q Consensus 194 lkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~-~p 268 (420)
|||+|||+ +.++.+||+|||+++...... ......||+.|+|||.+.+ .|+.++|||||||++|||++|. +|
T Consensus 166 lKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 166 LATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999 456789999999998664332 2234678999999999865 6999999999999999999985 78
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 269 FWGETEQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 269 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
|.+.+..++...+..+.... ....+++++.+||.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~e~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999888876432 22478999999999999999999999999954
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=388.37 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=211.9
Q ss_pred ccccceeecceecccCCeEEEEEEEcCCC-------ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE
Q 014704 64 DVRNTYIFGRELGRGQFGVTYLVTHKDTK-------QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (420)
Q Consensus 64 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 136 (420)
.-.++|.+++.||+|+||.||+|++..++ ..||||++.+.. .......+.+|+..+.++.+|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 34578999999999999999999986554 479999986533 445567899999999999569999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEE
Q 014704 137 YEDRHSVNLIMDLCAGGELFDRIIAK----------------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFL 200 (420)
Q Consensus 137 ~~~~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil 200 (420)
+.+++.+++|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999999999999754 34899999999999999999999999999999999999
Q ss_pred EecCCCCCCeeEeecccccccCCCC---ceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHH
Q 014704 201 FSSSAEDSPLKATDFGLSVFFKPGD---VFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQ 275 (420)
Q Consensus 201 l~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~ 275 (420)
+ +.++.+||+|||+++...... ......||+.|+|||.+. +.|+.++|||||||++|+|++ |.+||.+.+..
T Consensus 168 l---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 168 V---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp E---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred e---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 9 566789999999998764432 223457899999999885 569999999999999999998 79999999988
Q ss_pred HHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 276 SIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 276 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.++..+..+.. ++. ...+++++.+||.+||+.||++|||+.|+++
T Consensus 245 ~~~~~i~~~~~-~~~--p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 245 ELFKLLKEGHR-MDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHTTCC-CCC--CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCC-CCC--CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 88888776532 222 2468999999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=383.75 Aligned_cols=243 Identities=22% Similarity=0.376 Sum_probs=201.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEE-eCCeEE
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYE-DRHSVN 144 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~-~~~~~~ 144 (420)
.++|++++.||+|+||.||+|+++ |..||||+++.. ...+.+.+|++++++++ ||||+++++++. +.+.+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCcEE
Confidence 467999999999999999999984 678999998643 23467999999999998 999999999885 456789
Q ss_pred EEEecCCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccC
Q 014704 145 LIMDLCAGGELFDRIIAKG--HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFK 222 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~ 222 (420)
+||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++...
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecC
Confidence 9999999999999987653 48999999999999999999999999999999999999 567789999999998754
Q ss_pred CCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCCCChHH
Q 014704 223 PGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGETEQSIFDAILRGHIDFSSDPWPNISSSA 300 (420)
Q Consensus 223 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 300 (420)
.. .....+|+.|+|||++. +.++.++|||||||++|||+| |.+||...+..++...+.++... + ..+.+++++
T Consensus 155 ~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~-~--~~~~~~~~~ 229 (262)
T d1byga_ 155 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-D--APDGCPPAV 229 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-C--CCTTCCHHH
T ss_pred CC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-C--CCccCCHHH
Confidence 32 34457899999999885 569999999999999999998 79999988888888887665322 1 224678999
Q ss_pred HHHHHHhcccCcCCCCCHHHHhcC
Q 014704 301 KDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 301 ~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
++||++||..||++|||+.+++++
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999999764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-52 Score=385.92 Aligned_cols=255 Identities=27% Similarity=0.380 Sum_probs=213.8
Q ss_pred ccccccceeecceecccCCeEEEEEEEc-----CCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHK-----DTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 136 (420)
++.-.++|.+++.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+++++.+|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444579999999999999999999863 456789999997543 345567899999999999669999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCc
Q 014704 137 YEDRHSVNLIMDLCAGGELFDRIIAKG------------------HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPEN 198 (420)
Q Consensus 137 ~~~~~~~~iv~e~~~g~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 198 (420)
+.+...+|+|||||+||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999987643 58999999999999999999999999999999999
Q ss_pred EEEecCCCCCCeeEeecccccccCCCCc---eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 014704 199 FLFSSSAEDSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLS-GVPPFWGET 273 (420)
Q Consensus 199 ill~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~-g~~pf~~~~ 273 (420)
|+++ .++.+||+|||.++....... .....||+.|+|||++. +.++.++|||||||++|+|+| |.+||.+..
T Consensus 176 Il~~---~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 176 ILLT---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEEE---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccc---ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9994 566799999999987654322 23457899999999986 568999999999999999998 677777766
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 274 EQSIFDAILRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 274 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
....+..+......... ...+++++.+||.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 65555555444333322 2467899999999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=382.22 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=217.4
Q ss_pred ccccccceeecceecccCCeEEEEEEEcC-----CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEE
Q 014704 62 MEDVRNTYIFGRELGRGQFGVTYLVTHKD-----TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGA 136 (420)
Q Consensus 62 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 136 (420)
++.-.++|.+++.||+|+||.||+|.++. ++..||||++.... .......+.+|+.++++++ ||||++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~~ 91 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGV 91 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeeeE
Confidence 34456899999999999999999999853 35789999986432 4455677999999999999 9999999999
Q ss_pred EEeCCeEEEEEecCCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCC
Q 014704 137 YEDRHSVNLIMDLCAGGELFDRIIAK----------GHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAE 206 (420)
Q Consensus 137 ~~~~~~~~iv~e~~~g~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~ 206 (420)
+..++..++|||||.+|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+ +.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~ 168 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AE 168 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cC
Confidence 99999999999999999999988643 247889999999999999999999999999999999999 56
Q ss_pred CCCeeEeecccccccCCCCc---eecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhC-CCCCCCCCHHHHHHHH
Q 014704 207 DSPLKATDFGLSVFFKPGDV---FKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSG-VPPFWGETEQSIFDAI 281 (420)
Q Consensus 207 ~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g-~~pf~~~~~~~~~~~i 281 (420)
+..+||+|||+++....... .....||+.|+|||.+.+ .++.++||||||+++|||+|| .+||.+.+..+.+..+
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 78899999999987644322 233468999999999864 588999999999999999998 5889999999999988
Q ss_pred HcCCCCCCCCCCCCCChHHHHHHHHhcccCcCCCCCHHHHhc
Q 014704 282 LRGHIDFSSDPWPNISSSAKDIVKKMLHADPKERLSAAEVLN 323 (420)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 323 (420)
.++..... .+.+++.+.++|.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 249 MEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 87654222 2468899999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-52 Score=384.44 Aligned_cols=258 Identities=21% Similarity=0.291 Sum_probs=205.9
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
+.++|++.+.||+|+||.||+|+++.+|+.||||++..... ...+.+|+++++.+.+|++|+.+.+++.+.+.++
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 45789999999999999999999999999999999875432 1347899999999995666777778888999999
Q ss_pred EEEecCCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCC
Q 014704 145 LIMDLCAGGELFDRII-AKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKP 223 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~ 223 (420)
+|||||. ++|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||+...+.+..+||+|||+|+....
T Consensus 80 ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9999995 56655554 456799999999999999999999999999999999999997666677899999999987654
Q ss_pred CC--------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---cCCCCCC-C
Q 014704 224 GD--------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGETEQSIFDAIL---RGHIDFS-S 290 (420)
Q Consensus 224 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~~~~~~~~i~---~~~~~~~-~ 290 (420)
.. ......||+.|||||++.+ .++.++|||||||++|+|++|..||.+.........+. ......+ .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 32 2234579999999999875 59999999999999999999999998765443332221 1111111 1
Q ss_pred CCCCCCChHHHHHHHHhcccCcCCCCCHHH---HhcCCccc
Q 014704 291 DPWPNISSSAKDIVKKMLHADPKERLSAAE---VLNHPWMR 328 (420)
Q Consensus 291 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e---~l~h~~~~ 328 (420)
...+.+|+++.+||.+||+.||++||++.+ +|+|+|.+
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 113468999999999999999999999875 46777654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=376.29 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=202.0
Q ss_pred eecceecccCCeEEEEEEEcCCC---ceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEe-CCeEEE
Q 014704 70 IFGRELGRGQFGVTYLVTHKDTK---QQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYED-RHSVNL 145 (420)
Q Consensus 70 ~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-~~~~~i 145 (420)
.+.++||+|+||+||+|.+..++ ..||||++.. ..+....+.+.+|+++|++++ ||||+++++++.+ ++.+++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC--CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEE
Confidence 44688999999999999987643 3589999864 235566788999999999999 9999999999765 568999
Q ss_pred EEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEeecccccccCCC
Q 014704 146 IMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVFFKPG 224 (420)
Q Consensus 146 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~~~~~ 224 (420)
|||||++|+|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||+ +++..+||+|||+++.....
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTT
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccc
Confidence 999999999999887543 57788999999999999999999999999999999999 56778999999999876543
Q ss_pred Cc-----eecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCCCCCCCCCCC
Q 014704 225 DV-----FKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGE-TEQSIFDAILRGHIDFSSDPWPNIS 297 (420)
Q Consensus 225 ~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 297 (420)
.. .....||+.|+|||.+. +.++.++||||||+++|||+||..||... +..+....+..+..... .+.++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~---p~~~~ 260 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYCP 260 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC---CTTCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---cccCc
Confidence 22 12346899999999876 56999999999999999999977777544 34455666666643322 24678
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
+++.+||.+||+.||++|||+.|+++|
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999877
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-49 Score=367.86 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=207.3
Q ss_pred cccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEE
Q 014704 65 VRNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVN 144 (420)
Q Consensus 65 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 144 (420)
+.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|++.++.+.+|+|++.+++++.+....+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 46789999999999999999999999999999999865432 2347789999999986799999999999999999
Q ss_pred EEEecCCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCC--CCCCeeEeeccccccc
Q 014704 145 LIMDLCAGGELFDRIIAKG-HYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSA--EDSPLKATDFGLSVFF 221 (420)
Q Consensus 145 iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~~~~kl~Dfg~~~~~ 221 (420)
+||||| |++|.+.+...+ .+++..+..++.|++.||+|||++||+||||||+|||++... ..+.+||+|||+|+..
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999 789988887654 699999999999999999999999999999999999996432 3567999999999876
Q ss_pred CCCC--------ceecccCCcccccchhhcc-cCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCC
Q 014704 222 KPGD--------VFKDLVGSAYYVAPEVLRR-NYGAEADIWSAGVILYILLSGVPPFWGET---EQSIFDAILRGHIDFS 289 (420)
Q Consensus 222 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DvwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~ 289 (420)
.... .....+||+.|||||++.+ .++.++|||||||++|+|++|..||.+.. .......+.......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 4321 2335679999999999875 59999999999999999999999997543 3333333332211111
Q ss_pred -CCCCCCCChHHHHHHHHhcccCcCCCCCHHHHh
Q 014704 290 -SDPWPNISSSAKDIVKKMLHADPKERLSAAEVL 322 (420)
Q Consensus 290 -~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 322 (420)
....+.+|+++.+++..|+..+|++||+++.+.
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 112246789999999999999999999987764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=365.73 Aligned_cols=248 Identities=21% Similarity=0.288 Sum_probs=190.4
Q ss_pred ccceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCC----
Q 014704 66 RNTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRH---- 141 (420)
Q Consensus 66 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~---- 141 (420)
..+|.+.+.||+|+||.||+|++ +|+.||||++..+. ......+.|+..+..++ ||||+++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCcce
Confidence 45799999999999999999986 57899999985432 12222344555556777 999999999987654
Q ss_pred eEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 142 SVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHS--------MGVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 142 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~--------~~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
.+|+|||||++|+|.+++.+. .+++.....++.|++.||.|||+ +||+||||||+|||+ +.++.+||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~ 150 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEEC
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEE
Confidence 689999999999999999764 69999999999999999999996 599999999999999 567789999
Q ss_pred ecccccccCCCC-----ceecccCCcccccchhhccc-------CCCccchhhhHHHHHHHHhCCCCCCCC---------
Q 014704 214 DFGLSVFFKPGD-----VFKDLVGSAYYVAPEVLRRN-------YGAEADIWSAGVILYILLSGVPPFWGE--------- 272 (420)
Q Consensus 214 Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~DvwslGvil~~ll~g~~pf~~~--------- 272 (420)
|||++....... .....+||+.|+|||++... ++.++|||||||++|||+||..||...
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 999998765432 22346799999999998642 567899999999999999998877321
Q ss_pred ------CHHHHHHHHHcCCCCCCCC-CC--CCCChHHHHHHHHhcccCcCCCCCHHHHhcC
Q 014704 273 ------TEQSIFDAILRGHIDFSSD-PW--PNISSSAKDIVKKMLHADPKERLSAAEVLNH 324 (420)
Q Consensus 273 ------~~~~~~~~i~~~~~~~~~~-~~--~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 324 (420)
........+.........+ .+ ......+.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1223333333333221110 00 1122458899999999999999999999753
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-46 Score=357.97 Aligned_cols=261 Identities=24% Similarity=0.457 Sum_probs=196.7
Q ss_pred cccc-cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhcc----------CCCCcc
Q 014704 63 EDVR-NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLT----------GHRNIV 131 (420)
Q Consensus 63 ~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~hpniv 131 (420)
+.+. ++|+++++||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+.+++.+. +|+||+
T Consensus 8 ~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 4444 46999999999999999999999999999999997532 33467788999998885 268899
Q ss_pred EEEEEEEe--CCeEEEEEecCCCCChHHH-HH--hcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeccCCCCcEEEecCC
Q 014704 132 ELKGAYED--RHSVNLIMDLCAGGELFDR-II--AKGHYSERAAANLCRQMVTVVHYCHS-MGVMHRDLKPENFLFSSSA 205 (420)
Q Consensus 132 ~~~~~~~~--~~~~~iv~e~~~g~~L~~~-l~--~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~ 205 (420)
++++++.. ....+++|+++..+..... .. ....+++..+..++.||+.||.|||+ .||+||||||+|||++..+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence 99998754 4567777777765443322 22 23568999999999999999999998 8999999999999997533
Q ss_pred CC---CCeeEeecccccccCCCCceecccCCcccccchhhc-ccCCCccchhhhHHHHHHHHhCCCCCCCCCHH------
Q 014704 206 ED---SPLKATDFGLSVFFKPGDVFKDLVGSAYYVAPEVLR-RNYGAEADIWSAGVILYILLSGVPPFWGETEQ------ 275 (420)
Q Consensus 206 ~~---~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DvwslGvil~~ll~g~~pf~~~~~~------ 275 (420)
.. ..++++|||.+..... .....+||+.|+|||++. ..|+.++||||+||++++|++|+.||.+....
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 22 2489999999886543 335568999999999875 46899999999999999999999999754321
Q ss_pred HHHHHHHc--CC------------------C----CC--------------CCCCCCCCChHHHHHHHHhcccCcCCCCC
Q 014704 276 SIFDAILR--GH------------------I----DF--------------SSDPWPNISSSAKDIVKKMLHADPKERLS 317 (420)
Q Consensus 276 ~~~~~i~~--~~------------------~----~~--------------~~~~~~~~~~~~~~li~~~L~~dp~~R~t 317 (420)
........ +. . .. ....+...++++++||.+||+.||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 11111100 00 0 00 00011234578999999999999999999
Q ss_pred HHHHhcCCcccc
Q 014704 318 AAEVLNHPWMRV 329 (420)
Q Consensus 318 ~~e~l~h~~~~~ 329 (420)
++|+|+||||+.
T Consensus 322 a~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 322 AGGLVNHPWLKD 333 (362)
T ss_dssp HHHHHTCGGGTT
T ss_pred HHHHhcCcccCC
Confidence 999999999983
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=8.6e-28 Score=206.79 Aligned_cols=166 Identities=18% Similarity=0.170 Sum_probs=123.8
Q ss_pred eeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCC-----C----------hhhHHHHHHHHHHHHhccCCCCccEE
Q 014704 69 YIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI-----N----------RDDVEDVRREVQIMHHLTGHRNIVEL 133 (420)
Q Consensus 69 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~----------~~~~~~~~~E~~~l~~l~~hpniv~~ 133 (420)
|.+++.||+|+||+||+|.+. +|+.||||+++..... . ........+|...+.++. |++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence 568899999999999999985 5889999987532110 0 011234567899999998 9999998
Q ss_pred EEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeccCCCCcEEEecCCCCCCeeEe
Q 014704 134 KGAYEDRHSVNLIMDLCAGGELFDRIIAKGHYSERAAANLCRQMVTVVHYCHSMGVMHRDLKPENFLFSSSAEDSPLKAT 213 (420)
Q Consensus 134 ~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~~~~kl~ 213 (420)
+++.. .+++|||+++..+. .+++..+..++.|++.+|.|||++||+||||||+|||++. ..++|+
T Consensus 80 ~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~----~~~~li 144 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE----EGIWII 144 (191)
T ss_dssp EEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET----TEEEEC
T ss_pred EEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC----CCEEEE
Confidence 86632 37999999886653 2456667889999999999999999999999999999962 338999
Q ss_pred ecccccccCCCCceecccCCccccc------chhhcccCCCccchhhhHHH
Q 014704 214 DFGLSVFFKPGDVFKDLVGSAYYVA------PEVLRRNYGAEADIWSAGVI 258 (420)
Q Consensus 214 Dfg~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DvwslGvi 258 (420)
|||.|........ ..|.. .+.+.+.|+.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 9999976543221 11221 13345678999999997543
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.84 E-value=1.4e-09 Score=76.71 Aligned_cols=55 Identities=42% Similarity=0.625 Sum_probs=52.2
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+++++++.+++++|..+|.|++|+|+.+||+.+|+.+|..++++++.+||..+|.
T Consensus 3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~ 57 (77)
T d1f54a_ 3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDV 57 (77)
T ss_dssp CCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 5678899999999999999999999999999999999999999999999999884
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.81 E-value=3.3e-09 Score=75.55 Aligned_cols=59 Identities=24% Similarity=0.365 Sum_probs=54.2
Q ss_pred HHHhhhhHHHHhhHHHHhhccCCCC-CCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 362 VIAENLSEEEIMGLKEMFKSMDTDN-SGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 362 ~i~~~~~~~~~~~l~~~F~~~D~~~-~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+.+++++..+++++|..||.|+ +|.|+..||+.+|+.+|..++++|+++||+++|.
T Consensus 4 ~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~ 63 (82)
T d1wrka1 4 AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDE 63 (82)
T ss_dssp HHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCT
T ss_pred HHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 3456788999999999999999995 7999999999999999999999999999999984
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.78 E-value=3.9e-09 Score=75.15 Aligned_cols=55 Identities=33% Similarity=0.459 Sum_probs=51.8
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.++++++.+++++|..||.|++|+|+.+||+.+++.+|..++++++++||..+|.
T Consensus 7 ~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~ 61 (81)
T d1avsa_ 7 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDE 61 (81)
T ss_dssp HBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 3578889999999999999999999999999999999999999999999999884
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.74 E-value=9.7e-10 Score=79.47 Aligned_cols=60 Identities=63% Similarity=0.950 Sum_probs=55.4
Q ss_pred HHHHhhhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 361 KVIAENLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 361 ~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..|++.++++++..++++|..+|.|++|.|+.+||+.+|+.+|..++++|+++||+++|.
T Consensus 11 ~~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~ 70 (87)
T d1s6ja_ 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADI 70 (87)
T ss_dssp HHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCT
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCC
Confidence 346677888888899999999999999999999999999999999999999999999984
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=98.74 E-value=3.9e-09 Score=73.54 Aligned_cols=54 Identities=37% Similarity=0.580 Sum_probs=51.3
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++++++.+++.+|..||.|++|+|+.+||+.++..+|..++++++.++++.+|.
T Consensus 2 Ls~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~ 55 (73)
T d2pq3a1 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA 55 (73)
T ss_dssp CCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred cCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 567889999999999999999999999999999999999999999999999884
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=98.69 E-value=9.2e-09 Score=73.12 Aligned_cols=51 Identities=31% Similarity=0.571 Sum_probs=47.9
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++++.+++++|..+|.|++|.|+.+||+.+|+.+| .++++|+.+||+++|.
T Consensus 2 ~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~D~ 52 (81)
T d2opoa1 2 PQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDT 52 (81)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHhCC
Confidence 57888999999999999999999999999999999 6899999999999984
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.65 E-value=1.4e-08 Score=67.88 Aligned_cols=48 Identities=25% Similarity=0.556 Sum_probs=45.4
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++++++|..||.+++|+|+.+||+.+|+.+|..+++.++..|++.+|.
T Consensus 1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~ 48 (61)
T d2fcea1 1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEV 48 (61)
T ss_dssp HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCC
T ss_pred ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCC
Confidence 367899999999999999999999999999999999999999999884
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.65 E-value=8.5e-08 Score=84.38 Aligned_cols=87 Identities=18% Similarity=0.124 Sum_probs=63.5
Q ss_pred cceeecceecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeEEEE
Q 014704 67 NTYIFGRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSVNLI 146 (420)
Q Consensus 67 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~iv 146 (420)
..|+..+..+.++.+.||+... .++.+++|+....... ....+.+|...+..+..+--+.+++.+..+++..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 4566666655566678998753 4567888987543321 2235778999998887665578899988899999999
Q ss_pred EecCCCCChHHH
Q 014704 147 MDLCAGGELFDR 158 (420)
Q Consensus 147 ~e~~~g~~L~~~ 158 (420)
|++++|.++.+.
T Consensus 89 ~~~l~G~~~~~~ 100 (263)
T d1j7la_ 89 MSEADGVLCSEE 100 (263)
T ss_dssp EECCSSEEHHHH
T ss_pred EEeccccccccc
Confidence 999999877543
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.63 E-value=1.8e-08 Score=68.24 Aligned_cols=48 Identities=27% Similarity=0.581 Sum_probs=45.4
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++++++|..||.|++|+|+.+||+.+++.+|.++++.++++|++.+|.
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~ 50 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADI 50 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCT
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCC
Confidence 457899999999999999999999999999999999999999999884
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.57 E-value=2.9e-08 Score=69.25 Aligned_cols=48 Identities=27% Similarity=0.407 Sum_probs=45.5
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.+++.+|..||.|++|+|+.+||+.+|+.+|..++++++++||+++|.
T Consensus 9 eel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~ 56 (75)
T d1jc2a_ 9 EELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDK 56 (75)
T ss_dssp HHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCC
Confidence 468899999999999999999999999999999999999999999984
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.49 E-value=3.2e-08 Score=55.71 Aligned_cols=31 Identities=32% Similarity=0.593 Sum_probs=29.0
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLG 403 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg 403 (420)
++++++|+.||+|++|+|+.+||+.+|..||
T Consensus 3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~lG 33 (33)
T d2hf5a1 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLG 33 (33)
T ss_dssp HHHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence 4789999999999999999999999999887
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.48 E-value=6.7e-08 Score=65.79 Aligned_cols=47 Identities=13% Similarity=0.451 Sum_probs=44.4
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.++++|..+|.|++|+|+.+||+.+++.+|..+++++++++|+.+|.
T Consensus 2 ~~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~ 48 (67)
T d1tiza_ 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDV 48 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCC
T ss_pred hHHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCC
Confidence 36789999999999999999999999999999999999999999984
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.48 E-value=7e-08 Score=67.73 Aligned_cols=50 Identities=30% Similarity=0.507 Sum_probs=46.7
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..++++++|..+|.|++|+|+.+||+.+|+.+|..++.+++.+||+.+|.
T Consensus 7 ~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~ 56 (77)
T d1oqpa_ 7 SREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADR 56 (77)
T ss_dssp HHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCC
Confidence 34578999999999999999999999999999999999999999999984
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=98.47 E-value=7.2e-08 Score=68.31 Aligned_cols=48 Identities=29% Similarity=0.513 Sum_probs=45.3
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.+++++|..+|.|++|+|+.+||+.+++.+|..++++++++||.++|.
T Consensus 15 e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~ 62 (81)
T d1fi5a_ 15 EELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDK 62 (81)
T ss_dssp HHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCC
Confidence 468899999999999999999999999999999999999999999884
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.43 E-value=3.9e-07 Score=85.03 Aligned_cols=82 Identities=11% Similarity=0.149 Sum_probs=53.1
Q ss_pred cceecccCCeEEEEEEEcCCCceEEEEEecCCcCC----ChhhHHHHHHHHHHHHhccCC--CCccEEEEEEEeCCeEEE
Q 014704 72 GRELGRGQFGVTYLVTHKDTKQQFACKSISSRKLI----NRDDVEDVRREVQIMHHLTGH--RNIVELKGAYEDRHSVNL 145 (420)
Q Consensus 72 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~E~~~l~~l~~h--pniv~~~~~~~~~~~~~i 145 (420)
.+.||.|....||++....+++.++||.-...... -.....+...|.+.|+.+..+ ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999998877889999975431110 012334567788888877643 245666644 5556689
Q ss_pred EEecCCCCCh
Q 014704 146 IMDLCAGGEL 155 (420)
Q Consensus 146 v~e~~~g~~L 155 (420)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=98.41 E-value=8e-08 Score=65.52 Aligned_cols=48 Identities=29% Similarity=0.515 Sum_probs=44.5
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCC-CCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTR-LSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~ 420 (420)
++++++|..+|.|++|+|+.+||+.+|+.+|.. +++++++.||+.+|.
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~ 50 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADE 50 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCS
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCC
Confidence 357899999999999999999999999999985 799999999999984
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.25 E-value=9.8e-07 Score=62.63 Aligned_cols=50 Identities=20% Similarity=0.303 Sum_probs=46.3
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....+.++|..+|.+++|.|+.+||+.+|..+|..++++|+..++..+|.
T Consensus 18 ~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~ 67 (83)
T d1wlza1 18 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPV 67 (83)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCB
T ss_pred HHHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhcccc
Confidence 34568899999999999999999999999999999999999999999873
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=98.20 E-value=6.8e-07 Score=66.94 Aligned_cols=48 Identities=38% Similarity=0.529 Sum_probs=44.0
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh---CCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~ 420 (420)
..++.+|..+|.|++|+|+.+||+.+++.+ |..++++|+++||+++|.
T Consensus 41 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~D~ 91 (109)
T d5pala_ 41 AQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDS 91 (109)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHhCC
Confidence 468899999999999999999999999876 778999999999999984
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.19 E-value=2.1e-06 Score=74.69 Aligned_cols=74 Identities=11% Similarity=0.111 Sum_probs=52.5
Q ss_pred ecccC-CeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC-CCccEEEEEEEeCCeEEEEEecCCC
Q 014704 75 LGRGQ-FGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH-RNIVELKGAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 75 lG~G~-~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pniv~~~~~~~~~~~~~iv~e~~~g 152 (420)
+..|. -+.||+.... ++..+++|...... ...+..|...++.|..+ -.+.+++.+..+++..++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 34444 3678988754 46678899865432 23477888888887633 2367788888888899999999998
Q ss_pred CCh
Q 014704 153 GEL 155 (420)
Q Consensus 153 ~~L 155 (420)
.++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 665
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.18 E-value=1e-06 Score=65.89 Aligned_cols=48 Identities=35% Similarity=0.546 Sum_probs=43.7
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh---CCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~ 420 (420)
..++.+|+.+|.|++|+|+.+||+.+++.+ |..++++|+++||+.+|.
T Consensus 41 ~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~ 91 (109)
T d1pvaa_ 41 NDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADK 91 (109)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCC
Confidence 457789999999999999999999999887 678999999999999884
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.09 E-value=1.6e-06 Score=68.48 Aligned_cols=53 Identities=26% Similarity=0.481 Sum_probs=48.9
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
++++++.+++++|..+|.|++|.|+.+||..+|+.+|..++++++.+++...+
T Consensus 1 L~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~~~~~ 53 (142)
T d1wdcb_ 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKEAP 53 (142)
T ss_dssp CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHTTSS
T ss_pred CCHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHHHhcc
Confidence 36788999999999999999999999999999999999999999999987643
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.07 E-value=1.9e-06 Score=46.13 Aligned_cols=31 Identities=32% Similarity=0.442 Sum_probs=27.5
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLG 403 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg 403 (420)
++|.++|+.||+|.||+|+.+||..+++.-|
T Consensus 4 eELae~FRifDkNaDGyiD~eEl~~ilr~tG 34 (34)
T d1ctda_ 4 EELANAFRIFDKNADGYIDIEELGEILRATG 34 (34)
T ss_dssp HHHHHHHHTTCCSSSSCBCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCCcccccHHHHHHHHHhcC
Confidence 5678899999999999999999999987644
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.06 E-value=1.6e-06 Score=64.80 Aligned_cols=52 Identities=35% Similarity=0.485 Sum_probs=45.5
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhh---CCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL---GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~ 420 (420)
......++++|..+|.|++|+|+.+||+.+++.+ |..++++++++||+.+|.
T Consensus 37 ~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~ 91 (108)
T d1rroa_ 37 KMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADN 91 (108)
T ss_dssp GSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCC
T ss_pred cCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCC
Confidence 3344568899999999999999999999999987 456899999999999984
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.04 E-value=2.5e-06 Score=63.52 Aligned_cols=50 Identities=26% Similarity=0.382 Sum_probs=44.7
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhC---CCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG---TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg---~~~~~~e~~~~~~~~d~ 420 (420)
...+++.+|+.+|.|++|+|+.+|+..+++.++ ..++++++++||+.+|.
T Consensus 38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D~ 90 (107)
T d2pvba_ 38 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDK 90 (107)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCT
T ss_pred CHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhCC
Confidence 345688999999999999999999999999984 56899999999999884
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.03 E-value=3.1e-06 Score=66.73 Aligned_cols=48 Identities=17% Similarity=0.346 Sum_probs=45.2
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
...+..+|+.+|.|++|+|+.+||+.++..+|..++++|+.+||+.+|
T Consensus 75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d 122 (142)
T d1wdcb_ 75 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAP 122 (142)
T ss_dssp HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCC
T ss_pred hhhHHHhhhhhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhC
Confidence 356788999999999999999999999999999999999999999987
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.94 E-value=4.2e-06 Score=60.80 Aligned_cols=52 Identities=21% Similarity=0.261 Sum_probs=46.6
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+++++...+.++|..+|+|++|.|+.+|+..++.+.| ++.+++.++++.+|.
T Consensus 4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~--l~~~~l~~i~~~~D~ 55 (95)
T d1c07a_ 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDT 55 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCT
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC--CCHHHHHHHHHHhCC
Confidence 3567778899999999999999999999999998876 689999999999984
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.93 E-value=4.8e-06 Score=65.40 Aligned_cols=49 Identities=31% Similarity=0.483 Sum_probs=45.6
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+.++|+.+|.|++|+|+.+||+.+|..+|..++++|+++|++.+|.
T Consensus 75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~ 123 (140)
T d1ggwa_ 75 PEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV 123 (140)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCC
Confidence 3568899999999999999999999999999999999999999999874
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.92 E-value=6.1e-06 Score=59.53 Aligned_cols=52 Identities=21% Similarity=0.226 Sum_probs=47.3
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+++++...++++|..+|.|++|+|+.+|++.++.+.| ++.+++.+|++.+|.
T Consensus 3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~--l~~~~l~~i~~~~D~ 54 (92)
T d1fi6a_ 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDF 54 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCT
T ss_pred CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc--CCHHHHHHHHHHhCC
Confidence 4677888999999999999999999999999999876 689999999999984
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=97.87 E-value=6.5e-06 Score=65.56 Aligned_cols=48 Identities=31% Similarity=0.523 Sum_probs=45.1
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
..++.++|+.+|.+++|+|+.+||+.+|..+|..++++|+++|++.+|
T Consensus 81 ~~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d 128 (152)
T d1wdcc_ 81 FADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTD 128 (152)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHT
T ss_pred HHhhhhhhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhc
Confidence 456889999999999999999999999999999999999999999887
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=97.87 E-value=6.6e-06 Score=64.94 Aligned_cols=55 Identities=36% Similarity=0.571 Sum_probs=51.0
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+++++++.+++++|..+|.|++|.|+.+|+..++..+|..++..++..+++.+|.
T Consensus 2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~ 56 (146)
T d1exra_ 2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDA 56 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCT
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcCC
Confidence 4677888999999999999999999999999999999999999999999998873
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=97.86 E-value=6.2e-06 Score=61.61 Aligned_cols=49 Identities=33% Similarity=0.396 Sum_probs=43.7
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhC---CCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLG---TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg---~~~~~~e~~~~~~~~d~ 420 (420)
...++.+|+.+|.|++|+|+.+||+.+++.++ ..+++++++.||+.+|.
T Consensus 40 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e~~~~~~~~D~ 91 (109)
T d1rwya_ 40 ADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDK 91 (109)
T ss_dssp HHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHHHHHHHHHhCC
Confidence 44678899999999999999999999999875 45899999999999984
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.83 E-value=7.4e-06 Score=65.90 Aligned_cols=55 Identities=33% Similarity=0.459 Sum_probs=51.2
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.++.+++.+++++|..+|+|++|+|+.+||..++..++..+++.++.+++..+|.
T Consensus 13 ~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d~ 67 (162)
T d1topa_ 13 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDE 67 (162)
T ss_dssp HSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheecc
Confidence 4578888999999999999999999999999999999999999999999998873
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.83 E-value=1.1e-05 Score=65.12 Aligned_cols=47 Identities=32% Similarity=0.502 Sum_probs=44.3
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
..++.+|+.+|.|++|+|+.+||+.+++.+|.+++.++++.|+..+|
T Consensus 70 ~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~d 116 (165)
T d1k94a_ 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYS 116 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHC
T ss_pred chhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHcC
Confidence 45788999999999999999999999999999999999999999876
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.79 E-value=8.3e-06 Score=64.40 Aligned_cols=54 Identities=43% Similarity=0.626 Sum_probs=49.8
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
+++++++.+++++|..+|.|++|.|+.+||..++..+|..+++.++..++...+
T Consensus 3 ~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~~ 56 (146)
T d1lkja_ 3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEID 56 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHC
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCCCCCHHHHHHHHHHhc
Confidence 567889999999999999999999999999999999999999999998887654
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.78 E-value=6.7e-06 Score=64.90 Aligned_cols=48 Identities=21% Similarity=0.278 Sum_probs=44.2
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
.++++++|..+|.|++|.|+.+||..+|+.+|..++..|+.+++..+|
T Consensus 3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~ 50 (145)
T d2mysc_ 3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPS 50 (145)
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHh
Confidence 457899999999999999999999999999999999999999987654
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.75 E-value=1.5e-05 Score=63.58 Aligned_cols=55 Identities=25% Similarity=0.411 Sum_probs=50.5
Q ss_pred hhhhHHHHhhHHHHhhccCCCC-CCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 365 ENLSEEEIMGLKEMFKSMDTDN-SGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 365 ~~~~~~~~~~l~~~F~~~D~~~-~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
+.++++++.+++++|..+|.|+ +|.|+..|+..+|+.+|..++..++.+++..++
T Consensus 6 ~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~ 61 (156)
T d1dtla_ 6 EQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVD 61 (156)
T ss_dssp GGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHC
T ss_pred HHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhh
Confidence 4678888999999999999995 899999999999999999999999999988765
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.73 E-value=1.8e-05 Score=63.08 Aligned_cols=49 Identities=29% Similarity=0.484 Sum_probs=43.7
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|+.+|.|++|+|+.+|+++++..+|..+++++++++|+.+|.
T Consensus 90 ~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~ 138 (156)
T d1dtla_ 90 EEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDK 138 (156)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCC
Confidence 3567889999999999999999999999999999999999999999874
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.70 E-value=1.6e-05 Score=62.65 Aligned_cols=48 Identities=25% Similarity=0.556 Sum_probs=45.3
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.+++|.|+.+||..+|..+|..++++++.+||..+|.
T Consensus 81 ~~l~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~ 128 (146)
T d1m45a_ 81 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEV 128 (146)
T ss_dssp HHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCC
T ss_pred HHHHHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCC
Confidence 468889999999999999999999999999999999999999999884
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.69 E-value=2.5e-05 Score=61.50 Aligned_cols=48 Identities=35% Similarity=0.549 Sum_probs=44.9
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
...+..+|+.+|.|++|+|+.+||+.++..+|..++++++++|++++|
T Consensus 82 ~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d 129 (146)
T d1lkja_ 82 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS 129 (146)
T ss_dssp HHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc
Confidence 356788999999999999999999999999999999999999999876
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.68 E-value=1.8e-05 Score=61.82 Aligned_cols=51 Identities=29% Similarity=0.573 Sum_probs=47.7
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
+++..+++++|..+|.|++|.|+.+||..+++.+|..++..++..++..+|
T Consensus 2 ~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d 52 (141)
T d2obha1 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEID 52 (141)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhc
Confidence 457788999999999999999999999999999999999999999998876
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=97.67 E-value=6.4e-05 Score=58.94 Aligned_cols=50 Identities=30% Similarity=0.525 Sum_probs=46.3
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|+.+|.|++|.|+.+|++..+..+|..+++++++++|+.+|.
T Consensus 80 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D~ 129 (146)
T d1exra_ 80 SEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADI 129 (146)
T ss_dssp HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCS
T ss_pred hHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhCC
Confidence 34578899999999999999999999999999999999999999999874
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.66 E-value=1e-05 Score=56.03 Aligned_cols=48 Identities=27% Similarity=0.387 Sum_probs=39.6
Q ss_pred hhHHHHhhccCCC--CCCcccHHHHHhhhhhhCCCCC--HHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTD--NSGTITFEELKAGLPKLGTRLS--ESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~--~~G~i~~~el~~~l~~lg~~~~--~~e~~~~~~~~d~ 420 (420)
++++++|..||.+ ++|+|+.+||+.+|+.+|.+++ +.|+++||+.+|.
T Consensus 5 eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~ 56 (76)
T d1qx2a_ 5 EEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDK 56 (76)
T ss_dssp HHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCT
T ss_pred HHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhc
Confidence 4578889988543 5799999999999999998775 4579999999884
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.65 E-value=2.6e-05 Score=56.41 Aligned_cols=51 Identities=16% Similarity=0.228 Sum_probs=45.5
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
++.++...+.++|..+| +++|+|+.+|++.++.+.| ++.+++++|++.+|.
T Consensus 4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g--l~~~~L~~Iw~~~D~ 54 (95)
T d2jxca1 4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDI 54 (95)
T ss_dssp SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS--CCHHHHHHHHHHHCT
T ss_pred CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC--CCHHHHHHHHHHhcC
Confidence 46778888999999999 8999999999999998876 588999999999884
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.63 E-value=1.8e-05 Score=61.99 Aligned_cols=46 Identities=17% Similarity=0.263 Sum_probs=42.4
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhc
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~ 418 (420)
..++++|..+|.|++|.|+.+||..+|+.+|.+++++++.++....
T Consensus 5 ~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~~~t~~ei~~~~~~~ 50 (140)
T d1ggwa_ 5 SPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIESTL 50 (140)
T ss_dssp TTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHTTS
T ss_pred HHHHHHHHHHCCCCCCeECHHHHHHHHHHHHhhhHHHhhhhhhccc
Confidence 5679999999999999999999999999999999999999887654
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=97.62 E-value=5.4e-05 Score=62.10 Aligned_cols=50 Identities=22% Similarity=0.292 Sum_probs=45.9
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....+..+|..+|.|++|.|+.+||+.++..+|..+++++++++|+.+|.
T Consensus 103 ~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~ 152 (187)
T d1uhka1 103 IRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDI 152 (187)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCC
Confidence 34557889999999999999999999999999999999999999999984
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.62 E-value=7.9e-06 Score=63.89 Aligned_cols=46 Identities=22% Similarity=0.359 Sum_probs=42.6
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
+++++|..+|.|++|.|+.+||..+|+.+|..++.+++.+++..++
T Consensus 1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~ 46 (139)
T d1w7jb1 1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPK 46 (139)
T ss_dssp CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCC
T ss_pred CHHHHHHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHh
Confidence 4789999999999999999999999999999999999999987654
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.61 E-value=9.5e-05 Score=59.09 Aligned_cols=50 Identities=26% Similarity=0.397 Sum_probs=45.7
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|+.+|.|++|+|+.+|++.++...|...+.++++.+|+.+|.
T Consensus 94 ~~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D~ 143 (162)
T d1topa_ 94 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDK 143 (162)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCT
T ss_pred cHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhCC
Confidence 34567789999999999999999999999999999999999999999884
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.57 E-value=3.1e-05 Score=60.89 Aligned_cols=49 Identities=24% Similarity=0.305 Sum_probs=45.3
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|+.+|.+++|+|+.+|++.+|+.+|..++++|++++++.+|.
T Consensus 76 ~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~ 124 (145)
T d2mysb_ 76 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPP 124 (145)
T ss_pred HHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCC
Confidence 3467889999999999999999999999999999999999999998873
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.55 E-value=3.9e-05 Score=60.23 Aligned_cols=47 Identities=30% Similarity=0.504 Sum_probs=43.5
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHh
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~ 417 (420)
....+..+|+.+|.|++|+|+.+||+.+|..+|..++++|+++|++.
T Consensus 79 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~ 125 (145)
T d2mysc_ 79 TFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG 125 (145)
T ss_pred hHHHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHhh
Confidence 34568899999999999999999999999999999999999999975
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=97.54 E-value=2.8e-05 Score=63.76 Aligned_cols=49 Identities=33% Similarity=0.465 Sum_probs=45.5
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+++++|..+|.|++|+|+.+||..+|+.+|..+++++++.+++.+|.
T Consensus 17 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~~~s~~~~~~l~~~~d~ 65 (182)
T d1y1xa_ 17 NQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDK 65 (182)
T ss_dssp TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcccCchhhhhhhhccccc
Confidence 3578999999999999999999999999999999999999999998863
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=97.54 E-value=1.2e-05 Score=63.95 Aligned_cols=49 Identities=24% Similarity=0.290 Sum_probs=44.0
Q ss_pred hHHHHhhHHHHhhccCC--CCCCcccHHHHHhhhhhhCCCCCHHHHHHHHH
Q 014704 368 SEEEIMGLKEMFKSMDT--DNSGTITFEELKAGLPKLGTRLSESEVRQLME 416 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~--~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~ 416 (420)
+++++.+++++|..||. |++|.|+.+||+.+|+++|..++++|+..++.
T Consensus 2 s~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~~t~~e~~~~~~ 52 (152)
T d1wdcc_ 2 SQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGG 52 (152)
T ss_dssp CHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHTTC
T ss_pred CHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhccCccHhhhhhhhh
Confidence 56788899999999994 89999999999999999999999999987653
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=97.53 E-value=8.7e-05 Score=60.95 Aligned_cols=49 Identities=29% Similarity=0.268 Sum_probs=41.2
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|+|+.+|+..++..+|..+++++++.||+.+|.
T Consensus 106 ~~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~ 154 (189)
T d1qv0a_ 106 REWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDL 154 (189)
T ss_dssp HHHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCC
T ss_pred HHHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCC
Confidence 3456778999999999999999999999999999999999999999984
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.50 E-value=0.00023 Score=65.76 Aligned_cols=76 Identities=11% Similarity=0.105 Sum_probs=53.5
Q ss_pred ecceecccCCeEEEEEEEcC-------CCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCccEEEEEEEeCCeE
Q 014704 71 FGRELGRGQFGVTYLVTHKD-------TKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNIVELKGAYEDRHSV 143 (420)
Q Consensus 71 ~~~~lG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 143 (420)
-.+.|+.|-.-.+|++.... ..+.|.+++.-.. ...-...+|..+++.+..+.-.+++++++.+
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 34678999999999998753 2356777776421 1223467899999999855555688887643
Q ss_pred EEEEecCCCCCh
Q 014704 144 NLIMDLCAGGEL 155 (420)
Q Consensus 144 ~iv~e~~~g~~L 155 (420)
.+||||++|.+|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 688999988544
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.46 E-value=0.00019 Score=55.68 Aligned_cols=50 Identities=26% Similarity=0.507 Sum_probs=46.4
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|..+|.+++|.|+..||..++..+|..++++++.++|+.+|.
T Consensus 77 ~~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D~ 126 (141)
T d2obha1 77 TKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADR 126 (141)
T ss_dssp HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCT
T ss_pred cHHHHHHHHHHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHCC
Confidence 34678899999999999999999999999999999999999999999884
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.41 E-value=1.7e-05 Score=62.50 Aligned_cols=45 Identities=22% Similarity=0.356 Sum_probs=41.1
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhc
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~ 418 (420)
.++++|..+|.|++|.|+.+||..+|+.+|..++.+|+++++...
T Consensus 3 ~~k~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~ei~~l~~~~ 47 (146)
T d1m45a_ 3 ANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINAD 47 (146)
T ss_dssp CCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC-
T ss_pred HHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCchhHHHHhhhhccc
Confidence 357899999999999999999999999999999999999998753
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=97.40 E-value=0.0001 Score=52.94 Aligned_cols=51 Identities=16% Similarity=0.190 Sum_probs=42.9
Q ss_pred HHHhhHHHHhhcc-CCCCC-CcccHHHHHhhhhhhC-----CCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSM-DTDNS-GTITFEELKAGLPKLG-----TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~-D~~~~-G~i~~~el~~~l~~lg-----~~~~~~e~~~~~~~~d~ 420 (420)
..+..+.++|..+ |.|++ |+|+.+||+++|..++ ...+++++++||+++|.
T Consensus 6 ~~i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~ 63 (93)
T d1zfsa1 6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDE 63 (93)
T ss_dssp HHHHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcC
Confidence 3457788999887 88875 9999999999998875 35689999999999984
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=97.36 E-value=6.1e-05 Score=58.00 Aligned_cols=45 Identities=22% Similarity=0.461 Sum_probs=38.6
Q ss_pred HHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 376 KEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 376 ~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+|+.+|.|++|.|+.+||..++..+|...++++++.++..+|.
T Consensus 3 e~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D~ 47 (134)
T d1jfja_ 3 EALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDA 47 (134)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCS
T ss_pred HHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhhh
Confidence 467888999999999999999999888888888888888888773
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.32 E-value=7e-05 Score=58.19 Aligned_cols=48 Identities=25% Similarity=0.430 Sum_probs=41.8
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHh
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~ 417 (420)
.....+..+|+.+|.|++|+|+.+||+.++..+|..+++++++.|++.
T Consensus 74 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~ 121 (139)
T d1w7jb1 74 GTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG 121 (139)
T ss_dssp ----CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTT
T ss_pred cHHHHHHHhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHhh
Confidence 344568899999999999999999999999999999999999999865
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.32 E-value=0.00011 Score=57.51 Aligned_cols=50 Identities=24% Similarity=0.458 Sum_probs=41.4
Q ss_pred hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCC-HHHHHHHHHh
Q 014704 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLS-ESEVRQLMEA 417 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~-~~e~~~~~~~ 417 (420)
+++++.+++++|..+|.|++|.|+.+||..+|+.+|...+ .+++..+++.
T Consensus 2 ~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~ 52 (145)
T d2mysb_ 2 DETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKE 52 (145)
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHHHHHHHHHh
Confidence 5678899999999999999999999999999999996644 4455555543
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.21 E-value=3e-05 Score=57.69 Aligned_cols=52 Identities=25% Similarity=0.194 Sum_probs=43.7
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
+++++...+.++|..+|+|++|+|+.+|++.++.+.| ++.+++.+|++.+|.
T Consensus 16 lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~--L~~~~L~~Iw~l~D~ 67 (110)
T d1iq3a_ 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDA 67 (110)
T ss_dssp CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCS
T ss_pred cCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc--cchHHHHHHHHHhcc
Confidence 3566777888999999999999999999999997765 577889999988874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.20 E-value=0.001 Score=59.45 Aligned_cols=69 Identities=10% Similarity=0.131 Sum_probs=45.8
Q ss_pred CeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCCCCc--cEEE-----EEEEeCCeEEEEEecCCC
Q 014704 80 FGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGHRNI--VELK-----GAYEDRHSVNLIMDLCAG 152 (420)
Q Consensus 80 ~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpni--v~~~-----~~~~~~~~~~iv~e~~~g 152 (420)
--.||++... +|..|++|+..... ...+.+..|...+..|.. .+| +..+ ..+...+..+.+++++.|
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~-~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPER----WTADQILEEHQFALQLVN-DEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHH-TTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHh-cCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 3679999874 57889999976432 234668889999988862 222 1111 123456778899999987
Q ss_pred CC
Q 014704 153 GE 154 (420)
Q Consensus 153 ~~ 154 (420)
..
T Consensus 109 ~~ 110 (325)
T d1zyla1 109 RQ 110 (325)
T ss_dssp EE
T ss_pred cC
Confidence 43
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=97.19 E-value=6.4e-05 Score=53.84 Aligned_cols=50 Identities=20% Similarity=0.299 Sum_probs=42.4
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+..+|..+|.| +|+|+.+||..++.. ++...++.++++||+.+|.
T Consensus 6 ~~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~ 60 (92)
T d1a4pa_ 6 HAMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQ 60 (92)
T ss_dssp HHHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhC
Confidence 3567789999999987 899999999999976 3455678899999999984
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=97.18 E-value=2.1e-05 Score=54.55 Aligned_cols=50 Identities=16% Similarity=0.215 Sum_probs=38.3
Q ss_pred HHhhHHHHhhccCC--CCCCcccHHHHHhhhhhh--CCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDT--DNSGTITFEELKAGLPKL--GTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~--~~~G~i~~~el~~~l~~l--g~~~~~~e~~~~~~~~d~ 420 (420)
....+..+|..+|. +++|+|+.+||+.+++.+ +...+++++++||+++|.
T Consensus 5 ~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~ 58 (78)
T d1cb1a_ 5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDK 58 (78)
T ss_dssp CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCC
T ss_pred hHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcC
Confidence 35677888888864 345889999999999887 445667788889988874
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=97.15 E-value=0.00027 Score=57.63 Aligned_cols=48 Identities=25% Similarity=0.449 Sum_probs=43.7
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+.+.|..+|.+++|.|+.+||+.++..+|..+++++++.+|+.+|.
T Consensus 84 ~~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d~ 131 (182)
T d1y1xa_ 84 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDR 131 (182)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCT
T ss_pred cccccchhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhccc
Confidence 346778999999999999999999999999999999999999999874
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=97.15 E-value=0.00026 Score=58.08 Aligned_cols=45 Identities=18% Similarity=0.341 Sum_probs=40.7
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~ 417 (420)
..++.+|+.+|+|++|.|+..||+.+|..+|..++++.++.|++.
T Consensus 93 ~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~ 137 (188)
T d1qxpa2 93 RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVAR 137 (188)
T ss_dssp HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHH
Confidence 457889999999999999999999999999999998888877765
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=97.14 E-value=0.00037 Score=49.81 Aligned_cols=51 Identities=22% Similarity=0.347 Sum_probs=42.4
Q ss_pred HHHhhHHHHhhcc-CCCCCC-cccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSM-DTDNSG-TITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~-D~~~~G-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+.++|..+ |.|++| +|+.+||+++|+. ++...+++++++||+++|.
T Consensus 6 ~~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~ 63 (93)
T d3c1va1 6 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDS 63 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcC
Confidence 3456788999987 677654 7999999999987 4667899999999999984
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=97.13 E-value=0.00016 Score=52.29 Aligned_cols=51 Identities=12% Similarity=0.191 Sum_probs=40.0
Q ss_pred HHHhhHHHHhhcc-CCCCC-CcccHHHHHhhhhhhCC--CCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSM-DTDNS-GTITFEELKAGLPKLGT--RLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~-D~~~~-G~i~~~el~~~l~~lg~--~~~~~e~~~~~~~~d~ 420 (420)
..+..+..+|..+ |.+++ |+|+.+||+.+++.++. ..+.+++++||+++|.
T Consensus 11 ~~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~ 65 (98)
T d1yuta1 11 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDV 65 (98)
T ss_dssp HHHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcC
Confidence 3456788889887 77774 99999999999987643 3567779999999884
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.05 E-value=0.00042 Score=55.84 Aligned_cols=46 Identities=39% Similarity=0.588 Sum_probs=42.9
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
....+|+.+|.|++|.|+.+|+..++..+|..++.++++++++++|
T Consensus 78 ~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d 123 (172)
T d1juoa_ 78 GWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYS 123 (172)
T ss_dssp HHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTC
T ss_pred hhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHH
Confidence 3567899999999999999999999999999999999999999887
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=97.04 E-value=0.00014 Score=64.87 Aligned_cols=53 Identities=32% Similarity=0.503 Sum_probs=48.8
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
++.++...++++|..+|.|++|.|+.+||+.+|..+|..++++++..+|..+|
T Consensus 116 l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d 168 (321)
T d1ij5a_ 116 LSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVE 168 (321)
T ss_dssp CCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCCcccHHHHHHHHHHHh
Confidence 45667788999999999999999999999999999999999999999998876
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=97.03 E-value=0.00041 Score=55.73 Aligned_cols=48 Identities=25% Similarity=0.299 Sum_probs=42.7
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|..+|.|++|.|+.+|++.+++.+| +++++++++|+.+|.
T Consensus 100 ~~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~--~~~~~~~~~f~~~D~ 147 (176)
T d1nyaa_ 100 LGPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDT 147 (176)
T ss_dssp HHHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHccCCChhhhHHHHHHHHHhcC--CcHHHHHHHHHHHCC
Confidence 345678899999999999999999999999887 589999999999984
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.02 E-value=0.00022 Score=58.11 Aligned_cols=51 Identities=24% Similarity=0.298 Sum_probs=44.3
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCC-CCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTR-LSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~ 420 (420)
.+...|..+|..+|.|++|+|+.+||..+++.++.. .+.++++.+++.+|.
T Consensus 16 ~~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~ 67 (181)
T d1hqva_ 16 PDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDR 67 (181)
T ss_dssp SCHHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCC
T ss_pred ccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhcccc
Confidence 345678999999999999999999999999988764 789999999998863
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.99 E-value=0.00034 Score=50.71 Aligned_cols=45 Identities=16% Similarity=0.275 Sum_probs=39.1
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.+.++|+.+|.|++|+|+.+|+..++...| ++.+++.+|++.+|.
T Consensus 12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~--L~~~~L~~i~~~~D~ 56 (99)
T d1qjta_ 12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADT 56 (99)
T ss_dssp HHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHCCCCCCcccHHHHHHHHHHcC--CcHHHHHHHHHHHcC
Confidence 456789999999999999999999998765 689999999998884
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=96.89 E-value=0.0006 Score=48.55 Aligned_cols=50 Identities=18% Similarity=0.246 Sum_probs=41.9
Q ss_pred HHHhhHHHHhhcc-CCCCCC-cccHHHHHhhhhhh-----CCCCCHHHHHHHHHhcC
Q 014704 370 EEIMGLKEMFKSM-DTDNSG-TITFEELKAGLPKL-----GTRLSESEVRQLMEAVS 419 (420)
Q Consensus 370 ~~~~~l~~~F~~~-D~~~~G-~i~~~el~~~l~~l-----g~~~~~~e~~~~~~~~d 419 (420)
..+..+..+|..+ |.+++| +|+.+||+.+|+.. +...++.++++||+.+|
T Consensus 6 ~~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD 62 (93)
T d1ksoa_ 6 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLD 62 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHc
Confidence 4456788899987 999999 59999999999764 44567999999999987
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=96.84 E-value=0.00035 Score=49.40 Aligned_cols=49 Identities=29% Similarity=0.483 Sum_probs=35.1
Q ss_pred HHhhHHHHhhcc-CCCCCC-cccHHHHHhhhhh---hCCCCCHHHHHHHHHhcC
Q 014704 371 EIMGLKEMFKSM-DTDNSG-TITFEELKAGLPK---LGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 371 ~~~~l~~~F~~~-D~~~~G-~i~~~el~~~l~~---lg~~~~~~e~~~~~~~~d 419 (420)
.+..+..+|..+ |++++| +|+..||+..++. +|...+++++++||+++|
T Consensus 7 ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD 60 (89)
T d1k8ua_ 7 AIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLD 60 (89)
T ss_dssp HHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhc
Confidence 345666777766 777777 5788888777765 566667777888887776
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.74 E-value=0.00046 Score=49.97 Aligned_cols=46 Identities=22% Similarity=0.234 Sum_probs=35.8
Q ss_pred HHHHhhccCCCCCCcccHHHHHhhhhhhCCCC----------------CHHHHHHHHHhcCC
Q 014704 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRL----------------SESEVRQLMEAVSL 420 (420)
Q Consensus 375 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~----------------~~~e~~~~~~~~d~ 420 (420)
++.+|..+|.|++|+|+.+||..++.+++..+ .+..++.+|+++|.
T Consensus 18 ~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~ 79 (99)
T d1snla_ 18 PKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDT 79 (99)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCS
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCC
Confidence 57889999999999999999999997654211 13356778888874
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=96.64 E-value=0.00035 Score=56.78 Aligned_cols=47 Identities=19% Similarity=0.318 Sum_probs=41.2
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+..+|..+|.|++|+|+.+|++.++..+| ++.++++++++.+|.
T Consensus 104 ~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~--l~~~~~~~~f~~~D~ 150 (185)
T d2sasa_ 104 QNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITD 150 (185)
T ss_dssp HHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHT
T ss_pred HHHHHHHHHHHccCCCccCCHHHHHHHHHHcC--CCHHHHHHHHHHcCC
Confidence 34577899999999999999999999999887 478899999998873
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.61 E-value=0.0013 Score=53.33 Aligned_cols=46 Identities=35% Similarity=0.516 Sum_probs=42.3
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
.++.+|..+|.+++|.|+.+||+.++...|..+++++++++++.+|
T Consensus 87 ~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d 132 (181)
T d1hqva_ 87 DWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFD 132 (181)
T ss_dssp HHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHC
T ss_pred ccccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhC
Confidence 4567899999999999999999999999999999999999999886
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=96.50 E-value=0.0011 Score=53.16 Aligned_cols=49 Identities=18% Similarity=0.217 Sum_probs=42.2
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.....+..+|..+|.|++|.|+.+|+..+++.+|. +.+++..+|+.+|.
T Consensus 91 ~~~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~--~~~~~~~~f~~~D~ 139 (174)
T d2scpa_ 91 VVEGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGL--DKTMAPASFDAIDT 139 (174)
T ss_dssp HHHTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--CGGGHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHCCCccccCCHHHHHHHHHHHhh--hhHHHHHHHhhcCC
Confidence 34456788999999999999999999999998874 77889999999884
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=96.34 E-value=0.00053 Score=48.22 Aligned_cols=29 Identities=28% Similarity=0.535 Sum_probs=18.7
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
.+.+++..+|.|+||.|+++||...+..+
T Consensus 50 ~v~~i~~~~D~n~DG~IdF~EF~~l~~~l 78 (87)
T d1xk4a1 50 GADVWFKELDINTDGAVNFQEFLILVIKM 78 (87)
T ss_dssp CHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 45566666677777777777766666543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.28 E-value=0.0042 Score=54.89 Aligned_cols=145 Identities=17% Similarity=0.157 Sum_probs=73.8
Q ss_pred ccceeecce-----ecccCCeEEEEEEEcCCCceEEEEEecCCcCCChhhHHHHHHHHHHHHhccCC----CCccEEE--
Q 014704 66 RNTYIFGRE-----LGRGQFGVTYLVTHKDTKQQFACKSISSRKLINRDDVEDVRREVQIMHHLTGH----RNIVELK-- 134 (420)
Q Consensus 66 ~~~y~~~~~-----lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h----pniv~~~-- 134 (420)
-..|.+++. |..|---+.|++.... ..+++|++.... ..+.+..|++++..|..+ |..+...
T Consensus 12 l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g 84 (316)
T d2ppqa1 12 LTQYDVGSLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDG 84 (316)
T ss_dssp HTTBCCCCEEEEEEECC---EEEEEEEESS--CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTC
T ss_pred HHhCCCCCceEeecCCCCcccCeEEEEECC--CcEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCC
Confidence 345655443 4567678899987653 359999985421 124566677777777621 1111110
Q ss_pred -EEEEeCCeEEEEEecCCCCChH--------------HHHHhc-C--------CCCH------------------HHHHH
Q 014704 135 -GAYEDRHSVNLIMDLCAGGELF--------------DRIIAK-G--------HYSE------------------RAAAN 172 (420)
Q Consensus 135 -~~~~~~~~~~iv~e~~~g~~L~--------------~~l~~~-~--------~~~~------------------~~~~~ 172 (420)
.+..-......++.+..|.... ..+... . .... .....
T Consensus 85 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (316)
T d2ppqa1 85 ELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLRE 164 (316)
T ss_dssp CSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHH
T ss_pred CcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHH
Confidence 0122345566677776663321 001000 0 0000 11112
Q ss_pred HHHHHHHHHHHHH----HcCCeeccCCCCcEEEecCCCCCCeeEeecccccc
Q 014704 173 LCRQMVTVVHYCH----SMGVMHRDLKPENFLFSSSAEDSPLKATDFGLSVF 220 (420)
Q Consensus 173 i~~qi~~al~~lH----~~~ivH~Dlkp~Nill~~~~~~~~~kl~Dfg~~~~ 220 (420)
.+..+...+.-.+ ..|+||+|+.++||+++ ++...-++||+.+..
T Consensus 165 ~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 165 EIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred HHHHHHHhhhccCccccccccccCCcchhhhhcc---cccceeEeccccccc
Confidence 2222233333222 24799999999999995 344568999998753
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.27 E-value=0.0011 Score=52.75 Aligned_cols=35 Identities=34% Similarity=0.528 Sum_probs=24.3
Q ss_pred hhhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhh
Q 014704 366 NLSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLP 400 (420)
Q Consensus 366 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~ 400 (420)
.++++++..++++|..+|.|++|.|+.+||..++.
T Consensus 9 ~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~ 43 (165)
T d1auib_ 9 HFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPE 43 (165)
T ss_dssp SCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhh
Confidence 45666777777777777777777777777766554
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=96.15 E-value=0.00069 Score=49.06 Aligned_cols=52 Identities=15% Similarity=0.217 Sum_probs=41.5
Q ss_pred hHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCC-------CCCHHHHHHHHHhcCC
Q 014704 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGT-------RLSESEVRQLMEAVSL 420 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-------~~~~~e~~~~~~~~d~ 420 (420)
.+..+..+..+|..++ +++|.|+.+||+.+++..+. ..+++++++||+.+|.
T Consensus 5 ~E~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~ 63 (100)
T d1psra_ 5 AERSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDK 63 (100)
T ss_dssp HHHHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCT
T ss_pred HHHHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcC
Confidence 3456777888999997 78899999999999988653 2355678999999884
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.15 E-value=0.0024 Score=51.60 Aligned_cols=48 Identities=33% Similarity=0.444 Sum_probs=36.7
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh-----CCCCCHHHHHH----HHHhcC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL-----GTRLSESEVRQ----LMEAVS 419 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l-----g~~~~~~e~~~----~~~~~d 419 (420)
...++.+|+.+|.|++|+|+.+|+..++..+ +..++++++++ +++++|
T Consensus 94 ~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D 150 (180)
T d1xo5a_ 94 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESD 150 (180)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHC
T ss_pred HHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhC
Confidence 3467788999999999999999999999876 45566665544 666666
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=96.12 E-value=0.0024 Score=51.20 Aligned_cols=45 Identities=27% Similarity=0.397 Sum_probs=37.4
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEA 417 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~ 417 (420)
..++.+|+.+|.|++|.|+..|++.+|+..|..+++++++.+++.
T Consensus 77 ~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~~~~~~~~ 121 (173)
T d1alva_ 77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRR 121 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHH
T ss_pred hHHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHHHHHHHhhcc
Confidence 345678888999999999999999999999988888887776653
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=96.12 E-value=0.0052 Score=42.79 Aligned_cols=51 Identities=18% Similarity=0.282 Sum_probs=40.4
Q ss_pred HHHhhHHHHhhcc-CCCCCC-cccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 370 EEIMGLKEMFKSM-DTDNSG-TITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 370 ~~~~~l~~~F~~~-D~~~~G-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+..+|..+ +.++++ +|+.+||+.+++. ++...+.+.++++|+.+|.
T Consensus 5 ~ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~ 62 (87)
T d1e8aa_ 5 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDA 62 (87)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcC
Confidence 3456788899987 566554 6999999999987 3445678999999999984
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=96.11 E-value=0.0017 Score=52.86 Aligned_cols=44 Identities=20% Similarity=0.403 Sum_probs=37.6
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHH
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLME 416 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~ 416 (420)
..++.+|..+|+|++|+|+.+||+.+++.+|..++.+.++.++.
T Consensus 91 ~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~~~~~~ 134 (186)
T d1df0a1 91 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVA 134 (186)
T ss_dssp HHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHHHHHHH
T ss_pred HHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHHHHHHH
Confidence 45788999999999999999999999999999999776655443
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.86 E-value=0.0044 Score=49.86 Aligned_cols=50 Identities=18% Similarity=0.178 Sum_probs=41.0
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhhC------------CCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKLG------------TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg------------~~~~~~e~~~~~~~~d~ 420 (420)
....++.+|..+|.|++|.|+.+|+..++..+. ...+++.+++||+++|.
T Consensus 93 ~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~ 154 (181)
T d1bjfa_ 93 LEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDT 154 (181)
T ss_dssp HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCT
T ss_pred hHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCC
Confidence 344677899999999999999999999987642 24567789999999984
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.85 E-value=0.0044 Score=50.23 Aligned_cols=49 Identities=24% Similarity=0.238 Sum_probs=38.2
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhC------------CCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLG------------TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg------------~~~~~~e~~~~~~~~d~ 420 (420)
...++.+|+.+|.|++|.|+.+|+..++..+. ....++.++.+|+++|.
T Consensus 95 ~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~ 155 (187)
T d1g8ia_ 95 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDK 155 (187)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCS
T ss_pred hhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCC
Confidence 34578899999999999999999999886532 12335678889999884
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=95.75 E-value=0.002 Score=52.16 Aligned_cols=45 Identities=24% Similarity=0.521 Sum_probs=36.4
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
.+..+|..+|.+++|.|+.+||..++..+| +++++++.||+.+|.
T Consensus 83 ~l~~aF~~~D~d~~G~i~~~el~~~l~~~g--l~~~ev~~~f~~~D~ 127 (182)
T d1s6ia_ 83 NLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQ 127 (182)
T ss_dssp STHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCS
T ss_pred HHHHHHHHHhhcCCCccchhhhhhhhhhcC--ccHHHHHHHHHHhhc
Confidence 456778888888888888888888888876 578888888888874
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=95.75 E-value=0.0032 Score=51.03 Aligned_cols=51 Identities=24% Similarity=0.329 Sum_probs=40.6
Q ss_pred hHHHHhhHHHHhhccCCCCCCcccHHHHHhh-----hhhhCCCCCHHHHHHHHHhc
Q 014704 368 SEEEIMGLKEMFKSMDTDNSGTITFEELKAG-----LPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 368 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~-----l~~lg~~~~~~e~~~~~~~~ 418 (420)
.++.+..++.+|..+|.|++|.|+.+||... ++.+|...+..++.+++.++
T Consensus 9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 64 (189)
T d1qv0a_ 9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEA 64 (189)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHH
Confidence 3456678999999999999999999999764 45678877877777666544
|
| >d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=95.38 E-value=0.016 Score=36.46 Aligned_cols=52 Identities=21% Similarity=0.309 Sum_probs=46.8
Q ss_pred hhHHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhc
Q 014704 367 LSEEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAV 418 (420)
Q Consensus 367 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~ 418 (420)
+.+++.++..++|..||.|..+.....+-..+|.+||...+..|.+.+|+++
T Consensus 8 lgpeekdecmkifdifdrnaeniapvsdtmdmltklgqtytkreteaimkea 59 (86)
T d1j7qa_ 8 LGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEA 59 (86)
T ss_dssp CSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHH
T ss_pred cCchhHHHHHHHHHHHhccccccCCcchHHHHHHHhhhHHhHHHHHHHHHHh
Confidence 3456778888999999999999999999999999999999999999999875
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.35 E-value=0.0072 Score=48.95 Aligned_cols=48 Identities=23% Similarity=0.273 Sum_probs=40.0
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+..+|+.+|.|++|.|++.|+..++..+.....++.++.+++.+|.
T Consensus 58 ~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~~~~~F~~~D~ 105 (189)
T d1jbaa_ 58 QYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDK 105 (189)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCS
T ss_pred HHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHhhhcc
Confidence 346788999999999999999999999887777778888888888773
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=95.15 E-value=0.0095 Score=48.29 Aligned_cols=45 Identities=29% Similarity=0.405 Sum_probs=35.9
Q ss_pred HHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 376 KEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 376 ~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+|..+|.|++|.|+++|+..++..++....++.++.+|+.+|.
T Consensus 66 ~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~~e~~~~~F~~~D~ 110 (190)
T d1fpwa_ 66 NHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDL 110 (190)
T ss_dssp HHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCS
T ss_pred HHHHHHhCcCCCCcccHHHHHHHHHHHccCchHHHHHHHHHHhcc
Confidence 457888888888888888888888887777777888888887763
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=95.09 E-value=0.0068 Score=42.86 Aligned_cols=31 Identities=13% Similarity=0.339 Sum_probs=27.1
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
...+.++|..+|.|+||.|+++|+...+..+
T Consensus 51 ~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l 81 (93)
T d3c1va1 51 EAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI 81 (93)
T ss_dssp HHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Confidence 3557888999999999999999999988765
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=94.94 E-value=0.0092 Score=48.38 Aligned_cols=48 Identities=21% Similarity=0.305 Sum_probs=37.9
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCC------------CCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGT------------RLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~------------~~~~~e~~~~~~~~d~ 420 (420)
..++.+|+.+|.|++|.|+.+|+..++..++. ...++.++++|+++|.
T Consensus 99 e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~ 158 (190)
T d1fpwa_ 99 EKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDK 158 (190)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCC
Confidence 45678899999999999999999999876532 1125678889999884
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=94.79 E-value=0.01 Score=38.99 Aligned_cols=29 Identities=21% Similarity=0.508 Sum_probs=25.4
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPK 401 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~ 401 (420)
.++..+|..+|.|++|.|+++|+..++.+
T Consensus 37 ~~i~~~~~~~D~d~dg~I~~~EF~~~m~~ 65 (67)
T d1tiza_ 37 EDIVKFFEEIDVDGNGELNADEFTSCIEK 65 (67)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 34677899999999999999999998875
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=94.75 E-value=0.013 Score=44.00 Aligned_cols=43 Identities=33% Similarity=0.501 Sum_probs=34.1
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
..++.+|+.+|.|++|+|+.+|+..++..+|. +++.++|+++|
T Consensus 75 ~~~~~~F~~~D~~~~g~i~~~el~~~~~~~~~----~~~~~~~~~~D 117 (134)
T d1jfja_ 75 IGLKVLYKLMDVDGDGKLTKEEVTSFFKKHGI----EKVAEQVMKAD 117 (134)
T ss_dssp HHHHHHHHHHCCSSSSEEEHHHHHHHHTTTTC----HHHHHHHHHHH
T ss_pred ccccccccccccccCCcccHHHHHHHHHhcCc----HHHHHHHHHHC
Confidence 34567888899999999999999998887654 67777887776
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=94.71 E-value=0.0081 Score=52.85 Aligned_cols=48 Identities=19% Similarity=0.291 Sum_probs=42.7
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCC-CCCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGT-RLSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~ 420 (420)
..+..+|..+|.|++|+|+.+||+.++..+|. .++.+++..||..+|.
T Consensus 253 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~ 301 (321)
T d1ij5a_ 253 LVLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDV 301 (321)
T ss_dssp HHHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTT
T ss_pred hHHHHHHHHHhcCCCCCCcHHHHHHHHHHcCCCcCcHHHHHHHHHHhCC
Confidence 34567899999999999999999999999997 4888999999999884
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=94.63 E-value=0.0092 Score=42.05 Aligned_cols=30 Identities=17% Similarity=0.431 Sum_probs=26.2
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
..+.++|..+|.|+||.|+++|+...+..+
T Consensus 49 ~~v~~~~~~~D~n~DG~I~F~EF~~li~~l 78 (92)
T d1a4pa_ 49 LAVDKIMKDLDQCRDGKVGFQSFFSLIAGL 78 (92)
T ss_dssp THHHHHHHHHCTTSSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCcHHHHHHHHHHH
Confidence 457888999999999999999999888654
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=94.59 E-value=0.015 Score=46.99 Aligned_cols=99 Identities=20% Similarity=0.151 Sum_probs=51.2
Q ss_pred hHHHHHHHHhcccCcCCCCCHHHHhcCCcccccCCCCCCcccHHHHHHHHHHHhhh---hh-HHHHHHHHHhhhhHHHHh
Q 014704 298 SSAKDIVKKMLHADPKERLSAAEVLNHPWMRVDGDASDKPLDIAVLTRMKQFRAMN---KL-KKVALKVIAENLSEEEIM 373 (420)
Q Consensus 298 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~l~~i~~~~~~~~~~ 373 (420)
.+++.+-++-...+|.-+++..|.-+- +.... .......+..+-+.-..+ .+ ....+..+..........
T Consensus 21 ~ei~~~~~~F~~~~~~G~i~~~Ef~~~--l~~~~----~~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~ 94 (189)
T d1jbaa_ 21 AQLQEWYKKFLEECPSGTLFMHEFKRF--FKVPD----NEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEH 94 (189)
T ss_dssp HHHHHHHHHHHSSSTTCCEEHHHHHHH--HHCCS----SSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTH
T ss_pred HHHHHHHHHhcccCCCCeeeHHHHHHH--HHHcC----CCccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHH
Confidence 345666666666678888887775322 22111 111222233322211111 01 111222222222222234
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
.++.+|+.+|.|++|.|+.+|+..++..+
T Consensus 95 ~~~~~F~~~D~d~~g~i~~~E~~~~~~~~ 123 (189)
T d1jbaa_ 95 KLKWTFKIYDKDRNGCIDRQELLDIVESI 123 (189)
T ss_dssp HHHHHHHHHCSSCSSCBCHHHHHHHHHHH
T ss_pred HHHHHHhhhccCCCCcccHhHHHHHHHHH
Confidence 56778999999999999999998887653
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=94.49 E-value=0.0068 Score=49.03 Aligned_cols=47 Identities=15% Similarity=0.299 Sum_probs=39.7
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCC--------CCHHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTR--------LSESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~--------~~~~e~~~~~~~~d~ 420 (420)
+.++++|..+| |++|.|+.+||..+|..+|.. ++.+++..+|..+|.
T Consensus 18 ~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~ 72 (186)
T d1df0a1 18 DGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDE 72 (186)
T ss_dssp HHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcC
Confidence 45789999998 899999999999999887643 567889999998873
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=94.48 E-value=0.015 Score=39.81 Aligned_cols=39 Identities=23% Similarity=0.346 Sum_probs=30.0
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHH
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQL 414 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~ 414 (420)
++.++|..+|.|++|.|+++|+..++.... -..+++.++
T Consensus 42 ei~~~~~~~D~d~~G~I~~~EF~~~~~~~~--~~~~e~~~~ 80 (81)
T d2opoa1 42 EVRRMMAEIDTDGDGFISFDEFTDFARANR--GLVKDVSKI 80 (81)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHHHHHCT--TTHHHHHHH
T ss_pred HHHHHHHHhCCCCCCeEeHHHHHHHHHHCc--cchHHHHhh
Confidence 467889999999999999999999987642 234455443
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=94.23 E-value=0.0053 Score=49.82 Aligned_cols=53 Identities=26% Similarity=0.417 Sum_probs=31.0
Q ss_pred hhHHHH-hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCC--------CCHHHHHHHHHhcCC
Q 014704 367 LSEEEI-MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTR--------LSESEVRQLMEAVSL 420 (420)
Q Consensus 367 ~~~~~~-~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~--------~~~~e~~~~~~~~d~ 420 (420)
++++++ ..++++|..+| +.+|.|+..||..+|..+|.. ++.++++.||..+|.
T Consensus 13 ls~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~ 74 (188)
T d1qxpa2 13 LSEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDR 74 (188)
T ss_dssp --------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC
T ss_pred CCHHHHHHHHHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcC
Confidence 345554 35899999999 558999999999999876654 456889999998874
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=94.10 E-value=0.026 Score=45.20 Aligned_cols=47 Identities=19% Similarity=0.256 Sum_probs=36.5
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhh----hCCCCCHHHHHH----HHHhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPK----LGTRLSESEVRQ----LMEAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~----lg~~~~~~e~~~----~~~~~d 419 (420)
..++.+|+.+|.|++|.|+.+|+..++.. .|...++.++++ +|+++|
T Consensus 91 ~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D 145 (183)
T d2zfda1 91 DKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEAD 145 (183)
T ss_dssp HHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhC
Confidence 35777899999999999999999887754 467777776554 556666
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.06 E-value=0.016 Score=45.62 Aligned_cols=50 Identities=24% Similarity=0.301 Sum_probs=39.1
Q ss_pred HHHhhHHHHhhccCCCCCCcccHHHHHhhhhhh-CCCCC----HHHHHHHHHhcC
Q 014704 370 EEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL-GTRLS----ESEVRQLMEAVS 419 (420)
Q Consensus 370 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l-g~~~~----~~e~~~~~~~~d 419 (420)
.....+..+|..+|.|++|.|+.+|+...++.. |..++ +..++.+|+++|
T Consensus 82 ~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D 136 (165)
T d1auib_ 82 DKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINAD 136 (165)
T ss_dssp CHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHC
T ss_pred hhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcC
Confidence 345668899999999999999999999998763 55555 444666777766
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=94.05 E-value=0.028 Score=45.68 Aligned_cols=48 Identities=21% Similarity=0.212 Sum_probs=37.0
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCC--------------HHHHHHHHHhcCC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLS--------------ESEVRQLMEAVSL 420 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~--------------~~e~~~~~~~~d~ 420 (420)
..++.+|+.+|.|++|.|+.+|+...+..++.... ++.++.+|+.+|.
T Consensus 99 ~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~ 160 (201)
T d1omra_ 99 QKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGK 160 (201)
T ss_dssp GSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhCC
Confidence 45778899999999999999999998876543322 3346778888874
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=93.96 E-value=0.01 Score=41.88 Aligned_cols=31 Identities=19% Similarity=0.450 Sum_probs=26.9
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
...+.++|..+|.|++|.|+++|+..++..+
T Consensus 51 ~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l 81 (93)
T d1zfsa1 51 ADAVDKIMKELDENGDGEVDFQEFVVLVAAL 81 (93)
T ss_dssp HHHHHHHHHHHTTTCCSEECSHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 3457788999999999999999999988765
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=93.70 E-value=0.0096 Score=42.01 Aligned_cols=32 Identities=19% Similarity=0.293 Sum_probs=27.4
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
....+.+++..+|.|+||.|+++|+...+..+
T Consensus 50 ~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l 81 (93)
T d1ksoa_ 50 RECDYNKFMSVLDTNKDCEVDFVEYVRSLACL 81 (93)
T ss_dssp CHHHHHHHHHHHHHTTTCEECHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 34567888999999999999999999888765
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=93.70 E-value=0.02 Score=39.66 Aligned_cols=32 Identities=16% Similarity=0.380 Sum_probs=27.3
Q ss_pred HHhhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 371 EIMGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 371 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
....+.++++.+|.|+||.|+++|+...+..+
T Consensus 49 ~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l 80 (87)
T d1e8aa_ 49 DKAVIDEIFQGLDANQDEQVDFQEFISLVAIA 80 (87)
T ss_dssp SHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHH
Confidence 34567889999999999999999998887654
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.46 E-value=0.025 Score=40.28 Aligned_cols=29 Identities=24% Similarity=0.347 Sum_probs=25.6
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPK 401 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~ 401 (420)
..+..+|..+|.|+||.|+++|+..++++
T Consensus 68 ~~v~~~~~~~D~d~DG~Is~~EF~~~~~~ 96 (99)
T d1snla_ 68 RMREHVMKNVDTNQDRLVTLEEFLASTQR 96 (99)
T ss_dssp HHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred HHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence 45778999999999999999999998764
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=93.39 E-value=0.015 Score=38.34 Aligned_cols=29 Identities=28% Similarity=0.407 Sum_probs=25.0
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPK 401 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~ 401 (420)
.++..+|..+|.|++|.|+++|+..++++
T Consensus 39 ~e~~~~~~~~D~d~dG~i~~~EF~~~m~r 67 (68)
T d1c7va_ 39 AEVEEAMKEADEDGNGVIDIPEFMDLIKK 67 (68)
T ss_dssp HHHHHHHHHHCSSGGGSEEHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 45677889999999999999999998864
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=93.06 E-value=0.022 Score=38.29 Aligned_cols=29 Identities=31% Similarity=0.612 Sum_probs=25.9
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
++.++|..+|.|++|.|+++|+..++.++
T Consensus 46 ei~~~~~~~D~d~dG~I~f~EF~~~m~~~ 74 (76)
T d1qx2a_ 46 TLDEMIEEVDKNGDGEVSFEEFLVMMKKI 74 (76)
T ss_dssp SHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHHHhhcCCCCcCcHHHHHHHHHHH
Confidence 47788999999999999999999988764
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=93.02 E-value=0.022 Score=46.43 Aligned_cols=46 Identities=17% Similarity=0.352 Sum_probs=39.4
Q ss_pred HHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 375 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+|..+|.|++|.|++.|+..++..+.....++.++.+++.+|.
T Consensus 65 ~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~~~~~l~~~F~~~D~ 110 (201)
T d1omra_ 65 AQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDV 110 (201)
T ss_dssp HHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSCGGGSHHHHHHHHCT
T ss_pred HHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHHHHcc
Confidence 4578999999999999999999999887777777788888888773
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=92.73 E-value=0.036 Score=37.25 Aligned_cols=29 Identities=24% Similarity=0.320 Sum_probs=25.3
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
++..+|..+|.|++|.|+++|+..+|++.
T Consensus 46 e~~~~~~~~D~d~~G~I~~~EF~~~m~k~ 74 (77)
T d1oqpa_ 46 ELQEMIAEADRNDDNEIDEDEFIRIMKKT 74 (77)
T ss_dssp HHHHHHHHHCCSSSSEECHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHHHHHcc
Confidence 45678899999999999999999998763
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=92.68 E-value=0.055 Score=43.13 Aligned_cols=46 Identities=20% Similarity=0.387 Sum_probs=36.7
Q ss_pred HHHHhhccCCCCCCcccHHHHHhhhhhhCCCCC-HHHHHHHHHhcCC
Q 014704 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLS-ESEVRQLMEAVSL 420 (420)
Q Consensus 375 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~-~~e~~~~~~~~d~ 420 (420)
...+|..+|.|++|.|++.|+..++..+....+ ++.++.+++.+|.
T Consensus 56 ~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~ 102 (183)
T d2zfda1 56 ADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDL 102 (183)
T ss_dssp HHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhccccc
Confidence 467899999999999999999998877654434 5568888888873
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=92.66 E-value=0.067 Score=36.89 Aligned_cols=52 Identities=8% Similarity=0.109 Sum_probs=43.7
Q ss_pred HHHHhhHHHHhhcc-CCCCCCcc-cHHHHHhhhhh-hCCCCCHHHHHHHHHhcCC
Q 014704 369 EEEIMGLKEMFKSM-DTDNSGTI-TFEELKAGLPK-LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 369 ~~~~~~l~~~F~~~-D~~~~G~i-~~~el~~~l~~-lg~~~~~~e~~~~~~~~d~ 420 (420)
+..+..+..+|..+ |.|++|.+ +.+||+.++.. +|..++..++++||+++|.
T Consensus 6 E~ai~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~ 60 (87)
T d1xk4a1 6 EKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDI 60 (87)
T ss_dssp HHHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCC
Confidence 34567788999988 99999865 99999999975 7877888899999999984
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=92.57 E-value=0.029 Score=40.02 Aligned_cols=31 Identities=23% Similarity=0.363 Sum_probs=26.9
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLG 403 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg 403 (420)
..+.++|..+|.|+||.|+++|+..++..+.
T Consensus 52 ~~v~~~~~~~D~n~DG~I~F~EF~~li~~l~ 82 (100)
T d1psra_ 52 NYLADVFEKKDKNEDKKIDFSEFLSLLGDIA 82 (100)
T ss_dssp CGGGTHHHHHCTTCSSCBCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHH
Confidence 4578889999999999999999999887653
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.22 E-value=0.03 Score=44.31 Aligned_cols=47 Identities=17% Similarity=0.209 Sum_probs=27.3
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCC----------CCHHHHHHHHHhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTR----------LSESEVRQLMEAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~----------~~~~e~~~~~~~~d 419 (420)
.++..+|..+|.|++|.|+.+||...|...+.. ++.+.++++|+.++
T Consensus 78 ~ei~~~F~~~d~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~ 134 (170)
T d2zkmx1 78 PEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYE 134 (170)
T ss_dssp HHHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHC
T ss_pred HHHHHHHHHHcCCCCCcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHc
Confidence 346789999999999999999999999875543 46777888887754
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.85 E-value=0.045 Score=36.61 Aligned_cols=29 Identities=24% Similarity=0.547 Sum_probs=25.0
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
++..+|..+|.|++|.|+++||..+|+.+
T Consensus 46 e~~~~~~~~D~d~dg~I~~~EF~~~m~~~ 74 (75)
T d1jc2a_ 46 DIEDLMKDSDKNNDGRIDFDEFLKMMEGV 74 (75)
T ss_dssp HHHHHHHHHCSSSCSEECHHHHHHHHHTC
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHHHHHhC
Confidence 45677889999999999999999988653
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=91.82 E-value=0.025 Score=38.29 Aligned_cols=29 Identities=28% Similarity=0.690 Sum_probs=25.8
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
.+.+++..+|.|+||.|+++|+..++..+
T Consensus 48 ~v~~~~~~~D~d~dG~Idf~EF~~l~~~l 76 (78)
T d1cb1a_ 48 TLDDLFQELDKNGDGEVSFEEFQVLVKKI 76 (78)
T ss_dssp CSSHHHHHTCCCSSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence 46778999999999999999999988765
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=91.70 E-value=0.049 Score=39.44 Aligned_cols=28 Identities=25% Similarity=0.440 Sum_probs=24.0
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPK 401 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~ 401 (420)
++..+|..+|.|++|.|+++|+..++.+
T Consensus 81 ev~~~~~~~D~d~dG~I~~~EF~~~m~~ 108 (109)
T d1pvaa_ 81 ETKAFLKAADKDGDGKIGIDEFETLVHE 108 (109)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred HHHHHHHHHCCCCcCcEeHHHHHHHHHh
Confidence 3567788899999999999999998753
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=91.70 E-value=0.2 Score=34.52 Aligned_cols=50 Identities=18% Similarity=0.295 Sum_probs=38.3
Q ss_pred HHhhHHHHhhcc-CCCCC-CcccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSM-DTDNS-GTITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~-D~~~~-G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
.+..+..+|..+ ..+++ ++++.+||+..++. ++...+...++++|+.+|.
T Consensus 7 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~ 63 (90)
T d3cr5x1 7 AVVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDS 63 (90)
T ss_dssp HHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcC
Confidence 445677888876 45555 57999999999976 4445567889999999884
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=91.63 E-value=0.043 Score=37.34 Aligned_cols=28 Identities=25% Similarity=0.491 Sum_probs=24.6
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPK 401 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~ 401 (420)
++..+|..+|.|++|.|+++|+...++.
T Consensus 52 ev~~~~~~~D~d~dg~I~~~EF~~~m~~ 79 (81)
T d1fi5a_ 52 DIEELMKDGDKNNDGRIDYDEFLEFMKG 79 (81)
T ss_dssp HHHHHHHHHCSSSSSSEEHHHHHHHHSC
T ss_pred HHHHHHHHHCCCCCCcEeHHHHHHHHHh
Confidence 4667889999999999999999998864
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=91.59 E-value=0.043 Score=39.70 Aligned_cols=28 Identities=21% Similarity=0.362 Sum_probs=24.3
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLP 400 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~ 400 (420)
.++..+|..+|.|++|.|+++|+..+++
T Consensus 80 ~~~~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (108)
T d1rroa_ 80 SETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp HHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence 3467788999999999999999999875
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=91.50 E-value=0.15 Score=40.05 Aligned_cols=49 Identities=16% Similarity=0.173 Sum_probs=35.1
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhhC------------CCCCHHHHHHHHHhcCC
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKLG------------TRLSESEVRQLMEAVSL 420 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg------------~~~~~~e~~~~~~~~d~ 420 (420)
...++.+|+.+|.|++|.|+.+|+...+..+. ....+..++.+|+++|.
T Consensus 86 ~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~ 146 (178)
T d1s6ca_ 86 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDK 146 (178)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCT
T ss_pred HHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCC
Confidence 34567889999999999999999988765431 11224556788888874
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=91.43 E-value=0.069 Score=34.45 Aligned_cols=27 Identities=26% Similarity=0.522 Sum_probs=22.8
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGL 399 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l 399 (420)
.++..+|..+|.|++|.|+++|+..+|
T Consensus 39 ~e~~~l~~~~D~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 39 EEVDEMIREADIDGDGQVNYEEFVQMM 65 (65)
T ss_dssp HHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred HHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence 346777899999999999999998754
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=91.40 E-value=0.056 Score=39.00 Aligned_cols=28 Identities=25% Similarity=0.347 Sum_probs=24.5
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLP 400 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~ 400 (420)
.+++++|+.+|.|++|.|+++|+..+++
T Consensus 79 ~~~~~l~~~~D~d~dG~I~~~EF~~~m~ 106 (107)
T d2pvba_ 79 AETKAFLADGDKDGDGMIGVDEFAAMIK 106 (107)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 3567789999999999999999998876
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=91.24 E-value=0.054 Score=42.93 Aligned_cols=46 Identities=20% Similarity=0.375 Sum_probs=37.4
Q ss_pred HHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 375 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
...+|..+|.|++|.|+.+|+..++..+.....++.++.+++.+|.
T Consensus 53 ~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~~~~~~~~f~~~D~ 98 (178)
T d1s6ca_ 53 AHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDI 98 (178)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCT
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHHhccchHHHHHHHHHhhcc
Confidence 4568999999999999999999888766555667778888887763
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=91.19 E-value=0.084 Score=35.89 Aligned_cols=29 Identities=34% Similarity=0.593 Sum_probs=25.1
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPK 401 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~ 401 (420)
.++++++..+|.|++|.|+++||...+.+
T Consensus 52 ~el~~~i~~~D~d~~G~I~f~eFl~im~~ 80 (82)
T d1wrka1 52 EELQEMIDEVDEDGSGTVDFDEFLVMMVR 80 (82)
T ss_dssp HHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 45677899999999999999999988754
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=90.94 E-value=0.061 Score=38.91 Aligned_cols=28 Identities=21% Similarity=0.366 Sum_probs=24.4
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPK 401 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~ 401 (420)
++.++|..+|.|++|.|+++|+..++.+
T Consensus 81 e~~~~~~~~D~d~dG~I~~~EF~~~m~~ 108 (109)
T d5pala_ 81 ETKALLAAGDSDHDGKIGADEFAKMVAQ 108 (109)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCEeHHHHHHHHHh
Confidence 3677888999999999999999998864
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=90.73 E-value=0.068 Score=37.05 Aligned_cols=31 Identities=19% Similarity=0.386 Sum_probs=26.3
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
...+.++|+.+|.|+||.|+++|+...+..+
T Consensus 51 ~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~l 81 (90)
T d3cr5x1 51 QEVVDKVMETLDSDGDGECDFQEFMAFVAMI 81 (90)
T ss_dssp HHHHHHHHHHHCTTSSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 4457888999999999999999998877654
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=90.67 E-value=0.064 Score=37.97 Aligned_cols=30 Identities=27% Similarity=0.380 Sum_probs=26.2
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
..+.++|..+|.|+||.|+++||..++..+
T Consensus 54 ~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l 83 (98)
T d1yuta1 54 GSLDEKMKSLDVNQDSELKFNEYWRLIGEL 83 (98)
T ss_dssp SCHHHHHHHHCTTCCSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 357788999999999999999999888664
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=90.54 E-value=0.082 Score=41.87 Aligned_cols=45 Identities=20% Similarity=0.367 Sum_probs=33.3
Q ss_pred HHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 375 LKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 375 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
...+|..+|.+++|.|+++|+..++..+-....++.++.+++.+|
T Consensus 61 ~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~~~~~~~~f~~~D 105 (181)
T d1bjfa_ 61 AEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYD 105 (181)
T ss_dssp HHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHC
T ss_pred HHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhchHHHHHHHHHHhc
Confidence 456778888888888888888887776655555666777777776
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=90.23 E-value=0.084 Score=35.78 Aligned_cols=28 Identities=36% Similarity=0.591 Sum_probs=24.3
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPK 401 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~ 401 (420)
++.++|..+|.|++|.|+++||..++.+
T Consensus 51 e~~~~~~~~D~d~~g~I~~~eF~~~m~~ 78 (81)
T d1avsa_ 51 ELDAIIEEVDEDGSGTIDFEEFLVMMVR 78 (81)
T ss_dssp HHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 4577899999999999999999988753
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=90.23 E-value=0.076 Score=38.37 Aligned_cols=28 Identities=25% Similarity=0.376 Sum_probs=24.2
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPK 401 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~ 401 (420)
++..+|..+|.|++|.|+++|+..++.+
T Consensus 81 e~~~~~~~~D~d~dG~i~~~EF~~~m~~ 108 (109)
T d1rwya_ 81 ETKTLMAAGDKDGDGKIGVEEFSTLVAE 108 (109)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 3567889999999999999999998864
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=90.02 E-value=0.1 Score=36.49 Aligned_cols=34 Identities=12% Similarity=0.348 Sum_probs=26.3
Q ss_pred HHHHhhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 369 EEEIMGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 369 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
+.....+.++|+.+|.|+||.|+++|+...+..+
T Consensus 48 ~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~l 81 (94)
T d1j55a_ 48 GKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAI 81 (94)
T ss_dssp ----CHHHHHHHHHCSSSSSSEEHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 3345568889999999999999999998887654
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=89.75 E-value=0.087 Score=34.84 Aligned_cols=27 Identities=33% Similarity=0.616 Sum_probs=23.7
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLP 400 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~ 400 (420)
.+..+|..+|.|++|.|+++|+..++.
T Consensus 45 ~~~~~~~~~D~d~~g~I~f~eF~~~m~ 71 (73)
T d2pq3a1 45 ELQDMINEVDADGNGTIDFPEFLTMMA 71 (73)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 467788899999999999999998875
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.61 E-value=0.082 Score=42.19 Aligned_cols=45 Identities=20% Similarity=0.331 Sum_probs=37.5
Q ss_pred HHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcCC
Q 014704 376 KEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 376 ~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 420 (420)
..+|..+|.|++|.|+++|+..++..+-....++.++.+|+.+|.
T Consensus 63 ~~if~~~d~~~dg~I~~~EF~~~l~~~~~~~~~e~l~~~F~~~D~ 107 (187)
T d1g8ia_ 63 TFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDL 107 (187)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCT
T ss_pred HHHHHHhCcCCCCCCcHHHHHHHHHHhccCchhhhHHHHHHHHhc
Confidence 457999999999999999999998876555567778889988874
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=89.54 E-value=0.1 Score=34.81 Aligned_cols=29 Identities=21% Similarity=0.455 Sum_probs=24.9
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPK 401 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~ 401 (420)
.++..+|..+|.|++|.|+++|+..++.+
T Consensus 46 ~e~~~~~~~~D~~~~g~I~~~eF~~~m~~ 74 (77)
T d1f54a_ 46 AEVNDLMNEIDVDGNHQIEFSEFLALMSR 74 (77)
T ss_dssp HHHHHHHHTTCCSSCCEEEHHHHHHHHTT
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 34677899999999999999999988753
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.33 E-value=0.21 Score=38.97 Aligned_cols=41 Identities=20% Similarity=0.306 Sum_probs=30.4
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
+.++.++..+|.|++|.|+++|+..++..+ ++++++|+.+|
T Consensus 40 ~~~~~li~~~D~~~~G~i~~~EF~~l~~~~------~~~~~~F~~fD 80 (165)
T d1k94a_ 40 ETCRIMIAMLDRDHTGKMGFNAFKELWAAL------NAWKENFMTVD 80 (165)
T ss_dssp HHHHHHHHHHCTTCSSCBCHHHHHHHHHHH------HHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHhhcc------chhHHHHHHhC
Confidence 445677788899999999999998877543 45555555555
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=89.26 E-value=0.19 Score=34.04 Aligned_cols=30 Identities=17% Similarity=0.370 Sum_probs=25.4
Q ss_pred HhhHHHHhhccCCCCCCcccHHHHHhhhhh
Q 014704 372 IMGLKEMFKSMDTDNSGTITFEELKAGLPK 401 (420)
Q Consensus 372 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~ 401 (420)
...+.++|..+|.|+||.|+++|+...+..
T Consensus 53 ~~~vd~~m~~LD~n~Dg~vdF~EF~~li~~ 82 (83)
T d1xk4c1 53 EKVIEHIMEDLDTNADKQLSFEEFIMLMAR 82 (83)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHhh
Confidence 345788999999999999999999877643
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=89.24 E-value=0.066 Score=37.53 Aligned_cols=30 Identities=30% Similarity=0.452 Sum_probs=26.0
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
..+.++|+.+|.|+||.|+++|+...+..+
T Consensus 52 ~~vd~im~~LD~n~Dg~vdF~EF~~li~~l 81 (95)
T d1qlsa_ 52 GVLDRMMKKLDLDSDGQLDFQEFLNLIGGL 81 (95)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence 457888999999999999999998887654
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=89.03 E-value=0.22 Score=34.73 Aligned_cols=50 Identities=16% Similarity=0.208 Sum_probs=38.5
Q ss_pred HHhhHHHHhhcc-CCCCC-CcccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSM-DTDNS-GTITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~-D~~~~-G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
.+..+..+|..+ ..+++ ++++.+||+..+.+ ++..-+...++++|+.+|.
T Consensus 7 ai~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~ 63 (95)
T d1qlsa_ 7 CIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDL 63 (95)
T ss_dssp HHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcC
Confidence 355667788775 45555 67999999999976 5556678889999999884
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=88.87 E-value=0.1 Score=36.31 Aligned_cols=28 Identities=25% Similarity=0.508 Sum_probs=24.0
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLP 400 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~ 400 (420)
..+..+++.+|.|++|.|+++|+..++.
T Consensus 43 ~~l~~i~~~~D~d~dG~l~~~EF~~a~~ 70 (92)
T d1fi6a_ 43 LELSHIWELSDFDKDGALTLDEFCAAFH 70 (92)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeecHHHHHHHHH
Confidence 3577889999999999999999987664
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=88.86 E-value=0.16 Score=32.06 Aligned_cols=24 Identities=21% Similarity=0.577 Sum_probs=20.7
Q ss_pred hhHHHHhhccCCCCCCcccHHHHH
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELK 396 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~ 396 (420)
.++..+|+.+|.|++|.|+++|+.
T Consensus 37 ~ei~~l~~~~D~d~dg~I~~~eFl 60 (61)
T d2fcea1 37 AEVDELLKGVEVDSNGEIDYKKFI 60 (61)
T ss_dssp HHHHHHHTTCCCCTTSEECHHHHH
T ss_pred HHHHHHHHHcCCCCCCcEeHHHhc
Confidence 345678999999999999999985
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.63 E-value=0.068 Score=37.55 Aligned_cols=27 Identities=15% Similarity=0.331 Sum_probs=23.6
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLP 400 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~ 400 (420)
.+.++|+.+|.|++|+|+++|+..+|.
T Consensus 45 ~l~~i~~~~D~d~dG~l~~~EF~~am~ 71 (95)
T d1c07a_ 45 LLAHIWSLCDTKDCGKLSKDQFALAFH 71 (95)
T ss_dssp HHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 467889999999999999999987764
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=88.42 E-value=0.068 Score=37.02 Aligned_cols=30 Identities=17% Similarity=0.365 Sum_probs=26.0
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
..+.++++.+|.|+||.|+++|+...+..+
T Consensus 50 ~~~~~~~~~lD~d~Dg~IdF~EF~~l~~~l 79 (89)
T d1k8ua_ 50 AEIARLMEDLDRNKDQEVNFQEYVTFLGAL 79 (89)
T ss_dssp HHHHHHHHHHHHTTTCEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCcHHHHHHHHHHH
Confidence 457788999999999999999999888654
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=88.39 E-value=0.11 Score=36.64 Aligned_cols=27 Identities=26% Similarity=0.385 Sum_probs=24.4
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLP 400 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~ 400 (420)
.+.++++..|.|++|.|+++||..+|+
T Consensus 46 ~L~~i~~~~D~d~dG~L~~~EF~~am~ 72 (99)
T d1qjta_ 46 ILGKIWDLADTDGKGVLSKQEFFVALR 72 (99)
T ss_dssp HHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCccCHHHHHHHHH
Confidence 467889999999999999999998886
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=87.61 E-value=0.098 Score=36.00 Aligned_cols=26 Identities=35% Similarity=0.609 Sum_probs=22.7
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGL 399 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l 399 (420)
++.++|..+|.|++|.|+++||..++
T Consensus 60 e~~~l~~~~D~d~~g~I~~~EFl~am 85 (87)
T d1s6ja_ 60 EIKDLMDAADIDKSGTIDYGEFIAAT 85 (87)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHTTCC
T ss_pred HHHHHHHHcCCCCCCeEeHHHHHHHH
Confidence 46778999999999999999998764
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.70 E-value=0.28 Score=38.68 Aligned_cols=46 Identities=9% Similarity=0.211 Sum_probs=36.0
Q ss_pred HHHHhhccCCC-CCCcccHHHHHhhhhhhCCC-CCHHHHHHHHHhcCC
Q 014704 375 LKEMFKSMDTD-NSGTITFEELKAGLPKLGTR-LSESEVRQLMEAVSL 420 (420)
Q Consensus 375 l~~~F~~~D~~-~~G~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~ 420 (420)
...+|+.||.| ++|.|+++|+..++..+... ..++.++.+++.+|.
T Consensus 59 ~~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~ 106 (180)
T d1xo5a_ 59 KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDF 106 (180)
T ss_dssp HHHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCT
T ss_pred HHHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccC
Confidence 35678899987 68999999999999876533 446678888888773
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.18 E-value=0.26 Score=33.21 Aligned_cols=26 Identities=8% Similarity=0.431 Sum_probs=22.7
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGL 399 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l 399 (420)
++..+|..+|.|++|.|++.|+...+
T Consensus 57 e~~~l~~~~d~~~~g~I~y~eFl~~f 82 (83)
T d1wlza1 57 QFDRLWNEMPVNAKGRLKYPDFLSRF 82 (83)
T ss_dssp HHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred HHHHHhhccccCCCCcEeHHHHHHHh
Confidence 45777999999999999999998765
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=85.99 E-value=0.3 Score=38.15 Aligned_cols=37 Identities=16% Similarity=0.359 Sum_probs=26.8
Q ss_pred HHhhccCCCCCCcccHHHHHhhhhhhCCCCCHHHHHHHHHhcC
Q 014704 377 EMFKSMDTDNSGTITFEELKAGLPKLGTRLSESEVRQLMEAVS 419 (420)
Q Consensus 377 ~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 419 (420)
+.|..+|.|++|.|+++|+..++..+ +.+.++|+.+|
T Consensus 116 ~~~~~~d~d~~G~i~~~EF~~~~~~~------~~~~~~f~~~D 152 (173)
T d1alva_ 116 SMIIRRYSDEGGNMDFDNFISCLVRL------DAMFRAFKSLD 152 (173)
T ss_dssp HHHHHHHTCSSSCBCHHHHHHHHHHH------HHHHHHHHHHS
T ss_pred HHhhccccCCCCeEeHHHHHHHHHHH------HHHHHHHHHhC
Confidence 34556677888999999888887643 56677777766
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.80 E-value=0.2 Score=35.02 Aligned_cols=27 Identities=19% Similarity=0.314 Sum_probs=23.6
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLP 400 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~ 400 (420)
.+..++...|.|++|.|+++|+..++.
T Consensus 44 ~L~~Iw~~~D~~~dG~l~~~EF~~a~~ 70 (95)
T d2jxca1 44 ILGRVWELSDIDHDGMLDRDEFAVAMF 70 (95)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCeEcHHHHHHHHH
Confidence 577889999999999999999977664
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=85.55 E-value=0.41 Score=33.18 Aligned_cols=50 Identities=22% Similarity=0.307 Sum_probs=33.6
Q ss_pred HHhhHHHHhhcc-CCCCC-CcccHHHHHhhhhh-----hCCCCCHHHHHHHHHhcCC
Q 014704 371 EIMGLKEMFKSM-DTDNS-GTITFEELKAGLPK-----LGTRLSESEVRQLMEAVSL 420 (420)
Q Consensus 371 ~~~~l~~~F~~~-D~~~~-G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~ 420 (420)
.+..+..+|..+ ..+++ ++++.+||+..+.. ++...+.+.++++|+.+|.
T Consensus 7 ai~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~ 63 (94)
T d1j55a_ 7 AMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDA 63 (94)
T ss_dssp HHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcC
Confidence 345667788876 34444 58999999999976 3444456779999999884
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=85.04 E-value=0.19 Score=39.01 Aligned_cols=31 Identities=23% Similarity=0.476 Sum_probs=26.9
Q ss_pred hhHHHHhhccCCCCCCcccHHHHHhhhhhhC
Q 014704 373 MGLKEMFKSMDTDNSGTITFEELKAGLPKLG 403 (420)
Q Consensus 373 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg 403 (420)
.++..+|..+|.|++|.|+++|+..+++...
T Consensus 136 ~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~~~ 166 (176)
T d1nyaa_ 136 AEAAEAFNQVDTNGNGELSLDELLTAVRDFH 166 (176)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHSCCS
T ss_pred HHHHHHHHHHCCCCCCcEeHHHHHHHHHHHh
Confidence 3467789999999999999999999998754
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.15 E-value=0.23 Score=35.73 Aligned_cols=27 Identities=26% Similarity=0.417 Sum_probs=23.5
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLP 400 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~ 400 (420)
.+.+++...|.|++|+|+++||..+|.
T Consensus 57 ~L~~Iw~l~D~d~dG~l~~~EF~~am~ 83 (110)
T d1iq3a_ 57 ELSYIWELSDADCDGALTLPEFCAAFH 83 (110)
T ss_dssp CHHHHHHHHCSSSCSEEEHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCeECHHHHHHHHH
Confidence 467788899999999999999987774
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=82.79 E-value=0.31 Score=37.83 Aligned_cols=29 Identities=24% Similarity=0.408 Sum_probs=25.4
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
.+..+|..+|.|++|.|+.+|+..++...
T Consensus 129 ~~~~~f~~~D~d~dG~Is~~Ef~~~~~~f 157 (174)
T d2scpa_ 129 MAPASFDAIDTNNDGLLSLEEFVIAGSDF 157 (174)
T ss_dssp GHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCcEeHHHHHHHHHHH
Confidence 46678999999999999999999988654
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=82.62 E-value=0.23 Score=39.02 Aligned_cols=29 Identities=10% Similarity=0.195 Sum_probs=25.4
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
++..+|..+|.|++|.|+++|+..++..+
T Consensus 140 ~~~~~f~~~D~d~dG~i~~~EF~~~~~~f 168 (185)
T d2sasa_ 140 DVPAVYNVITDGGKVTFDLNRYKELYYRL 168 (185)
T ss_dssp SHHHHHHHHHTTTTSCCSHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCcHHHHHHHHHHH
Confidence 46778999999999999999999988654
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=82.15 E-value=0.34 Score=38.11 Aligned_cols=29 Identities=24% Similarity=0.418 Sum_probs=25.2
Q ss_pred hHHHHhhccCCCCCCcccHHHHHhhhhhh
Q 014704 374 GLKEMFKSMDTDNSGTITFEELKAGLPKL 402 (420)
Q Consensus 374 ~l~~~F~~~D~~~~G~i~~~el~~~l~~l 402 (420)
++..+|..+|.|++|.|+++|+.+++..+
T Consensus 142 ~~~~lf~~~D~d~dG~Is~~EF~~~~~~~ 170 (187)
T d1uhka1 142 DCEETFRVCDIDESGQLDVDEMTRQHLGF 170 (187)
T ss_dssp HHHHHHHHSCCCTTSCEEHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCEeHHHHHHHHHHh
Confidence 46778999999999999999998887654
|